{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/2f/nxrbr3pn1msgrl4ffyj33zd00000gn/T/ipykernel_1831/148481545.py:20: FutureWarning: You are using `torch.load` with `weights_only=False` (the current default value), which uses the default pickle module implicitly. It is possible to construct malicious pickle data which will execute arbitrary code during unpickling (See https://github.com/pytorch/pytorch/blob/main/SECURITY.md#untrusted-models for more details). In a future release, the default value for `weights_only` will be flipped to `True`. This limits the functions that could be executed during unpickling. Arbitrary objects will no longer be allowed to be loaded via this mode unless they are explicitly allowlisted by the user via `torch.serialization.add_safe_globals`. We recommend you start setting `weights_only=True` for any use case where you don't have full control of the loaded file. Please open an issue on GitHub for any issues related to this experimental feature.\n",
      "  checkpoint = torch.load(model_path)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_0_10000_20241225_062028\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_100000_110000_20241225_225116\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_10000_20000_20241225_062028\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_110000_120000_20241225_225127\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_120000_130000_20241226_020120\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_130000_140000_20241226_020134\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_140000_150000_20241226_051212\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_150000_160000_20241226_051223\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_160000_170000_20241226_082535\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_170000_180000_20241226_082558\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_180000_190000_20241226_113728\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_190000_200000_20241226_113741\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_200000_210000_20241225_064324\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_20000_30000_20241225_093441\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_210000_220000_20241225_064324\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_220000_230000_20241225_094650\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_230000_240000_20241225_094700\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_240000_250000_20241225_125056\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_250000_260000_20241225_125114\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_260000_270000_20241225_155547\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_270000_280000_20241225_155604\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_280000_290000_20241225_190119\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_290000_300000_20241225_190127\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_300000_310000_20241225_220551\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_30000_40000_20241225_093452\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_310000_320000_20241225_220601\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_320000_330000_20241226_010910\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_330000_340000_20241226_011037\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_340000_350000_20241226_041424\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_350000_360000_20241226_041550\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_360000_370000_20241226_071910\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_370000_380000_20241226_072111\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_380000_390000_20241226_102351\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_390000_400000_20241226_102603\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_40000_50000_20241225_124544\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_50000_60000_20241225_124613\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_60000_70000_20241225_155446\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_70000_80000_20241225_155500\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_80000_90000_20241225_193439\n",
      "Loaded phi from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_90000_100000_20241225_193459\n"
     ]
    }
   ],
   "source": [
    "import torch\n",
    "import numpy as np\n",
    "import os\n",
    "import glob\n",
    "\n",
    "# Base directory containing all output folders\n",
    "base_dir = '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/'\n",
    "\n",
    "# List all output directories\n",
    "output_dirs = sorted(glob.glob(os.path.join(base_dir, 'output_*')))\n",
    "\n",
    "# Initialize list to store all phis\n",
    "all_phis = []\n",
    "\n",
    "# Load phi from each model\n",
    "for dir_path in output_dirs:\n",
    "    model_path = os.path.join(dir_path, 'model.pt')\n",
    "    try:\n",
    "        # Load the saved model\n",
    "        checkpoint = torch.load(model_path)\n",
    "        \n",
    "        # Extract phi - might need to adjust based on how it's stored\n",
    "        if 'model_state_dict' in checkpoint:\n",
    "            # If phi is in state dict\n",
    "            phi = checkpoint['model_state_dict']['phi']\n",
    "        else:\n",
    "            # If phi is stored directly\n",
    "            phi = checkpoint['phi']\n",
    "            \n",
    "        # Convert to numpy if it's a tensor\n",
    "        if torch.is_tensor(phi):\n",
    "            phi = phi.detach().cpu().numpy()\n",
    "            \n",
    "        all_phis.append(phi)\n",
    "        print(f\"Loaded phi from {dir_path}\")\n",
    "        \n",
    "    except Exception as e:\n",
    "        print(f\"Error loading from {dir_path}: {e}\")\n",
    "\n",
    "# Convert list to numpy array\n",
    "all_phis = np.array(all_phis)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Starting processing...\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_0_10000_20241225_062028\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.250\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 0.750\n",
      "  To trajectory 13: 0.250\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.535\n",
      "  Time 31: 0.536\n",
      "  Time 32: 0.532\n",
      "  Time 33: 0.524\n",
      "  Time 34: 0.512\n",
      "  Time 35: 0.496\n",
      "  Time 36: 0.477\n",
      "  Time 37: 0.456\n",
      "  Time 38: 0.434\n",
      "  Time 39: 0.411\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.857\n",
      "  To trajectory 7: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.535\n",
      "  Time 31: 0.530\n",
      "  Time 32: 0.520\n",
      "  Time 33: 0.504\n",
      "  Time 34: 0.483\n",
      "  Time 35: 0.458\n",
      "  Time 36: 0.430\n",
      "  Time 37: 0.398\n",
      "  Time 38: 0.365\n",
      "  Time 39: 0.331\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.708\n",
      "  Time 31: 0.718\n",
      "  Time 32: 0.721\n",
      "  Time 33: 0.718\n",
      "  Time 34: 0.709\n",
      "  Time 35: 0.693\n",
      "  Time 36: 0.671\n",
      "  Time 37: 0.642\n",
      "  Time 38: 0.607\n",
      "  Time 39: 0.566\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 0.800\n",
      "  To trajectory 5: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.566\n",
      "  Time 31: 0.567\n",
      "  Time 32: 0.562\n",
      "  Time 33: 0.553\n",
      "  Time 34: 0.539\n",
      "  Time 35: 0.522\n",
      "  Time 36: 0.501\n",
      "  Time 37: 0.478\n",
      "  Time 38: 0.451\n",
      "  Time 39: 0.422\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.538\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 0.200\n",
      "  To trajectory 4: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.568\n",
      "  Time 31: 0.550\n",
      "  Time 32: 0.525\n",
      "  Time 33: 0.496\n",
      "  Time 34: 0.463\n",
      "  Time 35: 0.428\n",
      "  Time 36: 0.393\n",
      "  Time 37: 0.358\n",
      "  Time 38: 0.324\n",
      "  Time 39: 0.292\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 0.833\n",
      "  To trajectory 15: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.569\n",
      "  Time 31: 0.570\n",
      "  Time 32: 0.565\n",
      "  Time 33: 0.555\n",
      "  Time 34: 0.541\n",
      "  Time 35: 0.522\n",
      "  Time 36: 0.499\n",
      "  Time 37: 0.475\n",
      "  Time 38: 0.448\n",
      "  Time 39: 0.421\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 0.833\n",
      "  To trajectory 7: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.567\n",
      "  Time 31: 0.566\n",
      "  Time 32: 0.561\n",
      "  Time 33: 0.550\n",
      "  Time 34: 0.534\n",
      "  Time 35: 0.513\n",
      "  Time 36: 0.486\n",
      "  Time 37: 0.455\n",
      "  Time 38: 0.420\n",
      "  Time 39: 0.381\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.800\n",
      "  To trajectory 9: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.543\n",
      "  Time 31: 0.543\n",
      "  Time 32: 0.537\n",
      "  Time 33: 0.525\n",
      "  Time 34: 0.508\n",
      "  Time 35: 0.487\n",
      "  Time 36: 0.462\n",
      "  Time 37: 0.433\n",
      "  Time 38: 0.402\n",
      "  Time 39: 0.370\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.833\n",
      "  To trajectory 19: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.546\n",
      "  Time 31: 0.535\n",
      "  Time 32: 0.519\n",
      "  Time 33: 0.498\n",
      "  Time 34: 0.473\n",
      "  Time 35: 0.445\n",
      "  Time 36: 0.415\n",
      "  Time 37: 0.383\n",
      "  Time 38: 0.350\n",
      "  Time 39: 0.317\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.120\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.875\n",
      "  To trajectory 15: 0.125\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.567\n",
      "  Time 31: 0.565\n",
      "  Time 32: 0.559\n",
      "  Time 33: 0.548\n",
      "  Time 34: 0.533\n",
      "  Time 35: 0.514\n",
      "  Time 36: 0.491\n",
      "  Time 37: 0.465\n",
      "  Time 38: 0.437\n",
      "  Time 39: 0.408\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 10: 0.750\n",
      "  To trajectory 18: 0.250\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.530\n",
      "  Time 31: 0.527\n",
      "  Time 32: 0.517\n",
      "  Time 33: 0.502\n",
      "  Time 34: 0.483\n",
      "  Time 35: 0.461\n",
      "  Time 36: 0.436\n",
      "  Time 37: 0.409\n",
      "  Time 38: 0.383\n",
      "  Time 39: 0.356\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.200\n",
      "  To trajectory 11: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.579\n",
      "  Time 31: 0.576\n",
      "  Time 32: 0.567\n",
      "  Time 33: 0.552\n",
      "  Time 34: 0.533\n",
      "  Time 35: 0.508\n",
      "  Time 36: 0.479\n",
      "  Time 37: 0.446\n",
      "  Time 38: 0.409\n",
      "  Time 39: 0.371\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 4: 0.200\n",
      "  To trajectory 7: 0.200\n",
      "  To trajectory 12: 0.600\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.578\n",
      "  Time 31: 0.576\n",
      "  Time 32: 0.566\n",
      "  Time 33: 0.550\n",
      "  Time 34: 0.528\n",
      "  Time 35: 0.501\n",
      "  Time 36: 0.471\n",
      "  Time 37: 0.441\n",
      "  Time 38: 0.410\n",
      "  Time 39: 0.379\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.606\n",
      "  Time 31: 0.614\n",
      "  Time 32: 0.616\n",
      "  Time 33: 0.613\n",
      "  Time 34: 0.605\n",
      "  Time 35: 0.593\n",
      "  Time 36: 0.575\n",
      "  Time 37: 0.554\n",
      "  Time 38: 0.529\n",
      "  Time 39: 0.501\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.875\n",
      "  To trajectory 16: 0.125\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.565\n",
      "  Time 31: 0.561\n",
      "  Time 32: 0.553\n",
      "  Time 33: 0.541\n",
      "  Time 34: 0.525\n",
      "  Time 35: 0.505\n",
      "  Time 36: 0.482\n",
      "  Time 37: 0.456\n",
      "  Time 38: 0.429\n",
      "  Time 39: 0.400\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 15: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.625\n",
      "  Time 31: 0.624\n",
      "  Time 32: 0.618\n",
      "  Time 33: 0.608\n",
      "  Time 34: 0.594\n",
      "  Time 35: 0.576\n",
      "  Time 36: 0.555\n",
      "  Time 37: 0.530\n",
      "  Time 38: 0.503\n",
      "  Time 39: 0.474\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.250\n",
      "  To trajectory 16: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.538\n",
      "  Time 31: 0.540\n",
      "  Time 32: 0.537\n",
      "  Time 33: 0.529\n",
      "  Time 34: 0.518\n",
      "  Time 35: 0.502\n",
      "  Time 36: 0.483\n",
      "  Time 37: 0.462\n",
      "  Time 38: 0.438\n",
      "  Time 39: 0.413\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 17: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.577\n",
      "  Time 31: 0.568\n",
      "  Time 32: 0.554\n",
      "  Time 33: 0.537\n",
      "  Time 34: 0.518\n",
      "  Time 35: 0.495\n",
      "  Time 36: 0.470\n",
      "  Time 37: 0.443\n",
      "  Time 38: 0.414\n",
      "  Time 39: 0.384\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 18: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.558\n",
      "  Time 31: 0.560\n",
      "  Time 32: 0.556\n",
      "  Time 33: 0.546\n",
      "  Time 34: 0.530\n",
      "  Time 35: 0.509\n",
      "  Time 36: 0.485\n",
      "  Time 37: 0.456\n",
      "  Time 38: 0.426\n",
      "  Time 39: 0.393\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 19: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.562\n",
      "  Time 31: 0.563\n",
      "  Time 32: 0.559\n",
      "  Time 33: 0.548\n",
      "  Time 34: 0.531\n",
      "  Time 35: 0.509\n",
      "  Time 36: 0.483\n",
      "  Time 37: 0.453\n",
      "  Time 38: 0.420\n",
      "  Time 39: 0.386\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_100000_110000_20241225_225116\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/2f/nxrbr3pn1msgrl4ffyj33zd00000gn/T/ipykernel_6481/470383245.py:21: FutureWarning: You are using `torch.load` with `weights_only=False` (the current default value), which uses the default pickle module implicitly. It is possible to construct malicious pickle data which will execute arbitrary code during unpickling (See https://github.com/pytorch/pytorch/blob/main/SECURITY.md#untrusted-models for more details). In a future release, the default value for `weights_only` will be flipped to `True`. This limits the functions that could be executed during unpickling. Arbitrary objects will no longer be allowed to be loaded via this mode unless they are explicitly allowlisted by the user via `torch.serialization.add_safe_globals`. We recommend you start setting `weights_only=True` for any use case where you don't have full control of the loaded file. Please open an issue on GitHub for any issues related to this experimental feature.\n",
      "  checkpoint = torch.load(model_path)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 0.800\n",
      "  To trajectory 13: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.536\n",
      "  Time 31: 0.527\n",
      "  Time 32: 0.513\n",
      "  Time 33: 0.496\n",
      "  Time 34: 0.476\n",
      "  Time 35: 0.454\n",
      "  Time 36: 0.430\n",
      "  Time 37: 0.406\n",
      "  Time 38: 0.381\n",
      "  Time 39: 0.357\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.800\n",
      "  To trajectory 19: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.547\n",
      "  Time 31: 0.543\n",
      "  Time 32: 0.534\n",
      "  Time 33: 0.521\n",
      "  Time 34: 0.503\n",
      "  Time 35: 0.480\n",
      "  Time 36: 0.453\n",
      "  Time 37: 0.423\n",
      "  Time 38: 0.391\n",
      "  Time 39: 0.356\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.500\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.727\n",
      "  Time 31: 0.736\n",
      "  Time 32: 0.740\n",
      "  Time 33: 0.738\n",
      "  Time 34: 0.729\n",
      "  Time 35: 0.714\n",
      "  Time 36: 0.693\n",
      "  Time 37: 0.665\n",
      "  Time 38: 0.630\n",
      "  Time 39: 0.589\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.569\n",
      "  Time 31: 0.579\n",
      "  Time 32: 0.584\n",
      "  Time 33: 0.584\n",
      "  Time 34: 0.578\n",
      "  Time 35: 0.568\n",
      "  Time 36: 0.553\n",
      "  Time 37: 0.533\n",
      "  Time 38: 0.508\n",
      "  Time 39: 0.480\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.538\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 0.167\n",
      "  To trajectory 4: 0.833\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.565\n",
      "  Time 31: 0.553\n",
      "  Time 32: 0.535\n",
      "  Time 33: 0.512\n",
      "  Time 34: 0.486\n",
      "  Time 35: 0.457\n",
      "  Time 36: 0.426\n",
      "  Time 37: 0.395\n",
      "  Time 38: 0.364\n",
      "  Time 39: 0.333\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 0.750\n",
      "  To trajectory 16: 0.250\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.584\n",
      "  Time 31: 0.583\n",
      "  Time 32: 0.579\n",
      "  Time 33: 0.570\n",
      "  Time 34: 0.558\n",
      "  Time 35: 0.542\n",
      "  Time 36: 0.523\n",
      "  Time 37: 0.502\n",
      "  Time 38: 0.480\n",
      "  Time 39: 0.456\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.200\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 0.800\n",
      "  To trajectory 7: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.574\n",
      "  Time 31: 0.571\n",
      "  Time 32: 0.561\n",
      "  Time 33: 0.547\n",
      "  Time 34: 0.526\n",
      "  Time 35: 0.500\n",
      "  Time 36: 0.469\n",
      "  Time 37: 0.433\n",
      "  Time 38: 0.393\n",
      "  Time 39: 0.350\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.533\n",
      "  Time 31: 0.544\n",
      "  Time 32: 0.548\n",
      "  Time 33: 0.544\n",
      "  Time 34: 0.533\n",
      "  Time 35: 0.516\n",
      "  Time 36: 0.491\n",
      "  Time 37: 0.461\n",
      "  Time 38: 0.425\n",
      "  Time 39: 0.387\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.833\n",
      "  To trajectory 19: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.558\n",
      "  Time 31: 0.547\n",
      "  Time 32: 0.531\n",
      "  Time 33: 0.511\n",
      "  Time 34: 0.486\n",
      "  Time 35: 0.458\n",
      "  Time 36: 0.427\n",
      "  Time 37: 0.395\n",
      "  Time 38: 0.362\n",
      "  Time 39: 0.329\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.119\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.857\n",
      "  To trajectory 15: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.574\n",
      "  Time 31: 0.572\n",
      "  Time 32: 0.565\n",
      "  Time 33: 0.554\n",
      "  Time 34: 0.537\n",
      "  Time 35: 0.516\n",
      "  Time 36: 0.492\n",
      "  Time 37: 0.464\n",
      "  Time 38: 0.433\n",
      "  Time 39: 0.402\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 10: 0.750\n",
      "  To trajectory 18: 0.250\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.537\n",
      "  Time 31: 0.525\n",
      "  Time 32: 0.506\n",
      "  Time 33: 0.482\n",
      "  Time 34: 0.452\n",
      "  Time 35: 0.419\n",
      "  Time 36: 0.384\n",
      "  Time 37: 0.347\n",
      "  Time 38: 0.310\n",
      "  Time 39: 0.275\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.250\n",
      "  To trajectory 11: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.588\n",
      "  Time 31: 0.587\n",
      "  Time 32: 0.580\n",
      "  Time 33: 0.567\n",
      "  Time 34: 0.548\n",
      "  Time 35: 0.523\n",
      "  Time 36: 0.493\n",
      "  Time 37: 0.459\n",
      "  Time 38: 0.420\n",
      "  Time 39: 0.379\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.200\n",
      "  To trajectory 8: 0.200\n",
      "  To trajectory 12: 0.600\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.581\n",
      "  Time 31: 0.579\n",
      "  Time 32: 0.570\n",
      "  Time 33: 0.554\n",
      "  Time 34: 0.532\n",
      "  Time 35: 0.506\n",
      "  Time 36: 0.476\n",
      "  Time 37: 0.446\n",
      "  Time 38: 0.415\n",
      "  Time 39: 0.384\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.591\n",
      "  Time 31: 0.596\n",
      "  Time 32: 0.596\n",
      "  Time 33: 0.591\n",
      "  Time 34: 0.581\n",
      "  Time 35: 0.567\n",
      "  Time 36: 0.549\n",
      "  Time 37: 0.527\n",
      "  Time 38: 0.502\n",
      "  Time 39: 0.474\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.857\n",
      "  To trajectory 16: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.572\n",
      "  Time 31: 0.569\n",
      "  Time 32: 0.562\n",
      "  Time 33: 0.550\n",
      "  Time 34: 0.534\n",
      "  Time 35: 0.514\n",
      "  Time 36: 0.491\n",
      "  Time 37: 0.465\n",
      "  Time 38: 0.437\n",
      "  Time 39: 0.407\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 15: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.618\n",
      "  Time 31: 0.606\n",
      "  Time 32: 0.591\n",
      "  Time 33: 0.573\n",
      "  Time 34: 0.552\n",
      "  Time 35: 0.529\n",
      "  Time 36: 0.505\n",
      "  Time 37: 0.478\n",
      "  Time 38: 0.451\n",
      "  Time 39: 0.422\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.200\n",
      "  To trajectory 16: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.526\n",
      "  Time 31: 0.522\n",
      "  Time 32: 0.514\n",
      "  Time 33: 0.502\n",
      "  Time 34: 0.486\n",
      "  Time 35: 0.468\n",
      "  Time 36: 0.447\n",
      "  Time 37: 0.423\n",
      "  Time 38: 0.399\n",
      "  Time 39: 0.373\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 17: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.574\n",
      "  Time 31: 0.559\n",
      "  Time 32: 0.539\n",
      "  Time 33: 0.515\n",
      "  Time 34: 0.488\n",
      "  Time 35: 0.458\n",
      "  Time 36: 0.426\n",
      "  Time 37: 0.392\n",
      "  Time 38: 0.357\n",
      "  Time 39: 0.322\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 18: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.556\n",
      "  Time 31: 0.548\n",
      "  Time 32: 0.535\n",
      "  Time 33: 0.517\n",
      "  Time 34: 0.493\n",
      "  Time 35: 0.466\n",
      "  Time 36: 0.435\n",
      "  Time 37: 0.402\n",
      "  Time 38: 0.369\n",
      "  Time 39: 0.336\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 19: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.560\n",
      "  Time 31: 0.561\n",
      "  Time 32: 0.556\n",
      "  Time 33: 0.545\n",
      "  Time 34: 0.529\n",
      "  Time 35: 0.509\n",
      "  Time 36: 0.484\n",
      "  Time 37: 0.456\n",
      "  Time 38: 0.427\n",
      "  Time 39: 0.397\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_10000_20000_20241225_062028\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.557\n",
      "  Time 31: 0.565\n",
      "  Time 32: 0.570\n",
      "  Time 33: 0.570\n",
      "  Time 34: 0.566\n",
      "  Time 35: 0.558\n",
      "  Time 36: 0.547\n",
      "  Time 37: 0.531\n",
      "  Time 38: 0.513\n",
      "  Time 39: 0.491\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.800\n",
      "  To trajectory 19: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.555\n",
      "  Time 31: 0.550\n",
      "  Time 32: 0.539\n",
      "  Time 33: 0.524\n",
      "  Time 34: 0.503\n",
      "  Time 35: 0.478\n",
      "  Time 36: 0.449\n",
      "  Time 37: 0.417\n",
      "  Time 38: 0.382\n",
      "  Time 39: 0.346\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.708\n",
      "  Time 31: 0.717\n",
      "  Time 32: 0.720\n",
      "  Time 33: 0.717\n",
      "  Time 34: 0.708\n",
      "  Time 35: 0.692\n",
      "  Time 36: 0.670\n",
      "  Time 37: 0.641\n",
      "  Time 38: 0.605\n",
      "  Time 39: 0.564\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.597\n",
      "  Time 31: 0.609\n",
      "  Time 32: 0.616\n",
      "  Time 33: 0.618\n",
      "  Time 34: 0.616\n",
      "  Time 35: 0.609\n",
      "  Time 36: 0.597\n",
      "  Time 37: 0.581\n",
      "  Time 38: 0.559\n",
      "  Time 39: 0.533\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.538\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 0.167\n",
      "  To trajectory 4: 0.667\n",
      "  To trajectory 7: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.549\n",
      "  Time 31: 0.530\n",
      "  Time 32: 0.504\n",
      "  Time 33: 0.473\n",
      "  Time 34: 0.438\n",
      "  Time 35: 0.401\n",
      "  Time 36: 0.363\n",
      "  Time 37: 0.327\n",
      "  Time 38: 0.292\n",
      "  Time 39: 0.260\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.143\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 0.857\n",
      "  To trajectory 17: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.558\n",
      "  Time 31: 0.551\n",
      "  Time 32: 0.541\n",
      "  Time 33: 0.528\n",
      "  Time 34: 0.512\n",
      "  Time 35: 0.493\n",
      "  Time 36: 0.473\n",
      "  Time 37: 0.451\n",
      "  Time 38: 0.429\n",
      "  Time 39: 0.407\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 0.833\n",
      "  To trajectory 7: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.554\n",
      "  Time 31: 0.552\n",
      "  Time 32: 0.545\n",
      "  Time 33: 0.533\n",
      "  Time 34: 0.515\n",
      "  Time 35: 0.492\n",
      "  Time 36: 0.464\n",
      "  Time 37: 0.431\n",
      "  Time 38: 0.395\n",
      "  Time 39: 0.356\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.547\n",
      "  Time 31: 0.549\n",
      "  Time 32: 0.544\n",
      "  Time 33: 0.534\n",
      "  Time 34: 0.517\n",
      "  Time 35: 0.495\n",
      "  Time 36: 0.469\n",
      "  Time 37: 0.440\n",
      "  Time 38: 0.408\n",
      "  Time 39: 0.374\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.667\n",
      "  To trajectory 16: 0.167\n",
      "  To trajectory 19: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.540\n",
      "  Time 31: 0.526\n",
      "  Time 32: 0.508\n",
      "  Time 33: 0.485\n",
      "  Time 34: 0.460\n",
      "  Time 35: 0.431\n",
      "  Time 36: 0.401\n",
      "  Time 37: 0.370\n",
      "  Time 38: 0.339\n",
      "  Time 39: 0.308\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.119\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.143\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.857\n",
      "  To trajectory 15: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.578\n",
      "  Time 31: 0.570\n",
      "  Time 32: 0.557\n",
      "  Time 33: 0.540\n",
      "  Time 34: 0.518\n",
      "  Time 35: 0.492\n",
      "  Time 36: 0.463\n",
      "  Time 37: 0.431\n",
      "  Time 38: 0.398\n",
      "  Time 39: 0.364\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 10: 0.800\n",
      "  To trajectory 18: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.542\n",
      "  Time 31: 0.526\n",
      "  Time 32: 0.505\n",
      "  Time 33: 0.478\n",
      "  Time 34: 0.448\n",
      "  Time 35: 0.415\n",
      "  Time 36: 0.381\n",
      "  Time 37: 0.345\n",
      "  Time 38: 0.310\n",
      "  Time 39: 0.277\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.250\n",
      "  To trajectory 11: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.592\n",
      "  Time 31: 0.590\n",
      "  Time 32: 0.583\n",
      "  Time 33: 0.570\n",
      "  Time 34: 0.551\n",
      "  Time 35: 0.527\n",
      "  Time 36: 0.497\n",
      "  Time 37: 0.463\n",
      "  Time 38: 0.426\n",
      "  Time 39: 0.385\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.200\n",
      "  To trajectory 8: 0.200\n",
      "  To trajectory 12: 0.600\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.577\n",
      "  Time 31: 0.575\n",
      "  Time 32: 0.566\n",
      "  Time 33: 0.550\n",
      "  Time 34: 0.528\n",
      "  Time 35: 0.501\n",
      "  Time 36: 0.472\n",
      "  Time 37: 0.442\n",
      "  Time 38: 0.411\n",
      "  Time 39: 0.380\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.597\n",
      "  Time 31: 0.605\n",
      "  Time 32: 0.608\n",
      "  Time 33: 0.607\n",
      "  Time 34: 0.600\n",
      "  Time 35: 0.588\n",
      "  Time 36: 0.572\n",
      "  Time 37: 0.551\n",
      "  Time 38: 0.525\n",
      "  Time 39: 0.496\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.875\n",
      "  To trajectory 16: 0.125\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.570\n",
      "  Time 31: 0.566\n",
      "  Time 32: 0.558\n",
      "  Time 33: 0.546\n",
      "  Time 34: 0.529\n",
      "  Time 35: 0.508\n",
      "  Time 36: 0.484\n",
      "  Time 37: 0.458\n",
      "  Time 38: 0.430\n",
      "  Time 39: 0.400\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 15: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.558\n",
      "  Time 31: 0.558\n",
      "  Time 32: 0.553\n",
      "  Time 33: 0.543\n",
      "  Time 34: 0.530\n",
      "  Time 35: 0.512\n",
      "  Time 36: 0.491\n",
      "  Time 37: 0.467\n",
      "  Time 38: 0.439\n",
      "  Time 39: 0.410\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.167\n",
      "  To trajectory 16: 0.833\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.532\n",
      "  Time 31: 0.543\n",
      "  Time 32: 0.549\n",
      "  Time 33: 0.549\n",
      "  Time 34: 0.544\n",
      "  Time 35: 0.534\n",
      "  Time 36: 0.520\n",
      "  Time 37: 0.503\n",
      "  Time 38: 0.483\n",
      "  Time 39: 0.460\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.333\n",
      "  To trajectory 17: 0.667\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.577\n",
      "  Time 31: 0.556\n",
      "  Time 32: 0.531\n",
      "  Time 33: 0.502\n",
      "  Time 34: 0.469\n",
      "  Time 35: 0.434\n",
      "  Time 36: 0.398\n",
      "  Time 37: 0.360\n",
      "  Time 38: 0.323\n",
      "  Time 39: 0.286\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 18: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.568\n",
      "  Time 31: 0.561\n",
      "  Time 32: 0.548\n",
      "  Time 33: 0.531\n",
      "  Time 34: 0.508\n",
      "  Time 35: 0.482\n",
      "  Time 36: 0.453\n",
      "  Time 37: 0.422\n",
      "  Time 38: 0.391\n",
      "  Time 39: 0.360\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 19: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.556\n",
      "  Time 31: 0.557\n",
      "  Time 32: 0.552\n",
      "  Time 33: 0.542\n",
      "  Time 34: 0.526\n",
      "  Time 35: 0.505\n",
      "  Time 36: 0.481\n",
      "  Time 37: 0.453\n",
      "  Time 38: 0.424\n",
      "  Time 39: 0.394\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_110000_120000_20241225_225127\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.535\n",
      "  Time 31: 0.533\n",
      "  Time 32: 0.526\n",
      "  Time 33: 0.515\n",
      "  Time 34: 0.500\n",
      "  Time 35: 0.480\n",
      "  Time 36: 0.458\n",
      "  Time 37: 0.433\n",
      "  Time 38: 0.407\n",
      "  Time 39: 0.380\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.547\n",
      "  Time 31: 0.543\n",
      "  Time 32: 0.535\n",
      "  Time 33: 0.522\n",
      "  Time 34: 0.505\n",
      "  Time 35: 0.483\n",
      "  Time 36: 0.457\n",
      "  Time 37: 0.428\n",
      "  Time 38: 0.396\n",
      "  Time 39: 0.362\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.715\n",
      "  Time 31: 0.724\n",
      "  Time 32: 0.727\n",
      "  Time 33: 0.723\n",
      "  Time 34: 0.714\n",
      "  Time 35: 0.699\n",
      "  Time 36: 0.678\n",
      "  Time 37: 0.650\n",
      "  Time 38: 0.616\n",
      "  Time 39: 0.577\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.557\n",
      "  Time 31: 0.563\n",
      "  Time 32: 0.565\n",
      "  Time 33: 0.563\n",
      "  Time 34: 0.556\n",
      "  Time 35: 0.545\n",
      "  Time 36: 0.531\n",
      "  Time 37: 0.512\n",
      "  Time 38: 0.489\n",
      "  Time 39: 0.462\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.538\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 0.167\n",
      "  To trajectory 4: 0.833\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.557\n",
      "  Time 31: 0.545\n",
      "  Time 32: 0.527\n",
      "  Time 33: 0.505\n",
      "  Time 34: 0.479\n",
      "  Time 35: 0.451\n",
      "  Time 36: 0.421\n",
      "  Time 37: 0.391\n",
      "  Time 38: 0.360\n",
      "  Time 39: 0.329\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 9\n",
      "CAD risk: 0.111\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.532\n",
      "  Time 31: 0.525\n",
      "  Time 32: 0.515\n",
      "  Time 33: 0.501\n",
      "  Time 34: 0.484\n",
      "  Time 35: 0.464\n",
      "  Time 36: 0.441\n",
      "  Time 37: 0.416\n",
      "  Time 38: 0.390\n",
      "  Time 39: 0.364\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.577\n",
      "  Time 31: 0.574\n",
      "  Time 32: 0.565\n",
      "  Time 33: 0.551\n",
      "  Time 34: 0.530\n",
      "  Time 35: 0.505\n",
      "  Time 36: 0.474\n",
      "  Time 37: 0.439\n",
      "  Time 38: 0.399\n",
      "  Time 39: 0.357\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 0.500\n",
      "  To trajectory 7: 0.500\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.527\n",
      "  Time 31: 0.524\n",
      "  Time 32: 0.514\n",
      "  Time 33: 0.498\n",
      "  Time 34: 0.475\n",
      "  Time 35: 0.447\n",
      "  Time 36: 0.415\n",
      "  Time 37: 0.380\n",
      "  Time 38: 0.343\n",
      "  Time 39: 0.306\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.667\n",
      "  To trajectory 16: 0.167\n",
      "  To trajectory 19: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.546\n",
      "  Time 31: 0.535\n",
      "  Time 32: 0.519\n",
      "  Time 33: 0.498\n",
      "  Time 34: 0.473\n",
      "  Time 35: 0.445\n",
      "  Time 36: 0.414\n",
      "  Time 37: 0.381\n",
      "  Time 38: 0.348\n",
      "  Time 39: 0.315\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.119\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.800\n",
      "  To trajectory 15: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.607\n",
      "  Time 31: 0.599\n",
      "  Time 32: 0.586\n",
      "  Time 33: 0.568\n",
      "  Time 34: 0.546\n",
      "  Time 35: 0.519\n",
      "  Time 36: 0.488\n",
      "  Time 37: 0.455\n",
      "  Time 38: 0.420\n",
      "  Time 39: 0.384\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 10: 0.800\n",
      "  To trajectory 18: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.535\n",
      "  Time 31: 0.520\n",
      "  Time 32: 0.500\n",
      "  Time 33: 0.476\n",
      "  Time 34: 0.449\n",
      "  Time 35: 0.420\n",
      "  Time 36: 0.390\n",
      "  Time 37: 0.360\n",
      "  Time 38: 0.331\n",
      "  Time 39: 0.303\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.250\n",
      "  To trajectory 11: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.593\n",
      "  Time 31: 0.591\n",
      "  Time 32: 0.584\n",
      "  Time 33: 0.570\n",
      "  Time 34: 0.551\n",
      "  Time 35: 0.526\n",
      "  Time 36: 0.496\n",
      "  Time 37: 0.462\n",
      "  Time 38: 0.423\n",
      "  Time 39: 0.382\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.200\n",
      "  To trajectory 8: 0.200\n",
      "  To trajectory 12: 0.600\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.569\n",
      "  Time 31: 0.567\n",
      "  Time 32: 0.558\n",
      "  Time 33: 0.542\n",
      "  Time 34: 0.520\n",
      "  Time 35: 0.493\n",
      "  Time 36: 0.463\n",
      "  Time 37: 0.433\n",
      "  Time 38: 0.402\n",
      "  Time 39: 0.371\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.564\n",
      "  Time 31: 0.570\n",
      "  Time 32: 0.572\n",
      "  Time 33: 0.569\n",
      "  Time 34: 0.561\n",
      "  Time 35: 0.550\n",
      "  Time 36: 0.533\n",
      "  Time 37: 0.513\n",
      "  Time 38: 0.489\n",
      "  Time 39: 0.461\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.143\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.857\n",
      "  To trajectory 16: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.571\n",
      "  Time 31: 0.568\n",
      "  Time 32: 0.560\n",
      "  Time 33: 0.548\n",
      "  Time 34: 0.531\n",
      "  Time 35: 0.511\n",
      "  Time 36: 0.488\n",
      "  Time 37: 0.463\n",
      "  Time 38: 0.436\n",
      "  Time 39: 0.409\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 15: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.592\n",
      "  Time 31: 0.587\n",
      "  Time 32: 0.576\n",
      "  Time 33: 0.560\n",
      "  Time 34: 0.540\n",
      "  Time 35: 0.515\n",
      "  Time 36: 0.487\n",
      "  Time 37: 0.456\n",
      "  Time 38: 0.422\n",
      "  Time 39: 0.386\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.250\n",
      "  To trajectory 16: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.538\n",
      "  Time 31: 0.540\n",
      "  Time 32: 0.538\n",
      "  Time 33: 0.530\n",
      "  Time 34: 0.518\n",
      "  Time 35: 0.502\n",
      "  Time 36: 0.483\n",
      "  Time 37: 0.461\n",
      "  Time 38: 0.438\n",
      "  Time 39: 0.412\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 17: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.599\n",
      "  Time 31: 0.584\n",
      "  Time 32: 0.565\n",
      "  Time 33: 0.541\n",
      "  Time 34: 0.514\n",
      "  Time 35: 0.484\n",
      "  Time 36: 0.452\n",
      "  Time 37: 0.417\n",
      "  Time 38: 0.382\n",
      "  Time 39: 0.346\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 18: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.577\n",
      "  Time 31: 0.571\n",
      "  Time 32: 0.560\n",
      "  Time 33: 0.544\n",
      "  Time 34: 0.524\n",
      "  Time 35: 0.499\n",
      "  Time 36: 0.471\n",
      "  Time 37: 0.441\n",
      "  Time 38: 0.410\n",
      "  Time 39: 0.378\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 19: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.555\n",
      "  Time 31: 0.554\n",
      "  Time 32: 0.547\n",
      "  Time 33: 0.534\n",
      "  Time 34: 0.515\n",
      "  Time 35: 0.491\n",
      "  Time 36: 0.464\n",
      "  Time 37: 0.433\n",
      "  Time 38: 0.401\n",
      "  Time 39: 0.368\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_120000_130000_20241226_020120\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 0.800\n",
      "  To trajectory 13: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.548\n",
      "  Time 31: 0.546\n",
      "  Time 32: 0.540\n",
      "  Time 33: 0.529\n",
      "  Time 34: 0.514\n",
      "  Time 35: 0.495\n",
      "  Time 36: 0.472\n",
      "  Time 37: 0.446\n",
      "  Time 38: 0.418\n",
      "  Time 39: 0.388\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.537\n",
      "  Time 31: 0.534\n",
      "  Time 32: 0.525\n",
      "  Time 33: 0.512\n",
      "  Time 34: 0.494\n",
      "  Time 35: 0.472\n",
      "  Time 36: 0.446\n",
      "  Time 37: 0.417\n",
      "  Time 38: 0.385\n",
      "  Time 39: 0.352\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.708\n",
      "  Time 31: 0.717\n",
      "  Time 32: 0.720\n",
      "  Time 33: 0.717\n",
      "  Time 34: 0.708\n",
      "  Time 35: 0.692\n",
      "  Time 36: 0.671\n",
      "  Time 37: 0.642\n",
      "  Time 38: 0.608\n",
      "  Time 39: 0.567\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 0.167\n",
      "  To trajectory 3: 0.833\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.569\n",
      "  Time 31: 0.568\n",
      "  Time 32: 0.562\n",
      "  Time 33: 0.552\n",
      "  Time 34: 0.539\n",
      "  Time 35: 0.522\n",
      "  Time 36: 0.502\n",
      "  Time 37: 0.480\n",
      "  Time 38: 0.454\n",
      "  Time 39: 0.426\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.538\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 4: 0.833\n",
      "  To trajectory 7: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.544\n",
      "  Time 31: 0.537\n",
      "  Time 32: 0.525\n",
      "  Time 33: 0.507\n",
      "  Time 34: 0.485\n",
      "  Time 35: 0.458\n",
      "  Time 36: 0.429\n",
      "  Time 37: 0.398\n",
      "  Time 38: 0.366\n",
      "  Time 39: 0.333\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 10\n",
      "CAD risk: 0.200\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 0.900\n",
      "  To trajectory 16: 0.100\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.581\n",
      "  Time 31: 0.584\n",
      "  Time 32: 0.583\n",
      "  Time 33: 0.577\n",
      "  Time 34: 0.568\n",
      "  Time 35: 0.555\n",
      "  Time 36: 0.540\n",
      "  Time 37: 0.522\n",
      "  Time 38: 0.502\n",
      "  Time 39: 0.481\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 0.800\n",
      "  To trajectory 7: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.572\n",
      "  Time 31: 0.569\n",
      "  Time 32: 0.560\n",
      "  Time 33: 0.546\n",
      "  Time 34: 0.526\n",
      "  Time 35: 0.501\n",
      "  Time 36: 0.470\n",
      "  Time 37: 0.434\n",
      "  Time 38: 0.394\n",
      "  Time 39: 0.352\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.552\n",
      "  Time 31: 0.551\n",
      "  Time 32: 0.543\n",
      "  Time 33: 0.529\n",
      "  Time 34: 0.508\n",
      "  Time 35: 0.482\n",
      "  Time 36: 0.452\n",
      "  Time 37: 0.418\n",
      "  Time 38: 0.382\n",
      "  Time 39: 0.345\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.550\n",
      "  Time 31: 0.543\n",
      "  Time 32: 0.531\n",
      "  Time 33: 0.515\n",
      "  Time 34: 0.494\n",
      "  Time 35: 0.470\n",
      "  Time 36: 0.442\n",
      "  Time 37: 0.412\n",
      "  Time 38: 0.380\n",
      "  Time 39: 0.348\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.120\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.833\n",
      "  To trajectory 15: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.581\n",
      "  Time 31: 0.573\n",
      "  Time 32: 0.559\n",
      "  Time 33: 0.541\n",
      "  Time 34: 0.519\n",
      "  Time 35: 0.492\n",
      "  Time 36: 0.463\n",
      "  Time 37: 0.430\n",
      "  Time 38: 0.397\n",
      "  Time 39: 0.362\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 10: 0.667\n",
      "  To trajectory 18: 0.333\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.532\n",
      "  Time 31: 0.507\n",
      "  Time 32: 0.477\n",
      "  Time 33: 0.444\n",
      "  Time 34: 0.410\n",
      "  Time 35: 0.377\n",
      "  Time 36: 0.344\n",
      "  Time 37: 0.314\n",
      "  Time 38: 0.287\n",
      "  Time 39: 0.262\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.333\n",
      "  To trajectory 11: 0.667\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.617\n",
      "  Time 31: 0.622\n",
      "  Time 32: 0.620\n",
      "  Time 33: 0.611\n",
      "  Time 34: 0.594\n",
      "  Time 35: 0.569\n",
      "  Time 36: 0.538\n",
      "  Time 37: 0.499\n",
      "  Time 38: 0.456\n",
      "  Time 39: 0.409\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 4: 0.250\n",
      "  To trajectory 7: 0.250\n",
      "  To trajectory 12: 0.500\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.614\n",
      "  Time 31: 0.613\n",
      "  Time 32: 0.603\n",
      "  Time 33: 0.585\n",
      "  Time 34: 0.560\n",
      "  Time 35: 0.530\n",
      "  Time 36: 0.496\n",
      "  Time 37: 0.461\n",
      "  Time 38: 0.427\n",
      "  Time 39: 0.393\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.586\n",
      "  Time 31: 0.594\n",
      "  Time 32: 0.596\n",
      "  Time 33: 0.595\n",
      "  Time 34: 0.588\n",
      "  Time 35: 0.577\n",
      "  Time 36: 0.562\n",
      "  Time 37: 0.541\n",
      "  Time 38: 0.516\n",
      "  Time 39: 0.488\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.167\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.833\n",
      "  To trajectory 16: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.585\n",
      "  Time 31: 0.577\n",
      "  Time 32: 0.566\n",
      "  Time 33: 0.550\n",
      "  Time 34: 0.530\n",
      "  Time 35: 0.506\n",
      "  Time 36: 0.480\n",
      "  Time 37: 0.453\n",
      "  Time 38: 0.425\n",
      "  Time 39: 0.396\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 15: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.575\n",
      "  Time 31: 0.569\n",
      "  Time 32: 0.558\n",
      "  Time 33: 0.543\n",
      "  Time 34: 0.523\n",
      "  Time 35: 0.500\n",
      "  Time 36: 0.473\n",
      "  Time 37: 0.443\n",
      "  Time 38: 0.411\n",
      "  Time 39: 0.377\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.167\n",
      "  To trajectory 16: 0.833\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.526\n",
      "  Time 31: 0.537\n",
      "  Time 32: 0.542\n",
      "  Time 33: 0.543\n",
      "  Time 34: 0.537\n",
      "  Time 35: 0.528\n",
      "  Time 36: 0.514\n",
      "  Time 37: 0.497\n",
      "  Time 38: 0.476\n",
      "  Time 39: 0.454\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.250\n",
      "  To trajectory 17: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.583\n",
      "  Time 31: 0.573\n",
      "  Time 32: 0.559\n",
      "  Time 33: 0.542\n",
      "  Time 34: 0.522\n",
      "  Time 35: 0.499\n",
      "  Time 36: 0.473\n",
      "  Time 37: 0.446\n",
      "  Time 38: 0.416\n",
      "  Time 39: 0.386\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.200\n",
      "  To trajectory 18: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.564\n",
      "  Time 31: 0.557\n",
      "  Time 32: 0.544\n",
      "  Time 33: 0.526\n",
      "  Time 34: 0.503\n",
      "  Time 35: 0.477\n",
      "  Time 36: 0.447\n",
      "  Time 37: 0.417\n",
      "  Time 38: 0.385\n",
      "  Time 39: 0.354\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.143\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 19: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.545\n",
      "  Time 31: 0.545\n",
      "  Time 32: 0.539\n",
      "  Time 33: 0.528\n",
      "  Time 34: 0.512\n",
      "  Time 35: 0.492\n",
      "  Time 36: 0.469\n",
      "  Time 37: 0.443\n",
      "  Time 38: 0.415\n",
      "  Time 39: 0.387\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_130000_140000_20241226_020134\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 0.750\n",
      "  To trajectory 13: 0.250\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.563\n",
      "  Time 31: 0.561\n",
      "  Time 32: 0.555\n",
      "  Time 33: 0.546\n",
      "  Time 34: 0.533\n",
      "  Time 35: 0.517\n",
      "  Time 36: 0.499\n",
      "  Time 37: 0.478\n",
      "  Time 38: 0.456\n",
      "  Time 39: 0.433\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.833\n",
      "  To trajectory 19: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.543\n",
      "  Time 31: 0.539\n",
      "  Time 32: 0.530\n",
      "  Time 33: 0.517\n",
      "  Time 34: 0.499\n",
      "  Time 35: 0.477\n",
      "  Time 36: 0.451\n",
      "  Time 37: 0.421\n",
      "  Time 38: 0.389\n",
      "  Time 39: 0.355\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.663\n",
      "  Time 31: 0.673\n",
      "  Time 32: 0.677\n",
      "  Time 33: 0.676\n",
      "  Time 34: 0.669\n",
      "  Time 35: 0.658\n",
      "  Time 36: 0.640\n",
      "  Time 37: 0.618\n",
      "  Time 38: 0.589\n",
      "  Time 39: 0.556\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.573\n",
      "  Time 31: 0.581\n",
      "  Time 32: 0.584\n",
      "  Time 33: 0.582\n",
      "  Time 34: 0.576\n",
      "  Time 35: 0.565\n",
      "  Time 36: 0.549\n",
      "  Time 37: 0.530\n",
      "  Time 38: 0.505\n",
      "  Time 39: 0.477\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.538\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 4: 0.833\n",
      "  To trajectory 7: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.550\n",
      "  Time 31: 0.540\n",
      "  Time 32: 0.525\n",
      "  Time 33: 0.505\n",
      "  Time 34: 0.482\n",
      "  Time 35: 0.456\n",
      "  Time 36: 0.427\n",
      "  Time 37: 0.398\n",
      "  Time 38: 0.368\n",
      "  Time 39: 0.338\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.125\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 0.875\n",
      "  To trajectory 8: 0.125\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.536\n",
      "  Time 31: 0.535\n",
      "  Time 32: 0.531\n",
      "  Time 33: 0.522\n",
      "  Time 34: 0.510\n",
      "  Time 35: 0.494\n",
      "  Time 36: 0.475\n",
      "  Time 37: 0.454\n",
      "  Time 38: 0.431\n",
      "  Time 39: 0.406\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.598\n",
      "  Time 31: 0.603\n",
      "  Time 32: 0.602\n",
      "  Time 33: 0.595\n",
      "  Time 34: 0.580\n",
      "  Time 35: 0.559\n",
      "  Time 36: 0.530\n",
      "  Time 37: 0.495\n",
      "  Time 38: 0.453\n",
      "  Time 39: 0.407\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.550\n",
      "  Time 31: 0.551\n",
      "  Time 32: 0.546\n",
      "  Time 33: 0.534\n",
      "  Time 34: 0.516\n",
      "  Time 35: 0.492\n",
      "  Time 36: 0.464\n",
      "  Time 37: 0.432\n",
      "  Time 38: 0.397\n",
      "  Time 39: 0.360\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.548\n",
      "  Time 31: 0.543\n",
      "  Time 32: 0.533\n",
      "  Time 33: 0.520\n",
      "  Time 34: 0.502\n",
      "  Time 35: 0.480\n",
      "  Time 36: 0.455\n",
      "  Time 37: 0.427\n",
      "  Time 38: 0.397\n",
      "  Time 39: 0.366\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.120\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.200\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.800\n",
      "  To trajectory 15: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.609\n",
      "  Time 31: 0.601\n",
      "  Time 32: 0.588\n",
      "  Time 33: 0.570\n",
      "  Time 34: 0.549\n",
      "  Time 35: 0.523\n",
      "  Time 36: 0.494\n",
      "  Time 37: 0.463\n",
      "  Time 38: 0.430\n",
      "  Time 39: 0.397\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 10: 0.800\n",
      "  To trajectory 18: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.537\n",
      "  Time 31: 0.537\n",
      "  Time 32: 0.531\n",
      "  Time 33: 0.519\n",
      "  Time 34: 0.502\n",
      "  Time 35: 0.480\n",
      "  Time 36: 0.455\n",
      "  Time 37: 0.427\n",
      "  Time 38: 0.397\n",
      "  Time 39: 0.367\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.333\n",
      "  To trajectory 11: 0.667\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.616\n",
      "  Time 31: 0.621\n",
      "  Time 32: 0.620\n",
      "  Time 33: 0.611\n",
      "  Time 34: 0.594\n",
      "  Time 35: 0.570\n",
      "  Time 36: 0.539\n",
      "  Time 37: 0.501\n",
      "  Time 38: 0.459\n",
      "  Time 39: 0.412\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.200\n",
      "  To trajectory 8: 0.200\n",
      "  To trajectory 12: 0.600\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.574\n",
      "  Time 31: 0.572\n",
      "  Time 32: 0.563\n",
      "  Time 33: 0.546\n",
      "  Time 34: 0.525\n",
      "  Time 35: 0.499\n",
      "  Time 36: 0.471\n",
      "  Time 37: 0.441\n",
      "  Time 38: 0.412\n",
      "  Time 39: 0.382\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.620\n",
      "  Time 31: 0.627\n",
      "  Time 32: 0.629\n",
      "  Time 33: 0.626\n",
      "  Time 34: 0.618\n",
      "  Time 35: 0.605\n",
      "  Time 36: 0.588\n",
      "  Time 37: 0.566\n",
      "  Time 38: 0.541\n",
      "  Time 39: 0.513\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.875\n",
      "  To trajectory 16: 0.125\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.564\n",
      "  Time 31: 0.560\n",
      "  Time 32: 0.553\n",
      "  Time 33: 0.540\n",
      "  Time 34: 0.524\n",
      "  Time 35: 0.504\n",
      "  Time 36: 0.480\n",
      "  Time 37: 0.454\n",
      "  Time 38: 0.426\n",
      "  Time 39: 0.396\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 15: 0.833\n",
      "  To trajectory 17: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.579\n",
      "  Time 31: 0.569\n",
      "  Time 32: 0.554\n",
      "  Time 33: 0.535\n",
      "  Time 34: 0.511\n",
      "  Time 35: 0.484\n",
      "  Time 36: 0.453\n",
      "  Time 37: 0.419\n",
      "  Time 38: 0.384\n",
      "  Time 39: 0.347\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.250\n",
      "  To trajectory 16: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.538\n",
      "  Time 31: 0.540\n",
      "  Time 32: 0.537\n",
      "  Time 33: 0.529\n",
      "  Time 34: 0.517\n",
      "  Time 35: 0.502\n",
      "  Time 36: 0.483\n",
      "  Time 37: 0.461\n",
      "  Time 38: 0.437\n",
      "  Time 39: 0.412\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 17: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.573\n",
      "  Time 31: 0.562\n",
      "  Time 32: 0.547\n",
      "  Time 33: 0.528\n",
      "  Time 34: 0.506\n",
      "  Time 35: 0.481\n",
      "  Time 36: 0.454\n",
      "  Time 37: 0.425\n",
      "  Time 38: 0.394\n",
      "  Time 39: 0.363\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.200\n",
      "  To trajectory 18: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.563\n",
      "  Time 31: 0.563\n",
      "  Time 32: 0.558\n",
      "  Time 33: 0.548\n",
      "  Time 34: 0.533\n",
      "  Time 35: 0.513\n",
      "  Time 36: 0.489\n",
      "  Time 37: 0.461\n",
      "  Time 38: 0.431\n",
      "  Time 39: 0.399\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 19: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.544\n",
      "  Time 31: 0.545\n",
      "  Time 32: 0.539\n",
      "  Time 33: 0.528\n",
      "  Time 34: 0.511\n",
      "  Time 35: 0.491\n",
      "  Time 36: 0.466\n",
      "  Time 37: 0.439\n",
      "  Time 38: 0.410\n",
      "  Time 39: 0.381\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_140000_150000_20241226_051212\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.555\n",
      "  Time 31: 0.552\n",
      "  Time 32: 0.544\n",
      "  Time 33: 0.533\n",
      "  Time 34: 0.518\n",
      "  Time 35: 0.500\n",
      "  Time 36: 0.480\n",
      "  Time 37: 0.459\n",
      "  Time 38: 0.436\n",
      "  Time 39: 0.412\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.833\n",
      "  To trajectory 7: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.548\n",
      "  Time 31: 0.543\n",
      "  Time 32: 0.532\n",
      "  Time 33: 0.515\n",
      "  Time 34: 0.493\n",
      "  Time 35: 0.467\n",
      "  Time 36: 0.437\n",
      "  Time 37: 0.404\n",
      "  Time 38: 0.369\n",
      "  Time 39: 0.334\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.723\n",
      "  Time 31: 0.732\n",
      "  Time 32: 0.735\n",
      "  Time 33: 0.731\n",
      "  Time 34: 0.722\n",
      "  Time 35: 0.707\n",
      "  Time 36: 0.685\n",
      "  Time 37: 0.657\n",
      "  Time 38: 0.623\n",
      "  Time 39: 0.584\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 0.857\n",
      "  To trajectory 5: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.561\n",
      "  Time 31: 0.560\n",
      "  Time 32: 0.554\n",
      "  Time 33: 0.545\n",
      "  Time 34: 0.532\n",
      "  Time 35: 0.515\n",
      "  Time 36: 0.496\n",
      "  Time 37: 0.473\n",
      "  Time 38: 0.448\n",
      "  Time 39: 0.420\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.538\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 0.200\n",
      "  To trajectory 4: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.571\n",
      "  Time 31: 0.553\n",
      "  Time 32: 0.529\n",
      "  Time 33: 0.500\n",
      "  Time 34: 0.467\n",
      "  Time 35: 0.432\n",
      "  Time 36: 0.397\n",
      "  Time 37: 0.362\n",
      "  Time 38: 0.329\n",
      "  Time 39: 0.297\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.563\n",
      "  Time 31: 0.568\n",
      "  Time 32: 0.569\n",
      "  Time 33: 0.567\n",
      "  Time 34: 0.561\n",
      "  Time 35: 0.552\n",
      "  Time 36: 0.540\n",
      "  Time 37: 0.525\n",
      "  Time 38: 0.507\n",
      "  Time 39: 0.487\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.579\n",
      "  Time 31: 0.569\n",
      "  Time 32: 0.555\n",
      "  Time 33: 0.535\n",
      "  Time 34: 0.511\n",
      "  Time 35: 0.482\n",
      "  Time 36: 0.449\n",
      "  Time 37: 0.412\n",
      "  Time 38: 0.372\n",
      "  Time 39: 0.331\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.526\n",
      "  Time 31: 0.531\n",
      "  Time 32: 0.530\n",
      "  Time 33: 0.523\n",
      "  Time 34: 0.510\n",
      "  Time 35: 0.492\n",
      "  Time 36: 0.469\n",
      "  Time 37: 0.441\n",
      "  Time 38: 0.411\n",
      "  Time 39: 0.377\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.857\n",
      "  To trajectory 19: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.535\n",
      "  Time 31: 0.521\n",
      "  Time 32: 0.502\n",
      "  Time 33: 0.479\n",
      "  Time 34: 0.453\n",
      "  Time 35: 0.424\n",
      "  Time 36: 0.393\n",
      "  Time 37: 0.361\n",
      "  Time 38: 0.329\n",
      "  Time 39: 0.297\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.120\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.875\n",
      "  To trajectory 15: 0.125\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.571\n",
      "  Time 31: 0.569\n",
      "  Time 32: 0.561\n",
      "  Time 33: 0.549\n",
      "  Time 34: 0.533\n",
      "  Time 35: 0.512\n",
      "  Time 36: 0.487\n",
      "  Time 37: 0.459\n",
      "  Time 38: 0.429\n",
      "  Time 39: 0.398\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 10: 0.750\n",
      "  To trajectory 18: 0.250\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.541\n",
      "  Time 31: 0.536\n",
      "  Time 32: 0.524\n",
      "  Time 33: 0.508\n",
      "  Time 34: 0.486\n",
      "  Time 35: 0.461\n",
      "  Time 36: 0.434\n",
      "  Time 37: 0.405\n",
      "  Time 38: 0.377\n",
      "  Time 39: 0.349\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.200\n",
      "  To trajectory 11: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.568\n",
      "  Time 31: 0.565\n",
      "  Time 32: 0.556\n",
      "  Time 33: 0.541\n",
      "  Time 34: 0.521\n",
      "  Time 35: 0.496\n",
      "  Time 36: 0.466\n",
      "  Time 37: 0.433\n",
      "  Time 38: 0.396\n",
      "  Time 39: 0.358\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.200\n",
      "  To trajectory 8: 0.200\n",
      "  To trajectory 12: 0.600\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.572\n",
      "  Time 31: 0.569\n",
      "  Time 32: 0.560\n",
      "  Time 33: 0.544\n",
      "  Time 34: 0.522\n",
      "  Time 35: 0.495\n",
      "  Time 36: 0.466\n",
      "  Time 37: 0.436\n",
      "  Time 38: 0.405\n",
      "  Time 39: 0.375\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 9\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.563\n",
      "  Time 31: 0.569\n",
      "  Time 32: 0.570\n",
      "  Time 33: 0.567\n",
      "  Time 34: 0.559\n",
      "  Time 35: 0.545\n",
      "  Time 36: 0.528\n",
      "  Time 37: 0.506\n",
      "  Time 38: 0.480\n",
      "  Time 39: 0.451\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 9\n",
      "CAD risk: 0.111\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.889\n",
      "  To trajectory 16: 0.111\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.565\n",
      "  Time 31: 0.562\n",
      "  Time 32: 0.554\n",
      "  Time 33: 0.541\n",
      "  Time 34: 0.524\n",
      "  Time 35: 0.503\n",
      "  Time 36: 0.479\n",
      "  Time 37: 0.452\n",
      "  Time 38: 0.422\n",
      "  Time 39: 0.392\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 15: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.613\n",
      "  Time 31: 0.608\n",
      "  Time 32: 0.596\n",
      "  Time 33: 0.580\n",
      "  Time 34: 0.559\n",
      "  Time 35: 0.534\n",
      "  Time 36: 0.505\n",
      "  Time 37: 0.472\n",
      "  Time 38: 0.437\n",
      "  Time 39: 0.399\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.250\n",
      "  To trajectory 16: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.539\n",
      "  Time 31: 0.541\n",
      "  Time 32: 0.538\n",
      "  Time 33: 0.531\n",
      "  Time 34: 0.519\n",
      "  Time 35: 0.503\n",
      "  Time 36: 0.484\n",
      "  Time 37: 0.462\n",
      "  Time 38: 0.437\n",
      "  Time 39: 0.412\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 17: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.549\n",
      "  Time 31: 0.542\n",
      "  Time 32: 0.531\n",
      "  Time 33: 0.517\n",
      "  Time 34: 0.500\n",
      "  Time 35: 0.479\n",
      "  Time 36: 0.456\n",
      "  Time 37: 0.431\n",
      "  Time 38: 0.404\n",
      "  Time 39: 0.376\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.200\n",
      "  To trajectory 18: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.562\n",
      "  Time 31: 0.556\n",
      "  Time 32: 0.545\n",
      "  Time 33: 0.528\n",
      "  Time 34: 0.507\n",
      "  Time 35: 0.482\n",
      "  Time 36: 0.454\n",
      "  Time 37: 0.424\n",
      "  Time 38: 0.393\n",
      "  Time 39: 0.362\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.167\n",
      "  To trajectory 19: 0.833\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.537\n",
      "  Time 31: 0.538\n",
      "  Time 32: 0.532\n",
      "  Time 33: 0.520\n",
      "  Time 34: 0.504\n",
      "  Time 35: 0.483\n",
      "  Time 36: 0.459\n",
      "  Time 37: 0.432\n",
      "  Time 38: 0.404\n",
      "  Time 39: 0.375\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_150000_160000_20241226_051223\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 0.667\n",
      "  To trajectory 13: 0.167\n",
      "  To trajectory 15: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.533\n",
      "  Time 31: 0.527\n",
      "  Time 32: 0.516\n",
      "  Time 33: 0.501\n",
      "  Time 34: 0.483\n",
      "  Time 35: 0.462\n",
      "  Time 36: 0.440\n",
      "  Time 37: 0.415\n",
      "  Time 38: 0.390\n",
      "  Time 39: 0.365\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.833\n",
      "  To trajectory 19: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.535\n",
      "  Time 31: 0.531\n",
      "  Time 32: 0.523\n",
      "  Time 33: 0.510\n",
      "  Time 34: 0.492\n",
      "  Time 35: 0.471\n",
      "  Time 36: 0.445\n",
      "  Time 37: 0.416\n",
      "  Time 38: 0.384\n",
      "  Time 39: 0.351\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.703\n",
      "  Time 31: 0.712\n",
      "  Time 32: 0.716\n",
      "  Time 33: 0.714\n",
      "  Time 34: 0.705\n",
      "  Time 35: 0.690\n",
      "  Time 36: 0.669\n",
      "  Time 37: 0.641\n",
      "  Time 38: 0.607\n",
      "  Time 39: 0.567\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.143\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.557\n",
      "  Time 31: 0.561\n",
      "  Time 32: 0.561\n",
      "  Time 33: 0.556\n",
      "  Time 34: 0.546\n",
      "  Time 35: 0.533\n",
      "  Time 36: 0.515\n",
      "  Time 37: 0.493\n",
      "  Time 38: 0.467\n",
      "  Time 39: 0.438\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.538\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 0.167\n",
      "  To trajectory 4: 0.667\n",
      "  To trajectory 7: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.549\n",
      "  Time 31: 0.527\n",
      "  Time 32: 0.498\n",
      "  Time 33: 0.465\n",
      "  Time 34: 0.430\n",
      "  Time 35: 0.393\n",
      "  Time 36: 0.357\n",
      "  Time 37: 0.322\n",
      "  Time 38: 0.290\n",
      "  Time 39: 0.261\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 10\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 0.900\n",
      "  To trajectory 17: 0.100\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.549\n",
      "  Time 31: 0.552\n",
      "  Time 32: 0.548\n",
      "  Time 33: 0.540\n",
      "  Time 34: 0.526\n",
      "  Time 35: 0.507\n",
      "  Time 36: 0.484\n",
      "  Time 37: 0.458\n",
      "  Time 38: 0.429\n",
      "  Time 39: 0.399\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 0.800\n",
      "  To trajectory 7: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.554\n",
      "  Time 31: 0.551\n",
      "  Time 32: 0.542\n",
      "  Time 33: 0.528\n",
      "  Time 34: 0.508\n",
      "  Time 35: 0.482\n",
      "  Time 36: 0.451\n",
      "  Time 37: 0.416\n",
      "  Time 38: 0.377\n",
      "  Time 39: 0.335\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.800\n",
      "  To trajectory 18: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.529\n",
      "  Time 31: 0.533\n",
      "  Time 32: 0.530\n",
      "  Time 33: 0.521\n",
      "  Time 34: 0.506\n",
      "  Time 35: 0.485\n",
      "  Time 36: 0.460\n",
      "  Time 37: 0.431\n",
      "  Time 38: 0.398\n",
      "  Time 39: 0.364\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.833\n",
      "  To trajectory 19: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.537\n",
      "  Time 31: 0.526\n",
      "  Time 32: 0.509\n",
      "  Time 33: 0.488\n",
      "  Time 34: 0.463\n",
      "  Time 35: 0.435\n",
      "  Time 36: 0.404\n",
      "  Time 37: 0.372\n",
      "  Time 38: 0.339\n",
      "  Time 39: 0.307\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.120\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.857\n",
      "  To trajectory 15: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.581\n",
      "  Time 31: 0.579\n",
      "  Time 32: 0.572\n",
      "  Time 33: 0.560\n",
      "  Time 34: 0.544\n",
      "  Time 35: 0.523\n",
      "  Time 36: 0.498\n",
      "  Time 37: 0.470\n",
      "  Time 38: 0.440\n",
      "  Time 39: 0.408\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 10: 0.667\n",
      "  To trajectory 18: 0.333\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.542\n",
      "  Time 31: 0.527\n",
      "  Time 32: 0.507\n",
      "  Time 33: 0.481\n",
      "  Time 34: 0.452\n",
      "  Time 35: 0.420\n",
      "  Time 36: 0.386\n",
      "  Time 37: 0.351\n",
      "  Time 38: 0.318\n",
      "  Time 39: 0.286\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.333\n",
      "  To trajectory 11: 0.667\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.604\n",
      "  Time 31: 0.610\n",
      "  Time 32: 0.608\n",
      "  Time 33: 0.598\n",
      "  Time 34: 0.581\n",
      "  Time 35: 0.557\n",
      "  Time 36: 0.525\n",
      "  Time 37: 0.487\n",
      "  Time 38: 0.444\n",
      "  Time 39: 0.398\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.200\n",
      "  To trajectory 8: 0.200\n",
      "  To trajectory 12: 0.600\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.586\n",
      "  Time 31: 0.584\n",
      "  Time 32: 0.574\n",
      "  Time 33: 0.558\n",
      "  Time 34: 0.535\n",
      "  Time 35: 0.508\n",
      "  Time 36: 0.478\n",
      "  Time 37: 0.446\n",
      "  Time 38: 0.415\n",
      "  Time 39: 0.383\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.575\n",
      "  Time 31: 0.587\n",
      "  Time 32: 0.593\n",
      "  Time 33: 0.594\n",
      "  Time 34: 0.589\n",
      "  Time 35: 0.579\n",
      "  Time 36: 0.564\n",
      "  Time 37: 0.544\n",
      "  Time 38: 0.519\n",
      "  Time 39: 0.490\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.875\n",
      "  To trajectory 16: 0.125\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.555\n",
      "  Time 31: 0.552\n",
      "  Time 32: 0.544\n",
      "  Time 33: 0.531\n",
      "  Time 34: 0.514\n",
      "  Time 35: 0.493\n",
      "  Time 36: 0.469\n",
      "  Time 37: 0.443\n",
      "  Time 38: 0.414\n",
      "  Time 39: 0.385\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 15: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.581\n",
      "  Time 31: 0.576\n",
      "  Time 32: 0.566\n",
      "  Time 33: 0.551\n",
      "  Time 34: 0.531\n",
      "  Time 35: 0.506\n",
      "  Time 36: 0.479\n",
      "  Time 37: 0.448\n",
      "  Time 38: 0.414\n",
      "  Time 39: 0.379\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.167\n",
      "  To trajectory 16: 0.833\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.534\n",
      "  Time 31: 0.539\n",
      "  Time 32: 0.539\n",
      "  Time 33: 0.535\n",
      "  Time 34: 0.527\n",
      "  Time 35: 0.515\n",
      "  Time 36: 0.500\n",
      "  Time 37: 0.482\n",
      "  Time 38: 0.463\n",
      "  Time 39: 0.441\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 17: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.624\n",
      "  Time 31: 0.602\n",
      "  Time 32: 0.576\n",
      "  Time 33: 0.546\n",
      "  Time 34: 0.513\n",
      "  Time 35: 0.477\n",
      "  Time 36: 0.440\n",
      "  Time 37: 0.401\n",
      "  Time 38: 0.361\n",
      "  Time 39: 0.322\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 18: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.550\n",
      "  Time 31: 0.545\n",
      "  Time 32: 0.535\n",
      "  Time 33: 0.520\n",
      "  Time 34: 0.500\n",
      "  Time 35: 0.475\n",
      "  Time 36: 0.448\n",
      "  Time 37: 0.418\n",
      "  Time 38: 0.387\n",
      "  Time 39: 0.356\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.143\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 19: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.538\n",
      "  Time 31: 0.540\n",
      "  Time 32: 0.537\n",
      "  Time 33: 0.528\n",
      "  Time 34: 0.515\n",
      "  Time 35: 0.498\n",
      "  Time 36: 0.477\n",
      "  Time 37: 0.453\n",
      "  Time 38: 0.427\n",
      "  Time 39: 0.401\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_160000_170000_20241226_082535\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.542\n",
      "  Time 31: 0.540\n",
      "  Time 32: 0.533\n",
      "  Time 33: 0.521\n",
      "  Time 34: 0.505\n",
      "  Time 35: 0.485\n",
      "  Time 36: 0.462\n",
      "  Time 37: 0.437\n",
      "  Time 38: 0.410\n",
      "  Time 39: 0.382\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.833\n",
      "  To trajectory 19: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.545\n",
      "  Time 31: 0.542\n",
      "  Time 32: 0.533\n",
      "  Time 33: 0.520\n",
      "  Time 34: 0.503\n",
      "  Time 35: 0.481\n",
      "  Time 36: 0.455\n",
      "  Time 37: 0.426\n",
      "  Time 38: 0.394\n",
      "  Time 39: 0.361\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.721\n",
      "  Time 31: 0.731\n",
      "  Time 32: 0.735\n",
      "  Time 33: 0.732\n",
      "  Time 34: 0.723\n",
      "  Time 35: 0.708\n",
      "  Time 36: 0.686\n",
      "  Time 37: 0.658\n",
      "  Time 38: 0.623\n",
      "  Time 39: 0.581\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.167\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 0.833\n",
      "  To trajectory 5: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.569\n",
      "  Time 31: 0.567\n",
      "  Time 32: 0.561\n",
      "  Time 33: 0.550\n",
      "  Time 34: 0.536\n",
      "  Time 35: 0.519\n",
      "  Time 36: 0.499\n",
      "  Time 37: 0.476\n",
      "  Time 38: 0.451\n",
      "  Time 39: 0.423\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.538\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 0.167\n",
      "  To trajectory 4: 0.667\n",
      "  To trajectory 7: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.561\n",
      "  Time 31: 0.542\n",
      "  Time 32: 0.516\n",
      "  Time 33: 0.485\n",
      "  Time 34: 0.451\n",
      "  Time 35: 0.414\n",
      "  Time 36: 0.377\n",
      "  Time 37: 0.341\n",
      "  Time 38: 0.306\n",
      "  Time 39: 0.273\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.527\n",
      "  Time 31: 0.541\n",
      "  Time 32: 0.552\n",
      "  Time 33: 0.561\n",
      "  Time 34: 0.567\n",
      "  Time 35: 0.570\n",
      "  Time 36: 0.570\n",
      "  Time 37: 0.567\n",
      "  Time 38: 0.561\n",
      "  Time 39: 0.552\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 0.800\n",
      "  To trajectory 7: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.579\n",
      "  Time 31: 0.576\n",
      "  Time 32: 0.568\n",
      "  Time 33: 0.553\n",
      "  Time 34: 0.533\n",
      "  Time 35: 0.508\n",
      "  Time 36: 0.477\n",
      "  Time 37: 0.441\n",
      "  Time 38: 0.401\n",
      "  Time 39: 0.358\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.544\n",
      "  Time 31: 0.546\n",
      "  Time 32: 0.542\n",
      "  Time 33: 0.532\n",
      "  Time 34: 0.517\n",
      "  Time 35: 0.497\n",
      "  Time 36: 0.473\n",
      "  Time 37: 0.445\n",
      "  Time 38: 0.414\n",
      "  Time 39: 0.381\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.200\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.555\n",
      "  Time 31: 0.549\n",
      "  Time 32: 0.538\n",
      "  Time 33: 0.523\n",
      "  Time 34: 0.504\n",
      "  Time 35: 0.481\n",
      "  Time 36: 0.454\n",
      "  Time 37: 0.424\n",
      "  Time 38: 0.393\n",
      "  Time 39: 0.360\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.120\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.800\n",
      "  To trajectory 15: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.600\n",
      "  Time 31: 0.600\n",
      "  Time 32: 0.595\n",
      "  Time 33: 0.585\n",
      "  Time 34: 0.571\n",
      "  Time 35: 0.551\n",
      "  Time 36: 0.528\n",
      "  Time 37: 0.502\n",
      "  Time 38: 0.474\n",
      "  Time 39: 0.444\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 0.200\n",
      "  To trajectory 10: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.534\n",
      "  Time 31: 0.525\n",
      "  Time 32: 0.510\n",
      "  Time 33: 0.489\n",
      "  Time 34: 0.463\n",
      "  Time 35: 0.431\n",
      "  Time 36: 0.395\n",
      "  Time 37: 0.358\n",
      "  Time 38: 0.319\n",
      "  Time 39: 0.282\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.333\n",
      "  To trajectory 11: 0.667\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.621\n",
      "  Time 31: 0.626\n",
      "  Time 32: 0.624\n",
      "  Time 33: 0.615\n",
      "  Time 34: 0.597\n",
      "  Time 35: 0.573\n",
      "  Time 36: 0.541\n",
      "  Time 37: 0.503\n",
      "  Time 38: 0.460\n",
      "  Time 39: 0.413\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 4: 0.167\n",
      "  To trajectory 7: 0.167\n",
      "  To trajectory 12: 0.667\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.576\n",
      "  Time 31: 0.579\n",
      "  Time 32: 0.576\n",
      "  Time 33: 0.565\n",
      "  Time 34: 0.549\n",
      "  Time 35: 0.528\n",
      "  Time 36: 0.503\n",
      "  Time 37: 0.476\n",
      "  Time 38: 0.449\n",
      "  Time 39: 0.420\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.583\n",
      "  Time 31: 0.590\n",
      "  Time 32: 0.593\n",
      "  Time 33: 0.590\n",
      "  Time 34: 0.582\n",
      "  Time 35: 0.570\n",
      "  Time 36: 0.553\n",
      "  Time 37: 0.532\n",
      "  Time 38: 0.508\n",
      "  Time 39: 0.480\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.125\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.875\n",
      "  To trajectory 16: 0.125\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.574\n",
      "  Time 31: 0.571\n",
      "  Time 32: 0.563\n",
      "  Time 33: 0.550\n",
      "  Time 34: 0.534\n",
      "  Time 35: 0.514\n",
      "  Time 36: 0.491\n",
      "  Time 37: 0.466\n",
      "  Time 38: 0.439\n",
      "  Time 39: 0.410\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.250\n",
      "  To trajectory 15: 0.500\n",
      "  To trajectory 16: 0.250\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.565\n",
      "  Time 31: 0.554\n",
      "  Time 32: 0.537\n",
      "  Time 33: 0.517\n",
      "  Time 34: 0.493\n",
      "  Time 35: 0.466\n",
      "  Time 36: 0.436\n",
      "  Time 37: 0.404\n",
      "  Time 38: 0.371\n",
      "  Time 39: 0.337\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.200\n",
      "  To trajectory 16: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.532\n",
      "  Time 31: 0.535\n",
      "  Time 32: 0.532\n",
      "  Time 33: 0.525\n",
      "  Time 34: 0.513\n",
      "  Time 35: 0.496\n",
      "  Time 36: 0.477\n",
      "  Time 37: 0.454\n",
      "  Time 38: 0.429\n",
      "  Time 39: 0.402\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 17: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.565\n",
      "  Time 31: 0.561\n",
      "  Time 32: 0.553\n",
      "  Time 33: 0.541\n",
      "  Time 34: 0.525\n",
      "  Time 35: 0.505\n",
      "  Time 36: 0.481\n",
      "  Time 37: 0.454\n",
      "  Time 38: 0.425\n",
      "  Time 39: 0.393\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 18: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.556\n",
      "  Time 31: 0.552\n",
      "  Time 32: 0.542\n",
      "  Time 33: 0.528\n",
      "  Time 34: 0.509\n",
      "  Time 35: 0.487\n",
      "  Time 36: 0.461\n",
      "  Time 37: 0.432\n",
      "  Time 38: 0.403\n",
      "  Time 39: 0.372\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 19: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.555\n",
      "  Time 31: 0.556\n",
      "  Time 32: 0.551\n",
      "  Time 33: 0.540\n",
      "  Time 34: 0.524\n",
      "  Time 35: 0.504\n",
      "  Time 36: 0.479\n",
      "  Time 37: 0.451\n",
      "  Time 38: 0.422\n",
      "  Time 39: 0.391\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_170000_180000_20241226_082558\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.533\n",
      "  Time 31: 0.533\n",
      "  Time 32: 0.528\n",
      "  Time 33: 0.518\n",
      "  Time 34: 0.502\n",
      "  Time 35: 0.483\n",
      "  Time 36: 0.460\n",
      "  Time 37: 0.434\n",
      "  Time 38: 0.407\n",
      "  Time 39: 0.379\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.552\n",
      "  Time 31: 0.548\n",
      "  Time 32: 0.539\n",
      "  Time 33: 0.526\n",
      "  Time 34: 0.508\n",
      "  Time 35: 0.486\n",
      "  Time 36: 0.460\n",
      "  Time 37: 0.431\n",
      "  Time 38: 0.399\n",
      "  Time 39: 0.365\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.706\n",
      "  Time 31: 0.715\n",
      "  Time 32: 0.718\n",
      "  Time 33: 0.715\n",
      "  Time 34: 0.706\n",
      "  Time 35: 0.690\n",
      "  Time 36: 0.667\n",
      "  Time 37: 0.638\n",
      "  Time 38: 0.603\n",
      "  Time 39: 0.562\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 0.714\n",
      "  To trajectory 5: 0.143\n",
      "  To trajectory 17: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.562\n",
      "  Time 31: 0.559\n",
      "  Time 32: 0.551\n",
      "  Time 33: 0.538\n",
      "  Time 34: 0.521\n",
      "  Time 35: 0.500\n",
      "  Time 36: 0.477\n",
      "  Time 37: 0.451\n",
      "  Time 38: 0.423\n",
      "  Time 39: 0.393\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.538\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 0.143\n",
      "  To trajectory 4: 0.714\n",
      "  To trajectory 7: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.556\n",
      "  Time 31: 0.541\n",
      "  Time 32: 0.521\n",
      "  Time 33: 0.496\n",
      "  Time 34: 0.467\n",
      "  Time 35: 0.435\n",
      "  Time 36: 0.403\n",
      "  Time 37: 0.370\n",
      "  Time 38: 0.338\n",
      "  Time 39: 0.307\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.552\n",
      "  Time 31: 0.550\n",
      "  Time 32: 0.544\n",
      "  Time 33: 0.535\n",
      "  Time 34: 0.521\n",
      "  Time 35: 0.505\n",
      "  Time 36: 0.485\n",
      "  Time 37: 0.464\n",
      "  Time 38: 0.440\n",
      "  Time 39: 0.416\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 0.800\n",
      "  To trajectory 7: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.569\n",
      "  Time 31: 0.574\n",
      "  Time 32: 0.573\n",
      "  Time 33: 0.567\n",
      "  Time 34: 0.555\n",
      "  Time 35: 0.537\n",
      "  Time 36: 0.513\n",
      "  Time 37: 0.484\n",
      "  Time 38: 0.451\n",
      "  Time 39: 0.414\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 0.200\n",
      "  To trajectory 7: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.529\n",
      "  Time 31: 0.532\n",
      "  Time 32: 0.528\n",
      "  Time 33: 0.520\n",
      "  Time 34: 0.506\n",
      "  Time 35: 0.487\n",
      "  Time 36: 0.464\n",
      "  Time 37: 0.437\n",
      "  Time 38: 0.407\n",
      "  Time 39: 0.375\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.857\n",
      "  To trajectory 19: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.537\n",
      "  Time 31: 0.525\n",
      "  Time 32: 0.508\n",
      "  Time 33: 0.487\n",
      "  Time 34: 0.462\n",
      "  Time 35: 0.435\n",
      "  Time 36: 0.405\n",
      "  Time 37: 0.374\n",
      "  Time 38: 0.342\n",
      "  Time 39: 0.311\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.120\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.800\n",
      "  To trajectory 15: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.592\n",
      "  Time 31: 0.584\n",
      "  Time 32: 0.571\n",
      "  Time 33: 0.553\n",
      "  Time 34: 0.531\n",
      "  Time 35: 0.504\n",
      "  Time 36: 0.474\n",
      "  Time 37: 0.441\n",
      "  Time 38: 0.407\n",
      "  Time 39: 0.372\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 0.200\n",
      "  To trajectory 10: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.539\n",
      "  Time 31: 0.543\n",
      "  Time 32: 0.539\n",
      "  Time 33: 0.527\n",
      "  Time 34: 0.509\n",
      "  Time 35: 0.484\n",
      "  Time 36: 0.454\n",
      "  Time 37: 0.421\n",
      "  Time 38: 0.385\n",
      "  Time 39: 0.350\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.250\n",
      "  To trajectory 11: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.576\n",
      "  Time 31: 0.575\n",
      "  Time 32: 0.567\n",
      "  Time 33: 0.554\n",
      "  Time 34: 0.535\n",
      "  Time 35: 0.510\n",
      "  Time 36: 0.480\n",
      "  Time 37: 0.445\n",
      "  Time 38: 0.407\n",
      "  Time 39: 0.366\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.143\n",
      "  To trajectory 8: 0.143\n",
      "  To trajectory 12: 0.714\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.565\n",
      "  Time 31: 0.560\n",
      "  Time 32: 0.548\n",
      "  Time 33: 0.531\n",
      "  Time 34: 0.509\n",
      "  Time 35: 0.483\n",
      "  Time 36: 0.454\n",
      "  Time 37: 0.424\n",
      "  Time 38: 0.394\n",
      "  Time 39: 0.363\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.581\n",
      "  Time 31: 0.590\n",
      "  Time 32: 0.594\n",
      "  Time 33: 0.593\n",
      "  Time 34: 0.587\n",
      "  Time 35: 0.575\n",
      "  Time 36: 0.559\n",
      "  Time 37: 0.539\n",
      "  Time 38: 0.514\n",
      "  Time 39: 0.485\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.857\n",
      "  To trajectory 16: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.572\n",
      "  Time 31: 0.565\n",
      "  Time 32: 0.555\n",
      "  Time 33: 0.539\n",
      "  Time 34: 0.520\n",
      "  Time 35: 0.498\n",
      "  Time 36: 0.473\n",
      "  Time 37: 0.445\n",
      "  Time 38: 0.417\n",
      "  Time 39: 0.388\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.143\n",
      "  To trajectory 15: 0.857\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.574\n",
      "  Time 31: 0.578\n",
      "  Time 32: 0.577\n",
      "  Time 33: 0.570\n",
      "  Time 34: 0.559\n",
      "  Time 35: 0.542\n",
      "  Time 36: 0.522\n",
      "  Time 37: 0.497\n",
      "  Time 38: 0.470\n",
      "  Time 39: 0.440\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.250\n",
      "  To trajectory 16: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.541\n",
      "  Time 31: 0.543\n",
      "  Time 32: 0.540\n",
      "  Time 33: 0.532\n",
      "  Time 34: 0.520\n",
      "  Time 35: 0.503\n",
      "  Time 36: 0.484\n",
      "  Time 37: 0.462\n",
      "  Time 38: 0.437\n",
      "  Time 39: 0.412\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.200\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 17: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.550\n",
      "  Time 31: 0.545\n",
      "  Time 32: 0.536\n",
      "  Time 33: 0.523\n",
      "  Time 34: 0.507\n",
      "  Time 35: 0.487\n",
      "  Time 36: 0.464\n",
      "  Time 37: 0.438\n",
      "  Time 38: 0.410\n",
      "  Time 39: 0.380\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.143\n",
      "  To trajectory 18: 0.857\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.554\n",
      "  Time 31: 0.550\n",
      "  Time 32: 0.540\n",
      "  Time 33: 0.526\n",
      "  Time 34: 0.507\n",
      "  Time 35: 0.484\n",
      "  Time 36: 0.458\n",
      "  Time 37: 0.429\n",
      "  Time 38: 0.399\n",
      "  Time 39: 0.369\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 19: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.539\n",
      "  Time 31: 0.539\n",
      "  Time 32: 0.534\n",
      "  Time 33: 0.523\n",
      "  Time 34: 0.507\n",
      "  Time 35: 0.487\n",
      "  Time 36: 0.463\n",
      "  Time 37: 0.436\n",
      "  Time 38: 0.408\n",
      "  Time 39: 0.379\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_180000_190000_20241226_113728\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 0.800\n",
      "  To trajectory 15: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.532\n",
      "  Time 31: 0.531\n",
      "  Time 32: 0.524\n",
      "  Time 33: 0.513\n",
      "  Time 34: 0.498\n",
      "  Time 35: 0.479\n",
      "  Time 36: 0.456\n",
      "  Time 37: 0.431\n",
      "  Time 38: 0.405\n",
      "  Time 39: 0.377\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.533\n",
      "  Time 31: 0.529\n",
      "  Time 32: 0.520\n",
      "  Time 33: 0.507\n",
      "  Time 34: 0.489\n",
      "  Time 35: 0.467\n",
      "  Time 36: 0.441\n",
      "  Time 37: 0.412\n",
      "  Time 38: 0.381\n",
      "  Time 39: 0.347\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.725\n",
      "  Time 31: 0.734\n",
      "  Time 32: 0.737\n",
      "  Time 33: 0.734\n",
      "  Time 34: 0.725\n",
      "  Time 35: 0.710\n",
      "  Time 36: 0.688\n",
      "  Time 37: 0.660\n",
      "  Time 38: 0.625\n",
      "  Time 39: 0.584\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 0.714\n",
      "  To trajectory 5: 0.143\n",
      "  To trajectory 17: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.559\n",
      "  Time 31: 0.555\n",
      "  Time 32: 0.547\n",
      "  Time 33: 0.535\n",
      "  Time 34: 0.518\n",
      "  Time 35: 0.498\n",
      "  Time 36: 0.474\n",
      "  Time 37: 0.449\n",
      "  Time 38: 0.421\n",
      "  Time 39: 0.391\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.538\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 4: 0.800\n",
      "  To trajectory 7: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.570\n",
      "  Time 31: 0.559\n",
      "  Time 32: 0.542\n",
      "  Time 33: 0.519\n",
      "  Time 34: 0.491\n",
      "  Time 35: 0.460\n",
      "  Time 36: 0.425\n",
      "  Time 37: 0.389\n",
      "  Time 38: 0.352\n",
      "  Time 39: 0.317\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 0.833\n",
      "  To trajectory 16: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.563\n",
      "  Time 31: 0.554\n",
      "  Time 32: 0.540\n",
      "  Time 33: 0.522\n",
      "  Time 34: 0.501\n",
      "  Time 35: 0.478\n",
      "  Time 36: 0.453\n",
      "  Time 37: 0.428\n",
      "  Time 38: 0.402\n",
      "  Time 39: 0.377\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 0.750\n",
      "  To trajectory 7: 0.250\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.600\n",
      "  Time 31: 0.593\n",
      "  Time 32: 0.581\n",
      "  Time 33: 0.563\n",
      "  Time 34: 0.539\n",
      "  Time 35: 0.510\n",
      "  Time 36: 0.476\n",
      "  Time 37: 0.438\n",
      "  Time 38: 0.394\n",
      "  Time 39: 0.348\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.400\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.531\n",
      "  Time 31: 0.535\n",
      "  Time 32: 0.532\n",
      "  Time 33: 0.523\n",
      "  Time 34: 0.508\n",
      "  Time 35: 0.487\n",
      "  Time 36: 0.462\n",
      "  Time 37: 0.433\n",
      "  Time 38: 0.401\n",
      "  Time 39: 0.367\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.545\n",
      "  Time 31: 0.533\n",
      "  Time 32: 0.517\n",
      "  Time 33: 0.498\n",
      "  Time 34: 0.476\n",
      "  Time 35: 0.451\n",
      "  Time 36: 0.424\n",
      "  Time 37: 0.395\n",
      "  Time 38: 0.366\n",
      "  Time 39: 0.336\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.120\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.125\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.875\n",
      "  To trajectory 15: 0.125\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.564\n",
      "  Time 31: 0.561\n",
      "  Time 32: 0.554\n",
      "  Time 33: 0.542\n",
      "  Time 34: 0.525\n",
      "  Time 35: 0.504\n",
      "  Time 36: 0.480\n",
      "  Time 37: 0.453\n",
      "  Time 38: 0.424\n",
      "  Time 39: 0.394\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 10: 0.750\n",
      "  To trajectory 18: 0.250\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.528\n",
      "  Time 31: 0.517\n",
      "  Time 32: 0.500\n",
      "  Time 33: 0.479\n",
      "  Time 34: 0.454\n",
      "  Time 35: 0.427\n",
      "  Time 36: 0.397\n",
      "  Time 37: 0.367\n",
      "  Time 38: 0.337\n",
      "  Time 39: 0.308\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 11: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.623\n",
      "  Time 31: 0.629\n",
      "  Time 32: 0.627\n",
      "  Time 33: 0.618\n",
      "  Time 34: 0.601\n",
      "  Time 35: 0.577\n",
      "  Time 36: 0.546\n",
      "  Time 37: 0.507\n",
      "  Time 38: 0.463\n",
      "  Time 39: 0.415\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.200\n",
      "  To trajectory 8: 0.200\n",
      "  To trajectory 12: 0.600\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.565\n",
      "  Time 31: 0.559\n",
      "  Time 32: 0.546\n",
      "  Time 33: 0.526\n",
      "  Time 34: 0.500\n",
      "  Time 35: 0.471\n",
      "  Time 36: 0.439\n",
      "  Time 37: 0.407\n",
      "  Time 38: 0.375\n",
      "  Time 39: 0.344\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.565\n",
      "  Time 31: 0.571\n",
      "  Time 32: 0.573\n",
      "  Time 33: 0.570\n",
      "  Time 34: 0.562\n",
      "  Time 35: 0.550\n",
      "  Time 36: 0.534\n",
      "  Time 37: 0.513\n",
      "  Time 38: 0.488\n",
      "  Time 39: 0.461\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.875\n",
      "  To trajectory 16: 0.125\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.565\n",
      "  Time 31: 0.562\n",
      "  Time 32: 0.554\n",
      "  Time 33: 0.542\n",
      "  Time 34: 0.525\n",
      "  Time 35: 0.505\n",
      "  Time 36: 0.482\n",
      "  Time 37: 0.456\n",
      "  Time 38: 0.429\n",
      "  Time 39: 0.400\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.167\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 15: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.587\n",
      "  Time 31: 0.587\n",
      "  Time 32: 0.582\n",
      "  Time 33: 0.572\n",
      "  Time 34: 0.559\n",
      "  Time 35: 0.541\n",
      "  Time 36: 0.520\n",
      "  Time 37: 0.495\n",
      "  Time 38: 0.467\n",
      "  Time 39: 0.437\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.250\n",
      "  To trajectory 16: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.543\n",
      "  Time 31: 0.544\n",
      "  Time 32: 0.541\n",
      "  Time 33: 0.533\n",
      "  Time 34: 0.521\n",
      "  Time 35: 0.504\n",
      "  Time 36: 0.485\n",
      "  Time 37: 0.463\n",
      "  Time 38: 0.438\n",
      "  Time 39: 0.413\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 17: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.584\n",
      "  Time 31: 0.571\n",
      "  Time 32: 0.555\n",
      "  Time 33: 0.537\n",
      "  Time 34: 0.515\n",
      "  Time 35: 0.492\n",
      "  Time 36: 0.466\n",
      "  Time 37: 0.439\n",
      "  Time 38: 0.411\n",
      "  Time 39: 0.381\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 15: 0.167\n",
      "  To trajectory 18: 0.833\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.554\n",
      "  Time 31: 0.551\n",
      "  Time 32: 0.543\n",
      "  Time 33: 0.530\n",
      "  Time 34: 0.511\n",
      "  Time 35: 0.488\n",
      "  Time 36: 0.461\n",
      "  Time 37: 0.432\n",
      "  Time 38: 0.401\n",
      "  Time 39: 0.370\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.167\n",
      "  To trajectory 19: 0.833\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.547\n",
      "  Time 31: 0.547\n",
      "  Time 32: 0.541\n",
      "  Time 33: 0.530\n",
      "  Time 34: 0.514\n",
      "  Time 35: 0.493\n",
      "  Time 36: 0.469\n",
      "  Time 37: 0.441\n",
      "  Time 38: 0.412\n",
      "  Time 39: 0.383\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_190000_200000_20241226_113741\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 0.857\n",
      "  To trajectory 13: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.528\n",
      "  Time 31: 0.531\n",
      "  Time 32: 0.530\n",
      "  Time 33: 0.524\n",
      "  Time 34: 0.513\n",
      "  Time 35: 0.497\n",
      "  Time 36: 0.477\n",
      "  Time 37: 0.454\n",
      "  Time 38: 0.428\n",
      "  Time 39: 0.399\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.833\n",
      "  To trajectory 19: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.540\n",
      "  Time 31: 0.536\n",
      "  Time 32: 0.527\n",
      "  Time 33: 0.514\n",
      "  Time 34: 0.496\n",
      "  Time 35: 0.474\n",
      "  Time 36: 0.448\n",
      "  Time 37: 0.419\n",
      "  Time 38: 0.387\n",
      "  Time 39: 0.354\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.720\n",
      "  Time 31: 0.729\n",
      "  Time 32: 0.732\n",
      "  Time 33: 0.729\n",
      "  Time 34: 0.720\n",
      "  Time 35: 0.704\n",
      "  Time 36: 0.682\n",
      "  Time 37: 0.653\n",
      "  Time 38: 0.618\n",
      "  Time 39: 0.576\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.579\n",
      "  Time 31: 0.580\n",
      "  Time 32: 0.577\n",
      "  Time 33: 0.570\n",
      "  Time 34: 0.558\n",
      "  Time 35: 0.543\n",
      "  Time 36: 0.523\n",
      "  Time 37: 0.500\n",
      "  Time 38: 0.473\n",
      "  Time 39: 0.442\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.538\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 0.167\n",
      "  To trajectory 4: 0.667\n",
      "  To trajectory 7: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.556\n",
      "  Time 31: 0.536\n",
      "  Time 32: 0.511\n",
      "  Time 33: 0.480\n",
      "  Time 34: 0.445\n",
      "  Time 35: 0.409\n",
      "  Time 36: 0.372\n",
      "  Time 37: 0.335\n",
      "  Time 38: 0.301\n",
      "  Time 39: 0.268\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 0.800\n",
      "  To trajectory 16: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.576\n",
      "  Time 31: 0.566\n",
      "  Time 32: 0.553\n",
      "  Time 33: 0.538\n",
      "  Time 34: 0.521\n",
      "  Time 35: 0.504\n",
      "  Time 36: 0.485\n",
      "  Time 37: 0.467\n",
      "  Time 38: 0.448\n",
      "  Time 39: 0.430\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.573\n",
      "  Time 31: 0.579\n",
      "  Time 32: 0.578\n",
      "  Time 33: 0.571\n",
      "  Time 34: 0.557\n",
      "  Time 35: 0.535\n",
      "  Time 36: 0.507\n",
      "  Time 37: 0.472\n",
      "  Time 38: 0.431\n",
      "  Time 39: 0.385\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.524\n",
      "  Time 31: 0.523\n",
      "  Time 32: 0.515\n",
      "  Time 33: 0.502\n",
      "  Time 34: 0.482\n",
      "  Time 35: 0.459\n",
      "  Time 36: 0.432\n",
      "  Time 37: 0.402\n",
      "  Time 38: 0.371\n",
      "  Time 39: 0.339\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.833\n",
      "  To trajectory 19: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.537\n",
      "  Time 31: 0.521\n",
      "  Time 32: 0.501\n",
      "  Time 33: 0.476\n",
      "  Time 34: 0.449\n",
      "  Time 35: 0.419\n",
      "  Time 36: 0.387\n",
      "  Time 37: 0.356\n",
      "  Time 38: 0.324\n",
      "  Time 39: 0.293\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.120\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.833\n",
      "  To trajectory 15: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.590\n",
      "  Time 31: 0.581\n",
      "  Time 32: 0.568\n",
      "  Time 33: 0.549\n",
      "  Time 34: 0.527\n",
      "  Time 35: 0.500\n",
      "  Time 36: 0.470\n",
      "  Time 37: 0.437\n",
      "  Time 38: 0.402\n",
      "  Time 39: 0.367\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 10: 0.667\n",
      "  To trajectory 18: 0.333\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.550\n",
      "  Time 31: 0.536\n",
      "  Time 32: 0.516\n",
      "  Time 33: 0.491\n",
      "  Time 34: 0.462\n",
      "  Time 35: 0.430\n",
      "  Time 36: 0.397\n",
      "  Time 37: 0.363\n",
      "  Time 38: 0.329\n",
      "  Time 39: 0.297\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.333\n",
      "  To trajectory 11: 0.667\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.609\n",
      "  Time 31: 0.615\n",
      "  Time 32: 0.613\n",
      "  Time 33: 0.603\n",
      "  Time 34: 0.586\n",
      "  Time 35: 0.561\n",
      "  Time 36: 0.529\n",
      "  Time 37: 0.490\n",
      "  Time 38: 0.447\n",
      "  Time 39: 0.399\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.167\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 4: 0.167\n",
      "  To trajectory 7: 0.167\n",
      "  To trajectory 12: 0.667\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.570\n",
      "  Time 31: 0.568\n",
      "  Time 32: 0.559\n",
      "  Time 33: 0.544\n",
      "  Time 34: 0.523\n",
      "  Time 35: 0.498\n",
      "  Time 36: 0.470\n",
      "  Time 37: 0.441\n",
      "  Time 38: 0.411\n",
      "  Time 39: 0.381\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.578\n",
      "  Time 31: 0.585\n",
      "  Time 32: 0.588\n",
      "  Time 33: 0.587\n",
      "  Time 34: 0.581\n",
      "  Time 35: 0.570\n",
      "  Time 36: 0.555\n",
      "  Time 37: 0.535\n",
      "  Time 38: 0.511\n",
      "  Time 39: 0.482\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.857\n",
      "  To trajectory 16: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.570\n",
      "  Time 31: 0.567\n",
      "  Time 32: 0.558\n",
      "  Time 33: 0.546\n",
      "  Time 34: 0.529\n",
      "  Time 35: 0.509\n",
      "  Time 36: 0.486\n",
      "  Time 37: 0.460\n",
      "  Time 38: 0.434\n",
      "  Time 39: 0.406\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 15: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.582\n",
      "  Time 31: 0.582\n",
      "  Time 32: 0.576\n",
      "  Time 33: 0.566\n",
      "  Time 34: 0.551\n",
      "  Time 35: 0.531\n",
      "  Time 36: 0.508\n",
      "  Time 37: 0.482\n",
      "  Time 38: 0.452\n",
      "  Time 39: 0.421\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.333\n",
      "  To trajectory 16: 0.667\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.537\n",
      "  Time 31: 0.535\n",
      "  Time 32: 0.527\n",
      "  Time 33: 0.514\n",
      "  Time 34: 0.495\n",
      "  Time 35: 0.472\n",
      "  Time 36: 0.445\n",
      "  Time 37: 0.414\n",
      "  Time 38: 0.382\n",
      "  Time 39: 0.348\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.500\n",
      "  To trajectory 17: 0.500\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.572\n",
      "  Time 31: 0.549\n",
      "  Time 32: 0.522\n",
      "  Time 33: 0.492\n",
      "  Time 34: 0.459\n",
      "  Time 35: 0.425\n",
      "  Time 36: 0.388\n",
      "  Time 37: 0.351\n",
      "  Time 38: 0.314\n",
      "  Time 39: 0.278\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.250\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.250\n",
      "  To trajectory 18: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.575\n",
      "  Time 31: 0.572\n",
      "  Time 32: 0.562\n",
      "  Time 33: 0.546\n",
      "  Time 34: 0.525\n",
      "  Time 35: 0.499\n",
      "  Time 36: 0.470\n",
      "  Time 37: 0.438\n",
      "  Time 38: 0.405\n",
      "  Time 39: 0.372\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 19: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.536\n",
      "  Time 31: 0.537\n",
      "  Time 32: 0.531\n",
      "  Time 33: 0.520\n",
      "  Time 34: 0.504\n",
      "  Time 35: 0.483\n",
      "  Time 36: 0.459\n",
      "  Time 37: 0.432\n",
      "  Time 38: 0.403\n",
      "  Time 39: 0.374\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_200000_210000_20241225_064324\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.143\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 0.857\n",
      "  To trajectory 13: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.532\n",
      "  Time 31: 0.529\n",
      "  Time 32: 0.523\n",
      "  Time 33: 0.512\n",
      "  Time 34: 0.497\n",
      "  Time 35: 0.479\n",
      "  Time 36: 0.459\n",
      "  Time 37: 0.435\n",
      "  Time 38: 0.410\n",
      "  Time 39: 0.384\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.714\n",
      "  To trajectory 7: 0.143\n",
      "  To trajectory 19: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.536\n",
      "  Time 31: 0.531\n",
      "  Time 32: 0.520\n",
      "  Time 33: 0.504\n",
      "  Time 34: 0.483\n",
      "  Time 35: 0.458\n",
      "  Time 36: 0.429\n",
      "  Time 37: 0.398\n",
      "  Time 38: 0.364\n",
      "  Time 39: 0.330\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.731\n",
      "  Time 31: 0.740\n",
      "  Time 32: 0.743\n",
      "  Time 33: 0.740\n",
      "  Time 34: 0.731\n",
      "  Time 35: 0.715\n",
      "  Time 36: 0.693\n",
      "  Time 37: 0.665\n",
      "  Time 38: 0.629\n",
      "  Time 39: 0.588\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 9\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 0.889\n",
      "  To trajectory 5: 0.111\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.547\n",
      "  Time 31: 0.542\n",
      "  Time 32: 0.533\n",
      "  Time 33: 0.520\n",
      "  Time 34: 0.503\n",
      "  Time 35: 0.483\n",
      "  Time 36: 0.459\n",
      "  Time 37: 0.433\n",
      "  Time 38: 0.405\n",
      "  Time 39: 0.376\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.538\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 0.200\n",
      "  To trajectory 4: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.548\n",
      "  Time 31: 0.530\n",
      "  Time 32: 0.506\n",
      "  Time 33: 0.477\n",
      "  Time 34: 0.444\n",
      "  Time 35: 0.410\n",
      "  Time 36: 0.375\n",
      "  Time 37: 0.340\n",
      "  Time 38: 0.307\n",
      "  Time 39: 0.276\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 9\n",
      "CAD risk: 0.111\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.568\n",
      "  Time 31: 0.577\n",
      "  Time 32: 0.580\n",
      "  Time 33: 0.578\n",
      "  Time 34: 0.571\n",
      "  Time 35: 0.558\n",
      "  Time 36: 0.541\n",
      "  Time 37: 0.520\n",
      "  Time 38: 0.495\n",
      "  Time 39: 0.467\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.587\n",
      "  Time 31: 0.593\n",
      "  Time 32: 0.592\n",
      "  Time 33: 0.585\n",
      "  Time 34: 0.571\n",
      "  Time 35: 0.550\n",
      "  Time 36: 0.522\n",
      "  Time 37: 0.487\n",
      "  Time 38: 0.445\n",
      "  Time 39: 0.400\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.533\n",
      "  Time 31: 0.533\n",
      "  Time 32: 0.527\n",
      "  Time 33: 0.514\n",
      "  Time 34: 0.496\n",
      "  Time 35: 0.472\n",
      "  Time 36: 0.444\n",
      "  Time 37: 0.412\n",
      "  Time 38: 0.377\n",
      "  Time 39: 0.341\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.833\n",
      "  To trajectory 19: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.532\n",
      "  Time 31: 0.516\n",
      "  Time 32: 0.495\n",
      "  Time 33: 0.470\n",
      "  Time 34: 0.443\n",
      "  Time 35: 0.413\n",
      "  Time 36: 0.382\n",
      "  Time 37: 0.351\n",
      "  Time 38: 0.320\n",
      "  Time 39: 0.290\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.119\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.857\n",
      "  To trajectory 15: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.572\n",
      "  Time 31: 0.570\n",
      "  Time 32: 0.563\n",
      "  Time 33: 0.551\n",
      "  Time 34: 0.535\n",
      "  Time 35: 0.514\n",
      "  Time 36: 0.490\n",
      "  Time 37: 0.463\n",
      "  Time 38: 0.433\n",
      "  Time 39: 0.402\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 10: 0.833\n",
      "  To trajectory 18: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.526\n",
      "  Time 31: 0.520\n",
      "  Time 32: 0.509\n",
      "  Time 33: 0.493\n",
      "  Time 34: 0.473\n",
      "  Time 35: 0.449\n",
      "  Time 36: 0.424\n",
      "  Time 37: 0.397\n",
      "  Time 38: 0.369\n",
      "  Time 39: 0.341\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.200\n",
      "  To trajectory 11: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.578\n",
      "  Time 31: 0.580\n",
      "  Time 32: 0.575\n",
      "  Time 33: 0.563\n",
      "  Time 34: 0.545\n",
      "  Time 35: 0.520\n",
      "  Time 36: 0.489\n",
      "  Time 37: 0.453\n",
      "  Time 38: 0.413\n",
      "  Time 39: 0.371\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.200\n",
      "  To trajectory 8: 0.200\n",
      "  To trajectory 12: 0.600\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.582\n",
      "  Time 31: 0.579\n",
      "  Time 32: 0.570\n",
      "  Time 33: 0.553\n",
      "  Time 34: 0.531\n",
      "  Time 35: 0.504\n",
      "  Time 36: 0.474\n",
      "  Time 37: 0.443\n",
      "  Time 38: 0.412\n",
      "  Time 39: 0.381\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.600\n",
      "  Time 31: 0.607\n",
      "  Time 32: 0.610\n",
      "  Time 33: 0.607\n",
      "  Time 34: 0.600\n",
      "  Time 35: 0.587\n",
      "  Time 36: 0.571\n",
      "  Time 37: 0.550\n",
      "  Time 38: 0.525\n",
      "  Time 39: 0.497\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.875\n",
      "  To trajectory 16: 0.125\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.562\n",
      "  Time 31: 0.559\n",
      "  Time 32: 0.552\n",
      "  Time 33: 0.540\n",
      "  Time 34: 0.525\n",
      "  Time 35: 0.505\n",
      "  Time 36: 0.483\n",
      "  Time 37: 0.457\n",
      "  Time 38: 0.430\n",
      "  Time 39: 0.401\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 15: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.561\n",
      "  Time 31: 0.562\n",
      "  Time 32: 0.557\n",
      "  Time 33: 0.547\n",
      "  Time 34: 0.532\n",
      "  Time 35: 0.513\n",
      "  Time 36: 0.489\n",
      "  Time 37: 0.460\n",
      "  Time 38: 0.429\n",
      "  Time 39: 0.394\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.200\n",
      "  To trajectory 16: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.528\n",
      "  Time 31: 0.540\n",
      "  Time 32: 0.547\n",
      "  Time 33: 0.549\n",
      "  Time 34: 0.545\n",
      "  Time 35: 0.538\n",
      "  Time 36: 0.526\n",
      "  Time 37: 0.511\n",
      "  Time 38: 0.492\n",
      "  Time 39: 0.472\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.250\n",
      "  To trajectory 17: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.559\n",
      "  Time 31: 0.551\n",
      "  Time 32: 0.538\n",
      "  Time 33: 0.522\n",
      "  Time 34: 0.501\n",
      "  Time 35: 0.476\n",
      "  Time 36: 0.448\n",
      "  Time 37: 0.418\n",
      "  Time 38: 0.385\n",
      "  Time 39: 0.352\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.167\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 18: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.570\n",
      "  Time 31: 0.572\n",
      "  Time 32: 0.570\n",
      "  Time 33: 0.562\n",
      "  Time 34: 0.548\n",
      "  Time 35: 0.531\n",
      "  Time 36: 0.509\n",
      "  Time 37: 0.484\n",
      "  Time 38: 0.456\n",
      "  Time 39: 0.427\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 19: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.554\n",
      "  Time 31: 0.552\n",
      "  Time 32: 0.545\n",
      "  Time 33: 0.532\n",
      "  Time 34: 0.515\n",
      "  Time 35: 0.494\n",
      "  Time 36: 0.470\n",
      "  Time 37: 0.444\n",
      "  Time 38: 0.418\n",
      "  Time 39: 0.391\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_20000_30000_20241225_093441\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 0.833\n",
      "  To trajectory 13: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.526\n",
      "  Time 31: 0.520\n",
      "  Time 32: 0.509\n",
      "  Time 33: 0.494\n",
      "  Time 34: 0.477\n",
      "  Time 35: 0.456\n",
      "  Time 36: 0.434\n",
      "  Time 37: 0.410\n",
      "  Time 38: 0.386\n",
      "  Time 39: 0.361\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.547\n",
      "  Time 31: 0.543\n",
      "  Time 32: 0.535\n",
      "  Time 33: 0.522\n",
      "  Time 34: 0.504\n",
      "  Time 35: 0.483\n",
      "  Time 36: 0.457\n",
      "  Time 37: 0.427\n",
      "  Time 38: 0.395\n",
      "  Time 39: 0.361\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.720\n",
      "  Time 31: 0.730\n",
      "  Time 32: 0.734\n",
      "  Time 33: 0.731\n",
      "  Time 34: 0.723\n",
      "  Time 35: 0.708\n",
      "  Time 36: 0.687\n",
      "  Time 37: 0.659\n",
      "  Time 38: 0.625\n",
      "  Time 39: 0.583\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.563\n",
      "  Time 31: 0.571\n",
      "  Time 32: 0.573\n",
      "  Time 33: 0.572\n",
      "  Time 34: 0.566\n",
      "  Time 35: 0.555\n",
      "  Time 36: 0.539\n",
      "  Time 37: 0.520\n",
      "  Time 38: 0.496\n",
      "  Time 39: 0.468\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.538\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 4: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.559\n",
      "  Time 31: 0.556\n",
      "  Time 32: 0.547\n",
      "  Time 33: 0.534\n",
      "  Time 34: 0.516\n",
      "  Time 35: 0.494\n",
      "  Time 36: 0.468\n",
      "  Time 37: 0.439\n",
      "  Time 38: 0.408\n",
      "  Time 39: 0.376\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.556\n",
      "  Time 31: 0.553\n",
      "  Time 32: 0.545\n",
      "  Time 33: 0.532\n",
      "  Time 34: 0.514\n",
      "  Time 35: 0.493\n",
      "  Time 36: 0.468\n",
      "  Time 37: 0.442\n",
      "  Time 38: 0.414\n",
      "  Time 39: 0.387\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.200\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 0.800\n",
      "  To trajectory 7: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.581\n",
      "  Time 31: 0.578\n",
      "  Time 32: 0.569\n",
      "  Time 33: 0.555\n",
      "  Time 34: 0.535\n",
      "  Time 35: 0.510\n",
      "  Time 36: 0.479\n",
      "  Time 37: 0.443\n",
      "  Time 38: 0.403\n",
      "  Time 39: 0.360\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.167\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.534\n",
      "  Time 31: 0.538\n",
      "  Time 32: 0.536\n",
      "  Time 33: 0.527\n",
      "  Time 34: 0.514\n",
      "  Time 35: 0.495\n",
      "  Time 36: 0.471\n",
      "  Time 37: 0.444\n",
      "  Time 38: 0.414\n",
      "  Time 39: 0.381\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.125\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.750\n",
      "  To trajectory 16: 0.125\n",
      "  To trajectory 19: 0.125\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.535\n",
      "  Time 31: 0.524\n",
      "  Time 32: 0.508\n",
      "  Time 33: 0.488\n",
      "  Time 34: 0.463\n",
      "  Time 35: 0.436\n",
      "  Time 36: 0.405\n",
      "  Time 37: 0.374\n",
      "  Time 38: 0.341\n",
      "  Time 39: 0.309\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.120\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.833\n",
      "  To trajectory 15: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.592\n",
      "  Time 31: 0.581\n",
      "  Time 32: 0.565\n",
      "  Time 33: 0.545\n",
      "  Time 34: 0.521\n",
      "  Time 35: 0.494\n",
      "  Time 36: 0.463\n",
      "  Time 37: 0.430\n",
      "  Time 38: 0.396\n",
      "  Time 39: 0.361\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 10: 0.750\n",
      "  To trajectory 18: 0.250\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.527\n",
      "  Time 31: 0.509\n",
      "  Time 32: 0.485\n",
      "  Time 33: 0.457\n",
      "  Time 34: 0.427\n",
      "  Time 35: 0.395\n",
      "  Time 36: 0.362\n",
      "  Time 37: 0.330\n",
      "  Time 38: 0.299\n",
      "  Time 39: 0.270\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.250\n",
      "  To trajectory 11: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.583\n",
      "  Time 31: 0.582\n",
      "  Time 32: 0.574\n",
      "  Time 33: 0.561\n",
      "  Time 34: 0.542\n",
      "  Time 35: 0.517\n",
      "  Time 36: 0.488\n",
      "  Time 37: 0.453\n",
      "  Time 38: 0.415\n",
      "  Time 39: 0.374\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.200\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.200\n",
      "  To trajectory 8: 0.200\n",
      "  To trajectory 12: 0.600\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.572\n",
      "  Time 31: 0.570\n",
      "  Time 32: 0.561\n",
      "  Time 33: 0.545\n",
      "  Time 34: 0.524\n",
      "  Time 35: 0.498\n",
      "  Time 36: 0.469\n",
      "  Time 37: 0.440\n",
      "  Time 38: 0.410\n",
      "  Time 39: 0.380\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.125\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.559\n",
      "  Time 31: 0.565\n",
      "  Time 32: 0.566\n",
      "  Time 33: 0.564\n",
      "  Time 34: 0.556\n",
      "  Time 35: 0.544\n",
      "  Time 36: 0.528\n",
      "  Time 37: 0.507\n",
      "  Time 38: 0.483\n",
      "  Time 39: 0.455\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.857\n",
      "  To trajectory 16: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.566\n",
      "  Time 31: 0.563\n",
      "  Time 32: 0.555\n",
      "  Time 33: 0.543\n",
      "  Time 34: 0.527\n",
      "  Time 35: 0.507\n",
      "  Time 36: 0.484\n",
      "  Time 37: 0.460\n",
      "  Time 38: 0.434\n",
      "  Time 39: 0.406\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 15: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.587\n",
      "  Time 31: 0.582\n",
      "  Time 32: 0.571\n",
      "  Time 33: 0.554\n",
      "  Time 34: 0.532\n",
      "  Time 35: 0.506\n",
      "  Time 36: 0.476\n",
      "  Time 37: 0.442\n",
      "  Time 38: 0.406\n",
      "  Time 39: 0.369\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.333\n",
      "  To trajectory 16: 0.667\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.532\n",
      "  Time 31: 0.533\n",
      "  Time 32: 0.529\n",
      "  Time 33: 0.522\n",
      "  Time 34: 0.512\n",
      "  Time 35: 0.499\n",
      "  Time 36: 0.483\n",
      "  Time 37: 0.466\n",
      "  Time 38: 0.448\n",
      "  Time 39: 0.428\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 17: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.549\n",
      "  Time 31: 0.544\n",
      "  Time 32: 0.535\n",
      "  Time 33: 0.522\n",
      "  Time 34: 0.507\n",
      "  Time 35: 0.488\n",
      "  Time 36: 0.467\n",
      "  Time 37: 0.443\n",
      "  Time 38: 0.417\n",
      "  Time 39: 0.390\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 18: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.569\n",
      "  Time 31: 0.562\n",
      "  Time 32: 0.549\n",
      "  Time 33: 0.532\n",
      "  Time 34: 0.509\n",
      "  Time 35: 0.483\n",
      "  Time 36: 0.454\n",
      "  Time 37: 0.424\n",
      "  Time 38: 0.392\n",
      "  Time 39: 0.361\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.167\n",
      "  To trajectory 19: 0.833\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.548\n",
      "  Time 31: 0.548\n",
      "  Time 32: 0.542\n",
      "  Time 33: 0.530\n",
      "  Time 34: 0.514\n",
      "  Time 35: 0.493\n",
      "  Time 36: 0.468\n",
      "  Time 37: 0.441\n",
      "  Time 38: 0.412\n",
      "  Time 39: 0.382\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_210000_220000_20241225_064324\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 0.800\n",
      "  To trajectory 13: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.541\n",
      "  Time 31: 0.527\n",
      "  Time 32: 0.508\n",
      "  Time 33: 0.484\n",
      "  Time 34: 0.457\n",
      "  Time 35: 0.426\n",
      "  Time 36: 0.394\n",
      "  Time 37: 0.362\n",
      "  Time 38: 0.329\n",
      "  Time 39: 0.298\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.833\n",
      "  To trajectory 19: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.542\n",
      "  Time 31: 0.538\n",
      "  Time 32: 0.530\n",
      "  Time 33: 0.517\n",
      "  Time 34: 0.499\n",
      "  Time 35: 0.477\n",
      "  Time 36: 0.451\n",
      "  Time 37: 0.422\n",
      "  Time 38: 0.391\n",
      "  Time 39: 0.357\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.730\n",
      "  Time 31: 0.739\n",
      "  Time 32: 0.742\n",
      "  Time 33: 0.739\n",
      "  Time 34: 0.731\n",
      "  Time 35: 0.716\n",
      "  Time 36: 0.694\n",
      "  Time 37: 0.667\n",
      "  Time 38: 0.632\n",
      "  Time 39: 0.592\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 0.833\n",
      "  To trajectory 17: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.560\n",
      "  Time 31: 0.562\n",
      "  Time 32: 0.559\n",
      "  Time 33: 0.551\n",
      "  Time 34: 0.538\n",
      "  Time 35: 0.521\n",
      "  Time 36: 0.499\n",
      "  Time 37: 0.474\n",
      "  Time 38: 0.445\n",
      "  Time 39: 0.413\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.539\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 4: 0.833\n",
      "  To trajectory 12: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.557\n",
      "  Time 31: 0.544\n",
      "  Time 32: 0.526\n",
      "  Time 33: 0.503\n",
      "  Time 34: 0.476\n",
      "  Time 35: 0.448\n",
      "  Time 36: 0.418\n",
      "  Time 37: 0.387\n",
      "  Time 38: 0.356\n",
      "  Time 39: 0.326\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.569\n",
      "  Time 31: 0.570\n",
      "  Time 32: 0.567\n",
      "  Time 33: 0.559\n",
      "  Time 34: 0.547\n",
      "  Time 35: 0.530\n",
      "  Time 36: 0.511\n",
      "  Time 37: 0.488\n",
      "  Time 38: 0.462\n",
      "  Time 39: 0.435\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.581\n",
      "  Time 31: 0.578\n",
      "  Time 32: 0.569\n",
      "  Time 33: 0.554\n",
      "  Time 34: 0.534\n",
      "  Time 35: 0.508\n",
      "  Time 36: 0.476\n",
      "  Time 37: 0.440\n",
      "  Time 38: 0.400\n",
      "  Time 39: 0.357\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.200\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 0.200\n",
      "  To trajectory 7: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.533\n",
      "  Time 31: 0.537\n",
      "  Time 32: 0.534\n",
      "  Time 33: 0.525\n",
      "  Time 34: 0.510\n",
      "  Time 35: 0.489\n",
      "  Time 36: 0.464\n",
      "  Time 37: 0.435\n",
      "  Time 38: 0.402\n",
      "  Time 39: 0.368\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.714\n",
      "  To trajectory 16: 0.143\n",
      "  To trajectory 19: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.532\n",
      "  Time 31: 0.518\n",
      "  Time 32: 0.499\n",
      "  Time 33: 0.476\n",
      "  Time 34: 0.449\n",
      "  Time 35: 0.419\n",
      "  Time 36: 0.388\n",
      "  Time 37: 0.356\n",
      "  Time 38: 0.323\n",
      "  Time 39: 0.292\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.119\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.800\n",
      "  To trajectory 15: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.606\n",
      "  Time 31: 0.599\n",
      "  Time 32: 0.586\n",
      "  Time 33: 0.568\n",
      "  Time 34: 0.545\n",
      "  Time 35: 0.519\n",
      "  Time 36: 0.488\n",
      "  Time 37: 0.455\n",
      "  Time 38: 0.420\n",
      "  Time 39: 0.384\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 10: 0.833\n",
      "  To trajectory 18: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.533\n",
      "  Time 31: 0.524\n",
      "  Time 32: 0.510\n",
      "  Time 33: 0.491\n",
      "  Time 34: 0.468\n",
      "  Time 35: 0.442\n",
      "  Time 36: 0.413\n",
      "  Time 37: 0.384\n",
      "  Time 38: 0.354\n",
      "  Time 39: 0.326\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.333\n",
      "  To trajectory 11: 0.667\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.610\n",
      "  Time 31: 0.616\n",
      "  Time 32: 0.614\n",
      "  Time 33: 0.605\n",
      "  Time 34: 0.588\n",
      "  Time 35: 0.564\n",
      "  Time 36: 0.533\n",
      "  Time 37: 0.495\n",
      "  Time 38: 0.452\n",
      "  Time 39: 0.405\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.200\n",
      "  To trajectory 8: 0.200\n",
      "  To trajectory 12: 0.600\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.570\n",
      "  Time 31: 0.568\n",
      "  Time 32: 0.559\n",
      "  Time 33: 0.543\n",
      "  Time 34: 0.522\n",
      "  Time 35: 0.496\n",
      "  Time 36: 0.467\n",
      "  Time 37: 0.438\n",
      "  Time 38: 0.408\n",
      "  Time 39: 0.378\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.574\n",
      "  Time 31: 0.580\n",
      "  Time 32: 0.580\n",
      "  Time 33: 0.577\n",
      "  Time 34: 0.568\n",
      "  Time 35: 0.556\n",
      "  Time 36: 0.539\n",
      "  Time 37: 0.518\n",
      "  Time 38: 0.494\n",
      "  Time 39: 0.467\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.833\n",
      "  To trajectory 16: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.576\n",
      "  Time 31: 0.572\n",
      "  Time 32: 0.563\n",
      "  Time 33: 0.550\n",
      "  Time 34: 0.534\n",
      "  Time 35: 0.514\n",
      "  Time 36: 0.491\n",
      "  Time 37: 0.466\n",
      "  Time 38: 0.440\n",
      "  Time 39: 0.413\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 15: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.597\n",
      "  Time 31: 0.609\n",
      "  Time 32: 0.614\n",
      "  Time 33: 0.612\n",
      "  Time 34: 0.605\n",
      "  Time 35: 0.593\n",
      "  Time 36: 0.576\n",
      "  Time 37: 0.555\n",
      "  Time 38: 0.530\n",
      "  Time 39: 0.503\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.200\n",
      "  To trajectory 16: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.529\n",
      "  Time 31: 0.525\n",
      "  Time 32: 0.517\n",
      "  Time 33: 0.505\n",
      "  Time 34: 0.490\n",
      "  Time 35: 0.471\n",
      "  Time 36: 0.449\n",
      "  Time 37: 0.426\n",
      "  Time 38: 0.401\n",
      "  Time 39: 0.375\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.250\n",
      "  To trajectory 17: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.569\n",
      "  Time 31: 0.564\n",
      "  Time 32: 0.556\n",
      "  Time 33: 0.543\n",
      "  Time 34: 0.526\n",
      "  Time 35: 0.505\n",
      "  Time 36: 0.481\n",
      "  Time 37: 0.454\n",
      "  Time 38: 0.424\n",
      "  Time 39: 0.392\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.167\n",
      "  To trajectory 18: 0.833\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.556\n",
      "  Time 31: 0.547\n",
      "  Time 32: 0.533\n",
      "  Time 33: 0.514\n",
      "  Time 34: 0.492\n",
      "  Time 35: 0.466\n",
      "  Time 36: 0.438\n",
      "  Time 37: 0.408\n",
      "  Time 38: 0.377\n",
      "  Time 39: 0.347\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 19: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.569\n",
      "  Time 31: 0.568\n",
      "  Time 32: 0.561\n",
      "  Time 33: 0.548\n",
      "  Time 34: 0.529\n",
      "  Time 35: 0.505\n",
      "  Time 36: 0.478\n",
      "  Time 37: 0.447\n",
      "  Time 38: 0.415\n",
      "  Time 39: 0.381\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_220000_230000_20241225_094650\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 0.800\n",
      "  To trajectory 13: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.543\n",
      "  Time 31: 0.533\n",
      "  Time 32: 0.519\n",
      "  Time 33: 0.502\n",
      "  Time 34: 0.482\n",
      "  Time 35: 0.460\n",
      "  Time 36: 0.436\n",
      "  Time 37: 0.411\n",
      "  Time 38: 0.386\n",
      "  Time 39: 0.362\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.548\n",
      "  Time 31: 0.543\n",
      "  Time 32: 0.533\n",
      "  Time 33: 0.517\n",
      "  Time 34: 0.497\n",
      "  Time 35: 0.472\n",
      "  Time 36: 0.443\n",
      "  Time 37: 0.411\n",
      "  Time 38: 0.376\n",
      "  Time 39: 0.341\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.718\n",
      "  Time 31: 0.727\n",
      "  Time 32: 0.730\n",
      "  Time 33: 0.727\n",
      "  Time 34: 0.718\n",
      "  Time 35: 0.702\n",
      "  Time 36: 0.680\n",
      "  Time 37: 0.651\n",
      "  Time 38: 0.616\n",
      "  Time 39: 0.576\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.563\n",
      "  Time 31: 0.570\n",
      "  Time 32: 0.573\n",
      "  Time 33: 0.571\n",
      "  Time 34: 0.565\n",
      "  Time 35: 0.554\n",
      "  Time 36: 0.538\n",
      "  Time 37: 0.518\n",
      "  Time 38: 0.494\n",
      "  Time 39: 0.466\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.538\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 0.143\n",
      "  To trajectory 4: 0.714\n",
      "  To trajectory 7: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.544\n",
      "  Time 31: 0.530\n",
      "  Time 32: 0.509\n",
      "  Time 33: 0.484\n",
      "  Time 34: 0.455\n",
      "  Time 35: 0.424\n",
      "  Time 36: 0.392\n",
      "  Time 37: 0.360\n",
      "  Time 38: 0.328\n",
      "  Time 39: 0.298\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 9\n",
      "CAD risk: 0.222\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.595\n",
      "  Time 31: 0.606\n",
      "  Time 32: 0.612\n",
      "  Time 33: 0.615\n",
      "  Time 34: 0.614\n",
      "  Time 35: 0.609\n",
      "  Time 36: 0.600\n",
      "  Time 37: 0.589\n",
      "  Time 38: 0.574\n",
      "  Time 39: 0.557\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.568\n",
      "  Time 31: 0.562\n",
      "  Time 32: 0.549\n",
      "  Time 33: 0.531\n",
      "  Time 34: 0.508\n",
      "  Time 35: 0.479\n",
      "  Time 36: 0.445\n",
      "  Time 37: 0.406\n",
      "  Time 38: 0.363\n",
      "  Time 39: 0.318\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.550\n",
      "  Time 31: 0.547\n",
      "  Time 32: 0.537\n",
      "  Time 33: 0.520\n",
      "  Time 34: 0.498\n",
      "  Time 35: 0.470\n",
      "  Time 36: 0.439\n",
      "  Time 37: 0.404\n",
      "  Time 38: 0.368\n",
      "  Time 39: 0.332\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.714\n",
      "  To trajectory 16: 0.143\n",
      "  To trajectory 19: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.537\n",
      "  Time 31: 0.526\n",
      "  Time 32: 0.510\n",
      "  Time 33: 0.490\n",
      "  Time 34: 0.465\n",
      "  Time 35: 0.437\n",
      "  Time 36: 0.407\n",
      "  Time 37: 0.375\n",
      "  Time 38: 0.343\n",
      "  Time 39: 0.310\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.119\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.800\n",
      "  To trajectory 15: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.609\n",
      "  Time 31: 0.601\n",
      "  Time 32: 0.589\n",
      "  Time 33: 0.571\n",
      "  Time 34: 0.548\n",
      "  Time 35: 0.521\n",
      "  Time 36: 0.491\n",
      "  Time 37: 0.457\n",
      "  Time 38: 0.422\n",
      "  Time 39: 0.386\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 10: 0.800\n",
      "  To trajectory 18: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.538\n",
      "  Time 31: 0.535\n",
      "  Time 32: 0.525\n",
      "  Time 33: 0.509\n",
      "  Time 34: 0.487\n",
      "  Time 35: 0.462\n",
      "  Time 36: 0.433\n",
      "  Time 37: 0.403\n",
      "  Time 38: 0.372\n",
      "  Time 39: 0.341\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.250\n",
      "  To trajectory 11: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.592\n",
      "  Time 31: 0.593\n",
      "  Time 32: 0.588\n",
      "  Time 33: 0.576\n",
      "  Time 34: 0.557\n",
      "  Time 35: 0.533\n",
      "  Time 36: 0.502\n",
      "  Time 37: 0.467\n",
      "  Time 38: 0.427\n",
      "  Time 39: 0.385\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.200\n",
      "  To trajectory 8: 0.200\n",
      "  To trajectory 12: 0.600\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.584\n",
      "  Time 31: 0.581\n",
      "  Time 32: 0.570\n",
      "  Time 33: 0.553\n",
      "  Time 34: 0.530\n",
      "  Time 35: 0.503\n",
      "  Time 36: 0.474\n",
      "  Time 37: 0.443\n",
      "  Time 38: 0.413\n",
      "  Time 39: 0.382\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.579\n",
      "  Time 31: 0.585\n",
      "  Time 32: 0.587\n",
      "  Time 33: 0.584\n",
      "  Time 34: 0.577\n",
      "  Time 35: 0.565\n",
      "  Time 36: 0.549\n",
      "  Time 37: 0.529\n",
      "  Time 38: 0.505\n",
      "  Time 39: 0.477\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.857\n",
      "  To trajectory 16: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.577\n",
      "  Time 31: 0.573\n",
      "  Time 32: 0.565\n",
      "  Time 33: 0.553\n",
      "  Time 34: 0.536\n",
      "  Time 35: 0.516\n",
      "  Time 36: 0.492\n",
      "  Time 37: 0.467\n",
      "  Time 38: 0.439\n",
      "  Time 39: 0.411\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 15: 0.857\n",
      "  To trajectory 16: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.567\n",
      "  Time 31: 0.562\n",
      "  Time 32: 0.552\n",
      "  Time 33: 0.538\n",
      "  Time 34: 0.519\n",
      "  Time 35: 0.497\n",
      "  Time 36: 0.471\n",
      "  Time 37: 0.442\n",
      "  Time 38: 0.411\n",
      "  Time 39: 0.379\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.167\n",
      "  To trajectory 16: 0.833\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.522\n",
      "  Time 31: 0.527\n",
      "  Time 32: 0.528\n",
      "  Time 33: 0.524\n",
      "  Time 34: 0.517\n",
      "  Time 35: 0.505\n",
      "  Time 36: 0.490\n",
      "  Time 37: 0.472\n",
      "  Time 38: 0.452\n",
      "  Time 39: 0.431\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 17: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.567\n",
      "  Time 31: 0.559\n",
      "  Time 32: 0.547\n",
      "  Time 33: 0.531\n",
      "  Time 34: 0.511\n",
      "  Time 35: 0.489\n",
      "  Time 36: 0.463\n",
      "  Time 37: 0.435\n",
      "  Time 38: 0.405\n",
      "  Time 39: 0.373\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.250\n",
      "  To trajectory 18: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.580\n",
      "  Time 31: 0.577\n",
      "  Time 32: 0.567\n",
      "  Time 33: 0.552\n",
      "  Time 34: 0.531\n",
      "  Time 35: 0.506\n",
      "  Time 36: 0.477\n",
      "  Time 37: 0.446\n",
      "  Time 38: 0.413\n",
      "  Time 39: 0.380\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 19: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.554\n",
      "  Time 31: 0.557\n",
      "  Time 32: 0.553\n",
      "  Time 33: 0.545\n",
      "  Time 34: 0.530\n",
      "  Time 35: 0.511\n",
      "  Time 36: 0.488\n",
      "  Time 37: 0.461\n",
      "  Time 38: 0.432\n",
      "  Time 39: 0.402\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_230000_240000_20241225_094700\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.536\n",
      "  Time 31: 0.527\n",
      "  Time 32: 0.512\n",
      "  Time 33: 0.492\n",
      "  Time 34: 0.468\n",
      "  Time 35: 0.440\n",
      "  Time 36: 0.410\n",
      "  Time 37: 0.379\n",
      "  Time 38: 0.347\n",
      "  Time 39: 0.316\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.143\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.857\n",
      "  To trajectory 7: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.544\n",
      "  Time 31: 0.539\n",
      "  Time 32: 0.529\n",
      "  Time 33: 0.513\n",
      "  Time 34: 0.492\n",
      "  Time 35: 0.467\n",
      "  Time 36: 0.438\n",
      "  Time 37: 0.406\n",
      "  Time 38: 0.372\n",
      "  Time 39: 0.337\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.742\n",
      "  Time 31: 0.751\n",
      "  Time 32: 0.754\n",
      "  Time 33: 0.751\n",
      "  Time 34: 0.742\n",
      "  Time 35: 0.727\n",
      "  Time 36: 0.706\n",
      "  Time 37: 0.679\n",
      "  Time 38: 0.645\n",
      "  Time 39: 0.604\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 0.833\n",
      "  To trajectory 5: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.566\n",
      "  Time 31: 0.565\n",
      "  Time 32: 0.559\n",
      "  Time 33: 0.550\n",
      "  Time 34: 0.537\n",
      "  Time 35: 0.522\n",
      "  Time 36: 0.504\n",
      "  Time 37: 0.483\n",
      "  Time 38: 0.460\n",
      "  Time 39: 0.433\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.538\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.250\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 4: 0.750\n",
      "  To trajectory 7: 0.250\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.574\n",
      "  Time 31: 0.561\n",
      "  Time 32: 0.543\n",
      "  Time 33: 0.518\n",
      "  Time 34: 0.489\n",
      "  Time 35: 0.456\n",
      "  Time 36: 0.421\n",
      "  Time 37: 0.385\n",
      "  Time 38: 0.350\n",
      "  Time 39: 0.316\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 9\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 0.111\n",
      "  To trajectory 5: 0.889\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.557\n",
      "  Time 31: 0.558\n",
      "  Time 32: 0.553\n",
      "  Time 33: 0.543\n",
      "  Time 34: 0.527\n",
      "  Time 35: 0.507\n",
      "  Time 36: 0.483\n",
      "  Time 37: 0.457\n",
      "  Time 38: 0.429\n",
      "  Time 39: 0.401\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.200\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.564\n",
      "  Time 31: 0.561\n",
      "  Time 32: 0.552\n",
      "  Time 33: 0.537\n",
      "  Time 34: 0.517\n",
      "  Time 35: 0.492\n",
      "  Time 36: 0.461\n",
      "  Time 37: 0.425\n",
      "  Time 38: 0.386\n",
      "  Time 39: 0.344\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 0.143\n",
      "  To trajectory 7: 0.714\n",
      "  To trajectory 9: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.526\n",
      "  Time 31: 0.522\n",
      "  Time 32: 0.512\n",
      "  Time 33: 0.496\n",
      "  Time 34: 0.474\n",
      "  Time 35: 0.447\n",
      "  Time 36: 0.416\n",
      "  Time 37: 0.383\n",
      "  Time 38: 0.347\n",
      "  Time 39: 0.312\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.833\n",
      "  To trajectory 19: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.545\n",
      "  Time 31: 0.534\n",
      "  Time 32: 0.517\n",
      "  Time 33: 0.496\n",
      "  Time 34: 0.471\n",
      "  Time 35: 0.443\n",
      "  Time 36: 0.412\n",
      "  Time 37: 0.380\n",
      "  Time 38: 0.347\n",
      "  Time 39: 0.315\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.120\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.800\n",
      "  To trajectory 15: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.613\n",
      "  Time 31: 0.606\n",
      "  Time 32: 0.594\n",
      "  Time 33: 0.577\n",
      "  Time 34: 0.555\n",
      "  Time 35: 0.528\n",
      "  Time 36: 0.498\n",
      "  Time 37: 0.465\n",
      "  Time 38: 0.429\n",
      "  Time 39: 0.393\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 10: 0.800\n",
      "  To trajectory 18: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.532\n",
      "  Time 31: 0.522\n",
      "  Time 32: 0.506\n",
      "  Time 33: 0.486\n",
      "  Time 34: 0.462\n",
      "  Time 35: 0.436\n",
      "  Time 36: 0.409\n",
      "  Time 37: 0.381\n",
      "  Time 38: 0.354\n",
      "  Time 39: 0.328\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.250\n",
      "  To trajectory 3: 0.250\n",
      "  To trajectory 11: 0.500\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.585\n",
      "  Time 31: 0.578\n",
      "  Time 32: 0.564\n",
      "  Time 33: 0.544\n",
      "  Time 34: 0.517\n",
      "  Time 35: 0.486\n",
      "  Time 36: 0.450\n",
      "  Time 37: 0.410\n",
      "  Time 38: 0.369\n",
      "  Time 39: 0.326\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 4: 0.167\n",
      "  To trajectory 7: 0.167\n",
      "  To trajectory 12: 0.667\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.575\n",
      "  Time 31: 0.573\n",
      "  Time 32: 0.563\n",
      "  Time 33: 0.548\n",
      "  Time 34: 0.526\n",
      "  Time 35: 0.500\n",
      "  Time 36: 0.472\n",
      "  Time 37: 0.442\n",
      "  Time 38: 0.411\n",
      "  Time 39: 0.381\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.601\n",
      "  Time 31: 0.613\n",
      "  Time 32: 0.619\n",
      "  Time 33: 0.620\n",
      "  Time 34: 0.616\n",
      "  Time 35: 0.606\n",
      "  Time 36: 0.590\n",
      "  Time 37: 0.570\n",
      "  Time 38: 0.544\n",
      "  Time 39: 0.514\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 9\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.889\n",
      "  To trajectory 16: 0.111\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.559\n",
      "  Time 31: 0.555\n",
      "  Time 32: 0.548\n",
      "  Time 33: 0.535\n",
      "  Time 34: 0.519\n",
      "  Time 35: 0.498\n",
      "  Time 36: 0.475\n",
      "  Time 37: 0.448\n",
      "  Time 38: 0.420\n",
      "  Time 39: 0.390\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 15: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.573\n",
      "  Time 31: 0.581\n",
      "  Time 32: 0.584\n",
      "  Time 33: 0.580\n",
      "  Time 34: 0.571\n",
      "  Time 35: 0.557\n",
      "  Time 36: 0.537\n",
      "  Time 37: 0.512\n",
      "  Time 38: 0.484\n",
      "  Time 39: 0.453\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.200\n",
      "  To trajectory 16: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.533\n",
      "  Time 31: 0.545\n",
      "  Time 32: 0.552\n",
      "  Time 33: 0.553\n",
      "  Time 34: 0.549\n",
      "  Time 35: 0.541\n",
      "  Time 36: 0.529\n",
      "  Time 37: 0.513\n",
      "  Time 38: 0.495\n",
      "  Time 39: 0.474\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.250\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.250\n",
      "  To trajectory 17: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.560\n",
      "  Time 31: 0.553\n",
      "  Time 32: 0.543\n",
      "  Time 33: 0.531\n",
      "  Time 34: 0.515\n",
      "  Time 35: 0.497\n",
      "  Time 36: 0.476\n",
      "  Time 37: 0.453\n",
      "  Time 38: 0.427\n",
      "  Time 39: 0.399\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.200\n",
      "  To trajectory 18: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.564\n",
      "  Time 31: 0.564\n",
      "  Time 32: 0.558\n",
      "  Time 33: 0.547\n",
      "  Time 34: 0.531\n",
      "  Time 35: 0.511\n",
      "  Time 36: 0.487\n",
      "  Time 37: 0.461\n",
      "  Time 38: 0.432\n",
      "  Time 39: 0.403\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 19: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.559\n",
      "  Time 31: 0.559\n",
      "  Time 32: 0.554\n",
      "  Time 33: 0.542\n",
      "  Time 34: 0.526\n",
      "  Time 35: 0.505\n",
      "  Time 36: 0.480\n",
      "  Time 37: 0.453\n",
      "  Time 38: 0.423\n",
      "  Time 39: 0.393\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_240000_250000_20241225_125056\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.167\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 0.833\n",
      "  To trajectory 13: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.530\n",
      "  Time 31: 0.521\n",
      "  Time 32: 0.507\n",
      "  Time 33: 0.489\n",
      "  Time 34: 0.467\n",
      "  Time 35: 0.441\n",
      "  Time 36: 0.413\n",
      "  Time 37: 0.383\n",
      "  Time 38: 0.352\n",
      "  Time 39: 0.322\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.541\n",
      "  Time 31: 0.537\n",
      "  Time 32: 0.529\n",
      "  Time 33: 0.516\n",
      "  Time 34: 0.498\n",
      "  Time 35: 0.476\n",
      "  Time 36: 0.450\n",
      "  Time 37: 0.421\n",
      "  Time 38: 0.389\n",
      "  Time 39: 0.356\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.726\n",
      "  Time 31: 0.735\n",
      "  Time 32: 0.739\n",
      "  Time 33: 0.736\n",
      "  Time 34: 0.727\n",
      "  Time 35: 0.712\n",
      "  Time 36: 0.690\n",
      "  Time 37: 0.662\n",
      "  Time 38: 0.627\n",
      "  Time 39: 0.586\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 0.833\n",
      "  To trajectory 5: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.563\n",
      "  Time 31: 0.561\n",
      "  Time 32: 0.555\n",
      "  Time 33: 0.545\n",
      "  Time 34: 0.531\n",
      "  Time 35: 0.514\n",
      "  Time 36: 0.494\n",
      "  Time 37: 0.472\n",
      "  Time 38: 0.447\n",
      "  Time 39: 0.419\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.538\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 4: 0.833\n",
      "  To trajectory 7: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.560\n",
      "  Time 31: 0.553\n",
      "  Time 32: 0.540\n",
      "  Time 33: 0.522\n",
      "  Time 34: 0.500\n",
      "  Time 35: 0.473\n",
      "  Time 36: 0.444\n",
      "  Time 37: 0.412\n",
      "  Time 38: 0.380\n",
      "  Time 39: 0.347\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 11\n",
      "CAD risk: 0.091\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.561\n",
      "  Time 31: 0.556\n",
      "  Time 32: 0.548\n",
      "  Time 33: 0.537\n",
      "  Time 34: 0.524\n",
      "  Time 35: 0.509\n",
      "  Time 36: 0.491\n",
      "  Time 37: 0.471\n",
      "  Time 38: 0.450\n",
      "  Time 39: 0.428\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.587\n",
      "  Time 31: 0.593\n",
      "  Time 32: 0.592\n",
      "  Time 33: 0.585\n",
      "  Time 34: 0.571\n",
      "  Time 35: 0.550\n",
      "  Time 36: 0.522\n",
      "  Time 37: 0.486\n",
      "  Time 38: 0.445\n",
      "  Time 39: 0.400\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.556\n",
      "  Time 31: 0.541\n",
      "  Time 32: 0.521\n",
      "  Time 33: 0.495\n",
      "  Time 34: 0.464\n",
      "  Time 35: 0.430\n",
      "  Time 36: 0.395\n",
      "  Time 37: 0.359\n",
      "  Time 38: 0.323\n",
      "  Time 39: 0.290\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.714\n",
      "  To trajectory 16: 0.143\n",
      "  To trajectory 19: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.534\n",
      "  Time 31: 0.520\n",
      "  Time 32: 0.502\n",
      "  Time 33: 0.479\n",
      "  Time 34: 0.452\n",
      "  Time 35: 0.423\n",
      "  Time 36: 0.393\n",
      "  Time 37: 0.361\n",
      "  Time 38: 0.329\n",
      "  Time 39: 0.297\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.119\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.800\n",
      "  To trajectory 15: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.609\n",
      "  Time 31: 0.602\n",
      "  Time 32: 0.589\n",
      "  Time 33: 0.571\n",
      "  Time 34: 0.549\n",
      "  Time 35: 0.522\n",
      "  Time 36: 0.492\n",
      "  Time 37: 0.459\n",
      "  Time 38: 0.424\n",
      "  Time 39: 0.388\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 10: 0.800\n",
      "  To trajectory 18: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.540\n",
      "  Time 31: 0.535\n",
      "  Time 32: 0.525\n",
      "  Time 33: 0.508\n",
      "  Time 34: 0.487\n",
      "  Time 35: 0.462\n",
      "  Time 36: 0.434\n",
      "  Time 37: 0.404\n",
      "  Time 38: 0.373\n",
      "  Time 39: 0.342\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.200\n",
      "  To trajectory 11: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.574\n",
      "  Time 31: 0.571\n",
      "  Time 32: 0.562\n",
      "  Time 33: 0.549\n",
      "  Time 34: 0.531\n",
      "  Time 35: 0.508\n",
      "  Time 36: 0.480\n",
      "  Time 37: 0.448\n",
      "  Time 38: 0.413\n",
      "  Time 39: 0.376\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.167\n",
      "  To trajectory 8: 0.167\n",
      "  To trajectory 12: 0.667\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.574\n",
      "  Time 31: 0.567\n",
      "  Time 32: 0.553\n",
      "  Time 33: 0.533\n",
      "  Time 34: 0.509\n",
      "  Time 35: 0.480\n",
      "  Time 36: 0.450\n",
      "  Time 37: 0.419\n",
      "  Time 38: 0.389\n",
      "  Time 39: 0.359\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.125\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.559\n",
      "  Time 31: 0.566\n",
      "  Time 32: 0.568\n",
      "  Time 33: 0.565\n",
      "  Time 34: 0.558\n",
      "  Time 35: 0.547\n",
      "  Time 36: 0.531\n",
      "  Time 37: 0.510\n",
      "  Time 38: 0.486\n",
      "  Time 39: 0.458\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.875\n",
      "  To trajectory 16: 0.125\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.567\n",
      "  Time 31: 0.564\n",
      "  Time 32: 0.556\n",
      "  Time 33: 0.545\n",
      "  Time 34: 0.529\n",
      "  Time 35: 0.509\n",
      "  Time 36: 0.486\n",
      "  Time 37: 0.460\n",
      "  Time 38: 0.433\n",
      "  Time 39: 0.404\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 15: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.574\n",
      "  Time 31: 0.570\n",
      "  Time 32: 0.562\n",
      "  Time 33: 0.550\n",
      "  Time 34: 0.533\n",
      "  Time 35: 0.513\n",
      "  Time 36: 0.489\n",
      "  Time 37: 0.463\n",
      "  Time 38: 0.434\n",
      "  Time 39: 0.404\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.200\n",
      "  To trajectory 16: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.534\n",
      "  Time 31: 0.545\n",
      "  Time 32: 0.552\n",
      "  Time 33: 0.553\n",
      "  Time 34: 0.549\n",
      "  Time 35: 0.540\n",
      "  Time 36: 0.528\n",
      "  Time 37: 0.512\n",
      "  Time 38: 0.493\n",
      "  Time 39: 0.472\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 17: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.555\n",
      "  Time 31: 0.548\n",
      "  Time 32: 0.537\n",
      "  Time 33: 0.523\n",
      "  Time 34: 0.505\n",
      "  Time 35: 0.484\n",
      "  Time 36: 0.460\n",
      "  Time 37: 0.434\n",
      "  Time 38: 0.406\n",
      "  Time 39: 0.377\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.250\n",
      "  To trajectory 18: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.579\n",
      "  Time 31: 0.574\n",
      "  Time 32: 0.564\n",
      "  Time 33: 0.549\n",
      "  Time 34: 0.529\n",
      "  Time 35: 0.505\n",
      "  Time 36: 0.477\n",
      "  Time 37: 0.447\n",
      "  Time 38: 0.415\n",
      "  Time 39: 0.384\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 19: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.557\n",
      "  Time 31: 0.556\n",
      "  Time 32: 0.548\n",
      "  Time 33: 0.535\n",
      "  Time 34: 0.516\n",
      "  Time 35: 0.492\n",
      "  Time 36: 0.464\n",
      "  Time 37: 0.434\n",
      "  Time 38: 0.401\n",
      "  Time 39: 0.369\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_250000_260000_20241225_125114\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 0.750\n",
      "  To trajectory 15: 0.250\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.540\n",
      "  Time 31: 0.537\n",
      "  Time 32: 0.530\n",
      "  Time 33: 0.520\n",
      "  Time 34: 0.506\n",
      "  Time 35: 0.490\n",
      "  Time 36: 0.471\n",
      "  Time 37: 0.451\n",
      "  Time 38: 0.430\n",
      "  Time 39: 0.408\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.833\n",
      "  To trajectory 19: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.571\n",
      "  Time 31: 0.567\n",
      "  Time 32: 0.559\n",
      "  Time 33: 0.546\n",
      "  Time 34: 0.529\n",
      "  Time 35: 0.507\n",
      "  Time 36: 0.481\n",
      "  Time 37: 0.451\n",
      "  Time 38: 0.419\n",
      "  Time 39: 0.384\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.730\n",
      "  Time 31: 0.739\n",
      "  Time 32: 0.741\n",
      "  Time 33: 0.738\n",
      "  Time 34: 0.729\n",
      "  Time 35: 0.714\n",
      "  Time 36: 0.692\n",
      "  Time 37: 0.664\n",
      "  Time 38: 0.630\n",
      "  Time 39: 0.590\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 0.714\n",
      "  To trajectory 5: 0.143\n",
      "  To trajectory 17: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.547\n",
      "  Time 31: 0.544\n",
      "  Time 32: 0.536\n",
      "  Time 33: 0.524\n",
      "  Time 34: 0.507\n",
      "  Time 35: 0.487\n",
      "  Time 36: 0.465\n",
      "  Time 37: 0.439\n",
      "  Time 38: 0.411\n",
      "  Time 39: 0.382\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.538\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 4: 0.800\n",
      "  To trajectory 7: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.574\n",
      "  Time 31: 0.567\n",
      "  Time 32: 0.555\n",
      "  Time 33: 0.537\n",
      "  Time 34: 0.515\n",
      "  Time 35: 0.489\n",
      "  Time 36: 0.460\n",
      "  Time 37: 0.429\n",
      "  Time 38: 0.398\n",
      "  Time 39: 0.366\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 9\n",
      "CAD risk: 0.222\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 0.111\n",
      "  To trajectory 5: 0.778\n",
      "  To trajectory 16: 0.111\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.555\n",
      "  Time 31: 0.548\n",
      "  Time 32: 0.537\n",
      "  Time 33: 0.523\n",
      "  Time 34: 0.504\n",
      "  Time 35: 0.484\n",
      "  Time 36: 0.461\n",
      "  Time 37: 0.437\n",
      "  Time 38: 0.413\n",
      "  Time 39: 0.389\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.598\n",
      "  Time 31: 0.598\n",
      "  Time 32: 0.592\n",
      "  Time 33: 0.581\n",
      "  Time 34: 0.562\n",
      "  Time 35: 0.538\n",
      "  Time 36: 0.507\n",
      "  Time 37: 0.470\n",
      "  Time 38: 0.427\n",
      "  Time 39: 0.381\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.530\n",
      "  Time 31: 0.534\n",
      "  Time 32: 0.531\n",
      "  Time 33: 0.523\n",
      "  Time 34: 0.508\n",
      "  Time 35: 0.487\n",
      "  Time 36: 0.462\n",
      "  Time 37: 0.432\n",
      "  Time 38: 0.400\n",
      "  Time 39: 0.365\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.569\n",
      "  Time 31: 0.563\n",
      "  Time 32: 0.553\n",
      "  Time 33: 0.538\n",
      "  Time 34: 0.520\n",
      "  Time 35: 0.499\n",
      "  Time 36: 0.474\n",
      "  Time 37: 0.446\n",
      "  Time 38: 0.416\n",
      "  Time 39: 0.385\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.119\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.833\n",
      "  To trajectory 15: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.585\n",
      "  Time 31: 0.576\n",
      "  Time 32: 0.562\n",
      "  Time 33: 0.544\n",
      "  Time 34: 0.521\n",
      "  Time 35: 0.494\n",
      "  Time 36: 0.464\n",
      "  Time 37: 0.432\n",
      "  Time 38: 0.397\n",
      "  Time 39: 0.362\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 10: 0.833\n",
      "  To trajectory 18: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.537\n",
      "  Time 31: 0.528\n",
      "  Time 32: 0.512\n",
      "  Time 33: 0.492\n",
      "  Time 34: 0.468\n",
      "  Time 35: 0.442\n",
      "  Time 36: 0.413\n",
      "  Time 37: 0.383\n",
      "  Time 38: 0.353\n",
      "  Time 39: 0.325\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.333\n",
      "  To trajectory 11: 0.667\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.599\n",
      "  Time 31: 0.604\n",
      "  Time 32: 0.603\n",
      "  Time 33: 0.593\n",
      "  Time 34: 0.577\n",
      "  Time 35: 0.552\n",
      "  Time 36: 0.521\n",
      "  Time 37: 0.483\n",
      "  Time 38: 0.440\n",
      "  Time 39: 0.394\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.200\n",
      "  To trajectory 8: 0.200\n",
      "  To trajectory 12: 0.600\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.584\n",
      "  Time 31: 0.582\n",
      "  Time 32: 0.573\n",
      "  Time 33: 0.558\n",
      "  Time 34: 0.535\n",
      "  Time 35: 0.508\n",
      "  Time 36: 0.478\n",
      "  Time 37: 0.447\n",
      "  Time 38: 0.415\n",
      "  Time 39: 0.383\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.604\n",
      "  Time 31: 0.613\n",
      "  Time 32: 0.616\n",
      "  Time 33: 0.615\n",
      "  Time 34: 0.608\n",
      "  Time 35: 0.596\n",
      "  Time 36: 0.580\n",
      "  Time 37: 0.559\n",
      "  Time 38: 0.533\n",
      "  Time 39: 0.504\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 9\n",
      "CAD risk: 0.111\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.889\n",
      "  To trajectory 16: 0.111\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.562\n",
      "  Time 31: 0.559\n",
      "  Time 32: 0.550\n",
      "  Time 33: 0.538\n",
      "  Time 34: 0.521\n",
      "  Time 35: 0.500\n",
      "  Time 36: 0.476\n",
      "  Time 37: 0.449\n",
      "  Time 38: 0.420\n",
      "  Time 39: 0.391\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 15: 0.833\n",
      "  To trajectory 16: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.571\n",
      "  Time 31: 0.570\n",
      "  Time 32: 0.564\n",
      "  Time 33: 0.553\n",
      "  Time 34: 0.538\n",
      "  Time 35: 0.519\n",
      "  Time 36: 0.495\n",
      "  Time 37: 0.469\n",
      "  Time 38: 0.439\n",
      "  Time 39: 0.407\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.200\n",
      "  To trajectory 16: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.530\n",
      "  Time 31: 0.541\n",
      "  Time 32: 0.548\n",
      "  Time 33: 0.549\n",
      "  Time 34: 0.545\n",
      "  Time 35: 0.537\n",
      "  Time 36: 0.526\n",
      "  Time 37: 0.510\n",
      "  Time 38: 0.492\n",
      "  Time 39: 0.472\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 17: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.562\n",
      "  Time 31: 0.552\n",
      "  Time 32: 0.538\n",
      "  Time 33: 0.521\n",
      "  Time 34: 0.501\n",
      "  Time 35: 0.478\n",
      "  Time 36: 0.453\n",
      "  Time 37: 0.426\n",
      "  Time 38: 0.397\n",
      "  Time 39: 0.368\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.143\n",
      "  To trajectory 18: 0.857\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.548\n",
      "  Time 31: 0.544\n",
      "  Time 32: 0.535\n",
      "  Time 33: 0.520\n",
      "  Time 34: 0.502\n",
      "  Time 35: 0.479\n",
      "  Time 36: 0.453\n",
      "  Time 37: 0.425\n",
      "  Time 38: 0.395\n",
      "  Time 39: 0.365\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 19: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.561\n",
      "  Time 31: 0.561\n",
      "  Time 32: 0.554\n",
      "  Time 33: 0.540\n",
      "  Time 34: 0.522\n",
      "  Time 35: 0.498\n",
      "  Time 36: 0.471\n",
      "  Time 37: 0.440\n",
      "  Time 38: 0.408\n",
      "  Time 39: 0.375\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_260000_270000_20241225_155547\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 0.750\n",
      "  To trajectory 13: 0.250\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.558\n",
      "  Time 31: 0.539\n",
      "  Time 32: 0.515\n",
      "  Time 33: 0.489\n",
      "  Time 34: 0.459\n",
      "  Time 35: 0.428\n",
      "  Time 36: 0.397\n",
      "  Time 37: 0.366\n",
      "  Time 38: 0.336\n",
      "  Time 39: 0.308\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.714\n",
      "  To trajectory 7: 0.143\n",
      "  To trajectory 11: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.548\n",
      "  Time 31: 0.537\n",
      "  Time 32: 0.521\n",
      "  Time 33: 0.499\n",
      "  Time 34: 0.472\n",
      "  Time 35: 0.441\n",
      "  Time 36: 0.406\n",
      "  Time 37: 0.370\n",
      "  Time 38: 0.333\n",
      "  Time 39: 0.297\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.713\n",
      "  Time 31: 0.722\n",
      "  Time 32: 0.725\n",
      "  Time 33: 0.722\n",
      "  Time 34: 0.713\n",
      "  Time 35: 0.698\n",
      "  Time 36: 0.676\n",
      "  Time 37: 0.648\n",
      "  Time 38: 0.613\n",
      "  Time 39: 0.573\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.559\n",
      "  Time 31: 0.565\n",
      "  Time 32: 0.567\n",
      "  Time 33: 0.564\n",
      "  Time 34: 0.557\n",
      "  Time 35: 0.546\n",
      "  Time 36: 0.531\n",
      "  Time 37: 0.512\n",
      "  Time 38: 0.489\n",
      "  Time 39: 0.461\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.538\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 0.143\n",
      "  To trajectory 4: 0.714\n",
      "  To trajectory 7: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.545\n",
      "  Time 31: 0.530\n",
      "  Time 32: 0.510\n",
      "  Time 33: 0.484\n",
      "  Time 34: 0.455\n",
      "  Time 35: 0.423\n",
      "  Time 36: 0.391\n",
      "  Time 37: 0.358\n",
      "  Time 38: 0.326\n",
      "  Time 39: 0.295\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 9\n",
      "CAD risk: 0.111\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.563\n",
      "  Time 31: 0.569\n",
      "  Time 32: 0.569\n",
      "  Time 33: 0.565\n",
      "  Time 34: 0.556\n",
      "  Time 35: 0.542\n",
      "  Time 36: 0.525\n",
      "  Time 37: 0.505\n",
      "  Time 38: 0.482\n",
      "  Time 39: 0.457\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.584\n",
      "  Time 31: 0.581\n",
      "  Time 32: 0.573\n",
      "  Time 33: 0.558\n",
      "  Time 34: 0.538\n",
      "  Time 35: 0.512\n",
      "  Time 36: 0.481\n",
      "  Time 37: 0.445\n",
      "  Time 38: 0.405\n",
      "  Time 39: 0.361\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 0.250\n",
      "  To trajectory 7: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.529\n",
      "  Time 31: 0.529\n",
      "  Time 32: 0.523\n",
      "  Time 33: 0.510\n",
      "  Time 34: 0.492\n",
      "  Time 35: 0.469\n",
      "  Time 36: 0.442\n",
      "  Time 37: 0.412\n",
      "  Time 38: 0.380\n",
      "  Time 39: 0.347\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.833\n",
      "  To trajectory 16: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.546\n",
      "  Time 31: 0.537\n",
      "  Time 32: 0.522\n",
      "  Time 33: 0.504\n",
      "  Time 34: 0.482\n",
      "  Time 35: 0.457\n",
      "  Time 36: 0.428\n",
      "  Time 37: 0.398\n",
      "  Time 38: 0.366\n",
      "  Time 39: 0.334\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.119\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.800\n",
      "  To trajectory 15: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.604\n",
      "  Time 31: 0.597\n",
      "  Time 32: 0.585\n",
      "  Time 33: 0.568\n",
      "  Time 34: 0.546\n",
      "  Time 35: 0.520\n",
      "  Time 36: 0.489\n",
      "  Time 37: 0.456\n",
      "  Time 38: 0.422\n",
      "  Time 39: 0.386\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 10: 0.667\n",
      "  To trajectory 18: 0.333\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.538\n",
      "  Time 31: 0.524\n",
      "  Time 32: 0.505\n",
      "  Time 33: 0.480\n",
      "  Time 34: 0.452\n",
      "  Time 35: 0.421\n",
      "  Time 36: 0.388\n",
      "  Time 37: 0.354\n",
      "  Time 38: 0.321\n",
      "  Time 39: 0.289\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.250\n",
      "  To trajectory 11: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.600\n",
      "  Time 31: 0.605\n",
      "  Time 32: 0.603\n",
      "  Time 33: 0.593\n",
      "  Time 34: 0.575\n",
      "  Time 35: 0.550\n",
      "  Time 36: 0.519\n",
      "  Time 37: 0.481\n",
      "  Time 38: 0.438\n",
      "  Time 39: 0.393\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.167\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.167\n",
      "  To trajectory 8: 0.167\n",
      "  To trajectory 12: 0.667\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.570\n",
      "  Time 31: 0.563\n",
      "  Time 32: 0.549\n",
      "  Time 33: 0.529\n",
      "  Time 34: 0.504\n",
      "  Time 35: 0.476\n",
      "  Time 36: 0.445\n",
      "  Time 37: 0.414\n",
      "  Time 38: 0.384\n",
      "  Time 39: 0.354\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.587\n",
      "  Time 31: 0.596\n",
      "  Time 32: 0.600\n",
      "  Time 33: 0.599\n",
      "  Time 34: 0.593\n",
      "  Time 35: 0.583\n",
      "  Time 36: 0.567\n",
      "  Time 37: 0.548\n",
      "  Time 38: 0.524\n",
      "  Time 39: 0.496\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.800\n",
      "  To trajectory 16: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.586\n",
      "  Time 31: 0.578\n",
      "  Time 32: 0.566\n",
      "  Time 33: 0.549\n",
      "  Time 34: 0.528\n",
      "  Time 35: 0.504\n",
      "  Time 36: 0.478\n",
      "  Time 37: 0.451\n",
      "  Time 38: 0.423\n",
      "  Time 39: 0.395\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.200\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.200\n",
      "  To trajectory 15: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.606\n",
      "  Time 31: 0.617\n",
      "  Time 32: 0.622\n",
      "  Time 33: 0.622\n",
      "  Time 34: 0.617\n",
      "  Time 35: 0.608\n",
      "  Time 36: 0.595\n",
      "  Time 37: 0.578\n",
      "  Time 38: 0.558\n",
      "  Time 39: 0.535\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.250\n",
      "  To trajectory 16: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.537\n",
      "  Time 31: 0.539\n",
      "  Time 32: 0.536\n",
      "  Time 33: 0.528\n",
      "  Time 34: 0.516\n",
      "  Time 35: 0.500\n",
      "  Time 36: 0.480\n",
      "  Time 37: 0.458\n",
      "  Time 38: 0.434\n",
      "  Time 39: 0.409\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 17: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.574\n",
      "  Time 31: 0.565\n",
      "  Time 32: 0.551\n",
      "  Time 33: 0.532\n",
      "  Time 34: 0.509\n",
      "  Time 35: 0.483\n",
      "  Time 36: 0.453\n",
      "  Time 37: 0.420\n",
      "  Time 38: 0.386\n",
      "  Time 39: 0.351\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 18: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.587\n",
      "  Time 31: 0.584\n",
      "  Time 32: 0.574\n",
      "  Time 33: 0.558\n",
      "  Time 34: 0.537\n",
      "  Time 35: 0.511\n",
      "  Time 36: 0.482\n",
      "  Time 37: 0.450\n",
      "  Time 38: 0.417\n",
      "  Time 39: 0.383\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 19: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.545\n",
      "  Time 31: 0.548\n",
      "  Time 32: 0.546\n",
      "  Time 33: 0.537\n",
      "  Time 34: 0.524\n",
      "  Time 35: 0.505\n",
      "  Time 36: 0.482\n",
      "  Time 37: 0.456\n",
      "  Time 38: 0.428\n",
      "  Time 39: 0.398\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_270000_280000_20241225_155604\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.534\n",
      "  Time 31: 0.532\n",
      "  Time 32: 0.525\n",
      "  Time 33: 0.513\n",
      "  Time 34: 0.497\n",
      "  Time 35: 0.477\n",
      "  Time 36: 0.454\n",
      "  Time 37: 0.429\n",
      "  Time 38: 0.403\n",
      "  Time 39: 0.375\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.833\n",
      "  To trajectory 19: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.539\n",
      "  Time 31: 0.542\n",
      "  Time 32: 0.539\n",
      "  Time 33: 0.531\n",
      "  Time 34: 0.518\n",
      "  Time 35: 0.499\n",
      "  Time 36: 0.475\n",
      "  Time 37: 0.446\n",
      "  Time 38: 0.414\n",
      "  Time 39: 0.379\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.717\n",
      "  Time 31: 0.726\n",
      "  Time 32: 0.729\n",
      "  Time 33: 0.726\n",
      "  Time 34: 0.718\n",
      "  Time 35: 0.702\n",
      "  Time 36: 0.681\n",
      "  Time 37: 0.653\n",
      "  Time 38: 0.618\n",
      "  Time 39: 0.578\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.167\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 0.833\n",
      "  To trajectory 5: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.567\n",
      "  Time 31: 0.565\n",
      "  Time 32: 0.558\n",
      "  Time 33: 0.548\n",
      "  Time 34: 0.534\n",
      "  Time 35: 0.518\n",
      "  Time 36: 0.499\n",
      "  Time 37: 0.477\n",
      "  Time 38: 0.452\n",
      "  Time 39: 0.425\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.538\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 0.200\n",
      "  To trajectory 4: 0.600\n",
      "  To trajectory 7: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.568\n",
      "  Time 31: 0.546\n",
      "  Time 32: 0.517\n",
      "  Time 33: 0.483\n",
      "  Time 34: 0.445\n",
      "  Time 35: 0.407\n",
      "  Time 36: 0.369\n",
      "  Time 37: 0.332\n",
      "  Time 38: 0.298\n",
      "  Time 39: 0.268\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.167\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 0.833\n",
      "  To trajectory 16: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.565\n",
      "  Time 31: 0.564\n",
      "  Time 32: 0.561\n",
      "  Time 33: 0.555\n",
      "  Time 34: 0.547\n",
      "  Time 35: 0.537\n",
      "  Time 36: 0.525\n",
      "  Time 37: 0.511\n",
      "  Time 38: 0.496\n",
      "  Time 39: 0.478\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.576\n",
      "  Time 31: 0.581\n",
      "  Time 32: 0.580\n",
      "  Time 33: 0.573\n",
      "  Time 34: 0.559\n",
      "  Time 35: 0.537\n",
      "  Time 36: 0.509\n",
      "  Time 37: 0.474\n",
      "  Time 38: 0.433\n",
      "  Time 39: 0.388\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 0.200\n",
      "  To trajectory 7: 0.600\n",
      "  To trajectory 18: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.527\n",
      "  Time 31: 0.528\n",
      "  Time 32: 0.521\n",
      "  Time 33: 0.508\n",
      "  Time 34: 0.490\n",
      "  Time 35: 0.466\n",
      "  Time 36: 0.437\n",
      "  Time 37: 0.406\n",
      "  Time 38: 0.372\n",
      "  Time 39: 0.337\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.857\n",
      "  To trajectory 19: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.535\n",
      "  Time 31: 0.520\n",
      "  Time 32: 0.502\n",
      "  Time 33: 0.479\n",
      "  Time 34: 0.452\n",
      "  Time 35: 0.423\n",
      "  Time 36: 0.392\n",
      "  Time 37: 0.361\n",
      "  Time 38: 0.328\n",
      "  Time 39: 0.297\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.119\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.833\n",
      "  To trajectory 15: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.592\n",
      "  Time 31: 0.591\n",
      "  Time 32: 0.586\n",
      "  Time 33: 0.576\n",
      "  Time 34: 0.560\n",
      "  Time 35: 0.540\n",
      "  Time 36: 0.516\n",
      "  Time 37: 0.488\n",
      "  Time 38: 0.457\n",
      "  Time 39: 0.425\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 10: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.564\n",
      "  Time 31: 0.559\n",
      "  Time 32: 0.548\n",
      "  Time 33: 0.531\n",
      "  Time 34: 0.510\n",
      "  Time 35: 0.484\n",
      "  Time 36: 0.456\n",
      "  Time 37: 0.427\n",
      "  Time 38: 0.397\n",
      "  Time 39: 0.368\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.250\n",
      "  To trajectory 11: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.588\n",
      "  Time 31: 0.587\n",
      "  Time 32: 0.580\n",
      "  Time 33: 0.566\n",
      "  Time 34: 0.547\n",
      "  Time 35: 0.523\n",
      "  Time 36: 0.493\n",
      "  Time 37: 0.458\n",
      "  Time 38: 0.419\n",
      "  Time 39: 0.379\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.200\n",
      "  To trajectory 8: 0.200\n",
      "  To trajectory 12: 0.600\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.584\n",
      "  Time 31: 0.581\n",
      "  Time 32: 0.572\n",
      "  Time 33: 0.556\n",
      "  Time 34: 0.533\n",
      "  Time 35: 0.506\n",
      "  Time 36: 0.476\n",
      "  Time 37: 0.445\n",
      "  Time 38: 0.413\n",
      "  Time 39: 0.382\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.575\n",
      "  Time 31: 0.581\n",
      "  Time 32: 0.582\n",
      "  Time 33: 0.579\n",
      "  Time 34: 0.572\n",
      "  Time 35: 0.560\n",
      "  Time 36: 0.544\n",
      "  Time 37: 0.524\n",
      "  Time 38: 0.500\n",
      "  Time 39: 0.472\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.125\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.875\n",
      "  To trajectory 16: 0.125\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.571\n",
      "  Time 31: 0.565\n",
      "  Time 32: 0.555\n",
      "  Time 33: 0.539\n",
      "  Time 34: 0.520\n",
      "  Time 35: 0.496\n",
      "  Time 36: 0.470\n",
      "  Time 37: 0.441\n",
      "  Time 38: 0.411\n",
      "  Time 39: 0.380\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 0.200\n",
      "  To trajectory 15: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.572\n",
      "  Time 31: 0.580\n",
      "  Time 32: 0.581\n",
      "  Time 33: 0.577\n",
      "  Time 34: 0.566\n",
      "  Time 35: 0.551\n",
      "  Time 36: 0.531\n",
      "  Time 37: 0.507\n",
      "  Time 38: 0.480\n",
      "  Time 39: 0.451\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.250\n",
      "  To trajectory 16: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.549\n",
      "  Time 31: 0.550\n",
      "  Time 32: 0.547\n",
      "  Time 33: 0.539\n",
      "  Time 34: 0.527\n",
      "  Time 35: 0.510\n",
      "  Time 36: 0.490\n",
      "  Time 37: 0.468\n",
      "  Time 38: 0.443\n",
      "  Time 39: 0.417\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 0.200\n",
      "  To trajectory 17: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.548\n",
      "  Time 31: 0.531\n",
      "  Time 32: 0.510\n",
      "  Time 33: 0.485\n",
      "  Time 34: 0.457\n",
      "  Time 35: 0.427\n",
      "  Time 36: 0.395\n",
      "  Time 37: 0.363\n",
      "  Time 38: 0.330\n",
      "  Time 39: 0.299\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 18: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.575\n",
      "  Time 31: 0.576\n",
      "  Time 32: 0.572\n",
      "  Time 33: 0.563\n",
      "  Time 34: 0.547\n",
      "  Time 35: 0.527\n",
      "  Time 36: 0.502\n",
      "  Time 37: 0.474\n",
      "  Time 38: 0.444\n",
      "  Time 39: 0.412\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 19: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.559\n",
      "  Time 31: 0.560\n",
      "  Time 32: 0.554\n",
      "  Time 33: 0.543\n",
      "  Time 34: 0.527\n",
      "  Time 35: 0.506\n",
      "  Time 36: 0.482\n",
      "  Time 37: 0.454\n",
      "  Time 38: 0.425\n",
      "  Time 39: 0.395\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_280000_290000_20241225_190119\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.566\n",
      "  Time 31: 0.578\n",
      "  Time 32: 0.585\n",
      "  Time 33: 0.587\n",
      "  Time 34: 0.584\n",
      "  Time 35: 0.575\n",
      "  Time 36: 0.562\n",
      "  Time 37: 0.545\n",
      "  Time 38: 0.525\n",
      "  Time 39: 0.503\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.535\n",
      "  Time 31: 0.531\n",
      "  Time 32: 0.523\n",
      "  Time 33: 0.510\n",
      "  Time 34: 0.492\n",
      "  Time 35: 0.470\n",
      "  Time 36: 0.444\n",
      "  Time 37: 0.415\n",
      "  Time 38: 0.384\n",
      "  Time 39: 0.350\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.500\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.729\n",
      "  Time 31: 0.738\n",
      "  Time 32: 0.741\n",
      "  Time 33: 0.738\n",
      "  Time 34: 0.729\n",
      "  Time 35: 0.714\n",
      "  Time 36: 0.693\n",
      "  Time 37: 0.665\n",
      "  Time 38: 0.631\n",
      "  Time 39: 0.591\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.568\n",
      "  Time 31: 0.575\n",
      "  Time 32: 0.577\n",
      "  Time 33: 0.575\n",
      "  Time 34: 0.569\n",
      "  Time 35: 0.558\n",
      "  Time 36: 0.542\n",
      "  Time 37: 0.522\n",
      "  Time 38: 0.498\n",
      "  Time 39: 0.470\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.538\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 4: 0.833\n",
      "  To trajectory 7: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.554\n",
      "  Time 31: 0.541\n",
      "  Time 32: 0.522\n",
      "  Time 33: 0.498\n",
      "  Time 34: 0.470\n",
      "  Time 35: 0.438\n",
      "  Time 36: 0.404\n",
      "  Time 37: 0.369\n",
      "  Time 38: 0.335\n",
      "  Time 39: 0.302\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.250\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.551\n",
      "  Time 31: 0.555\n",
      "  Time 32: 0.557\n",
      "  Time 33: 0.555\n",
      "  Time 34: 0.552\n",
      "  Time 35: 0.547\n",
      "  Time 36: 0.540\n",
      "  Time 37: 0.533\n",
      "  Time 38: 0.525\n",
      "  Time 39: 0.516\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.581\n",
      "  Time 31: 0.587\n",
      "  Time 32: 0.586\n",
      "  Time 33: 0.578\n",
      "  Time 34: 0.564\n",
      "  Time 35: 0.543\n",
      "  Time 36: 0.514\n",
      "  Time 37: 0.478\n",
      "  Time 38: 0.437\n",
      "  Time 39: 0.391\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.538\n",
      "  Time 31: 0.539\n",
      "  Time 32: 0.534\n",
      "  Time 33: 0.521\n",
      "  Time 34: 0.503\n",
      "  Time 35: 0.480\n",
      "  Time 36: 0.452\n",
      "  Time 37: 0.422\n",
      "  Time 38: 0.389\n",
      "  Time 39: 0.355\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.833\n",
      "  To trajectory 19: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.543\n",
      "  Time 31: 0.532\n",
      "  Time 32: 0.516\n",
      "  Time 33: 0.495\n",
      "  Time 34: 0.470\n",
      "  Time 35: 0.442\n",
      "  Time 36: 0.411\n",
      "  Time 37: 0.379\n",
      "  Time 38: 0.346\n",
      "  Time 39: 0.313\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.119\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.714\n",
      "  To trajectory 14: 0.143\n",
      "  To trajectory 15: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.572\n",
      "  Time 31: 0.570\n",
      "  Time 32: 0.563\n",
      "  Time 33: 0.551\n",
      "  Time 34: 0.534\n",
      "  Time 35: 0.513\n",
      "  Time 36: 0.488\n",
      "  Time 37: 0.460\n",
      "  Time 38: 0.430\n",
      "  Time 39: 0.398\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 10: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.530\n",
      "  Time 31: 0.527\n",
      "  Time 32: 0.519\n",
      "  Time 33: 0.506\n",
      "  Time 34: 0.490\n",
      "  Time 35: 0.470\n",
      "  Time 36: 0.448\n",
      "  Time 37: 0.424\n",
      "  Time 38: 0.399\n",
      "  Time 39: 0.373\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.250\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.250\n",
      "  To trajectory 11: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.592\n",
      "  Time 31: 0.590\n",
      "  Time 32: 0.583\n",
      "  Time 33: 0.569\n",
      "  Time 34: 0.550\n",
      "  Time 35: 0.525\n",
      "  Time 36: 0.495\n",
      "  Time 37: 0.461\n",
      "  Time 38: 0.422\n",
      "  Time 39: 0.382\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.200\n",
      "  To trajectory 8: 0.200\n",
      "  To trajectory 12: 0.600\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.591\n",
      "  Time 31: 0.589\n",
      "  Time 32: 0.580\n",
      "  Time 33: 0.563\n",
      "  Time 34: 0.541\n",
      "  Time 35: 0.514\n",
      "  Time 36: 0.485\n",
      "  Time 37: 0.454\n",
      "  Time 38: 0.423\n",
      "  Time 39: 0.392\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.167\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.585\n",
      "  Time 31: 0.592\n",
      "  Time 32: 0.595\n",
      "  Time 33: 0.592\n",
      "  Time 34: 0.585\n",
      "  Time 35: 0.572\n",
      "  Time 36: 0.556\n",
      "  Time 37: 0.535\n",
      "  Time 38: 0.510\n",
      "  Time 39: 0.482\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.875\n",
      "  To trajectory 16: 0.125\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.562\n",
      "  Time 31: 0.559\n",
      "  Time 32: 0.552\n",
      "  Time 33: 0.540\n",
      "  Time 34: 0.524\n",
      "  Time 35: 0.505\n",
      "  Time 36: 0.482\n",
      "  Time 37: 0.456\n",
      "  Time 38: 0.429\n",
      "  Time 39: 0.400\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 15: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.597\n",
      "  Time 31: 0.591\n",
      "  Time 32: 0.580\n",
      "  Time 33: 0.564\n",
      "  Time 34: 0.542\n",
      "  Time 35: 0.517\n",
      "  Time 36: 0.487\n",
      "  Time 37: 0.455\n",
      "  Time 38: 0.420\n",
      "  Time 39: 0.383\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.200\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.200\n",
      "  To trajectory 16: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.533\n",
      "  Time 31: 0.529\n",
      "  Time 32: 0.521\n",
      "  Time 33: 0.508\n",
      "  Time 34: 0.492\n",
      "  Time 35: 0.473\n",
      "  Time 36: 0.451\n",
      "  Time 37: 0.427\n",
      "  Time 38: 0.402\n",
      "  Time 39: 0.375\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.250\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.250\n",
      "  To trajectory 17: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.561\n",
      "  Time 31: 0.545\n",
      "  Time 32: 0.525\n",
      "  Time 33: 0.501\n",
      "  Time 34: 0.473\n",
      "  Time 35: 0.442\n",
      "  Time 36: 0.409\n",
      "  Time 37: 0.375\n",
      "  Time 38: 0.341\n",
      "  Time 39: 0.307\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 18: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.566\n",
      "  Time 31: 0.561\n",
      "  Time 32: 0.550\n",
      "  Time 33: 0.533\n",
      "  Time 34: 0.510\n",
      "  Time 35: 0.483\n",
      "  Time 36: 0.453\n",
      "  Time 37: 0.419\n",
      "  Time 38: 0.385\n",
      "  Time 39: 0.351\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 19: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.549\n",
      "  Time 31: 0.551\n",
      "  Time 32: 0.547\n",
      "  Time 33: 0.537\n",
      "  Time 34: 0.522\n",
      "  Time 35: 0.501\n",
      "  Time 36: 0.476\n",
      "  Time 37: 0.448\n",
      "  Time 38: 0.417\n",
      "  Time 39: 0.385\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_290000_300000_20241225_190127\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.542\n",
      "  Time 31: 0.538\n",
      "  Time 32: 0.531\n",
      "  Time 33: 0.520\n",
      "  Time 34: 0.505\n",
      "  Time 35: 0.488\n",
      "  Time 36: 0.468\n",
      "  Time 37: 0.447\n",
      "  Time 38: 0.424\n",
      "  Time 39: 0.401\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.547\n",
      "  Time 31: 0.544\n",
      "  Time 32: 0.535\n",
      "  Time 33: 0.522\n",
      "  Time 34: 0.505\n",
      "  Time 35: 0.483\n",
      "  Time 36: 0.457\n",
      "  Time 37: 0.427\n",
      "  Time 38: 0.395\n",
      "  Time 39: 0.361\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.710\n",
      "  Time 31: 0.720\n",
      "  Time 32: 0.723\n",
      "  Time 33: 0.720\n",
      "  Time 34: 0.711\n",
      "  Time 35: 0.695\n",
      "  Time 36: 0.673\n",
      "  Time 37: 0.644\n",
      "  Time 38: 0.609\n",
      "  Time 39: 0.568\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.579\n",
      "  Time 31: 0.589\n",
      "  Time 32: 0.594\n",
      "  Time 33: 0.594\n",
      "  Time 34: 0.590\n",
      "  Time 35: 0.581\n",
      "  Time 36: 0.568\n",
      "  Time 37: 0.551\n",
      "  Time 38: 0.529\n",
      "  Time 39: 0.502\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.538\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 0.250\n",
      "  To trajectory 4: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.573\n",
      "  Time 31: 0.551\n",
      "  Time 32: 0.524\n",
      "  Time 33: 0.491\n",
      "  Time 34: 0.456\n",
      "  Time 35: 0.420\n",
      "  Time 36: 0.384\n",
      "  Time 37: 0.350\n",
      "  Time 38: 0.319\n",
      "  Time 39: 0.290\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 11\n",
      "CAD risk: 0.182\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 0.909\n",
      "  To trajectory 16: 0.091\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.561\n",
      "  Time 31: 0.557\n",
      "  Time 32: 0.549\n",
      "  Time 33: 0.536\n",
      "  Time 34: 0.520\n",
      "  Time 35: 0.501\n",
      "  Time 36: 0.479\n",
      "  Time 37: 0.455\n",
      "  Time 38: 0.430\n",
      "  Time 39: 0.404\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.577\n",
      "  Time 31: 0.583\n",
      "  Time 32: 0.584\n",
      "  Time 33: 0.579\n",
      "  Time 34: 0.569\n",
      "  Time 35: 0.552\n",
      "  Time 36: 0.528\n",
      "  Time 37: 0.499\n",
      "  Time 38: 0.463\n",
      "  Time 39: 0.423\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.800\n",
      "  To trajectory 18: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.527\n",
      "  Time 31: 0.533\n",
      "  Time 32: 0.532\n",
      "  Time 33: 0.526\n",
      "  Time 34: 0.513\n",
      "  Time 35: 0.496\n",
      "  Time 36: 0.474\n",
      "  Time 37: 0.449\n",
      "  Time 38: 0.421\n",
      "  Time 39: 0.391\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.551\n",
      "  Time 31: 0.540\n",
      "  Time 32: 0.526\n",
      "  Time 33: 0.507\n",
      "  Time 34: 0.485\n",
      "  Time 35: 0.460\n",
      "  Time 36: 0.431\n",
      "  Time 37: 0.401\n",
      "  Time 38: 0.369\n",
      "  Time 39: 0.336\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.120\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.800\n",
      "  To trajectory 15: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.603\n",
      "  Time 31: 0.596\n",
      "  Time 32: 0.583\n",
      "  Time 33: 0.566\n",
      "  Time 34: 0.543\n",
      "  Time 35: 0.517\n",
      "  Time 36: 0.487\n",
      "  Time 37: 0.454\n",
      "  Time 38: 0.419\n",
      "  Time 39: 0.383\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 10: 0.800\n",
      "  To trajectory 18: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.520\n",
      "  Time 31: 0.519\n",
      "  Time 32: 0.512\n",
      "  Time 33: 0.499\n",
      "  Time 34: 0.481\n",
      "  Time 35: 0.459\n",
      "  Time 36: 0.433\n",
      "  Time 37: 0.405\n",
      "  Time 38: 0.375\n",
      "  Time 39: 0.344\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.200\n",
      "  To trajectory 11: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.578\n",
      "  Time 31: 0.580\n",
      "  Time 32: 0.575\n",
      "  Time 33: 0.563\n",
      "  Time 34: 0.545\n",
      "  Time 35: 0.520\n",
      "  Time 36: 0.490\n",
      "  Time 37: 0.454\n",
      "  Time 38: 0.415\n",
      "  Time 39: 0.373\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.167\n",
      "  To trajectory 8: 0.167\n",
      "  To trajectory 12: 0.667\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.562\n",
      "  Time 31: 0.555\n",
      "  Time 32: 0.541\n",
      "  Time 33: 0.522\n",
      "  Time 34: 0.497\n",
      "  Time 35: 0.470\n",
      "  Time 36: 0.440\n",
      "  Time 37: 0.410\n",
      "  Time 38: 0.380\n",
      "  Time 39: 0.351\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.200\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.608\n",
      "  Time 31: 0.617\n",
      "  Time 32: 0.621\n",
      "  Time 33: 0.619\n",
      "  Time 34: 0.613\n",
      "  Time 35: 0.601\n",
      "  Time 36: 0.585\n",
      "  Time 37: 0.564\n",
      "  Time 38: 0.539\n",
      "  Time 39: 0.510\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.857\n",
      "  To trajectory 16: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.566\n",
      "  Time 31: 0.563\n",
      "  Time 32: 0.555\n",
      "  Time 33: 0.542\n",
      "  Time 34: 0.525\n",
      "  Time 35: 0.505\n",
      "  Time 36: 0.482\n",
      "  Time 37: 0.456\n",
      "  Time 38: 0.429\n",
      "  Time 39: 0.401\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 15: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.575\n",
      "  Time 31: 0.576\n",
      "  Time 32: 0.572\n",
      "  Time 33: 0.563\n",
      "  Time 34: 0.549\n",
      "  Time 35: 0.531\n",
      "  Time 36: 0.509\n",
      "  Time 37: 0.483\n",
      "  Time 38: 0.453\n",
      "  Time 39: 0.421\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.250\n",
      "  To trajectory 16: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.543\n",
      "  Time 31: 0.544\n",
      "  Time 32: 0.541\n",
      "  Time 33: 0.533\n",
      "  Time 34: 0.520\n",
      "  Time 35: 0.504\n",
      "  Time 36: 0.484\n",
      "  Time 37: 0.462\n",
      "  Time 38: 0.438\n",
      "  Time 39: 0.412\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.200\n",
      "  To trajectory 17: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.562\n",
      "  Time 31: 0.557\n",
      "  Time 32: 0.548\n",
      "  Time 33: 0.535\n",
      "  Time 34: 0.520\n",
      "  Time 35: 0.501\n",
      "  Time 36: 0.481\n",
      "  Time 37: 0.458\n",
      "  Time 38: 0.434\n",
      "  Time 39: 0.409\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 18: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.565\n",
      "  Time 31: 0.560\n",
      "  Time 32: 0.548\n",
      "  Time 33: 0.532\n",
      "  Time 34: 0.511\n",
      "  Time 35: 0.487\n",
      "  Time 36: 0.459\n",
      "  Time 37: 0.429\n",
      "  Time 38: 0.397\n",
      "  Time 39: 0.366\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.143\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 19: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.550\n",
      "  Time 31: 0.551\n",
      "  Time 32: 0.546\n",
      "  Time 33: 0.536\n",
      "  Time 34: 0.521\n",
      "  Time 35: 0.501\n",
      "  Time 36: 0.477\n",
      "  Time 37: 0.450\n",
      "  Time 38: 0.421\n",
      "  Time 39: 0.390\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_300000_310000_20241225_220551\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 0.750\n",
      "  To trajectory 13: 0.250\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.551\n",
      "  Time 31: 0.548\n",
      "  Time 32: 0.541\n",
      "  Time 33: 0.531\n",
      "  Time 34: 0.518\n",
      "  Time 35: 0.501\n",
      "  Time 36: 0.482\n",
      "  Time 37: 0.461\n",
      "  Time 38: 0.438\n",
      "  Time 39: 0.414\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.167\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.550\n",
      "  Time 31: 0.547\n",
      "  Time 32: 0.538\n",
      "  Time 33: 0.525\n",
      "  Time 34: 0.508\n",
      "  Time 35: 0.486\n",
      "  Time 36: 0.460\n",
      "  Time 37: 0.430\n",
      "  Time 38: 0.398\n",
      "  Time 39: 0.364\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.713\n",
      "  Time 31: 0.723\n",
      "  Time 32: 0.726\n",
      "  Time 33: 0.723\n",
      "  Time 34: 0.713\n",
      "  Time 35: 0.698\n",
      "  Time 36: 0.676\n",
      "  Time 37: 0.647\n",
      "  Time 38: 0.613\n",
      "  Time 39: 0.572\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 0.857\n",
      "  To trajectory 5: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.549\n",
      "  Time 31: 0.548\n",
      "  Time 32: 0.543\n",
      "  Time 33: 0.534\n",
      "  Time 34: 0.521\n",
      "  Time 35: 0.504\n",
      "  Time 36: 0.485\n",
      "  Time 37: 0.463\n",
      "  Time 38: 0.438\n",
      "  Time 39: 0.410\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.538\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.200\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 0.200\n",
      "  To trajectory 4: 0.600\n",
      "  To trajectory 7: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.569\n",
      "  Time 31: 0.546\n",
      "  Time 32: 0.518\n",
      "  Time 33: 0.484\n",
      "  Time 34: 0.447\n",
      "  Time 35: 0.409\n",
      "  Time 36: 0.371\n",
      "  Time 37: 0.334\n",
      "  Time 38: 0.300\n",
      "  Time 39: 0.270\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.572\n",
      "  Time 31: 0.576\n",
      "  Time 32: 0.577\n",
      "  Time 33: 0.574\n",
      "  Time 34: 0.567\n",
      "  Time 35: 0.557\n",
      "  Time 36: 0.543\n",
      "  Time 37: 0.526\n",
      "  Time 38: 0.507\n",
      "  Time 39: 0.484\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.593\n",
      "  Time 31: 0.599\n",
      "  Time 32: 0.598\n",
      "  Time 33: 0.590\n",
      "  Time 34: 0.576\n",
      "  Time 35: 0.555\n",
      "  Time 36: 0.526\n",
      "  Time 37: 0.491\n",
      "  Time 38: 0.449\n",
      "  Time 39: 0.403\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.522\n",
      "  Time 31: 0.524\n",
      "  Time 32: 0.520\n",
      "  Time 33: 0.509\n",
      "  Time 34: 0.492\n",
      "  Time 35: 0.470\n",
      "  Time 36: 0.444\n",
      "  Time 37: 0.415\n",
      "  Time 38: 0.383\n",
      "  Time 39: 0.350\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.200\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.559\n",
      "  Time 31: 0.547\n",
      "  Time 32: 0.530\n",
      "  Time 33: 0.511\n",
      "  Time 34: 0.488\n",
      "  Time 35: 0.462\n",
      "  Time 36: 0.434\n",
      "  Time 37: 0.404\n",
      "  Time 38: 0.374\n",
      "  Time 39: 0.343\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.119\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.857\n",
      "  To trajectory 15: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.577\n",
      "  Time 31: 0.575\n",
      "  Time 32: 0.568\n",
      "  Time 33: 0.557\n",
      "  Time 34: 0.540\n",
      "  Time 35: 0.520\n",
      "  Time 36: 0.495\n",
      "  Time 37: 0.467\n",
      "  Time 38: 0.437\n",
      "  Time 39: 0.405\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 0.200\n",
      "  To trajectory 10: 0.600\n",
      "  To trajectory 18: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.524\n",
      "  Time 31: 0.521\n",
      "  Time 32: 0.510\n",
      "  Time 33: 0.493\n",
      "  Time 34: 0.470\n",
      "  Time 35: 0.443\n",
      "  Time 36: 0.413\n",
      "  Time 37: 0.380\n",
      "  Time 38: 0.348\n",
      "  Time 39: 0.317\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.333\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.333\n",
      "  To trajectory 11: 0.667\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.635\n",
      "  Time 31: 0.640\n",
      "  Time 32: 0.638\n",
      "  Time 33: 0.629\n",
      "  Time 34: 0.613\n",
      "  Time 35: 0.589\n",
      "  Time 36: 0.558\n",
      "  Time 37: 0.521\n",
      "  Time 38: 0.477\n",
      "  Time 39: 0.430\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.200\n",
      "  To trajectory 8: 0.200\n",
      "  To trajectory 12: 0.600\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.575\n",
      "  Time 31: 0.573\n",
      "  Time 32: 0.563\n",
      "  Time 33: 0.547\n",
      "  Time 34: 0.524\n",
      "  Time 35: 0.497\n",
      "  Time 36: 0.467\n",
      "  Time 37: 0.436\n",
      "  Time 38: 0.405\n",
      "  Time 39: 0.374\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.592\n",
      "  Time 31: 0.600\n",
      "  Time 32: 0.604\n",
      "  Time 33: 0.602\n",
      "  Time 34: 0.596\n",
      "  Time 35: 0.585\n",
      "  Time 36: 0.568\n",
      "  Time 37: 0.548\n",
      "  Time 38: 0.522\n",
      "  Time 39: 0.494\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.875\n",
      "  To trajectory 16: 0.125\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.564\n",
      "  Time 31: 0.561\n",
      "  Time 32: 0.553\n",
      "  Time 33: 0.541\n",
      "  Time 34: 0.525\n",
      "  Time 35: 0.505\n",
      "  Time 36: 0.482\n",
      "  Time 37: 0.457\n",
      "  Time 38: 0.430\n",
      "  Time 39: 0.402\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.250\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 15: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.570\n",
      "  Time 31: 0.568\n",
      "  Time 32: 0.560\n",
      "  Time 33: 0.547\n",
      "  Time 34: 0.528\n",
      "  Time 35: 0.505\n",
      "  Time 36: 0.476\n",
      "  Time 37: 0.444\n",
      "  Time 38: 0.408\n",
      "  Time 39: 0.370\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.250\n",
      "  To trajectory 16: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.536\n",
      "  Time 31: 0.537\n",
      "  Time 32: 0.534\n",
      "  Time 33: 0.527\n",
      "  Time 34: 0.515\n",
      "  Time 35: 0.499\n",
      "  Time 36: 0.480\n",
      "  Time 37: 0.458\n",
      "  Time 38: 0.435\n",
      "  Time 39: 0.409\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 17: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.630\n",
      "  Time 31: 0.615\n",
      "  Time 32: 0.596\n",
      "  Time 33: 0.572\n",
      "  Time 34: 0.545\n",
      "  Time 35: 0.515\n",
      "  Time 36: 0.481\n",
      "  Time 37: 0.446\n",
      "  Time 38: 0.409\n",
      "  Time 39: 0.372\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.167\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.167\n",
      "  To trajectory 18: 0.833\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.557\n",
      "  Time 31: 0.548\n",
      "  Time 32: 0.535\n",
      "  Time 33: 0.517\n",
      "  Time 34: 0.494\n",
      "  Time 35: 0.469\n",
      "  Time 36: 0.440\n",
      "  Time 37: 0.410\n",
      "  Time 38: 0.380\n",
      "  Time 39: 0.350\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 19: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.565\n",
      "  Time 31: 0.564\n",
      "  Time 32: 0.557\n",
      "  Time 33: 0.544\n",
      "  Time 34: 0.526\n",
      "  Time 35: 0.502\n",
      "  Time 36: 0.475\n",
      "  Time 37: 0.444\n",
      "  Time 38: 0.411\n",
      "  Time 39: 0.378\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_30000_40000_20241225_093452\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 0.833\n",
      "  To trajectory 13: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.540\n",
      "  Time 31: 0.532\n",
      "  Time 32: 0.520\n",
      "  Time 33: 0.503\n",
      "  Time 34: 0.483\n",
      "  Time 35: 0.459\n",
      "  Time 36: 0.433\n",
      "  Time 37: 0.406\n",
      "  Time 38: 0.377\n",
      "  Time 39: 0.349\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.557\n",
      "  Time 31: 0.552\n",
      "  Time 32: 0.542\n",
      "  Time 33: 0.527\n",
      "  Time 34: 0.506\n",
      "  Time 35: 0.481\n",
      "  Time 36: 0.452\n",
      "  Time 37: 0.420\n",
      "  Time 38: 0.385\n",
      "  Time 39: 0.349\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.737\n",
      "  Time 31: 0.746\n",
      "  Time 32: 0.749\n",
      "  Time 33: 0.746\n",
      "  Time 34: 0.737\n",
      "  Time 35: 0.722\n",
      "  Time 36: 0.701\n",
      "  Time 37: 0.673\n",
      "  Time 38: 0.639\n",
      "  Time 39: 0.598\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 0.857\n",
      "  To trajectory 5: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.547\n",
      "  Time 31: 0.540\n",
      "  Time 32: 0.529\n",
      "  Time 33: 0.515\n",
      "  Time 34: 0.498\n",
      "  Time 35: 0.477\n",
      "  Time 36: 0.455\n",
      "  Time 37: 0.430\n",
      "  Time 38: 0.403\n",
      "  Time 39: 0.374\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.539\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 4: 0.750\n",
      "  To trajectory 7: 0.250\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.568\n",
      "  Time 31: 0.555\n",
      "  Time 32: 0.536\n",
      "  Time 33: 0.511\n",
      "  Time 34: 0.481\n",
      "  Time 35: 0.447\n",
      "  Time 36: 0.412\n",
      "  Time 37: 0.376\n",
      "  Time 38: 0.341\n",
      "  Time 39: 0.308\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.586\n",
      "  Time 31: 0.596\n",
      "  Time 32: 0.603\n",
      "  Time 33: 0.606\n",
      "  Time 34: 0.607\n",
      "  Time 35: 0.605\n",
      "  Time 36: 0.601\n",
      "  Time 37: 0.593\n",
      "  Time 38: 0.582\n",
      "  Time 39: 0.568\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 0.800\n",
      "  To trajectory 7: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.570\n",
      "  Time 31: 0.567\n",
      "  Time 32: 0.558\n",
      "  Time 33: 0.544\n",
      "  Time 34: 0.523\n",
      "  Time 35: 0.498\n",
      "  Time 36: 0.467\n",
      "  Time 37: 0.431\n",
      "  Time 38: 0.392\n",
      "  Time 39: 0.349\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.530\n",
      "  Time 31: 0.532\n",
      "  Time 32: 0.527\n",
      "  Time 33: 0.516\n",
      "  Time 34: 0.499\n",
      "  Time 35: 0.475\n",
      "  Time 36: 0.447\n",
      "  Time 37: 0.415\n",
      "  Time 38: 0.380\n",
      "  Time 39: 0.343\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.857\n",
      "  To trajectory 19: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.537\n",
      "  Time 31: 0.522\n",
      "  Time 32: 0.503\n",
      "  Time 33: 0.480\n",
      "  Time 34: 0.453\n",
      "  Time 35: 0.423\n",
      "  Time 36: 0.392\n",
      "  Time 37: 0.359\n",
      "  Time 38: 0.327\n",
      "  Time 39: 0.295\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.119\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 9\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.889\n",
      "  To trajectory 15: 0.111\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.561\n",
      "  Time 31: 0.559\n",
      "  Time 32: 0.553\n",
      "  Time 33: 0.542\n",
      "  Time 34: 0.527\n",
      "  Time 35: 0.508\n",
      "  Time 36: 0.485\n",
      "  Time 37: 0.460\n",
      "  Time 38: 0.432\n",
      "  Time 39: 0.403\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.200\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 10: 0.800\n",
      "  To trajectory 18: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.523\n",
      "  Time 31: 0.513\n",
      "  Time 32: 0.499\n",
      "  Time 33: 0.480\n",
      "  Time 34: 0.457\n",
      "  Time 35: 0.433\n",
      "  Time 36: 0.407\n",
      "  Time 37: 0.381\n",
      "  Time 38: 0.356\n",
      "  Time 39: 0.331\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.250\n",
      "  To trajectory 11: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.578\n",
      "  Time 31: 0.579\n",
      "  Time 32: 0.575\n",
      "  Time 33: 0.564\n",
      "  Time 34: 0.548\n",
      "  Time 35: 0.525\n",
      "  Time 36: 0.497\n",
      "  Time 37: 0.464\n",
      "  Time 38: 0.426\n",
      "  Time 39: 0.386\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.200\n",
      "  To trajectory 8: 0.200\n",
      "  To trajectory 12: 0.600\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.591\n",
      "  Time 31: 0.589\n",
      "  Time 32: 0.579\n",
      "  Time 33: 0.563\n",
      "  Time 34: 0.541\n",
      "  Time 35: 0.513\n",
      "  Time 36: 0.483\n",
      "  Time 37: 0.451\n",
      "  Time 38: 0.420\n",
      "  Time 39: 0.388\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.606\n",
      "  Time 31: 0.615\n",
      "  Time 32: 0.618\n",
      "  Time 33: 0.616\n",
      "  Time 34: 0.610\n",
      "  Time 35: 0.598\n",
      "  Time 36: 0.581\n",
      "  Time 37: 0.560\n",
      "  Time 38: 0.534\n",
      "  Time 39: 0.504\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 10\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 4: 0.100\n",
      "  To trajectory 14: 0.800\n",
      "  To trajectory 16: 0.100\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.561\n",
      "  Time 31: 0.557\n",
      "  Time 32: 0.549\n",
      "  Time 33: 0.537\n",
      "  Time 34: 0.520\n",
      "  Time 35: 0.499\n",
      "  Time 36: 0.474\n",
      "  Time 37: 0.446\n",
      "  Time 38: 0.416\n",
      "  Time 39: 0.385\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 0.250\n",
      "  To trajectory 15: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.576\n",
      "  Time 31: 0.582\n",
      "  Time 32: 0.583\n",
      "  Time 33: 0.579\n",
      "  Time 34: 0.570\n",
      "  Time 35: 0.556\n",
      "  Time 36: 0.538\n",
      "  Time 37: 0.516\n",
      "  Time 38: 0.492\n",
      "  Time 39: 0.466\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.167\n",
      "  To trajectory 16: 0.833\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.525\n",
      "  Time 31: 0.531\n",
      "  Time 32: 0.532\n",
      "  Time 33: 0.528\n",
      "  Time 34: 0.520\n",
      "  Time 35: 0.509\n",
      "  Time 36: 0.494\n",
      "  Time 37: 0.476\n",
      "  Time 38: 0.456\n",
      "  Time 39: 0.434\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.250\n",
      "  To trajectory 17: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.551\n",
      "  Time 31: 0.541\n",
      "  Time 32: 0.528\n",
      "  Time 33: 0.511\n",
      "  Time 34: 0.491\n",
      "  Time 35: 0.468\n",
      "  Time 36: 0.443\n",
      "  Time 37: 0.416\n",
      "  Time 38: 0.388\n",
      "  Time 39: 0.359\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.250\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.250\n",
      "  To trajectory 18: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.583\n",
      "  Time 31: 0.580\n",
      "  Time 32: 0.571\n",
      "  Time 33: 0.556\n",
      "  Time 34: 0.536\n",
      "  Time 35: 0.510\n",
      "  Time 36: 0.482\n",
      "  Time 37: 0.450\n",
      "  Time 38: 0.418\n",
      "  Time 39: 0.385\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 19: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.570\n",
      "  Time 31: 0.570\n",
      "  Time 32: 0.564\n",
      "  Time 33: 0.552\n",
      "  Time 34: 0.535\n",
      "  Time 35: 0.513\n",
      "  Time 36: 0.487\n",
      "  Time 37: 0.459\n",
      "  Time 38: 0.428\n",
      "  Time 39: 0.397\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_310000_320000_20241225_220601\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.564\n",
      "  Time 31: 0.572\n",
      "  Time 32: 0.576\n",
      "  Time 33: 0.577\n",
      "  Time 34: 0.573\n",
      "  Time 35: 0.565\n",
      "  Time 36: 0.553\n",
      "  Time 37: 0.537\n",
      "  Time 38: 0.518\n",
      "  Time 39: 0.497\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.167\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.833\n",
      "  To trajectory 19: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.547\n",
      "  Time 31: 0.543\n",
      "  Time 32: 0.534\n",
      "  Time 33: 0.521\n",
      "  Time 34: 0.503\n",
      "  Time 35: 0.481\n",
      "  Time 36: 0.455\n",
      "  Time 37: 0.426\n",
      "  Time 38: 0.394\n",
      "  Time 39: 0.360\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.720\n",
      "  Time 31: 0.729\n",
      "  Time 32: 0.731\n",
      "  Time 33: 0.728\n",
      "  Time 34: 0.719\n",
      "  Time 35: 0.703\n",
      "  Time 36: 0.681\n",
      "  Time 37: 0.652\n",
      "  Time 38: 0.617\n",
      "  Time 39: 0.576\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.167\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 0.833\n",
      "  To trajectory 5: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.560\n",
      "  Time 31: 0.559\n",
      "  Time 32: 0.552\n",
      "  Time 33: 0.542\n",
      "  Time 34: 0.529\n",
      "  Time 35: 0.512\n",
      "  Time 36: 0.493\n",
      "  Time 37: 0.470\n",
      "  Time 38: 0.445\n",
      "  Time 39: 0.417\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.538\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 0.200\n",
      "  To trajectory 4: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.569\n",
      "  Time 31: 0.554\n",
      "  Time 32: 0.534\n",
      "  Time 33: 0.510\n",
      "  Time 34: 0.483\n",
      "  Time 35: 0.454\n",
      "  Time 36: 0.424\n",
      "  Time 37: 0.394\n",
      "  Time 38: 0.365\n",
      "  Time 39: 0.337\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 9\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.523\n",
      "  Time 31: 0.525\n",
      "  Time 32: 0.523\n",
      "  Time 33: 0.517\n",
      "  Time 34: 0.507\n",
      "  Time 35: 0.493\n",
      "  Time 36: 0.476\n",
      "  Time 37: 0.456\n",
      "  Time 38: 0.435\n",
      "  Time 39: 0.412\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.579\n",
      "  Time 31: 0.585\n",
      "  Time 32: 0.584\n",
      "  Time 33: 0.576\n",
      "  Time 34: 0.562\n",
      "  Time 35: 0.541\n",
      "  Time 36: 0.512\n",
      "  Time 37: 0.477\n",
      "  Time 38: 0.436\n",
      "  Time 39: 0.391\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.750\n",
      "  To trajectory 9: 0.250\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.535\n",
      "  Time 31: 0.528\n",
      "  Time 32: 0.515\n",
      "  Time 33: 0.496\n",
      "  Time 34: 0.471\n",
      "  Time 35: 0.442\n",
      "  Time 36: 0.410\n",
      "  Time 37: 0.376\n",
      "  Time 38: 0.342\n",
      "  Time 39: 0.307\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.167\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.833\n",
      "  To trajectory 16: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.541\n",
      "  Time 31: 0.531\n",
      "  Time 32: 0.517\n",
      "  Time 33: 0.498\n",
      "  Time 34: 0.476\n",
      "  Time 35: 0.451\n",
      "  Time 36: 0.424\n",
      "  Time 37: 0.394\n",
      "  Time 38: 0.363\n",
      "  Time 39: 0.331\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.119\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.800\n",
      "  To trajectory 15: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.612\n",
      "  Time 31: 0.610\n",
      "  Time 32: 0.603\n",
      "  Time 33: 0.591\n",
      "  Time 34: 0.574\n",
      "  Time 35: 0.552\n",
      "  Time 36: 0.526\n",
      "  Time 37: 0.496\n",
      "  Time 38: 0.464\n",
      "  Time 39: 0.430\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.200\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 10: 0.800\n",
      "  To trajectory 18: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.520\n",
      "  Time 31: 0.511\n",
      "  Time 32: 0.497\n",
      "  Time 33: 0.479\n",
      "  Time 34: 0.457\n",
      "  Time 35: 0.432\n",
      "  Time 36: 0.407\n",
      "  Time 37: 0.381\n",
      "  Time 38: 0.355\n",
      "  Time 39: 0.330\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.333\n",
      "  To trajectory 11: 0.667\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.614\n",
      "  Time 31: 0.619\n",
      "  Time 32: 0.617\n",
      "  Time 33: 0.608\n",
      "  Time 34: 0.591\n",
      "  Time 35: 0.567\n",
      "  Time 36: 0.536\n",
      "  Time 37: 0.498\n",
      "  Time 38: 0.455\n",
      "  Time 39: 0.409\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.200\n",
      "  To trajectory 8: 0.200\n",
      "  To trajectory 12: 0.600\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.577\n",
      "  Time 31: 0.575\n",
      "  Time 32: 0.565\n",
      "  Time 33: 0.549\n",
      "  Time 34: 0.527\n",
      "  Time 35: 0.500\n",
      "  Time 36: 0.471\n",
      "  Time 37: 0.441\n",
      "  Time 38: 0.410\n",
      "  Time 39: 0.380\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.143\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.574\n",
      "  Time 31: 0.581\n",
      "  Time 32: 0.583\n",
      "  Time 33: 0.580\n",
      "  Time 34: 0.573\n",
      "  Time 35: 0.560\n",
      "  Time 36: 0.544\n",
      "  Time 37: 0.523\n",
      "  Time 38: 0.499\n",
      "  Time 39: 0.471\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.875\n",
      "  To trajectory 16: 0.125\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.562\n",
      "  Time 31: 0.559\n",
      "  Time 32: 0.551\n",
      "  Time 33: 0.538\n",
      "  Time 34: 0.521\n",
      "  Time 35: 0.501\n",
      "  Time 36: 0.477\n",
      "  Time 37: 0.450\n",
      "  Time 38: 0.421\n",
      "  Time 39: 0.391\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 15: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.587\n",
      "  Time 31: 0.582\n",
      "  Time 32: 0.571\n",
      "  Time 33: 0.555\n",
      "  Time 34: 0.534\n",
      "  Time 35: 0.508\n",
      "  Time 36: 0.479\n",
      "  Time 37: 0.446\n",
      "  Time 38: 0.411\n",
      "  Time 39: 0.374\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.200\n",
      "  To trajectory 16: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.524\n",
      "  Time 31: 0.535\n",
      "  Time 32: 0.542\n",
      "  Time 33: 0.544\n",
      "  Time 34: 0.540\n",
      "  Time 35: 0.533\n",
      "  Time 36: 0.521\n",
      "  Time 37: 0.507\n",
      "  Time 38: 0.489\n",
      "  Time 39: 0.469\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.250\n",
      "  To trajectory 17: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.571\n",
      "  Time 31: 0.561\n",
      "  Time 32: 0.547\n",
      "  Time 33: 0.530\n",
      "  Time 34: 0.510\n",
      "  Time 35: 0.487\n",
      "  Time 36: 0.463\n",
      "  Time 37: 0.436\n",
      "  Time 38: 0.408\n",
      "  Time 39: 0.379\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.167\n",
      "  To trajectory 18: 0.833\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.556\n",
      "  Time 31: 0.550\n",
      "  Time 32: 0.538\n",
      "  Time 33: 0.521\n",
      "  Time 34: 0.500\n",
      "  Time 35: 0.475\n",
      "  Time 36: 0.447\n",
      "  Time 37: 0.417\n",
      "  Time 38: 0.387\n",
      "  Time 39: 0.356\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 19: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.566\n",
      "  Time 31: 0.567\n",
      "  Time 32: 0.562\n",
      "  Time 33: 0.551\n",
      "  Time 34: 0.535\n",
      "  Time 35: 0.514\n",
      "  Time 36: 0.489\n",
      "  Time 37: 0.461\n",
      "  Time 38: 0.431\n",
      "  Time 39: 0.401\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_320000_330000_20241226_010910\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.547\n",
      "  Time 31: 0.544\n",
      "  Time 32: 0.536\n",
      "  Time 33: 0.525\n",
      "  Time 34: 0.510\n",
      "  Time 35: 0.493\n",
      "  Time 36: 0.473\n",
      "  Time 37: 0.451\n",
      "  Time 38: 0.428\n",
      "  Time 39: 0.405\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.857\n",
      "  To trajectory 19: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.538\n",
      "  Time 31: 0.534\n",
      "  Time 32: 0.526\n",
      "  Time 33: 0.513\n",
      "  Time 34: 0.495\n",
      "  Time 35: 0.473\n",
      "  Time 36: 0.446\n",
      "  Time 37: 0.417\n",
      "  Time 38: 0.385\n",
      "  Time 39: 0.351\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.697\n",
      "  Time 31: 0.707\n",
      "  Time 32: 0.710\n",
      "  Time 33: 0.707\n",
      "  Time 34: 0.698\n",
      "  Time 35: 0.682\n",
      "  Time 36: 0.659\n",
      "  Time 37: 0.630\n",
      "  Time 38: 0.595\n",
      "  Time 39: 0.554\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.200\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.567\n",
      "  Time 31: 0.577\n",
      "  Time 32: 0.582\n",
      "  Time 33: 0.583\n",
      "  Time 34: 0.579\n",
      "  Time 35: 0.570\n",
      "  Time 36: 0.557\n",
      "  Time 37: 0.539\n",
      "  Time 38: 0.517\n",
      "  Time 39: 0.490\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.538\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 0.167\n",
      "  To trajectory 4: 0.667\n",
      "  To trajectory 7: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.557\n",
      "  Time 31: 0.538\n",
      "  Time 32: 0.512\n",
      "  Time 33: 0.481\n",
      "  Time 34: 0.445\n",
      "  Time 35: 0.408\n",
      "  Time 36: 0.370\n",
      "  Time 37: 0.333\n",
      "  Time 38: 0.298\n",
      "  Time 39: 0.266\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 14\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.548\n",
      "  Time 31: 0.546\n",
      "  Time 32: 0.541\n",
      "  Time 33: 0.534\n",
      "  Time 34: 0.523\n",
      "  Time 35: 0.510\n",
      "  Time 36: 0.496\n",
      "  Time 37: 0.479\n",
      "  Time 38: 0.461\n",
      "  Time 39: 0.442\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.579\n",
      "  Time 31: 0.585\n",
      "  Time 32: 0.584\n",
      "  Time 33: 0.577\n",
      "  Time 34: 0.563\n",
      "  Time 35: 0.542\n",
      "  Time 36: 0.514\n",
      "  Time 37: 0.478\n",
      "  Time 38: 0.437\n",
      "  Time 39: 0.391\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.250\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.545\n",
      "  Time 31: 0.545\n",
      "  Time 32: 0.538\n",
      "  Time 33: 0.524\n",
      "  Time 34: 0.505\n",
      "  Time 35: 0.480\n",
      "  Time 36: 0.451\n",
      "  Time 37: 0.418\n",
      "  Time 38: 0.382\n",
      "  Time 39: 0.345\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.667\n",
      "  To trajectory 16: 0.167\n",
      "  To trajectory 19: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.537\n",
      "  Time 31: 0.524\n",
      "  Time 32: 0.506\n",
      "  Time 33: 0.484\n",
      "  Time 34: 0.458\n",
      "  Time 35: 0.430\n",
      "  Time 36: 0.401\n",
      "  Time 37: 0.370\n",
      "  Time 38: 0.339\n",
      "  Time 39: 0.308\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.120\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.800\n",
      "  To trajectory 15: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.599\n",
      "  Time 31: 0.591\n",
      "  Time 32: 0.579\n",
      "  Time 33: 0.561\n",
      "  Time 34: 0.538\n",
      "  Time 35: 0.512\n",
      "  Time 36: 0.481\n",
      "  Time 37: 0.448\n",
      "  Time 38: 0.413\n",
      "  Time 39: 0.378\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 10: 0.500\n",
      "  To trajectory 18: 0.500\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.552\n",
      "  Time 31: 0.532\n",
      "  Time 32: 0.507\n",
      "  Time 33: 0.477\n",
      "  Time 34: 0.445\n",
      "  Time 35: 0.411\n",
      "  Time 36: 0.377\n",
      "  Time 37: 0.345\n",
      "  Time 38: 0.315\n",
      "  Time 39: 0.288\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.167\n",
      "  To trajectory 11: 0.833\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.560\n",
      "  Time 31: 0.558\n",
      "  Time 32: 0.550\n",
      "  Time 33: 0.537\n",
      "  Time 34: 0.519\n",
      "  Time 35: 0.495\n",
      "  Time 36: 0.467\n",
      "  Time 37: 0.434\n",
      "  Time 38: 0.398\n",
      "  Time 39: 0.361\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.167\n",
      "  To trajectory 8: 0.167\n",
      "  To trajectory 12: 0.667\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.583\n",
      "  Time 31: 0.580\n",
      "  Time 32: 0.569\n",
      "  Time 33: 0.553\n",
      "  Time 34: 0.531\n",
      "  Time 35: 0.504\n",
      "  Time 36: 0.475\n",
      "  Time 37: 0.444\n",
      "  Time 38: 0.413\n",
      "  Time 39: 0.382\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.575\n",
      "  Time 31: 0.583\n",
      "  Time 32: 0.586\n",
      "  Time 33: 0.584\n",
      "  Time 34: 0.577\n",
      "  Time 35: 0.566\n",
      "  Time 36: 0.550\n",
      "  Time 37: 0.530\n",
      "  Time 38: 0.505\n",
      "  Time 39: 0.476\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.875\n",
      "  To trajectory 16: 0.125\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.565\n",
      "  Time 31: 0.561\n",
      "  Time 32: 0.553\n",
      "  Time 33: 0.540\n",
      "  Time 34: 0.522\n",
      "  Time 35: 0.500\n",
      "  Time 36: 0.475\n",
      "  Time 37: 0.446\n",
      "  Time 38: 0.416\n",
      "  Time 39: 0.384\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 15: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.629\n",
      "  Time 31: 0.632\n",
      "  Time 32: 0.630\n",
      "  Time 33: 0.622\n",
      "  Time 34: 0.610\n",
      "  Time 35: 0.593\n",
      "  Time 36: 0.572\n",
      "  Time 37: 0.547\n",
      "  Time 38: 0.520\n",
      "  Time 39: 0.491\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.200\n",
      "  To trajectory 16: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.537\n",
      "  Time 31: 0.533\n",
      "  Time 32: 0.525\n",
      "  Time 33: 0.513\n",
      "  Time 34: 0.497\n",
      "  Time 35: 0.478\n",
      "  Time 36: 0.456\n",
      "  Time 37: 0.432\n",
      "  Time 38: 0.407\n",
      "  Time 39: 0.380\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.250\n",
      "  To trajectory 17: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.533\n",
      "  Time 31: 0.517\n",
      "  Time 32: 0.498\n",
      "  Time 33: 0.474\n",
      "  Time 34: 0.447\n",
      "  Time 35: 0.417\n",
      "  Time 36: 0.385\n",
      "  Time 37: 0.352\n",
      "  Time 38: 0.319\n",
      "  Time 39: 0.287\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.167\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 18: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.560\n",
      "  Time 31: 0.552\n",
      "  Time 32: 0.538\n",
      "  Time 33: 0.520\n",
      "  Time 34: 0.498\n",
      "  Time 35: 0.472\n",
      "  Time 36: 0.444\n",
      "  Time 37: 0.413\n",
      "  Time 38: 0.383\n",
      "  Time 39: 0.352\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 19: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.572\n",
      "  Time 31: 0.571\n",
      "  Time 32: 0.564\n",
      "  Time 33: 0.551\n",
      "  Time 34: 0.532\n",
      "  Time 35: 0.509\n",
      "  Time 36: 0.481\n",
      "  Time 37: 0.451\n",
      "  Time 38: 0.418\n",
      "  Time 39: 0.385\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_330000_340000_20241226_011037\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.558\n",
      "  Time 31: 0.555\n",
      "  Time 32: 0.547\n",
      "  Time 33: 0.536\n",
      "  Time 34: 0.521\n",
      "  Time 35: 0.503\n",
      "  Time 36: 0.482\n",
      "  Time 37: 0.460\n",
      "  Time 38: 0.437\n",
      "  Time 39: 0.413\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.833\n",
      "  To trajectory 19: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.545\n",
      "  Time 31: 0.541\n",
      "  Time 32: 0.532\n",
      "  Time 33: 0.519\n",
      "  Time 34: 0.501\n",
      "  Time 35: 0.479\n",
      "  Time 36: 0.453\n",
      "  Time 37: 0.424\n",
      "  Time 38: 0.392\n",
      "  Time 39: 0.359\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.729\n",
      "  Time 31: 0.738\n",
      "  Time 32: 0.742\n",
      "  Time 33: 0.739\n",
      "  Time 34: 0.730\n",
      "  Time 35: 0.714\n",
      "  Time 36: 0.692\n",
      "  Time 37: 0.664\n",
      "  Time 38: 0.629\n",
      "  Time 39: 0.587\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.561\n",
      "  Time 31: 0.567\n",
      "  Time 32: 0.568\n",
      "  Time 33: 0.564\n",
      "  Time 34: 0.555\n",
      "  Time 35: 0.541\n",
      "  Time 36: 0.523\n",
      "  Time 37: 0.501\n",
      "  Time 38: 0.476\n",
      "  Time 39: 0.447\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.538\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 0.167\n",
      "  To trajectory 4: 0.667\n",
      "  To trajectory 7: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.559\n",
      "  Time 31: 0.540\n",
      "  Time 32: 0.514\n",
      "  Time 33: 0.483\n",
      "  Time 34: 0.448\n",
      "  Time 35: 0.411\n",
      "  Time 36: 0.373\n",
      "  Time 37: 0.336\n",
      "  Time 38: 0.301\n",
      "  Time 39: 0.269\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 9\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.547\n",
      "  Time 31: 0.553\n",
      "  Time 32: 0.556\n",
      "  Time 33: 0.555\n",
      "  Time 34: 0.550\n",
      "  Time 35: 0.541\n",
      "  Time 36: 0.529\n",
      "  Time 37: 0.514\n",
      "  Time 38: 0.497\n",
      "  Time 39: 0.478\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.598\n",
      "  Time 31: 0.604\n",
      "  Time 32: 0.603\n",
      "  Time 33: 0.595\n",
      "  Time 34: 0.581\n",
      "  Time 35: 0.560\n",
      "  Time 36: 0.531\n",
      "  Time 37: 0.496\n",
      "  Time 38: 0.454\n",
      "  Time 39: 0.407\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 0.400\n",
      "  To trajectory 7: 0.600\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.539\n",
      "  Time 31: 0.547\n",
      "  Time 32: 0.549\n",
      "  Time 33: 0.545\n",
      "  Time 34: 0.534\n",
      "  Time 35: 0.518\n",
      "  Time 36: 0.498\n",
      "  Time 37: 0.473\n",
      "  Time 38: 0.446\n",
      "  Time 39: 0.416\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.833\n",
      "  To trajectory 19: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.546\n",
      "  Time 31: 0.530\n",
      "  Time 32: 0.509\n",
      "  Time 33: 0.485\n",
      "  Time 34: 0.457\n",
      "  Time 35: 0.427\n",
      "  Time 36: 0.396\n",
      "  Time 37: 0.365\n",
      "  Time 38: 0.333\n",
      "  Time 39: 0.302\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.120\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.857\n",
      "  To trajectory 15: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.586\n",
      "  Time 31: 0.584\n",
      "  Time 32: 0.577\n",
      "  Time 33: 0.565\n",
      "  Time 34: 0.549\n",
      "  Time 35: 0.528\n",
      "  Time 36: 0.503\n",
      "  Time 37: 0.474\n",
      "  Time 38: 0.443\n",
      "  Time 39: 0.411\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 10: 0.833\n",
      "  To trajectory 18: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.538\n",
      "  Time 31: 0.538\n",
      "  Time 32: 0.532\n",
      "  Time 33: 0.520\n",
      "  Time 34: 0.504\n",
      "  Time 35: 0.483\n",
      "  Time 36: 0.460\n",
      "  Time 37: 0.433\n",
      "  Time 38: 0.405\n",
      "  Time 39: 0.376\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.333\n",
      "  To trajectory 11: 0.667\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.621\n",
      "  Time 31: 0.627\n",
      "  Time 32: 0.625\n",
      "  Time 33: 0.616\n",
      "  Time 34: 0.600\n",
      "  Time 35: 0.576\n",
      "  Time 36: 0.545\n",
      "  Time 37: 0.507\n",
      "  Time 38: 0.463\n",
      "  Time 39: 0.416\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.167\n",
      "  To trajectory 8: 0.167\n",
      "  To trajectory 12: 0.667\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.562\n",
      "  Time 31: 0.555\n",
      "  Time 32: 0.541\n",
      "  Time 33: 0.521\n",
      "  Time 34: 0.496\n",
      "  Time 35: 0.467\n",
      "  Time 36: 0.437\n",
      "  Time 37: 0.405\n",
      "  Time 38: 0.374\n",
      "  Time 39: 0.344\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.568\n",
      "  Time 31: 0.576\n",
      "  Time 32: 0.579\n",
      "  Time 33: 0.578\n",
      "  Time 34: 0.572\n",
      "  Time 35: 0.561\n",
      "  Time 36: 0.546\n",
      "  Time 37: 0.526\n",
      "  Time 38: 0.501\n",
      "  Time 39: 0.473\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.125\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.875\n",
      "  To trajectory 16: 0.125\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.556\n",
      "  Time 31: 0.553\n",
      "  Time 32: 0.545\n",
      "  Time 33: 0.534\n",
      "  Time 34: 0.518\n",
      "  Time 35: 0.498\n",
      "  Time 36: 0.476\n",
      "  Time 37: 0.451\n",
      "  Time 38: 0.424\n",
      "  Time 39: 0.395\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.167\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 15: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.588\n",
      "  Time 31: 0.598\n",
      "  Time 32: 0.603\n",
      "  Time 33: 0.602\n",
      "  Time 34: 0.596\n",
      "  Time 35: 0.585\n",
      "  Time 36: 0.570\n",
      "  Time 37: 0.550\n",
      "  Time 38: 0.528\n",
      "  Time 39: 0.502\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.167\n",
      "  To trajectory 16: 0.833\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.534\n",
      "  Time 31: 0.545\n",
      "  Time 32: 0.550\n",
      "  Time 33: 0.550\n",
      "  Time 34: 0.545\n",
      "  Time 35: 0.535\n",
      "  Time 36: 0.521\n",
      "  Time 37: 0.503\n",
      "  Time 38: 0.483\n",
      "  Time 39: 0.461\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 17: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.562\n",
      "  Time 31: 0.557\n",
      "  Time 32: 0.548\n",
      "  Time 33: 0.535\n",
      "  Time 34: 0.519\n",
      "  Time 35: 0.500\n",
      "  Time 36: 0.478\n",
      "  Time 37: 0.453\n",
      "  Time 38: 0.426\n",
      "  Time 39: 0.397\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 18: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.578\n",
      "  Time 31: 0.574\n",
      "  Time 32: 0.564\n",
      "  Time 33: 0.549\n",
      "  Time 34: 0.528\n",
      "  Time 35: 0.503\n",
      "  Time 36: 0.474\n",
      "  Time 37: 0.443\n",
      "  Time 38: 0.411\n",
      "  Time 39: 0.378\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 19: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.566\n",
      "  Time 31: 0.565\n",
      "  Time 32: 0.557\n",
      "  Time 33: 0.545\n",
      "  Time 34: 0.527\n",
      "  Time 35: 0.505\n",
      "  Time 36: 0.479\n",
      "  Time 37: 0.450\n",
      "  Time 38: 0.420\n",
      "  Time 39: 0.389\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_340000_350000_20241226_041424\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 0.750\n",
      "  To trajectory 13: 0.250\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.569\n",
      "  Time 31: 0.550\n",
      "  Time 32: 0.526\n",
      "  Time 33: 0.499\n",
      "  Time 34: 0.469\n",
      "  Time 35: 0.437\n",
      "  Time 36: 0.405\n",
      "  Time 37: 0.372\n",
      "  Time 38: 0.341\n",
      "  Time 39: 0.312\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.539\n",
      "  Time 31: 0.535\n",
      "  Time 32: 0.526\n",
      "  Time 33: 0.513\n",
      "  Time 34: 0.496\n",
      "  Time 35: 0.474\n",
      "  Time 36: 0.448\n",
      "  Time 37: 0.419\n",
      "  Time 38: 0.387\n",
      "  Time 39: 0.354\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.712\n",
      "  Time 31: 0.721\n",
      "  Time 32: 0.724\n",
      "  Time 33: 0.721\n",
      "  Time 34: 0.712\n",
      "  Time 35: 0.696\n",
      "  Time 36: 0.674\n",
      "  Time 37: 0.645\n",
      "  Time 38: 0.610\n",
      "  Time 39: 0.568\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 0.833\n",
      "  To trajectory 5: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.565\n",
      "  Time 31: 0.564\n",
      "  Time 32: 0.559\n",
      "  Time 33: 0.550\n",
      "  Time 34: 0.537\n",
      "  Time 35: 0.522\n",
      "  Time 36: 0.503\n",
      "  Time 37: 0.482\n",
      "  Time 38: 0.459\n",
      "  Time 39: 0.432\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.538\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 0.167\n",
      "  To trajectory 4: 0.667\n",
      "  To trajectory 7: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.549\n",
      "  Time 31: 0.530\n",
      "  Time 32: 0.504\n",
      "  Time 33: 0.473\n",
      "  Time 34: 0.438\n",
      "  Time 35: 0.401\n",
      "  Time 36: 0.364\n",
      "  Time 37: 0.327\n",
      "  Time 38: 0.292\n",
      "  Time 39: 0.260\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 11\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 0.909\n",
      "  To trajectory 11: 0.091\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.584\n",
      "  Time 31: 0.582\n",
      "  Time 32: 0.577\n",
      "  Time 33: 0.567\n",
      "  Time 34: 0.554\n",
      "  Time 35: 0.537\n",
      "  Time 36: 0.518\n",
      "  Time 37: 0.496\n",
      "  Time 38: 0.473\n",
      "  Time 39: 0.448\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.567\n",
      "  Time 31: 0.573\n",
      "  Time 32: 0.573\n",
      "  Time 33: 0.565\n",
      "  Time 34: 0.551\n",
      "  Time 35: 0.530\n",
      "  Time 36: 0.502\n",
      "  Time 37: 0.467\n",
      "  Time 38: 0.427\n",
      "  Time 39: 0.382\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 0.200\n",
      "  To trajectory 7: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.540\n",
      "  Time 31: 0.543\n",
      "  Time 32: 0.542\n",
      "  Time 33: 0.535\n",
      "  Time 34: 0.522\n",
      "  Time 35: 0.505\n",
      "  Time 36: 0.483\n",
      "  Time 37: 0.458\n",
      "  Time 38: 0.429\n",
      "  Time 39: 0.399\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.167\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.539\n",
      "  Time 31: 0.531\n",
      "  Time 32: 0.519\n",
      "  Time 33: 0.502\n",
      "  Time 34: 0.481\n",
      "  Time 35: 0.456\n",
      "  Time 36: 0.428\n",
      "  Time 37: 0.397\n",
      "  Time 38: 0.366\n",
      "  Time 39: 0.333\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.119\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.857\n",
      "  To trajectory 15: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.583\n",
      "  Time 31: 0.582\n",
      "  Time 32: 0.576\n",
      "  Time 33: 0.565\n",
      "  Time 34: 0.548\n",
      "  Time 35: 0.528\n",
      "  Time 36: 0.503\n",
      "  Time 37: 0.475\n",
      "  Time 38: 0.444\n",
      "  Time 39: 0.411\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 0.167\n",
      "  To trajectory 10: 0.667\n",
      "  To trajectory 18: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.535\n",
      "  Time 31: 0.532\n",
      "  Time 32: 0.522\n",
      "  Time 33: 0.506\n",
      "  Time 34: 0.483\n",
      "  Time 35: 0.456\n",
      "  Time 36: 0.424\n",
      "  Time 37: 0.391\n",
      "  Time 38: 0.356\n",
      "  Time 39: 0.322\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.250\n",
      "  To trajectory 3: 0.250\n",
      "  To trajectory 11: 0.500\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.588\n",
      "  Time 31: 0.582\n",
      "  Time 32: 0.569\n",
      "  Time 33: 0.549\n",
      "  Time 34: 0.523\n",
      "  Time 35: 0.492\n",
      "  Time 36: 0.457\n",
      "  Time 37: 0.418\n",
      "  Time 38: 0.377\n",
      "  Time 39: 0.334\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 4: 0.200\n",
      "  To trajectory 7: 0.200\n",
      "  To trajectory 12: 0.600\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.577\n",
      "  Time 31: 0.575\n",
      "  Time 32: 0.566\n",
      "  Time 33: 0.550\n",
      "  Time 34: 0.529\n",
      "  Time 35: 0.502\n",
      "  Time 36: 0.473\n",
      "  Time 37: 0.443\n",
      "  Time 38: 0.412\n",
      "  Time 39: 0.382\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.581\n",
      "  Time 31: 0.588\n",
      "  Time 32: 0.590\n",
      "  Time 33: 0.587\n",
      "  Time 34: 0.579\n",
      "  Time 35: 0.566\n",
      "  Time 36: 0.549\n",
      "  Time 37: 0.527\n",
      "  Time 38: 0.502\n",
      "  Time 39: 0.473\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 9\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.889\n",
      "  To trajectory 16: 0.111\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.558\n",
      "  Time 31: 0.554\n",
      "  Time 32: 0.547\n",
      "  Time 33: 0.534\n",
      "  Time 34: 0.518\n",
      "  Time 35: 0.497\n",
      "  Time 36: 0.473\n",
      "  Time 37: 0.446\n",
      "  Time 38: 0.417\n",
      "  Time 39: 0.387\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.200\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 15: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.609\n",
      "  Time 31: 0.618\n",
      "  Time 32: 0.621\n",
      "  Time 33: 0.619\n",
      "  Time 34: 0.610\n",
      "  Time 35: 0.596\n",
      "  Time 36: 0.576\n",
      "  Time 37: 0.552\n",
      "  Time 38: 0.524\n",
      "  Time 39: 0.493\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.250\n",
      "  To trajectory 16: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.531\n",
      "  Time 31: 0.544\n",
      "  Time 32: 0.553\n",
      "  Time 33: 0.557\n",
      "  Time 34: 0.557\n",
      "  Time 35: 0.553\n",
      "  Time 36: 0.546\n",
      "  Time 37: 0.535\n",
      "  Time 38: 0.522\n",
      "  Time 39: 0.507\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 17: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.562\n",
      "  Time 31: 0.551\n",
      "  Time 32: 0.536\n",
      "  Time 33: 0.517\n",
      "  Time 34: 0.495\n",
      "  Time 35: 0.470\n",
      "  Time 36: 0.443\n",
      "  Time 37: 0.414\n",
      "  Time 38: 0.384\n",
      "  Time 39: 0.353\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.200\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 18: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.563\n",
      "  Time 31: 0.558\n",
      "  Time 32: 0.547\n",
      "  Time 33: 0.531\n",
      "  Time 34: 0.511\n",
      "  Time 35: 0.486\n",
      "  Time 36: 0.459\n",
      "  Time 37: 0.429\n",
      "  Time 38: 0.398\n",
      "  Time 39: 0.366\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 19: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.538\n",
      "  Time 31: 0.541\n",
      "  Time 32: 0.538\n",
      "  Time 33: 0.530\n",
      "  Time 34: 0.516\n",
      "  Time 35: 0.498\n",
      "  Time 36: 0.475\n",
      "  Time 37: 0.450\n",
      "  Time 38: 0.422\n",
      "  Time 39: 0.392\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_350000_360000_20241226_041550\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.167\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 0.833\n",
      "  To trajectory 13: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.539\n",
      "  Time 31: 0.531\n",
      "  Time 32: 0.519\n",
      "  Time 33: 0.502\n",
      "  Time 34: 0.482\n",
      "  Time 35: 0.458\n",
      "  Time 36: 0.432\n",
      "  Time 37: 0.404\n",
      "  Time 38: 0.375\n",
      "  Time 39: 0.347\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.167\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.548\n",
      "  Time 31: 0.545\n",
      "  Time 32: 0.537\n",
      "  Time 33: 0.524\n",
      "  Time 34: 0.506\n",
      "  Time 35: 0.485\n",
      "  Time 36: 0.459\n",
      "  Time 37: 0.429\n",
      "  Time 38: 0.397\n",
      "  Time 39: 0.364\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.718\n",
      "  Time 31: 0.727\n",
      "  Time 32: 0.730\n",
      "  Time 33: 0.727\n",
      "  Time 34: 0.718\n",
      "  Time 35: 0.702\n",
      "  Time 36: 0.680\n",
      "  Time 37: 0.652\n",
      "  Time 38: 0.617\n",
      "  Time 39: 0.576\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.558\n",
      "  Time 31: 0.563\n",
      "  Time 32: 0.562\n",
      "  Time 33: 0.557\n",
      "  Time 34: 0.547\n",
      "  Time 35: 0.531\n",
      "  Time 36: 0.512\n",
      "  Time 37: 0.489\n",
      "  Time 38: 0.462\n",
      "  Time 39: 0.432\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.538\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 0.167\n",
      "  To trajectory 4: 0.667\n",
      "  To trajectory 7: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.551\n",
      "  Time 31: 0.532\n",
      "  Time 32: 0.506\n",
      "  Time 33: 0.475\n",
      "  Time 34: 0.440\n",
      "  Time 35: 0.403\n",
      "  Time 36: 0.365\n",
      "  Time 37: 0.329\n",
      "  Time 38: 0.294\n",
      "  Time 39: 0.262\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 9\n",
      "CAD risk: 0.111\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.558\n",
      "  Time 31: 0.572\n",
      "  Time 32: 0.580\n",
      "  Time 33: 0.584\n",
      "  Time 34: 0.583\n",
      "  Time 35: 0.578\n",
      "  Time 36: 0.568\n",
      "  Time 37: 0.554\n",
      "  Time 38: 0.536\n",
      "  Time 39: 0.516\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.587\n",
      "  Time 31: 0.592\n",
      "  Time 32: 0.591\n",
      "  Time 33: 0.584\n",
      "  Time 34: 0.570\n",
      "  Time 35: 0.549\n",
      "  Time 36: 0.522\n",
      "  Time 37: 0.487\n",
      "  Time 38: 0.447\n",
      "  Time 39: 0.402\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 0.333\n",
      "  To trajectory 7: 0.667\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.559\n",
      "  Time 31: 0.556\n",
      "  Time 32: 0.546\n",
      "  Time 33: 0.529\n",
      "  Time 34: 0.507\n",
      "  Time 35: 0.479\n",
      "  Time 36: 0.448\n",
      "  Time 37: 0.414\n",
      "  Time 38: 0.378\n",
      "  Time 39: 0.340\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.143\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.857\n",
      "  To trajectory 16: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.539\n",
      "  Time 31: 0.528\n",
      "  Time 32: 0.513\n",
      "  Time 33: 0.494\n",
      "  Time 34: 0.472\n",
      "  Time 35: 0.446\n",
      "  Time 36: 0.418\n",
      "  Time 37: 0.388\n",
      "  Time 38: 0.356\n",
      "  Time 39: 0.325\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.120\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.595\n",
      "  Time 31: 0.585\n",
      "  Time 32: 0.570\n",
      "  Time 33: 0.552\n",
      "  Time 34: 0.529\n",
      "  Time 35: 0.502\n",
      "  Time 36: 0.472\n",
      "  Time 37: 0.439\n",
      "  Time 38: 0.405\n",
      "  Time 39: 0.370\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 10: 0.750\n",
      "  To trajectory 18: 0.250\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.524\n",
      "  Time 31: 0.505\n",
      "  Time 32: 0.481\n",
      "  Time 33: 0.453\n",
      "  Time 34: 0.422\n",
      "  Time 35: 0.390\n",
      "  Time 36: 0.357\n",
      "  Time 37: 0.325\n",
      "  Time 38: 0.295\n",
      "  Time 39: 0.267\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.333\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 11: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.629\n",
      "  Time 31: 0.635\n",
      "  Time 32: 0.633\n",
      "  Time 33: 0.624\n",
      "  Time 34: 0.608\n",
      "  Time 35: 0.584\n",
      "  Time 36: 0.552\n",
      "  Time 37: 0.514\n",
      "  Time 38: 0.470\n",
      "  Time 39: 0.422\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.200\n",
      "  To trajectory 8: 0.200\n",
      "  To trajectory 12: 0.600\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.572\n",
      "  Time 31: 0.570\n",
      "  Time 32: 0.561\n",
      "  Time 33: 0.546\n",
      "  Time 34: 0.525\n",
      "  Time 35: 0.499\n",
      "  Time 36: 0.471\n",
      "  Time 37: 0.442\n",
      "  Time 38: 0.412\n",
      "  Time 39: 0.383\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.592\n",
      "  Time 31: 0.598\n",
      "  Time 32: 0.599\n",
      "  Time 33: 0.596\n",
      "  Time 34: 0.589\n",
      "  Time 35: 0.577\n",
      "  Time 36: 0.561\n",
      "  Time 37: 0.541\n",
      "  Time 38: 0.517\n",
      "  Time 39: 0.490\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.875\n",
      "  To trajectory 16: 0.125\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.565\n",
      "  Time 31: 0.562\n",
      "  Time 32: 0.554\n",
      "  Time 33: 0.542\n",
      "  Time 34: 0.526\n",
      "  Time 35: 0.506\n",
      "  Time 36: 0.483\n",
      "  Time 37: 0.457\n",
      "  Time 38: 0.430\n",
      "  Time 39: 0.401\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 15: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.576\n",
      "  Time 31: 0.574\n",
      "  Time 32: 0.567\n",
      "  Time 33: 0.556\n",
      "  Time 34: 0.540\n",
      "  Time 35: 0.520\n",
      "  Time 36: 0.496\n",
      "  Time 37: 0.468\n",
      "  Time 38: 0.437\n",
      "  Time 39: 0.404\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.200\n",
      "  To trajectory 16: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.525\n",
      "  Time 31: 0.521\n",
      "  Time 32: 0.513\n",
      "  Time 33: 0.501\n",
      "  Time 34: 0.485\n",
      "  Time 35: 0.466\n",
      "  Time 36: 0.444\n",
      "  Time 37: 0.421\n",
      "  Time 38: 0.396\n",
      "  Time 39: 0.370\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 17: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.596\n",
      "  Time 31: 0.581\n",
      "  Time 32: 0.561\n",
      "  Time 33: 0.538\n",
      "  Time 34: 0.510\n",
      "  Time 35: 0.480\n",
      "  Time 36: 0.447\n",
      "  Time 37: 0.413\n",
      "  Time 38: 0.377\n",
      "  Time 39: 0.342\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 18: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.556\n",
      "  Time 31: 0.553\n",
      "  Time 32: 0.545\n",
      "  Time 33: 0.532\n",
      "  Time 34: 0.514\n",
      "  Time 35: 0.493\n",
      "  Time 36: 0.469\n",
      "  Time 37: 0.442\n",
      "  Time 38: 0.414\n",
      "  Time 39: 0.386\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 19: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.543\n",
      "  Time 31: 0.543\n",
      "  Time 32: 0.537\n",
      "  Time 33: 0.526\n",
      "  Time 34: 0.509\n",
      "  Time 35: 0.488\n",
      "  Time 36: 0.464\n",
      "  Time 37: 0.437\n",
      "  Time 38: 0.409\n",
      "  Time 39: 0.379\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_360000_370000_20241226_071910\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.250\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 0.750\n",
      "  To trajectory 15: 0.250\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.539\n",
      "  Time 31: 0.536\n",
      "  Time 32: 0.529\n",
      "  Time 33: 0.518\n",
      "  Time 34: 0.504\n",
      "  Time 35: 0.487\n",
      "  Time 36: 0.468\n",
      "  Time 37: 0.447\n",
      "  Time 38: 0.425\n",
      "  Time 39: 0.402\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.857\n",
      "  To trajectory 7: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.543\n",
      "  Time 31: 0.538\n",
      "  Time 32: 0.527\n",
      "  Time 33: 0.511\n",
      "  Time 34: 0.490\n",
      "  Time 35: 0.464\n",
      "  Time 36: 0.435\n",
      "  Time 37: 0.403\n",
      "  Time 38: 0.370\n",
      "  Time 39: 0.336\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.707\n",
      "  Time 31: 0.716\n",
      "  Time 32: 0.720\n",
      "  Time 33: 0.717\n",
      "  Time 34: 0.708\n",
      "  Time 35: 0.692\n",
      "  Time 36: 0.670\n",
      "  Time 37: 0.641\n",
      "  Time 38: 0.606\n",
      "  Time 39: 0.565\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.167\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 0.833\n",
      "  To trajectory 5: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.560\n",
      "  Time 31: 0.559\n",
      "  Time 32: 0.552\n",
      "  Time 33: 0.542\n",
      "  Time 34: 0.529\n",
      "  Time 35: 0.512\n",
      "  Time 36: 0.492\n",
      "  Time 37: 0.470\n",
      "  Time 38: 0.444\n",
      "  Time 39: 0.416\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.538\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 4: 0.833\n",
      "  To trajectory 7: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.568\n",
      "  Time 31: 0.561\n",
      "  Time 32: 0.549\n",
      "  Time 33: 0.531\n",
      "  Time 34: 0.509\n",
      "  Time 35: 0.483\n",
      "  Time 36: 0.453\n",
      "  Time 37: 0.422\n",
      "  Time 38: 0.389\n",
      "  Time 39: 0.357\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 9\n",
      "CAD risk: 0.111\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 0.889\n",
      "  To trajectory 16: 0.111\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.566\n",
      "  Time 31: 0.559\n",
      "  Time 32: 0.548\n",
      "  Time 33: 0.533\n",
      "  Time 34: 0.515\n",
      "  Time 35: 0.495\n",
      "  Time 36: 0.472\n",
      "  Time 37: 0.449\n",
      "  Time 38: 0.424\n",
      "  Time 39: 0.399\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 0.800\n",
      "  To trajectory 7: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.588\n",
      "  Time 31: 0.585\n",
      "  Time 32: 0.575\n",
      "  Time 33: 0.560\n",
      "  Time 34: 0.540\n",
      "  Time 35: 0.514\n",
      "  Time 36: 0.482\n",
      "  Time 37: 0.446\n",
      "  Time 38: 0.406\n",
      "  Time 39: 0.363\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.200\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 0.200\n",
      "  To trajectory 7: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.525\n",
      "  Time 31: 0.528\n",
      "  Time 32: 0.524\n",
      "  Time 33: 0.514\n",
      "  Time 34: 0.499\n",
      "  Time 35: 0.477\n",
      "  Time 36: 0.452\n",
      "  Time 37: 0.422\n",
      "  Time 38: 0.390\n",
      "  Time 39: 0.356\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.667\n",
      "  To trajectory 16: 0.167\n",
      "  To trajectory 19: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.539\n",
      "  Time 31: 0.525\n",
      "  Time 32: 0.507\n",
      "  Time 33: 0.485\n",
      "  Time 34: 0.459\n",
      "  Time 35: 0.431\n",
      "  Time 36: 0.400\n",
      "  Time 37: 0.369\n",
      "  Time 38: 0.338\n",
      "  Time 39: 0.307\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.120\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.833\n",
      "  To trajectory 15: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.593\n",
      "  Time 31: 0.584\n",
      "  Time 32: 0.571\n",
      "  Time 33: 0.553\n",
      "  Time 34: 0.530\n",
      "  Time 35: 0.504\n",
      "  Time 36: 0.474\n",
      "  Time 37: 0.441\n",
      "  Time 38: 0.406\n",
      "  Time 39: 0.371\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 10: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.528\n",
      "  Time 31: 0.526\n",
      "  Time 32: 0.518\n",
      "  Time 33: 0.506\n",
      "  Time 34: 0.490\n",
      "  Time 35: 0.470\n",
      "  Time 36: 0.448\n",
      "  Time 37: 0.424\n",
      "  Time 38: 0.399\n",
      "  Time 39: 0.374\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.250\n",
      "  To trajectory 11: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.584\n",
      "  Time 31: 0.590\n",
      "  Time 32: 0.587\n",
      "  Time 33: 0.578\n",
      "  Time 34: 0.560\n",
      "  Time 35: 0.536\n",
      "  Time 36: 0.504\n",
      "  Time 37: 0.466\n",
      "  Time 38: 0.424\n",
      "  Time 39: 0.379\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.143\n",
      "  To trajectory 8: 0.143\n",
      "  To trajectory 12: 0.714\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.556\n",
      "  Time 31: 0.549\n",
      "  Time 32: 0.535\n",
      "  Time 33: 0.516\n",
      "  Time 34: 0.493\n",
      "  Time 35: 0.466\n",
      "  Time 36: 0.437\n",
      "  Time 37: 0.407\n",
      "  Time 38: 0.377\n",
      "  Time 39: 0.348\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.589\n",
      "  Time 31: 0.597\n",
      "  Time 32: 0.600\n",
      "  Time 33: 0.598\n",
      "  Time 34: 0.591\n",
      "  Time 35: 0.580\n",
      "  Time 36: 0.563\n",
      "  Time 37: 0.541\n",
      "  Time 38: 0.516\n",
      "  Time 39: 0.486\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.857\n",
      "  To trajectory 16: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.577\n",
      "  Time 31: 0.574\n",
      "  Time 32: 0.566\n",
      "  Time 33: 0.553\n",
      "  Time 34: 0.536\n",
      "  Time 35: 0.516\n",
      "  Time 36: 0.492\n",
      "  Time 37: 0.466\n",
      "  Time 38: 0.439\n",
      "  Time 39: 0.411\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 15: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.592\n",
      "  Time 31: 0.587\n",
      "  Time 32: 0.577\n",
      "  Time 33: 0.562\n",
      "  Time 34: 0.542\n",
      "  Time 35: 0.517\n",
      "  Time 36: 0.490\n",
      "  Time 37: 0.458\n",
      "  Time 38: 0.425\n",
      "  Time 39: 0.389\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.200\n",
      "  To trajectory 16: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.525\n",
      "  Time 31: 0.537\n",
      "  Time 32: 0.543\n",
      "  Time 33: 0.545\n",
      "  Time 34: 0.541\n",
      "  Time 35: 0.533\n",
      "  Time 36: 0.521\n",
      "  Time 37: 0.506\n",
      "  Time 38: 0.488\n",
      "  Time 39: 0.468\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 17: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.540\n",
      "  Time 31: 0.536\n",
      "  Time 32: 0.529\n",
      "  Time 33: 0.517\n",
      "  Time 34: 0.501\n",
      "  Time 35: 0.482\n",
      "  Time 36: 0.460\n",
      "  Time 37: 0.435\n",
      "  Time 38: 0.408\n",
      "  Time 39: 0.379\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.167\n",
      "  To trajectory 18: 0.833\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.551\n",
      "  Time 31: 0.545\n",
      "  Time 32: 0.532\n",
      "  Time 33: 0.514\n",
      "  Time 34: 0.491\n",
      "  Time 35: 0.463\n",
      "  Time 36: 0.432\n",
      "  Time 37: 0.399\n",
      "  Time 38: 0.365\n",
      "  Time 39: 0.331\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 19: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.555\n",
      "  Time 31: 0.554\n",
      "  Time 32: 0.548\n",
      "  Time 33: 0.536\n",
      "  Time 34: 0.518\n",
      "  Time 35: 0.496\n",
      "  Time 36: 0.470\n",
      "  Time 37: 0.442\n",
      "  Time 38: 0.412\n",
      "  Time 39: 0.382\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_370000_380000_20241226_072111\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.543\n",
      "  Time 31: 0.534\n",
      "  Time 32: 0.519\n",
      "  Time 33: 0.499\n",
      "  Time 34: 0.475\n",
      "  Time 35: 0.447\n",
      "  Time 36: 0.416\n",
      "  Time 37: 0.385\n",
      "  Time 38: 0.352\n",
      "  Time 39: 0.321\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.143\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.546\n",
      "  Time 31: 0.543\n",
      "  Time 32: 0.536\n",
      "  Time 33: 0.525\n",
      "  Time 34: 0.510\n",
      "  Time 35: 0.491\n",
      "  Time 36: 0.468\n",
      "  Time 37: 0.442\n",
      "  Time 38: 0.413\n",
      "  Time 39: 0.382\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.687\n",
      "  Time 31: 0.697\n",
      "  Time 32: 0.701\n",
      "  Time 33: 0.697\n",
      "  Time 34: 0.688\n",
      "  Time 35: 0.671\n",
      "  Time 36: 0.648\n",
      "  Time 37: 0.619\n",
      "  Time 38: 0.583\n",
      "  Time 39: 0.541\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 0.857\n",
      "  To trajectory 5: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.557\n",
      "  Time 31: 0.553\n",
      "  Time 32: 0.545\n",
      "  Time 33: 0.533\n",
      "  Time 34: 0.518\n",
      "  Time 35: 0.499\n",
      "  Time 36: 0.477\n",
      "  Time 37: 0.453\n",
      "  Time 38: 0.426\n",
      "  Time 39: 0.398\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.538\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 0.167\n",
      "  To trajectory 4: 0.833\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.556\n",
      "  Time 31: 0.543\n",
      "  Time 32: 0.524\n",
      "  Time 33: 0.502\n",
      "  Time 34: 0.475\n",
      "  Time 35: 0.447\n",
      "  Time 36: 0.417\n",
      "  Time 37: 0.387\n",
      "  Time 38: 0.357\n",
      "  Time 39: 0.327\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 0.833\n",
      "  To trajectory 17: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.546\n",
      "  Time 31: 0.549\n",
      "  Time 32: 0.548\n",
      "  Time 33: 0.543\n",
      "  Time 34: 0.533\n",
      "  Time 35: 0.519\n",
      "  Time 36: 0.503\n",
      "  Time 37: 0.484\n",
      "  Time 38: 0.463\n",
      "  Time 39: 0.441\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.200\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 0.800\n",
      "  To trajectory 7: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.576\n",
      "  Time 31: 0.573\n",
      "  Time 32: 0.565\n",
      "  Time 33: 0.550\n",
      "  Time 34: 0.530\n",
      "  Time 35: 0.505\n",
      "  Time 36: 0.474\n",
      "  Time 37: 0.438\n",
      "  Time 38: 0.398\n",
      "  Time 39: 0.355\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.537\n",
      "  Time 31: 0.538\n",
      "  Time 32: 0.532\n",
      "  Time 33: 0.520\n",
      "  Time 34: 0.502\n",
      "  Time 35: 0.478\n",
      "  Time 36: 0.449\n",
      "  Time 37: 0.417\n",
      "  Time 38: 0.382\n",
      "  Time 39: 0.344\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.549\n",
      "  Time 31: 0.536\n",
      "  Time 32: 0.520\n",
      "  Time 33: 0.500\n",
      "  Time 34: 0.477\n",
      "  Time 35: 0.451\n",
      "  Time 36: 0.423\n",
      "  Time 37: 0.394\n",
      "  Time 38: 0.364\n",
      "  Time 39: 0.333\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.120\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.833\n",
      "  To trajectory 15: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.588\n",
      "  Time 31: 0.580\n",
      "  Time 32: 0.568\n",
      "  Time 33: 0.550\n",
      "  Time 34: 0.529\n",
      "  Time 35: 0.503\n",
      "  Time 36: 0.474\n",
      "  Time 37: 0.442\n",
      "  Time 38: 0.409\n",
      "  Time 39: 0.375\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 0.143\n",
      "  To trajectory 10: 0.714\n",
      "  To trajectory 18: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.530\n",
      "  Time 31: 0.523\n",
      "  Time 32: 0.510\n",
      "  Time 33: 0.491\n",
      "  Time 34: 0.466\n",
      "  Time 35: 0.438\n",
      "  Time 36: 0.407\n",
      "  Time 37: 0.374\n",
      "  Time 38: 0.341\n",
      "  Time 39: 0.309\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.250\n",
      "  To trajectory 11: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.601\n",
      "  Time 31: 0.606\n",
      "  Time 32: 0.604\n",
      "  Time 33: 0.594\n",
      "  Time 34: 0.576\n",
      "  Time 35: 0.551\n",
      "  Time 36: 0.519\n",
      "  Time 37: 0.481\n",
      "  Time 38: 0.438\n",
      "  Time 39: 0.392\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.250\n",
      "  To trajectory 8: 0.250\n",
      "  To trajectory 12: 0.500\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.601\n",
      "  Time 31: 0.590\n",
      "  Time 32: 0.570\n",
      "  Time 33: 0.544\n",
      "  Time 34: 0.511\n",
      "  Time 35: 0.475\n",
      "  Time 36: 0.437\n",
      "  Time 37: 0.399\n",
      "  Time 38: 0.362\n",
      "  Time 39: 0.328\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.575\n",
      "  Time 31: 0.582\n",
      "  Time 32: 0.583\n",
      "  Time 33: 0.580\n",
      "  Time 34: 0.573\n",
      "  Time 35: 0.561\n",
      "  Time 36: 0.545\n",
      "  Time 37: 0.524\n",
      "  Time 38: 0.500\n",
      "  Time 39: 0.472\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.125\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.875\n",
      "  To trajectory 16: 0.125\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.569\n",
      "  Time 31: 0.566\n",
      "  Time 32: 0.558\n",
      "  Time 33: 0.546\n",
      "  Time 34: 0.530\n",
      "  Time 35: 0.510\n",
      "  Time 36: 0.487\n",
      "  Time 37: 0.462\n",
      "  Time 38: 0.434\n",
      "  Time 39: 0.405\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 15: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.603\n",
      "  Time 31: 0.607\n",
      "  Time 32: 0.605\n",
      "  Time 33: 0.598\n",
      "  Time 34: 0.586\n",
      "  Time 35: 0.570\n",
      "  Time 36: 0.548\n",
      "  Time 37: 0.523\n",
      "  Time 38: 0.493\n",
      "  Time 39: 0.460\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.250\n",
      "  To trajectory 16: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.540\n",
      "  Time 31: 0.542\n",
      "  Time 32: 0.538\n",
      "  Time 33: 0.531\n",
      "  Time 34: 0.519\n",
      "  Time 35: 0.503\n",
      "  Time 36: 0.483\n",
      "  Time 37: 0.461\n",
      "  Time 38: 0.437\n",
      "  Time 39: 0.411\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 17: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.567\n",
      "  Time 31: 0.560\n",
      "  Time 32: 0.549\n",
      "  Time 33: 0.534\n",
      "  Time 34: 0.517\n",
      "  Time 35: 0.496\n",
      "  Time 36: 0.472\n",
      "  Time 37: 0.446\n",
      "  Time 38: 0.419\n",
      "  Time 39: 0.390\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 18: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.579\n",
      "  Time 31: 0.575\n",
      "  Time 32: 0.566\n",
      "  Time 33: 0.551\n",
      "  Time 34: 0.530\n",
      "  Time 35: 0.504\n",
      "  Time 36: 0.475\n",
      "  Time 37: 0.443\n",
      "  Time 38: 0.410\n",
      "  Time 39: 0.377\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.167\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 19: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.543\n",
      "  Time 31: 0.543\n",
      "  Time 32: 0.537\n",
      "  Time 33: 0.526\n",
      "  Time 34: 0.509\n",
      "  Time 35: 0.488\n",
      "  Time 36: 0.464\n",
      "  Time 37: 0.437\n",
      "  Time 38: 0.409\n",
      "  Time 39: 0.379\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_380000_390000_20241226_102351\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 0.750\n",
      "  To trajectory 13: 0.250\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.548\n",
      "  Time 31: 0.546\n",
      "  Time 32: 0.541\n",
      "  Time 33: 0.531\n",
      "  Time 34: 0.518\n",
      "  Time 35: 0.501\n",
      "  Time 36: 0.482\n",
      "  Time 37: 0.460\n",
      "  Time 38: 0.437\n",
      "  Time 39: 0.412\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.200\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.552\n",
      "  Time 31: 0.549\n",
      "  Time 32: 0.541\n",
      "  Time 33: 0.529\n",
      "  Time 34: 0.512\n",
      "  Time 35: 0.491\n",
      "  Time 36: 0.466\n",
      "  Time 37: 0.438\n",
      "  Time 38: 0.406\n",
      "  Time 39: 0.373\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.733\n",
      "  Time 31: 0.742\n",
      "  Time 32: 0.745\n",
      "  Time 33: 0.742\n",
      "  Time 34: 0.733\n",
      "  Time 35: 0.718\n",
      "  Time 36: 0.697\n",
      "  Time 37: 0.669\n",
      "  Time 38: 0.635\n",
      "  Time 39: 0.595\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 0.875\n",
      "  To trajectory 5: 0.125\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.550\n",
      "  Time 31: 0.549\n",
      "  Time 32: 0.543\n",
      "  Time 33: 0.534\n",
      "  Time 34: 0.522\n",
      "  Time 35: 0.506\n",
      "  Time 36: 0.488\n",
      "  Time 37: 0.466\n",
      "  Time 38: 0.442\n",
      "  Time 39: 0.415\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.538\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 4: 0.833\n",
      "  To trajectory 7: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.565\n",
      "  Time 31: 0.555\n",
      "  Time 32: 0.540\n",
      "  Time 33: 0.520\n",
      "  Time 34: 0.497\n",
      "  Time 35: 0.470\n",
      "  Time 36: 0.442\n",
      "  Time 37: 0.412\n",
      "  Time 38: 0.382\n",
      "  Time 39: 0.353\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 9\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 0.889\n",
      "  To trajectory 15: 0.111\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.544\n",
      "  Time 31: 0.540\n",
      "  Time 32: 0.531\n",
      "  Time 33: 0.516\n",
      "  Time 34: 0.498\n",
      "  Time 35: 0.476\n",
      "  Time 36: 0.452\n",
      "  Time 37: 0.426\n",
      "  Time 38: 0.400\n",
      "  Time 39: 0.374\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.595\n",
      "  Time 31: 0.601\n",
      "  Time 32: 0.600\n",
      "  Time 33: 0.593\n",
      "  Time 34: 0.579\n",
      "  Time 35: 0.558\n",
      "  Time 36: 0.529\n",
      "  Time 37: 0.494\n",
      "  Time 38: 0.452\n",
      "  Time 39: 0.406\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.549\n",
      "  Time 31: 0.548\n",
      "  Time 32: 0.540\n",
      "  Time 33: 0.526\n",
      "  Time 34: 0.506\n",
      "  Time 35: 0.481\n",
      "  Time 36: 0.451\n",
      "  Time 37: 0.418\n",
      "  Time 38: 0.382\n",
      "  Time 39: 0.345\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.833\n",
      "  To trajectory 19: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.542\n",
      "  Time 31: 0.526\n",
      "  Time 32: 0.506\n",
      "  Time 33: 0.481\n",
      "  Time 34: 0.454\n",
      "  Time 35: 0.424\n",
      "  Time 36: 0.393\n",
      "  Time 37: 0.361\n",
      "  Time 38: 0.330\n",
      "  Time 39: 0.299\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.120\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.833\n",
      "  To trajectory 15: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.596\n",
      "  Time 31: 0.595\n",
      "  Time 32: 0.590\n",
      "  Time 33: 0.580\n",
      "  Time 34: 0.565\n",
      "  Time 35: 0.545\n",
      "  Time 36: 0.521\n",
      "  Time 37: 0.493\n",
      "  Time 38: 0.463\n",
      "  Time 39: 0.431\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.250\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 10: 0.750\n",
      "  To trajectory 18: 0.250\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.547\n",
      "  Time 31: 0.544\n",
      "  Time 32: 0.534\n",
      "  Time 33: 0.519\n",
      "  Time 34: 0.500\n",
      "  Time 35: 0.477\n",
      "  Time 36: 0.452\n",
      "  Time 37: 0.426\n",
      "  Time 38: 0.399\n",
      "  Time 39: 0.372\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.250\n",
      "  To trajectory 11: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.597\n",
      "  Time 31: 0.598\n",
      "  Time 32: 0.594\n",
      "  Time 33: 0.584\n",
      "  Time 34: 0.568\n",
      "  Time 35: 0.545\n",
      "  Time 36: 0.517\n",
      "  Time 37: 0.483\n",
      "  Time 38: 0.445\n",
      "  Time 39: 0.403\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.167\n",
      "  To trajectory 8: 0.167\n",
      "  To trajectory 12: 0.667\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.578\n",
      "  Time 31: 0.572\n",
      "  Time 32: 0.558\n",
      "  Time 33: 0.538\n",
      "  Time 34: 0.513\n",
      "  Time 35: 0.484\n",
      "  Time 36: 0.454\n",
      "  Time 37: 0.422\n",
      "  Time 38: 0.391\n",
      "  Time 39: 0.361\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.569\n",
      "  Time 31: 0.575\n",
      "  Time 32: 0.576\n",
      "  Time 33: 0.573\n",
      "  Time 34: 0.566\n",
      "  Time 35: 0.554\n",
      "  Time 36: 0.537\n",
      "  Time 37: 0.517\n",
      "  Time 38: 0.493\n",
      "  Time 39: 0.465\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.875\n",
      "  To trajectory 16: 0.125\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.568\n",
      "  Time 31: 0.565\n",
      "  Time 32: 0.558\n",
      "  Time 33: 0.546\n",
      "  Time 34: 0.530\n",
      "  Time 35: 0.511\n",
      "  Time 36: 0.488\n",
      "  Time 37: 0.463\n",
      "  Time 38: 0.435\n",
      "  Time 39: 0.407\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 15: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.558\n",
      "  Time 31: 0.562\n",
      "  Time 32: 0.560\n",
      "  Time 33: 0.554\n",
      "  Time 34: 0.542\n",
      "  Time 35: 0.526\n",
      "  Time 36: 0.505\n",
      "  Time 37: 0.481\n",
      "  Time 38: 0.455\n",
      "  Time 39: 0.426\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.200\n",
      "  To trajectory 16: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.536\n",
      "  Time 31: 0.532\n",
      "  Time 32: 0.524\n",
      "  Time 33: 0.512\n",
      "  Time 34: 0.496\n",
      "  Time 35: 0.477\n",
      "  Time 36: 0.456\n",
      "  Time 37: 0.432\n",
      "  Time 38: 0.407\n",
      "  Time 39: 0.381\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 17: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.570\n",
      "  Time 31: 0.561\n",
      "  Time 32: 0.548\n",
      "  Time 33: 0.531\n",
      "  Time 34: 0.511\n",
      "  Time 35: 0.489\n",
      "  Time 36: 0.463\n",
      "  Time 37: 0.436\n",
      "  Time 38: 0.407\n",
      "  Time 39: 0.377\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.125\n",
      "  To trajectory 18: 0.875\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.540\n",
      "  Time 31: 0.536\n",
      "  Time 32: 0.526\n",
      "  Time 33: 0.512\n",
      "  Time 34: 0.492\n",
      "  Time 35: 0.468\n",
      "  Time 36: 0.440\n",
      "  Time 37: 0.410\n",
      "  Time 38: 0.378\n",
      "  Time 39: 0.346\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.167\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 19: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.550\n",
      "  Time 31: 0.552\n",
      "  Time 32: 0.549\n",
      "  Time 33: 0.540\n",
      "  Time 34: 0.526\n",
      "  Time 35: 0.508\n",
      "  Time 36: 0.486\n",
      "  Time 37: 0.461\n",
      "  Time 38: 0.434\n",
      "  Time 39: 0.407\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_390000_400000_20241226_102603\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.536\n",
      "  Time 31: 0.532\n",
      "  Time 32: 0.524\n",
      "  Time 33: 0.513\n",
      "  Time 34: 0.498\n",
      "  Time 35: 0.481\n",
      "  Time 36: 0.461\n",
      "  Time 37: 0.440\n",
      "  Time 38: 0.417\n",
      "  Time 39: 0.394\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.143\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.857\n",
      "  To trajectory 7: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.540\n",
      "  Time 31: 0.535\n",
      "  Time 32: 0.524\n",
      "  Time 33: 0.508\n",
      "  Time 34: 0.488\n",
      "  Time 35: 0.463\n",
      "  Time 36: 0.434\n",
      "  Time 37: 0.403\n",
      "  Time 38: 0.370\n",
      "  Time 39: 0.336\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.712\n",
      "  Time 31: 0.722\n",
      "  Time 32: 0.725\n",
      "  Time 33: 0.723\n",
      "  Time 34: 0.714\n",
      "  Time 35: 0.699\n",
      "  Time 36: 0.677\n",
      "  Time 37: 0.649\n",
      "  Time 38: 0.614\n",
      "  Time 39: 0.574\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 0.750\n",
      "  To trajectory 17: 0.250\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.589\n",
      "  Time 31: 0.592\n",
      "  Time 32: 0.590\n",
      "  Time 33: 0.583\n",
      "  Time 34: 0.572\n",
      "  Time 35: 0.556\n",
      "  Time 36: 0.535\n",
      "  Time 37: 0.511\n",
      "  Time 38: 0.484\n",
      "  Time 39: 0.454\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.538\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 4: 0.750\n",
      "  To trajectory 7: 0.250\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.580\n",
      "  Time 31: 0.567\n",
      "  Time 32: 0.549\n",
      "  Time 33: 0.524\n",
      "  Time 34: 0.495\n",
      "  Time 35: 0.462\n",
      "  Time 36: 0.427\n",
      "  Time 37: 0.391\n",
      "  Time 38: 0.356\n",
      "  Time 39: 0.323\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 10\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.537\n",
      "  Time 31: 0.529\n",
      "  Time 32: 0.516\n",
      "  Time 33: 0.500\n",
      "  Time 34: 0.481\n",
      "  Time 35: 0.459\n",
      "  Time 36: 0.435\n",
      "  Time 37: 0.409\n",
      "  Time 38: 0.382\n",
      "  Time 39: 0.355\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.250\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.582\n",
      "  Time 31: 0.587\n",
      "  Time 32: 0.586\n",
      "  Time 33: 0.579\n",
      "  Time 34: 0.565\n",
      "  Time 35: 0.544\n",
      "  Time 36: 0.516\n",
      "  Time 37: 0.481\n",
      "  Time 38: 0.440\n",
      "  Time 39: 0.394\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.526\n",
      "  Time 31: 0.530\n",
      "  Time 32: 0.529\n",
      "  Time 33: 0.521\n",
      "  Time 34: 0.508\n",
      "  Time 35: 0.490\n",
      "  Time 36: 0.466\n",
      "  Time 37: 0.439\n",
      "  Time 38: 0.408\n",
      "  Time 39: 0.374\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.750\n",
      "  To trajectory 16: 0.250\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.548\n",
      "  Time 31: 0.543\n",
      "  Time 32: 0.533\n",
      "  Time 33: 0.519\n",
      "  Time 34: 0.500\n",
      "  Time 35: 0.477\n",
      "  Time 36: 0.450\n",
      "  Time 37: 0.420\n",
      "  Time 38: 0.388\n",
      "  Time 39: 0.354\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.120\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.800\n",
      "  To trajectory 15: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.603\n",
      "  Time 31: 0.595\n",
      "  Time 32: 0.583\n",
      "  Time 33: 0.566\n",
      "  Time 34: 0.544\n",
      "  Time 35: 0.518\n",
      "  Time 36: 0.488\n",
      "  Time 37: 0.455\n",
      "  Time 38: 0.420\n",
      "  Time 39: 0.384\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 0.200\n",
      "  To trajectory 10: 0.600\n",
      "  To trajectory 18: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.527\n",
      "  Time 31: 0.524\n",
      "  Time 32: 0.515\n",
      "  Time 33: 0.499\n",
      "  Time 34: 0.478\n",
      "  Time 35: 0.452\n",
      "  Time 36: 0.423\n",
      "  Time 37: 0.392\n",
      "  Time 38: 0.360\n",
      "  Time 39: 0.329\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.250\n",
      "  To trajectory 11: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.592\n",
      "  Time 31: 0.596\n",
      "  Time 32: 0.594\n",
      "  Time 33: 0.583\n",
      "  Time 34: 0.565\n",
      "  Time 35: 0.540\n",
      "  Time 36: 0.508\n",
      "  Time 37: 0.469\n",
      "  Time 38: 0.427\n",
      "  Time 39: 0.381\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.200\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.200\n",
      "  To trajectory 8: 0.200\n",
      "  To trajectory 12: 0.600\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.573\n",
      "  Time 31: 0.570\n",
      "  Time 32: 0.561\n",
      "  Time 33: 0.544\n",
      "  Time 34: 0.523\n",
      "  Time 35: 0.496\n",
      "  Time 36: 0.467\n",
      "  Time 37: 0.437\n",
      "  Time 38: 0.407\n",
      "  Time 39: 0.377\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.143\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.570\n",
      "  Time 31: 0.578\n",
      "  Time 32: 0.580\n",
      "  Time 33: 0.577\n",
      "  Time 34: 0.569\n",
      "  Time 35: 0.557\n",
      "  Time 36: 0.540\n",
      "  Time 37: 0.519\n",
      "  Time 38: 0.494\n",
      "  Time 39: 0.465\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.875\n",
      "  To trajectory 16: 0.125\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.560\n",
      "  Time 31: 0.557\n",
      "  Time 32: 0.549\n",
      "  Time 33: 0.536\n",
      "  Time 34: 0.519\n",
      "  Time 35: 0.498\n",
      "  Time 36: 0.474\n",
      "  Time 37: 0.447\n",
      "  Time 38: 0.419\n",
      "  Time 39: 0.390\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.200\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 15: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.586\n",
      "  Time 31: 0.596\n",
      "  Time 32: 0.602\n",
      "  Time 33: 0.602\n",
      "  Time 34: 0.597\n",
      "  Time 35: 0.588\n",
      "  Time 36: 0.575\n",
      "  Time 37: 0.559\n",
      "  Time 38: 0.539\n",
      "  Time 39: 0.518\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.200\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.200\n",
      "  To trajectory 16: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.528\n",
      "  Time 31: 0.540\n",
      "  Time 32: 0.546\n",
      "  Time 33: 0.548\n",
      "  Time 34: 0.544\n",
      "  Time 35: 0.536\n",
      "  Time 36: 0.525\n",
      "  Time 37: 0.509\n",
      "  Time 38: 0.491\n",
      "  Time 39: 0.470\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 17: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.603\n",
      "  Time 31: 0.588\n",
      "  Time 32: 0.568\n",
      "  Time 33: 0.545\n",
      "  Time 34: 0.518\n",
      "  Time 35: 0.488\n",
      "  Time 36: 0.455\n",
      "  Time 37: 0.421\n",
      "  Time 38: 0.385\n",
      "  Time 39: 0.350\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.200\n",
      "  To trajectory 18: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.553\n",
      "  Time 31: 0.549\n",
      "  Time 32: 0.540\n",
      "  Time 33: 0.524\n",
      "  Time 34: 0.502\n",
      "  Time 35: 0.476\n",
      "  Time 36: 0.446\n",
      "  Time 37: 0.413\n",
      "  Time 38: 0.379\n",
      "  Time 39: 0.345\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 19: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.556\n",
      "  Time 31: 0.557\n",
      "  Time 32: 0.551\n",
      "  Time 33: 0.540\n",
      "  Time 34: 0.523\n",
      "  Time 35: 0.502\n",
      "  Time 36: 0.478\n",
      "  Time 37: 0.450\n",
      "  Time 38: 0.421\n",
      "  Time 39: 0.391\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_40000_50000_20241225_124544\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 0.800\n",
      "  To trajectory 13: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.535\n",
      "  Time 31: 0.537\n",
      "  Time 32: 0.536\n",
      "  Time 33: 0.531\n",
      "  Time 34: 0.522\n",
      "  Time 35: 0.509\n",
      "  Time 36: 0.492\n",
      "  Time 37: 0.473\n",
      "  Time 38: 0.450\n",
      "  Time 39: 0.425\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.561\n",
      "  Time 31: 0.558\n",
      "  Time 32: 0.549\n",
      "  Time 33: 0.536\n",
      "  Time 34: 0.519\n",
      "  Time 35: 0.497\n",
      "  Time 36: 0.471\n",
      "  Time 37: 0.442\n",
      "  Time 38: 0.410\n",
      "  Time 39: 0.376\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.722\n",
      "  Time 31: 0.732\n",
      "  Time 32: 0.735\n",
      "  Time 33: 0.733\n",
      "  Time 34: 0.724\n",
      "  Time 35: 0.709\n",
      "  Time 36: 0.688\n",
      "  Time 37: 0.660\n",
      "  Time 38: 0.625\n",
      "  Time 39: 0.584\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.564\n",
      "  Time 31: 0.572\n",
      "  Time 32: 0.574\n",
      "  Time 33: 0.573\n",
      "  Time 34: 0.566\n",
      "  Time 35: 0.556\n",
      "  Time 36: 0.540\n",
      "  Time 37: 0.521\n",
      "  Time 38: 0.497\n",
      "  Time 39: 0.469\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.538\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 4: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.564\n",
      "  Time 31: 0.556\n",
      "  Time 32: 0.543\n",
      "  Time 33: 0.524\n",
      "  Time 34: 0.500\n",
      "  Time 35: 0.472\n",
      "  Time 36: 0.441\n",
      "  Time 37: 0.407\n",
      "  Time 38: 0.373\n",
      "  Time 39: 0.339\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 9\n",
      "CAD risk: 0.333\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.111\n",
      "  To trajectory 5: 0.889\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.539\n",
      "  Time 31: 0.536\n",
      "  Time 32: 0.529\n",
      "  Time 33: 0.520\n",
      "  Time 34: 0.508\n",
      "  Time 35: 0.494\n",
      "  Time 36: 0.480\n",
      "  Time 37: 0.465\n",
      "  Time 38: 0.449\n",
      "  Time 39: 0.433\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.200\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 0.800\n",
      "  To trajectory 7: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.569\n",
      "  Time 31: 0.566\n",
      "  Time 32: 0.557\n",
      "  Time 33: 0.543\n",
      "  Time 34: 0.523\n",
      "  Time 35: 0.498\n",
      "  Time 36: 0.467\n",
      "  Time 37: 0.431\n",
      "  Time 38: 0.391\n",
      "  Time 39: 0.349\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 0.250\n",
      "  To trajectory 7: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.528\n",
      "  Time 31: 0.529\n",
      "  Time 32: 0.523\n",
      "  Time 33: 0.511\n",
      "  Time 34: 0.493\n",
      "  Time 35: 0.470\n",
      "  Time 36: 0.442\n",
      "  Time 37: 0.410\n",
      "  Time 38: 0.375\n",
      "  Time 39: 0.338\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.857\n",
      "  To trajectory 19: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.533\n",
      "  Time 31: 0.522\n",
      "  Time 32: 0.505\n",
      "  Time 33: 0.484\n",
      "  Time 34: 0.459\n",
      "  Time 35: 0.431\n",
      "  Time 36: 0.401\n",
      "  Time 37: 0.369\n",
      "  Time 38: 0.336\n",
      "  Time 39: 0.304\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.120\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.143\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.857\n",
      "  To trajectory 15: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.582\n",
      "  Time 31: 0.572\n",
      "  Time 32: 0.558\n",
      "  Time 33: 0.540\n",
      "  Time 34: 0.518\n",
      "  Time 35: 0.492\n",
      "  Time 36: 0.464\n",
      "  Time 37: 0.433\n",
      "  Time 38: 0.401\n",
      "  Time 39: 0.369\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 10: 0.667\n",
      "  To trajectory 18: 0.333\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.535\n",
      "  Time 31: 0.526\n",
      "  Time 32: 0.511\n",
      "  Time 33: 0.492\n",
      "  Time 34: 0.468\n",
      "  Time 35: 0.442\n",
      "  Time 36: 0.412\n",
      "  Time 37: 0.382\n",
      "  Time 38: 0.350\n",
      "  Time 39: 0.318\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.333\n",
      "  To trajectory 11: 0.667\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.619\n",
      "  Time 31: 0.624\n",
      "  Time 32: 0.622\n",
      "  Time 33: 0.613\n",
      "  Time 34: 0.596\n",
      "  Time 35: 0.571\n",
      "  Time 36: 0.539\n",
      "  Time 37: 0.501\n",
      "  Time 38: 0.457\n",
      "  Time 39: 0.409\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.143\n",
      "  To trajectory 8: 0.143\n",
      "  To trajectory 12: 0.714\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.554\n",
      "  Time 31: 0.548\n",
      "  Time 32: 0.535\n",
      "  Time 33: 0.516\n",
      "  Time 34: 0.493\n",
      "  Time 35: 0.467\n",
      "  Time 36: 0.439\n",
      "  Time 37: 0.409\n",
      "  Time 38: 0.380\n",
      "  Time 39: 0.351\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.596\n",
      "  Time 31: 0.603\n",
      "  Time 32: 0.605\n",
      "  Time 33: 0.602\n",
      "  Time 34: 0.593\n",
      "  Time 35: 0.580\n",
      "  Time 36: 0.562\n",
      "  Time 37: 0.541\n",
      "  Time 38: 0.516\n",
      "  Time 39: 0.488\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.875\n",
      "  To trajectory 16: 0.125\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.571\n",
      "  Time 31: 0.568\n",
      "  Time 32: 0.560\n",
      "  Time 33: 0.548\n",
      "  Time 34: 0.532\n",
      "  Time 35: 0.512\n",
      "  Time 36: 0.489\n",
      "  Time 37: 0.463\n",
      "  Time 38: 0.435\n",
      "  Time 39: 0.406\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 15: 0.875\n",
      "  To trajectory 16: 0.125\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.558\n",
      "  Time 31: 0.556\n",
      "  Time 32: 0.551\n",
      "  Time 33: 0.541\n",
      "  Time 34: 0.528\n",
      "  Time 35: 0.512\n",
      "  Time 36: 0.492\n",
      "  Time 37: 0.470\n",
      "  Time 38: 0.445\n",
      "  Time 39: 0.418\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.333\n",
      "  To trajectory 16: 0.667\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.540\n",
      "  Time 31: 0.541\n",
      "  Time 32: 0.538\n",
      "  Time 33: 0.531\n",
      "  Time 34: 0.521\n",
      "  Time 35: 0.508\n",
      "  Time 36: 0.493\n",
      "  Time 37: 0.476\n",
      "  Time 38: 0.457\n",
      "  Time 39: 0.438\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.200\n",
      "  To trajectory 17: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.546\n",
      "  Time 31: 0.540\n",
      "  Time 32: 0.532\n",
      "  Time 33: 0.520\n",
      "  Time 34: 0.505\n",
      "  Time 35: 0.488\n",
      "  Time 36: 0.468\n",
      "  Time 37: 0.445\n",
      "  Time 38: 0.420\n",
      "  Time 39: 0.394\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.200\n",
      "  To trajectory 18: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.566\n",
      "  Time 31: 0.557\n",
      "  Time 32: 0.544\n",
      "  Time 33: 0.526\n",
      "  Time 34: 0.503\n",
      "  Time 35: 0.478\n",
      "  Time 36: 0.449\n",
      "  Time 37: 0.419\n",
      "  Time 38: 0.389\n",
      "  Time 39: 0.359\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.200\n",
      "  To trajectory 19: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.550\n",
      "  Time 31: 0.548\n",
      "  Time 32: 0.540\n",
      "  Time 33: 0.527\n",
      "  Time 34: 0.508\n",
      "  Time 35: 0.484\n",
      "  Time 36: 0.457\n",
      "  Time 37: 0.427\n",
      "  Time 38: 0.395\n",
      "  Time 39: 0.363\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_50000_60000_20241225_124613\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.538\n",
      "  Time 31: 0.544\n",
      "  Time 32: 0.544\n",
      "  Time 33: 0.538\n",
      "  Time 34: 0.528\n",
      "  Time 35: 0.513\n",
      "  Time 36: 0.495\n",
      "  Time 37: 0.473\n",
      "  Time 38: 0.448\n",
      "  Time 39: 0.422\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.167\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.552\n",
      "  Time 31: 0.548\n",
      "  Time 32: 0.540\n",
      "  Time 33: 0.527\n",
      "  Time 34: 0.509\n",
      "  Time 35: 0.488\n",
      "  Time 36: 0.462\n",
      "  Time 37: 0.432\n",
      "  Time 38: 0.400\n",
      "  Time 39: 0.366\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.716\n",
      "  Time 31: 0.725\n",
      "  Time 32: 0.728\n",
      "  Time 33: 0.725\n",
      "  Time 34: 0.716\n",
      "  Time 35: 0.700\n",
      "  Time 36: 0.678\n",
      "  Time 37: 0.649\n",
      "  Time 38: 0.614\n",
      "  Time 39: 0.573\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.143\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 0.857\n",
      "  To trajectory 5: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.553\n",
      "  Time 31: 0.552\n",
      "  Time 32: 0.546\n",
      "  Time 33: 0.536\n",
      "  Time 34: 0.523\n",
      "  Time 35: 0.506\n",
      "  Time 36: 0.487\n",
      "  Time 37: 0.465\n",
      "  Time 38: 0.440\n",
      "  Time 39: 0.413\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.538\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 0.200\n",
      "  To trajectory 4: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.565\n",
      "  Time 31: 0.547\n",
      "  Time 32: 0.523\n",
      "  Time 33: 0.493\n",
      "  Time 34: 0.461\n",
      "  Time 35: 0.426\n",
      "  Time 36: 0.390\n",
      "  Time 37: 0.355\n",
      "  Time 38: 0.321\n",
      "  Time 39: 0.289\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 13\n",
      "CAD risk: 0.077\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 0.923\n",
      "  To trajectory 16: 0.077\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.552\n",
      "  Time 31: 0.552\n",
      "  Time 32: 0.549\n",
      "  Time 33: 0.541\n",
      "  Time 34: 0.529\n",
      "  Time 35: 0.515\n",
      "  Time 36: 0.497\n",
      "  Time 37: 0.477\n",
      "  Time 38: 0.455\n",
      "  Time 39: 0.432\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.583\n",
      "  Time 31: 0.588\n",
      "  Time 32: 0.587\n",
      "  Time 33: 0.579\n",
      "  Time 34: 0.565\n",
      "  Time 35: 0.543\n",
      "  Time 36: 0.515\n",
      "  Time 37: 0.479\n",
      "  Time 38: 0.438\n",
      "  Time 39: 0.392\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.250\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 0.250\n",
      "  To trajectory 7: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.541\n",
      "  Time 31: 0.540\n",
      "  Time 32: 0.532\n",
      "  Time 33: 0.517\n",
      "  Time 34: 0.496\n",
      "  Time 35: 0.469\n",
      "  Time 36: 0.438\n",
      "  Time 37: 0.403\n",
      "  Time 38: 0.366\n",
      "  Time 39: 0.327\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.875\n",
      "  To trajectory 19: 0.125\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.528\n",
      "  Time 31: 0.514\n",
      "  Time 32: 0.496\n",
      "  Time 33: 0.473\n",
      "  Time 34: 0.447\n",
      "  Time 35: 0.418\n",
      "  Time 36: 0.387\n",
      "  Time 37: 0.355\n",
      "  Time 38: 0.323\n",
      "  Time 39: 0.291\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.120\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.800\n",
      "  To trajectory 15: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.603\n",
      "  Time 31: 0.591\n",
      "  Time 32: 0.575\n",
      "  Time 33: 0.555\n",
      "  Time 34: 0.530\n",
      "  Time 35: 0.502\n",
      "  Time 36: 0.471\n",
      "  Time 37: 0.438\n",
      "  Time 38: 0.404\n",
      "  Time 39: 0.370\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 10: 0.500\n",
      "  To trajectory 18: 0.500\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.556\n",
      "  Time 31: 0.536\n",
      "  Time 32: 0.510\n",
      "  Time 33: 0.480\n",
      "  Time 34: 0.448\n",
      "  Time 35: 0.414\n",
      "  Time 36: 0.380\n",
      "  Time 37: 0.348\n",
      "  Time 38: 0.318\n",
      "  Time 39: 0.291\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.167\n",
      "  To trajectory 11: 0.833\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.564\n",
      "  Time 31: 0.561\n",
      "  Time 32: 0.553\n",
      "  Time 33: 0.539\n",
      "  Time 34: 0.519\n",
      "  Time 35: 0.494\n",
      "  Time 36: 0.464\n",
      "  Time 37: 0.430\n",
      "  Time 38: 0.393\n",
      "  Time 39: 0.355\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.250\n",
      "  To trajectory 8: 0.250\n",
      "  To trajectory 12: 0.500\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.600\n",
      "  Time 31: 0.599\n",
      "  Time 32: 0.590\n",
      "  Time 33: 0.573\n",
      "  Time 34: 0.549\n",
      "  Time 35: 0.520\n",
      "  Time 36: 0.488\n",
      "  Time 37: 0.455\n",
      "  Time 38: 0.421\n",
      "  Time 39: 0.389\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.595\n",
      "  Time 31: 0.602\n",
      "  Time 32: 0.605\n",
      "  Time 33: 0.602\n",
      "  Time 34: 0.594\n",
      "  Time 35: 0.581\n",
      "  Time 36: 0.564\n",
      "  Time 37: 0.542\n",
      "  Time 38: 0.517\n",
      "  Time 39: 0.489\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.875\n",
      "  To trajectory 16: 0.125\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.575\n",
      "  Time 31: 0.572\n",
      "  Time 32: 0.564\n",
      "  Time 33: 0.552\n",
      "  Time 34: 0.536\n",
      "  Time 35: 0.516\n",
      "  Time 36: 0.493\n",
      "  Time 37: 0.466\n",
      "  Time 38: 0.438\n",
      "  Time 39: 0.409\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 15: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.540\n",
      "  Time 31: 0.536\n",
      "  Time 32: 0.526\n",
      "  Time 33: 0.512\n",
      "  Time 34: 0.494\n",
      "  Time 35: 0.471\n",
      "  Time 36: 0.445\n",
      "  Time 37: 0.416\n",
      "  Time 38: 0.385\n",
      "  Time 39: 0.353\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.200\n",
      "  To trajectory 16: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.536\n",
      "  Time 31: 0.548\n",
      "  Time 32: 0.554\n",
      "  Time 33: 0.556\n",
      "  Time 34: 0.552\n",
      "  Time 35: 0.544\n",
      "  Time 36: 0.532\n",
      "  Time 37: 0.516\n",
      "  Time 38: 0.497\n",
      "  Time 39: 0.476\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 17: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.566\n",
      "  Time 31: 0.555\n",
      "  Time 32: 0.540\n",
      "  Time 33: 0.521\n",
      "  Time 34: 0.499\n",
      "  Time 35: 0.474\n",
      "  Time 36: 0.446\n",
      "  Time 37: 0.417\n",
      "  Time 38: 0.387\n",
      "  Time 39: 0.356\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 18: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.551\n",
      "  Time 31: 0.545\n",
      "  Time 32: 0.535\n",
      "  Time 33: 0.520\n",
      "  Time 34: 0.502\n",
      "  Time 35: 0.481\n",
      "  Time 36: 0.457\n",
      "  Time 37: 0.431\n",
      "  Time 38: 0.404\n",
      "  Time 39: 0.377\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 19: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.542\n",
      "  Time 31: 0.542\n",
      "  Time 32: 0.536\n",
      "  Time 33: 0.525\n",
      "  Time 34: 0.508\n",
      "  Time 35: 0.487\n",
      "  Time 36: 0.463\n",
      "  Time 37: 0.436\n",
      "  Time 38: 0.407\n",
      "  Time 39: 0.378\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_60000_70000_20241225_155446\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 0.833\n",
      "  To trajectory 13: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.546\n",
      "  Time 31: 0.548\n",
      "  Time 32: 0.546\n",
      "  Time 33: 0.539\n",
      "  Time 34: 0.527\n",
      "  Time 35: 0.511\n",
      "  Time 36: 0.490\n",
      "  Time 37: 0.466\n",
      "  Time 38: 0.440\n",
      "  Time 39: 0.411\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.544\n",
      "  Time 31: 0.540\n",
      "  Time 32: 0.532\n",
      "  Time 33: 0.519\n",
      "  Time 34: 0.501\n",
      "  Time 35: 0.479\n",
      "  Time 36: 0.454\n",
      "  Time 37: 0.424\n",
      "  Time 38: 0.393\n",
      "  Time 39: 0.359\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.722\n",
      "  Time 31: 0.731\n",
      "  Time 32: 0.734\n",
      "  Time 33: 0.731\n",
      "  Time 34: 0.722\n",
      "  Time 35: 0.707\n",
      "  Time 36: 0.686\n",
      "  Time 37: 0.658\n",
      "  Time 38: 0.624\n",
      "  Time 39: 0.584\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.563\n",
      "  Time 31: 0.571\n",
      "  Time 32: 0.573\n",
      "  Time 33: 0.571\n",
      "  Time 34: 0.565\n",
      "  Time 35: 0.555\n",
      "  Time 36: 0.540\n",
      "  Time 37: 0.521\n",
      "  Time 38: 0.498\n",
      "  Time 39: 0.471\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.538\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 0.167\n",
      "  To trajectory 4: 0.667\n",
      "  To trajectory 7: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.562\n",
      "  Time 31: 0.546\n",
      "  Time 32: 0.524\n",
      "  Time 33: 0.498\n",
      "  Time 34: 0.468\n",
      "  Time 35: 0.436\n",
      "  Time 36: 0.404\n",
      "  Time 37: 0.372\n",
      "  Time 38: 0.341\n",
      "  Time 39: 0.312\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.143\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.564\n",
      "  Time 31: 0.557\n",
      "  Time 32: 0.546\n",
      "  Time 33: 0.530\n",
      "  Time 34: 0.510\n",
      "  Time 35: 0.486\n",
      "  Time 36: 0.459\n",
      "  Time 37: 0.430\n",
      "  Time 38: 0.401\n",
      "  Time 39: 0.372\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.571\n",
      "  Time 31: 0.585\n",
      "  Time 32: 0.594\n",
      "  Time 33: 0.596\n",
      "  Time 34: 0.591\n",
      "  Time 35: 0.579\n",
      "  Time 36: 0.560\n",
      "  Time 37: 0.535\n",
      "  Time 38: 0.503\n",
      "  Time 39: 0.467\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 0.250\n",
      "  To trajectory 7: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.520\n",
      "  Time 31: 0.517\n",
      "  Time 32: 0.507\n",
      "  Time 33: 0.490\n",
      "  Time 34: 0.468\n",
      "  Time 35: 0.440\n",
      "  Time 36: 0.409\n",
      "  Time 37: 0.375\n",
      "  Time 38: 0.339\n",
      "  Time 39: 0.302\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.800\n",
      "  To trajectory 19: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.551\n",
      "  Time 31: 0.538\n",
      "  Time 32: 0.520\n",
      "  Time 33: 0.498\n",
      "  Time 34: 0.471\n",
      "  Time 35: 0.442\n",
      "  Time 36: 0.412\n",
      "  Time 37: 0.380\n",
      "  Time 38: 0.348\n",
      "  Time 39: 0.317\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.119\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.800\n",
      "  To trajectory 15: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.604\n",
      "  Time 31: 0.597\n",
      "  Time 32: 0.584\n",
      "  Time 33: 0.566\n",
      "  Time 34: 0.544\n",
      "  Time 35: 0.517\n",
      "  Time 36: 0.487\n",
      "  Time 37: 0.454\n",
      "  Time 38: 0.420\n",
      "  Time 39: 0.384\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 10: 0.833\n",
      "  To trajectory 18: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.544\n",
      "  Time 31: 0.535\n",
      "  Time 32: 0.520\n",
      "  Time 33: 0.501\n",
      "  Time 34: 0.477\n",
      "  Time 35: 0.450\n",
      "  Time 36: 0.421\n",
      "  Time 37: 0.391\n",
      "  Time 38: 0.361\n",
      "  Time 39: 0.332\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.333\n",
      "  To trajectory 11: 0.667\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.609\n",
      "  Time 31: 0.614\n",
      "  Time 32: 0.612\n",
      "  Time 33: 0.602\n",
      "  Time 34: 0.585\n",
      "  Time 35: 0.561\n",
      "  Time 36: 0.529\n",
      "  Time 37: 0.492\n",
      "  Time 38: 0.449\n",
      "  Time 39: 0.403\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.167\n",
      "  To trajectory 8: 0.167\n",
      "  To trajectory 12: 0.667\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.573\n",
      "  Time 31: 0.567\n",
      "  Time 32: 0.554\n",
      "  Time 33: 0.535\n",
      "  Time 34: 0.510\n",
      "  Time 35: 0.481\n",
      "  Time 36: 0.451\n",
      "  Time 37: 0.419\n",
      "  Time 38: 0.388\n",
      "  Time 39: 0.357\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.590\n",
      "  Time 31: 0.598\n",
      "  Time 32: 0.602\n",
      "  Time 33: 0.600\n",
      "  Time 34: 0.594\n",
      "  Time 35: 0.583\n",
      "  Time 36: 0.567\n",
      "  Time 37: 0.546\n",
      "  Time 38: 0.521\n",
      "  Time 39: 0.493\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.875\n",
      "  To trajectory 16: 0.125\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.565\n",
      "  Time 31: 0.562\n",
      "  Time 32: 0.554\n",
      "  Time 33: 0.541\n",
      "  Time 34: 0.524\n",
      "  Time 35: 0.502\n",
      "  Time 36: 0.478\n",
      "  Time 37: 0.451\n",
      "  Time 38: 0.423\n",
      "  Time 39: 0.393\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.143\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.143\n",
      "  To trajectory 15: 0.714\n",
      "  To trajectory 16: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.535\n",
      "  Time 31: 0.528\n",
      "  Time 32: 0.517\n",
      "  Time 33: 0.500\n",
      "  Time 34: 0.479\n",
      "  Time 35: 0.454\n",
      "  Time 36: 0.425\n",
      "  Time 37: 0.394\n",
      "  Time 38: 0.360\n",
      "  Time 39: 0.325\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.200\n",
      "  To trajectory 16: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.535\n",
      "  Time 31: 0.547\n",
      "  Time 32: 0.554\n",
      "  Time 33: 0.556\n",
      "  Time 34: 0.553\n",
      "  Time 35: 0.545\n",
      "  Time 36: 0.534\n",
      "  Time 37: 0.519\n",
      "  Time 38: 0.501\n",
      "  Time 39: 0.481\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 0.200\n",
      "  To trajectory 17: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.551\n",
      "  Time 31: 0.533\n",
      "  Time 32: 0.510\n",
      "  Time 33: 0.483\n",
      "  Time 34: 0.452\n",
      "  Time 35: 0.418\n",
      "  Time 36: 0.383\n",
      "  Time 37: 0.346\n",
      "  Time 38: 0.311\n",
      "  Time 39: 0.277\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.167\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.167\n",
      "  To trajectory 18: 0.833\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.562\n",
      "  Time 31: 0.561\n",
      "  Time 32: 0.553\n",
      "  Time 33: 0.541\n",
      "  Time 34: 0.524\n",
      "  Time 35: 0.502\n",
      "  Time 36: 0.477\n",
      "  Time 37: 0.448\n",
      "  Time 38: 0.418\n",
      "  Time 39: 0.386\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.143\n",
      "  To trajectory 19: 0.857\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.539\n",
      "  Time 31: 0.542\n",
      "  Time 32: 0.539\n",
      "  Time 33: 0.531\n",
      "  Time 34: 0.517\n",
      "  Time 35: 0.498\n",
      "  Time 36: 0.476\n",
      "  Time 37: 0.450\n",
      "  Time 38: 0.422\n",
      "  Time 39: 0.392\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_70000_80000_20241225_155500\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.167\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 0.833\n",
      "  To trajectory 13: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.526\n",
      "  Time 31: 0.519\n",
      "  Time 32: 0.507\n",
      "  Time 33: 0.491\n",
      "  Time 34: 0.471\n",
      "  Time 35: 0.448\n",
      "  Time 36: 0.423\n",
      "  Time 37: 0.396\n",
      "  Time 38: 0.369\n",
      "  Time 39: 0.342\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.167\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.543\n",
      "  Time 31: 0.539\n",
      "  Time 32: 0.530\n",
      "  Time 33: 0.517\n",
      "  Time 34: 0.500\n",
      "  Time 35: 0.478\n",
      "  Time 36: 0.452\n",
      "  Time 37: 0.423\n",
      "  Time 38: 0.391\n",
      "  Time 39: 0.358\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.723\n",
      "  Time 31: 0.732\n",
      "  Time 32: 0.735\n",
      "  Time 33: 0.732\n",
      "  Time 34: 0.723\n",
      "  Time 35: 0.707\n",
      "  Time 36: 0.686\n",
      "  Time 37: 0.658\n",
      "  Time 38: 0.623\n",
      "  Time 39: 0.583\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.559\n",
      "  Time 31: 0.566\n",
      "  Time 32: 0.569\n",
      "  Time 33: 0.567\n",
      "  Time 34: 0.561\n",
      "  Time 35: 0.550\n",
      "  Time 36: 0.534\n",
      "  Time 37: 0.514\n",
      "  Time 38: 0.490\n",
      "  Time 39: 0.462\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.538\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 0.143\n",
      "  To trajectory 4: 0.714\n",
      "  To trajectory 7: 0.143\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.555\n",
      "  Time 31: 0.540\n",
      "  Time 32: 0.520\n",
      "  Time 33: 0.494\n",
      "  Time 34: 0.465\n",
      "  Time 35: 0.433\n",
      "  Time 36: 0.400\n",
      "  Time 37: 0.367\n",
      "  Time 38: 0.334\n",
      "  Time 39: 0.303\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.537\n",
      "  Time 31: 0.534\n",
      "  Time 32: 0.528\n",
      "  Time 33: 0.519\n",
      "  Time 34: 0.509\n",
      "  Time 35: 0.496\n",
      "  Time 36: 0.482\n",
      "  Time 37: 0.465\n",
      "  Time 38: 0.448\n",
      "  Time 39: 0.428\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.500\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.580\n",
      "  Time 31: 0.586\n",
      "  Time 32: 0.586\n",
      "  Time 33: 0.578\n",
      "  Time 34: 0.564\n",
      "  Time 35: 0.543\n",
      "  Time 36: 0.515\n",
      "  Time 37: 0.479\n",
      "  Time 38: 0.438\n",
      "  Time 39: 0.393\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.750\n",
      "  To trajectory 18: 0.250\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.516\n",
      "  Time 31: 0.517\n",
      "  Time 32: 0.512\n",
      "  Time 33: 0.502\n",
      "  Time 34: 0.487\n",
      "  Time 35: 0.468\n",
      "  Time 36: 0.444\n",
      "  Time 37: 0.418\n",
      "  Time 38: 0.389\n",
      "  Time 39: 0.358\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.200\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.800\n",
      "  To trajectory 16: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.556\n",
      "  Time 31: 0.546\n",
      "  Time 32: 0.531\n",
      "  Time 33: 0.513\n",
      "  Time 34: 0.491\n",
      "  Time 35: 0.466\n",
      "  Time 36: 0.439\n",
      "  Time 37: 0.409\n",
      "  Time 38: 0.377\n",
      "  Time 39: 0.344\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.119\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.667\n",
      "  To trajectory 14: 0.167\n",
      "  To trajectory 15: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.590\n",
      "  Time 31: 0.582\n",
      "  Time 32: 0.569\n",
      "  Time 33: 0.551\n",
      "  Time 34: 0.528\n",
      "  Time 35: 0.502\n",
      "  Time 36: 0.472\n",
      "  Time 37: 0.439\n",
      "  Time 38: 0.404\n",
      "  Time 39: 0.368\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 10: 0.750\n",
      "  To trajectory 18: 0.250\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.542\n",
      "  Time 31: 0.539\n",
      "  Time 32: 0.530\n",
      "  Time 33: 0.516\n",
      "  Time 34: 0.496\n",
      "  Time 35: 0.473\n",
      "  Time 36: 0.448\n",
      "  Time 37: 0.421\n",
      "  Time 38: 0.393\n",
      "  Time 39: 0.365\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.250\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.250\n",
      "  To trajectory 11: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.594\n",
      "  Time 31: 0.593\n",
      "  Time 32: 0.585\n",
      "  Time 33: 0.571\n",
      "  Time 34: 0.552\n",
      "  Time 35: 0.526\n",
      "  Time 36: 0.496\n",
      "  Time 37: 0.461\n",
      "  Time 38: 0.422\n",
      "  Time 39: 0.381\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.200\n",
      "  To trajectory 8: 0.200\n",
      "  To trajectory 12: 0.600\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.586\n",
      "  Time 31: 0.584\n",
      "  Time 32: 0.575\n",
      "  Time 33: 0.558\n",
      "  Time 34: 0.535\n",
      "  Time 35: 0.508\n",
      "  Time 36: 0.478\n",
      "  Time 37: 0.446\n",
      "  Time 38: 0.414\n",
      "  Time 39: 0.383\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.577\n",
      "  Time 31: 0.583\n",
      "  Time 32: 0.585\n",
      "  Time 33: 0.582\n",
      "  Time 34: 0.575\n",
      "  Time 35: 0.563\n",
      "  Time 36: 0.547\n",
      "  Time 37: 0.527\n",
      "  Time 38: 0.502\n",
      "  Time 39: 0.475\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.875\n",
      "  To trajectory 16: 0.125\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.577\n",
      "  Time 31: 0.573\n",
      "  Time 32: 0.565\n",
      "  Time 33: 0.553\n",
      "  Time 34: 0.537\n",
      "  Time 35: 0.517\n",
      "  Time 36: 0.494\n",
      "  Time 37: 0.468\n",
      "  Time 38: 0.440\n",
      "  Time 39: 0.411\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 15: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.606\n",
      "  Time 31: 0.600\n",
      "  Time 32: 0.589\n",
      "  Time 33: 0.574\n",
      "  Time 34: 0.554\n",
      "  Time 35: 0.531\n",
      "  Time 36: 0.504\n",
      "  Time 37: 0.474\n",
      "  Time 38: 0.441\n",
      "  Time 39: 0.406\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.200\n",
      "  To trajectory 16: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.526\n",
      "  Time 31: 0.538\n",
      "  Time 32: 0.545\n",
      "  Time 33: 0.546\n",
      "  Time 34: 0.543\n",
      "  Time 35: 0.535\n",
      "  Time 36: 0.524\n",
      "  Time 37: 0.509\n",
      "  Time 38: 0.490\n",
      "  Time 39: 0.470\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 17: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.556\n",
      "  Time 31: 0.549\n",
      "  Time 32: 0.538\n",
      "  Time 33: 0.523\n",
      "  Time 34: 0.504\n",
      "  Time 35: 0.481\n",
      "  Time 36: 0.456\n",
      "  Time 37: 0.428\n",
      "  Time 38: 0.398\n",
      "  Time 39: 0.367\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 18: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.554\n",
      "  Time 31: 0.550\n",
      "  Time 32: 0.540\n",
      "  Time 33: 0.525\n",
      "  Time 34: 0.506\n",
      "  Time 35: 0.483\n",
      "  Time 36: 0.456\n",
      "  Time 37: 0.428\n",
      "  Time 38: 0.398\n",
      "  Time 39: 0.367\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 19: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.554\n",
      "  Time 31: 0.553\n",
      "  Time 32: 0.547\n",
      "  Time 33: 0.534\n",
      "  Time 34: 0.517\n",
      "  Time 35: 0.495\n",
      "  Time 36: 0.469\n",
      "  Time 37: 0.441\n",
      "  Time 38: 0.411\n",
      "  Time 39: 0.381\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_80000_90000_20241225_193439\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.250\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 0.750\n",
      "  To trajectory 13: 0.250\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.549\n",
      "  Time 31: 0.545\n",
      "  Time 32: 0.536\n",
      "  Time 33: 0.523\n",
      "  Time 34: 0.507\n",
      "  Time 35: 0.487\n",
      "  Time 36: 0.464\n",
      "  Time 37: 0.439\n",
      "  Time 38: 0.412\n",
      "  Time 39: 0.384\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.167\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.555\n",
      "  Time 31: 0.551\n",
      "  Time 32: 0.542\n",
      "  Time 33: 0.529\n",
      "  Time 34: 0.511\n",
      "  Time 35: 0.489\n",
      "  Time 36: 0.463\n",
      "  Time 37: 0.434\n",
      "  Time 38: 0.401\n",
      "  Time 39: 0.367\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 2\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.722\n",
      "  Time 31: 0.731\n",
      "  Time 32: 0.734\n",
      "  Time 33: 0.731\n",
      "  Time 34: 0.722\n",
      "  Time 35: 0.707\n",
      "  Time 36: 0.685\n",
      "  Time 37: 0.657\n",
      "  Time 38: 0.622\n",
      "  Time 39: 0.581\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.565\n",
      "  Time 31: 0.573\n",
      "  Time 32: 0.575\n",
      "  Time 33: 0.573\n",
      "  Time 34: 0.567\n",
      "  Time 35: 0.556\n",
      "  Time 36: 0.541\n",
      "  Time 37: 0.521\n",
      "  Time 38: 0.496\n",
      "  Time 39: 0.468\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.538\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 0.125\n",
      "  To trajectory 4: 0.750\n",
      "  To trajectory 7: 0.125\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.543\n",
      "  Time 31: 0.528\n",
      "  Time 32: 0.506\n",
      "  Time 33: 0.481\n",
      "  Time 34: 0.452\n",
      "  Time 35: 0.420\n",
      "  Time 36: 0.388\n",
      "  Time 37: 0.356\n",
      "  Time 38: 0.325\n",
      "  Time 39: 0.295\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.200\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.548\n",
      "  Time 31: 0.540\n",
      "  Time 32: 0.529\n",
      "  Time 33: 0.515\n",
      "  Time 34: 0.498\n",
      "  Time 35: 0.479\n",
      "  Time 36: 0.458\n",
      "  Time 37: 0.437\n",
      "  Time 38: 0.415\n",
      "  Time 39: 0.393\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 0.800\n",
      "  To trajectory 7: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.577\n",
      "  Time 31: 0.574\n",
      "  Time 32: 0.565\n",
      "  Time 33: 0.551\n",
      "  Time 34: 0.531\n",
      "  Time 35: 0.505\n",
      "  Time 36: 0.474\n",
      "  Time 37: 0.439\n",
      "  Time 38: 0.399\n",
      "  Time 39: 0.356\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 0.200\n",
      "  To trajectory 7: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.532\n",
      "  Time 31: 0.535\n",
      "  Time 32: 0.531\n",
      "  Time 33: 0.521\n",
      "  Time 34: 0.505\n",
      "  Time 35: 0.484\n",
      "  Time 36: 0.458\n",
      "  Time 37: 0.428\n",
      "  Time 38: 0.395\n",
      "  Time 39: 0.361\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.546\n",
      "  Time 31: 0.538\n",
      "  Time 32: 0.526\n",
      "  Time 33: 0.509\n",
      "  Time 34: 0.488\n",
      "  Time 35: 0.463\n",
      "  Time 36: 0.436\n",
      "  Time 37: 0.405\n",
      "  Time 38: 0.373\n",
      "  Time 39: 0.341\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.120\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.600\n",
      "  To trajectory 14: 0.200\n",
      "  To trajectory 15: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.595\n",
      "  Time 31: 0.586\n",
      "  Time 32: 0.572\n",
      "  Time 33: 0.554\n",
      "  Time 34: 0.532\n",
      "  Time 35: 0.506\n",
      "  Time 36: 0.477\n",
      "  Time 37: 0.446\n",
      "  Time 38: 0.414\n",
      "  Time 39: 0.381\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 0.167\n",
      "  To trajectory 10: 0.667\n",
      "  To trajectory 18: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.546\n",
      "  Time 31: 0.537\n",
      "  Time 32: 0.522\n",
      "  Time 33: 0.501\n",
      "  Time 34: 0.475\n",
      "  Time 35: 0.446\n",
      "  Time 36: 0.415\n",
      "  Time 37: 0.383\n",
      "  Time 38: 0.351\n",
      "  Time 39: 0.320\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.250\n",
      "  To trajectory 11: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.582\n",
      "  Time 31: 0.587\n",
      "  Time 32: 0.585\n",
      "  Time 33: 0.575\n",
      "  Time 34: 0.558\n",
      "  Time 35: 0.533\n",
      "  Time 36: 0.501\n",
      "  Time 37: 0.463\n",
      "  Time 38: 0.421\n",
      "  Time 39: 0.376\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.200\n",
      "  To trajectory 8: 0.200\n",
      "  To trajectory 12: 0.600\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.579\n",
      "  Time 31: 0.577\n",
      "  Time 32: 0.567\n",
      "  Time 33: 0.551\n",
      "  Time 34: 0.529\n",
      "  Time 35: 0.502\n",
      "  Time 36: 0.472\n",
      "  Time 37: 0.441\n",
      "  Time 38: 0.410\n",
      "  Time 39: 0.379\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.584\n",
      "  Time 31: 0.589\n",
      "  Time 32: 0.590\n",
      "  Time 33: 0.586\n",
      "  Time 34: 0.578\n",
      "  Time 35: 0.566\n",
      "  Time 36: 0.550\n",
      "  Time 37: 0.530\n",
      "  Time 38: 0.506\n",
      "  Time 39: 0.480\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 8\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.875\n",
      "  To trajectory 16: 0.125\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.566\n",
      "  Time 31: 0.563\n",
      "  Time 32: 0.555\n",
      "  Time 33: 0.544\n",
      "  Time 34: 0.528\n",
      "  Time 35: 0.508\n",
      "  Time 36: 0.485\n",
      "  Time 37: 0.460\n",
      "  Time 38: 0.433\n",
      "  Time 39: 0.404\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 15: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.590\n",
      "  Time 31: 0.599\n",
      "  Time 32: 0.603\n",
      "  Time 33: 0.601\n",
      "  Time 34: 0.593\n",
      "  Time 35: 0.580\n",
      "  Time 36: 0.562\n",
      "  Time 37: 0.539\n",
      "  Time 38: 0.512\n",
      "  Time 39: 0.482\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.200\n",
      "  To trajectory 16: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.531\n",
      "  Time 31: 0.543\n",
      "  Time 32: 0.551\n",
      "  Time 33: 0.553\n",
      "  Time 34: 0.551\n",
      "  Time 35: 0.545\n",
      "  Time 36: 0.535\n",
      "  Time 37: 0.522\n",
      "  Time 38: 0.506\n",
      "  Time 39: 0.488\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 17: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.567\n",
      "  Time 31: 0.557\n",
      "  Time 32: 0.543\n",
      "  Time 33: 0.526\n",
      "  Time 34: 0.506\n",
      "  Time 35: 0.484\n",
      "  Time 36: 0.458\n",
      "  Time 37: 0.431\n",
      "  Time 38: 0.403\n",
      "  Time 39: 0.373\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.143\n",
      "  To trajectory 18: 0.857\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.554\n",
      "  Time 31: 0.553\n",
      "  Time 32: 0.546\n",
      "  Time 33: 0.533\n",
      "  Time 34: 0.514\n",
      "  Time 35: 0.490\n",
      "  Time 36: 0.463\n",
      "  Time 37: 0.432\n",
      "  Time 38: 0.399\n",
      "  Time 39: 0.365\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.200\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 19: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.562\n",
      "  Time 31: 0.562\n",
      "  Time 32: 0.555\n",
      "  Time 33: 0.542\n",
      "  Time 34: 0.523\n",
      "  Time 35: 0.500\n",
      "  Time 36: 0.472\n",
      "  Time 37: 0.442\n",
      "  Time 38: 0.409\n",
      "  Time 39: 0.376\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_90000_100000_20241225_193459\n",
      "Lambda shape: (10000, 20, 52)\n",
      "Phi shape: (20, 348, 52)\n",
      "Y shape: (10000, 348, 52)\n",
      "Available diseases: [np.str_('Bacterial enteritis'), np.str_('Viral Enteritis'), np.str_('Gram negative septicemia'), np.str_('Bacterial infection NOS'), np.str_('Staphylococcus infections'), np.str_('Streptococcus infection'), np.str_('E. coli'), np.str_('Viral warts & HPV'), np.str_('Viral infection'), np.str_('Candidiasis'), np.str_('Colon cancer'), np.str_('Malignant neoplasm of rectum, rectosigmoid junction, and anus'), np.str_('Neoplasm of unspecified nature of digestive system'), np.str_('Cancer of bronchus; lung'), np.str_('Melanomas of skin'), np.str_('Other non-epithelial cancer of skin'), np.str_('Breast cancer [female]'), np.str_('Malignant neoplasm of female breast'), np.str_('Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]'), np.str_('Malignant neoplasm of uterus'), np.str_('Malignant neoplasm of ovary'), np.str_('Cancer of prostate'), np.str_('Malignant neoplasm of kidney, except pelvis'), np.str_('Malignant neoplasm of bladder'), np.str_('Malignant neoplasm, other'), np.str_('Secondary malignant neoplasm'), np.str_('Secondary malignancy of lymph nodes'), np.str_('Secondary malignancy of respiratory organs'), np.str_('Secondary malignant neoplasm of digestive systems'), np.str_('Secondary malignant neoplasm of liver'), np.str_('Secondary malignancy of bone'), np.str_('Neoplasm of uncertain behavior'), np.str_('Non-Hodgkins lymphoma'), np.str_('Benign neoplasm of colon'), np.str_('Benign neoplasm of lip, oral cavity, and pharynx'), np.str_('Benign neoplasm of other parts of digestive system'), np.str_('Lipoma'), np.str_('Lipoma of skin and subcutaneous tissue'), np.str_('Other benign neoplasm of connective and other soft tissue'), np.str_('Benign neoplasm of skin'), np.str_('Uterine leiomyoma'), np.str_('Benign neoplasm of ovary'), np.str_('Hemangioma and lymphangioma, any site'), np.str_('Thyrotoxicosis with or without goiter'), np.str_('Secondary hypothyroidism'), np.str_('Hypothyroidism NOS'), np.str_('Type 1 diabetes'), np.str_('Type 2 diabetes'), np.str_('Type 2 diabetes with ophthalmic manifestations'), np.str_('Diabetic retinopathy'), np.str_('Hypoglycemia'), np.str_('Hyperlipidemia'), np.str_('Hypercholesterolemia'), np.str_('Gout'), np.str_('Disorders of calcium/phosphorus metabolism'), np.str_('Hyposmolality and/or hyponatremia'), np.str_('Hyperpotassemia'), np.str_('Hypopotassemia'), np.str_('Acidosis'), np.str_('Hypovolemia'), np.str_('Obesity'), np.str_('Iron deficiency anemias, unspecified or not due to blood loss'), np.str_('Other anemias'), np.str_('Thrombocytopenia'), np.str_('Neutropenia'), np.str_('Bipolar'), np.str_('Major depressive disorder'), np.str_('Anxiety disorder'), np.str_('Alcohol-related disorders'), np.str_('Alcoholic liver damage'), np.str_('Tobacco use disorder'), np.str_('Sleep disorders'), np.str_('Sleep apnea'), np.str_(\"Parkinson's disease\"), np.str_('Degenerative disease of the spinal cord'), np.str_('Multiple sclerosis'), np.str_('Migraine'), np.str_('Hemiplegia'), np.str_('Epilepsy, recurrent seizures, convulsions'), np.str_('Other peripheral nerve disorders'), np.str_('Facial nerve disorders [CN7]'), np.str_('Inflammatory and toxic neuropathy'), np.str_('Retinal detachments and defects'), np.str_('Retinal detachment with retinal defect'), np.str_('Other retinal disorders'), np.str_('Macular degeneration (senile) of retina NOS'), np.str_('Retinal vascular changes and abnomalities'), np.str_('Glaucoma'), np.str_('Primary open angle glaucoma'), np.str_('Cataract'), np.str_('Senile cataract'), np.str_('Myopia'), np.str_('Visual disturbances'), np.str_('Inflammation of eyelids'), np.str_('Disorders of conjunctiva'), np.str_('Other disorders of eyelids'), np.str_('Ectropion or entropion'), np.str_('Ptosis of eyelid'), np.str_('Disorders of lacrimal system'), np.str_('Epiphora'), np.str_('Strabismus (not specified as paralytic)'), np.str_('Disorders of vitreous body'), np.str_('Otitis media'), np.str_('Perforation of tympanic membrane'), np.str_('Hearing loss'), np.str_('Rheumatic disease of the heart valves'), np.str_('Mitral valve disease'), np.str_('Aortic valve disease'), np.str_('Disease of tricuspid valve'), np.str_('Essential hypertension'), np.str_('Hypertensive chronic kidney disease'), np.str_('Unstable angina (intermediate coronary syndrome)'), np.str_('Myocardial infarction'), np.str_('Angina pectoris'), np.str_('Coronary atherosclerosis'), np.str_('Other chronic ischemic heart disease, unspecified'), np.str_('Other acute and subacute forms of ischemic heart disease'), np.str_('Other forms of chronic heart disease'), np.str_('Pulmonary heart disease'), np.str_('Cardiomegaly'), np.str_('Pericarditis'), np.str_('Primary/intrinsic cardiomyopathies'), np.str_('First degree AV block'), np.str_('Right bundle branch block'), np.str_('Left bundle branch block'), np.str_('Paroxysmal supraventricular tachycardia'), np.str_('Paroxysmal ventricular tachycardia'), np.str_('Atrial fibrillation and flutter'), np.str_('Cardiac arrest'), np.str_('Arrhythmia (cardiac) NOS'), np.str_('Congestive heart failure (CHF) NOS'), np.str_('Heart failure NOS'), np.str_('Cerebrovascular disease'), np.str_('Occlusion and stenosis of precerebral arteries'), np.str_('Occlusion of cerebral arteries'), np.str_('Cerebral artery occlusion, with cerebral infarction'), np.str_('Cerebral ischemia'), np.str_('Transient cerebral ischemia'), np.str_('Late effects of cerebrovascular disease'), np.str_('Abdominal aortic aneurysm'), np.str_(\"Raynaud's syndrome\"), np.str_('Peripheral vascular disease, unspecified'), np.str_('Stricture of artery'), np.str_('Phlebitis and thrombophlebitis of lower extremities'), np.str_('Varicose veins of lower extremity'), np.str_('Hemorrhoids'), np.str_('Orthostatic hypotension'), np.str_('Hypotension NOS'), np.str_('Acute upper respiratory infections of multiple or unspecified sites'), np.str_('Acute pharyngitis'), np.str_('Septal Deviations/Turbinate Hypertrophy'), np.str_('Nasal polyps'), np.str_('Chronic pharyngitis and nasopharyngitis'), np.str_('Diseases of the larynx and vocal cords'), np.str_('Chronic tonsillitis and adenoiditis'), np.str_('Chronic sinusitis'), np.str_('Allergic rhinitis'), np.str_('Other upper respiratory disease'), np.str_('Pneumonia'), np.str_('Bacterial pneumonia'), np.str_('Pneumococcal pneumonia'), np.str_('Asthma'), np.str_('Chronic airway obstruction'), np.str_('Emphysema'), np.str_('Obstructive chronic bronchitis'), np.str_('Bronchiectasis'), np.str_('Postinflammatory pulmonary fibrosis'), np.str_('Empyema and pneumothorax'), np.str_('Pleurisy; pleural effusion'), np.str_('Pulmonary collapse; interstitial and compensatory emphysema'), np.str_('Respiratory failure'), np.str_('Other diseases of respiratory system, NEC'), np.str_('Disturbances in tooth eruption'), np.str_('Dental caries'), np.str_('Periapical abscess'), np.str_('Chronic periodontitis'), np.str_('Other diseases of the teeth and supporting structures'), np.str_('Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue'), np.str_('Diseases and other conditions of the tongue'), np.str_('Esophagitis, GERD and related diseases'), np.str_('GERD'), np.str_('Ulcer of esophagus'), np.str_(\"Barrett's esophagus\"), np.str_('Reflux esophagitis'), np.str_('Esophageal bleeding (varices/hemorrhage)'), np.str_('Stricture and stenosis of esophagus'), np.str_('Gastric ulcer'), np.str_('Duodenal ulcer'), np.str_('Gastritis and duodenitis'), np.str_('Acute gastritis'), np.str_('Duodenitis'), np.str_('Other specified gastritis'), np.str_('Other disorders of stomach and duodenum'), np.str_('Acute appendicitis'), np.str_('Inguinal hernia'), np.str_('Diaphragmatic hernia'), np.str_('Umbilical hernia'), np.str_('Ventral hernia'), np.str_('Regional enteritis'), np.str_('Ulcerative colitis'), np.str_('Celiac disease'), np.str_('Noninfectious gastroenteritis'), np.str_('Other intestinal obstruction'), np.str_('Diverticulosis'), np.str_('Constipation'), np.str_('Functional digestive disorders'), np.str_('Irritable Bowel Syndrome'), np.str_('Anal and rectal conditions'), np.str_('Anal and rectal polyp'), np.str_('Peritonitis and retroperitoneal infections'), np.str_('Peritoneal adhesions (postoperative) (postinfection)'), np.str_('Other disorders of intestine'), np.str_('Gastrointestinal complications'), np.str_('Other chronic nonalcoholic liver disease'), np.str_('Other disorders of liver'), np.str_('Cholelithiasis'), np.str_('Cholelithiasis with acute cholecystitis'), np.str_('Cholelithiasis with other cholecystitis'), np.str_('Calculus of bile duct'), np.str_('Cholecystitis without cholelithiasis'), np.str_('Other disorders of gallbladder'), np.str_('Other disorders of biliary tract'), np.str_('Acute pancreatitis'), np.str_('Hematemesis'), np.str_('Blood in stool'), np.str_('Hemorrhage of rectum and anus'), np.str_('Hemorrhage of gastrointestinal tract'), np.str_('Chronic glomerulonephritis, NOS'), np.str_('Acute renal failure'), np.str_('Renal failure NOS'), np.str_('Chronic renal failure [CKD]'), np.str_('Chronic Kidney Disease, Stage III'), np.str_('Other disorders of the kidney and ureters'), np.str_('Cyst of kidney, acquired'), np.str_('Stricture/obstruction of ureter'), np.str_('Pyelonephritis'), np.str_('Urinary tract infection'), np.str_('Cystitis'), np.str_('Chronic cystitis'), np.str_('Calculus of kidney'), np.str_('Calculus of ureter'), np.str_('Renal colic'), np.str_('Hydronephrosis'), np.str_('Other disorders of bladder'), np.str_('Bladder neck obstruction'), np.str_('Functional disorders of bladder'), np.str_('Urethral stricture (not specified as infectious)'), np.str_('Other symptoms/disorders or the urinary system'), np.str_('Urinary incontinence'), np.str_('Hyperplasia of prostate'), np.str_('Chronic prostatitis'), np.str_('Other disorders of prostate'), np.str_('Other disorders of testis'), np.str_('Hydrocele'), np.str_('Redundant prepuce and phimosis/BXO'), np.str_('Other disorders of male genital organs'), np.str_('Benign neoplasm of breast'), np.str_('Lump or mass in breast'), np.str_('Hypertrophy of breast (Gynecomastia)'), np.str_('Pelvic peritoneal adhesions, female (postoperative) (postinfection)'), np.str_('Cervicitis and endocervicitis'), np.str_('Endometriosis'), np.str_('Prolapse of vaginal walls'), np.str_('Uterine/Uterovaginal prolapse'), np.str_('Disorders of uterus, NEC'), np.str_('Noninflammatory disorders of cervix'), np.str_('Noninflammatory disorders of vagina'), np.str_('Noninflammatory disorders of vulva and perineum'), np.str_('Endometrial hyperplasia'), np.str_('Polyp of corpus uteri'), np.str_('Mucous polyp of cervix'), np.str_('Hypertrophy of female genital organs'), np.str_('Pain and other symptoms associated with female genital organs'), np.str_('Dyspareunia'), np.str_('Disorders of menstruation and other abnormal bleeding from female genital tract'), np.str_('Irregular menstrual cycle/bleeding'), np.str_('Excessive or frequent menstruation'), np.str_('Irregular menstrual cycle'), np.str_('Irregular menstrual bleeding'), np.str_('Dysmenorrhea'), np.str_('Infertility, female'), np.str_('Postmenopausal bleeding'), np.str_('Postmenopausal atrophic vaginitis'), np.str_('Ovarian cyst'), np.str_('Cellulitis and abscess of arm/hand'), np.str_('Other local infections of skin and subcutaneous tissue'), np.str_('Carbuncle and furuncle'), np.str_('Disorder of skin and subcutaneous tissue NOS'), np.str_('Psoriasis vulgaris'), np.str_('Other hypertrophic and atrophic conditions of skin'), np.str_('Scar conditions and fibrosis of skin'), np.str_('Actinic keratosis'), np.str_('Seborrheic keratosis'), np.str_('Ingrowing nail'), np.str_('Sebaceous cyst'), np.str_('Chronic ulcer of skin'), np.str_('Decubitus ulcer'), np.str_('Rheumatoid arthritis'), np.str_('Other inflammatory spondylopathies'), np.str_('Arthropathy NOS'), np.str_('Polymyalgia Rheumatica'), np.str_('Spinal stenosis'), np.str_('Spondylosis and allied disorders'), np.str_('Spondylosis without myelopathy'), np.str_('Displacement of intervertebral disc'), np.str_('Degeneration of intervertebral disc'), np.str_('Other and unspecified disc disorder'), np.str_('Peripheral enthesopathies and allied syndromes'), np.str_('Enthesopathy'), np.str_('Bursitis'), np.str_('Other disorders of synovium, tendon, and bursa'), np.str_('Synovitis and tenosynovitis'), np.str_('Ganglion and cyst of synovium, tendon, and bursa'), np.str_(\"Contracture of palmar fascia [Dupuytren's disease]\"), np.str_('Other disorders of soft tissues'), np.str_('Rheumatism, unspecified and fibrositis'), np.str_('Other disorders of bone and cartilage'), np.str_('Malunion and nonunion of fracture'), np.str_('Acquired toe deformities'), np.str_('Hammer toe (acquired)'), np.str_('Hallux rigidus'), np.str_('Hallux valgus (Bunion)'), np.str_('Other acquired deformities of limbs'), np.str_('Kyphoscoliosis and scoliosis'), np.str_('Acquired spondylolisthesis'), np.str_('Osteoarthritis; localized'), np.str_('Osteoarthrosis, localized, primary'), np.str_('Osteoarthrosis, generalized'), np.str_('Osteoarthrosis NOS'), np.str_('Symptoms and disorders of the joints'), np.str_('Joint effusions'), np.str_('Other derangement of joint'), np.str_('Osteoporosis NOS'), np.str_('Osteopenia or other disorder of bone and cartilage'), np.str_('Pain in joint'), np.str_('Congenital anomalies of great vessels'), np.str_('Back pain'), np.str_('Cervicalgia'), np.str_('Thoracic or lumbosacral neuritis or radiculitis, unspecified'), np.str_('Sciatica'), np.str_('Neuralgia, neuritis, and radiculitis NOS'), np.str_('Myalgia and myositis unspecified'), np.str_('Pain in limb'), np.str_('Abdominal pain'), np.str_('Internal derangement of knee'), np.str_('Atopic/contact dermatitis due to other or unspecified'), np.str_('Sepsis'), np.str_('Other tests')]\n",
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Trajectory 0 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 0: 0.800\n",
      "  To trajectory 13: 0.200\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.540\n",
      "  Time 31: 0.542\n",
      "  Time 32: 0.540\n",
      "  Time 33: 0.534\n",
      "  Time 34: 0.525\n",
      "  Time 35: 0.512\n",
      "  Time 36: 0.495\n",
      "  Time 37: 0.474\n",
      "  Time 38: 0.451\n",
      "  Time 39: 0.426\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.552\n",
      "  Time 31: 0.549\n",
      "  Time 32: 0.540\n",
      "  Time 33: 0.527\n",
      "  Time 34: 0.509\n",
      "  Time 35: 0.487\n",
      "  Time 36: 0.461\n",
      "  Time 37: 0.432\n",
      "  Time 38: 0.400\n",
      "  Time 39: 0.366\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.651\n",
      "  Time 31: 0.660\n",
      "  Time 32: 0.664\n",
      "  Time 33: 0.663\n",
      "  Time 34: 0.656\n",
      "  Time 35: 0.644\n",
      "  Time 36: 0.626\n",
      "  Time 37: 0.602\n",
      "  Time 38: 0.573\n",
      "  Time 39: 0.539\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Analysis:\n",
      "Number of individuals: 7\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 3: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.556\n",
      "  Time 31: 0.561\n",
      "  Time 32: 0.561\n",
      "  Time 33: 0.555\n",
      "  Time 34: 0.545\n",
      "  Time 35: 0.530\n",
      "  Time 36: 0.511\n",
      "  Time 37: 0.487\n",
      "  Time 38: 0.461\n",
      "  Time 39: 0.431\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Right bundle branch block: -5.539\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 2: 0.167\n",
      "  To trajectory 4: 0.667\n",
      "  To trajectory 7: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.555\n",
      "  Time 31: 0.538\n",
      "  Time 32: 0.516\n",
      "  Time 33: 0.490\n",
      "  Time 34: 0.460\n",
      "  Time 35: 0.429\n",
      "  Time 36: 0.397\n",
      "  Time 37: 0.366\n",
      "  Time 38: 0.335\n",
      "  Time 39: 0.307\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Analysis:\n",
      "Number of individuals: 9\n",
      "CAD risk: 0.111\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 5: 0.889\n",
      "  To trajectory 16: 0.111\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.592\n",
      "  Time 31: 0.587\n",
      "  Time 32: 0.579\n",
      "  Time 33: 0.568\n",
      "  Time 34: 0.553\n",
      "  Time 35: 0.536\n",
      "  Time 36: 0.517\n",
      "  Time 37: 0.495\n",
      "  Time 38: 0.472\n",
      "  Time 39: 0.448\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.250\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 6: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.574\n",
      "  Time 31: 0.579\n",
      "  Time 32: 0.578\n",
      "  Time 33: 0.570\n",
      "  Time 34: 0.556\n",
      "  Time 35: 0.534\n",
      "  Time 36: 0.505\n",
      "  Time 37: 0.470\n",
      "  Time 38: 0.428\n",
      "  Time 39: 0.383\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.551\n",
      "  Time 31: 0.546\n",
      "  Time 32: 0.534\n",
      "  Time 33: 0.516\n",
      "  Time 34: 0.492\n",
      "  Time 35: 0.464\n",
      "  Time 36: 0.433\n",
      "  Time 37: 0.399\n",
      "  Time 38: 0.363\n",
      "  Time 39: 0.328\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.833\n",
      "  To trajectory 16: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.529\n",
      "  Time 31: 0.518\n",
      "  Time 32: 0.503\n",
      "  Time 33: 0.484\n",
      "  Time 34: 0.461\n",
      "  Time 35: 0.435\n",
      "  Time 36: 0.407\n",
      "  Time 37: 0.377\n",
      "  Time 38: 0.346\n",
      "  Time 39: 0.315\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.120\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 9: 0.833\n",
      "  To trajectory 15: 0.167\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.593\n",
      "  Time 31: 0.585\n",
      "  Time 32: 0.571\n",
      "  Time 33: 0.553\n",
      "  Time 34: 0.531\n",
      "  Time 35: 0.504\n",
      "  Time 36: 0.474\n",
      "  Time 37: 0.441\n",
      "  Time 38: 0.406\n",
      "  Time 39: 0.371\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 10: 0.750\n",
      "  To trajectory 18: 0.250\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.545\n",
      "  Time 31: 0.542\n",
      "  Time 32: 0.532\n",
      "  Time 33: 0.517\n",
      "  Time 34: 0.498\n",
      "  Time 35: 0.475\n",
      "  Time 36: 0.450\n",
      "  Time 37: 0.423\n",
      "  Time 38: 0.396\n",
      "  Time 39: 0.369\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Analysis:\n",
      "Number of individuals: 3\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 1: 0.333\n",
      "  To trajectory 11: 0.667\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.612\n",
      "  Time 31: 0.618\n",
      "  Time 32: 0.616\n",
      "  Time 33: 0.606\n",
      "  Time 34: 0.590\n",
      "  Time 35: 0.565\n",
      "  Time 36: 0.534\n",
      "  Time 37: 0.496\n",
      "  Time 38: 0.453\n",
      "  Time 39: 0.407\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Analysis:\n",
      "Number of individuals: 6\n",
      "CAD risk: 0.167\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 7: 0.167\n",
      "  To trajectory 8: 0.167\n",
      "  To trajectory 12: 0.667\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.569\n",
      "  Time 31: 0.567\n",
      "  Time 32: 0.557\n",
      "  Time 33: 0.542\n",
      "  Time 34: 0.521\n",
      "  Time 35: 0.496\n",
      "  Time 36: 0.467\n",
      "  Time 37: 0.438\n",
      "  Time 38: 0.408\n",
      "  Time 39: 0.377\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Analysis:\n",
      "Number of individuals: 9\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.567\n",
      "  Time 31: 0.574\n",
      "  Time 32: 0.575\n",
      "  Time 33: 0.573\n",
      "  Time 34: 0.565\n",
      "  Time 35: 0.553\n",
      "  Time 36: 0.536\n",
      "  Time 37: 0.516\n",
      "  Time 38: 0.491\n",
      "  Time 39: 0.464\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Analysis:\n",
      "Number of individuals: 9\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.889\n",
      "  To trajectory 16: 0.111\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.564\n",
      "  Time 31: 0.560\n",
      "  Time 32: 0.552\n",
      "  Time 33: 0.539\n",
      "  Time 34: 0.522\n",
      "  Time 35: 0.501\n",
      "  Time 36: 0.476\n",
      "  Time 37: 0.449\n",
      "  Time 38: 0.420\n",
      "  Time 39: 0.390\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 15: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.594\n",
      "  Time 31: 0.592\n",
      "  Time 32: 0.584\n",
      "  Time 33: 0.572\n",
      "  Time 34: 0.554\n",
      "  Time 35: 0.531\n",
      "  Time 36: 0.504\n",
      "  Time 37: 0.473\n",
      "  Time 38: 0.440\n",
      "  Time 39: 0.404\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.200\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 14: 0.200\n",
      "  To trajectory 16: 0.800\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.545\n",
      "  Time 31: 0.556\n",
      "  Time 32: 0.563\n",
      "  Time 33: 0.565\n",
      "  Time 34: 0.561\n",
      "  Time 35: 0.553\n",
      "  Time 36: 0.541\n",
      "  Time 37: 0.526\n",
      "  Time 38: 0.508\n",
      "  Time 39: 0.487\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.250\n",
      "  To trajectory 17: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.572\n",
      "  Time 31: 0.562\n",
      "  Time 32: 0.548\n",
      "  Time 33: 0.530\n",
      "  Time 34: 0.510\n",
      "  Time 35: 0.487\n",
      "  Time 36: 0.461\n",
      "  Time 37: 0.433\n",
      "  Time 38: 0.404\n",
      "  Time 39: 0.375\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Analysis:\n",
      "Number of individuals: 4\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 8: 0.250\n",
      "  To trajectory 18: 0.750\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.599\n",
      "  Time 31: 0.603\n",
      "  Time 32: 0.601\n",
      "  Time 33: 0.592\n",
      "  Time 34: 0.578\n",
      "  Time 35: 0.557\n",
      "  Time 36: 0.532\n",
      "  Time 37: 0.502\n",
      "  Time 38: 0.470\n",
      "  Time 39: 0.435\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Analysis:\n",
      "Number of individuals: 5\n",
      "CAD risk: 0.000\n",
      "\n",
      "Transition probabilities:\n",
      "  To trajectory 19: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.559\n",
      "  Time 31: 0.558\n",
      "  Time 32: 0.550\n",
      "  Time 33: 0.537\n",
      "  Time 34: 0.518\n",
      "  Time 35: 0.494\n",
      "  Time 36: 0.467\n",
      "  Time 37: 0.436\n",
      "  Time 38: 0.404\n",
      "  Time 39: 0.371\n",
      "\n",
      "Top diseases in this trajectory:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "\n",
      "Overall Summary:\n",
      "\n",
      "Trajectory 0 Summary:\n",
      "Total individuals: 191\n",
      "Average CAD risk: 0.035\n",
      "\n",
      "Average transition probabilities:\n",
      "  To trajectory 0: 0.868\n",
      "  To trajectory 13: 0.110\n",
      "\n",
      "Characteristic diseases:\n",
      "  Pericarditis: -6.094\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Abdominal pain: -4.541\n",
      "\n",
      "Trajectory 1 Summary:\n",
      "Total individuals: 243\n",
      "Average CAD risk: 0.041\n",
      "\n",
      "Average transition probabilities:\n",
      "  To trajectory 1: 0.916\n",
      "  To trajectory 19: 0.055\n",
      "\n",
      "Characteristic diseases:\n",
      "  Rheumatoid arthritis: -5.069\n",
      "  Arthropathy NOS: -4.652\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Internal derangement of knee: -4.417\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "\n",
      "Trajectory 2 Summary:\n",
      "Total individuals: 82\n",
      "Average CAD risk: 0.025\n",
      "\n",
      "Average transition probabilities:\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Characteristic diseases:\n",
      "  Major depressive disorder: -5.440\n",
      "  Arthropathy NOS: -5.387\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Gastritis and duodenitis: -3.499\n",
      "\n",
      "Trajectory 3 Summary:\n",
      "Total individuals: 249\n",
      "Average CAD risk: 0.029\n",
      "\n",
      "Average transition probabilities:\n",
      "  To trajectory 3: 0.906\n",
      "  To trajectory 5: 0.069\n",
      "\n",
      "Characteristic diseases:\n",
      "  Right bundle branch block: -5.538\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Multiple sclerosis: -5.077\n",
      "  Viral infection: -5.020\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "\n",
      "Trajectory 4 Summary:\n",
      "Total individuals: 226\n",
      "Average CAD risk: 0.011\n",
      "\n",
      "Average transition probabilities:\n",
      "  To trajectory 2: 0.113\n",
      "  To trajectory 4: 0.760\n",
      "  To trajectory 7: 0.123\n",
      "\n",
      "Characteristic diseases:\n",
      "  Other upper respiratory disease: -6.669\n",
      "  Cataract: -6.653\n",
      "  Diverticulosis: -6.225\n",
      "  Obesity: -6.210\n",
      "  Hypercholesterolemia: -5.968\n",
      "\n",
      "Trajectory 5 Summary:\n",
      "Total individuals: 322\n",
      "Average CAD risk: 0.076\n",
      "\n",
      "Average transition probabilities:\n",
      "  To trajectory 5: 0.934\n",
      "\n",
      "Characteristic diseases:\n",
      "  Essential hypertension: -5.813\n",
      "  Myocardial infarction: -4.883\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Hypercholesterolemia: -3.961\n",
      "\n",
      "Trajectory 6 Summary:\n",
      "Total individuals: 180\n",
      "Average CAD risk: 0.050\n",
      "\n",
      "Average transition probabilities:\n",
      "  To trajectory 6: 0.930\n",
      "  To trajectory 7: 0.070\n",
      "\n",
      "Characteristic diseases:\n",
      "  Type 2 diabetes: -6.878\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Arthropathy NOS: -6.245\n",
      "  Duodenitis: -6.221\n",
      "\n",
      "Trajectory 7 Summary:\n",
      "Total individuals: 175\n",
      "Average CAD risk: 0.037\n",
      "\n",
      "Average transition probabilities:\n",
      "  To trajectory 5: 0.089\n",
      "  To trajectory 7: 0.875\n",
      "\n",
      "Characteristic diseases:\n",
      "  Obesity: -4.305\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Major depressive disorder: -3.769\n",
      "  Asthma: -3.749\n",
      "  Essential hypertension: -2.986\n",
      "\n",
      "Trajectory 8 Summary:\n",
      "Total individuals: 239\n",
      "Average CAD risk: 0.030\n",
      "\n",
      "Average transition probabilities:\n",
      "  To trajectory 8: 0.848\n",
      "  To trajectory 16: 0.058\n",
      "  To trajectory 19: 0.094\n",
      "\n",
      "Characteristic diseases:\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "  Essential hypertension: -5.370\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Postmenopausal bleeding: -5.120\n",
      "  Uterine leiomyoma: -4.155\n",
      "\n",
      "Trajectory 9 Summary:\n",
      "Total individuals: 242\n",
      "Average CAD risk: 0.015\n",
      "\n",
      "Average transition probabilities:\n",
      "  To trajectory 9: 0.821\n",
      "  To trajectory 15: 0.166\n",
      "\n",
      "Characteristic diseases:\n",
      "  Spinal stenosis: -5.700\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Major depressive disorder: -5.346\n",
      "  Essential hypertension: -5.316\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "\n",
      "Trajectory 10 Summary:\n",
      "Total individuals: 181\n",
      "Average CAD risk: 0.016\n",
      "\n",
      "Average transition probabilities:\n",
      "  To trajectory 10: 0.757\n",
      "  To trajectory 18: 0.211\n",
      "\n",
      "Characteristic diseases:\n",
      "  Other retinal disorders: -5.826\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Senile cataract: -3.485\n",
      "\n",
      "Trajectory 11 Summary:\n",
      "Total individuals: 154\n",
      "Average CAD risk: 0.029\n",
      "\n",
      "Average transition probabilities:\n",
      "  To trajectory 1: 0.254\n",
      "  To trajectory 11: 0.733\n",
      "\n",
      "Characteristic diseases:\n",
      "  Osteoarthritis; localized: -6.210\n",
      "  Internal derangement of knee: -6.012\n",
      "  Urinary tract infection: -5.751\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Hemiplegia: -3.982\n",
      "\n",
      "Trajectory 12 Summary:\n",
      "Total individuals: 214\n",
      "Average CAD risk: 0.022\n",
      "\n",
      "Average transition probabilities:\n",
      "  To trajectory 7: 0.190\n",
      "  To trajectory 8: 0.162\n",
      "  To trajectory 12: 0.619\n",
      "\n",
      "Characteristic diseases:\n",
      "  Other anemias: -6.324\n",
      "  Calculus of ureter: -5.977\n",
      "  Essential hypertension: -5.679\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Calculus of kidney: -5.493\n",
      "\n",
      "Trajectory 13 Summary:\n",
      "Total individuals: 268\n",
      "Average CAD risk: 0.023\n",
      "\n",
      "Average transition probabilities:\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Characteristic diseases:\n",
      "  Diverticulosis: -6.039\n",
      "  Cancer of prostate: -5.450\n",
      "  Other disorders of bladder: -5.402\n",
      "  Urinary incontinence: -5.152\n",
      "  Hyperplasia of prostate: -4.750\n",
      "\n",
      "Trajectory 14 Summary:\n",
      "Total individuals: 312\n",
      "Average CAD risk: 0.026\n",
      "\n",
      "Average transition probabilities:\n",
      "  To trajectory 14: 0.867\n",
      "  To trajectory 16: 0.130\n",
      "\n",
      "Characteristic diseases:\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "  Bronchiectasis: -5.574\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Tobacco use disorder: -4.709\n",
      "\n",
      "Trajectory 15 Summary:\n",
      "Total individuals: 208\n",
      "Average CAD risk: 0.033\n",
      "\n",
      "Average transition probabilities:\n",
      "  To trajectory 15: 0.946\n",
      "\n",
      "Characteristic diseases:\n",
      "  Anal and rectal conditions: -6.815\n",
      "  Arthropathy NOS: -6.223\n",
      "  GERD: -5.988\n",
      "  Back pain: -5.676\n",
      "  Type 2 diabetes: -4.827\n",
      "\n",
      "Trajectory 16 Summary:\n",
      "Total individuals: 188\n",
      "Average CAD risk: 0.015\n",
      "\n",
      "Average transition probabilities:\n",
      "  To trajectory 14: 0.220\n",
      "  To trajectory 16: 0.780\n",
      "\n",
      "Characteristic diseases:\n",
      "  E. coli: -5.776\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  Staphylococcus infections: -5.553\n",
      "  Other anemias: -5.339\n",
      "  Urinary tract infection: -4.986\n",
      "\n",
      "Trajectory 17 Summary:\n",
      "Total individuals: 172\n",
      "Average CAD risk: 0.017\n",
      "\n",
      "Average transition probabilities:\n",
      "  To trajectory 8: 0.087\n",
      "  To trajectory 17: 0.903\n",
      "\n",
      "Characteristic diseases:\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Diverticulosis: -3.053\n",
      "\n",
      "Trajectory 18 Summary:\n",
      "Total individuals: 220\n",
      "Average CAD risk: 0.034\n",
      "\n",
      "Average transition probabilities:\n",
      "  To trajectory 8: 0.096\n",
      "  To trajectory 18: 0.900\n",
      "\n",
      "Characteristic diseases:\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "  Acute pancreatitis: -5.694\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "\n",
      "Trajectory 19 Summary:\n",
      "Total individuals: 232\n",
      "Average CAD risk: 0.024\n",
      "\n",
      "Average transition probabilities:\n",
      "  To trajectory 19: 0.979\n",
      "\n",
      "Characteristic diseases:\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "  Obesity: -5.970\n",
      "  Essential hypertension: -5.928\n",
      "  Arthropathy NOS: -5.638\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n"
     ]
    }
   ],
   "source": [
    "import os\n",
    "import glob\n",
    "import numpy as np\n",
    "import torch\n",
    "from scipy.special import softmax, expit\n",
    "\n",
    "# Initialize storage for results\n",
    "all_conditional_probs = []\n",
    "all_cad_statuses = []\n",
    "all_transitions = []\n",
    "all_trajectory_stats = []\n",
    "\n",
    "print(\"Starting processing...\")\n",
    "\n",
    "for dir_path in output_dirs:\n",
    "    model_path = os.path.join(dir_path, 'model.pt')\n",
    "    try:\n",
    "        print(f\"\\nProcessing {dir_path}\")\n",
    "        \n",
    "        # Load the saved model\n",
    "        checkpoint = torch.load(model_path)\n",
    "        \n",
    "        # Extract necessary components\n",
    "        if 'model_state_dict' in checkpoint:\n",
    "            lambda_values = checkpoint['model_state_dict']['lambda_']\n",
    "            phi_values = checkpoint['model_state_dict']['phi']\n",
    "        else:\n",
    "            lambda_values = checkpoint['lambda_']\n",
    "            phi_values = checkpoint['phi']\n",
    "            \n",
    "        if torch.is_tensor(lambda_values):\n",
    "            lambda_values = lambda_values.detach().cpu().numpy()\n",
    "        if torch.is_tensor(phi_values):\n",
    "            phi_values = phi_values.detach().cpu().numpy()\n",
    "            \n",
    "        Y_batch = checkpoint['Y']\n",
    "        if torch.is_tensor(Y_batch):\n",
    "            Y_batch = Y_batch.detach().cpu().numpy()\n",
    "            \n",
    "        print(f\"Lambda shape: {lambda_values.shape}\")\n",
    "        print(f\"Phi shape: {phi_values.shape}\")\n",
    "        print(f\"Y shape: {Y_batch.shape}\")\n",
    "        \n",
    "        disease_names = checkpoint['disease_names']\n",
    "        print(f\"Available diseases: {disease_names}\")\n",
    "        \n",
    "        # Find indices for both CAD conditions\n",
    "        cad_indices = []\n",
    "        for condition in ['Coronary atherosclerosis', 'Myocardial infarction']:\n",
    "            try:\n",
    "                idx = disease_names.index(condition)\n",
    "                cad_indices.append(idx)\n",
    "                print(f\"Found {condition} at index: {idx}\")\n",
    "            except ValueError:\n",
    "                print(f\"Warning: {condition} not found in disease names\")\n",
    "        \n",
    "        if not cad_indices:\n",
    "            raise ValueError(\"Neither CAD condition found in disease names\")\n",
    "        \n",
    "        time_x = 30  # Age 60\n",
    "        future_window = 10  # Look ahead 2.5 years\n",
    "        \n",
    "        # Get CAD status before time_x (either condition)\n",
    "        cad_before_x = np.zeros(Y_batch.shape[0], dtype=bool)\n",
    "        for cad_idx in cad_indices:\n",
    "            cad_before_x |= np.any(Y_batch[:, cad_idx, :time_x], axis=1)\n",
    "        \n",
    "        # Calculate thetas (trajectory memberships)\n",
    "        thetas = softmax(lambda_values, axis=1)\n",
    "        \n",
    "        # Find dominant trajectory at time_x and future time for each individual\n",
    "        dominant_trajectory_x = np.argmax(thetas[:, :, time_x], axis=1)\n",
    "        dominant_trajectory_future = np.argmax(thetas[:, :, time_x + future_window], axis=1)\n",
    "        \n",
    "        # Store batch results\n",
    "        batch_transitions = []\n",
    "        batch_stats = []\n",
    "        \n",
    "        # Analyze each trajectory\n",
    "        for k in range(thetas.shape[1]):  # for each trajectory\n",
    "            # Get individuals with high loading (>0.5) on trajectory k at time_x\n",
    "            high_loading_k = thetas[:, k, time_x] > 0.5\n",
    "            \n",
    "            if np.sum(high_loading_k) > 0:\n",
    "                # Basic statistics\n",
    "                n_individuals = np.sum(high_loading_k)\n",
    "                \n",
    "                # Calculate transition probabilities\n",
    "                future_trajectories = dominant_trajectory_future[high_loading_k]\n",
    "                transitions = np.bincount(future_trajectories, minlength=thetas.shape[1]) / len(future_trajectories)\n",
    "                \n",
    "                # Calculate CAD outcomes\n",
    "                cad_risk = np.mean(cad_before_x[high_loading_k])\n",
    "                \n",
    "                # Track trajectory strength over time\n",
    "                mean_loading = np.mean(thetas[high_loading_k, k, time_x:time_x+future_window], axis=0)\n",
    "                \n",
    "                # Store trajectory statistics\n",
    "                trajectory_stats = {\n",
    "                    'trajectory': k,\n",
    "                    'n_individuals': n_individuals,\n",
    "                    'cad_risk': cad_risk,\n",
    "                    'mean_loading': mean_loading,\n",
    "                    'transitions': transitions\n",
    "                }\n",
    "                \n",
    "                # Get top diseases for this trajectory\n",
    "                top_diseases = np.argsort(phi_values[k, :, time_x])[-5:]\n",
    "                trajectory_stats['top_diseases'] = [(disease_names[idx], phi_values[k, idx, time_x]) \n",
    "                                                  for idx in top_diseases]\n",
    "                \n",
    "                batch_stats.append(trajectory_stats)\n",
    "                batch_transitions.append(transitions)\n",
    "                \n",
    "                print(f\"\\nTrajectory {k} Analysis:\")\n",
    "                print(f\"Number of individuals: {n_individuals}\")\n",
    "                print(f\"CAD risk: {cad_risk:.3f}\")\n",
    "                print(\"\\nTransition probabilities:\")\n",
    "                for j, prob in enumerate(transitions):\n",
    "                    if prob > 0.05:  # Only show significant transitions\n",
    "                        print(f\"  To trajectory {j}: {prob:.3f}\")\n",
    "                \n",
    "                print(\"\\nTrajectory strength over time:\")\n",
    "                for t, strength in enumerate(mean_loading):\n",
    "                    print(f\"  Time {time_x + t}: {strength:.3f}\")\n",
    "                \n",
    "                print(\"\\nTop diseases in this trajectory:\")\n",
    "                for disease, phi_value in trajectory_stats['top_diseases']:\n",
    "                    print(f\"  {disease}: {phi_value:.3f}\")\n",
    "        \n",
    "        all_transitions.append(batch_transitions)\n",
    "        all_trajectory_stats.append(batch_stats)\n",
    "        \n",
    "    except Exception as e:\n",
    "        print(f\"Error processing {dir_path}: {str(e)}\")\n",
    "        print(\"Full error:\")\n",
    "        import traceback\n",
    "        traceback.print_exc()\n",
    "\n",
    "# Aggregate results across all batches\n",
    "if len(all_trajectory_stats) > 0:\n",
    "    print(\"\\nOverall Summary:\")\n",
    "    \n",
    "    # Calculate average statistics across batches\n",
    "    n_trajectories = len(all_trajectory_stats[0])\n",
    "    \n",
    "    for k in range(n_trajectories):\n",
    "        print(f\"\\nTrajectory {k} Summary:\")\n",
    "        \n",
    "        # Aggregate statistics\n",
    "        total_individuals = sum(batch[k]['n_individuals'] for batch in all_trajectory_stats)\n",
    "        avg_cad_risk = np.mean([batch[k]['cad_risk'] for batch in all_trajectory_stats])\n",
    "        \n",
    "        print(f\"Total individuals: {total_individuals}\")\n",
    "        print(f\"Average CAD risk: {avg_cad_risk:.3f}\")\n",
    "        \n",
    "        # Average transition probabilities\n",
    "        avg_transitions = np.mean([batch[k]['transitions'] for batch in all_trajectory_stats], axis=0)\n",
    "        print(\"\\nAverage transition probabilities:\")\n",
    "        for j, prob in enumerate(avg_transitions):\n",
    "            if prob > 0.05:\n",
    "                print(f\"  To trajectory {j}: {prob:.3f}\")\n",
    "        \n",
    "        # Most common diseases (using first batch as representative)\n",
    "        print(\"\\nCharacteristic diseases:\")\n",
    "        for disease, phi_value in all_trajectory_stats[0][k]['top_diseases']:\n",
    "            print(f\"  {disease}: {phi_value:.3f}\")\n",
    "else:\n",
    "    print(\"No data was processed successfully!\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Starting processing...\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_0_10000_20241225_062028\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_100000_110000_20241225_225116\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/2f/nxrbr3pn1msgrl4ffyj33zd00000gn/T/ipykernel_6481/450648821.py:19: FutureWarning: You are using `torch.load` with `weights_only=False` (the current default value), which uses the default pickle module implicitly. It is possible to construct malicious pickle data which will execute arbitrary code during unpickling (See https://github.com/pytorch/pytorch/blob/main/SECURITY.md#untrusted-models for more details). In a future release, the default value for `weights_only` will be flipped to `True`. This limits the functions that could be executed during unpickling. Arbitrary objects will no longer be allowed to be loaded via this mode unless they are explicitly allowlisted by the user via `torch.serialization.add_safe_globals`. We recommend you start setting `weights_only=True` for any use case where you don't have full control of the loaded file. Please open an issue on GitHub for any issues related to this experimental feature.\n",
      "  checkpoint = torch.load(model_path)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_10000_20000_20241225_062028\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_110000_120000_20241225_225127\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_120000_130000_20241226_020120\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_130000_140000_20241226_020134\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_140000_150000_20241226_051212\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_150000_160000_20241226_051223\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_160000_170000_20241226_082535\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_170000_180000_20241226_082558\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_180000_190000_20241226_113728\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_190000_200000_20241226_113741\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_200000_210000_20241225_064324\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_20000_30000_20241225_093441\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_210000_220000_20241225_064324\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_220000_230000_20241225_094650\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_230000_240000_20241225_094700\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_240000_250000_20241225_125056\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_250000_260000_20241225_125114\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_260000_270000_20241225_155547\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_270000_280000_20241225_155604\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_280000_290000_20241225_190119\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_290000_300000_20241225_190127\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_300000_310000_20241225_220551\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_30000_40000_20241225_093452\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_310000_320000_20241225_220601\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_320000_330000_20241226_010910\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_330000_340000_20241226_011037\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_340000_350000_20241226_041424\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_350000_360000_20241226_041550\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_360000_370000_20241226_071910\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_370000_380000_20241226_072111\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_380000_390000_20241226_102351\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_390000_400000_20241226_102603\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_40000_50000_20241225_124544\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_50000_60000_20241225_124613\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_60000_70000_20241225_155446\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_70000_80000_20241225_155500\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_80000_90000_20241225_193439\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_90000_100000_20241225_193459\n",
      "\n",
      "Comparing phi values across batches...\n",
      "\n",
      "Batch 0 vs Batch 1:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000070\n",
      "\n",
      "Batch 0 vs Batch 2:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000111\n",
      "\n",
      "Batch 0 vs Batch 3:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000087\n",
      "\n",
      "Batch 0 vs Batch 4:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000079\n",
      "\n",
      "Batch 0 vs Batch 5:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000114\n",
      "\n",
      "Batch 0 vs Batch 6:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000085\n",
      "\n",
      "Batch 0 vs Batch 7:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000060\n",
      "\n",
      "Batch 0 vs Batch 8:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000082\n",
      "\n",
      "Batch 0 vs Batch 9:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000085\n",
      "\n",
      "Batch 0 vs Batch 10:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000096\n",
      "\n",
      "Batch 0 vs Batch 11:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000064\n",
      "\n",
      "Batch 0 vs Batch 12:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000081\n",
      "\n",
      "Batch 0 vs Batch 13:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000112\n",
      "\n",
      "Batch 0 vs Batch 14:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000070\n",
      "\n",
      "Batch 0 vs Batch 15:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000081\n",
      "\n",
      "Batch 0 vs Batch 16:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000082\n",
      "\n",
      "Batch 0 vs Batch 17:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000089\n",
      "\n",
      "Batch 0 vs Batch 18:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000106\n",
      "\n",
      "Batch 0 vs Batch 19:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000071\n",
      "\n",
      "Batch 0 vs Batch 20:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000128\n",
      "\n",
      "Batch 0 vs Batch 21:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000071\n",
      "\n",
      "Batch 0 vs Batch 22:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000085\n",
      "\n",
      "Batch 0 vs Batch 23:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000076\n",
      "\n",
      "Batch 0 vs Batch 24:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000070\n",
      "\n",
      "Batch 0 vs Batch 25:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000112\n",
      "\n",
      "Batch 0 vs Batch 26:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000089\n",
      "\n",
      "Batch 0 vs Batch 27:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000088\n",
      "\n",
      "Batch 0 vs Batch 28:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000088\n",
      "\n",
      "Batch 0 vs Batch 29:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000089\n",
      "\n",
      "Batch 0 vs Batch 30:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000100\n",
      "\n",
      "Batch 0 vs Batch 31:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000110\n",
      "\n",
      "Batch 0 vs Batch 32:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000113\n",
      "\n",
      "Batch 0 vs Batch 33:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000107\n",
      "\n",
      "Batch 0 vs Batch 34:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000113\n",
      "\n",
      "Batch 0 vs Batch 35:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000081\n",
      "\n",
      "Batch 0 vs Batch 36:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000094\n",
      "\n",
      "Batch 0 vs Batch 37:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000083\n",
      "\n",
      "Batch 0 vs Batch 38:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000095\n",
      "\n",
      "Batch 0 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000048\n",
      "\n",
      "Batch 1 vs Batch 2:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000063\n",
      "\n",
      "Batch 1 vs Batch 3:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000060\n",
      "\n",
      "Batch 1 vs Batch 4:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000048\n",
      "\n",
      "Batch 1 vs Batch 5:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000048\n",
      "\n",
      "Batch 1 vs Batch 6:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000046\n",
      "\n",
      "Batch 1 vs Batch 7:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000052\n",
      "\n",
      "Batch 1 vs Batch 8:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000056\n",
      "\n",
      "Batch 1 vs Batch 9:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000067\n",
      "\n",
      "Batch 1 vs Batch 10:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000051\n",
      "\n",
      "Batch 1 vs Batch 11:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000061\n",
      "\n",
      "Batch 1 vs Batch 12:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000061\n",
      "\n",
      "Batch 1 vs Batch 13:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000055\n",
      "\n",
      "Batch 1 vs Batch 14:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000095\n",
      "\n",
      "Batch 1 vs Batch 15:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000048\n",
      "\n",
      "Batch 1 vs Batch 16:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000062\n",
      "\n",
      "Batch 1 vs Batch 17:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000102\n",
      "\n",
      "Batch 1 vs Batch 18:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000059\n",
      "\n",
      "Batch 1 vs Batch 19:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000047\n",
      "\n",
      "Batch 1 vs Batch 20:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000066\n",
      "\n",
      "Batch 1 vs Batch 21:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000056\n",
      "\n",
      "Batch 1 vs Batch 22:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000063\n",
      "\n",
      "Batch 1 vs Batch 23:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000065\n",
      "\n",
      "Batch 1 vs Batch 24:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000080\n",
      "\n",
      "Batch 1 vs Batch 25:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000052\n",
      "\n",
      "Batch 1 vs Batch 26:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000060\n",
      "\n",
      "Batch 1 vs Batch 27:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000073\n",
      "\n",
      "Batch 1 vs Batch 28:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000066\n",
      "\n",
      "Batch 1 vs Batch 29:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000070\n",
      "\n",
      "Batch 1 vs Batch 30:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000053\n",
      "\n",
      "Batch 1 vs Batch 31:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000048\n",
      "\n",
      "Batch 1 vs Batch 32:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000065\n",
      "\n",
      "Batch 1 vs Batch 33:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000115\n",
      "\n",
      "Batch 1 vs Batch 34:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000081\n",
      "\n",
      "Batch 1 vs Batch 35:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000053\n",
      "\n",
      "Batch 1 vs Batch 36:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000047\n",
      "\n",
      "Batch 1 vs Batch 37:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000051\n",
      "\n",
      "Batch 1 vs Batch 38:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000058\n",
      "\n",
      "Batch 1 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000044\n",
      "\n",
      "Batch 2 vs Batch 3:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000059\n",
      "\n",
      "Batch 2 vs Batch 4:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000074\n",
      "\n",
      "Batch 2 vs Batch 5:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000109\n",
      "\n",
      "Batch 2 vs Batch 6:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000062\n",
      "\n",
      "Batch 2 vs Batch 7:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000066\n",
      "\n",
      "Batch 2 vs Batch 8:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000065\n",
      "\n",
      "Batch 2 vs Batch 9:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000087\n",
      "\n",
      "Batch 2 vs Batch 10:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000057\n",
      "\n",
      "Batch 2 vs Batch 11:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000080\n",
      "\n",
      "Batch 2 vs Batch 12:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000103\n",
      "\n",
      "Batch 2 vs Batch 13:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000067\n",
      "\n",
      "Batch 2 vs Batch 14:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000108\n",
      "\n",
      "Batch 2 vs Batch 15:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000069\n",
      "\n",
      "Batch 2 vs Batch 16:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000071\n",
      "\n",
      "Batch 2 vs Batch 17:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000101\n",
      "\n",
      "Batch 2 vs Batch 18:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000071\n",
      "\n",
      "Batch 2 vs Batch 19:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000077\n",
      "\n",
      "Batch 2 vs Batch 20:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000065\n",
      "\n",
      "Batch 2 vs Batch 21:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000070\n",
      "\n",
      "Batch 2 vs Batch 22:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000071\n",
      "\n",
      "Batch 2 vs Batch 23:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000054\n",
      "\n",
      "Batch 2 vs Batch 24:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000091\n",
      "\n",
      "Batch 2 vs Batch 25:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000059\n",
      "\n",
      "Batch 2 vs Batch 26:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000075\n",
      "\n",
      "Batch 2 vs Batch 27:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000073\n",
      "\n",
      "Batch 2 vs Batch 28:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000077\n",
      "\n",
      "Batch 2 vs Batch 29:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000069\n",
      "\n",
      "Batch 2 vs Batch 30:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000078\n",
      "\n",
      "Batch 2 vs Batch 31:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000083\n",
      "\n",
      "Batch 2 vs Batch 32:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000059\n",
      "\n",
      "Batch 2 vs Batch 33:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000114\n",
      "\n",
      "Batch 2 vs Batch 34:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000080\n",
      "\n",
      "Batch 2 vs Batch 35:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000070\n",
      "\n",
      "Batch 2 vs Batch 36:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000085\n",
      "\n",
      "Batch 2 vs Batch 37:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000056\n",
      "\n",
      "Batch 2 vs Batch 38:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000068\n",
      "\n",
      "Batch 2 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000067\n",
      "\n",
      "Batch 3 vs Batch 4:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000078\n",
      "\n",
      "Batch 3 vs Batch 5:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000077\n",
      "\n",
      "Batch 3 vs Batch 6:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000062\n",
      "\n",
      "Batch 3 vs Batch 7:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000065\n",
      "\n",
      "Batch 3 vs Batch 8:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000056\n",
      "\n",
      "Batch 3 vs Batch 9:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000051\n",
      "\n",
      "Batch 3 vs Batch 10:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000058\n",
      "\n",
      "Batch 3 vs Batch 11:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000069\n",
      "\n",
      "Batch 3 vs Batch 12:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000072\n",
      "\n",
      "Batch 3 vs Batch 13:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000113\n",
      "\n",
      "Batch 3 vs Batch 14:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000076\n",
      "\n",
      "Batch 3 vs Batch 15:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000082\n",
      "\n",
      "Batch 3 vs Batch 16:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000050\n",
      "\n",
      "Batch 3 vs Batch 17:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000066\n",
      "\n",
      "Batch 3 vs Batch 18:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000045\n",
      "\n",
      "Batch 3 vs Batch 19:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000066\n",
      "\n",
      "Batch 3 vs Batch 20:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000067\n",
      "\n",
      "Batch 3 vs Batch 21:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000069\n",
      "\n",
      "Batch 3 vs Batch 22:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000060\n",
      "\n",
      "Batch 3 vs Batch 23:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000059\n",
      "\n",
      "Batch 3 vs Batch 24:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000054\n",
      "\n",
      "Batch 3 vs Batch 25:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000057\n",
      "\n",
      "Batch 3 vs Batch 26:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000054\n",
      "\n",
      "Batch 3 vs Batch 27:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000057\n",
      "\n",
      "Batch 3 vs Batch 28:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000062\n",
      "\n",
      "Batch 3 vs Batch 29:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000056\n",
      "\n",
      "Batch 3 vs Batch 30:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000102\n",
      "\n",
      "Batch 3 vs Batch 31:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000050\n",
      "\n",
      "Batch 3 vs Batch 32:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000053\n",
      "\n",
      "Batch 3 vs Batch 33:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000084\n",
      "\n",
      "Batch 3 vs Batch 34:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000062\n",
      "\n",
      "Batch 3 vs Batch 35:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000068\n",
      "\n",
      "Batch 3 vs Batch 36:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000062\n",
      "\n",
      "Batch 3 vs Batch 37:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000051\n",
      "\n",
      "Batch 3 vs Batch 38:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000055\n",
      "\n",
      "Batch 3 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000047\n",
      "\n",
      "Batch 4 vs Batch 5:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000077\n",
      "\n",
      "Batch 4 vs Batch 6:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000067\n",
      "\n",
      "Batch 4 vs Batch 7:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000069\n",
      "\n",
      "Batch 4 vs Batch 8:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000053\n",
      "\n",
      "Batch 4 vs Batch 9:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000086\n",
      "\n",
      "Batch 4 vs Batch 10:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000055\n",
      "\n",
      "Batch 4 vs Batch 11:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000052\n",
      "\n",
      "Batch 4 vs Batch 12:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000078\n",
      "\n",
      "Batch 4 vs Batch 13:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000072\n",
      "\n",
      "Batch 4 vs Batch 14:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000114\n",
      "\n",
      "Batch 4 vs Batch 15:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000056\n",
      "\n",
      "Batch 4 vs Batch 16:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000052\n",
      "\n",
      "Batch 4 vs Batch 17:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000120\n",
      "\n",
      "Batch 4 vs Batch 18:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000070\n",
      "\n",
      "Batch 4 vs Batch 19:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000064\n",
      "\n",
      "Batch 4 vs Batch 20:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000084\n",
      "\n",
      "Batch 4 vs Batch 21:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000073\n",
      "\n",
      "Batch 4 vs Batch 22:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000082\n",
      "\n",
      "Batch 4 vs Batch 23:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000060\n",
      "\n",
      "Batch 4 vs Batch 24:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000098\n",
      "\n",
      "Batch 4 vs Batch 25:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000054\n",
      "\n",
      "Batch 4 vs Batch 26:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000079\n",
      "\n",
      "Batch 4 vs Batch 27:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000061\n",
      "\n",
      "Batch 4 vs Batch 28:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000060\n",
      "\n",
      "Batch 4 vs Batch 29:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000089\n",
      "\n",
      "Batch 4 vs Batch 30:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000051\n",
      "\n",
      "Batch 4 vs Batch 31:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000063\n",
      "\n",
      "Batch 4 vs Batch 32:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000052\n",
      "\n",
      "Batch 4 vs Batch 33:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000133\n",
      "\n",
      "Batch 4 vs Batch 34:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000099\n",
      "\n",
      "Batch 4 vs Batch 35:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000062\n",
      "\n",
      "Batch 4 vs Batch 36:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000052\n",
      "\n",
      "Batch 4 vs Batch 37:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000051\n",
      "\n",
      "Batch 4 vs Batch 38:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000077\n",
      "\n",
      "Batch 4 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000056\n",
      "\n",
      "Batch 5 vs Batch 6:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000093\n",
      "\n",
      "Batch 5 vs Batch 7:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000092\n",
      "\n",
      "Batch 5 vs Batch 8:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000081\n",
      "\n",
      "Batch 5 vs Batch 9:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000085\n",
      "\n",
      "Batch 5 vs Batch 10:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000062\n",
      "\n",
      "Batch 5 vs Batch 11:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000108\n",
      "\n",
      "Batch 5 vs Batch 12:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000086\n",
      "\n",
      "Batch 5 vs Batch 13:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000097\n",
      "\n",
      "Batch 5 vs Batch 14:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000070\n",
      "\n",
      "Batch 5 vs Batch 15:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000066\n",
      "\n",
      "Batch 5 vs Batch 16:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000093\n",
      "\n",
      "Batch 5 vs Batch 17:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000133\n",
      "\n",
      "Batch 5 vs Batch 18:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000051\n",
      "\n",
      "Batch 5 vs Batch 19:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000080\n",
      "\n",
      "Batch 5 vs Batch 20:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000059\n",
      "\n",
      "Batch 5 vs Batch 21:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000101\n",
      "\n",
      "Batch 5 vs Batch 22:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000062\n",
      "\n",
      "Batch 5 vs Batch 23:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000112\n",
      "\n",
      "Batch 5 vs Batch 24:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000079\n",
      "\n",
      "Batch 5 vs Batch 25:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000067\n",
      "\n",
      "Batch 5 vs Batch 26:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000088\n",
      "\n",
      "Batch 5 vs Batch 27:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000066\n",
      "\n",
      "Batch 5 vs Batch 28:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000070\n",
      "\n",
      "Batch 5 vs Batch 29:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000110\n",
      "\n",
      "Batch 5 vs Batch 30:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000086\n",
      "\n",
      "Batch 5 vs Batch 31:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000071\n",
      "\n",
      "Batch 5 vs Batch 32:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000062\n",
      "\n",
      "Batch 5 vs Batch 33:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000151\n",
      "\n",
      "Batch 5 vs Batch 34:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000089\n",
      "\n",
      "Batch 5 vs Batch 35:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000098\n",
      "\n",
      "Batch 5 vs Batch 36:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000066\n",
      "\n",
      "Batch 5 vs Batch 37:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000078\n",
      "\n",
      "Batch 5 vs Batch 38:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000066\n",
      "\n",
      "Batch 5 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000078\n",
      "\n",
      "Batch 6 vs Batch 7:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000049\n",
      "\n",
      "Batch 6 vs Batch 8:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000077\n",
      "\n",
      "Batch 6 vs Batch 9:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000067\n",
      "\n",
      "Batch 6 vs Batch 10:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000071\n",
      "\n",
      "Batch 6 vs Batch 11:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000056\n",
      "\n",
      "Batch 6 vs Batch 12:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000077\n",
      "\n",
      "Batch 6 vs Batch 13:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000076\n",
      "\n",
      "Batch 6 vs Batch 14:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000095\n",
      "\n",
      "Batch 6 vs Batch 15:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000052\n",
      "\n",
      "Batch 6 vs Batch 16:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000052\n",
      "\n",
      "Batch 6 vs Batch 17:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000102\n",
      "\n",
      "Batch 6 vs Batch 18:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000081\n",
      "\n",
      "Batch 6 vs Batch 19:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000060\n",
      "\n",
      "Batch 6 vs Batch 20:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000102\n",
      "\n",
      "Batch 6 vs Batch 21:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000054\n",
      "\n",
      "Batch 6 vs Batch 22:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000063\n",
      "\n",
      "Batch 6 vs Batch 23:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000053\n",
      "\n",
      "Batch 6 vs Batch 24:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000085\n",
      "\n",
      "Batch 6 vs Batch 25:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000086\n",
      "\n",
      "Batch 6 vs Batch 26:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000067\n",
      "\n",
      "Batch 6 vs Batch 27:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000064\n",
      "\n",
      "Batch 6 vs Batch 28:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000062\n",
      "\n",
      "Batch 6 vs Batch 29:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000070\n",
      "\n",
      "Batch 6 vs Batch 30:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000068\n",
      "\n",
      "Batch 6 vs Batch 31:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000084\n",
      "\n",
      "Batch 6 vs Batch 32:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000051\n",
      "\n",
      "Batch 6 vs Batch 33:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000115\n",
      "\n",
      "Batch 6 vs Batch 34:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000081\n",
      "\n",
      "Batch 6 vs Batch 35:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000056\n",
      "\n",
      "Batch 6 vs Batch 36:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000069\n",
      "\n",
      "Batch 6 vs Batch 37:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000052\n",
      "\n",
      "Batch 6 vs Batch 38:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000058\n",
      "\n",
      "Batch 6 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000049\n",
      "\n",
      "Batch 7 vs Batch 8:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000075\n",
      "\n",
      "Batch 7 vs Batch 9:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000063\n",
      "\n",
      "Batch 7 vs Batch 10:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000074\n",
      "\n",
      "Batch 7 vs Batch 11:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000068\n",
      "\n",
      "Batch 7 vs Batch 12:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000055\n",
      "\n",
      "Batch 7 vs Batch 13:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000080\n",
      "\n",
      "Batch 7 vs Batch 14:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000082\n",
      "\n",
      "Batch 7 vs Batch 15:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000056\n",
      "\n",
      "Batch 7 vs Batch 16:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000057\n",
      "\n",
      "Batch 7 vs Batch 17:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000094\n",
      "\n",
      "Batch 7 vs Batch 18:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000084\n",
      "\n",
      "Batch 7 vs Batch 19:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000072\n",
      "\n",
      "Batch 7 vs Batch 20:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000105\n",
      "\n",
      "Batch 7 vs Batch 21:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000069\n",
      "\n",
      "Batch 7 vs Batch 22:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000063\n",
      "\n",
      "Batch 7 vs Batch 23:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000065\n",
      "\n",
      "Batch 7 vs Batch 24:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000097\n",
      "\n",
      "Batch 7 vs Batch 25:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000089\n",
      "\n",
      "Batch 7 vs Batch 26:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000067\n",
      "\n",
      "Batch 7 vs Batch 27:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000065\n",
      "\n",
      "Batch 7 vs Batch 28:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000050\n",
      "\n",
      "Batch 7 vs Batch 29:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000080\n",
      "\n",
      "Batch 7 vs Batch 30:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000072\n",
      "\n",
      "Batch 7 vs Batch 31:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000087\n",
      "\n",
      "Batch 7 vs Batch 32:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000062\n",
      "\n",
      "Batch 7 vs Batch 33:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000101\n",
      "\n",
      "Batch 7 vs Batch 34:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000067\n",
      "\n",
      "Batch 7 vs Batch 35:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000059\n",
      "\n",
      "Batch 7 vs Batch 36:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000066\n",
      "\n",
      "Batch 7 vs Batch 37:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000047\n",
      "\n",
      "Batch 7 vs Batch 38:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000070\n",
      "\n",
      "Batch 7 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000050\n",
      "\n",
      "Batch 8 vs Batch 9:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000063\n",
      "\n",
      "Batch 8 vs Batch 10:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000067\n",
      "\n",
      "Batch 8 vs Batch 11:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000074\n",
      "\n",
      "Batch 8 vs Batch 12:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000084\n",
      "\n",
      "Batch 8 vs Batch 13:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000078\n",
      "\n",
      "Batch 8 vs Batch 14:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000088\n",
      "\n",
      "Batch 8 vs Batch 15:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000062\n",
      "\n",
      "Batch 8 vs Batch 16:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000062\n",
      "\n",
      "Batch 8 vs Batch 17:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000078\n",
      "\n",
      "Batch 8 vs Batch 18:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000073\n",
      "\n",
      "Batch 8 vs Batch 19:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000103\n",
      "\n",
      "Batch 8 vs Batch 20:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000079\n",
      "\n",
      "Batch 8 vs Batch 21:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000079\n",
      "\n",
      "Batch 8 vs Batch 22:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000077\n",
      "\n",
      "Batch 8 vs Batch 23:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000096\n",
      "\n",
      "Batch 8 vs Batch 24:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000056\n",
      "\n",
      "Batch 8 vs Batch 25:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000066\n",
      "\n",
      "Batch 8 vs Batch 26:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000055\n",
      "\n",
      "Batch 8 vs Batch 27:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000062\n",
      "\n",
      "Batch 8 vs Batch 28:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000080\n",
      "\n",
      "Batch 8 vs Batch 29:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000078\n",
      "\n",
      "Batch 8 vs Batch 30:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000072\n",
      "\n",
      "Batch 8 vs Batch 31:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000057\n",
      "\n",
      "Batch 8 vs Batch 32:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000082\n",
      "\n",
      "Batch 8 vs Batch 33:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000091\n",
      "\n",
      "Batch 8 vs Batch 34:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000071\n",
      "\n",
      "Batch 8 vs Batch 35:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000068\n",
      "\n",
      "Batch 8 vs Batch 36:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000068\n",
      "\n",
      "Batch 8 vs Batch 37:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000063\n",
      "\n",
      "Batch 8 vs Batch 38:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000066\n",
      "\n",
      "Batch 8 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000073\n",
      "\n",
      "Batch 9 vs Batch 10:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000063\n",
      "\n",
      "Batch 9 vs Batch 11:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000077\n",
      "\n",
      "Batch 9 vs Batch 12:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000072\n",
      "\n",
      "Batch 9 vs Batch 13:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000121\n",
      "\n",
      "Batch 9 vs Batch 14:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000084\n",
      "\n",
      "Batch 9 vs Batch 15:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000090\n",
      "\n",
      "Batch 9 vs Batch 16:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000062\n",
      "\n",
      "Batch 9 vs Batch 17:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000102\n",
      "\n",
      "Batch 9 vs Batch 18:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000058\n",
      "\n",
      "Batch 9 vs Batch 19:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000052\n",
      "\n",
      "Batch 9 vs Batch 20:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000055\n",
      "\n",
      "Batch 9 vs Batch 21:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000070\n",
      "\n",
      "Batch 9 vs Batch 22:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000057\n",
      "\n",
      "Batch 9 vs Batch 23:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000081\n",
      "\n",
      "Batch 9 vs Batch 24:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000051\n",
      "\n",
      "Batch 9 vs Batch 25:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000076\n",
      "\n",
      "Batch 9 vs Batch 26:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000065\n",
      "\n",
      "Batch 9 vs Batch 27:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000066\n",
      "\n",
      "Batch 9 vs Batch 28:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000072\n",
      "\n",
      "Batch 9 vs Batch 29:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000090\n",
      "\n",
      "Batch 9 vs Batch 30:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000109\n",
      "\n",
      "Batch 9 vs Batch 31:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000042\n",
      "\n",
      "Batch 9 vs Batch 32:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000089\n",
      "\n",
      "Batch 9 vs Batch 33:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000120\n",
      "\n",
      "Batch 9 vs Batch 34:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000089\n",
      "\n",
      "Batch 9 vs Batch 35:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000076\n",
      "\n",
      "Batch 9 vs Batch 36:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000071\n",
      "\n",
      "Batch 9 vs Batch 37:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000059\n",
      "\n",
      "Batch 9 vs Batch 38:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000071\n",
      "\n",
      "Batch 9 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000057\n",
      "\n",
      "Batch 10 vs Batch 11:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000057\n",
      "\n",
      "Batch 10 vs Batch 12:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000079\n",
      "\n",
      "Batch 10 vs Batch 13:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000072\n",
      "\n",
      "Batch 10 vs Batch 14:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000091\n",
      "\n",
      "Batch 10 vs Batch 15:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000056\n",
      "\n",
      "Batch 10 vs Batch 16:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000058\n",
      "\n",
      "Batch 10 vs Batch 17:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000097\n",
      "\n",
      "Batch 10 vs Batch 18:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000070\n",
      "\n",
      "Batch 10 vs Batch 19:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000054\n",
      "\n",
      "Batch 10 vs Batch 20:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000061\n",
      "\n",
      "Batch 10 vs Batch 21:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000078\n",
      "\n",
      "Batch 10 vs Batch 22:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000059\n",
      "\n",
      "Batch 10 vs Batch 23:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000059\n",
      "\n",
      "Batch 10 vs Batch 24:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000075\n",
      "\n",
      "Batch 10 vs Batch 25:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000054\n",
      "\n",
      "Batch 10 vs Batch 26:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000056\n",
      "\n",
      "Batch 10 vs Batch 27:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000064\n",
      "\n",
      "Batch 10 vs Batch 28:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000074\n",
      "\n",
      "Batch 10 vs Batch 29:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000066\n",
      "\n",
      "Batch 10 vs Batch 30:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000062\n",
      "\n",
      "Batch 10 vs Batch 31:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000060\n",
      "\n",
      "Batch 10 vs Batch 32:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000048\n",
      "\n",
      "Batch 10 vs Batch 33:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000110\n",
      "\n",
      "Batch 10 vs Batch 34:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000076\n",
      "\n",
      "Batch 10 vs Batch 35:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000062\n",
      "\n",
      "Batch 10 vs Batch 36:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000061\n",
      "\n",
      "Batch 10 vs Batch 37:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000060\n",
      "\n",
      "Batch 10 vs Batch 38:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000057\n",
      "\n",
      "Batch 10 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000053\n",
      "\n",
      "Batch 11 vs Batch 12:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000077\n",
      "\n",
      "Batch 11 vs Batch 13:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000075\n",
      "\n",
      "Batch 11 vs Batch 14:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000083\n",
      "\n",
      "Batch 11 vs Batch 15:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000055\n",
      "\n",
      "Batch 11 vs Batch 16:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000056\n",
      "\n",
      "Batch 11 vs Batch 17:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000080\n",
      "\n",
      "Batch 11 vs Batch 18:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000080\n",
      "\n",
      "Batch 11 vs Batch 19:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000050\n",
      "\n",
      "Batch 11 vs Batch 20:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000069\n",
      "\n",
      "Batch 11 vs Batch 21:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000072\n",
      "\n",
      "Batch 11 vs Batch 22:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000065\n",
      "\n",
      "Batch 11 vs Batch 23:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000061\n",
      "\n",
      "Batch 11 vs Batch 24:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000058\n",
      "\n",
      "Batch 11 vs Batch 25:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000070\n",
      "\n",
      "Batch 11 vs Batch 26:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000063\n",
      "\n",
      "Batch 11 vs Batch 27:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000074\n",
      "\n",
      "Batch 11 vs Batch 28:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000063\n",
      "\n",
      "Batch 11 vs Batch 29:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000059\n",
      "\n",
      "Batch 11 vs Batch 30:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000063\n",
      "\n",
      "Batch 11 vs Batch 31:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000047\n",
      "\n",
      "Batch 11 vs Batch 32:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000082\n",
      "\n",
      "Batch 11 vs Batch 33:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000093\n",
      "\n",
      "Batch 11 vs Batch 34:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000082\n",
      "\n",
      "Batch 11 vs Batch 35:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000068\n",
      "\n",
      "Batch 11 vs Batch 36:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000085\n",
      "\n",
      "Batch 11 vs Batch 37:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000052\n",
      "\n",
      "Batch 11 vs Batch 38:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000064\n",
      "\n",
      "Batch 11 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000061\n",
      "\n",
      "Batch 12 vs Batch 13:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000078\n",
      "\n",
      "Batch 12 vs Batch 14:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000079\n",
      "\n",
      "Batch 12 vs Batch 15:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000050\n",
      "\n",
      "Batch 12 vs Batch 16:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000074\n",
      "\n",
      "Batch 12 vs Batch 17:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000103\n",
      "\n",
      "Batch 12 vs Batch 18:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000070\n",
      "\n",
      "Batch 12 vs Batch 19:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000081\n",
      "\n",
      "Batch 12 vs Batch 20:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000091\n",
      "\n",
      "Batch 12 vs Batch 21:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000061\n",
      "\n",
      "Batch 12 vs Batch 22:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000058\n",
      "\n",
      "Batch 12 vs Batch 23:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000074\n",
      "\n",
      "Batch 12 vs Batch 24:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000106\n",
      "\n",
      "Batch 12 vs Batch 25:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000092\n",
      "\n",
      "Batch 12 vs Batch 26:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000081\n",
      "\n",
      "Batch 12 vs Batch 27:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000078\n",
      "\n",
      "Batch 12 vs Batch 28:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000050\n",
      "\n",
      "Batch 12 vs Batch 29:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000089\n",
      "\n",
      "Batch 12 vs Batch 30:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000066\n",
      "\n",
      "Batch 12 vs Batch 31:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000073\n",
      "\n",
      "Batch 12 vs Batch 32:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000105\n",
      "\n",
      "Batch 12 vs Batch 33:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000098\n",
      "\n",
      "Batch 12 vs Batch 34:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000105\n",
      "\n",
      "Batch 12 vs Batch 35:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000070\n",
      "\n",
      "Batch 12 vs Batch 36:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000086\n",
      "\n",
      "Batch 12 vs Batch 37:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000075\n",
      "\n",
      "Batch 12 vs Batch 38:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000087\n",
      "\n",
      "Batch 12 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000059\n",
      "\n",
      "Batch 13 vs Batch 14:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000149\n",
      "\n",
      "Batch 13 vs Batch 15:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000052\n",
      "\n",
      "Batch 13 vs Batch 16:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000076\n",
      "\n",
      "Batch 13 vs Batch 17:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000155\n",
      "\n",
      "Batch 13 vs Batch 18:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000085\n",
      "\n",
      "Batch 13 vs Batch 19:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000075\n",
      "\n",
      "Batch 13 vs Batch 20:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000120\n",
      "\n",
      "Batch 13 vs Batch 21:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000088\n",
      "\n",
      "Batch 13 vs Batch 22:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000117\n",
      "\n",
      "Batch 13 vs Batch 23:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000096\n",
      "\n",
      "Batch 13 vs Batch 24:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000134\n",
      "\n",
      "Batch 13 vs Batch 25:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000089\n",
      "\n",
      "Batch 13 vs Batch 26:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000114\n",
      "\n",
      "Batch 13 vs Batch 27:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000057\n",
      "\n",
      "Batch 13 vs Batch 28:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000095\n",
      "\n",
      "Batch 13 vs Batch 29:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000124\n",
      "\n",
      "Batch 13 vs Batch 30:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000043\n",
      "\n",
      "Batch 13 vs Batch 31:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000099\n",
      "\n",
      "Batch 13 vs Batch 32:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000061\n",
      "\n",
      "Batch 13 vs Batch 33:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000169\n",
      "\n",
      "Batch 13 vs Batch 34:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000134\n",
      "\n",
      "Batch 13 vs Batch 35:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000081\n",
      "\n",
      "Batch 13 vs Batch 36:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000075\n",
      "\n",
      "Batch 13 vs Batch 37:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000081\n",
      "\n",
      "Batch 13 vs Batch 38:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000112\n",
      "\n",
      "Batch 13 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000075\n",
      "\n",
      "Batch 14 vs Batch 15:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000118\n",
      "\n",
      "Batch 14 vs Batch 16:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000087\n",
      "\n",
      "Batch 14 vs Batch 17:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000078\n",
      "\n",
      "Batch 14 vs Batch 18:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000079\n",
      "\n",
      "Batch 14 vs Batch 19:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000080\n",
      "\n",
      "Batch 14 vs Batch 20:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000097\n",
      "\n",
      "Batch 14 vs Batch 21:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000087\n",
      "\n",
      "Batch 14 vs Batch 22:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000071\n",
      "\n",
      "Batch 14 vs Batch 23:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000064\n",
      "\n",
      "Batch 14 vs Batch 24:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000051\n",
      "\n",
      "Batch 14 vs Batch 25:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000067\n",
      "\n",
      "Batch 14 vs Batch 26:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000076\n",
      "\n",
      "Batch 14 vs Batch 27:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000092\n",
      "\n",
      "Batch 14 vs Batch 28:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000054\n",
      "\n",
      "Batch 14 vs Batch 29:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000064\n",
      "\n",
      "Batch 14 vs Batch 30:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000137\n",
      "\n",
      "Batch 14 vs Batch 31:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000092\n",
      "\n",
      "Batch 14 vs Batch 32:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000088\n",
      "\n",
      "Batch 14 vs Batch 33:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000096\n",
      "\n",
      "Batch 14 vs Batch 34:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000068\n",
      "\n",
      "Batch 14 vs Batch 35:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000083\n",
      "\n",
      "Batch 14 vs Batch 36:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000094\n",
      "\n",
      "Batch 14 vs Batch 37:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000075\n",
      "\n",
      "Batch 14 vs Batch 38:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000098\n",
      "\n",
      "Batch 14 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000078\n",
      "\n",
      "Batch 15 vs Batch 16:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000050\n",
      "\n",
      "Batch 15 vs Batch 17:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000124\n",
      "\n",
      "Batch 15 vs Batch 18:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000060\n",
      "\n",
      "Batch 15 vs Batch 19:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000059\n",
      "\n",
      "Batch 15 vs Batch 20:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000089\n",
      "\n",
      "Batch 15 vs Batch 21:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000060\n",
      "\n",
      "Batch 15 vs Batch 22:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000086\n",
      "\n",
      "Batch 15 vs Batch 23:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000069\n",
      "\n",
      "Batch 15 vs Batch 24:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000103\n",
      "\n",
      "Batch 15 vs Batch 25:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000059\n",
      "\n",
      "Batch 15 vs Batch 26:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000083\n",
      "\n",
      "Batch 15 vs Batch 27:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000069\n",
      "\n",
      "Batch 15 vs Batch 28:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000064\n",
      "\n",
      "Batch 15 vs Batch 29:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000093\n",
      "\n",
      "Batch 15 vs Batch 30:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000046\n",
      "\n",
      "Batch 15 vs Batch 31:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000068\n",
      "\n",
      "Batch 15 vs Batch 32:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000072\n",
      "\n",
      "Batch 15 vs Batch 33:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000138\n",
      "\n",
      "Batch 15 vs Batch 34:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000103\n",
      "\n",
      "Batch 15 vs Batch 35:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000055\n",
      "\n",
      "Batch 15 vs Batch 36:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000053\n",
      "\n",
      "Batch 15 vs Batch 37:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000050\n",
      "\n",
      "Batch 15 vs Batch 38:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000081\n",
      "\n",
      "Batch 15 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000044\n",
      "\n",
      "Batch 16 vs Batch 17:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000079\n",
      "\n",
      "Batch 16 vs Batch 18:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000058\n",
      "\n",
      "Batch 16 vs Batch 19:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000049\n",
      "\n",
      "Batch 16 vs Batch 20:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000050\n",
      "\n",
      "Batch 16 vs Batch 21:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000060\n",
      "\n",
      "Batch 16 vs Batch 22:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000051\n",
      "\n",
      "Batch 16 vs Batch 23:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000076\n",
      "\n",
      "Batch 16 vs Batch 24:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000065\n",
      "\n",
      "Batch 16 vs Batch 25:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000063\n",
      "\n",
      "Batch 16 vs Batch 26:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000051\n",
      "\n",
      "Batch 16 vs Batch 27:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000057\n",
      "\n",
      "Batch 16 vs Batch 28:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000059\n",
      "\n",
      "Batch 16 vs Batch 29:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000062\n",
      "\n",
      "Batch 16 vs Batch 30:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000064\n",
      "\n",
      "Batch 16 vs Batch 31:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000055\n",
      "\n",
      "Batch 16 vs Batch 32:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000054\n",
      "\n",
      "Batch 16 vs Batch 33:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000092\n",
      "\n",
      "Batch 16 vs Batch 34:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000073\n",
      "\n",
      "Batch 16 vs Batch 35:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000051\n",
      "\n",
      "Batch 16 vs Batch 36:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000069\n",
      "\n",
      "Batch 16 vs Batch 37:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000050\n",
      "\n",
      "Batch 16 vs Batch 38:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000047\n",
      "\n",
      "Batch 16 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000046\n",
      "\n",
      "Batch 17 vs Batch 18:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000089\n",
      "\n",
      "Batch 17 vs Batch 19:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000086\n",
      "\n",
      "Batch 17 vs Batch 20:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000074\n",
      "\n",
      "Batch 17 vs Batch 21:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000099\n",
      "\n",
      "Batch 17 vs Batch 22:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000091\n",
      "\n",
      "Batch 17 vs Batch 23:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000071\n",
      "\n",
      "Batch 17 vs Batch 24:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000064\n",
      "\n",
      "Batch 17 vs Batch 25:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000067\n",
      "\n",
      "Batch 17 vs Batch 26:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000061\n",
      "\n",
      "Batch 17 vs Batch 27:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000099\n",
      "\n",
      "Batch 17 vs Batch 28:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000078\n",
      "\n",
      "Batch 17 vs Batch 29:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000056\n",
      "\n",
      "Batch 17 vs Batch 30:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000144\n",
      "\n",
      "Batch 17 vs Batch 31:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000067\n",
      "\n",
      "Batch 17 vs Batch 32:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000095\n",
      "\n",
      "Batch 17 vs Batch 33:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000068\n",
      "\n",
      "Batch 17 vs Batch 34:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000075\n",
      "\n",
      "Batch 17 vs Batch 35:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000089\n",
      "\n",
      "Batch 17 vs Batch 36:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000109\n",
      "\n",
      "Batch 17 vs Batch 37:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000075\n",
      "\n",
      "Batch 17 vs Batch 38:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000071\n",
      "\n",
      "Batch 17 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000081\n",
      "\n",
      "Batch 18 vs Batch 19:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000066\n",
      "\n",
      "Batch 18 vs Batch 20:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000078\n",
      "\n",
      "Batch 18 vs Batch 21:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000088\n",
      "\n",
      "Batch 18 vs Batch 22:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000072\n",
      "\n",
      "Batch 18 vs Batch 23:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000070\n",
      "\n",
      "Batch 18 vs Batch 24:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000081\n",
      "\n",
      "Batch 18 vs Batch 25:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000079\n",
      "\n",
      "Batch 18 vs Batch 26:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000060\n",
      "\n",
      "Batch 18 vs Batch 27:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000055\n",
      "\n",
      "Batch 18 vs Batch 28:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000074\n",
      "\n",
      "Batch 18 vs Batch 29:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000065\n",
      "\n",
      "Batch 18 vs Batch 30:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000073\n",
      "\n",
      "Batch 18 vs Batch 31:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000056\n",
      "\n",
      "Batch 18 vs Batch 32:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000068\n",
      "\n",
      "Batch 18 vs Batch 33:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000107\n",
      "\n",
      "Batch 18 vs Batch 34:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000062\n",
      "\n",
      "Batch 18 vs Batch 35:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000072\n",
      "\n",
      "Batch 18 vs Batch 36:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000067\n",
      "\n",
      "Batch 18 vs Batch 37:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000070\n",
      "\n",
      "Batch 18 vs Batch 38:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000067\n",
      "\n",
      "Batch 18 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000063\n",
      "\n",
      "Batch 19 vs Batch 20:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000057\n",
      "\n",
      "Batch 19 vs Batch 21:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000078\n",
      "\n",
      "Batch 19 vs Batch 22:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000053\n",
      "\n",
      "Batch 19 vs Batch 23:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000050\n",
      "\n",
      "Batch 19 vs Batch 24:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000064\n",
      "\n",
      "Batch 19 vs Batch 25:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000067\n",
      "\n",
      "Batch 19 vs Batch 26:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000092\n",
      "\n",
      "Batch 19 vs Batch 27:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000062\n",
      "\n",
      "Batch 19 vs Batch 28:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000061\n",
      "\n",
      "Batch 19 vs Batch 29:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000055\n",
      "\n",
      "Batch 19 vs Batch 30:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000058\n",
      "\n",
      "Batch 19 vs Batch 31:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000066\n",
      "\n",
      "Batch 19 vs Batch 32:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000080\n",
      "\n",
      "Batch 19 vs Batch 33:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000099\n",
      "\n",
      "Batch 19 vs Batch 34:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000080\n",
      "\n",
      "Batch 19 vs Batch 35:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000064\n",
      "\n",
      "Batch 19 vs Batch 36:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000073\n",
      "\n",
      "Batch 19 vs Batch 37:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000050\n",
      "\n",
      "Batch 19 vs Batch 38:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000062\n",
      "\n",
      "Batch 19 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000049\n",
      "\n",
      "Batch 20 vs Batch 21:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000110\n",
      "\n",
      "Batch 20 vs Batch 22:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000052\n",
      "\n",
      "Batch 20 vs Batch 23:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000076\n",
      "\n",
      "Batch 20 vs Batch 24:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000084\n",
      "\n",
      "Batch 20 vs Batch 25:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000082\n",
      "\n",
      "Batch 20 vs Batch 26:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000067\n",
      "\n",
      "Batch 20 vs Batch 27:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000065\n",
      "\n",
      "Batch 20 vs Batch 28:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000083\n",
      "\n",
      "Batch 20 vs Batch 29:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000079\n",
      "\n",
      "Batch 20 vs Batch 30:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000108\n",
      "\n",
      "Batch 20 vs Batch 31:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000057\n",
      "\n",
      "Batch 20 vs Batch 32:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000075\n",
      "\n",
      "Batch 20 vs Batch 33:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000092\n",
      "\n",
      "Batch 20 vs Batch 34:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000061\n",
      "\n",
      "Batch 20 vs Batch 35:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000068\n",
      "\n",
      "Batch 20 vs Batch 36:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000065\n",
      "\n",
      "Batch 20 vs Batch 37:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000092\n",
      "\n",
      "Batch 20 vs Batch 38:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000058\n",
      "\n",
      "Batch 20 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000085\n",
      "\n",
      "Batch 21 vs Batch 22:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000074\n",
      "\n",
      "Batch 21 vs Batch 23:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000071\n",
      "\n",
      "Batch 21 vs Batch 24:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000102\n",
      "\n",
      "Batch 21 vs Batch 25:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000093\n",
      "\n",
      "Batch 21 vs Batch 26:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000071\n",
      "\n",
      "Batch 21 vs Batch 27:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000068\n",
      "\n",
      "Batch 21 vs Batch 28:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000082\n",
      "\n",
      "Batch 21 vs Batch 29:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000084\n",
      "\n",
      "Batch 21 vs Batch 30:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000076\n",
      "\n",
      "Batch 21 vs Batch 31:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000092\n",
      "\n",
      "Batch 21 vs Batch 32:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000067\n",
      "\n",
      "Batch 21 vs Batch 33:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000081\n",
      "\n",
      "Batch 21 vs Batch 34:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000067\n",
      "\n",
      "Batch 21 vs Batch 35:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000074\n",
      "\n",
      "Batch 21 vs Batch 36:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000077\n",
      "\n",
      "Batch 21 vs Batch 37:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000050\n",
      "\n",
      "Batch 21 vs Batch 38:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000074\n",
      "\n",
      "Batch 21 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000069\n",
      "\n",
      "Batch 22 vs Batch 23:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000069\n",
      "\n",
      "Batch 22 vs Batch 24:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000063\n",
      "\n",
      "Batch 22 vs Batch 25:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000048\n",
      "\n",
      "Batch 22 vs Batch 26:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000068\n",
      "\n",
      "Batch 22 vs Batch 27:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000064\n",
      "\n",
      "Batch 22 vs Batch 28:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000065\n",
      "\n",
      "Batch 22 vs Batch 29:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000073\n",
      "\n",
      "Batch 22 vs Batch 30:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000105\n",
      "\n",
      "Batch 22 vs Batch 31:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000055\n",
      "\n",
      "Batch 22 vs Batch 32:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000057\n",
      "\n",
      "Batch 22 vs Batch 33:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000109\n",
      "\n",
      "Batch 22 vs Batch 34:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000057\n",
      "\n",
      "Batch 22 vs Batch 35:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000059\n",
      "\n",
      "Batch 22 vs Batch 36:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000062\n",
      "\n",
      "Batch 22 vs Batch 37:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000049\n",
      "\n",
      "Batch 22 vs Batch 38:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000052\n",
      "\n",
      "Batch 22 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000055\n",
      "\n",
      "Batch 23 vs Batch 24:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000063\n",
      "\n",
      "Batch 23 vs Batch 25:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000063\n",
      "\n",
      "Batch 23 vs Batch 26:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000084\n",
      "\n",
      "Batch 23 vs Batch 27:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000081\n",
      "\n",
      "Batch 23 vs Batch 28:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000087\n",
      "\n",
      "Batch 23 vs Batch 29:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000105\n",
      "\n",
      "Batch 23 vs Batch 30:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000084\n",
      "\n",
      "Batch 23 vs Batch 31:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000058\n",
      "\n",
      "Batch 23 vs Batch 32:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000050\n",
      "\n",
      "Batch 23 vs Batch 33:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000077\n",
      "\n",
      "Batch 23 vs Batch 34:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000055\n",
      "\n",
      "Batch 23 vs Batch 35:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000090\n",
      "\n",
      "Batch 23 vs Batch 36:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000087\n",
      "\n",
      "Batch 23 vs Batch 37:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000050\n",
      "\n",
      "Batch 23 vs Batch 38:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000052\n",
      "\n",
      "Batch 23 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000072\n",
      "\n",
      "Batch 24 vs Batch 25:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000080\n",
      "\n",
      "Batch 24 vs Batch 26:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000073\n",
      "\n",
      "Batch 24 vs Batch 27:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000095\n",
      "\n",
      "Batch 24 vs Batch 28:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000081\n",
      "\n",
      "Batch 24 vs Batch 29:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000072\n",
      "\n",
      "Batch 24 vs Batch 30:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000122\n",
      "\n",
      "Batch 24 vs Batch 31:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000070\n",
      "\n",
      "Batch 24 vs Batch 32:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000093\n",
      "\n",
      "Batch 24 vs Batch 33:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000086\n",
      "\n",
      "Batch 24 vs Batch 34:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000093\n",
      "\n",
      "Batch 24 vs Batch 35:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000090\n",
      "\n",
      "Batch 24 vs Batch 36:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000079\n",
      "\n",
      "Batch 24 vs Batch 37:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000069\n",
      "\n",
      "Batch 24 vs Batch 38:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000075\n",
      "\n",
      "Batch 24 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000061\n",
      "\n",
      "Batch 25 vs Batch 26:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000072\n",
      "\n",
      "Batch 25 vs Batch 27:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000093\n",
      "\n",
      "Batch 25 vs Batch 28:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000067\n",
      "\n",
      "Batch 25 vs Batch 29:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000067\n",
      "\n",
      "Batch 25 vs Batch 30:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000077\n",
      "\n",
      "Batch 25 vs Batch 31:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000073\n",
      "\n",
      "Batch 25 vs Batch 32:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000068\n",
      "\n",
      "Batch 25 vs Batch 33:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000084\n",
      "\n",
      "Batch 25 vs Batch 34:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000059\n",
      "\n",
      "Batch 25 vs Batch 35:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000062\n",
      "\n",
      "Batch 25 vs Batch 36:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000059\n",
      "\n",
      "Batch 25 vs Batch 37:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000075\n",
      "\n",
      "Batch 25 vs Batch 38:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000069\n",
      "\n",
      "Batch 25 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000069\n",
      "\n",
      "Batch 26 vs Batch 27:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000061\n",
      "\n",
      "Batch 26 vs Batch 28:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000075\n",
      "\n",
      "Batch 26 vs Batch 29:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000066\n",
      "\n",
      "Batch 26 vs Batch 30:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000102\n",
      "\n",
      "Batch 26 vs Batch 31:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000062\n",
      "\n",
      "Batch 26 vs Batch 32:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000070\n",
      "\n",
      "Batch 26 vs Batch 33:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000063\n",
      "\n",
      "Batch 26 vs Batch 34:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000062\n",
      "\n",
      "Batch 26 vs Batch 35:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000071\n",
      "\n",
      "Batch 26 vs Batch 36:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000065\n",
      "\n",
      "Batch 26 vs Batch 37:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000053\n",
      "\n",
      "Batch 26 vs Batch 38:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000054\n",
      "\n",
      "Batch 26 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000062\n",
      "\n",
      "Batch 27 vs Batch 28:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000089\n",
      "\n",
      "Batch 27 vs Batch 29:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000074\n",
      "\n",
      "Batch 27 vs Batch 30:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000051\n",
      "\n",
      "Batch 27 vs Batch 31:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000054\n",
      "\n",
      "Batch 27 vs Batch 32:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000069\n",
      "\n",
      "Batch 27 vs Batch 33:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000115\n",
      "\n",
      "Batch 27 vs Batch 34:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000078\n",
      "\n",
      "Batch 27 vs Batch 35:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000062\n",
      "\n",
      "Batch 27 vs Batch 36:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000061\n",
      "\n",
      "Batch 27 vs Batch 37:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000057\n",
      "\n",
      "Batch 27 vs Batch 38:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000056\n",
      "\n",
      "Batch 27 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000045\n",
      "\n",
      "Batch 28 vs Batch 29:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000079\n",
      "\n",
      "Batch 28 vs Batch 30:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000083\n",
      "\n",
      "Batch 28 vs Batch 31:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000065\n",
      "\n",
      "Batch 28 vs Batch 32:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000062\n",
      "\n",
      "Batch 28 vs Batch 33:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000084\n",
      "\n",
      "Batch 28 vs Batch 34:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000084\n",
      "\n",
      "Batch 28 vs Batch 35:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000055\n",
      "\n",
      "Batch 28 vs Batch 36:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000067\n",
      "\n",
      "Batch 28 vs Batch 37:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000059\n",
      "\n",
      "Batch 28 vs Batch 38:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000067\n",
      "\n",
      "Batch 28 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000055\n",
      "\n",
      "Batch 29 vs Batch 30:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000112\n",
      "\n",
      "Batch 29 vs Batch 31:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000078\n",
      "\n",
      "Batch 29 vs Batch 32:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000079\n",
      "\n",
      "Batch 29 vs Batch 33:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000057\n",
      "\n",
      "Batch 29 vs Batch 34:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000102\n",
      "\n",
      "Batch 29 vs Batch 35:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000072\n",
      "\n",
      "Batch 29 vs Batch 36:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000085\n",
      "\n",
      "Batch 29 vs Batch 37:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000077\n",
      "\n",
      "Batch 29 vs Batch 38:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000062\n",
      "\n",
      "Batch 29 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000053\n",
      "\n",
      "Batch 30 vs Batch 31:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000087\n",
      "\n",
      "Batch 30 vs Batch 32:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000056\n",
      "\n",
      "Batch 30 vs Batch 33:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000157\n",
      "\n",
      "Batch 30 vs Batch 34:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000123\n",
      "\n",
      "Batch 30 vs Batch 35:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000054\n",
      "\n",
      "Batch 30 vs Batch 36:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000062\n",
      "\n",
      "Batch 30 vs Batch 37:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000069\n",
      "\n",
      "Batch 30 vs Batch 38:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000100\n",
      "\n",
      "Batch 30 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000063\n",
      "\n",
      "Batch 31 vs Batch 32:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000086\n",
      "\n",
      "Batch 31 vs Batch 33:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000080\n",
      "\n",
      "Batch 31 vs Batch 34:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000092\n",
      "\n",
      "Batch 31 vs Batch 35:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000080\n",
      "\n",
      "Batch 31 vs Batch 36:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000075\n",
      "\n",
      "Batch 31 vs Batch 37:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000073\n",
      "\n",
      "Batch 31 vs Batch 38:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000068\n",
      "\n",
      "Batch 31 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000067\n",
      "\n",
      "Batch 32 vs Batch 33:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000108\n",
      "\n",
      "Batch 32 vs Batch 34:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000074\n",
      "\n",
      "Batch 32 vs Batch 35:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000079\n",
      "\n",
      "Batch 32 vs Batch 36:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000074\n",
      "\n",
      "Batch 32 vs Batch 37:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000040\n",
      "\n",
      "Batch 32 vs Batch 38:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000057\n",
      "\n",
      "Batch 32 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000069\n",
      "\n",
      "Batch 33 vs Batch 34:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000074\n",
      "\n",
      "Batch 33 vs Batch 35:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000102\n",
      "\n",
      "Batch 33 vs Batch 36:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000127\n",
      "\n",
      "Batch 33 vs Batch 37:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000090\n",
      "\n",
      "Batch 33 vs Batch 38:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000089\n",
      "\n",
      "Batch 33 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000094\n",
      "\n",
      "Batch 34 vs Batch 35:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000087\n",
      "\n",
      "Batch 34 vs Batch 36:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000080\n",
      "\n",
      "Batch 34 vs Batch 37:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000059\n",
      "\n",
      "Batch 34 vs Batch 38:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000067\n",
      "\n",
      "Batch 34 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000003\n",
      "Maximum absolute difference: 0.000069\n",
      "\n",
      "Batch 35 vs Batch 36:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000075\n",
      "\n",
      "Batch 35 vs Batch 37:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000062\n",
      "\n",
      "Batch 35 vs Batch 38:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000062\n",
      "\n",
      "Batch 35 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000043\n",
      "\n",
      "Batch 36 vs Batch 37:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000063\n",
      "\n",
      "Batch 36 vs Batch 38:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000057\n",
      "\n",
      "Batch 36 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000051\n",
      "\n",
      "Batch 37 vs Batch 38:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000044\n",
      "\n",
      "Batch 37 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000051\n",
      "\n",
      "Batch 38 vs Batch 39:\n",
      "Correlation: 1.000000\n",
      "Mean absolute difference: 0.000002\n",
      "Maximum absolute difference: 0.000051\n",
      "\n",
      "Phi values are very similar across batches (mean absolute difference < 0.01)\n",
      "Safe to use average or first batch phi values for analysis\n"
     ]
    }
   ],
   "source": [
    "import os\n",
    "import glob\n",
    "import numpy as np\n",
    "import torch\n",
    "from scipy.special import softmax, expit\n",
    "\n",
    "# Initialize storage for phi values\n",
    "all_phi_values = []\n",
    "disease_names = None\n",
    "\n",
    "print(\"Starting processing...\")\n",
    "\n",
    "# First pass: collect all phi values\n",
    "for dir_path in output_dirs:\n",
    "    model_path = os.path.join(dir_path, 'model.pt')\n",
    "    try:\n",
    "        print(f\"\\nLoading data from {dir_path}\")\n",
    "        \n",
    "        checkpoint = torch.load(model_path)\n",
    "        \n",
    "        # Extract and convert phi values\n",
    "        if 'model_state_dict' in checkpoint:\n",
    "            phi_values = checkpoint['model_state_dict']['phi']\n",
    "        else:\n",
    "            phi_values = checkpoint['phi']\n",
    "            \n",
    "        if torch.is_tensor(phi_values):\n",
    "            phi_values = phi_values.detach().cpu().numpy()\n",
    "            \n",
    "        # Store disease names from first batch\n",
    "        if disease_names is None:\n",
    "            disease_names = checkpoint['disease_names']\n",
    "            \n",
    "        # Append to list\n",
    "        all_phi_values.append(phi_values)\n",
    "        \n",
    "    except Exception as e:\n",
    "        print(f\"Error processing {dir_path}: {str(e)}\")\n",
    "        continue\n",
    "\n",
    "# Compare phi values across batches\n",
    "if len(all_phi_values) > 1:\n",
    "    print(\"\\nComparing phi values across batches...\")\n",
    "    \n",
    "    # Calculate pairwise correlations and differences\n",
    "    n_batches = len(all_phi_values)\n",
    "    for i in range(n_batches):\n",
    "        for j in range(i+1, n_batches):\n",
    "            # Correlation\n",
    "            corr = np.corrcoef(all_phi_values[i].flatten(), all_phi_values[j].flatten())[0,1]\n",
    "            \n",
    "            # Mean absolute difference\n",
    "            mad = np.mean(np.abs(all_phi_values[i] - all_phi_values[j]))\n",
    "            \n",
    "            # Maximum absolute difference\n",
    "            max_diff = np.max(np.abs(all_phi_values[i] - all_phi_values[j]))\n",
    "            \n",
    "            print(f\"\\nBatch {i} vs Batch {j}:\")\n",
    "            print(f\"Correlation: {corr:.6f}\")\n",
    "            print(f\"Mean absolute difference: {mad:.6f}\")\n",
    "            print(f\"Maximum absolute difference: {max_diff:.6f}\")\n",
    "            \n",
    "            # If differences are large, show where they occur\n",
    "            if max_diff > 0.1:  # threshold for \"significant\" difference\n",
    "                large_diffs = np.where(np.abs(all_phi_values[i] - all_phi_values[j]) > 0.1)\n",
    "                print(\"\\nLargest differences occur at:\")\n",
    "                for idx in zip(*large_diffs):\n",
    "                    print(f\"Trajectory {idx[0]}, Disease {disease_names[idx[1]]}, Time {idx[2]}\")\n",
    "                    print(f\"Batch {i} value: {all_phi_values[i][idx]:.3f}\")\n",
    "                    print(f\"Batch {j} value: {all_phi_values[j][idx]:.3f}\")\n",
    "    \n",
    "    # If they're very similar, we can use the average\n",
    "    if all(np.mean(np.abs(all_phi_values[0] - phi)) < 0.01 for phi in all_phi_values[1:]):\n",
    "        print(\"\\nPhi values are very similar across batches (mean absolute difference < 0.01)\")\n",
    "        print(\"Safe to use average or first batch phi values for analysis\")\n",
    "    else:\n",
    "        print(\"\\nWarning: Notable differences in phi values across batches\")\n",
    "        \n",
    "else:\n",
    "    print(\"Need at least two batches to compare!\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Starting processing...\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_0_10000_20241225_062028\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_100000_110000_20241225_225116\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/2f/nxrbr3pn1msgrl4ffyj33zd00000gn/T/ipykernel_6481/3653514571.py:21: FutureWarning: You are using `torch.load` with `weights_only=False` (the current default value), which uses the default pickle module implicitly. It is possible to construct malicious pickle data which will execute arbitrary code during unpickling (See https://github.com/pytorch/pytorch/blob/main/SECURITY.md#untrusted-models for more details). In a future release, the default value for `weights_only` will be flipped to `True`. This limits the functions that could be executed during unpickling. Arbitrary objects will no longer be allowed to be loaded via this mode unless they are explicitly allowlisted by the user via `torch.serialization.add_safe_globals`. We recommend you start setting `weights_only=True` for any use case where you don't have full control of the loaded file. Please open an issue on GitHub for any issues related to this experimental feature.\n",
      "  checkpoint = torch.load(model_path)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_10000_20000_20241225_062028\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_110000_120000_20241225_225127\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_120000_130000_20241226_020120\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_130000_140000_20241226_020134\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_140000_150000_20241226_051212\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_150000_160000_20241226_051223\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_160000_170000_20241226_082535\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_170000_180000_20241226_082558\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_180000_190000_20241226_113728\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_190000_200000_20241226_113741\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_200000_210000_20241225_064324\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_20000_30000_20241225_093441\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_210000_220000_20241225_064324\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_220000_230000_20241225_094650\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_230000_240000_20241225_094700\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_240000_250000_20241225_125056\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_250000_260000_20241225_125114\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_260000_270000_20241225_155547\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_270000_280000_20241225_155604\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_280000_290000_20241225_190119\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_290000_300000_20241225_190127\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_300000_310000_20241225_220551\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_30000_40000_20241225_093452\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_310000_320000_20241225_220601\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_320000_330000_20241226_010910\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_330000_340000_20241226_011037\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_340000_350000_20241226_041424\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_350000_360000_20241226_041550\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_360000_370000_20241226_071910\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_370000_380000_20241226_072111\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_380000_390000_20241226_102351\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_390000_400000_20241226_102603\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_40000_50000_20241225_124544\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_50000_60000_20241225_124613\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_60000_70000_20241225_155446\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_70000_80000_20241225_155500\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_80000_90000_20241225_193439\n",
      "\n",
      "Loading data from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_90000_100000_20241225_193459\n",
      "\n",
      "Data loading complete!\n",
      "Total samples: 400000\n",
      "Number of trajectories: 20\n",
      "Number of timepoints: 52\n",
      "Number of diseases: 348\n"
     ]
    }
   ],
   "source": [
    "import os\n",
    "import glob\n",
    "import numpy as np\n",
    "import torch\n",
    "from scipy.special import softmax, expit\n",
    "\n",
    "# Initialize storage for combined data\n",
    "all_lambda_values = []\n",
    "all_Y_values = []\n",
    "phi_values = None\n",
    "disease_names = None\n",
    "\n",
    "print(\"Starting processing...\")\n",
    "\n",
    "# Load and combine data\n",
    "for dir_path in output_dirs:\n",
    "    model_path = os.path.join(dir_path, 'model.pt')\n",
    "    try:\n",
    "        print(f\"\\nLoading data from {dir_path}\")\n",
    "        \n",
    "        checkpoint = torch.load(model_path)\n",
    "        \n",
    "        # Extract lambda values and Y\n",
    "        if 'model_state_dict' in checkpoint:\n",
    "            lambda_values = checkpoint['model_state_dict']['lambda_']\n",
    "            # Only get phi from first batch\n",
    "            if phi_values is None:\n",
    "                phi_values = checkpoint['model_state_dict']['phi']\n",
    "        else:\n",
    "            lambda_values = checkpoint['lambda_']\n",
    "            if phi_values is None:\n",
    "                phi_values = checkpoint['phi']\n",
    "            \n",
    "        # Convert to numpy if needed\n",
    "        if torch.is_tensor(lambda_values):\n",
    "            lambda_values = lambda_values.detach().cpu().numpy()\n",
    "        if torch.is_tensor(phi_values):\n",
    "            phi_values = phi_values.detach().cpu().numpy()\n",
    "            \n",
    "        Y_batch = checkpoint['Y']\n",
    "        if torch.is_tensor(Y_batch):\n",
    "            Y_batch = Y_batch.detach().cpu().numpy()\n",
    "        \n",
    "        # Store disease names from first batch\n",
    "        if disease_names is None:\n",
    "            disease_names = checkpoint['disease_names']\n",
    "            \n",
    "        # Append to lists\n",
    "        all_lambda_values.append(lambda_values)\n",
    "        all_Y_values.append(Y_batch)\n",
    "        \n",
    "    except Exception as e:\n",
    "        print(f\"Error processing {dir_path}: {str(e)}\")\n",
    "        continue\n",
    "\n",
    "# Combine all data\n",
    "if all_lambda_values:\n",
    "    combined_lambda = np.concatenate(all_lambda_values, axis=0)\n",
    "    combined_Y = np.concatenate(all_Y_values, axis=0)\n",
    "    \n",
    "    print(\"\\nData loading complete!\")\n",
    "    print(f\"Total samples: {combined_lambda.shape[0]}\")\n",
    "    print(f\"Number of trajectories: {combined_lambda.shape[1]}\")\n",
    "    print(f\"Number of timepoints: {combined_lambda.shape[2]}\")\n",
    "    print(f\"Number of diseases: {len(disease_names)}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Distribution of dominant signatures at CAD diagnosis:\n",
      "\n",
      "Signature 5: 3336 patients (7.8%)\n",
      "Top diseases in this signature:\n",
      "  Coronary atherosclerosis: 1.595\n",
      "  Other chronic ischemic heart disease, unspecified: 1.550\n",
      "  Myocardial infarction: 1.378\n",
      "  Hypercholesterolemia: 1.185\n",
      "  Other acute and subacute forms of ischemic heart disease: 0.864\n",
      "\n",
      "Signature 15: 2281 patients (5.3%)\n",
      "Top diseases in this signature:\n",
      "  Hypoglycemia: 1.240\n",
      "  Type 2 diabetes with ophthalmic manifestations: 1.108\n",
      "  Type 2 diabetes: 0.983\n",
      "  Back pain: 0.342\n",
      "  Retinal detachments and defects: 0.009\n",
      "\n",
      "Signature 16: 2195 patients (5.1%)\n",
      "Top diseases in this signature:\n",
      "  Staphylococcus infections: 1.687\n",
      "  Other local infections of skin and subcutaneous tissue: 1.663\n",
      "  Hyposmolality and/or hyponatremia: 1.597\n",
      "  E. coli: 1.560\n",
      "  Thrombocytopenia: 1.504\n",
      "\n",
      "Signature 7: 2167 patients (5.1%)\n",
      "Top diseases in this signature:\n",
      "  Other disorders of bone and cartilage: 2.792\n",
      "  Asthma: 2.307\n",
      "  Cervicalgia: 2.054\n",
      "  Sleep apnea: 1.925\n",
      "  Hyperlipidemia: 1.748\n",
      "\n",
      "Signature 10: 2159 patients (5.0%)\n",
      "Top diseases in this signature:\n",
      "  Senile cataract: 2.722\n",
      "  Retinal detachments and defects: 2.291\n",
      "  Other retinal disorders: 2.281\n",
      "  Retinal vascular changes and abnomalities: 1.591\n",
      "  Macular degeneration (senile) of retina NOS: 1.102\n",
      "\n",
      "Signature 0: 2142 patients (5.0%)\n",
      "Top diseases in this signature:\n",
      "  Paroxysmal ventricular tachycardia: 2.679\n",
      "  Left bundle branch block: 1.833\n",
      "  Pericarditis: 1.770\n",
      "  Aortic valve disease: 1.746\n",
      "  Heart failure NOS: 1.595\n",
      "\n",
      "Signature 11: 2128 patients (5.0%)\n",
      "Top diseases in this signature:\n",
      "  Hemiplegia: 3.584\n",
      "  Cerebral artery occlusion, with cerebral infarction: 1.689\n",
      "  Occlusion and stenosis of precerebral arteries: 1.478\n",
      "  Occlusion of cerebral arteries: 0.772\n",
      "  Transient cerebral ischemia: 0.634\n",
      "\n",
      "Signature 19: 2087 patients (4.9%)\n",
      "Top diseases in this signature:\n",
      "  Thyrotoxicosis with or without goiter: 1.977\n",
      "  Chronic glomerulonephritis, NOS: 1.837\n",
      "  Chronic renal failure [CKD]: 1.763\n",
      "  Renal failure NOS: 1.746\n",
      "  Viral warts & HPV: 1.732\n",
      "\n",
      "Signature 12: 2083 patients (4.9%)\n",
      "Top diseases in this signature:\n",
      "  Calculus of kidney: 2.454\n",
      "  Other disorders of the kidney and ureters: 1.813\n",
      "  Renal colic: 1.548\n",
      "  Calculus of ureter: 1.355\n",
      "  Stricture/obstruction of ureter: 1.166\n",
      "\n",
      "Signature 17: 2074 patients (4.8%)\n",
      "Top diseases in this signature:\n",
      "  Gastrointestinal complications: 2.395\n",
      "  Diverticulosis: 1.931\n",
      "  Benign neoplasm of colon: 1.702\n",
      "  Anal and rectal conditions: 1.626\n",
      "  Malignant neoplasm of rectum, rectosigmoid junction, and anus: 1.424\n",
      "\n",
      "Signature 6: 2050 patients (4.8%)\n",
      "Top diseases in this signature:\n",
      "  Secondary malignancy of bone: 1.751\n",
      "  Secondary malignant neoplasm of digestive systems: 1.345\n",
      "  Cancer of bronchus; lung: 1.293\n",
      "  Secondary malignancy of lymph nodes: 0.729\n",
      "  Malignant neoplasm, other: 0.385\n",
      "\n",
      "Signature 18: 2037 patients (4.8%)\n",
      "Top diseases in this signature:\n",
      "  Cholelithiasis with acute cholecystitis: 2.370\n",
      "  Peritoneal adhesions (postoperative) (postinfection): 2.001\n",
      "  Acute pancreatitis: 1.679\n",
      "  Cholecystitis without cholelithiasis: 1.504\n",
      "  Cholelithiasis with other cholecystitis: 1.363\n",
      "\n",
      "Signature 14: 2031 patients (4.7%)\n",
      "Top diseases in this signature:\n",
      "  Bronchiectasis: 2.060\n",
      "  Chronic airway obstruction: 1.970\n",
      "  Pneumococcal pneumonia: 1.682\n",
      "  Respiratory failure: 1.670\n",
      "  Obstructive chronic bronchitis: 1.396\n",
      "\n",
      "Signature 4: 2031 patients (4.7%)\n",
      "Top diseases in this signature:\n",
      "  Nasal polyps: 0.895\n",
      "  Other upper respiratory disease: 0.738\n",
      "  Chronic sinusitis: 0.362\n",
      "  Septal Deviations/Turbinate Hypertrophy: 0.281\n",
      "  Chronic pharyngitis and nasopharyngitis: 0.200\n",
      "\n",
      "Signature 8: 2030 patients (4.7%)\n",
      "Top diseases in this signature:\n",
      "  Malignant neoplasm of uterus: 2.872\n",
      "  Uterine leiomyoma: 2.460\n",
      "  Cervicitis and endocervicitis: 1.833\n",
      "  Uterine/Uterovaginal prolapse: 1.715\n",
      "  Pain and other symptoms associated with female genital organs: 1.669\n",
      "\n",
      "Signature 9: 2030 patients (4.7%)\n",
      "Top diseases in this signature:\n",
      "  Displacement of intervertebral disc: 1.951\n",
      "  Spinal stenosis: 1.718\n",
      "  Back pain: 1.459\n",
      "  Spondylosis without myelopathy: 1.357\n",
      "  Thoracic or lumbosacral neuritis or radiculitis, unspecified: 1.244\n",
      "\n",
      "Signature 3: 2022 patients (4.7%)\n",
      "Top diseases in this signature:\n",
      "  Stricture of artery: 2.983\n",
      "  Alcoholic liver damage: 2.629\n",
      "  Atopic/contact dermatitis due to other or unspecified: 2.593\n",
      "  Multiple sclerosis: 2.425\n",
      "  Benign neoplasm of lip, oral cavity, and pharynx: 2.399\n",
      "\n",
      "Signature 13: 2012 patients (4.7%)\n",
      "Top diseases in this signature:\n",
      "  Other symptoms/disorders or the urinary system: 1.968\n",
      "  Hyperplasia of prostate: 1.914\n",
      "  Cancer of prostate: 1.694\n",
      "  Chronic cystitis: 1.671\n",
      "  Urinary incontinence: 1.643\n",
      "\n",
      "Signature 1: 1972 patients (4.6%)\n",
      "Top diseases in this signature:\n",
      "  Acquired toe deformities: 2.335\n",
      "  Rheumatoid arthritis: 2.318\n",
      "  Other peripheral nerve disorders: 2.113\n",
      "  Symptoms and disorders of the joints: 2.091\n",
      "  Osteoarthritis; localized: 1.736\n",
      "\n",
      "Signature 2: 1910 patients (4.5%)\n",
      "Top diseases in this signature:\n",
      "  Gastritis and duodenitis: 2.279\n",
      "  Iron deficiency anemias, unspecified or not due to blood loss: 1.123\n",
      "  Duodenitis: 0.726\n",
      "  Duodenal ulcer: 0.637\n",
      "  Benign neoplasm of other parts of digestive system: 0.563\n"
     ]
    }
   ],
   "source": [
    "# For each CAD patient, get their dominant signature at time of diagnosis\n",
    "dominant_sigs = []\n",
    "max_thetas = []\n",
    "\n",
    "for patient in np.where(cad_mask)[0]:\n",
    "    # Find first CAD occurrence\n",
    "    for cad_idx in cad_indices:\n",
    "        if np.any(combined_Y[patient, cad_idx, :]):\n",
    "            cad_time = np.argmax(combined_Y[patient, cad_idx, :])\n",
    "            # Get dominant signature at that time\n",
    "            dom_sig = np.argmax(thetas[patient, :, cad_time])\n",
    "            max_theta = np.max(thetas[patient, :, cad_time])\n",
    "            dominant_sigs.append(dom_sig)\n",
    "            max_thetas.append(max_theta)\n",
    "            break\n",
    "\n",
    "# Count frequency of each signature\n",
    "from collections import Counter\n",
    "sig_counts = Counter(dominant_sigs)\n",
    "\n",
    "print(\"Distribution of dominant signatures at CAD diagnosis:\")\n",
    "total = len(dominant_sigs)\n",
    "for sig, count in sig_counts.most_common():\n",
    "    print(f\"\\nSignature {sig}: {count} patients ({count/total*100:.1f}%)\")\n",
    "    print(\"Top diseases in this signature:\")\n",
    "    top_diseases = np.argsort(phi_avg[sig])[-5:]\n",
    "    for idx in reversed(top_diseases):\n",
    "        print(f\"  {disease_names[idx]}: {phi_avg[sig, idx]:.3f}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Analyzing 20 trajectories:\n",
      "\n",
      "Trajectory 0:\n",
      "Population size: 191 (0.0%)\n",
      "CAD risk: 0.037\n",
      "\n",
      "Characteristic diseases at time_x:\n",
      "  Abdominal pain: -4.541\n",
      "  Atrial fibrillation and flutter: -5.066\n",
      "  Paroxysmal ventricular tachycardia: -5.438\n",
      "  Pleurisy; pleural effusion: -5.733\n",
      "  Pericarditis: -6.094\n",
      "\n",
      "Major transitions (>5%):\n",
      "  To trajectory 0: 0.864\n",
      "  To trajectory 13: 0.115\n",
      "    Top diseases in destination trajectory:\n",
      "    Hyperplasia of prostate: -4.120\n",
      "    Other disorders of bladder: -4.950\n",
      "    Cancer of prostate: -5.355\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.541\n",
      "  Time 31: 0.538\n",
      "  Time 32: 0.530\n",
      "  Time 33: 0.517\n",
      "  Time 34: 0.501\n",
      "  Time 35: 0.482\n",
      "  Time 36: 0.460\n",
      "  Time 37: 0.435\n",
      "  Time 38: 0.410\n",
      "  Time 39: 0.383\n",
      "\n",
      "Trajectory 1:\n",
      "Population size: 243 (0.1%)\n",
      "CAD risk: 0.041\n",
      "\n",
      "Characteristic diseases at time_x:\n",
      "  Other peripheral nerve disorders: -4.182\n",
      "  Internal derangement of knee: -4.417\n",
      "  Osteoarthritis; localized: -4.600\n",
      "  Arthropathy NOS: -4.652\n",
      "  Rheumatoid arthritis: -5.069\n",
      "\n",
      "Major transitions (>5%):\n",
      "  To trajectory 1: 0.914\n",
      "  To trajectory 19: 0.053\n",
      "    Top diseases in destination trajectory:\n",
      "    Thyrotoxicosis with or without goiter: -4.603\n",
      "    Other non-epithelial cancer of skin: -4.969\n",
      "    Arthropathy NOS: -5.494\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.545\n",
      "  Time 31: 0.541\n",
      "  Time 32: 0.532\n",
      "  Time 33: 0.519\n",
      "  Time 34: 0.500\n",
      "  Time 35: 0.477\n",
      "  Time 36: 0.451\n",
      "  Time 37: 0.421\n",
      "  Time 38: 0.388\n",
      "  Time 39: 0.354\n",
      "\n",
      "Trajectory 2:\n",
      "Population size: 82 (0.0%)\n",
      "CAD risk: 0.024\n",
      "\n",
      "Characteristic diseases at time_x:\n",
      "  Gastritis and duodenitis: -3.499\n",
      "  Diaphragmatic hernia: -5.325\n",
      "  Other chronic ischemic heart disease, unspecified: -5.327\n",
      "  Arthropathy NOS: -5.387\n",
      "  Major depressive disorder: -5.440\n",
      "\n",
      "Major transitions (>5%):\n",
      "  To trajectory 2: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.714\n",
      "  Time 31: 0.723\n",
      "  Time 32: 0.726\n",
      "  Time 33: 0.724\n",
      "  Time 34: 0.715\n",
      "  Time 35: 0.700\n",
      "  Time 36: 0.678\n",
      "  Time 37: 0.650\n",
      "  Time 38: 0.616\n",
      "  Time 39: 0.576\n",
      "\n",
      "Trajectory 3:\n",
      "Population size: 249 (0.1%)\n",
      "CAD risk: 0.028\n",
      "\n",
      "Characteristic diseases at time_x:\n",
      "  Atopic/contact dermatitis due to other or unspecified: -4.598\n",
      "  Viral infection: -5.020\n",
      "  Multiple sclerosis: -5.077\n",
      "  Phlebitis and thrombophlebitis of lower extremities: -5.220\n",
      "  Right bundle branch block: -5.538\n",
      "\n",
      "Major transitions (>5%):\n",
      "  To trajectory 3: 0.904\n",
      "  To trajectory 5: 0.072\n",
      "    Top diseases in destination trajectory:\n",
      "    Hypercholesterolemia: -3.747\n",
      "    Coronary atherosclerosis: -4.299\n",
      "    Other chronic ischemic heart disease, unspecified: -4.464\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.562\n",
      "  Time 31: 0.564\n",
      "  Time 32: 0.561\n",
      "  Time 33: 0.554\n",
      "  Time 34: 0.543\n",
      "  Time 35: 0.528\n",
      "  Time 36: 0.510\n",
      "  Time 37: 0.488\n",
      "  Time 38: 0.463\n",
      "  Time 39: 0.435\n",
      "\n",
      "Trajectory 4:\n",
      "Population size: 226 (0.1%)\n",
      "CAD risk: 0.009\n",
      "\n",
      "Characteristic diseases at time_x:\n",
      "  Hypercholesterolemia: -5.968\n",
      "  Obesity: -6.210\n",
      "  Diverticulosis: -6.225\n",
      "  Cataract: -6.653\n",
      "  Other upper respiratory disease: -6.669\n",
      "\n",
      "Major transitions (>5%):\n",
      "  To trajectory 2: 0.115\n",
      "    Top diseases in destination trajectory:\n",
      "    Gastritis and duodenitis: -2.985\n",
      "    Other chronic ischemic heart disease, unspecified: -4.362\n",
      "    Iron deficiency anemias, unspecified or not due to blood loss: -4.569\n",
      "  To trajectory 4: 0.757\n",
      "  To trajectory 7: 0.124\n",
      "    Top diseases in destination trajectory:\n",
      "    Asthma: -2.789\n",
      "    Other disorders of bone and cartilage: -3.238\n",
      "    Essential hypertension: -3.694\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.559\n",
      "  Time 31: 0.544\n",
      "  Time 32: 0.523\n",
      "  Time 33: 0.498\n",
      "  Time 34: 0.468\n",
      "  Time 35: 0.436\n",
      "  Time 36: 0.403\n",
      "  Time 37: 0.369\n",
      "  Time 38: 0.337\n",
      "  Time 39: 0.305\n",
      "\n",
      "Trajectory 5:\n",
      "Population size: 322 (0.1%)\n",
      "CAD risk: 0.078\n",
      "\n",
      "Characteristic diseases at time_x:\n",
      "  Hypercholesterolemia: -3.961\n",
      "  Coronary atherosclerosis: -4.044\n",
      "  Other chronic ischemic heart disease, unspecified: -4.314\n",
      "  Myocardial infarction: -4.883\n",
      "  Essential hypertension: -5.813\n",
      "\n",
      "Major transitions (>5%):\n",
      "  To trajectory 5: 0.938\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.558\n",
      "  Time 31: 0.558\n",
      "  Time 32: 0.554\n",
      "  Time 33: 0.545\n",
      "  Time 34: 0.533\n",
      "  Time 35: 0.518\n",
      "  Time 36: 0.500\n",
      "  Time 37: 0.480\n",
      "  Time 38: 0.459\n",
      "  Time 39: 0.436\n",
      "\n",
      "Trajectory 6:\n",
      "Population size: 180 (0.0%)\n",
      "CAD risk: 0.050\n",
      "\n",
      "Characteristic diseases at time_x:\n",
      "  Duodenitis: -6.221\n",
      "  Arthropathy NOS: -6.245\n",
      "  Secondary malignancy of lymph nodes: -6.437\n",
      "  Cancer of bronchus; lung: -6.512\n",
      "  Type 2 diabetes: -6.878\n",
      "\n",
      "Major transitions (>5%):\n",
      "  To trajectory 6: 0.922\n",
      "  To trajectory 7: 0.078\n",
      "    Top diseases in destination trajectory:\n",
      "    Asthma: -2.789\n",
      "    Other disorders of bone and cartilage: -3.238\n",
      "    Essential hypertension: -3.694\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.578\n",
      "  Time 31: 0.579\n",
      "  Time 32: 0.574\n",
      "  Time 33: 0.563\n",
      "  Time 34: 0.546\n",
      "  Time 35: 0.523\n",
      "  Time 36: 0.494\n",
      "  Time 37: 0.459\n",
      "  Time 38: 0.419\n",
      "  Time 39: 0.376\n",
      "\n",
      "Trajectory 7:\n",
      "Population size: 175 (0.0%)\n",
      "CAD risk: 0.040\n",
      "\n",
      "Characteristic diseases at time_x:\n",
      "  Essential hypertension: -2.986\n",
      "  Asthma: -3.749\n",
      "  Major depressive disorder: -3.769\n",
      "  Other disorders of bone and cartilage: -4.214\n",
      "  Obesity: -4.305\n",
      "\n",
      "Major transitions (>5%):\n",
      "  To trajectory 5: 0.091\n",
      "    Top diseases in destination trajectory:\n",
      "    Hypercholesterolemia: -3.747\n",
      "    Coronary atherosclerosis: -4.299\n",
      "    Other chronic ischemic heart disease, unspecified: -4.464\n",
      "  To trajectory 7: 0.869\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.534\n",
      "  Time 31: 0.535\n",
      "  Time 32: 0.530\n",
      "  Time 33: 0.519\n",
      "  Time 34: 0.501\n",
      "  Time 35: 0.479\n",
      "  Time 36: 0.452\n",
      "  Time 37: 0.422\n",
      "  Time 38: 0.389\n",
      "  Time 39: 0.355\n",
      "\n",
      "Trajectory 8:\n",
      "Population size: 239 (0.1%)\n",
      "CAD risk: 0.029\n",
      "\n",
      "Characteristic diseases at time_x:\n",
      "  Uterine leiomyoma: -4.155\n",
      "  Postmenopausal bleeding: -5.120\n",
      "  Uterine/Uterovaginal prolapse: -5.123\n",
      "  Essential hypertension: -5.370\n",
      "  Malignant neoplasm of uterus: -5.583\n",
      "\n",
      "Major transitions (>5%):\n",
      "  To trajectory 8: 0.841\n",
      "  To trajectory 16: 0.059\n",
      "    Top diseases in destination trajectory:\n",
      "    Urinary tract infection: -4.331\n",
      "    Constipation: -4.799\n",
      "    Other anemias: -4.969\n",
      "  To trajectory 19: 0.100\n",
      "    Top diseases in destination trajectory:\n",
      "    Thyrotoxicosis with or without goiter: -4.603\n",
      "    Other non-epithelial cancer of skin: -4.969\n",
      "    Arthropathy NOS: -5.494\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.542\n",
      "  Time 31: 0.530\n",
      "  Time 32: 0.514\n",
      "  Time 33: 0.493\n",
      "  Time 34: 0.469\n",
      "  Time 35: 0.441\n",
      "  Time 36: 0.412\n",
      "  Time 37: 0.381\n",
      "  Time 38: 0.349\n",
      "  Time 39: 0.317\n",
      "\n",
      "Trajectory 9:\n",
      "Population size: 242 (0.1%)\n",
      "CAD risk: 0.017\n",
      "\n",
      "Characteristic diseases at time_x:\n",
      "  Spondylosis without myelopathy: -5.053\n",
      "  Essential hypertension: -5.316\n",
      "  Major depressive disorder: -5.346\n",
      "  Atrial fibrillation and flutter: -5.684\n",
      "  Spinal stenosis: -5.700\n",
      "\n",
      "Major transitions (>5%):\n",
      "  To trajectory 9: 0.826\n",
      "  To trajectory 15: 0.161\n",
      "    Top diseases in destination trajectory:\n",
      "    Type 2 diabetes: -5.267\n",
      "    Back pain: -5.411\n",
      "    GERD: -5.942\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.589\n",
      "  Time 31: 0.583\n",
      "  Time 32: 0.573\n",
      "  Time 33: 0.557\n",
      "  Time 34: 0.538\n",
      "  Time 35: 0.514\n",
      "  Time 36: 0.486\n",
      "  Time 37: 0.456\n",
      "  Time 38: 0.423\n",
      "  Time 39: 0.390\n",
      "\n",
      "Trajectory 10:\n",
      "Population size: 181 (0.0%)\n",
      "CAD risk: 0.017\n",
      "\n",
      "Characteristic diseases at time_x:\n",
      "  Senile cataract: -3.485\n",
      "  Hypercholesterolemia: -4.522\n",
      "  Retinal detachments and defects: -5.282\n",
      "  Other chronic ischemic heart disease, unspecified: -5.335\n",
      "  Other retinal disorders: -5.826\n",
      "\n",
      "Major transitions (>5%):\n",
      "  To trajectory 10: 0.768\n",
      "  To trajectory 18: 0.193\n",
      "    Top diseases in destination trajectory:\n",
      "    Cholecystitis without cholelithiasis: -4.732\n",
      "    Diaphragmatic hernia: -5.264\n",
      "    Essential hypertension: -5.369\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.535\n",
      "  Time 31: 0.528\n",
      "  Time 32: 0.514\n",
      "  Time 33: 0.495\n",
      "  Time 34: 0.472\n",
      "  Time 35: 0.446\n",
      "  Time 36: 0.417\n",
      "  Time 37: 0.387\n",
      "  Time 38: 0.356\n",
      "  Time 39: 0.327\n",
      "\n",
      "Trajectory 11:\n",
      "Population size: 154 (0.0%)\n",
      "CAD risk: 0.026\n",
      "\n",
      "Characteristic diseases at time_x:\n",
      "  Hemiplegia: -3.982\n",
      "  Gastritis and duodenitis: -4.728\n",
      "  Urinary tract infection: -5.751\n",
      "  Internal derangement of knee: -6.012\n",
      "  Osteoarthritis; localized: -6.210\n",
      "\n",
      "Major transitions (>5%):\n",
      "  To trajectory 1: 0.247\n",
      "    Top diseases in destination trajectory:\n",
      "    Osteoarthritis; localized: -3.859\n",
      "    Rheumatoid arthritis: -4.057\n",
      "    Arthropathy NOS: -4.678\n",
      "  To trajectory 11: 0.740\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.593\n",
      "  Time 31: 0.594\n",
      "  Time 32: 0.589\n",
      "  Time 33: 0.577\n",
      "  Time 34: 0.558\n",
      "  Time 35: 0.534\n",
      "  Time 36: 0.503\n",
      "  Time 37: 0.467\n",
      "  Time 38: 0.427\n",
      "  Time 39: 0.384\n",
      "\n",
      "Trajectory 12:\n",
      "Population size: 214 (0.1%)\n",
      "CAD risk: 0.023\n",
      "\n",
      "Characteristic diseases at time_x:\n",
      "  Calculus of kidney: -5.493\n",
      "  Hemorrhage of rectum and anus: -5.578\n",
      "  Essential hypertension: -5.679\n",
      "  Calculus of ureter: -5.977\n",
      "  Other anemias: -6.324\n",
      "\n",
      "Major transitions (>5%):\n",
      "  To trajectory 7: 0.187\n",
      "    Top diseases in destination trajectory:\n",
      "    Asthma: -2.789\n",
      "    Other disorders of bone and cartilage: -3.238\n",
      "    Essential hypertension: -3.694\n",
      "  To trajectory 8: 0.159\n",
      "    Top diseases in destination trajectory:\n",
      "    Uterine leiomyoma: -4.507\n",
      "    Essential hypertension: -4.901\n",
      "    Uterine/Uterovaginal prolapse: -6.200\n",
      "  To trajectory 12: 0.626\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.576\n",
      "  Time 31: 0.572\n",
      "  Time 32: 0.562\n",
      "  Time 33: 0.545\n",
      "  Time 34: 0.522\n",
      "  Time 35: 0.495\n",
      "  Time 36: 0.465\n",
      "  Time 37: 0.435\n",
      "  Time 38: 0.404\n",
      "  Time 39: 0.373\n",
      "\n",
      "Trajectory 13:\n",
      "Population size: 268 (0.1%)\n",
      "CAD risk: 0.022\n",
      "\n",
      "Characteristic diseases at time_x:\n",
      "  Hyperplasia of prostate: -4.750\n",
      "  Urinary incontinence: -5.152\n",
      "  Other disorders of bladder: -5.402\n",
      "  Cancer of prostate: -5.450\n",
      "  Diverticulosis: -6.039\n",
      "\n",
      "Major transitions (>5%):\n",
      "  To trajectory 13: 1.000\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.581\n",
      "  Time 31: 0.588\n",
      "  Time 32: 0.591\n",
      "  Time 33: 0.588\n",
      "  Time 34: 0.581\n",
      "  Time 35: 0.569\n",
      "  Time 36: 0.553\n",
      "  Time 37: 0.532\n",
      "  Time 38: 0.507\n",
      "  Time 39: 0.479\n",
      "\n",
      "Trajectory 14:\n",
      "Population size: 312 (0.1%)\n",
      "CAD risk: 0.026\n",
      "\n",
      "Characteristic diseases at time_x:\n",
      "  Tobacco use disorder: -4.709\n",
      "  Chronic airway obstruction: -5.240\n",
      "  Pneumococcal pneumonia: -5.505\n",
      "  Bronchiectasis: -5.574\n",
      "  Obstructive chronic bronchitis: -6.191\n",
      "\n",
      "Major transitions (>5%):\n",
      "  To trajectory 14: 0.869\n",
      "  To trajectory 16: 0.128\n",
      "    Top diseases in destination trajectory:\n",
      "    Urinary tract infection: -4.331\n",
      "    Constipation: -4.799\n",
      "    Other anemias: -4.969\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.567\n",
      "  Time 31: 0.563\n",
      "  Time 32: 0.555\n",
      "  Time 33: 0.543\n",
      "  Time 34: 0.526\n",
      "  Time 35: 0.505\n",
      "  Time 36: 0.482\n",
      "  Time 37: 0.456\n",
      "  Time 38: 0.428\n",
      "  Time 39: 0.398\n",
      "\n",
      "Trajectory 15:\n",
      "Population size: 208 (0.1%)\n",
      "CAD risk: 0.034\n",
      "\n",
      "Characteristic diseases at time_x:\n",
      "  Type 2 diabetes: -4.827\n",
      "  Back pain: -5.676\n",
      "  GERD: -5.988\n",
      "  Arthropathy NOS: -6.223\n",
      "  Anal and rectal conditions: -6.815\n",
      "\n",
      "Major transitions (>5%):\n",
      "  To trajectory 15: 0.942\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.581\n",
      "  Time 31: 0.581\n",
      "  Time 32: 0.576\n",
      "  Time 33: 0.566\n",
      "  Time 34: 0.551\n",
      "  Time 35: 0.532\n",
      "  Time 36: 0.509\n",
      "  Time 37: 0.483\n",
      "  Time 38: 0.453\n",
      "  Time 39: 0.422\n",
      "\n",
      "Trajectory 16:\n",
      "Population size: 188 (0.0%)\n",
      "CAD risk: 0.016\n",
      "\n",
      "Characteristic diseases at time_x:\n",
      "  Urinary tract infection: -4.986\n",
      "  Other anemias: -5.339\n",
      "  Staphylococcus infections: -5.553\n",
      "  Cellulitis and abscess of arm/hand: -5.677\n",
      "  E. coli: -5.776\n",
      "\n",
      "Major transitions (>5%):\n",
      "  To trajectory 14: 0.213\n",
      "    Top diseases in destination trajectory:\n",
      "    Tobacco use disorder: -4.272\n",
      "    Bronchiectasis: -4.858\n",
      "    Chronic airway obstruction: -4.997\n",
      "  To trajectory 16: 0.787\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.533\n",
      "  Time 31: 0.539\n",
      "  Time 32: 0.539\n",
      "  Time 33: 0.535\n",
      "  Time 34: 0.526\n",
      "  Time 35: 0.514\n",
      "  Time 36: 0.498\n",
      "  Time 37: 0.479\n",
      "  Time 38: 0.457\n",
      "  Time 39: 0.434\n",
      "\n",
      "Trajectory 17:\n",
      "Population size: 172 (0.0%)\n",
      "CAD risk: 0.017\n",
      "\n",
      "Characteristic diseases at time_x:\n",
      "  Diverticulosis: -3.053\n",
      "  Benign neoplasm of colon: -3.704\n",
      "  Anal and rectal conditions: -5.128\n",
      "  Noninfectious gastroenteritis: -5.307\n",
      "  Hemorrhage of gastrointestinal tract: -5.602\n",
      "\n",
      "Major transitions (>5%):\n",
      "  To trajectory 8: 0.076\n",
      "    Top diseases in destination trajectory:\n",
      "    Uterine leiomyoma: -4.507\n",
      "    Essential hypertension: -4.901\n",
      "    Uterine/Uterovaginal prolapse: -6.200\n",
      "  To trajectory 17: 0.913\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.565\n",
      "  Time 31: 0.555\n",
      "  Time 32: 0.541\n",
      "  Time 33: 0.524\n",
      "  Time 34: 0.503\n",
      "  Time 35: 0.479\n",
      "  Time 36: 0.452\n",
      "  Time 37: 0.423\n",
      "  Time 38: 0.393\n",
      "  Time 39: 0.363\n",
      "\n",
      "Trajectory 18:\n",
      "Population size: 220 (0.1%)\n",
      "CAD risk: 0.032\n",
      "\n",
      "Characteristic diseases at time_x:\n",
      "  Peritoneal adhesions (postoperative) (postinfection): -4.829\n",
      "  Cholecystitis without cholelithiasis: -5.456\n",
      "  Diaphragmatic hernia: -5.637\n",
      "  Acute pancreatitis: -5.694\n",
      "  Cholelithiasis with acute cholecystitis: -5.952\n",
      "\n",
      "Major transitions (>5%):\n",
      "  To trajectory 8: 0.091\n",
      "    Top diseases in destination trajectory:\n",
      "    Uterine leiomyoma: -4.507\n",
      "    Essential hypertension: -4.901\n",
      "    Uterine/Uterovaginal prolapse: -6.200\n",
      "  To trajectory 18: 0.905\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.562\n",
      "  Time 31: 0.558\n",
      "  Time 32: 0.548\n",
      "  Time 33: 0.533\n",
      "  Time 34: 0.513\n",
      "  Time 35: 0.489\n",
      "  Time 36: 0.462\n",
      "  Time 37: 0.432\n",
      "  Time 38: 0.401\n",
      "  Time 39: 0.370\n",
      "\n",
      "Trajectory 19:\n",
      "Population size: 232 (0.1%)\n",
      "CAD risk: 0.026\n",
      "\n",
      "Characteristic diseases at time_x:\n",
      "  Thyrotoxicosis with or without goiter: -5.634\n",
      "  Arthropathy NOS: -5.638\n",
      "  Essential hypertension: -5.928\n",
      "  Obesity: -5.970\n",
      "  Malignant neoplasm of female breast: -5.971\n",
      "\n",
      "Major transitions (>5%):\n",
      "  To trajectory 19: 0.978\n",
      "\n",
      "Trajectory strength over time:\n",
      "  Time 30: 0.552\n",
      "  Time 31: 0.553\n",
      "  Time 32: 0.547\n",
      "  Time 33: 0.536\n",
      "  Time 34: 0.519\n",
      "  Time 35: 0.498\n",
      "  Time 36: 0.474\n",
      "  Time 37: 0.446\n",
      "  Time 38: 0.416\n",
      "  Time 39: 0.386\n"
     ]
    }
   ],
   "source": [
    "# Calculate thetas (trajectory memberships) from combined lambda\n",
    "thetas = softmax(combined_lambda, axis=1)\n",
    "\n",
    "# Analysis parameters\n",
    "time_x = 30  # Age 60\n",
    "future_window = 10  # Look ahead 2.5 years\n",
    "\n",
    "# Find CAD indices\n",
    "cad_indices = []\n",
    "for condition in ['Coronary atherosclerosis', 'Myocardial infarction']:\n",
    "    try:\n",
    "        idx = disease_names.index(condition)\n",
    "        cad_indices.append(idx)\n",
    "        print(f\"Found {condition} at index: {idx}\")\n",
    "    except ValueError:\n",
    "        print(f\"Warning: {condition} not found in disease names\")\n",
    "\n",
    "# Get CAD status before time_x\n",
    "cad_before_x = np.zeros(combined_Y.shape[0], dtype=bool)\n",
    "for cad_idx in cad_indices:\n",
    "    cad_before_x |= np.any(combined_Y[:, cad_idx, :time_x], axis=1)\n",
    "\n",
    "# Analyze each trajectory\n",
    "n_trajectories = thetas.shape[1]\n",
    "print(f\"\\nAnalyzing {n_trajectories} trajectories:\")\n",
    "\n",
    "for k in range(n_trajectories):\n",
    "    # Get individuals with high loading on trajectory k at time_x\n",
    "    high_loading_k = thetas[:, k, time_x] > 0.5\n",
    "    n_individuals = np.sum(high_loading_k)\n",
    "    \n",
    "    if n_individuals > 0:\n",
    "        # Calculate CAD risk\n",
    "        cad_risk = np.mean(cad_before_x[high_loading_k])\n",
    "        \n",
    "        # Track trajectory strength over time\n",
    "        mean_loading = np.mean(thetas[high_loading_k, k, time_x:time_x+future_window], axis=0)\n",
    "        \n",
    "        # Find future trajectories\n",
    "        future_trajectories = np.argmax(thetas[high_loading_k, :, time_x + future_window], axis=1)\n",
    "        transitions = np.bincount(future_trajectories, minlength=n_trajectories) / len(future_trajectories)\n",
    "        \n",
    "        print(f\"\\nTrajectory {k}:\")\n",
    "        print(f\"Population size: {n_individuals} ({n_individuals/len(cad_before_x)*100:.1f}%)\")\n",
    "        print(f\"CAD risk: {cad_risk:.3f}\")\n",
    "        \n",
    "        # Show top diseases at current time\n",
    "        print(\"\\nCharacteristic diseases at time_x:\")\n",
    "        top_diseases = np.argsort(phi_values[k, :, time_x])[-5:]\n",
    "        for idx in reversed(top_diseases):\n",
    "            print(f\"  {disease_names[idx]}: {phi_values[k, idx, time_x]:.3f}\")\n",
    "        \n",
    "        # Show major transitions\n",
    "        print(\"\\nMajor transitions (>5%):\")\n",
    "        for j, prob in enumerate(transitions):\n",
    "            if prob > 0.05:\n",
    "                print(f\"  To trajectory {j}: {prob:.3f}\")\n",
    "                if j != k:\n",
    "                    # Show top diseases in destination trajectory\n",
    "                    dest_diseases = np.argsort(phi_values[j, :, time_x + future_window])[-3:]\n",
    "                    print(\"    Top diseases in destination trajectory:\")\n",
    "                    for idx in reversed(dest_diseases):\n",
    "                        print(f\"    {disease_names[idx]}: {phi_values[j, idx, time_x + future_window]:.3f}\")\n",
    "        \n",
    "        # Show trajectory strength evolution\n",
    "        print(\"\\nTrajectory strength over time:\")\n",
    "        for t, strength in enumerate(mean_loading):\n",
    "            print(f\"  Time {time_x + t}: {strength:.3f}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/2f/nxrbr3pn1msgrl4ffyj33zd00000gn/T/ipykernel_6481/3593108353.py:3: FutureWarning: You are using `torch.load` with `weights_only=False` (the current default value), which uses the default pickle module implicitly. It is possible to construct malicious pickle data which will execute arbitrary code during unpickling (See https://github.com/pytorch/pytorch/blob/main/SECURITY.md#untrusted-models for more details). In a future release, the default value for `weights_only` will be flipped to `True`. This limits the functions that could be executed during unpickling. Arbitrary objects will no longer be allowed to be loaded via this mode unless they are explicitly allowlisted by the user via `torch.serialization.add_safe_globals`. We recommend you start setting `weights_only=True` for any use case where you don't have full control of the loaded file. Please open an issue on GitHub for any issues related to this experimental feature.\n",
      "  checkpoint = torch.load(model_path)\n"
     ]
    }
   ],
   "source": [
    "# Load single checkpoint and get phi values and prevalence logits\n",
    "model_path = os.path.join(output_dirs[0], 'model.pt')\n",
    "checkpoint = torch.load(model_path)\n",
    "\n",
    "# Extract phi and prevalence logits\n",
    "if 'model_state_dict' in checkpoint:\n",
    "    phi_values = checkpoint['model_state_dict']['phi']\n",
    "else:\n",
    "    phi_values = checkpoint['phi']\n",
    "\n",
    "prevalence_logit = checkpoint['logit_prevalence_t']\n",
    "\n",
    "# Convert to numpy if needed\n",
    "if torch.is_tensor(phi_values):\n",
    "    phi_values = phi_values.detach().cpu().numpy()\n",
    "if torch.is_tensor(prevalence_logit):\n",
    "    prevalence_logit = prevalence_logit.detach().cpu().numpy()\n",
    "\n",
    "# Center phi values relative to prevalence logits\n",
    "phi_centered = np.zeros_like(phi_values)\n",
    "for k in range(phi_values.shape[0]):\n",
    "    for d in range(phi_values.shape[1]):\n",
    "        phi_centered[k, d, :] = phi_values[k, d, :] - prevalence_logit[d, :]\n",
    "\n",
    "# Calculate average centered phi\n",
    "phi_avg = phi_centered.mean(axis=2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 61,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Overall theta statistics:\n",
      "Min theta: 0.000\n",
      "Max theta: 0.897\n",
      "Mean theta: 0.050\n",
      "\n",
      "Signature 5 theta statistics:\n",
      "Min theta: 0.000\n",
      "Max theta: 0.873\n",
      "Mean theta: 0.052\n",
      "\n",
      "Sample of individual CAD patients (signature 5 theta values):\n",
      "\n",
      "Patient 9:\n",
      "[0.06689463 0.06515361 0.06283845 0.06007703 0.05699869 0.05372193\n",
      " 0.05034612 0.04695016 0.04359633 0.04033837 0.03722684 0.03431246\n",
      " 0.03164484 0.02926717 0.02721253 0.02550169 0.0241446  0.02314394\n",
      " 0.02249951 0.02221152 0.02228368 0.02272427 0.02354611 0.02476522\n",
      " 0.02639826 0.02845884 0.030953   0.03387463 0.03720137 0.04089195\n",
      " 0.04488588 0.04910483 0.05345472 0.05782946 0.06211553 0.06619817\n",
      " 0.06996925 0.07333699 0.07623468 0.07862316 0.0804918  0.08185023\n",
      " 0.08272043 0.0831271  0.08309232 0.08263264 0.08175959 0.08048241\n",
      " 0.07880972 0.07675268 0.07432777 0.07156136]\n",
      "\n",
      "Patient 71:\n",
      "[0.06816287 0.06977394 0.07156375 0.07348695 0.07549414 0.0775124\n",
      " 0.07942726 0.08106467 0.08219616 0.0825551  0.08187583 0.07994623\n",
      " 0.07665794 0.07204847 0.06630222 0.05972935 0.05271202 0.04564296\n",
      " 0.03886763 0.03264707 0.02714235 0.02242101 0.01847621 0.01525059\n",
      " 0.0126593  0.010608   0.00900505 0.00776824 0.00682842 0.00612973\n",
      " 0.00562892 0.00529403 0.00510281 0.00504116 0.00510207 0.00528411\n",
      " 0.00559012 0.00602551 0.00659619 0.00730568 0.00815201 0.00912475\n",
      " 0.01020315 0.01135674 0.0125476  0.01373469 0.01487836 0.01594409\n",
      " 0.01690402 0.01773792 0.0184321  0.01898036]\n",
      "\n",
      "Patient 87:\n",
      "[0.01998494 0.01961434 0.01898386 0.01811834 0.01706791 0.01589919\n",
      " 0.01468528 0.01349593 0.01239159 0.01141966 0.01061401 0.00999811\n",
      " 0.00958732 0.00939311 0.00942678 0.00970183 0.01023577 0.01105086\n",
      " 0.01217269 0.01362908 0.01544692 0.01764829 0.02024399 0.02322364\n",
      " 0.02654224 0.03010471 0.03375428 0.03727267 0.04039722 0.04286467\n",
      " 0.04446843 0.04511239 0.04484129 0.04382969 0.04233535 0.04064242\n",
      " 0.03901249 0.03765391 0.03671807 0.03630529 0.03647926 0.03727798\n",
      " 0.03872145 0.04081411 0.04354697 0.04689644 0.05082559 0.05528694\n",
      " 0.06022498 0.06558236 0.07129353 0.07728649]\n",
      "\n",
      "Patient 90:\n",
      "[0.0022182  0.00209855 0.00202048 0.0019797  0.001973   0.00199809\n",
      " 0.0020534  0.00213768 0.00224981 0.00238841 0.00255151 0.00273632\n",
      " 0.00293913 0.00315538 0.00338015 0.00360873 0.00383741 0.00406421\n",
      " 0.00428944 0.00451602 0.00474946 0.00499764 0.00527051 0.00557968\n",
      " 0.00593809 0.00635959 0.00685849 0.00744876 0.00814319 0.008952\n",
      " 0.00988108 0.01093015 0.01209102 0.01334629 0.01466939 0.01602596\n",
      " 0.01737743 0.01868593 0.01992058 0.02106288 0.02211005 0.0230759\n",
      " 0.02398808 0.02488357 0.02580257 0.02678306 0.02785593 0.02904106\n",
      " 0.03034503 0.03175878 0.03325711 0.03479981]\n",
      "\n",
      "Patient 93:\n",
      "[0.08012787 0.08580426 0.09203854 0.09877577 0.10593335 0.11339948\n",
      " 0.12103482 0.1286808  0.1361663  0.14331086 0.14992276 0.15580383\n",
      " 0.1607383  0.16450256 0.16687094 0.16763495 0.1666263  0.16374387\n",
      " 0.15898037 0.15244743 0.14437805 0.13512032 0.12510952 0.11481387\n",
      " 0.10468312 0.09509422 0.08631997 0.07852077 0.07175255 0.06599066\n",
      " 0.06115416 0.05712975 0.05379239 0.05101871 0.04869495 0.04672981\n",
      " 0.04505086 0.04360925 0.04237469 0.04133438 0.04048532 0.0398329\n",
      " 0.03938479 0.0391493  0.03913202 0.03933474 0.03975288 0.04037273\n",
      " 0.04117389 0.04212604 0.04319298 0.04433721]\n"
     ]
    }
   ],
   "source": [
    "# First check the range of theta values\n",
    "print(\"Overall theta statistics:\")\n",
    "print(f\"Min theta: {np.min(thetas):.3f}\")\n",
    "print(f\"Max theta: {np.max(thetas):.3f}\")\n",
    "print(f\"Mean theta: {np.mean(thetas):.3f}\")\n",
    "\n",
    "# Look at distribution of signature 5 values specifically\n",
    "sig5_thetas = thetas[:, 5, :]\n",
    "print(\"\\nSignature 5 theta statistics:\")\n",
    "print(f\"Min theta: {np.min(sig5_thetas):.3f}\")\n",
    "print(f\"Max theta: {np.max(sig5_thetas):.3f}\")\n",
    "print(f\"Mean theta: {np.mean(sig5_thetas):.3f}\")\n",
    "\n",
    "# Check a few individual CAD patients\n",
    "cad_indices = [disease_names.index(d) for d in ['Coronary atherosclerosis', 'Myocardial infarction']]\n",
    "cad_mask = np.zeros(combined_Y.shape[0], dtype=bool)\n",
    "for cad_idx in cad_indices:\n",
    "    cad_mask |= np.any(combined_Y[:, cad_idx, :], axis=1)\n",
    "\n",
    "print(\"\\nSample of individual CAD patients (signature 5 theta values):\")\n",
    "sample_patients = np.where(cad_mask)[0][:5]\n",
    "for patient in sample_patients:\n",
    "    print(f\"\\nPatient {patient}:\")\n",
    "    print(thetas[patient, 5, :])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Signature 5 theta values:\n",
      "CAD patients mean: 0.061\n",
      "Non-CAD patients mean: 0.051\n"
     ]
    }
   ],
   "source": [
    "# Get average theta values for signature 5 \n",
    "cad_indices = [disease_names.index(d) for d in ['Coronary atherosclerosis', 'Myocardial infarction']]\n",
    "cad_mask = np.zeros(combined_Y.shape[0], dtype=bool)\n",
    "for cad_idx in cad_indices:\n",
    "    cad_mask |= np.any(combined_Y[:, cad_idx, :], axis=1)\n",
    "\n",
    "# Compare CAD vs non-CAD patients\n",
    "cad_theta_5 = thetas[cad_mask, 5, :]\n",
    "non_cad_theta_5 = thetas[~cad_mask, 5, :]\n",
    "\n",
    "print(\"Signature 5 theta values:\")\n",
    "print(f\"CAD patients mean: {np.mean(cad_theta_5):.3f}\")\n",
    "print(f\"Non-CAD patients mean: {np.mean(non_cad_theta_5):.3f}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 64,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Check when CAD diagnoses typically occur\n",
    "cad_times = []\n",
    "for patient in np.where(cad_mask)[0]:\n",
    "    for cad_idx in cad_indices:\n",
    "        if np.any(combined_Y[patient, cad_idx, :]):\n",
    "            first_cad = np.argmax(combined_Y[patient, cad_idx, :])\n",
    "            cad_times.append(first_cad)\n",
    "\n",
    "# Look at theta values around diagnosis time\n",
    "window = 5  # Look 5 years before/after\n",
    "theta_around_cad = []\n",
    "for patient, cad_time in zip(np.where(cad_mask)[0], cad_times):\n",
    "    if cad_time >= window and cad_time + window < combined_Y.shape[2]:\n",
    "        theta_around_cad.append(thetas[patient, 5, cad_time-window:cad_time+window])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[np.int64(46),\n",
       " np.int64(36),\n",
       " np.int64(37),\n",
       " np.int64(33),\n",
       " np.int64(32),\n",
       " np.int64(34),\n",
       " np.int64(35),\n",
       " np.int64(47),\n",
       " np.int64(27),\n",
       " np.int64(38),\n",
       " np.int64(40),\n",
       " np.int64(40),\n",
       " np.int64(28),\n",
       " np.int64(46),\n",
       " np.int64(44),\n",
       " np.int64(36),\n",
       " np.int64(37),\n",
       " np.int64(36),\n",
       " np.int64(34),\n",
       " np.int64(34),\n",
       " np.int64(9),\n",
       " np.int64(44),\n",
       " np.int64(26),\n",
       " np.int64(45),\n",
       " np.int64(50),\n",
       " np.int64(27),\n",
       " np.int64(27),\n",
       " np.int64(38),\n",
       " np.int64(27),\n",
       " np.int64(41),\n",
       " np.int64(41),\n",
       " np.int64(26),\n",
       " np.int64(26),\n",
       " np.int64(50),\n",
       " np.int64(30),\n",
       " np.int64(31),\n",
       " np.int64(31),\n",
       " np.int64(42),\n",
       " np.int64(45),\n",
       " np.int64(20),\n",
       " np.int64(29),\n",
       " np.int64(43),\n",
       " np.int64(36),\n",
       " np.int64(36),\n",
       " np.int64(47),\n",
       " np.int64(28),\n",
       " np.int64(27),\n",
       " np.int64(40),\n",
       " np.int64(25),\n",
       " np.int64(29),\n",
       " np.int64(48),\n",
       " np.int64(45),\n",
       " np.int64(45),\n",
       " np.int64(37),\n",
       " np.int64(37),\n",
       " np.int64(37),\n",
       " np.int64(37),\n",
       " np.int64(23),\n",
       " np.int64(20),\n",
       " np.int64(21),\n",
       " np.int64(21),\n",
       " np.int64(28),\n",
       " np.int64(28),\n",
       " np.int64(31),\n",
       " np.int64(30),\n",
       " np.int64(42),\n",
       " np.int64(42),\n",
       " np.int64(31),\n",
       " np.int64(38),\n",
       " np.int64(29),\n",
       " np.int64(43),\n",
       " np.int64(44),\n",
       " np.int64(38),\n",
       " np.int64(45),\n",
       " np.int64(15),\n",
       " np.int64(15),\n",
       " np.int64(33),\n",
       " np.int64(36),\n",
       " np.int64(35),\n",
       " np.int64(35),\n",
       " np.int64(30),\n",
       " np.int64(20),\n",
       " np.int64(20),\n",
       " np.int64(13),\n",
       " np.int64(13),\n",
       " np.int64(38),\n",
       " np.int64(42),\n",
       " np.int64(41),\n",
       " np.int64(37),\n",
       " np.int64(43),\n",
       " np.int64(49),\n",
       " np.int64(49),\n",
       " np.int64(46),\n",
       " np.int64(34),\n",
       " np.int64(34),\n",
       " np.int64(36),\n",
       " np.int64(45),\n",
       " np.int64(34),\n",
       " np.int64(34),\n",
       " np.int64(28),\n",
       " np.int64(32),\n",
       " np.int64(34),\n",
       " np.int64(32),\n",
       " np.int64(30),\n",
       " np.int64(18),\n",
       " np.int64(33),\n",
       " np.int64(46),\n",
       " np.int64(50),\n",
       " np.int64(36),\n",
       " np.int64(29),\n",
       " np.int64(38),\n",
       " np.int64(43),\n",
       " np.int64(38),\n",
       " np.int64(18),\n",
       " np.int64(18),\n",
       " np.int64(40),\n",
       " np.int64(40),\n",
       " np.int64(35),\n",
       " np.int64(24),\n",
       " np.int64(38),\n",
       " np.int64(29),\n",
       " np.int64(27),\n",
       " np.int64(27),\n",
       " np.int64(38),\n",
       " np.int64(22),\n",
       " np.int64(43),\n",
       " np.int64(45),\n",
       " np.int64(36),\n",
       " np.int64(34),\n",
       " np.int64(34),\n",
       " np.int64(41),\n",
       " np.int64(41),\n",
       " np.int64(19),\n",
       " np.int64(19),\n",
       " np.int64(22),\n",
       " np.int64(41),\n",
       " np.int64(41),\n",
       " np.int64(33),\n",
       " np.int64(33),\n",
       " np.int64(23),\n",
       " np.int64(36),\n",
       " np.int64(15),\n",
       " np.int64(30),\n",
       " np.int64(38),\n",
       " np.int64(41),\n",
       " np.int64(30),\n",
       " np.int64(32),\n",
       " np.int64(37),\n",
       " np.int64(37),\n",
       " np.int64(37),\n",
       " np.int64(32),\n",
       " np.int64(50),\n",
       " np.int64(34),\n",
       " np.int64(37),\n",
       " np.int64(37),\n",
       " np.int64(42),\n",
       " np.int64(37),\n",
       " np.int64(38),\n",
       " np.int64(49),\n",
       " np.int64(40),\n",
       " np.int64(37),\n",
       " np.int64(41),\n",
       " np.int64(47),\n",
       " np.int64(42),\n",
       " np.int64(44),\n",
       " np.int64(28),\n",
       " np.int64(19),\n",
       " np.int64(44),\n",
       " np.int64(46),\n",
       " np.int64(47),\n",
       " np.int64(40),\n",
       " np.int64(28),\n",
       " np.int64(26),\n",
       " np.int64(42),\n",
       " np.int64(47),\n",
       " np.int64(34),\n",
       " np.int64(38),\n",
       " np.int64(38),\n",
       " np.int64(24),\n",
       " np.int64(32),\n",
       " np.int64(16),\n",
       " np.int64(13),\n",
       " np.int64(34),\n",
       " np.int64(37),\n",
       " np.int64(39),\n",
       " np.int64(44),\n",
       " np.int64(44),\n",
       " np.int64(30),\n",
       " np.int64(30),\n",
       " np.int64(38),\n",
       " np.int64(44),\n",
       " np.int64(39),\n",
       " np.int64(37),\n",
       " np.int64(39),\n",
       " np.int64(32),\n",
       " np.int64(37),\n",
       " np.int64(47),\n",
       " np.int64(38),\n",
       " np.int64(48),\n",
       " np.int64(41),\n",
       " np.int64(38),\n",
       " np.int64(45),\n",
       " np.int64(28),\n",
       " np.int64(27),\n",
       " np.int64(30),\n",
       " np.int64(36),\n",
       " np.int64(36),\n",
       " np.int64(31),\n",
       " np.int64(31),\n",
       " np.int64(45),\n",
       " np.int64(45),\n",
       " np.int64(33),\n",
       " np.int64(30),\n",
       " np.int64(45),\n",
       " np.int64(40),\n",
       " np.int64(38),\n",
       " np.int64(37),\n",
       " np.int64(35),\n",
       " np.int64(32),\n",
       " np.int64(32),\n",
       " np.int64(34),\n",
       " np.int64(50),\n",
       " np.int64(31),\n",
       " np.int64(40),\n",
       " np.int64(44),\n",
       " np.int64(42),\n",
       " np.int64(23),\n",
       " np.int64(31),\n",
       " np.int64(42),\n",
       " np.int64(45),\n",
       " np.int64(35),\n",
       " np.int64(36),\n",
       " np.int64(28),\n",
       " np.int64(28),\n",
       " np.int64(46),\n",
       " np.int64(35),\n",
       " np.int64(20),\n",
       " np.int64(19),\n",
       " np.int64(42),\n",
       " np.int64(42),\n",
       " np.int64(38),\n",
       " np.int64(42),\n",
       " np.int64(40),\n",
       " np.int64(41),\n",
       " np.int64(34),\n",
       " np.int64(34),\n",
       " np.int64(24),\n",
       " np.int64(24),\n",
       " np.int64(31),\n",
       " np.int64(21),\n",
       " np.int64(40),\n",
       " np.int64(32),\n",
       " np.int64(41),\n",
       " np.int64(41),\n",
       " np.int64(14),\n",
       " np.int64(38),\n",
       " np.int64(39),\n",
       " np.int64(39),\n",
       " np.int64(28),\n",
       " np.int64(28),\n",
       " np.int64(29),\n",
       " np.int64(38),\n",
       " np.int64(43),\n",
       " np.int64(50),\n",
       " np.int64(50),\n",
       " np.int64(35),\n",
       " np.int64(39),\n",
       " np.int64(48),\n",
       " np.int64(29),\n",
       " np.int64(23),\n",
       " np.int64(34),\n",
       " np.int64(39),\n",
       " np.int64(41),\n",
       " np.int64(42),\n",
       " np.int64(36),\n",
       " np.int64(35),\n",
       " np.int64(25),\n",
       " np.int64(19),\n",
       " np.int64(19),\n",
       " np.int64(23),\n",
       " np.int64(26),\n",
       " np.int64(33),\n",
       " np.int64(37),\n",
       " np.int64(37),\n",
       " np.int64(29),\n",
       " np.int64(28),\n",
       " np.int64(34),\n",
       " np.int64(27),\n",
       " np.int64(27),\n",
       " np.int64(33),\n",
       " np.int64(23),\n",
       " np.int64(27),\n",
       " np.int64(42),\n",
       " np.int64(42),\n",
       " np.int64(35),\n",
       " np.int64(45),\n",
       " np.int64(45),\n",
       " np.int64(40),\n",
       " np.int64(38),\n",
       " np.int64(25),\n",
       " np.int64(38),\n",
       " np.int64(45),\n",
       " np.int64(45),\n",
       " np.int64(44),\n",
       " np.int64(29),\n",
       " np.int64(34),\n",
       " np.int64(34),\n",
       " np.int64(37),\n",
       " np.int64(46),\n",
       " np.int64(36),\n",
       " np.int64(29),\n",
       " np.int64(46),\n",
       " np.int64(41),\n",
       " np.int64(41),\n",
       " np.int64(27),\n",
       " np.int64(27),\n",
       " np.int64(34),\n",
       " np.int64(32),\n",
       " np.int64(40),\n",
       " np.int64(40),\n",
       " np.int64(24),\n",
       " np.int64(24),\n",
       " np.int64(27),\n",
       " np.int64(37),\n",
       " np.int64(13),\n",
       " np.int64(21),\n",
       " np.int64(21),\n",
       " np.int64(30),\n",
       " np.int64(30),\n",
       " np.int64(40),\n",
       " np.int64(40),\n",
       " np.int64(29),\n",
       " np.int64(42),\n",
       " np.int64(42),\n",
       " np.int64(19),\n",
       " np.int64(36),\n",
       " np.int64(42),\n",
       " np.int64(42),\n",
       " np.int64(30),\n",
       " np.int64(32),\n",
       " np.int64(32),\n",
       " np.int64(32),\n",
       " np.int64(32),\n",
       " np.int64(44),\n",
       " np.int64(29),\n",
       " np.int64(25),\n",
       " np.int64(25),\n",
       " np.int64(38),\n",
       " np.int64(34),\n",
       " np.int64(45),\n",
       " np.int64(26),\n",
       " np.int64(26),\n",
       " np.int64(28),\n",
       " np.int64(28),\n",
       " np.int64(30),\n",
       " np.int64(30),\n",
       " np.int64(16),\n",
       " np.int64(41),\n",
       " np.int64(40),\n",
       " np.int64(26),\n",
       " np.int64(27),\n",
       " np.int64(45),\n",
       " np.int64(37),\n",
       " np.int64(37),\n",
       " np.int64(33),\n",
       " np.int64(44),\n",
       " np.int64(36),\n",
       " np.int64(42),\n",
       " np.int64(36),\n",
       " np.int64(42),\n",
       " np.int64(42),\n",
       " np.int64(35),\n",
       " np.int64(39),\n",
       " np.int64(32),\n",
       " np.int64(43),\n",
       " np.int64(36),\n",
       " np.int64(38),\n",
       " np.int64(38),\n",
       " np.int64(26),\n",
       " np.int64(41),\n",
       " np.int64(29),\n",
       " np.int64(45),\n",
       " np.int64(36),\n",
       " np.int64(27),\n",
       " np.int64(43),\n",
       " np.int64(40),\n",
       " np.int64(40),\n",
       " np.int64(49),\n",
       " np.int64(24),\n",
       " np.int64(36),\n",
       " np.int64(30),\n",
       " np.int64(30),\n",
       " np.int64(38),\n",
       " np.int64(40),\n",
       " np.int64(47),\n",
       " np.int64(27),\n",
       " np.int64(30),\n",
       " np.int64(40),\n",
       " np.int64(25),\n",
       " np.int64(25),\n",
       " np.int64(50),\n",
       " np.int64(45),\n",
       " np.int64(46),\n",
       " np.int64(44),\n",
       " np.int64(44),\n",
       " np.int64(36),\n",
       " np.int64(41),\n",
       " np.int64(30),\n",
       " np.int64(43),\n",
       " np.int64(28),\n",
       " np.int64(38),\n",
       " np.int64(38),\n",
       " np.int64(51),\n",
       " np.int64(41),\n",
       " np.int64(41),\n",
       " np.int64(35),\n",
       " np.int64(35),\n",
       " np.int64(24),\n",
       " np.int64(31),\n",
       " np.int64(35),\n",
       " np.int64(43),\n",
       " np.int64(20),\n",
       " np.int64(43),\n",
       " np.int64(43),\n",
       " np.int64(43),\n",
       " np.int64(19),\n",
       " np.int64(19),\n",
       " np.int64(28),\n",
       " np.int64(44),\n",
       " np.int64(43),\n",
       " np.int64(32),\n",
       " np.int64(16),\n",
       " np.int64(16),\n",
       " np.int64(51),\n",
       " np.int64(32),\n",
       " np.int64(32),\n",
       " np.int64(39),\n",
       " np.int64(46),\n",
       " np.int64(39),\n",
       " np.int64(50),\n",
       " np.int64(16),\n",
       " np.int64(16),\n",
       " np.int64(39),\n",
       " np.int64(37),\n",
       " np.int64(32),\n",
       " np.int64(47),\n",
       " np.int64(30),\n",
       " np.int64(33),\n",
       " np.int64(50),\n",
       " np.int64(42),\n",
       " np.int64(42),\n",
       " np.int64(24),\n",
       " np.int64(30),\n",
       " np.int64(35),\n",
       " np.int64(41),\n",
       " np.int64(31),\n",
       " np.int64(36),\n",
       " np.int64(25),\n",
       " np.int64(39),\n",
       " np.int64(39),\n",
       " np.int64(46),\n",
       " np.int64(43),\n",
       " np.int64(36),\n",
       " np.int64(30),\n",
       " np.int64(38),\n",
       " np.int64(35),\n",
       " np.int64(30),\n",
       " np.int64(35),\n",
       " np.int64(41),\n",
       " np.int64(38),\n",
       " np.int64(38),\n",
       " np.int64(34),\n",
       " np.int64(30),\n",
       " np.int64(50),\n",
       " np.int64(11),\n",
       " np.int64(31),\n",
       " np.int64(31),\n",
       " np.int64(45),\n",
       " np.int64(22),\n",
       " np.int64(43),\n",
       " np.int64(44),\n",
       " np.int64(43),\n",
       " np.int64(43),\n",
       " np.int64(33),\n",
       " np.int64(35),\n",
       " np.int64(45),\n",
       " np.int64(45),\n",
       " np.int64(44),\n",
       " np.int64(27),\n",
       " np.int64(44),\n",
       " np.int64(44),\n",
       " np.int64(41),\n",
       " np.int64(41),\n",
       " np.int64(37),\n",
       " np.int64(37),\n",
       " np.int64(27),\n",
       " np.int64(27),\n",
       " np.int64(50),\n",
       " np.int64(46),\n",
       " np.int64(31),\n",
       " np.int64(31),\n",
       " np.int64(38),\n",
       " np.int64(26),\n",
       " np.int64(21),\n",
       " np.int64(30),\n",
       " np.int64(16),\n",
       " np.int64(18),\n",
       " np.int64(32),\n",
       " np.int64(25),\n",
       " np.int64(24),\n",
       " np.int64(30),\n",
       " np.int64(26),\n",
       " np.int64(26),\n",
       " np.int64(26),\n",
       " np.int64(31),\n",
       " np.int64(31),\n",
       " np.int64(37),\n",
       " np.int64(16),\n",
       " np.int64(28),\n",
       " np.int64(32),\n",
       " np.int64(32),\n",
       " np.int64(32),\n",
       " np.int64(38),\n",
       " np.int64(42),\n",
       " np.int64(18),\n",
       " np.int64(35),\n",
       " np.int64(35),\n",
       " np.int64(27),\n",
       " np.int64(34),\n",
       " np.int64(22),\n",
       " np.int64(22),\n",
       " np.int64(39),\n",
       " np.int64(34),\n",
       " np.int64(35),\n",
       " np.int64(42),\n",
       " np.int64(44),\n",
       " np.int64(26),\n",
       " np.int64(18),\n",
       " np.int64(24),\n",
       " np.int64(27),\n",
       " np.int64(36),\n",
       " np.int64(36),\n",
       " np.int64(35),\n",
       " np.int64(35),\n",
       " np.int64(34),\n",
       " np.int64(30),\n",
       " np.int64(32),\n",
       " np.int64(35),\n",
       " np.int64(35),\n",
       " np.int64(35),\n",
       " np.int64(37),\n",
       " np.int64(37),\n",
       " np.int64(48),\n",
       " np.int64(25),\n",
       " np.int64(25),\n",
       " np.int64(44),\n",
       " np.int64(39),\n",
       " np.int64(40),\n",
       " np.int64(29),\n",
       " np.int64(12),\n",
       " np.int64(31),\n",
       " np.int64(41),\n",
       " np.int64(41),\n",
       " np.int64(27),\n",
       " np.int64(35),\n",
       " np.int64(51),\n",
       " np.int64(31),\n",
       " np.int64(34),\n",
       " np.int64(34),\n",
       " np.int64(33),\n",
       " np.int64(23),\n",
       " np.int64(29),\n",
       " np.int64(40),\n",
       " np.int64(36),\n",
       " np.int64(30),\n",
       " np.int64(21),\n",
       " np.int64(24),\n",
       " np.int64(24),\n",
       " np.int64(30),\n",
       " np.int64(45),\n",
       " np.int64(48),\n",
       " np.int64(13),\n",
       " np.int64(44),\n",
       " np.int64(32),\n",
       " np.int64(32),\n",
       " np.int64(31),\n",
       " np.int64(24),\n",
       " np.int64(24),\n",
       " np.int64(23),\n",
       " np.int64(42),\n",
       " np.int64(39),\n",
       " np.int64(21),\n",
       " np.int64(32),\n",
       " np.int64(32),\n",
       " np.int64(29),\n",
       " np.int64(29),\n",
       " np.int64(47),\n",
       " np.int64(47),\n",
       " np.int64(35),\n",
       " np.int64(35),\n",
       " np.int64(18),\n",
       " np.int64(33),\n",
       " np.int64(23),\n",
       " np.int64(23),\n",
       " np.int64(12),\n",
       " np.int64(19),\n",
       " np.int64(38),\n",
       " np.int64(42),\n",
       " np.int64(34),\n",
       " np.int64(32),\n",
       " np.int64(44),\n",
       " np.int64(20),\n",
       " np.int64(44),\n",
       " np.int64(33),\n",
       " np.int64(38),\n",
       " np.int64(38),\n",
       " np.int64(32),\n",
       " np.int64(24),\n",
       " np.int64(36),\n",
       " np.int64(43),\n",
       " np.int64(32),\n",
       " np.int64(37),\n",
       " np.int64(31),\n",
       " np.int64(37),\n",
       " np.int64(37),\n",
       " np.int64(20),\n",
       " np.int64(20),\n",
       " np.int64(42),\n",
       " np.int64(21),\n",
       " np.int64(27),\n",
       " np.int64(27),\n",
       " np.int64(41),\n",
       " np.int64(41),\n",
       " np.int64(38),\n",
       " np.int64(38),\n",
       " np.int64(16),\n",
       " np.int64(25),\n",
       " np.int64(46),\n",
       " np.int64(46),\n",
       " np.int64(21),\n",
       " np.int64(32),\n",
       " np.int64(41),\n",
       " np.int64(43),\n",
       " np.int64(13),\n",
       " np.int64(12),\n",
       " np.int64(23),\n",
       " np.int64(28),\n",
       " np.int64(51),\n",
       " np.int64(39),\n",
       " np.int64(50),\n",
       " np.int64(29),\n",
       " np.int64(43),\n",
       " np.int64(26),\n",
       " np.int64(25),\n",
       " np.int64(19),\n",
       " np.int64(36),\n",
       " np.int64(17),\n",
       " np.int64(17),\n",
       " np.int64(33),\n",
       " np.int64(33),\n",
       " np.int64(48),\n",
       " np.int64(37),\n",
       " np.int64(37),\n",
       " np.int64(25),\n",
       " np.int64(39),\n",
       " np.int64(21),\n",
       " np.int64(21),\n",
       " np.int64(35),\n",
       " np.int64(30),\n",
       " np.int64(29),\n",
       " np.int64(35),\n",
       " np.int64(35),\n",
       " np.int64(24),\n",
       " np.int64(24),\n",
       " np.int64(35),\n",
       " np.int64(32),\n",
       " np.int64(45),\n",
       " np.int64(24),\n",
       " np.int64(50),\n",
       " np.int64(45),\n",
       " np.int64(31),\n",
       " np.int64(38),\n",
       " np.int64(28),\n",
       " np.int64(40),\n",
       " np.int64(34),\n",
       " np.int64(42),\n",
       " np.int64(42),\n",
       " np.int64(42),\n",
       " np.int64(31),\n",
       " np.int64(30),\n",
       " np.int64(37),\n",
       " np.int64(38),\n",
       " np.int64(38),\n",
       " np.int64(37),\n",
       " np.int64(38),\n",
       " np.int64(37),\n",
       " np.int64(36),\n",
       " np.int64(17),\n",
       " np.int64(17),\n",
       " np.int64(45),\n",
       " np.int64(45),\n",
       " np.int64(31),\n",
       " np.int64(22),\n",
       " np.int64(34),\n",
       " np.int64(35),\n",
       " np.int64(35),\n",
       " np.int64(37),\n",
       " np.int64(49),\n",
       " np.int64(17),\n",
       " np.int64(17),\n",
       " np.int64(41),\n",
       " np.int64(41),\n",
       " np.int64(33),\n",
       " np.int64(33),\n",
       " np.int64(36),\n",
       " np.int64(35),\n",
       " np.int64(42),\n",
       " np.int64(42),\n",
       " np.int64(42),\n",
       " np.int64(42),\n",
       " np.int64(39),\n",
       " np.int64(35),\n",
       " np.int64(35),\n",
       " np.int64(35),\n",
       " np.int64(50),\n",
       " np.int64(20),\n",
       " np.int64(25),\n",
       " np.int64(17),\n",
       " np.int64(17),\n",
       " np.int64(28),\n",
       " np.int64(24),\n",
       " np.int64(24),\n",
       " np.int64(20),\n",
       " np.int64(32),\n",
       " np.int64(32),\n",
       " np.int64(39),\n",
       " np.int64(39),\n",
       " np.int64(47),\n",
       " np.int64(48),\n",
       " np.int64(32),\n",
       " np.int64(32),\n",
       " np.int64(25),\n",
       " np.int64(25),\n",
       " np.int64(23),\n",
       " np.int64(19),\n",
       " np.int64(29),\n",
       " np.int64(30),\n",
       " np.int64(46),\n",
       " np.int64(45),\n",
       " np.int64(34),\n",
       " np.int64(34),\n",
       " np.int64(29),\n",
       " np.int64(34),\n",
       " np.int64(38),\n",
       " np.int64(38),\n",
       " np.int64(33),\n",
       " np.int64(30),\n",
       " np.int64(26),\n",
       " np.int64(45),\n",
       " np.int64(45),\n",
       " np.int64(37),\n",
       " np.int64(48),\n",
       " np.int64(21),\n",
       " np.int64(21),\n",
       " np.int64(48),\n",
       " np.int64(31),\n",
       " np.int64(47),\n",
       " np.int64(43),\n",
       " np.int64(27),\n",
       " np.int64(27),\n",
       " np.int64(33),\n",
       " np.int64(28),\n",
       " np.int64(30),\n",
       " np.int64(27),\n",
       " np.int64(44),\n",
       " np.int64(44),\n",
       " np.int64(21),\n",
       " np.int64(44),\n",
       " np.int64(44),\n",
       " np.int64(35),\n",
       " np.int64(35),\n",
       " np.int64(31),\n",
       " np.int64(46),\n",
       " np.int64(33),\n",
       " np.int64(44),\n",
       " np.int64(35),\n",
       " np.int64(25),\n",
       " np.int64(50),\n",
       " np.int64(25),\n",
       " np.int64(40),\n",
       " np.int64(47),\n",
       " np.int64(35),\n",
       " np.int64(26),\n",
       " np.int64(38),\n",
       " np.int64(38),\n",
       " np.int64(22),\n",
       " np.int64(28),\n",
       " np.int64(21),\n",
       " np.int64(32),\n",
       " np.int64(44),\n",
       " np.int64(18),\n",
       " np.int64(37),\n",
       " np.int64(47),\n",
       " np.int64(36),\n",
       " np.int64(44),\n",
       " np.int64(22),\n",
       " np.int64(22),\n",
       " np.int64(25),\n",
       " np.int64(47),\n",
       " np.int64(36),\n",
       " np.int64(28),\n",
       " np.int64(44),\n",
       " np.int64(35),\n",
       " np.int64(36),\n",
       " np.int64(36),\n",
       " np.int64(27),\n",
       " np.int64(41),\n",
       " np.int64(35),\n",
       " np.int64(46),\n",
       " np.int64(33),\n",
       " np.int64(33),\n",
       " np.int64(36),\n",
       " np.int64(36),\n",
       " np.int64(39),\n",
       " np.int64(42),\n",
       " np.int64(24),\n",
       " np.int64(24),\n",
       " np.int64(41),\n",
       " np.int64(41),\n",
       " np.int64(38),\n",
       " np.int64(39),\n",
       " np.int64(49),\n",
       " np.int64(26),\n",
       " np.int64(41),\n",
       " np.int64(28),\n",
       " np.int64(28),\n",
       " np.int64(19),\n",
       " np.int64(34),\n",
       " np.int64(40),\n",
       " np.int64(38),\n",
       " np.int64(47),\n",
       " np.int64(34),\n",
       " np.int64(36),\n",
       " np.int64(33),\n",
       " np.int64(39),\n",
       " np.int64(35),\n",
       " np.int64(37),\n",
       " np.int64(38),\n",
       " np.int64(48),\n",
       " np.int64(43),\n",
       " np.int64(42),\n",
       " np.int64(42),\n",
       " np.int64(41),\n",
       " np.int64(40),\n",
       " np.int64(42),\n",
       " np.int64(31),\n",
       " np.int64(31),\n",
       " np.int64(42),\n",
       " np.int64(27),\n",
       " np.int64(38),\n",
       " np.int64(38),\n",
       " np.int64(37),\n",
       " np.int64(42),\n",
       " np.int64(49),\n",
       " np.int64(26),\n",
       " np.int64(43),\n",
       " np.int64(43),\n",
       " np.int64(48),\n",
       " np.int64(21),\n",
       " np.int64(34),\n",
       " np.int64(34),\n",
       " np.int64(36),\n",
       " np.int64(36),\n",
       " np.int64(35),\n",
       " np.int64(35),\n",
       " np.int64(35),\n",
       " np.int64(35),\n",
       " np.int64(49),\n",
       " np.int64(42),\n",
       " np.int64(41),\n",
       " np.int64(41),\n",
       " np.int64(35),\n",
       " np.int64(32),\n",
       " np.int64(32),\n",
       " np.int64(41),\n",
       " np.int64(41),\n",
       " np.int64(33),\n",
       " np.int64(33),\n",
       " np.int64(24),\n",
       " np.int64(31),\n",
       " np.int64(23),\n",
       " np.int64(45),\n",
       " np.int64(42),\n",
       " np.int64(26),\n",
       " np.int64(40),\n",
       " np.int64(46),\n",
       " np.int64(36),\n",
       " np.int64(36),\n",
       " np.int64(26),\n",
       " np.int64(26),\n",
       " np.int64(27),\n",
       " np.int64(25),\n",
       " np.int64(40),\n",
       " np.int64(30),\n",
       " np.int64(32),\n",
       " np.int64(28),\n",
       " np.int64(39),\n",
       " np.int64(28),\n",
       " np.int64(28),\n",
       " np.int64(47),\n",
       " np.int64(34),\n",
       " np.int64(36),\n",
       " np.int64(25),\n",
       " np.int64(34),\n",
       " np.int64(34),\n",
       " np.int64(30),\n",
       " np.int64(26),\n",
       " np.int64(28),\n",
       " np.int64(16),\n",
       " np.int64(31),\n",
       " np.int64(30),\n",
       " np.int64(39),\n",
       " np.int64(49),\n",
       " np.int64(42),\n",
       " np.int64(33),\n",
       " np.int64(29),\n",
       " np.int64(18),\n",
       " np.int64(34),\n",
       " np.int64(32),\n",
       " np.int64(37),\n",
       " np.int64(37),\n",
       " np.int64(46),\n",
       " np.int64(31),\n",
       " np.int64(42),\n",
       " np.int64(38),\n",
       " np.int64(29),\n",
       " np.int64(46),\n",
       " np.int64(47),\n",
       " np.int64(31),\n",
       " np.int64(34),\n",
       " np.int64(42),\n",
       " np.int64(37),\n",
       " np.int64(48),\n",
       " np.int64(30),\n",
       " np.int64(38),\n",
       " np.int64(35),\n",
       " np.int64(36),\n",
       " np.int64(36),\n",
       " np.int64(28),\n",
       " np.int64(43),\n",
       " np.int64(45),\n",
       " np.int64(45),\n",
       " np.int64(46),\n",
       " np.int64(29),\n",
       " np.int64(35),\n",
       " np.int64(22),\n",
       " np.int64(28),\n",
       " np.int64(40),\n",
       " np.int64(40),\n",
       " np.int64(31),\n",
       " np.int64(36),\n",
       " np.int64(49),\n",
       " np.int64(40),\n",
       " np.int64(40),\n",
       " np.int64(18),\n",
       " np.int64(10),\n",
       " np.int64(48),\n",
       " np.int64(48),\n",
       " np.int64(42),\n",
       " np.int64(33),\n",
       " np.int64(31),\n",
       " np.int64(23),\n",
       " np.int64(31),\n",
       " np.int64(35),\n",
       " np.int64(35),\n",
       " np.int64(15),\n",
       " np.int64(38),\n",
       " np.int64(20),\n",
       " np.int64(20),\n",
       " np.int64(22),\n",
       " np.int64(15),\n",
       " np.int64(24),\n",
       " np.int64(42),\n",
       " np.int64(36),\n",
       " np.int64(44),\n",
       " np.int64(44),\n",
       " np.int64(39),\n",
       " np.int64(39),\n",
       " np.int64(38),\n",
       " np.int64(43),\n",
       " np.int64(42),\n",
       " np.int64(42),\n",
       " np.int64(18),\n",
       " np.int64(25),\n",
       " np.int64(25),\n",
       " np.int64(42),\n",
       " np.int64(42),\n",
       " np.int64(28),\n",
       " np.int64(35),\n",
       " np.int64(14),\n",
       " ...]"
      ]
     },
     "execution_count": 65,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cad_times"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Found 11898 patients with CAD before age 60\n",
      "\n",
      "Most common trajectories BEFORE CAD onset:\n",
      "\n",
      "Trajectory 5: 1079 patients (9.1%)\n",
      "  Coronary atherosclerosis: 1.595\n",
      "  Other chronic ischemic heart disease, unspecified: 1.550\n",
      "  Myocardial infarction: 1.378\n",
      "  Hypercholesterolemia: 1.185\n",
      "  Other acute and subacute forms of ischemic heart disease: 0.864\n",
      "\n",
      "Trajectory 15: 671 patients (5.6%)\n",
      "  Hypoglycemia: 1.240\n",
      "  Type 2 diabetes with ophthalmic manifestations: 1.108\n",
      "  Type 2 diabetes: 0.983\n",
      "  Back pain: 0.342\n",
      "  Retinal detachments and defects: 0.009\n",
      "\n",
      "Trajectory 7: 624 patients (5.2%)\n",
      "  Other disorders of bone and cartilage: 2.792\n",
      "  Asthma: 2.307\n",
      "  Cervicalgia: 2.054\n",
      "  Sleep apnea: 1.925\n",
      "  Hyperlipidemia: 1.748\n",
      "\n",
      "Trajectory 11: 606 patients (5.1%)\n",
      "  Hemiplegia: 3.584\n",
      "  Cerebral artery occlusion, with cerebral infarction: 1.689\n",
      "  Occlusion and stenosis of precerebral arteries: 1.478\n",
      "  Occlusion of cerebral arteries: 0.772\n",
      "  Transient cerebral ischemia: 0.634\n",
      "\n",
      "Trajectory 8: 595 patients (5.0%)\n",
      "  Malignant neoplasm of uterus: 2.872\n",
      "  Uterine leiomyoma: 2.460\n",
      "  Cervicitis and endocervicitis: 1.833\n",
      "  Uterine/Uterovaginal prolapse: 1.715\n",
      "  Pain and other symptoms associated with female genital organs: 1.669\n",
      "\n",
      "Most common trajectories AT CAD onset:\n",
      "\n",
      "Trajectory 5: 1052 patients (8.9%)\n",
      "  Coronary atherosclerosis: 1.595\n",
      "  Other chronic ischemic heart disease, unspecified: 1.550\n",
      "  Myocardial infarction: 1.378\n",
      "  Hypercholesterolemia: 1.185\n",
      "  Other acute and subacute forms of ischemic heart disease: 0.864\n",
      "\n",
      "Trajectory 15: 673 patients (5.7%)\n",
      "  Hypoglycemia: 1.240\n",
      "  Type 2 diabetes with ophthalmic manifestations: 1.108\n",
      "  Type 2 diabetes: 0.983\n",
      "  Back pain: 0.342\n",
      "  Retinal detachments and defects: 0.009\n",
      "\n",
      "Trajectory 7: 608 patients (5.1%)\n",
      "  Other disorders of bone and cartilage: 2.792\n",
      "  Asthma: 2.307\n",
      "  Cervicalgia: 2.054\n",
      "  Sleep apnea: 1.925\n",
      "  Hyperlipidemia: 1.748\n",
      "\n",
      "Trajectory 11: 602 patients (5.1%)\n",
      "  Hemiplegia: 3.584\n",
      "  Cerebral artery occlusion, with cerebral infarction: 1.689\n",
      "  Occlusion and stenosis of precerebral arteries: 1.478\n",
      "  Occlusion of cerebral arteries: 0.772\n",
      "  Transient cerebral ischemia: 0.634\n",
      "\n",
      "Trajectory 12: 585 patients (4.9%)\n",
      "  Calculus of kidney: 2.454\n",
      "  Other disorders of the kidney and ureters: 1.813\n",
      "  Renal colic: 1.548\n",
      "  Calculus of ureter: 1.355\n",
      "  Stricture/obstruction of ureter: 1.166\n",
      "\n",
      "Most common trajectories AFTER CAD:\n",
      "\n",
      "Trajectory 5: 1029 patients (8.7%)\n",
      "  Coronary atherosclerosis: 1.595\n",
      "  Other chronic ischemic heart disease, unspecified: 1.550\n",
      "  Myocardial infarction: 1.378\n",
      "  Hypercholesterolemia: 1.185\n",
      "  Other acute and subacute forms of ischemic heart disease: 0.864\n",
      "\n",
      "Trajectory 15: 707 patients (5.9%)\n",
      "  Hypoglycemia: 1.240\n",
      "  Type 2 diabetes with ophthalmic manifestations: 1.108\n",
      "  Type 2 diabetes: 0.983\n",
      "  Back pain: 0.342\n",
      "  Retinal detachments and defects: 0.009\n",
      "\n",
      "Trajectory 7: 629 patients (5.3%)\n",
      "  Other disorders of bone and cartilage: 2.792\n",
      "  Asthma: 2.307\n",
      "  Cervicalgia: 2.054\n",
      "  Sleep apnea: 1.925\n",
      "  Hyperlipidemia: 1.748\n",
      "\n",
      "Trajectory 10: 604 patients (5.1%)\n",
      "  Senile cataract: 2.722\n",
      "  Retinal detachments and defects: 2.291\n",
      "  Other retinal disorders: 2.281\n",
      "  Retinal vascular changes and abnomalities: 1.591\n",
      "  Macular degeneration (senile) of retina NOS: 1.102\n",
      "\n",
      "Trajectory 0: 590 patients (5.0%)\n",
      "  Paroxysmal ventricular tachycardia: 2.679\n",
      "  Left bundle branch block: 1.833\n",
      "  Pericarditis: 1.770\n",
      "  Aortic valve disease: 1.746\n",
      "  Heart failure NOS: 1.595\n"
     ]
    }
   ],
   "source": [
    "# First identify people who develop CAD before age 60 (index 30)\n",
    "early_age = 30\n",
    "cad_indices = [disease_names.index(d) for d in ['Coronary atherosclerosis', 'Myocardial infarction']]\n",
    "\n",
    "# Find first CAD occurrence for each person\n",
    "early_cad_mask = np.zeros(combined_Y.shape[0], dtype=bool)\n",
    "first_cad_time = np.full(combined_Y.shape[0], np.inf)\n",
    "\n",
    "for cad_idx in cad_indices:\n",
    "    has_cad = np.any(combined_Y[:, cad_idx, :early_age], axis=1)\n",
    "    early_cad_mask |= has_cad\n",
    "    # For those with CAD, find first occurrence\n",
    "    cad_patients = np.where(has_cad)[0]\n",
    "    for patient in cad_patients:\n",
    "        onset = np.argmax(combined_Y[patient, cad_idx, :early_age])\n",
    "        first_cad_time[patient] = min(first_cad_time[patient], onset)\n",
    "\n",
    "print(f\"Found {np.sum(early_cad_mask)} patients with CAD before age 60\")\n",
    "\n",
    "# For these patients:\n",
    "# 1. What trajectory were they in 5 years before CAD?\n",
    "# 2. What trajectory at CAD onset?\n",
    "# 3. What trajectory 5 years after?\n",
    "\n",
    "look_window = 5\n",
    "trajectories_before = []\n",
    "trajectories_at = []\n",
    "trajectories_after = []\n",
    "\n",
    "for patient in np.where(early_cad_mask)[0]:\n",
    "    onset = int(first_cad_time[patient])\n",
    "    if onset >= look_window and onset + look_window < combined_Y.shape[2]:\n",
    "        # Get dominant trajectories at each timepoint\n",
    "        traj_before = np.argmax(thetas[patient, :, onset-look_window])\n",
    "        traj_at = np.argmax(thetas[patient, :, onset])\n",
    "        traj_after = np.argmax(thetas[patient, :, onset+look_window])\n",
    "        \n",
    "        trajectories_before.append(traj_before)\n",
    "        trajectories_at.append(traj_at)\n",
    "        trajectories_after.append(traj_after)\n",
    "\n",
    "# Analyze common patterns\n",
    "from collections import Counter\n",
    "\n",
    "print(\"\\nMost common trajectories BEFORE CAD onset:\")\n",
    "for traj, count in Counter(trajectories_before).most_common(5):\n",
    "    print(f\"\\nTrajectory {traj}: {count} patients ({count/len(trajectories_before)*100:.1f}%)\")\n",
    "    top_diseases = np.argsort(phi_avg[traj])[-5:]\n",
    "    for idx in reversed(top_diseases):\n",
    "        print(f\"  {disease_names[idx]}: {phi_avg[traj, idx]:.3f}\")\n",
    "\n",
    "print(\"\\nMost common trajectories AT CAD onset:\")\n",
    "for traj, count in Counter(trajectories_at).most_common(5):\n",
    "    print(f\"\\nTrajectory {traj}: {count} patients ({count/len(trajectories_at)*100:.1f}%)\")\n",
    "    top_diseases = np.argsort(phi_avg[traj])[-5:]\n",
    "    for idx in reversed(top_diseases):\n",
    "        print(f\"  {disease_names[idx]}: {phi_avg[traj, idx]:.3f}\")\n",
    "\n",
    "print(\"\\nMost common trajectories AFTER CAD:\")\n",
    "for traj, count in Counter(trajectories_after).most_common(5):\n",
    "    print(f\"\\nTrajectory {traj}: {count} patients ({count/len(trajectories_after)*100:.1f}%)\")\n",
    "    top_diseases = np.argsort(phi_avg[traj])[-5:]\n",
    "    for idx in reversed(top_diseases):\n",
    "        print(f\"  {disease_names[idx]}: {phi_avg[traj, idx]:.3f}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Found 11898 patients with CAD before age 60\n",
      "\n",
      "Most common trajectories BEFORE CAD onset:\n",
      "\n",
      "Trajectory 5: 1079 patients (9.1%)\n",
      "  Coronary atherosclerosis: 1.595\n",
      "  Other chronic ischemic heart disease, unspecified: 1.550\n",
      "  Myocardial infarction: 1.378\n",
      "  Hypercholesterolemia: 1.185\n",
      "  Other acute and subacute forms of ischemic heart disease: 0.864\n",
      "\n",
      "Trajectory 15: 671 patients (5.6%)\n",
      "  Hypoglycemia: 1.240\n",
      "  Type 2 diabetes with ophthalmic manifestations: 1.108\n",
      "  Type 2 diabetes: 0.983\n",
      "  Back pain: 0.342\n",
      "  Retinal detachments and defects: 0.009\n",
      "\n",
      "Trajectory 7: 624 patients (5.2%)\n",
      "  Other disorders of bone and cartilage: 2.792\n",
      "  Asthma: 2.307\n",
      "  Cervicalgia: 2.054\n",
      "  Sleep apnea: 1.925\n",
      "  Hyperlipidemia: 1.748\n",
      "\n",
      "Trajectory 11: 606 patients (5.1%)\n",
      "  Hemiplegia: 3.584\n",
      "  Cerebral artery occlusion, with cerebral infarction: 1.689\n",
      "  Occlusion and stenosis of precerebral arteries: 1.478\n",
      "  Occlusion of cerebral arteries: 0.772\n",
      "  Transient cerebral ischemia: 0.634\n",
      "\n",
      "Trajectory 8: 595 patients (5.0%)\n",
      "  Malignant neoplasm of uterus: 2.872\n",
      "  Uterine leiomyoma: 2.460\n",
      "  Cervicitis and endocervicitis: 1.833\n",
      "  Uterine/Uterovaginal prolapse: 1.715\n",
      "  Pain and other symptoms associated with female genital organs: 1.669\n",
      "\n",
      "Most common trajectories AT CAD onset:\n",
      "\n",
      "Trajectory 5: 1052 patients (8.9%)\n",
      "  Coronary atherosclerosis: 1.595\n",
      "  Other chronic ischemic heart disease, unspecified: 1.550\n",
      "  Myocardial infarction: 1.378\n",
      "  Hypercholesterolemia: 1.185\n",
      "  Other acute and subacute forms of ischemic heart disease: 0.864\n",
      "\n",
      "Trajectory 15: 673 patients (5.7%)\n",
      "  Hypoglycemia: 1.240\n",
      "  Type 2 diabetes with ophthalmic manifestations: 1.108\n",
      "  Type 2 diabetes: 0.983\n",
      "  Back pain: 0.342\n",
      "  Retinal detachments and defects: 0.009\n",
      "\n",
      "Trajectory 7: 608 patients (5.1%)\n",
      "  Other disorders of bone and cartilage: 2.792\n",
      "  Asthma: 2.307\n",
      "  Cervicalgia: 2.054\n",
      "  Sleep apnea: 1.925\n",
      "  Hyperlipidemia: 1.748\n",
      "\n",
      "Trajectory 11: 602 patients (5.1%)\n",
      "  Hemiplegia: 3.584\n",
      "  Cerebral artery occlusion, with cerebral infarction: 1.689\n",
      "  Occlusion and stenosis of precerebral arteries: 1.478\n",
      "  Occlusion of cerebral arteries: 0.772\n",
      "  Transient cerebral ischemia: 0.634\n",
      "\n",
      "Trajectory 12: 585 patients (4.9%)\n",
      "  Calculus of kidney: 2.454\n",
      "  Other disorders of the kidney and ureters: 1.813\n",
      "  Renal colic: 1.548\n",
      "  Calculus of ureter: 1.355\n",
      "  Stricture/obstruction of ureter: 1.166\n",
      "\n",
      "Most common trajectories AFTER CAD:\n",
      "\n",
      "Trajectory 5: 1029 patients (8.7%)\n",
      "  Coronary atherosclerosis: 1.595\n",
      "  Other chronic ischemic heart disease, unspecified: 1.550\n",
      "  Myocardial infarction: 1.378\n",
      "  Hypercholesterolemia: 1.185\n",
      "  Other acute and subacute forms of ischemic heart disease: 0.864\n",
      "\n",
      "Trajectory 15: 707 patients (5.9%)\n",
      "  Hypoglycemia: 1.240\n",
      "  Type 2 diabetes with ophthalmic manifestations: 1.108\n",
      "  Type 2 diabetes: 0.983\n",
      "  Back pain: 0.342\n",
      "  Retinal detachments and defects: 0.009\n",
      "\n",
      "Trajectory 7: 629 patients (5.3%)\n",
      "  Other disorders of bone and cartilage: 2.792\n",
      "  Asthma: 2.307\n",
      "  Cervicalgia: 2.054\n",
      "  Sleep apnea: 1.925\n",
      "  Hyperlipidemia: 1.748\n",
      "\n",
      "Trajectory 10: 604 patients (5.1%)\n",
      "  Senile cataract: 2.722\n",
      "  Retinal detachments and defects: 2.291\n",
      "  Other retinal disorders: 2.281\n",
      "  Retinal vascular changes and abnomalities: 1.591\n",
      "  Macular degeneration (senile) of retina NOS: 1.102\n",
      "\n",
      "Trajectory 0: 590 patients (5.0%)\n",
      "  Paroxysmal ventricular tachycardia: 2.679\n",
      "  Left bundle branch block: 1.833\n",
      "  Pericarditis: 1.770\n",
      "  Aortic valve disease: 1.746\n",
      "  Heart failure NOS: 1.595\n"
     ]
    }
   ],
   "source": [
    "# First identify people who develop CAD before age 60 (index 30)\n",
    "early_age = 30\n",
    "cad_indices = [disease_names.index(d) for d in ['Coronary atherosclerosis', 'Myocardial infarction']]\n",
    "\n",
    "# Find first CAD occurrence for each person\n",
    "early_cad_mask = np.zeros(combined_Y.shape[0], dtype=bool)\n",
    "first_cad_time = np.full(combined_Y.shape[0], np.inf)\n",
    "\n",
    "for cad_idx in cad_indices:\n",
    "    has_cad = np.any(combined_Y[:, cad_idx, :early_age], axis=1)\n",
    "    early_cad_mask |= has_cad\n",
    "    # For those with CAD, find first occurrence\n",
    "    cad_patients = np.where(has_cad)[0]\n",
    "    for patient in cad_patients:\n",
    "        onset = np.argmax(combined_Y[patient, cad_idx, :early_age])\n",
    "        first_cad_time[patient] = min(first_cad_time[patient], onset)\n",
    "\n",
    "print(f\"Found {np.sum(early_cad_mask)} patients with CAD before age 60\")\n",
    "\n",
    "# For these patients:\n",
    "# 1. What trajectory were they in 5 years before CAD?\n",
    "# 2. What trajectory at CAD onset?\n",
    "# 3. What trajectory 5 years after?\n",
    "\n",
    "look_window = 5\n",
    "trajectories_before = []\n",
    "trajectories_at = []\n",
    "trajectories_after = []\n",
    "\n",
    "for patient in np.where(early_cad_mask)[0]:\n",
    "    onset = int(first_cad_time[patient])\n",
    "    if onset >= look_window and onset + look_window < combined_Y.shape[2]:\n",
    "        # Get dominant trajectories at each timepoint\n",
    "        traj_before = np.argmax(thetas[patient, :, onset-look_window])\n",
    "        traj_at = np.argmax(thetas[patient, :, onset])\n",
    "        traj_after = np.argmax(thetas[patient, :, onset+look_window])\n",
    "        \n",
    "        trajectories_before.append(traj_before)\n",
    "        trajectories_at.append(traj_at)\n",
    "        trajectories_after.append(traj_after)\n",
    "\n",
    "# Analyze common patterns\n",
    "from collections import Counter\n",
    "\n",
    "print(\"\\nMost common trajectories BEFORE CAD onset:\")\n",
    "for traj, count in Counter(trajectories_before).most_common(5):\n",
    "    print(f\"\\nTrajectory {traj}: {count} patients ({count/len(trajectories_before)*100:.1f}%)\")\n",
    "    top_diseases = np.argsort(phi_avg[traj])[-5:]\n",
    "    for idx in reversed(top_diseases):\n",
    "        print(f\"  {disease_names[idx]}: {phi_avg[traj, idx]:.3f}\")\n",
    "\n",
    "print(\"\\nMost common trajectories AT CAD onset:\")\n",
    "for traj, count in Counter(trajectories_at).most_common(5):\n",
    "    print(f\"\\nTrajectory {traj}: {count} patients ({count/len(trajectories_at)*100:.1f}%)\")\n",
    "    top_diseases = np.argsort(phi_avg[traj])[-5:]\n",
    "    for idx in reversed(top_diseases):\n",
    "        print(f\"  {disease_names[idx]}: {phi_avg[traj, idx]:.3f}\")\n",
    "\n",
    "print(\"\\nMost common trajectories AFTER CAD:\")\n",
    "for traj, count in Counter(trajectories_after).most_common(5):\n",
    "    print(f\"\\nTrajectory {traj}: {count} patients ({count/len(trajectories_after)*100:.1f}%)\")\n",
    "    top_diseases = np.argsort(phi_avg[traj])[-5:]\n",
    "    for idx in reversed(top_diseases):\n",
    "        print(f\"  {disease_names[idx]}: {phi_avg[traj, idx]:.3f}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Transitions from CAD Trajectory (#5):\n",
      "Starting population: 322 individuals\n",
      "\n",
      "To Trajectory 5: 0.938\n",
      "Top diseases (centered phi):\n",
      "  Coronary atherosclerosis: 1.595\n",
      "  Other chronic ischemic heart disease, unspecified: 1.550\n",
      "  Myocardial infarction: 1.378\n",
      "  Hypercholesterolemia: 1.185\n",
      "  Other acute and subacute forms of ischemic heart disease: 0.864\n"
     ]
    }
   ],
   "source": [
    "\n",
    "\n",
    "# Analyze transitions from Trajectory 5 (CAD cluster)\n",
    "cad_traj = 5\n",
    "time_x = 30  # Age 60\n",
    "\n",
    "# Get individuals with high loading on trajectory 5 at time_x\n",
    "high_loading_cad = thetas[:, cad_traj, time_x] > 0.5\n",
    "n_individuals = np.sum(high_loading_cad)\n",
    "n_trajectories=20\n",
    "\n",
    "# Get their future trajectories\n",
    "future_trajectories = np.argmax(thetas[high_loading_cad, :, time_x + future_window], axis=1)\n",
    "transitions = np.bincount(future_trajectories, minlength=n_trajectories) / len(future_trajectories)\n",
    "\n",
    "print(f\"\\nTransitions from CAD Trajectory (#{cad_traj}):\")\n",
    "print(f\"Starting population: {n_individuals} individuals\")\n",
    "\n",
    "# Show major transitions and characteristic diseases of destination trajectories\n",
    "for j, prob in enumerate(transitions):\n",
    "    if prob > 0.05:  # Show transitions >5%\n",
    "        print(f\"\\nTo Trajectory {j}: {prob:.3f}\")\n",
    "        # Get top diseases by centered phi for destination trajectory\n",
    "        top_diseases = np.argsort(phi_avg[j])[-5:]\n",
    "        print(\"Top diseases (centered phi):\")\n",
    "        for idx in reversed(top_diseases):\n",
    "            print(f\"  {disease_names[idx]}: {phi_avg[j, idx]:.3f}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Found Coronary atherosclerosis at index: 114\n",
      "Found Myocardial infarction at index: 112\n",
      "\n",
      "Found 1 trajectories with high CAD loading:\n",
      "\n",
      "\n",
      "Transitions from Trajectory 5:\n",
      "Starting population: 322 individuals\n",
      "CAD-related phi values:\n",
      "  Coronary atherosclerosis: 1.595\n",
      "  Myocardial infarction: 1.378\n",
      "\n",
      "Major transitions (>5%):\n",
      "\n",
      "To Trajectory 5: 0.938\n",
      "Top diseases (centered phi):\n",
      "  Coronary atherosclerosis: 1.595\n",
      "  Other chronic ischemic heart disease, unspecified: 1.550\n",
      "  Myocardial infarction: 1.378\n",
      "  Hypercholesterolemia: 1.185\n",
      "  Other acute and subacute forms of ischemic heart disease: 0.864\n"
     ]
    }
   ],
   "source": [
    "# First get trajectories with high CAD-related diseases from phi_avg\n",
    "cad_indices = []\n",
    "for condition in ['Coronary atherosclerosis', 'Myocardial infarction']:\n",
    "    try:\n",
    "        idx = disease_names.index(condition)\n",
    "        cad_indices.append(idx)\n",
    "        print(f\"Found {condition} at index: {idx}\")\n",
    "    except ValueError:\n",
    "        print(f\"Warning: {condition} not found in disease names\")\n",
    "\n",
    "# Find trajectories with high CAD loading\n",
    "cad_related_trajectories = []\n",
    "for k in range(n_trajectories):\n",
    "    if any(phi_avg[k, idx] > 0 for idx in cad_indices):\n",
    "        cad_related_trajectories.append(k)\n",
    "\n",
    "print(f\"\\nFound {len(cad_related_trajectories)} trajectories with high CAD loading:\")\n",
    "\n",
    "# Analyze transitions from each CAD-related trajectory\n",
    "time_x = 30  # Age 60\n",
    "future_window = 10\n",
    "\n",
    "for source_traj in cad_related_trajectories:\n",
    "    # Get individuals with high loading on this trajectory at time_x\n",
    "    high_loading = thetas[:, source_traj, time_x] > 0.5\n",
    "    n_individuals = np.sum(high_loading)\n",
    "    \n",
    "    if n_individuals > 0:\n",
    "        # Get their future trajectories\n",
    "        future_trajectories = np.argmax(thetas[high_loading, :, time_x + future_window], axis=1)\n",
    "        transitions = np.bincount(future_trajectories, minlength=n_trajectories) / len(future_trajectories)\n",
    "        \n",
    "        print(f\"\\n\\nTransitions from Trajectory {source_traj}:\")\n",
    "        print(f\"Starting population: {n_individuals} individuals\")\n",
    "        print(f\"CAD-related phi values:\")\n",
    "        for idx in cad_indices:\n",
    "            print(f\"  {disease_names[idx]}: {phi_avg[source_traj, idx]:.3f}\")\n",
    "        \n",
    "        # Show major transitions\n",
    "        print(\"\\nMajor transitions (>5%):\")\n",
    "        for j, prob in enumerate(transitions):\n",
    "            if prob > 0.05:\n",
    "                print(f\"\\nTo Trajectory {j}: {prob:.3f}\")\n",
    "                # Get top diseases by centered phi for destination trajectory\n",
    "                top_diseases = np.argsort(phi_avg[j])[-5:]\n",
    "                print(\"Top diseases (centered phi):\")\n",
    "                for idx in reversed(top_diseases):\n",
    "                    print(f\"  {disease_names[idx]}: {phi_avg[j, idx]:.3f}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Trajectory progression for early CAD individuals:\n",
      "Before CAD -> At CAD -> After CAD\n",
      "\n",
      "Progression pattern (n=41, 6.9%):\n",
      "Trajectory 5 -> 5 -> 5\n",
      "\n",
      "Pre-CAD Trajectory 5 top diseases:\n",
      "  Coronary atherosclerosis: 1.595\n",
      "  Other chronic ischemic heart disease, unspecified: 1.550\n",
      "  Myocardial infarction: 1.378\n",
      "  Hypercholesterolemia: 1.185\n",
      "  Other acute and subacute forms of ischemic heart disease: 0.864\n",
      "\n",
      "Final Trajectory 5 top diseases:\n",
      "  Coronary atherosclerosis: 1.595\n",
      "  Other chronic ischemic heart disease, unspecified: 1.550\n",
      "  Myocardial infarction: 1.378\n",
      "  Hypercholesterolemia: 1.185\n",
      "  Other acute and subacute forms of ischemic heart disease: 0.864\n",
      "\n",
      "Progression pattern (n=16, 2.7%):\n",
      "Trajectory 16 -> 16 -> 16\n",
      "\n",
      "Pre-CAD Trajectory 16 top diseases:\n",
      "  Staphylococcus infections: 1.687\n",
      "  Other local infections of skin and subcutaneous tissue: 1.663\n",
      "  Hyposmolality and/or hyponatremia: 1.597\n",
      "  E. coli: 1.560\n",
      "  Thrombocytopenia: 1.504\n",
      "\n",
      "Final Trajectory 16 top diseases:\n",
      "  Staphylococcus infections: 1.687\n",
      "  Other local infections of skin and subcutaneous tissue: 1.663\n",
      "  Hyposmolality and/or hyponatremia: 1.597\n",
      "  E. coli: 1.560\n",
      "  Thrombocytopenia: 1.504\n",
      "\n",
      "Progression pattern (n=15, 2.5%):\n",
      "Trajectory 18 -> 18 -> 18\n",
      "\n",
      "Pre-CAD Trajectory 18 top diseases:\n",
      "  Cholelithiasis with acute cholecystitis: 2.370\n",
      "  Peritoneal adhesions (postoperative) (postinfection): 2.001\n",
      "  Acute pancreatitis: 1.679\n",
      "  Cholecystitis without cholelithiasis: 1.504\n",
      "  Cholelithiasis with other cholecystitis: 1.363\n",
      "\n",
      "Final Trajectory 18 top diseases:\n",
      "  Cholelithiasis with acute cholecystitis: 2.370\n",
      "  Peritoneal adhesions (postoperative) (postinfection): 2.001\n",
      "  Acute pancreatitis: 1.679\n",
      "  Cholecystitis without cholelithiasis: 1.504\n",
      "  Cholelithiasis with other cholecystitis: 1.363\n",
      "\n",
      "Progression pattern (n=14, 2.4%):\n",
      "Trajectory 15 -> 15 -> 15\n",
      "\n",
      "Pre-CAD Trajectory 15 top diseases:\n",
      "  Hypoglycemia: 1.240\n",
      "  Type 2 diabetes with ophthalmic manifestations: 1.108\n",
      "  Type 2 diabetes: 0.983\n",
      "  Back pain: 0.342\n",
      "  Retinal detachments and defects: 0.009\n",
      "\n",
      "Final Trajectory 15 top diseases:\n",
      "  Hypoglycemia: 1.240\n",
      "  Type 2 diabetes with ophthalmic manifestations: 1.108\n",
      "  Type 2 diabetes: 0.983\n",
      "  Back pain: 0.342\n",
      "  Retinal detachments and defects: 0.009\n",
      "\n",
      "Progression pattern (n=13, 2.2%):\n",
      "Trajectory 6 -> 6 -> 6\n",
      "\n",
      "Pre-CAD Trajectory 6 top diseases:\n",
      "  Secondary malignancy of bone: 1.751\n",
      "  Secondary malignant neoplasm of digestive systems: 1.345\n",
      "  Cancer of bronchus; lung: 1.293\n",
      "  Secondary malignancy of lymph nodes: 0.729\n",
      "  Malignant neoplasm, other: 0.385\n",
      "\n",
      "Final Trajectory 6 top diseases:\n",
      "  Secondary malignancy of bone: 1.751\n",
      "  Secondary malignant neoplasm of digestive systems: 1.345\n",
      "  Cancer of bronchus; lung: 1.293\n",
      "  Secondary malignancy of lymph nodes: 0.729\n",
      "  Malignant neoplasm, other: 0.385\n",
      "\n",
      "Progression pattern (n=13, 2.2%):\n",
      "Trajectory 2 -> 2 -> 2\n",
      "\n",
      "Pre-CAD Trajectory 2 top diseases:\n",
      "  Gastritis and duodenitis: 2.279\n",
      "  Iron deficiency anemias, unspecified or not due to blood loss: 1.123\n",
      "  Duodenitis: 0.726\n",
      "  Duodenal ulcer: 0.637\n",
      "  Benign neoplasm of other parts of digestive system: 0.563\n",
      "\n",
      "Final Trajectory 2 top diseases:\n",
      "  Gastritis and duodenitis: 2.279\n",
      "  Iron deficiency anemias, unspecified or not due to blood loss: 1.123\n",
      "  Duodenitis: 0.726\n",
      "  Duodenal ulcer: 0.637\n",
      "  Benign neoplasm of other parts of digestive system: 0.563\n",
      "\n",
      "Progression pattern (n=11, 1.9%):\n",
      "Trajectory 13 -> 13 -> 13\n",
      "\n",
      "Pre-CAD Trajectory 13 top diseases:\n",
      "  Other symptoms/disorders or the urinary system: 1.968\n",
      "  Hyperplasia of prostate: 1.914\n",
      "  Cancer of prostate: 1.694\n",
      "  Chronic cystitis: 1.671\n",
      "  Urinary incontinence: 1.643\n",
      "\n",
      "Final Trajectory 13 top diseases:\n",
      "  Other symptoms/disorders or the urinary system: 1.968\n",
      "  Hyperplasia of prostate: 1.914\n",
      "  Cancer of prostate: 1.694\n",
      "  Chronic cystitis: 1.671\n",
      "  Urinary incontinence: 1.643\n",
      "\n",
      "Progression pattern (n=11, 1.9%):\n",
      "Trajectory 4 -> 4 -> 4\n",
      "\n",
      "Pre-CAD Trajectory 4 top diseases:\n",
      "  Nasal polyps: 0.895\n",
      "  Other upper respiratory disease: 0.738\n",
      "  Chronic sinusitis: 0.362\n",
      "  Septal Deviations/Turbinate Hypertrophy: 0.281\n",
      "  Chronic pharyngitis and nasopharyngitis: 0.200\n",
      "\n",
      "Final Trajectory 4 top diseases:\n",
      "  Nasal polyps: 0.895\n",
      "  Other upper respiratory disease: 0.738\n",
      "  Chronic sinusitis: 0.362\n",
      "  Septal Deviations/Turbinate Hypertrophy: 0.281\n",
      "  Chronic pharyngitis and nasopharyngitis: 0.200\n",
      "\n",
      "Progression pattern (n=11, 1.9%):\n",
      "Trajectory 11 -> 11 -> 11\n",
      "\n",
      "Pre-CAD Trajectory 11 top diseases:\n",
      "  Hemiplegia: 3.584\n",
      "  Cerebral artery occlusion, with cerebral infarction: 1.689\n",
      "  Occlusion and stenosis of precerebral arteries: 1.478\n",
      "  Occlusion of cerebral arteries: 0.772\n",
      "  Transient cerebral ischemia: 0.634\n",
      "\n",
      "Final Trajectory 11 top diseases:\n",
      "  Hemiplegia: 3.584\n",
      "  Cerebral artery occlusion, with cerebral infarction: 1.689\n",
      "  Occlusion and stenosis of precerebral arteries: 1.478\n",
      "  Occlusion of cerebral arteries: 0.772\n",
      "  Transient cerebral ischemia: 0.634\n",
      "\n",
      "Progression pattern (n=10, 1.7%):\n",
      "Trajectory 7 -> 7 -> 7\n",
      "\n",
      "Pre-CAD Trajectory 7 top diseases:\n",
      "  Other disorders of bone and cartilage: 2.792\n",
      "  Asthma: 2.307\n",
      "  Cervicalgia: 2.054\n",
      "  Sleep apnea: 1.925\n",
      "  Hyperlipidemia: 1.748\n",
      "\n",
      "Final Trajectory 7 top diseases:\n",
      "  Other disorders of bone and cartilage: 2.792\n",
      "  Asthma: 2.307\n",
      "  Cervicalgia: 2.054\n",
      "  Sleep apnea: 1.925\n",
      "  Hyperlipidemia: 1.748\n",
      "\n",
      "Progression pattern (n=10, 1.7%):\n",
      "Trajectory 1 -> 1 -> 1\n",
      "\n",
      "Pre-CAD Trajectory 1 top diseases:\n",
      "  Acquired toe deformities: 2.335\n",
      "  Rheumatoid arthritis: 2.318\n",
      "  Other peripheral nerve disorders: 2.113\n",
      "  Symptoms and disorders of the joints: 2.091\n",
      "  Osteoarthritis; localized: 1.736\n",
      "\n",
      "Final Trajectory 1 top diseases:\n",
      "  Acquired toe deformities: 2.335\n",
      "  Rheumatoid arthritis: 2.318\n",
      "  Other peripheral nerve disorders: 2.113\n",
      "  Symptoms and disorders of the joints: 2.091\n",
      "  Osteoarthritis; localized: 1.736\n",
      "\n",
      "Progression pattern (n=9, 1.5%):\n",
      "Trajectory 14 -> 14 -> 14\n",
      "\n",
      "Pre-CAD Trajectory 14 top diseases:\n",
      "  Bronchiectasis: 2.060\n",
      "  Chronic airway obstruction: 1.970\n",
      "  Pneumococcal pneumonia: 1.682\n",
      "  Respiratory failure: 1.670\n",
      "  Obstructive chronic bronchitis: 1.396\n",
      "\n",
      "Final Trajectory 14 top diseases:\n",
      "  Bronchiectasis: 2.060\n",
      "  Chronic airway obstruction: 1.970\n",
      "  Pneumococcal pneumonia: 1.682\n",
      "  Respiratory failure: 1.670\n",
      "  Obstructive chronic bronchitis: 1.396\n",
      "\n",
      "Progression pattern (n=9, 1.5%):\n",
      "Trajectory 3 -> 3 -> 3\n",
      "\n",
      "Pre-CAD Trajectory 3 top diseases:\n",
      "  Stricture of artery: 2.983\n",
      "  Alcoholic liver damage: 2.629\n",
      "  Atopic/contact dermatitis due to other or unspecified: 2.593\n",
      "  Multiple sclerosis: 2.425\n",
      "  Benign neoplasm of lip, oral cavity, and pharynx: 2.399\n",
      "\n",
      "Final Trajectory 3 top diseases:\n",
      "  Stricture of artery: 2.983\n",
      "  Alcoholic liver damage: 2.629\n",
      "  Atopic/contact dermatitis due to other or unspecified: 2.593\n",
      "  Multiple sclerosis: 2.425\n",
      "  Benign neoplasm of lip, oral cavity, and pharynx: 2.399\n",
      "\n",
      "Progression pattern (n=8, 1.3%):\n",
      "Trajectory 10 -> 10 -> 10\n",
      "\n",
      "Pre-CAD Trajectory 10 top diseases:\n",
      "  Senile cataract: 2.722\n",
      "  Retinal detachments and defects: 2.291\n",
      "  Other retinal disorders: 2.281\n",
      "  Retinal vascular changes and abnomalities: 1.591\n",
      "  Macular degeneration (senile) of retina NOS: 1.102\n",
      "\n",
      "Final Trajectory 10 top diseases:\n",
      "  Senile cataract: 2.722\n",
      "  Retinal detachments and defects: 2.291\n",
      "  Other retinal disorders: 2.281\n",
      "  Retinal vascular changes and abnomalities: 1.591\n",
      "  Macular degeneration (senile) of retina NOS: 1.102\n",
      "\n",
      "Progression pattern (n=8, 1.3%):\n",
      "Trajectory 0 -> 0 -> 0\n",
      "\n",
      "Pre-CAD Trajectory 0 top diseases:\n",
      "  Paroxysmal ventricular tachycardia: 2.679\n",
      "  Left bundle branch block: 1.833\n",
      "  Pericarditis: 1.770\n",
      "  Aortic valve disease: 1.746\n",
      "  Heart failure NOS: 1.595\n",
      "\n",
      "Final Trajectory 0 top diseases:\n",
      "  Paroxysmal ventricular tachycardia: 2.679\n",
      "  Left bundle branch block: 1.833\n",
      "  Pericarditis: 1.770\n",
      "  Aortic valve disease: 1.746\n",
      "  Heart failure NOS: 1.595\n",
      "\n",
      "Summary of Pre-CAD Trajectories:\n",
      "\n",
      "Trajectory 5: 72 individuals (12.1%)\n",
      "  Coronary atherosclerosis: 1.595\n",
      "  Other chronic ischemic heart disease, unspecified: 1.550\n",
      "  Myocardial infarction: 1.378\n",
      "  Hypercholesterolemia: 1.185\n",
      "  Other acute and subacute forms of ischemic heart disease: 0.864\n",
      "\n",
      "Trajectory 8: 38 individuals (6.4%)\n",
      "  Malignant neoplasm of uterus: 2.872\n",
      "  Uterine leiomyoma: 2.460\n",
      "  Cervicitis and endocervicitis: 1.833\n",
      "  Uterine/Uterovaginal prolapse: 1.715\n",
      "  Pain and other symptoms associated with female genital organs: 1.669\n",
      "\n",
      "Trajectory 16: 37 individuals (6.2%)\n",
      "  Staphylococcus infections: 1.687\n",
      "  Other local infections of skin and subcutaneous tissue: 1.663\n",
      "  Hyposmolality and/or hyponatremia: 1.597\n",
      "  E. coli: 1.560\n",
      "  Thrombocytopenia: 1.504\n",
      "\n",
      "Trajectory 15: 34 individuals (5.7%)\n",
      "  Hypoglycemia: 1.240\n",
      "  Type 2 diabetes with ophthalmic manifestations: 1.108\n",
      "  Type 2 diabetes: 0.983\n",
      "  Back pain: 0.342\n",
      "  Retinal detachments and defects: 0.009\n",
      "\n",
      "Trajectory 4: 33 individuals (5.6%)\n",
      "  Nasal polyps: 0.895\n",
      "  Other upper respiratory disease: 0.738\n",
      "  Chronic sinusitis: 0.362\n",
      "  Septal Deviations/Turbinate Hypertrophy: 0.281\n",
      "  Chronic pharyngitis and nasopharyngitis: 0.200\n",
      "\n",
      "Trajectory 14: 32 individuals (5.4%)\n",
      "  Bronchiectasis: 2.060\n",
      "  Chronic airway obstruction: 1.970\n",
      "  Pneumococcal pneumonia: 1.682\n",
      "  Respiratory failure: 1.670\n",
      "  Obstructive chronic bronchitis: 1.396\n",
      "\n",
      "Trajectory 13: 29 individuals (4.9%)\n",
      "  Other symptoms/disorders or the urinary system: 1.968\n",
      "  Hyperplasia of prostate: 1.914\n",
      "  Cancer of prostate: 1.694\n",
      "  Chronic cystitis: 1.671\n",
      "  Urinary incontinence: 1.643\n",
      "\n",
      "Trajectory 18: 28 individuals (4.7%)\n",
      "  Cholelithiasis with acute cholecystitis: 2.370\n",
      "  Peritoneal adhesions (postoperative) (postinfection): 2.001\n",
      "  Acute pancreatitis: 1.679\n",
      "  Cholecystitis without cholelithiasis: 1.504\n",
      "  Cholelithiasis with other cholecystitis: 1.363\n",
      "\n",
      "Trajectory 9: 27 individuals (4.5%)\n",
      "  Displacement of intervertebral disc: 1.951\n",
      "  Spinal stenosis: 1.718\n",
      "  Back pain: 1.459\n",
      "  Spondylosis without myelopathy: 1.357\n",
      "  Thoracic or lumbosacral neuritis or radiculitis, unspecified: 1.244\n",
      "\n",
      "Trajectory 7: 26 individuals (4.4%)\n",
      "  Other disorders of bone and cartilage: 2.792\n",
      "  Asthma: 2.307\n",
      "  Cervicalgia: 2.054\n",
      "  Sleep apnea: 1.925\n",
      "  Hyperlipidemia: 1.748\n",
      "\n",
      "Trajectory 19: 26 individuals (4.4%)\n",
      "  Thyrotoxicosis with or without goiter: 1.977\n",
      "  Chronic glomerulonephritis, NOS: 1.837\n",
      "  Chronic renal failure [CKD]: 1.763\n",
      "  Renal failure NOS: 1.746\n",
      "  Viral warts & HPV: 1.732\n",
      "\n",
      "Trajectory 10: 26 individuals (4.4%)\n",
      "  Senile cataract: 2.722\n",
      "  Retinal detachments and defects: 2.291\n",
      "  Other retinal disorders: 2.281\n",
      "  Retinal vascular changes and abnomalities: 1.591\n",
      "  Macular degeneration (senile) of retina NOS: 1.102\n",
      "\n",
      "Trajectory 6: 26 individuals (4.4%)\n",
      "  Secondary malignancy of bone: 1.751\n",
      "  Secondary malignant neoplasm of digestive systems: 1.345\n",
      "  Cancer of bronchus; lung: 1.293\n",
      "  Secondary malignancy of lymph nodes: 0.729\n",
      "  Malignant neoplasm, other: 0.385\n",
      "\n",
      "Trajectory 0: 26 individuals (4.4%)\n",
      "  Paroxysmal ventricular tachycardia: 2.679\n",
      "  Left bundle branch block: 1.833\n",
      "  Pericarditis: 1.770\n",
      "  Aortic valve disease: 1.746\n",
      "  Heart failure NOS: 1.595\n",
      "\n",
      "Trajectory 2: 26 individuals (4.4%)\n",
      "  Gastritis and duodenitis: 2.279\n",
      "  Iron deficiency anemias, unspecified or not due to blood loss: 1.123\n",
      "  Duodenitis: 0.726\n",
      "  Duodenal ulcer: 0.637\n",
      "  Benign neoplasm of other parts of digestive system: 0.563\n",
      "\n",
      "Trajectory 3: 25 individuals (4.2%)\n",
      "  Stricture of artery: 2.983\n",
      "  Alcoholic liver damage: 2.629\n",
      "  Atopic/contact dermatitis due to other or unspecified: 2.593\n",
      "  Multiple sclerosis: 2.425\n",
      "  Benign neoplasm of lip, oral cavity, and pharynx: 2.399\n",
      "\n",
      "Trajectory 11: 25 individuals (4.2%)\n",
      "  Hemiplegia: 3.584\n",
      "  Cerebral artery occlusion, with cerebral infarction: 1.689\n",
      "  Occlusion and stenosis of precerebral arteries: 1.478\n",
      "  Occlusion of cerebral arteries: 0.772\n",
      "  Transient cerebral ischemia: 0.634\n",
      "\n",
      "Trajectory 1: 23 individuals (3.9%)\n",
      "  Acquired toe deformities: 2.335\n",
      "  Rheumatoid arthritis: 2.318\n",
      "  Other peripheral nerve disorders: 2.113\n",
      "  Symptoms and disorders of the joints: 2.091\n",
      "  Osteoarthritis; localized: 1.736\n",
      "\n",
      "Trajectory 17: 19 individuals (3.2%)\n",
      "  Gastrointestinal complications: 2.395\n",
      "  Diverticulosis: 1.931\n",
      "  Benign neoplasm of colon: 1.702\n",
      "  Anal and rectal conditions: 1.626\n",
      "  Malignant neoplasm of rectum, rectosigmoid junction, and anus: 1.424\n",
      "\n",
      "Trajectory 12: 16 individuals (2.7%)\n",
      "  Calculus of kidney: 2.454\n",
      "  Other disorders of the kidney and ureters: 1.813\n",
      "  Renal colic: 1.548\n",
      "  Calculus of ureter: 1.355\n",
      "  Stricture/obstruction of ureter: 1.166\n"
     ]
    }
   ],
   "source": [
    "# For early CAD, let's look at ages 30-45 (indices 0-15)\n",
    "early_time = 15  # Age 45\n",
    "look_back = 5   # Look back 5 years (age 40)\n",
    "look_forward = 5 # Look forward 5 years (age 50)\n",
    "\n",
    "# Find people with early CAD (before age 45)\n",
    "early_cad = np.zeros(combined_Y.shape[0], dtype=bool)\n",
    "for cad_idx in cad_indices:\n",
    "    early_cad |= np.any(combined_Y[:, cad_idx, :early_time], axis=1)\n",
    "\n",
    "# Get trajectories at different time points\n",
    "pre_cad_trajectories = np.argmax(thetas[early_cad, :, early_time-look_back], axis=1)  # Age 40\n",
    "current_trajectories = np.argmax(thetas[early_cad, :, early_time], axis=1)  # Age 45\n",
    "future_trajectories = np.argmax(thetas[early_cad, :, early_time+look_forward], axis=1)  # Age 50 2.5 years after\n",
    "\n",
    "print(\"\\nTrajectory progression for early CAD individuals:\")\n",
    "print(\"Before CAD -> At CAD -> After CAD\")\n",
    "\n",
    "# Count and show more progression patterns\n",
    "from collections import Counter\n",
    "progression_patterns = Counter(zip(pre_cad_trajectories, current_trajectories, future_trajectories))\n",
    "\n",
    "# Show top 15 patterns and calculate percentage\n",
    "total_early_cad = np.sum(early_cad)\n",
    "for (pre, curr, post), count in progression_patterns.most_common(15):\n",
    "    percentage = (count / total_early_cad) * 100\n",
    "    print(f\"\\nProgression pattern (n={count}, {percentage:.1f}%):\")\n",
    "    print(f\"Trajectory {pre} -> {curr} -> {post}\")\n",
    "    \n",
    "    # Show diseases for pre-CAD trajectory to understand what came before\n",
    "    print(f\"\\nPre-CAD Trajectory {pre} top diseases:\")\n",
    "    top_diseases = np.argsort(phi_avg[pre])[-5:]\n",
    "    for idx in reversed(top_diseases):\n",
    "        print(f\"  {disease_names[idx]}: {phi_avg[pre, idx]:.3f}\")\n",
    "    \n",
    "    # Show where they ended up\n",
    "    print(f\"\\nFinal Trajectory {post} top diseases:\")\n",
    "    top_diseases = np.argsort(phi_avg[post])[-5:]\n",
    "    for idx in reversed(top_diseases):\n",
    "        print(f\"  {disease_names[idx]}: {phi_avg[post, idx]:.3f}\")\n",
    "\n",
    "# Also show summary of initial trajectories\n",
    "print(\"\\nSummary of Pre-CAD Trajectories:\")\n",
    "pre_cad_counts = Counter(pre_cad_trajectories)\n",
    "for traj, count in pre_cad_counts.most_common():\n",
    "    percentage = (count / total_early_cad) * 100\n",
    "    print(f\"\\nTrajectory {traj}: {count} individuals ({percentage:.1f}%)\")\n",
    "    top_diseases = np.argsort(phi_avg[traj])[-5:]\n",
    "    for idx in reversed(top_diseases):\n",
    "        print(f\"  {disease_names[idx]}: {phi_avg[traj, idx]:.3f}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "# Select some interesting diseases and signatures to plot\n",
    "diseases_to_plot = [0, 1, 2]  # replace with actual disease indices of interest\n",
    "signatures_to_plot = [0, 1, 2]  # replace with signatures of interest\n",
    "\n",
    "# Create plots\n",
    "for k in signatures_to_plot:\n",
    "    for d in diseases_to_plot:\n",
    "        plt.figure(figsize=(12, 6))\n",
    "        \n",
    "        # Plot individual batch trajectories in light gray\n",
    "        for batch_phi in all_phis:\n",
    "            plt.plot(batch_phi[k, d, :], color='gray', alpha=0.2)\n",
    "        \n",
    "        # Plot mean trajectory in bold\n",
    "        plt.plot(mean_phi[k, d, :], color='blue', linewidth=2, label='Mean')\n",
    "        \n",
    "        # Add confidence intervals\n",
    "        std_phi = np.std(all_phis[:, k, d, :], axis=0)\n",
    "        ci = 1.96 * std_phi / np.sqrt(len(all_phis))\n",
    "        plt.fill_between(range(mean_phi.shape[2]), \n",
    "                        mean_phi[k, d, :] - ci,\n",
    "                        mean_phi[k, d, :] + ci,\n",
    "                        alpha=0.2, color='blue')\n",
    "        \n",
    "        plt.title(f'Signature {k}, Disease {d} Temporal Pattern,unsharedseed')\n",
    "        plt.xlabel('Time')\n",
    "        plt.ylabel('Phi Value')\n",
    "        plt.grid(True, alpha=0.3)\n",
    "        plt.savefig(f'phi_trajectory_sig{k}_disease{d}_unshared.png')\n",
    "        plt.close()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [],
   "source": [
    "import numpy as np\n",
    "import matplotlib.pyplot as plt\n",
    "from scipy.special import expit  # for sigmoid function\n",
    "\n",
    "# Select some interesting diseases and signatures to plot\n",
    "diseases_to_plot = [0, 1, 2]  # replace with actual disease indices of interest\n",
    "signatures_to_plot = [0, 1, 2]  # replace with signatures of interest\n",
    "\n",
    "# Create plots\n",
    "for k in signatures_to_plot:\n",
    "    for d in diseases_to_plot:\n",
    "        plt.figure(figsize=(12, 6))\n",
    "        \n",
    "        # Plot individual batch trajectories in light gray\n",
    "        for batch_phi in all_phis:\n",
    "            plt.plot(expit(batch_phi[k, d, :]), color='gray', alpha=0.2)\n",
    "        \n",
    "        # Plot mean trajectory in bold\n",
    "        # Note: We should apply expit to individual values before taking mean\n",
    "        mean_prob = expit(mean_phi[k, d, :])\n",
    "        plt.plot(mean_prob, color='blue', linewidth=2, label='Mean')\n",
    "        \n",
    "        # For confidence intervals, transform the bounds\n",
    "        std_phi = np.std(all_phis[:, k, d, :], axis=0)\n",
    "        ci = 1.96 * std_phi / np.sqrt(len(all_phis))\n",
    "        lower_ci = expit(mean_phi[k, d, :] - ci)\n",
    "        upper_ci = expit(mean_phi[k, d, :] + ci)\n",
    "        \n",
    "        plt.fill_between(range(mean_phi.shape[2]), \n",
    "                        lower_ci,\n",
    "                        upper_ci,\n",
    "                        alpha=0.2, color='blue')\n",
    "        \n",
    "        plt.title(f'Signature {k}, Disease {d} Temporal Pattern (Probability),unsharedseed')\n",
    "        plt.xlabel('Time')\n",
    "        plt.ylabel('Probability')\n",
    "        #plt.ylim(0, 1)  # Removed fixed y-axis limits\n",
    "        plt.grid(True, alpha=0.3)\n",
    "        plt.savefig(f'phi_probability_sig{k}_disease{d}_unshared.png')\n",
    "        plt.close()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 70,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/2f/nxrbr3pn1msgrl4ffyj33zd00000gn/T/ipykernel_68206/901596302.py:14: FutureWarning: You are using `torch.load` with `weights_only=False` (the current default value), which uses the default pickle module implicitly. It is possible to construct malicious pickle data which will execute arbitrary code during unpickling (See https://github.com/pytorch/pytorch/blob/main/SECURITY.md#untrusted-models for more details). In a future release, the default value for `weights_only` will be flipped to `True`. This limits the functions that could be executed during unpickling. Arbitrary objects will no longer be allowed to be loaded via this mode unless they are explicitly allowlisted by the user via `torch.serialization.add_safe_globals`. We recommend you start setting `weights_only=True` for any use case where you don't have full control of the loaded file. Please open an issue on GitHub for any issues related to this experimental feature.\n",
      "  first_model = torch.load(os.path.join(output_dirs[0], 'model.pt'))\n",
      "/var/folders/2f/nxrbr3pn1msgrl4ffyj33zd00000gn/T/ipykernel_68206/901596302.py:23: FutureWarning: You are using `torch.load` with `weights_only=False` (the current default value), which uses the default pickle module implicitly. It is possible to construct malicious pickle data which will execute arbitrary code during unpickling (See https://github.com/pytorch/pytorch/blob/main/SECURITY.md#untrusted-models for more details). In a future release, the default value for `weights_only` will be flipped to `True`. This limits the functions that could be executed during unpickling. Arbitrary objects will no longer be allowed to be loaded via this mode unless they are explicitly allowlisted by the user via `torch.serialization.add_safe_globals`. We recommend you start setting `weights_only=True` for any use case where you don't have full control of the loaded file. Please open an issue on GitHub for any issues related to this experimental feature.\n",
      "  checkpoint = torch.load(model_path)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Cluster 0 diseases:\n",
      "------------------------\n",
      "Top diseases (strongest in signature 14):\n",
      "- Rheumatic disease of the heart valves: strength = -13.237  0.897\n",
      "- Disease of tricuspid valve: strength = -13.075  0.985\n",
      "- Aortic valve disease: strength = -12.486  0.799\n",
      "- Left bundle branch block: strength = -12.291  0.783\n",
      "- Congestive heart failure (CHF) NOS: strength = -12.187  0.956\n",
      "\n",
      "Non-specific diseases (strong effects in multiple signatures):\n",
      "\n",
      "Rheumatic disease of the heart valves:\n",
      "  Signature 0: -9.862  0.884\n",
      "  Signature 1: -12.441  1.110\n",
      "  Signature 2: -13.092  1.022\n",
      "  Signature 3: -12.627  0.984\n",
      "  Signature 4: -12.477  0.949\n",
      "  Signature 5: -12.398  1.199\n",
      "  Signature 6: -12.669  0.893\n",
      "  Signature 7: -12.741  0.959\n",
      "  Signature 8: -12.979  0.853\n",
      "  Signature 9: -12.572  0.858\n",
      "  Signature 10: -12.742  0.878\n",
      "  Signature 11: -12.911  1.005\n",
      "  Signature 12: -12.553  0.899\n",
      "  Signature 13: -12.801  0.727\n",
      "  Signature 14: -13.237  0.897\n",
      "  Signature 15: -12.556  0.837\n",
      "  Signature 16: -12.638  1.039\n",
      "  Signature 17: -12.755  0.856\n",
      "  Signature 18: -12.685  0.916\n",
      "  Signature 19: -12.883  0.920\n",
      "\n",
      "Mitral valve disease:\n",
      "  Signature 0: -7.966  0.843\n",
      "  Signature 1: -10.712  1.000\n",
      "  Signature 2: -10.743  0.944\n",
      "  Signature 3: -11.140  0.959\n",
      "  Signature 4: -11.373  1.023\n",
      "  Signature 5: -10.716  1.160\n",
      "  Signature 6: -11.152  0.907\n",
      "  Signature 7: -11.264  0.758\n",
      "  Signature 8: -11.440  0.772\n",
      "  Signature 9: -11.003  0.896\n",
      "  Signature 10: -10.831  0.773\n",
      "  Signature 11: -11.618  0.937\n",
      "  Signature 12: -10.691  0.911\n",
      "  Signature 13: -11.305  0.842\n",
      "  Signature 14: -11.221  0.894\n",
      "  Signature 15: -10.979  0.956\n",
      "  Signature 16: -11.079  0.755\n",
      "  Signature 17: -10.673  0.811\n",
      "  Signature 18: -10.859  0.945\n",
      "  Signature 19: -10.936  0.925\n",
      "\n",
      "Aortic valve disease:\n",
      "  Signature 0: -9.201  0.998\n",
      "  Signature 1: -12.456  0.975\n",
      "  Signature 2: -12.183  0.606\n",
      "  Signature 3: -11.857  1.136\n",
      "  Signature 4: -12.139  1.128\n",
      "  Signature 5: -11.747  0.960\n",
      "  Signature 6: -12.084  0.995\n",
      "  Signature 7: -12.168  0.872\n",
      "  Signature 8: -12.019  0.882\n",
      "  Signature 9: -11.754  0.872\n",
      "  Signature 10: -12.463  1.102\n",
      "  Signature 11: -12.135  0.960\n",
      "  Signature 12: -11.440  0.769\n",
      "  Signature 13: -11.933  1.079\n",
      "  Signature 14: -12.486  0.799\n",
      "  Signature 15: -11.889  0.819\n",
      "  Signature 16: -12.543  0.868\n",
      "  Signature 17: -11.993  0.862\n",
      "  Signature 18: -11.485  0.935\n",
      "  Signature 19: -12.185  0.721\n",
      "\n",
      "Disease of tricuspid valve:\n",
      "  Signature 0: -9.555  0.797\n",
      "  Signature 1: -12.817  0.968\n",
      "  Signature 2: -12.776  0.858\n",
      "  Signature 3: -12.066  1.019\n",
      "  Signature 4: -12.627  0.886\n",
      "  Signature 5: -12.531  0.746\n",
      "  Signature 6: -12.525  0.879\n",
      "  Signature 7: -12.478  0.942\n",
      "  Signature 8: -12.458  0.785\n",
      "  Signature 9: -12.144  0.918\n",
      "  Signature 10: -12.044  1.100\n",
      "  Signature 11: -12.797  0.956\n",
      "  Signature 12: -12.047  0.856\n",
      "  Signature 13: -12.069  0.899\n",
      "  Signature 14: -13.075  0.985\n",
      "  Signature 15: -12.203  0.925\n",
      "  Signature 16: -12.794  1.000\n",
      "  Signature 17: -12.754  0.973\n",
      "  Signature 18: -13.008  1.166\n",
      "  Signature 19: -12.460  0.948\n",
      "\n",
      "Other forms of chronic heart disease:\n",
      "  Signature 0: -8.550  0.901\n",
      "  Signature 1: -11.989  1.027\n",
      "  Signature 2: -11.899  0.773\n",
      "  Signature 3: -11.617  0.979\n",
      "  Signature 4: -11.868  1.005\n",
      "  Signature 5: -12.054  0.786\n",
      "  Signature 6: -12.056  1.188\n",
      "  Signature 7: -11.837  0.944\n",
      "  Signature 8: -11.732  0.793\n",
      "  Signature 9: -11.949  0.828\n",
      "  Signature 10: -11.937  0.837\n",
      "  Signature 11: -11.522  0.861\n",
      "  Signature 12: -12.102  1.204\n",
      "  Signature 13: -11.805  0.905\n",
      "  Signature 14: -11.386  0.873\n",
      "  Signature 15: -11.588  0.866\n",
      "  Signature 16: -11.437  0.942\n",
      "  Signature 17: -11.472  1.470\n",
      "  Signature 18: -12.483  0.860\n",
      "  Signature 19: -12.106  0.803\n",
      "\n",
      "Cluster 1 diseases:\n",
      "------------------------\n",
      "Top diseases (strongest in signature 11):\n",
      "- Osteoarthrosis NOS: strength = -12.258  0.815\n",
      "- Osteoarthrosis, generalized: strength = -12.238  0.914\n",
      "- Other disorders of synovium, tendon, and bursa: strength = -12.224  0.805\n",
      "- Hallux rigidus: strength = -12.105  0.802\n",
      "- Other acquired deformities of limbs: strength = -11.986  0.859\n",
      "\n",
      "Non-specific diseases (strong effects in multiple signatures):\n",
      "\n",
      "Other peripheral nerve disorders:\n",
      "  Signature 0: -9.089  0.758\n",
      "  Signature 1: -6.668  0.757\n",
      "  Signature 2: -9.763  0.809\n",
      "  Signature 3: -9.399  0.758\n",
      "  Signature 4: -9.828  1.099\n",
      "  Signature 5: -9.252  0.694\n",
      "  Signature 6: -9.197  1.048\n",
      "  Signature 7: -9.539  0.768\n",
      "  Signature 8: -9.053  0.886\n",
      "  Signature 9: -10.209  0.956\n",
      "  Signature 10: -9.470  0.931\n",
      "  Signature 11: -10.440  1.206\n",
      "  Signature 12: -9.607  0.752\n",
      "  Signature 13: -9.312  0.919\n",
      "  Signature 14: -9.285  1.084\n",
      "  Signature 15: -9.296  1.029\n",
      "  Signature 16: -9.272  0.860\n",
      "  Signature 17: -9.162  1.111\n",
      "  Signature 18: -9.331  0.929\n",
      "  Signature 19: -8.861  1.139\n",
      "\n",
      "Rheumatoid arthritis:\n",
      "  Signature 0: -10.575  0.845\n",
      "  Signature 1: -7.232  0.981\n",
      "  Signature 2: -10.173  0.871\n",
      "  Signature 3: -9.940  1.033\n",
      "  Signature 4: -10.387  0.861\n",
      "  Signature 5: -10.562  1.042\n",
      "  Signature 6: -10.397  0.995\n",
      "  Signature 7: -10.185  0.881\n",
      "  Signature 8: -10.490  1.070\n",
      "  Signature 9: -11.062  0.922\n",
      "  Signature 10: -10.462  0.906\n",
      "  Signature 11: -10.395  0.748\n",
      "  Signature 12: -10.302  0.953\n",
      "  Signature 13: -10.368  1.042\n",
      "  Signature 14: -10.535  0.882\n",
      "  Signature 15: -10.716  0.875\n",
      "  Signature 16: -9.901  0.884\n",
      "  Signature 17: -10.612  0.793\n",
      "  Signature 18: -10.413  0.810\n",
      "  Signature 19: -10.586  0.752\n",
      "\n",
      "Arthropathy NOS:\n",
      "  Signature 0: -7.745  0.897\n",
      "  Signature 1: -5.402  0.838\n",
      "  Signature 2: -8.001  0.874\n",
      "  Signature 3: -8.234  0.961\n",
      "  Signature 4: -8.304  0.748\n",
      "  Signature 5: -8.855  1.045\n",
      "  Signature 6: -8.580  0.954\n",
      "  Signature 7: -8.533  0.978\n",
      "  Signature 8: -8.175  0.844\n",
      "  Signature 9: -8.247  0.783\n",
      "  Signature 10: -8.477  0.926\n",
      "  Signature 11: -8.595  0.787\n",
      "  Signature 12: -9.189  1.040\n",
      "  Signature 13: -8.431  0.969\n",
      "  Signature 14: -8.569  1.008\n",
      "  Signature 15: -8.744  0.869\n",
      "  Signature 16: -8.189  1.051\n",
      "  Signature 17: -8.345  0.930\n",
      "  Signature 18: -7.796  1.027\n",
      "  Signature 19: -8.255  0.937\n",
      "\n",
      "Peripheral enthesopathies and allied syndromes:\n",
      "  Signature 0: -10.133  0.916\n",
      "  Signature 1: -7.295  0.948\n",
      "  Signature 2: -10.223  1.016\n",
      "  Signature 3: -10.299  0.852\n",
      "  Signature 4: -10.596  0.781\n",
      "  Signature 5: -9.980  1.032\n",
      "  Signature 6: -10.245  1.031\n",
      "  Signature 7: -10.720  0.933\n",
      "  Signature 8: -10.228  0.885\n",
      "  Signature 9: -10.786  0.873\n",
      "  Signature 10: -10.207  1.059\n",
      "  Signature 11: -10.187  0.894\n",
      "  Signature 12: -10.283  0.993\n",
      "  Signature 13: -11.079  0.727\n",
      "  Signature 14: -10.418  1.109\n",
      "  Signature 15: -10.223  0.725\n",
      "  Signature 16: -10.646  1.125\n",
      "  Signature 17: -10.024  0.657\n",
      "  Signature 18: -10.275  0.981\n",
      "  Signature 19: -10.716  1.163\n",
      "\n",
      "Enthesopathy:\n",
      "  Signature 0: -9.231  0.839\n",
      "  Signature 1: -6.136  1.028\n",
      "  Signature 2: -10.366  0.998\n",
      "  Signature 3: -9.899  0.945\n",
      "  Signature 4: -9.823  0.904\n",
      "  Signature 5: -10.062  0.953\n",
      "  Signature 6: -9.893  0.936\n",
      "  Signature 7: -9.775  0.930\n",
      "  Signature 8: -9.107  0.935\n",
      "  Signature 9: -9.942  0.947\n",
      "  Signature 10: -9.231  1.007\n",
      "  Signature 11: -9.765  1.072\n",
      "  Signature 12: -10.156  0.853\n",
      "  Signature 13: -10.019  0.833\n",
      "  Signature 14: -9.596  1.052\n",
      "  Signature 15: -9.402  0.820\n",
      "  Signature 16: -9.490  0.904\n",
      "  Signature 17: -10.075  0.841\n",
      "  Signature 18: -9.913  0.669\n",
      "  Signature 19: -9.778  1.102\n",
      "\n",
      "Cluster 2 diseases:\n",
      "------------------------\n",
      "Top diseases (strongest in signature 11):\n",
      "- Barrett's esophagus: strength = -12.853  0.836\n",
      "- Stricture and stenosis of esophagus: strength = -11.848  0.877\n",
      "- Esophageal bleeding (varices/hemorrhage): strength = -11.545  0.818\n",
      "- Other disorders of stomach and duodenum: strength = -11.174  0.769\n",
      "- Gastric ulcer: strength = -11.066  1.128\n",
      "\n",
      "Non-specific diseases (strong effects in multiple signatures):\n",
      "\n",
      "Benign neoplasm of other parts of digestive system:\n",
      "  Signature 0: -10.281  0.924\n",
      "  Signature 1: -10.976  0.779\n",
      "  Signature 2: -7.448  1.042\n",
      "  Signature 3: -10.821  0.997\n",
      "  Signature 4: -10.647  0.805\n",
      "  Signature 5: -10.642  0.871\n",
      "  Signature 6: -10.762  0.677\n",
      "  Signature 7: -10.785  1.134\n",
      "  Signature 8: -10.393  1.135\n",
      "  Signature 9: -10.610  0.844\n",
      "  Signature 10: -10.785  0.795\n",
      "  Signature 11: -10.469  1.150\n",
      "  Signature 12: -10.769  0.871\n",
      "  Signature 13: -10.664  0.993\n",
      "  Signature 14: -10.659  1.009\n",
      "  Signature 15: -10.723  0.776\n",
      "  Signature 16: -10.566  1.075\n",
      "  Signature 17: -10.571  0.943\n",
      "  Signature 18: -10.918  1.029\n",
      "  Signature 19: -10.874  1.013\n",
      "\n",
      "Iron deficiency anemias, unspecified or not due to blood loss:\n",
      "  Signature 0: -8.933  0.841\n",
      "  Signature 1: -9.290  0.968\n",
      "  Signature 2: -6.708  0.683\n",
      "  Signature 3: -9.115  0.844\n",
      "  Signature 4: -9.475  0.982\n",
      "  Signature 5: -9.430  0.875\n",
      "  Signature 6: -9.525  0.975\n",
      "  Signature 7: -9.603  0.871\n",
      "  Signature 8: -8.626  0.715\n",
      "  Signature 9: -9.541  0.753\n",
      "  Signature 10: -9.034  0.830\n",
      "  Signature 11: -9.690  1.053\n",
      "  Signature 12: -9.318  1.013\n",
      "  Signature 13: -9.277  0.924\n",
      "  Signature 14: -10.118  0.915\n",
      "  Signature 15: -10.037  1.048\n",
      "  Signature 16: -9.513  1.109\n",
      "  Signature 17: -9.125  1.062\n",
      "  Signature 18: -9.828  0.977\n",
      "  Signature 19: -9.168  0.914\n",
      "\n",
      "Esophagitis, GERD and related diseases:\n",
      "  Signature 0: -9.269  1.282\n",
      "  Signature 1: -9.537  1.166\n",
      "  Signature 2: -6.876  0.901\n",
      "  Signature 3: -9.990  0.832\n",
      "  Signature 4: -9.637  0.988\n",
      "  Signature 5: -9.738  0.943\n",
      "  Signature 6: -9.307  0.948\n",
      "  Signature 7: -9.648  1.106\n",
      "  Signature 8: -10.015  0.952\n",
      "  Signature 9: -9.642  0.990\n",
      "  Signature 10: -9.653  0.921\n",
      "  Signature 11: -9.626  1.020\n",
      "  Signature 12: -9.579  0.884\n",
      "  Signature 13: -9.480  0.788\n",
      "  Signature 14: -9.773  0.995\n",
      "  Signature 15: -9.803  0.858\n",
      "  Signature 16: -10.252  1.002\n",
      "  Signature 17: -9.725  0.864\n",
      "  Signature 18: -9.833  0.890\n",
      "  Signature 19: -9.648  0.895\n",
      "\n",
      "Ulcer of esophagus:\n",
      "  Signature 0: -10.471  0.969\n",
      "  Signature 1: -10.913  0.838\n",
      "  Signature 2: -7.913  1.044\n",
      "  Signature 3: -10.596  0.812\n",
      "  Signature 4: -10.552  0.846\n",
      "  Signature 5: -9.879  0.836\n",
      "  Signature 6: -10.145  0.986\n",
      "  Signature 7: -10.237  0.882\n",
      "  Signature 8: -11.067  1.102\n",
      "  Signature 9: -10.507  0.906\n",
      "  Signature 10: -10.328  0.904\n",
      "  Signature 11: -10.825  0.752\n",
      "  Signature 12: -10.646  0.925\n",
      "  Signature 13: -10.204  0.962\n",
      "  Signature 14: -10.239  0.852\n",
      "  Signature 15: -10.551  0.987\n",
      "  Signature 16: -10.518  0.757\n",
      "  Signature 17: -10.374  0.923\n",
      "  Signature 18: -10.884  1.129\n",
      "  Signature 19: -10.786  0.914\n",
      "\n",
      "Barrett's esophagus:\n",
      "  Signature 0: -12.737  0.953\n",
      "  Signature 1: -13.100  1.042\n",
      "  Signature 2: -9.568  0.819\n",
      "  Signature 3: -12.950  1.020\n",
      "  Signature 4: -13.229  0.898\n",
      "  Signature 5: -12.449  1.052\n",
      "  Signature 6: -12.458  1.002\n",
      "  Signature 7: -12.543  0.786\n",
      "  Signature 8: -12.881  0.688\n",
      "  Signature 9: -12.945  0.868\n",
      "  Signature 10: -12.973  0.905\n",
      "  Signature 11: -12.853  0.836\n",
      "  Signature 12: -12.775  0.996\n",
      "  Signature 13: -12.459  0.883\n",
      "  Signature 14: -12.851  0.808\n",
      "  Signature 15: -12.680  1.017\n",
      "  Signature 16: -12.417  0.920\n",
      "  Signature 17: -13.299  1.048\n",
      "  Signature 18: -12.556  0.899\n",
      "  Signature 19: -12.854  0.822\n",
      "\n",
      "Cluster 3 diseases:\n",
      "------------------------\n",
      "Top diseases (strongest in signature 14):\n",
      "- Infertility, female: strength = -16.645  1.158\n",
      "- Abdominal aortic aneurysm: strength = -13.936  0.722\n",
      "- Stricture of artery: strength = -13.532  0.885\n",
      "- Polymyalgia Rheumatica: strength = -12.767  1.242\n",
      "- First degree AV block: strength = -12.722  0.860\n",
      "\n",
      "Non-specific diseases (strong effects in multiple signatures):\n",
      "\n",
      "Bacterial enteritis:\n",
      "  Signature 0: -11.617  0.959\n",
      "  Signature 1: -10.731  0.942\n",
      "  Signature 2: -10.897  0.750\n",
      "  Signature 3: -8.365  0.815\n",
      "  Signature 4: -10.848  0.925\n",
      "  Signature 5: -10.511  0.782\n",
      "  Signature 6: -11.221  0.855\n",
      "  Signature 7: -10.664  0.786\n",
      "  Signature 8: -11.100  1.045\n",
      "  Signature 9: -10.745  0.817\n",
      "  Signature 10: -11.187  0.700\n",
      "  Signature 11: -11.362  0.908\n",
      "  Signature 12: -10.896  1.087\n",
      "  Signature 13: -10.921  0.636\n",
      "  Signature 14: -10.900  0.805\n",
      "  Signature 15: -11.222  0.814\n",
      "  Signature 16: -10.876  0.929\n",
      "  Signature 17: -11.288  0.734\n",
      "  Signature 18: -10.732  1.119\n",
      "  Signature 19: -10.660  0.876\n",
      "\n",
      "Viral Enteritis:\n",
      "  Signature 0: -11.905  0.979\n",
      "  Signature 1: -11.807  0.991\n",
      "  Signature 2: -11.736  0.731\n",
      "  Signature 3: -9.197  0.936\n",
      "  Signature 4: -11.867  0.984\n",
      "  Signature 5: -11.942  0.877\n",
      "  Signature 6: -12.049  0.812\n",
      "  Signature 7: -11.563  1.082\n",
      "  Signature 8: -11.654  0.826\n",
      "  Signature 9: -11.700  0.897\n",
      "  Signature 10: -11.910  0.786\n",
      "  Signature 11: -11.742  0.726\n",
      "  Signature 12: -11.638  0.901\n",
      "  Signature 13: -12.292  0.838\n",
      "  Signature 14: -11.586  0.953\n",
      "  Signature 15: -12.119  1.047\n",
      "  Signature 16: -11.536  0.942\n",
      "  Signature 17: -12.061  0.914\n",
      "  Signature 18: -12.054  1.012\n",
      "  Signature 19: -11.803  0.898\n",
      "\n",
      "Viral infection:\n",
      "  Signature 0: -10.475  0.894\n",
      "  Signature 1: -10.159  0.831\n",
      "  Signature 2: -10.063  0.763\n",
      "  Signature 3: -6.799  0.918\n",
      "  Signature 4: -10.360  0.829\n",
      "  Signature 5: -9.852  0.696\n",
      "  Signature 6: -9.831  0.785\n",
      "  Signature 7: -10.367  0.971\n",
      "  Signature 8: -9.617  1.070\n",
      "  Signature 9: -10.004  0.867\n",
      "  Signature 10: -10.041  0.738\n",
      "  Signature 11: -10.178  1.023\n",
      "  Signature 12: -10.586  0.978\n",
      "  Signature 13: -10.072  0.756\n",
      "  Signature 14: -10.364  0.818\n",
      "  Signature 15: -10.596  0.751\n",
      "  Signature 16: -10.528  1.020\n",
      "  Signature 17: -9.983  0.889\n",
      "  Signature 18: -10.432  1.289\n",
      "  Signature 19: -10.822  1.277\n",
      "\n",
      "Malignant neoplasm of kidney, except pelvis:\n",
      "  Signature 0: -12.326  1.195\n",
      "  Signature 1: -12.824  0.974\n",
      "  Signature 2: -12.842  0.842\n",
      "  Signature 3: -10.026  0.836\n",
      "  Signature 4: -12.851  0.734\n",
      "  Signature 5: -12.929  1.064\n",
      "  Signature 6: -12.970  1.197\n",
      "  Signature 7: -12.823  0.780\n",
      "  Signature 8: -12.881  0.752\n",
      "  Signature 9: -12.368  1.217\n",
      "  Signature 10: -13.196  0.841\n",
      "  Signature 11: -12.750  0.846\n",
      "  Signature 12: -12.924  1.095\n",
      "  Signature 13: -12.892  1.090\n",
      "  Signature 14: -12.555  1.005\n",
      "  Signature 15: -12.792  0.851\n",
      "  Signature 16: -12.768  0.904\n",
      "  Signature 17: -12.630  1.003\n",
      "  Signature 18: -12.961  1.009\n",
      "  Signature 19: -13.290  0.641\n",
      "\n",
      "Neoplasm of uncertain behavior:\n",
      "  Signature 0: -11.402  0.961\n",
      "  Signature 1: -11.328  1.077\n",
      "  Signature 2: -11.308  1.011\n",
      "  Signature 3: -9.318  1.113\n",
      "  Signature 4: -11.406  0.836\n",
      "  Signature 5: -11.879  1.051\n",
      "  Signature 6: -11.319  0.901\n",
      "  Signature 7: -11.412  0.870\n",
      "  Signature 8: -11.724  0.812\n",
      "  Signature 9: -11.142  0.650\n",
      "  Signature 10: -11.186  0.605\n",
      "  Signature 11: -10.855  0.983\n",
      "  Signature 12: -11.855  0.937\n",
      "  Signature 13: -10.816  0.846\n",
      "  Signature 14: -11.264  1.007\n",
      "  Signature 15: -11.399  0.678\n",
      "  Signature 16: -11.479  0.865\n",
      "  Signature 17: -12.120  0.903\n",
      "  Signature 18: -11.365  0.931\n",
      "  Signature 19: -11.603  1.157\n",
      "\n",
      "Cluster 4 diseases:\n",
      "------------------------\n",
      "Top diseases (strongest in signature 13):\n",
      "- Chronic pharyngitis and nasopharyngitis: strength = -11.517  0.952\n",
      "- Nasal polyps: strength = -11.493  1.150\n",
      "- Septal Deviations/Turbinate Hypertrophy: strength = -11.306  0.726\n",
      "- Other upper respiratory disease: strength = -11.042  1.063\n",
      "- Chronic sinusitis: strength = -10.995  0.947\n",
      "\n",
      "Non-specific diseases (strong effects in multiple signatures):\n",
      "\n",
      "Septal Deviations/Turbinate Hypertrophy:\n",
      "  Signature 0: -9.987  0.794\n",
      "  Signature 1: -10.311  0.816\n",
      "  Signature 2: -10.278  1.046\n",
      "  Signature 3: -10.500  0.939\n",
      "  Signature 4: -7.617  1.425\n",
      "  Signature 5: -10.659  0.843\n",
      "  Signature 6: -10.019  1.033\n",
      "  Signature 7: -10.100  0.928\n",
      "  Signature 8: -10.750  0.987\n",
      "  Signature 9: -10.562  0.869\n",
      "  Signature 10: -10.727  0.856\n",
      "  Signature 11: -10.198  1.120\n",
      "  Signature 12: -10.123  0.989\n",
      "  Signature 13: -11.306  0.726\n",
      "  Signature 14: -10.754  0.853\n",
      "  Signature 15: -10.354  1.075\n",
      "  Signature 16: -10.520  0.685\n",
      "  Signature 17: -10.761  0.792\n",
      "  Signature 18: -10.673  1.116\n",
      "  Signature 19: -10.963  0.979\n",
      "\n",
      "Nasal polyps:\n",
      "  Signature 0: -10.652  0.946\n",
      "  Signature 1: -11.145  0.669\n",
      "  Signature 2: -10.851  0.651\n",
      "  Signature 3: -11.070  0.897\n",
      "  Signature 4: -7.624  1.158\n",
      "  Signature 5: -10.627  0.820\n",
      "  Signature 6: -10.582  0.783\n",
      "  Signature 7: -10.878  0.744\n",
      "  Signature 8: -10.795  0.845\n",
      "  Signature 9: -10.932  1.019\n",
      "  Signature 10: -10.358  0.912\n",
      "  Signature 11: -10.700  0.819\n",
      "  Signature 12: -10.518  0.644\n",
      "  Signature 13: -11.493  1.150\n",
      "  Signature 14: -11.295  0.991\n",
      "  Signature 15: -10.912  1.041\n",
      "  Signature 16: -10.474  0.894\n",
      "  Signature 17: -11.038  0.843\n",
      "  Signature 18: -10.460  0.909\n",
      "  Signature 19: -10.760  0.744\n",
      "\n",
      "Chronic pharyngitis and nasopharyngitis:\n",
      "  Signature 0: -10.917  1.008\n",
      "  Signature 1: -12.021  0.817\n",
      "  Signature 2: -11.631  1.226\n",
      "  Signature 3: -11.776  0.782\n",
      "  Signature 4: -8.690  0.800\n",
      "  Signature 5: -11.906  0.859\n",
      "  Signature 6: -11.476  0.984\n",
      "  Signature 7: -12.081  0.853\n",
      "  Signature 8: -11.439  0.804\n",
      "  Signature 9: -11.652  1.015\n",
      "  Signature 10: -11.576  0.944\n",
      "  Signature 11: -11.334  0.694\n",
      "  Signature 12: -11.566  0.931\n",
      "  Signature 13: -11.517  0.952\n",
      "  Signature 14: -11.832  1.219\n",
      "  Signature 15: -11.626  0.821\n",
      "  Signature 16: -11.627  0.972\n",
      "  Signature 17: -11.955  0.798\n",
      "  Signature 18: -11.076  0.744\n",
      "  Signature 19: -11.389  0.867\n",
      "\n",
      "Chronic sinusitis:\n",
      "  Signature 0: -10.785  0.852\n",
      "  Signature 1: -10.696  0.811\n",
      "  Signature 2: -11.319  1.033\n",
      "  Signature 3: -10.546  0.847\n",
      "  Signature 4: -8.103  0.763\n",
      "  Signature 5: -11.162  0.820\n",
      "  Signature 6: -10.677  1.022\n",
      "  Signature 7: -10.953  0.715\n",
      "  Signature 8: -10.866  1.118\n",
      "  Signature 9: -10.660  1.018\n",
      "  Signature 10: -10.949  0.727\n",
      "  Signature 11: -10.622  0.863\n",
      "  Signature 12: -10.852  1.022\n",
      "  Signature 13: -10.995  0.947\n",
      "  Signature 14: -10.813  0.775\n",
      "  Signature 15: -10.588  0.769\n",
      "  Signature 16: -10.883  0.938\n",
      "  Signature 17: -11.084  0.822\n",
      "  Signature 18: -10.927  0.909\n",
      "  Signature 19: -10.680  0.869\n",
      "\n",
      "Other upper respiratory disease:\n",
      "  Signature 0: -10.442  0.962\n",
      "  Signature 1: -9.823  1.156\n",
      "  Signature 2: -9.614  0.796\n",
      "  Signature 3: -10.115  1.051\n",
      "  Signature 4: -6.617  0.902\n",
      "  Signature 5: -10.626  1.261\n",
      "  Signature 6: -9.806  1.044\n",
      "  Signature 7: -10.230  0.982\n",
      "  Signature 8: -10.327  0.985\n",
      "  Signature 9: -10.252  0.691\n",
      "  Signature 10: -9.909  1.015\n",
      "  Signature 11: -10.460  0.985\n",
      "  Signature 12: -10.265  1.067\n",
      "  Signature 13: -11.042  1.063\n",
      "  Signature 14: -10.212  0.914\n",
      "  Signature 15: -9.896  0.825\n",
      "  Signature 16: -10.906  1.049\n",
      "  Signature 17: -10.646  0.834\n",
      "  Signature 18: -10.055  0.838\n",
      "  Signature 19: -9.884  0.989\n",
      "\n",
      "Cluster 5 diseases:\n",
      "------------------------\n",
      "Top diseases (strongest in signature 3):\n",
      "- Other acute and subacute forms of ischemic heart disease: strength = -12.723  0.818\n",
      "- Unstable angina (intermediate coronary syndrome): strength = -11.180  0.939\n",
      "- Myocardial infarction: strength = -10.388  0.971\n",
      "- Angina pectoris: strength = -10.122  0.695\n",
      "- Other chronic ischemic heart disease, unspecified: strength = -10.050  0.674\n",
      "\n",
      "Non-specific diseases (strong effects in multiple signatures):\n",
      "\n",
      "Hypercholesterolemia:\n",
      "  Signature 0: -8.625  0.882\n",
      "  Signature 1: -9.350  0.999\n",
      "  Signature 2: -8.493  0.782\n",
      "  Signature 3: -9.318  0.905\n",
      "  Signature 4: -9.266  0.681\n",
      "  Signature 5: -6.298  0.970\n",
      "  Signature 6: -8.793  0.930\n",
      "  Signature 7: -8.935  0.893\n",
      "  Signature 8: -9.076  0.761\n",
      "  Signature 9: -9.052  1.201\n",
      "  Signature 10: -8.859  0.649\n",
      "  Signature 11: -9.221  0.853\n",
      "  Signature 12: -8.948  1.144\n",
      "  Signature 13: -8.897  0.942\n",
      "  Signature 14: -9.050  0.756\n",
      "  Signature 15: -9.049  0.905\n",
      "  Signature 16: -8.850  0.803\n",
      "  Signature 17: -8.470  0.902\n",
      "  Signature 18: -8.641  0.812\n",
      "  Signature 19: -9.204  0.918\n",
      "\n",
      "Unstable angina (intermediate coronary syndrome):\n",
      "  Signature 0: -10.982  1.201\n",
      "  Signature 1: -10.327  0.771\n",
      "  Signature 2: -10.986  0.993\n",
      "  Signature 3: -11.180  0.939\n",
      "  Signature 4: -10.926  0.878\n",
      "  Signature 5: -8.250  0.890\n",
      "  Signature 6: -10.717  0.719\n",
      "  Signature 7: -10.678  0.877\n",
      "  Signature 8: -10.885  1.072\n",
      "  Signature 9: -11.097  0.768\n",
      "  Signature 10: -10.972  1.068\n",
      "  Signature 11: -10.880  0.821\n",
      "  Signature 12: -10.884  1.002\n",
      "  Signature 13: -11.086  0.964\n",
      "  Signature 14: -10.752  0.950\n",
      "  Signature 15: -11.348  0.718\n",
      "  Signature 16: -10.846  0.863\n",
      "  Signature 17: -10.962  1.080\n",
      "  Signature 18: -11.292  0.966\n",
      "  Signature 19: -10.681  0.695\n",
      "\n",
      "Myocardial infarction:\n",
      "  Signature 0: -9.822  1.040\n",
      "  Signature 1: -9.578  0.892\n",
      "  Signature 2: -9.460  0.809\n",
      "  Signature 3: -10.388  0.971\n",
      "  Signature 4: -10.297  1.173\n",
      "  Signature 5: -7.561  0.776\n",
      "  Signature 6: -9.439  0.926\n",
      "  Signature 7: -10.067  1.037\n",
      "  Signature 8: -10.526  0.944\n",
      "  Signature 9: -9.669  0.883\n",
      "  Signature 10: -10.430  0.862\n",
      "  Signature 11: -10.034  0.888\n",
      "  Signature 12: -9.318  1.110\n",
      "  Signature 13: -10.148  0.813\n",
      "  Signature 14: -9.754  0.811\n",
      "  Signature 15: -9.380  0.792\n",
      "  Signature 16: -10.309  0.922\n",
      "  Signature 17: -9.325  0.893\n",
      "  Signature 18: -10.342  1.133\n",
      "  Signature 19: -9.884  0.833\n",
      "\n",
      "Angina pectoris:\n",
      "  Signature 0: -10.165  0.832\n",
      "  Signature 1: -9.642  0.669\n",
      "  Signature 2: -9.569  1.047\n",
      "  Signature 3: -10.122  0.695\n",
      "  Signature 4: -9.144  0.802\n",
      "  Signature 5: -6.591  0.888\n",
      "  Signature 6: -9.426  1.223\n",
      "  Signature 7: -9.449  0.806\n",
      "  Signature 8: -9.682  1.160\n",
      "  Signature 9: -9.871  0.917\n",
      "  Signature 10: -10.327  1.086\n",
      "  Signature 11: -10.074  1.241\n",
      "  Signature 12: -10.041  1.004\n",
      "  Signature 13: -10.153  0.678\n",
      "  Signature 14: -9.332  1.006\n",
      "  Signature 15: -9.552  0.737\n",
      "  Signature 16: -9.987  0.898\n",
      "  Signature 17: -9.537  0.870\n",
      "  Signature 18: -9.230  0.899\n",
      "  Signature 19: -9.882  1.113\n",
      "\n",
      "Coronary atherosclerosis:\n",
      "  Signature 0: -9.843  1.021\n",
      "  Signature 1: -9.345  0.720\n",
      "  Signature 2: -9.565  0.786\n",
      "  Signature 3: -9.580  0.760\n",
      "  Signature 4: -9.753  0.956\n",
      "  Signature 5: -6.639  0.816\n",
      "  Signature 6: -10.151  0.885\n",
      "  Signature 7: -9.582  0.714\n",
      "  Signature 8: -9.890  0.906\n",
      "  Signature 9: -9.116  0.895\n",
      "  Signature 10: -9.795  0.869\n",
      "  Signature 11: -9.778  1.261\n",
      "  Signature 12: -9.444  0.802\n",
      "  Signature 13: -9.599  0.816\n",
      "  Signature 14: -9.264  1.164\n",
      "  Signature 15: -9.954  0.822\n",
      "  Signature 16: -9.776  0.985\n",
      "  Signature 17: -9.569  0.861\n",
      "  Signature 18: -9.638  0.904\n",
      "  Signature 19: -10.103  0.849\n",
      "\n",
      "Cluster 6 diseases:\n",
      "------------------------\n",
      "Top diseases (strongest in signature 12):\n",
      "- Secondary malignant neoplasm of digestive systems: strength = -12.997  0.949\n",
      "- Secondary malignancy of respiratory organs: strength = -12.738  1.075\n",
      "- Secondary malignant neoplasm: strength = -12.481  1.259\n",
      "- Malignant neoplasm, other: strength = -12.454  1.105\n",
      "- Secondary malignancy of bone: strength = -12.287  1.024\n",
      "\n",
      "Non-specific diseases (strong effects in multiple signatures):\n",
      "\n",
      "Cancer of bronchus; lung:\n",
      "  Signature 0: -11.690  0.888\n",
      "  Signature 1: -12.415  0.921\n",
      "  Signature 2: -12.185  0.750\n",
      "  Signature 3: -12.219  0.987\n",
      "  Signature 4: -11.890  1.002\n",
      "  Signature 5: -11.667  1.065\n",
      "  Signature 6: -8.997  0.918\n",
      "  Signature 7: -11.624  1.113\n",
      "  Signature 8: -12.171  1.037\n",
      "  Signature 9: -12.444  0.909\n",
      "  Signature 10: -11.994  1.090\n",
      "  Signature 11: -12.557  0.983\n",
      "  Signature 12: -12.139  0.883\n",
      "  Signature 13: -12.341  0.988\n",
      "  Signature 14: -12.232  0.882\n",
      "  Signature 15: -12.345  0.958\n",
      "  Signature 16: -12.094  0.898\n",
      "  Signature 17: -12.014  0.916\n",
      "  Signature 18: -12.346  0.899\n",
      "  Signature 19: -12.674  1.024\n",
      "\n",
      "Malignant neoplasm, other:\n",
      "  Signature 0: -12.050  1.156\n",
      "  Signature 1: -12.379  0.794\n",
      "  Signature 2: -11.990  1.079\n",
      "  Signature 3: -12.070  1.190\n",
      "  Signature 4: -12.446  0.771\n",
      "  Signature 5: -12.294  1.034\n",
      "  Signature 6: -9.580  0.748\n",
      "  Signature 7: -12.433  1.076\n",
      "  Signature 8: -12.865  0.986\n",
      "  Signature 9: -12.291  1.035\n",
      "  Signature 10: -12.462  0.905\n",
      "  Signature 11: -12.649  0.689\n",
      "  Signature 12: -12.454  1.105\n",
      "  Signature 13: -12.052  1.179\n",
      "  Signature 14: -12.180  0.997\n",
      "  Signature 15: -12.186  0.961\n",
      "  Signature 16: -12.902  1.033\n",
      "  Signature 17: -12.722  0.850\n",
      "  Signature 18: -12.333  1.029\n",
      "  Signature 19: -11.799  0.808\n",
      "\n",
      "Secondary malignant neoplasm:\n",
      "  Signature 0: -12.189  1.043\n",
      "  Signature 1: -12.309  0.629\n",
      "  Signature 2: -12.151  0.645\n",
      "  Signature 3: -12.136  0.874\n",
      "  Signature 4: -12.705  1.073\n",
      "  Signature 5: -12.329  0.764\n",
      "  Signature 6: -9.553  0.779\n",
      "  Signature 7: -12.595  0.855\n",
      "  Signature 8: -12.412  1.092\n",
      "  Signature 9: -12.536  0.865\n",
      "  Signature 10: -12.387  1.196\n",
      "  Signature 11: -12.430  0.899\n",
      "  Signature 12: -12.481  1.259\n",
      "  Signature 13: -12.345  0.873\n",
      "  Signature 14: -12.936  1.041\n",
      "  Signature 15: -12.315  0.954\n",
      "  Signature 16: -12.053  0.892\n",
      "  Signature 17: -12.391  0.945\n",
      "  Signature 18: -12.450  0.960\n",
      "  Signature 19: -12.200  0.940\n",
      "\n",
      "Secondary malignancy of lymph nodes:\n",
      "  Signature 0: -10.439  1.078\n",
      "  Signature 1: -10.563  0.763\n",
      "  Signature 2: -10.357  0.598\n",
      "  Signature 3: -9.956  0.820\n",
      "  Signature 4: -10.463  0.882\n",
      "  Signature 5: -10.274  0.854\n",
      "  Signature 6: -7.689  0.870\n",
      "  Signature 7: -10.394  0.667\n",
      "  Signature 8: -10.211  1.148\n",
      "  Signature 9: -10.492  0.861\n",
      "  Signature 10: -10.266  0.817\n",
      "  Signature 11: -10.109  0.898\n",
      "  Signature 12: -10.111  0.989\n",
      "  Signature 13: -10.884  0.816\n",
      "  Signature 14: -10.408  0.969\n",
      "  Signature 15: -10.673  0.728\n",
      "  Signature 16: -9.904  0.933\n",
      "  Signature 17: -10.012  0.816\n",
      "  Signature 18: -10.127  0.893\n",
      "  Signature 19: -10.519  1.235\n",
      "\n",
      "Secondary malignancy of respiratory organs:\n",
      "  Signature 0: -12.278  0.949\n",
      "  Signature 1: -12.218  0.876\n",
      "  Signature 2: -12.476  1.111\n",
      "  Signature 3: -11.998  0.827\n",
      "  Signature 4: -12.247  0.975\n",
      "  Signature 5: -12.358  0.930\n",
      "  Signature 6: -9.350  0.839\n",
      "  Signature 7: -11.646  1.077\n",
      "  Signature 8: -11.833  0.884\n",
      "  Signature 9: -11.687  0.831\n",
      "  Signature 10: -12.393  0.819\n",
      "  Signature 11: -11.902  0.835\n",
      "  Signature 12: -12.738  1.075\n",
      "  Signature 13: -12.227  0.980\n",
      "  Signature 14: -11.886  1.201\n",
      "  Signature 15: -12.578  1.130\n",
      "  Signature 16: -11.794  0.763\n",
      "  Signature 17: -11.671  1.063\n",
      "  Signature 18: -11.807  0.912\n",
      "  Signature 19: -12.017  0.819\n",
      "\n",
      "Cluster 7 diseases:\n",
      "------------------------\n",
      "Top diseases (strongest in signature 0):\n",
      "- Rheumatism, unspecified and fibrositis: strength = -12.991  0.885\n",
      "- Other inflammatory spondylopathies: strength = -12.484  0.840\n",
      "- Myalgia and myositis unspecified: strength = -11.532  0.863\n",
      "- Hyperlipidemia: strength = -11.485  0.788\n",
      "- Other chronic nonalcoholic liver disease: strength = -11.367  1.040\n",
      "\n",
      "Non-specific diseases (strong effects in multiple signatures):\n",
      "\n",
      "Hypothyroidism NOS:\n",
      "  Signature 0: -9.317  0.914\n",
      "  Signature 1: -9.699  0.676\n",
      "  Signature 2: -8.923  1.014\n",
      "  Signature 3: -9.187  1.058\n",
      "  Signature 4: -9.177  0.820\n",
      "  Signature 5: -8.923  1.079\n",
      "  Signature 6: -9.184  1.272\n",
      "  Signature 7: -6.205  0.873\n",
      "  Signature 8: -8.834  0.878\n",
      "  Signature 9: -9.551  1.292\n",
      "  Signature 10: -9.286  0.733\n",
      "  Signature 11: -9.512  0.710\n",
      "  Signature 12: -9.624  0.919\n",
      "  Signature 13: -9.215  1.164\n",
      "  Signature 14: -8.873  1.135\n",
      "  Signature 15: -9.808  0.907\n",
      "  Signature 16: -9.054  0.899\n",
      "  Signature 17: -9.609  0.827\n",
      "  Signature 18: -8.945  1.025\n",
      "  Signature 19: -9.457  1.156\n",
      "\n",
      "Hyperlipidemia:\n",
      "  Signature 0: -11.485  0.788\n",
      "  Signature 1: -11.114  0.955\n",
      "  Signature 2: -10.715  0.889\n",
      "  Signature 3: -11.084  0.836\n",
      "  Signature 4: -11.102  1.006\n",
      "  Signature 5: -11.466  0.980\n",
      "  Signature 6: -11.367  0.885\n",
      "  Signature 7: -8.066  1.112\n",
      "  Signature 8: -11.257  0.899\n",
      "  Signature 9: -11.219  1.057\n",
      "  Signature 10: -11.102  0.905\n",
      "  Signature 11: -10.818  0.954\n",
      "  Signature 12: -10.674  1.075\n",
      "  Signature 13: -10.367  1.108\n",
      "  Signature 14: -10.855  0.725\n",
      "  Signature 15: -11.544  1.078\n",
      "  Signature 16: -10.611  0.946\n",
      "  Signature 17: -10.593  0.824\n",
      "  Signature 18: -10.880  0.854\n",
      "  Signature 19: -11.099  0.899\n",
      "\n",
      "Obesity:\n",
      "  Signature 0: -9.148  1.092\n",
      "  Signature 1: -9.492  0.752\n",
      "  Signature 2: -9.312  0.767\n",
      "  Signature 3: -9.116  0.704\n",
      "  Signature 4: -9.701  0.989\n",
      "  Signature 5: -9.168  0.894\n",
      "  Signature 6: -9.170  1.029\n",
      "  Signature 7: -6.111  0.842\n",
      "  Signature 8: -9.065  0.911\n",
      "  Signature 9: -9.570  0.946\n",
      "  Signature 10: -9.293  0.985\n",
      "  Signature 11: -9.424  1.079\n",
      "  Signature 12: -8.975  1.198\n",
      "  Signature 13: -9.780  0.788\n",
      "  Signature 14: -9.618  0.891\n",
      "  Signature 15: -9.715  1.005\n",
      "  Signature 16: -9.616  0.862\n",
      "  Signature 17: -9.103  0.801\n",
      "  Signature 18: -8.978  0.967\n",
      "  Signature 19: -8.858  0.977\n",
      "\n",
      "Major depressive disorder:\n",
      "  Signature 0: -9.057  0.800\n",
      "  Signature 1: -9.288  0.852\n",
      "  Signature 2: -9.574  1.030\n",
      "  Signature 3: -9.071  1.182\n",
      "  Signature 4: -9.094  1.202\n",
      "  Signature 5: -9.459  0.785\n",
      "  Signature 6: -9.270  0.801\n",
      "  Signature 7: -5.972  1.171\n",
      "  Signature 8: -8.970  0.861\n",
      "  Signature 9: -9.240  0.930\n",
      "  Signature 10: -8.869  0.968\n",
      "  Signature 11: -8.500  0.731\n",
      "  Signature 12: -8.556  1.032\n",
      "  Signature 13: -9.312  0.864\n",
      "  Signature 14: -9.212  0.933\n",
      "  Signature 15: -8.771  0.869\n",
      "  Signature 16: -8.567  0.855\n",
      "  Signature 17: -9.262  1.059\n",
      "  Signature 18: -9.263  1.022\n",
      "  Signature 19: -8.426  1.013\n",
      "\n",
      "Anxiety disorder:\n",
      "  Signature 0: -10.155  0.908\n",
      "  Signature 1: -9.800  1.132\n",
      "  Signature 2: -10.157  0.958\n",
      "  Signature 3: -9.578  1.205\n",
      "  Signature 4: -9.688  0.913\n",
      "  Signature 5: -9.706  0.864\n",
      "  Signature 6: -9.071  0.876\n",
      "  Signature 7: -6.824  0.947\n",
      "  Signature 8: -10.013  0.725\n",
      "  Signature 9: -10.030  1.001\n",
      "  Signature 10: -9.802  1.006\n",
      "  Signature 11: -9.461  0.972\n",
      "  Signature 12: -9.535  0.913\n",
      "  Signature 13: -9.267  0.972\n",
      "  Signature 14: -10.002  0.987\n",
      "  Signature 15: -9.593  0.952\n",
      "  Signature 16: -10.107  0.821\n",
      "  Signature 17: -9.790  0.813\n",
      "  Signature 18: -10.334  1.067\n",
      "  Signature 19: -9.382  0.710\n",
      "\n",
      "Cluster 8 diseases:\n",
      "------------------------\n",
      "Top diseases (strongest in signature 19):\n",
      "- Dysmenorrhea: strength = -14.707  0.986\n",
      "- Irregular menstrual bleeding: strength = -13.946  1.044\n",
      "- Irregular menstrual cycle: strength = -13.838  0.768\n",
      "- Postmenopausal atrophic vaginitis: strength = -13.461  0.779\n",
      "- Dyspareunia: strength = -12.957  1.018\n",
      "\n",
      "Non-specific diseases (strong effects in multiple signatures):\n",
      "\n",
      "Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia]:\n",
      "  Signature 0: -12.370  0.635\n",
      "  Signature 1: -12.273  0.877\n",
      "  Signature 2: -11.785  0.957\n",
      "  Signature 3: -12.439  0.979\n",
      "  Signature 4: -12.269  0.859\n",
      "  Signature 5: -12.273  0.971\n",
      "  Signature 6: -12.130  0.739\n",
      "  Signature 7: -12.642  0.779\n",
      "  Signature 8: -9.273  0.953\n",
      "  Signature 9: -11.756  0.667\n",
      "  Signature 10: -12.217  0.840\n",
      "  Signature 11: -12.758  0.928\n",
      "  Signature 12: -11.844  0.847\n",
      "  Signature 13: -12.216  0.961\n",
      "  Signature 14: -12.031  0.960\n",
      "  Signature 15: -12.170  0.869\n",
      "  Signature 16: -11.845  0.820\n",
      "  Signature 17: -12.023  0.851\n",
      "  Signature 18: -12.049  1.181\n",
      "  Signature 19: -12.383  0.748\n",
      "\n",
      "Malignant neoplasm of uterus:\n",
      "  Signature 0: -12.381  0.972\n",
      "  Signature 1: -12.312  0.917\n",
      "  Signature 2: -12.932  0.885\n",
      "  Signature 3: -13.435  0.806\n",
      "  Signature 4: -12.609  0.728\n",
      "  Signature 5: -12.103  0.812\n",
      "  Signature 6: -12.945  0.958\n",
      "  Signature 7: -12.691  0.961\n",
      "  Signature 8: -9.010  0.872\n",
      "  Signature 9: -12.432  0.886\n",
      "  Signature 10: -12.373  0.854\n",
      "  Signature 11: -12.675  1.121\n",
      "  Signature 12: -12.322  0.774\n",
      "  Signature 13: -12.294  0.748\n",
      "  Signature 14: -12.006  0.942\n",
      "  Signature 15: -12.241  0.773\n",
      "  Signature 16: -12.823  0.981\n",
      "  Signature 17: -12.114  1.013\n",
      "  Signature 18: -12.564  0.955\n",
      "  Signature 19: -12.813  0.541\n",
      "\n",
      "Malignant neoplasm of ovary:\n",
      "  Signature 0: -11.501  0.832\n",
      "  Signature 1: -12.357  1.291\n",
      "  Signature 2: -12.117  0.901\n",
      "  Signature 3: -12.181  0.899\n",
      "  Signature 4: -12.059  1.050\n",
      "  Signature 5: -12.232  0.819\n",
      "  Signature 6: -12.155  0.813\n",
      "  Signature 7: -12.023  1.004\n",
      "  Signature 8: -8.728  0.921\n",
      "  Signature 9: -12.193  1.003\n",
      "  Signature 10: -11.552  0.833\n",
      "  Signature 11: -11.892  0.872\n",
      "  Signature 12: -11.989  1.140\n",
      "  Signature 13: -11.876  0.974\n",
      "  Signature 14: -12.299  0.689\n",
      "  Signature 15: -12.469  0.970\n",
      "  Signature 16: -12.385  1.001\n",
      "  Signature 17: -11.498  0.902\n",
      "  Signature 18: -12.010  0.880\n",
      "  Signature 19: -11.790  0.805\n",
      "\n",
      "Uterine leiomyoma:\n",
      "  Signature 0: -10.257  0.795\n",
      "  Signature 1: -9.989  1.010\n",
      "  Signature 2: -9.705  0.820\n",
      "  Signature 3: -10.271  1.149\n",
      "  Signature 4: -10.211  1.088\n",
      "  Signature 5: -9.196  1.190\n",
      "  Signature 6: -10.411  0.737\n",
      "  Signature 7: -9.115  1.018\n",
      "  Signature 8: -6.445  0.858\n",
      "  Signature 9: -9.728  0.798\n",
      "  Signature 10: -10.092  0.876\n",
      "  Signature 11: -9.337  0.733\n",
      "  Signature 12: -9.719  0.984\n",
      "  Signature 13: -9.432  0.861\n",
      "  Signature 14: -9.886  1.056\n",
      "  Signature 15: -9.431  0.849\n",
      "  Signature 16: -9.645  1.000\n",
      "  Signature 17: -9.766  0.904\n",
      "  Signature 18: -9.563  0.868\n",
      "  Signature 19: -9.703  0.810\n",
      "\n",
      "Benign neoplasm of ovary:\n",
      "  Signature 0: -11.170  0.939\n",
      "  Signature 1: -11.454  0.929\n",
      "  Signature 2: -11.049  0.805\n",
      "  Signature 3: -11.027  1.256\n",
      "  Signature 4: -11.559  0.863\n",
      "  Signature 5: -11.572  0.916\n",
      "  Signature 6: -11.621  0.840\n",
      "  Signature 7: -10.940  1.087\n",
      "  Signature 8: -8.632  0.793\n",
      "  Signature 9: -11.222  0.911\n",
      "  Signature 10: -11.435  0.951\n",
      "  Signature 11: -10.731  0.857\n",
      "  Signature 12: -12.075  1.003\n",
      "  Signature 13: -11.403  0.789\n",
      "  Signature 14: -11.606  0.977\n",
      "  Signature 15: -11.542  0.865\n",
      "  Signature 16: -11.400  0.951\n",
      "  Signature 17: -11.826  0.808\n",
      "  Signature 18: -11.107  0.725\n",
      "  Signature 19: -11.969  1.031\n",
      "\n",
      "Cluster 9 diseases:\n",
      "------------------------\n",
      "Top diseases (strongest in signature 12):\n",
      "- Acquired spondylolisthesis: strength = -11.868  0.900\n",
      "- Degenerative disease of the spinal cord: strength = -11.587  0.893\n",
      "- Neuralgia, neuritis, and radiculitis NOS: strength = -11.552  0.947\n",
      "- Spinal stenosis: strength = -11.547  0.881\n",
      "- Kyphoscoliosis and scoliosis: strength = -11.365  0.939\n",
      "\n",
      "Non-specific diseases (strong effects in multiple signatures):\n",
      "\n",
      "Degenerative disease of the spinal cord:\n",
      "  Signature 0: -11.625  0.887\n",
      "  Signature 1: -11.363  0.686\n",
      "  Signature 2: -11.931  0.845\n",
      "  Signature 3: -11.808  0.893\n",
      "  Signature 4: -11.550  1.015\n",
      "  Signature 5: -11.823  0.917\n",
      "  Signature 6: -12.203  1.113\n",
      "  Signature 7: -11.988  0.959\n",
      "  Signature 8: -11.988  0.923\n",
      "  Signature 9: -8.792  0.927\n",
      "  Signature 10: -11.922  0.850\n",
      "  Signature 11: -12.399  0.872\n",
      "  Signature 12: -11.587  0.893\n",
      "  Signature 13: -12.507  0.924\n",
      "  Signature 14: -12.375  1.088\n",
      "  Signature 15: -11.745  0.787\n",
      "  Signature 16: -11.259  0.704\n",
      "  Signature 17: -11.933  0.888\n",
      "  Signature 18: -11.502  0.846\n",
      "  Signature 19: -11.435  1.005\n",
      "\n",
      "Spinal stenosis:\n",
      "  Signature 0: -11.018  0.755\n",
      "  Signature 1: -10.956  0.801\n",
      "  Signature 2: -11.367  0.956\n",
      "  Signature 3: -10.281  0.995\n",
      "  Signature 4: -10.990  0.739\n",
      "  Signature 5: -10.965  0.770\n",
      "  Signature 6: -10.988  0.649\n",
      "  Signature 7: -10.956  0.926\n",
      "  Signature 8: -10.564  0.882\n",
      "  Signature 9: -7.886  0.799\n",
      "  Signature 10: -10.739  1.010\n",
      "  Signature 11: -11.002  0.842\n",
      "  Signature 12: -11.547  0.881\n",
      "  Signature 13: -10.523  0.797\n",
      "  Signature 14: -11.161  0.879\n",
      "  Signature 15: -10.662  0.753\n",
      "  Signature 16: -11.137  0.747\n",
      "  Signature 17: -10.668  0.953\n",
      "  Signature 18: -11.038  0.730\n",
      "  Signature 19: -10.562  0.981\n",
      "\n",
      "Spondylosis without myelopathy:\n",
      "  Signature 0: -10.454  1.053\n",
      "  Signature 1: -10.210  1.097\n",
      "  Signature 2: -10.691  1.001\n",
      "  Signature 3: -10.294  0.922\n",
      "  Signature 4: -10.291  0.884\n",
      "  Signature 5: -9.972  0.868\n",
      "  Signature 6: -9.741  1.137\n",
      "  Signature 7: -10.339  0.779\n",
      "  Signature 8: -10.286  0.877\n",
      "  Signature 9: -7.181  0.727\n",
      "  Signature 10: -10.291  0.968\n",
      "  Signature 11: -10.450  0.779\n",
      "  Signature 12: -10.625  0.940\n",
      "  Signature 13: -10.165  0.833\n",
      "  Signature 14: -10.331  0.966\n",
      "  Signature 15: -10.605  0.645\n",
      "  Signature 16: -10.392  1.046\n",
      "  Signature 17: -10.554  0.859\n",
      "  Signature 18: -10.375  0.692\n",
      "  Signature 19: -9.903  1.020\n",
      "\n",
      "Displacement of intervertebral disc:\n",
      "  Signature 0: -10.760  0.805\n",
      "  Signature 1: -10.285  1.144\n",
      "  Signature 2: -10.569  0.761\n",
      "  Signature 3: -10.274  0.840\n",
      "  Signature 4: -10.866  0.802\n",
      "  Signature 5: -10.088  0.842\n",
      "  Signature 6: -9.968  0.976\n",
      "  Signature 7: -10.353  0.728\n",
      "  Signature 8: -11.209  0.834\n",
      "  Signature 9: -7.450  0.876\n",
      "  Signature 10: -10.048  0.817\n",
      "  Signature 11: -10.614  1.019\n",
      "  Signature 12: -11.046  0.944\n",
      "  Signature 13: -10.373  0.819\n",
      "  Signature 14: -10.472  0.851\n",
      "  Signature 15: -10.577  1.142\n",
      "  Signature 16: -10.823  0.804\n",
      "  Signature 17: -10.088  1.175\n",
      "  Signature 18: -10.345  0.821\n",
      "  Signature 19: -10.869  1.247\n",
      "\n",
      "Degeneration of intervertebral disc:\n",
      "  Signature 0: -10.259  0.968\n",
      "  Signature 1: -10.630  1.109\n",
      "  Signature 2: -10.308  0.778\n",
      "  Signature 3: -11.267  1.074\n",
      "  Signature 4: -10.974  0.808\n",
      "  Signature 5: -10.599  0.984\n",
      "  Signature 6: -10.995  0.881\n",
      "  Signature 7: -10.998  0.942\n",
      "  Signature 8: -10.687  0.964\n",
      "  Signature 9: -7.754  0.811\n",
      "  Signature 10: -11.359  1.361\n",
      "  Signature 11: -10.201  1.018\n",
      "  Signature 12: -10.866  0.952\n",
      "  Signature 13: -10.607  0.830\n",
      "  Signature 14: -10.689  0.978\n",
      "  Signature 15: -11.017  1.073\n",
      "  Signature 16: -10.665  0.839\n",
      "  Signature 17: -10.937  0.979\n",
      "  Signature 18: -10.799  0.695\n",
      "  Signature 19: -10.907  1.014\n",
      "\n",
      "Cluster 10 diseases:\n",
      "------------------------\n",
      "Top diseases (strongest in signature 2):\n",
      "- Other retinal disorders: strength = -12.973  0.914\n",
      "- Primary open angle glaucoma: strength = -12.733  0.810\n",
      "- Retinal vascular changes and abnomalities: strength = -12.705  0.921\n",
      "- Disorders of vitreous body: strength = -12.163  1.019\n",
      "- Retinal detachments and defects: strength = -12.011  1.088\n",
      "\n",
      "Non-specific diseases (strong effects in multiple signatures):\n",
      "\n",
      "Retinal detachments and defects:\n",
      "  Signature 0: -10.910  0.875\n",
      "  Signature 1: -11.636  0.829\n",
      "  Signature 2: -12.011  1.088\n",
      "  Signature 3: -11.831  0.804\n",
      "  Signature 4: -11.764  0.993\n",
      "  Signature 5: -11.776  0.897\n",
      "  Signature 6: -11.684  0.827\n",
      "  Signature 7: -11.479  0.815\n",
      "  Signature 8: -12.154  0.817\n",
      "  Signature 9: -11.313  0.931\n",
      "  Signature 10: -8.475  0.943\n",
      "  Signature 11: -11.952  0.995\n",
      "  Signature 12: -11.510  1.038\n",
      "  Signature 13: -11.700  1.159\n",
      "  Signature 14: -11.335  0.939\n",
      "  Signature 15: -10.830  0.937\n",
      "  Signature 16: -12.233  0.773\n",
      "  Signature 17: -11.433  1.111\n",
      "  Signature 18: -11.863  0.919\n",
      "  Signature 19: -11.313  0.891\n",
      "\n",
      "Retinal detachment with retinal defect:\n",
      "  Signature 0: -11.231  1.044\n",
      "  Signature 1: -11.603  1.289\n",
      "  Signature 2: -11.692  0.980\n",
      "  Signature 3: -11.460  1.091\n",
      "  Signature 4: -11.440  0.949\n",
      "  Signature 5: -11.427  0.851\n",
      "  Signature 6: -11.850  0.754\n",
      "  Signature 7: -11.618  0.782\n",
      "  Signature 8: -11.769  0.748\n",
      "  Signature 9: -11.366  0.812\n",
      "  Signature 10: -8.450  1.141\n",
      "  Signature 11: -12.090  0.757\n",
      "  Signature 12: -11.407  1.038\n",
      "  Signature 13: -11.759  0.922\n",
      "  Signature 14: -11.791  0.740\n",
      "  Signature 15: -11.542  0.759\n",
      "  Signature 16: -11.336  1.224\n",
      "  Signature 17: -11.446  0.752\n",
      "  Signature 18: -11.870  0.846\n",
      "  Signature 19: -11.593  0.809\n",
      "\n",
      "Other retinal disorders:\n",
      "  Signature 0: -13.224  0.835\n",
      "  Signature 1: -12.676  0.952\n",
      "  Signature 2: -12.973  0.914\n",
      "  Signature 3: -12.694  0.859\n",
      "  Signature 4: -12.939  1.060\n",
      "  Signature 5: -12.939  1.094\n",
      "  Signature 6: -12.884  0.884\n",
      "  Signature 7: -13.188  0.798\n",
      "  Signature 8: -12.785  0.739\n",
      "  Signature 9: -13.055  1.034\n",
      "  Signature 10: -9.662  0.891\n",
      "  Signature 11: -13.097  0.839\n",
      "  Signature 12: -12.804  0.931\n",
      "  Signature 13: -12.283  0.590\n",
      "  Signature 14: -12.553  1.013\n",
      "  Signature 15: -12.648  0.841\n",
      "  Signature 16: -13.037  0.796\n",
      "  Signature 17: -12.986  0.851\n",
      "  Signature 18: -12.604  0.752\n",
      "  Signature 19: -12.398  0.862\n",
      "\n",
      "Macular degeneration (senile) of retina NOS:\n",
      "  Signature 0: -11.657  1.129\n",
      "  Signature 1: -11.827  1.035\n",
      "  Signature 2: -11.831  0.931\n",
      "  Signature 3: -11.600  1.005\n",
      "  Signature 4: -11.854  0.880\n",
      "  Signature 5: -11.543  0.839\n",
      "  Signature 6: -11.628  1.001\n",
      "  Signature 7: -11.894  0.890\n",
      "  Signature 8: -11.900  0.675\n",
      "  Signature 9: -11.667  0.993\n",
      "  Signature 10: -8.332  1.014\n",
      "  Signature 11: -11.743  0.810\n",
      "  Signature 12: -11.714  0.803\n",
      "  Signature 13: -11.526  0.745\n",
      "  Signature 14: -11.186  0.872\n",
      "  Signature 15: -11.061  0.865\n",
      "  Signature 16: -12.122  1.052\n",
      "  Signature 17: -11.623  0.822\n",
      "  Signature 18: -11.155  0.742\n",
      "  Signature 19: -11.557  0.910\n",
      "\n",
      "Retinal vascular changes and abnomalities:\n",
      "  Signature 0: -12.866  0.982\n",
      "  Signature 1: -12.909  0.829\n",
      "  Signature 2: -12.705  0.921\n",
      "  Signature 3: -12.529  0.917\n",
      "  Signature 4: -12.789  0.884\n",
      "  Signature 5: -13.045  1.018\n",
      "  Signature 6: -12.400  0.943\n",
      "  Signature 7: -12.396  0.901\n",
      "  Signature 8: -12.658  0.755\n",
      "  Signature 9: -12.282  1.139\n",
      "  Signature 10: -9.034  0.902\n",
      "  Signature 11: -12.403  0.909\n",
      "  Signature 12: -12.829  1.081\n",
      "  Signature 13: -12.562  0.875\n",
      "  Signature 14: -12.242  1.074\n",
      "  Signature 15: -11.908  1.127\n",
      "  Signature 16: -12.602  0.888\n",
      "  Signature 17: -12.173  0.839\n",
      "  Signature 18: -12.147  1.188\n",
      "  Signature 19: -12.626  0.873\n",
      "\n",
      "Cluster 11 diseases:\n",
      "------------------------\n",
      "Top diseases (strongest in signature 1):\n",
      "- Cerebrovascular disease: strength = -12.919  1.004\n",
      "- Occlusion and stenosis of precerebral arteries: strength = -12.745  0.912\n",
      "- Cerebral ischemia: strength = -12.744  0.921\n",
      "- Late effects of cerebrovascular disease: strength = -12.253  0.762\n",
      "- Transient cerebral ischemia: strength = -12.039  0.749\n",
      "\n",
      "Non-specific diseases (strong effects in multiple signatures):\n",
      "\n",
      "Hemiplegia:\n",
      "  Signature 0: -10.981  0.678\n",
      "  Signature 1: -11.448  1.085\n",
      "  Signature 2: -10.996  0.751\n",
      "  Signature 3: -10.882  0.770\n",
      "  Signature 4: -10.929  0.811\n",
      "  Signature 5: -11.066  0.789\n",
      "  Signature 6: -11.247  0.777\n",
      "  Signature 7: -11.403  0.933\n",
      "  Signature 8: -11.035  0.982\n",
      "  Signature 9: -10.979  0.756\n",
      "  Signature 10: -10.866  1.091\n",
      "  Signature 11: -8.274  1.215\n",
      "  Signature 12: -12.410  0.757\n",
      "  Signature 13: -11.445  1.058\n",
      "  Signature 14: -11.117  0.948\n",
      "  Signature 15: -10.760  1.056\n",
      "  Signature 16: -11.228  0.861\n",
      "  Signature 17: -11.284  0.885\n",
      "  Signature 18: -11.344  0.704\n",
      "  Signature 19: -11.696  1.051\n",
      "\n",
      "Cerebrovascular disease:\n",
      "  Signature 0: -12.665  1.001\n",
      "  Signature 1: -12.919  1.004\n",
      "  Signature 2: -12.384  0.964\n",
      "  Signature 3: -12.305  0.838\n",
      "  Signature 4: -12.442  0.878\n",
      "  Signature 5: -12.187  1.091\n",
      "  Signature 6: -11.822  0.747\n",
      "  Signature 7: -12.679  0.960\n",
      "  Signature 8: -11.612  0.825\n",
      "  Signature 9: -12.264  0.691\n",
      "  Signature 10: -12.140  0.914\n",
      "  Signature 11: -9.482  0.826\n",
      "  Signature 12: -12.055  0.917\n",
      "  Signature 13: -12.009  0.817\n",
      "  Signature 14: -11.730  0.901\n",
      "  Signature 15: -12.621  1.041\n",
      "  Signature 16: -12.259  0.974\n",
      "  Signature 17: -12.262  0.699\n",
      "  Signature 18: -12.526  0.860\n",
      "  Signature 19: -11.363  1.359\n",
      "\n",
      "Occlusion and stenosis of precerebral arteries:\n",
      "  Signature 0: -13.160  0.983\n",
      "  Signature 1: -12.745  0.912\n",
      "  Signature 2: -12.939  0.741\n",
      "  Signature 3: -12.844  0.791\n",
      "  Signature 4: -12.601  0.776\n",
      "  Signature 5: -12.517  0.844\n",
      "  Signature 6: -12.418  0.967\n",
      "  Signature 7: -12.759  0.668\n",
      "  Signature 8: -12.231  0.813\n",
      "  Signature 9: -12.232  0.849\n",
      "  Signature 10: -12.589  0.769\n",
      "  Signature 11: -10.027  0.835\n",
      "  Signature 12: -12.341  0.946\n",
      "  Signature 13: -12.647  0.888\n",
      "  Signature 14: -12.497  0.917\n",
      "  Signature 15: -12.930  0.864\n",
      "  Signature 16: -12.436  0.895\n",
      "  Signature 17: -12.567  1.015\n",
      "  Signature 18: -12.890  0.965\n",
      "  Signature 19: -12.378  0.788\n",
      "\n",
      "Occlusion of cerebral arteries:\n",
      "  Signature 0: -11.322  0.741\n",
      "  Signature 1: -11.116  0.695\n",
      "  Signature 2: -11.203  0.786\n",
      "  Signature 3: -12.055  0.793\n",
      "  Signature 4: -12.134  0.971\n",
      "  Signature 5: -11.706  1.226\n",
      "  Signature 6: -11.331  0.885\n",
      "  Signature 7: -11.662  0.912\n",
      "  Signature 8: -11.300  1.062\n",
      "  Signature 9: -11.429  0.868\n",
      "  Signature 10: -11.809  0.751\n",
      "  Signature 11: -8.499  1.181\n",
      "  Signature 12: -11.560  1.097\n",
      "  Signature 13: -11.886  0.898\n",
      "  Signature 14: -11.461  0.905\n",
      "  Signature 15: -12.168  0.733\n",
      "  Signature 16: -11.624  0.990\n",
      "  Signature 17: -11.214  0.903\n",
      "  Signature 18: -11.439  0.929\n",
      "  Signature 19: -11.275  1.065\n",
      "\n",
      "Cerebral artery occlusion, with cerebral infarction:\n",
      "  Signature 0: -11.273  0.869\n",
      "  Signature 1: -11.377  1.022\n",
      "  Signature 2: -11.451  0.942\n",
      "  Signature 3: -10.972  0.956\n",
      "  Signature 4: -11.445  0.880\n",
      "  Signature 5: -11.154  0.940\n",
      "  Signature 6: -11.658  0.832\n",
      "  Signature 7: -11.660  0.870\n",
      "  Signature 8: -11.498  0.899\n",
      "  Signature 9: -11.616  1.051\n",
      "  Signature 10: -11.631  0.947\n",
      "  Signature 11: -8.383  0.701\n",
      "  Signature 12: -11.447  1.074\n",
      "  Signature 13: -11.379  0.903\n",
      "  Signature 14: -11.161  0.824\n",
      "  Signature 15: -11.494  0.842\n",
      "  Signature 16: -11.369  1.113\n",
      "  Signature 17: -11.440  0.855\n",
      "  Signature 18: -10.948  0.885\n",
      "  Signature 19: -11.781  0.984\n",
      "\n",
      "Cluster 12 diseases:\n",
      "------------------------\n",
      "Top diseases (strongest in signature 9):\n",
      "- Other disorders of the kidney and ureters: strength = -12.998  0.877\n",
      "- Renal colic: strength = -11.981  0.841\n",
      "- Stricture/obstruction of ureter: strength = -11.794  0.918\n",
      "- Calculus of ureter: strength = -11.291  0.941\n",
      "- Hydronephrosis: strength = -11.099  0.887\n",
      "\n",
      "Non-specific diseases (strong effects in multiple signatures):\n",
      "\n",
      "Other disorders of the kidney and ureters:\n",
      "  Signature 0: -12.631  0.992\n",
      "  Signature 1: -12.543  1.039\n",
      "  Signature 2: -11.879  1.033\n",
      "  Signature 3: -11.663  0.929\n",
      "  Signature 4: -12.092  0.872\n",
      "  Signature 5: -11.638  0.753\n",
      "  Signature 6: -10.965  1.381\n",
      "  Signature 7: -12.431  0.922\n",
      "  Signature 8: -11.671  0.919\n",
      "  Signature 9: -12.998  0.877\n",
      "  Signature 10: -12.020  0.826\n",
      "  Signature 11: -11.922  0.775\n",
      "  Signature 12: -8.855  0.871\n",
      "  Signature 13: -11.719  0.977\n",
      "  Signature 14: -11.809  0.751\n",
      "  Signature 15: -12.115  0.938\n",
      "  Signature 16: -12.146  1.020\n",
      "  Signature 17: -12.852  0.798\n",
      "  Signature 18: -11.794  1.071\n",
      "  Signature 19: -11.265  0.911\n",
      "\n",
      "Stricture/obstruction of ureter:\n",
      "  Signature 0: -11.835  1.095\n",
      "  Signature 1: -11.335  0.940\n",
      "  Signature 2: -11.864  1.056\n",
      "  Signature 3: -11.426  0.795\n",
      "  Signature 4: -11.951  1.024\n",
      "  Signature 5: -11.097  0.919\n",
      "  Signature 6: -11.614  0.970\n",
      "  Signature 7: -12.147  0.830\n",
      "  Signature 8: -11.763  0.960\n",
      "  Signature 9: -11.794  0.918\n",
      "  Signature 10: -11.391  0.854\n",
      "  Signature 11: -11.590  0.921\n",
      "  Signature 12: -8.483  0.996\n",
      "  Signature 13: -11.478  0.774\n",
      "  Signature 14: -11.980  0.954\n",
      "  Signature 15: -11.430  0.883\n",
      "  Signature 16: -11.499  0.780\n",
      "  Signature 17: -11.332  1.122\n",
      "  Signature 18: -11.351  0.867\n",
      "  Signature 19: -11.721  0.695\n",
      "\n",
      "Pyelonephritis:\n",
      "  Signature 0: -10.843  0.968\n",
      "  Signature 1: -10.521  1.008\n",
      "  Signature 2: -11.822  1.022\n",
      "  Signature 3: -10.504  0.954\n",
      "  Signature 4: -11.239  0.693\n",
      "  Signature 5: -10.961  1.005\n",
      "  Signature 6: -11.071  1.025\n",
      "  Signature 7: -11.459  0.835\n",
      "  Signature 8: -11.556  0.820\n",
      "  Signature 9: -11.083  0.742\n",
      "  Signature 10: -10.667  1.012\n",
      "  Signature 11: -11.044  0.925\n",
      "  Signature 12: -8.026  0.958\n",
      "  Signature 13: -11.050  1.009\n",
      "  Signature 14: -11.016  0.973\n",
      "  Signature 15: -10.998  0.873\n",
      "  Signature 16: -10.810  1.059\n",
      "  Signature 17: -10.949  0.795\n",
      "  Signature 18: -11.117  0.795\n",
      "  Signature 19: -10.852  0.854\n",
      "\n",
      "Calculus of kidney:\n",
      "  Signature 0: -10.425  0.942\n",
      "  Signature 1: -10.856  0.732\n",
      "  Signature 2: -10.526  0.886\n",
      "  Signature 3: -10.948  1.017\n",
      "  Signature 4: -10.932  0.978\n",
      "  Signature 5: -10.664  0.868\n",
      "  Signature 6: -10.722  0.858\n",
      "  Signature 7: -10.427  0.958\n",
      "  Signature 8: -11.447  1.058\n",
      "  Signature 9: -10.790  0.828\n",
      "  Signature 10: -10.545  1.068\n",
      "  Signature 11: -10.979  0.763\n",
      "  Signature 12: -8.184  0.851\n",
      "  Signature 13: -10.108  0.745\n",
      "  Signature 14: -11.654  1.021\n",
      "  Signature 15: -10.134  0.847\n",
      "  Signature 16: -11.178  0.903\n",
      "  Signature 17: -10.381  1.159\n",
      "  Signature 18: -10.719  1.056\n",
      "  Signature 19: -10.645  1.074\n",
      "\n",
      "Calculus of ureter:\n",
      "  Signature 0: -11.473  1.287\n",
      "  Signature 1: -10.955  0.630\n",
      "  Signature 2: -10.510  0.785\n",
      "  Signature 3: -11.150  0.620\n",
      "  Signature 4: -11.064  0.992\n",
      "  Signature 5: -10.755  0.739\n",
      "  Signature 6: -11.007  1.199\n",
      "  Signature 7: -10.812  0.982\n",
      "  Signature 8: -11.462  0.878\n",
      "  Signature 9: -11.291  0.941\n",
      "  Signature 10: -10.890  0.826\n",
      "  Signature 11: -11.300  1.043\n",
      "  Signature 12: -7.710  1.012\n",
      "  Signature 13: -10.822  0.806\n",
      "  Signature 14: -11.284  1.061\n",
      "  Signature 15: -11.634  0.931\n",
      "  Signature 16: -11.100  0.891\n",
      "  Signature 17: -11.438  0.890\n",
      "  Signature 18: -11.396  0.922\n",
      "  Signature 19: -11.085  0.808\n",
      "\n",
      "Cluster 13 diseases:\n",
      "------------------------\n",
      "Top diseases (strongest in signature 15):\n",
      "- Cancer of prostate: strength = -13.222  0.756\n",
      "- Chronic prostatitis: strength = -13.162  0.863\n",
      "- Other disorders of prostate: strength = -12.967  0.838\n",
      "- Other symptoms/disorders or the urinary system: strength = -12.144  1.109\n",
      "- Functional disorders of bladder: strength = -11.897  0.805\n",
      "\n",
      "Non-specific diseases (strong effects in multiple signatures):\n",
      "\n",
      "Cancer of prostate:\n",
      "  Signature 0: -11.815  0.673\n",
      "  Signature 1: -12.470  1.225\n",
      "  Signature 2: -12.188  0.860\n",
      "  Signature 3: -12.494  1.118\n",
      "  Signature 4: -11.999  1.005\n",
      "  Signature 5: -12.358  1.102\n",
      "  Signature 6: -11.923  0.936\n",
      "  Signature 7: -11.645  1.087\n",
      "  Signature 8: -12.414  0.826\n",
      "  Signature 9: -12.337  0.923\n",
      "  Signature 10: -12.096  0.862\n",
      "  Signature 11: -12.272  0.884\n",
      "  Signature 12: -12.340  0.955\n",
      "  Signature 13: -9.432  0.801\n",
      "  Signature 14: -12.445  0.801\n",
      "  Signature 15: -13.222  0.756\n",
      "  Signature 16: -12.008  0.936\n",
      "  Signature 17: -12.353  0.938\n",
      "  Signature 18: -12.293  0.959\n",
      "  Signature 19: -12.717  1.097\n",
      "\n",
      "Malignant neoplasm of bladder:\n",
      "  Signature 0: -12.127  1.228\n",
      "  Signature 1: -12.178  1.085\n",
      "  Signature 2: -12.194  1.052\n",
      "  Signature 3: -12.468  0.855\n",
      "  Signature 4: -12.105  0.805\n",
      "  Signature 5: -11.872  0.736\n",
      "  Signature 6: -11.935  0.889\n",
      "  Signature 7: -11.721  0.774\n",
      "  Signature 8: -12.081  0.850\n",
      "  Signature 9: -11.652  1.083\n",
      "  Signature 10: -11.843  0.881\n",
      "  Signature 11: -12.306  0.962\n",
      "  Signature 12: -12.067  0.809\n",
      "  Signature 13: -9.246  0.919\n",
      "  Signature 14: -12.347  0.890\n",
      "  Signature 15: -11.727  0.700\n",
      "  Signature 16: -11.968  1.111\n",
      "  Signature 17: -11.354  1.227\n",
      "  Signature 18: -11.640  0.847\n",
      "  Signature 19: -11.688  0.746\n",
      "\n",
      "Cystitis:\n",
      "  Signature 0: -11.315  1.006\n",
      "  Signature 1: -11.196  0.901\n",
      "  Signature 2: -11.395  1.001\n",
      "  Signature 3: -10.885  0.779\n",
      "  Signature 4: -10.773  1.008\n",
      "  Signature 5: -11.197  1.067\n",
      "  Signature 6: -11.446  0.990\n",
      "  Signature 7: -10.841  0.879\n",
      "  Signature 8: -11.268  0.855\n",
      "  Signature 9: -11.342  0.848\n",
      "  Signature 10: -11.298  0.790\n",
      "  Signature 11: -11.247  0.644\n",
      "  Signature 12: -11.396  1.074\n",
      "  Signature 13: -7.897  0.849\n",
      "  Signature 14: -10.734  0.821\n",
      "  Signature 15: -11.183  0.853\n",
      "  Signature 16: -11.830  1.320\n",
      "  Signature 17: -11.569  0.837\n",
      "  Signature 18: -11.610  0.893\n",
      "  Signature 19: -11.398  0.676\n",
      "\n",
      "Chronic cystitis:\n",
      "  Signature 0: -12.063  0.771\n",
      "  Signature 1: -12.211  0.989\n",
      "  Signature 2: -12.220  0.922\n",
      "  Signature 3: -12.314  0.901\n",
      "  Signature 4: -11.637  0.917\n",
      "  Signature 5: -11.516  1.055\n",
      "  Signature 6: -12.646  0.887\n",
      "  Signature 7: -11.917  0.854\n",
      "  Signature 8: -11.971  0.764\n",
      "  Signature 9: -11.554  0.888\n",
      "  Signature 10: -11.497  0.934\n",
      "  Signature 11: -12.258  0.692\n",
      "  Signature 12: -12.569  0.900\n",
      "  Signature 13: -9.227  0.937\n",
      "  Signature 14: -12.400  0.904\n",
      "  Signature 15: -11.673  1.116\n",
      "  Signature 16: -11.796  0.897\n",
      "  Signature 17: -11.916  0.792\n",
      "  Signature 18: -11.590  1.015\n",
      "  Signature 19: -11.585  0.823\n",
      "\n",
      "Other disorders of bladder:\n",
      "  Signature 0: -9.685  0.990\n",
      "  Signature 1: -10.234  0.915\n",
      "  Signature 2: -10.029  0.953\n",
      "  Signature 3: -10.102  0.992\n",
      "  Signature 4: -9.545  0.932\n",
      "  Signature 5: -9.559  0.770\n",
      "  Signature 6: -10.030  0.858\n",
      "  Signature 7: -9.778  0.829\n",
      "  Signature 8: -9.878  1.000\n",
      "  Signature 9: -10.471  0.835\n",
      "  Signature 10: -9.827  0.889\n",
      "  Signature 11: -9.730  0.854\n",
      "  Signature 12: -9.856  0.693\n",
      "  Signature 13: -7.168  0.665\n",
      "  Signature 14: -9.940  0.794\n",
      "  Signature 15: -9.513  1.036\n",
      "  Signature 16: -9.969  1.037\n",
      "  Signature 17: -10.213  0.975\n",
      "  Signature 18: -9.617  1.099\n",
      "  Signature 19: -9.849  0.906\n",
      "\n",
      "Cluster 14 diseases:\n",
      "------------------------\n",
      "Top diseases (strongest in signature 2):\n",
      "- Postinflammatory pulmonary fibrosis: strength = -13.211  1.079\n",
      "- Emphysema: strength = -12.271  0.860\n",
      "- Respiratory failure: strength = -11.988  1.161\n",
      "- Empyema and pneumothorax: strength = -11.597  0.831\n",
      "- Bronchiectasis: strength = -11.412  1.054\n",
      "\n",
      "Non-specific diseases (strong effects in multiple signatures):\n",
      "\n",
      "Tobacco use disorder:\n",
      "  Signature 0: -10.078  1.238\n",
      "  Signature 1: -10.135  0.776\n",
      "  Signature 2: -9.622  0.801\n",
      "  Signature 3: -10.576  1.112\n",
      "  Signature 4: -9.894  0.748\n",
      "  Signature 5: -9.784  0.948\n",
      "  Signature 6: -10.111  1.106\n",
      "  Signature 7: -10.455  0.759\n",
      "  Signature 8: -9.745  0.961\n",
      "  Signature 9: -10.193  0.903\n",
      "  Signature 10: -10.225  1.009\n",
      "  Signature 11: -10.109  0.945\n",
      "  Signature 12: -10.103  1.009\n",
      "  Signature 13: -10.932  0.878\n",
      "  Signature 14: -7.379  0.887\n",
      "  Signature 15: -10.625  1.131\n",
      "  Signature 16: -9.909  0.812\n",
      "  Signature 17: -10.168  1.022\n",
      "  Signature 18: -10.101  1.100\n",
      "  Signature 19: -9.974  0.919\n",
      "\n",
      "Pneumonia:\n",
      "  Signature 0: -10.344  0.865\n",
      "  Signature 1: -10.253  0.816\n",
      "  Signature 2: -10.335  0.883\n",
      "  Signature 3: -10.595  1.048\n",
      "  Signature 4: -10.420  0.996\n",
      "  Signature 5: -10.341  0.959\n",
      "  Signature 6: -10.375  0.883\n",
      "  Signature 7: -10.141  0.905\n",
      "  Signature 8: -9.881  0.773\n",
      "  Signature 9: -10.012  0.924\n",
      "  Signature 10: -10.048  0.742\n",
      "  Signature 11: -10.231  0.715\n",
      "  Signature 12: -10.211  0.880\n",
      "  Signature 13: -10.409  1.042\n",
      "  Signature 14: -7.684  0.711\n",
      "  Signature 15: -9.886  0.997\n",
      "  Signature 16: -10.037  0.770\n",
      "  Signature 17: -10.583  0.853\n",
      "  Signature 18: -10.409  0.794\n",
      "  Signature 19: -10.035  0.840\n",
      "\n",
      "Pneumococcal pneumonia:\n",
      "  Signature 0: -10.138  0.980\n",
      "  Signature 1: -9.794  0.856\n",
      "  Signature 2: -9.886  0.965\n",
      "  Signature 3: -9.849  0.859\n",
      "  Signature 4: -10.225  0.982\n",
      "  Signature 5: -10.574  1.048\n",
      "  Signature 6: -10.059  0.930\n",
      "  Signature 7: -10.068  1.077\n",
      "  Signature 8: -9.895  0.965\n",
      "  Signature 9: -9.930  0.813\n",
      "  Signature 10: -9.804  0.931\n",
      "  Signature 11: -9.932  1.074\n",
      "  Signature 12: -9.740  0.771\n",
      "  Signature 13: -10.174  0.944\n",
      "  Signature 14: -6.893  0.966\n",
      "  Signature 15: -9.900  0.963\n",
      "  Signature 16: -10.152  0.904\n",
      "  Signature 17: -10.084  1.023\n",
      "  Signature 18: -10.203  1.145\n",
      "  Signature 19: -9.723  1.063\n",
      "\n",
      "Chronic airway obstruction:\n",
      "  Signature 0: -10.671  0.973\n",
      "  Signature 1: -10.778  0.820\n",
      "  Signature 2: -10.952  0.883\n",
      "  Signature 3: -10.511  1.005\n",
      "  Signature 4: -10.877  0.963\n",
      "  Signature 5: -10.789  0.756\n",
      "  Signature 6: -10.840  1.030\n",
      "  Signature 7: -10.503  0.837\n",
      "  Signature 8: -11.285  1.233\n",
      "  Signature 9: -10.611  0.962\n",
      "  Signature 10: -11.139  0.786\n",
      "  Signature 11: -10.665  0.884\n",
      "  Signature 12: -11.027  0.840\n",
      "  Signature 13: -10.477  0.819\n",
      "  Signature 14: -7.745  0.787\n",
      "  Signature 15: -10.360  0.874\n",
      "  Signature 16: -10.823  1.065\n",
      "  Signature 17: -10.502  0.900\n",
      "  Signature 18: -11.157  0.782\n",
      "  Signature 19: -10.227  1.039\n",
      "\n",
      "Emphysema:\n",
      "  Signature 0: -12.008  0.782\n",
      "  Signature 1: -13.124  1.156\n",
      "  Signature 2: -12.271  0.860\n",
      "  Signature 3: -11.437  0.931\n",
      "  Signature 4: -12.153  0.870\n",
      "  Signature 5: -11.622  0.875\n",
      "  Signature 6: -11.692  0.948\n",
      "  Signature 7: -12.374  0.960\n",
      "  Signature 8: -12.044  1.122\n",
      "  Signature 9: -11.665  1.060\n",
      "  Signature 10: -12.194  0.833\n",
      "  Signature 11: -11.540  0.844\n",
      "  Signature 12: -12.433  0.720\n",
      "  Signature 13: -11.646  0.751\n",
      "  Signature 14: -9.031  0.947\n",
      "  Signature 15: -11.773  0.736\n",
      "  Signature 16: -11.665  1.134\n",
      "  Signature 17: -12.235  0.858\n",
      "  Signature 18: -11.579  0.836\n",
      "  Signature 19: -12.198  1.093\n",
      "\n",
      "Cluster 15 diseases:\n",
      "------------------------\n",
      "Top diseases (strongest in signature 17):\n",
      "- Type 2 diabetes with ophthalmic manifestations: strength = -12.201  1.299\n",
      "- Hypoglycemia: strength = -11.982  0.970\n",
      "- Diabetic retinopathy: strength = -11.719  1.209\n",
      "- Type 1 diabetes: strength = -11.339  1.097\n",
      "- Type 2 diabetes: strength = -9.402  0.974\n",
      "\n",
      "Non-specific diseases (strong effects in multiple signatures):\n",
      "\n",
      "Type 1 diabetes:\n",
      "  Signature 0: -11.003  0.944\n",
      "  Signature 1: -11.309  0.873\n",
      "  Signature 2: -10.637  0.802\n",
      "  Signature 3: -10.909  0.780\n",
      "  Signature 4: -10.436  0.702\n",
      "  Signature 5: -11.141  0.973\n",
      "  Signature 6: -10.416  1.016\n",
      "  Signature 7: -10.505  0.809\n",
      "  Signature 8: -11.089  0.822\n",
      "  Signature 9: -11.028  0.767\n",
      "  Signature 10: -11.173  0.952\n",
      "  Signature 11: -11.341  0.798\n",
      "  Signature 12: -10.623  0.908\n",
      "  Signature 13: -10.687  0.773\n",
      "  Signature 14: -10.951  0.886\n",
      "  Signature 15: -7.813  1.056\n",
      "  Signature 16: -10.901  0.706\n",
      "  Signature 17: -11.339  1.097\n",
      "  Signature 18: -10.632  0.957\n",
      "  Signature 19: -10.250  0.755\n",
      "\n",
      "Type 2 diabetes:\n",
      "  Signature 0: -8.866  0.922\n",
      "  Signature 1: -9.416  0.641\n",
      "  Signature 2: -9.299  0.685\n",
      "  Signature 3: -9.421  0.779\n",
      "  Signature 4: -9.068  0.879\n",
      "  Signature 5: -9.441  0.925\n",
      "  Signature 6: -8.795  1.007\n",
      "  Signature 7: -9.134  0.731\n",
      "  Signature 8: -9.269  0.753\n",
      "  Signature 9: -8.920  0.773\n",
      "  Signature 10: -10.135  0.919\n",
      "  Signature 11: -9.322  0.892\n",
      "  Signature 12: -9.055  0.803\n",
      "  Signature 13: -8.757  0.785\n",
      "  Signature 14: -8.951  1.104\n",
      "  Signature 15: -5.716  0.805\n",
      "  Signature 16: -8.978  0.805\n",
      "  Signature 17: -9.402  0.974\n",
      "  Signature 18: -9.306  0.909\n",
      "  Signature 19: -9.331  0.807\n",
      "\n",
      "Type 2 diabetes with ophthalmic manifestations:\n",
      "  Signature 0: -12.314  1.120\n",
      "  Signature 1: -12.299  0.847\n",
      "  Signature 2: -12.519  0.832\n",
      "  Signature 3: -11.958  1.023\n",
      "  Signature 4: -12.654  1.026\n",
      "  Signature 5: -12.395  1.150\n",
      "  Signature 6: -11.266  0.916\n",
      "  Signature 7: -12.309  0.888\n",
      "  Signature 8: -12.027  1.094\n",
      "  Signature 9: -11.956  0.966\n",
      "  Signature 10: -11.997  0.978\n",
      "  Signature 11: -12.379  0.678\n",
      "  Signature 12: -11.859  1.082\n",
      "  Signature 13: -11.599  0.971\n",
      "  Signature 14: -12.526  0.983\n",
      "  Signature 15: -9.265  0.932\n",
      "  Signature 16: -11.748  1.134\n",
      "  Signature 17: -12.201  1.299\n",
      "  Signature 18: -12.066  0.892\n",
      "  Signature 19: -12.068  0.982\n",
      "\n",
      "Diabetic retinopathy:\n",
      "  Signature 0: -11.427  0.874\n",
      "  Signature 1: -11.368  0.832\n",
      "  Signature 2: -11.542  0.736\n",
      "  Signature 3: -11.380  0.727\n",
      "  Signature 4: -11.094  0.744\n",
      "  Signature 5: -11.555  0.708\n",
      "  Signature 6: -10.560  1.067\n",
      "  Signature 7: -11.534  0.819\n",
      "  Signature 8: -10.972  0.810\n",
      "  Signature 9: -10.916  1.042\n",
      "  Signature 10: -11.151  1.017\n",
      "  Signature 11: -11.200  0.720\n",
      "  Signature 12: -11.466  0.784\n",
      "  Signature 13: -11.225  0.958\n",
      "  Signature 14: -11.103  0.733\n",
      "  Signature 15: -8.649  0.767\n",
      "  Signature 16: -11.380  1.017\n",
      "  Signature 17: -11.719  1.209\n",
      "  Signature 18: -11.160  1.235\n",
      "  Signature 19: -11.500  1.039\n",
      "\n",
      "Hypoglycemia:\n",
      "  Signature 0: -11.798  0.955\n",
      "  Signature 1: -11.471  0.860\n",
      "  Signature 2: -11.370  0.904\n",
      "  Signature 3: -11.553  0.698\n",
      "  Signature 4: -12.010  0.896\n",
      "  Signature 5: -11.921  0.979\n",
      "  Signature 6: -12.134  0.929\n",
      "  Signature 7: -11.696  0.864\n",
      "  Signature 8: -11.961  0.979\n",
      "  Signature 9: -11.653  1.024\n",
      "  Signature 10: -11.972  1.270\n",
      "  Signature 11: -11.824  0.780\n",
      "  Signature 12: -10.743  0.999\n",
      "  Signature 13: -11.474  0.996\n",
      "  Signature 14: -11.265  0.794\n",
      "  Signature 15: -8.302  0.907\n",
      "  Signature 16: -11.317  1.113\n",
      "  Signature 17: -11.982  0.970\n",
      "  Signature 18: -11.834  0.973\n",
      "  Signature 19: -11.503  0.733\n",
      "\n",
      "Cluster 16 diseases:\n",
      "------------------------\n",
      "Top diseases (strongest in signature 12):\n",
      "- Acidosis: strength = -12.707  0.785\n",
      "- Decubitus ulcer: strength = -12.607  1.120\n",
      "- Hyperpotassemia: strength = -12.548  1.073\n",
      "- Disorders of calcium/phosphorus metabolism: strength = -12.197  0.912\n",
      "- Hypopotassemia: strength = -12.156  0.811\n",
      "\n",
      "Non-specific diseases (strong effects in multiple signatures):\n",
      "\n",
      "Gram negative septicemia:\n",
      "  Signature 0: -12.375  0.843\n",
      "  Signature 1: -11.720  0.846\n",
      "  Signature 2: -12.249  0.986\n",
      "  Signature 3: -12.375  0.786\n",
      "  Signature 4: -11.650  0.848\n",
      "  Signature 5: -11.910  0.920\n",
      "  Signature 6: -11.973  0.852\n",
      "  Signature 7: -11.018  0.986\n",
      "  Signature 8: -12.282  1.022\n",
      "  Signature 9: -12.310  0.896\n",
      "  Signature 10: -11.710  0.753\n",
      "  Signature 11: -12.163  0.795\n",
      "  Signature 12: -12.056  0.953\n",
      "  Signature 13: -12.073  0.941\n",
      "  Signature 14: -11.972  0.761\n",
      "  Signature 15: -11.195  1.007\n",
      "  Signature 16: -8.805  1.068\n",
      "  Signature 17: -12.054  1.033\n",
      "  Signature 18: -12.546  0.927\n",
      "  Signature 19: -11.912  0.826\n",
      "\n",
      "Bacterial infection NOS:\n",
      "  Signature 0: -9.492  0.946\n",
      "  Signature 1: -9.610  0.722\n",
      "  Signature 2: -9.932  0.824\n",
      "  Signature 3: -9.445  0.948\n",
      "  Signature 4: -9.496  0.884\n",
      "  Signature 5: -9.696  0.819\n",
      "  Signature 6: -9.748  0.930\n",
      "  Signature 7: -9.843  0.944\n",
      "  Signature 8: -9.616  1.069\n",
      "  Signature 9: -9.774  1.052\n",
      "  Signature 10: -10.063  0.913\n",
      "  Signature 11: -10.153  0.987\n",
      "  Signature 12: -9.442  0.967\n",
      "  Signature 13: -9.832  0.957\n",
      "  Signature 14: -9.875  0.906\n",
      "  Signature 15: -9.632  0.884\n",
      "  Signature 16: -6.758  1.074\n",
      "  Signature 17: -10.247  0.873\n",
      "  Signature 18: -9.902  0.758\n",
      "  Signature 19: -9.945  0.951\n",
      "\n",
      "Staphylococcus infections:\n",
      "  Signature 0: -10.989  0.868\n",
      "  Signature 1: -10.273  0.934\n",
      "  Signature 2: -10.444  1.109\n",
      "  Signature 3: -10.461  0.868\n",
      "  Signature 4: -10.777  1.044\n",
      "  Signature 5: -10.229  0.889\n",
      "  Signature 6: -10.444  0.810\n",
      "  Signature 7: -10.907  0.839\n",
      "  Signature 8: -10.629  0.777\n",
      "  Signature 9: -10.205  1.022\n",
      "  Signature 10: -10.594  1.065\n",
      "  Signature 11: -10.857  0.829\n",
      "  Signature 12: -10.873  0.758\n",
      "  Signature 13: -11.022  1.402\n",
      "  Signature 14: -9.826  1.125\n",
      "  Signature 15: -10.441  0.784\n",
      "  Signature 16: -7.527  0.921\n",
      "  Signature 17: -10.550  0.898\n",
      "  Signature 18: -11.074  0.816\n",
      "  Signature 19: -10.699  0.967\n",
      "\n",
      "Streptococcus infection:\n",
      "  Signature 0: -10.977  1.100\n",
      "  Signature 1: -10.993  0.723\n",
      "  Signature 2: -10.546  0.994\n",
      "  Signature 3: -11.148  0.777\n",
      "  Signature 4: -11.039  0.984\n",
      "  Signature 5: -10.825  1.080\n",
      "  Signature 6: -10.437  1.035\n",
      "  Signature 7: -11.080  0.936\n",
      "  Signature 8: -11.389  0.952\n",
      "  Signature 9: -10.951  0.941\n",
      "  Signature 10: -10.594  0.912\n",
      "  Signature 11: -10.736  1.049\n",
      "  Signature 12: -11.073  0.899\n",
      "  Signature 13: -11.037  1.019\n",
      "  Signature 14: -11.133  0.980\n",
      "  Signature 15: -10.807  0.733\n",
      "  Signature 16: -8.008  0.860\n",
      "  Signature 17: -10.747  0.962\n",
      "  Signature 18: -11.511  0.893\n",
      "  Signature 19: -11.517  0.944\n",
      "\n",
      "E. coli:\n",
      "  Signature 0: -10.385  0.871\n",
      "  Signature 1: -10.956  0.849\n",
      "  Signature 2: -10.452  0.802\n",
      "  Signature 3: -10.909  0.792\n",
      "  Signature 4: -10.991  0.844\n",
      "  Signature 5: -11.037  0.934\n",
      "  Signature 6: -10.270  1.007\n",
      "  Signature 7: -10.594  0.869\n",
      "  Signature 8: -10.542  0.873\n",
      "  Signature 9: -10.726  0.981\n",
      "  Signature 10: -10.755  0.875\n",
      "  Signature 11: -10.716  0.800\n",
      "  Signature 12: -10.757  0.869\n",
      "  Signature 13: -10.540  0.945\n",
      "  Signature 14: -10.587  1.028\n",
      "  Signature 15: -10.679  0.951\n",
      "  Signature 16: -7.637  0.843\n",
      "  Signature 17: -10.691  0.940\n",
      "  Signature 18: -11.128  1.045\n",
      "  Signature 19: -10.313  0.894\n",
      "\n",
      "Cluster 17 diseases:\n",
      "------------------------\n",
      "Top diseases (strongest in signature 9):\n",
      "- Gastrointestinal complications: strength = -12.918  0.951\n",
      "- Malignant neoplasm of rectum, rectosigmoid junction, and anus: strength = -12.271  0.866\n",
      "- Colon cancer: strength = -12.044  0.786\n",
      "- Neoplasm of unspecified nature of digestive system: strength = -11.933  1.069\n",
      "- Other intestinal obstruction: strength = -11.616  0.840\n",
      "\n",
      "Non-specific diseases (strong effects in multiple signatures):\n",
      "\n",
      "Colon cancer:\n",
      "  Signature 0: -11.836  0.998\n",
      "  Signature 1: -11.932  0.896\n",
      "  Signature 2: -11.600  0.833\n",
      "  Signature 3: -11.601  0.983\n",
      "  Signature 4: -11.800  1.042\n",
      "  Signature 5: -11.226  0.995\n",
      "  Signature 6: -11.603  0.907\n",
      "  Signature 7: -12.255  0.977\n",
      "  Signature 8: -11.841  0.732\n",
      "  Signature 9: -12.044  0.786\n",
      "  Signature 10: -11.665  0.888\n",
      "  Signature 11: -11.905  0.963\n",
      "  Signature 12: -11.471  0.790\n",
      "  Signature 13: -11.757  0.936\n",
      "  Signature 14: -11.446  0.806\n",
      "  Signature 15: -11.586  0.745\n",
      "  Signature 16: -11.608  0.709\n",
      "  Signature 17: -9.470  1.116\n",
      "  Signature 18: -11.534  0.748\n",
      "  Signature 19: -11.790  0.826\n",
      "\n",
      "Malignant neoplasm of rectum, rectosigmoid junction, and anus:\n",
      "  Signature 0: -11.480  0.845\n",
      "  Signature 1: -11.982  1.271\n",
      "  Signature 2: -11.500  0.868\n",
      "  Signature 3: -12.091  0.818\n",
      "  Signature 4: -12.033  1.064\n",
      "  Signature 5: -12.363  0.967\n",
      "  Signature 6: -11.855  0.861\n",
      "  Signature 7: -12.287  0.977\n",
      "  Signature 8: -12.113  0.916\n",
      "  Signature 9: -12.271  0.866\n",
      "  Signature 10: -12.542  1.032\n",
      "  Signature 11: -11.676  0.737\n",
      "  Signature 12: -11.779  1.056\n",
      "  Signature 13: -12.042  0.728\n",
      "  Signature 14: -11.733  0.890\n",
      "  Signature 15: -12.447  0.936\n",
      "  Signature 16: -11.879  0.881\n",
      "  Signature 17: -9.531  1.087\n",
      "  Signature 18: -11.954  0.918\n",
      "  Signature 19: -11.860  1.130\n",
      "\n",
      "Neoplasm of unspecified nature of digestive system:\n",
      "  Signature 0: -11.885  0.802\n",
      "  Signature 1: -12.260  0.898\n",
      "  Signature 2: -11.755  0.857\n",
      "  Signature 3: -12.137  0.797\n",
      "  Signature 4: -12.547  0.917\n",
      "  Signature 5: -12.004  0.776\n",
      "  Signature 6: -12.541  1.180\n",
      "  Signature 7: -12.292  0.803\n",
      "  Signature 8: -11.397  0.883\n",
      "  Signature 9: -11.933  1.069\n",
      "  Signature 10: -12.175  0.716\n",
      "  Signature 11: -11.676  0.937\n",
      "  Signature 12: -12.204  0.827\n",
      "  Signature 13: -12.364  0.946\n",
      "  Signature 14: -12.306  0.703\n",
      "  Signature 15: -12.342  1.009\n",
      "  Signature 16: -12.186  0.996\n",
      "  Signature 17: -9.095  1.050\n",
      "  Signature 18: -12.221  0.808\n",
      "  Signature 19: -12.738  0.877\n",
      "\n",
      "Benign neoplasm of colon:\n",
      "  Signature 0: -9.137  0.846\n",
      "  Signature 1: -8.750  0.930\n",
      "  Signature 2: -9.040  0.824\n",
      "  Signature 3: -9.153  1.029\n",
      "  Signature 4: -9.023  0.745\n",
      "  Signature 5: -8.615  0.758\n",
      "  Signature 6: -9.127  0.863\n",
      "  Signature 7: -9.134  1.061\n",
      "  Signature 8: -9.284  0.923\n",
      "  Signature 9: -8.973  0.992\n",
      "  Signature 10: -9.118  0.736\n",
      "  Signature 11: -8.997  1.106\n",
      "  Signature 12: -9.044  0.819\n",
      "  Signature 13: -9.371  1.080\n",
      "  Signature 14: -8.835  0.796\n",
      "  Signature 15: -8.234  0.979\n",
      "  Signature 16: -8.925  1.001\n",
      "  Signature 17: -5.734  0.848\n",
      "  Signature 18: -8.865  0.941\n",
      "  Signature 19: -9.565  1.032\n",
      "\n",
      "Hemorrhoids:\n",
      "  Signature 0: -8.771  0.983\n",
      "  Signature 1: -8.740  0.833\n",
      "  Signature 2: -8.493  0.845\n",
      "  Signature 3: -8.509  0.782\n",
      "  Signature 4: -8.264  0.930\n",
      "  Signature 5: -8.287  0.806\n",
      "  Signature 6: -8.276  0.987\n",
      "  Signature 7: -8.262  0.902\n",
      "  Signature 8: -8.756  0.856\n",
      "  Signature 9: -8.497  1.037\n",
      "  Signature 10: -8.641  0.909\n",
      "  Signature 11: -8.341  0.926\n",
      "  Signature 12: -8.206  0.878\n",
      "  Signature 13: -8.147  1.022\n",
      "  Signature 14: -8.514  0.925\n",
      "  Signature 15: -8.474  0.846\n",
      "  Signature 16: -8.769  0.972\n",
      "  Signature 17: -5.241  0.782\n",
      "  Signature 18: -8.841  0.913\n",
      "  Signature 19: -8.768  0.884\n",
      "\n",
      "Cluster 18 diseases:\n",
      "------------------------\n",
      "Top diseases (strongest in signature 3):\n",
      "- Other disorders of biliary tract: strength = -12.182  0.925\n",
      "- Other disorders of gallbladder: strength = -12.162  0.738\n",
      "- Calculus of bile duct: strength = -11.494  1.241\n",
      "- Cholelithiasis with acute cholecystitis: strength = -11.428  1.054\n",
      "- Cholecystitis without cholelithiasis: strength = -10.880  0.852\n",
      "\n",
      "Non-specific diseases (strong effects in multiple signatures):\n",
      "\n",
      "Peritoneal adhesions (postoperative) (postinfection):\n",
      "  Signature 0: -10.351  1.309\n",
      "  Signature 1: -10.332  0.901\n",
      "  Signature 2: -11.014  0.856\n",
      "  Signature 3: -10.460  0.886\n",
      "  Signature 4: -10.764  0.932\n",
      "  Signature 5: -10.697  0.726\n",
      "  Signature 6: -10.642  0.998\n",
      "  Signature 7: -10.288  0.880\n",
      "  Signature 8: -10.273  1.270\n",
      "  Signature 9: -10.945  0.856\n",
      "  Signature 10: -10.157  1.073\n",
      "  Signature 11: -10.736  0.808\n",
      "  Signature 12: -10.571  0.872\n",
      "  Signature 13: -9.757  1.055\n",
      "  Signature 14: -9.773  0.970\n",
      "  Signature 15: -10.138  1.126\n",
      "  Signature 16: -10.017  0.977\n",
      "  Signature 17: -10.344  0.870\n",
      "  Signature 18: -7.281  0.811\n",
      "  Signature 19: -10.650  1.191\n",
      "\n",
      "Cholelithiasis:\n",
      "  Signature 0: -8.596  1.104\n",
      "  Signature 1: -10.560  1.384\n",
      "  Signature 2: -9.654  1.018\n",
      "  Signature 3: -9.522  0.739\n",
      "  Signature 4: -9.880  0.739\n",
      "  Signature 5: -9.513  0.891\n",
      "  Signature 6: -10.117  0.879\n",
      "  Signature 7: -9.838  0.976\n",
      "  Signature 8: -9.690  0.951\n",
      "  Signature 9: -9.813  0.784\n",
      "  Signature 10: -9.589  0.861\n",
      "  Signature 11: -9.647  0.814\n",
      "  Signature 12: -10.034  0.767\n",
      "  Signature 13: -9.328  0.885\n",
      "  Signature 14: -9.956  0.736\n",
      "  Signature 15: -9.527  0.812\n",
      "  Signature 16: -9.720  0.840\n",
      "  Signature 17: -9.428  0.956\n",
      "  Signature 18: -6.561  0.858\n",
      "  Signature 19: -9.305  0.719\n",
      "\n",
      "Cholelithiasis with acute cholecystitis:\n",
      "  Signature 0: -11.255  0.807\n",
      "  Signature 1: -10.846  1.095\n",
      "  Signature 2: -11.227  0.801\n",
      "  Signature 3: -11.428  1.054\n",
      "  Signature 4: -11.536  0.747\n",
      "  Signature 5: -10.694  0.712\n",
      "  Signature 6: -11.440  0.827\n",
      "  Signature 7: -11.255  1.249\n",
      "  Signature 8: -11.610  0.839\n",
      "  Signature 9: -11.259  0.789\n",
      "  Signature 10: -11.251  1.022\n",
      "  Signature 11: -11.894  0.860\n",
      "  Signature 12: -12.088  0.803\n",
      "  Signature 13: -10.900  0.796\n",
      "  Signature 14: -11.283  0.731\n",
      "  Signature 15: -11.055  0.786\n",
      "  Signature 16: -11.116  0.905\n",
      "  Signature 17: -11.626  1.150\n",
      "  Signature 18: -8.343  0.973\n",
      "  Signature 19: -10.975  1.009\n",
      "\n",
      "Cholelithiasis with other cholecystitis:\n",
      "  Signature 0: -9.389  1.066\n",
      "  Signature 1: -10.193  0.725\n",
      "  Signature 2: -10.106  1.002\n",
      "  Signature 3: -10.660  1.024\n",
      "  Signature 4: -10.045  0.983\n",
      "  Signature 5: -10.589  0.840\n",
      "  Signature 6: -10.314  0.762\n",
      "  Signature 7: -10.021  0.781\n",
      "  Signature 8: -10.205  0.956\n",
      "  Signature 9: -10.217  0.999\n",
      "  Signature 10: -10.415  1.001\n",
      "  Signature 11: -9.743  1.212\n",
      "  Signature 12: -10.353  1.063\n",
      "  Signature 13: -9.877  0.766\n",
      "  Signature 14: -10.226  1.059\n",
      "  Signature 15: -9.723  0.894\n",
      "  Signature 16: -10.182  0.813\n",
      "  Signature 17: -10.685  0.658\n",
      "  Signature 18: -7.548  1.090\n",
      "  Signature 19: -10.153  1.211\n",
      "\n",
      "Calculus of bile duct:\n",
      "  Signature 0: -11.485  1.080\n",
      "  Signature 1: -10.657  0.767\n",
      "  Signature 2: -10.960  0.991\n",
      "  Signature 3: -11.494  1.241\n",
      "  Signature 4: -11.272  0.886\n",
      "  Signature 5: -10.518  0.858\n",
      "  Signature 6: -10.407  1.056\n",
      "  Signature 7: -11.147  1.228\n",
      "  Signature 8: -11.067  1.280\n",
      "  Signature 9: -10.535  0.705\n",
      "  Signature 10: -10.812  0.884\n",
      "  Signature 11: -10.689  0.936\n",
      "  Signature 12: -10.559  0.827\n",
      "  Signature 13: -11.026  0.978\n",
      "  Signature 14: -10.662  0.696\n",
      "  Signature 15: -10.555  1.074\n",
      "  Signature 16: -10.903  0.941\n",
      "  Signature 17: -10.573  1.009\n",
      "  Signature 18: -7.899  0.843\n",
      "  Signature 19: -11.208  1.080\n",
      "\n",
      "Cluster 19 diseases:\n",
      "------------------------\n",
      "Top diseases (strongest in signature 16):\n",
      "- Chronic glomerulonephritis, NOS: strength = -13.883  0.921\n",
      "- Chronic Kidney Disease, Stage III: strength = -12.949  0.833\n",
      "- Ectropion or entropion: strength = -12.767  0.897\n",
      "- Hypertensive chronic kidney disease: strength = -12.687  0.974\n",
      "- Secondary hypothyroidism: strength = -12.624  1.063\n",
      "\n",
      "Non-specific diseases (strong effects in multiple signatures):\n",
      "\n",
      "Viral warts & HPV:\n",
      "  Signature 0: -12.094  0.899\n",
      "  Signature 1: -11.770  0.755\n",
      "  Signature 2: -11.672  0.787\n",
      "  Signature 3: -11.928  0.742\n",
      "  Signature 4: -11.805  0.915\n",
      "  Signature 5: -11.791  0.889\n",
      "  Signature 6: -11.340  1.092\n",
      "  Signature 7: -11.324  0.897\n",
      "  Signature 8: -11.116  0.732\n",
      "  Signature 9: -11.168  0.915\n",
      "  Signature 10: -11.620  0.788\n",
      "  Signature 11: -11.348  0.966\n",
      "  Signature 12: -11.930  0.880\n",
      "  Signature 13: -11.565  0.915\n",
      "  Signature 14: -12.135  1.081\n",
      "  Signature 15: -11.597  0.820\n",
      "  Signature 16: -12.259  0.991\n",
      "  Signature 17: -11.262  1.033\n",
      "  Signature 18: -11.242  0.965\n",
      "  Signature 19: -8.582  0.888\n",
      "\n",
      "Melanomas of skin:\n",
      "  Signature 0: -11.619  0.797\n",
      "  Signature 1: -10.917  0.973\n",
      "  Signature 2: -10.773  1.113\n",
      "  Signature 3: -10.673  1.088\n",
      "  Signature 4: -10.976  1.100\n",
      "  Signature 5: -11.236  0.941\n",
      "  Signature 6: -10.903  1.059\n",
      "  Signature 7: -10.953  0.956\n",
      "  Signature 8: -10.845  0.812\n",
      "  Signature 9: -10.805  0.824\n",
      "  Signature 10: -10.926  0.783\n",
      "  Signature 11: -11.113  0.915\n",
      "  Signature 12: -10.838  0.866\n",
      "  Signature 13: -11.086  0.865\n",
      "  Signature 14: -11.092  0.823\n",
      "  Signature 15: -11.795  1.212\n",
      "  Signature 16: -10.934  0.897\n",
      "  Signature 17: -10.712  0.872\n",
      "  Signature 18: -10.920  1.171\n",
      "  Signature 19: -7.939  0.915\n",
      "\n",
      "Other non-epithelial cancer of skin:\n",
      "  Signature 0: -9.731  0.744\n",
      "  Signature 1: -9.873  0.834\n",
      "  Signature 2: -9.938  0.892\n",
      "  Signature 3: -9.638  0.953\n",
      "  Signature 4: -9.585  0.970\n",
      "  Signature 5: -9.311  0.907\n",
      "  Signature 6: -10.448  0.952\n",
      "  Signature 7: -9.855  0.997\n",
      "  Signature 8: -9.401  0.727\n",
      "  Signature 9: -9.563  0.722\n",
      "  Signature 10: -9.076  0.933\n",
      "  Signature 11: -10.434  0.864\n",
      "  Signature 12: -9.760  0.836\n",
      "  Signature 13: -10.116  0.890\n",
      "  Signature 14: -10.389  0.824\n",
      "  Signature 15: -9.790  0.998\n",
      "  Signature 16: -10.126  0.757\n",
      "  Signature 17: -9.929  0.946\n",
      "  Signature 18: -10.149  0.850\n",
      "  Signature 19: -6.890  0.902\n",
      "\n",
      "Breast cancer [female]:\n",
      "  Signature 0: -11.664  0.897\n",
      "  Signature 1: -11.668  0.971\n",
      "  Signature 2: -11.565  0.839\n",
      "  Signature 3: -11.639  0.780\n",
      "  Signature 4: -12.161  0.724\n",
      "  Signature 5: -11.047  0.768\n",
      "  Signature 6: -11.564  0.913\n",
      "  Signature 7: -11.686  0.672\n",
      "  Signature 8: -11.171  0.815\n",
      "  Signature 9: -11.968  0.904\n",
      "  Signature 10: -11.365  1.008\n",
      "  Signature 11: -11.875  1.107\n",
      "  Signature 12: -11.939  0.760\n",
      "  Signature 13: -10.900  0.875\n",
      "  Signature 14: -11.871  1.035\n",
      "  Signature 15: -11.597  0.851\n",
      "  Signature 16: -11.413  1.127\n",
      "  Signature 17: -11.777  0.853\n",
      "  Signature 18: -11.933  1.191\n",
      "  Signature 19: -8.991  1.342\n",
      "\n",
      "Malignant neoplasm of female breast:\n",
      "  Signature 0: -9.966  0.692\n",
      "  Signature 1: -9.596  1.206\n",
      "  Signature 2: -9.907  0.751\n",
      "  Signature 3: -9.809  1.075\n",
      "  Signature 4: -9.731  0.996\n",
      "  Signature 5: -9.912  0.765\n",
      "  Signature 6: -9.815  1.020\n",
      "  Signature 7: -10.202  0.881\n",
      "  Signature 8: -9.772  0.881\n",
      "  Signature 9: -9.287  0.945\n",
      "  Signature 10: -10.106  0.985\n",
      "  Signature 11: -9.854  0.889\n",
      "  Signature 12: -9.750  0.999\n",
      "  Signature 13: -9.775  0.738\n",
      "  Signature 14: -10.010  0.740\n",
      "  Signature 15: -9.795  0.755\n",
      "  Signature 16: -10.081  0.900\n",
      "  Signature 17: -9.967  0.897\n",
      "  Signature 18: -9.618  1.104\n",
      "  Signature 19: -6.683  0.845\n"
     ]
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAABdQAAAXuCAYAAABiUKo2AAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjkuMywgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy/GU6VOAAAACXBIWXMAAA9hAAAPYQGoP6dpAAEAAElEQVR4nOzdd3wUdf4G8Oc7u8mmUxO6hHYUFRBsoBikCIIISBFRMXCCBe8URUCRIggoReEKNjxEgRNR4EQOFRF+Ija8UzwbClKUGkp62d2Z7++PKTuzu0k2kBAIz9vXutN2Z7bMLnnms58RUkoJIiIiIiIiIiIiIiIqkVLZG0BEREREREREREREdD5goE5EREREREREREREFAEG6kREREREREREREREEWCgTkREREREREREREQUAQbqREREREREREREREQRYKBORERERERERERERBQBBupERERERERERERERBFgoE5EREREREREREREFAEG6kREREREREREREREEWCgTkRERBc0IQSmT59e2Ztxxl5//XW0atUKUVFRqF69erndb1V5fs4XW7duhRACW7dudUwP9/p27doVXbt2PevbSGfX9OnTIYRwTPP7/ZgwYQIaNWoERVEwYMAAAJW7v+7btw9CCLz66quVsn4iIiKis4WBOhER0QVuz549uOeee9C0aVPExMQgKSkJ11xzDRYtWoSCgoLK3jyKwE8//YT09HQ0a9YML7/8Ml566aVSb/PNN9/gjjvuQKNGjeDxeFCzZk306NEDS5cuhaqqZ2GrgUOHDmH69On45ptvzsr6TOvXr0daWhpSUlIQFxeHpk2bYujQoXjvvffO6nZE6nRe33NNamoqhBD405/+FDLPPIjw1ltvVcKWAV6vF4sWLcJll12GpKQkVK9eHRdffDHGjBmDn376qVK2qTT/+Mc/MG/ePAwePBjLli3DuHHjyn0dQgjr4na7UbNmTXTs2BEPPvggfvjhh3JfHxEREdH5wl3ZG0BERESVZ8OGDRgyZAg8Hg9GjBiBSy65BF6vF5988gkeffRRfP/99+dleFcWBQUFcLvP738Sbd26FZqmYdGiRWjevHmpyy9ZsgT33nsv6tSpgzvvvBMtWrRATk4ONm/ejD/+8Y84fPgwHn/88Qrf7kOHDuHJJ59Eamoq2rdvX+HrA4D58+fj0UcfRVpaGh577DHExcVh9+7d+PDDD/HGG2+gd+/eZ2U7inPdddehoKAA0dHR1rTiXt8PPvigMjbxjLz88st47LHHUL9+/creFMugQYOwceNG3HbbbRg9ejR8Ph9++uknvPvuu+jcuTNatWpVqdv3xBNPYNKkSY5pH330ERo0aIDnnnvOMb28P8969uyJESNGQEqJrKws7Ny5E8uWLcPixYvxzDPP4OGHH7aWbdy4MQoKChAVFVVu6yciIiI6F53ffz0SERHRadu7dy+GDRuGxo0b46OPPkK9evWseWPHjsXu3buxYcOGStzCiqNpGrxeL2JiYhATE1PZm3PGjh07BgARtXr5/PPPce+996JTp07497//jcTERGveQw89hK+++grfffddRW3qWZGXl4f4+PiQ6X6/HzNnzkTPnj3DhtHm81iZFEUJeU8W9/raQ/fzwcUXX4xdu3bh6aefxl/+8pfK3hwAwI4dO/Duu+9i1qxZIQeR/va3vyEzM7NyNszG7XaHhOTHjh0Lu7+X9+fZH/7wB9xxxx2OaU8//TT69euHRx55BK1atUKfPn0A6BXtVeHzlIiIiKg0bPlCRER0gZo7dy5yc3PxyiuvOMJ0U/PmzfHggw9a42YY2axZM3g8HqSmpuLxxx9HUVGR43apqam46aabsHXrVlx++eWIjY3FpZdeavWEXrNmDS699FLExMSgY8eO+Prrrx23T09PR0JCAn799Vf06tUL8fHxqF+/PmbMmAEppWPZ+fPno3PnzqhVqxZiY2PRsWPHsG0jhBB44IEHsGLFClx88cXweDxWe4/gnsM5OTl46KGHkJqaCo/Hg5SUFPTs2RP//e9/Hfe5evVqdOzYEbGxsahduzbuuOMOHDx4MOxjOXjwIAYMGICEhAQkJydj/PjxEbdVWbx4sbXN9evXx9ixYx0hX2pqKqZNmwYASE5OLrWH8pNPPgkhBFasWOEI002XX3450tPTi719eno6UlNTQ6aH6/O8adMmXHvttahevToSEhLQsmVLK7TcunUrrrjiCgDAyJEjrdYS9v7LX3zxBXr37o1q1aohLi4OaWlp2L59e9j1/vDDDxg+fDhq1KiBa6+9Nuy2Hz9+HNnZ2bjmmmvCzk9JSbGGzTYkq1atwuOPP466desiPj4eN998M3777beQ20ayrQBw8OBB/PGPf0T9+vXh8XjQpEkT3HffffB6vY71mvtLSa9vuB7qhYWFmD59Ov7whz8gJiYG9erVwy233II9e/aEfcwAcNNNN6Fp06Zh53Xq1AmXX365NV7Sa1qa1NRUjBgxAi+//DIOHTpU6vJff/01brzxRiQlJSEhIQHdu3fH559/7ljm1VdfhRAC27dvx8MPP4zk5GTEx8dj4MCByMjIKHUd5vMS7j3hcrlQq1Yta9x8r/30008YOnQokpKSUKtWLTz44IMoLCwMuf3y5cutz4iaNWti2LBhxb53+vTpgxo1aiA+Ph5t27bFokWLQtYLBPqUb9myBd9//72135jvl3D7f2nvubKqVasW3njjDbjdbsyaNcuaHq6H+pEjRzBy5Eg0bNgQHo8H9erVQ//+/bFv3z7HfW7cuBFdunRBfHw8EhMT0bdvX3z//feOZb799lukp6db7cnq1q2LUaNG4cSJE47lIv0Mj2SfjfS+iIiI6MLCQJ2IiOgCtX79ejRt2hSdO3eOaPm7774bU6dORYcOHfDcc88hLS0Nc+bMwbBhw0KW3b17N4YPH45+/fphzpw5OHXqFPr164cVK1Zg3LhxuOOOO/Dkk09iz549GDp0KDRNc9xeVVX07t0bderUwdy5c9GxY0dMmzbNChZNZt/jGTNmYPbs2XC73RgyZEjYyvqPPvoI48aNw6233opFixaFDYUB4N5778Xzzz+PQYMGYfHixRg/fjxiY2Px448/Wsu8+uqrGDp0KFwuF+bMmYPRo0djzZo1uPbaa0MqWlVVRa9evVCrVi3Mnz8faWlpWLBgQUStdKZPn46xY8eifv36WLBgAQYNGoQXX3wRN9xwA3w+HwBg4cKFGDhwIADg+eefx+uvv45bbrkl7P3l5+dj8+bNuO6663DRRReVuv4z8f333+Omm25CUVERZsyYgQULFuDmm2+2AqvWrVtjxowZAIAxY8bg9ddfx+uvv47rrrsOgP56XXfddcjOzsa0adMwe/ZsZGZmolu3bvjyyy9D1jdkyBDk5+dj9uzZGD16dNhtSklJQWxsLNavX4+TJ09G9DhmzZqFDRs2YOLEifjzn/+MTZs2oUePHo7zC0S6rYcOHcKVV16JN954A7feeiv+8pe/4M4778T//d//IT8/P+z6y/L6qqqKm266CU8++SQ6duyIBQsW4MEHH0RWVlaJvzq49dZbsXfvXuzYscMxff/+/fj888+tfby01zQSkydPht/vx9NPP13ict9//z26dOmCnTt3YsKECZgyZQr27t2Lrl274osvvghZ/k9/+hN27tyJadOm4b777sP69evxwAMPlLo9jRs3BgCsWLECfr8/oscwdOhQFBYWYs6cOejTpw/+8pe/YMyYMY5lZs2ahREjRqBFixZ49tln8dBDD1n7nv0zYtOmTbjuuuvwww8/4MEHH8SCBQtw/fXX49133w277uTkZOsEtQ0bNrT2m9atW4dd/nTec5G46KKLkJaWhs8//xzZ2dnFLjdo0CCsXbsWI0eOxOLFi/HnP/8ZOTk5OHDggLXM66+/jr59+yIhIQHPPPMMpkyZgh9++AHXXnutI3jftGkTfv31V4wcORJ//etfMWzYMLzxxhvo06eP42BrJJ/hke6zkdwXERERXYAkERERXXCysrIkANm/f/+Ilv/mm28kAHn33Xc7po8fP14CkB999JE1rXHjxhKA/PTTT61p77//vgQgY2Nj5f79+63pL774ogQgt2zZYk276667JAD5pz/9yZqmaZrs27evjI6OlhkZGdb0/Px8x/Z4vV55ySWXyG7dujmmA5CKosjvv/8+5LEBkNOmTbPGq1WrJseOHVvsc+H1emVKSoq85JJLZEFBgTX93XfflQDk1KlTQx7LjBkzHPdx2WWXyY4dOxa7DimlPHbsmIyOjpY33HCDVFXVmv63v/1NApD/+Mc/rGnTpk2TABzPTTg7d+6UAOSDDz5Y4nJ2wc/PXXfdJRs3bhyynLkNpueee67UbdqxY4cEIJcuXeqYrmmabNGihezVq5fUNM2anp+fL5s0aSJ79uwZst7bbrstosczdepUCUDGx8fLG2+8Uc6aNUv+5z//CVluy5YtEoBs0KCBzM7Otqa/+eabEoBctGhRmbd1xIgRUlEUuWPHjpD1mbc112vfJ4p7fdPS0mRaWpo1/o9//EMCkM8++2yx9x9OVlaW9Hg88pFHHnFMnzt3rhRCWPtsJK9pcRo3biz79u0rpZRy5MiRMiYmRh46dEhKGXjMq1evtpYfMGCAjI6Olnv27LGmHTp0SCYmJsrrrrvOmrZ06VIJQPbo0cPxGMeNGyddLpfMzMwscbs0TZNpaWkSgKxTp4687bbb5N///nfH55TJfB1uvvlmx/T7779fApA7d+6UUkq5b98+6XK55KxZsxzL/e9//5Nut9ua7vf7ZZMmTWTjxo3lqVOnQrYreL12aWlp8uKLLw7ZxuD9NZL3XHEAlPhZ+OCDDzoe9969ex3786lTpyQAOW/evGLvIycnR1avXl2OHj3aMf3IkSOyWrVqjunBn/dSSvnPf/5TApAff/yxNa20z/Cy7LOl3RcRERFdmFihTkREdAEyKwrDtfwI59///jcAOE5ABwCPPPIIAIRUhLdp0wadOnWyxq+66ioAQLdu3RyV0eb0X3/9NWSd9upSs2WL1+vFhx9+aE2PjY21hk+dOoWsrCx06dIl7M/x09LS0KZNm1Ieqd6n+osvvii2JcVXX32FY8eO4f7773f0C+7bty9atWoVtjr+3nvvdYx36dIl7GO2+/DDD+H1evHQQw9BUQL/ZBs9ejSSkpJOq799WV/3M2H2d/7Xv/4V8guE0nzzzTf45ZdfMHz4cJw4cQLHjx/H8ePHkZeXh+7du+Pjjz8Ouc/g57g4Tz75JFauXInLLrsM77//PiZPnoyOHTuiQ4cOYatOR4wY4Xi+Bg8ejHr16ln7RKTbqmka1q1bh379+jlaqJiC2+Wcjrfffhu1a9fGn/70pzLdf1JSEm688Ua8+eabjkrfVatW4eqrr7b22TN5Te2eeOKJEqvUVVXFBx98gAEDBjha0dSrVw/Dhw/HJ598ElIVPWbMGMdj7NKlC1RVxf79+0vcFiEE3n//fTz11FOoUaMG/vnPf2Ls2LFo3Lgxbr311rA91MeOHesYN59v8z2xZs0aaJqGoUOHWu+H48ePo27dumjRogW2bNkCQG9ps3fvXjz00EMh/dDL4/1Q0e+5hIQEAHpblHBiY2MRHR2NrVu34tSpU2GX2bRpEzIzM3Hbbbc5niuXy4WrrrrKeq7M+zMVFhbi+PHjuPrqqwHA8Zlf2md4WT5fSrsvIiIiujAxUCciIroAJSUlASg+CAm2f/9+KIqC5s2bO6bXrVsX1atXDwmtgtuJVKtWDQDQqFGjsNODwxZFUUJ6Ov/hD38AAEcLgHfffRdXX301YmJiULNmTSQnJ+P5559HVlZWyGNo0qRJaQ8TgN5b/rvvvkOjRo1w5ZVXYvr06Y7w23ysLVu2DLltq1atQp6LmJgYJCcnO6bVqFGj2ICptPVER0ejadOmpQaF4ZT1dT8Tt956K6655hrcfffdqFOnDoYNG4Y333wzoiD2l19+AQDcddddSE5OdlyWLFmCoqKikNfY/voWFBTgyJEjjovdbbfdhm3btuHUqVP44IMPMHz4cHz99dfo169fSC/sFi1aOMaFEGjevLn1Pox0WzMyMpCdnY1LLrkksifwNOzZswctW7YMOYFlJG699Vb89ttv+Oyzz6z7+s9//oNbb73VsczpvqZ2TZs2xZ133omXXnoJhw8fDpmfkZGB/Pz8sPtY69atoWlaSC/y4M+cGjVqAAh8tmRlZTneD/aWPx6PB5MnT8aPP/6IQ4cO4Z///CeuvvpqvPnmm2HbxgS/J5o1awZFURzvCSklWrRoEfKe+PHHH62TzJr92yvqPVHR77nc3FwAxR+g83g8eOaZZ7Bx40bUqVMH1113HebOnevYH839p1u3biHP1QcffOA4UfDJkyfx4IMPok6dOoiNjUVycrK139s/D0r7DC/L50tp90VEREQXprL/a5uIiIjOe0lJSahfv36JfZXDibSi0eVylWm6DDrZaCS2bduGm2++Gddddx0WL16MevXqISoqCkuXLsXKlStDlrdXN5Zk6NCh6NKlC9auXYsPPvgA8+bNwzPPPIM1a9bgxhtvLPN2FveYK0Pz5s3hdrvxv//977Tvo7j3QPBJVmNjY/Hxxx9jy5Yt2LBhA9577z2sWrUK3bp1wwcffFDi82IGtPPmzUP79u3DLmNWx9rXZ1q1ahVGjhzpmB/uPZaUlISePXuiZ8+eiIqKwrJly/DFF18gLS2t2G073W2NtGd7ZenXrx/i4uLw5ptvonPnznjzzTehKAqGDBliLXMmr2mwyZMn4/XXX8czzzyDAQMGnPH2l/bZ8uCDD2LZsmXW9LS0NOtEnnb16tXDsGHDMGjQIFx88cV488038eqrr5Z4kCJ4n9A0DUIIbNy4Mex2Bb93z1ffffcdXC5XiQcrH3roIfTr1w/r1q3D+++/jylTpmDOnDn46KOPcNlll1n7z+uvv466deuG3N7+vA8dOhSffvopHn30UbRv3x4JCQnQNA29e/d2HNQp7TO8LJ8v5f19QERERFUDA3UiIqIL1E033YSXXnoJn332maM9SziNGzeGpmn45ZdfHCe/O3r0KDIzM60T+5UXTdPw66+/WlXpAPDzzz8DgHUy0bfffhsxMTF4//334fF4rOWWLl16xuuvV68e7r//ftx///04duwYOnTogFmzZuHGG2+0HuuuXbvQrVs3x+127dpVbs+FfT32an2v14u9e/eiR48eZb7PuLg4dOvWDR999BF+++23kF8MRKJGjRph22CEq5hXFAXdu3dH9+7d8eyzz2L27NmYPHkytmzZgh49ehQbzjdr1gyAHnifzuPs1asXNm3aVKbbXH755Vi2bFlIxbRZzWqSUmL37t1o27ZtmbY1OTkZSUlJZT6IVRbNmjXDF198AZ/Ph6ioqDLdNj4+HjfddBNWr16NZ599FqtWrUKXLl1Qv359x3KlvaZl2dY77rgDL774otX6yZScnIy4uDjs2rUr5HY//fQTFEUp83t3woQJuOOOO6xxs4K9OFFRUWjbti1++eUXq12L6ZdffnGEyLt374amadZnU7NmzSClRJMmTRyfYcHM98533313Wu/z0lTke+7AgQP4v//7P3Tq1KnUFlLNmjXDI488gkceeQS//PIL2rdvjwULFmD58uXWc5CSklLic3Dq1Cls3rwZTz75JKZOnWpND94/TSV9hpf186Wk+yIiIqILE1u+EBERXaAmTJiA+Ph43H333Th69GjI/D179mDRokUAgD59+gAAFi5c6Fjm2WefBaD3Dy9vf/vb36xhKSX+9re/ISoqCt27dwegV6QKIRyV0fv27cO6detOe52qqoa0EklJSUH9+vVRVFQEQA9eU1JS8MILL1jTAGDjxo348ccfy+256NGjB6Kjo/GXv/zFUV39yiuvICsr67TXM23aNEgpceedd1otG+z+85//OCp5gzVr1gxZWVn49ttvrWmHDx/G2rVrHcuFq8g2q0HN5y0+Ph4AQgL6jh07olmzZpg/f37YbczIyCh2+wA9AOvRo4fjAgD5+flWS5NgGzduBBDaYue1115ztMh56623cPjwYStMi3RbFUXBgAEDsH79enz11Vchy53OrzSCDRo0CMePH3fsO2W5/1tvvRWHDh3CkiVLsHPnTke7FyCy17QsnnjiCfh8PsydO9cx3eVy4YYbbsC//vUvR4uno0ePYuXKlbj22mut9kWRatOmjeP90LFjRwB6IHvgwIGQ5TMzM/HZZ5+hRo0aIS2b/v73vzvG//rXvwKA9Z645ZZb4HK58OSTT4Y871JKnDhxAgDQoUMHNGnSBAsXLgzZB8rj/VBR77mTJ0/itttug6qqmDx5crHL5efnh7RQatasGRITE633S69evZCUlITZs2fD5/OF3Ie5/5iV/sHbHPydFMlneKT7bCT3RURERBcmVqgTERFdoJo1a4aVK1fi1ltvRevWrTFixAhccskl8Hq9+PTTT7F69Wqkp6cDANq1a4e77roLL730EjIzM5GWloYvv/wSy5Ytw4ABA3D99deX67bFxMTgvffew1133YWrrroKGzduxIYNG/D4449b4Vbfvn3x7LPPonfv3hg+fDiOHTuGv//972jevLkj7C2LnJwcNGzYEIMHD0a7du2QkJCADz/8EDt27MCCBQsA6JWrzzzzDEaOHIm0tDTcdtttOHr0KBYtWoTU1FSMGzeuXJ6D5ORkPPbYY3jyySfRu3dv3Hzzzdi1axcWL16MK664wlFtWxadO3fG3//+d9x///1o1aoV7rzzTrRo0QI5OTnYunUr3nnnHTz11FPF3n7YsGGYOHEiBg4ciD//+c/Iz8/H888/jz/84Q+OEwPOmDEDH3/8Mfr27YvGjRvj2LFjWLx4MRo2bIhrr70WgP4erF69Ol544QUkJiYiPj4eV111FZo0aYIlS5bgxhtvxMUXX4yRI0eiQYMGOHjwILZs2YKkpCSsX7++zI89Pz8fnTt3xtVXX43evXujUaNGyMzMxLp167Bt2zYMGDAAl112meM2NWvWxLXXXouRI0fi6NGjWLhwIZo3b47Ro0cD0EPLSLd19uzZ+OCDD5CWloYxY8agdevWOHz4MFavXo1PPvkk5MSUZTVixAi89tprePjhh/Hll1+iS5cuyMvLw4cffoj7778f/fv3L/H2ffr0QWJiIsaPHw+Xy4VBgwY55kfympaFWaUe7gDOU089hU2bNuHaa6/F/fffD7fbjRdffBFFRUUhAfyZ2LlzJ4YPH44bb7wRXbp0Qc2aNXHw4EEsW7YMhw4dwsKFC0Patuzduxc333wzevfujc8++wzLly/H8OHD0a5dO+txPfXUU3jsscewb98+DBgwAImJidi7dy/Wrl2LMWPGYPz48VAUBc8//zz69euH9u3bY+TIkahXrx5++uknfP/993j//ffP+PGd6Xvu559/xvLlyyGlRHZ2Nnbu3InVq1cjNzfX+vwt6bbdu3fH0KFD0aZNG7jdbqxduxZHjx7FsGHDAOhV4s8//zzuvPNOdOjQAcOGDUNycjIOHDiADRs24JprrsHf/vY3JCUlWT3YfT4fGjRogA8++AB79+51rDOSz/BI99lI7ouIiIguUJKIiIguaD///LMcPXq0TE1NldHR0TIxMVFec8018q9//assLCy0lvP5fPLJJ5+UTZo0kVFRUbJRo0bysccecywjpZSNGzeWffv2DVkPADl27FjHtL1790oAct68eda0u+66S8bHx8s9e/bIG264QcbFxck6derIadOmSVVVHbd/5ZVXZIsWLaTH45GtWrWSS5culdOmTZPB/8QJt277vGnTpkkppSwqKpKPPvqobNeunUxMTJTx8fGyXbt2cvHixSG3W7Vqlbzsssukx+ORNWvWlLfffrv8/fffHcuYjyVYuG0szt/+9jfZqlUrGRUVJevUqSPvu+8+eerUqbD3l5GREdF9Sinlf/7zHzl8+HBZv359GRUVJWvUqCG7d+8uly1b5nie7c+P6YMPPpCXXHKJjI6Oli1btpTLly8PeUybN2+W/fv3l/Xr15fR0dGyfv368rbbbpM///yz477+9a9/yTZt2ki32y0ByKVLl1rzvv76a3nLLbfIWrVqSY/HIxs3biyHDh0qN2/efFqP3efzyZdfflkOGDBANm7cWHo8HhkXFycvu+wyOW/ePFlUVGQtu2XLFglA/vOf/5SPPfaYTElJkbGxsbJv375y//79IfcdybZKKeX+/fvliBEjZHJysvR4PLJp06Zy7Nix1rrN9W7ZsqXUx5iWlibT0tIc0/Lz8+XkyZOt/bRu3bpy8ODBcs+ePaU+P1JKefvtt0sAskePHiHzIn1Nwynuc+GXX36RLpdLApCrV692zPvvf/8re/XqJRMSEmRcXJy8/vrr5aeffupYZunSpRKA3LFjh2N6uOcxnKNHj8qnn35apqWlyXr16km32y1r1Kghu3XrJt966y3Hsubr8MMPP8jBgwfLxMREWaNGDfnAAw/IgoKCkPt+++235bXXXivj4+NlfHy8bNWqlRw7dqzctWuXY7lPPvlE9uzZ0/rMadu2rfzrX/8asl67tLQ0efHFF4esM9z+Wtp7rjgArIuiKLJ69erysssukw8++KD8/vvvQ5Y3P8/Nffj48eNy7NixslWrVjI+Pl5Wq1ZNXnXVVfLNN98Mue2WLVtkr169ZLVq1WRMTIxs1qyZTE9Pl1999ZW1zO+//y4HDhwoq1evLqtVqyaHDBkiDx06dNqf4aXts2W5LyIiIrqwCCnL4feEREREROUkPT0db731Vtif4hOdLVu3bsX111+P1atXY/DgwZW9OXQOmD59Op588klkZGSgdu3alb05RERERFRJ2EOdiIiIiIiIiIiIiCgCDNSJiIiIiIiIiIiIiCLAQJ2IiIiIiIiIiIiIKALsoU5EREREREREREREFAFWqBMRERERERERERERRYCBOhERERERERERERFRBBioExERERERERERERFFgIE6EREREREREREREVEEGKgTEREREREREREREUWAgToRERERERERERERUQQYqBMRERERERERERERRYCBOhERERERERERERFRBBioExERERERERERERFFgIE6EREREREREREREVEEGKgTEREREREREREREUWAgToRERERERERERERUQQYqBMRERERERERERERRYCBOhERERERERERERFRBBioExERERERERERERFFgIE6EREREREREREREVEEGKgTEREREREREREREUWAgToRERERERERERERUQQYqBMRERERERERERERRYCBOhERERERERERERFRBBioExERERERERERERFFgIE6EREREREREREREVEEGKgTEREREREREREREUWAgToRERERERERERERUQQYqBMRERERERERERERRYCBOhERERERERERERFRBBioExERERERERERERFFgIE6EREREREREREREVEEGKgTEREREREREREREUWAgToRERERERERERERUQQYqBMRERERERERERERRYCBOhERERERERERERFRBBioExERERERERERERFFgIE6EREREREREREREVEEGKgTEREREREREREREUWAgToRERERERERERERUQQYqBMRERERERERERERRYCBOhERERERERERERFRBBioExERERERERERERFFgIE6EREREREREREREVEEGKgTEREREREREREREUWAgToRERERERERERERUQQYqBMRERERERERERERRYCBOhERERERERERERFRBBioExERERERERERERFFgIE6EREREREREREREVEEGKgTEREREREREREREUWAgToRERERERERERERUQQYqBMRERERERERERERRYCBOhERERERERERERFRBBioExERERERERERERFFgIE6EREREREREREREVEEGKgTEREREREREREREUWAgToRERERERERERERUQQYqBMRERERERERERERRYCBOhERERERERERERFRBBioExERERERERERERFFgIE6EREREREREREREVEEGKgTEREREREREREREUWAgToRERGd17p27YquXbtW9mYQYfr06RBCVPZmEBERERFRBWKgTkRERGfVnj17cM8996Bp06aIiYlBUlISrrnmGixatAgFBQWVvXlUjPT0dAghSr2kp6dX9qae84Kfy6SkJLRr1w4LFixAUVFRme7r0KFDmD59Or755puQeStXrsTChQvLZ6OJiIiIiAgA4K7sDSAiIqILx4YNGzBkyBB4PB6MGDECl1xyCbxeLz755BM8+uij+P777/HSSy9V9mZSGPfccw969Ohhje/duxdTp07FmDFj0KVLF2t6s2bNKmPzzjsejwdLliwBAGRmZuLtt9/G+PHjsWPHDrzxxhsR38+hQ4fw5JNPIjU1Fe3bt3fMW7lyJb777js89NBD5bjlREREREQXNgbqREREdFbs3bsXw4YNQ+PGjfHRRx+hXr161ryxY8di9+7d2LBhQyVuIQFAYWEhoqOjoSjOHzJ26tQJnTp1ssa/+uorTJ06FZ06dcIdd9xxtjfzrMjLy0N8fHyF3Lfb7XY8b/fffz+uuuoqrFq1Cs8++yzq169fIes9U5qmwev1IiYmprI3hYiIiIioUrDlCxEREZ0Vc+fORW5uLl555RVHmG5q3rw5HnzwQWvc7/dj5syZaNasGTweD1JTU/H4449H1BLj2LFj+OMf/4g6deogJiYG7dq1w7JlyxzL7Nu3D0IIzJ8/Hy+99JK1niuuuAI7duyI6DFlZmZi3LhxSE1NhcfjQcOGDTFixAgcP34cAOD1ejF16lR07NgR1apVQ3x8PLp06YItW7ac0bb89NNPGDp0KJKTkxEbG4uWLVti8uTJjmUOHjyIUaNGoU6dOvB4PLj44ovxj3/8w7HM1q1bIYTAG2+8gSeeeAINGjRAXFwcsrOzI3r84XzxxRfo3bs3qlWrhri4OKSlpWH79u2OZcxe4z///DPuuOMOVKtWDcnJyZgyZQqklPjtt9/Qv39/JCUloW7duliwYEHY7V61ahUef/xx1K1bF/Hx8bj55pvx22+/hWzT6tWr0bFjR8TGxqJ27dq44447cPDgQccy6enpSEhIwJ49e9CnTx8kJibi9ttvBwBs27YNQ4YMwUUXXQSPx4NGjRph3Lhx5dqiSFEU61wA+/btw8mTJzF+/HhceumlSEhIQFJSEm688Ubs3LnT8TxcccUVAICRI0daLWReffVVdO3aFRs2bMD+/fut6ampqdZti4qKMG3aNDRv3tx6TBMmTAjZv4QQeOCBB7BixQpcfPHF8Hg8eO+99/Dqq69CCIHt27fj4YcfRnJyMuLj4zFw4EBkZGQ47uOrr75Cr169ULt2bcTGxqJJkyYYNWpUuT13RERERERnEyvUiYiI6KxYv349mjZtis6dO0e0/N13341ly5Zh8ODBeOSRR/DFF19gzpw5+PHHH7F27dpib1dQUICuXbti9+7deOCBB9CkSROsXr0a6enpyMzMdIT2gN4WIycnB/fccw+EEJg7dy5uueUW/Prrr4iKiip2Pbm5uejSpQt+/PFHjBo1Ch06dMDx48fxzjvv4Pfff0ft2rWRnZ2NJUuW4LbbbsPo0aORk5ODV155Bb169cKXX34ZtkVHadvy7bffokuXLoiKisKYMWOQmpqKPXv2YP369Zg1axYA4OjRo7j66qutMDQ5ORkbN27EH//4R2RnZ4e0AJk5cyaio6Mxfvx4FBUVITo6OqLXKNhHH32EG2+8ER07dsS0adOgKAqWLl2Kbt26Ydu2bbjyyisdy996661o3bo1nn76aWzYsAFPPfUUatasiRdffBHdunXDM888gxUrVmD8+PG44oorcN111zluP2vWLAghMHHiRBw7dgwLFy5Ejx498M033yA2NhYA8Oqrr2LkyJG44oorMGfOHBw9ehSLFi3C9u3b8fXXX6N69erW/fn9fvTq1QvXXnst5s+fj7i4OAB6IJ+fn4/77rsPtWrVwpdffom//vWv+P3337F69erTeq7C2bNnDwCgVq1a+PXXX7Fu3ToMGTIETZo0wdGjR/Hiiy8iLS0NP/zwA+rXr4/WrVtjxowZIa13OnfujAYNGiArKwu///47nnvuOQBAQkICAL3K/Oabb8Ynn3yCMWPGoHXr1vjf//6H5557Dj///DPWrVvn2K6PPvoIb775Jh544AHUrl0bqampVs/2P/3pT6hRowamTZuGffv2YeHChXjggQewatUqAPrBrRtuuAHJycmYNGkSqlevjn379mHNmjXl9rwREREREZ1VkoiIiKiCZWVlSQCyf//+ES3/zTffSADy7rvvdkwfP368BCA/+ugja1paWppMS0uzxhcuXCgByOXLl1vTvF6v7NSpk0xISJDZ2dlSSin37t0rAchatWrJkydPWsv+61//kgDk+vXrS9zGqVOnSgByzZo1IfM0TZNSSun3+2VRUZFj3qlTp2SdOnXkqFGjrGll2ZbrrrtOJiYmyv3794ddp5RS/vGPf5T16tWTx48fdywzbNgwWa1aNZmfny+llHLLli0SgGzatKk1LVI7duyQAOTSpUut9bdo0UL26tXLsS35+fmySZMmsmfPnta0adOmSQByzJgx1jS/3y8bNmwohRDy6aefdjxfsbGx8q677rKmmdvdoEED6/WUUso333xTApCLFi2SUuqve0pKirzkkktkQUGBtdy7774rAcipU6da0+666y4JQE6aNCnksYZ7bubMmSOFEI7XwXxcpbnrrrtkfHy8zMjIkBkZGXL37t1y9uzZUggh27ZtK6WUsrCwUKqq6rjd3r17pcfjkTNmzLCmBb8Odn379pWNGzcOmf76669LRVHktm3bHNNfeOEFCUBu377dmgZAKooiv//+e8eyS5culQBkjx49HK/3uHHjpMvlkpmZmVJKKdeuXSsByB07dpT6vBARERERnQ/Y8oWIiIgqnNlCJDExMaLl//3vfwMAHn74Ycf0Rx55BABK7LX+73//G3Xr1sVtt91mTYuKisKf//xn5Obm4v/+7/8cy996662oUaOGNW5W+f76668lbuPbb7+Ndu3aYeDAgSHzhBAAAJfLZVV7a5qGkydPwu/34/LLL8d///vfkNuVti0ZGRn4+OOPMWrUKFx00UVh1ymlxNtvv41+/fpBSonjx49bl169eiErKytk3XfddZdV0X26vvnmG/zyyy8YPnw4Tpw4Ya0zLy8P3bt3x8cffwxN0xy3ufvuu61hl8uFyy+/HFJK/PGPf7SmV69eHS1btgz7eowYMcLxnho8eDDq1atnvX+++uorHDt2DPfff7+j53ffvn3RqlWrsO+j++67L2Sa/bnJy8vD8ePH0blzZ0gp8fXXX0fy9ITIy8tDcnIykpOT0bx5czz++OPo1KmT9esLj8dj9bFXVRUnTpxAQkICWrZsGfa9UxarV69G69at0apVK8f7o1u3bgAQ0pIoLS0Nbdq0CXtfY8aMsd57gP6eVVUV+/fvBwDrFwDvvvsufD7fGW03EREREdG5gC1fiIiIqMIlJSUBAHJyciJafv/+/VAUBc2bN3dMr1u3LqpXr26FdcXdtkWLFiEn1WzdurU13y44mDYD7VOnTpW4jXv27MGgQYNKfiAAli1bhgULFuCnn35yBIpNmjQJWba0bTFD5UsuuaTY9WVkZCAzMxMvvfQSXnrppbDLHDt2zDEeblvK6pdffgGgh/PFycrKchwwCH681apVQ0xMDGrXrh0y/cSJEyH316JFC8e4EALNmzfHvn37AARe65YtW4bctlWrVvjkk08c09xuNxo2bBiy7IEDBzB16lS88847Ie+LrKyskOUjERMTg/Xr1wPQw/MmTZo41q1pGhYtWoTFixdj7969UFXVmlerVq3TWqfpl19+wY8//ojk5OSw88vy/ijtPZuWloZBgwbhySefxHPPPYeuXbtiwIABGD58ODwez5k8DCIiIiKiSsFAnYiIiCpcUlIS6tevj++++65Mt7NXvlYUl8sVdrqU8ozve/ny5UhPT8eAAQPw6KOPIiUlBS6XC3PmzLH6ZZf3tphV4HfccUex4Xbbtm0d42danW5f77x580J6w5vMHt6mcI+3Il+P0tirwk2qqqJnz544efIkJk6ciFatWiE+Ph4HDx5Eenp6SNV9pFwuF3r06FHs/NmzZ2PKlCkYNWoUZs6ciZo1a0JRFDz00EOnvU6Tpmm49NJL8eyzz4ad36hRI8d4Se+P0l4vIQTeeustfP7551i/fj3ef/99jBo1CgsWLMDnn38e8p4gIiIiIjrXMVAnIiKis+Kmm27CSy+9hM8++wydOnUqcdnGjRtD0zT88ssvVmU5oJ9sMzMzE40bNy7xtt9++y00TXOEoz/99JM1vzw0a9as1AMEb731Fpo2bYo1a9Y4Dg5MmzbttNbZtGlTAChxvcnJyUhMTISqqiUGtuWtWbNmAPSDJ2drvWZVvElKid27d1sHDMzXeteuXVY7E9OuXbsiei/873//w88//4xly5ZhxIgR1vRNmzad6eaX6K233sL111+PV155xTE9MzPTUcFf0kGn4uY1a9YMO3fuRPfu3c/KQSsAuPrqq3H11Vdj1qxZWLlyJW6//Xa88cYbjrY/RERERETnA/ZQJyIiorNiwoQJiI+Px913342jR4+GzN+zZw8WLVoEAOjTpw8AYOHChY5lzIravn37FruePn364MiRI1i1apU1ze/3469//SsSEhKQlpZ2pg8FADBo0CDs3LnT6nltZ1bnmtW79urqL774Ap999tlprTM5ORnXXXcd/vGPf+DAgQPFrnPQoEF4++23wwbvGRkZp7Xu0nTs2BHNmjXD/PnzkZube1bW+9prrznaCL311ls4fPgwbrzxRgDA5ZdfjpSUFLzwwgsoKiqyltu4cSN+/PHHEt9HpnCvoZTSeq9WFJfLFVKVv3r1ahw8eNAxLT4+HoAetAeLj48P25Jm6NChOHjwIF5++eWQeQUFBcjLyzuDLXc6depUyOMwf8Fgf02IiIiIiM4XrFAnIiKis6JZs2ZYuXIlbr31VrRu3RojRozAJZdcAq/Xi08//RSrV69Geno6AKBdu3a466678NJLLyEzMxNpaWn48ssvsWzZMgwYMADXX399sesZM2YMXnzxRaSnp+M///kPUlNT8dZbb2H79u1YuHBhxCdGLc2jjz6Kt956C0OGDMGoUaPQsWNHnDx5Eu+88w5eeOEFtGvXDjfddBPWrFmDgQMHom/fvti7dy9eeOEFtGnTJmzoHIm//OUvuPbaa9GhQweMGTMGTZo0wb59+7BhwwZ88803AICnn34aW7ZswVVXXYXRo0ejTZs2OHnyJP773//iww8/xMmTJ8vlObBTFAVLlizBjTfeiIsvvhgjR45EgwYNcPDgQWzZsgVJSUlWz/DyUrNmTVx77bUYOXIkjh49ioULF6J58+YYPXo0AP1ktM888wxGjhyJtLQ03HbbbTh69CgWLVqE1NRUjBs3rtR1tGrVCs2aNcP48eNx8OBBJCUl4e233y61x/6ZuummmzBjxgyMHDkSnTt3xv/+9z+sWLHC+pWCqVmzZqhevTpeeOEFJCYmIj4+HldddRWaNGmCjh07YtWqVXj44YdxxRVXICEhAf369cOdd96JN998E/feey+2bNmCa665Bqqq4qeffsKbb76J999/H5dffnm5PI5ly5Zh8eLFGDhwIJo1a4acnBy8/PLLSEpKsg6cERERERGdTxioExER0Vlz880349tvv8W8efPwr3/9C88//zw8Hg/atm2LBQsWWEEoACxZsgRNmzbFq6++irVr16Ju3bp47LHHSm2XEhsbi61bt2LSpElYtmwZsrOz0bJlSyxdutQK7MtDQkICtm3bhmnTpmHt2rVYtmwZUlJS0L17d+vkkunp6Thy5AhefPFFvP/++2jTpg2WL1+O1atXY+vWrae13nbt2uHzzz/HlClT8Pzzz6OwsBCNGzfG0KFDrWXq1KmDL7/8EjNmzMCaNWuwePFi1KpVCxdffDGeeeaZ8nj4YXXt2hWfffYZZs6cib/97W/Izc1F3bp1cdVVV+Gee+4p9/U9/vjj+PbbbzFnzhzk5OSge/fuWLx4MeLi4qxl0tPTERcXh6effhoTJ05EfHw8Bg4ciGeeeQbVq1cvdR1RUVFYv349/vznP2POnDmIiYnBwIED8cADD6Bdu3bl/pjsjy0vLw8rV67EqlWr0KFDB2zYsAGTJk0K2b5ly5bhsccew7333gu/34+lS5eiSZMmuP/++/HNN99g6dKleO6559C4cWP069cPiqJg3bp1eO655/Daa69h7dq1iIuLQ9OmTfHggw/iD3/4Q7k9DvNg2BtvvIGjR4+iWrVquPLKK7FixYpyORkuEREREdHZJuTZOMMTEREREVE52bp1K66//nqsXr0agwcPruzNISIiIiKiCwh7qBMRERERERERERERRYCBOhERERERERERERFRBBioExERERERERERERFFgD3UiYiIiIiIiIiIiIgiwAp1IiIiIiIiIiIiIqIIMFAnIiIiIiIiIiIiIoqAu7I34FyjaRoOHTqExMRECCEqe3OIiIiIiIiIiIgiJqVETk4O6tevD0VhLS1ReWOgHuTQoUNo1KhRZW8GERERERERERHRafvtt9/QsGHDyt4MoiqHgXqQxMREAPqHTlJSUiVvTfnSNA0ZGRlITk7mEUqicsR9i6hicN8iqhjct4gqBvctoorBfavssrOz0ahRIyvjIqLyxUA9iNnmJSkpqUoG6oWFhUhKSuKXEFE54r5FVDG4bxFVDO5bRBWD+xZRxeC+dfrYypioYvCTiIiIiIiIiIiIiIgoAgzUiYiIiIiIiIiIiIgiwECdiIiIiIiIiIiIiCgC7KFOREREREREREREVZqqqvD5fJW9GXQOioqKgsvlinh5BupERERERERERERUJUkpceTIEWRmZlb2ptA5rHr16qhbt25EJ/OtcoH6hg0bMGPGDHz77beIiYlBWloa1q1bV9mbRURERERERERERGeZGaanpKQgLi4uosCULhxSSuTn5+PYsWMAgHr16pV6myoVqL/99tsYPXo0Zs+ejW7dusHv9+O7776r7M0iIiIiIiIiIiKis0xVVStMr1WrVmVvDp2jYmNjAQDHjh1DSkpKqe1fqkyg7vf78eCDD2LevHn44x//aE1v06ZNJW4VERERERERERERVQazZ3pcXFwlbwmd68z3iM/nu3AC9f/+9784ePAgFEXBZZddhiNHjqB9+/aYN28eLrnkkmJvV1RUhKKiIms8OzsbAKBpGjRNq/DtPps0TYOUsso9LqLKxn2LqGJw3yKqGNy3iCoG9y2iisF9q+z4XIVimxcqTVneI1UmUP/1118BANOnT8ezzz6L1NRULFiwAF27dsXPP/+MmjVrhr3dnDlz8OSTT4ZMz8jIQGFhYYVu89mmaRqysrIgpYSiKJW9OURVBvctoorBfYuoYnDfIqoY3LeIKgb3rbLLycmp7E0gqtLO+UB90qRJeOaZZ0pc5scff7SOvk2ePBmDBg0CACxduhQNGzbE6tWrcc8994S97WOPPYaHH37YGs/OzkajRo2QnJyMpKSkcnoU5wZN0yCEQHJyMr+EiMoR9y2iisF9i6hicN8iqhjct4gqBvetsouJiansTaCzQAiBtWvXYsCAAZW9KReccz5Qf+SRR5Cenl7iMk2bNsXhw4cBOHumezweNG3aFAcOHCj2th6PBx6PJ2S6oihV8oNaCFFlHxtRZeK+RVQxuG8RVQzuW0QVg/sWUcXgvlU2fJ7OfxkZGZg6dSo2bNiAo0ePokaNGmjXrh2mTp2Ka665BgBw+PBh1KhR46xvW2pqKh566CE89NBDZ33dpgMHDuC+++7Dli1bkJCQgLvuugtz5syB2312ou5zPlBPTk5GcnJyqct17NgRHo8Hu3btwrXXXgtAbyK/b98+NG7cuKI3k4iIiIiIiIiIiOiMDRo0CF6vF8uWLUPTpk1x9OhRbN68GSdOnLCWqVu3biVu4Znzer2Ijo4u8+1UVUXfvn1Rt25dfPrppzh8+DBGjBiBqKgozJ49uwK2NNQ5H6hHKikpCffeey+mTZuGRo0aoXHjxpg3bx4AYMiQIZW8dUREREREROcPKSWklGUaDnddXtOKG49kXkm3Caekk5KVNE9KiZycHERFRTmqQ83b2G8bPC2SeUKIkOFw81iZSkR0fsvMzMS2bduwdetWpKWlAQAaN26MK6+80rFccMuXTz/9FPfffz9++uknXHLJJXjiiScwcOBAfP3112jfvj22bt2K66+/Hh9++CEmTpyIH374Ae3bt8fSpUvRsmVLAMCePXvw8MMP4/PPP0deXh5at26NOXPmoEePHgCArl27Yv/+/Rg3bhzGjRsHQP/+mz59OtatW4dvvvnG2r6FCxdi4cKF2LdvHwAgPT0dmZmZuOKKK/D3v/8dHo8He/fuxW+//YZHHnkEH3zwARRFQZcuXbBo0SKkpqaGfX4++OAD/PDDD/jwww9Rp04dtG/fHjNnzsTEiRMxffr00wrpy6rKBOoAMG/ePLjdbtx5550oKCjAVVddhY8++qhSfv5ARERERER0JjRNs0Jr+wVAmaYXN88+zRy2X1PZSCnh8/lQWFhYYvB+tkQSwJfnhYjofCGlRIFPPevrjY1yRfR5mZCQgISEBKxbtw5XX3112FbVwbKzs9GvXz/06dMHK1euxP79+4ttyTJ58mQsWLAAycnJuPfeezFq1Chs374dAJCbm4s+ffpg1qxZ8Hg8eO2119CvXz/s2rULF110EdasWYN27dphzJgxGD16dJkePwBs3rwZSUlJ2LRpEwC9u0ivXr3QqVMnbNu2DW63G0899RR69+6Nb7/9Nmw4/tlnn+HSSy9FnTp1rGm9evXCfffdh++//x6XXXZZmberrKpUoB4VFYX58+dj/vz5lb0pRERERERUxdkD7+LC77Jc7PdBdKbO9nvJHq4rilLieCTLsNKeiCpKgU9Fm6nvn/X1/jCjF+KiS49i3W43Xn31VYwePRovvPACOnTogLS0NAwbNgxt27YNe5uVK1dCCIGXX34ZMTExaNOmDQ4ePBg29J41a5ZV+T5p0iT07dsXhYWFiImJQbt27dCuXTtr2ZkzZ2Lt2rV455138MADD6BmzZpwuVxITEw8rZYz8fHxWLJkiRWUL1++HJqmYcmSJdbBhqVLl6J69erYunUrbrjhhpD7OHLkiCNMB2CNHzlypMzbdDqqVKBOREREREQUTnBoHRyAhwvES1uGiALs+4Wqlk/lZ3DQHm64pGn2eURE55NBgwahb9++2LZtGz7//HNs3LgRc+fOxZIlS5Cenh6y/K5du9C2bVvExMRY04JbxJjsoXy9evUAAMeOHcNFF12E3NxcTJ8+HRs2bMDhw4fh9/tRUFCAAwcOlMvjuvTSSx1V5zt37sTu3buRmJjoWK6wsBB79uwpl3VWBAbqRERERER0ziouCA9XHV7SPAbgROcfKWW5hPORBPKRXBNR1RAb5cIPM3pVynrLIiYmBj179kTPnj0xZcoU3H333Zg2bVrYQL0soqKirGHzgKOmaQCA8ePHY9OmTZg/fz6aN2+O2NhYDB48GF6vt8T7VBQl5N9aPp8vZLn4+HjHeG5uLjp27IgVK1aELJucnBx2XXXr1sWXX37pmHb06FFr3tnAQJ2IiIiIiCqUpmnWJTj4Lm7Yfk1EdCbsB9jORFmq4lktT3TuEkJE1HrlXNOmTRusW7cu7LyWLVti+fLlKCoqsnqu79ixo8zr2L59O9LT0zFw4EAAeuBtnlTUFB0dHXKwMzk5GUeOHIGU0vqcs5+gtDgdOnTAqlWrkJKSgqSkpIi2sVOnTpg1axaOHTuGlJQUAMCmTZuQlJSENm3aRHQfZ+r8e/cQEREREdFZZw/Fg0Pw0oJxIqKqwAzkz6RqPpL2NJHMYzBPVHWdOHECQ4YMwahRo9C2bVskJibiq6++wty5c9G/f/+wtxk+fDgmT56MMWPGYNKkSThw4IB1jsmyfF60aNECa9asQb9+/SCEwJQpU0IORqampuLjjz/GsGHD4PF4ULt2bXTt2hUZGRmYO3cuBg8ejPfeew8bN24sNSS//fbbMW/ePPTv3x8zZsxAw4YNsX//fqxZswYTJkxAw4YNQ25zww03oE2bNrjzzjsxd+5cHDlyBE888QTGjh0b0QlcywMDdSIiIiKiC4imaVBV1frpbrhgPFxgTkREZ668quXLcpLXSE8SS0TnhoSEBFx11VV47rnnsGfPHvh8PjRq1AijR4/G448/HvY2SUlJWL9+Pe677z60b98el156KaZOnYrhw4c7+qqX5tlnn8WoUaPQuXNn1K5dGxMnTkR2drZjmRkzZuCee+5Bs2bNUFRUBCklWrdujcWLF2P27NmYOXMmBg0ahPHjx+Oll14qcX1xcXH4+OOPMXHiRNxyyy3IyclBgwYN0L1792LDeJfLhXfffRf33XcfOnXqhPj4eNx1112YMWNGxI/zTAnJkhGH7OxsVKtWDVlZWRH/1OB8oWma9XMIflkSlR/uW0QVg/sWUemKC8PDXVRVtZbPyspCtWrVWOFIVI6klNy36LwXHLSf7sV+X+ZwcdelVdzz34RlV5WzrbIqLCzE3r170aRJkzIFy1XBihUrMHLkSGRlZSE2NrayN+ecV5b3CivUiYiIiIjOEeYJ+EoLxu1V5EREROWlsk/iXFzwnpmZWWzwfroHsNxuN2rUqHGaW0p07nnttdfQtGlTNGjQADt37sTEiRMxdOhQhukVgIE6EREREVEFKi4MDw7OzQpyIiKiC5X5PWj/PjR/XeX3+8v11x/8zqWq5siRI5g6dSqOHDmCevXqYciQIZg1a1Zlb1aVxECdiIiIiKiMzEpyMxQPF46zipyIiIiIzpYJEyZgwoQJlb0ZFwQG6kREREREBnsYXtI1Q3IiIiIiogsTA3UiIiIiqvKCA/HiwnIG5UREREREVBIG6kRERER0XgsOysONMygnIiIiIqLywECdiIiIiM5Z9lC8uOCcYTkREREREZ0tDNSJiIiIqFIEh+PhLkREREREROcSBupEREREVCFKC8s1TavsTSQiIiIiIioTBupEREREVGZSSkc47vf7WV1ORERERHSWCCGwdu1aDBgwoLI35YKjVPYGEBEREdG5SVVVeL1e5OfnIycnB5mZmTh+/DiOHj2Kw4cP49ixYzhx4gQyMzORm5uLgoICeL1ehulERERERGcgIyMD9913Hy666CJ4PB7UrVsXvXr1wvbt261lDh8+jBtvvPGsb1tqaioWLlx41tdr9+c//xkdO3aEx+NB+/btz/r6WaFOREREdIEye5jbq8vtwzzZJxERERHR2Tdo0CB4vV4sW7YMTZs2xdGjR7F582acOHHCWqZu3bqVuIVnzuv1Ijo6+rRvP2rUKHzxxRf49ttvy3GrIsMKdSIiIqIqTFVVFBUVIS8vD9nZ2Th58iQyMjJw5MgRHDlyBBkZGTh16hSys7ORl5eHoqIi+P1+hulERERERJUgMzMT27ZtwzPPPIPrr78ejRs3xpVXXonHHnsMN998s7WcEALr1q2zxj/99FO0b98eMTExuPzyy7Fu3ToIIfDNN98AALZu3QohBDZv3ozLL78ccXFx6Ny5M3bt2mXdx549e9C/f3/UqVMHCQkJuOKKK/Dhhx9a87t27Yr9+/dj3LhxEEJACAEAmD59ekil+MKFC5GammqNp6enY8CAAZg1axbq16+Pli1bAgB+++03DB06FNWrV0fNmjXRv39/7Nu3r8Tn6C9/+QvGjh2Lpk2bluGZLT8M1ImIiIjOc36/PyQ0P3bsGA4fPoyjR4/ixIkTyMrKQm5uLgoLC+Hz+XhCUCIiIiK6MEkJePPO/iXCgpWEhAQkJCRg3bp1KCoqiug22dnZ6NevHy699FL897//xcyZMzFx4sSwy06ePBkLFizAV199BbfbjVGjRlnzcnNz0adPH2zevBlff/01evfujX79+uHAgQMAgDVr1qBhw4aYMWMGDh8+jMOHD0e0fabNmzdj165d2LRpE9599134fD706tULiYmJ2LZtG7Zv346EhAT07t0bXq+3TPd9NrHlCxEREdF5wO/3W+1Ygq9ZTU5EREREFCFfPjC7/tlf7+OHgOj4Uhdzu9149dVXMXr0aLzwwgvo0KED0tLSMGzYMLRt2zbsbVauXAkhBF5++WXExMSgTZs2OHjwIEaPHh2y7KxZs5CWlgYAmDRpEvr27YvCwkLExMSgXbt2aNeunbXszJkzsXbtWrzzzjt44IEHULNmTbhcLiQmJp5Wy5n4+HgsWbLEavWyfPlyaJqGJUuWWNXuS5cuRfXq1bF161bccMMNZV7H2cAKdSIiIqJzhL09S1ZWFk6cOIFjx47h0KFDOHbsGE6ePImsrCzk5eWhsLCQrVmIiIiIiKqgQYMG4dChQ3jnnXfQu3dvbN26FR06dMCrr74advldu3ahbdu2iImJsaZdeeWVYZe1h/L16tUDABw7dgyAXqE+fvx4tG7dGtWrV0dCQgJ+/PFHq0L9TF166aWOvuk7d+7E7t27kZiYaFXm16xZE4WFhdizZ0+5rLMisEKdiIiI6CySUlrV5vaLqqpsw0JEREREVNGi4vRq8cpYbxnExMSgZ8+e6NmzJ6ZMmYK7774b06ZNQ3p6+pltRlSUNWxWhZt/h4wfPx6bNm3C/Pnz0bx5c8TGxmLw4MGltl9RFCWk0Mfn84UsFx/vrNDPzc1Fx44dsWLFipBlk5OTI3tAlYCBOhEREVEF0DQNPp/Pas1ivxARERERUSURIqLWK+eaNm3aOE5CateyZUssX74cRUVF8Hg8AIAdO3aUeR3bt29Heno6Bg4cCEAPvINPEBodHQ1VVR3TkpOTceTIEUgprZDePBlqSTp06IBVq1YhJSUFSUlJZd7eysJAnYiIiOgMhKs29/v9rDYnokolpbR++WJegsc1TYOUsthrczh4vLTbmBVq4a4jnRc8HwhU0YUbL25eabdRFAVCiBKHSxu3D+fn5yM/Px8ulwuKokBRFMdwuPHgbSQiogvbiRMnMGTIEIwaNQpt27ZFYmIivvrqK8ydOxf9+/cPe5vhw4dj8uTJGDNmDCZNmoQDBw5g/vz5AEK/C0vSokULrFmzBv369YMQAlOmTAn5uyY1NRUff/wxhg0bBo/Hg9q1a6Nr167IyMjA3LlzMXjwYLz33nvYuHFjqSH57bffjnnz5qF///6YMWMGGjZsiP3792PNmjWYMGECGjZsGPZ2u3fvRm5uLo4cOYKCggIrvG/Tpo2jpUxFYaBOREREFAFVVeHz+azA3BxmD3MiAvRfpZjtm8xfpgRPK+5S2jLBYXhxQbl9Oj+bzh8lhe3muMvlgsvlgtvttobDTYtk2D7udrvhdruhKDy9GhHRuSIhIQFXXXUVnnvuOezZswc+nw+NGjXC6NGj8fjjj4e9TVJSEtavX4/77rsP7du3x6WXXoqpU6di+PDhjr7qpXn22WcxatQodO7cGbVr18bEiRORnZ3tWGbGjBm455570KxZMxQVFUFKidatW2Px4sWYPXs2Zs6ciUGDBmH8+PF46aWXSlxfXFwcPv74Y0ycOBG33HILcnJy0KBBA3Tv3r3EMP7uu+/G//3f/1njl112GQBg7969SE1Njfjxni4h+S8th+zsbFSrVg1ZWVnn1U8NIqFpGo4dO4aUlBT+g4moHHHfIqoYlbVv2Vu02AN0VpxTVSGlRFZWFqpVq3ZBVMaa1dM+n8+6FPfLkpIu4do32S/nw59VwWGtWR1d2rU5HK4qO9w0wFkhHslwSbcxBT/H4arYg8dLuk3wJVwlfrjq++Bx+zSfzwchRIkHPs5F9nDdvERFRYVMC54ebpmoqCjHxeVyXRCfNVRxKup7y+12IyUlpdzu71xSlbOtsiosLMTevXvRpEmTMgXLVcGKFSswcuRIZGVlITY2trI355xXlvcKK9SJiIjogmRWjgZXnZ+rYQfRhcIMv71eL7xeb0gQbh8PNy3cMmc77A6uIC7uEq7auLhLuArmklqJhAvPqWJFEvrZA/hIfnVgDpf0q4bihiOZZzKnFRUVlfvzIoSwwnW3243o6OiwwXskF/O2fD8TEYV67bXX0LRpUzRo0AA7d+7ExIkTMXToUIbpFYCBOhEREVV54QK34BPpENGZsVeBm2G4GYiHGy5uXkWeuNflcjmCPfslXIVuSZdwy5vhN6txqTj2an63u3L/HDf77If7VVa48Uin279rzfWY+3l5MQP56Ohox3VxwyUtx/2ViKqKI0eOYOrUqThy5Ajq1auHIUOGYNasWZW9WVUSA3UiIiKqMsyf2wcH6OdDKwaic4FZoer1elFUVFTicPC4z+cr121xuVyO8Mt+CVfdWto0VrUSOQkhrINBFUFKGfYXI5Fe7Lc1D7qZvyIzQ/yCgoIz3s7gCvhIAvlw1zyYRkSVbcKECZgwYUJlb8YFgYE6ERERnZfC9UQu70CP6HylqioKCwtRWFiIoqIia9i85OTkWFWj9mC8PKrDzSpwezAVbri0+Qy/ic5v9lYv5cU8Qbj9Vy326+KGw00zw3lz+pkyH29xBwKDg/vSlmFAT0R07mKgTkREROc88w9o+4UtW+hC4ff7QwLx4KA8ePhMw6Ho6Gh4PJ6Qa/vFPs2+nMvlKqdHTkTkZLZVOtMTC5rtbooL3st6bd5neba2EUJYPePN60hPFlvacuY5FoiI6PQwUCciIqJziqqqVrVsdna2dQI3oqpC0zQUFhaioKAg7CV43ukePBJCwOPxICYmBjExMdawx+OBlBLVqlVDTExMSDDO6nAiqurs7W7O9GR9Zru5cBXy9ml+vz/svHCtbsz7NVtq5eXllcfDdjDPA2GexLi4kyGXNF7cNPNcAeV1AWD9ssp8buwn+LWPl2WaEAIZGRm4+OKLy/35JaKqjYE6ERERVZrgkxjaK8/N3quapvEnz3TO83q9jkA8Pz+/2NC8qKiozPevKIojHLcH5MVNi46ODrvvSCmRlZWFatWqcd8iIjpDZiV5dHR0udyfpmlh+8ef7gljg6eZVFXlr/0A1KxZk4E6EZUZA3UiIiI6a4J/Jl0e/ZqJKor58/38/Hzk5+cjLy/PGs7Pz0dBQYE1razvZSGEFXzHxcUhJiYGsbGxIRdzmaioKIbfREQXAEVRyjWgtzNb3diDdlVVoWmaFbCbl3DTSppnnxZcCX4mFwBWdbmiKI7K9eDx4qYVN09RFNSuXbvcn2ciqvoYqBMREVGFMFu32EN0tm6hc4GU0qoiL+1Sluo9s3VAccG4fdzj8bCtCtE5xvqOkhIh31bW95e0DUpzin6tSag+H/xeb/gDYKUcExMlLSAE9LsUgO2+hTWPB9yodPZWN2fah/5sqqhfVrndbqSkpJTb/RHRhYOBOhEREZ0xs3WLPUDXNK2yN4suQJqmWZXjubm5yMvLCxnOz88v0/vT4/EgLi4OcXFxiI2NRVxcHOLj461p5iUqKqoCHxlR1SE1TY+gpQYpASk1wLiW+gTbdLNSFQCkfpFwLGdG2ubysHJxfXlrWeihtzHXFpKX0+OSEvlFRUBRQeUF3NZ6hTEq9AzeNk/ftqD5QrGmC0Uf1xdRIIS5nFHZa96hUCCUwLh+H8Z0hvxERBVOCIG1a9diwIABlb0pFxwG6kRERFRmZvW5efH5fJW9SXQB0DTNar0SHJKb4/n5+RH/EsJstxIfH28F5faLOd3t5j+Z6cJhtVmQUg++pYSEPgwtMBx2OSlt4bi0BeJmAM4DrRXOVklvH62034eZobsQgdBeMYYh9HmKAKBAUczQPvQ2QhGAUPjLHiK6YGRkZGDq1KnYsGEDjh49iho1aqBdu3aYOnUqrrnmGgDA4cOHUaNGjbO+bampqXjooYfw0EMPnfV1A8DOnTvx9NNP45NPPsHx48eRmpqKe++9Fw8++OBZ2wb+dUBERESl8vv9jgCdvc+pvEkpUVRUhNzcXOTk5FjX9rC8oKAgorBcCIG4uDgkJCQgPj7eutjH4+LiGMxQlWEF2lawrRU/TZOh06XUK7cZeFN5kxqkWs6BvhG46/2wFUARUKzgXTGCd33YnKaH9EpgGqvniegcN2jQIHi9XixbtgxNmzbF0aNHsXnzZpw4ccJapm7dupW4hWfO6/We1vki/vOf/yAlJQXLly9Ho0aN8Omnn2LMmDFwuVx44IEHKmBLQ1WpQP3nn3/Go48+iu3bt8Pr9aJt27aYOXMmrr/++sreNCIiovOK3+9HUVGRFaCXpY80UThSShQUFFhBuRma2wP0SH7pIIQICceDx2NjYxmW03lDD7Y166R7euitXzQj5JaaBk1KSE21WqNoRjjOEJwuOEZIf0b/NnFUwisQLkUP5RUBobj0E1a6XIFAXlGsAF/w+4WIKlhmZia2bduGrVu3Ii0tDQDQuHFjXHnllY7lglu+fPrpp7j//vvx008/4ZJLLsETTzyBgQMH4uuvv0b79u2xdetWXH/99fjwww8xceJE/PDDD2jfvj2WLl2Kli1bAgD27NmDhx9+GJ9//jny8vLQunVrzJkzBz169AAAdO3aFfv378e4ceMwbtw4APq/86dPn45169bhm2++sbZv4cKFWLhwIfbt2wcASE9PR2ZmJq644gr8/e9/h8fjwd69e/Hbb7/hkUcewQcffABFUdClSxcsWrQIqampYZ+fUaNGOcabNm2Kzz77DGvWrGGgfjpuuukmtGjRAh999BFiY2OxcOFC3HTTTdizZ895f9SGiIioIpl9z80Qnf3PqazMdiz26nL7dW5ubkThR2xsLBISEpCYmIiEhATrYg/LWVlI5xJ7CK45qsA1aKrmDMRV1VhetcJyIqoEUkJKNbALlrVznVCguBQrlFcUlxHG69OsMN641ucr/P4iOkdIKVHgLzjr6411R/bvWPPfv+vWrcPVV18Nj8dT6m2ys7PRr18/9OnTBytXrsT+/fuLbckyefJkLFiwAMnJybj33nsxatQobN++HQCQm5uLPn36YNasWfB4PHjttdfQr18/7Nq1CxdddBHWrFmDdu3aYcyYMRg9enSZHj8AbN68GUlJSdi0aRMA/e/QXr16oVOnTti2bRvcbjeeeuop9O7dG99++23EFexZWVmoWbNmmbfndFWZQP348eP45Zdf8Morr6Bt27YAgKeffhqLFy/Gd999x0CdiIjIIKW0AnTzwgCdIuH1epGTk4Ps7GzrYo7n5ORE1I7FrCY3A/Pga/Yrp8pi9QBXVVswrkELCsGlpkJqEppxzVCc6AIkNWj+09j3jYp3q9rd5YIiBIQrUP2uKIqtKp5BPFFFKPAX4KqVV5319X4x/AvERcWVupzb7carr76K0aNH44UXXkCHDh2QlpaGYcOGWZlnsJUrV0IIgZdffhkxMTFo06YNDh48GDb0njVrllX5PmnSJPTt2xeFhYWIiYlBu3bt0K5dO2vZmTNnYu3atXjnnXfwwAMPoGbNmnC5XEhMTDytrDU+Ph5LliyxgvLly5dD0zQsWbLE+qxbunQpqlevjq1bt+KGG24o9T4//fRTrFq1Chs2bCjz9pyuKvMXS61atdCyZUu89tpr6NChAzweD1588UWkpKSgY8eOxd6uqKgIRUVF1nh2djYAvcqqqoUL5s9Iq9rjIqps3LfofODz+RwtXCI9aWNlCpzg7tzf1qpCSon8/HxHUG4fLiwsLPH2QgiroiY4KDerzF0uV6nbQBXrQti3HOG4pkKqevW4pmpGIK5ZgTirxam8XAj7Fp0h4xctZf60MVrUKMHBe0lBvNlTvgqoqH2rKv8NV1Uf14Vk0KBB6Nu3L7Zt24bPP/8cGzduxNy5c7FkyRKkp6eHLL9r1y60bdsWMTEx1rTgFjEmeyhfr149AMCxY8dw0UUXITc3F9OnT8eGDRtw+PBh+P1+FBQU4MCBA+XyuC699FJH1fnOnTuxe/duJCYmOpYrLCzEnj17Sr2/7777Dv3798e0adMiCt/LS5UJ1IUQ+PDDDzFgwAAkJiZCURSkpKTgvffeK/GMt3PmzMGTTz4ZMj0jI6PUPxrPN5qmISsrC1JK9hUlKkfct+hcpGkafD4ffD4f/H7/efmPaikl8vLyAICVWeVIVVXk5uZaJ/q0X+fl5ZXalsXj8Th6ltuvY2Jiiv0clFIiNze3Ih4SldH5uG/ZT7CpSWmEUqpxok1pBeJWX/Gyx1VEZ0xKoMjnByBwnuxaVOUJ24lZReCErcaw1UNeERAQgLHcufY3TUV9bymKUmUPgOXk5FT2JpzTYt2x+GL4F5Wy3rKIiYlBz5490bNnT0yZMgV33303pk2bFjZQL4uoqChr2NynzL8Xx48fj02bNmH+/Plo3rw5YmNjMXjwYHi93hLvM9z+FO78SPHx8Y7x3NxcdOzYEStWrAhZNjk5ucR1/vDDD+jevTvGjBmDJ554osRly9s5H6hPmjQJzzzzTInL/Pjjj2jZsiXGjh2LlJQUbNu2DbGxsViyZAn69euHHTt2WEdcgj322GN4+OGHrfHs7Gw0atQIycnJSEpKKtfHUtk0TYMQAsnJyefcFyTR+Yz7Fp0LzDYuhYWF1klE3W73ed0+w/wHWbVq1c6b0O9coWkacnNzkZWVFXIpLdQ2q8yTkpKQmJiIpKQk65KYmBhxH0M6d50r+5ZmnXhThfSrRgW5alSVG8OaPgzbH2hhv2kV438ufg9T5dH3LYk4TzS/t+gcph+UhNTCHnuUAFQgEL5b/eHDtKcRChBSHV/+n8MV9b3ldrtLDezOV/YqZQolhIio9cq5pk2bNli3bl3YeS1btsTy5ctRVFRk9VzfsWNHmdexfft2pKenY+DAgQD0wNs8qagpOjo6pAgnOTkZR44cgZTS2k/tJygtTocOHbBq1SqkpKSUKYf9/vvv0a1bN9x1112YNWtWxLcrL+f8X9mPPPJIqUdemjZtio8++gjvvvsuTp06Zb0AixcvxqZNm7Bs2TJMmjQp7G09Hk/Y5v5KBX0RVDbzaHNVfGxElYn7FlUGv99vtS4rKipyVARUlT/khRDWhZzM9izhQvPs7OwSf5UQFRUVEpSbwwkJCfwsuwBU1L6laVqgB7lfb7diTlPN1itGyxVEWBUo9A0u1+0kKo31nRr8Ng33tjWnaQBUAehF6hVHBF2Hmxc0zu9RKjtptMU6nV7xZvW7rQLeDOQVxRbWK7YKesVRTR/crqYivrfOxWr88lJVH9eF4sSJExgyZAhGjRqFtm3bIjExEV999RXmzp2L/v37h73N8OHDMXnyZIwZMwaTJk3CgQMHMH/+fABl+w5o0aIF1qxZg379+kEIgSlTpoT8XZGamoqPP/4Yw4YNg8fjQe3atdG1a1dkZGRg7ty5GDx4MN577z1s3Lix1JD89ttvx7x589C/f3/MmDEDDRs2xP79+7FmzRpMmDABDRs2DLnNd999h27duqFXr154+OGHceTIEQCAy+U6awfJzvlAPTk5OaInIz8/H0Doh4aiKOflz9yJiIiCaZoGr9drBeh+v7+yN4nOgqKiIkdYnpmZaYXm4X5GaXK5XKhWrRqSkpJQvXp1VKtWzbrExMQwXKEy0SvG/VYPck01LpoGze83+pSX3C6IKJgZWhuF3YGsWtqOt2jSOc28QHOOW7cx7kizbmZbxhaS24Nxx4rP4PFAwgcfilBMeGFMC8m8wy0aNCNkGRG4I2H8z8rZw9yh9bDss4KHhe0OHfOEM8QXthvblw0zzO+aC5TUINUz2p10RvAOoSC/sBDC79X7w0NAKIAQejivd7BRAoG7rY2NFc6zSIPOIwkJCbjqqqvw3HPPYc+ePfD5fGjUqBFGjx6Nxx9/POxtkpKSsH79etx3331o3749Lr30UkydOhXDhw8v0y8Wnn32WYwaNQqdO3dG7dq1MXHiROt8k6YZM2bgnnvuQbNmzazCrtatW2Px4sWYPXs2Zs6ciUGDBmH8+PF46aWXSlxfXFwcPv74Y0ycOBG33HILcnJy0KBBA3Tv3r3YMP6tt95CRkYGli9fjuXLl1vTGzduHFJNX1GErCINo44fP45WrVohLS0NU6dORWxsLF5++WUsWrQIO3bscJyhtiTZ2dmoVq0asrKyqmTLl2PHjiElJYVHK4nKEfctqkjmyUTNVi4XEiklsrKyKr0txdlg9gbNzMzEqVOnHNclndNFCIHExERHWF6tWjVUr14d8fHxVf55o9Nj37eklAzKCYB50j9YmbIME1RLW6ht/zMyMF0GMmtpC7bNeWadk22avjACyZuUENZwxTzWiiIh4RV+REu33o+6soUJ4YWRvFshfFAoH1zRbmXpwtYX3gzLEbgu8fsmJGgXQdNEoJeTeT/muOK8D36vXZiklMgvKkKcx1M+7wGjGj4mNg7N2rQ58/s7B1XlbKusCgsLsXfvXjRp0uSCa4WzYsUKjBw5EllZWYiNLVv/9gtRWd4r53yFeqRq166N9957D5MnT0a3bt3g8/lw8cUX41//+lfEYToREVFlk1JaAXphYSF/ZVXFSCmRk5PjCM3N4ZKqzePi4hxhuVl1npiYCJfLdRYfAZ1PrHDcCMY1VYVqjOfm5ULNzWY4dZ4yw2+9DbK0xjVptGiwBeFSSr0FD/RAWxYXkodfUeBaQg+6jSA8MKwvEjxuJxxpKkoMm4UQkIggpKXShWlXI42JpR+rOI2jGUEV78II4YUtfDcDdUeurjir3a154Srt7UG8Ukwwb67MHLaW53uKDFL/hYumFv9vL6Lz0WuvvYamTZuiQYMG2LlzJyZOnIihQ4cyTK8AVSZQB4DLL78c77//fmVvBhERUZlomuYI0avIj8cuaJqmWe1ZgivOg0/gYxJCICkpCTVq1ECNGjVQvXp11KhRA0lJSTwRKIUoLiyXqgpV9ZdYVS7lafbEJQc9qDbCbGjQzKBSGsNGmK3/pxnzoL9eZiCuGe10jOU1VerDRiiumWG5FmhdYt6nsRURbixCgm/rGsIZhktbLnqOfB0Z8WuYliaBcFSB4uhMYiazwnYa2+CQ3rpfYbaGCEy3305hm4jIBLXRsb9Ti1+wFLanXe/JHRrQW8E9woTzQRX0jkDeTO4VOKvm7cOKcz1EROeyI0eOYOrUqThy5Ajq1auHIUOGVMoJOy8EVSpQJyIiOl+oqmqF6MEnFKXzhxmcnzhxwlFxnpWVVexravY2t4fmZo9zVpsTgEC7FdVvBeeRhuVUPE1KI7w2qrWl5gjEJYyAHFogLDeXg205abxGZnsT+/lVNXv7k9Drcg2ozWMiRjgeNiDXjOzwfPmKkWEHjc/TM3sQxd06JCIVxY8K23/WFCGgGFMkJFQ34PMrUIRiLWmG84pxLaygXwQdBCjDhpfF6eTApbVwKeu8oFYyEbO/J9QzDOjNbSgtmLe3t1ECGbujIj64TY1im24G8cZ9WyE/EVEFmzBhAiZMmFDZm3FBYKBORER0lvj9fqsK/ULrh36+k1KioKAAJ0+exIkTJ3Dy5EmcPHkSp06dKrYtj9vtDgnNa9SogcTERJ5v4QJnheRWaO4PBOZ+fwn9Ny5smtG6xGxfokkVUgKq9OshN1RIKaFKLRCWQ7/WrKbdTjI4ALf1+LZaqthD8/IOxUM2CM7qcS20grzM/cWlrbod9mEZvFhgmu1xmq3OzdsF38Z+T/a3rqOxiOP+JIJnhX08tm4zQODAgCOalHqMLcLcDlI47lOEGwr6+BZhly8bES8g8wMbavUiD7csgpaxKq2NKN5qjSL0MN4IZ11GYmuGv4oigsJ6QFitT5Sg+v5IVcwbXYZ7UZxHLZxKfOLMaxE6r6TbyuIeXQSP+XRCeQEIl/6aCEUJE8SzIp6I6HzDQJ2IiKgC+Xw+K0QvqUc2nTv8fj9OnToVEp4Xd3LQqKgo1KxZ0xGa16hRgycFvUDp7TnMsFyF6lchVb8tPGd1OQComh56q9CgSRWaJqFBtcJw1QjOrUsxgbidFXwDjl7h0GC1TJGaMzQ/W6Sx+cI6GSf0wFcDoEljuwVgVsZrgU109LzWbHkxzPYvgD2sDrSGCdkKZyge7uksJt227ksWm0Tqt9H0az38FlZGCCAk1LVXzofLVaWRSQtbk3dzvvmciGK3xbxvad1KhnnwjtY5Jd5XcUdSglJ/AIorGlqe7aC542ugpHS4tHe4QImheHAbHKEH6YotrAeEUTlvjAtFL7oWChRFQDjmCavVjZ7LC0frG2HM15czbwNbObftwEBxynpwqNQ7inRp2xsvXAAfLtR3LCf0+yhh+eK//1XHwRbjZXCE8taBFCUQ3MNlTFeEEc7b0nx7RTz7xBMRnRUM1ImIiMqZ1+u1QnS/31/Zm0PFME8QagbmZoCenZ1dbLuWatWqoWbNmqhVqxZq1qyJmjVrIjExkX+8XmDsFeaq32+1Z7mQ27H4NdUKvvV2KIFw3C9Vq2JclWpE4TgQJiC3V4/bK8jtIXUJ92VmwdYluHI7XEW2/fbQs29Is1reXLcRgGvCWkiYgblVba7fmyYBo0u69TnjqORGmApuaU4VzgcqJaQMRMx6nm1PKIX9Doz7tU233Wsg3A5UdRf3qSascn4z0NbHA5XzzuBeONJ9c1iDsG5jXmvGtgSWNYeFNW6fb88zS5omrdtKAPbfB5nTnFPsQ6HPQvB0ETxNiwfUPNt8Yfu/fVroOsum2FcIxT8L+ttUHxfOZR2BvBHWwmxlowT6zFvLB1qUmS1s9Kp6W6BrtsMxg2DAFswbbXBc+jIwwnpFCL2K2wjqAUBRjMRYCAhXhGF9JEr53Cj5hqUtUXpo77gXx8smwi6PoOXt/eJDTgDrMgYUoQfzAhAuM5wPnif0p5dhPBFRxBioExERnSEppSNEL+6kk1R5VFXFyZMnkZGR4ag6L+5XAx6PxxGa16pVCzVq1IDbzX86XQikphl9y/Ww3Kw214xK8wulJYuUEqqmQYWqB+GaalSO69eqppYpILfu1wzDzZBcIiQglxqgqTALzJ1tWWALt415mi0A12zhuVU0DSAQMJvTBCAlNCEBKYzb6CG1Bg2aBISmQWj6dMW2YkUKW3W0Lai2TkJqa2xhVG3bA3QzCHTeRdnfV8JWDQ5A3y7Hk20E0tZLJCCkDITcZuZn72djhNuQZuhtW94Kp82gW59uD7xhDZ92WnkaArGxNRRSvi4hhPnaB4J6R94p7Jmmcxl7q5LAtDAUN6SrwLFloVsSmBgcX0qzdYt+Z4EFpT5uxckycEurHzuE49Zho/viXpLTfqnsr7TRryRQXm1thXD2MtEfiwiUVkvbNgcq3OF4TewtcABAEYoeCkMP7PXgXcCl6O1wFKFAGMNmKbgijE2DXvYtFATu40wD+nBOazeI7Ab20N48Hgb7dfCwOe6Y7wzv9TDeWMZoTxNcIa8oCLzUtmX0NkNK6I8l7MdtgtdlPwBDRHQe4V+FREREp8nr9aKgoAAFBQXF9tGms8/v91vh+fHjx3H8+HGcPHkybNW5oiioUaOGFZyb4XlsbCz/wKviAoG56qwy9/shtap9UEyTEn5NRaFaZPQc90OVKlRbZblebR7582AF4dIMwyU0IxTXJKCq0INqNRCEa9I5DCmMaF5YwZk9dTHDF8CospQCqiaNHFtCA6BKqR8QETAeh3EiUqH3U1c180SjEi4JQGpGOC7h0qCf3BMCLimM+bBVYgeCUOu3R6cZhMugQFevZreFiPajB1ognBYyUBkeHHLrT54KITUo5lEKSAhNQtirv6U+bq3fKv0PBOX2pF9AOpNYEX6aPt2Y5khuA+PCXNZ2bf5fD92CU2YZfpq5JtvHtLSC3PDPeaRk0HVJ7LmhtepoN0RstmOZsEXK5fEVY3vvBbZbWO9T8x2lj+tb4Wi7I21nzrTNl9K2/0lbEG6lts4EV0rbI5S2a+Oib1PxD9hcs3WPZtAuAECBtKrlFf2+jPn6O9zeLyUonBe2wwthgnn7+szWN/qwYrVUcevJvB4kGyeahVExrxgV3Wb7HKGY911B4XxxyvKmLfbG4cbUsHfr+GYIt8/ZfgZivTWCz75rvFyBt5T5CwbnsFmFL6WEF35otrZDp812ezWOJ4MnotPDQJ2IiKgMVFVFfn4+CgoK2M7lHOD3+63Q3LycOnUqbHju8XhQu3Zt1K5d26o+r169Ok8QWoU5q8x9UP0qNL+vSleZ6wGyCj9UqKpeQa4H5oGKclWq0PwCiipRWi6hano7E7+qh+KaFriWmoBmXKQURpW4HpwJe/BtK1PUwyhjnjENAFwQ8KuaHnpLFaqmn3RUhYSqqYFg3DzJqHXSUQm90YmtftjIl11SQNGMcFzTL1FSr5NVNDNkVAK3sXHcXymsYE4KPaw2Q29NQjGOMlh9wDUNihmQS03PijX9MQgpIaSmV8VDAlCt4FwY8/V8WQOEhsDhBwlFaEFBtRFwm8G2NU0fF/Zl7Wc5FUb8WmJz8jN0RuFfWQTe3FbGa59sz4Wd8WogALTdXgoR+G4xW/5IW8W71A/UKMiHVlAEQIZ+zISetdV2oMO2Cfae7MGPyAgYA21VjL3JegjOfcvaB63d0LY/Clj90s3pIS+PrX+9ORQcGNtieesRBbZZOF9qM2CX9hcgEOhL2zKOcN62jDlfkYFUVgg9/NcbyARO0GqUoNu21FiP8byYrW9Uq4xa2Kabt7c9vmKDeX2GM5g3nlcjjFdsw8JaLnByWRgnl3Vuij6g2J7Tc0q4CnxbjYlwLBiqtPnW+1FISLcK6dffr4592fGihL3zwMG3oFDf5+f5jYjo9DBQJyIiKoWmaSgsLER+fj68Xm/pN6AK4fP5cOLECUfleWZmZtjwPCYmBsnJyahVqxaSk5NRu3ZtJCQksOq8CtI0zRaYB3qa66F51frliKMFi6ZaleV+TbW1Xym+qly/PaBKQKpCryCXAlITUCX0YFwTUFUjHNcUSM0M4IQtuLNVCBpZlYDeEUBfj9EvXdOr3P2aXvGumj3UjWGrdYzRaz1snCKDhs1cWNMDbJcUEFLRA3MpoGh6kF7anh44qaUehCr6hhvtXIyITQOg6XWwQtMAzQi9NT341nulG8NWvxp9AxXbWUgVK/zWQ28BIxAXEkIYbVWE9aD01tS2UDxQEV41DwKVRBoHEaTUIDU9sNZP/Bt0Xdz84pYxrvUQ3Hg/GMNmMG6uP3haVaafANPYx+3DEY475il6L3TFuNZbhegtWFyKYlWB68u4oCgCinAZFcmBzvPBHwGBa1nCPDiDe1sQb3Wzl0bbHKEAUg+yIfUKeGGUTwsogGZ8yEmhV8MbobxZNW8G8poxrn8CK2EDecdzbfwvbDhvnZRUsT5/FQDCZQTwAFxG7xqzQj5QKW+cXNZ8fQDb/dpWblWM27v8n8PsL7BE0NaWvm8W9+iEq2r9O4EuPEIIrF27FgMGDKjsTbngMFAnIiIKQ0qJoqIiFBQUoLCw8IL4Q/pc4vf7cezYMfz222/Iy8uzwvNwYmNjrdDcvMTHxzM8r0ICobkZmAfC86oUmksp4dfMkNwPv/TrYblUjSpt41cxtopAKTVIIaBqRphjFLqqfgFVz4ChqYCqKkYhtABUIMoF6D+yCb+fGBERAL3+WzP+r6oq/EabGE2T8Bs91DWpWcF5IBoPvW9H6GWOBDqOBOaretW6SxNQpAKXMNuwGCc5NNujSKm3N7EqvvUTXCpG4K1IafUPF1KDomkQWmBZRyN282ynVoCth+ACqlEBDgih6iG41CAUaQTjgYpxMyS/0ATCaw2apl9LTf9VgdRs02Ux083lpX26Pny+sAfRgQpz80BUyMKBQceAbcngFNT2EwxZ2rDtDLvS2rFkqbmj1Mry24wKYlRuhw3kXUb47lKgKMbF5YJLcUEY01wulzE9MF9RFAiXguKq8M3HHJTZBm9W4P/SrNHXA3ZphPN6lbwrENpbQbwZ6iuQ0riNEeCbLXWkdEEKxbpduJ7yETx1QSG9ceJXMzg3T/iqjwVODmtVwht9523hvFVlD/OAixL2PWvvkx76vIXf2JLmBT8oKaT1XWQ/f4Au9JcfYYWZp6nnz2cMXXgyMjIwdepUbNiwAUePHkWNGjXQrl07TJ06Fddccw0A4PDhw6hRo8ZZ37bU1FQ89NBDeOihh876ugHgxIkTuP322/Htt9/ixIkTSElJQf/+/TF79mwkJSWdlW1goE5ERGTj8/msli7si352SCmRk5ODo0eP4ujRozh27BhOnDgR9iBGfHy8o+rcDM/p/Cel1Fu0+H1QfT4rQPf7fOdkaC5VPaWVml6dLI2QFmY1K2zjViioQfUbAbnqg6r59QBd8+uBuaZazQbMu9P7ggfaqajQg3IpFfhVAc1sQquZlZj6cDjmVCklNI8CX5FXb5YiNfiNNioqNPiNinE9LJdWlW6xr4ItrwsEFsIat0KqoDsQEnBBgVsD3FLApUm4pIIoCSjGiTwVqwrcLNY26kGl/fnWn3MY1d4KVKPa2wi7Yc4zm6Tr04Ui9epE+zTzcUAzQiiJEmKfEmeV840qhCMIV40QWzXa62iac3opy5wN9spo69oMAEOm6y00rOpdRQmZL4wqXWG2IxJwTNNDSFtYbgSPjmURuAYERFItyOwTiKRqtpyfnUArfgVW5TQAq02MZl5LGBXWRuW9rWLfalGkBar0zV9jBKr6A9eOan8t8H7SD4yYw+aBE9s8qb+PzIMsFusXCQCgluFMDhE8Q0JYwbsjnHe54HIpcCkuY1i/1ufZl9ODecXlMt4PRsOfoGMemmMsEOLbj5kottcn8IlgntBTGME7jMBdsarspdnTXipWL3krrDcDfnO+MU8z7wMAVFvFvv09UrYn0toHzKDeitmNfQUizAlybYm/sC3r6OvvuJ9A6x4JCS1Wg7dAg97n37xFCftZMbPsN41Sz53PY6JggwYNgtfrxbJly9C0aVMcPXoUmzdvxokTJ6xl6tatW4lbeOa8Xi+io6PLfDtFUdC/f3889dRTSE5Oxu7duzF27FicPHkSK1eurIAtDcVAnYiILniqqqKgoAD5+fnsi34W+Hw+ZGRkOAL0wsLCkOXi4uJQo0YN1K1b1wrQ4+LiKmGLqTxJTbOqy802LZoRolfoeo3+1VLvcwIpzSDcaNdhNkQ2Kpsh7UG5DJyoVNNK/MWK3lbFDw2aUVWu19RJ6Cf81IeE46JqRlAON1Qp4Df6k+uZvB5+6B1EjCCkmNVrUkKPxPUqPg0aNE2FT0qo0IyTdKpQpUSCKxY5RfmRBeX2BYzkSIabB1jtUITUw3C3BihSwC0Bt6af6NMlBdyaUdtpVt2bLU2kEYJLDYrVHkWF2SYFVgW4LTA326MAgWp125MUOCFnCaFvuJLUSAKbihQu53H0bNDpB6M0K+DWVFUfN6ep4adVVBBuVrGGtvqwVRwL53QYrUCEtZwLUBTAZc53BaqLhRkWG4/fSOfsr7h1ECeoIhkQjuNN4U6UGfJqh6kOLukd4YnyoMjj/K6y7kHK0GmOLbZNc0xybql5YMmaLgP3IWD8KsN2v0KV1rICEooMqowXZqG0EWIqxmlwzWuzijnoMZn11FYGiqB+6hFmlY72PLZfL9iv9QM5gfetfi2Dxp3XUnW+x6WUkP6SW2NFTAi4bGG7PYQPDOtBvVlFr7hdersbtwLhckFRXMZBH/M9pVlvETPqlvYn16rqLj4Il0KU8LTb3zXGu8H6BYRim287Ea3xqsqQEF6xveP0A7/WOozvqZBn2X7AtVTBywgIlwco9Do+8403v758cW2xrPNJODZC31Q1NoJtoapISglZUHDW1ytiYyP6FW1mZia2bduGrVu3Ii0tDQDQuHFjXHnllc77C2r58umnn+L+++/HTz/9hEsuuQRPPPEEBg4ciK+//hrt27fH1q1bcf311+PDDz/ExIkT8cMPP6B9+/ZYunQpWrZsCQDYs2cPHn74YXz++efIy8tD69atMWfOHPTo0QMA0LVrV+zfvx/jxo3DuHHjAOjP5/Tp07Fu3Tp888031vYtXLgQCxcuxL59+wAA6enpyMzMxBVXXIG///3v8Hg82Lt3L3777Tc88sgj+OCDD6AoCrp06YJFixYhNTU17PNTo0YN3HfffdZ448aNcf/992PevHmlPrflhYE6ERFdkMy+6AUFBSgqKqrszamypJTIysrCsWPHrPD85MmTIYGkoiioXbs26tSpgzp16iAlJQXx8fHIyspCtWrV2L7lPGSvNtev9RDdCqZPk1T16mlHOK6pRgiuGg3C9SDFCsLNAL2c6BXkmn6SNE2FChWaVOHTVPilBk2vkYYGBX4J+KWAqrngl279NJJmFbkZmJdQXS6lGccb1eLQoEJCQoWq6dXkKvTe5NI8USLMgKqY4E/qJxsNHD8Ujmpyacsq9J7hgYDcPGGmPqyPR2kCLgi4pQIXpN6eRZhFsXobFDMoty4uDTAqyc0TcIZnnuY0NCQH9P7mVUUg/NaME+rawnAtKCC3LVteLcnMIFu4jGuzTYZLD//0gNtljLshXS5j3AXNuJaKoi8nYBzG0AM+FcYraQvDnUF41fmM11zRyI+KqezNKBM9lA8E7o5fgsCoedb0nFQICSn0A2V6eyTY0l+z+lhakauQEi4jxFeE3obJ1vTEqvTXf1EABM7GUD7M6nk9ZJfhw3fbASdpO/AUbro0f70opf6LozMN5wVsYbu9Yt4ZyAemKUEV9EbLG7NnurQFzeYKrP3L+By1H5iTImh5O9uBlLC7aGBfDnRhMYN6WPNsRwICy4QcHHQeYnIOG4eG3CoQXVDskvq4CDMv/FQAiBJlr4ylqkEWFGBXh45nfb0t//sfiAgKhBISEpCQkIB169bh6quvhsfjKfU22dnZ6NevH/r06YOVK1di//79xbZkmTx5MhYsWIDk5GTce++9GDVqFLZv3w4AyM3NRZ8+fTBr1ix4PB689tpr6NevH3bt2oWLLroIa9asQbt27TBmzBiMHj26TI8fADZv3oykpCRs2rQJgF5s1atXL3Tq1Anbtm2D2+3GU089hd69e+Pbb7+NqIL90KFDWLNmjXXw4WxgoE5ERBcUM0RnX/SK4fV6cezYMUeAHu6ARUJCAlJSUqzwvHbt2nC5nH9E8/U5P6h+P1Sf17guW29zKSWgqkYloX6t9zNRAb/e/FtqFROKh6MY/WLNi2b1B9d7mHs1FUWaCq/U4JdCv2iwhqXxT+tIA3NpVI5rxv/t/6lGOK9CWn2NrSJ6FBOWSwTWHyjRtaaZ0xVND7SVAlUflpred9yo1lc0CUUzDgkICUVIuATgFkIfBuBWBPTs1GyVoul9WsyVBCfzIaQtJgm8rhFVk5/jzEpb1V4VbgbktgpyNahy/Iw/8xQj+DbCbbj1YbhcgNsN6XIDbhek2w243IF5RlguRbg66XIgixkufkbxisndFQgo0gUXFL3nvv0aClxSMZbRh835ZidsIQMnZtR79CvWePD8wLj5nx4um/+58qKgqj7jEdn/rw85HrWwz7HPD72dZvaQFsY5DYT5SxR9moRmW8Y864G5nG2acS2F8csVoUEVqn7Izqr0PY3XwpHjiqDWMzCq3m0HVRSj/lrq4brLOB+CdepPY9wcFsI8YXDgNuY5FIQx3ZxvPw2o2a7HpYQ/OWhZOVokWUG76gzjVdU2HDweWNZ8vlRVhaqqONPfaYUG8GYFvXO6YrW3URzLCVtver2QQQvZNc0KeatSXtin258oZ4wNOJ//4Hw93FqAQO6uV8G74NLygu7XvomRvMbO27rY8oXOUW63G6+++ipGjx6NF154AR06dEBaWhqGDRuGtm3bhr3NypUrIYTAyy+/jJiYGLRp0wYHDx4MG3rPmjXLCp8nTZqEvn37orCwEDExMWjXrh3atWtnLTtz5kysXbsW77zzDh544AHUrFkTLpcLiYmJp9VyJj4+HkuWLLGC8uXLl0PTNCxZssQqolq6dCmqV6+OrVu34oYbbij2vm677Tb861//QkFBAfr164clS5aUeXtOFwN1IiKq8syWLnl5eVDV8uzGSbm5uTh06BCOHDmCo0eP4tSpUyHLuFwuJCcnOwJ09j0//4QPzn2OFgYArGBcqmYVuV+vGldVq3Jcqv6zEpCbBARcRvWey2hFoYfmgJQaVKnCq/lRpGooUv0oVP0o0jT4NQGf1H/K7rf9VF1KlxWOB1qyOAPzQPsVPTC3qsqNGnNV04xloD9f0J8m2KrMnU+scRUclpvLahqECgipwWVUjitSBkJyqcIl/Vb4HR9VHW7vSf3EmkYVucutnwhUgR6am6fWUyAQEpTbX3dzUA2MKGGCcn36+ReUS2n0C/drRkiuQjWGVVswrqoqNL9+cOiMuN2hF1sw7ri2D9sC8XPicKTU3ztu6YJLuuCGC27pCh3XXHBLN1zSbcx3h1lOMaJxYYXjLgSuqXz4oQYCdqF/cqlCgz9o3JwfsrxQ4Ye+vF/44RcqfMIPv6LBJ/xQoTnyTGlUKktF//hQIYw2M7ZWJIDRisZoMWMPcIV5kCOUHqw7Q3fFCOMd4bsV0hsBvm26IgOV9oFNEXq7FteZVdKbB97Che1W1bzfrIoPDAcq69WQljaa8fmEM47mYTvpa9CJYIs56WvwcsIM5q3WTop+wlOzkt7xZETwfAHQNB9UtSii4z2ROlvnf6Bzj4iNRcv//qdS1hupQYMGoW/fvti2bRs+//xzbNy4EXPnzsWSJUuQnp4esvyuXbvQtm1bxMQEfiUV3CLGZA/l69WrBwA4duwYLrroIuTm5mL69OnYsGEDDh8+DL/fj4KCAhw4cCDibS/JpZde6qg637lzJ3bv3o3ExETHcoWFhdizZ0+J9/Xcc89h2rRp+Pnnn/HYY4/h4YcfxuLFi8tlO0vDQJ2IiKosr9eLvLw8VqOXo5ycHBw+fBiHDh3C4cOHkZOTE7JMYmKiIzyvVatWSPU5nbus3uY+s02L3rJF+lVITdUDc1UF/CqgqXpobpt3tgkIKyB3CUUPys3AXNHHBSSK/HpQnqUWoLBIQ5GqV5v7pIRPC62HllKxBeYIVJlrQq8+tmrJ/baw3Kg2lxKa0XJFBQBNgyZhtHspvrpcD8bNcXO9+oEJRTMqyDUj6NH8RkiuQhGB1imKIqEIPSAXil6JLhQJmBW2moQCBR53HKJdXqP1goBiBvUlHuQIDcuNwwcItGU5txnd16FKwO/XoGpGIO5XrYpy6VehqX5ofhXSrwKne24NRXEG4OFC8uBpimJrhVAJJABNgVtGIUqLRrQWDbcWhSgtCtEyClHSjSjNrV9LN6Lg0i/ShSgocFsXvQ2QUgmPRTUOVJn7nGpc6+MyMA5Y+6LjYk2TYaY5l4N5P8bF2o8R2lscKH44tG0FQgrFza7WijA7WAvbMMIPlzI/+DUyD3JARpX0FJ82DTI0bBeqYzgwzQ+f7dqn+FGkqPC5/PAKFX6XZpxWIrD99n9pGPXV1vOoGOF9yWmsCDsIwFEFr8hAa5zQ0F4/sBka3sNqd6NvioBwCSiuMzsgFD6YNwJ5TSuxct6srre3wjGZ52RABZxayDxJsGKdV0FxnHchJIg3ruHJhOIr0r/XFf31FCVcSpxv3B6KCr/PB3dUxbzn6dwlhIio9Upli4mJQc+ePdGzZ09MmTIFd999N6ZNmxY2UC+LKNt73jzIpRmfAePHj8emTZswf/58NG/eHLGxsRg8eDC8Xm+J96koSsjf3L4w50gKLqzKzc1Fx44dsWLFipBlk5OTS1xn3bp1UbduXbRq1Qo1a9ZEly5dMGXKFOsgQUVioE5ERFWK2Rs9Ly8v7Bc4RU5KaQXoZoiem5vrWEYIgeTkZNSrV88K0Hni0PODpvrh9+nBub+wEP6iQqhFRdD8fr2a3G9WkquBvuWVwF5R7qwuDwTmJq/qR4FfQ4HPi3y/H4WqigJVrzwPjvqtSm9NsYJyGC1aNNXWSgF+Kyi3N2aR5rlMoVeYq1bxdgmBeXB1uarpPclVow2L5ocbfgiocGsqFGFWlEsIRcIlNAiXtPUdF4GgXML4I0a/KFJA0fSASagKXFZLCuN5NbrrWBtnXIerLD8XWrDoxzT02F4TevWqBgFNKNa4qhk9jVU9CNf8Riju80P6fYDPr4fjvtBfVkTEDMCjopwhePC4PRyvaFIAmgtCcwGaG5D6sFDdiNaiES2jEW2E4R4ZhWjpRjTciJYuREPRQ3AhEAWBKKHADSBKILSCtDSlLK5JCb9xgEmV0M8tYITbqtQzO9VaRupVzsa1agxr0KAKafyyQ0IV5oEtCVVYe6Z+bgMrMvcDUoU06p8BFZC2a2mLw2XgWgpzJ7bPs7U0Clo+MA1wu1zwq2pgb7NO5mg+UeHGYezLxSwr9WY0+p/vLkAqEMJ4vY3fk0C6IYQLemTuAoRiDOthpTkMaxlzuv454RK2a6GH7eY0RQBuoYfSjuWs5Y1ftgjAJSTcQm8R5RaAGwJu6CGmAqG/B+WZxxAaNHiFHz7hh0/xwyt88CkqvMIHr2IE8Eb47lX88Cp++BU//MIYFqqVrwujF7ywn9Qy6CPC+sqwQvnTP1gU0qLGuna2srFPt27jCPAFXHpvFSBK0S+lrz3cw9On2U4MW+yJX82TvWrSuNZs1/aTxxq3s04CHrQeVcUZnlKl3Py+917c/ddXKnsziCLSpk0brFu3Luy8li1bYvny5SgqKrJ6ru/YsaPM69i+fTvS09MxcOBAAHrgbZ5U1BQdHR3yy+/k5GQcOXIEUkrr3xH2E5QWp0OHDli1ahVSUlKQlJRU5u01mQcEztb50RioExFRleD3+5GXl4eCggLry5TKxgzQzerzw4cPhw3QU1JSUK9ePStEj+REMVR5NNUPf34+/AWF8BcWGOF5EaTfF6g2r0RmSB641oNy89pOSgmvBhRoKgq9fuSrPhT6VRSqfhSqevQdTGoIqi43AnNpNmTxI9CYJRCjmzmZvcpclYHA3PEpE9yORQJC1YyTdqpQVBUuqHDBD0X6oUgtEJYLCZeQUFwa4DbvSMDsfa5Y923bIGNFQsIIYITeJxowGmCEC3rMk3ualeUqXPA5plU0zQjD9YviCMjNcWvYmK5KvY0BfEYQbgbi5sU+XtbPfkVxhuHFDVdUQC4FoLohNDegBa6tYWOeR4s2QsgoeGxheDRciBYCUUIgWgDRAvqwol872HPaSDdPSvgA/VccUg+3fdDghQYfVD2ohB9Fig9e4UOh8MErilBojHsVrz4PRfArPkAWQUojKpc+SKkC0gdofkipQkhVP8CkGSe9VY1+/qrxywoNRq9/QGj6e18Yrfvtw9Yy5fU6lZFZ0Hs6v9eolN94CCN8F25j2LzoUbgewEcFxvXDL/o0REGIKABuPeCHcTsRbdwmSh8WUXDBjSjFCNnNwB1whu8CxjQBt5D6RYEVzEcZB38UoX/mxchoxMhonM5HmAYJn/DDq/hQZATuXsUXuDaDesUHr8sHn+KD36WPa+LMXilpffad0d1YggN6sxo+XEsbZ995QJFmOy7joIILEIqA261/s5TXfuQI6zVj2DZNGtPMAN4cD9wGkK5owFdofA8bB7+0wPej+f0cflga3+uBYZPiYixG554TJ05gyJAhGDVqFNq2bYvExER89dVXmDt3Lvr37x/2NsOHD8fkyZMxZswYTJo0CQcOHMD8+fMBlO1AeYsWLbBmzRr069cPQghMmTIl5O/r1NRUfPzxxxg2bBg8Hg9q166Nrl27IiMjA3PnzsXgwYPx3nvvYePGjaWG5LfffjvmzZuH/v37Y8aMGWjYsCH279+PNWvWYMKECWjYsGHIbf7973/j6NGjuOKKK5CQkIDvv/8ejz76KK655hqkpqZG/FjPBD85iIjovFZQUID8/PyzdiS6KrEH6GaInpeX51jGHqDXr18fderUcfxEkCqf1DRIvx/S54NaVAh/gRGaFxbAX1QEtZJ/qeGoMDcqyu3XwTQp4dOAQhUoLPKjQPWjwO9HgaqiSFXhlyqC680DobnRpkUFVKlB1fR+5X6rwlzVK1jN9EUabSAkrBN/2kNzR2Rijmv6z/mFqkFRVSjSB5fRn1yB2YJFD8sVoZ9IT9j/xS2dVeXWfdurxaVmTZBSgyL19hkuo6LUBTPosP9xZA/M9TsWxbZiERDmgYMyRnhmhaYq9JNYqmYQDiV8MG5UkpsBUuCOpB6Ge73OgNznc04ra7sVIfQw3H4xA/LgaWcakEsAUgG0KECNglADYbgejkcZ1eNBAbl0wyOj4BEueATgMUJwjwCihYBHMaYJIFoBhOv0I60iqaJIqCiED4XCi3zFi3xRiFxXAfKUfOS5CpDrykeuKw857lxku3OQ7cpGrpIFn/RC0SRcfgmXCrhVgSi/gii/QLRfsYajvLZhvwK3KuBW9es4VSBJLa7L9dmjQUJTJFRFQlNgXEv9hylCWsewJMzhwDQt7PzAMtZ9IDBNAMauJazh4GcgkMkKozUInCc7leYJUvXpihRwSQFFU6xfoNivhXFQQV/evOgH3mBehyPNqv3Q74rgm5xx4C/cgOIGhBm2RwGINgL4aAh4ABENgWjbMtGBa0RDCA9cIhpRSjSiFUUP2QWMiz7stoYlohTALSSihYBbCERbgbzQ90M1CollPK7sFyq8IiiAV3x6AO8KTNPb1Pis+aqomCM95R3QBxO2oN4Z3gda3ziHpe19b37yh5umD0PaAn1j3H4bfZqAEl8TMu8kIn8nFr+cGaoLlwc3j32yzM8JUUVLSEjAVVddheeeew579uyBz+dDo0aNMHr0aDz++ONhb5OUlIT169fjvvvuQ/v27XHppZdi6tSpGD58uKOvemmeffZZjBo1Cp07d0bt2rUxceJEZGdnO5aZMWMG7rnnHjRr1gxFRUWQUqJ169ZYvHgxZs+ejZkzZ2LQoEEYP348XnrppRLXFxcXh48//hgTJ07ELbfcgpycHDRo0ADdu3cvNoyPjY3Fyy+/jHHjxqGoqAiNGjXCLbfcgkmTJkX8OM+UkGwq65CdnY1q1aohKyvrjH5qcC7SNA3Hjh1DSkpKSMUXEZ0+7ltnn6qqyM/PR35+Pk8yWkbZ2dklBuiKoiA5ORn169e3KtArK0CXUiIrKwvVqlUre/uBKkRKCWlU4Uq/H9Lvh1ZU5Kg29/v9eh/USqhvtLdiCb5WzD6mYfg0vdrcqwFeVUOeT0W+plecq5o/JDjXOy4YPc01AU2T8GuqEZrbW7Lo14Eb2kNzZ2sWLUxaJCUgVD/cUoWi+ayTeSrSD5fU4IIfQj/7p9XTOHD7MGG5tf1BrSLMBN3sHQNpBeUuYZ6AUf/P3LhAOF5aYF4aAVGtNvzZJ6zA2wzAA0G5PRxXAiF6aWmQlHrLoNKC8rIe6CkpILePn24PcglITQ/FhRGQQ3NDqFH6uG1YqG49QNeiIKT+y4AYBYixgnGhB+VKICCPNqZFn047FQAFwos8UYg8pRDZrjxkGwF4ljsbWa5sZLuNaa485Cl5KNIK4VML4fYD0T4F0X4F0T4FHp9+bU6L8jvD8Gi/Are/POtSnVQhobokVBf0a0XCbw4b0/2KhOrW56kuY77iDMQ1WzBuzRPm9DDBueOfZ/ZPSomyJZyB5Yv9vBVCb3FhBvAwr/WUW7OGy/bcnTFpVu8LRKsuRGluRKtueNQoeFQ3PKob0X43olSXPt+4uFWBKE2BS1Xg1gRcqoBLE/ovB6SE0KR1rgdI/YTI0DT9c0DT21pVGOEGlGg9hBce6IF7DIAYCHOa8BjX0cZwNBThQbQSg2glGtGKC1HmLzwUYfzSw/i1hxHIW7/+QPHfaZFQoVnhutdW/W4P5cMNV1QQf76JjUlCQWF26QuWQbRw4f77J5frfZ4rqnK2VVaFhYXYu3cvmjRpUqZguSpYsWIFRo4ciaysLMSW4YSoF6qyvFdYoU5EROeNoqIi5Ofno6CgoLI35bzh8/lw6NAh/Pbbb/j9999DqgsURQmpQHe7+c+Ds80Rmnu9kD4fNJ8P0uuDWlQEv2qeHFSF6vdDk2f3QJJZTW4F5kZLFpeilBgu+DUJryrhk4BXBbyaRIGqosDvh1/TLz7ND9UIzs3QHFI/36mqAarx8/Biq8wBK6PWg3P959xmpbkjNJcSgAqX6ocbKhTND5fm10NyqcJl9C0HQjsdG8+E/n8tdE4gMNeMn5iHBuYmlxmdC5d+CkehWAGm4qgw90ccmEvAqhbXrxVHSB4IyPXhmJgk5KtlDOKlBPxGMG6G48HDZe1PHlw5Hh0dvpq8DCGW/ksCJRCMq9F6GK5GQWj6MKxxW4geJFoAMQLwKMIKzD0KEOMW8ETr4zGK3p6irHKVfGS6cpHpzkamOwdZrlxkuXKQ5TaulRzkIx+FWh68/kJEmcG4GYoXKrZxFxJ9CmoZIblbjQVw5n80S0j43BJ+t4TPpcHrlvC5VXijNPjcEj63pl9c+rDXrU/3uyT8bk0Pxm3DfpeErOS6AyGFdUJVt3TBJV16uySpOK4VqQ+7zOHiroNu55LBvxwx1htmmv5poUET5kFBfVhK2zTjWgrnyTytC1SoQg30kDeuVev2RisroVnV86oiUeD2o6AczjYZeD71E9eaz63evz9Kv9ai4PFHIcbvRrTfBY/fbR3MUTSzPVYggIemQZjDquqcp6r6NPMzRvoB1Q8g3/qUjPTTp9B6EC5b6O7RA3kRa4zHOK6F8CBKiUW0KwZRigfRIgrRijBaLwW3XYLViinaOO+HCwpiNQ9iNU+ZnmcVakhLGp99XOjXPns479L7yzOIJ7qwvPbaa2jatCkaNGiAnTt3YuLEiRg6dCjD9ArAv5iJiOicpmkaCgoKkJeXB39Zf/p/AZJS4tSpU/j999/x22+/4fDhw46ed2aAbq9AZ4B+9ki/H9Lr0/uX28Jz6ffr1dN+P/x+v3HtO6tV51ZobutfHklobvY1D74UqSqKVD00V6VqXWvQHNXmftWoMtc0+KVZa+6HCmcIDQSyaRV6tblmC831JTUo0PQ2LJoKl/Tpgbn0Q0g/XDIQxBRbXS6VYlsjSFsblkCluVltHnojPThXoAgXXNBPKqj3OTf7mJvbHPrZZgbkqnA5gnFNCKhKIBjXbC1Xzoi9BUtwWG4fj1RwFXm4oDzq/9n782jbsru+D/3MOVe3m9PevqrurU5SUQVSlcAQZMKQ3AEPooGJIE/BjhGKhRH280PgIUGAsiIsMyLsBDKGEw9bGRIEk5FhBzRsK2TQ2Hro4SjBeZYUS6ipUvVV995z72l2u5rZvD/mXGuvfc4+zW2q1f7ese6aq9lrr7V2d9Znftf3Fx8Lypuz6kSA4zMo7oF5C5brVvuQoocCH63SCZA8FYIsCWMJiXQenjNf8PY45aJgO9pjJxqyp4YNJN+NhgzkiDEjcjOlMlOMLslKSadSpGNFWgY4XgqyClYqwb1a4Es+robhxlVGliK2lLGhjB1FgOHNEDnK2KIbWB4AeWhrdTIXtXLKw2fnk/yVq9/tksQJfy6dQFbKR2zYhMylpNa30wBe62V1AdU4FFNNXExsIyJUA8EjpB/X006iUK159bRfTyGJAjz/epXBUMiKXBTksqSQJVOZM5UFE5kzkVMmKmci83CnwzREA02ZypyJypmKglz6oY69KUVFSeXfrjco6aR/D4TXvX7NZ699QmKzBs5nodBuqiOk8XfDiADZG9jeHrch/P716r+NnAE3wTHxk8fscwnM7u0T3vkukxl4pwXjZdbAeCU6pKpDIjvBGZ+QStkC72LeDR/mexCv6Fh1wyDe4UIW/D73ezNvBucrqalCAVffPgGMP5BjdEO7t9RSS70Iunz5Mo8++iiXL1/mwoUL/NAP/RAf/vCHX+7dek1qeQW91FJLLbXUK1JVVTWxLst0sqNVliXPPfcczzzzDM8888yBGJeVlRUuXrzIXXfdxZ133rnMQH+R5azFBQBpa1geoGT9VrbWO81NC54b++K7zuehuUTJGTg/7jZ2uw+cF8aPK+u8y9waKld5N73zWechcBttfJ65sQbt6oKgdTTL/myUBREtdVExYZHCINBEAZSr4DKXTiOxCL0AmIcsY0IO8WGqXebuiFiWRZqBcxmyzmmw3SyWxTSQXLfAuBFxy0UeQLm8DYB8/sBmMSxhKN0WjIc3B8vbgDxJZkM9fUQ+eSs2OjjJowDC/UDdDmNZTy9wkO+XBDoSMiXoCEilI440qbJ0hKAnIrrEJ44zsVgGahxA+YBd5SH5SE6Y2gmFnVCYCWU1QVSaJIe4hLiCqIK4EqxUsKnbz3dj7vEiNhRxDcb9UMTeDV7um19PV5EFpZABQMdEATR7J3HkogY8d/dBZ2UVSRHTmaakNqHjvJu2DbxTG0BnKJRau73bru95wB3g980Q1xdZtglgCXnq2JCFbsO3U/jXimrxeemHT6soQptbq12xvyO1drjPZaxTR0s1S8NdNfUy2ZqeZbKnLqGjU9/BF16nG434cThyUTQAfiJzxmrqx3I6y+aXE4Zq0mqPQ2b/xLvqhWWqcqYqP/5J96ljUnq2S9dkdGxG12ZkNiWzGYmNyWyP2HmHfOQilI1wQqCF79gFNw/YtZ6Bd61nAL49vz1d/ya4AkyBYxjOzWJVtFzxtUQMsnbFZwgyhOh4p3yA8bHskMguqewQq9TDeBGH/Hhm7ng5A/E+R96/7nVO/IKa3ceqEh6s14C9Cm749vTcsta0FvoGomqOWaleXN+Kdlv10hTlXmqpl0rvf//7ef/73/9y78bXhZZAfamlllpqqVeUyrJkNBqR5zd+cfX1Iucc169fb2JcLl++PNfpoJTijjvu4K677uLixYtf9xnkL5acMbiixFUlriiwlYaqxJn5izNj9Bw8N9oD5xdLAoGSLXB+Qqd5rRqcF9bHtBS2Bufema2tobIlxhmqENviLBhjMdaircU4h7GzVPOFLvsQu2sAwmP8lAFhiFyJcobEViHD3CBMnc/rr69la1s1MBfu6PKH81nm9liXeVuzqBZJhAiu81nRQiMkWkrK/YD8xYDk8wd10FFellAUs/a+HOND7/c5DpbHdfyKP1dOuH3T+NcnRK2gPRyXJgWdIE2C0OkMmp/wnEQCUuFQSU4UVaTSkCpHTyh6xKy6jJ5b5N48COI1mp1oyECNmtzxoRgzcWOmdszUjMj1iLIaI3NDXEJUQlJBWghSLTn4TMcfRxEb8thSJIYisU27ikHHoGOBjSQ2lrgoAhURizhAcA/E63HWnkZ5gFimdPKMzCU+HzvEb8QutG3dPgjBPWxXt9XF7XPCDU5WOFmihcZJP2hRYVSJkSVaVhhZYmWFViVWVBhVYWU9aKzQOGH8IO2sLax/DmFb07N5hKHdRoTPurCI1u0oYi7XvI5dolUQIVQQmFUcnT2uNV8K1dwZVpdUxDWPBidmW3ezdZxrNuLnuXrrYT3naxg4J8EJbBg7J3FO4Ahj1xofu77E+lB6cDGYCNyssK6wftoaiXUCnJx1htE6bOrCqh7a90yHVdMLdy+Ejp3wPktCxw4OD1/xTulClExVMYPuctLA92GYHoRlTjimqmCqikUf8UPVMSkrptcMfdNlxXbpmk6A8x06Acp3TEbsImyI26lC3E4VondKW6JtSWVyrK1wVjewvQ3oF8L5xh1fgalwjFrvunlpYGHQoYhDfnzacsdnCOEHKTJS1SWWXVKZBRifksiYREQNgF9U0LWOsaq/P26WOTscGkMlzXxkkWxFF8l9MUbCUEmNac71bB1hAHO76w8sTTtLLbXUzWkJ1JdaaqmllnpFKM9zRqMR5Y24JL+OlOd5E+Py7LPPHsiRX1tb4+LFi1y8eJELFy4sY1xuo5y1uKJoIlps7TY3B68wjZlFtvihwroXx/20yG1eT59EpgbnpuU6t6DD7toQ06KtRruKSmsqYwI0N+hWTItPNV98nO2YFlyFxTvMwUeyRM67zaXVSGcRxoFxvnje3IZakSzHHNutQHOgKQYqpEAICUJhpcIJQRUyyr273MexHFuo81Zl7UFY3obmJ80tj6IAyGOi3gpaWEjiZh7JLIKl6aNoP96BMxGiSj0U1ylSZ0idIkzqwblOT+QmbyuPRoh4QpQUpMrQUY4eilVS1l2XDdMnc0lYO5k9cMFNA4Uom6iVPTlkIIaM3JCh3WOkd5noAWU1IhlBUgo6pSIrJFGoWpmGYabFrmorHHliyBNLmUCVOHQs0bHAxRIbKX++owgRRUiVEDPLmO67mI3QrrO3Exv7IY/82IXpFgSfQfEZLI9tRHzEZZ3D4lSBVSVWlbiowMoRTpW4ALKNqtABYDtZ4QLsNqrwg/SPtbLEqqqB5B6QVyA1qDAWFiEMQt6e7746/Gapl1/+q1RhbYDxTuFsGDvZtK0NQ2hXNqIM09oqtBOUznfUls5ROCiwVA4q6+G9sQpjfWfRabvBWbfZxPg4HMKJpvCrz4o3TZ54IUtyWTKRU8YyPwDhr7J9ouMVTrBiuqyZPmtmhTXdZ9X0/bTus2FWWBXnWdMrrLguXZUhlPRQGA+QayjcBvKlK6lcTmGmaFNQ2QJtC7QpsbbCmNLXVTG6ccwfjKrxMB7Gh+bHH/4XtQDp3fF1oVZEgsBPS0I0jeqSiIxIehgfy4RYxiQyJhaKWEqifUC+bvtnEcT476jbJYfDhMFHxLlQQ8CP65oBzXxhw3zTmvZtIwxCOHb+rytsfMu527aPSy211NeHllfbSy211FJLvWxyzjUgvapu7fbo15qstVy7do2nn36aZ599lqtXr84tj6KIO++8s4lyWV29uYzdpWZy1npo3oLnPu98sZd3Bs8rdKWxRt92eD7nNt8HzU9614FzjiLA8hqeFwZ068rbOkNlK4zVlEZTVhWFLdHBcW6txTi7MNe8eZ7gYHdowLtJha0Q+DiWxGqEs0jjobk01gORZgNAKOgnjohlmT+2dpZ5C5wfY6ez+LgVX4xO4qRCyKhp14U9X3RQXqt2mBfFzFXebp/0+zFpucrTeH6cJDhVB+E44t465WQPCGfLiQaSz2B5gtBZaIf5J3QvG6GZxAMmyYAyGhHHFZkydKWkLyLWXMqG7XNKr3JKr6PYoNmZQ16+sZyyp0bsqAF7Yo899hi4XYZml7EeUJYjZFHRzRWdQpGVswKRMbARBsgWbl8rR5k4yhh0IjCxxMYKFyuIY6RKUHGKUql3e5Kw0jofyskQhxLPgHgZAHmYl7o4uMXjkBXu4bkUDhvlWJVjVeHbUY5VE2xUeCAuyxYY92BwXENxVXgIrgr/+DDtZAnqxas/crA87+HaD2M9kJ21Z0C2nlat9sxpPXNei+D2nrmuCfPrdeYd2e3HzNavv9IOOsjrI6z3X8zNazvK6/nOQSfrkxcjGpe7cPvarWcTtVfdHdGezRMiREgFd/3CcVjO/mUseowfpDR+HDpCZOgUkXKfi18Q5r+0hbGtE1gbeUhvIoyNMFahnaSyksoJfyeVEx7OW8hx5M4xdTBxKRMMubOUVmCcxNoYbSXG+e9FG8B8HXNSygonHINozCAa8wxXTrSvHZM2AH7V9FjTKw2An5tnT7Nm+3Rd5n/PFXM9R5ZQiJYZlNfCUFJS2Cm5nVLaPAweyFe2QJsCE6C8tRXWVDijm6GJqrGlHxgeAPIW74yfHHewQnowH9zyDZgXKZHIiESHWGREMiPGg/lYxkQyJhIxkYiIpPJjIYmEIhKicclHwgMrJUC1IH2ECCBLze/4TZrNr/3TryyB+lJLLXXDWgL1pZZaaqmlXnLVhUZHoxHGvLQXZa9kWWt5/vnneeKJJ3jyyScPuNA3NzcbF/q5c+dQaunZuxk553AhHsOWZQDnwQ12yMWYMQajq1bR0NvvPI/aES1SNtM3osq6BpzX48rOH5YJrvPSVuRlQW6qANOtd52HwqCHyvlYlgacY5C2QDqNsgZpHcJYhLFI4/ZB83Ysy8nev24ux3xBe58sYKQKLnKFFRInBU5EIBVO+sKJN5oZfEuqM8wPA+ZlebzDXAhIkxk0r9tpgqsd5kLQPt22BQjRKTJPEZV3lNudNZKcGTw3Jyt257BM4xGjZJdxssck2aOKR3SUpS8kKyJhzXY4b1Y5V53ibHUHK7bnA4SP6BfQGK5Hu1xTO2zLHXbdNiOzx6QaUJRDTD4hLqwH5dX8e2clDP7SZv7yxgpHlQh0IjwcTyKIE0ScoKIUFaXIOOS+K0UMxM5HHbQzw+vCmVkVkxQJCZJEWBKpiZQfRFRgkxqIjzwcj8K0ynGhraOcUuUMa3CucniJAKUxagYmnR/PuYqdwtl2e95xrK2HmdpGVDZC25jKRlQmjMO0Cetq59fVVmFQGOerClgnQgnhut0eh/nteQF81+9pF4JWXCs+xbXnN8tmd1y4ALzrdeZh+Kz7rHmEqDsMWmuHO2cUDulCvQQnkMKhnO9uioVCWI0Ufl2JC3UVXDPtx4e0Q4qSxCGdvxtJOIcUfs+lcIQuhaY9Ny0IZ9aP/eOYA+NtuRbAp4H/fp7vMzAIqT10lwapNEJokAYptZ9Xj4UBqZFKI6UfhKqQYR0pNVL59WTYZjO05glpUK3PhBQOqSp/F8RtLgPjHN41byVVAPRlAPRT5yicY+o8nM+dIyd0TAeXfWHCOMD8UuZcj3Iuu2twgt+ZyCn6psua7rNuVtjQq3Mu+P1g/rRZRdW/n/Wb58TH6tCuYmonTN2E3HkwX9mc0hVU1jvnqxBnY2zVjE2A8z7eJrw2zoIpgMJP1s+Dd8ffzD2nDkBGCKlARCAjEBFSJMSqgxARETFSxigxG6SIiESMEhGSiEhEvi2Uv7NBRD62TYT6DiIYFVDYdPn39FJLLXXjWgL1pZZaaqmlXjJZaxmPx4zH4yZf9OtdWmueffZZnnzySZ566imKomiWJUnSuNAvXrxIr9d7Gff01SnnnIflRYHL8wagH+VistbO4HlV3fbM8waWC4lSs4zzG8m5N87N3OYtgL6/VpdxmlJXTHVOXhUUpgq55xbrQvHNBRIYhDA4Z3BCI6jAaaTxWdzS1k5zizIO7EFoLt3Jr/IXR7QcLARqIRTtVBgRt8C5j19xIaJFEFxtgHip4Lm1LUjeHpd+OO47TzAD5WFwSQJpCmnsM7XDe8SG9ZszYyJklSEqH8EidOandQo6Qx3iLN9/IWCEZhxAeRuYT5I9MmVZIea07XNndYb7yzOcqy5wunqQXnF8kc2xnHJNbbMtd9hzewztHhO9R14M0fkQN83p5grV6hGQQD8MB0E5mERiE4WLY0QcI+MUEfu8d5fEPu89iohRrNiE1CZkNqYjIZXWA3FliKUhUhVKVShZIaISp3JsNG0NOSaaNO1SlTcFi46TtorKJB5Qm6RplybxENvEVDZGm8THaJiYyiYUOqG0CaVJyE1CqRNym1LohMImFMYPDokJTm3bwsW2Ac31e0w0sNoxW/dlkQvmXRe6TFrjGEkUlvv5opmOA/DePz9yEDnvcJVhu5IajtMUFa4BeXu+ernOwStc9bfbSX4pHdaDe+FabRumZ22EBVUiVYmICkRUIqMcGRWIqECqEhkVflpVSFUgI7++VFVr3BpkhVQaJSuk8nsrBMTKECtzA+WCT3CcDkoHpRO+FknddlDaMK6hvJ1Sum0KBxMn2G0B+za8L52gcoCJyEIh1p7t0DddVk2PVd0PYH6VDbPCRrXGpl5lU6+RkSCEIBYJsUxYZf2mj8066/PjbUHlwrhxyftp7So/2ArtSipXhraH89pVmLDcuKrpPBcAVvuB2d/Edm7q9mpl9TTfwttepK0vtdRSr1UtgfpSSy211FIvuowxjEYjJpPJXPHMr1eVZckzzzzDE088wdNPP41uRYp0Oh3uvvtu7rvvPi5cuLB0od+AnLUzt/kJ4blzduY6ryq0rjD29sDzdkRL231+I+DchZzzGpznZj7nvC1jNRM9Jdcl0xY8N3ZxTIvAOwKF8HnmYMBVCFuGnNYQy2KD09y0NnMT0Lw+nhk0P+g2N0JghAqAPPbjObe5qPFfY8yLUERA4suF3tD+nHCvZ4OtXeYl5MUMoOcnjGWJowDLU1yaNADdpTOHef3SNlzZCZ9NXmTBXZ4RaQ/PCRnmyiaHPWMjIzSjdIdhssMo3WGU7DBO9xgnu0yiPTIlOG/Wuas8yx3VGc5Vpzhd3cXmaJU10z+2UOWeHHJNbrMrdhjYPSZ6wLQcUBVD9GRENNULOzZm4StRc7ZtrObja+IoAPIYFytUEtGNJR0JHeVIpYfiSmpEVCHUCFQJUY6IphBPIZog4gkyms45dW/FSQlQmISpzsh1xkRnFDojNym5TimMH3Kdkh/Sbs8rTYpxh3znO0fkDMoaYmtQzhBZi7KGyBkiGwZnUNY281bshHU3JLIG5Syx1c1yZUM8iHNIZ73L2TmkC25nZ33budayw9cDh1ESKxVWCozyn2UrFVaFz7IUWKkwyq9jhQqP8R1jTsnwGF/Q1zbTYVtCYEI9g7ror5PBny0kpZQUQuCECndsSB9Lsa+NCPFHQoYymn6QQgXnufAAPwx1WzJv5vbtljfeBTe4De5yG86R9edMhHnSucCNHdKCcP5WIul7Npp1RZiGGlqL0HG6z5Hv9jn3F3WALPgtrNeS7babtUX4Vt0/v1k/dEbMzW9c/Is7IARyZoJf/G5fKEfzS3WbZD2kV/tAfTz13xNxjoxzRFgmm3FYr3lsMYP3UYlS/rdACEgFpDhWmo/17fsbuLRDn0Nf59G3gHvlBM86eMLO5vnM+jruRuFMjLAJkU6JbEpsOmQmI9U9urpPT/fpVytkpkdiM2KTkdgkFDKO/G+vkyjXpUOfFefz7VWoQXLDr4azAbaXLRA/g+9122IwzmCdwToftWecxrrWfEyY1mG9+WUmPM6G5ap6kQqGL7XUUq9pLYH6UksttdRSL5q01g1I/3pXnuc8/fTTfO1rX+O5556bi7rp9Xrce++93HvvvZw7dw55gzEfX49qw3Ob503u+XHXqh6eV+gAz60xh7q0T6q6OGi0L6rlRsA5gHXzcS01PN/fB+Uz0QtyPWWqS3JdUeiSypoFx28baC6lAacRGJwrQFukMb4AqA0RLTa4zRtwLpH2xp2pB2JaguPcCGbAXMZoqRp3uYdks22I4IsFh0KQYoPbXCJv+Z7/dqxB84ReuvKAvCgCNC9n40Py9Bsp6bPK03TmMm+NXfhsz0XEOxAmQRQZsuoQ6w6iynA6QVYdoqp7oo6CaTRqQPko3WGYbjNKd5gkA2w0RQnDXdV5Lpbn+cbyFGfd61iddFgf9tnQq6TuaChfipJrcpsddtgzO4z1Lnk+oMoHmPEQaxefG0ldRjQEZyTePW7jGNdViK7EdSQiA5UqVCLIooo4KominDjaI4knxFFOEk1J4ylK3nomeGUiJrrTwPCpyZhWHaYmTLcGP91ppqsqxuUSCkFcGTJTkumSnp6S6ZLMlKS6IjUlqano2YpU75HYisRoUlM17dhqElMRWx0GQxTGHpZ7aK5O8D1lpKSIE/IkpUgSijihSFKKJCaPw7wkoeikflmcUEURVRxTRRHTyI+rKA5DRBnFVHE0P33IOkYtLy1fLAlnfQdK6CiZdYq03iPOElk919kiXbijyDqk9R2kwrpmjAFpLM44f5uCdjgDTjusAYPPKZ8NYZp9006iF8V4uVlR2dndAB60t+8G8G2xb535+bGzJDgS4UhwxMzG/i4E14Q+qVYcT32ngayLWjuP/oWVOJ3gdIYpbmcdGouMyuCiD+A9ygO8Lw5C+ShvXPhzy1SBjP3Yu/OLuez6RNbfre3vhhfXtOId9KCdwDRjgXY+nsk40dQ9EFYhnAqFxBXCytm0U0hXTytkM5ZNu54Ps8dEIsa6+vvfH6sS/rVvn4OmCoKYhT7NahYIfG6QAxEjgJXu2Rf1vC211IspIQS//du/zV/8i3/x5d6Vrzst/+pZaqmlllrqtqssS0ajEXmev9y78rJqMpnw5JNP8sQTT/D888/PufNXV1cbiH7mzJkbhq9fT5qD50VxYnheR7d4eH57cs/3g/NIypvqAKkjWxpwHuJb9h9SZTWFyZnonEJXFLqg1Bqzj7ILWtmzQiMxQOUd1dp4x7m2YC3KWE9067vqEWH6xo9jVhTUQ3PvHhQYKTwsF0nLZT4PzGf77sG5RzR1TEudcp4gbtjD2NhG6ydg7sw658H4fmheO82Pq+sQKQ/Ms+AyD2OXpbhINbEsczIKWXVQuoOoOlCloBNE1SGuekh39J/kRmhGya4H5ukOw8TD8mm8h4mnuLggI6ZnOpwvT3NvtckpfRfr4wdZH/hM3lN6jeiI3HqLZVcM2GGbgd1lVO2SF3tU0yFVPiA340MfK5Ql6ltsX0FPYTsSOgKRgUwdKjVEiSZJCjrxhG48oRtNUfLmP4/WCSZVh7HuMq06THSHSdVlojsUVUZRpugixk0lamKJR4ZkZEhHmmxY0S0q0gC/+6bilKlI7C6xMcS2atzetbNbWTtzZ9/0XkOlFNM0Y5pmTLIO0zRlkPaaedM0I08zplnGNE1n85IAx2MPxfNWuwbnOnrlXdop4+sqRNYgjT+Ps7YhMh4KN20TnPbG12RQxre9Cz4AYWhc3AAEtzyEeS58r9jaLR4Ca5xrBhnc+X5TAiHACYEVoXipDGMhsFL6bxYhsdJ3MFrhl7WHep4N33la1UMU3PqzeaaZL9Eqms0PdR72ywlJpSTVS3z5Hpl2J49v150/HWuIjSa2lV/H+LsfpPGvrzQGoZ3/7TEB1muHMQLtFJVTPrO8aSuKfdOVUws+cbcaP2RJREUsDIkwJBgyocmwZMKRYpshwZEAiXDEzsP7GB8Z5IG9hDCIemwlOOXvLnISyi6i6B9YD9t6zEkd3cIgVYVoonDC+MC0d8sLVSJUgYsn2HiCi6cQTaEdm9Nk3Buk8AVplXREwhHvO82+OCgkc2npL61u932bDrg2PnObt7rUUrdHW1tbPProo3zyk5/kypUrbGxs8PDDD/Poo4/yHd/xHQC88MILbGxsvOT7ds899/CTP/mT/ORP/uRL/tz7df36dR5++GGee+45dnZ2WF9ff0me95X3V9dSSy211FKvWuV5zmg0oixfjGTZV4eGw2ED0S9fvjy3bHNzs4HoGxsbS4h+iGyIbDHTKdVgQHnt+onOlTE+89wP5S1FtwiC61zNA/Sbec10KBSatwB6tY8jGmcoXeXzzquCXOcUpkLrdoFQ52G5MERteO40GIurwXmA5z4qQCBMjR5kAOc3fjlag3PnLAaBFhIjRAOA9AKH+X55aF6nNNdF+mRwnUfIIy+T94Fy0Z5/iIzxsHz/UBRgjga5Lo58dnkblocx0SIXpkBUGWrSRVYZTqc4nSCqjLjqEZns4GNasljGyS7D7DqDdJthep1Ruk0Vj3FxjlSarsvomg6ZSblgemyYs6wU97I66bFuVjhdrXNGbxAfAecrKq6LbXbNdgDmA6rpgGm1y1jvYZ3P9ZGJJcoMUUcTnTZ0M0Ov47BdieiC7FjiTJOmJZ10ShqdIO7mEBUmYVr2yKsuZdWjKjvoIoM8Qo0k8cgQjTXxUJMMKpJhTrxXkIxzTlvDBVMRuynKWpSzrRTw26cyihj1e0yyDqNOl0nWYdzpMsq6DLtdRp0eo26PUbfLJO0wzTLyAMPzJKVIU/IkJU+Sl8zFHWtDYiyJMcEVb0htRRoc8pktZ055VxG7ksRWpK4ksSWJK0hdSeoKEuvHqStIbUnmclJbkNmczIWxLejYgszlxLYicZoI0xTMfMVpfxqKwzuzjcBZgTMC25q2WmCNn2+0xBo/ba3AaunH1s83RmK1DOPwOC18PWcNvm6n5ZAaodj6u7WG7lJSqQgdRZRxTBklflwPUUwZz+ZN0g6TpnPGv/+KJKFMYqokpoqT5q6DIoop4sRvI4qpZIRuvUc97I+AkxUtPtGpd47YVKRWExt/p0YS7tRYae7YKPwdHKYiNtoDem39b5u2uMqBtqGQaEQZ4HsZhsqquXl+HDVROKWLKF3E4d2EJ1MsDLHQPnaqBvTCEMuymT5yHB4XORuicFqQfQF4p+Wwb9pOhmiwDKqub9e/9/Wy5vF1W8yeo+5UD+O6k91iKWVOFY+pojE6GVNFE3QywsQTTDTFxJNQfNnXlnBRgVOFB/atoryzNnNtKXzn16xNU8x3vh2K7Tox31nR7pCws/PSHB9+7JwMHW3SxyM52cQk4SRWZPw/bvG9sNRSL4be8Y53UJYlv/Zrv8Z9993HlStX+IM/+AOuX7/erHP+/PmXcQ9vXWVZkiTHRxcepf/8P//PedOb3sRzzz13m/bqZFoC9aWWWmqppW5Z0+mU0WhEdZIM4degdnd3eeKJJ3jiiSe4du3a3LIzZ840EH1tbe1l2sNXrpy1Pu88z3F1dEuorOmc8+7q+KBz63a6z6UQM2iuVAPPb0aVdXPgvDCg58zRDo2mtBWF8VEtuS6pdIU2FussDoMUGiENKtJEAaILNFKHAHVjcNogjIUAzIWldVE8y6i9ETnn8b0WwgPzGpy3CoAeRyt9+cIanNtwu3/IJw6RLfNuvPC6CVNv4OQ7bh2U5QJwnkN1eCxIHT3igXkLmmehIOii2gVWIqsOIveRLFYnUGVEZY+k6h/rMJxGQwbZdYbpNoP0OuN0Bx2PMckUJSu6ZPRMh8TFrFk4Q0rPrrMy6bGuVzil1zhXbXKuOkXiDo+80Wi27YA9vcu42iXPr5PbK+TRVap0j7hjiLraw/LM0OkYVjKN7DhUx5CkFVLdOAA1VlGWfXTVw1Q9bNVDFh3UNCaaQDKyxHuGdFiQ7BYkuznx3hSR5zhTgrkGbN3w8x67X0Iw6PS4vrrBtZV1tvvr7KysstdfYdT1kHzS6ZBnGXkW4GM6i0cp4wTzItSyiIwh05qOqch0RdcUftA5XZPTM1N6dkLfTOiZMX0zoWsndNyEvh3TtRN6dkzPTj3MNgWdALYzW74qS2fa1rdG+xvEiRmSnzuu1p06s/mL5tGaN//elvUdMsL59726iS/Om5QzeOCuBbaG79rDd9sejMRWoV1KTCWwYz/PVGFZJXH29rzqRew7kAb9FUb9HqN+n3G3y6TXY9Lxn5dp1gl3UWRNZ1GlYiqlqGREJSNKFVPKiFLN2gQXfxkllNwaQAGIrPbxSrYiMZXvJArjVaNJTdlMx7oiMmYG5ivrHfNONiDew/hobroB8lYFEK9CFQ8aF/2tBhsK3JHgPZY6gHpLJAyxsESUxMJ6IB/m+bYfq8N6bG5QEt+dMutSScFloPFDyPT3EBsIxYw1Fi0qKqGppKYSGi00payopG9XovJj2W6Hx4jZelYc9vedZVYS9+a1Fq/xs7e8laVebXLOoctbf//cqKLkZAad3d1dPv3pT/OpT32Kt771rQDcfffdfNu3fdvcevsjX/7Nv/k3/MRP/ARf+tKX+KZv+iZ+/ud/nh/4gR/g3/27f8cjjzzCpz71Kf7Mn/kz/P7v/z4f+MAH+OIXv8gjjzzCxz72MR544AEAHn/8cX7qp36Kz3zmM4zHYx588EF+6Zd+iT//5/88AG9729t46qmneN/73sf73vc+wJ/PD37wg3ziE5/gs5/9bLN/v/Irv8Kv/Mqv8OSTTwLwrne9i93dXb71W7+Vf/AP/gFpmvLEE0/wzDPP8NM//dP87u/+LlJKvvM7v5Nf/dVf5Z577jnyPP33//1/z+7uLo8++ii/8zu/c+x5vZ1aAvWlllpqqaVuWtPplOFwOFdU8+tFeZ7z+OOP85WvfIWtrXkIdOHCBe69917uuece+v3+y7SHr0zZqsJNp7ii8BC9PFknzJz7XFcYc3PvuXZUSw3Q5U3eKaCtY2pmzvOpIRSLC/vsDCUlpakojaE0FUVVYrRFW18My4kSKTRSalSkifeDcx2iWmrHOfhrxxqc18XdbvB6QOO8q1yIAM+lH4eifyfRAuzVimrxLVEHtszllN/gBXAd0TItZhEt01ZB0COYgYsiyGpYnvlxJ+SbL+o0CdBcTrvYKsHWsSxlP0Dzw89NJQsG6fUAza8zSXep4jE2niKikg4RPdslMwlrAjJZUghLx66yUvU4pVc5U21yR3mWi+U5erZz6HNpZ9jmOgP1PIV6jkq9QJlso5M9XDppgHnc0ax2NRvxTQBynWKqPq5cQRR9oiIjmaak45h0rIiGFrlbws4EuT1FDMY4nePMCMwOWHMiqHvUnmkhGcUdhkmXayvrXFtZZ6e/xm5/lb3eCsNen3Gnw7TboehkFFlKkSVUaUKVeLeujm81b38mn5Ne0NUFfZ3T11NW9JgVM2ZND1kzQ1bMgFUzZMUOWDETD8b3DV07JXa3r7RiLSN83FIR1cU//WCkjyOxkjDP36hihWjMnFaKxtBq6/iTYBO1jeFT+GVh3fZ6PvYkbAfm+BphWWBtfprwLSAI3W6zwVGv2CQfe0jnBM6F+1yCw3ThdDNv5kR1tJeL2TwrsU753GcboLRTfmxncVgitJ0V3hVs/TZEiM9qXLTO0k97FMWezzTHF5BVzqCw+8amWUdSF5b1cSqR1T4j3Wm/jjMkaCIqVACoSliknH2CrAFbSUwZXPPlPHA3+8b1clP6wZb+/KeVJt3Z49TO3g29/2wksInEpAqTRVRZQtFJKLKMvNNhnHXZ6a97UN/tMe50qVQ8B9wXQfhSeed8EeYVKqEKLnotI3QSMebw78vjFAfgPht8DYTMVKw18yZz68S6atzy2niXfLEfwtv9DvlZjE17Xh18Vrvmb5cktoHr9TgWhgjrgXw9Lfx6CosSFiUcUdP286Mwv15ntr5r1mn/pNYp5TGKDooGx9eVZXW91hFq/ThYZ6mEIel1GE73MMJgsBhhfVtYDGbWFiZM18vr9c2B9a0wvPGuR27beV/q1SNdWv7R//v/85I/74/96luJ0+M76vv9Pv1+n0984hN8+7d/O2l6/J1Cg8GAt7/97Xzv934vv/mbv8lTTz11aCTLz/3cz/H3//7f58yZM/z4j/847373u/mjP/ojAEajEd/7vd/Lhz/8YdI05dd//dd5+9vfzpe//GUuXbrEb/3Wb/Hwww/zYz/2Y7znPe+5oeMH+IM/+ANWV1f5vd/7PQCqquK7v/u7ectb3sKnP/1poiji7/ydv8P3fM/38PnPf/5QB/sXv/hFPvShD/F//B//B1/72tdueD9uVUugvtRSSy211A0rz3OGw+HXnSPdGMPTTz/NV7/6VZ5++mms9VBQCMGdd97Jvffey9133023232Z9/SVIedc4zpvCofq4yGScw6jK6qyZFp5eO5uwn0uhSAOjvNYKpSSNw3PjfPO8/ZQO8+dc1RUFK6iMhWVMVRGo41Ba4sxGkvh4bnUCKmJlPbg3PhioFR+kMb6+JaaNrkWaGqI1Mn22SKohERL7zRvg/Ojoln266Bn1L+Gsv4nBJL4ELfNDYBc6zwgnwaH+TSfOc7t4a+/kwLStIHlLgtRLVkKizKlrURWXSg7WB1jdYosOyTlCqk+ugOsVDl72RZ72RbD9DpFMsQkY4hzUgE926VjM9YcpKpkrHJGYooDomqNXnmGC+U5LpZnuEtvcsH0UW1vrTCYZIDuX2aQ7DCMrzCNL6Pja5hkD5uOIJuiOiUqQPK6CN9xOMmZBFeuoopV4rxHOs1QkwQ5UaihQI5ADDwkF7sTGI9x5QhXXUPo54/Z+uyV3v8uqKRiGHcZxR1GSYe9tMfW6ibXVjbYWV1jp7/KoNdn1Osx6XYpOwlVlqCzGJsoTBxh4lu/ZElNSV9PWa3GrOox63rIqh6xZoas6iHrZsC6HrCiJ6yYESt6wqoZ09d+/b6ZoG7SCWkEWCUwSmASwVTBSEYYJfx8GZYpgZEcnC8FVtGC5B6GW9WC5AFUvxoVSvXycuQx3y65uhijlThiEiOwNsJahXaKMrTrecZGWJeFeX6+aS23bn6eq6M59kk4S4yH77HTRE4H13ZBWlWkuiDTJUkokhvbCml9zQuJRdRAVBpiaYiNIao0kTZE2iBL54F74UF9Dd/rebb080EgtUNqQzQxQAnH+baFQyRABjaT2EyhswidRZRZQpGlTDsZ006XaafLOO2Syy6FSNAiolIRhUooVBxA+2woj2pL366jbbyzPmZ0k699HJzw6SIwbypWTRVc9JNQrHi2PNEVznFIRE0rxsa2cuXxOfN1Qdg6i16Hce2et0hKJ28rpD9KsobwOCIRIt6Em0W9Cdd0PPkIFxdsAe3psE7TDiE9YTtJkVDqMnxb1J1uNPEtdTnSA9P1um42r32/SrLyjS/JOVpqqRtRFEV8/OMf5z3veQ//8B/+Q775m7+Zt771rbzzne/kTW9608LH/OZv/iZCCP7xP/7HZFnGQw89xHPPPbcQen/4wx9unO8/8zM/w/d93/eR5zlZlvHwww/z8MMPN+v+4i/+Ir/927/NP//n/5y/8Tf+BpubmyilWFlZuanImV6vx0c/+tEGlP/Gb/wG1lo++tGPNtcTH/vYx1hfX+dTn/oU3/Vd33VgG0VR8J/+p/8pv/zLv8ylS5eWQH2ppZZaaqlXtoqiYDgcfl1lpDvn2Nra4itf+QqPP/44RVE0y06dOsUb3vAG7r///iVEB5zWDTyvAfpJ+IhzFl1pdFWiQ4yLw4VbhgVRcyl0uOrYlkipZnyz8Ny6WeZ5brzzvM48t856eG4rKltRGI3WBmsc1hisKzEUOEqErLzzXGpiaxHWIEvvaKOyTY63s3i3I/VF38ld5w7v4tVSUQnpi4EKiRYyPPzkALAG5x7F25B77F9AJYTPOhcCSXLyAmqLdtiYAMxb8Sx1YVC3+A3jAJpYlhkwd1nqo1v2v9YOhM4Q4y5GJ9gqQZZdknKVrFo5chfzaMxetsUgu8Y43aFMhth4gogLMiR926NjEyKh2ZM528CO7TIxEWvVJuf1Ke6qTvE6vcYl0+OiS1lFeFCe7vph9Ql09v9jK9mjTLcpk+uYdBeXThDy4DkQLP6j3ekIkfeJq3WSfBU1SVHjGDlSqAHIPYvYqZA7BQyGUAxxxfPhTXf0y9R+bvDvpHHcYS/ts5f0GCQ99pIeW6vrbK2d4vrqOrsrq4yCazzvZJRZgk0UIpUQS2yssPHNx6dkJg+ge8SaHrFeDVjXQzaqPTarPdb1kHU9ZE0PWdcj1qrZdOJOfleLFaAjD7N1JDCpYCeqi0gKdCT9WM3WqdszMC58Z5b0cNQ1LugwdjN3tHMSa8O4HqzP5XZG+RiQ4K62jVO7PQTs1JrGSe8ab+ck105uEdzbTeK8w2Pt2Svvl/vsY79toAWi5qdDu7am+7Di0CcYcJkAK2ToF5wV8awd6s0yURcAbRUIDZ2AImwXYRuUJnxl5bDMha+CurPb1ZWXfZs23Avfc9I7xaWwKHy8lhI+dksGJ7hsDc0yaX27iYzxcFpK653BkUYxJUV7cH2jb/Z9cg7/3jEKZyIP5E0A8GHamAhrY4yNyE3M2CZo08PYGG1jtIkxLvLI8qjfR+dQlSEuKrKiIMkLXzXb2PCiutm5l/6YY2tIrQfEmanoFTmdoiAtSuJCIwuLKEAXAcRX/rYHVwAFiD2HQqPQpEBv8Y6hUkuUWWTmIAPXEZhMoTsxRSem7CTk3Q6TrEOhUqYipRAZhUgp8O0K/5thEZQByBcqpoiSOShfw/q8DeWjeA7iA1TKw/2bBfLKmiaWZtGQBPi+aipS47PlE1M1ufOJ8R0q9StqnFgI2iun0A2MnxV/1U5inEQjMKFtkGgnWu16vp+nw/z2X2cW/91V+ZfqVSX19M7LvQtLvQyKEsmP/epbX5bnPane8Y538H3f9318+tOf5jOf+Qy/8zu/w0c+8hE++tGP8q53vevA+l/+8pd505veRJbNavfsj4ip1YbyFy5cAODq1atcunSJ0WjEBz/4QT75yU/ywgsvoLVmOp3y9NNPn3jfj9Ib3/jGOdf55z73OR577DFWVub/Rq/vCF+kn/3Zn+XBBx/kL//lv3xb9ulmtATqSy211FJLHauyLBkOh3Mw+bWu4XDIV7/6Vb761a+ytze77bnb7fK6172ON7zhDWxubr6Me/jyy2mNm06x06kH6EdkVs89zll0VVGFCBejq4DPTyYpxJzrPJYSeZOZ5wCF8dEtdWxLaQL3rSNbAjwvtUEb6wvUGYN1BY4pjhwnK6TSSGuQxqC0885z7V3n1tf0BFs7pKD2ZZ4EntfQ3EjpXedCBcd5eDz1E9Q6fIMirOtxgr8kRtTwXDR550pEiBDfciK5VsPhY1ryYt5pnudwRMyPk9JD8k6K69QRLdnhES0mQhYdTJViqhhRdYnLPlmxjjrClTeNRg00n6Z7VMkQG09RUUlHRPR0l9h2cU4wdD329AqjMmZiUyrd40K1wT16nXtch/8wKrg72+N0toPr7qHTy+j0T9DpLibd41q6w+V0j0MrELYk8KzbThOYdFH5CnG+QjLpkY5SooFA7Bnkrp7FrBQDXHkZ3OEu8kXPPI1ThkmXQdpjN+6xk6wwSHtsZytcW9tkOwDyYb/HuNsl72TYNIJU4hKJSCQ2Ub5q3A1KOMuqGbGuB2zoAZvVHqfKXU6Xu74dAPlGNQigfMCaHp0IiltAxx5wV7FEp4KdSKKjjCoSPuNZeDhWichHSoiYstXWxDOncMstXE87qzBVhCtVy2Ec1nEKawXGBRgcOolcg65da174f1+tXelPUpgpwmeUAI5pYpScwEc3KeW/H4TCqlmRYB0KBtfLmnG9XEis8LURrJBz4/l5auGyw6atuP2Z8692xbYkwngHOcFJjvERLhgUfr4Svq2EQQnto2DwtTRiVZGokpiKmIKEipiyNS6IqUgoiclJGJA106Ufu5KOLomMI9IOZRyRBqVBNmOBTAQiFQgtEVrib52QOBfeC3ig6tuteVZQlYqt/DS7VY/dqsee6bFnewzoUIoIoyQoR8eWrOsRp8o9NsoR68WIfjGhV+ZkRUlSVAHGOyj975MpFKZQcCCNxpBgSMjpMwBAJYaoYwOEN0SZRQUYbzuSqhNRdSKKTkKuMnKR+oFWO0x7KD+D8YIayEfkc1B+BtwPOuYTin2ueicERiqmUjGNjy5efZSEs6H4cCg0bHQo9lo10D0JhWCTUOi1bysSU5CYisga4hA3FJ8wrgv8jWUG2YLsM+De3NfmWn91uPY9b8xPO1rLBLZxk88eF8cZVZXPuvbEDOnX3YOzZQvm4Zq+pHqZwvH//I9++KbP/VKvXgkhThS98nIryzL+wl/4C/yFv/AX+IVf+AX+6l/9q/ztv/23FwL1G1HcisSrXeH13dd/62/9LX7v936Pv/f3/h6ve93r6HQ6/OAP/uCxpjopZfM3Tq1Fd7T3evPdpqPRiG/5lm/hn/yTf3Jg3TNnzix8rn/1r/4V//f//X/zz/7ZPwNonvf06dP83M/9HP/lf/lfHrmvt0NLoL7UUksttdShqqqK4XBInucv9668JCrLkieeeIKvfvWrPP/8DE4ppbj33nt5wxvewB133HFL8PbVLGftDKBPJicG6NbaOfe50frEAF0AsVTEauY+V7dw/uuioXX2eR4At3Z6HzzXGOtwRoI1OAqsy3Eix1GCKJHGoqxFVgZpnAfnpr79GLDOb7s5Eo6E543bXEVooQL48zEtDhcC2u38Ro48jd6B2Tgx92WXC1RIOY+QQiLmwkcO2cH6CevnbfLN81lUSw3Oj4j3cZFqgDltcL7QbS4QVQdbJWidQJWiyj5ZsUaqF/sYAYzQ7GVb7HauMkl3qNIhLp6AKpF0odyg0H123DqD6jSjImZqUirdRZs+kojXRwUPZrvcm+1xR2fAqewq3WwXm22js22qdAcXFWjg8lHnDg/K9TRCTyLsJENMu0STHumoSzpI6O5IsmslYnsK0z1cvgf2CnDl0Jdj/8s/SVJGWY+9rMdOusL1ZJWtZI2r3Q2urm+yvbbhXeT9HjqLIZG4VOESCUkYLygCfNjz1+qbEZt6l9PVLpvVLqfLPTYLD8Y39IBT1e4cIF/ToyPjU6zAw+9YUkYRVRJzRa4G8J1SimTOcToVKTkpUzIKYp8l7gSmic2IsLl38robvLvCn2c7B8IDFg+ObDf7PnMgMP6zLCMPrUORRh35sZERWimf/awUWsZUUlHJuDUdoUNhRy0jqgaAz0NxK1/5IOAwRVZ7Z7izTUa4dLbJFfdDaGMQ7mBQgzef75vXWrZoPvuWO+G/HZsOA1odA7Q6CvD1JZp5CIxQHoi21quLqO5XJRNeESF5AkRsieOqgewZOf7TlBNwMilFGM9Pd8yUrpnSMzl9PaGvp76WQDlhtZrSq3ISbYkrR1zNxofVOR67lC27xpVyg8vVBs+ac2zZdbbcGltinWtyjetqlV3Zo6cLNosBdxTXuFBc50yxy+lij41iyEo+oV9MPYjPKwRgSoUpT/IZcaTpiF428OC948F71PEQvobxUcdgY0EhU6YiIRfeAZ/X3z/Cg/gizC8IzniRUogOFVGAVrOokjojft4V76F7qWLyaD62ppQxhYp89ryMKFQcahRI77CPbr3QK3jXfGw1sfGA3ef6mwa4x03Wv/HTRh9YJ7Kzz3difR0B6fzfTVGrPe9zP1r97hqjyY1l+x97rA7+3IPnbus2l1rqxdRDDz3EJz7xiYXLHnjgAX7jN36DoiiazPU//uM/vuHn+KM/+iPe9a538QM/8AOAB951UdFaSZJgzPzf+mfOnOHy5cs45xpI3y5Qepi++Zu/mf/5f/6fOXv2LKurqyfax//lf/lfmE6nzfQf//Ef8+53v5tPf/rT3H///Sfaxq1qCdSXWmqppZY6oK8nkG6t5fnnn+crX/kKTzzxxNwfBnfccQevf/3ruffeew8thvJalrMWF+Jb7GSCK04W9WOtadznuipvqICoEpJISZ99LgQTBKtKHpLPfcz+h+iWqZkN2kLlKkpKPzYVpdEehBuBcAbw96BbChwFzpVgNEo7pLYoY0G7xmluHVjrMI75y8JQrO7A+QGMVFS1g1RGIetceurqXE3kw/QRufPCr9fEtQiLdHV0SzuMQQV8HiOFRLIAMiwC5m014HyWb+6mOcIcAc6TeN5p3vHFQVmUiW0llB10FWOqFFn2SIs1OuUa0h0ORcbxLrudq4yybcpkjyqeUkaawiU4fZppscGevchoGDM1HXLXAwHdaMpmtsOpbJdvya5zKd3jbLbLWrZLlu0gsm2cmn/PW1h4W7/NY8pxTDES6EmMmcTIcZdolJGNUrJtQe+6pjcaEo13EHqCzxe+dvCc7ZvO05Rx1mHQ6bGX9j0oT1e5mqzxfO8UV9ZOs7uyxnClh8liD8hT5Z3kqcKlEm4wZiVyFZt6l1PVLqerHc6Uu5zJtzlb7nC62uF0tcvpcocz5Q6nql1Sdzgq1FL6AoPSw/BxvMJ2co7c9chtj9z1mbgeE9dn4vqMbZ8JKVorrDG4qMKpEqeqE7n8j1MNyK2boXIrFKVSFCKmUopSRVTCA25fENHnLdfFEX3mckQlPeiq21WAY0a+9JdYyhkyU5DaksyWpK0hc/umbUlmCmJXkThNbCtiF9ypzkdJxK4idobY7lvHeddr5PRsPavDsgphbXDiCw+x6+9F5+G1H0tMcDUbgmMeiZkbt5cHuE0LbrfA9qy9CHzLJlKmXt5A8Brl3ebs+W7nFIN8Z87134b0B+8IUFghDhnP3wmgZRTuUGp3skRNZ8vCOxKkohJRc5xOSEpSSlLGN3pwddGGQyScDfB9SocpHSZ0mNJ1E7p2Ss9O6JkJfT3x8U3V2Mc3FUNOl7u8vniWjWLERj4is7O/HawT7NDnqlvnitvgst7kst7kK/YSV9wGV9lgS65zXa3iEKyUYzZyv92Noh4POZ3vcbrYZaMYslaM6RU50rnG+V7sHV3EWEhHlBlUxxJlFSudgo0WcPcA3qIyw/7+LoNsQHwuUqak5GG6aIH5XKSUIiUPrvhcZJQksKCjxuHrVJQBtreLuRZzBV/rdvguDssKWX9/RVRSNe8RI/37K4+OL4J4y3Ju1olmWx1qtu5Uc838RCqMqZoONhEe3wRYuZYTPfxNI2C+Q86154F0DvXkZd53z43nQC+11Iup69ev80M/9EO8+93v5k1vehMrKyv823/7b/nIRz7C93//9y98zA//8A/zcz/3c/zYj/0YP/MzP8PTTz/N3/t7fw/ghq6lXv/61/Nbv/VbvP3tb0cIwS/8wi807vVa99xzD3/4h3/IO9/5TtI05fTp07ztbW9ja2uLj3zkI/zgD/4g/9v/9r/xO7/zO8dC8r/0l/4Sv/zLv8z3f//386EPfYi77rqLp556it/6rd/i/e9/P3fdddeBx+yH5teu+b+pH3zwQdbX1098rLeiVw1Q//CHP8wnP/lJPvvZz5IkCbu7uwfWefrpp3nve9/Lv/7X/5p+v8+P/MiP8Eu/9EtEiwpSLbXUUkstdUBaa4bD4Vxv72tV29vbfOUrX+Gxxx5jMpkVzlpbW+MNb3gDr3vd6w7kuL3WVRcRtdMpdprjivxEOZgzgF6iyxJjjy88WiuWiii4z+N9uefOuSZn/CTS1pFbmGrvPPfZ58F57koKW1JqgzOeUQtnEFQIWSCch+dWF2C0L6wWXOeYAIGc83ES1rViW2rn+UF4bqEB5roN0EXIKna1nd2Cq2DRaaujWBqQaGc3RDsXcs5bT+xqeB4hQ+a5qOF5DcwbC/0hMqYFzXPc1Me2CH2wY6RJnAnA3AVg7jo+5xy1AORahcszKh1hywxV9UjzdbrlGodls1ey8IVAs2tM0gHTaMJUGYYyoixPUUxPMS7vYVB0qESCwLKWDjiVbXN67RqXOtuczna4o7PDmWyblWwbFR3dQVSfIVF0cdMeZpxSjCSTgWU8NOhRQjzMSHcVvZGmNx6xMRnSK3JiM0EczCSYP82xz/oddLrsdHvsZKtsZatcTTd4uneWp9fOcW1lE91NcAGOk0pEBqQKk0S4Ref3EMWu5Ey1zZlqm3PFNc4VO5wttmdwvNrhdADma3p0qGOwFDGFzMhFl6lb5UlxFxO7zlRvMNanmVSbjO0KU7pMZYpWDhuVAYqXuHY7rhbUWaw7G45XHbngc44j8pbb00cx+GKDRQOUYsoo8e0wrlS00FF8u5SZgswWdExOxxZ0Te4dvtY7fTumoGtzOiYP49a0yenYPDy+mAPi+9vRwi8QqFC+gKOIqAjjMGhqOBv59Ooj2pWImZLNz1f18rAd1G2H0y+VROv/49c7eg2FIKm/22+ykO3tlsNn2NcwXrdgfCUVpayhqh/K0EE0m67vqAh3T9XzRUIpYirpTQdOSHI65HTYbe9AKA9yI4pd6cG8y8lcTmbz8PnJ6eqcnp7Sq6ZcLEd8Y3GVFT2hX41RpcZUgqJSDGyXHbvCtunzJXMP1+wq18QaO2IFJ6SPnyonbOQeuG/mAzaK4dz0qal3wfd0gbOCahJRneArSsYtyN5yu8dZSdbJOV274RN77MfGQUiY95+3MnyWS+Jw505CQULZAPqMaT3QZSo7TMgwrY6Vhc9Rd8CoKNw5M4PtVfO3TNS8B7Rsrzd7P1UqQtedRbLdIeQ7yub2IXQeGRSoozs0XiztXN5eAvWlXnHq9/v8B//Bf8B/89/8Nzz++ONUVcXFixd5z3vew3/xX/wXCx+zurrKv/gX/4L3vve9PPLII7zxjW/k0Ucf5Yd/+IfnctWP03/9X//XvPvd7+ZP/+k/zenTp/nABz7AYDCYW+dDH/oQf+2v/TXuv/9+iqLAOceDDz7If/ff/Xf83b/7d/nFX/xF3vGOd/C3/tbf4h/9o3905PN1u13+8A//kA984AP8x//xf8xwOOTOO+/kz/25P3dix/rLIeH2B9y8QvW3//bfZn19nWeffZb/4X/4Hw4AdWMMjzzyCOfPn+eXf/mXeeGFF/grf+Wv8J73vIe/+3f/7omfZzAYsLa2xt7e3iv6hbsZWWu5evUqZ8+e/bqNK1hqqRdDr4XPljGG4XA4B5Zfi5pOpzz22GN85Stf4fr16838NE25//77ecMb3sCZM2duyg39apUtCh/jMpng8vxIzlprloFeUpUnd6D7wqHz8S1HnWvnHANjD3Wo19nneeNANzN47koqrTEteC4pEaLEiQJrctAVVBUYgzI+81xY0ZwD65xPWanHh8S2eHAetRznqsk7d8EF66E5wW2+7yQfgOZ+elYklIWuc8BDc+QMnjtFO5P5SBkbioPW4NzHtogFWYe1XJoEcD4b6KSH5pubKqGsIqg6RGWfLN+gW60duv08GrPTucIw3WaUjBmqij2rGFSrjMvzDN06TkiUMGxku5zKrnO6s8OpbJtTnW1OZTuc6lznVLaLksd37KiyT5RvovI17LhLOY7IhzAaaPb2pgwGBWkh6RcVvemUXlHQyyv6RUVW6YVwzUlF1e1RdLuMuhnbnS7XO322sjWupBs8s3KGp1fPsdNZo0pjRCaJuhaRCWwWUSUp5gagQs+MOa13OFNe53xxnfP5Nc6X25wrrnOuvM7Z0o/X9XDh/hokOT1y+kztChO7wURvMtGnmOhNpnaNiV1j4laYBEDuosIPqsSGsYsKbFT4IOYbiN0vZUQeJRQqCePYZxJHCdNQENAD8lnucA3N9W2GL6nxwLsXYi36ZuKHUAh1JUz3zJSemfrIizDtx5MG+HWsB+gnORUVHljXWe5VnekukgaElyKegfF9cFwHsFaD7xkwVy9qZ8FLpcPqOByce7I33ov9E9/NNpnk2y/uk7zC5J3SUQPmSxk6sWREqRQ6RDhVysPW2ildqIRCJOQy5JbToRA3nyW+X6ktyFxOagqyUDQ1MZqo1KjCIAoDhcEVDluBriRFpZhWMSObUTC7OzE2FRv5kM0A3DeLwRx4PzPZZbMYsFpOUMcUfp6TcKg4xMzU8L1jiDveCR93bBNFI6PbdZdOnVdeZ53P3+3h7+DYf6dI5AuUMuuMMyI6cBdIcydIK928ft7GAY/04F3UsVbhbyjhY6/K5s6LAPTDNHGG0a3O8P2fZdH686dZFqpVtA0bzZ9zvnHp1Cne+x/9zVs+t680vZbZ1o0qz3OeeOIJ7r333hsCy68F/ZN/8k/40R/9Ufb29uh0Oi/37rzidSPvlVeNdbsOlP/4xz++cPnv/u7v8sUvfpHf//3f59y5czzyyCP84i/+Ih/4wAf44Ac/+HV5q/5SSy211HEyxjAajZhMJgcKiLxW5Jzj6tWrfOELX+BrX/tac7ualJJLly7xhje8gYsXL6JuwOn5apatqiYH3U2nuBM6wLWu0GVJVZXo6mRFRCMpiYIDPVbqlrLPrXMtcA4TbZk6D89LSgpTYgze5W0twlVIURGJElyOq0pcVeF05WNbajbdxLY47++0dgE8n12EaREuApOZM8uE43KuBucOrAFb0VzaNYG+Nmy6ff5m8Hyh6zxIopBOIYVvCzfLYm32ddHr4hwU3mXupjlMPEAX+yJ82telTVRLA82D63zB58QZhc4Tqir24LxYoVts0qkOv8NjEg/Y7VxlkOwyUFN2sFx1HbbMBYw5hzJnOOV2OJNc41y2zUOdr3Eq+7ec7mxzKttmPdtDHhf/YSVRsUE8PU2cnyKenkZO1ilGEZOBY7BXMMh32SuvUZV79IoRvaKil1ecKkouFRW9okK1vhudkJjuCuX6Jjv9LoNexpV+lxe6azyXbfLU6gUudzcZJR1MRyC7IDsCm3pQnkfdhXEgi7owembM+WqLc6WH5Bfya5wvr3O23OZceZ1zhW/37OI7igrXYWzXmZhNrpi7ecJsMrYbTOwGY7PhXeV2nULEWFUFSF7iVOEd5VkR2gVOPQPSHMortZDkUcI06s0B8Xw/JA/TuYp93q+KbwvwTUwZYiQ82F7RI9bMmDU9ZE0P2dADVvWYFT1m1YxY1eOw3riB4V2TH5nr3laFogjO3NqhWwQgfk1sUEa+Xc0B8npeKILKbPqVDL1du58P0ZpuQbIZnfJRL+3v0LANsW/64HdXKzLL0br9Zd+6B3bwmP0/evHc5kV77X1PKRZ93+x/XD1tDKWO/Hyx7/GhUGKbNc6vd+xuviIlgMT6GKBblQVMBCZx6EigY+FrKkSqiTDJVUIhE3KZMpUZE3ph6DKhSyE8NCqkT4dflHJ2rJwjLXOSSUE8LVG5oMjXeKFY4bnCYSqBLiWllsy/nx0r1WQOvm8E5/vp6S5np7ts5gNWizFdU4ITTd57OTh0b7yEQ0QgEodMbVNoNepY4q4H8UlHE3c1KrFIsZA5N4hbLbqzZf9b/bV5eTCv3XuB1x5QX+rrU7/+67/Offfdx5133snnPvc5PvCBD/Cf/Cf/yRKmvwh61QD14/S//+//O2984xs5d25WUOK7v/u7ee9738sXvvAF3vzmNy98XFEUFEXRTNe3MVhrD2QEvdplrfW3q7/GjmuppV5uvRo/W9ba1zxI11rz+OOP88UvfrHJVANf+fuBBx7gvvvum+t1fq2eB+ccbppjpxPseHziQqLGaO9CLwu01thj3FYCQSQlsZRNhIvcRwZu5Bxr65hox66xbFnLxJgAzysKW6KNASPBGITTCCoiWSFdjtMVriy9+1wbhHWzAnQhntwAroluCZeXLXhuYXbbcqyaW5kbbtTAcxuKb4aL0pBp7m9tX3S8bl9kS/1sc6sE57lo3OeidQl85MVtyDl3Tdb51Me12LmAmtlTxdECcJ5BtCiqRaKLmEJHuLJDXKzSzU/RrQ53PY2SHXazLfbiATuy4opUXBGrTKpNenKVMx3NmW7OXZ1d3tx5jDPdT3Emu8ZmZ/d4YG6iBpTX4yg/RZyfJpqcIh879opt9sot9sotdsstzORP6OcFvaKin5fcXXi3eaKN53dpH91dpVw5w/RCh+1eylY/49len2d6p3m6f5ZRL0F3FWUnwmQxVZqSx13GagUrTkZtNvQu56otLhTXuDO/yp3Tq1wornFHscWFYosL5RZ9sxiUT+wqE7PJ2J7lafNAgOSbAZJvMLabTMw6mqhxktt9YxfldPrbjKqvgJx//xlEgOMp0yglj3qztqrnJ+Rh3jRKqG7RKR6bkhUzYaUasaZHAYIP2ax2OaX32NBDVrQH4StmzGrdDtOJO9n3WklEITyIK0RMIRL2xApb0SZFvB+OJ/vGs+X2JQTgbYDdgGgHrg2xm/a+dervNSdm4Hvh/PCY5vkW2jyXOqEKDHCzDsg2eKfpjPW1LOu2B/D1vNl0a9xab+EyWttoPe2N6MV6Z0j8jS6xbu9c3dFcAfu/Gx1KVqioJFYFUVQgVIWOBWUkKWNFFfm88FzFFDJlIjx8H9NnQo9xAPJjeozpU4oUhKBIOxRpBzaO2GHroLSI3DveRW7YKVbYy0/xdK6DC94tLIcSWc16MZpzum/mA85Odjg73eHUdMBaOaZXTYmc9Z/ZClwlsGPJUd984SOOVRITSWwqsJnEdgR0JfRA9kD0HarriGJHJDQxhhhN5AyxM96P7gwRhsgZVKg+8ErUrP9PNOPZO17M3f9Ha7oTd3Cvouu4k+rVdG261O3T5cuXefTRR7l8+TIXLlzgh37oh/jwhz/8cu/Wa1KvGaB++fLlOZgONNOXL18+9HG/9Eu/1Ljf29ra2nrNFeOz1rK3t4dz7lUbS7HUUq9EvZo+W9ZaiqJ4TWekD4dDHn/8cZ588knK0jtwazf66173OjY3N4GDHaqvJTljcEWBLUtcfsIcdGcxWmOMxmi94I9wcWBKSYmSkkhKpBQIBBr8BZ6tL4BPJuMcpYXCwlgbcqepnMYJS2kqfyFqQWBQThMLgxAlQhmoNM4YD7adw7lQNS2MrAt+eutCoTxQrd0zCLRU2JBvbqQvalcrchARIlsaN5dtnZLDjrN16ebqSzd74CE+WlYFfF6D86NRhe8omWLHY+x4hB2NseOxd6IverSUiF4P0e8he33f7vUQyQIQ6qAsBePCofMYkXfJphv08g3kISG4w2Sbnewa2/GYLWXZEjF7pPQiyZlsyJnuNhc713lz5xpnOtc527lGFh/9+bNG4fI1kulZupPzpPnZFjw/hSpXEUhyM2Gv3OJ6gOaD8jGq4Qt08jH9vAbnJQ8Vlqi7gemtU66skp/rMV7tcmU15dl+jyfXVrjeSxgnikkaMU0TpklGHvcYqlUmsn/k/gJIZzittzlfw/LpVe4KsPxCucWF4irni+sLi3hqFzM2pxjZUzxn7mFkTjGypxmbU4ztBmOzydSuY4lw0kBcQly1xnX7OsQvQKQRwrvHxyphEiWMVcI46jNWCWXaY8DrmaqYiUqYqJhpiFK5GUlnfJFB7YH3uh6yXg3Y1ANOlTts6r0GlK9V3jm+HhzkHXt8wWOLoBQphUwppR/vRWe4mlyklOm+Zdn8tPDjk3Z4HCYFHObvci500LXqCjvnfIz2vunZ8lbH3iHrvBK5laghLfVYzMHZuYiuxiEr9k37Dc19V7WnBeBEy7F9QnwrFjYPlZv/72DsmWP+jizXfknc/HTNwqX0BXXDBuvN153KLsxY3MfcdvszfyfAiyQhQEiBEP58S+nHQgjquGtZL5curOuXS+l83FgwafvXfr/Tf/78vZhyzvelUwH5YTVULUoWKLWLUi+gVE6kpig1DeMcqypKJciVYiozxvRb0L3fgPcJPcaixzjtMUnDPHHIb4W2AbhbCOBdF4YrRZ+r+RlEEeYv7It3dHXRFFldK0ZsFAPO5HucLkLOe3C998opifWdxMKB1JZIW8jhmNIeWCAXgqlKMZHERBE6jdFpTJkllN2MopdR9jN0P0Z0JMQCkYCMBVJaElcRu9LD9zBETvs2ejbNvmVhuX+c9kNrncPqRLQ1u/Fj7taaY6WLCdeuXj3Ruq8mDYfDl3sXlnoZ9P73v5/3v//9L/dufF3oZQXqP/MzP8N/9V/9V0eu8yd/8id8wzd8w4u2Dz/7sz/LT/3UTzXTg8GAixcvcubMmddczpS1FiEEZ86cecVDv6WWejXp1fDZcs4xmUwYjUYkSfKai8Gy1vLMM8/wxS9+kWeffbaZv7KywoMPPsgDDzzwms/Ls2WJG48xk+l8MdFoMRxzzmF0RRViXKzx2d6Kw++MjkP+eXyC/PPjpK3PPx9py66pGJsQ3WJLjAkWcqtJowhdDZEuR5kKYTSu1Liq8neHWDu7bAoN6/zgAkD3C8FaWsXUZsWzEGEh1Szz3Cej+w2JunPh8AuzGpbPnOf2IGXBgyfvPVeNB/1YeK617xiZeMe5mHj3uTjE8e+SBNfNcN2OH3c6kCUHswSqMTqX5FphqwxZ9snydVby06Q2IV2w7Twas51tcS0ZsRVpBpFGpBUbacWZzjZ3da/xSADmG9nusVnFw0pSlH2i6RlWhnewMbzE2vRukulZVLk2FxNhrGZQXeN6ucVe+RSD4irl8DmS8Q79oqKfV1wkoxOvYXtrTFfuZHShy95qzJObjidPRVzvdxhmHcZph3HSYxT1GUar7IkN70g8Rl074UJ5hTuKq1ycXuHu6WUuTS9zZ3GFu/IrnC23F170axd7QG5O86R9gJE5HYD5qaadu1VA4ITGxjkuyr2jvJM3sSsu/ipGFRSJZBJlTOKUSZQxjVImccYkWgnjMD9OKW8CkAtnWdFj1isPxU9Ve5yufMHSM9UOm9Uem9Uep6o9NrRvr+rxsa5FB+T4onm5SJnKlB21yjTy8DsXPsIhFymFTJiG9ep4lRsKv3b47xFj8Y7Wgx3J8+7v4O4ObfZP28XL6/ZL4+R28xEhws2gdhsk185kZvCb9h420wdyTfx5CxsTrl5XzK2ycL+OnL5JiVvb0okfKw5pHzLruFe631tlND4uu8NrMcCftZtRm0m7+fEMvh8zf9922ttz5vb13hzocGm55AWAnHfMi/0O+n3u/HZ9kf3xOo17fT+4b+/PkXubhWH9kOUOKTWJKuhGBXG0S6SuEEXeCR9HOVFwxUdRQaQqrJNN9Ewbwk9Uj3HXD21X/IgVxq6OrOlQVVHjdBeFd75TGIZFxqhY4bnCeEf8EUeVmCpA9yHrxYj1asSpasBmMWAz9zE069Mhq/mYbpm3QDT+bwttUNoAFYxObsKxgI28I15HCh37YZpEVElEmUaUaUaVxmFZ1BpUeMz8PCfrwuqO9c4mw+l2qCvjmv2t/eezAXC2td7B5cL5v9kSBz/6zp/i7NmzJz7OV4te69c+Sy31cutlBeo//dM/zbve9a4j17nvvvtOtK3z58/zf/6f/+fcvCtXrjTLDlOapqTpwQsoKeUrFozdiryT4LV5bEst9XLqlfzZyvOcwWCA1v7G0NdSwc3pdMqXv/xl/uRP/mTOhXHx4kW+8Ru/kYsXL76mjretxqE8mfiCoq0oF9Fcjc7LGO1z0ANE35+Dvv8hHqD7ITqkMOhJpa1jYmCoNbu6ZGhKSgpKW+GMAOMQViNcRexypC2QWhNFfdTgGtYanHFYXLPfLsAC6xzOtgqHOrBOBHDui59VMmqyztvnEKG9pRTL4oKhB49FBFLXXKi5xcBdBGwu6qKhx8Bzh7fWufEUJn4Qkyni0OKX0ke1dDNow/MFcS3WQq4lVZkiyh5pvk4/P82K7i3cFy1KtjvXuJ4M2E1H2N4AlU1ZTXPOdnd4c3eLc92rrKajQ48H/B0H17VgWytsvkZvdAfnti9ybu9eTuWvoyMW30c/0UN2y6+xW15hkF+lGj6HGFxmRcOK6HI+WuXO7hrTlfsZ3hkzPF3ylbOa51citrMug6THIFlhEK2xoza5xmmqEwDzU/o6F8ot7sivcml6mXsmL3CpuMyduQfmq2Z04LWwTjKypxiaszxmvrEB5+M5WL6Cf+fYEL2S4+IAyqMcGz9BmVQMO4JRGjNOMsZRh3GcMYlX5uF5nN5w5EhkNRvVHqdKD8bPltucra5zptxhQw84Ve02kHyz2mNNj46E4xZBLjzwnoiUq2Kdp6LzDQDPW3B8GqaL4BQX8vZ9Jzdg0daAuwW7rQiu4DYQb8Pwmtbe7t+IFhhstwM4BGbtNvQOk2Jm+0bUyFuI5u4a/x1Xb+hF+JvjGLi81O3VgZ/VxT/ft1VtiN++C2IO1Ldg/H6Av3/5wu27RYtO9uaaAfjZdHveYfPDs7c272adTm3o3gb2IuyoaMF6Zo9FCIyNMTamrI6/S0kIQ6RKoigPgL1gIyo4E10jUs818zyML+ay9WuVScwk6TFZ6THeH0vjeozcCkPTZ1iuMix6TIsOeZlQlBGmlJgS8iKmKFKulhuLHe8tSWfpl1NWy7rOxJRVM2FVT1irJqyWY1aLMWvTIWvTEWvTEf18MWT3cT3eEZ8eEUhjASckTswgvgfjB2WkaAC9SxJK6bCRwEQKqyRWCqxSWCkwSmKVCPMVptX285VfR/r5RkqIIvLnSroXXnnXcLeqV+J16VJLvZb0sgL1M2fOcObMmduyrbe85S18+MMf5urVq03v4u/93u+xurrKQw89dFueY6mlllrq1aSqqhgMBq+5WBPnHFtbW02RUWO8GzRNUx544AEeeuih19wdRrWcMT7iYzLxBUXt8W4yXZWUZUlVFhhzdM5wJGUD0GOlbhmgj7VjV1fs6ZKRLShdSWV99rkwGpxG2hJlp0hTIiuD1AanNTbUJTC9mKrycRDOeXhuAYyj9mcZJ6hE3GSeL4TnOEDTZMdQZyocdyQWQXA5OTO7MD8ggSJqMs+PgudN3HFeNOCccYDnxix8lEuTBpjX7nPSBa5zoDR413mZoULO+er0NGsL7j2wWPay6+x2t6hWruB6e8SdESvZhPPdbR7uXGUtO/qW4aGBLS3Z0oLrlcJO+txx7SJ3X72HC6O7uUeep5ecQcl9Tmnho4aG1Ta75RV2iysUo+dxo6t0DPSiVfrdDTqbEaO7z7N7bp3H1gRbWcJO2mc3XmM3WmNbnGKLc4zE4UVQoY5juT6D5dPnuW/6HHcFd/mFYmthFItxiqE5w8Dcx3PmbGj78dCcZWw3w70dYFUZnOU5Li0wUU6ePsuwC6OOZJwpRnHGOO4wjlcYx2eYxB6c36iTvK/HbJYehp8tr3OuvM7Z6jqny13OVNtz4xUzPhRfaSRTkTbDFbHBE/H5MJ2RB2g+FVmzTiFS5qrdBbIlEIveko0OW+SjT1pQfF+7Dcn3u8dvD37cD773TUOAazXAc/PHI30hTtdA8AC9a9rn5EE3+I3v3lJL3RbN381w69tb5IhvIovq5fumj4LyhwP5YyRoYmug1W6D+LrNrH3CowwbnYF50Z7HDNKbKqNgdfZd0t5G07HmD1LJKsD3kkgFx3uA7t2oYDW6TqyeJ4oKlNKBPuPJdQws6BO3CHIypnQZuy5X87Ns5WfZzk+xW6wxKPqMyy7TMqUoY6pKMYy6DNLFHeyLJK1hpZqwYqas2omH8HrCajX2ED5Ez/TLKf18Qj+f0Cum9KcT/3jwZoYTvMjKOlRpSEoDk7I5ZC0lVRSHIQqDpFIKF0UYpdAqjKXCKF9E3kqJkbO2FZL/8aP/I3/tT/2pEx//UksttRS8ijLUn376aba3t3n66acxxvDZz34WgNe97nX0+32+67u+i4ceeoj/7D/7z/jIRz7C5cuX+fmf/3n++l//6wsd6EsttdRSr1UZYxgOh0wmk5d7V26rtNY89thjB4qMnjlzhoceeoj777+fKHrV/KydWLYssaMRdjr1APa49a2lqkp0WVCV5ZHFRCPpi4fWAH1/EdEbkbaOoTbs6LIF0CusdWAEwnj3eWQKlJkibYUsDMI4sBoTALquHejNhbajMoRoF4FBUInoCHjuQDqc1YBpuc+Pu2oLF8fNLcJmn1utLdHEtdQOdLHAKerCFbtz1hcKrV3n4yliOkUu6BBxQvjCoN0OrtdpYltQC2C4c+TGUZQxBNf5yvQMp6q1hXudxwMmm19Frz2P7G+TdYesdgY82LnOenZ0PMGoBc23tORaCdF2hzuePcWDO3fzQHkX3xadp5udJ0s3EbWDujvbRmVL9sqr7BZXmEyvYKbbiCon6ySIUzHR/ZbhuYrLq6fYyjpcj9e5rja5Ks6xxVl22MQd48xe0UPOF1e5K7/CPdPneWD8FPflz3F3/jx3FFeJF1SF0y5mYM5y2XxTA8mHLXA+sevUTmAPzKfYOKfo5Qx7Ywa9MYOuZJgp7yyPM0bxacYBnBt58tzujsk5Xe5wtrweipNe42zpneRnqh1OlzucKXc4Ve0uhP/gC29ORMpYZExExhPiPJMkYyJSJiJr5ovuea7lORo1I0216izrZnYA5qF9mMm8BuOu7Qa3R4DxenzLuHgGwoVsR0k4mIPj4fCaw3TN8TWFOuuDdoCbdYzVmdGtkzTba7dvvH/+K0Ut93vrxd23/JCHEc5Sy1DbRCvMwrVmY+dm76OwztxTNNtZcKeUm193/241j5j7Xncz4/6B12P/gv1Twj/W1UfiWpsIv0cCmiKuon3E4ddDzNr12+qV9vK/WBKtF+pmPslzQH6/M34RpN+33mxDJ+wnX7T/i6D73PTsbhHRvNb7juMGnxccGiiaTrqWm779eWk6+jRRXBCrnCgughO+2Bc5UxBFJYkq6KjrnBLXudR55vDiDy0VJmZY9hmWK+zma+zl6+wU6+yWG+yWqwyrPuOqy6TKmOqEPbnCHkd3ZO+XdJaOK+m5nJ7L6dqSnsnpmZy+zulVU3qVB/G9MqdfTOgVE/pTP/SmE1R4w0TWEpUFnfLWjUNbG5u3vI2lllrq60+vGvLw6KOP8mu/9mvN9Jvf/GYA/vW//te87W1vQynFv/yX/5L3vve9vOUtb6HX6/EjP/IjfOhDH3q5dnmppZZa6iWVtZbxeMxoNGoKX70WNBgM+OIXv8iXv/zlxm2vlOL+++/noYceek1mHto890700Rinj3aVg49yqUKUi14Q5VJLCkESRbcFoFvnAfr1qmBHF4xMQYUO8S3Wx7eYisRMkSZHaoOsTAg3d74IqjOhYOgMoHtnul/NIIicYkBGFXuIPgfPw0WmQ4PVEIA4+rD3fwufuDrv3DvQD3eee2zmE89VUzx03wozoGIMdhqgeR3ZMs0X3nLtpJxlnQd4TieDBbfols4w1RJTpqhpj6w4zVp+jjW7ILYunlCe+jLVxpOolS2y3g5r3V1Od7ZR8vAOlrGBay1ovqUFw7Ggcznm7ssZ92+v8m3FRdaiO0m7d9Dp30mWbsCCG0J8ZMtVxvlVymIHLfZw/RFcsIwvGa6uxmylPa7Fd3BVnOMK57nCBQZicWdArcQWnC6ucyG/xt3T53nd9Bm+Yfok9+bPczF/gb45eBu6dYKRPcUV/RB75hwDcz4MHp5P7Ro1BqqBeZ4VDPqWvV7BoHuVYVcxTGNGacYw3mCUdMijkxs2+nrM2XKbc8U17ii3gqN8m3PF9cZdfr68tnD/PSCfgfAtscpT8dkDgLye1qL9530baLaBuaQfbWDk9hxU9rBoBpAbQO4EGImtYbjdD8tlK0v8ZhWgkXQzGN5uB+i02F3rXeHtffD9VbKJSmlMoTUg33d+xL6ztYg3v+QSNEQvpE/42c4198C0ix4LaA2utdyfBWFdOCMuuN5dc15kA/Dml92+U3DU3yWv4r9Z5jJT/KCSmPV8QA3mfeeSB/4uzHV1sVHhIb0Tdbpz6FhdMM//zogQlyGaeba17NV4Jm8FyC9ywbdB/ML5bsE2bhDEL4yhOazdPsb5rYQdoPneOhrSp5iqx/H4OByMsB6wxwWRyonjgijOvSO+jp2JPYRXqkSpktOdHU53duDon2Kcg4nuMCxXGJR9BuWKbxcr7BWr7BVrjKsuY91lWnWY6A6FTbBCMhYZY24821sJS6wsKQVdW9KxBR1X0jUlmS3o2JLMlKSmJDOVb+uSxFSkpiLVFUlVkoRxWlYkVUVSVojzF254f5ZaaqmlXjVA/eMf/zgf//jHj1zn7rvv5n/9X//Xl2aHllpqqaVeQZpMJgyHwyb+5NUu5xzPPPMMX/jCF3jmmWea+SsrKzz00EOvySKjtigCRB/N5aEvUl1QtCxLqiLH2MNf91gpkiYH/eRO2UUaa+0BuinYrdoA3SCsJqpypJmiTImoDMJYn64CWAzaOpyz2DCziXCxYBzedS4iShVTKu88X407DNMKZI0hKnAmPNhy+FVwa6azAShZ5DHwnAaeL45u8QwxADtjguN80gB08mLhH1dOqZnjvIbnWXrgKtvhyG1FNQU37SL0Jv3yLBvFaU7NgXxL1N0hWv0S+tTjiJUXyFaus9rdZiUdH3JsPtP8ipZsVaIB59dLAdcFp69K7r0Wc+ma4luGa6xGdxKt3EW0dolu/06yOxZfYQ+rbfaKq0z1NYroGtONy4zun7J7LuZ6d4Ur8ixX+IYGmh8XzdKvRpzNt7hzcpXXT57mG6df4xvyJ7mUv8DpamchcKlcwkCf56o5z8CcY8+cZ6DPs2fOMTRnsfg4FScrpp2c3XXDoG8ZdC2D7oBhFjHMYkZJh2G8SRmdrHBzZgouFFvcWfjImPPlNc6V25wtrof2dc6U23TtPAKpUIxFl7HoMBIdBqLLC/IBRtHMWT6SHcYioxJHR8HMI+Gaje/D6LXp2glAgpNUlcCadM497qyAAMedvVmcWrspa7f4rN1AcmjGjuD8dvV4X855874XDRRz9fNQo/SZt7N2kqsaZL0oVLwG94dYVREIKTz4DrnA9TeJxCGc8MBa+K82GYC3BH+u6sc414Lnxx3H/uUvd2/A7VYLXDfTx627aJ1DtiHa65/0eZjRU2YjpAQlm1nHvhL7bdcNJW7tgnOcJKqs9jm70NE7D9sFtukAruF8GDdtn2ttkf6xr3BIfzSwPlwL42eOa+97/A15V2rA3m4fAeJv5pjmnwxAoU0XbbrHPaAli1JVcLt7yO7jZnwkjYrKMN874deigs3ekGjtSeQRHfYA2ioP2cMw0XW7Nzd/NvTCeh0cEuMkRktyIvbq4BfBTREtgSMWhlhoEul45P5LfOeNb2appZb6OterBqgvtdRSSy11UEVRMBgMqKrFt/6/2mSt5bHHHuNzn/scOzs7zfy6yOhdd931miqw08S5nACiN1EuRUFVHR7lIoUgURFxdOsu9NxotnXBdnChF077BBXjEKYiKqcoPcs/9+5z/1iHQTsXolrCvxZArxCUMqKScVM01AUHqgcbIapFVDgKD88XXsG2wXlACXWxUGxwXR4Fzw+PbvGQwbetszDJAzz3AF1N84WgxMXxQXiexAfhubPY0ZByKsntOsqeZqU8z9ny1GwPVUnSv0py5v9CrD+NWH+GtL/FSm+bWB3+nhlqxeUKLmvBVS24Ukl2J4KVK3DXNbjnWsSfuia5Yxu6po85fS9i4x7i1Yv0776TLD4IvZ1zDKtthvoqE3WZ7dMv8OxdA7bPJVxNLnCZO7jM67nCBSbi6CzWXjni9HSbOydXuH/yDA/nX+Xh/KvcM32OFbM4rmpiV7msH2BgzgdgHsC5OR9iWQQWx6hXsrum2V2x7PUEe92KQRf2spRhskFxQlje12PuKK5yR7Hl41eKLd8uw7i4ypqeFSk1yADJwyC7PMsFvhzdx1hkjGTKWHQYiIQKdQPFORe5zGdWTudAOIGjBuEKkCGHXLZguZxzkBcYTpQDQAuM145xaefiVeazguUM7R+A4wJqUG/BhcfMl/Vtl9+c7yRon7JjAXMDvMW+r4B2B4RYMD8chfPObxmAtnQOKWagW0IzX0gXwLhFImbg7Ia06HvqtQbFb0W31y9/QCeCo4sLUM+W1T+AEbh4ft0G2C+A9g1JvZEdrjdTd1zXHUz1U9UA/mQ51UfJH1kLvAs5g/PCd1PX8N024F6GdWcu+leSbgZan8T5fqgTfq4z8Ab2cRF4Z/H8Gz2exZIYk2JMegIn/P791UTRDLYrWaFUhVRV01ayIlaaU6ribLKD6lydWy6lPgDmrRNMdcYkON5znZLrjNykFCY9cjqvp01GrlMK4804DkHpIkoXMbbwpee+BHzbrZ68pZZ6WSSE4Ld/+7f5i3/xL77cu/J1pyVQX2qppZZ6FaqqKobDIXmev9y7cltUVRVf+tKX+PznP8947N21cRzz4IMPvuaKjNqqwg6H2PEYVx7dETKLcinQVcVhUS6xVMSRd6Lfigu9spodXXC9Ktg1BWOj/QWhcciqQumcqAwRLtV+p5zBBIDeIPQA0I2FQkQNOC+jkHs+B881jtp57jwEwIHtzOJcGs2uVGfw3AP0o7x0h0W3eO7mH1l7/V0d2xIAuprkPhN4n1wc4/odXK8bAHoX4vk/r4S1dPeGVOMBO/TJ5Wkid4a16jzrpc/tFLIiWblCev4xktU/RG08SbL6At3uzqEXyMYJdsuYq1rynDZc1oIrWjAYCc5sCe667ri4BW/bUly8BisjzWT9DNWZ+1Hrd5Pec5GVBy+QRf0D27bOMtLb7IoXeGrzOs+cH/H8abja2+QFcScv8B+yK47OHO0VIzanO1yYbPG6ydM8nH+Vb57+Cfflz9Gzi7+7JnaN5/U3sKfvYNfcwa6+gz1zgYE5R+U6WAF7XcvuagDmfdjrKfY6MMgSBunJMsvXqwF3FFdnkLwG5uWsXYN9i2Aken6QXUaix5Y4wxPRPYziPkM6jGSHKbF/34tQ+FYc7tY76CWed5k7B4gZFLcBhjtXR6vIfTErN0JRPABWSmGpEMJ6UF47yJu8XkLsS+0Bb4Fx64EaLRf73CdUuLl5c45yQfic+seKGpS7Gp4HL/d+CF7nZew7V3Pr7J9TA/FQG0G5usgwKOeP0Y8DEEcgsQHch2NrU/zDmHc9/xUGDZe63TqqQ7/9vRMB+yKhDv1pOsxN3wL07fF+MC8kC+pNH/JU4XEtAD/bhcPhu6xXan7zb/xuSP9LPw/la1d83Z5bFtY1Qr5iXPI30+9xKGw/YtmBx97QTh4N3W+tMOvRci6iqiKq6kYc8QclhAlwfQbhldJIVdLtxIhqRE8YD9+jAhEbpDRIYRBy1pbSIMK4biMs2kkKG1PaOAD4jE52Hvgrt+dELLXUbdTW1haPPvoon/zkJ7ly5QobGxs8/PDDPProo3zHd3wHAC+88AIbGxsv+b7dc889/ORP/iQ/+ZM/+ZI/dy2x4Avsf/qf/ife+c53viTPvwTqSy211FKvIhljGI1GDXR+tSvPc77whS/w7//9v2/y0TudDm984xt56KGHSJKTOUlf6XJVhR2NMOMxriiPXNcYTVUUFEWOMYsdyFIIH+US8tBv1oWunWFX5+xo70AfGu1TVAwIXRKVOUpPUVWO0LYOJW5kMVhrsc7OAfTKCfIQ3VKJiEpEOLnPeR7Kj86uJNuFQ1tjZ6EuJOlamcCY2UX+Iapd5zVEp74NvobnAYS5ovDgfDRB1kVD7UEY6pTC9bvedd7reniezOI4pDas7A3p7Q7YNpqryWny5BSpOIMrz7NSbnBeaJKVq6Srz5OufZpk9Xni9WdJe1tIufhYSh2xU6ZsacVz2vC0qbiiJdMR3HFdcNc1x13XJA9vwaVrko2hoVSS0co6+sz9qDP3EN93iaRzB+vRQee5dZbn1XW+srrLE5sTnjnleGEl43J0nit8K/qIyJG0zFmf7HLH+CpvmD7Fm6Zf5dum/57XFc/QsYvf66XtcNXc38DyXe3B+a65g5wew45ke8Wys2bYWYHdnmSvEzHoJIySrMkXPkzCWc6V17krv8JdxRXuyi+H9uVmXt9MsQjGohtgeZeR9ND8MXEfn03eyFj0GIoeU9FFAFbMitw6/AfFw3PwgOloyFRD8zkgjgzO8RYgtxLn5qOGjlcrTkXOO8h9mxCx4qjDRfqdDUbj6Wx/HB5a29kna4GXFl+3IMwXULt2BS3wHlzq9f9++Sy6Ze7YGlB+tERwgKsWIJ8NAZL7M9pylOOBY/OUwsdxzJ3a/R0StxaNdVvVytKe0S+/yM2Rvboo5my95maElnXVtaeDDnyeFny+Dq4z33DiwIKblmi3xPxLF/bGN2uePLstirmG23f/gWseMD8NzW+Lf6gLj60LsLaIZr1eM8/NnqeVISKURClxMCbkmCNuOmcW9JG1+20Wq/5trZ9rP5APg5jNm8fUan532neE1b/9NXRvnmZRR8BN6ASbqXPjjZANcJ8D8828mTPeBCf9iffhZdD+p90fRdP8abQPvB90wjdfDDdRmNUthu4cAuP3zQduCMofv6rE2RRjU/b/GWyqNcbTvZM/2ZFyCGHoZhF/6d3/r9u0zaWWur16xzveQVmW/Nqv/Rr33XcfV65c4Q/+4A+4fv16s8758+dfxj28dZVleUvX/B/72Mf4nu/5nmZ6fX39NuzVybQE6ksttdRSrwI55xiPxwyHw9dEwdHRaMTnP/95vvSlL6FD0c3V1VUefvhhXv/61xNFr/6fJ6c1djzGjEa4/OgbZ08C0SOpSG7RhW6cZWSnbFcF2wGg68CrH4/jXQABAABJREFURVURFROSKkfpPOSf73+veRe6DTEu1nmIPkWSy8Q70EWEkaIFzwE8WHW4sE07fzUYlu6nDyLkBytnkRiOukSs3ee1B10gm4xYAF1DprKcwfM6+3xB7QEnZQucB+d5mvirRuvoDUasPneVbGfAk1HClZWzVNkZOuJuTkXn6LtV7k23SNeeI119vIHnyeplpFwMXisdMyi6bJUxz2nHE6bkSaOxE8ed1ywXrxnuuuZ48zXBpWuOzaEHm3msGPZW0KfvpfyGe9hbucRa5w7ujucd5AZ4qgNf7A15bG3M02uW51dSnk83GYr7Dj+31tCbjDk93uaeyXN84/Rxvm367/n26RdYM6OFjzEu4rq+yJ6ZwfJdfYE9cwfbaoOdnmJn1bGzathZEez2FLvdmL0swx4T65TYkjuKqx6O7wPlF/PLXCi2UM4yFD2GcoWB6DEUfYayzxfFg3wm/VZGosdYdHFiBnlFcCw7NM7VcMrixDDAKY4kAc4JhPMwvIHk+6ftDDCfSHPu8Va7ng6gfObgDpTD1m52wEYB0M/jNZvEWL3vAka4fe7ymRtctmC5pO0kFwsdQieRdA5lTeMen40tynpQrsJ6UrbITRuS16TnxBE6N6AAsl078DjME+H7pR7vn9+0w3bqc+RkDYrD431wuueoYTsC5o5n0Ttm/9Ee6CNYsM6JDrl+nGiF6rTAmd+f2RO02a9oZ90I/Htj356IVv+JZEGnzX4+vnCZOxgz7ubX3z9/0fb3R5a3VX+c2odDa97cW74FGhEgRYJzXd/BZGd3UUEA+WL2xA3Utn6vm7iW1l1Y7R2dTS9o2xPSVBd+j+u2s61zFr733AzKu/Bb7YLPvO5LqPfb75r/XfdpdNbHtDXg/ehs7ZNI4o9fueM7L9tyEJzwM9BuhWyc7wafG2/EPIy3N/I9fQs68Dm+iQ+tCy/IHGyvS8wcNtj2s4ubc8P7Zz8A3ffD9zkgD/Prt5afSLf1a17gXIS1KUly+nZueKlXiZxz6OJGw41uXVGanujvpt3dXT796U/zqU99ire+9a2Arxv5bd82H0+0P/Ll3/ybf8NP/MRP8KUvfYlv+qZv4ud//uf5gR/4Af7dv/t3PPLII3zqU5/iz/yZP8Pv//7v84EPfIAvfvGLPPLII3zsYx/jgQceAODxxx/np37qp/jMZz7DeDzmwQcf5Jd+6Zf483/+zwPwtre9jaeeeor3ve99vO997wP8+fzgBz/IJz7xCT772c82+/crv/Ir/Mqv/ApPPvkkAO9617vY3d3lW7/1W/kH/+AfkKYpTzzxBM888ww//dM/ze/+7u8ipeQ7v/M7+dVf/VXuueeeI8/T+vr6y9ap8OonFksttdRSr3FNp1MGg8FrouDozs4On/vc5/jqV7/adAycPn2aRx55hHvuuedVn4/ujPEQfTjCHRPHcxxEF4gGoMdRdNMu9NwW7Jqc61XOri7Jjb/OlWWJyqekVY4yuYfKC655vQvdYZ1pIMZUSAoSplFMKdWcSxVmx+KoL6ht+wqORfAcaMW3mOZSVmIWwvS6aGjtQidcHENwniNw1sJkghxNkKMxYjhBlAdd004IXDdrXOeu14WOLxiaTAtWt/dYff4Zot0xT8UpT586x3TlLN3eGzitznBKKs6tPxvg+ZdI154nWXkBGS2O9DEmYpyvsFNmXCkVT2vDYzZny0y583rJ3VcLLl11vH0L7r7q2Bw1Z41xGjPodhidvcTkgXvorFxiPbuDe5PTyACHtYBnu5I/7km+3M95bLXkqZWI5zqrocDl4qKgUV6yOh5wx+QKr58+zSPTL/Md08/xYPEk6hAgMjbr7Oi72DF3saPvYlffyba5g+eyM+z0YrbXYWfVstMX7PYi9rox0/hoF0psKy7ml7k7f55L0xe4WFzmrvwyF/Mr3FlcYbPc9e5x2WcQQPlQ9LkiLvBV+XqG3T4T0Vl4hd7gbOcjWYQLUUMYrHCHgnMPG4Jz3Kq5sasd5TcUvRKc421HeXssHEh8NrqTAabVbRlcizfgvmydgcar6mpoJBpcjhNInwIe1hbHH1Jr+X4XuXIOadvTM2iunDsAqf1BixBOLkFEB56/XrWGmjXMFkLgpGigdNNW3jnvpC8UWkPwhY8R+GKiQjQZ9zVcfqVJtIcWyPanTzRtv65oAa5WwFD4on31/fIu/mzvB9tzb62mk2O+06CBeQL/QRf4nygh5oF7qz3nA2/9nNVM27qQsC/C58y5+XVY0JFwO7UQurfgvJ1f1oxtDebt3LpzsL517M3goAHxzXITdiF8r9b1VMJ2nPUnoo56851/84fR3tqi1kkk8LFOCnNDD/W7M4PsDYA/EFVzk47426ibcYmDf20WQfcj5zGbrj9JNw/j5/Zm1kHXAu71cTWfUVtQVq3POwuOv/0dsGC9pZaqpYuC//ZHfvAlf96/+Wv/jDjLjl2v3+/T7/f5xCc+wbd/+7eTpumxjxkMBrz97W/ne7/3e/nN3/xNnnrqqUMjWX7u536Ov//3/z5nzpzhx3/8x3n3u9/NH/3RHwHe/Pa93/u9fPjDHyZNU37913+dt7/97Xz5y1/m0qVL/NZv/RYPP/wwP/ZjP8Z73vOeGzp+gD/4gz9gdXWV3/u93wN8/Ot3f/d385a3vIVPf/rTRFHE3/k7f4fv+Z7v4fOf//yRDva//tf/On/1r/5V7rvvPn78x3+cH/3RH71po8eNagnUl1pqqaVeoSrLksFgQLkAAL7adOXKFT772c/y1FNPNfPuvPNOHn74Ye68886X7EfvxZCztiksavP8yCuKGqKXZYHWB2FrXVA0CQVFb+a8aGeYuJztasq2LhhpS2GA0hDlE5IyR+mJB+gL99VinG2y0I1zFEKSkzBV+wG6Yw6g1/mrLgDw+fuR5+Xq+BaLv1EbDu7Q7OrI+849RBdCUTs6bXO15HCVRozGiNHEj8cTxD6XvQPoZHOxLa6bIa1jZXfA6vaA1cefxQ4MT8UZj91xjtH6BTrnH+LMqXUuxPDNa8+RrT9Duv7HZOvPoNLFEUzGKvJ8lXG+wrUy4fkKnjAVT7kh8XTKpatT7t6CN191fP9Vx53XIbL1qwDDTsKgk7F93wXUqfvp9O9iI73A/clZIhlTCXi6K/m3fcnX+pLHeobHV+G5TopucsQ7+3eKbDzl9GSbS5PneXD6BH9q8gW+M/8sp+1g4XE4J9gz5+bA+Za5iyfSSzy/ssb2puD6mmOnL3yeeZYe6zI/XW5zd/4Cd0+f51L+Apea9vP0yylj0WNPrjCQKwzECkPZ5/Pijfx/47cwTbJjroy923zmyTY4Z3BYnDBobOPC9sALD6utmrm5D8Dyk0awOJDOF1UTDqkOQnPvTg1ovynQKXBO4azCmRuBMqIFNmaIq9V14KeECp+3WfBKJBJicfwFHbRBuQfhyoa2XQDJm+eU3kguAsxVofCvAkSMiJR3YYsadMsGZqPCtArLVXCkS+UPuXapvxiu9BdZs85C0UzIGnSL1jIRzh0cBMGvMS1yszY59uGlXgTBZx0GcFto2dwGOcHJPriCc1AYQarkkbvkQXML0oePzrzJfAbsG77drO/m1p1j0a2Tsx+B37JCgXCxD8p7CM9BGB+mhfFxMcKGXv3wd4LfJ+vPRxMpYxvH++wE1X9ziPCI9rmcHaDbP781wzZn9fgzIvARUsrdBIhvwXXTjqQR85nxL4cjvq25z90NapErfj+Ib083j2m/v1u/XfVvWQPsD1FVFNz8t2D4ddwH3vNxxT/9p/+UH/qhH7rJ7S611IujKIr4+Mc/znve8x7+4T/8h3zzN38zb33rW3nnO9/Jm970poWP+c3f/E2EEPzjf/yPybKMhx56iOeee24h9P7whz/cON9/5md+hu/7vu8jz3OyLOPhhx/m4Ycfbtb9xV/8RX77t3+bf/7P/zl/42/8DTY3N1FKsbKyclPu8F6vx0c/+tEGlP/Gb/wG1lo++tGPNte/H/vYx1hfX+dTn/oU3/Vd37VwOx/60If4s3/2z9Ltdvnd3/1dfuInfoLRaMTf/Jt/84b36Wa0BOpLLbXUUq8wGWMYDAZMp9OXe1duSc45nnnmGT73uc/xwgsvNPPvvfdeHn74Yc6ePfsy7t2ty+Y5djDwxUUPRKPMdCKIHkXeiX4TEN05x9QVjG3OdZ2zW1XkBirjUNMclU/pllOkLQ6969pivIPO+kiXUkZMRMxUKkoZBYBeX7LvB+jOXxi3r6AWSIRlPt/YHroeeLBU557HIiWTvQae2xqeOweT3DvPa4C+IJ/eKYnr93z2eb+H63bo1q7z567R394jzxVPJat8/uJpBqfuJTu9xh0u4WKi+fbVq2TrXyNdf4Z05QWEWhAP4wTTfJXpdI1RvsLVMuJZbXnKTRmyy9rOFndfdVy66vjmLbh01bHa+nhbYJQlvLCeMl7bRJy+n273IpvZHbwuuYCLM57qSR7vSZ4I8PxrPcEzPYU95P0itCUZTzk93ube8bO8afIV/vTk8/zp4vN0xeJOOuMidvUdDTi/Zu7i6fgSj3UvcmWzw/UV2FmF7b5ir5MemWWe2oJL08tcyp9vwPnd+fPcmV9hPR+iSRjIFfbECgPZZyBW+Lx8E38UvwWbnDzSSLgavDlwtuU2tx6ch+gC7+pWOBvhnAo55aqJYjkxLBdtJ7lFKg/LpbLBLe0Q1MVE/eABvcDZUNDzRM8VHl+38Y+d+9SE8+9BrG+r1rZP8l2yCJRHzhJhiYKzPHKWuAUiBHgAriQijkBFiCgCJRGRBOXbPtrEQ28XCKmrIfghdw8cNn1bQOBtUgPEW2BXtmF4/brsg+GvPhf4ydUGcw38rg++ddNBveBFgeGvMjXvDzjiK+HGzosNkL4G7bYB9fNg3u4D8+15xyp0lrrwNX3Tn83G/W5bLvhW25iwzCCsxVkD1oDRoA3K6ADeA/C2RxeC9lr8LdP+y2URnHcwd3L8+m043+pIJDji3Y3dVer/wtoH2Y9ww88VbX0VueL3q3HJc9CDMQfm8WOlErQuD75Oc5C+DeXbOyjml9WdUdbNXacs9fWjKE35m7/2z16W5z2p3vGOd/B93/d9fPrTn+Yzn/kMv/M7v8NHPvIRPvrRj/Kud73rwPpf/vKXedOb3kTWcsDvj4ip1YbyFy5cAODq1atcunSJ0WjEBz/4QT75yU/ywgsvoLVmOp3y9NNPn3jfj9Ib3/jGOdf55z73OR577DFWVubvos3znMcff/zQ7fzCL/xC037zm9/MeDzml3/5l5dAfamlllrq602vlZx0ay1f+9rX+OxnP8v29jYAUkre8IY38KY3veklLRRyu+WM8cVFBwNcuTjOA3ynSFUWlEV+JERPVUQc/f/Ze/MoS8o6T/953zfiLrlnVmbWvu9V1IrsOoCI2jBIK2A72HMGGbGX0zNt2w442qKDjc4g2nafo6fHxqPNoDP29KC/dmidRhRR1iqgqqgqoPa9Mqtyu/sSEe/7+yMi7pJ5MyuzKKgsjIeT3P3euEvd5YlPfL5T70N3jEteF0l7fgo95xoKGkzRxSoUsEo5Ym7JT4I1vidoo9Haw8NQEoqCVBRVjKK0gvRu+OfVXqqSTqt0pI5Dtb5lagJdCJuwesHgCzhXAI4bdJ+HAj3feHBoMo5paUa3NGGammguO3QMpug4epqWgb1kynH2t8zi1/PaGZk3j+SSJhbZLvNjDte0DpFof4V4x1HsppGGy+q6NvlCB4VCJ9lCO/1li0Oey2k5gsgN0TV4ioWnYfNpw++eMsweDiquAzSQS8Q42hUn3dGK7ppHIjGfrvhc5iTnMNLezb4WydZWyb4Wyf4WxfEmMa44l66HnS3SlRtmce44F+X3cGX+Fa4s76BNNFgpJ6CsEwy78xny5jHkzuOYNZ99yYXsa53D6TY7qGhRjCRjEybNm908SwrHWFw4VtmdXThNZzlDzPXIiJYaad7KHrGSbWIjNE3tF7io/IXaoDoUVAuNa7Qvi3SYKLd8Ya6VL88nJbENiLCnfNSfMkhlfBGICCR8KMsVaIHWIhDzk7g3tam8UOaHQoEay1hJDsogsVtT1TFBrFBWL+7L8ECY20ZjGQ9LB/ttUKVhhPST4Ujhi3AlQVoYW2GUAikxgTA3SoFl+bKcUcLpAsMv5agVvqLymIf7K3Jcvr2FOAQvp+BOhsK7khKvk+LByoPRqfGI8074elVjno7JPT+mRsiHAt4LLKWnG8t4raur26dEuCXKGceLT4D/xl9Jv+O5GNdBeG6w30NoF+O6vqD3XOqqbWq25xmzcmP0QzbmDaCBqGXUe2KtDA6PH5U7qK21UTDlRHx4M+GQViNqB7T6+01FyteIesLznp90fMhUU/LNTUly+clvuVv5PTWBeI/ZNjfccMOkrzPi7YMQYlLVK+ebRCLB9ddfz/XXX8/nP/95Pv7xj/OFL3yhoVCfCrZtV/aHIQwd/Lb69Kc/zeOPP86DDz7IsmXLSCaT3HrrrWfccl5KOcZjOM7Y38LNzc11h7PZLBdffDHf//73x5y3p6dncncIuOyyy/jSl75EqVSaVEXOGyUS6hERERHTgGKxSDqdrgzovBBxXZfXX3+dHTt2kMlkAP+DevXq1axbt27MB+eFhM7n8TIZdC437g+dqkQv4bpjv2xIIYhbFjHLwp7iUFFtNAVTIm9KjLgF0q5LwYNCWaNyJexSgUSpgKQ8wbayfvrc05qikBSkomDFKAlZk0AfLdCNnwirTaGPQ1WgaySjfjGOPi8ChQXCQgn/q4gWYbdzkD4vlBGZLOXiSayREUSDwa5GykrynOYkTa5H53CGjpNDtA0coFiQ7G+dw/MzZ3J44ULia+OsTGZZkMjzO01pEh2vEW8/jrQafzksFlvJF9opFDvI5TsYLCU4booMqWFUeoCugaMs7Nf8Tr9hcT80jVpEA2TjNqn2ZkZmJCi0dBC3F9IZm4tsW4DXPZuDrTH2tSr2tfjp89JYEwKAclxiuSLtmRQL88e5KL+PK3I7uMJ9hRmiwWBQ4SfOh915DLoLOGkWcjC+iN0tS9jbNovBdsFQq2C4aWJp3uTlWVw4zuLCcZYUjrEgf4Ke0gidxTTCE6RlGyOijRHZxnG5kINiOdj4f2eBL4PDOiCDwUMbD60FnjEYLfx+Yq0w2g6E+WRkQDVVjvCqCXNhIKxlIexBV/6SaIUxNsYTaHcyUn5UqjxcLuPfs3r5bKpiEhEIW1FdeSCq1SyCarOJCP6tSvzkuDIG23jYWmPjD/BUAqQwWAiMClPhEiMVSBtjBWI82YbXGQehggfeP9+FWqMiAaRomBgP08AXghivffRl8K+hulKp/nxj3J8QQX1MVYgL6R8nAwketOgghKjZb+oS08LUXnfNK1cQiMjRt23qzlu7LUXjTPDkHoXK/8WYe1o5OLF7PMOtB587GFNzL82o6wz+xVa9XPX0Olnq79NGkDbQqgARdqfX1LvUXVe9iK19jxhzXM1Kt9GnnSvC18DYt4AzP2vGmBrRHs4kNdX9gYj3Z7JMIRE/EdJ/vzaV71S+PKkT2HXLCHgeGhfjaV++B8JduB7GcwLh7lWS8WGtjQgWerSMr2XMp8RkPjbGeY2eTaUNxv++GF7a1Pz/TGioiHcjgm9ztbs1p9XKeDPecechNd+IMb3qDYjHJcuWLXurFiki4g2zZs0afvzjHzc8beXKlTzyyCN1QnnLli1Tvo2nn36aO+64gw9+8IOAL7zDoaIhsVhszIy3np4e+vr6MMZUJH3tgNLx2Lx5Mz/84Q/p7e2lra1tyssbsm3bNjo7O98SmQ6RUI+IiIg4r7iuSzqdpniGAZbTmVKpxK5du9i5c2flfiQSCS666CLWrl37ln2gnWuM4/gSPZvFOI1XdBijKZf8JLrjjJWySkh/sOhZSHTHuGR1gbwpMuwUyXtQcA1uwcHKF1GlPC1uiVoBPmb5AonuGENeKnLKpmRJPATVn2t149WC7cOrPyTHY+wA0fHPW+0+t5A1Ah3AC7fvzReQmRwik0VkcojgMddUfwSZRBzT0gRNSZo8TWc6R8dAio7XjqCzLvvb5rGzcx675iyisDbOypYUy5oyvKvpNL/Tvp14+wmEHPt4eZ5FPt9BodhBvthOodBButjCKZljWAxip07TPnCI+acc3t9nWHgK4qNeEga/83xkZhPDHTbZeAKLhTQnF5DtWcJg92yOtrewr0Wyr1UyEmus9ZTnEcsVac2kmZc5yUX5vVyR28Gl7m7myqEGT4Q/AC/lzWLQXcBxuZD98cW82rKYne0LGOiQDLRaFGLjf+VLeCUWBcJ8UeEYs4sDdBdHaC/lkC6kZSsjso0R0c4xsYhjQrwhaR4sdkUxC+NvMWE0uAZ0kPj20+b2FIW5B6NT5sLvMxehdg0He2IjjMR4AuPKM2iH0cnysO+gXnWGK4XAVAZFypqKCxXIURlI9MrKA1G9FiGqNSwWYIUCPRDlClBBbYqR0pfkUlaqGMKBnI4MRXntrqjaMhmrFjdPM2rT4yqsVqFasxIK88m5/5pVNCJ4xwqkT2U3fP6EDA4FozuFqOyXwmCQlZS2DMSmFDI4h6m5XPU6Kj5H1J6H4FaqEnP07QY3U6mKFzLcH7x2KpI8EObBy1uONkgi2GahEisP94v6/Yw+LzXnq1m9U3fZUcdNJL9DvVd5Qw//LQVWMFzBVGMJQxlN+DlRsytG7Y49XddfP36amcoKgdrD4X4dHN/odTQ5jDG4BY+25KgKt1orWtmtsfR1EdpGBrX2fgSPj/Z7x6vd4AaN8ed/m2B/pavdVFZY++NOgqoXdOX4sB4mHAPunx7MKznD/RZCoKD6tNcdGP+x0lSC5njGX64wDe+ZcHeKtTTjLiRgKQQKYQHx5NjzaBNUyxiM8TDaRWvPH3KuPag8Xroq3mtqayrivdIrP/q4cJXIxNR96o33T2rcO9n4cJ2kr/yP+pdhsM8PVNQdWTlP41VOY/f5sj2s6qvd8lDUnD52P6GgD/b7Ut+/L7Z2SXhO9X2E+hVT1ffysafXHl8n/Kfnx2BEBIODg9x2223ceeedrF+/ntbWVrZu3coDDzzAzTff3PAyt99+O5/73Of4xCc+wWc+8xmOHDnCgw8+CDClWtHly5fz6KOPctNNNyGE4POf/3wlvR6yaNEinnrqKT7ykY8Qj8fp7u7mmmuu4fTp0zzwwAPceuut/OxnP+OnP/3pGSX5Rz/6Ub761a9y8803c9999zFv3jwOHz7Mo48+yt133828efPGXOYnP/kJ/f39XH755SQSCR5//HG+/OUv8+lPf3rS9/ONEgn1iIiIiPOA1ppcLkc2m71g613K5TI7d+5kx44dlc2/WltbWb9+PStXrsSyLryPGGMMJp/HS6fR+fE77F2nTKlYxCmXgjRQFSUl8WCwqDVFiV7UZXKmQMbLk/Zc8i4Uiy4mV0IVC9jlEjHKTPTtX+PhaUNBCPJSkrMsHKT/a9W/l5XLG8LhYl6daICxtzCVBLov0C2EtBCouq7tikDP5ZGZHDIU6G696DZCYFqaiLV3YpWKdOQLzBhM0b7vOFa6xIG2OezpXMCr3as4stpiUdcIq5sGWdV0gitbXiHRfgKpxq4IKZeT5LIzKBQ7KJTayBc6yJeaSascI2aQWOoUbQP7mH2qyIZ+w4LT1UGhtRSSNkNzEwx1WaTsOK47C69zNemeJQzMmMXxjjb2t1ocT4qGXePCGFoKJaxsjhmZQZZmj3BpbifvLG1jlThGXIzaPDL4dZ3xZjDgLeSoXMj+xGJ2tSxmR8di+jpiDLbaeOOkzYXRLCieZFn+CIsKJ5hVGKCrlKa1lEc6kAmkeUa0MChmM8jsYPvzcZ/mSRGK87AlKKzJ9QJproPBn2c2BQYhvZqU+ShhjvGvw8igp1z50lvHMEYiRGNhXj1O1PzSrtawhPdg7P0yIEwQ6BYIYZBBOlgG0rXWN46+tBACSxh8tWNQAv+wCBLEUgYDOBs/LlpKUKEcDWPH0zthLqkKcVVZyeAvtxAKI1Vwul8DYYQ/cSE8HPYGS+GXSEnhrxyUhB3yIpDJIpDcvv6upG7xnwoVqJTaapzaw2/qY6CkX7GjBDKo2hFKIqVEKt+K+/v951IqRUVoV9a61Cy5qDmtIr5rRfmFxVS+Db2p35xMYHjDNy3jf/YRDt6u7A8GaofDNE0guL08OhGrkfbal64meK/SXnB9we2d5VNV+9o9p4TLGZZYB/fNL9sK9hv/u2xwDCZYKWpCkY8ORHjY3+4FgjyonAsEqiCoqKnciYkfjHAYa/WvmoKvFfB+Qv4sXidSgLTAAoE9dmlC4a4B7fkrNbRX6XjXldUP4bYOtaNQg+85lf54Uze4tVJHo6v7q8dV0/Jny7itNVN+/Y13gRpxzejHfvQKpZpDjU+qO1yR5bEElLMNznzmpRsPW7ZM8RIREW8NLS0tXHbZZfzVX/0V+/fvx3Ec5s+fz1133cVnP/vZhpdpa2vjJz/5CX/0R3/Exo0bWbduHffeey+33357Xa/6mfj617/OnXfeyZVXXkl3dzf33HMP6XS67jz33Xcff/AHf8DSpUsplUoYY1i9ejXf+ta3+PKXv8yXvvQlbrnlFj796U/z7W9/e8Lba2pq4qmnnuKee+7hQx/6EJlMhrlz53LdddeNK+Nt2+ab3/wmf/Znf4YxhmXLlvH1r3+94QDWNwthLlST8yaRTqdpb28nlUq9oU0NpiNaa06dOkVvby9ygs27IyIipsZU/20VCgXS6fSYTaQuFFzXZdeuXWzbto1Sye+46OzsZNOmTSxZsuSCfH/R5TI6k0FnMhivcf7J81zKxSLlUhFvVDe5ktKvc1FTk+iVgaKmSE4XyLouWcdQzDuIbAGrWEC4ZYRwJ/yFoPEoG0NOKvLSr3PR4fbh1VuDQGwK7QJ6wmGqU+lAl0gENlKqUQI9yDFpg8jnEekggZ7N+Z2ntUsX1LfELIv2okPPUJruU0MkUnkOt87k9c4FvN45n9dnttA+d4h1LX0sbhqmt3mE5rY+pDW2n88pJ8hme8jnuyiU2sgVOig7TRRFmbQ+jT3cR9vgMD2ncyzs18wbrO87DyknFUMLYgzPsEnZCYbdNjJt68jMWsGp7jkc7ezgQJs9bl1LS9mhLVvEzo7QmznJ2tx+rspvY6PZz3x5uuFlyjpJv17EEbWEvYnF7GpZwrbOxRzubCXdNH40POkVA2l+nNmF0/QWRmgvZYmXXHKimRHZTkm8CVuNGJDGoI2ouiUt0CZIm58xZW7qJXmNPBcylDvhYE9/yKcvvqt/QooJ0jfjCXN/f3ipSg5XGKTQIIQvfzFBRYYIUssNfKWQ/utY+OJYyWA4nfQTLEqE4nwSAqwy0DMQ5GECXQhfpJ8LZBz02CqlM1Evu30Zjgp2pb/yAin9rVGEwJLS195CVnvghUQFsltSL7mrf2bU4bcQKWtEdU2quyKs/fsTynAhBdJSiECYS1W7XyKUOsPrM+LtgjGGVCpFe3v7mZ/vWnGvdY20rxH2tZVrxquK+br9upqUvlAIpL3W2t9CyRi84D5WxbtXkfV+aj3I0xuNp0PBX93CqdH3lFoB7wXJfE9TJ+W9sIbmXNyvOuGuMTr4rmWC1HuwuoEa8T5WvldrWxrfhq7K+Npd00DGjz5ukgn56YhBQMsMyA6e0/sQa2rj/f/x/nN2fdOJt7PbmirFYpGDBw+yePHiKYnltwPf//73+djHPkYqlSKZbLBlTkQdU3mtXHjxwYiIiIgLFMdxSKfTFQl9oeF5Hq+99hovv/wy+XwegPb2di6++GKWLl16wYkCo7U/YDSTxYxTuWOMplwuUy4WcZz65y0cLJqwrClJ9LAPPasL5EyRvOuRdwzFbAkyRVSxQMw4CBmkq8exSK7xKAhBTgny0sYhGAJjqKlx8H+chQl0E/zgavgzxITyfHJDRCU2QlpIEaqw6k9CtOcPDQ0T6A0GiBolEU1Jkga6skVm9Q/TtfMgOZFg14xFPNF1EbvWz6W4KMVFHYdZ0TzA+5r38eHW06gGneeuEyeb6SWb66JY7CRfaqHkNGOAnEkhho/TOrCXmafSLOxzmT3c+L55LYLhBYrh7jipWJxTpovjieVkZ65koGc+x7u6ONYSx2uQAo57mlm5Mi3ZPInsaWZmDrIp9xqXuq+yWh6hTeRrH8TKSpK018NRuYR9sSXsbFnGlq7lvNI9h1xifHHeUx5kcf44cwunmFkcorOQoblURLiClGynLGKAIEsnWTrP2Te+MGlOpZalWtEy1ZT56MQ5UBn4abQAT6Jd23ftqEryWoRSu+45CAR5WMFiZHA5/7KhAJfBkX6CPFgOgr7y4H9+ENiXwNUEXyDLA7mtpajIcQuDkgILv9fcMuFWHGcgTJlLQaWORYTJ80k9HWeFn/ZWIGNoVDC0To4V5VKhpEQJhZQCJRWWVNhCYAUrCULR7W/MMFaAT3w3Jt7SZcpUJHil+6RGgKuaNHdNsp/646RSwUFRSY0LQbArgmR50Hl/Aa48jphmiOC1iV/LNPFWNJMkkO2+dK2dgVIv4EVwHv+08LxvoZgPaoSkUpWvOW+gRcwX8hVBHw5e11XhbsDTni/UQ4GvfcGtQzkfyH1Pm5qud9Mw/T5uJCZMuId3k1Hvg5WJr77VN55XI9zxtxys3qvG8l0G8l2FsYUpZvFD+T5aygfLN1rO++dl7GXC4y9QQR8R8Xbl4YcfZsmSJcydO5ft27dzzz338OEPfziS6W8CkVCPiIiIeJPRWpPJZMjlcud7Uc4KrTV79uzhpZdeIpv1hx+2tLRw8cUXs3z58gtOKuhiEZ1Oo3O5cRParuNQKhVwSmMrXWLKIm77afTJrkTwjCYfpNBzpkjR0+RKHqVMCbJFVLGIhetL9HG9pKGIJi8leSnIy7ifQq8EmcIfVdQMEtVnEOgg0WcU6L5etJDSQgirsoAm/OnneYhsrtqBns2P2SzZKIUVj9HiePSkcszpG6Q5k+NYSw+7ZyzmiZmb2Lexm7YFB9nUfohNrc/z3tYBbHvsCijPjZNLzSSTm0G+0Emx3ErRTQACz7jo7Enig7vpPjXM7P4CC07phrUtXgdkFgiGuuOMJBIct2ZyWC1mcMZShnoWcmJGDwPNjZMJHWXNgkyJjmyOtkwfM9M72VTcyXpxiCXiOJaoucFgfYtnLPrNfA7aS3m1aSkvdSznhZ6lHGvtangb0ngsKPQxv3CSWcVBugoZWkt5EiWHkkniiFA/CAq0UaDtDVe0QM1LR4ug2UBMXpqHAz+FRqhAmotQmvsrfPxudD9lblyJ1pZ/W4hqijcw4LIu1VtNmQsT9FabcAWPfxn/NW2CfvLwYmGDayDig+sWgTwfLcuNFOjg37cCLGnqZLllPCwzauRaI/8U9Jwja2V5jTR/g4QCXAuFqRHj4WF/v6+7/VoUFYh/QSxYuRCTAltKLAk2AqWCXSZKhL8J8qQiw0eL70YiPHiRVypx1LgvSyFEcNX+aysU4zIU48qvifFvJkqQR7wNqJTtT9igMTEVCV8v3v39YUVc2B3unh8hPwoh/Pe2N/Le6gXfl8KmdO3pGtEeini/ykYbg6s1juf/uYGM96vWfZnv4Yc3fHEfPPq1E4JpUCtj8O09QaJdB2EIz18RYrQe5+2uNule/zemeiaYK2LAb0c760csvOmxqfiKoA+DHuHxhoqMD/texKjT66ptImkfETFl+vr6uPfee+nr62P27Nncdttt3H//23MrjPNNJNQjIiIi3kTy+TzpdHrMEI8LAa01Bw4cYOvWrZXOtKamJjZv3szKlStRU+wHP58YYzDZLG46jSk23kLA8zycUpFSsTCm0sWSkrhlE7etmoFvE+Maz69xMQUKukRZGwpFl2K6hEkXkE4ZJQKJPs7vP40mJyEvBTmhcIRVqTb1f3CFQ9fCntdqCr0RwoQd6JVxT+MgEPgDRIVQfoWDf0PB7x/tDxFNZRHpjN+BPvo2LUVcKtqLZWYNppjVP4Q2gr0d89netYT/ueZa+hckmT/nVda1HeZ9rbv4vebhMTUa2rUppOaSznaTyXdQKrZT1FY1rVxIYw0epOv0aXpOpVnQ79DU4Cn2WgzFRTA0O8ZQU5JDifkcVEs42TKfod6F9M2YSTbRuAplTl6zJFOmO5unI9NPT3Y3S4tb2KgOsUierJ6x5p9E3rRyRC5hT2IpO9qW8cKM5bw8YzGObJzBm1M8xYL8SWYVBuksZmgpFlElw2hD7pIkS/INJ5hrpblfo1K7/0zSPEyXe/XiXGqECK8n6DLXAm0CYV4j5CtSOxiwKJUvn6XwE+pBdtEXwcZfpSMxY3vJg10hQsEt66W5AKTyZbny64i0kpUhnlIKLKOxTa0w19jGRYWv6YnevkdL87Ca5Sy6zLWwgvS4hRb+bijItQgVt0QKiRTK35rE+Mlwhd/BbuMLclsYbCmIBSslpBBYNctjjCHveTRNYcXghISPQV06XNWI8FFCPDx/WKcypZsKJHklLR7cxzEpcn83IiJiiggBwQDx2k/2sxLygXBHu4F0rx3k6dadRxj3vHpTFbwX+fdcgDV5Oe8n5KkKeVMduKoxuJ7B8Txc4+86nsY1BtfTuJ4v67WuyvvKcF2qgroiyY0GLwhOhCn3SnLcl+61TE3AU3O8rnk6JqihCWdfyOo1n3OCx0TazZikU7OooXiHuoHCwfF1Uj84XYy6nEr+dtV/RLz9ufvuu7n77rvP92L8VhAJ9YiIiIg3gXK5TDqdrgzrvJAwxnDo0CG2bt3K8PAwAIlEgo0bN7JmzZoLatio0RqdSuGlMxh37IBKYwzlcgmnWMRxytRmuaUQxC2L+BQqXRzjktUFsrpAyZRxjCGfK1POlNCpIsJzEMJFSnfcJLGLJqcEWSXJYxNucev/jqn5MROm0CfqQjd+hctketDBQgmFCCR6cAWVn1yUyoh0BhVK9FFDRIWSNBnoyhaY2z9MZzpHxm5i94xF/EvXpby+Yh7OoiLLenaxtm03F7c+RSI2tmqnnO0mO7SA4VwX2Xwntj2TnDvg13Q4DonBfroGT9B5apjZ/XlmZMbeJ2MbygsMuQWSwc4E+5vnsc9azuHEEvp6FnCqezZle6zYVtqwKKdZkfaYky3QmT1NT2YvPe6LrFG7WCBOIkVwezUXH6KHvbHlvNKyghc7lvN8z3JOxHsbisLu0jDzC330FobpKGRpLpVIFB1iZvQG5OcgwRz8PtahKK8T6JOQ5kIjpFtTz2IQyquX5jXVLKbSaz7qqkRQj2HhF6koEQhyUfmvup9xt9DwZXolax72tlSrUwJhbiyFFgITDHZUgSy3axLmtnGwXD25R/kspXlYraKFwgS71TS5fxzI4N+dQAVy3CKoTzF+nUxYqWJJv488XAQlZGVXSTGONDkLpN+FTlizI1RNUjw4rU6Kj58QnywTSvKwfqUmaR4RETGNqRXyKlY5elKitU60h1U13ij5Hkr5cPf8ingIE/I+tn9E/RkUTKReQgHv4W/VWPYMrgHXAzc47GFwPD9J72pfxnuV6ppQtocrgoOtCTwddLl7GC/YisDzD9env+vDGNWlHy3Rpyriwy+wb/AJCudYSIkZ5zv52d6Cl4hqMCIiIs6OC8eKRERERFwAeJ5HJpOpdIxfSBhjOHr0KFu3bmVgYACAWCzGhg0buOiii7AbCMjpii6X0amUP2S0wTds13UoFYs4pWJdpYtAELMUccvCnmRy0zEuGZ0nq/OUjYvrafL5MuV0CS9VAjMJiS40GSXISUmBGNqYIIle80PmnKfQJVLYyECWhTrOhD+IPA+RziJTGWQ6ixid7BeCZmPoTueZf3KQlmKZvuYZ7OpazC+WXMaxeTNomj/Iihk72dD6a97bPIQcNfFTexbFoUVkRuYxnOskW2jHKANWCTC0jIzQNnKInpNH6TmVYdagM2ZoqBEGd7ahtNCQmm1zuG0mr8VXckAt43j7fPp751FINI2593HPsDyjWZn2WJJx6M4O05U7QKu3k4XqeRbKw748F9TJ80HRw57Ycra1reTZGat4sXMVg7GOMdff6mSZV+j3h4IWsjSVyrQX8yS9c7+SbXTaXNfI84lNp0HKatqcMHUuNULWyne/nkU7ClOyG0pzglvyPbOfiJbB4EZ/qKdAVC438b8rfyuQUK4LvybFUpWk+WhhDr5br6TLdSDNXf+wmszP7ClIcz9BHgpyq25X4A/ilCiUoCLJfXVuRh0OnwZ/E34lRNBZ7g80lVJgCYlSb0CW18pxFSbGFSDALUG8JaiHsKoJ8nOIrFSq1Ijy2rqVqI88IiKiFiEhkPBVTTsJalPwWoNxAyHvVvvkR0l5PzH/Zt2RqSGDAc0WgFA0TeEtsZJ0NwZXg6sNZe2L9trjnEC+V5L0ng4qaQLpHlTNGG38x1D7A2Ar6e4wAR6mwRuUCokJvp/WynVTe9jUPtNjhX1dr7y0Kq+PsYz+/BKNjx6NPd71RURERExMJNQjIiIizhG5XI5cLndB1rucOHGCLVu20N/fD4Bt21x00UWsX7+eeLxxDcZ0ROfzeKkUOl8Yc5oxmnKpRLGQx/Pq0+q2VH4vujW5ShfPeGR0nkyQRHddj2K2RClTwkuXMcb1Jboam4oPlhRXQFoJckpRNJYv0T2ojroKftAEm/dOlEKf3DBRPzGmhN+DXivQw8dHZPPIdAaRyvg96KOuIWGgO1tgbv8QHbki/c0z2NaznP+7/hqGliaZOfMoK7pe5X2tL9MWH/scOPkOCoNLSQ/PZajQRqHcgooXMVYR6Xl0DB+l6dRxOvtPM6cvS7I09r54HYbyYkNhvuH4jE52tazigFjB4eQiTnbPI9PSPuYytjasSGvWpD3WpjwWpHO05Y9is5eZcgvz5VaU1OFkxQqDopvXEst5qX0Vz81Yxfa2lQzEOkddt8Oi7HF6C8O0F3O0FgrMKKZpckvnfK5ktZalNnUugvUu492aQQqDlNWBoEgHIT2M0P5m2l6107ySNG8g4yv95MK/TiEFComUEhXI82ohq6hdhDGEafOw1xyl/JS5pfw+cyXxrLAmpHr71UoWje25WK6/f1LSXATdteNI8zA5HspxT1ZlucCvPpJCoYLkeBxQxlQGcqrwXhsIpsvV3bQlBFK9AWFeW6vi9+TU1KrUJMdrzzMexoARYCXOqnIlrOnxU+QykOICoWRwXNRJ/nYmfF5rn+PRu6P3T+W0RoffKGZcyVd/Wrh/9O5kj5vodiLeRAIRX/voT+qZCFPwo6tpKsd7NXK+pq5mGmEJgWVNvobRH6wayvVgyKr2k/Cu9gW9pw2e8UW852k8zwvEu/GHu2p/2KtXScAbvOC1P5k8+pn+dY93upA2QrQEh+pFvKk7rnp8I/Ffm7wXamzoIiIiImIyREI9IiIi4g1SKpVIpVJ4nnfByYP+/n62bNnCiRMnAFBKsXbtWjZs2HDBTAI3WqOzWbxUClN2xpzueS6lYoFysT6NLoUgEfSiq0mkI7XR5EyRjM6T10WM1hSzRUqpIk7aQQcSXUh3HD/lURKQtQR5aVFC4WmNccONfMPNdINBoqY2tVOPqEh07wwpdL/CRUkrGDNYL9AplqsCPZNFePU/Em0DXbkCc0+PMCNbJBVrYXvPMn6+6ioGVzQxa9YxVnXv5Pfaniam6itLjFYUR+ZRGFhGemQ2A8VWPAQqkcdYRWI6x+zBIzT3n6Crf4CZp/JjBofquMFZ5KfPh+fE2dm5gj1yNYespRxrn8dQZ0/Dx2ZxVrM2rVmb8liT8piVHcEzB2mT25ivniIm+2FUIGlQdrM7uZyX2lfyQtdqtreuYCBWPyy0xcmxInWYrkKG9kKOnsIIncXM5GTuFAjT5bVJc60FTFjT4ktzJcPUuQ5S5y5G6OBlJdGeX9FiHGtMgt0/ZALXHHS3hg5aSCS+sBVSBWlzMXoRxiBFVZobJRGWBcrfZFsHafPRCXBlDDGjsY2HpZ2gqqXBINDxCCtggroSoyRa2hgrhiesQJiHiXJfQEskfr7cEGMCUT6mmid47EJhLv36FSUCYS7PUMdSkeS1VSqBFJc1+8OKlTeR0bUr44nyKE1+fgjl9WiZPfpvvNPOdPzo3YmOixgfrTVKKXp6ehBC+DNcamT7eIcne57RfzoYWhmJ/LMkqK2aUjVN2BEf1s3UyffRcl5POxGvhEApgT2FUUjaGL8PPpDtukbEG4wv5LXGuB6ep3FdFy8YzuoHRrR/Ps9/7Hwhb2qrzBv+hY9Yo4KZak7+jb0vKdH8hi4fERHx20sk1CMiIiLOEs/zSKfT5PN5PK+xZJmuDAwMsGXLFo4ePQr4gmT16tVs2rSJpqYLI6lhXBcvnUan0xhv7I8Up1yiVChQdqpVJWGlS8KysSeR5jHGUDAl0jpHzvgS3cmXKKaKlFMl/3kXLkI641QpexQlZJWkoGKUjKyR6C6TluiTTqEDwkZiIWWYQq/pQXc9RDqDTAUSfdQKCGUMnfkSs4bSdGcKOCLGju5l/J/Fl9K3spWeOf2s7N7FB9u3Eh+VvndLLRQGllIYXEpqZBZDpSQiVkImsxhVoMkco6tvgNZTfXT1DdA9PHZyqNduKC/VFJcYXpu/kFfi69nPKg63zON0x0x0g97MOflAnKc91qQ0q9IeeEMIsYdu+Tzt1ouo2FDdZYZkFzubV7KlYyUvt69ie+sKTsdm1J2npzjM6qGDdBaydBdS9BRGaHEK5zR17v8mF/7TX1PXMpE4F8IX5r44DyW6xggv+IHr966iBcaVGK9a0RIKc1+S+5dFhK8rAmHr15UQJM4F1liJZkYvU5A2lxIjFUL5cljHLF+aq3AYZc1l8F9vtvGwvbCmRRMz3hR6zX1xrqWFVjaeFUerGEZaeMIKBusqpKxNlZvK/sqXYAMTTx718SW5L8gtKQJx7osJOfqVocIKlbBOJZTk0u8WnkyK/BzRKFGOMGhl09qeQCkZ+PxIlL9RRstqKeW44nsyp9eeJ+LCInzu3koaSfaJBPzo40bvRpJ+HMKOeBluq+QzNRHvjbN/+g1rhaCSxu9hG7e+sBEm6IY3oZDX4bBWX8hrz/M74D3PP811fWGvNdr1giR90PuOoWQgJiZQ6KaReK+cNCrT7pOI3l4jIiLOkkioR0RERJwFuVyOdDp9wf3YGBoa4sUXX+TgwYOA/4NvxYoVbN68mdbW1vO8dJNDl0p+rUs2O+bbstaacqlIqZDH09WVHEpIErZF3LYnVelS1GUyxu9F94zGlHyJXhopUSp5COEhpIMYHan28zcUlSCvFDkZoxxKdEdT2RDWVP/Gk+iTT6FLEDZKKl+EImo2fDVQKiGH04iRtJ9Cr9sa1tBedJg5kqE7U8B2YNeMxfy/uZs4uaKNtnnDrJrxKr/T8SMSVr1890rN5E+vJH9qBSNDCxn2QCZyyGQWmgboLKXoOjJIW38/3f2DtOTG1t84s3yBnl5ms2PuSnZxMXutZRzqnE+xQe95Z8ljbcqwNu0nz9ekNJ2OoUw/CbmTDvkCcWsnyk5VLlPGZmdyDc93rmVr+xpebFvL8ZqBobZ26CmMcFFqPz2BOO8upIjp8ep6pk5Y1aK1L9AnJ841Uhos5Qt0X5z7i+1vda3xNJSDiljj+c99rTRXIhjkKXUwnBbfZBu/vAUCmYcKuvQnTqD6P6YlQkm0UghpgaXQlkRbNYMpa65Cgl/Poj0/cR7WtQS94Wd87JRCq5gvzFUMbcXwVCzY7NtfbguJwhDDYAWyvJIqBz89OEmUEFija1mkxArXmKlQjof1Kla1f1zWiPK3CH9gJ8ggQS6kQFk1gzytxsliYwxlT2HHJzcr4u1MI3ldK7onuz9aIRFxvql9PZ4LziTcJ7sbEVAn4qtM6hGqFe0mGC4aCvjgcLU/3mt8vvOAEMH2keHnzBgZPzkdZYzfBz+S92iNCzC+jDcYjBu+3gxGe76s93Tw3UsHxwdJ+aCepvL61BCL3rojLnCEEPzoRz/id3/3d8/3ovzWEQn1iIiIiClQLpdJpVI4zthqkelMLpdj69atvP7665Xjli1bxsUXX0x7+9jO6emIzuVwUylMoTjmNM9zKRbylIvFikwGiClFwraJWWf+uAuHi2Z0Hse44Dg46QKlVJFCXqONh1Au0h4tWjUal4JSFJQip5I4Gj9R42hM2IlekejjDxUNB4qqM6bQ/fStkvaoYaL4P6KyecRIGjmSRox6vJJll5mpLN2ZAi0Fh70dC3i691KOXdVF8/wUK2bs4d2d/5ekVT880ys3kT+9gvyplWROL2PIUZhkGtWUQbbtZ+apIbqODdLe309P/zC2U7/8RhmcBYbyUsPJlW28PGMjr+tN7E0s4njHTLSqf45sz2PNiMuGNKxJaS5KecwshhsAH6NJbaNJ7iAW34USmcrljtmz2dr+DrZ0rOWl1jXsallKWfqbcsfdEr35ES5OvU5PfoTewggdxSzyHEW/aoeDai0q8txMInFeK8+VNEghMZ4MEl0CzxWUgtRW2D3u14z4yy6UCQbRUmOShZ9ONyKQ5RYi6Dz3W1gaL5cUVCtHlC+KjRVUp1jh4EpTJ86VMXWy3DaenzqfxGOrpeXLchXDs+K+MLfiKBULhLlfw2IZU5Hl1YGehurcgcnhp8ur1SxKCZSysCyrKskrsjwQ56FIf4uoT5VLpPIP+2nyIGkeCPTfdhqJ8FBwT3RcrRCPiIgYy7kQ9KG4DP+mcjiihgbDWkfvPyNhD3xDKR+EPrRGhINCK7Le1Ih7/3j/POfw/p0BIQQWoKQgboUrgs+NypKxC2PL3IjfTk6fPs29997LY489Rn9/P52dnWzYsIF7772Xq666CoCTJ0/S2dn5li/bokWL+OQnP8knP/nJt/y2a/ne977H17/+dfbs2UNbWxu33XYb3/zmN9+S246EekRERMQk0FpX6l0uJBzHYceOHWzfvh3X9UXwokWLeMc73kFXV9cZLn3+MVqjMxm/H90Zmxgul4qUigUcpyp/pRDELYuEbZ+xG90zHlldIGPyFHUZXA+dLVBMFylmXVxXg/QQykGK0T9hPAoK8soiq1pwtMHTLpTdqtSvlei60Qaok5PoBl+GSmEjhUKMTqF7HiKVRY6kECMZhFvzWBlDZ67IzHSO7lSBk00zebl3PYcu6SGxIMPyGfu5svNxmu36ChavnPQF+umV5E+tZLjQRLlpCDuZw3TuZ8bAIN0HT9F94iRd/SOo0f3nSUN5iaGwFPatnMfOlst4Va9mX8t8hls6xtzH9kKJ9SMu70gpNox4rExrbAMGDyUO0SS3EbdfIS53I4X/7zAvkjzXuootHWt5sXUNL7etqQwNtTyXnsIIawYOMSs3TG9+iM5S9pxUtpjgqQyleUWeGxh3lJYIK1p8Ya6UxpLG/1GoJWiF0QrtQDkY9mVwQWiU8OV1TBi/7nXMTYRpdxkI9KCuRUwsz6XwE+BCWv6ustDKT5sbGVa0mMpNQJA4125FnMe0d8ahoAbhd5erGJ4Vw1NxhIohVAxpxbClrAhze3S6fJzO8jOhBFhK+UlzS6EsG2XZWJZdI8qtqjx/C51qfVe5L8tr61j8kPtvl+gdnfQe/TeRJP9tepwiIi40hBAopVANKtvOxETifby/KBE/AbI6ef2spXwtYYVNsKWlCIU7OkwXBF8jdPWLU81uRdyH5xlzevU7NAQVRQKMbDBTZNznvcH37ka9dRER05RbbrmFcrnM3//937NkyRL6+/t54oknGBwcrJxn1qxZ53EJ3zjlcplYLHbmMzbg61//Ol/72tf46le/ymWXXUYul+PQoUPndgEnQJjoU6eOdDpNe3s7qVSKtra287045xStNadOnaK3tzfaLDUiYgrk83nS6fS4aRljDKlUivb29mnzw15rzd69e9myZUtlJUBvby9XXHEFM2fOPM9Ld2aM5/m1LqlUIKKraO1RLhYpFQp4NbLNkpKEbRO3GnQ+117eaPKmSDoYLoqnEfkCpXSRYsah6AC4COWCrJV5vkR3pCGnFBkVwzECT7v+FrYNJXrj14wwfpp4wj50oQALS9qIII9bm76nVPYT6CNpRDqLqPk4tzxNTzpHbzpPsqB5pXs521YswVvlsLx3Pyu79tBiF+puznMSFE4vJ396JblTq8ime8g3n0Ym04jECK2ZU/QcP03PiT5m9A1gjUqgex2G0nJNanmc3UvXsNu6jFflEg60zaYUi9edVxjDvFSGdSOaS1M2m1KGOYVqJ6YlDpGQLxOX24nLXUjhL+vexEJfnret4cXWNexpXoQWCqk9egopevPDzMoP0ZsfZkYhfU6S5+FvudrEufbqh3mOugRCVYeDqlCgy3pxjpZoI/3Nj4WLFi7gD7Stq2epf+QCcR4kz4NdX75KpGgsz31xbkEgzcP9xpKVqwuXvV6ce3WJ85geX5xrofCEhSf8ahajYigrhlA2yopjS4mFL8ytCR69qSAFKGWhLCuQ5TEsy6qR5udXlivlPzdVYS4Dl3/+v4O9mZ9bE8nwiU6LiHg7EP3eOr9EEv7ty5v1uWVZFr29vefs+qYTb2e3NVWKxSIHDx5k8eLFJBKJ8704k2JkZITOzk6efPJJrr766nHPN7ry5ZlnnuGP//iPee2117jooov4i7/4Cz74wQ/y8ssvs3HjRp588kmuvfZafv7zn3PPPfewe/duNm7cyHe/+11WrlwJwP79+/nUpz7Fc889Ry6XY/Xq1XzlK1/hPe95DwDXXHMNv/rVr+qWwxjDF7/4RX784x+zbdu2yvHf+MY3+MY3vlER3XfccQcjIyNccsklfPOb3yQej3Pw4EGOHj3Kn//5n/Mv//IvSCl517vexV//9V+zaNGihvd7eHiYuXPn8pOf/ITrrrvu7B7kBkzltRIl1CMiIiLGwXEcUqkU5XL5zGeeRhw7doznn3++sua6tbWVSy+9lCVLlkwb4T8exnWrIn3U7xvXdfwho6X6WpcwjW6fIf1UMg4pL0vW5NGeRhSL6HSBYtqhUPK7GYVyEPboOh8PT3jklCRvxSkIhed5eI5HRXFXNo01b1CiWwgUSsbGDhQ1BpErBFUuKUS+vsqlqeTQm87Rk86TEe1snbeGX1zZSef801zU/Sq3tW6pv1du3Bfop1aSP72SwvA8cskhdHIY1dxP0trGkhOn6DnZR/fJ08QK9Ulhr9lQXqk5dVErOxZfxivqHbwam8/x1hmYURIh5pRZMphiQ1pzebqJTSlocQV+UkojOUVShQJ9O0qkyMkkz7avY2vbR9jatpZtbatIW60Io5lRTNObG+bqoW3MzA/TXUhhnYN+0Io4D6S5PygUGhtZE8yU1EhlAnGu/cGVJpTmFrgWRkuMkQhhAnnuAC4ID2H51z5Gu5iwriUQ51oEg0JBSOnPAhiVYhYCUH49iZEKYdmgJEYp/6oqd8VUdhuJ8/GqWjQSR9gVaS5UDKlshEpgK0VCSWzpb5Y9ViOdzfMjQFoo28ZSNkrZWLYv0G0rhlDWW54sG5smr9k/TWT5uWQiGR7+KaXqDkdEREScL87mfehMwt3zvEjAR0S8DTHGBDOu3lqEPbmt61paWmhpaeHHP/4xl19+OfF4/IyXSafT3HTTTdxwww384Ac/4PDhw+NWsnzuc5/ja1/7Gj09PfzhH/4hd955J08//TQA2WyWG264gfvvv594PM7DDz/MTTfdxOuvv86CBQt49NFH2bBhA5/4xCe46667pnT/AZ544gna2tp4/PHHAd+7vO997+OKK67g17/+NZZl8Zd/+Ze8//3vZ8eOHQ0T7I8//jhaa44fP87q1avJZDJceeWVfO1rX2P+/PlTXqaz4ayE+sjICP/4j//I/v37+U//6T/R1dXFSy+9xMyZM5k7d+65XsaIiIiItxStNZlMhlwud74XZUoMDw/z3HPPcfToUQBisRibNm3ioosuOqtNbd9KjOP4Ij2drhPpxhjK5RKlQgHXra91Sdg2iTMMGdVGkzUFUl6OkikjimXI5CmnS+RLhpJLMFx0dKWLhxYuBSnJWzHyMonrGbTroo1XI9HPRRK9vg+9vspFI9KZahLdGVXlki/Sm8rTni2zv20hv1q9AWeVy5KZB3nHjCd5Z00PujGCwuAScn1ryfWtoTi8kKKVp9R8GiuZJjbzCeb2naR3/0l6TpwikalfsaDjhvIyw+BFSV5Zdhk7EpezI76A460zxtyl9kyK5YMpNmQEV6WbWJOLYZnqGn5JOpDn20jI7SjRx6DdwS861vN8+7/l+fb17GpZiicsuso5erIDbDy5n1n5IXoKI9hTGDLZiEZd5xMPCTVIZRDST59b0vPrW4xAGInwLHBjGKOQWvrd1xgQHgYXI/0Eum74GhiVOg9FuhAVeS4QCGuUPFfKT5nXps4tfzNoI4LNooNlR/iJ95jR2DpImweDQkeL87CepSRsPGEF1SxxVCC0E1JiB+L8jatsgQlrV5SfLLcsGytmV/e/hR3hQoigOr5aw6KkRFgCJQVCXfg1LLU1KbZt09TUNEaIj/6LiIiIeDsz1fe6MPk+WrRP9BcRETH9MI7mxL3PvOW3O+e+KxGxM/82tyyL733ve9x111387d/+LZs3b+bqq6/mIx/5COvXr294mR/84AcIIfi7v/s7EokEa9as4fjx4w2l9/33319Jvn/mM5/hxhtvpFgskkgk2LBhAxs2bKic90tf+hI/+tGP+Kd/+if+5E/+hK6uLpRStLa2nlXlTHNzMw899FBFlD/yyCNorXnooYcq37W/+93v0tHRwZNPPsl73/veMddx4MABtNZ8+ctf5q//+q9pb2/nL/7iL7j++uvHlfDnmikL9R07dvCe97yH9vZ2Dh06xF133UVXVxePPvooR44c4eGHH34zljMiIiLiLeFM9S7TkXw+z4svvshrr72GMX4n89q1a9m8efO036TNOA7eyAheJlPnm7XWlIsFioUCuqbWxQ6HjCo1odgqG4eUzpHRObTrIfMFzEieXM4jV6Laix6rFbMeBo+SNOStGDnVgqNBaxcvkPnGXzg/iW5quh8rd8jvfJSYNyDRPT+FPpTyJXrNbShP05PJ05vOo50YL85bzZbrumibP8Dante4uWV73c04xRbyfevInryIXP8aXCdJrrkPmUxhzXyaGacPM3PvSXpP9tM0VN+hbixDebFheE2MXasuY0frFWy3F3KkdQZm1GPfM3SKVaeH2ZSBd2VaWFxuA6rDcQRFYnIXCbmNuNyOLQ5yLNHLLzo28Fz77/N8+3r2JRdgGY+ZuSHm5Ab51/3PMis3RE+8iWx+ZNzn+kyMrmwJk+fjps5FMOBTGoTS/sBQgS/PtQrkedwX54H09uvGDUZ6aFlC4+HiMvb5r02d41fAVDpWBFIIX6CL6rBJUTMUVCoLLRXCUkEHuL/MWoRL78tzZQyxGmkeps/De2wALWw8maAgbEAhZRxlWUgVJx4mzZVCviGhXRXmRiqMsJCW5Vez2Da2ZWMpsJWccMXYuaKuekUJlCUQSgay/MJNl9emyGvl+Hj7oZrIbG9vv2Dvd0RERMT5YKq98ONVz0wk5CMiIiLA71C/8cYb+fWvf81zzz3HT3/6Ux544AEeeugh7rjjjjHnf/3111m/fn2dA7j00ksbXnetlJ89ezYAp06dYsGCBWSzWb74xS/y2GOPcfLkSVzXpVAocOTIkXNyv9atW1cnvLdv386+fftobW2tO1+xWGT//v0Nr0NrjeM4/M3f/E1FuP/P//k/mTVrFr/85S953/ved06WdSKmLNQ/9alPcccdd/DAAw/U3dkbbriB22+//ZwuXERERMRbxYVY7+K6Lq+88grbtm3Dcfw08aJFi7j00kvp6Og4vwt3BrTjoIeH8bLZOufoeR6lYoFysYAOKjwEgrjt17pYE4gfY4yfRtdZitpPo8tsHi9VIlUyFMM0eqxc41J9ie4KTd6yyVlNlLTAMxqv7AtRP42uQY8j0QFhdJBEbzx41D+ThRA2SlhjJbrWgUQfQQ6n624jUXaYmc7TlSnQl5jFi2s3U17lsXDmITZ0/YbLRqXQ84OLyZ9cR7ZvHaXh+TiqTKG5D6tzH+3ZfSw+dojek/20nMpTG8o3wuAsMKTX2OxadQk7Z1zJy/ZiDrZ0oUc97l3Dp1nW38c7Ui7vzjax0JmFEHNqzuERE3uIy+0k1DZi4jX2NM/jufb1PNd+O8+3b+BEopeWcp7ZuUHmDg7wjtxeevIjDTq6m8Z9zkdTlzyfjDyXYfKcYFcjMAgtkZ5EuDZCK5QJUufCf+aEBCRoXDxcHFw0o4bmmuBMldR5zXIEwlxafvc5AqQUdWlzoSyMZYEKHnvhv1qpJM990R/TXpA6Hzsg1IBfzyKSlITlD7SVCZSyiVnKl+aWhVDqrJtTqsLcwgh/F6mCTnMrSLNLbCWwlWz8VJwDRneXV+S5kih1YabLa0X4mUR5RERERMT05GwGs04l/R7V0EREnB3Clsy578rzcrtTIZFIcP3113P99dfz+c9/no9//ON84QtfaCjUp4Jt29VlCr4jhyv0Pv3pT/P444/z4IMPsmzZMpLJJLfeeusZXYmUcsz7Uegpamlubq47nM1mufjii/n+978/5rw9PT0NbytcCbBmzZq683Z3d58z8X8mpizUt2zZwn//7/99zPFz586lr6/vnCxURERExFuF1ppsNks2mz3fizJpjDHs27ePF154oVJL093dzeWXX86cOXPOcOnziy6X8UZG0GNEukuxkKdcrPajKylJTmLIqGNcUjpLWufRrovMF5CpPIW8R7YELhohHWQsFJ6+RPeER0FZ5K0kBZSfFnI8dPAlwFTt7JjBqDCFOpeJJHoqG0j0Eai5jWTJYfZIlqaCYceclTz1r7ponj/Emu7XuaHl/6u7iXKpmcKJ9WT71pHrX4MuN1OMpXGbTxPrfoHegV3MffUwM44MY5XqU0/ObE1mlcWray5m18yr2BZbyp7WTjxZ/6OvPTXEohOH2DiS59qszSpvHpZYVHM/wRJHggT6NpTcza62eTzfvp5n2/8NW9ovYthqp7swwpzsAOtPHuD92RdodQpn7VfHyPMggT6ePA8rW6Tya1vCcwotEZ5EliVKKwS+mA2D2aLmodA4uLhovBqBHshyY9Xsr/miHFa3KInEj7NLKcHyK1qEstFKQe3rXODXwwgwQfe4hZ86tz3t7xoPO3ytIvCEjSsSeNJCh4lzFSNpSWJKIsOhpFN+wIOUubLQo+Q5ysIK0uy2CqpglPBXfJ1jdx0Kc2lJv7PcunDrWBqJ8trdcP+Fcn8iIiIiIs4tUxXwkx3AGkn4iIgqQohJVa9MN9asWcOPf/zjhqetXLmSRx55hFKpVOlc37JlS8PzTsTTTz/NHXfcwQc/+EHAF97hUNGQWCyG59XXcPb09NDX11fZah6oG1A6Hps3b+aHP/whvb29kx6ge9VVVwF+Kn/evHkADA0NMTAwwMKFCyd1HW+UKQv1eDxOOp0ec/yePXvGXXMQERERMR0pFAqk0+kxHwTTmRMnTvDcc88xMDAA+Gt3L730UpYtWzat5cu4It11KeZzlMulimy2pCIZ80X6eBhjyJkCKZ2joEuVNLpIlciWDTlHYISHUGWkDCWy32NdlIK8laAgbVzP4LkuXlArY87Qiy6MQaBR40h0g0AIhRQ2sqFEN34n+tAIcmikTqInyg6zR3LEiooXV6xhz9UW82cfYU3Xc2yuSaFrI8gNLaB4YhPZkxdRGpkPSHLJ09B6jNbyYZb17WT2Kydo6SvUpdC9FkNureTV9ZvYNfedbE8s59WWTpxRP9paMyMsOHGQVadPc23OsN6bTVIuQYR2Wfg1LnG5nYTcilLb2NbRy7PtG3iu/cNsbV+Layxm5waZkxvk2oPbmJkfInaW3edTledhZUtVnvuiW2gJGqQjiRkZSFq/CzxMndeicQOB7kv0+r5zu5o+r0UG1ylkkEK3ql3nlo0J5HnlNoT/2jCVIaH1dS2xoPNc4g8F9YSFkQlABR3ncSxl+wNBlURYZyHOhQrS5SpInNu+NPcLxQFQUhCTEtuqdqif68R5mCRXStYL8yBpPt0ZnRqvleO1u9P5vToiIiIi4sLjbFLwtRJ+MvtrD0cyPiLizWdwcJDbbruNO++8k/Xr19Pa2srWrVt54IEHuPnmmxte5vbbb+dzn/scn/jEJ/jMZz7DkSNHePDBBwGm9P1z+fLlPProo9x0000IIfj85z8/po5q0aJFPPXUU3zkIx8hHo/T3d3NNddcw+nTp3nggQe49dZb+dnPfsZPf/rTM0ryj370o3z1q1/l5ptv5r777mPevHkcPnyYRx99lLvvvrsizGtZsWIFN998M3/6p3/Kt7/9bdra2vjP//k/s2rVKq699tpJ39c3wpSF+gc+8AHuu+8+/uEf/gHwn5QjR45wzz33cMstt5zzBYyIiIg417iuSyqVolQqnfnM04SRkRFeeOGFypph27bZuHEj69atw5pAPJ9vdLmMNzyMztYPeHWdMsV8nrJTfQ5iSpGMxbAn+DHgp9H9bnQvSKNbqTylgke2DEUvqHWxy4FQrKbRc0EvetkIPO2iXQcd6u4z9KL7nege4gxJdKuRRDcGkckiB0ZQQyN1oj7uuMweyaJKFi+vXsOBawWL5+znys7H64akFktJcn3rKB7f6KfQnWY84VJo7sfq2kV3aherj7xG96FB7Fz9l53yfM3xzTN5acX1vNx5CVtbuymNes005TMsPH6AxSeP8K5sgXfobtqsFSixzD9D8JRY4igJ+SIJuZW9bUV+3bmRpzrfzQvtf4rleMzNDTAnM8CH+n7NjGL67NPnmkply0ixgOsE6e+x56yX5zJIQxiF0QKpBcIByygsCUr4MlyM8xILK1wqAt0EHedG+gn00fJcVJPRYepcWkFlS7AbVrYIqEhzHTy3Ck3cBENCPV+iW0YDAlfYGBFDCgXCApkgZtlBTUsg5acizivSPJTlQT2LsKpxfEAiAmkusJXCVv7sgnPhgP3+clEZ+qmsC6eSpZEor/2LBnhGRERERFxInI2ED6kV6xOJeGPMmP2RlI+ImBwtLS1cdtll/NVf/RX79+/HcRzmz5/PXXfdxWc/+9mGl2lra+MnP/kJf/RHf1RxBffeey+33377lGarff3rX+fOO+/kyiuvpLu7m3vuuWdMsPq+++7jD/7gD1i6dCmlUgljDKtXr+Zb3/oWX/7yl/nSl77ELbfcwqc//Wm+/e1vT3h7TU1NPPXUU9xzzz186EMfIpPJMHfuXK677roJZfzDDz/Mn/3Zn3HjjTcipeTqq6/mZz/7WV2dzZuJMFN8J0ulUtx6661s3bqVTCbDnDlz6Ovr44orruCf//mfx3ThXGik02na29tJpVKT3tTgQkFrzalTp+jt7Y1+9EX8VhLWu+RyuXP6Jc4YQyqVor29/ZwLoWKxyIsvvsju3bsrm06tXr2aiy++mGQyeU5v61yiSyVfpOfydcc75RKFfB7XrSau45ZF0raxxvlC76fRi6R1jrwuVtLoZEoUyoZsGRxjEKqMUGENh59GLwvIWQlyMoanPTyt8SqVLmfqRfclumSc4VBCATbWqMGiwZUjsjnkwDBqsF6ixxyPWakswomxfe0qihd5LJ21j6Udh+okeirdQ/HI5eRPbKQ0Mg+QOKpAqfkUTeYkc4e2MufoYdqO5RE1i6jjhtwaxc6Nl/LywnfzQssSDo/6bE4Wcsw/cZAFJw7wjpFTvNNrpTO2hpicX02hE6bQd5CQLzKUPMyvuhfxm46L+U3HZoomxoLsKeZn/L9Wp9D4cToDfvq82nmuPTFWXPvnrFS2VOQ5fqzceAq0QWqBNAIbsP1Job70Hue26wS6MVTl+ajalpBgcKiUEmwLaduBNLcRtkWdda5LnoNlNDE8YrqaPrcweEKhRQxhLKSwUDKGZcWwpUQFtTAoa5JCW2CEv0x+0jyGlgqkXSfNg8XDshSxQJiHHedvZDioEAI/1C5RVrXHXCmJCGT6dKRRmnz033SW/WdD9J0wIuLNIfq3FRExeSYj3WtF/eDgIJ2d1aH3tec3le/39YfPhGVZ9Pb2vin373zzdnZbU6VYLHLw4EEWL148JbH8duD73/8+H/vYx0ilUtPaH0wXpvJamXKssb29nccff5zf/OY37Nixg2w2y+bNm3nPe95z1gscERER8WZTLBZJpVIXTL2L53ns3LmTl19+uTL8Y8GCBVx22WV1XySnG7pY9EV6vl6ulkpFivkcnucL73DQaNK2UeP84HSNR1rnSOscruv4afR0Aa/gknEIal00QpWCWhc/ja6FS17Z5FQTRRQ6SKN74ZfrN9CLrhFIYaOkjUSNTaLn8qjTQ6iB4WoXO2C7HrNSOYyXYOe6FRy/vszyWXu4pv1nddc/nJpJ8fCV5I9egpPza9SKsRSm/QCdxb2sOLWFnpcGiA/Xv47dXsOJTTN5cc17eLn7Mra0dVGsSaELrZl96hhLjuzhopN7uMYx9CYuotm6GBWr/4JtiRMk5FYcezfPzUjwq64NPNX5+5xSXSzInmJB5hQ3nXqG9nLurBLotenz8atbwkGhmmQySdnN1chzCzyBKPtpaksYLAHKnxo6oXgOBbpntN9NXpHnDVIMQiAkCCGRloWwbbBsv1LFskBWk+fgD3U1wu9mt40X9JzrQKB7gEQHWzJIYyGVhZQJkpbytzJRQaf6JKRzWMuiZW09i1WpZxmNFQwFjSmJFVS2WGcpt4X0k+Xh4E+lgloWS0xLeVSbwBvv7+0myyMiIiIiIi4EpvK9QWtNqVSis7Nz0pebSLZHCfmItysPP/wwS5YsYe7cuWzfvp177rmHD3/4w5FMfxOYslA/cuQIM2fO5J3vfCfvfOc7K8cbYzh69CgLFiw4pwsYERER8UZwXZd0Ok2xWDzfizIpjDEcPnyYZ599lkwmA8CMGTO4/PLLmTt37nleuvHRxSLe0BC6UH2cjTGUQ5EedGcLBAnbIhmLjZuELRmHES9DRucraXQ7W6JYNmSd2loXByEMYRrdFYacipNTTbgaXO1htOvXuoSVLg06vP1edIPCY/zhojZCWMRqKl0qifRCEfvkadTgcCX9rgHL85iZyqFNE7s3LKN/ZYEVM1/nmtafVh83A0MjsykdvorC0UtwC13+YxBLI1pfZU5mC/MO7qTjUA5ZMyDdWIb8CsWuzZfy0qJr2dK+nAMt9V+SmgpZFh3Zy5Ijr3Pl0D7WxpbQGb+IZPxiRKL2479MXO5AqW282pHnF92LearzEl6P38K87CALs/1cc3AHncXMlAX6VNLnleS5Mr6rNgo8m5hqxsn6j6oSBlsYpPD7tv30+fhLZfD8/4xGGx3Ic4HfYTNKPofpc1shLRuseDA4tFrbUrle4T//QlTledyrSnQtLMBGijgShbLjWCqBbcnK9YkzbWIdVrQoO9i1MMIGaU3YW25birgS/rBQJYgrNeWe89pkuQzleZg4n2Yp8/ES5bV/EREREREREb99CDG96+QiIt4M+vr6uPfee+nr62P27Nncdttt3H///ed7sd6WTFmoL1q0iNWrV/NP//RPLF26tHL8qVOnWLx48QWT/oyIiHh7Y4whm82SzWYvmATCyMgIzz77LEePHgX8LrFLLrmE5cuXT8vkJwQd6YODdYl0YzSlQoFioYAOhn1KIUjaNnHbHlek53WRYZ2h4BWROb8b3RRdCmXIuVAOal1kzCVMoxvhUpQWWZUkLxRGGzzXQ5tAeetx0uiT6kVXCPw0+phedM9DnR4ifrwfJ/jc8wDlaXrTORzZyp4NSxhYnmPVzNe4trkq0T0jGBieTfnQOykevQyv5CfEy3YW0fw683LPseC17bQeqe/49zoM/Rtm8uK69/DiLD+FnrdrPsaNZvap4yw5soflx17jivwAc1o20xXbRKzjd4KEt48SfcTli5xo7uOXvW082bWRl5v/gBm5NIuzfaw/doh3F7ZPXaBPMX0eCnS0AqMQnoSSf58EHpbQxNEY5aHwB31OePtoPOP/aTx/4ifhX41YFX6SXVoW0rbAjiGsGMayEKOHXwrQtfI8SJyHw0IRNhILSRIpEygrhm1ZiKDn/MziPOwzD5PmsSBtPvF9VVJgS0ksHBIaSPTJ4He+g7TGVrNIJSaVkn+rOJMsn67vjRERERERERERERFvNXfffTd33333+V6M3wrOapLd6tWrufTSS/mHf/gHrrvuusrxF4q0ioiIeHtzodW7lMtlXnrpJXbu3InWGikl69evZ9OmTW/ZQI2pYhwHd3gYnclWjtPao1QoUCoW/DQwoKT0RbplNUyIGGPImDwjXoayW0bm8lipAl7JI+NAtiww0gtqXTwIKl00mpwVJycTlI1CGxetPT8hHgj0Rt3oZ6p0MQiEiAW96HJspUs6S9OREzj5AkYInOA6e9J5ylYbBzYuZGRJhtUzX+XdyVcr1+tqwanhOZQOvRPn6BXost9p7lh5aN7DvNzzLHztJVqOluuWp7BYsusdl/Ly0mt5oWsF+1rre9yShRyLju5lydG9rDu5k1V2O73JTXQmb8Bu6q47ry324ca281y3y2O9K3i2/f3ECi5LsydY0H+Ki/P/jBxv5UIDjP+Q+PLclRhPYCaTPhdBP7lng6OgrBAYBB5SGpRyUAgUEiEUllBY44h0Y8BDo42fQq9f/JrLCOEPvrRsiMWRsXjD5Lk/ONSAIKhrcbGNJq49LOMhRcyX5yKOUgk/eR6m2K2Je87ra1pilbqW0d3mjbAtiS0FMWtqXedKiXppbkmsaTYAtDZhbllWnSy3xnnfiIiIiIiIiIiIiIiIOJ9MWagLIfjWt77F97//fW688UYeeOAB/uN//I+V0yIiIiLOFxdivcvevXt5/vnnKRT8hPeCBQu44ooraG9vP89L1xjjeXgjI3ipVEVeep5HqZinVChUBLQlJclYjLjV+GPGM5q0zpHSWdxyCZXN+/3oZcOIA3lHYJSDjJURwq2k0ctCkrXi5ISNNgZP66DWJUihG2/cNPqZKl2ksFHBQE4D1UqXUpmmIydgKIUjoAwgBM3FMsmyZN/GxeRWplnd+yrvTuysXGXZk/QNz8E59C68I1eiXV+Gu6oITfuYm3uBRa9toflYVaIbYcguj7Pl8vfw7JLreLZrJjm7JuFsNLNOn2DJkT0sOfI66zKHmNu0kt7kGjq6L0eKjtpHmbjcxUDyAE/MivPjmRs5Yj7E0swJlg+f4PeP/xw1hRXhowV64/qWMH1uEEpXqluEtjBaIkoqqGjxBbqQGiX99LklRF2KvsGThDECbTw0Gk979YNga5ECZVkIy/LluR2D0UNDCRpgMNhoP3VuPGKeX9uihIUyFkI1B+I87qfZz5A6N8IfUqqF7YtzZQU1LZP7jhRWtthKEQvk+USbClTS5YE0V5acVknz2g7zWmEe7o8S5hERERERERERERERFxpTFuphCv3P/uzPWLVqFf/m3/wbXnnlFe69995zvnARERERk+FCrHcZGBjg6aefpr+/H4C2tjauvPLKaTuHwmiNTqXwRkYqwlprj2KhQKmQr4hNWymStk1sHJHuGJeUzpLWOUyxhEznsbNFHAeyri/SUQ4iVkIIvxvd4JGXNjnVTBGFMcaXqQZfpHv6rNLoCAuJjZS1vegBWhM/OUD8RD8F7eEIAcKvdOnKFjm6aDEjGw0r577KNc3/UrnKoqc4OTiH8qF3wdErMV4cAE+WMckDzCu8wMLXnqf5eL1ET61o5oUr3suzi6/l2RndlGqS04linsVH97L4yF5WHH+VRZTpbd7IrMRltDb/LoKWmjtVxlI7ONB2ip/M6eSfuzai8stYnTnCFQdf4z3u9sk94dQIdFegvYkEukFaQQpdCIxRCM9COApjZKVSR6IRwkVJjQIsoc4g0GVlGRzP70DXNN7qRAbpc2HHELE4MmZjGkhvIwwKTbymuiVuNAoLKWykakHF4ygr4Q8hVeMPCa0mzmvFuT2lvvKY5UvzmFLELIElG8vzukGg07DTXEqJZVkNhXnUYR4RERERERERERER8XbjrCpfQn7nd36HZ555hg984AO88MIL52qZGnL//ffz2GOPsW3bNmKxGCMjI3Wnb9++nf/6X/8rv/nNbxgYGGDRokX84R/+IX/6p3/6pi5XRETE+aVYLJJOp3Fd93wvyqQoFAps2bKF1157DQDLsti8eTPr1q2bluLJGIPOZPCGhzGuLzO11pQK+bpql7hlkbRtrHHuQ1GXGdEZsl4eUSih0jlE3qHsQtaBvAtCOYh4CYODFh4eJkijN+PiD/D0qz0MaF+iG63H3JY0etxu9AkrXQArlaHl4DFKxSKulBQAhKAjVyTb2s2py9qx5x/m0q5fIYV/mbKWHB2cTfHgv8I68i6M9mt6tHAxiUPMLb7Awtefo/l4tRPdCMPQ6naev+z9PLv4ap7v6sCpkehtmRGWH9jFioO7WTl0gBnxTmY1rWNWz00k5RygOoBUkMWzd7Ktq8AP581la2wTs7NDrM0c5sOnnkJNssZl0gJd1VS4IBFa+R3oJVVpK/eXSyOFgxQaJUAJiUSOK9GNkeFN4GmDh4PGQ5kYrqmZyCpAKn9wqIjFEbEgfV6TdDaEC6KJGU3cuMSDwaG2UEiZQKomlOXXtmDb46fOhcQI2+84V3bQcT65qpaaRfbrWqxAno/Td15b0aKscL+YFinuWkk+enc6LF9ERERERERERERERMRbxZSF+tVXX00sFqscXrNmDc8//zwf+tCH3tRkaLlc5rbbbuOKK67gO9/5zpjTX3zxRXp7e3nkkUeYP38+zzzzDJ/4xCdQSvEnf/Inb9pyRUREnB8utHoXrTW7d+9m69atlMt+OnnZsmVcdtllNDc3n+ela4zO5XAHBzGOv7KiOmw0XxHpMWXRFBtfpFcGjbqFyqBRUfIouZBxoegKvx89XsTgoYWDIxQZFScrbAygjfa7so0GrdG6cRpdoFETpNGVsJHC/9irrXQRZYf2/Ucww2nyliQHICUxxyWmbY5vmou3dIC1vdu5yKomy49l2hk+cgn26zeC24ICPDxM4ghzC1tYuPc5mo/nK+c3wnB6bTfPXfY7PLPonWztasOrkbKdIwOsOLCLFQd3sXzkGJ3JecxvXs2sOZdgiQVAtU9fMkQquZene+CR2cs47W5iReY4a04eZZ1zYFLP75QFugQhJFIrjKfAVXVhaoFGCIMQGksYpJB+D/oZBbrCaA//PxfDqJUkQqBiNsK2EXYg0C3VsL7FNmHq3CVmPJIapIxjWU1IO4m0k/4A0glS50bFggGh/h9qal+VJMIfFGpJYkpih8nzyt0RVXFu+2nzsK7lfFe0NBLm4f6o1i8iIiIiIiIiIiIiIsJnykL9l7/85ZjjZsyYwa9+9atzskDj8V/+y38B4Hvf+17D0++88866w0uWLOHZZ5/l0UcfjYR6RMTbiAux3uXEiRM888wzDA0NAf575lVXXcWsWbPO85I1RhcKuENDmKKfqDbGUCoWKObzaOOn1G2laIrFsBvVatQOGnVKyKAfXTiaogsZR1DSJhDpJYxw0biUhCKjkuSF7Qt07Yt0bTyMbpxG92td3HGHaQoRQ8lYJY1eW+nSdrSP2IlTZIQhJyVYEmEMbUWXk8vmk1tbYtWs3SxL7q5c32ApzvG+5cjXbsZKLaoobi9+kjnF51m491laTlQHtRpp6F83m6cvvZFnFl7Oy13NmBox2T3Uz/IDu1h5YBeLM320J+eyoHkl8+ZdhmQJtR/TQpzkWMtx/t/sJP/YuZRkfiUXZQ7znoMvYpmxj00jjAZvigJdaAvhKYyrKqn/2hS6kBolNEpI/PKcxitXjJHB7SnQBg8XDxdNkdqVIEIKpGX56XM7htXahmoZu9JJorHxiGuPuHZpwsWSCaSdQKl2ZKwJ7ETj6nKhMHV1LfaUes4rV0NQ21KR5xIrkOK13ebKkpWBoNI6v2nuWkk+en9ERERERERERERERETEmZnUr6d0Ok1bW1tl/0SE55sOpFIpurq6zvdiREREnCNKpRKpVOqCqXfJZrM899xzHDjgJ4bj8TiXXHIJq1atmpYVCbpcxhscROf9AanGGMqlIsVcDi8U6VLRFG8s0v1Bo1lGdBZdKiEzOexsCRxDIRDpZW2QVhEZK6GFg8GjICwyqpmiUBWRro3B6ECkj15xcsYhowIh4ihp13Sj++dLDqVo3X+EYrlMwbYoKL+kpKnskOvqJr0pSfvc/VzZXl15nHctDg71Utx/Hc1H30Us0MmeytPJyyw5+Au6DvRVF08ajm9YwDOX3sjTCy/hlY5knUSfefo4Kw7sZsWBXSzID9Acn8vC5pUsnPcOJMuBePU5UUd4tWOYf5zTxVOxWSzMGNbnDnL78JOTek6rQ0R9iW70JAS6Fwp0OSqBbvw/4Q8TtWoGiTZKofsCXQISNGg8NC4exWoKXeAn0C0bEUsg7BjEY4jaOhQlERps7QYC3ZfncWkjVRwVa/bludXUOOEtLF+eq1ilsgV5dvVKtiWJK1ntPFeyTppPl5qW2h7z2r8oaR4RERERERERERHx9kEIwY9+9CN+93d/93wvym8dkxLqnZ2dnDx5kt7eXjo6Ohr+GDPGIITA8xoPDHureeaZZ/jhD3/IY489NuH5SqUSpVK11zZcYaDDWoG3EToQU2+3+xXx9sfzvGld72KMqfyBX0ezY8cOtm3bhud5CCFYvXo1F198MYlEonKZ6YJxHNzhYXSmmqwulYoU8zk87b+nW1LRZFuVYaO1y+8aj+Fg0CiFIjKTQ+XKGBdyHmQdgWO0L9LtUjBoVJOXioxsoSyk349eI9LHq3WRGGTdYMqazyNhBd3oVl03utCarv1HsfpOMxyzGBYCbAvlaZQVY2BjD2pRH+u6t2BJ/7o9IziYaWPw6Caa9nwA22mlGTBobHs/Cwd/xbwdL6Pc4Hak4fDmJTzzjn/NbxZu5tWORN2yz+47woqDu1hxYDdzCyMk43NZ2LKSxV0bsViJqRksquUpdnUO8PdzenmVblZmClzU9xofY9eZn8tKjYsMJHptq7n/iIwV6HYg0MUoge4j0aD8Op1qCn301weBMcIX6EYG6znCFHopGCZqRgn0ODIWx8RGCXRAYogFvefNniauc1gqgbSasWJNYDdhxFhhrYUKBoWG8jxe161e90CdAUtKYpaoDA6Nxywse7Q4l+MOBX2z/40LIcYkzMPd8WR+7ftUxG830XfCiIg3h+jfVkTEm0P0b2vqRI/Vhc/p06e59957eeyxx+jv76ezs5MNGzZw7733ctVVVwFw8uRJOjs73/JlW7RoEZ/85Cf55Cc/+ZbfNvjtJR/72Mcantbf309vb++bvgyTEuq/+MUvKknvRpUvZ8tnPvMZ/tt/+28TnufVV19l1apVU7renTt3cvPNN/OFL3yB9773vROe9ytf+UqlTqaW06dPT1t5d7ZorUmlUhhjpmU6NiJiNMYYisUihULhfC/KhBhjyOVyGGM4efIk27ZtI5fLAdDd3c2mTZvo7OwcswLvfGM8D53LofP5StDbccqUSyV0INKVlMQtCykVRaDoVb+YeWiyukBeFxDFMrJQgrKH68Upqzh5A1oZRLKMJRyMiKGxKUuLgrTxEFgGlDH+gFFjxta6GIOAURK9HhF0owvq8+p2Jkvrjt3kMinSiRjE/YKWpGsYXjUXa2WWlb07WRN7pXKZk4UmDp9aiHztX9OWWkF7uBhWitmlZ1m061c0DVW31Opf3sMvr/4Qv1h2OXvbayS60cw7eZiVB3ax/OBuZpayJOLzWdC8gqXdcWKsRON/rhpAixH2dJzikdkz2K7a2ZzPcUVqH+8MXW1T67j3X2uDU/b8v5KH1vXCVEqBHVPE4grLiiGNQmhJvWiveTwB8BDSoPA7wf0Uej2GoDLGyJrjdJBE9wW6QoFIIJREKBthW2DZYwS6QmMZjW084kITlwopWxBWHGPFEcLX+ADh9ilGSL/jXFgYqTDSgtGS3ZSY4KVTfYyEwJICOxgWGospLMsgFUjl+fUt0s/VawOOAzhnutZzg5SyMvgzTJ6Hh7XWlZkMERFTIfpOGBHx5hD924qIeHOI/m1NnUwmc74XIeINcsstt1Aul/n7v/97lixZQn9/P0888QSDg4OV80zXGtnJUi6X6+Z0Tpbf+73f4/3vf3/dcXfccQfFYvEtkekAwpzHqNLp06frXgiNWLJkSd2D+73vfY9PfvKTjIyMNDz/7t27ufbaa/n4xz/O/ffff8ZlaJRQnz9/PsPDw9OqvuZcoLXm9OnT9PT0RB9CEdOeUqlEOp2+IOpdjDEcPXqUXbt2cezYMQCam5u59NJLWbp06bSrWDBao1MpvJERTCBfnXKJfC6Hp/3HW0lJk20Tb9CrHCbSU24GmS8gUzlE0cPzIO9BzpFo4YIqgCr5w0YNZJVFWsbxhAy60XWwNZA3RqRX0+jjDBlFoWT9kFF/j6HraB/Nh44zrAQl2z9daINpbiZ3aZIl8/Yyu6W/ck1pJ8ae4S5yB/8V3UeuRRn/Mlq4tImdLDr6JD1791X6wwvtMZ6+/nd44qL38UJvBzp4foX2WHD8ICsO7GL5od10O0Xi8YXMa57BymZFXCzHM3Oqz4PIcaCtn/85q4PnVII16YNcVDzKmeZSGuN3oWvX70FvlEKXyiAtf8sxoSVC26CrHeijqaTQhUYRptBHDf2sGSJKTXWMn0J30Lgg/UsJZSFjwQDReHyMQLeNJmZcEni0SE3cslF2E5bdhJYJX47jb2Hggf88yzhGxoKhoTHO+EBNQNxSxC1JImGRiCvicYWyFZYlkOqt/3z0B5UqbNseU9Uy3d4/It4eRN8JIyLeHKJ/WxERbw7Rv62pk06n6ezsJJVKve3c1lQpFoscPHiQxYsXV7YYn+6MjIzQ2dnJk08+ydVXXz3u+UZXvjzzzDP88R//Ma+99hoXXXQRf/EXf8EHP/hBXn75ZTZu3MiTTz7Jtddey89//nPuuecedu/ezcaNG/nud7/LypUrAdi/fz+f+tSneO6558jlcqxevZqvfOUrvOc97wHgmmuuGTNH0xjDF7/4RX784x+zbdu2yvHf+MY3+MY3vsGhQ4cAX3qPjIxwySWX8M1vfpN4PM7Bgwc5evQof/7nf86//Mu/IKXkXe96F3/913/NokWLJvV4nT59mrlz5/Kd73yHf/tv/+3kHuQGTOW1MukJVAMDA+RyORYuXFg5bteuXTz44IPkcjl+93d/l9tvv31KC9rT00NPT8+ULjMRu3bt4t3vfjf/7t/9u0nJdPA7jePx+JjjpZRvyzdqIcTb9r5FvD1wXbeu3mW6y6RyucxLL73EK6+8UklMrF+/nk2bNmHb9pmv4C3GS6fxhocxblBt4jrkczlc10+5WkKSjNkkGiy7L9IzvkjPFbBrRHrOg0xZoIWHsLMYWQI8PAMZK05GxtDG17mhRPdFeqNaFz1uIl2KGFLaCFTdkFG7WGbm6wdhYJjTzXEyCX/5LU+TXdJDfH2WNTN3EFd+rLisJa9nWjl9fC2te/81raWeSumKUieYl/oN83c8T6zsvw61gm3/6jJ+8Y6b+eX8heTs6nvonL7DrH19GysP7KTLK2PFljC/ZTmrWgRJsRTXLPUfawOGMkda+/jfM1v5lR1ndbrA2sE9LKpO+WyIX+Mi0K7EazBMVAiDtHTQbqKQ2gLHGq3Eq+cHhPRAeCgBFhI1psqlpsZFy7rrcXHQOP7zLQRSWljx5hqBrupuK2Y8YmiSQtMqPWIqjoy1oVQcrRKYYMWIBhAWKBst42gZw8PFWE117wVTeVdQUpCIKZIJi6aETTKhsGIKqcRb/v5SW9Ni23adOI+IeKuJvhNGRLw5RP+2IiLeHKJ/W1MjepwmxhiD47xFm5zWYNv2pH6DtLS00NLSwo9//GMuv/zyht5yNOl0mptuuokbbriBH/zgBxw+fHjcSpbPfe5zfO1rX6Onp4c//MM/5M477+Tpp58G/FlwN9xwA/fffz/xeJyHH36Ym266iddff50FCxbw6KOPsmHDBj7xiU9w1113Ten+AzzxxBO0tbXx+OOPA+A4Du973/u44oor+PWvf41lWfzlX/4l73//+9mxY8ekEuwPP/wwTU1N3HrrrVNenrNl0r/g/sN/+A/MmTOHr33tawCcOnWKd73rXcyZM4elS5dyxx134HneG1oTMBFHjhxhaGiII0eO4HleZY3HsmXLaGlpYefOnbz73e/mfe97H5/61Kfo6/MHxCmlzqm0j4iIeHPQWpPNZivVKdMdYwz79+/nueeeI5/PA7BgwQKuuOIK2tvbz3Dptx5dKOAODmJKvjh3HYdCPofj+FvoSCFoisWIN0jEjhbpViDStQdZDzJliZYuIp4FUcagcRBkZIKsimGMqHQeau2ijR5HpLvIcYaMKhFHjB4yagwdp4bo2nOIrOvQ35yE1iQASkjSl3Qxd/FhLur4TeWaThSaeO30bMTe9zNrcD1zgmGaRhbodray6LVf0376eOX8R1cv4Imrb+XxZRs50VxdydCWGWbtnm2s3bON3swwdnwpC1qXsaZV0yQW4Zg1gMQ1fpP4yeZ+ftTbzM9jNkszWS4aeZXfEya8e2OoTaF7rgiGiTZIoSt/JY7QFsJV4EkaJ/pBoBFSI4OBoqFAr7vWSge6rLsag8bDwRMuRhikEEg7jkzEIR5H1ghhaQwx45EQhiY8WiyDZSexVRxUAk8mMMIX7h4CI2PBwFA/gU6NjDfGwBRnsyTiikTcojlp05S0iCfUW/6DQko5ZiBomD6PiIiIiIiIiIiIiDi/OI7Dl7/85bf8dj/72c9OShBblsX3vvc97rrrLv72b/+WzZs3c/XVV/ORj3yE9evXN7zMD37wA4QQ/N3f/R2JRII1a9Zw/PjxhtL7/vvvryTfP/OZz3DjjTdSLBZJJBJs2LCBDRs2VM77pS99iR/96Ef80z/9E3/yJ39CV1cXSilaW1vPqnKmubmZhx56qPI4PPLII2iteeihhyou4rvf/S4dHR08+eSTZ6zyBvjOd77D7bffTjKZnPLynC2TFurPPfcc3/ve9yqHH374Ybq6uti2bRuWZfHggw/yzW9+800T6vfeey9///d/Xzm8adMmwO90v+aaa/jHf/xHTp8+zSOPPMIjjzxSOd/ChQsrmxZERERMT/L5POl0+oIZnDI8PMzTTz/NiRMnAGhra2PDhg2sWrVq2iXqRw8c9VyXQi5LuUakJ+0YCXsCke5kkLk8ViqPKHsYNxDpjsTDRcRTIBwMmpLwRXpe1op0D0+7mGCYUC3CaKxwYOUYLCwZQ4j6IaPKcZmz7wjxo32caopxNG5D3AJjcGe0oi8WrJq7m7a4P8TT04JdmTZOHNlA774PMMeprvBIyn3MP/EUs/fsQGk/oZDubuFX7/kAT6y9lu3d1WGhdrnEygM7WbtnGwtOHCIZn0lXci6bF3TSoeZR1psBCye4K6eSp/m/PTF+ZlvMz49wUeYVbjmTRPcEnivwXDk2hS4NUmmkEqAlQscQ7ugal1H96UKDHF3lUv3oN0b6KXRUEA+vonHxcNHSQ2CQKoaKN/sJ9JiNCCS1NIYEmrg0tEiPZgW2iqNUAi19gY6QuIARll/ZomJoGQcVm1rcvP4RwbKlnzxP+n/NCestrWwRQlSS5rWJ80icR0RERERERERERES8EW655RZuvPFGfv3rX/Pcc8/x05/+lAceeICHHnqIO+64Y8z5X3/9ddavX19XVXLppZc2vO5aKT979mzAD04vWLCAbDbLF7/4RR577DFOnjyJ67oUCgWOHDlyTu7XunXr6lYqbN++nX379tHaWj83rFgssn///jNe37PPPsurr77K//gf/+OcLN9kmbRQ7+vrq+uu+cUvfsGHPvShymbKH/jAB/jKV75yzhcw5Hvf+16d0B/NF7/4Rb74xS++abcfERFx7imXy6RSqfOyqdXZ4DgOL774YqXeRSnFpk2bWLduXWUI6XTBaI03MoIeGcEP+XoU8znKpSIGE4h0v9plKiI950HaEXhohD0CsowxHkUkaZWkKO2xIt3TNeUsQNCPrsYR6QIbpeIIZDWNDrQOpZn96gGcTJaT7c14Hc3++Y0hv2YGHasGWd+zFRlI65FynB0j7eT3Xs/8E+9kUdCNLmSaOdmnmb/zGZryQ/59tiXPXnctT1x8E7+eN5NyKGWNZtGx/azds43lB3fTIuLEY8vYOHcxC5NJXO9yNJ2UAxk9HB/mZ92Kx2IWPfkB1uWP8gGhwzs29nky+D3oQRK9XqL7PehSGaRQCG2BayG82vGro1ZQAEJokF4g0dUoiR7WuNT3oIf4At3F4PnJdzuGircgEtUaFwHEMSSUR5swNCmIKRupkmgZx5MJtJBoIf30uYxhrBhGxuFsk+JCoGy/6zwU6M1Ji5j11onr0eI8SpxHREREREREREREXJjYts1nP/vZ83K7UyGRSHD99ddz/fXX8/nPf56Pf/zjfOELX2go1M92OUIfEAYcP/3pT/P444/z4IMPsmzZMpLJJLfeeivlcnnC65RSjgnQNXI9zc3NdYez2SwXX3wx3//+98ecdzKNIw899BAbN27k4osvPuN5zyWTFuptbW2MjIxUOtRfeOEF/v2///eV04UQdcM9IyIiIsbD8zzS6TSFQuF8L8qkMMZw4MCBylAO8Ld+ueKKK2hra5t2FTU6m8UdHMK4LsZoivk8xUIeg0HgV7skbBs5SZFOMGw040gcoxF2GmSpItJTdhNFYUONSHc9B7Su171BP7oaZ9CoFHGkjNXVukjPY9aB43QeOMaQJTjY2gRd/pprk7AoXdLC4oX7mNn8WuV69mVbef3UHJr23MTs9MrK8QkOsfjgE8w8sg1p/C8Lezes4ol33sLjy1YxlKh+JM4Y6mftnpdZs3c7nYU8VnwlSzoXs64tT8zMoWzeRzloIimpPE90u/yfhE1rsZ91xaO8PzxxPIkepNC126DKxTIoiV/K4tngyAlT6PV96CaQ6BKBCm5P1lS5jFkaPOGihQd4YMUQ8aRf5RKsbBFSEjOGpDQ0CY8OpbGlhVRNaJXElUk8IXGF7de2KL/CBXW2MwQEypZIW5CMK6SBGTM6SNoW8g0MIp0s4XDQ0anz6bb1SURERERERERERETE2SGEmFT1ynRjzZo1/PjHP2542sqVK3nkkUcolUqVzvUtW7ZM+Taefvpp7rjjDj74wQ8CvvAe3fwRi8XwRlVz9vT00NfXhzGm8tupdkDpeGzevJkf/vCH9Pb2TnmAbjab5R/+4R/e1ID3eExaqF9++eX8zd/8DX/3d3/Ho48+SiaT4d3vfnfl9D179jB//vw3ZSEjIiLeHhhjyGazZLPZaSehx2NkZISnn36a48f9Xu3W1lauvPLKugHN0wVdKuEODGKCga6lYoFCLoc2/gddwrZpisWmJNKLQSK9rI0v0lURYzxKCFJWEwUZinQdiHR3jEivDhptJNIFSsQQo0R6Ildg4a59WP2DHOto5nRnsBbbGJz5rdgbyqye9SoJy19LXvQstqVbOHF0PfMP3sDS0gz/7Hh0l19i0a5f0J7yN1EbmNXFL99zCz9fcwV7Oqsda8lCjtX7drD29ZeZNXACOzaf7qYlbOo5Sa9lUfSuxegWyvid4ntb0zzS0Uy/089m5wDX5oO17w1C2BNKdGFQlvZ7vrVCejZCj59CJ3ikfInuooQI6lz8VnT/9gKJrscujBEaT3iAi5ECEY8jY03BMFEJUmILQUJ4tApDqyiTkKBUEq1acWUSV9oYEcNYcbSKY9TZps8F0pJIy5foTUmb5iaLpKVIBINfUylNU+zcC+2w53y0PI8GOEVEREREREREREREnE8GBwe57bbbuPPOO1m/fj2tra1s3bqVBx54gJtvvrnhZW6//XY+97nP8YlPfILPfOYzHDlyhAcffBBgSr+lli9fzqOPPspNN92EEILPf/7zY+p5Fy1axFNPPcVHPvIR4vE43d3dXHPNNZw+fZoHHniAW2+9lZ/97Gf89Kc/PaMk/+hHP8pXv/pVbr75Zu677z7mzZvH4cOHefTRR7n77ruZN2/euJf94Q9/iOu6/P7v//6k79+5YtJC/Utf+hLXXXcdjzzyCK7r8tnPfpbOzs7K6f/rf/2vSqF9RERExGgKhQLpdHrMWszpiuM4vPzyy+zYsQOtNUopNm7cyIYNGypVV9MF43l4g4N4QU+6Uy6Tz2XwPBeAmLJojsdQo0ThGJGeziNKvkgvaV+klzwQdhZiBYzxKBtIWUnyMlZNpHsurnZAm3FE+tjnXASDRpE2oTo2GFqH0yzcsRcnk+HIjDbcmcHnjITihg5mLj/B4s5qGr2v2MzLI82U913Hkr6rWKP9NfFC5Jg38BQLXv818XIKA2x55xX833d9mN/Mm4kOks7Sc1l6+HXW7nmZJUf2kpAtJOLLWDdHsKzZQXtLccz7KQR3IWPn+f9mSH4lCywtvs7ywggrBI0luqYi0LVXL9GFCOpcpEBohfASiLqHaXQKXYAwCOH6dS4ILGSl0AWk38FurDFd6P4d1Wg8P4luWYhEHOJtyFgMhMCSIhgiauigTFIalIphVFMg0OM4KuEPD7XiGJmAs0iLCyVRlkBYEismaU5YJOIWTbYibskxX/TO1Yq3MHVe+xfVtURERERERERERERETEdaWlq47LLL+Ku/+iv279+P4zjMnz+fu+66a9yqmra2Nn7yk5/wR3/0R2zcuJF169Zx7733cvvtt9f1qp+Jr3/969x5551ceeWVdHd3c88995BOp+vOc9999/EHf/AHLF26lFKphDGG1atX861vfYsvf/nLfOlLX+KWW27h05/+NN/+9rcnvL2mpiaeeuop7rnnHj70oQ+RyWSYO3cu11133Rll/He+8x0+9KEP0dHRMen7d64QZgq/VgcGBnj66aeZNWsWl112Wd1pjz32GGvWrGHx4sXnfCHfStLpNO3t7aRSqSlvajDd0Vpz6tQpent7owRexFuG4zik0+kLphLKGMPBgwd59tlnK/Uu8+fP56qrrhr3PcEYQyqVor29/S2thTDGoFMpvOFhjDZ4nkshWx04aklFczyGPUocjhbpcpRIz7iCggvCyoGVB+PhACkrQU7GfZGOQXsennYwDUW6i2zYjy5QMhEMGq3cEbr6Bln4yl6yTpmjXW14QYe5brPRl8RYPn8P7XH/Q9wzgt3pdl4b6KV9/w0sGFlbuf6EOc7Cg79k1rGtKO2QaWvm/91wKz/ZfC1HWuOV883uP8raPS+zat8rtDguKraKJa1F1rX30WJWUNDvxOB/6dB4vNhR5H8nFbq8n7XiOLZoPEBXa/w+dEdg9CiJLv0+dCElwguS6GL8j2AR/E9I169zqUh06a+EqNS4NKpyAaRBE9S5xG0/gZ5sQlgKKSVJoWkymnbj0iQ1lrJAJXFVEk8mMCrpp8+teNB/PrXXtpASqQTSlkhLYsUETXGLhK1osi1iljjjv5ez+bcVps1r/6LPvIiIeqLvhBERbw7Rv62IiDeH6N/W1Hk7u62pUiwWOXjwIIsXL56SWH478P3vf5+PfexjpFIpksnkmS/wW85UXitTill2d3ePu2nBjTfeOJWrioiIeJvjeR6ZTIZ8Pn++F2XSpFIpnn76aY4dOwb49S5XXHEFCxcunHb9yTqfxx0YwDguWnsU8jnKxerA0eZYjPiogSee8RiqS6TnECUNHjgG0g7kHYmw8ohEFoyHawwjKklOxWs60l08z8EYQ+0qWWE01jiDRiUSWRHpgYDXhtmHTzBv134GJezuakPLJgCceUlaLs6xvHcnlvTldbqcYGu6iZPH1rLk6HtZV5gVPhp0Fl9h0Wu/pGNkLwLYu2o5P3nvR3l8+XKKlv+lO1YusnbPNjbueoGe4dPI2CJ6mlaycfY+5tinKHnX4XrzCV+xp+N5/ndHjJ26j9XuPta7xYZJdK1BOxLPlYFEr3lMpEYpEEIidAzhKYRnwgdszHVVkuiBRLfw61wUtl/0YgQYiWlQ5ULg7w0unvQgHoNkCyKRRFgWcWFoNpp2HFrwiAkBdhIvqHEpWs2BQE9glJ9cnzx+ZYtQwa4lsSxJMiZJ2oqmmEXMOrc/foQQY+R5VNkSEREREREREREREfHbysMPP8ySJUuYO3cu27dv55577uHDH/5wJNPfBKZXb0FERMQFjzGGXC5HNpsd07M1XXFdl5dffpnt27ejtd9lvXHjRjZu3Djt6l10uYw3OIjOFzDGUCr4A0e10ZWBo8lgmGTlMkYzorOMeGnI5OpEumsg40KuLMHKI5JVkZ5SCbIqMUqk+4NOa0W6NBo1jkhXWH4/ekWkG6TrMX/vEea8doCTyTjbe9owwi9+cZY3MWPDIEtmvFq5jgPZDl5Kx9AHr2Zl3zuZ4/nSXVBkzsDTzN/3FE3FAcqW4on338hPrriJHb3tlct3D/WzcefzrN27jYSOk0ysYN0cxYqWo0hvDgX9CXKuv/LBES5Pdnr8P6tES+l1lniDXCkY82lpDHhOmESvFbh+Cl2qcKhowpfolR6WcSQ6BqFGJ9FtRFDlgrEwDf45ieCmNS6eNJC0IdmGSCZQSpLE0KJdOkyeJqFRVhzPasFVzRTstkr/+ZQFuhAoSyJjsiLSLeXL86QtSZ5jgR4ODRotz6fbiq6IiIiIiIiIiIiIiIjzRV9fH/feey99fX3Mnj2b2267jfvvv/98L9bbkulliiIiIi5oSqUSqVQK13XP96JMCmMMhw8f5plnniGb9fvH58+fz5VXXkl7e/sZLv3WYrTGGxrCS6fBQKlUpJjN4k0wcNQYQ1rnGNJpdDaHSmX9ahe3VqQrjMojkhkwHp7WpKwkmTcs0m2EjCOErIh0u1Rm0e4D9Ow9wtGOZrbOmQFCYITBvSjJnItOMrfN70f3jGBbqpPtA53MPPR+1gytRwbx8Lg+xYJDTzL7+PNYXpFTM3v4X//mT3ls/TsYSvgfa1J7LD+4m007n2feyUNY9iLmtCzjHZ276Vb95Nz3U3J6K8t7sKnIPzYr+t1DrBBH2GgcGDX0ffzBoqFEF2AUwrORrqyR6I1WLI0eLAoKhRVk0o32r6tRKZuQEtB+nYstMMk4prkNGY9jC2jSHh26TJvrkVBgYglc1UXZasezWzBWMhDo47zYGi2tlChbIG2FtPxBogJIxhTJmKL5HAp0IUSdNAeYNWtWlDyPiIiIiIiIiIiIiIiYgLvvvpu77777fC/GbwWRUI+IiHjDuK5LOp2mWCye70WZNKlUimeeeYajR48C/tCPK6+8clrWu3jpNN7QEMbTuE6ZfC6L6zqAP3C0KR7DGiUbszrPoJfGzedQqQxWwa2I9GyQSNdWEZHMIIyLpzVplSBjJYJuboM3ZZEufCEs41Aj0pPZPEtf2Uf74RMcmtHGlkUzgyvSuJubWLjqCD3NAwCUPYsXUm3sPbmIpYdu5Mrcgsq1txdfY+HeXzJjcBdgeOnSS/nJNR/m1wvnVIaMNufSbNi9hQ2vbqW1UMSOr2bNrHmsb9uL9P4VBf1p0q7fKV9QLv/cBs+LIXr0HmaZLLMbJNGNFniOwHMkDTvRsfw+dNeX5D4TSHShQbpIYbCQZ5boAqSQgEELDy8m0M0JRHMSadk0GY9m7dLp5mkWHpaU6EQTrmojG+vAWM1oKw5TENJC+clzaUmkLZBBp33ckjTFLF+k22OHiJ4NYW1LbQI9vF6tNZlM5g3fRkRERERERERERERERETEuSIS6hEREWeN53lks9nK8M4LAdd12bZtG9u2bavUu6xfv55NmzZhj+ocP9/oQgF3cBBTKjcYOCppjsWxrfqBowVdYsBLUS5mkaksVr4Mji+Gsx6kyxIti4hEBoGL1pq0ipO2koFIB0+7aM9FjxLp43ekCyxiSBnDCBE0pBvaBkdYumMvyb4BDvR28PqS2QAY22AuTbB02QHaE/6g0ZwT59l0M4ePr2D14Ru5IuhHF5SZOfACCw7+ipbcCTJNSX50y+/zT5dcy+H2ag/c/BMH2bTzOZYdehVbdNHetIyL5+9mceJVCu6NlJyPVs67q9nhJ3GHrLuHpeoU64WG+oex2ovuSL+3vPogoCwT1LnEkZ6csM7Fvw8EEt0LetEllt8q7w8U1dYYiS4CiW4waGlwExLTEodkElsKmrRHm3bpcIokpEEqGzfRQtnuohDrQFsJUJN9PfuJc2n5/efSlohgBYWlBE1BB3oyJlFvMCUupayI83A3Sp5HREREREREREREREREXEhMWagrpTh58iS9vb11xw8ODtLb24vneeds4SIiIqYnWutKT7pp1EkxTQnrXcLE69y5c7nqqqvo6Og4vws2CuO6uEND6Ew2GDiap1wsTDhwtGQcBr0U+VIWlcpiZYvgAgbygUh3KEE8g8BBG4+MSpCqFenGxbguntFgqnp4siJdY8Bouk+cZtn2PYh0lv0zOxheOse/X0mQl1usWLyPJrsAwHCpiafTcfqOrmPd0d/hqlI3ANLkmX/kSeYfe5KYk+PA0iU89P57+X+rVlaGjNpOibWvv1wZMqpiy1nYuZKLO16kQ1pk3X9L2pkBgCs0/9JqeIZ+Zqq9zFOFMRJ9wl50yyCFDOpcbF+QA42T6H4WXQgD0vUrXQKJrohVJHqDhxMlJAiBJw1Ok0K3JJGJBAmjgxR6gRbhEVfgxRK4Vjf5+Aw8uxWjEiAnkxgPBLodpNBtUUmES+HXuDTZimTcIqbOXnaH1S21yfPpNpMgIiIiIiIiIiIiIiIiImKqTPmX7XjyrFQqEYvFGp4WERHx9sAYQz6fJ5PJXDADR8Gvd3n22Wc5cuQIAM3NzVxxxRUsXrx4WtW7GGPQQb2L9vSkBo46xmXIS5NxMqhUFjtbBMeAhpKGtCMouh7EUwhR9EW6jJOyW9EoMKCNh3ZdtPH8ipPguoUxWKGVr0NgYSNlvCLShfaYe/A4S3fspeQ47O3tJN0dJNLbIXa5YPn8PcSU36/fX2jj12lF6sg72HD8epaVOwGwdIb5h3/B/GNPgXF46trr+clVH2Db7M7KrXcNnWLTrudZu2cbCU+RiK9i3WzJ2tYXEPoact5nSes4ACnL5R+bDQe9fSy2j7FK1q/0PWMvupQYY2N5VjCz04CYQKJjQIUSXQS96IFEN9ZY/x4k0YWQGAVuQqGbY8hkgmaj6dAO7eUMSWGwlMBNNuHEukjFO9FWC6jJfYz7CXSJiqk6gS6AuB3UuNiKxBuocbEsqy59Hg0NjYiIiIiIiIiIiIiIiHg7Mmmh/jd/8zeAnzh76KGHaGlpqZzmeR5PPfUUq1atOvdLGBERMS0oFAqk0+kLaisU13V5+eWX2b59e6XeZd26dWzevHl61rsMDGDKDk65RD6bwdPjDxz1jGZYp0m5GUQ6i5XJI0q+SHcNpB3IOWDsDDKRB+OSxWYk1ooXRLPrRDpUakcmFukWUiYqIl16LgtfP8zS7XtIWZJXZnaSTQQrV7sFycsdls3ej5K+ST6c6+SptMA9cjkbTlxHk9MGgO2NsPDgz5l74mmKMcX//tBH+D9XXMtg0r8uoT2WH3yVTbueZ/6JgyhrHjOa1vCOrpdZEHuBgncjeeffVZZ07//P3n3H2VnW+f9/XdfdTp0+k4T0AimkkZBAqEEpCouIlOWLWxCFZXXXH5YvQZHIoqiLqLi/n67fXVyEL+K6BRBEukaygUACqaRBSCPJzGQmc3q7y/X74z5zMpNMSCKEhOR6Ph556Myccp/JnDnkfX/O+xP1edwuUg7WMMzazYQ+53sP3IsOQpnhNLoiDMnF/upcBKAQRrhcVEK10uUgQnQZhtd+1MCLWYhYhFg1RG/0csRQYBm4ViMlpxnPbkSZkYNbJioEpi2RloFh76lwAbAMGU6hVyfR5UFNte/Ltu1+f3R1i6ZpmqZpmqZpmnY8OOhA/Uc/+hEQTlD+7Gc/wzD2vFfetm1GjRrFz372s/f/CDVNO6JKpRLZbBbXdY/0oRw0pVSt3iWXywFHcb2L7+N1dxNkc/v0pNuGQcxx+i0cDVRAOsjR42cgm8fI5BGVADzwqz3p2bIgMAvIaA4ReJSUpMeqoyKs6m3sP0g38Pos1tzDxMKQEYI+E+kjN2xh3LJ1pCyTpcNaKDjVkxTDBHWzCoxp21y7/rpMC/+TVdhbz2LqzvOIeHEAHLebkZueY0j7y6TqEtz/lzfxmxmzydnha0yskGHamqVMW7uEZKGIaU9gbOt4Tml4iXrGkPP/kpQbVsoEKP6YUCwUnTQYGxhkFfp/r4PeSpcBetENwl70wNrTi76fEB16K10CkG6fXnQTqYz9h+gynEQXUuLbEi9qIuMOMaFoCDwa3RxRoRCmQSXSSt5pwXUaQRoDHsPed9Dbf27Y4TR6n7vGsSRxxyRum9jmoQffQoh+4bnuPtc0TdM0TdM0TdOOVwcdqG/atAmA8847j0ceeYTGxsYDXEPTtA+zSqVCNpulXC4f6UM5JOl0mpdeeolt27YBYb3LGWecwahRo466+gk/k8Hv7ibww570crGAQmFISdy2sffqm077eXqCDH4uh5HJIUo+eGEgnvfDehePMjKSQeLi+oIeK05RhvUne4L0AIU66CA9nEgHn3BSfMSbWzlx2TpyQvD60JbqRLqCsYKWmWmGNW6v3p9gZbqVRdmAxq3nMav9bBw/XCQaLXcwctOzDO54lR2D2/h/b7yF300+Gbfa2d20u5PTli9k4lsrMUkSj4xn+tC3mRB/FuWfR977JinCUD5vBDweC9ig3maos5Ux0qsdv1KgfIHnDlDpYiqkMBCehfTNg+tFr1W6hHP+BgamigwcokvC25cCIQ0CS+JHDIjZxA2oD1wa/UIYohsGlUQrebutGqIf+GdVGGEH+t41LhBePe6YxGyDuG0e8hR67/LQvgH60fb80TRN0zRN0zRNO54JIXj00Uf55Cc/eaQP5bhzyB3qf/jDHw7HcWiadpTwPI9MJkOpVDrSh3JIXNdl2bJlrFy5slbvMnXqVE455ZSjr96lXA7rXUplyuUSxVyOQPkIwoWjkb3Cy3xQpNtP4xbyGOksZsmD6hsGij6kPUHFryDsHFKU8f2AtBUla0UBgVIBge/hB/4hBemGdKoT6SCCgGEb32H862sp+z4rhjSTjkcAhZgAQ2Z005bcBYAbGLzW08pLuYChW8/nnI4zsKqd5rHidkZveoa2ztd5c8xY7rr5Wyw4cTRB9fEOad/K6cteZOyW9UhzOEPqpjKz8RWGW1vI+5eSrXwWCEP3bU7A41aRtFjLMKeLsX3y3j0LRiUq2LvSRYBvY/gmUvTWuexvJ0BY6iJkWOkiRBAuGFUWUpkQ7DWlLQVCymqQLsEQeDEDEbWImYL6wKUpKBLxq5Po8RZyTiue0wQHmvjuU+MiLRk+jj5sU4Y1LrZJ9BC70A3D2CdA1zRN0zRN0zRN046MXbt2MX/+fJ588kk6OjpobGxk2rRpzJ8/nzPPPBOAnTt3HpGB51GjRnHzzTdz8803f+D33WvJkiXceuutvPbaawghmD17NnfffTfTpk37QO7/kAP1K664gtmzZzNv3rx+n7/77rtZsmQJ//mf//m+HZymaR8c3/fJZrMUCoUDX/goopRi06ZNvPzyy+TzeQCGDx/OGWecQX19/RE+uv5UEOB3d+NnsnieSyGXw/MqAERMi5jTvye9FJTpCtKUizlkJoeZr9BbbV4JIO1B0QvAyiLNEsr3SRsO6UgchUChCPxKGKRXt40qwiBd4iEHDNLNWrWLDxAohr79DhNeX4tfqbBmSDNdyRigEOMUg2d1M6guDNKLns0rqSZeyQjGbruACztPx1RhMJvIb2H0pqdp7lrF8qnT+eFnf8irIwbX7nfMlvXMXr6QYTu3YFrjGNt6IrMbf09CjSXnf5pud0ztsotjAQvFLixrPS1Wgb5/y4EPvmvgu3tPo4PEQPg20hfVSpf9L9bdM43uVrvRBSYGprIhMPvXy8uwxqW30gUp8B0DEbeI2oJBgUtTUMLpDdETreSdVly76QCT6PuvcaH66CKWJPYnVLn0LhDt/WOah/yfA5qmaZqmaZqmadphcsUVV1CpVHjggQcYM2YMHR0dvPDCC3R3d9cuM3jw4He5haNfpVLBtu0DX3AvuVyOj33sY3ziE5/gpz/9KZ7n8c1vfpOLLrqIbdu2fSADYkIptf+S2AG0trby+9//nilTpvT7/KpVqzj//PPp6Oh4Xw/wg5bJZKivryedTlNXV3ekD+d9FQQBnZ2dtLW16e5brSYIAnK5HPl8nkP8dXDEpVIpFi1axPbtYcVIIpHgjDPOYOTIkR9oPYVSinQ6TX19/X7v189k8HfvxnddioU85VIRAFMaJBwbs89eCld5dPtpcuUsRiaHzJfCifTqwtGsB7mKQpl5pJEHfHKYpK04njDDID3wCXwPpYJaT/oBg3QRIZDVeXWlOOHt7Ux4fS2iWGLD4CbaGxKAQo5StJ6WYkhD+Pu+4Dks7Gnk9ZTFhHcu5KSuWRgqfDx1mbcYvfkZGnrWsmjOOfz6wmtYM6gBCOtjJmxczezlC2nr7sR0JjCpocCpDX/ACE4n511GQHi2vSwUT8d83lCbaI1uIbpXrUvgCbyKRPWZGBdShVUngYWp+la67M++0+gSiaVMpLKgz6R7GKILpDTCEF0IVMSEmEnMFtQrl0bfw5EKYZhUok2UI614TiOId/v9KzDssMZl72Wi8KdXuUgpcRyn9qfvHpSjmX7d0rTDQz+3NO3w0M8tTTs89HPr0B3L2dahKpVKbNq0idGjRxOJRI704RyUVCpFY2MjCxYs4Nxzz93v5faufHnppZf4/Oc/z7p165g8eTLf+MY3uPzyy1m2bBnTp09nwYIFnHfeeTz//PPMmzePNWvWMH36dO6//37Gjx8PwMaNG/nyl7/M4sWLyefzTJw4ke9+97ucf/75AMydO5c//vGP/Y5DKcUdd9zBY489xvLly2ufv/fee7n33nvZvHkzANdddx2pVIpZs2bxk5/8BMdx2LRpE9u2beMrX/kKzz77LFJKzj77bH784x8zatSoAR/30qVLmTVrFlu3bmX48OFAmEtPnTqVN998k3Hjxv0J3/VD+1k55JG0XC434NkDy7LIZDKHenOaph0hSiny+Ty5XI4gOFDQeHRxXZfXX3+dVatWEQQBhmEwbdo0pk+fftRN2gaVCt6uLoJikUqpSLGQJ1ABUghi1XqX2mVVwO4gS9rNINJZrFwRXAU+BNWe9HRFEcgS0skiqC4ctcOFo2GQ7lWDdFWrdwmrXQJkOHPeTxikOwSy+lWlGLJ5BxNeW4uVy/PWoCbeGdGKEgIx1Kd5To5hzTsAKPkWi3qaWNLjcPK2j3NZ1wxktY6lsWctozY/TTy3iec/cjG//siX2doQdp4bnsvUda9x6opFNOTyOM4kpg4RTK9/AuWdR65yD4oEAJ2m4rd2gU65niGRXYzosyg0CMCvSHxPguozjW6AEAbCNzEC40+bRlcGZlCdRu8lw+lzKcJOdIEAKwzRIxFoED6NfolIoBCmSTnRZ7GoeJcAu1rlYtgm0hb7nJT5U6pcepeI9gbousJF0zRN0zRN0zQtpJQiCIof+P1KGT2of88lEgkSiQSPPfYYp59+Oo7jHPA6mUyGSy+9lIsvvpiHH36YLVu27LeS5bbbbuMHP/gBra2t3HTTTVx//fUsWrQICHPfiy++mLvuugvHcXjwwQe59NJLWb9+PSNGjOCRRx5h2rRp3Hjjjdxwww2H9PgBXnjhBerq6njuueeAMN+56KKLmDNnDgsXLsQ0Tb797W/zsY99jJUrVw6YQY8fP57m5mZ+/vOf8/Wvfx3f9/n5z3/OxIkT9xvCv98OOXmaMmUKv/71r5k/f36/z//7v/87kyZNet8OTNO0w6dQKJDNZvH9fQPWo5lSirfffrt2phRgxIgRzJkz5+isd9m9Gz+TwS1XKOSz+H44VR21LKJ2/3qXTJCn20uhsjmMTB5RCcJ6FyDvQcZVuFQQdh5JCVdRXTganjXtnUjvt3BUKSQBxn6DdJtAGPgivOzgLTsZ//paYqksG9sa2TJsJIEUGIM86s8oMqLtHQBc3+ClnlYWZQSTtlzCJ3bNqgXpzd2rGLXlaaxyO7+9+Er+68xvsCsevvg75SIzVi/mlFWLiZcV0ehETh26kcmJ/6TifZxs+ccowqWlW2zFb80eXGsNLXaOYb3fVwWBL/ArksDvM50iFIYhILCRgYlxgG50Ua2D2Xsa3VQ2RmDvqXQxJAgQolrpggyn06MmVlRQbygagzIxwkl0N9FKzmnDc+pQYv8vsUKGNS6mE/ah780xJfGIScIxsY2Dm8IxTbMWoNu2rad3NE3TNE3TNE3TBhAERRb8ccqBL/g+m3vuKgwjdsDLmabJL37xC2644QZ+9rOfMWPGDM4991yuueYapk6dOuB1Hn74YYQQ/Ou//iuRSIRJkyaxffv2AUPvu+66qzb5fuutt3LJJZdQKpWIRCJMmzatXw/5t771LR599FEef/xx/u7v/o6mpiYMwyCZTP5JlTPxeJz77ruvFpQ/9NBDBEHAfffdVzvZcP/999PQ0MCCBQu48MIL97mNZDLJggUL+OQnP8m3vvUtAE488USeeeaZD2zI8pDv5fbbb+dTn/oUGzdu5CMf+QgQnl341a9+pfvTNe0oVywWyWazeJ534AsfZXp6enjppZdq9S7JZLJW73K0CbJZvN278cplivkclUoZANswiDsORp+gsxiU6fJTVAo5jHQW2WfhaCmAtAslzw2DdFkk8AN6zBhZs3fhaBik+yoAFQbpCpCqN0jvX+9iYGIKG9UnSB+0tZ0Jr60lsTvN5pZ63p44Es+QGM0e9WeWGT1kKwBeIHm1p40/Zj3Gbvsol7WfhaHCl5GWXcsZveUpPJHhvz/xFzw6ew45O/xaPJ9m1oqXmLZ2CbYfJRmbxGltKxkf+3eK3ifZXf4MEL6YvukonhZdyMgb1Ft7FuOqIFwy6rkDT6PjW5i+DGtd/qRpdAeC6hR5NURHSAzROxEuEI6FGTGIOdBMhQQBpmHixpsoRAfh2g0ouf+XVWmGC0VNZ98+dDj0EP3DWuOiaZqmaZqmaZqmvbsrrriCSy65hIULF7J48WKeeuop7r77bu677z6uu+66fS6/fv16pk6d2q+qZPbs2QPedt9QfsiQIQB0dnYyYsQIcrkcd9xxB08++SQ7d+7E8zyKxSJbt259Xx7XlClT+k2dr1ixgrfeeotkMtnvcqVSiY0bNw54G8Vikc9+9rOceeaZ/OpXv8L3fe655x4uueQSlixZQjQafV+O9d0ccqB+6aWX8thjj/Gd73yH//qv/yIajTJ16lSef/75d+310TTtyFBKUSwWyeVyH8ogvVKp1OpdlFIYhsH06dOZNm3aUVnv4nd3ExQKlAoFSsUCCoUhJHHHxu5zvHt60jMYqRxmoRxOpFd70lMuFFwPzAKGU0AFPmkcMpE4ARKlAgLfDSfS+/WkB1gDBOkSiYUD0qwF6a3bOpn42hrqu3rY2lTH0gkjqVgGZoNH3RklxgzfEj4uJVjaM5jf50sM3XYGl+w4DzsIX6QbetYz9u3HyUcK3H/NdTw5fRoVo7f2ZRenLV/IxDdXYIlmGmPTmNP8KmOcX5Pzr6Cr/Hf0vgytchS/F+3Y0XU0muEJCKVA+QLPlQRenyWjQmEYgLKQgYUUVPvR3y1Il9Vp9MqeafTAwQiqVSiGDA9FhItFpQijd2EYCMckFhU0SJd65eIIiR+JUY61kXea8Y39vVgLpCkxnOpS0QFCctuUJA4yRNc1LpqmaZqmaZqmae+dlFHmnrvqiNzvoYhEIlxwwQVccMEF3H777Xzuc5/jm9/85oCB+qHo+2/J3qnw3irgr371qzz33HPcc889jBs3jmg0ypVXXkmlUnnX25RS7rOXz3XdfS4Xj8f7fZzL5Zg5cya//OUv97lsa2vrgPf18MMPs3nzZl5++eXaO7MffvhhGhsb+c1vfsM111zzrsf6fviT0qhLLrmESy655P0+Fk3T3kdKKQqFArlc7kNX7QLh8W/cuJHFixdTKBSAsN7ljDPOOOqWqqggwM9mcbu7catT6X7gIwh70qOWVXuR8lVAT5AlVUljZHL79KTnfEi7PkqUkU4WAo88FimnDk8YKAICv0IQBPv0pJt4iL2CdIHAwkZIuxakt2zfxYTX1tDUsZsdDQmWTxhB0bYwkh6JOUXGjNqCrHaVv94zhOfyBVp2TOeidy4k6oXd5snsVsa+/RsK5m7++S9v5LmTJxFUF2QO6djG7GUvcuLmdRjmMNrqTuH0pj8ywlpKxruKzsr/BsJp6qWRgIVsJx7bQLMRvtgqBb4n8CsGqs8iUCEVUkgIbAzfQB7ENHp4PQ9kGYHCVCZmEEEEsk+IHvaWSxFWuggEwraIOIJ4VNGkKsSkAitCJdpGNtqGayb3s1xUYFgSwxl4qShUQ3SnGqIPMKnel2VZ/WpcPshlu5qmaZqmaZqmacciIcRBVa8cbSZNmsRjjz024NfGjx/PQw89RLlcrnWuL1my5JDvY9GiRVx33XVcfvnlQBh49y4V7WXb9j45U2trK+3t7Silav9u7bugdH9mzJjBr3/9a9ra2g466ykUCmEla59/H/d+/EHtCPyTAvVUKsV//dd/8fbbb/PVr36VpqYmXn/9dQYNGsTQoUPf72PUNO0QBEFQC9I/bMtGe3V3d/PSSy+xc+dOIKx3OfPMMxkxYsQRPrJ9Bfk87q4uvHyObKmE54VnbR3TJL5Xj3Xaz7PbD3vSzb160gs+pN2AiqogjRxSVKoLR+upyHDhqApcfN+vBem9Y+kGPnKf6WyBhYUhHXwRzm43dnQz6dU3aG7vojMZY+H44eQiNkbMI356iTFjt2DI8HZWpQbzbK5ArGM8H9n2cZKVJgCihQ7GbnqCwNvGL676LL+bNhW/+hhHbd3AacsXMnzHJgxrHMOapjGn+TnapEfG+3M6KnNqR7coErBYbKE+tpFWGX4TlAqXjO5T62KGj0b6Zhh3H3AafaBaFwvTt0GK8I8hQAgMZBioI5CGieNIohFBg+GGlS6mjec0Uoi14dr1BHKgZTBiTx+6PfDS0EMJ0R3HIRKJ4DjOUfcuDE3TNE3TNE3TNO3w6u7u5qqrruL6669n6tSpJJNJli5dyt13381ll1024HWuvfZabrvtNm688UZuvfVWtm7dyj333ANwSINZJ554Io888giXXnopQghuv/32fbKlUaNG8eKLL3LNNdfgOA4tLS3MnTuXXbt2cffdd3PllVfy9NNP89RTTx0wJP/0pz/N97//fS677DLuvPNOhg0bxpYtW3jkkUe45ZZbGDZs2D7XueCCC/jf//t/84UvfIG///u/JwgCvve972GaJuedd95BP9b34pD/pb5y5UrOP/986uvr2bx5M5/73OdoamrikUceYevWrTz44IOH4zg1TTsA3/fJ5/MUCoUPbZBeLBZZunQp69atq9W7nHLKKUydOvWoCxaV6+J1d+NlcxQLOQqlEg4KS0rijoPVp8+6EJTo9tNUClmMVBZZ9sMgXYXD6alKQNH3wShgmHlcX5Ey4xTMaDVI91G+i4+q9aT3LhyVAy4ctaoLRyWegHg6x6Qlqzlh0w52xyO8PG4oqXgEI+IRm11i9EnbsIww1F6bHsSzuRKqayRztl5CUzHsU7PLKUZvfhKnsJZffeo6nph5Km61omT01vWcteQFBu9qx7AnMrZ1Mqc1Pkm9SJLx/hed3kwAAhQvRgJeF2/TGN/EoOp0uQrAcyV+RdKv1kWG0+jSN/osGe0/gd/XvkG6xFQRTGWG0+RWtQu9No0e/n/bsog6gjpHkaSCY5gE0TiVSDMFpxHPSMAA/wEiTQMz8t4n0YUQtRA9EonoZaKapmmapmmapmnHsUQiwWmnncaPfvQjNm7ciOu6DB8+nBtuuIGvf/3rA16nrq6OJ554gr/9279l+vTpTJkyhfnz53Pttdf261U/kB/+8Idcf/31nHHGGbS0tDBv3jwymUy/y9x55538zd/8DWPHjqVcLqOUYuLEifz0pz/lO9/5Dt/61re44oor+OpXv8q//Mu/vOv9xWIxXnzxRebNm8enPvUpstksQ4cO5aMf/eh+w/gJEybwxBNP8A//8A/MmTMHKSWnnHIKTz/9dK0T/nATau+CmwM4//zzmTFjBnfffTfJZJIVK1YwZswYXnrpJa699tp93gbwYZPJZKivryedTh91tRLvVRAEdHZ20tbWpgObY4jv++RyOQqFwj59VR8Wvu/zxhtv8Prrr9d6ucaMGcNpp522z2KKI00pRZBK4ff0UCqVKOZy+MqnLATNlkW0z3INV3l0+Sny5WqQXqyEC0erPek5HzIVF4wS0sijAo+0ESVjxVEIgsBHBV61J51quK6QqAEXjpqYmNgoGS4ctYtlxi9bx6g1b1OyDNae0ExHfQJp+0Rmuoyc9A6OGdasvJVp5dm8R657OKdtvZRBuVHhbbp5Rm19hkTqdf7zsmt59LQ5lM3wZMHw7W9z1pLnGda+HdOZzMSGAqfW/5YYQ8l4f05FTQbAR/FCxGOVfJPm2DbMap1M4IPvGvjunn50IVT4+8m3MUV1yei7qnadSw+EF/ajKxNTWRjCCoNwIUCAwZ4Fo6ZhErMMEjFIygpRKRCOgxuppxJpxjXrB1wwKoxwEt1wDKTxp4foUspagO44jq5y2Q/9uqVph4d+bmna4aGfW5p2eOjn1qE7lrOtQ1Uqldi0aROjR48+pGD5WPDLX/6Sz3zmM6TT6Q9kUeeH3aH8rBzyyOeSJUv4P//n/+zz+aFDh9Le3n6oN6dp2p/I87xakP5hpZRi69atLF68mHQ6DUBzczNnnHHGB3ZW8VAExSJeVxdeoUghn8V1w/A/YppYpkmkOpUe9qRnwp70dA4rXwyDdD+sNQnrXTxc5SGtLEJVKCiTHqcp7ElXPoHvV4P0PT3pUgWYAwTpBgYWNkqaeAIMz+PEVW9x4ooN4PtsGNzIptYGhKWInlJixJQdRK1w8efmXAvPZRUdqQZmb72UEemJAEi/zPB3fk9T10s8dvGn+M8zr6NohS8ZJ7Rv5axXn2fkjs2YziSmDhbMrH8IS40n491KlzoJgIpQPOu4rDfW0xLdwaBakC7wKpLA2/Mfw2E/uhEG6YFAyAPXugAIoxqkA4YyMYNY+B/Z1f/QFoI93ehCEDUNEhGDetsnalQwTAc/0kQ52kTFqscfqEdPCEwnnEaXA4TkpiGoi1gHDNFN06yF6H23mmuapmmapmmapmnae/Xggw8yZswYhg4dyooVK5g3bx5XX321DtMPg0MO1B3H2WfUH2DDhg373b6qadr7x3VdcrkcxWLxSB/Ke7J7925efvlltm/fDkA0GmXWrFmcdNJJR93UgfJ9/O5u3HSGUjFPuVhEobCkQdyxMaQk44fhb9rP0+2nIJPDzPbvSS8H0OP6lAMPIfIYZomKgpSVpGg41YWjLirwCcJel1q9i9XbEdOHQGDjIKSFL0AFihEbtjDhtTVE8iXeaUqy7oQWXFMQmVBm6OxOkpE8ANvzTTyfMXg7G2XWtks4u3tGeJuBzwk7/4dBO//Akxd8jH8/915yTrgBvG3XDs5e8jyjt76JaU9k0qDRnNbwayw1kYz7bTw1CoCSUDzllNlsrqUl0sEgsWfRqFeRKL/371chDRCYiMDGgGqQfvC1LgKJqSwsbJAGeybdJbLajW5KQcI0qYsJkoaHbUsCO4YXbaRo11cXjBr73JPpSAzHRFpinwlyASQiJsmIRcze+7p72LZdC9GPttoiTdM0TdM0TdM07djR3t7O/PnzaW9vZ8iQIVx11VXcddddR/qwjkmH/K/7T3ziE9x55538x3/8BxB2v27dupV58+ZxxRVXvO8HqGlaqFKpkM1mKZfLR/pQ3pNSqcTSpUtZu3YtSoX1HlOmTOGUU045Kqd2/UwGf/duSoUCxVyOQPlIIUjYDo4VBs1KKcrKZaubwivkMNJZRJ+edE9B1ldkKy7ICoaZxQt80jJG1ooRACrwUL5HgKpOpQOBQuIh9wmYBTY2Ulj4QqBQtG3rYNKrq6nfnaE7HmHJhBHkHAt7WJmhZ6ZpbegGYFexjudSUd4owIx3Ps6fd5yOxAAVMKhzKSe88yzPn3s2D//tPaSi4d9H8+4OzlryAiduWoNpT+CktvHMaXiEKMNJu/PJqnEA5KXid1aR7fYamp0uWqtBuucK/IqBCvosGjUEQtnIwEQKDljtEk6YByArIHykMsJ+dGHXptH31LqEH0ekpM42qI8oomaAEXHwIg0UI41UzAYCY+8FowLDkhiOgeEMvFw0YsnaNLocoDddCNEvRDeM/YftmqZpmqZpmqZpmvZ+ueWWW7jllluO9GEcFw45UP/BD37AlVdeSVtbG8VikXPPPZf29nbmzJmjz3po2mFQKpXI5XK1bvEPqyAIWLNmDa+99lrtpMCoUaM4/fTTj8pOt6BSwdvVhZfL9at3iVZ70mU1bHWVxy4vRbZcwUp1YZb29KSr3p5018OjgrRyoCrkhE0qUo8nJCoIqj3pqlbvEgbpAy0cFZhYmFgoGS4cre9KcfIrq2jdsYuCbbJ09BA662JYDS7NZ6UYPnQnAAXP4YXdTbyULzN1+1z+V/s5mEE1MO9exfAtv+PF00/hm5/7Dt2xsCusId3FmUt+z4SNqzDNcYxpmcxZzY+RoIG0+xXy1Y70glQ8YeXpcFbT5KRooRqkVyReRYLaK0gPHGRgIIU6QJAeFrsI6YOohP3qysAgjilN9kyj76l1kQjiUlDnmNRFFLYFIhrDc5KUnLDWBdH/HRDSlBj2/nvRa5UuERPb2PfdE0KIfn3oR9s7LDRN0zRN0zRN0zRNe/8ccqBeX1/Pc889x6JFi1ixYgW5XI4ZM2Zw/vnnH47j07TjVrFYJJfL4brukT6U92zbtm28/PLLpFIpAJqampgzZw5Dhw49sgc2ABUE+KkU7u7dlAp96l0Mg7htY1YnjgMV0BNkSblpRCqL9ExkvlKrdylWe9LLykPIAoYoUlaSHquesmGHPemei1JBv3oXoYIDLhz1BESzBSYufYPhb23Dk4K1Q5rZ3NqAjHrUnZ5j5InbMWSAF0he2j2E5wppRu88hWveuQjHD3vC69MbGbX5CV6ZPo7v/eU3aU+Gn09mezhz6R84ecNyTHMUI5umcVbzb2gQBhnvBnYFswEoC8Xv7BLb7FU0RXbTBKgAPFfiVyS9gTdCYUgJgYMMJIZQvFs/ei1Ir/ajAxhYmNgYfRaF9q11sYCkadDgSOK2wogYqGg0XDJqNeKZif73ICWGLffbi34wlS6O4xCNRolEIjpE1zRN0zRN0zRN07TjxEEF6k1NTWzYsIGWlhauv/56fvzjH3PmmWdy5plnHu7j07Tjiu/7FAoFCoUCvr/3dPKHTyqV4uWXX2bbtm0ARCIRTj31VCZMmHBUBpBBoYDX1UUpl9tvvQtANijQ7aUIslmMTB7cAN9MggeugrTnU/A8oIRh5PGUoseMkzMjKKUIPBeUX613oTaVbg7Qk25gVheOhkG6Wa4wafl6xryxEekHbGtKsnZoK76liE0vMHzaTiJWOE2/MjWEJ3M5It0ncMmWz9NQagMgntvOqM1PsGp8K/fecgvvNIRhczyfYc7rC5iy9jVsOZwTGmdwTtMTtBp50t6n6QzmAuCjeMap8Ja1hsZIB00CAh9818B3BXsmx8NKH/wIMhAY4t0Xje4bpEsMHCxhIxm41iUG1FsmdRFB1BGIqI0XiVOyG6jYDQTS6Xf7YYhuYtgD//wdqNLFtu1aiK7rXDRN0zRN0zRN0zTt+HNQgXqlUiGTydDS0sIDDzzAP/7jP5JMJg/3sWnacaNcLpPP5ymVSkf6UN4X5XKZ1157jTfeeKPWkz558mROOeUUHGfv3uojT7kuXnXp6LvVu5SCCl1BinIhi5HKYpQ9cMN6k8CElKfIuS4BLtLIoZRLRkZIW/Gw69z3w4Wj7F3vsm9PerhwNIIQBr4UCN9nzJq3Gb9sPXa5wu54hJUjB1OwJNGTyow4bRd1sRwAW3PNPJkJ6MzGOGPztQxPTwDArmQY/fbjvDXc4Gs3f4FNzfXh4yzmOW3ZH5n+xqs4YjCD6k7lnJYnGWJ2kvGuob1yIRCGx39wXFaa62iKbq8F6W7FIPD2BNRCKoQwEb6FEQjkQSwahb5BuoEpIljYe762V61LEkWjbRKPSixbouJRPCdKxW7EtepRos8kuwx70c3In1bpYpom0WiUaDSqF4tqmqZpmqZpmqZp2nHuoJKBOXPm8MlPfpKZM2eilOKLX/wi0Wh0wMv+27/92/t6gJp2rPJ9n2KxSD6fPyam0SHsSV+7di1Lly6t9aSPGDGCOXPmUF9ff4SPbl9KKYJ0Gre7m2I+17/exXEwq1P0vvLp9jNkKmmMVBazWA570qt/bQUfsp5HuVJEGEWkKFISJim7gbI0w5503631pFMN1KUauCfdxsbAwpcCH8XQjduYuOQN4tkCBdtk2YnD6I45OIPLnHBWmrbmcOHo7nKSZ3qirCwEnLrtE8ztOCNc5hm4jNj2e7rj27nzps+wYVAzAE65yOzl/8OMVS/jqBZaErM4t/kZhtm/Jetdyc7ynwHhCZDFjs+rcgP18a00CzVAkK6QEgQWQtkYSiEOIkgXKOgN0oWBSQwLsxakSxEuBxUIHKWok9DgGESjJjJqEESjuHaCst2IZyTC5L1KmgZW1EDa+y4YPVCli5SyFqIfjctyNU3TNE3TNE3TNE07Mg4qUH/ooYf40Y9+xMaNGwFIp9PHzCStpn3QyuUyhUKBYrF4pA/lffXOO+/w8ssv09PTA0BjYyNz5sxh2LBhR/jIBhaUSmG9SybTv97FieBUp5CVUqSDHLu9NGSyWNlC2OlS7UmvBJByfYqBi2lLDDNNRQVkzCR5MxJOo3suqAAfBdV6FxEEmAP2pFtY2ARS4gpo3rmLk19ZTeOuHjwpWD28ja1NSay6Cs1nphg+Ilw4WvJsfr+7hT+WMozfeSr/652LsKs96a27lmHlXubnV36al8eNBsCqlDl15UucunIRUb+exvgszm76PWMij5PzL6O9/HUUcQBW2gEvGm+TiL9NkwgIAqiUDAJvT7WLNEAENkJZGCiEePcTRHuCdBdEAEL2D9IFSGR1Ih3iQUC9aVAfNbEjBsQcgohD2U5StpoIjEi/Wzcjxn670R1TUh8duNJFCFEL0Y/Gd1JomqZpmqZpmqZpmnbkHVSgPmjQIL73ve8BMHr0aP7v//2/NDc3H9YD07RjSRAEtW50z/OO9OG8r1KpFIsXL2br1q1AuKjx1FNPZeLEiUdlT7oKAvzubiq7e/apd4nZdm2SuRCU6PJTuPksRiqHcP1wKl2BryDrB2S9CoHvIc08SEFa2qTtOEGtJz3Yp97l3XrSEWFPeiyT4+RXVjFky04UsLmlnvVDW8DxqZuVY8TE7ZgyIFCCl7tP4JliisbdQ/nU5i9QXw570hPZrbS2P81jF32U3556G4EQyMBn+huvMOe1BcTdGHWxUzmraSEnRh+n4H+M9vIXCWgA4E1L8byxDSe2ngbDJwjALRn4fYJ0IUEqCxFYGEIh9pm272/fIN3AJNovSO/tR5cK6v2AJscgGolhxQ2CaATfsalYjVSsBlSfBaXSrHajO/ufRq+PWkSsfafRI5FIrRd97+tqmqZpmqZpmqZp2tFICMGjjz7KJz/5ySN9KMedQ15Ket555+m3v2vaQapUKrVu9LDq49iRz+d5/fXXWbduHUophBCcfPLJzJw586id7vUzGdyuLoq57H7rXVzl0eWnKJSyyFQWs1yBCrVdmjkPMn4F13cRsogwSxSEg2cl6PHVPj3pe+pdfOReCznDnnQHiYknBYbrMnHZesaufhMZKLriUVaMHULFgPiUPENndBC1wyqdN1KD+V2+QDEb4ZwtNzGsT0/6sK1P8j8zR3LHX3+VohX+mj/x7Tc455Vnac56JGIzOWPQYiZEv0/ZP4/O8s/wCYP4rZbiGbkT4mtIGh6qN0jvs2xUShDK+hMm0j0QPggTEwcbM7xNAUa1H91UUO/7NEdsovEYRtTEi0Wo2BEqViOuWden1kVgOmGQLq0Bus8NQV3Uoj5iYux1cqd3uWg0Gj0qT/xomqZpmqZpmqZpx69du3Yxf/58nnzySTo6OmhsbGTatGnMnz+fM888E4CdO3fS2Nj4gR/bqFGjuPnmm7n55ps/8Pvu9cILL3D77bezatUq4vE4f/3Xf81dd931ge0900tJNe19FgRBrRv9WJtGByiVSqxYsYLVq1fXut9HjBjB6aefTkNDw5E9uP0IKhW8XV2U0qn91rsEKqAnyJJyM8hUBjNfDKtd+tS7pD2Pgu8iqCDNHC6CtFVH3rBJKEHgVUCpvepd/Gq9S18CCwsTK6x3QTFiw2YmLnmDSLFMyTRYdtJQehyT2JgiI+fspiGRBeCdfBO/SwveLvnM2nY5k/r0pA/b9nveGlZm3v/zGToTYeXL4M53mPvy0wxvbycanc6coauZHL8bNziNrsr/i6eGA9BpwpPGLtzYamJmuRqkS3xXsmciXSHVn1DtYnpAANLAVDFsDPYO0m2laFA+jY5NJB5HJmz8qE3RSlCxG/GN2J7blbJW6yLkvhPlUUtSH7OJ20a/iXPDMIjFYnq5qKZpmqZpmqZpmnZUu+KKK6hUKjzwwAOMGTOGjo4OXnjhBbq7u2uXGTx48BE8wveuUqn8SUPbK1as4OKLL+a2227jwQcfZPv27dx00034vs8999xzGI50X0IdxNjsBRdcQEdHBzNnzuSBBx7gz//8z4/ZpaSZTIb6+nrS6TR1dXVH+nDeV0EQ0NnZSVtbm57IPAwqlUqtG/1Ym0YHcF2X1atXs2LFCiqVsCZl0KBBnHbaaUftL3EVBPg9PVS6u8lns3jewPUuuaBAl5ciyGaRmTzCC2r1Lp6CnB+Q9coEgY+UOQLhkTOiYb1LEBAEPsloA+nC7lq9iwgCjAF70k1MbBASXwgaOruZ+tIKGrpSBMD64W1saq7DaS7RdHaGQW1dAKTKcZ7tSfJKOcfJ7ecwa9tFWEG1J73zdQrGGv7timvZMKgFgLpsirNfeZaJb63BdqZwSnMXs5KPgJpI2vsrXHVieLsG/NbsIRdbRcIsoALwKgME6fQN0vtP2u9tT5Dug1AgJJaysQYI0p0goEkFNEQcnHgUEjZB1KJi11O2m1Byz4urYRm1Wpe9SQHJiEV91MLeqzvdcRzi8TiO4+hKlw8Z/bqlaYeHfm5p2uGhn1uadnjo59ahO5azrUNVKpXYtGkTo0ePJhKJHPgKR4FUKkVjYyMLFizg3HPP3e/l9q58eemll/j85z/PunXrmDx5Mt/4xje4/PLLWbZsGdOnT2fBggWcd955PP/888ybN481a9Ywffp07r//fsaPHw/Axo0b+fKXv8zixYvJ5/NMnDiR7373u5x//vkAzJ07lz/+8Y/9jkMpxR133MFjjz3G8uXLa5+/9957uffee9m8eTMA1113HalUilmzZvGTn/wEx3HYtGkT27Zt4ytf+QrPPvssUkrOPvtsfvzjHzNq1KgBH/fXv/51nnvuOZYsWVL73BNPPMHVV19NZ2fnnzwEfig/K4e8lFQIoZeSalqV7/uUSiUKhQKu6x7pwzksfN9n3bp1vP7667VFqk1NTcyePZvhw4cftQFlkMtR2dVFIZOmUhq43qWsXLr8FKVCFiOVwXC9fepd0n4JLwgQoogwihSFRcpppCIkgefVetLDipcAlMJQXhgo9yGR2DgIDDwpcPIFpr76BsM3bgOgoz7OytFDUI5L0xkpRpy4IzxG32JB9yBeKHUzpGcEf775Mur69KRH03/k15f+GYtOCl/c7EqJ01//IzNXvYxtjOOk1gmc1fRLYiRIeV+nHMwAIC/hd1aWruhKklaW+P4m0qtBukQhD2YiXfRWu/QG6Q6WCoN0IUAKA4Eg6gc04dIQiWAnYqiEgx81cO0GylYTSlrVGxWYzv6XjNqmpD5ikoxY/ZaMSimJxWLEYjE9ja5pmqZpmqZpmqbVKKUoBO8+KHY4xOS+O78GkkgkSCQSPPbYY5x++ukHVaubyWS49NJLufjii3n44YfZsmXLfitZbrvtNn7wgx/Q2trKTTfdxPXXX8+iRYsAyOVyXHzxxdx11104jsODDz7IpZdeyvr16xkxYgSPPPII06ZN48Ybb+SGG244pMcPYVVLXV0dzz33HBAOb1500UXMmTOHhQsXYpom3/72t/nYxz7GypUrB5xgL5fL+wTe0WiUUqnEa6+9xty5cw/5uA7Vh2Yp6V133cWTTz7J8uXLsW2bVCq138t2d3czbdo0tm/fTk9Pz1FbQ6F9OPWG6MVisTapfSxSSrFx40aWLFlCNhvWjSSTSU499VTGjRt39Abprou/axfFnh6K+RyBCvapd/GVT7efIVPJYKSymMVSv3qXcgAZz63Wu7gIkccD0laSvOmgAh/lhSPs/etdAiR71/wIbGwMLAIpCHyfE5dt4MQVGzA9n6Jp8NqEEWQsQXJylqGndhCxwp+rV7uH8lQxjcg5XLj5CwzLhGeM7XKalo7neOacaTw+6+8JpEQEPtPXLOGMpb8n4TUzuG4W57X8F61GNxnvL+jwLwIkFQFP2QW2Oyupc1IkFLhliV/pH6QLepeNclBBOlIhpAdSAQaWsgYM0hO+TxOK+mgUOxHDT9h4EYOK3UjFaqwtGhWGxIruf8lo3DGpi1rE7P5LRh3HIRaL6QWjmqZpmqZpmqZp2oAKQcDYF1d94Pe78ZwpxA3jgJczTZNf/OIX3HDDDfzsZz9jxowZnHvuuVxzzTVMnTp1wOs8/PDDCCH413/9VyKRCJMmTWL79u0Dht533XVXbfL91ltv5ZJLLqFUKhGJRJg2bRrTpk2rXfZb3/oWjz76KI8//jh/93d/R1NTE4ZhkEwm/6S2gng8zn333VcLyh966CGCIOC+++6r/Rv+/vvvp6GhgQULFnDhhRfucxsXXXQR9957L7/61a+4+uqraW9v58477wTCXvkPwiGP7W3atOlwHMcBVSoVrrrqKubMmcPPf/7zd73sZz/7WaZOncr27ds/oKPTjnWe51EqlSiVSsd0iA5hkL5t2zZeffVVdu/eDYRn+mbMmMGECRMwDuKX/5GgggA/laLS1UU+m8HzXASCmGUTtS2EECilyAR5ur00ZLKY2TzCU2GQXqt38cl6FQLfRxh5lHBr9S5+EIRBulL9lo6KIMAIPOReXekmFhY2Sgg8YMimdzj5lVXEckUCYNWYE9hWFyN6QoERZ/fQVJ8GYEuumcczAdtLFWZtvYJJnWFPugxcBu9YwGuT4nzvms+Qt8Mp7nGb1nLOK8/QkgmoT5zKuYOfY2zkP8n6n2Bn+c+BsBrmRcdllfUGdZF2krx7kC4FGPLA1S79gnRlYimzVu0ihEAKiURQ57k0IUjEo1iJOEHCpuJIKnYTFbsBJcKXI2kaWFEDw9n358yQgvqoRTJiYhl7ptX1NLqmaZqmaZqmaZp2LLniiiu45JJLWLhwIYsXL+app57i7rvv5r777uO6667b5/Lr169n6tSp/Sa3Z8+ePeBt9w3lhwwZAkBnZycjRowgl8txxx138OSTT7Jz5048z6NYLLJ169b35XFNmTKl39T5ihUreOutt/apaSmVSmzcuHHA27jwwgv5/ve/z0033cRf/uVf4jgOt99+OwsXLvzAaqEOOnm4+OKL+dWvfkV9fT0A3/ve97jppptq09/d3d2cffbZrFmz5rAc6D/8wz8A8Itf/OJdL/fP//zPpFIp5s+fz1NPPXVYjkU7PvT+0iiVSsdsncve2tvbefXVV2lvbwfAsiymT5/O5MmTsSzrCB/d/gWFApWODgrpNOVyWEtjGyZxx8ao/jItBCW6/BRuPoeRziJcP+xJr9W7KNJ+Gc/3EaKEMIuUhUWP3UhFCIJ9gnRABRhq38WztZ50JJ4U1HWnmPzyClraw+UhO1rqWTViEDJaovXMboaO6gAg60Z5ancdr5RynNx+Ln+x7WOYQbivoqXzdd5p6eCOGz9JRzIOwKBd25n78tOM2NlBJHoKZwxbwZTYd6kEZ9Be+Rm+GgTAWjvgD8bbxOMbqUPhVyRe3yBdKIToG6SHJwrejRAgDB9ksE+QLkU4VW4oQb3n0QTE40msZAwvYeI6JmW7kYrVACIMzg3LwIyaGPa+L36OKWmIWSQcs9/UuW3btSWjehpd0zRN0zRN0zRNOxgxKdl4zpQjcr+HIhKJcMEFF3DBBRdw++2387nPfY5vfvObAwbqh6JvvtP7b+mgWoHz1a9+leeee4577rmHcePGEY1GufLKKw84XCql3Gef4EBZWjwe7/dxLpdj5syZ/PKXv9znsq2trfu9vy9/+ct86UtfYufOnTQ2NrJ582a+9rWvMWbMmHc9zvfLQQfqzzzzDOVyufbxd77zHa6++upaoO55HuvXr3/fD/BQrFmzhjvvvJNXXnmFt99++6CuUy6X+z2uTCYDUF00+MH3KR1OQRCglDrmHtf7yXXd2iS65+0blB6ruru7Wbp0ae2Mo2EYnHzyyUybNq12dvNoXLSqXBevu5tiVxfFYoFABRhCErct7OqkciVw6fYz5MsZZCqLUa6AB6pPvUvar1DyPISqIGQRD8hYSXKmQ+B74IfLRcMwHSBABD6yFjpXg2kkNjYSg0AKjFKJk5euYeS6zQgg79gsnTiSgvSoOyXFsGntWKZHoAT/0z2Ep0sp6lNtXL3x89SXTwAgmd1KxX+Nn115KWuHhN3pyVyas195jklvvoEVmc4pg2F2/T8h1TB2V75HRU0CoNOE35rtqNgqktLHdyXlssGAQToHG6QLhFHtSQ8khnKwCYNuiUQKgaGgwfNoBGKJJGZdAi9mUIqYVMxGKlY9iDDQNyyJFTNr/ei9P2cCSERMGqI2jiX73X8kEiEWi9X+I0ApdVT+fGrvnX7d0rTDQz+3NO3w0M8tTTs89HPr0Onv1bsTQhxU9crRZtKkSTz22GMDfm38+PE89NBDlMvlWud636WdB2vRokVcd911XH755UAYePcuFe1l2za+3/8d+q2trbS3t6OUqoX0fReU7s+MGTP49a9/TVtb2yEv0BVCcMIJYXbyq1/9iuHDhzNjxoxDuo0/1UEH6nuHFUdbeFEul/lf/+t/8f3vf58RI0YcdKD+3e9+tzb93teuXbuOucWrQRCQTqdRSunN2H24rovrulQqlePuRSeXy7F69epakC6EYPTo0UyaNIlYLLbPCaejhVKKIJ/HS6cpFgoEgY8AbNNCmgYlBEXfJxcUyfsFRL6IKFXwAwdfOGBBYEExCCgEFfBNzGgZMCkZ9eQNBxTElV/rRw9/4ylEoBDs3SkuSEQasImACOtnhq5Yy5hXlmFW3LDeZeIY3olI4iOyjDpzN/WJHAAbMm38Jleipxhwxua/ZFz3qQBYlSyx1B/5zYVzWDj+s9XPlTl92YvMXPUyEXkS49omc3bj/yUuIO1+nmIwF4CihN9GcpTqNtBol6mUo+RzFQI/fBSGIYlEolhGFCnCRaJ7L1Hdm0CG0+hGAEoglYGJRFQrXYSQmEFAPPBJCIkdacSIOVQcSck2cM0knoyFo+1BBcOWGJZEGALfreC7vfcT9qPHbANT+ZQKZUqEHXKO42BZ1lH7c6m9//TrlqYdHvq5pWmHh35uadrhoZ9bh653D5r24dTd3c1VV13F9ddfz9SpU0kmkyxdupS7776byy67bMDrXHvttdx2223ceOON3HrrrWzdupV77rkH4JDe0X3iiSfyyCOPcOmllyKE4Pbbb98nKxs1ahQvvvgi11xzDY7j0NLSwty5c9m1axd33303V155JU8//TRPPfXUAUPyT3/603z/+9/nsssu484772TYsGFs2bKFRx55hFtuuYVhw4YNeL3vf//7fOxjH0NKySOPPML3vvc9/uM//uMDqyk+omWzt956K//4j//4rpdZu3YtEyZMOOBtfe1rX2PixIn8xV/8xSEdw9e+9jW+/OUv1z7OZDIMHz6c1tbWQz4zcrQLggAhBK2trcf9i1ClUqlNokspcRznoLYmHysKhQLLli1j7dq1tZNjY8aMYebMmUf9Et+gWMTt7CTfsxu/UsYGHMMkZlu1epdsUGS3lyLIZbEzeYQf1OpdlIK8r8h4Yb0LlMAoUZEmKTtO2fMIghyoMEYPaicPA4wgnFTvy8TEwqaCQ6aYpnVbO1MWrySRDgPzrSe0sOaEZsx4nsFnZxl8wi4AesoJnuiJsLycZ3L7uVy89WMYKgoqoLH7Ff7nlEZ+c/pf4EuJCAKmrl3CmUt/T9JtZVDdbM5r/k8GGe+Q9a6k3f8UYBMAz0fKvGWtpC7SjSoLdmckKqg+34VCChN8m0ohwBN5BAc4iSQk0ghA+kAYpFtYGPgoEU6kW4Gi0fdoMCSReD1GXRwvJvAdG89qxDXrQAgkAjMSVrtIo/8LuhSChphFQ9RCyt4JekE0Gu03ja4dX/TrlqYdHvq5pWmHh35uadrhoZ9bh65vj7b24ZNIJDjttNP40Y9+xMaNG3Fdl+HDh3PDDTfw9a9/fcDr1NXV8cQTT/C3f/u3TJ8+nSlTpjB//nyuvfbaQ/p5+OEPf8j111/PGWecQUtLC/Pmzau1efS68847+Zu/+RvGjh1LuVxGKcXEiRP56U9/yne+8x2+9a1vccUVV/DVr36Vf/mXf3nX+4vFYrz44ovMmzePT33qU2SzWYYOHcpHP/rRd81ln3rqKe666y7K5TLTpk3jN7/5DR//+McP+nG+V0Id5Ki5YRi0t7fX+muSySQrV65k9OjRAHR0dHDCCSfsM/L/bnbt2kV3d/e7XmbMmDH9yup/8YtfcPPNN5NKpfpdbvr06axatap21qX37UCGYXDbbbcNOIU+kEwmQ319Pel0+pgM1Ds7O2lrazvuXoSCIKBSqVAulymVSof0c3osKZfLrFixgtWrV9cqbYYNG8bs2bNpaWk5wkf37pTn4XZ3U9y1i1IhT6ACTCmJ2w6WGZ6BLAUVuoIU5UIWI5VFuF4YpFf/ussBpPwKZd9F+R5C5vEFpO0YOcMh8H1QYcAcENTqXYygurW0D4nEJoJAEkhBcxnGLFjEoG1hH3omEeW1CSMpU6J+Vo5hJ7djyAA3MPhD9yCeL/fQnBrHRzZeSbJa75LIbGJb8zYe+vjHSEXDF7wxW9Zz7uKnac1AfXwK5zQ/wzjnVQr+R0l5f4WiEYBlTsBLxnrqYltQAXgVg8DrfZ4rpCERvhN2mwsOKkgXRnXhKAKhJBYWJkY4lS4EdqBo9DyaDYNoXT0iGceLgec4lO1mPLO6VEQIrKiJGTEQsn+QbhmShqhJMrInSDcMg3g8TiwWO+5+V2n9Hc+vW5p2OOnnlqYdHvq5pWmHh35uHbpjOds6VKVSiU2bNjF69Ojj7kTDL3/5Sz7zmc+QTqeJRqNH+nCOeofys3JIlS/XXXddbYq3VCpx00031crk/5S337e2tr5rwfyh+O///m+KxWLt4yVLlnD99dezcOFCxo4d+77ch/bh4fs+lUql9ud4WSq6P6VSiTfeeIPVq1fXnqttbW3Mnj271jd1NPMzGUrt7eQzaXzfQyCI2zYRy0IIga98uv00mUoGI5XDLJbCEL361+4pyPg+Ob9E4CqELIDhkjMdUlYMXymUF154z9JRhVA+Uu1b72JjY2ChBOB6THh9LWPWbEQGCk8Klk0eS6cBdaN7GHZ6F/Fo+LtpVWoQj+fz5EsB5276K8burta7uDmC8mLuv3Qu6wbPBKCpp5OPLPodo7e3E42dyuknLGNq/Nt4wcl0VO7FU+GijW2W4inzHazYWuoI8MoS3+1dOBq+JVIEDiIwMIRCiIMI0iVhkC5AKAMLs0+QLrECaPIqNApJtL4Roy6JF1d4TqQapCeqNyUxo0YYpO/1FjPblDTutWjUsizi8bheMqppmqZpmqZpmqZph+jBBx9kzJgxDB06lBUrVjBv3jyuvvpqHaYfBgcdqP/1X/91v48Hqlb5q7/6q/d+RPuxdetWdu/ezdatW/F9v1ZsP27cOBKJxD6heVdXFwATJ0486isstPeuN0Avl8tUKpXjaqHou8nlcqxatYq1a9fWvieNjY3MmjWLkSNHHvWhZVAqUenspNDdTbkS7jRwTJO4bdc2SPf4WXq8NGSyWNkC+Ao8avUuOV+R9kr4no+igjALuMKkx6mnhET5fnhBFH5YmI4gQA4wlW5iYWEDgkDACW9tZdKrq4kUw5MUb44+gbda63GSaYadk6G1dTcAHcV6Hk8ZrK3kmdx+Nqdv/TiyWu+SSC3hhdOH8uz0qwGwyyXOfO33nLJ6KRF7BlOHKE6r+wGmaiDlfo1ScDoAGQMet3ooRpcRNSr4FUm5YlJbOCpBKgehTKRQSPFu78oQIARCCoTsPfkksVVvkC6QwsBU0FhxaRYQSTRi1ifwEoKS41CyW/HNWHhNU2JGTAxH7vMzFrUkjXGbmL3n5cdxHOLx+HE3LaBpmqZpmqZpmqZp75f29nbmz59Pe3s7Q4YM4aqrruKuu+460od1TDroQP3+++8/nMdxQPPnz+eBBx6ofXzKKacA8Ic//IG5c+ceoaPSjhTP82rT5+Vy+bitcNmfVCrF8uXLeeutt2rLI5qbm5k+fTqjR48+6t8mp3wfr7ubQkcHpWJhT72L42BVF0wUghK7/BRePouRyiF8v1+9SymAlFehElQI/ACMPEoo0naCrGFX613CkwwHqncxMLBwwnoXIUh09zD1pRU0dYaBeXdjkpWTxlLxemg6vYOhJ7UjBZQ8i+d2N7OgnKYtPY5Pv3Ul8Ur4joBYbjMbhu3m1586n4Id9oNPXvca57zyLEl/OGOap3JO4wPUywIZ79N0+X+GwMADnoqWeMdaRsJOY7mCcskkHJcHIRVS2QhlIVAYBxGkIyVSVkvmMTAxsfcJ0is0ArFEPVZdPV4CSlGHst1Sm0iXpoEVMzHsfX++4o5BY8wmYu1ZEBKNRkkkErofXdM0TdM0TdM0TdPeo1tuuYVbbrnlSB/GceGILiU9FL/4xS/4xS9+cdCXnzt3LgdZD699CLiu26/CRQfoA+vs7GT58uVs3ry59rkhQ4Ywffp0hg0bdtRPpCulCDIZiu07KWQy+IGPFIKE4xCphq6u8tjlpyiWsshUFrNcCSfSq29K8BSkPI9CUK13EUWE4VIwHFJ2DDcIwOsN0vfUu0jlI/aqdxEIbBwkJkqALFeYtPQNRq7bjABcy2Tp1HHsxqNh1A5GzuokYlcAWLJ7CE8W01RKcMHGv2RUahYQ1rvkxXIeuPwctjbNAGBIxzY+uui3nNDt0ZSYzUdaHmG4tY6cfzE7ytcCCQTwUsRnmbGaZGQnsUBQKZiooPp3KhQSExHYSAFSBAj29zuwb5De+82TGL0t6UIihYGhBA2VCs2BTyzZUA3SJaWISdlpwbXCLj7DCoN0acm974VkxKQhZmOb4deEEMRiMeLxOKb5oXkJ0jRN0zRN0zRN0zRNAz5Egbp2/AiCoN8EeqVSqU1Za/tSSrF9+3ZWrFjB9u3ba58fOXIk06dPZ9CgQUfw6A5eUChQbm8nn0rhumGFSsSyiNk2Ugh8FdATZEhVMhjpLGa+GA5Uu4CCQEHOD0j7JQLPQykXYZZwhUGPXUdJGCjfqw6f96138ZGBz771LjYWFr3rO4eve5uJS9dgl8NKlA0njeCtpiTR+t2MPCdFU2MagK35Jn6TDtjkZpm881zmbP04grDexc6/zlNnj+Wlkz4BQKyQ45xXnmXyhnVEY7M4Y+jrTI19GzeYTnvl/8NXwwB401Y8b24mFttAMlB4JYPA77NwVBphT7oQB+hJ7xOkCw+kC8rAwMTCRAqJISSGktT3BunxOuy6RvyEpBQzKDvNuGY9CIE0Dez4vkG6FFAXtWiIWZjVd0PoRaOapmmapmmapmmaph0LdKCuHTG9wbnnebiuW/v/evr84Cil2LRpEytWrGDXrl1AOP07btw4pk2bRlNT0xE+woMTuC5eZye5rl1USiUUCsswiNs2ZrXeJRPk6fZSqGwOM5NHBAFUCAN1oOBD2i/hBi5eJUCaBZShSNtxstImCHwI+k+l768nPQyX7Wq9CzR0dDP55RU0dIeBeXdzA69PGEngp2g9YwdDx3UAkHMjPLW7jpcqWQanx/GXb15J1A3rXSKFrawYW+TRMz+KaxhI32fG6pc547U/EhOTmDRoNGc2/BhHxehxv0YpmAPAbhN+Y3cRRJaTEB5uySDw+gbpEhFEEEpWg/T9PXeqQboQSOmDCCfSpQpn0g1h1IL0Otel2asQjcZw6hsJkjblKJQjTVSsRhASaUqsmLVPtYshBfUxi4aIhZTh5LxpmiQSCb1oVNM0TdM0TdM0TdO0Y4IO1LXDzvf9WljeNzzXU+d/Gt/3efPNN1mxYgXpdBjyGobBhAkTmDp1Kslk8ggf4cFRQYC3ezeFjnZK+TyBCjCEJOY4ONUqkFJQZpefolLIYaSzSNfrV+/iKkj31rtUApQsYdjVehcrGta7+PvWuxjKhwHrXSJIDBRglEpMeXU1w9/aBkDZtlh2ykl0B2G9y5BZu4jYFQIleGn3YH5XTEFZ8vG3/pIR6bDexXRz7Iqv5z8uOYPORByAkdve4qOLnqQ1n2Rw8jQ+0vx/aTV2kvWuYLd/JQIbD/htrEiH/RoxM4dXlpTdPQtHpQShIghlIMS79aSL8I8UCKkQ0qtO5UssTExRrXdBkqy4tAQVYk4Up7kJlbRxY4qy00DZbgJhIAyJHTMxHKPfvZiGoDFqkewTpOtFo5qmaZqmaZqmaZqmHYt0oK69b/qG5n3Dc91l//5wXZe1a9eyatUq8vk8ALZtc/LJJzN58mSi0egRPsKD52cyFNvbKaRT+IGPQBC3bSKWhRACV3l0+2lylSxGKotZLIfLRqsD5b6CrO+T9UsEno8KXIRVwhMGXXYdJSSq9k6HPfUuEh+xT72LqDaHh/UuKlCMXPsWE15fh+l6KODNCaN4q6WOaGxXWO/SFJ7I2JJv4pG0xzY3y9Qdczl928ehWu+iKqv47/PGs3L4BQDUZ3o476XfceLWDhLxGZwz7AUmOA9QCuawszIfpdoQwNJowCvGGySd7TiepJzbE6QLCVJZfRaOBuw9Yd/7mMIgndpUuiIAJbH3CtITrkuzXybuRIkkW1F1UbyYouzUUbabUdJESIkVMzEj/YN0QwqaYhZ1Uas2fR6NRonH49i2/Z5/TjRN0zRN0zRN0zRN0442OlDX3lUQBAf80zuBroPzw6NUKrF69WreeOMNyuWwWzwWizFlyhQmTpz4oQoug1Ip7EnfvXv/Pel+hrSXQaRzWLlCWI7uUqt3yfuKtF/G8108t1rvYgWkrBg5ww7f+VCdPu9X76I8UHv3pJuY1XoXBTTt6GTy4pUkU1kAutoaWTZpNEF5N62nbmPoSWG9S96N8LueBC+V8wxKj+GvN1yN44X1LmZ5G69MEjw981wCITHdCqcte5FZK18lZs3klCEFZie/g1StdLl3Ug7CxaTtFjxu78R0VpFQCrdgolQ1SBcKISxEYO3pSWd/7/CQ1SA97ElXIgAkJhaOMDEwEGJPkJ6wIzgNzchkDDcOlUickt2CkjZC9k6ky351LYYUNMYs6qoT6XrRqKZpmqZpmqZpmqZpxwudfBxHlFIEQYDrhksVDxSSK6V0SH4E5XI5Vq5cybp16/C8sLakrq6OadOmcdJJJ2EYxgFu4eihPA931y5ynR0D9qQrpUj7Obr9NGRzGNk8wg/61btUAkj5FUpBGa+iEKJvvUsEN1Dg9w/Se+tdhPL3mknvX+9i54tMemUlJ2zeAUAp6rB8xgS6/QoNQ7Yx5LQuInZ4AuCl3YN4spDBrwguefNahqVPB8Dwcmxt2sJ/nTeLTLXmZPzGVZz78jM0VYYzsnEa5zb9nAaRIeN9mqx/GQKDsoDfxPKk7KVERBGvbOD6vX+3CilNRGAjEAfoSa8G6QiE9KuXExgY2FiYwkQKQczzafbK1JkOTkMjsi6JF1cUI3HKTguB4YAQtYn0vkG6FILGuEX9XkF6IpH4UP08apqmaZqmaZqmadqHnRCCRx99lE9+8pNH+lCOOzpQP47kcjlSqVQ4sauXAx6VlFJ0dHSwdu1aNm7cWOuZb25uZvr06YwePRop5QFu5eihlMLr6aHYvpNiLhf2pEtJ3Hawq5PM+aBIl5/GK+Qw0jmE64X1LuF5HzwFOd8n4xcJvIAgcDGsEq4w6LKTFJHg905r99a7KAwCqNa77AnTBRZ2td4F8H3GrH6Tk5avx/ADAiF48+QxvNVST8xsZ+S5KZqaUwBsyzfySMZjk5tj8s45nLX5UhAJAApiLb+5YAJvtZ0NQEt3Ox9d9CQjOys0Jk5n7qD/ZJS1nEJwHjvcz4JqQAD/E/NZbqyi3mnHKksqtZ70/gtH370nvTdIZ8/SUcKTBhYmljCRwiDiB7R4ZeqlhVPfglGXwI8LCtEIZacF34iG35+YiRndN0hviO9ZNqqDdE3TNE3TNE3TNE07fHbt2sX8+fN58skn6ejooLGxkWnTpjF//nzOPPNMAHbu3EljY+MHfmyjRo3i5ptv5uabb/7A77vXF7/4RRYtWsTq1auZOHEiy5cv3+cyK1eu5Atf+AJLliyhtbWVv//7v+eWW255X+5fB+qadhQolUq8+eabrFu3jp6entrnhwwZwvTp0xk2bNiH7iRIkM9T2LGdQmrgnvSycunyU5RKOWQ6i1mqhLUuHrV6l5ynyASlaid/WO8irIAeK0bOsAj8oHbhA9e7WFjYgEApRcs77UxevJJ4tgBA55AWlk8eQ5Drom3qJoaM70AKKHg2T+2uY1E5T0PuBK5bezURbwwIUH47i6aa/GFy+GLmlIucteQFpq9ZQyx6GqcNeY3p8fkEaiSd7vdxg4kAbLXht/Y2Ys4aEp6gnDdB9e1JdxDKrAbp++tJ3ytIF36t3qU3SDeEgR0omisl6jGJxhsx6+vxE5JixKIUacU344DAjBpYURMh+wbp0BCzaYjqIF3TNE3TNE3TNE3TPihXXHEFlUqFBx54gDFjxtDR0cELL7xAd3d37TKDBw8+gkf43lUqlfdUY3z99dfzyiuvsHLlyn2+lslkuPDCCzn//PP52c9+xqpVq7j++utpaGjgxhtvfC+HDehAXdOOGKUU7e3trF27lk2bNuFX60oMw2Ds2LFMmjSJtra2I3yUhy6oVMKe9K6uAXvSPeXT7aXJulmMdA4zXwyvWKEWpJer9S7loIRXUgijXK13sekxo3hK1abS+9e7eAgV9IufJRIbB1Gtd4llc0x6eSWD3gn70IvxCMtnTgrrXZo2MeTiLqJOeNyv9LTx23yWkudzwZufZPTuc0EY4Jd4u207j54zjYJtgwqYuvY1zn71D9QxifFtYzir4QdECch4f0PO/zgCQUHCI7EsRWsJCVzcooEK+vSkYyNVOD2//550AUJU95RWF44KBQhMTBxhYQgDQ0kay2WaVEAslsRMNqDqLMpRg2K0Fc9MhteJGFgxHaRrmqZpmqZpmqZp2tEglUqxcOFCFixYwLnnngvAyJEjmT17dr/L7V358tJLL/H5z3+edevWMXnyZL7xjW9w+eWXs2zZMqZPn86CBQs477zzeP7555k3bx5r1qxh+vTp3H///YwfPx6AjRs38uUvf5nFixeTz+eZOHEi3/3udzn//PMBmDt3Llu2bOFLX/oSX/rSl4Aw37rjjjt47LHH+k2K33vvvdx7771s3rwZgOuuu45UKsWsWbP4yU9+guM4bNq0iW3btvGVr3yFZ599FiklZ599Nj/+8Y8ZNWrUfr9H//RP/wSEk/wDBeq//OUvqVQq/Nu//Ru2bXPyySezfPlyfvjDH+pAXdM+jEqlEhs2bGDdunWkUqna55uampg4cSInnnjih2rRaC/l+7hdXeQ6dlIp9ulJdxxMKQlUQLefIeVlEZkcZjaPUKpfT7qrIO15FIISnhtA4GHYRVxp0GUlwnqXYOB6FxF4hLF6L4GNjVGtdxGex4nL1zN29ZvIQOFLyZtTxrKxrYlIsI2RH03R3JoCYHuhnkfSARvdHCd1TuMjGz8FohEEZI23efwjY3i7dRYAgzvf4fyFTzA0FacteRrnNT/IEONt8v5F7PD/GqESCOCFuM9aYxn1VhdG2aDimbXHIaWBCJxw4SgKIQ4cpAsZ9OlJF1jCxsZECEFdxaXZD4g7UZy6eqiL4UahFGumYjWAkJgRAzNqIg3R9x7CID1mYlSrheLxuA7SNU3TNE3TNE3TtGOGUoqiu79a1cMnahkH1T6QSCRIJBI89thjnH766TiOc8DrZDIZLr30Ui6++GIefvhhtmzZst9Klttuu40f/OAHtLa2ctNNN3H99dezaNEiIKyLvvjii7nrrrtwHIcHH3yQSy+9lPXr1zNixAgeeeQRpk2bxo033sgNN9xwSI8f4IUXXqCuro7nnnsOANd1ueiii5gzZw4LFy7ENE2+/e1v87GPfYyVK1f+yfnYyy+/zDnnnNPv+hdddBH/+I//SE9Pz3uuytGBuqZ9AJRS7Ny5k3Xr1vH222/XutFN02Ts2LFMnDiR1tbWD12tC4SPzc9kKGzfTjGXHbAnPe3n2R2kUdkcRiaP8P1+Pem+gqzvkwtKeJ5P4AZIq4gyA1JmlIxho4I91ScD1bv0nUrfu95l8KbtTHp1FdFCCYCO4YNYMWUcQbqDtvEbGDKxEykUJc/iqZ46FpYKxIvN/NWaK4lVTgYBntrN4snwh8mnAhApFTj7leeYtmETidhszhr2PCdHfk4lmEh75V58NQYBvBWBp6zN1NnriLsyrHc5pJ70vkF674c+ohqs25hYwsaoLhxtcSvEzQjRxnpEfQI/BqVYkrLTjBImhh1OpEtT9r0H6mMWjTGrFqTHYjGSyaQO0jVN0zRN0zRN07RjStH1mTT/mQ/8ftfceREx+8BRrGma/OIXv+CGG27gZz/7GTNmzODcc8/lmmuuYerUqQNe5+GHH0YIwb/+678SiUSYNGkS27dvHzD0vuuuu2qT77feeiuXXHIJpVKJSCTCtGnTmDZtWu2y3/rWt3j00Ud5/PHH+bu/+zuampowDINkMvknVc7E43Huu+++WtD90EMPEQQB9913Xy0Tu//++2loaGDBggVceOGFh3wfAO3t7YwePbrf5wYNGlT7mg7UNe0o1juNvnbtWtLpdO3zzc3NTJw4kXHjxn0op9F7BbkchR07KKTDnnQpBAnHwTHDSelCUKLLT+EW8xipLNL1wloXF6rD5eR9RSYo4/oVfDdAyDKG45GXFikrEda7BPv2pIf1Lv2DdAMTCxuBRAHJ3WlOfnkFzR1hx1g+GWf57JPp8So0xjcw+PwuopGw3mVJTytPFLLkvApzN17I+F0XooSNUh6bWrfz2NmTyNvhWeGpa5dy9qt/oJ7pTB3UyOl1d2IRoafyZQrBRwDIGPDfsTS+uZQ65eEW9u5JtxHKArG/epe9gnQEQvrhpwETE7vakx7xA1rcEknDIpJsxmyow49LStEopWgrgXSQpoETN5FW/yC9LmrRGLcw+wTpiUQC09QvD5qmaZqmaZqmaZp2JFxxxRVccsklLFy4kMWLF/PUU09x9913c99993Hdddftc/n169czdepUIpFI7XN7V8T06hvKDxkyBIDOzk5GjBhBLpfjjjvu4Mknn2Tnzp14nkexWGTr1q3vy+OaMmVKvxxsxYoVvPXWWySTyX6XK5VKbNy48X25z8NBJyaa9j7rnUbv7UbvO40+btw4Jk6cSEtLy4dyGr1XUChQam8n37MbzwvHzPv2pJeVS5eXoljOY6SzmMUwtO7bk170Ie1XqKgiXkmArGDYZSrSoMdIUhICgt64vG+9ix/2pPcJ0wUCGwdZ/ZVmlMqMf30tI9dvQijwTIP1005i06AmouWtjJjbTcugFAA7i3U8kla86eYZ1XUSn95wFUoMRglI29t58syhbGw7BYBBu7Zz/sInGJ6q54S6U5nb9HNa5Q5y/ifY5X8aoSIEwNNJj7flUuqMFEHZwPWrv2qFQgoLEVjvUu8yUJAegAgXuxpIbGFhCgM7gKZyiXphEI3WY9bXoZI2pahFMRouHBVSYsdMzIjR9x5IRsOJdMvQQbqmaZqmaZqmaZp2/IhaBmvuvOiI3O+hiEQiXHDBBVxwwQXcfvvtfO5zn+Ob3/zmgIH6obAsq/b/e7Op3uzqq1/9Ks899xz33HMP48aNIxqNcuWVV1KpVN71NqWU1f12e7iuu8/l4vF4v49zuRwzZ87kl7/85T6XbW1tPbgHNIDBgwfT0dHR73O9H78fy1x1cqJp75NisVjrRu87jd7S0sLEiRMZO3bsh3oaHSAolSh1tFPo7sZ1w1+mjmkStW1MKfGUT5eXJuPmMDI5rHwxHEMfoCe9GBRx3QDl+5h2CV/AbjNKVlrhdVT/eheJj1T+XvUuAgsLEwsQqEAxfMMmJry2Brsc/uJ+Z+wwVk8ei9rdwaCRaxhycidSKsq+ydM9dbxYLGKXk/zFG5eRKM9GCXBFjlcmefxh8pTwMZaLnP3Kc0zfsJW62KmcNfS3TIr8jJI/hZ2V2wjUMATwRgyetzbSaLxJ3DWolPvUuxgS4UcQ7K/eRYR/ZJ/PSAUiqH5FYAs7nEpXkoZymcZAEY0kcJJJqIviRSWFeDOuWQ9CYsVMzGj/jrZkxKQpbusgXdM0TdM0TdM0TTsuCSEOqnrlaDNp0iQee+yxAb82fvx4HnroIcrlcq1zfcmSJYd8H4sWLeK6667j8ssvB8LAu3epaC/btvH9/plGa2sr7e3tYatANYPou6B0f2bMmMGvf/1r2traqKurO+Tj3Z85c+Zw22234bpu7QTCc889x/jx499z3QvoQF3T3pMgCGrT6Js3b66d0bMsi3HjxjFhwoT3dEbtaBFUKlQ6O8l3dlJxw2lzyzCI2zamYRCogN1+hh4vg8jmw4WjQdCvJ91TkKv2pLueR1AJMOwymD4ZwyFtOAQDBOn7q3cxw9ITRDWBbmjv4uTFK6nfHZ7MSDfVseK0yWTcCo3WGgZ9sptYNOxQfz3dwuP5HGmvzNlvn8Xk9j8jkDECAja1tfP4GSeSq74ATVn7Gue8+kfqxSlMa4tzWt03sYjSXfkqxWAuALsteCSRBRZTHygqhd4gHaQEoSKIwHiXehfZL0jfu96lb096uHDUJ2ZHiMSTUJ8kiEEh1kDZaQIRTqNbMRMh9wTpMdugJeFgmzpI1zRN0zRN0zRN07SjVXd3N1dddRXXX389U6dOJZlMsnTpUu6++24uu+yyAa9z7bXXctttt3HjjTdy6623snXrVu655x6AQ2pIOPHEE3nkkUe49NJLEUJw++2317KuXqNGjeLFF1/kmmuuwXEcWlpamDt3Lrt27eLuu+/myiuv5Omnn+app546YEj+6U9/mu9///tcdtll3HnnnQwbNowtW7bwyCOPcMsttzBs2LABr/fWW2+Ry+Vob2+nWCzWwvtJkyZh2zbXXnst//AP/8BnP/tZ5s2bx+rVq/nxj3/Mj370o4P+XrwbnaRo2iHyfZ8dO3awadMmtmzZQrFYrH2ttbW1No3e9y00H1bKdXG7ush1tlMplVEoLGkQc2wsw0ApRdrP0xNk8PM5jHQO4fn9etKD3p50v4QbVPDKYJhlzIhLQVqkjFiYuav91bv44cB69athvUsESfhWKSdfZPzS1Qzb+A4AFcdi7YyJbG1tIFbYzMgzu2iu1ru0F5M8mob1boETekZw7dqrCcRIAgk9kS6entPMW22TAWjr2sH5C3/LiFQjQ5PTmdv0r7TIneT8S+n0/xJZrXd5ot7jHbGEVscnmxZ4KgyshVR7etJhP/UuAwXpQW0q3cDAERaGMIhXF47GzAjRZD2yoY4gblCKxShFWlDSxrAMrHj/haOOKWlOOMTs8PsVjUZJJpM6SNc0TdM0TdM0TdO0o1AikeC0007jRz/6ERs3bsR1XYYPH84NN9zA17/+9QGvU1dXxxNPPMHf/u3fMn36dKZMmcL8+fO59tpr+/WqH8gPf/hDrr/+es444wxaWlqYN28emUym32XuvPNO/uZv/oaxY8dSLpdRSjFx4kR++tOf8p3vfIdvfetbXHHFFXz1q1/lX/7lX971/mKxGC+++CLz5s3jU5/6FNlslqFDh/LRj370XcP4z33uc/zxj3+sfXzKKWFV76ZNmxg1ahT19fU8++yzfOELX2DmzJm0tLQwf/58brzxxoP+XrwbofYuuDnOZTIZ6uvrSafT7+tbDY4G6XSa7du3U19f/6Hu7z4SXNdl27ZtbN68ma1bt/brjrJtuzaN3tLScgSP8v2jfB+3u5t8ezvlYgGFwpSSmG1jV4PYTJBnt5/BLxYx0llExQ1Tb5daT3rBh4xfpuyXcCsCKao96UhSVoSiMOg7dh5OpQcYBEjl9+tJB4GNjUEYUAvfZ9QbGzlx+TpMz0cBmyeMZu3kMdC1k9ZJOxgyaVet3uXZnjoWFIsYboQrV19CXfFsEJKSUWbp+BILJo9CCYFTLnLWq89zyobt1Mdmclbzo0x0FlEOTqbL/QJKjQBgdRyetTbSLN/ELxsEfm+IrZCGifBthBAIFMYBe9J7PxUgqq0vtnCwhEnED2iulEmYNlE7jlmfQCUcKjGTYqwN34ghDIkdtzDsPUG6aQia4zbJSPj9chyHurq6Y+JEj3b8CIKAzs5O2trakFIe+Aqaph0U/dzStMNDP7c07fDQz61DdyxnW4eqVCqxadMmRo8efUjB8rHgl7/8JZ/5zGdIp9NEo9EjfThHvUP5WdEjipq2H+VymS1btrB582a2bdvWrx8qGo0yevRoRo0axQknnHDMvKirIMDt6aG4cwfFfB6FwhCSmOPgVIP0XFCg28/glQrITA6zVD250KcnvRxAxnMpqRJeOSAIfEynhBKw24iQkzaKPWPnfetdTOUBas8+UsDEwsKmN4Fu2baTSa+sIpHJA9A9qJmVp08hVyrSyEoGX9q33qWZx/N5Ul6JOVtmMPOdy/GMepSAtwZ18uTpo8hWf1GevP51zn1lIQ3MYHpbJ6clb8MkSnflyxSDjwCQMuHfkxkMXqHRV7ilvvUuAhFEEIHcT73LAEH63vUuwgy70gNBc7lEnTSIRpJYyQTUx3AjBsV4M65VD0KEQbojayfJpIDGuE1DNFx8alkWdXV1tQ41TdM0TdM0TdM0TdOOPQ8++CBjxoxh6NChrFixgnnz5nH11VfrMP0w0IG6pvVRKBTYvHkzmzZtYseOHf02FCeTyVqIPmjQoGNqyl8phZ9OU9i5g2I2S6ACpBDE7TBIF0KQD4rs9jOUKwWMdA6zGHap9w3SPQVpz6cQFPE8D98F0y5hSp+ctOgxI9WgPPy+KhQBCqGqPeko+r5nRiKxcRDVepdYOsvEV1cxaFu4mbkUi7B61snsaK4nntvIqDm79tS7lBI8klJscIsMygziC6uvwhfj8QzYHU3zzGn1vDVoAgAt3e1csPBJRvY0MSw5lbnNP6VZtJP3L6bD/2ukihIATzb4bOI16lUPbtnAr9W7QDLeQCFXCYP0fepdBgrS+y8dDetdbCwk9eUKjYEiZseIxBNQH8ePSorx3p50Y5+edAHUxyyaYjZSCgzDIJlMEovF3vPPh6ZpmqZpmqZpmqZpR7f29nbmz59Pe3s7Q4YM4aqrruKuu+460od1TNKBunbcy2QytRC9o6Oj39eampoYNWoUo0ePpqmp6ZgK0Xv5mQz5nTsopTP4yq8G6TYRK5xwLgQlur1qkJ7JYRVK1SsSBukKfAU5PyDrl8Oe9BKYVgUr4lJC0mPGqQjZp95F1abSDeVj4BMo9lvvIl2XcSs2MGb1m8hAEUjBxsknsmHSaMSu7Zww+HUG96t3SbCgWEZ4Fp9efQF1+fPxpUnZcFnSp97FrpQ4a8kLzFy3g/rYKZw19L+Y4LxMOZjADvfrqGAUElgbFzzpbKFVrSFRMXD98FenEAohLERgYUgLQXmAepe9e9LZp97FEQ6mMEm4Hi1emagVJRqLIhvrUTGDUjxOMdKCkhaGXe1JN/bcaDJi0hS3sQyJlJJEIkE8Hj8mf141TdM0TdM0TdM0TdvXLbfcwi233HKkD+O4oAN17bijlKKnp4dNmzaxefNmuru7+329ra2tFqLX19cfoaM8/IJCgcLOHRR278YPfASCmG0TrQbpxaDMbj9DsW+QrlS/IF0pyPuQCUqU/RJBWSCkhx0t4SLoNqIUZP9fMwP1pO8p0xHVehcLEKAUQ95+hwlLVhOtBvkdwwax6rQpFEsFmvzXGXRx33qXJh7PF0j5Fc7YfDIzt12JazYTSHhzcA+/O20o2cggACZtWM65r/wPTcxgetsOTkt+DYMo3e7/Q9G/AIC0Cb+qz2MGL9PsBrhub72LQhoS4UcQhPUuUrBXmD5AkI6s1ruoar2LhSMsnACaS0WSpk002oBVn0DVRSlHLIrxVnwjijQNnLiJtPbcaNSStCQiOFZY+RKPx0kkEsdMBZGmaZqmaZqmaZqmadrRRgfq2nHB8zx27drF1q1b2bRpU78NxUIIhgwZUqtzicfjR/BID7+gVKK0cwe57m5830MgiFoWUdtGCkEpKNPtZyi6BYxMHitfDJPzgDBID8IPCz5kgwqVoIRbURAEGE6JgICUdMgYTt99owfRk25iYocBNZDsTjFp8UqaO8ITHvlknFVzptLZkCCReYtRp7XTPCgNVOtd0gEbKiXa0s38/epP4cqpuCZ0xfM8NyvOW4PGAtCyu4PzFz7JqJ42htdNYm7jj2kSneT9i9jtfwapwoqUJxsVG3idJr+rWu8S1s4ICVI5iMDsV++ypyt9P/UuQoD0wnoXIYngYGHQWCpRjyDqJIgk4lCfwI2aFOLNuHYdQkrsmIkZMWq3ZZuSloRNzA5/hUejUZLJJKapf6VrmqZpmqZpmqZpmqYdTjp90Y5J5XKZjo4Odu7cSXt7O7t27SII9kwPG4bB0KFDGT16NCNHjjwuNj0HpRLlzk7yXbtw3XCRaMSyiFkWUkrKymW3lybvFpDZPGaugFDVHhYXevPigg8Zv0IlKONWfFSgMK0ywvbJCZO0EcfrVzWi8Ks96abykNUgvTdLNzCwsGs96XahxEnL1jJ8/WYE4JkGG6aPZ+OE0Zi73uGElrUMPncXUoT1Ls+kYvyx4IJv8lcr5pIofAzXsCmaAUsmlHhx0rBavcuZS3/PzHWdNMamc9bQf2e8/Qrl4CR2uLehgtFIYH1c8Fj0HQb5q6grG7hB/3oXqezwY9ReE+kiTNv3blkRAiH8WsYeqda71LkezV6FiB0l5kQQDXWouEkhXk8p0gwi7Eg3o0atusU0BE0xm7poWIXjOA51dXVYlvXef0A0TdM0TdM0TdM0TdO0A9KBunZMyOVytLe31/7s3r17n8tEo1FOOOEERo8ezfDhw4+bEDIoFCi1t1NI9dSCdMc0idk2hpRUlMtur4ecl0dmC2GQHgT7BOlFHzK+Rzko4boeygPDqiBtlzKCHjNKWfT9lbJ3T3pA0KfeRSCwcZDVX0PS8xn1xluMW7kB0w23nL4zdhirZ52MWyjQVFnC4It2EY2Ey1BfTzfyeL5Iyvc4c/OJnLrlKsr2YDwT1g/J8vTsQeScFiCsd5n7ymKaxAymD3qH2fF5GETodv+eon8RAFkTftlYRPgv0Vb28fZX7wIYQg0wkb73VLpEyACEX613MXGETdRXNJcLxKwosVgMsy4JdVHKUZtCvI1AOtWedAtphDcoBTTEbRoiFlIKLMuirq4Ox3Hejx8RTdM0TdM0TdM0TdM07SDpQF370FFKkUqlatPn7e3t5HK5fS5XX1/P4MGDa3/q6uqOmyWNSilULkeho51CKoXvhwG1bZjEbAvTMHCVR5eXIuvlkbkCZjYfBukQBunV5LscQMbzKAUlKq5L4ApMy0VGK7hK0S0jFAy73/3v05OOwq/VuwgsbEyqgXW1J338a28QyxUB6GltZNWcqfQkoiRSGxg2aydNtXqXeLXepUxbup6bV15GyZxF2YbOZInnZkV5u3UkAC3d7Zz/P08xOjWUkcmxnN14T7Xe5UJ2+9cjVVjv87smWC1X0FZpx6vsqXeRBoggggiMsCcdhTxgT3q13kV4CFGtdxEOtpI0FcvUGQaRSB2ReAwaEnhRk3yiGc+qQxgSJ25h2LL6nYK6qEVT3MKQEsMwSCaTxGKxP/VHQ9M0TdM0TdM0TdM0TXsPdKCuHfV836erq6vfBHq5XO53GSEEzc3NDB48mCFDhjBo0KDjMnRUQYCfzVJo30kpk8EPwlQ8YlpEbAtTSjzl0+n1kPFz1SC9gPCr6blX/UMYpGd9n6JfouJVCDyJYXjYsQpeENAjIuStgXrSAyQBhvL3qXcJF47a9I5y13d2M+mVVTTu6gGgEI+yZvZkto8cgtX5DkMblzP4zC6kUJR8k2dSUV4seChfct3yM4kX/4ySGaVgKV6dUOZ/Jg4J613KJc5a+gIzN2Roik3jrKEPcaL1GpVgHDvcr6OCsUjgzbjgP+PtDHGX01yQeH3qXaSwEEHfehfFnkcycJAOAiH717tYwqS+UqHJD4g4MSJ2BNmYJIhaFBP1lCJNYb1LPOxJ7z3pE3cMmhMOtiGRUpJIJIjH48fNSSFN0zRN0zRN0zRN07SjkQ7UtaOKUopCoUBPT08tPO/o6MDvDXyrDMNg0KBBtenztrY2bNvez60e+1QQ4KVSFDvaKWZzBMrfs2y02pHuKo9dfoaMn0P0TqR7+wbplQAyvk/RL1PxK6iKRBoBtlPAVwE9wiZnRwgOoie992/NwKz2pIcpdCSbZ/zSNxi6aXt496bBm9PHs3HyWIJUmtbyYgadv6fe5bVMPY/nyqR9n3M2jWTmlqspOsNxTVg7tMizpzaTc5oBmLR+GXOXvE6zmMHMQW8zM/5zpIrQ7f4dBf8iBIKcAQ+1VPDdlxlSqOB7Zu1x7FPvUl06Ghp44SiE3enC6Fvv4hD3fFoqRSJ2lKhj1+pdStEIhXgrStqYjoEZ21PvEi4cdYjZYbgej8dJJBJIOWCCr2mapmmapmmapmnacUgIwaOPPsonP/nJI30oxx0dqGtHhOd5ZDIZUqlU7U86nSaVSuG67j6XdxynFjxxePUAAQAASURBVJ4PGTKE5uZmDMM4Akd+dFGeh9vTQ7GjnVKhQKACpBDEbJuIZSGFoBRUSHlZcn4BUShhZHIDBumugqwXkPfLVPwyqiKQ0seMFAiUT1paZIzEPkF6gAIVVHvSw497610kEgsHWV04alRcxq7cwOg33sLwAxSwdfxI1p46iUqgSPasYtCpO2lozgK99S4+Gyoug9NxPrf8z8jbZ1F0oL3O47lTLTa3DgWgtWsn5y96llHpkYypG8zZDd+inh7y3kV0+5/BUDEE8Eyz4HW5miGl7XhliV8Nzveud+m/dHR/QToIIav1LgGmMIgIm0ggaCmWiJkm0WgdTiIKdQm8iE0u2YxvJZBmWO8irer9C0FLYs/C0Wg0SjKZxDT1r2lN0zRN0zRN0zRNO57s2rWL+fPn8+STT9LR0UFjYyPTpk1j/vz5nHnmmQDs3LmTxsbGD/zYRo0axc0338zNN9/8gd93ry9+8YssWrSI1atXM3HiRJYvX97v66VSiZtuuonXXnuNtWvX8md/9mc89thj79v966RGO2yUUhSLxQFD82w2u9/rCSGoq6ujtbW1FqA3NDToqos+AtfF6+oit6uTSrGIQmEIScJxcEwTIQSFoESPn6XolZD56rLR3iDdJ+xJBzwFWV+R98q4QQnfBYGPGSkDPllhkDETeLL/CYw9Pek+UgXQr95FYGNjEIbDIggYumEL419fi1MKp853DWll9ZwpZOriRLo2M2LCJtrGhMtkC57FM2mH/yn4KF/yuWWziBQ+Sd5OkHcEiydUeGnCIICw3mXJ85z6VoWW2BTOHvpzRpurKQfj2e7dAcFoDMJ6l3+v62JoaSltRQMvCB+PkArJnnoX2Hvp6H7qXZQMJ9KFhwAcYWGiaCyXaVACJxIn4tjIxjqCiEUh2UDZaQIh+9W7CKA+ZtEUs/XCUU3TNE3TNE3TNE3TuOKKK6hUKjzwwAOMGTOGjo4OXnjhBbq7u2uXGTx48BE8wveuUqm8p7aJ66+/nldeeYWVK1fu8zXf94lGo3zxi1/kv//7v9/LYQ5IB+rae+b7fi0o7xua72/avJdt2zQ0NNDQ0EB9fX3t/9fV1enp8/0IymUqXbsodO2iUiqjUJhSErXDIF0pRU4V6fEyVLxK2JGeK+xZNuoTTqSrMEjP+YqcV8bzS3i+QAQBpl0G4VFAkDHiVIz+vyb2DtLFAXrSm7d3MvHVVdT1ZADI1SV44/TJtA8bjLm7kyHWMgZf2IVp+gQKXkrX8VTeJR8EnPf2EGZu+nNysTFUbHhjWJlnZzZScMIzsCevf53zlq6mWUxn1uBnmR79/xAqTpf7/1DyLwjvz4QH2jz88ssMzZYI+tS7GIYEPxJOmbN3vcv+e9IRIGS4dLRW7+JDXbFE1IkQNW3M+iQkopTiUQqxNpQ0MR0DK24h5MA96XV1dcdl97+maZqmaZqmaZqmaaFUKsXChQtZsGAB5557LgAjR45k9uzZ/S63d+XLSy+9xOc//3nWrVvH5MmT+cY3vsHll1/OsmXLmD59OgsWLOC8887j+eefZ968eaxZs4bp06dz//33M378eAA2btzIl7/8ZRYvXkw+n2fixIl897vf5fzzzwdg7ty5bNmyhS996Ut86UtfAsKB2jvuuIPHHnus36T4vffey7333svmzZsBuO6660ilUsyaNYuf/OQnOI7Dpk2b2LZtG1/5yld49tlnkVJy9tln8+Mf/5hRo0bt93v0T//0T0A4yT9QoB6Px/nnf/5nABYtWkQqlTqkv4MD0YG61k8QBJTLZUqlUu1/e////j4uFosopQa8PSEEyWSyX2DeG6BHo1E9dX6QgkKRclcnha5uKm444W0ZBjHLxjINAhXQ42dJBzk8t4yRLWDmi4jev5d9gnTCID0o4nlAAKZVBMulrAQpI0bZsPofQy1ID5Aq7AoPqmE6gImJ2acnPZ7KMOHV1Qx6pwOAimOxfsZENk0cA/kcLcVXGHRWB7FYCYAN+SSPZV12uB7DUw5fWPZxMs5ccjHJjgaf52da/P/s/XmAXVWd7/2/19rjGWvOPA9kgIzIqAg0Iv5AGhGwabxPN6YBta9tiyJBkWiDyBVxfH56vYqPyAW67X5+QEtzoUU0kg4yQyIEEjJWhhqSms+8917r98c+daoqqUyQMGW96LJyqvbZe5+T2gX9Od/zWduaxwMwZs8uzln9e6b3z2R2Js0H6r9GmgHy4fl0RX+LpRMAPNwied5ax5RcK2FFopDEPeniDdW7gKwuOqqxhIUvHJKRpKlcxPU9UokMfrXeJUi45NPNRE4KaVt4KbtW7xL3pLsk3fhXcDqdNj3phmEYhmEYhmEYhvFW0BqCwlt/XCcZ5w0HMZgRPPjgg5x66qmH9A72/v5+LrzwQs4//3zuu+8+tm3btt9KlhtvvJHvfve7tLS08JnPfIZly5axevVqAHK5HOeffz633nornudx9913c+GFF7J+/XqmTJnC/fffz6JFi7jmmmu4+uqrD+vhAzz++ONks1kee+wxAIIg4LzzzuO0005j1apV2LbNN7/5TT7ykY+wdu3ad+x6iSZQP0Z0dHSwZcsWOjo6EEKMCM2HB+UHmig/EMdxRgTmg6F5XV2dmTZ/E1Q+T6mjg0JvD0FQAcCzbRKOg21ZhDpiT9RHv8qhyxXkQB6nUBrawbCO9FBDMYL+sEKgioSRhhAsp4xwAgKl6JUJivbIX9TDg3Sh48bx4UG6hVVdcDT+e7ZLZY578TWmvLYFqTVKCLYcP5P1S+YSCMj0rmPswlYaxsQT63vKCX7Tr1lbCvHLks+/8D505SL6/Sx5T/DkvICn5oyJH3u5yAee+T0nboaxqTl8cOL/YrL1OmU1j53hP4CaggW8lpHcV9fFtNyzTMxJQn0o9S4HCNK1BEvX6l184eHj0FAqUS8kjp9Bej5e1kf5LoV0A2W/HqTETTnYfnx8KQRNKYdswkEIge/7ZLNZ05NuGIZhGIZhGIZhGG+VoADfmvDWH/eru8BNHXQz27a56667uPrqq/npT3/K0qVLOfPMM7n88stZuHDhqPe57777EELw85//HN/3mT9/Pjt37hw19L711ltrk+833HADF1xwAaVSCd/3WbRoEYsWLapte8stt/DAAw/wm9/8hs997nM0NjZiWRaZTOYNVc6kUinuvPPOWlB+zz33oJTizjvvrA3d/vKXv6S+vp6VK1fy4Q9/+LCP8VYwKc4xYs2aNTz55JOHvL3nebUP3/drnwf/PPx2Mpk00+ZHkFaKaGCAUmcHhb4+oihEIPAdh4TjYElJRQd0hn30qwKiVEYO5LFKlaGd7BWkxxPpFUJVIowiiCSWXUH4FUKt6JceeTfB8PcZaHS8yCnxgqPDg3TNvguOyihiyrrNzF6zHqcSvzDTNnU8r5x8AvlsCq97B1OmrWfsqXHfVymy+V2fy8q8JtKCK16ZwoT2y8ilpqI8WDsl4HdL6ihW611OeO15znr+dVrkAk4e9yCL/MfQuo7dlS9RVmcD0G/DL8dFqPJqpvUUUFH1xRyhseTIeheJRh5CvYtAgBXXuzjCxhcu2SCiMSziugmStouVTVGuT1LyEhTTY9DCxvZtnKSNkHFPejbh0JSKe9Jt26aurs70pBuGYRiGYRiGYRiGsY9LLrmECy64gFWrVvHUU0/xyCOPcPvtt3PnnXdy5ZVX7rP9+vXrWbhwIb7v1762d0XMoOGh/PjxcRNAZ2cnU6ZMIZfL8Y1vfIOHH36YtrY2wjCkWCzS2tp6RB7XggULRkydr1mzho0bN5LJZEZsVyqV2LRp0xE55tFgAvVjREtLC5MnT0ZrTTqdroXhw8Pywc+u65rqibeBKhYJenopde+mVCihdIRAkHRcfNdBCkFRlekNB8hHRUSxhN2fRwTh0E6GBellBfnqYqNhVCLSGh1JbCtEeGUiFTEgPAacJHrYayEajUIjdYRdDdKHLzgqEHh4yMFfH1ozdtsu5j77CqmBPAB9jXW8fOoC9kxoQfb3MJ7/YuxZnThOfHJP96d5eCCkX8Hp29Oc9epf0p05lVwKtjUrHl9is7MxXnR0zJ5dnPtff2Rq7jjm12lOy1xPkiK58EK6o7/B0j4K+M04yfPWemb0byE6aL2LZvBlgdGDdKpT6XG9ixQSX7ikIklzuUTC8fD9DF7Kh7oMlYRLLpkFtx7LsfHSNtKOd5x0LZrTHq4d96RnMhmSyaR5AcowDMMwDMMwDMMw3g5OMp4WfzuOexh83+fcc8/l3HPP5aabbuKqq67i61//+qiB+mGdhjNU8TuYTajq2nvXXXcdjz32GHfccQezZs0ikUhw6aWXUqlURt3XICnlPnXQo7VgpFIjJ/RzuRwnnngi99577z7btrS0HNoDehuYQP0YsWTJEmbMmMHOnTupq6szYd47hI4iov5+ynv2UBoYqPWjW0KScl18J64GyakiPeEA5aiMzFcXGg2j6k6IQ/TqzVIULzZaiMpEUYlIA5HAsgKEV0apiH4cBrwMasTPQRykoxW2DkcN0l1cLIZ+8da372Hu8+to7KhOnSc8Xj3peFpnT4VymcbC84x7305S6SIAWwopHhgIaa0opvbafO75D9Ln/n/ozvj0pCSrTghYMy3+hemXCrz/uZW8b7PLhOQ0PjjxR4yXWymrE9ge/gNSTcQCXslK7mnsYUbvM0wtC6IR9S4uQg2d79CiowKE3H+9i9S1RUc94eLj0Fgqx/UuiQwJ20Y2ZFBJn3ymkbJXh1Il/LSLk4h/re7dk55KpchkMubFKsMwDMMwDMMwDMN4OwlxSNUr7zTz58/nwQcfHPV7c+bM4Z577qFcLtfeDf/ss88e9jFWr17NlVdeycUXXwzEgffgoqKDXNcliqIRX2tpaaG9vR2tdS1zHL5A6f4sXbqUX//614wZM4ZsNnvY5/t2MYG6YbwNVKFA0NtLsWsP5WI8jQ5xP7pvO7WFRvtVgV41QBBWkLkCdr6AiKo1JcOCdK2hqGAgUJSiMqEuo1X8PcupILwKSoXktMOAW0c4ItQdCtKtWpAOSutqBcxgkG4zmEBn9vQw5/lXGbMzXnA0siQbF85m48LjCC1JauB1xs3dROO4PgB6Kh4P9cMLRUWiIrn2+TlQvJTu5BjKNjw7O+CJ45uILBuhIha/8iwfXNtGszWHU8f9Cyd4f0TpRjqD5VSiM5BAryP4+UQFhSeZtXsAHcVnLoRGWhaEbq3eZWjR0QME6QjQAmENLjpqkxAudUFEY1jGdX2StoOdTUE6SSmVopBuQQsH25MIaWP7FlIIGlMOddWedM/zyGazI14BNgzDMAzDMAzDMAzDGE1XVxeXXXYZy5YtY+HChWQyGZ577jluv/12LrroolHvc8UVV3DjjTdyzTXXcMMNN9Da2sodd9wBcFhDtbNnz+b+++/nwgsvRAjBTTfdVJteHzRt2jSeeOIJLr/8cjzPo7m5mbPOOovdu3dz++23c+mll/Loo4/yyCOPHDQk/+QnP8l3vvMdLrroIm6++WYmTZrEtm3buP/++7n++uuZNGnSqPfbuHEjuVyO9vZ2isViLbyfP39+rVJm3bp1VCoVuru7GRgYqG2zePHiQ34+9scE6obxFtFhSNTfT2nPHsq5XG0a3ZaShOPhOTZSCAIdsifqY0DliYIK1kABO19EDL51RhEH6Qqi6kKjA2FEOSoR6SAO0hVYdhlhVwhVSEF75Nz6vYJ0qkF6hNQh1rCvxYcSOLjYw4L0VE8/x734KuO3xm+NUkKwbc40NiyZQymVwOnvZPL4lxlz4h6k0FSUxe/7XX6fg0DBf3ulick7LqGn7gR0Al6ZpHh8SYL+ZCMAU7dv5JynX2JC5XhOqH+NU1JfxCcgF36c7ui/YWkXBdw/weJ5+3Vmd21EBRJdrXexbBH3pEdW9ZQ1VrXm5aD1LlIhZISUgoTwq/Uu5fjvJpHA8z1EfYYw4ZPLNBE5KaRt4aVthCUIi2XqEg5NaRdLSmzbJpvNjugvMwzDMAzDMAzDMAzDOJB0Os0pp5zC97//fTZt2kQQBEyePJmrr76ar371q6PeJ5vN8tBDD/HZz36WxYsXs2DBAlasWMEVV1xxWLnE9773PZYtW8bpp59Oc3Mzy5cvp7+/f8Q2N998M5/+9KeZOXMm5XIZrTXz5s3jJz/5Cd/61re45ZZbuOSSS7juuuv42c9+dsDjJZNJnnjiCZYvX87HP/5xBgYGmDhxIuecc84Bw/irrrqKP/7xj7XbS5YsAWDLli1MmzYNgPPPP59t27bts83e1TRvhNBHYi/vIf39/dTV1dHX1/eueqvBoejr6zOVL28xrTW6WCTo6aHY3UWlWCKqdqN7to3n2DhWPI2e1yX6VZ6iKiPK8US6LJZh8BKNqh8qXmi0EMFAJSRQJSICtJIIrbHsEogKYaTIWx45N0Ek9hekR1jVOfT4a6ARODjYOAwG6f5AnuNefJWJm7YjqhUwO2ZN5rUT51HIphGFPGP8lxi7oB3PjTuyXhhI8tCAoieSnLHD4S/Wnkdn3dloabO9AX6/FFqb4yC9vm8Pf/Gn/2LOnslMTXXxgfpf0CzbKUWL6Iz+AanilaPX1Enubu7juJ5nsYqKwfJ3aWmE9hB66DXCoXqXgwTpglq9iytcEjg0lsvUCwvb9fFtG6c+jUomyKcbKCfqQUrclIPtxy9DJByJq0o0NzbUetJTqZS5zgzjTVJK0dnZyZgxY0xdkmEcQebaMoyjw1xbhnF0mGvr8L2Xs63DVSqV2LJlC9OnTz/mBt7uvfdePvWpT9HX10cikXi7T+cd73B+Vt41E+q33norDz/8MC+99BKu69Lb2zvqdnfddRff+9732LBhA9lslssuu4wf//jHb+3JGsc8HQSE/QOUu+Jp9CCooNHYUpJ2PVw7nkYvqQo9YT85XUCFEbJQjKfRhy80GhFPpGsINORDGAgCIlUi1CFoidACyy4AAYGKyNsJconEXh3pg9PnEZZWWMRv2dHViXSNwMbGwWUwSHcLRWa/tJ7JG7YiVRy875o2gddOnMdAYx1UKjQU1zD2hG1k6goAbC8leKBPsbkCU3sln392KT3Ox+hoqKMvIVl1QoUXZ4yJ918ucdoL/8XJm2zGetN4//ifMd1+hVC30B7cSBidhgS6XcFPJ2tE4Rnmt/WilQBE3JMuLUQ09IvucOpdsCKk0FjCwhce9UFEQ1jGcxP4lo2bSUImRSmVIp9qRlsOtmfhpByEFDiWpCntknIt+voqJJNJstkslmWNdlDDMAzDMAzDMAzDMIyj4u6772bGjBlMnDiRNWvWsHz5cj7xiU+YMP0oeNcE6pVKhcsuu4zTTjuNX/ziF6Nu873vfY/vfve7fOc73+GUU04hn8/vU5xvGEeL1hqdz8fT6D09VErDptEdG9+2sS2LSCsGVJ5+laesA0SpjMwXcYZPo8OIIL2sIBdCoVIhoNq5riwEGmnngYBQaXJ2gpyXGBzcrqlNpKOQWlUz5qEFR+3qRLqojnLbpTIz//w609Ztwqp2tndOHMOrJ82nt6URoohM4TXGztpMw9j4rT/9gcPD/YJnCpAsS778/AQY+AQd2ekEFjwzK2TVCQ0Edj1oxYLXXuCsl3YzRszkpDH/wkLv96A9eoL/i/7oEixsIuDfJtk8625mfsd6dCjRCPapd6myhI7rXfYbpANKghVPpUtJrd6lqVQm4VbrXTwXWZ8hTCTIZeN6F2FJ/LSDdCQCaEi7NFR70h3HIZvNUldXZyYmDMMwDMMwDMMwDMN4y7W3t7NixQra29sZP348l112GbfeeuvbfVrvSe+aQP2f/umfgHgCfTQ9PT187Wtf46GHHuKcc86pfX3hwoVvxekZxzBVqRANDFDu6hoxje5IKw5obRshBAVVYk/YS16X0GGIzFen0cNhKyNrhoJ0qv3oARTDMiHFuOcpkkipkE4BrQMCBTknQd5PMLK/Sccz6DpCDptIh6EFR21sbNxakG5VAqa/spHpL2/EqU7Jd41t4tWT5tM1vgW0JlnYytgp62me3ANARUmeGHB4bEBSieD/Wpdk+pa/pKP5dHQWXp2oeXyJS28qrneZtGsrH3rmZSYXjmNB/YuclPohvi5RiM5md3gVts5iAc81WNw9ZoC5u59h3p6w1pMuLeJ6l2jo15dEI4WOV+reX82KlqBB2CFCgotNApfGUoV6LOxkGt+2cLJpVDpFPl1HKdEAQuIkbeyEhRCCjG/TlHaxpcSyLLLZLJ7n0dnZ+cZ+gAzDMAzDMAzDMAzDMN6k66+/nuuvv/7tPo1jwrsmUD+Yxx57DKUUO3fuZN68eQwMDHD66afz3e9+l8mTJ+/3fuVymXK5XLs9WLSvlNpnFdt3O6VUPEVtavPfNFUqoQoFgt7eeIHRcplIR0gh8GwLz3GwpSTUET3RAH0qT6jCuBs9X8AqVWrT6Br26UcvRZAPNaWwTEQprmRRAktGSLeAUgHlUDDgpij63ihBugatqh3pg0RtwdG9g3QZRkx9dTMz127ALVcA6G2q49X3HU/n5LEAeMU2xo19hZYlexACIi14asDntzlNXyQ5cwd8+IUz2NVwAR3NCXbWS36/OGTr2GYAsgM9nPX0U5zQMZEZacHpE75Co9hDWc1ne/jfkWoqNrA9IfifUyA58CyLtnePrHcRNkJ5wx5RvOho/CD2N5JerXeREULEtTtxvYuiPqzgOQk8x8JLJSCTpjis3sVyLJy0jbQkni1pTnsk3PgZTSaTpNNppJS1a+u99jvDMN5u5toyjKPDXFuGcXSYa8swjg5zbR0+81wZxtH1ngnUN2/ejFKKb33rW/zwhz+krq6Or33ta5x77rmsXbsW13VHvd9tt91Wm34fbvfu3ZRKpaN92m+pfD5PPp8HMIslHiatNbpSQZdKhPk8QblMGAa1f0nZUuI4LpaUhEBeVShEJcoqABUhShVkqYJWigiXyHXjJF0RB+k2BBaUIyiFCiUDlBMidBJbJZEyRMgArSICkhQdn4q0sYD00FkSz51rpI5GNJ5o4vxeYmFjM9iHIqKI8eteZ+qza/DycQd6vqGOzactpXPWNBCCTKGThuSfaF7UgWXFj/fFXIJHBjSdoeC4Pvjyn2bRbV/G9pZx5HzBE/MrPD+rJZ7uDiqc8tJTnPa6w3i3hTMm/JjJ8jVCNYb2cKgnPWfD/zPVZoe9lfltGwkrERqBkJBMJHDsZO0FAIjz87je5QA/y9XuGyGjeCpdOHiRIBuEuL6DY9s4tg2pBEXXpZjIEjk+QkbYrkA6EToISFk2ScumUgxQgU0qlaJUKtV+Ryil6OvrQ2ttKl8M4wgy15ZhHB3m2jKMo8NcW4ZxdJhr6/ANDAy83adgGO9pb2ugfsMNN/Dtb3/7gNu8+uqrzJ0796D7UkoRBAE/+tGP+PCHPwzAP//zPzNu3Dj+8Ic/cN555416v6985St88YtfrN3u7+9n8uTJtLS0vOdWQu7r66NUKlFXV2cC9UOglUIXCkSFApXeXsrFImGlEk+iAylp4bkOrmUhpSTQIX0qz4DKE6kIUSrj5ovIUnnkjveaRi9GkA805ahMRACE8VS2EkirgpAlIhVSxmbATVKyHYiCofNEo6qVLkIrhv/nxdBEulWbSK8AKM2Ezds57oVXSebiIL2QTvLaifPYMWsyWkpk307GpV9izAntOE5c/7K+4PMfA5rtFcHkPHzj2WaC3MfY0bSAUMKzM0OeWFBHxWkAYP6GNfzFS12MZxInt/xvjndXgfbpCf6W/ujiWk/6gxNtHs3uZmnbSxxXighrPelA5FEuCMoUgWFT6YMfo/7lyWo5fNyTPljvUlfOUYfE8nx8rXB8B51KUcjUUUo0gpC4CQsnGS8am004NKVcpBS1epfRVnpWSiGEoKWlxfwHnmEcQebaMoyjw1xbhnF0mGvLMI4Oc20dvtH+/1bDMI6ctzVQ/9KXvsSVV155wG1mzJhxSPsaP348APPnz699raWlhebmZlpbW/d7P8/z8Dxvn69LKd9zv6illAghah/GvnQYogoFolyOSn8/lXKJoFxBVRcXdW2LlOXh2HHgGumIvC7RH+UpqQoEcTe6Uygior3eYhXGH1pDSUE+gGIYEVJCEcRVPEoiEFhWGawSOoooaocBL0vZckae67Ag3a6G/IPiIF1Uq12GFhtFa8Zu28VxL7xKpjd+xbqU8NiwZC7b5k5DWRYiLDPWWcOYRTvw/bj+pbXk8R/9sKEsaS5pvvZCCrvzo7SPORXdJFk/QfH4YofuTNyTPq5jO+c+s57pueksql/N+5K34eqAQngOu6O/w9YZLODZRoufTaxw3O6nOGVLjsGUXFpxvQvRyHoXOViRvt8f3/iFCCyNEFG13sWlPtA0hBU8J4nrSLykh8hkqCTT5DLNaNvFdiyclI20JUnXojnt4drxNZNOp0mn0we8boQQ78nfG4bxdjPXlmEcHebaMoyjw1xbhnF0mGvr8JjnyTCOrrc1UG9paaGlpeWI7Ov9738/AOvXr2fSpEkAdHd3s2fPHqZOnXpEjmG8N6lKBZ3PE+XzlPv7CSoVgkoZpRVSCFzLxrUdHCtelDLQIf0qR16XKKoyKI0olrDyRWS1f7xm2DR6oCEfQi5QhKoyNI2uZTyNLiOknUPpEK0UBcsj52eoWCMv01o/OhGOViOy5cEg3cHFxqGWPGvNmNY2Zr20nvquXgAqnsPri+aw5fgZRLYNKqRZrGHMvC2k0nGVSWfF5eF+WFuUpCtw/Rqbutbz2Dn2LNRYlx0N8McFAZvHxz3r6Xw/Zz77PIt2jmd2ZoDTx3+JOtFDWR1Pa/DfsfSUWk/6/z3Dwsqv5ZSNu6rVLHFPumVJCH0Y9hKBJXT8SA703wRKxg/XDrEkeMIjHQmayxUSjo+TSOA5Nk5dmiiZoj/TROinQQjclIPtWziWpCntkvbi5zyRSJDJZLDt90w7lmEYhmEYhmEYhmEYhvEmvGtSotbWVrq7u2ltbSWKIl566SUAZs2aRTqd5rjjjuOiiy7iH//xH/nZz35GNpvlK1/5CnPnzuXss89+e0/eeMcZXFRUDQxQrnaiB0ElnvgWEs+2cG0Px4oXoCypCt0qT14VqegQlEKUyljFMqJUQey94Ed1Gl1VK11yIZTCkEiX0WJwGj0O6C1ZBLuMjiKCSJB3fApegnCvV5TjID1CaoVkeJCuURpA4OBh7dWRPnHTdmb8+XXSfbn41BybTSfMYuPC2YSuA1pRr9czbuYGMvVxx35fYPPogOTpvIUTwufWwaT1Z7F97Hn0T0ixOy1YdUKRV6ZOAMAKA05a+zwf2OAy2fb5wIRvM1FuJlRjaQu+RqROxSLuSb9zuss6exsntr6KFej4XIXGtgU69CAc+rVUq3c5UJA+WO9iVetdpE1CuzSVKtQJCyuRif8+04lqvUs9hWQjSCsO0ZM2UgoaUi71CQcpBbZtU1dXN+q7VwzDMAzDMAzDMAzDMIxj17smUF+xYgW/+tWvareXLFkCwB/+8AfOOussAO6++26uvfZaLrjgAqSUnHnmmTz66KM4jjPaLo1jiA5DdKmEKhYJczkqxSJBuURQqaDRcTWIY+NaFrZlobWmqMv0RgPkVZFQRxApZLGEVSojS5W4u2U4RRykKygrKATxNHqkK0SiAkRo4ml0QYi0c2gVoiNF2XLIeRlKtsdeex0WpEdYI74bB+kCiYuLHHY5W5WAKa9tYform/CL8bR5xXXYMn8Gm0+YRSXhgdZk9FbGTVpH/Zh+AAqRxeMDkidyNjqCT61XzF97Eq1jLmTLpEb6fMF/zSvw4qzxaNmAUIrjX3+ZD76cY3LUxCnN/w/znadQOkF3cCUD0cVYWETAA5MdHmzs58Qdqzk5X4ThPenKhdAZMW1vCX1o9S4ShBXW6l0aKoqGqIzrpnBsiZ/wEJk0lVSmVu8ibQs3Hde7pD2bprSLY8X1LplMhlQqZWqRDMMwDMMwDMMwDMN4xxJC8MADD/Cxj33s7T6VY867JlC/6667uOuuuw64TTab5Re/+AW/+MUv3pqTMt6xVKUSB+ilErpUIiyWCIIKYaVCEMQhumNZJF0X17awpERpRUGXyYdF8rqE0grCKA7Ri+V961wgnoyu1rqEqjqNHkA5DFFUp9HREA2bRhcltFJEIfE0up8gkNY+O1ZQDdJDrL2/p0Fi4+Igh33XLRSZ/sompry2BSeIFxItphJsXDCL1jnT4ol0IKHbGT92LU0TuwGoKMkTAxaPD9gUFVyxOeKU5+bT2vgxXp8ykYIDfzouzzNzxxHa8YKjs7as56y1e5hUnMLi+sdZmngYR0fkw3PpjP4OR6exgKcbLf7nNM203c9x1vrdDPWkK6S0IfQYnpofcr0LgBViWcPqXSohCdvDTiTxHQsnmyZKZRjINBLsVe/i2pKWtEfCjZ+/ZDJJJpPBsvb+uzAMwzAMwzAMwzAMw3jr7N69mxUrVvDwww/T0dFBQ0MDixYtYsWKFbXa67a2NhoaGt7yc5s2bRpf+MIX+MIXvvCWH3vQ5z//eVavXs3LL7/MvHnzak0mg1auXMn3v/99nnnmGfr7+5k9ezZf/vKX+eQnP3lEjv+uCdQNY3+0UiPCc1UqEQYBYaUSfw4DlFYIBI5lkfJc3GGLiuZUkXxYpKjLcRVLECCLZexiGVEJRjkgtRBdKyhXK10KYUSkApSsgIhq3ehD0+gBOtJUpE3OTVO0/bg6fMSuNRqF0Aprr4VGB4N0CxsPd2ihUSDZN8CMP7/OxI3bsar1M/31GTYuOo4dMyejrXhblx7GN75Ey5QOhIBIC57K2fx2wKIvFPzlTsW5f5rEztTHeXXKcQQWPDMzz+r5LZS9eMHRSW3bOPuFnUwfmMy8zAbeN/42MgxQVidUe9In4wCtScEPZzmUyxs47bVNWApG9qQnh4Jx4kjdEvoQ6l0EWCFCaDzLJqkdGoshdVJi+Slc28Kr1rvkMw0Ukw0gJbZn4aQcLEvSlHLIJhyEEDiOQ11dHa7rHtLPm2EYhmEYhmEYhmEYxtF0ySWXUKlU+NWvfsWMGTPo6Ojg8ccfp6urq7bNuHHj3sYzfPMqlcqbymKWLVvG008/zdq1a/f53pNPPsnChQtZvnw5Y8eO5T/+4z/4m7/5G+rq6vjoRz/6Zk4bMIG68S6kg6AWnKtSCVWpEAUhYTAyQLeExLYkSdfBlhK7Onkc6JA+lSOvi5RUPHUuypW4E71QQoTRKAelFqJH1RC9EEIxJA7RRSWeRhfDp9ELaFGC6jR60fbJe4l9FhkdOY2usFB7tZxolBZYOHg4I4L0us5uZq7dwNjWttp9usY28fqi4+iYMg6qtSWe6GZs/Z9pntyBFSfbvJh3eKTfojOU/EWH4uLVDey2LuKVSUuJBLw4Nc+qBfXkkpMBaOlq56wXtjBnzySOy7Ry8rjbqRc9hGocu8JrUepkLGDAhjtnejzrd3Dq1j+THJzsFxrbAR3s3ZMOUmjEARchr9a7CMAOcKSFL5xqvUuI6yWwbYnvuchshkoqSz7ThLJdhCXx0g6WI8kmHBpTDlZ1dfjBehfDMAzDMAzDMAzDMIx3gt7eXlatWsXKlSs588wzAZg6dSonn3zyiO32rnx58skn+fu//3tee+01TjjhBL72ta9x8cUX8+KLL7J48WJWrlzJ2Wefze9+9zuWL1/OunXrWLx4Mb/85S+ZM2cOAJs2beKLX/wiTz31FPl8nnnz5nHbbbfxoQ99CICzzjqLbdu2ce2113LttdcCoLXmG9/4Bg8++OCISfEf/OAH/OAHP2Dr1q0AXHnllfT29nLSSSfx4x//GM/z2LJlC9u3b+dLX/oSv/3tb5FScsYZZ/DDH/6QadOm7fc5+tGPfgTEk/yjBepf/epXR9z+x3/8R377299y//33m0DdeO/TWqPLZXS5PDSBHgSEgwF6GBAGQbUH3cKxJJ7n4lQDU4BQR5R0mWJUoahK8aKiWiPKAVaxhCiWEdGBQ/RQQSmCfAjlUKNUgBIBWgQgdXUaXSJlBWENTaMH0iLvpinYPkrsHZPH0+hy1Gn06hY6bkj3cajVomhNy44OZqzdQFPH0CuTbVPH8/qi4+gZ21T7WsLqZGzDyzRN3I2Ucf/6+qLNf/RbbK9YnNylufFJj/7yBawb/wGUtHhlfIE/LkrRXRcH6dn+Hj744uss2jWOGalOThn/PZpFJ5FuoCP4B8rRuUgkEXD/ZId/GV/mxO1P8hfbemuPw3Y0WrkQuIfZk87IehcJnnRJR5LmSkjS9rASzoh6l/5ME4GfAgROysb2LVKeTXPaw7XjfaVSKTKZTO1nxDAMwzAMwzAMwzCMY4PWmmJYfMuPm7ATh7ReWzqdJp1O8+CDD3Lqqafied5B79Pf38+FF17I+eefz3333ce2bdv2W8ly44038t3vfpeWlhY+85nPsGzZMlavXg1ALpfj/PPP59Zbb8XzPO6++24uvPBC1q9fz5QpU7j//vtZtGgR11xzDVdfffVhPX6Axx9/nGw2y2OPPQZAEAScd955nHbaaaxatQrbtvnmN7/JRz7yEdauXXtE2wT6+vqYN2/eEdmXCdSNdwwdhvH0eRCgwxBVLEG5hFIqnjwPAoIgIArjGhbHknEPuu9jVxeUBCjrgAFVpBSWKepyvKAogFKIcgWrWEaUyohIjXIS1EL0ShRPoBcDKEUKTVidQh8eoltAiJQFoASRQgFF2yPvJChbey+Ie7Bp9DhoF1pg4WFhM5g2i0gxfvMOZv55A5negfghScH2WVPYuOg4cvWZ2j7Szk7GNq+jcdxQ4P5KweZ3AxZbKhYn9MG1fxJUej7MhskfIrI8NjUX+cMih7bmSQAkijne/9J63tfayDSvl1PH/YhxcjtKp9gT/B256EJsbCTwpyaL/+9Mi/Fdr3De2m3I2oKjGiHinnQx7JEKoePm94PWu0iQIUKqoXqXUkidBMuvLjqaSqBTafKZRoqpepASy43rXTzXointkvbiX3Wu61JXV2cWKjYMwzAMwzAMwzCMY1QxLHLKfae85cd9+oqnSTrJg25n2zZ33XUXV199NT/96U9ZunQpZ555JpdffjkLFy4c9T733XcfQgh+/vOf4/s+8+fPZ+fOnaOG3rfeemtt8v2GG27gggsuoFQq4fs+ixYtYtGiRbVtb7nlFh544AF+85vf8LnPfY7GxkYsyyKTybyhyplUKsWdd95ZC8rvuecelFLceeedtVzvl7/8JfX19axcuZIPf/jDh32M0fzrv/4rzz77LP/rf/2vI7I/E6gbbymtFLpSgSBAVYPzwdtaxRPUURQShWFt+jwKQ6QQ2JbEtyxsx6/VtyitKOuAnCpT1BVKuozS8X6IFKJSQZYqyEqACOLJ9H1PirgPPYyrXEpBXOdSURGaCC0qaBkST4wPC9FFAWQZVBRPsYt4Gj3vvJFpdFBoLG1j77XQqAxCpqzfyvRXNpLIx6+gBo7N1nnT2XzCLEqpRO0odV4rY1pepb6lt/r8wEsFm8cHbHYGkll5+PYzEfb2D7Bl6vkEdVl21BVZuaDIlokTAXAqZU5++TVO25hhqlPg1DE/ZrLchNI+3eHl9IWX4eBhA2vrJD+e5VIOtnH6q6/hBSFDC45KiBJxKF4V17twaPUuAHa5Wu/i01jR1Echrp/AsuJ6F6tW79KMsh2EJXFTDo4nqU+5NFR70i3LIpvNkkgkDnRgwzAMwzAMwzAMwzCMt90ll1zCBRdcwKpVq3jqqad45JFHuP3227nzzju58sor99l+/fr1LFy4EN/3a1/buyJm0PBQfvz48QB0dnYyZcoUcrkc3/jGN3j44Ydpa2sjDEOKxSKtra1H5HEtWLBgxNT5mjVr2LhxI5lMZsR2pVKJTZs2HZFj/uEPf+BTn/oUP//5zzn++OOPyD5NoG4ccVopdBDEoXmlUps8JwjQw6bCB4NzFUVxgB7FfwawpMSxJAnbwnGdWjVHpKM4OI/KFFWFsq4MHTiM4gn0cgUxGKDvj4o/ohDK4WAfuiZS1Ul0GQyF6MoCbSFEiCQPogxKgY53U7Zc8k6Ckr3321AOPo0OGqElEgd32DQ6gFMsM23dJqa+uhm3ujhqKeGx+YRZbJk3ndAbPJ6iIbGZMePWk62PJ9dDLXgmL/n9gMOeULI4B194IcDftJTNUy+iOLuFPakSK48f4NXpUwGQUciSV9dzxnqPqaLCKc13MMN6Ba1t+sK/pDv8JA4pHOD1tOQnsz12inZO3bKObKEAVCfPHdCBD2r4rxcR17vIUV7QGPH3IuPnwAqQEjzpkQ0FTWFE0vKwkjauZeFmU0TpOvozjUP1LkkbO2FRl3BoTLvYMn7XQiqVIp1Om3oXwzAMwzAMwzAMwzBI2AmevuLpt+W4h8P3fc4991zOPfdcbrrpJq666iq+/vWvjxqoH47h79ofnApXKs7rrrvuOh577DHuuOMOZs2aRSKR4NJLL6VSqYy6r0FSSvReQ6xBEOyz3d7r2OVyOU488UTuvffefbZtaWk5tAd0AH/84x+58MIL+f73v8/f/M3fvOn9DTKBunHItFKgVPw5iuJp7yiqBeYqCCEM0MMW9dRao1QcmA+G52EUoqMIKUW8OKQQOFLiuw6W9JDDprsr+6tvAQgCZDmIFxStBKMvJjpcNUQPAyiFw/vQFVoEKBmCDONfAMoCLIQIkGIAqMQhenU3JdujaHuULA+9V0p+aNPoYGsbCxsxbBodrcnu6WHK+q1M3LQdq/oCRC6bZuOi2WyfNQVlx9sLEdGU2sCYca+TysSBdlkJnsxbrByw6QslZ/dqPv5siN5xItumfIT83An0e2WemNfDS7OnoaUFWnH8xk2c9YpmWhhxUsNPmGs/j9aSXHQOncGncKnHAXYkBD+d5bE22cdpW57h+P6+2qO23dF70oUAS45SrzPiCakG6TIaqndRNk2lkKx0sDwf27ZIJD1IZylmGimk6uJ6F8fCSdskfZuWtI/nxM+47/tks1ls2/yaMwzDMAzDMAzDMAwjJoQ4pOqVd5r58+fz4IMPjvq9OXPmcM8991Aul2ud688+++xhH2P16tVceeWVXHzxxUAceA8uKjrIdV2ivdYibGlpob29Ha11LaQfvkDp/ixdupRf//rXjBkzhmw2e9jneyArV67kox/9KN/+9re55pprjui+TdJ0jNFKxQF4NQxHKXQ1HNeDt6uBuVY6HuEeDM4PMFw8GJyHYYgKQ6LBaXOlkFIgpcSWEldKpO1i7TUtHOqIQIcUVEhAQEWHlHQFpdXgARCVIK5uKQeISmX0DvThBgP0CIIgnkQvRXEfOlpXQ/QArKgaottoBFKECJEHXYk7Uzh4iD5yGj3CQo+6zqZAYGkHudc0ulWuMGnTdiav30q2p7/29Z6WBl5fdBxtUyfEXSmAlCEt6VdpGb+JRLIEQD6SrMpJnsg5lELBxzoV5z0dUew5jc1TPkxxXgt5u8yfZu/h2XnTCJ34LT0zt23lL/5cZlZRsLThVxzvrEZoTTE6jbbwalw9BhfY7QnunOmysqHMydue5cLXO6tnr7EcjcCGYO+edIFEHbjeRUviJ1Mj7Aq2tEmQoKEc0aA1jpdEWvGLLXY2Q5CuJ5duQjkOQsb1Ll7SoinlkvHjV1ht2yabzY54m5NhGIZhGIZhGIZhGMa7QVdXF5dddhnLli1j4cKFZDIZnnvuOW6//XYuuuiiUe9zxRVXcOONN3LNNddwww030Nrayh133AFwSAuhDpo9ezb3338/F154IUIIbrrpptr0+qBp06bxxBNPcPnll+N5Hs3NzZx11lns3r2b22+/nUsvvZRHH32URx555KAh+Sc/+Um+853vcNFFF3HzzTczadIktm3bxv3338/111/PpEmTRr3fxo0byeVytLe3UywWa+H9/PnzcV2XP/zhD3z0ox/lH//xH7nkkktob28H4hcDGhsbD/n52B8TqB9Dou5uwo5OKt09h3wxxUG5Qus4aFfVwF1Vb2ul0Uoh0PHEeXXa3LMtLMcecRylFQERZR1QiUICHVLRcYCu9k7r1WCAXokn0MsB4kCJPtQC9KBa41IKoRJCoHT1bScKLcI4RCeMXyBQ1lCILnOggsMI0ePec4iQWu93Gl0AQttYOIjhW2hNQ3sXUzZsZdzWnbVp9MiS7Jo+ka1zp9M9rike8QYsq8KYzMu0TNiK58VvtekLJX/IWfwpZ6MjySd3hJzxJ0lP+QzWTf4Q5TGN9Ll5npq9mxfnTCeoBukT2ndxzpp+5vS6LG38VxZm/oBNRClaRFv4aRw9BRfos+FXM1z+fZxiyY4/c8nzO5BoBoN0KSx06I3oSUeABYgDTqUP9qTH9S62BE8mqA80jVGIZ/vxwqKWhZdOxvUu2aZavYvtW7hpm8aUR33CQUqBEIJMJkMqlTqsf1kYhmEYhmEYhmEYhmG8U6TTaU455RS+//3vs2nTJoIgYPLkyVx99dV89atfHfU+2WyWhx56iM9+9rMsXryYBQsWsGLFCq644orDGjj83ve+x7Jlyzj99NNpbm5m+fLl9Pf3j9jm5ptv5tOf/jQzZ86kXC6jtWbevHn85Cc/4Vvf+ha33HILl1xyCddddx0/+9nPDni8ZDLJE088wfLly/n4xz/OwMAAEydO5JxzzjlgGH/VVVfxxz/+sXZ7yZIlAGzZsoVp06bxq1/9ikKhwG233cZtt91W2+7MM89k5cqVh/x87I/QexfcHOP6+/upq6ujr6/viL/V4O3WtXkzO7ZsJWVZxN3g1YBcx38GQCvE4G0dz10LIZBCVCeOBULEr24Nfn1vgQ5rHxVCKjog0OHIupZBSsVd52GECEJEGFY/H6S+BUDF64FWQqhUa1zKShMpHU/VC4UmiqtcGFxUFNA2CIXQZYQogYq/V91lNUT3KVnugSfR0Yj9hOgAAomFjdR7d6OXmPR6K5M3bCXdn699vb8hy9a509kxezKBN9TH7lgFxta/TPP4Vhwn7oXfE0geH7B5Jm+RjGyWbS6z5EmX3dYHaZ18DoGbZY/fy5/mBvx51kwiK37tbOzuDs54uZcFnQkW1/8rS/z/xKVCWR1HW/hpbDUHgIIF/zzV5Z8nSY7r2MCC7ZtxVEQcpCuktNCBB3pYXU31Z+OQ611EiLQ0ruWSjSRNgSJpOVi2jW1beAkXmamjkG2imKoDIeJ6l5RNNuXSlHZxrPjZTyQSZLNZLMs68LGPEqUUnZ2djBkzxnS1G8YRZK4twzg6zLVlGEeHubYM4+gw19bhey9nW4erVCqxZcsWpk+ffsy9k/3ee+/lU5/6FH19fSQSh9fffiw6nJ8VM6F+DNGVMlGpgBYirmERAnswFK/9O2nwD/sGk0orqhE1kY5QWhEpTcjgtHlAQLTPIgQARBEiiGqBOWEY344OITivnUBc31KuQCmASgRBpKvT7RotIjRRdTHROPyNp9DjKheBRogKQvTHSXz8igEKcRghusLS6gAhOkhspB45ja6VpmVnB5M3bGNsaxuy+hyFjs2OmZPYNmcavS0NtWl0AM8ZYGzDn2ketwPLikPqXRXJ7wZsXipYjKk43LC+yHF/cmnLnM9z088isJO0p3fz5LyAV6fPRFf/Y2NS2y4+sC7PnN0pFtT9jhPH/YYEJQI1ldbwKqRagg1UBPz/JjvcNc1hQs9WLnrxNRJBAGikrbEtgQqS6HCUIF0oRu25qf39SeKfL4WwAzxpk8ChqRxRB1heAmFLfM/BTqeppBrIZxtRtgNC4KYcUmmH5rRHwo2P7zgOdXV1I1aINgzDMAzDMAzDMAzDONbcfffdzJgxg4kTJ7JmzRqWL1/OJz7xCROmHwUmUD+GWNUec1sKtNBEREQ6rm+JQ/L4cxycq6HgvBqiH9KbGQaD8sFJ88Hpc3WQqeVR6GHT5+UASpEmVLo6TF4N0EWIlhFDAboAJdFaIggRIkCIHOggvp8enEQXFG2fou1Rtl32fWSHHqIDCCxsbIS2GJ4qe7kCkzdsY/Lr20jki7Wvd7c0sG3udHbOnETkDL8MNZlUB81162kc044U8ZltLkt+1++wriSZXXT45isFJj2dYEfzx3hm3gcJLZftdW2snl9h49S5tb3N2L6DD7waMqvXZl72P1ky/hHS5AjVWHZG16Ki05EIIuDhiTY/m+mRyu/i3D+vo74YL3QqbYVlC3TgoyrDz1VU6100Qh7oZ0NW6100WBUcKUkIn4ZA0aAUjucjLYnrWLipFGGmgb50E6HvM1jv4qcdmjMe2UTcky6lJJvNkky++xYRMQzDMAzDMAzDMAzDONLa29tZsWIF7e3tjB8/nssuu4xbb7317T6t9yQTqB9Deip9tEdddEYVDrtiWum4nkUpiNTQn5VCVOtaCKOD95yPQmsII00QCIIo7kAPI6jUps8hDtDDYQG6ir+mJUSyOoEeIWSAEGXigL268+ouIgSlQwjRhY4QWmGjDjhwLZFIbCxtoYfH7UoxtrWNyeu30bKzo7aPiuewfdYUts2dxkBj3Yh9WVaZ5vpNNDZuJp3O1b7+alHy2IDD5rLkpAGbH6wpUv9Chh3jL+SpRacTSsGmxl08eXwDrRMXVB+GYu7Wnbz/NcHMXJEF9f/GgrEr8SkT6Qbaws9TiT6EhUQAj4+1+Z+zXEqqh9NefZqxA73x47MUlg068tBlZ9jZHmqQPtiTLkFWkBJ8y6MugOYowrN9pG9hS0kilUCn68hlGiknMyAE0q72pGc9GpMusrooayqVIpPJmLf6GYZhGIZhGIZhGIZhVF1//fVcf/31b/dpHBNMoH4MiafMiQeoDxSQRyM/E6k3FJTvLYw0lWpYHkQQhvHnSFWrWUZE3CqeQJdxiB4H6KCVREcCIeJFRoUoIqygWuFCbUHR+PEKyrZHxXIoWy6BHK1fW6PQSB2B1ocQoltIYWFVa2SGn3WiL8eUDVuZ9HorXqlcu8/u8S1smzuNtmkTUPbwc9Ckk7tprt9AY/OuWq1LSQleKFisztnsqlh8qEfw5edL+OsaaJ18CetPPIWIgNfG7mD1CeNpHxMvvCCjiBM27eT9G1xmlrtZVP8vzBvzNDYRoW5hV3g5legcbGws4Kkmix/P9mhzCpy6+SWmdsXhv5AK29UQeejK8CqVOEiXgDyknnQJIkJaFVzpkFEWTWVFSjpYno2wLRK+g5XOUsw0UUzXoy1Zq3epq3NpSnu41Z50z/PIZrM4jnPgYxuGYRiGYRiGYRiGYRjGUWIC9WOI7h/A6unDLvbXOryPtFDrODAPhz7CSA9m9qNQaBGH54gILRRD0+eAttBx90qtwkXawdDOtK4Nox9agA4ajUYhtQIdMXLJ0JHi+WoLKWyktuJKmaGhd2QQMG5bG5M3bKOpfU/tfqWER+txU2mdM418XXrEPi2rQlP9ZpoaN5FOD9S+vr0i+FPO5vmCjY5cPrY75Lyny4gtE9k29Tw6TjqRUA/w5wlb+dOCaXQ1vg8AOwxYvKGd0zb6zI5aWVL3L8zK/BkBBGoq26L/hohOqc7Tw9o6yY9ne6zLhJy0dS1ntLXGC6xKje0otHLQZW/YsyIG/+/gPelaxh8ohFXBlTYJkaCpElGPwHITYEt8x8LJZKikm+jPNsQ96dV6l3SdR3PGI1ntSbcsi2w2azq/DMMwDMMwDMMwDMMwjLedCdSPJVH0hqbNI0Draiiu44F2rSDS8XR5FEGo4olzFWfhe9EgBoPzanhe7TyvBefEQaxWutpzrhAiQso8yLA6eV5NsiNdPa9DC9BrVS7ElTRSRwfpQwcLG1EL0RkRojvFEmNb2xi3rY2mXbuxquG+FtA5aSxb506nY8q42oKgg+eQSnbR3LCBxqad2Fb8KkBZwYsFiyfzNq1lyawgyZe3DjDnuTzl7mlsmXIee05eTEXt5sXJG3l6wXH0ZacD4FbKvG/9bk7Z6DPX+jNLMv/GFLm5ut/57Az/FlcdX1te9plGi19Nd3m+XrN4xwauWLcJR0UIobFdBcpBVxIMLUx7GEF6rSddgKzgWAJP+jRVhnrSsSSObeGlEqhMI/2ZZoLqqsmWY5Goc2jJ+mT8eAJdCEE6nSaVSpl6F8MwDMMwDMMwDMMwDOMdwQTqx5AoUoRKE4U6bnwZDMc1RFqjVDwbriI92AgzNFWuiRPjwT+PStemzAc/IKx9Lw6mJVqJeIFTraqLbkYIGYIIh6pEBgN0NXTAOEB3DzlAjxcUjY8zVNAyOlFdVlQKC7FXiK6BRH+ecdt2Ma61jYaOrhH7ymdTcTf6nKmU0iMXyZQyoKlhC00Nm8hk+mpf31URPJm3eS5vQ5jgwt6Qr76cJ/u8ojuziHUTP0j3tDkU2cHz0zbw7AnHk0/NASBZLHLyaz2cvNnmeH8VSxoeZIxoR2tBPjqFtuhv8NVUXOKn7/djbe6e7rIhrTm+bQtXPLORZFAGobE9FT/eIFWdLI+fjcEHeFg96SJCWhG+dKkLJU0VhW97SN9CWhLf95CZBgrZJkrJNAiBsCRexqGl3qc+4SCq5f6JRIJMJoNtm19RhmEYhmEYhmEYhmEYxjuHSauOIbt7A7pymnAgDq0F7Cco3zt6rsbKQqFHfK5OmAvF0MQ5aC3QSoKK61VE9T5ChAgipDUUsseLhlYPPCw8h0MP0HX1H7RCoqoLih5koBoQyGEhuhwZomtNtruPsdvaGLdtF9me/hH37W2up23qBNqmTWCgIV5Ec7hkopuWxtdpbGzFtuNp9IqCl4oWT+ZstpZt5pVTfGVrHzOf60d3NLBzwl+wbun7KbspcmILz8zayAvHL6DkxyF9JpfntFdznNSqWJB8iCXND1NHH1pb9EUfZnf41/i6BR+oCPiPiQ73THNp8yNO2LmRT76yiURQGQrSsdBBEq0Hn9fDCdIZ6klHIe0KrrDJ6ASNlYi0tLB8D2Fb+K6NnamjlGmmkK6Le9IRuGmbpgafppRXW3DUdV2y2Syu6x7oyIZhGIZhGIZhGIZhGIbxtjCB+rEkBKFARDAiIB8MpGW1u1wMzmUPH0+v/knHtR5aEQfx1RBcoxDV7nMpA4SIEM5e9x8+dT5sEVINhMIisG1CaRFIm1DaB1hEFBjsQEcjtTpghctwEgururAoe4foStPY2cXYbbsYt62NZK5Qu58Sgu5xzbRNm0DbtPEU95pEh3gavbGhleaGjWQyPbWvdwSCJ3M2zxZsRDnFxT0Vbnw5T/rFgL7UXNZPOIM9MxYQRt1sr9vKC7ObeG3miUR2XH3S2DfA6etKnLQzz6Lsv7Go+XESFFHapyu6hJ7oUnydwQdyFvy/U1z+earDgBWyYMd6/mLnZvwwqAXpUkpUeXiQTu0FgcMN0oVVwZaSlEjQGCgadNyTrm0Lxxb46TSVbAu9mQai6mKitmfR0JigKTu04KjpSTcMwzAMwzAMwzAMwzDeDUygfgyJdA4li0RWf3UofHg4ThyQ68G+8fiLojadruOvVRcNFUIjhEI4e4evtXR6WB4/tE0oLAJpxYG5ZVfDc2v/LTJ79Z+jNRaHFqDHj86KQ3RRDYG1GDEUL8KI5l2djNvWxpjtbXilytDzZUl2TxobT6JPHUfge6MeJ5HooaVxI42N23DsePo+1PBStRt9S9FlYSnF17b0MPXZXtidoW3ch1m3+AMUEnUU9Eb+POllXpo7l93Nc2r7Hbenj/e/FvK+9jaW1P8rx7esxiEk0lnao7+mEJ6Pi48PdDlw3zSX/3eyS0SFBTte5YSdW/CiMF5s1I8QwkJVEig1/LIf1pM+WLezP7UgXdeCdF/4NATQqBSO54FtYVkSP+mjM030Z5sJPA+EQNoW2XqXMQ0JfCcO84UQZDIZUqlUre7FMAzDMAzDMAzDMAzDODAhBA888AAf+9jH3u5TOeaYQP0YUs4XUGGEqsSj6qLaeS5EdSpZKISA/TWTD6mm0Xpkx/nwqfNQyOqUuT0UoEu71i6zv/1Wl/dEUF089RD6zwfFTd42EhlPoCP3aZUBsMoVxuzoYNy2XbTs6MAOo9r3Kq5Dx9TxtE0dT+eksUTOaJeIJpHopbF+O3XZHaSSQ3UwnYHgT3mbZ/I2VrGOy7pL3PjKAKkXSwwkp/P6hDPomLWUSO9mZ2orLxzXzKuzTyZw4rDeDkPmb+3lxM02C/LrWVr3LxzX8iISTahb2BF+kjA6CxsbF2j1Bf97hsvDExysqMyi1lc4fteWeLFRS2EnFELbqCCFVsP/Zg9jwVEta/3qQoZYUuFLj/pQ0BBpPNdF2hbCkviei8w2Usg0U06l4sl3IUjXuYxpSpL2hp7PZDJJJpPBsg7+E2cYhmEYhmEYhmEYhnGs2L17NytWrODhhx+mo6ODhoYGFi1axIoVK3j/+98PQFtbGw0NDW/5uU2bNo0vfOELfOELX3jLjz3o85//PKtXr+bll19m3rx5vPTSSyO+v379ej7zmc+wbt06+vr6mDBhAldccQVf//rXcaoNCm+GCdSPIZHOY9kllFtk/yuLDq9nYeR2euRthUDVgvOh0DyUFmq/08aDJTPxHtC6unBoHKIfSvf5IFFtQZcinkIXDE2f62EZv1CKTHc/jR17GLOjg6Zdu5HDEvZiKkH71PG0TZ3AngnNaDna/LsmleymoRqiJxO52ndCDX+udqNvLiRYkk/xja1dTHy2C7p8OsZ8kFcXncFAqolS9BqvTFjDS/Pm0zZ2QW0fTb05TtwUsnhbhXne48xPPcZUbxMAgZrKtuhKrOhEJBIbWJeW/Gqmyx/G2iQqJU7a8hrz2rZiqwhpx9UuaBtVToysdhkWpMuD1btoWe3XFwipkDLEEy71kaQxUPi2g0zaICWuY+FmspSyYymmsmg77kn3kjZjW5LUJYcWHPU8j2w2e0R+gRmGYRiGYRiGYRiGYbzXXHLJJVQqFX71q18xY8YMOjo6ePzxx+nq6qptM27cuLfxDN+8SqXyptbQW7ZsGU8//TRr167d53uO4/A3f/M3LF26lPr6etasWcPVV1+NUopvfetbb+a0AROoH1u0qk6Vx7UtI78X/49CEAmJEhaRlCgRf0SjfD7UaXNZDc4Hx8VldeL8cAs+qvE5UsRT6GKwmEbVlk1FA1YQUr+7h4aOLho7umjo7MYOwxH7GqjP0D51ArumTaC3pX6fRUVjinRqDw31O6ir20HCG+pUryh4rWSxpmjxStEiUWjir7oKfPXlPpJr8+S9CWyaeAZts99HwG46/C28dFyBl+e8n7IX94TLKGLe9gGWbhIs6nud+XUPMa/pKRKU0BqK6nh2hlfiq3kMRs9PN0jumunxbKNFplzg/a+/wtz2ViwdYTkay1egHFQ5AaMsNgqH0pMuQQ3+DSmkHeALl6xK0BgqEtLGStpoKXFsiZtKEWZa6M02oqoT/bZr0TImSVN6aMFR27bJZrP4vn8of92GYRiGYRiGYRiGYRjHnN7eXlatWsXKlSs588wzAZg6dSonn3zyiO32rnx58skn+fu//3tee+01TjjhBL72ta9x8cUX8+KLL7J48WJWrlzJ2Wefze9+9zuWL1/OunXrWLx4Mb/85S+ZMyeuIN60aRNf/OIXeeqpp8jn88ybN4/bbruND33oQwCcddZZbNu2jWuvvZZrr70WAK013/jGN3jwwQdHTIr/4Ac/4Ac/+AFbt24F4Morr6S3t5eTTjqJH//4x3iex5YtW9i+fTtf+tKX+O1vf4uUkjPOOIMf/vCHTJs2bb/P0Y9+9CMgnuQfLVCfMWMGM2bMqN2eOnUqK1euZNWqVYf+F3EAJlA/hoRRQFlaFGyPSIgRAbkSkkjKA3SZ721oQdHBaXOhh3Wua0W1dOUNGd5/LoWsTqBX1zPVQwP0GnCL5Wp4vofGjm6yXb0jJtABAsemZ2wTXeNb2DV1PLmGzH6OrMikO2shuu+Wat8pKVhXslhTsHi14JAstnBmqcLftnbT/EwHstuhs+VkXlvwQXqzYygHr/Lq+BdZM28B2ycsre2nfqDI0k0B79uWZ4H7nxyf+B0TmrbHR9cJ9qi/pCu6kJQajw9EaH4/xuZXMzxeq7PIFnOctX4Dszu3Y2mF5SpsW6MjF1Vya/Ushx+ki2qQHi84Kq0AV9pkdbzgaEpKpOdWe9IFXjKFzjQxkGki9BwQAmFJmpp8xjQmsKuT/lJKMpkMyWTS9KQbhmEYhmEYhmEYhvG20lqji8W3/LgikTikXCSdTpNOp3nwwQc59dRT8bzR1/Qbrr+/nwsvvJDzzz+f++67j23btu23kuXGG2/ku9/9Li0tLXzmM59h2bJlrF69GoBcLsf555/Prbfeiud53H333Vx44YWsX7+eKVOmcP/997No0SKuueYarr766sN6/ACPP/442WyWxx57DIAgCDjvvPM47bTTWLVqFbZt881vfpOPfOQjrF279k1NsA+3ceNGHn30UT7+8Y8fkf2ZQP0YkpcuA45mwCvv9Z3BcFwPi8lBVBcl1ZpqUF79XnWaXQybNH+jMWl8P6ta2CIRQtamz2tT59UAPT6sJtmfp3Fw+ryji3R/bp/9FlMJusc20T2uia6xzfQ1ZkGOfpZCRGQzHTTUbSdbtxPPGVqYtKjg5WIcom8oJKgrNHNevshndnSRfXkHzi5J0W9k2/gPsHPOKZTppMvdwovHlXh57hkUEun4GEoxe2ee923WnNSzhhMyDzOn/jlcguo0+hx2RZciovfh4pACygL+Y4LN/57usSMlacj38xevbmBW506kUNiuwrI1OvCISs4RCtJ1HKQLi5RI0BRqMkJieS7aqgbpCR/qWiikG6n4XnW6X5Ct9xjfksRzhipmBv8lIEet0TEMwzAMwzAMwzAMw3hr6WKR9UtPfMuPO+eF5xHJ5EG3s22bu+66i6uvvpqf/vSnLF26lDPPPJPLL7+chQsXjnqf++67DyEEP//5z/F9n/nz57Nz585RQ+9bb721Nvl+ww03cMEFF1AqlfB9n0WLFrFo0aLatrfccgsPPPAAv/nNb/jc5z5HY2MjlmWRyWTeUOVMKpXizjvvrAXl99xzD0op7rzzztqLDb/85S+pr69n5cqVfPjDHz7sYwx3+umn88ILL1Aul7nmmmu4+eab39T+BplA/RgSRiXi3vKg+pXBlFqNCMaPxgxxHJfLvUJzWTvWYAHN3tPnQimyXX218LyxowuvNPIFAQ0MNGSrAXozXeOaKGQO/AtKiJC6bHs1RN+Fawe17+WiuBN9TdFmU3+GMYUmLsz184+t3aRebsXuEpTdOtpbltC5ZAk9qQaC4BU2jHmel+YtYuuUU2v7yuTLLNkccPLWHk50/oPjE39gTENH/Jh1ig71MXrD80npFgZfb9zmwoNTHP5jkkuPJ2nK9XHuK+uZsWcXUmosP8KSAhW6RAWHofcBHG6QDihZu7+UEY6EpPBoCqFOSCzHRtsWwgI/4SMzzRTSTVQSfvUFCkEy7TCuJUk6MdSJ7vs+2WwW2za/YgzDMAzDMAzDMAzDMA7HJZdcwgUXXMCqVat46qmneOSRR7j99tu58847ufLKK/fZfv369SxcuHBEze7eFTGDhofy48ePB6Czs5MpU6aQy+X4xje+wcMPP0xbWxthGFIsFmltbT0ij2vBggUjps7XrFnDxo0byWRGNkmUSiU2bdr0po/361//moGBAdasWcOXv/xl7rjjDq6//vo3vV+Tdh1DhKogtcDSiv0vSvom9g+ArP0jhKwF6TCsHkYPTZ4Pfh1AhhHpvhzpvgEyvf00dHRTv7sbO4xGHCeSkr6WhmET6E1U/IO/BUTKgLpsGw3128lmd+FYQ/vtiwRrCxZrixbbepuZXMzysb5ujt/WQ+LlPqwBQcmrp61lCe1LltCXShMFG9mTXMe6GVNYO/dscum66gPSzGgr8r5NIR/ofYYFqf9gdnYtNhFaQ14vYJe6FCdcjI0VT6OjebzZ4oHpHi82WCAELf3dnPf6BqZ1tSOlwk4opBCo0CMquwyl528+SLekIik8GkNBAwLbceIgXYLrudjZJorZZiqJJLo66Z9I2owdkyKbHHruHcehrq7uiL0lxzAMwzAMwzAMwzAM40gSiQRzXnj+bTnu4fB9n3PPPZdzzz2Xm266iauuuoqvf/3rowbqh8NxhgYiB6fClYpHXa+77joee+wx7rjjDmbNmkUikeDSSy+lUqmMuq9BUkr03vXLQbDPdqlUasTtXC7HiSeeyL333rvPti0tLYf2gA5g8uTJAMyfP58oirjmmmv40pe+hGVZB7nngZlA3TgoUfvfOBoX1Tl2gQAhGIzNRXXL4cudag3R8OBca7xiiXRfjlTvQPy5L/6cyBVGnY6vuA49Y5tqE+g9zfVEzsF/8C2rQjq1m0x6N6l0J+lkD1IMXdzdoWBt0eKlvE1b93iOK6b4675OZmzZjf9KJ7IUh+g7W5bQMXsJvQkHFWyiM7WG9dOmsX7mSexpGnp7S7IUsHhzwOlbOzjV/neO9/5IQ7YbgEhn2aX+koHwPFK6gcFfoa+78OBUh/8z2WPAEVgq4riO7Ry/azNjB3qR1mCQLokCnyh0qL2PYK8n67CDdKGwrAgfj0YFDVrgOC7YEqTAdR3sTD3l7FjyyRTaig/o+zZjW1LUZYZC88G3+yQP4a1LhmEYhmEYhmEYhmEYbxchxCFVr7zTzJ8/nwcffHDU782ZM4d77rmHcrlc61x/9tlnD/sYq1ev5sorr+Tiiy8G4sB7cFHRQa7rEkUjh19bWlpob29Ha10L6YcvULo/S5cu5de//jVjxowhm80e9vkeDqUUQRCglDKBunEYNLUofDAQH/4PYtifYUQly9Dio6PutjZtPriRCCOSA3nSe4Xmqb4BnCDc7ylWXId8fYZcXZqeMY10j2umvz5Tm4o+ENsukUntJp3uJJnpIOP3s/daD51BHKKvyXvs3jOJhXmHz/S0M37LDvzXQISCotfIjpYltI9dSJ+nCYNNdKZfYP2M2WyY8QG6GsfW9ieVYnp7hcVbK5zd8wSLk/+HGal1SDRaCwbU+2hTl+BFx2MhSQEFNI81Se6f6fNKfTyNni4VOGX7Fua2bSMRlbFshZVUCGyiIIEKB189PHJBuitcGiOHRiVwXRtsC6TAcWycTD2V7Bj6U5lakO65FmNaUjTUDS2GIaUknU6TTCZNT7phGIZhGIZhGIZhGMab1NXVxWWXXcayZctYuHAhmUyG5557jttvv52LLrpo1PtcccUV3HjjjVxzzTXccMMNtLa2cscddwAc0kKog2bPns3999/PhRdeiBCCm266qTa9PmjatGk88cQTXH755XieR3NzM2eddRa7d+/m9ttv59JLL+XRRx/lkUceOWhI/slPfpLvfOc7XHTRRdx8881MmjSJbdu2cf/993P99dczadKkUe+3ceNGcrkc7e3tFIvFWng/f/58XNfl3nvvxXEcFixYgOd5PPfcc3zlK1/hr/7qr0ZM6L9RJlA/hkjl4EgbV+z/LSbDg3MNI1P0EX/WyDDCLZVJ5IrVwHwwNM+RHMjvt4tdCyhkUuTqMuTr0gzUZcjXp8nVZyn5LlrsGxqPxnEKZNKdcYCe7iDj5/fZpiMQbCpbbCpLNg00EPSM5eSc4tqeXbRs2oy7EYQWFP0mto9fQtvYBfQ5ZaJgEx3Z51g/Yz4bZpxLd8PQ20xkpJjRHjB/R8BJu19jgf8YxzuryaQHAIh0I9vVxRTDc0jqLIOvea5zNQ9OcXh0qk/Bjh/g5O4OTti5mcnd7diWxnIU0tegbKJKAqLBS3TkcxK/X+DwgnQhFJaM8HCoVzaNSuA7DvhxkG7bFk46S1Q3joFkBuXI6vNsMbY5SWPDUA+XEIJ0Ok0qlTJBumEYhmEYhmEYhmEYxhGSTqc55ZRT+P73v8+mTZsIgoDJkydz9dVX89WvfnXU+2SzWR566CE++9nPsnjxYhYsWMCKFSu44oorRvSqH8z3vvc9li1bxumnn05zczPLly+nv79/xDY333wzn/70p5k5cyblchmtNfPmzeMnP/kJ3/rWt7jlllu45JJLuO666/jZz352wOMlk0meeOIJli9fzsc//nEGBgaYOHEi55xzzgHD+Kuuuoo//vGPtdtLliwBYMuWLUybNg3btvn2t7/Nhg0b0FozdepUPve5z3Httdce8nNxIELvXXBzjOvv76euro6+vr6j/laDt9r//r+/Sc52KeR6R35DaewgxC2VccoVnFIFt1zBLVVwyhXcUnnk7eo21l6vUO0tcB1ydWnydWlydZn4oz5NoS5NaFlxPn/IL5JpPDdfDc/bSaV3k/GK+2y1qyLYWLbYVLLZ1DsO0dvMzJLg7OIe5vR1k95YwN0eH7ToN9HZsoS2cfPotwqEwUY66hXrZxzP+pnH01vXXNuvFSlmtgXM31Hm9K4XON7/AzPtl6gnfi61lvTp0+iILiYRzanN9g+g+c9GwQOzfdbXx6+AuUGFue2tHL9rC3XlHJaj4iAdiQodVOCAHnzryRsJ0gWoeEsQSBF3pDvCok5ZNEaChGMjHAssiZQCrxqkF1N1KLcapNsWLc0+TQ2J2quZQghSqRSpVOpNvz3mvUQpRWdnJ2PGjDEvMBjGEWSuLcM4Osy1ZRhHh7m2DOPoMNfW4XsvZ1uHq1QqsWXLFqZPn35YwfJ7wb333sunPvUp+vr6SBxmf/ux6HB+VsyE+jEi91+rmfDki1AOkfmBfUJz+QZfV4ksSSmZqIbmw4LzhjSVhI8SAn3o7ywZRuN7A6TTHfiZNrLpPaSckQsgKA07AsmmsuT1QpJt3ZNwexqYXwj5aLGNaf1dJLbvxNkBQsUnUfBb2DllMW3jZjMg+omCTbTVr2H9jBPYMOMT9GUba/u3wzhEP35HgTP7/4vjnSeYbr1MKl2Iz1BDUU+nXZ9PGH6QhE4xuLTCGlfz75Nt/nN6gnK1MqV5oJfjd21hVud2PBnGIXoqnkZXFY9weD86HKEgXeNiU6dtGkJBwrEQnl0L0p1kGurGkk83ELkShMC2JM2NCZqb/BH/sZJKpUin0yZINwzDMAzDMAzDMAzDeIe5++67mTFjBhMnTmTNmjUsX76cT3ziEyZMPwpMoH6MKDz9FBNeXHfAbULbouK5BL5LxfOG/dml4rsEnkvF9yh7LpVEfDtybLQQcVXMGwzObbtMwu/D9fuwE134fh8ZP0fCHtm1HmporUg2lyUbco1s3zOZdHeWE3N5/rqykwk9rSRaX8fePXQiFSfD7sZZdI2dxZ50IwXdTRhsYld9yIYZx7Nhxt/Sn6mvbW+HitltIQt29PIXA79jvrOaafI1XD8+F60F/XohHfpcovBE0jqLAzhAL5r/0wD/fpzPpvp4wU6pImZ37OKEnZsZm+vGdhVWQiGEQAUuUXn/0+jVr7yBIF1hWxEeNnWRoFGD6zgIL55IF0LgJBKI+nEU041EXtzjbktJc4NPU3MCyxoK0hOJBJlMBts2vy4MwzAMwzAMwzAMwzDeidrb21mxYgXt7e2MHz+eyy67jFtvvfXtPq33JJOQHSMSJ55I29OrKCWS5KSqheOVajhe8VyUHQerey9A+saC8r1pHKeI7/ciE3twEr0k/X6ybpGEHY16j4qCbRXJxpLDxv5x7Nw9lcYun/cPdPN3wU7GdL+Gv62CNTAyQO9omcXu8TPpTmQo6gFUuIsKL7OrcTKbps1lw4wPMZCuq93HCRSz2wIW79zNuflHmG8/yWSxBenFz4LWNl36dPaoDyGjBSR0gsHX9sponnMUj06y+d3MFEE1iE6XCszftYV57VtJ6TK2oxDDptH1AabRB29KFOKA72aToKqfEUipcKTCxaYhsmhQAtd1wIk70oUQ2AkfmR1LOdtI4DkgBJYUNNb5tDQnsJ2h6XPf98lkMkdksQbDMAzDMAzDMAzDMAzj6Ln++uu5/vrr3+7TOCaYQP0YkTnrLF5f+18Ejkeu0HsUj6Rx3RwysQcr2YXn95H2ctR7Jbz9TFkrDd2RoD0QdFQc2or17MqNoXvPeCbucThjYBfnBTtp2vMc3vYAWd5rAn3sLDrHTafHT1BUfahwF4F4mV2NU9g+YTrbJ5xI29jJRNbQj7sbKI7bFXBiWyvn5R9mvv0049gVj5oDSvu067PoVmfihXPxcGp1Ljk0TzqKVWMFT05P0Jd0a/ud1N3BCbu2MLWnDcdRWJ5CIFChQ1RwDziNDnE0LoU6cLe8ltVXPCQCgZARrgQPi4ZQ0IDAdl2wJUgRLzjqJ5HZFirpRgLfARkH6Q0Zl5bmJI439Nx4nkcmk8F13f2egmEYhmEYhmEYhmEYhmEci0ygfgw5IqvPihDsAjh5hFNAOgVsbyCeNvcKNDgVnP1MVUca9oSC9opFWylNW7GRttx4+npaSOQ8pvQWmVvs4EN6N5PDnWQ7N+LuDGv95xAH6HsmzKJj3BR6bZdy1IuKdhFYr7KrcXI1QP8AbWMnjQjQAdJFxYyOCqd2rOcj+YeYZz1HAz21qyDUWdr0h+mPPkAqmo6NxeDSHXtQrHIVq8cKnpmeoJDwavv1ggrHdcSLjDaF/dVudCCyiCo+OnAYnCLfX1BuHbTWhWqQHk+1i8GJdKHxhU1DoKmXFo7roG1rMJnHSaURmTGU0/WErg1SIIWgIe3S0pzATQxNn7uuSyaTwfO8/Z6CYRiGYRiGYRiGYRiGYRzLTKB+DNJoQiIqMiCQJYSdR7hFLLuI5RSx7TKuVca1Azw7IGGFJCxFyopIHMKC2oGGjkDSUfZpK9axK99C28BE8j0t1PVLZvf0MLuyg1N0J+OCdaQGKjhdAVZu331VnAwdU2bS2TSJPsuiHHajow4CsYFdzZPZPmEGrRPOoW3MZNRei2VmCoqpuyvM7W7jtNzTLA6fZpp8jRQFqG5a1uPYqT9CMTqNTDQBiWCwDGY7EX90FU+Ph5emJSj6Q4s4uEGF6XvamLV7B5MGOnHtCGlrhBVPo4dlF9Tg5TV6kC6Ip9HFwSp1lBzcOs7JZYQtBAksGkOosyRWwgHLivN2SyJTWWS2hXKynsiTtY70TNKhucnHTzqI6oEdxyGTyRxzq10bhmEYhmEYhmEYhmEYxuEygfox4tfPf4X+qQ+RsEJarIi01KQtfUgB+d4iDblIkIsscpFNb+Czq9DIrtx42vsnU+5qZlxfmeMGdjCzsoO/CPfQUt5GYqCC0xUhRq9MJ7AT9IybQHfDGPr9egbQVMI9aNVDwKZqgD6f1gkX7DdAn95Z5oTeTZye+xNLwmeYKLbhU443kKA15PQs2jiPIDyJrGrGBQbLTdYT8YQX8cwEzWuTkxQTydr+nTBg+p42Zu7eyZSBdlyrGqInAGURVZy4G10fgWl0qAbp1X50QFoKW0jSyqYh1GQtiawG6QjQtoWVboirXZIZIkeAELi2RV3KobHBx03YtSDdtm0ymYxZ7dkwDMMwDMMwDMMwDMMwDpEJ1I8RXV3rOTFTHPV7cUBukQsdBkKPgcAnFyTor6QZCNIMlLMMlOvoLzVRKGag4JMKKjSV+mgq9TKh1Mniyi4+GmykubQWry/AHlD7PZey77FnwgR668aSc9IUgXJUIor6QBeATgLVw86xU9g+4US2T5hO25hJowboM3fnWNi3njNyqzkxeIaxtGFRPXY10C7qFjo5jZxahBXOJ60zJIAEEKFZQ8QqN+KFSRHbJqXJJeprx7CjkGl72pi5ZyfT+ttxrRBpaYQPKBl3o4cORIcwjX5IQboAFW8dB+kCy1I4QpBSFg2hImvbiKQD1QVQcR1kuhGyLQSJFMqJTyDhWNSlXerrfRzfqgXplmWRyWRIJpOjn4JhGIZhGIZhGIZhGIZhGKN61wTqt956Kw8//DAvvfQSruvS29u7zzbPPvssN9xwA88//zxCCE4++WRuv/12Fi1a9Naf8DtMd++pPJhPVoPxevrLjQyU68mXU4hiREupl+ZSL03lXhrKA9RX+pka5chG7WTVNtJhmUQY4FQirLJClhTiINlwvtFj97jx9CVbyFtJSkpRiYqoqB+IQO1GVbroqWtkT8MY9jTOpatxDHsaxtFT34iSewfoEbP39LC0bx1n5lZxYuVZGukZsY3W0Mtx7OFkSuoErHAaGZ3GglqVSxnNs4Ss8kJenhTSNiFLf7Khtg87CpnS3cGs3TuY1t+Gb4UIqREecYgeOESRA5FFHJXvfxpdANbBFhmFffrRhRBYUuEKQTqSNEaKpGsj/US80CigXReRbUFkmwl8H2ULBJD2berTHumsi+sPXeK2bZNKpUgmk7Vw3TAMwzAMwzAMwzAMwzCMQ/euCdQrlQqXXXYZp512Gr/4xS/2+X4ul+MjH/kIf/mXf8lPfvITwjDk61//Oueddx7bt2/HcZxR9nrsmPdCjinP9ZCNdpIOS6SiCn4Q4JQjrMr+p8kPJkxo+psSdDWNY8BvIo9HOQoJwgJaVyfig2500ENvtoE9jWPpaljInsax7GkcT3d9I9Fek+eDsoWIOV0dvK//z5w18AQnlZ8jSWnENkrbdLKUXt5HEM3FjyaR0C4+MNgIHqHZhGItEX/2Al6fXKFzXD29qcbafiwVMbm7g1l7djCjbxe+DBAShMtQiB46oA4eosOh1rrsO40uhcYWYEtBJhQ0aEXC9ZCJeEFRBCjXR9a1QKaZ0HfRlsCSgjrPoT7jksy4ON7Qc+o4Dul02lS7GIZhGIZhGIZhGIZhvEcIIXjggQf42Mc+9nafyjHnXROo/9M//RMAd91116jff+211+ju7ubmm29m8uTJAHz9619n4cKFbNu2jVmzZr1Vp/qONKv3Kdwd2w+4TZCCctqilJaUEjYlL0XJyVCRSSraJdAWkYJQRUQqRKkArYOhHZR60UB/up6u8ZPZ3TiGroaJ1RC9kdAe/cfNCTVjB/JMye9mZqGVecXXWVJ8iQXlV7AZGfaXdB0dnEpOL0ZFs8lEY7CRpIdvg+YVItYSsd4u0d5SotDk0l1fT2+qqbadVIrJPXGIPrN/FwlRQUjAYViIbh90cVGGvntotS5aggaQg/PoWDIO0n0sslFANgLXc5G2M5i3oxJJRHYspBsIfQctBY5tkfVsMhmHRNrFcYeCdM/zSKfTeJ534PMxDMMwDMMwDMMwDMMw3jF2797NihUrePjhh+no6KChoYFFixaxYsUK3v/+9wPQ1tZGQ0PDQfZ05E2bNo0vfOELfOELX3jLjz3o85//PKtXr+bll19m3rx5vPTSS/vdduPGjSxZsgTLskZtPHkj3jWB+sHMmTOHpqYmfvGLX/DVr36VKIr4xS9+wbx585g2bdp+71culymXy7Xb/f39ACilUOqNT26/0+THNrHp9AHKMkWFJIFyCJRFFEEYRdVwfK/HG1Y/KFU/ql+2bPKJNIVkA/lEht66ZvY0ToqD8/p6Ku7o7wawI8W43ABT8x3MLmxlfnE9SwtrmVvauE9wPqhPT2Y3p1FUJyCjGWRUHRaiVt8C0FOdPl9LxGY7R29LiUqjT1d9A3tSE2FYvYlUiom9nczu2sHMvp0kRSX+tkUcolccVC1Er97vIO0oEpCHUusyYpFRgRRgS7CFRSpS1AUhaRuEn0QMLjQqBFEija4fi0zWEXoWSEHCsUj7Npm0i592sZ24T11rTSKRIJVK1d6V8V76OX6nUkqhtTbPtWEcYebaMoyjw1xbhnF0mGvLMI4Oc20dPvNcvftdcsklVCoVfvWrXzFjxgw6Ojp4/PHH6erqqm0zbty4t/EM37xKpYLrum/4/suWLePpp59m7dq1+90mCAL++q//mjPOOIMnn3zyDR9rb++ZQD2TybBy5Uo+9rGPccsttwAwe/Zs/vM//xN7P5PRALfddltt+n243bt3UyqVRrnHu9PaPS3k8wPVWwooj/h+KC0KqTryySz5ZCOFRD35VJZCIks+mSKfSFFI+OQTHmX3wD82llKMz/cxvdDGnMIWTii8xpL8WmYVW4cWDN1LiQy9Yi45MYuynopWE3CCCaSUP6K+BWB7NTxfS0i7O0ClqUy5MUFntp7O9FSUlCP23ZDvZ1J/F1Pz3Uwv9ZC1VNwhnk6CTqEiGx1ZICXYhxaix6UvmoNWkevBDeJJdAaDdCGwESSjkCQa23aQtoMW8fC6FqD8NKTqEV4CZQsiEZCwFb4r8T2Bk4iIZJl8If679DwP3/epVCpUKpWDnJhxJCml6OvrQ2uN3OvnzzCMN85cW4ZxdJhryzCODnNtGcbRYa6twzcwMHDwjYx3rN7eXlatWsXKlSs588wzAZg6dSonn3zyiO32rnx58skn+fu//3tee+01TjjhBL72ta9x8cUX8+KLL7J48WJWrlzJ2Wefze9+9zuWL1/OunXrWLx4Mb/85S+ZM2cOAJs2beKLX/wiTz31FPl8nnnz5nHbbbfxoQ99CICzzjqLbdu2ce2113LttdcC8XDnN77xDR588MERk+I/+MEP+MEPfsDWrVsBuPLKK+nt7eWkk07ixz/+MZ7nsWXLFrZv386XvvQlfvvb3yKl5IwzzuCHP/zhAQekf/SjHwFxfnugQP1rX/sac+fO5ZxzznnvBOo33HAD3/72tw+4zauvvsrcuXMPuq9iscjf/d3f8f73v59//ud/Jooi7rjjDi644AKeffbZ/fZHf+UrX+GLX/xi7XZ/fz+TJ0+mpaWFbDZ7eA/oHWxr4zzax86lkMyQT6TikNyPA/J8wqHsjt5jvj+2iqgrF2ioDDC+vIe5hY0sLLzKwvx6ZhR34Ohon/uEWrJbzKCf2RT0NCI9EaHG4EaNpHUCgdgnPA/RbECxlpCXqdDrdCEbKhQbUnTWNdJeN51o78VLi3km9e9mUn8nU3KdpFVxRPCdVxIVOqhaJ3oQfxxCiH5IlS4w+jS6kNhS4EWKuiggJWyk7yEdCwIFQRnleoSZRkg3Y/keypFYlqTOs0l7Dn7KJpFykHb8HxFSSpLJJKlUyvyHxdtIqfhFmpaWFvP3YBhHkLm2DOPoMNeWYRwd5toyjKPDXFuHz/f9g290DNNaE76J9QTfKNuV8YDnQaTTadLpNA8++CCnnnrqIVX59vf3c+GFF3L++edz3333sW3btv1Wstx4441897vfpaWlhc985jMsW7aM1atXA/Ealeeffz633nornudx9913c+GFF7J+/XqmTJnC/fffz6JFi7jmmmu4+uqrD+vxAzz++ONks1kee+wxIJ4gP++88zjttNNYtWoVtm3zzW9+k4985COsXbv2TU2w//73v+ff/u3feOmll7j//vvf8H5G87YG6l/60pe48sorD7jNjBkzDmlf9913H1u3buVPf/pT7RfsfffdR0NDA//+7//O5ZdfPur9PM8b9QdTSvme+kXdetJSfp858AVoq5DGSj9NlT6agx7GVroYW9nN+GAPLZXu6kcPYyrdZKPcfvPnPhro5TjyzKCip4Aah6WaSUUZXGw8YLQz6UfTSkQrilYUr1MmcNrx6kNy9Rna65toz84lsEdWyiTLRSb17WZSrpPJuQ7qg8Jek+MCHVmo0EaHNujBhUU5siE6Mh7+RyKJf3YsIXEsgaMhGwbUhQrPcZGJdDwRD2hLEiTr0OlmZCqL7dooW2DbkoznkPQs/KSDn7ZrP5OWZdUWGn0v/Zy+mwkh3nO/NwzjncBcW4ZxdJhryzCODnNtGcbRYa6tw2OepwMLK4qf/eMf3/LjXvPDM3G8gw+02rbNXXfdxdVXX81Pf/pTli5dyplnnsnll1/OwoULR73PfffdhxCCn//85/i+z/z589m5c+eoofett95am3y/4YYbuOCCCyiVSvi+z6JFi1i0aFFt21tuuYUHHniA3/zmN3zuc5+jsbERy7LIZDJvqHImlUpx55131oLye+65B6UUd955Z+3Fhl/+8pfU19ezcuVKPvzhDx/2MQC6urq48sorueeee47KwPTbGqi3tLTQ0tJyRPZVKBSQcuQrPYO3TXcUXOS+iOxStFR6aAniULx5WEDeEnRTF+4/JAco4VLEpyBa6BZzqVBPQAOhHoNSE5CqBT9qIK0TWMBoP64hml3VwHzwo50KZauXpNVHxq0QpD3602nas83sql9I2Rn5apQXlIcm0POdNFYG9jrvYQF6ZFWn0OO6lcFPB3J4ITq1afTBBUYl8SS6LSVJFZKtBKSFwPJchOPGYb+AyE1QTjcjMo04vot2JFJIkp5FyrVxXQs/aeOlhoJ0x3FqQbphGIZhGIZhGIZhGIbx3nPJJZdwwQUXsGrVKp566ikeeeQRbr/9du68885Rh5PXr1/PwoULR7w7Ye+KmEHDQ/nx48cD0NnZyZQpU8jlcnzjG9/g4Ycfpq2tjTAMKRaLtLa2HpHHtWDBghFT52vWrGHjxo1kMpkR25VKJTZt2vSGj3P11VdzxRVX8MEPfvAN7+NA3jUd6q2trXR3d9Pa2koURbVOnlmzZpFOpzn33HP58pe/zH//7/+df/iHf0Apxf/4H/8D27Y5++yz396Tfwf4K7+Xv3rqNjRQwqOAT0lkKdFIhZlsZymbRT1KZ1GkETqN0EmkTmJrH1v5uNrB1/F0uFP92J/eali+HcU2FK1EDIg8WN002HkyskyQdOlPZsinMnSlmulOzSDnJ/fZlxMGTOzfw+SBTibnO2gp9Y3MxLVAq70D9OqrsYcQoA9udughugA1uGNZjdJBCgtHShyhyYQBdWGEb9uIVHWRUUBbFqVUPWGmGSuRwfUstCXwbIuUZ5NwLCxH4CUd3ISNlPHJe55HOp0+pLf5GIZhGIZhGIZhGIZhGKOzXck1PzzzbTnu4fB9n3PPPZdzzz2Xm266iauuuoqvf/3rB237OBjHGUr0BgeTB4eRr7vuOh577DHuuOMOZs2aRSKR4NJLLz3oWn1SSrQemakFQbDPdqlUasTtXC7HiSeeyL333rvPtm9mCPv3v/89v/nNb7jjjjsAagsb27bNz372M5YtW/aG9w3vokB9xYoV/OpXv6rdXrJkCQB/+MMfOOuss5g7dy4PPfQQ//RP/8Rpp52GlJIlS5bw6KOP1l5tOZbl7L9iczQPCx87tPC0g43cb/3KwQyg6UfTh2ZPNTgfnDavyB6STj+NokBKVIg8ByeZhlQdXalxvJ7K0pvM7LN46KB0uUBTsY8JuT1MGehkbLEHybCL8ggE6IObvpEQXdQidLCwsCyJLcBXEXVBmYzQWK6LcBIIKUFA6CUppZvQmWZcz8ZzJI5tkXRtkp6FLSWub+EmbZxhffaJRIJ0Oj3il51hGIZhGIZhGIZhGIbxxgghDql65Z1m/vz5PPjgg6N+b86cOdxzzz2Uy+XaMOazzz572MdYvXo1V155JRdffDEQB96Di4oOcl2XKBq5dmJLSwvt7e1orWsh/fAFSvdn6dKl/PrXv2bMmDFHtJrlT3/604hz/Pd//3e+/e1v8+STTzJx4sQ3vf93TaB+1113cddddx1wm8FXbYx9PfVKD3ODxn2+XhkWjPfv9eehrynyRISU0bKIlkUSMiAhAnwRkBQBSSpkLIswlaUrlWV3agLrU1m6U1kq9uhhsBsGNBX7aC720VTqo6X62Y/2egVLC7SyqwG6PWzBTw4rQB/c/PBD9KE6l/iWjWUJbCGwUaTDClmt8KVEJDyE4yAAZVmUUo1Uss1YyTSuI7Asq1bp4tgSyxK4SRsvOVTrMrjQaDKZxLbfNZeoYRiGYRiGYRiGYRiG8SZ1dXVx2WWXsWzZMhYuXEgmk+G5557j9ttv56KLLhr1PldccQU33ngj11xzDTfccAOtra216exDWQh10OzZs7n//vu58MILEUJw00037VOlPW3aNJ544gkuv/xyPM+jubmZs846i927d3P77bdz6aWX8uijj/LII48cNCT/5Cc/yXe+8x0uuugibr75ZiZNmsS2bdu4//77uf7665k0adKo99u4cSO5XI729naKxWItvJ8/fz6u6zJv3rwR2z/33HNIKTnhhBMO+bk4EJPWHSO2tXj8y5ZOioSUCAlECS1K2LJMQlZIiBBPhHiEOCLCRmFrTTOa5uo+So5LwfUpuB4F16fPzdLm+vQlUnSnsqPWtQBIpWgoDdBUisPz5mIfzaU+MpXC6Fm4kmglUdGbD9AH7/JmQnQ5+I9lYQuBowNSKiCjNJ7USMdBOD5SWiAg8NMUM82odCOOa5N0BL5j1ypdhBQ4nsRLOiNeEfU8j2Qyie/7h/XLzjAMwzAMwzAMwzAMw3hvSKfTnHLKKXz/+99n06ZNBEHA5MmTufrqq/nqV7866n2y2SwPPfQQn/3sZ1m8eDELFixgxYoVXHHFFSN61Q/me9/7HsuWLeP000+nubmZ5cuX09/fP2Kbm2++mU9/+tPMnDmTcrmM1pp58+bxk5/8hG9961vccsstXHLJJVx33XX87Gc/O+DxkskkTzzxBMuXL+fjH/84AwMDTJw4kXPOOeeAYfxVV13FH/84tLDsYJPJli1bmDZt2iE/3jdK6L0Lbo5x/f391NXV0dfXd1RWgX273P/Qw6x9ft+3eoRCUnB9itWQvOB6FDyfguPHn6tfLzrefitahktXCkOhebGP5mIvDeUBrNF+zJREa4mOLLSSaGVVw+xhb7t5A7lyLUAX+hDvPxSiy2pwbyGRwkJKC0uAowMyKiSlFJ4USNtC2DZCWgghUZZDKd1IKdOMTCbxHYHv2rVKF0uIUafRLcuqTaNb1rvv7UZGTClFZ2cnY8aMMaupG8YRZK4twzg6zLVlGEeHubYM4+gw19bhe69mW29EqVRiy5YtTJ8+/bCC5feCe++9l0996lP09fWRSCTe7tN5xzucnxUzoX6MaE3X8acZx5MfFp7nXZ+K4x78zsMkghKpsEQyKJGqfmQq+WptS/++dS1QDc6tQwvO35IAvXqvfUJ0C0taSCGRAhwVkomKpHUcomNbSOkiLAshJcqyKSezlBINBJkGPFeStQUp36lVugA4noWXtHE8qzZ57vt+bRrdMAzDMAzDMAzDMAzDMN6Mu+++mxkzZjBx4kTWrFnD8uXL+cQnPmHC9KPABOrHiL6JU1lDetTvWSqKA/JwMCQvDgXm1a8lqx8WB3hDg5JobQ8LzmW1ruXIBOfDdxF/HGqNyyAJiuqiojIO4oWNJaw4VpcaV4VkogopHeFZEhyBlC5YNlJaKNuhmKynnGigksriOALPETS5DinfJmHHtS/SEri+jZ+0kdVg3bZtkskkiUTCTKMbhmEYhmEYhmEYhmEYR0x7ezsrVqygvb2d8ePHc9lll3Hrrbe+3af1nmQC9WPEB5vqeOmlZ0jqCCffQzKMg/NUUMKLggPn21rEC4NqC61Ba1m9Xf36UQrOh5O8kQB9+BR6HMHLaphuSbs6ia5wVUhWl0kGCs8SYIOwXIS0EZZF5CYoJ+spJRuoJFM4Nvi2oMVzSLg2viOR1clzx7PwEjaOH0+jCyFIJBIkk0lc9/DeDWAYhmEYhmEYhmEYhmEYh+L666/n+uuvf7tP45hgAvVjxNlNWda3v0roeOQKvdWQXFZDcQelqrepBuZK1IL0EUH5oL2D8iO8hubhLSQ67F5KVKfP9w7Q44VNpbCQIsKLQjI6JIXCEQJhgXCcap2LQ5hIU0rUUUo1UPF9HEeQ8iTjHYuka+NZVu0xCynwEnE3ujVY8+I4tWl00/FmGIZhGIZhGIZhGIZhGO8NJlA/hujQI1I+Ya6OURPw0ULxIxyUj7b7Wn3LYXWgA0jQIHQcoAtENTCXCKw4WBcCgULy/2fvzuOqKvM/gH/OOXcDLogoiDuiZlICgkvalGgpLhEaaqa/RjSxHM20GJcc0TQst7LFsqJxCZ1xbJTRHCujSIY2rQFbjJLBJRVBTBblruf8/rhw5AKyKJvyec/rzr3nnOec89zLPWCf+9zvo8BFscHVboZRsEMrCoAAx6SikgbQ6GB18YDZxRMlbp6w6XWQtAI8dRK89Bq46CRoygXjoiRAq5egNWig1YnqaPSyCUa1Wm09v1JERERERERERETU1BiotyCCpAMUCRAaOCW/1vnhGHUOoI4jz8uIEEoDdMfocwmC4Dz63HEeBSJkuChWuMo26AUZLgAERzNAkCCKGihaHayurWFyaw2TaytY9RJ0WhGeBgltdBq4ajVOL1VZXXStQYJGK6oTjOr1eri4uMBgMHA0OhERERERERER0S2MgTrVuxsbdV5e+QBdLK15Xm4Eupp2K5Agw0WxwFWwwUWRoQNQPtsWRBGCIMGuc4XV2Bpm19YwuXrAqhOg10too9egjVaEi9b5kpAkwTEK3SBBqysN7AUBer0eBoOBIToREREREREREVELwkCdrltZnK2OOr/O8Lys3rmgACgdfe4o3+KYOFQQro4+LyPBDhfY4Vp6r1PKBegCAEGEIDoCdJuLB2wu7rAY3GExuMCqAQwuGnjrtWirE6GvEIiXheg6gwYanWObKIpqgK7T6RiiExERERERERERtUAM1KkSody9gKulWW5stHlZlfNSimOyUFEQAUWEKAgQBMdEnxXDcwCQIMMAO9xKA3S9oDh3RQAUUQu7wQiraytYXVrBZjDCptfCJgGiTgODXoSvVkIbjQSd6PxEJI0ArV4DnYsGGq0jLJckySlEF5qoVA4RERERERERERE1DwzUWxBBAMoycUdkfGMjy6s4Q9lY83JrJIiQAIhwTB3qCMtFUSq/W4WjAKKgwEVxhOcugg0GOAfoCgTYRR1sLu6wubSCzdUTVlc32LQioBMh6ES4aCS00YrwkCS4CIBUIRDXaERoXSTo9BpIpSG6VqtVQ3ROLEpERERERERERM2RIAjYs2cPxo4d29RdaXEYqLcgOgmwKgokUa7DXkK5/3cOy6+2ECGitM45JAgonTS0ipHmTvsJAkRFgVaQoYcMvWKHVpBhEGRoFOeQX4EEq0YHq4sHbC4esLp4QnZ1hV3rCM8lvQidToK3JMFNEOAqANoqRpRrtCK0Bgl6gwaixhGi63Q6NUTXaHhJEBERERERERFR08nLy0NcXBz279+P8+fPo3Xr1ggKCkJcXBzuvvtuAMC5c+fQunXrRu+bn58f5s2bh3nz5jX6ucvMnTsXaWlp+OGHH9C7d2+kp6c7bT9x4gS6detWab8vv/wSd9111w2fn+lhCyII5UeQO0fjAgBBEEvXiaXrri4LiuBopIiOoe6lMXptzwtBgA526BQZBkWGTpShU2zQCUq5ho47RREgCxpYNQZYXYywGjxhc2sFxdUF0EkQ9CIknQiDRoJRFOAmCHARAEOFAF0QBEgaARqdBI1OhEYnQhRFp0lF9Xo9JKn64J+IiIiIiIiIiKixREVFwWKxYOvWrfD398f58+eRnJyM/Px8tY2vr28T9vDGWSwW6HS6695/+vTp+Prrr3H06NFrtvnkk09wxx13qMtt2rS57vOVx5kVWxBXjSc0gh560RUughsMghsMghEGwQi94A4d3KGFO7RwgxZu0MAFElwgQQ9R0EGEzjFRKKRKYbojMxcgiCL0ogB3QUFb0Y6OogVdcQU9lUL4KZfRASXwEsxwU2zQCBKsogEmnQcuu7bFJY9OuNi2Jy50DEKefz8U9OoH0213QO7RBbqureHm6wqvNgZ0ctehu0GLXhoRnSQRrUUBBkGAIAjQ6EQY3LRw9zKglY8LPNq6wNVDBzd3FxiNRrRu3Rrt2rWDl5cXXF1dGaYTEREREREREVGzcenSJaSmpmL16tUYOnQounbtigEDBmDx4sV48MEH1XaCICApKUld/uKLLxAcHAyDwYB+/fohKSkJgiCoo7dTUlIgCAKSk5PRr18/uLq6YvDgwcjMzFSPkZWVhcjISLRr1w5GoxH9+/fHJ598om4PCwvDyZMnMX/+fEcOWDq4dfny5QgODnZ6Hhs2bICfn5+6HB0djbFjxyI+Ph4dOnRAr169AACnT5/GxIkT4enpCS8vL0RGRuLEiRPVvkavvvoqZs+eDX9//2rbtWnTBr6+vuqtvso7c4R6CyJJrhAhQ1Rq+elPuRHfZaPMHf9ToFEUSJAhCYAOMvSKY8S5VrZBLDfSXBEkyKIGFskVNo0Odo0eNo0eNq0eit4AGPQQdRoIOi0knQaiRoKkFSBJIgQB0MJRvsVVEOAK5zroZQG64yZBoxEhiI6LWavVQqfTqTdR5GdHREREREREREQtnaIosJnNjX5ejV6vBtDVMRqNMBqNSEpKwl133QW9Xl/jPoWFhYiIiMDo0aOxY8cOnDx58polWZYsWYL169fD29sbTzzxBKZPn460tDQAQHFxMUaPHo34+Hjo9Xps27YNERERyMzMRJcuXbB7924EBQVh5syZiImJqdPzB4Dk5GR4eHjg4MGDAACr1Yrw8HAMGjQIqamp0Gg0eP755zFy5EgcPXr0hkawA8CDDz4Ik8mE2267DQsWLHD6QOJGMFBvQQRJAuAYRQ4IpcPKAQgCJAUQ1aBcgRYKJEWGBnZIUCAqMiRZhgYyxHJlWtTQXBAhi3qYtB6wSTrYNAbYNDooWg0UnQ6CQQtBq4Vk0ELSaeGi10CURKc66QIAPQToBcAARxkXXfkAXRQcNdD1EjRaR/AuCAJEUXQKz7Vaba1+QRERERERERERUctiM5vx6tTxjX7euVvfh9ZgqLGdRqPBli1bEBMTg02bNiEkJARDhgzBpEmTEBgYWOU+O3bsgCAIeOedd2AwGBAQEIAzZ85UGXrHx8djyJAhAIBFixZhzJgxMJlMMBgMCAoKQlBQkNp25cqV2LNnD/bu3Ys5c+bAy8sLkiTB3d39ukrOuLm5ISEhQQ3KExMTIcsyEhIS1Cxv8+bN8PT0REpKCkaMGFHncwCODyXWr1+Pu+++G6Io4p///CfGjh2LpKSkegnVGai3IG4GLWxFCjwUGzSQISllNwWCKEABAFGEAhEKBCiCCLukhyKIkEUJVlECRAl2UYIiSrCLGiiiBGgkQKOBopMgaCQIeg0knQY6vRaSTgdRU7msigRHeG4oDc0NcA7PAUCUBGi0ErR6sTRAd4wy12g0TgE6JxIlIiIiIiIiIqJbRVRUFMaMGYPU1FR89dVXOHDgANasWYOEhARER0dXap+ZmYnAwEAYygX2AwYMqPLY5UP59u3bAwByc3PRpUsXFBcXY/ny5di/fz/OnTsHm82GkpISnDp1ql6eV58+fZxGnWdkZOD48eNwd3d3amcymZCVlXXd52nbti2efvppdbl///44e/Ys1q5dy0Cd6sbF6I7igiLYjQZYRREWUQNF1ACSCIgiIIiAJEGRREASoAgCFMExMhwi1MeCIELRCJAkR4AOrQRJo4UoaUpHvzvTqqPOr4bnmnLhuSgJECUBkkaEpBEhakRoJAGiRmT5FiIiIiIiIiIiqjcavR5zt77fJOetC4PBgOHDh2P48OFYunQpZsyYgWXLllUZqNdF+TriZaPCZVkGAMTGxuLgwYNYt24devToARcXF4wfPx4Wi6XaY4qiCEVRnNZZrdZK7dzc3JyWi4uLERoaiu3bt1dq6+3tXbsnVEsDBw5US83cKAbqLYiunQ9sVivs0AHlQvLyNwiOiwCiCFGSIJaG7JIgQhAlCKJYZWgOx67QlY06L73XAxBLL06pNCR3BOdljwU1IJckCZIkQaPRqKPQWb6FiIiIiIiIiIjqiyAItSq90twEBAQ4TUJaXq9evZCYmAiz2azWXD98+HCdz5GWlobo6GiMGzcOgCPwrjhBqE6ng91ud1rn7e2NnJwcKIqi5nhlk6FWJyQkBDt37oSPjw88PDzq3N+6SE9PV0fk3ygG6i2I5CJBNoiQNZrSsFwCJAmiIECQJIilgXl1BDhGnGsAaATHG0irhuiOMF7SCKUjzR2Ti0oaEaIkqBOGlgXm5W+SJHHkORERERERERERtWj5+fmYMGECpk+fjsDAQLi7u+PIkSNYs2YNIiMjq9xn8uTJWLJkCWbOnIlFixbh1KlTWLduHQDUaaBqz549sXv3bkREREAQBCxdulQdvV7Gz88Phw4dwqRJk6DX69G2bVuEhYUhLy8Pa9aswfjx4/Hhhx/iwIEDNYbkU6ZMwdq1axEZGYkVK1agU6dOOHnyJHbv3o0FCxagU6dOVe53/PhxFBcXIycnByUlJWp4HxAQAJ1Oh61bt0Kn06Fv374AgN27d+Ovf/0rEhISav1aVIeBegtiMLaC3q0Q0Ls5JiStoKqwXAMBmtI651oR0IhXg3Gx9PHVci2CY6JRoFJYXv4xERERERERERERVWY0GjFw4EC8/PLLyMrKgtVqRefOnRETE4Nnn322yn08PDywb98+zJo1C8HBwejTpw/i4uIwefJkp7rqNXnppZcwffp0DB48GG3btsXChQtRWFjo1GbFihV4/PHH0b17d5jNZiiKgt69e+ONN97AqlWrsHLlSkRFRSE2NhZvv/12tedzdXXFoUOHsHDhQjz00EMoKipCx44dcd9991Ubxs+YMQOff/65ulwWnGdnZ8PPzw+AY0LVkydPQqPR4Pbbb8fOnTsxfnz9TEYrKBUL3LRwhYWFaNWqFQoKChr8qwaN7djJ8/jfydPQu7hDLwnQigK0ogidKEBbuiyIgqNEi+S4F0UAoiM8LyOKonoTBMEpMC8LzVmmhVoSWZaRm5sLHx8fftOCqB7x2iJqGLy2iBoGry2ihsFrq+5u5WyrrkwmE7Kzs9GtW7c6Bcu3gu3bt2PatGkoKCiAi4tLU3en2avLe4Uj1FuQ9h56yF4u8GxtVMPw8uF4bdcRERERERERERFR87Ft2zb4+/ujY8eOyMjIwMKFCzFx4kSG6Q2AgXoL4mZ0Q2uv1vDx8YFGwx89ERERERERERHRrSAnJwdxcXHIyclB+/btMWHCBMTHxzd1t25JTFVbkLKJPznKnIiIiIiIiIiI6NaxYMECLFiwoKm70SIwWSUiIiIiIiIiIiIiqgUG6kREREREREREREREtcBAnYiIiIiIiIiIiIioFhioExERERERERERERHVAgN1IiIiIiIiIiIiIqJaYKBORERERERERERERFQLDNSJiIiIiIiIiIiIbiKCICApKampu9EiMVAnIiIiIiIiIiIiaiby8vIwa9YsdOnSBXq9Hr6+vggPD0daWpra5ty5cxg1alSj983Pzw8bNmxo9POWN3fuXISGhkKv1yM4OLjKNoqiYN26dbjtttug1+vRsWNHxMfH18v5NfVyFCIiIiIiIiIiIiK6YVFRUbBYLNi6dSv8/f1x/vx5JCcnIz8/X23j6+vbhD28cRaLBTqd7rr3nz59Or7++mscPXq0yu1PPfUUPv74Y6xbtw59+vTBxYsXcfHixes+X3kcoU5ERERERERERETUDFy6dAmpqalYvXo1hg4diq5du2LAgAFYvHgxHnzwQbVdxZIvX3zxBYKDg2EwGNCvXz8kJSVBEASkp6cDAFJSUiAIApKTk9GvXz+4urpi8ODByMzMVI+RlZWFyMhItGvXDkajEf3798cnn3yibg8LC8PJkycxf/58CIIAQRAAAMuXL680UnzDhg3w8/NTl6OjozF27FjEx8ejQ4cO6NWrFwDg9OnTmDhxIjw9PeHl5YXIyEicOHGi2tfo1VdfxezZs+Hv71/l9mPHjuHNN9/Ev/71Lzz44IPo1q0bQkNDMXz48GqPW1sM1ImIiIiIiIiIiKhFUBQFssXe6DdFUWrVP6PRCKPRiKSkJJjN5lrtU1hYiIiICPTp0wffffcdVq5ciYULF1bZdsmSJVi/fj2OHDkCjUaD6dOnq9uKi4sxevRoJCcn47///S9GjhyJiIgInDp1CgCwe/dudOrUCStWrMC5c+dw7ty5WvWvTHJyMjIzM3Hw4EF88MEHsFqtCA8Ph7u7O1JTU5GWlgaj0YiRI0fCYrHU6djl7du3D/7+/vjggw/QrVs3+Pn5YcaMGfU2Qp0lX4iIiIiIiIiIiKhFUKwyzsZ90ejn7bBiMASdVGM7jUaDLVu2ICYmBps2bUJISAiGDBmCSZMmITAwsMp9duzYAUEQ8M4778BgMCAgIABnzpxBTExMpbbx8fEYMmQIAGDRokUYM2YMTCYTDAYDgoKCEBQUpLZduXIl9uzZg71792LOnDnw8vKCJElwd3e/rpIzbm5uSEhIUEu9JCYmQpZlJCQkqKPdN2/eDE9PT6SkpGDEiBF1PgcA/O9//8PJkyexa9cubNu2DXa7HfPnz8f48ePx6aefXtcxy+MIdSIiIiIiIiIiIqJmIioqCmfPnsXevXsxcuRIpKSkICQkBFu2bKmyfWZmJgIDA2EwGNR1AwYMqLJt+VC+ffv2AIDc3FwAjhHqsbGx6N27Nzw9PWE0GnHs2DF1hPqN6tOnj1Pd9IyMDBw/fhzu7u7qyHwvLy+YTCZkZWVd93lkWYbZbMa2bdtwzz33ICwsDO+++y4+++wzpxI314sj1Cso+/pFYWFhE/ek/smyjKKiIhgMBogiP0shqi+8togaBq8toobBa4uoYfDaImoYvLbqrizTqm2JkZZG0IrosGJwk5y3LgwGA4YPH47hw4dj6dKlmDFjBpYtW4bo6Ogb6odWq73ap9JR4bIsAwBiY2Nx8OBBrFu3Dj169ICLiwvGjx9fY/kVURQrvd+sVmuldm5ubk7LxcXFCA0Nxfbt2yu19fb2rt0TqkL79u2h0Whw2223qet69+4NADh16pRav/16MVCvoKioCADQuXPnJu4JERERERERERHR9SkqKkKrVq2auhvNjiAItSq90twEBAQ4TUJaXq9evZCYmAiz2Qy9Xg8AOHz4cJ3PkZaWhujoaIwbNw6AI/CuOEGoTqeD3W53Wuft7Y2cnBwoiqKG9GWToVYnJCQEO3fuhI+PDzw8POrc32u5++67YbPZkJWVhe7duwMAfvnlFwBA165db/j4DNQr6NChA06fPg13d3f1DXCrKCwsROfOnXH69Ol6fZMStXS8togaBq8toobBa4uoYfDaImoYvLbqTlEUFBUVoUOHDk3dFboO+fn5mDBhAqZPn47AwEC4u7vjyJEjWLNmDSIjI6vcZ/LkyViyZAlmzpyJRYsW4dSpU1i3bh0A1Cnf7NmzJ3bv3o2IiAgIgoClS5eqo9fL+Pn54dChQ5g0aRL0ej3atm2LsLAw5OXlYc2aNRg/fjw+/PBDHDhwoMZrdsqUKVi7di0iIyOxYsUKdOrUCSdPnsTu3buxYMECdOrUqcr9jh8/juLiYuTk5KCkpEQN7wMCAqDT6XD//fcjJCQE06dPx4YNGyDLMmbPno3hw4c7jVq/XgzUKxBF8Zo/rFuFh4cH/wgRNQBeW0QNg9cWUcPgtUXUMHhtETUMXlt1w5HpNy+j0YiBAwfi5ZdfRlZWFqxWKzp37oyYmBg8++yzVe7j4eGBffv2YdasWQgODkafPn0QFxeHyZMnO9VVr8lLL72E6dOnY/DgwWjbti0WLlxYqSz2ihUr8Pjjj6N79+4wm81QFAW9e/fGG2+8gVWrVmHlypWIiopCbGws3n777WrP5+rqikOHDmHhwoV46KGHUFRUhI4dO+K+++6r9nqfMWMGPv/8c3W5b9++AIDs7Gz4+flBFEXs27cPTz75JO699164ublh1KhRWL9+fa1fi+oICgsqtRiFhYVo1aoVCgoK+EeIqB7x2iJqGLy2iBoGry2ihsFri6hh8NqiG2EymZCdnY1u3brVKVi+FWzfvh3Tpk1DQUEBXFxcmro7zV5d3iscoU5ERERERERERER0E9u2bRv8/f3RsWNHZGRkYOHChZg4cSLD9AbAQL0F0ev1WLZsmTo5ARHVD15bRA2D1xZRw+C1RdQweG0RNQxeW0S1k5OTg7i4OOTk5KB9+/aYMGEC4uPjm7pbtySWfCEiIiIiIiIiIqJbTksu+UJ1U5f3ithIfSIiIiIiIiIiIiIiuqkxUCciIiIiIiIiIiIiqgUG6kREREREREREREREtcBAnYiIiIiIiIiIiIioFhiotxAbN26En58fDAYDBg4ciG+++aapu0R0Uzl06BAiIiLQoUMHCIKApKQkp+2KoiAuLg7t27eHi4sL7r//fvz6669N01mim8gLL7yA/v37w93dHT4+Phg7diwyMzOd2phMJsyePRtt2rSB0WhEVFQUzp8/30Q9Jro5vPnmmwgMDISHhwc8PDwwaNAgHDhwQN3O64qofrz44osQBAHz5s1T1/H6Iro+y5cvhyAITrfbb79d3c5ri4iaCwbqLcDOnTvx9NNPY9myZfjuu+8QFBSE8PBw5ObmNnXXiG4aly9fRlBQEDZu3Fjl9jVr1uDVV1/Fpk2b8PXXX8PNzQ3h4eEwmUyN3FOim8vnn3+O2bNn46uvvsLBgwdhtVoxYsQIXL58WW0zf/587Nu3D7t27cLnn3+Os2fP4qGHHmrCXhM1f506dcKLL76Ib7/9FkeOHMGwYcMQGRmJH3/8EQCvK6L6cPjwYbz11lsIDAx0Ws/ri+j63XHHHTh37px6+89//qNu47VFRM2FoCiK0tSdoIY1cOBA9O/fH6+//joAQJZldO7cGU8++SQWLVrUxL0juvkIgoA9e/Zg7NixAByj0zt06IBnnnkGsbGxAICCggK0a9cOW7ZswaRJk5qwt0Q3l7y8PPj4+ODzzz/Hvffei4KCAnh7e2PHjh0YP348AODnn39G79698eWXX+Kuu+5q4h4T3Ty8vLywdu1ajB8/ntcV0Q0qLi5GSEgI3njjDTz//PMIDg7Ghg0b+HeL6AYsX74cSUlJSE9Pr7SN1xZdL5PJhOzsbHTr1g0Gg6Gpu1OvKmYTdGPq8l7hCPVbnMViwbfffov7779fXSeKIu6//358+eWXTdgzoltHdnY2cnJynK6zVq1aYeDAgbzOiOqooKAAgCP4A4Bvv/0WVqvV6fq6/fbb0aVLF15fRLVkt9vx97//HZcvX8agQYN4XRHVg9mzZ2PMmDFO1xHAv1tEN+rXX39Fhw4d4O/vjylTpuDUqVMAeG1Ry5OXl4dZs2ahS5cu0Ov18PX1RXh4ONLS0tQ2586dw6hRoxq9b35+ftiwYUOjn7e8uXPnIjQ0FHq9HsHBwZW2V1VCShAEuLm51cv5NfVyFGq2Lly4ALvdjnbt2jmtb9euHX7++ecm6hXRrSUnJwcAqrzOyrYRUc1kWca8efNw991348477wTguL50Oh08PT2d2vL6IqrZ999/j0GDBsFkMsFoNGLPnj0ICAhAeno6ryuiG/D3v/8d3333HQ4fPlxpG/9uEV2/gQMHYsuWLejVqxfOnTuH5557Dvfccw9++OEHXlvU4kRFRcFisWDr1q3w9/fH+fPnkZycjPz8fLWNr69vE/bwxlksFuh0uuvef/r06fj6669x9OjRSttiY2PxxBNPOK2777770L9//+s+X3kcoU5ERETNwuzZs/HDDz/g73//e1N3heiW0KtXL6Snp+Prr7/GrFmzMHXqVPz0009N3S2im9rp06fx1FNPYfv27bdc6QCipjZq1ChMmDABgYGBCA8Px7///W9cunQJ//jHP5q6a0SN6tKlS0hNTcXq1asxdOhQdO3aFQMGDMDixYvx4IMPqu0EQUBSUpK6/MUXXyA4OBgGgwH9+vVDUlISBEFQyyilpKRAEAQkJyejX79+cHV1xeDBg5GZmakeIysrC5GRkWjXrh2MRiP69++PTz75RN0eFhaGkydPYv78+eqob8AxIrziSPENGzbAz89PXY6OjsbYsWMRHx+PDh06oFevXgAcf1snTpwIT09PeHl5ITIyEidOnKj2NXr11Vcxe/Zs+Pv7V7ndaDTC19dXvZ0/fx4//fQTHnvssWqPW1sM1G9xbdu2hSRJlWa+Pn/+/E3/SRZRc1F2LfE6I7p+c+bMwQcffIDPPvsMnTp1Utf7+vrCYrHg0qVLTu15fRHVTKfToUePHggNDcULL7yAoKAgvPLKK7yuiG7At99+i9zcXISEhECj0UCj0eDzzz/Hq6++Co1Gg3bt2vH6Iqonnp6euO2223D8+HH+7aJ6pSgKLBZLo99qO42l0WiE0WhEUlISzGZzrfYpLCxEREQE+vTpg++++w4rV67EwoULq2y7ZMkSrF+/HkeOHIFGo8H06dPVbcXFxRg9ejSSk5Px3//+FyNHjkRERIRafmn37t3o1KkTVqxYoU4eXBfJycnIzMzEwYMH8cEHH8BqtSI8PBzu7u5ITU1FWloajEYjRo4cCYvFUqdjVychIQG33XYb7rnnnno5Hku+3OJ0Oh1CQ0ORnJysTlIgyzKSk5MxZ86cpu0c0S2iW7du8PX1RXJysvqJbGFhoToikIiuTVEUPPnkk9izZw9SUlLQrVs3p+2hoaHQarVITk5GVFQUACAzMxOnTp3CoEGDmqLLRDctWZZhNpt5XRHdgPvuuw/ff/+907pp06bh9ttvx8KFC9G5c2deX0T1pLi4GFlZWXj00Uf5t4vqldVqxapVqxr9vM8++2ytSpxoNBps2bIFMTEx2LRpE0JCQjBkyBBMmjQJgYGBVe6zY8cOCIKAd955BwaDAQEBAThz5gxiYmIqtY2Pj8eQIUMAAIsWLcKYMWNgMplgMBgQFBSEoKAgte3KlSuxZ88e7N27F3PmzIGXlxckSYK7u/t1fZjl5uaGhIQE9XVITEyELMtISEhQR7tv3rwZnp6eSElJwYgRI+p8jopMJhO2b9+ORYsW3fCxyjBQbwGefvppTJ06Ff369cOAAQOwYcMGXL58GdOmTWvqrhHdNIqLi3H8+HF1OTs7G+np6fDy8kKXLl0wb948PP/88+jZsye6deuGpUuXokOHDpxtm6gGs2fPxo4dO/Cvf/0L7u7uag3MVq1awcXFBa1atcJjjz2Gp59+Gl5eXvDw8MCTTz6JQYMG4a677mri3hM1X4sXL8aoUaPQpUsXFBUVYceOHUhJScFHH33E64roBri7u6vzfJRxc3NDmzZt1PW8voiuT2xsLCIiItC1a1ecPXsWy5YtgyRJeOSRR/i3i1qcqKgojBkzBqmpqfjqq69w4MABrFmzBgkJCYiOjq7UPjMzE4GBgU7lyAYMGFDlscuH8u3btwcA5ObmokuXLiguLsby5cuxf/9+nDt3DjabDSUlJeoI9RvVp08fpw8VMjIycPz4cbi7uzu1M5lMyMrKqpdz7tmzB0VFRZg6dWq9HA9goN4iPPzww8jLy0NcXBxycnIQHByMDz/8sNIEikR0bUeOHMHQoUPV5aeffhoAMHXqVGzZsgULFizA5cuXMXPmTFy6dAl/+MMf8OGHH7K2JlEN3nzzTQCOWnzlbd68Wf2H4ssvvwxRFBEVFQWz2Yzw8HC88cYbjdxToptLbm4u/vjHP+LcuXNo1aoVAgMD8dFHH2H48OEAeF0RNSReX0TX57fffsMjjzyC/Px8eHt74w9/+AO++uoreHt7A+C1RfVHq9Xi2WefbZLz1oXBYMDw4cMxfPhwLF26FDNmzMCyZcuqDNSvtx9lo8JlWQbg+GDr4MGDWLduHXr06AEXFxeMHz++xvIroihWKmljtVortXNzc3NaLi4uRmhoKLZv316pbdm1f6MSEhLwwAMP1GsOykC9hZgzZw5LvBDdgLCwsGrrnQmCgBUrVmDFihWN2Cuim19t6ggaDAZs3LgRGzdubIQeEd0a3n333Wq387oiqj8pKSlOy7y+iK5PTRPT89qi+iIIQq1KrzQ3AQEBTpOQlterVy8kJibCbDZDr9cDAA4fPlznc6SlpSE6Ohrjxo0D4Ai8K04QqtPpYLfbndZ5e3sjJycHiqKoIX3ZZKjVCQkJwc6dO+Hj4wMPD48697cm2dnZ+Oyzz7B37956PS4nJSUiIiIiIiIiIiJqBvLz8zFs2DAkJibi6NGjyM7Oxq5du7BmzRpERkZWuc/kyZMhyzJmzpyJY8eO4aOPPsK6desAXB2FXhs9e/bE7t27kZ6ejoyMDPW45fn5+eHQoUM4c+YMLly4AMAxCDEvLw9r1qxBVlYWNm7ciAMHDtR4vilTpqBt27aIjIxEamoqsrOzkZKSgrlz5+K333675n7Hjx9Heno6cnJyUFJSgvT0dKSnp1caSf/Xv/4V7du3x6hRo2r9GtQGA3UiIiIiIiIiIiKiZsBoNGLgwIF4+eWXce+99+LOO+/E0qVLERMTg9dff73KfTw8PLBv3z6kp6cjODgYS5YsQVxcHADUqRTtSy+9hNatW2Pw4MGIiIhAeHg4QkJCnNqsWLECJ06cQPfu3dWyLL1798Ybb7yBjRs3IigoCN988w1iY2NrPJ+rqysOHTqELl264KGHHkLv3r3x2GOPwWQyVTtifcaMGejbty/eeust/PLLL+jbty/69u2Ls2fPqm1kWcaWLVsQHR0NSZJq/RrUhqDU5rvWRERERERERERERDcRk8mE7OxsdOvWrcXNcbZ9+3ZMmzYNBQUFcHFxaeruNHt1ea+whjoRERERERERERHRTWzbtm3w9/dHx44dkZGRgYULF2LixIkM0xsAA3UiIiIiIiIiIiKim1hOTg7i4uKQk5OD9u3bY8KECYiPj2/qbt2SWPKFiIiIiIiIiIiIbjktueQL1U1d3iuclJSIiIiIiIiIiIiIqBYYqBMRERERERERERER1QIDdSIiIiKqV9HR0Rg7dmxTd4OIiIiIiKjecVJSIiIiIqo1QRCq3b5s2TK88sor4DQ9RERERER0K2KgTkRERES1du7cOfXxzp07ERcXh8zMTHWd0WiE0Whsiq4RERERERE1OJZ8ISIiIqJa8/X1VW+tWrWCIAhO64xGY6WSL2FhYXjyyScxb948tG7dGu3atcM777yDy5cvY9q0aXB3d0ePHj1w4MABp3P98MMPGDVqFIxGI9q1a4dHH30UFy5caORnTEREREREdBUDdSIiIiJqcFu3bkXbtm3xzTff4Mknn8SsWbMwYcIEDB48GN999x1GjBiBRx99FFeuXAEAXLp0CcOGDUPfvn1x5MgRfPjhhzh//jwmTpzYxM+EiIiIiKjpCYKApKSkpu5Gi8RAnYiIiIgaXFBQEP7yl7+gZ8+eWLx4MQwGA9q2bYuYmBj07NkTcXFxyM/Px9GjRwEAr7/+Ovr27YtVq1bh9ttvR9++ffHXv/4Vn332GX755ZcmfjZERERERA0nLy8Ps2bNQpcuXaDX6+Hr64vw8HCkpaWpbc6dO4dRo0Y1et/8/PywYcOGRj9veXPnzkVoaCj0ej2Cg4OrbPPRRx/hrrvugru7O7y9vREVFYUTJ07Uy/kZqBMRERFRgwsMDFQfS5KENm3aoE+fPuq6du3aAQByc3MBABkZGfjss8/UmuxGoxG33347ACArK6sRe05ERERE1LiioqLw3//+F1u3bsUvv/yCvXv3IiwsDPn5+WobX19f6PX6JuzljbFYLDe0//Tp0/Hwww9XuS07OxuRkZEYNmwY0tPT8dFHH+HChQt46KGHbuicZRioExEREVGD02q1TsuCIDitEwQBACDLMgCguLgYERERSE9Pd7r9+uuvuPfeexuv40REREREjejSpUtITU3F6tWrMXToUHTt2hUDBgzA4sWL8eCDD6rtKpZ8+eKLLxAcHAyDwYB+/fohKSkJgiAgPT0dAJCSkgJBEJCcnIx+/frB1dUVgwcPRmZmpnqMrKwsREZGol27djAajejfvz8++eQTdXtYWBhOnjyJ+fPnQxAE9d/wy5cvrzRSfMOGDfDz81OXy+ZZio+PR4cOHdCrVy8AwOnTpzFx4kR4enrCy8sLkZGRNY4kf/XVVzF79mz4+/tXuf3bb7+F3W7H888/j+7duyMkJASxsbFIT0+H1Wqt9ti1wUCdiIiIiJqdkJAQ/Pjjj/Dz80OPHj2cbm5ubk3dPSIiIiK6SSmKArv9SqPfFEWpVf/Kvp2ZlJQEs9lcq30KCwsRERGBPn364LvvvsPKlSuxcOHCKtsuWbIE69evx5EjR6DRaDB9+nR1W3FxMUaPHo3k5GT897//xciRIxEREYFTp04BAHbv3o1OnTphxYoVOHfuHM6dO1er/pVJTk5GZmYmDh48iA8++ABWqxXh4eFwd3dHamoq0tLSYDQaMXLkyBsawR4aGgpRFLF582bY7XYUFBTgvffew/33319poM/10NzwEYiIiIiI6tns2bPxzjvv4JFHHsGCBQvg5eWF48eP4+9//zsSEhIgSVJTd5GIiIiIbkKyXIKUz/vU3LCehQ35HpLkWmM7jUaDLVu2ICYmBps2bUJISAiGDBmCSZMmOZVRLG/Hjh0QBAHvvPMODAYDAgICcObMGcTExFRqGx8fjyFDhgAAFi1ahDFjxsBkMsFgMCAoKAhBQUFq25UrV2LPnj3Yu3cv5syZAy8vL0iSBHd3d/j6+tb5NXBzc0NCQgJ0Oh0AIDExEbIsIyEhQR3tvnnzZnh6eiIlJQUjRoyo8zkAoFu3bvj4448xceJEPP7447Db7Rg0aBD+/e9/X9fxKuIIdSIiIiJqdjp06IC0tDTY7XaMGDECffr0wbx58+Dp6QlR5D9hiYiIiOjWFRUVhbNnz2Lv3r0YOXIkUlJSEBISgi1btlTZPjMzE4GBgTAYDOq6AQMGVNm2fCjfvn17AFfnMSouLkZsbCx69+4NT09PGI1GHDt2TB2hfqP69OmjhumAY96k48ePw93dXR2Z7+XlBZPJdEPzJuXk5CAmJgZTp07F4cOH8fnnn0On02H8+PG1/qZAdThCnYiIiIiuS3R0NKKjoyutr/gP/ZSUlEptqqqLWPEftz179sTu3btvoIdERERERM5E0QVhQ75vkvPWhcFgwPDhwzF8+HAsXboUM2bMwLJly6r893ddVDePUWxsLA4ePIh169ahR48ecHFxwfjx42ssvyKKYqV/y1dVq7xi6cbi4mKEhoZi+/btldp6e3vX7glVYePGjWjVqhXWrFmjrktMTETnzp3x9ddf46677rruYwMM1ImIiIiIiIiIiKiFEAShVqVXmpuAgACnSUjL69WrFxITE2E2m6HX6wEAhw8frvM50tLSEB0djXHjxgFwBN4VB8LodDrY7Xandd7e3sjJyYGiKGpIXzYZanVCQkKwc+dO+Pj4wMPDo879vZYrV65U+lZrWcnIsg8PbgS/L0tERERERERERETUDOTn52PYsGFITEzE0aNHkZ2djV27dmHNmjWIjIyscp/JkydDlmXMnDkTx44dw0cffYR169YBuDoKvTbKviGanp6OjIwM9bjl+fn54dChQzhz5gwuXLgAAAgLC0NeXh7WrFmDrKwsbNy4EQcOHKjxfFOmTEHbtm0RGRmJ1NRUZGdnIyUlBXPnzsVvv/12zf2OHz+O9PR05OTkoKSkBOnp6UhPT1dH0o8ZMwaHDx/GihUr8Ouvv+K7777DtGnT0LVrV/Tt27fWr8e1MFAnIiIiIiIiIiIiagaMRiMGDhyIl19+Gffeey/uvPNOLF26FDExMXj99der3MfDwwP79u1Deno6goODsWTJEsTFxQGAU131mrz00kto3bo1Bg8ejIiICISHhyMkJMSpzYoVK3DixAl0795dLcvSu3dvvPHGG9i4cSOCgoLwzTffIDY2tsbzubq64tChQ+jSpQseeugh9O7dG4899hhMJlO1I9ZnzJiBvn374q233sIvv/yCvn37om/fvjh79iwAYNiwYdixYweSkpLQt29fjBw5Enq9Hh9++CFcXOpWeqcqglIfldiJiIiIiIiIiIiImhGTyYTs7Gx069atTsHyrWD79u2YNm0aCgoK6iVEvtXV5b3CGupEREREREREREREN7Ft27bB398fHTt2REZGBhYuXIiJEycyTG8ADNSJiIiIiIiIiIiIbmI5OTmIi4tDTk4O2rdvjwkTJiA+Pr6pu3VLYskXIiIiIiIiIiIiuuW05JIvVDd1ea9wUlIiIiIiIiIiIiIiolpgoE5EREREREREREREVAsM1ImIiIiIiIiIiIiIaoGBOhERERERERERERFRLTBQJyIiIiIiIiIiIiKqBQbqRERERERERERERES1wECdiIiIiIiIiIiI6CYiCAKSkpKauhstEgN1IiIiIiIiIiIiomYiLy8Ps2bNQpcuXaDX6+Hr64vw8HCkpaWpbc6dO4dRo0Y1et/8/PywYcOGRj9veXPnzkVoaCj0ej2Cg4OrbPOPf/wDwcHBcHV1RdeuXbF27dp6O7+m3o5ERERERERERERERDckKioKFosFW7duhb+/P86fP4/k5GTk5+erbXx9fZuwhzfOYrFAp9Nd9/7Tp0/H119/jaNHj1baduDAAUyZMgWvvfYaRowYgWPHjiEmJgYuLi6YM2fOjXQbAEeoExERERERERERETULly5dQmpqKlavXo2hQ4eia9euGDBgABYvXowHH3xQbVex5MsXX3yB4OBgGAwG9OvXD0lJSRAEAenp6QCAlJQUCIKA5ORk9OvXD66urhg8eDAyMzPVY2RlZSEyMhLt2rWD0WhE//798cknn6jbw8LCcPLkScyfPx+CIEAQBADA8uXLK40U37BhA/z8/NTl6OhojB07FvHx8ejQoQN69eoFADh9+jQmTpwIT09PeHl5ITIyEidOnKj2NXr11Vcxe/Zs+Pv7V7n9vffew9ixY/HEE0/A398fY8aMweLFi7F69WooilLtsWuDgToRERERERERERG1CIqi4LLd3ui32ga5RqMRRqMRSUlJMJvNtdqnsLAQERER6NOnD7777jusXLkSCxcurLLtkiVLsH79ehw5cgQajQbTp09XtxUXF2P06NFITk7Gf//7X4wcORIRERE4deoUAGD37t3o1KkTVqxYgXPnzuHcuXO16l+Z5ORkZGZm4uDBg/jggw9gtVoRHh4Od3d3pKamIi0tDUajESNHjoTFYqnTscszm80wGAxO61xcXPDbb7/h5MmT133cMiz5QkRERERERERERC3CFVlG90PfN/p5s+7tAzdJqrGdRqPBli1bEBMTg02bNiEkJARDhgzBpEmTEBgYWOU+O3bsgCAIeOedd2AwGBAQEIAzZ84gJiamUtv4+HgMGTIEALBo0SKMGTMGJpMJBoMBQUFBCAoKUtuuXLkSe/bswd69ezFnzhx4eXlBkiS4u7tfV8kZNzc3JCQkqKVeEhMTIcsyEhIS1NHumzdvhqenJ1JSUjBixIg6nwMAwsPDMX/+fERHR2Po0KE4fvw41q9fD8BRe778yPnrwRHqRERERERERERERM1EVFQUzp49i71792LkyJFISUlBSEgItmzZUmX7zMxMBAYGOo3KHjBgQJVty4fy7du3BwDk5uYCcIxQj42NRe/eveHp6Qmj0Yhjx46pI9RvVJ8+fZzqpmdkZOD48eNwd3dXR+Z7eXnBZDIhKyvrus8TExODOXPm4IEHHoBOp8Ndd92FSZMmAQBE8cbjcI5QJyIiIiIiIiIiohbBVRSRdW+fJjlvXRgMBgwfPhzDhw/H0qVLMWPGDCxbtgzR0dE31A+tVqs+LhsVLssyACA2NhYHDx7EunXr0KNHD7i4uGD8+PE1ll8RRbFSSRur1VqpnZubm9NycXExQkNDsX379kptvb29a/eEqiAIAlavXo1Vq1YhJycH3t7eSE5OBoBr1l2vCwbqRERERERERERE1CIIglCr0ivNTUBAgNMkpOX16tULiYmJMJvN0Ov1AIDDhw/X+RxpaWmIjo7GuHHjADgC74oThOp0Otjtdqd13t7eyMnJgaIoakhfNhlqdUJCQrBz5074+PjAw8Ojzv2tiSRJ6NixIwDgb3/7GwYNGnRDQX0ZlnwhIiIiIiIiIiIiagby8/MxbNgwJCYm4ujRo8jOzsauXbuwZs0aREZGVrnP5MmTIcsyZs6ciWPHjuGjjz7CunXrAFwdhV4bPXv2xO7du5Geno6MjAz1uOX5+fnh0KFDOHPmDC5cuAAACAsLQ15eHtasWYOsrCxs3LgRBw4cqPF8U6ZMQdu2bREZGYnU1FRkZ2cjJSUFc+fOxW+//XbN/Y4fP4709HTk5OSgpKQE6enpSE9PV0fSX7hwAZs2bcLPP/+M9PR0PPXUU9i1axc2bNhQ69eiOgzUiYiIiIiIiIiIiJoBo9GIgQMH4uWXX8a9996LO++8E0uXLkVMTAxef/31Kvfx8PDAvn37kJ6ejuDgYCxZsgRxcXEA4FRXvSYvvfQSWrdujcGDByMiIgLh4eEICQlxarNixQqcOHEC3bt3V0d79+7dG2+88QY2btyIoKAgfPPNN4iNja3xfK6urjh06BC6dOmChx56CL1798Zjjz0Gk8lU7Yj1GTNmoG/fvnjrrbfwyy+/oG/fvujbty/Onj2rttm6dSv69euHu+++Gz/++CNSUlKuWVe+rgSlYoEbIiIiIiIiIiIiopucyWRCdnY2unXrVqdg+Vawfft2TJs2DQUFBXBxcWnq7jR7dXmvsIY6ERERERERERER0U1s27Zt8Pf3R8eOHZGRkYGFCxdi4sSJDNMbAAN1IiIiIiIiIiIioptYTk4O4uLikJOTg/bt22PChAmIj49v6m7dkljyhYiIiIiIiIiIiG45LbnkC9VNXd4rnJSUiIiIiIiIiIiIiKgWGKgTERERERERERHRLYsFOqgmdXmPMFAnIiIiIiIiIiKiW45WqwUAXLlypYl7Qs1d2Xuk7D1THU5KSkRERERERERERLccSZLg6emJ3NxcAICrqysEQWjiXlFzoigKrly5gtzcXHh6ekKSpBr34aSkREREREREREREdEtSFAU5OTm4dOlSU3eFmjFPT0/4+vrW6gMXBupERERERERERER0S7Pb7bBarU3dDWqGtFptrUaml2GgTkRERERERERERERUC5yUlIiIiIiIiIiIiIioFhioExERERERERERERHVAgN1IiIiIiIiIiIiIqJaYKBORERERERERERERFQLDNSJiIiIiIiIiIiIiGqBgToRERERERERERERUS0wUCciIiIiIiIiIiIiqgUG6kREREREREREREREtcBAnYiIiIiIiIiIiIioFhioExERERERERERERHVAgN1IiIiIiIiIiIiIqJaYKBORERERERERERERFQLDNSJiIiIiIiIiIiIiGqBgToRERERERERERERUS0wUCciIiIiIiIiIiIiqgUG6kREREREREREREREtcBAnYiIiIiIiIiIiIioFhioExERERERERERERHVAgN1IiIiIiIiIiIiIqJaYKBORERERERERERERFQLDNSJiIiIiIiIiIiIiGqBgToRERERERERERERUS0wUCciIiIiIiIiIiIiqgUG6kREREREREREREREtcBAnYiIiIiIiIiIiIioFhioExERERERERERERHVAgN1IiIiIiIiIiIiIqJaYKBORERERERERERERFQLDNSJiIiIiIiIiIiIiGqBgToREdEtwM/PD9HR0epySkoKBEFASkpKk/WJrqr487nVrF27Fv7+/pAkCcHBwU3dHWomBEHA8uXLm7obRERERET1ioE6ERFRA9uyZQsEQYAgCPjPf/5TabuiKOjcuTMEQcADDzzQBD1sPq5cuYLly5fzg4CbyMcff4wFCxbg7rvvxubNm7Fq1aqm7lKDO3HihHpN13Q7ceJEU3e3Wav4WkqShC5dumDcuHFIT0+v8/F27NiBDRs2VFp/9uxZLF++/LqOSURERERUnqapO0BERNRSGAwG7NixA3/4wx+c1n/++ef47bffoNfr6+1c9957L0pKSqDT6ertmI3hypUreO655wAAYWFhTdsZqpVPP/0Uoiji3Xffveneb9fL29sb7733ntO69evX47fffsPLL79cqS3V7JFHHsHo0aNht9tx7NgxvPnmmzhw4AC++uqrOn3rYceOHfjhhx8wb948p/Vnz57Fc889Bz8/P36LgoiIiIhuCAN1IiKiRjJ69Gjs2rULr776KjSaq3+Cd+zYgdDQUFy4cKHeziWKIgwGQ70dj+hacnNz4eLictOF6ZcvX4abm9t17evm5ob/+7//c1r397//Hb///nul9bcKm80GWZYb7OccEhLi9NrdfffdePDBB/Hmm2/irbfeapBz1ocbeR8RERER0c2JJV+IiIgaySOPPIL8/HwcPHhQXWexWPD+++9j8uTJVe6zbt06DB48GG3atIGLiwtCQ0Px/vvv13iua9VQ37hxI/z9/eHi4oIBAwYgNTUVYWFhTqPBy/b9xz/+gfj4eHTq1AkGgwH33Xcfjh8/7nS81NRUTJgwAV26dIFer0fnzp0xf/58lJSUOLWLjo6G0WjEmTNnMHbsWBiNRnh7eyM2NhZ2ux2Ao/RD2Wje5557Ti0BUV0N5rJyOmlpaXj66afh7e0NNzc3jBs3Dnl5eZXaHzhwAPfccw/c3Nzg7u6OMWPG4Mcff6zU7tNPP1XbeXp6IjIyEseOHXNqs3z5cgiCgJ9//hkTJ06Eh4cH2rRpg6eeegomk+mafQaAixcvIjY2Fn369IHRaISHhwdGjRqFjIyMSm1fe+013HHHHXB1dUXr1q3Rr18/7Nixo1I/fvnlF/zf//0fWrVqBW9vbyxduhSKouD06dOIjIyEh4cHfH19sX79+mr7VsZms2HlypXo3r079Ho9/Pz88Oyzz8JsNqttBEHA5s2bcfnyZfXntWXLlmqPu2vXLoSGhsLFxQVt27bF//3f/+HMmTPq9nXr1kEQBJw8ebLSvosXL4ZOp8Pvv/8OoO7vv6ysLIwePRru7u6YMmUKli1bBq1WW+V7ZebMmfD09KzxZ1kds9mMZcuWoUePHmr/FixY4PQaAo7Xcc6cOdi1axcCAgLg4uKCQYMG4fvvvwcAvPXWW+jRowcMBgPCwsIqlZEJCwvDnXfeiW+//RaDBw+Gi4sLunXrhk2bNlXqU25uLh577DG0a9cOBoMBQUFB2Lp1q1ObsjIs69atw4YNG9T3wE8//QSLxYK4uDiEhoaiVatWcHNzwz333IPPPvvsul+nqgwbNgwAkJ2dDQD417/+hTFjxqBDhw7Q6/Xo3r07Vq5cqf7+KHsd9u/fj5MnT6rvRz8/P6SkpKB///4AgGnTplX5Xv36668xcuRItGrVCq6urhgyZAjS0tKc+lR2rf3000+YPHkyWrdurX7jyM/PDw888AD+85//YMCAATAYDPD398e2bducjmG1WvHcc8+hZ8+eMBgMaNOmDf7whz84/V0gIiIiouaNgToREVEj8fPzw6BBg/C3v/1NXXfgwAEUFBRg0qRJVe7zyiuvoG/fvlixYgVWrVoFjUaDCRMmYP/+/XU+/5tvvok5c+agU6dOWLNmDe655x6MHTsWv/32W5XtX3zxRezZswexsbFYvHgxvvrqK0yZMsWpza5du3DlyhXMmjULr732GsLDw/Haa6/hj3/8Y6Xj2e12hIeHo02bNli3bh2GDBmC9evX4+233wbgKI3x5ptvAgDGjRuH9957D++99x4eeuihGp/bk08+iYyMDCxbtgyzZs3Cvn37MGfOHKc27733HsaMGQOj0YjVq1dj6dKl+Omnn/CHP/zBKaD85JNPEB4ejtzcXCxfvhxPP/00vvjiC9x9991V1sOeOHEiTCYTXnjhBYwePRqvvvoqZs6cWW1///e//yEpKQkPPPAAXnrpJfz5z3/G999/jyFDhuDs2bNqu3feeQdz585FQEAANmzYgOeeew7BwcH4+uuvKx3z4YcfhizLePHFFzFw4EA8//zz2LBhA4YPH46OHTti9erV6NGjB2JjY3Ho0KEaX9MZM2YgLi4OISEhePnllzFkyBC88MILTu/V9957D/fccw/0er3687r33nuvecwtW7Zg4sSJkCQJL7zwAmJiYrB792784Q9/wKVLl9TXs+wDnYr+8Y9/YMSIEWjdujWAur3/bDYbwsPD4ePjg3Xr1iEqKgqPPvoobDYbdu7c6dS27IOuqKio6/6mhyzLePDBB7Fu3TpERETgtddew9ixY/Hyyy/j4YcfrtQ+NTUVzzzzDKZOnYrly5fj2LFjeOCBB7Bx40a8+uqr+NOf/oQ///nP+PLLLzF9+vRK+//+++8YPXo0QkNDsWbNGnTq1AmzZs3CX//6V7VNSUkJwsLC8N5772HKlClYu3YtWrVqhejoaLzyyiuVjrl582a89tprmDlzJtavXw8vLy8UFhYiISEBYWFhWL16NZYvX468vDyEh4fXa33yrKwsAECbNm0AON47RqMRTz/9NF555RWEhoYiLi4OixYtUvdZsmQJgoOD0bZtW/X9uGHDBvTu3RsrVqwA4PigpOJ79dNPP8W9996LwsJCLFu2DKtWrcKlS5cwbNgwfPPNN5X6NmHCBFy5cgWrVq1CTEyMuv748eMYP348hg8fjvXr16N169aIjo52+tBu+fLleO655zB06FC8/vrrWLJkCbp06YLvvvuu3l47IiIiImpgChERETWozZs3KwCUw4cPK6+//rri7u6uXLlyRVEURZkwYYIydOhQRVEUpWvXrsqYMWOc9i1rV8ZisSh33nmnMmzYMKf1Xbt2VaZOnaouf/bZZwoA5bPPPlMURVHMZrPSpk0bpX///orValXbbdmyRQGgDBkypNK+vXv3Vsxms7r+lVdeUQAo33///TX7pyiK8sILLyiCICgnT55U102dOlUBoKxYscKpbd++fZXQ0FB1OS8vTwGgLFu2rNJxq1L22t5///2KLMvq+vnz5yuSJCmXLl1SFEVRioqKFE9PTyUmJsZp/5ycHKVVq1ZO64ODgxUfHx8lPz9fXZeRkaGIoqj88Y9/VNctW7ZMAaA8+OCDTsf805/+pABQMjIy1HUVfz4mk0mx2+1O+2VnZyt6vd7pNYqMjFTuuOOOal+Dsn7MnDlTXWez2ZROnTopgiAoL774orr+999/V1xcXJz6UpX09HQFgDJjxgyn9bGxsQoA5dNPP1XXTZ06VXFzc6v2eIrieO/6+Pgod955p1JSUqKu/+CDDxQASlxcnLpu0KBBTu8LRVGUb775RgGgbNu2TV1X1/ffokWLKrUfNGiQMnDgQKd1u3fvdrp+amPMmDFK165d1eX33ntPEUVRSU1NdWq3adMmBYCSlpamrgOg6PV6JTs7W1331ltvKQAUX19fpbCwUF2/ePFiBYBT2yFDhigAlPXr16vrzGaz+l62WCyKoijKhg0bFABKYmKi2s5isSiDBg1SjEajep7s7GwFgOLh4aHk5uY69d9mszn9XlAUx/uqXbt2yvTp053W1+ZaLjvXc889p+Tl5Sk5OTlKSkqK0rdvXwWA8s9//lNRlKp/1o8//rji6uqqmEwmdV3Fn0OZw4cPKwCUzZs3O62XZVnp2bOnEh4e7vQ75MqVK0q3bt2U4cOHq+vKrrVHHnmk0vG7du2qAFAOHTqkrsvNzVX0er3yzDPPqOuCgoIq/Z4nIiIiopsLR6gTERE1ookTJ6KkpAQffPABioqK8MEHH1yz3AsAuLi4qI9///13FBQU4J577qnzaMYjR44gPz8fMTExTvXbp0yZoo72rWjatGlO9ZLvueceAI7R1VX17/Lly7hw4QIGDx4MRVHw3//+t9Ixn3jiCafle+65x+l412vmzJkQBMHpuHa7XS0bcvDgQVy6dAmPPPIILly4oN4kScLAgQPVchXnzp1Deno6oqOj4eXlpR4vMDAQw4cPx7///e9K5549e7bT8pNPPgkAVbYto9frIYqOf4bZ7Xbk5+fDaDSiV69eTj9bT09P/Pbbbzh8+HCNr8GMGTPUx5IkoV+/flAUBY899pjT8Xr16lXja17W96efftpp/TPPPAMA1/UNiSNHjiA3Nxd/+tOfnEZ9jxkzBrfffrvTMR9++GF8++236ihlANi5cyf0ej0iIyPVdXV9/82aNavSuj/+8Y/4+uuvnc61fft2dO7cGUOGDKnz8yyza9cu9O7dG7fffrvTe66slEnFEin33Xcf/Pz81OWBAwcCAKKiouDu7l5pfcWfoUajweOPP64u63Q6PP7448jNzcW3334LwPFz9fX1xSOPPKK202q1mDt3LoqLi/H55587HTMqKqrSpKqSJKm/F2RZxsWLF2Gz2dCvX78bGmW9bNkyeHt7w9fXF2FhYcjKysLq1avVb6iU/1kXFRXhwoULuOeee3DlyhX8/PPP133e9PR0/Prrr5g8eTLy8/PVn9Ply5dx33334dChQ5Bl2Wmfir/HygQEBKi/JwHHt24qXm+enp748ccf8euvv153n4mIiIioaTFQJyIiakTe3t64//77sWPHDuzevRt2ux3jx4+/ZvsPPvgAd911FwwGA7y8vNSyKAUFBXU6b1mw3KNHD6f1Go3GKcQrr0uXLk7LZcF7Wf1qADh16pQaPpfVRS8LISv20WAwVArnWrdu7XS861VTX8vCq2HDhsHb29vp9vHHHyM3NxfA1depV69elc7Ru3dvNWgrr2fPnk7L3bt3hyiKVZaHKSPLMl5++WX07NkTer0ebdu2hbe3N44ePer0ui1cuBBGoxEDBgxAz549MXv27Ep1na/1GrRq1QoGgwFt27attL6m1/zkyZMQRbHS+8XX1xeenp5V1jevSXWv7e233+50zAkTJkAURbUUi6Io2LVrF0aNGgUPDw+1XV3efxqNBp06dap07ocffhh6vR7bt29X9/vggw8wZcoUpw9p6urXX3/Fjz/+WOn9dttttwGA+p4rU9XPDwA6d+5c5fqKP8MOHTpUmhyz7Fxl78WTJ0+iZ8+e6oc5ZXr37q1uL69bt25VPretW7ciMDBQrQHu7e2N/fv31/n3UnkzZ87EwYMHkZycjG+//Ra5ublYsGCBuv3HH3/EuHHj0KpVK3h4eMDb21udxPRGzlv2u2Hq1KmVflYJCQkwm82Vjn+t16XizxCo/DtuxYoVuHTpEm677Tb06dMHf/7zn3H06NHr7j8RERERNT5NzU2IiIioPk2ePBkxMTHIycnBqFGj4OnpWWW71NRUPPjgg7j33nvxxhtvoH379tBqtdi8ebPTpJQNRZKkKtcrigLAMbJ6+PDhuHjxIhYuXIjbb78dbm5uOHPmDKKjoyuN6rzW8Rqjr2V9ee+99+Dr61upXflR+zeqNiHsqlWrsHTpUkyfPh0rV66El5cXRFHEvHnznF633r17IzMzEx988AE+/PBD/POf/8Qbb7yBuLg4PPfcc07HrOo1qOl1qY/n0hA6dOiAe+65B//4xz/w7LPP4quvvsKpU6ewevVqtU1d33/lvxVQXuvWrfHAAw9g+/btiIuLw/vvvw+z2ayGtddLlmX06dMHL730UpXbKwbl1/pZ3ejP8EaUHxVeJjExEdHR0Rg7diz+/Oc/w8fHR62JX36Uf1317NkT999/f5XbLl26hCFDhsDDwwMrVqxA9+7dYTAY8N1332HhwoWVftZ1Ubbv2rVrERwcXGUbo9HotFzV6wLU7md17733IisrC//617/w8ccfIyEhAS+//DI2bdrk9C0TIiIiImq+GKgTERE1snHjxuHxxx/HV199VWkyxPL++c9/wmAw4KOPPoJer1fXb968uc7n7Nq1KwDHpHlDhw5V19tsNpw4cQKBgYF1Pub333+PX375BVu3bnWaBPLgwYN1PlaZhgpwu3fvDgDw8fG5ZmgHXH2dMjMzK237+eef0bZt20qjgH/99VenEavHjx+HLMvXHPkPAO+//z6GDh2Kd99912n9pUuXKo0od3Nzw8MPP4yHH34YFosFDz30EOLj47F48eLrnjCzJl27doUsy/j111/V0csAcP78eVy6dEl9nep6TMDx2paVPSmTmZlZ6ZgPP/ww/vSnPyEzMxM7d+6Eq6srIiIi1O31+f774x//iMjISBw+fBjbt29H3759cccdd9T5OOV1794dGRkZuO+++xrlg4mzZ8/i8uXLTu/PX375BQDU92LXrl1x9OhRyLLs9OFCWcmU2vxc33//ffj7+2P37t1Oz2vZsmX18TSqlJKSgvz8fOzevdtp0tvs7OxKba/1Wl9rfdnvBg8Pj2p/N9QnLy8vTJs2DdOmTUNxcTHuvfdeLF++nIE6ERER0U2CJV+IiIgamdFoxJtvvonly5c7BYQVSZIEQRBgt9vVdSdOnEBSUlKdz9mvXz+0adMG77zzDmw2m7p++/bt111ypWw0ZvnRl4qi4JVXXrmu4wGAq6srAEewXJ/Cw8Ph4eGBVatWwWq1Vtqel5cHAGjfvj2Cg4OxdetWpz788MMP+PjjjzF69OhK+27cuNFp+bXXXgMAjBo16pr9kSSp0gjjXbt24cyZM07r8vPznZZ1Oh0CAgKgKEqVz6O+lD3PDRs2OK0vG209ZsyYOh+zX79+8PHxwaZNm2A2m9X1Bw4cwLFjxyodMyoqCpIk4W9/+xt27dqFBx54wCksrs/336hRo9C2bVusXr0an3/++Q2PTgcc8yWcOXMG77zzTqVtJSUllUoH3SibzYa33npLXbZYLHjrrbfg7e2N0NBQAI6fa05OjtMHeTabDa+99hqMRmOtasZX9bp//fXX+PLLL+vrqdTqnBaLBW+88Ualtm5ublWWgCl771T83RIaGoru3btj3bp1KC4urrRf2e+G+lLxmjYajejRo4fTNUFEREREzRtHqBMRETWBqVOn1thmzJgxeOmllzBy5EhMnjwZubm52LhxI3r06FHnmrs6nQ7Lly/Hk08+iWHDhmHixIk4ceIEtmzZgu7du1/XCNrbb78d3bt3R2xsLM6cOQMPDw/885//vKGa6C4uLggICMDOnTtx2223wcvLC3feeSfuvPPO6z4m4Bh9+uabb+LRRx9FSEgIJk2aBG9vb5w6dQr79+/H3Xffjddffx2Ao/TDqFGjMGjQIDz22GMoKSnBa6+9hlatWmH58uWVjp2dnY0HH3wQI0eOxJdffonExERMnjwZQUFB1+zPAw88gBUrVmDatGkYPHgwvv/+e2zfvh3+/v5O7UaMGAFfX1/cfffdaNeuHY4dO4bXX38dY8aMcZqosr4FBQVh6tSpePvtt9VyG9988w22bt2KsWPHOn3Loba0Wi1Wr16NadOmYciQIXjkkUdw/vx5vPLKK/Dz88P8+fOd2vv4+GDo0KF46aWXUFRUhIcffthpe32+/7RaLSZNmoTXX38dkiQ5Tdp5vR599FH84x//wBNPPIHPPvsMd999N+x2O37++Wf84x//wEcffYR+/frd8HnKdOjQAatXr8aJEydw2223YefOnUhPT8fbb78NrVYLwFGn/K233kJ0dDS+/fZb+Pn54f3330daWho2bNhQq/fUAw88gN27d2PcuHEYM2YMsrOzsWnTJgQEBFQZSNeHwYMHo3Xr1pg6dSrmzp0LQRDw3nvvVVn2JjQ0FDt37sTTTz+N/v37w2g0IiIiAt27d4enpyc2bdoEd3d3uLm5YeDAgejWrRsSEhIwatQo3HHHHZg2bRo6duyIM2fO4LPPPoOHhwf27dtXb88lICAAYWFhCA0NhZeXF44cOYL3338fc+bMqbdzEBEREVHD4gh1IiKiZmrYsGF49913kZOTg3nz5uFvf/sbVq9ejXHjxl3X8ebMmYNXX30Vp06dQmxsLFJTU7F37154enpeV+kQrVaLffv2ITg4GC+88AKee+459OzZE9u2bbuu/pVJSEhAx44dMX/+fDzyyCN4//33b+h4ZSZPnozk5GR07NgRa9euxVNPPYW///3vCA4OxrRp09R2999/Pz788EO0adMGcXFxWLduHe666y6kpaVVORnhzp07odfrsWjRIuzfvx9z5sypVMqlomeffRbPPPMMPvroIzz11FP47rvvsH///kp1tR9//HEUFxfjpZdewuzZs5GUlIS5c+ciMTGxXl6T6iQkJOC5557D4cOHMW/ePHz66adYvHgx/v73v1/3MaOjo7Fz505YLBYsXLgQb731FsaNG4f//Oc/Vc4l8PDDD6OoqAju7u6Vvh1Q3++/srIx9913H9q3b39dxyhPFEUkJSXhxRdfxPfff4/Y2Fj19XzqqafUCUPrS+vWrfHvf/8bR44cwZ///GecPn0ar7/+OmJiYtQ2Li4uSElJwZQpU7B161Y888wzuHjxIjZv3oynnnqqVueJjo7GqlWrkJGRgblz5+Kjjz5CYmJivX44UFGbNm3wwQcfoH379vjLX/6CdevWYfjw4VizZk2ltn/6058wefJkbN68GZMnT8aTTz4JwPF+2bp1KyRJwhNPPIFHHnkEn3/+OQAgLCwMX375Jfr164fXX38dTz75JLZs2QJfX99KH/TcqLlz5+LEiRN44YUXMHfuXHz++ed4/vnnsX79+no9DxERERE1HEFpjBmNiIiIqFmSZRne3t546KGHqixNQde2fPlyPPfcc8jLy6tU95xuPhkZGQgODsa2bdvw6KOPNnV36iQsLAwXLlzADz/80NRdISIiIiK65XGEOhERUQthMpkqlUjYtm0bLl68iLCwsKbpFFEz8c4778BoNOKhhx5q6q4QEREREVEzxhrqRERELcRXX32F+fPnY8KECWjTpg2+++47vPvuu7jzzjsxYcKEpu4eUZPYt28ffvrpJ7z99tuYM2eO08SnREREREREFTFQJyIiaiH8/PzQuXNnvPrqq7h48SK8vLzwxz/+ES+++CJ0Ol1Td4+oSTz55JM4f/48Ro8ejeeee66pu0NERERERM0ca6gTEREREREREREREdUCa6gTEREREREREREREdUCA3UiIiIiIiIiIiIiolpgDfUKZFnG2bNn4e7uDkEQmro7REREREREREREtaYoCoqKitChQweIIsfSEtU3BuoVnD17Fp07d27qbhAREREREREREV2306dPo1OnTk3dDaJbDgP1Ctzd3QE4ful4eHg0cW/qlyzLyMvLg7e3Nz+hJKpHvLaIGgavLaKGwWuLqGHw2iJqGLy26q6wsBCdO3dWMy4iql8M1CsoK/Pi4eFxSwbqJpMJHh4e/CNEVI94bRE1DF5bRA2D1xZRw+C1RdQweG1dP5YyJmoY/E1ERERERERERERERFQLt1ygvn//fgwcOBAuLi5o3bo1xo4d29RdIiIiIiIiIiIiIqJbwC1V8uWf//wnYmJisGrVKgwbNgw2mw0//PBDU3eLiIiIiIiIiIiIiG4Bt0ygbrPZ8NRTT2Ht2rV47LHH1PUBAQFN2CsiIiIiIiIiIiJqana7HVartam7Qc2QVquFJEm1bn/LBOrfffcdzpw5A1EU0bdvX+Tk5CA4OBhr167FnXfeec39zGYzzGazulxYWAjAMemFLMsN3u/GJMsyFEW55Z4XUVPjtUXUMHhtETUMXltEDYPXFlHD4LVVd3ytnCmKgpycHFy6dKmpu0LNmKenJ3x9fWs1me8tE6j/73//AwAsX74cL730Evz8/LB+/XqEhYXhl19+gZeXV5X7vfDCC3juuecqrc/Ly4PJZGrQPjc2WZZRUFAARVE4MzZRPeK1RdQweG0RNQxeW0QNg9cWUcPgtVV3RUVFTd2FZqUsTPfx8YGrq2utAlNqORRFwZUrV5CbmwsAaN++fY37NPtAfdGiRVi9enW1bY4dO6Z++rZkyRJERUUBADZv3oxOnTph165dePzxx6vcd/HixXj66afV5cLCQnTu3Bne3t7w8PCop2fRPMiyDEEQ4O3tzT9CRPWI1xZRw+C1RdQweG0RNQxeW0QNg9dW3RkMhqbuQrNht9vVML1NmzZN3R1qplxcXAAAubm58PHxqbH8S7MP1J955hlER0dX28bf3x/nzp0D4FwzXa/Xw9/fH6dOnbrmvnq9Hnq9vtJ6URRvyV/UgiDcss+NqCnx2iJqGLy2iBoGry2ihsFri6hh8NqqG75OV5XVTHd1dW3inlBzV/YesVqtN3+g7u3tDW9v7xrbhYaGQq/XIzMzE3/4wx8AOF6AEydOoGvXrg3dTSIiIiIiIiIiImqGWOaFalKX90izD9Rry8PDA0888QSWLVuGzp07o2vXrli7di0AYMKECU3cOyIiIiIiIiIiIiK62d0ygToArF27FhqNBo8++ihKSkowcOBAfPrpp2jdunVTd42IiIiIiIiIiIioXgiCgD179mDs2LFN3ZUW55YqqqTVarFu3TqcP38ehYWFOHjwIO64446m7hYRERERERERERFRreTl5WHWrFno0qUL9Ho9fH19ER4ejrS0NLXNuXPnMGrUqEbvm5+fHzZs2NDo5y3v1KlTGDNmDFxdXeHj44M///nPsNlsjXb+W2qEOhEREREREREREdHNLCoqChaLBVu3boW/vz/Onz+P5ORk5Ofnq218fX2bsIc3zmKxQKfT1Xk/u92OMWPGwNfXF1988QXOnTuHP/7xj9BqtVi1alUD9LSyW2qEOhERERERETUfiqJAUeyQZRtk2QK73Qy73QS7/QpstmLYbEWwWgthtRbAav0dFks+LJYLMJvzYDbnwmTOgcl0DibTWfVWUnKm9PZb6e00SkpOoaTkFK5cOVl6O4ErV7LV2+XL/yu9ZZXejpfeypYd28vv4zjGCfWYZedwnO90ufM7+mMynYPFchEm83mYzedhNufBYrkAiyUfVuvvsFoLYLMVld4uw24vgd1uhiybIctWKIodiiI39Y+MiIia2KVLl5CamorVq1dj6NCh6Nq1KwYMGIDFixfjwQcfVNsJgoCkpCR1+YsvvkBwcDAMBgP69euHpKQkCIKA9PR0AEBKSgoEQUBycjL69esHV1dXDB48GJmZmeoxsrKyEBkZiXbt2sFoNKJ///745JNP1O1hYWE4efIk5s+fD0EQ1Ik8ly9fjuDgYKfnsWHDBvj5+anL0dHRGDt2LOLj49GhQwf06tULAHD69GlMnDgRnp6e8PLyQmRkJE6cOHHN1+fjjz/GTz/9hMTERAQHB2PUqFFYuXIlNm7cCIvFUsdX+/pwhDoREREREVELpyhyaZhrV0NwoGydXBr2KlBgB5Rq1kMBFBmA0uLCYVlWYLNdgcVsgygKN3QsQRABCIAgQoAAQZAgCBIAsfSxWG5ZvOZ2xzoiIipPURSUWO2Nfl4XraQG0NUxGo0wGo1ISkrCXXfdBb1eX+M+hYWFiIiIwOjRo7Fjxw6cPHkS8+bNq7LtkiVLsH79enh7e+OJJ57A9OnT1VIyxcXFGD16NOLj46HX67Ft2zZEREQgMzMTXbp0we7duxEUFISZM2ciJiamTs8fAJKTk+Hh4YGDBw8CAKxWK8LDwzFo0CCkpqZCo9Hg+eefx8iRI3H06NEqR7B/+eWX6NOnD9q1a6euCw8Px6xZs/Djjz+ib9++de5XXTFQJyIiIiIiuok5AnBbuUDcXhqQO9ZdDcFt5bbZ4Qi97VAgA4rS1E+DylE/jFDsuNGfjBqsCyIEOIftV2/a0ntNufsb+1CAiKi5KrHaERD3UaOf96cV4XDV1RzFajQabNmyBTExMdi0aRNCQkIwZMgQTJo0CYGBgVXus2PHDgiCgHfeeQcGgwEBAQE4c+ZMlaF3fHw8hgwZAgBYtGgRxowZA5PJBIPBgKCgIAQFBaltV65ciT179mDv3r2YM2cOvLy8IEkS3N3dr6vkjJubGxISEtSgPDExEbIsIyEhQf27s3nzZnh6eiIlJQUjRoyodIycnBynMB2AupyTk1PnPl0PBupERERERERNrGxUuONmu3oPRxAORS633V4uCGeZEKpe2fulrq6G7ZqrN9GxLDqtL3vMirJERPUlKioKY8aMQWpqKr766iscOHAAa9asQUJCAqKjoyu1z8zMRGBgIAwGg7puwIABVR67fCjfvn17AEBubi66dOmC4uJiLF++HPv378e5c+dgs9lQUlKCU6dO1cvz6tOnj9Oo84yMDBw/fhzu7u5O7UwmE7KysurlnA2BgToREREREVE9UpxGg1cRkle5vvG/ek5Unavvy9rVo3WMfL8avoui1uneMQpeA1FkDEFETctFK+GnFeFNct66MBgMGD58OIYPH46lS5dixowZWLZsWZWBel1otVr1cdmocFl2fDgfGxuLgwcPYt26dejRowdcXFwwfvz4GmuTi6IIpcK33axWa6V2bm5uTsvFxcUIDQ3F9u3bK7X19vau8ly+vr745ptvnNadP39e3dYY+JeMiIiIiIioGuWDb1m2lQvBrVWE5DaOGKcWyfFBkgU1BvCCAFHQQhC0EEWNGrY7Hpdfz/rvRNQwBEGoVemV5iYgIMBpEtLyevXqhcTERJjNZrXm+uHDh+t8jrS0NERHR2PcuHEAHIF3xQlCdTod7HbngQDe3t7IycmBoihqSF82GWp1QkJCsHPnTvj4+MDDw6NWfRw0aBDi4+ORm5sLHx8fAMDBgwfh4eGBgICAWh3jRvE7WURERERE1KIoigxZNsNuvwKbrQgWy0WYzXkwmc6hpOQ0rlzJxuXLx1FcnInCoh9QVPQTiot/weXLWSgpOQmT6QzM5hxYLPmwWi/BZiuG3V4CWbYwTCeqiaJAli2w2y/Dai2AxZIPszkHJSW/lV57v6Co6CcUFf2I4uJMXL78P5SUnIap9Jqz2Ypgt5v4rQ4iumXl5+dj2LBhSExMxNGjR5GdnY1du3ZhzZo1iIyMrHKfyZMnQ5ZlzJw5E8eOHcNHH32EdevWAUCd5sTo2bMndu/ejfT0dGRkZKjHLc/Pzw+HDh3CmTNncOHCBQBAWFgY8vLysGbNGmRlZWHjxo04cOBAjeebMmUK2rZti8jISKSmpiI7OxspKSmYO3cufvvttyr3GTFiBAICAvDoo48iIyMDH330Ef7yl79g9uzZtZrAtT7cfB/HEBERERERVeAYHWstHUFeNnq8bFR52WMbR5AT3STKj3i3XyM7FwQJgqiFKGghirrS0e1ap3tOrkpENxuj0YiBAwfi5ZdfRlZWFqxWKzp37oyYmBg8++yzVe7j4eGBffv2YdasWQgODkafPn0QFxeHyZMnO9VVr8lLL72E6dOnY/DgwWjbti0WLlyIwsJCpzYrVqzA448/ju7du8NsNkNRFPTu3RtvvPEGVq1ahZUrVyIqKgqxsbF4++23qz2fq6srDh06hIULF+Khhx5CUVEROnbsiPvuu++aI9YlScIHH3yAWbNmYdCgQXBzc8PUqVOxYsWKWj/PGyUoFQvctHCFhYVo1aoVCgoKav1Vg5uFLMvq1yFEkV9OIKovvLaIGgavLaKGcTNdW2Uh+dVSK1dLrDhC8vLBOUNyalqyrODixSvw8nKFKDLEbS6cAvcqw3eWlmnubqa/W83FrZxt1ZXJZEJ2dja6detWp2D5VrB9+3ZMmzYNBQUFcHFxaeruNHt1ea9whDoRERERETUq54DcBlmxQSk3ivzqiHKWdCCiG6PIVthhhd1+pcrtgiCVC9h1EEUtRFGvLgsCA1wiujls27YN/v7+6NixIzIyMrBw4UJMnDiRYXoDYKBORERERET1Qq4yFC9btnE0ORE1O4pih91eAqCkyu2CoFGDdkHUlRvhXrqOgTsRNRM5OTmIi4tDTk4O2rdvjwkTJiA+Pr6pu3VLYqBORERERETVcoTh5UaUyxXuS9eD1SSJ6BajKDbY7bZr13GvVFJGdzWAF3Ss4U5EjWbBggVYsGBBU3ejRWCgTkRERETUQimKXBqKly+9YuGIciKiWqq2pIwgVKjZfjVoL3tMREQ3HwbqRERERES3IOdR5FbHKHLZBrvdgpKS31FUlA9BYFBORNRgFAWyYoEsW6reLgilI9qd67ZfDd0Z2RARNUf87UxEREREdBNRFMURkJcvt1IWmpeOKpcV6zXLr8iyUjryXMtSBERETUlRICtmyLIZQHGlzYIgltZtr6qGu5aBOxFRE+FvXyIiIiKiZsIRlluujiovC8jVUeY2KLK1qbtJRESNQFFkKHYTZJiq3C4IYmmwXn6Eu7bcOl0j95iIqGVgoE5ERERE1AicR5Zf697W1N0kIqKbhKLIUKoZ4V65hrvzY06aSkR0fRioExERERHdoKrLsFgqlWUhIiJqNDXVcAcgCJrScF1TGrZfXb4avEuN2GkiouaPgToRERERUQ0URS4Nxx3BRFlAXn7Cz2vVLCciImquFMUGu736b0c5SstcDdwFUQtR0KgTp5aF7xztTtS4BEHAnj17MHbs2KbuSovDQJ2IiIiIWrzyZVecR5ezFAsREbVsjtIy1Y90B1AuaC+7SaXrpKvLglQavouN1Huim1NeXh7i4uKwf/9+nD9/Hq1bt0ZQUBDi4uJw9913AwDOnTuH1q1bN3rf/Pz8MG/ePMybN6/Rz11m7ty5SEtLww8//IDevXsjPT29Uc/PQJ2IiIiIbmlXy7FYrobm6mMLR5cTERHVA0W2wo7alTcrG/V+NWSvEMSX3ouiBorC8J1anqioKFgsFmzduhX+/v44f/48kpOTkZ+fr7bx9fVtwh7eOIvFAp3u+idPnj59Or7++mscPXq0HntVO/ytREREREQ3PVm2wGa7DKv1d5jNuSgp+Q1XrmSjuDgTRcU/org4E1euZKOk5DeYzedhtf4Om63YMdqOYToREVGjcpRSs8BuL4HNVgyr9RIslgswm3NgMp1BSclJXLnyPxQX/4KiomO4UnISRUXHUFycieLLv+Ly5azSv+unUFLyG0ymszCbz8NszoPFkg+r9RKs1kLYbMWw20tgt5tLv3EmN/VTJ6rRpUuXkJqaitWrV2Po0KHo2rUrBgwYgMWLF+PBBx9U2wmCgKSkJHX5iy++QHBwMAwGA/r164ekpCQIgqCO3k5JSYEgCEhOTka/fv3g6uqKwYMHIzMzUz1GVlYWIiMj0a5dOxiNRvTv3x+ffPKJuj0sLAwnT57E/PnzIQiCWupp+fLlCA4OdnoeGzZsgJ+fn7ocHR2NsWPHIj4+Hh06dECvXr0AAKdPn8bEiRPh6ekJLy8vREZG4sSJE9W+Rq+++ipmz54Nf3//Oryy9Ycj1ImIiIio2as0qrxCPXOG4kRERLcwRYGi2CHL9ROIC4IESXKBq2u3ejke3WQUBbBeafzzal2BWsw1YDQaYTQakZSUhLvuugt6vb7GfQoLCxEREYHRo0djx44dOHny5DVLsixZsgTr16+Ht7c3nnjiCUyfPh1paWkAgOLiYowePRrx8fHQ6/XYtm0bIiIikJmZiS5dumD37t0ICgrCzJkzERMTU6enDwDJycnw8PDAwYMHAQBWqxXh4eEYNGgQUlNTodFo8Pzzz2PkyJE4evToDY1gb0gM1ImIiIioyZWNVHME5JbSGuZmtY45R5QRERFRfVEUO2TOj9JyWa8Aqzo0/nmfPQvo3GpsptFosGXLFsTExGDTpk0ICQnBkCFDMGnSJAQGBla5z44dOyAIAt555x0YDAYEBATgzJkzVYbe8fHxGDJkCABg0aJFGDNmDEwmEwwGA4KCghAUFKS2XblyJfbs2YO9e/dizpw58PLygiRJcHd3v66SM25ubkhISFCD8sTERMiyjISEBHW0++bNm+Hp6YmUlBSMGDGizudoDCz5QkRERESNQpatlcqyXL78PxQV/4yioh9x+fKvKCk5CbPpHCyW/NKSLGaG6URERETUokRFReHs2bPYu3cvRo4ciZSUFISEhGDLli1Vts/MzERgYCAMBoO6bsCAAVW2LR/Kt2/fHgCQm5sLwDFCPTY2Fr1794anpyeMRiOOHTuGU6dO1cvz6tOnj9Oo84yMDBw/fhzu7u7qyHwvLy+YTCZkZWXVyzkbAkeoExEREVG9cEz+abk60rzCiHMG40RERETU5LSujtHiTXHeOjAYDBg+fDiGDx+OpUuXYsaMGVi2bBmio6NvrBtarfq4bFR4WTml2NhYHDx4EOvWrUOPHj3g4uKC8ePHw2KxVHtMURShVCjBaLVWnqTYzc15hH5xcTFCQ0Oxffv2Sm29vb1r94SaAAN1IiIiIqo159Dc7HzPWuZELZKjZJMZdnuJOs+B477ssU39HaGo9xXaKRbHutJlx+8ZRztFsUGBXPqhXOm9Ipdbp5Te252WndpXulcACABECIIIQCi9r7jsuK96W+Vlmw24kG+AJOkhCFqIog6ioIUg6tTHoqiDIGohivqr28rairqr+4ll23SQJAMEQacGH0REdAMEoValV5qbgIAAp0lIy+vVqxcSExNhNpvVmuuHDx+u8znS0tIQHR2NcePGAXAE3hUnCNXpdLDb7U7rvL29kZOTA0VR1L9VZZOhVickJAQ7d+6Ej48PPDw86tzfpsJAnYiIiIgquTrCvGJobmFoTnQTUxQFsmyC3X4FdtkE2V4Cu73EsU42QbabYJdLSu/LLcsm2O2m0vsSp3tZNjf107oh9f0rzdxAL4cgSBBFV0iSCySp9F68+liUXKtYf7W9KLlAEl1Lw3mpYTpJREQ3LD8/HxMmTMD06dMRGBgId3d3HDlyBGvWrEFkZGSV+0yePBlLlizBzJkzsWjRIpw6dQrr1q0DgDp9GNuzZ0/s3r0bEREREAQBS5curTQZsJ+fHw4dOoRJkyZBr9ejbdu2CAsLQ15eHtasWYPx48fjww8/xIEDB2oMyadMmYK1a9ciMjISK1asQKdOnXDy5Ens3r0bCxYsQKdOnarc7/jx4yguLkZOTg5KSkrU8D4gIKBRJjJloE5ERETUQpWNHpVlM2TFAtluZnkWomZOUWTY7SWw2y/Dbr8Mm/0y7LbLpctXHMul69THTstXADTU9S2UjrDWQRQ1EIWykdhlo661V9cJ2mq3XR2drYUgaABBhOA0IlxS10EQym0rvXdqX2Ekedl+6sh2pdLo9fLLtWkDyJBlGUVFV+DqKgCwOX6vymWTLFvLLZc9LhuxX/GxxXmUvmIt/dnbYbcXwW4vuuGflCgaIEmu0GjcS28ejnvJvdy6cus17pAkt9LXkYiIGpLRaMTAgQPx8ssvIysrC1arFZ07d0ZMTAyeffbZKvfx8PDAvn37MGvWLAQHB6NPnz6Ii4vD5MmTneqq1+Sll17C9OnTMXjwYLRt2xYLFy5EYWGhU5sVK1bg8ccfR/fu3WE2m6EoCnr37o033ngDq1atwsqVKxEVFYXY2Fi8/fbb1Z7P1dUVhw4dwsKFC/HQQw+hqKgIHTt2xH333VdtGD9jxgx8/vnn6nLfvn0BANnZ2fDz86v1871eglKxwE0LV1hYiFatWqGgoOCm+qpBbciyjNzcXPj4+EAU+Q8hovrCa4uoYfDaqh+O0agWdRTp1ZsFimKv+QB0y5FlBRcvXoGXlytEkeUjmoqi2GGzFcNmK3Lc7EVXH9uKYLcVltvmCMLtaiBeH/8JJzpGNYuGcvcGdVkSDaUjmg3ltrlAlAxO28rv29JLkjTUteUoqVP6rYLSbxQ4vmFwRX0s26+UW1+ujf2K41sIpW0VxXYDPRGh0bg5QvZywbtUeq/VeEDSuEOraQWttjW0Wk9Ikku9vQ7UcjXUtSVKBhjdetbb8ZqTWznbqiuTyYTs7Gx069atTsHyrWD79u2YNm0aCgoK4OLC38c1qct7hSPUiYiIiG4BimJXw3K7bHaMNi8dec4SLUQNS5atsNkKYCsfgpe/OYXljjZ2++UbOqcgaCFJbtBo3CBJjptGcoOkcSst81G6XLpOfVx6c4wMb7nh981EEES1fMuNkmWrGrTb7Zed3pNVfbBTtk2WTQBkdX1tiaIBWm0raDWOgF2j9VTDdq2m3GOtJ0Sx4b+iT0R0K9u2bRv8/f3RsWNHZGRkYOHChZg4cSLD9AbAQJ2IiIjoJuIo02KuNNpcli1N3TWiW4Zj9HgRrNZLsNkKYLUVwmYtgNVWUOG+EDbbpdJR49dHLbsheTiN9nW6ScYKwbgrw0e6LqKohSi2glbbqk77OT40cg7c7aX3Vluh02ObrQBW66XSb0aZYDabYDafr/EckuTqCNg1FYL30vBdp2sDrbYNNBp3fhhERFSFnJwcxMXFIScnB+3bt8eECRMQHx/f1N26JTFQJyIiImqGymqbO402l803+HV9opbLbi+B1XoJVuvvpUH5paqDclsBbLZi1LWsiiBITqUwqg7GK6/j5JB0MxBFLXQ6L+jgVet9rl5zl2C1XYKt9NqzWn+H1VagXotW6+9QFJs6ct6EM9UeVxC00Gm9oNV5QadtU+6+DXRar9Lg3QuiqL3Rp01EdFNZsGABFixY0NTdaBEYqBMRERE1IVm2qaP4ZNkCu93xmPXNiWpWVmqlfFCu3tuclx0lK+pCgEbjAa2mFTRaD2g0jlG9Gk2r0nXO944JGzlqlqiMJLlAklxgMLSvtp2iKLDbL1cZtpeF8BbrRVitF2GzFUJRrDBbzsNsqX7Uu0bjAW1pwO4I4Ns4BfA6nRckiaPdiYio7hioExERETUCx6Ry5tKJ5RyhuV02Q5GtTd01omblarj2e2mI5hyM28oF5nWp5QyU1XMureVcGpCXheJlQbkjNPfg6HGiRiIIAjQaIzQaI1xcOlXbVpatsFovwmLJd/x+sOTDYs2H1XLR6V5RbKX13wtRUnLimscTRR202raO0F3X9upNe3WZH5YREVFFDNSJiIiI6pGiKKXlWkxO4TlrnBM5SkA4QjDHaNOyx1eDc8f6ulwvjlIr5estV7jXXK3DLEmclIvoZiaKWuj17aDXt7tmG0VRSudAyIfFkl9FAH8RVmt+6WSrFpjNZ2E2n63mnIZKIXvFAL4+JowlIqKbBwN1IiIioutUVq7FLpsgq8G5GYoiN3XXiBqV3W5Ww3DnkLzs8e+lQXnty65Ikjt02taOYFznmKiwqsBckowQBLEBnx0R3UwEQYBW6wGt1gOurt2u2U6WLY6g3XIBFuuFq49Lb1dDdxNMpt9gMv12zWOJokvlsF1bMXTnB3pERLcKBupEREREtXC1vnkJR51Ti1FWfsVRSiG/dJRn6ajPco/t9uJaH1OSXKHVekGrba1OLKjVejkea72g03lBq/WEKOob8JkRUUsnijoYDO2rrfHu+LCwQthuLR+8O37/yXIJTKbTMJlOX/NYkuQKnbato5b7NYJ3hu5ERDcHBupERERE5ThKtpTVOi9Ry7Yoiq2pu0ZUrxRFhtVaWBoUlQvKKwTmsmyu1fFE0VAaird2Dsl1V8NyrbY1JMnQwM+MiKh+SJIektQRBkPHa7ax20vK/Q4tHd1eGraXjXy32y/Dbr+CEvsplJhOVXO+6kL3NtBqvVjTnYioGWCgTkRERC2WY6JQR3B+ddS5iSVb6KbnqCFcWBru5DmVMTBbLsBkykP2iUsA7LU6nkbjDm1poKPTtikNe9qUC3naQJJcGfIQUYsjSS5wcelU7YSqauheboS7c+h+AXb7lVqF7oKgg07XuvRDysofXOpKP9DkaHeiW58gCNizZw/Gjh3b1F1pcRioExERUYugKHZHcC6bINtLSkef127kLVFz4whnKgbleWoJAovlAhSlNiWJRGi1nmoo7hSSq4+9WH6FiOgG1D50dx7Z7gjey4L4i7Dbi6EoFpjN52E2n6/2nI667l7lgvfWzt8Y0jnW8fc7UfOUl5eHuLg47N+/H+fPn0fr1q0RFBSEuLg43H333QCAc+fOoXXr1o3eNz8/P8ybNw/z5s1r9HMDQEZGBl588UX85z//wYULF+Dn54cnnngCTz31VKP1gYE6ERER3XKujjy/Ujr6nOE53TwUxV4uIM+DxXxBHcFYFqLb7VdqdSxHnfK20OnbOu51baHVtkVJiRvatu0Ivd4LgiA18DMiIqKaOEL3znBx6XzNNrJsdkzybKk4CfTvVyeGtlyELJeU1nU/A5PpTLXnFUUDtJpW0Gg9oNG0Kn3cClpN6bK2FTQaj9J1rSCKuvp+6kRUhaioKFgsFmzduhX+/v44f/48kpOTkZ+fr7bx9fVtwh7eOIvFAp2u7r9Tvv32W/j4+CAxMRGdO3fGF198gZkzZ0KSJMyZM6cBelqZoCiK0ihnukkUFhaiVatWKCgogIeHR1N3p17Jsozc3Fz4+PhAFMWm7g7RLYPXFlHDqO215ah5blKDc7t8xRGe85841EzJshlmywVYzLmwWPIcwbk5F2ZLbmlgfhFAzWWHJMlNnchOp/MurbXrfXWdtg1EUVvF+RVcvHgFXl6uEEWWaCGqL7y2qLmw20vUcN0RvJcG7pbSEL50W+2+yeRMFA2lIXurKoJ4D2g1rSBJRkgaN0iiCyTJDaKou6GSYA11bYmSAUa3nvV2vObkVs626spkMiE7OxvdunWDwXBzzONy6dIltG7dGikpKRgyZMg121Us+fLFF1/gT3/6E37++Wfceeed+Mtf/oJx48bhv//9L4KDg5GSkoKhQ4fik08+wcKFC/HTTz8hODgYmzdvRq9evQAAWVlZePrpp/HVV1/h8uXL6N27N1544QXcf//9AICwsDB8/vnnTv1QFAXLly9HUlIS0tPT1fUbNmzAhg0bcOLECQBAdHQ0Ll26hP79+2Pjxo3Q6/XIzs7G6dOn8cwzz+Djjz+GKIq455578Morr8DPz6/Wr9ns2bNx7NgxfPrpp7Xep6K6vFc4Qp2IiIhuKna7GbJcfuQ5a55T82KzFVcIystGmufBbMmFzVZQ4zEEQaMG5fryIXm5x6yPS0REVZEklxonU1UUBXb7FdhshbDaCmCzFpQ+vgSbtXSdraDc40Ioig2ybILZbKqx5Ex5gqAp7ZMrJMmt9L7yY8011guCARwLSvVJURSU2Eoa/bwuGpdafbhkNBphNBqRlJSEu+66C3p9zaWZCgsLERERgdGjR2PHjh04efLkNUuyLFmyBOvXr4e3tzeeeOIJTJ8+HWlpaQCA4uJijB49GvHx8dDr9di2bRsiIiKQmZmJLl26YPfu3QgKCsLMmTMRExNTp+cPAMnJyfDw8MDBgwcBAFarFeHh4Rg0aBBSU1Oh0Wjw/PPPY+TIkTh69GitR7AXFBTAy8urzv25XgzUiYiIqNmSZSus1gIoikkdha4otZtEkaih2O1XYDbnOmrYWs7DbM6FxXxeHWFem3IsomiAXucDnd67NDR3PHaE5z7Qaj0hCPzWExERNQxBEKDRuEGjcYMB7Wts7wjgL5eG7oWwWS85HlsdwbtjXQGstgLY7ZdLbyUAFCiKDTZbEWy2ohvpMU6e0kIUNRAELURR67gXtBAqrhO1EARN6Tateu9or1HXiZILjMbb4Nsu4gb6RTejElsJBu4Y2Ojn/Xry13DVutbYTqPRYMuWLYiJicGmTZsQEhKCIUOGYNKkSQgMDKxynx07dkAQBLzzzjswGAwICAjAmTNnqgy94+Pj1ZHvixYtwpgxY2AymWAwGBAUFISgoCC17cqVK7Fnzx7s3bsXc+bMgZeXFyRJgru7+3WVnHFzc0NCQoIalCcmJkKWZSQkJKgfNmzevBmenp5ISUnBiBEjajzmF198gZ07d2L//v117s/1YqBOREREzYKiyOVqnl+G1XoFJlMhSkr41XlqXLJsKR1dfl6d+M1sKQ3Qzbmw22sOBDQaj6ujy/U+To/1Om9IkvGGvv5ORETUmBwBvBEajREGdKjVPmVz2tjsl53+jed4fAV2W7nH5dbbyrexX4GjDJoCRbHAbq97mZrquBi6MFCnZikqKgpjxoxBamoqvvrqKxw4cABr1qxBQkICoqOjK7XPzMxEYGCgU6mSAQMGVHns8qF8+/aOD9Ryc3PRpUsXFBcXY/ny5di/fz/OnTsHm82GkpISnDp1ql6eV58+fZxGnWdkZOD48eNwd3d3amcymZCVlVXj8X744QdERkZi2bJltQrf6wsDdSIiImoSsmwu9x9XV2CXTU51z/nVXmoojkk/89Wg3FIhNLdaL9Z4DI3GHTpdO+j1PtDr20Ff+thRksUbknRz1OgkIiJqKIIgqqVbrpeiKLDZSpCffxGtWmkBwQZFtkJWrFBkKxTFClm2OsrRlK67em+72qbCOlmxQlFkuLp2rcdnTDcLF40Lvp78dZOcty4MBgOGDx+O4cOHY+nSpZgxYwaWLVtWZaBeF1rt1Tl2ygZ4yLKjhGZsbCwOHjyIdevWoUePHnBxccH48eNhsVT/YZYoipX++81qtVZq5+bm5rRcXFyM0NBQbN++vVJbb2/vas/5008/4b777sPMmTPxl7/8pdq29Y2BOhERETW4iqPPHaVbbE3dLbqF2e1mmC05MJtyYDY7biZzDszmc7BY8mosHSSKBkdQrm9XWo7FpzQ0d9xYv5yIiKjhCYIASXKBRtMaej0nJaX6IQhCrUqvNDcBAQFISkqqcluvXr2QmJgIs9ms1lw/fPhwnc+RlpaG6OhojBs3DoAj8C6bVLSMTqeD3e78b2lvb2/k5ORAURQ1pC8/Qem1hISEYOfOnfDx8anTBLo//vgjhg0bhqlTpyI+Pr7W+9UXBupERERU72oafU5UH2y2IphM59TAvHxobrX+Xu2+jkk/fSqPMC99rNG4syQLERERETW6/Px8TJgwAdOnT0dgYCDc3d1x5MgRrFmzBpGRkVXuM3nyZCxZsgQzZ87EokWLcOrUKaxbtw4A6vRv2p49e2L37t2IiIiAIAhYunSpOnq9jJ+fHw4dOoRJkyZBr9ejbdu2CAsLQ15eHtasWYPx48fjww8/xIEDB2oMyadMmYK1a9ciMjISK1asQKdOnXDy5Ens3r0bCxYsQKdOnSrt88MPP2DYsGEIDw/H008/jZycHACAJEk1jmqvLwzUiYiI6IZw9Dk1FEWRYbVedITkpcG5qVx4brdfrnZ/SXKDXu8Lg7499Hpf6A2+pcu+0Gq9OOknERERETU7RqMRAwcOxMsvv4ysrCxYrVZ07twZMTExePbZZ6vcx8PDA/v27cOsWbMQHByMPn36IC4uDpMnT3aqq16Tl156CdOnT8fgwYPRtm1bLFy4EIWFhU5tVqxYgccffxzdu3eH2WyGoijo3bs33njjDaxatQorV65EVFQUYmNj8fbbb1d7PldXVxw6dAgLFy7EQw89hKKiInTs2BH33XffNcP4999/H3l5eUhMTERiYqK6vmvXrpVG0zcUQWGBUieFhYVo1aoVCgoK6vRVg5uBLMvIzc2Fj48PRJH/AUlUX3htUUsjyzbnyaPkkgYZfS7LCi5evAIvL05Keitz1EYthMl0FibzWZhMZ2E2nYHJfA4m0zkoSvX1GrVaLzUkd4Tm7dVljca92n1bKl5bRA2D1xZRw2ioa+tWLvlyK2dbdWUymZCdnY1u3brVKVi+FWzfvh3Tpk1DQUEBXFxYrrAmdXmvcIQ6ERERVausfIvN5gjRZdnc1F2im5DdXuIUmjuCc8dydSPNBUEqLc1SLjTX+8JgaA+drh0kSd+Iz4KIiIiIqHnatm0b/P390bFjR2RkZGDhwoWYOHEiw/QGcEsF6r/88gv+/Oc/Iy0tDRaLBYGBgVi5ciWGDh3a1F0jIiK6adjtptLR55dhs1+BIleenZ2oKrJsdZRlUUeYXw3Nq69pLkCnawuDoQMM+g7QGzpcfaz3gSBIjfYciIiIiIhuRjk5OYiLi0NOTg7at2+PCRMmNMmEnS3BLRWoP/DAA+jZsyc+/fRTuLi4YMOGDXjggQeQlZUFX1/fpu4eERFRs6MoSmn5lqslXBTFXvOO1KLZbIUoKfkNJtNvKDH9BlPJbzCZzsBsyQMgX3M/jaaVIyg3dIBB3xF6Q/vSx74QRY40J6IGUDoRm4CyMhEV7xWne6VsmZVRiYjoJrNgwQIsWLCgqbvRItwygfqFCxfw66+/4t1330VgYCAA4MUXX8Qbb7yBH374gYE6ERERAEWxO8q32C/DbrsCu3yFoQFVSVEUWCwXrobmpcF5iek32GwF19xPFF3Kheal94aO0OvbQ6Nxa8RnQEQNShAgQAT+n71/j7qkqu/88dfeVef63Fu6Abk1F4Og0AgKouMCo6gDi6ACLoIzE+QrRE1WBpShMUhLQPQXvM9aOhlllsoSZmVWBhgNoyOSEBgMBoyAiREjIu0gfZHu53KuVbX3/v2xd9Wpc55znkv38/Rz6f2C03Wvs+s85/qqT723kAik6+RXIoQAhJsWXfOybRB91hO5joLTbdJ1YbYId6JczDd//+h0OdYj3vvM11rTaOxmaOhlSCkwRrvlJhvPhhj3+avduHb7dPPcMntfGoN262gMyn92ezwej8ezgqwbof6yl72ME088kTvvvJPTTz+dUqnEf/2v/5VNmzZxxhlnDNyu3W7TbneyYNOea7XWaD24wmotorX9YrbejsvjWWn8a8uzmjFGkST1XAV6c6WbtGCMMdnNv7yWD2MS2u0dHWme3V5A69bA7YrFjZTLR9pb6Qg3fgRhODZQZGntBdBqwL+2Dk6EkCACJ79DhBAuTsnJcCfGuwW5ldwdWd4ZduT3yjLbK/cK76WmV+Dn0e6xLbrHaJmaQPo6Vlj5rrvGrbhXs0V8z/p2mXLbeDyrl2X73BLr9zfcej0uj2e1sG6EuhCC73//+7zzne9kZGQEKSWbNm3iu9/9LhMTEwO3+9SnPsWf/dmfzZq/e/duWq3BPyLXIlprpqamMMYg5er4AuzxrAf8a8uzmtBaoXUbrVtuuHY7ENUaarUIYwT+pbX/GBMTxy8SRb8mil8gjl8gjn9DHO8EBsX8BBQKh1IoHEGh8HKKhZe78cORsty1ZhzbG6ydkzYHK/61tQbpquwOeqq/+wlvkY131lmI3TXY9wMf/bUvrM7vhAII3K3Qd42OnO8eWtHeX8bbKnvtK+U9B4Tl+twSMqFR37V0O1xFzMzMrHQTPJ51zaoX6jfccAN//ud/Puc6//Iv/8KJJ57IH/3RH7Fp0yYeeeQRKpUKd9xxBxdeeCGPP/44hx9+eN9tP/rRj/LhD384m56enuaoo45i48aNjI6OLumxrDRaa4QQbNy4cRV9wfN41j7+teVZSbROsurzRNXRKn8yOACqK9W0/cYYgxCGDRsqS3bp/sGAMYp2exet1naazedpNrfTbD1Pq/UbBuWbS1mmXD6iU3FePpJK+UhKpcMQYtV/XfQsEv/aWlmsEA9cJXNaLR7khkHP/MB3zLtGOBi/E1rxPuiWuJtCmwSj7bTHs1iW63NLBmWGhzYt2f5WE+Vyef6VPB7PPrPqfyF95CMf4YorrphzneOOO46/+Zu/4a//+q/Zu3dvJsK//OUv88ADD/CNb3yDG264oe+2pVKJUml2J1hSynX5JUgIsW6PzeNZSfxry3OgsAK9PkCgg5TrR45pjauyFOvquJYKYwxxvLcjzZvP02hup9XajtZR322CYIhK5WgqlaMzaV6uHEmxcIgXqwcR/rW1dHSEd6EjxaUbMkiW+8d8PXPwfSeUDKp8H4TWiRPucU689wh43Vnm8SzX55aUYt2+VtfrcXk8q4VVL9Q3btzIxo0b512v0WgAs980pJQ+O8rj8Xg8a5b5BLrn4CBJak6ab++S50r1v5xXiCKVypFUKsdQqRxDtXI0lcoxFAobvMzzeOZCCGQmx3OiXBaQmRgPc8v868njWSxShlgVMbuwrR9ap6I9zlW7x5mA99XvHo/H4znQrHqhvlDOPvtsJiYm+IO7LYtCAAEAAElEQVQ/+AO2bdtGpVLhq1/9Ks899xwXXHDBSjfP4/F4PJ4F0elEtOYF+kGIMZpW+0UajedoNJ6j2XiORvN54vilAVtIyuXDnTg/OpPnNqrFR0R4PEAuPsXepCx0TQsRIGVn3OPxrC46An7uCAubBZ90RHtOutvpVMonviNWj8ezLhBCcO+99/LOd75zpZty0LFuhPohhxzCd7/7XW688UZ+93d/lziOedWrXsX/+l//iy1btqx08zwej8fj6Ysx2lafJzVXie47dDxY0LpNo7mdZuM56o1fWoHefB6t+59EKRYPoVI+mkrVyvNq5RjK5SORsniAW+7xrA5svEqIzMtxWchNF5wo95Lc4zkYsJEgBRYSQWM7V427qt87le6xr3r3eDwrzu7du9m2bRv3338/O3fuZGJigi1btrBt2zbe+MY3AvDiiy8yMTFxwNu2efNmrrnmGq655poDft8AL730Eu9973t5+umneemll9i0aRMXXXQRn/zkJw9Yf5jrRqgDvPa1r+X//J//s9LN8Hg8Ho9nIMaYToRLUkfpBhiz0s3yLDNJMk2j8Rz1XOV5s/X/6NdJqJRFKpXNVKvHUq1splLZTKVyFGE4fOAb7vGsAN1V5AU3HuQEeejjVjwez35hr1wpIeXcsTO26j2eVeHeNe4q4P33OY/Hs5RcfPHFRFHEN77xDY477jh27tzJgw8+yEsvda5cPeyww1awhftPFEUUi4svDpJSctFFF/GJT3yCjRs38otf/II/+qM/Ys+ePdx9993L0NLZrCuh7vF4PB7PasMYg9bNLMZFqYa/zHgdY4whina5yBZbdd5oPkcU/bbv+mE4asV59TiqlWOpVo+lXH65r6j1rEs60SuFTJjbYe+4F+Uej2d1YKvei0CRYJ6P5u6s996IGZWLoFEHpO0ej2cwxhhM88BfGSwqlQV9z5mcnOSRRx7hoYce4pxzzgHgmGOO4cwzz+zeX0/kyw9+8AM+9KEP8bOf/YxXv/rVfOxjH+Nd73oXP/7xjznttNN46KGHePOb38z3v/99tm7dyk9/+lNOO+00vva1r3HiiScC8Oyzz/LhD3+Yxx57jHq9zkknncSnPvUp3vrWtwJw7rnn8vzzz3Pttddy7bXXAvbxvPnmm7nvvvt48skns/Z94Qtf4Atf+AK/+tWvALjiiiuYnJzkda97HV/60pcolUo899xz/PrXv+YjH/kI3/ve95BS8qY3vYkvfvGLbN68ue/jMzExwQc/+MFs+phjjuFDH/oQn/70p+d9bJcKL9Q9Ho/H41lilGqRqBoqSQW6/+G0HjFG026/SL3+C+r1X1iB3nwOpRp91y+VDusS59XqcRQKE14eetYF+apyKYs9eeWdKnOPx+NZryw8610PyHVXs3LffRGGx7M8mGaTZ04/44Df74n/+CNEtTrvesPDwwwPD3Pffffx+te/nlJp/k6cp6enufDCCzn//PO5++67ef755wdGstx444189rOfZePGjXzgAx/gyiuv5NFHHwWgVqtx/vnnc9ttt1Eqlbjzzju58MILeeaZZzj66KO555572LJlC1dffTVXXXXVoo4f4MEHH2R0dJQHHngAgDiOefvb387ZZ5/NI488QhiGfOITn+Ad73gHTz/99IIq2H/zm99wzz33ZCcfDgReqHs8Ho/Hs59o3c4y0JOk7vM21yFp5Xm9/iz1xr86gf5sX3kuRGgzzqvHOnl+HNXqZoJg/i/PHs9qRIjAZZMXMlneLcoLCCFXupkej8ezJrBX6yys6t1K9lS6q0y8d4S7cpEzysfOeDzriDAM+frXv85VV13FX/zFX3D66adzzjnncNlll3Hqqaf23ebuu+9GCMFXv/pVyuUyJ598Mi+88EJf6X3bbbdl8vmGG27gggsuoNVqUS6X2bJlS1dflLfeeiv33nsv3/rWt/jjP/5jNmzYQBAEjIyM7FPkzNDQEHfccUcmyr/5zW+iteaOO+7ICo2+9rWvMT4+zkMPPcTb3va2gfv6/d//ff7X//pfNJtNLrzwQu64445Ft2df8ULd4/F4PJ5FonWCUrUsxkXraKWb5FliomgP9cYvaLjq83rjFyTJ9Kz1hChSrR7L0NArGKoeR7V6HOXyEUg5f4doHs9qwIqdVIwXXUZ5ftrLco/H41kphAgIggCYvzoVyMS6lfD9BHw6rXwFvOegRlQqnPiPP1qR+10oF198MRdccAGPPPIIjz32GN/5zne4/fbbueOOO7jiiitmrf/MM89w6qmnUi53rpLpjYhJyUv5ww8/HIBdu3Zx9NFHU6vVuPnmm7n//vt58cUXSZKEZrPJ9u3bF9z2uTjllFO6qs6feuopfvGLXzAyMtK1XqvV4tlnn51zX5///Of5+Mc/zs9//nM++tGP8uEPf5gvf/nLS9LO+fBC3ePxeDyeeTBGu+rzGomqoVVrpZvkWUKSZNpWntf/lXrDCvQ43jNrPSECKpVjnDw/gaGhE6hUjvYxFp5VTaeyPK0oLwIhjcYUIyOHEwT+5I/H4/GsF2wHzsG8na2m2PgZ5cS6ysl2O8+gIFsn6ayPhmw7j2ftIYRYUPTKSlMulznvvPM477zzuOmmm3j/+9/Pxz/+8b5CfTEUCp3vf2lVuNb29XzdddfxwAMP8JnPfIYTTjiBSqXCJZdcQhTNXUQmpcT0XCUTx/Gs9YaGhrqma7UaZ5xxBnfdddesdTdu3DjnfR522GEcdthhvPKVr2TDhg286U1v4qabbspOEiwnXqh7PB6Px9NDpyNRF+Oi6v4S2nWCUs2s4rxetxXo7WhnnzUllcqRmTivVk+gWt3sZKTHs0oQAik6orw7hmVwdbnWGimb/mSQx+PxHOTYq5T2/SokY4zrK0jlsuE1oN3QOME2aFq7/Wgn6TUG4753ay/sPZ4eTj75ZO67776+y0488US++c1v0m63s8z1xx9/fNH38eijj3LFFVfwrne9C7DCO+1UNKVYLKJUdz9hGzduZMeOHRhjMkmf76B0EKeffjp/+Zd/yaZNmxgdHV10e1PSEwLtdnuf97EYvFD3eDwejwdQqo1SMy7Gpe47El0HGGNot39DrfYMtfoz1GrP0GxuJ/3xlqdUejlDQ8czVH0FQ0PHU60eRxAs/JJMj2dZcMLc5pZbQd4tywu+U1uPx+PxrBhCCIRIO2NdHmyhS0KjsZPh4Y1I2e8EwFyFL3Mt85+hntXJSy+9xKWXXsqVV17JqaeeysjICE888QS33347F110Ud9tLr/8cm688UauvvpqbrjhBrZv385nPvMZgEV9X3zFK17BPffcw4UXXogQgptuuimT1SmbN2/m4Ycf5rLLLqNUKnHIIYdw7rnnsnv3bm6//XYuueQSvvvd7/Kd73xnXkn+3ve+l09/+tNcdNFF3HLLLRx55JE8//zz3HPPPVx//fUceeSRs7b53//7f7Nz505e97rXMTw8zD//8z/zn/7Tf+KNb3wjmzdvXvCx7g9eqHs8Ho/noETrOItxUaruc9DXAbb6/F8zgV6vP0OSzMxar1g8pCu2pVo9njAcXoEWezw4WZ5WmBdzwrzos/g9Ho/Hc9BjpX2AlKE7sez79fCsf4aHhznrrLP4/Oc/z7PPPkscxxx11FFcddVV/Omf/mnfbUZHR/n2t7/NBz/4QU477TROOeUUtm3bxuWXX96Vqz4fn/vc57jyyit5wxvewCGHHMLWrVuZnu7uS+qWW27hD//wDzn++ONpt9sYYzjppJP48pe/zCc/+UluvfVWLr74Yq677jq+8pWvzHl/1WqVhx9+mK1bt/Lud7+bmZkZjjjiCN7ylrcMlPGVSoWvfvWrXHvttbTbbY466ije/e53c8MNNyz4OPcXYXoDbg5ypqenGRsbY2pqar8uNViNaK3ZtWsXmzZt8h9CHs8S4l9bawOfg7720NqwZ0+DDRuqSNldVbHQ6nMhCgxVj2do+ESGh09keOiVFIsbDuBReA52hEgFQBEhi1nFeVp1vhIV5v5zy+NZHvxry+NZHvxra/GsZ7e1WFqtFs899xzHHnvsosTyeuCuu+7ife97H1NTU1QW0SHqwcpiniu+Qt3j8Xg86xal0hz0ms9BX+PY6vOf5wT6z1GqX/X5RoaHTrQCfehEqtVjfZWvZ3kRAplVlKfSPF9t7nPKPR6Px+PxeDzLz5133slxxx3HEUccwVNPPcXWrVt5z3ve42X6MuCFusfj8XjWDVpHHYGe1DEmWekmefYBYwztaCcz0z/lpZf+iR07fzm4+nzoBCfQf8dXn3uWDSFkR5QHpS6B7juq9Xg8Ho/H4/GsBnbs2MG2bdvYsWMHhx9+OJdeeim33XbbSjdrXeKFusfj8XjWLMYo14lojSSpofWB6dHbs7QYo2k2tzNT+ym1mZ8yU/spcbxn1nq++tyznNholm5R7rPMPR6Px+PxeDxrheuvv57rr79+pZtxUOCFusfj8XjWDMYYtLYxLklSQ+mGj3FZg2gdU288m8nzWu1fUKretY4Qoe0sNDiBl73sVYyM+Opzz/5jpXnJ3XrluY9m8Xg8Ho/H4/F4PPPjhbrH4/F4VjVatzsCXdUxRq10kzyLRKkmtdrPsgr0Wv1fMSbqWkfKMsPDJzIyfDLDwyczNPQ7CFFkz54GExOzOyX1eAYhROAkeWnW0Etzj8fj8Xg8Ho/Hs794oe7xeDyeVUV3jMsMWkfzb+RZVcTxVFd8S6PxHL3552E4yvDwyYwMn8zIyMlUq8fOkp1a+6sPPAPIOgKdLc19PIvH4/F4PB6Px+NZTrxQ93g8Hs+Ko1TDx7isYdrt3czU/ikT6K3WC7PWKRY32urzESvRy+UjEcJXnXvmphPJ0i3OhSj654/H4/F4PB6Px+NZEbxQ93g8Hs8BR+uYJJlxVeh1jElWukmeRRBFLzE98xNmZn7CzMw/0W7vnLVOpXy0k+cnMTxyMqXixhVoqWdNkK82D0oEsoSUZRfRIle6dR6Px+PxeDwej8fThRfqHo/H41l2jNEoVXdV6DNo3V7pJnkWQRTtYWbmn5iZ+QnTM/9Mu/2bnjUkQ0PHMzL8KifRX0kYjq5IWz2rFyFkrkPQjjS3Fee+2tzj8Xg8Ho/H4/GsDbxQ93g8Hs+yoFSLRNVQyQxKNTBGz7+RZ1UQx5PMzPwT006iz45wkVSrxzE68mpGRk9hZPhkgqCyIm31rD6ECDvSPKs4t+Lc4/F4PB6Px+PxLA1CCO69917e+c53rnRTDjq8UPd4PB7PkqB14iJcaiSqhtHxSjfJs0DieJqZ2j8xM/1PTM/8hFbr1z1rCKrVYxkZeTWjI69mePhkwnB4RdrqWT0IESBlmSAo91Sc+6+XHo/H4/F4PB7P/rB79262bdvG/fffz86dO5mYmGDLli1s27aNN77xjQC8+OKLTExMHPC2bd68mWuuuYZrrrnmgN93Ly+99BJbtmzhhRdeYO/evYyPjx+Q+/W/eDwej8ezTxhjbGeiagaV1FCqudJN8iyQJKl1VaA3m8/PWqdS2Wwr0EdezcjIqwjDkRVoqWc10IlqKSODci7jvLDSTfN4PB6Px+PxeNYlF198MVEU8Y1vfIPjjjuOnTt38uCDD/LSSy9l6xx22GEr2ML9J4oiisX9u4r1//v//j9OPfVUXnih96rq5cX39OTxeDyeBaN1RBTtodF4nlrtX2g0fknU3u1l+ipHqTZTUz/m17/+Ov/80w/z4yf/Pb949v/Hrl1/ncn0SvloNm08n+OPv57TttzJq1/1BY4++v1MTLzey/SDBSGQskShMEapdCiVyjEMD/8OIyOvYmjoBCqVIykVDyEMR7xM93g8Ho/H4/GsWYwxxG11wG/GmAW1b3JykkceeYQ///M/581vfjPHHHMMZ555Jh/96Ef5vd/7vWw9IQT33XdfNv2DH/yA0047jXK5zGtf+1ruu+8+hBA8+eSTADz00EMIIXjwwQd57WtfS7Va5Q1veAPPPPNMto9nn32Wiy66iEMPPZTh4WFe97rX8f3vfz9bfu655/L8889z7bXXIoTI+kK6+eabOe2007qO4wtf+AKbN2/Opq+44gre+c53ctttt/Hyl7+cE088EYBf//rXvOc972F8fJwNGzZw0UUX8atf/Wrex+m//Jf/wuTkJNddd92CHtelxFeoezwej2cgnc5EZ0iSmu9MdI1gjKJef5bpmaeYnn6aWu1fMCbpWqdcPoKRkVOyKvRCYXxlGutZEaQsuozzMoEsZ3EtvnNQj8fj8Xg8Hs96J4k0X/mPf3fA7/fqL55DoRTMu97w8DDDw8Pcd999vP71r6dUKs27zfT0NBdeeCHnn38+d999N88///zASJYbb7yRz372s2zcuJEPfOADXHnllTz66KMA1Go1zj//fG677TZKpRJ33nknF154Ic888wxHH30099xzD1u2bOHqq6/mqquuWtTxAzz44IOMjo7ywAMPABDHMW9/+9s5++yzeeSRRwjDkE984hO84x3v4Omnnx5Ywf7Tn/6UW265hR/+8If88pe/XHQ79hcv1D0ej8fThVJtF+PiOxNdKxhjaLdfZHr6Saamn2Zm5icoVe9ap1B4GWOjWxgd3cLIyCkUixtWqLWeA4oQTphXCIKSG5YRYv4v8h6Px+PxeDwej+fAE4YhX//617nqqqv4i7/4C04//XTOOeccLrvsMk499dS+29x9990IIfjqV79KuVzm5JNP5oUXXugrvW+77TbOOeccAG644QYuuOACWq0W5XKZLVu2sGXLlmzdW2+9lXvvvZdvfetb/PEf/zEbNmwgCAJGRkb2KXJmaGiIO+64IxPl3/zmN9Fac8cdd2TFPV/72tcYHx/noYce4m1ve9usfbTbbX7/93+fT3/60xx99NFeqHs8Ho/nwGOMIklsFbpSNbSOVrpJngUQx5NMTz+dVaFH0e6u5UFQtRXoTqKXSy/31cfrHCFC10FomSCo+Kpzj8fj8Xg8Ho+nD2FRcvUXz1mR+10oF198MRdccAGPPPIIjz32GN/5zne4/fbbueOOO7jiiitmrf/MM89w6qmnUi6Xs3lnnnlm333npfzhhx8OwK5duzj66KOp1WrcfPPN3H///bz44oskSUKz2WT79u0LbvtcnHLKKV1V50899RS/+MUvGBnpjhlttVo8++yzfffx0Y9+lJNOOol/9+/+3ZK0aV/wQt3j8XgOQpRqZjEuSjdggVlunpVDqSYztZ8yPW0FerP5q67lQoQMD7+S0REr0IeGjvdVyOsYKYuZNLfDElLuX4c+Ho/H4/F4PB7PwYAQYkHRKytNuVzmvPPO47zzzuOmm27i/e9/Px//+Mf7CvXFUCh0+kNKi2+0tlemX3fddTzwwAN85jOf4YQTTqBSqXDJJZcQRXMX3kkpZ2XEx3E8a72hoaGu6VqtxhlnnMFdd901a92NGzf2va+/+Zu/4Sc/+Ql/9Vd/BZDd7yGHHMKNN97In/3Zn83Z1qXAC3WPx+M5CNA6QalaJtF787Q9qw+bg/6vmUCv1Z+Z9XerVo7NKtCHh08iCMoD9uZZqwghnSz3kS0ej8fj8Xg8Hs/BzMknn9zVCWmeE088kW9+85u02+0sc/3xxx9f9H08+uijXHHFFbzrXe8CrPDu7SC0WCyilOqat3HjRnbs2IExJpP0aWeoc3H66afzl3/5l2zatInR0dEFtfF//s//SbPZzKYff/xxrrzySh555BGOP/74Be1jf/FC3ePxeNYpSjU6VeiqsdLN8SyAdnsnU9NPMj31Y6Znnp71dysWNzI6epqV6COnUCiMrVBLPcuCyzsPgqqrPK/6yBaPZx2SVoAZY7LbQqbTeUsxnk7P9/4y1/JBy9L5QoiB4wudl45LufBL5D0ej8fjWeu89NJLXHrppVx55ZWceuqpjIyM8MQTT3D77bdz0UUX9d3m8ssv58Ybb+Tqq6/mhhtuYPv27XzmM58B5v487+UVr3gF99xzDxdeeCFCCG666absu0vK5s2befjhh7nssssolUoccsghnHvuuezevZvbb7+dSy65hO9+97t85zvfmVeSv/e97+XTn/40F110EbfccgtHHnkkzz//PPfccw/XX389Rx555KxteqX5b3/7WwBOOukkxsfHF3ys+4MX6h6Px7NOsFXoVqD7KvS1gVItZmb+ianpHzM99WNa7d90LQ+CYUZHT3UC/VRKpcO8XF0vCIGUJQJZJQg6Et3/fT2elcMYg9a6S2Tnbwtdlu6r37Rn30kFe7+blHKflqfzPR6Px+NZTQwPD3PWWWfx+c9/nmeffZY4jjnqqKO46qqr+NM//dO+24yOjvLtb3+bD37wg5x22mmccsopbNu2jcsvv7wrV30+Pve5z3HllVfyhje8gUMOOYStW7cyPT3dtc4tt9zCH/7hH3L88cfTbrcxxnDSSSfx5S9/mU9+8pPceuutXHzxxVx33XV85StfmfP+qtUqDz/8MFu3buXd7343MzMzHHHEEbzlLW9ZcMX6SiCM/2bXxfT0NGNjY0xNTa3qP9y+oLVm165dbNq0yVd5eDxLyEq9towxKNXIolyUas6/kWdFMUbTbP6KqaknmZr+MbXav/Sc+JAMD5/I2OhpjI6+5qDPQdfasGdPgw0bqki5toWHlCWCoFee+89iz8qw3r4TpjJ7scN+Itxz8JEX61LKRY/nWW+vLY9nteBfW4tnPbutxdJqtXjuuec49thjFyWW1wN33XUX73vf+5iamqJSqax0c1Y9i3mu+Ap1j8fjWUNoHfdkoav5N/KsKHE8mcW4TE0/RZJMdi0vFjcxNvYaxkZfw8jIqwnD4ZVpqGfJsPK8ggwqBLJCEFS8PPd45kEplQnu3tt8ctzj2R9sgcK+f5/KC3YhBLVajVKpRBiGSCkJgiBbJ715PB6Px7Mc3HnnnRx33HEcccQRPPXUU2zdupX3vOc9XqYvA16oezwezyomrUJP1Awqqfkq9DWA1jG12s9sjMv0kzQav+xaLmWZkZFXZxK9VDrcX26+hhGy4KR5lSBI5fnBe1WBx9NPiOfl96D5Hs9aJX0ug/3eFkURjUZjzoz5vFzvJ9zz8/13BI/H4/EslB07drBt2zZ27NjB4YcfzqWXXsptt9220s1al3ih7vF4PKsMrWMX4VLzVehrAGMM7faLTE39I1PTTzIz809o3epap1o9jtHR1zA2ehrDw69EysIKtdazXwiRVZxbgV5FyuJKt8rjWVZSWaiU6ivEe+d75sbGy4DBYMCNA4bOfDcvHcfNx63fb5/Z+IDh7Ik+iK7B7GGP2BXZ+t0bCmHnCUAKYdcTuGm3TCyug7T1RFoRv9CqeCFEJteDIBg4frA+nh6Px+PpcP3113P99devdDMOCrxQ93g8nlWAUg0X4+Kz0NcCtjPRnzA19WOmpn9Eu72za3kYjjM2dhpjo69hdHQLhcL4yjTUs19IWXTRLVUf3eJZNxhjSJKEOI5ptezJv7lk+XpGa5OJbe3EtTYGnYptbaeNMWic8DadeXY7k5tHTpKbbP2sY9KVO9RViyAV8wIpc7IdckM7T7pIlSCbtvOkEAgJkty4cNNrvP8N6Lxm5yNf1d5PvKfTHo/H4/F49h8v1D0ej2cF0DrpyUKf/4eSZ+UwxtBq/b9MoM/M/BRj4my5ECHDwycxNvoaxsZeQ6VyjBevawwhJHJW9bm/ksCzduitGB80TGNWZmZm1lycRFrdrXISWxuD1rlxwOh0nXR5KsnJprPKcM+Kkp6AAINW6ZylRQBSCiffyeR8IDuCXkrc0E4HsjNvrbxGFnKVSBo3kxfsYRh66e7xeDwezyLxQt3j8XgOEEq1OlXoutH/um3PqkGpJtMzP7FRLlM/Iop2dy23nYmeztjY6YyOnEIQ+I5e1hK2+ryaCXQpK2tGmngOLuYT5OnQrIHPFK0Nmo4AV6ns1gaVLnfyWxuDcuNKdyrCPZ7FYrDPIbWPz6BUyAfSCvlAiky+SykIgEBKpKuST5R9Pa7Gz5SFxM0IIWZJ9t6bx+PxeDwHO16oezwezzJhjCZJXBW6msHoeP6NPCuGrUL/NZNOoNdq/9J15YAQBUZGXsXYqJXo5fIRq/LHsqcPQhDIshPoQ7763LNqSMVWXo73zlttojyt+lbaSUonxZWrFM8kuRPiqczU2gtxz9okE/J6/mewMYa42WZvUieQgjCQSAGhlFbES0HoRHzoplM5v1owxhDHMXHc/3trmune75aKeI/H4/F41jteqHs8Hs8SolSbRM2gkhkSVfdV6KscpRpMTz/N1NSPmJr+MVH0267lpdKhjI2ewdjY6YyMvJogKK9QSz2LQQiZxbakNyH8D3zPgaVXjveT5itNvmJcGW2HWqNcVXgqxTuV4poFOEXPGkD3ybzpl/Wefo0Z9GdP8+LnI+u4lE5npoPXzY2L7vnCBatn46sYbSBK0giWuaNYbOW7JJBWvmfCXUAQyEy+h3LlI2jSTPe5ct3zcr136CNlPB6Px7Me8ELd4/F49gP7o2KGKNpDrTYJ+Cr01YwxhmbzeRvjMv2Prgq9I7WEKDI68uosyqVcfvkKttazUIQIuqrPrUBf3aLFs7bpFeNJksyS5ivTLlspnlaOK2VI0gry3C3Rmlatye524F8rK0CaBd/p2NTOzzo2zS/Diu90OvPgOR+uUxGeyu2sc9SO6s5vv57Id2Ca1/ayj3i3szrrpB2bpp2eCkTXtBR23a51lun1og1opYkVzCffU7EeBsJWvgeCguweX+nX9VwnDdMM90HC3ePxeDyetYAX6h6Px7NIbIeiM8TxNErVnExpoHV1VV2y67Eo1WR6+immpn7E5NQ/EscvdS0vlV7O2NjpjI+dzsjIq5CytEIt9SwUIQuEmTwf8lcOeJacftXlvZXmBwJjUjFuK8itDLcV5YnWHUnu5PlCXanPI18Yqfi2HZ52hLXWLvqGjhhXhkxka9charptWved7sOzdORPMPTU1i/L/aUSHmwnp5l4FzY/HQwyThDENlfddXiadoiado66P6Sv+3YCMEBaC0EhEFnsTBgIQuHGc7EzK0HaeWq/SJl8nEw/4b7SJwo8Ho9ntSGE4N577+Wd73znSjfloMMLdY/H41kAtkPRaduhqGqsdHM8c2CMod3+DZOTP2Jq6kfM1P65KwtdyiIjI6faKvTR11AuH76CrfUsBClLFArDhGHV5Z/7kx6e/aNXkOcrzJVSy55brp0YT7SxESvaZpKnkjzRhkSZrPLYszi0MRgXU5MK7rQjVE1umSGT4jonwMH+PTyeXozBnjxhQCenxhAohdLxnNk2gbQV8YGrJg+clLfTuGm3HDt/MQJcG0M7Sds3SLpDGEgKrtK9EFjhXnDjKyHc83Ey7XZ71vJewe5lu8fjWc/s3r2bbdu2cf/997Nz504mJibYsmUL27Zt441vfCMAL774IhMTEwe8bZs3b+aaa67hmmuuOeD3ndLvff+///f/zmWXXXZA7t8LdY/H4+mDMRql6rZD0WQGraOVbpJnDrSOmJn5ZyannmBq6ke02zu6lpdKhzE29lrGx85wVejFFWqpZyFIWSIMhxGiQrncYHj4cJ+56lkUxpguUd47XA5hnq8mT4y2cSv9pLnSvjp8HnTWsWmuOlybLvmtNVn+e9pRqlkPItwAxh2E0QidTttnjciXZGuTboDoZLt0htl+3D9uW5GOz7pv0388h1jAOt0b2B+7pisMXXQP+62fBrNkeS4uvwXhslvszQgA2ZlOJbCQgMDIdNwNV4lztc9T+/6wGPKdmAZCWDEvbfV5Wv2+0OrzNOM9GlDpPki4F12V+0oI97miZLxs93g8642LL76YKIr4xje+wXHHHcfOnTt58MEHeemlzhXXhx122Aq2cP+Joohicd9/m3/ta1/jHe94RzY9Pj6+BK1aGF6oezwej0PrOBPoStUwZq3/Kl/ftNu7XIzLj5iZebrrpIcQISMjr2Js7AzGx86gXD5iBVvqmQ8pi4ThSJaBLmUBsJeFSzm7Qs3jAfv8GCTMlzrDPF9RnihNYmwFudKaRKXS3GvyPGnkidI28kRpk510yOYb3LTpWm/VYu29lcraSm6h03FtpXZumbP/HYHtbiIdxyDcPruk9/I0PktBEeie3kYzG58bz5PLs6FHqve0Ob/MLKXEdFI922cq17u7MO3cRM92XYI+sCNSYGQq3iW4E7fZuJAdSS8Cu76w43aeTPNfDhhKu8r4BbzF9ZPvcta8wWJ8IcK94OJkCmmUzAoKdy/bPR7PYjDGkPS5Ema5CUulBb3vTE5O8sgjj/DQQw9xzjnnAHDMMcdw5plndq3XG/nygx/8gA996EP87Gc/49WvfjUf+9jHeNe73sWPf/xjTjvtNB566CHe/OY38/3vf5+tW7fy05/+lNNOO42vfe1rnHjiiQA8++yzfPjDH+axxx6jXq9z0kkn8alPfYq3vvWtAJx77rk8//zzXHvttVx77bWAfTxvvvlm7rvvPp588smsfV/4whf4whe+wK9+9SsArrjiCiYnJ3nd617Hl770JUqlEs899xy//vWv+chHPsL3vvc9pJS86U1v4otf/CKbN2+e83EaHx9fsZMKXqh7PJ6DGqWaTqJPo1RzpZvjmQOtE2r1nzE1+QRTU/9Is7W9a3mh8DLGx85gbOwMRkdPJQgqK9RSz3xIWSQIhgnDIYJgKBPoHk8vqSTPi/J0fKlyzK0Ut1XlSaJRBmKVj17RrGbHeyCYVTGuu8X47Plm5R+ztNLbaCu9jbbyWuuO0NYqW0+kzyedG0/nm+UU3ZDK7kx0G9sdadeyXMV5R1qn6+V6KHXV7CIT5YMk+fKz+jVlXtKLXAW7AGRnmRCYbFl6tZTsVNMHoZXsrkNNEYKg7uZLCAK7fSAxMugS9MvJQuV7GjETBjIT74G0onyuindtoJ3ogVnugbQ57oVAupvIhsEBvurMy3aPx9NL0m7zn//gkgN+v3/yjb+iUJ6//6fh4WGGh4e57777eP3rX0+pNH/k5fT0NBdeeCHnn38+d999N88///zASJYbb7yRz372s2zcuJEPfOADXHnllTz66KMA1Go1zj//fG677TZKpRJ33nknF154Ic888wxHH30099xzD1u2bOHqq6/mqquuWtTxAzz44IOMjo7ywAMPABDHMW9/+9s5++yzeeSRRwjDkE984hO84x3v4Omnn56zgv2P/uiPeP/7389xxx3HBz7wAd73vvcdsPduL9Q9Hs9BRRrlEsfTJGoGo2d3iORZPcTxXqam/pHJqR8xPf1kT369ZHj4lZlEr1SO8T98VilWoA/lBLqP3PF0SCvN87dUnO9vNEtaWR5rK8sTl1MeK22ryhfRked6wcbh2Mp6FSuMES5WxfSV42m2+AFFzyHC3TJMrro7leAmv84BaLTRrvpc5yR4vgrdtadXfGfSe2WF9/7QeXi7q9VNz6y+qy3qfmZvuN+f9aJr4AraeyvdXYrMvuy8VMZEcVbhDoET89JF0kh7kwEmCO1NBiCllfLCVsjbSvkAIyUmkCDDZTlLYQz2qhs92LxL1/lqP+k+qNI97Ty1Fc8++ZlWt+dle5iT7geShcj2fsLdf+f0eDzLSRiGfP3rX+eqq67iL/7iLzj99NM555xzuOyyyzj11FP7bnP33XcjhOCrX/0q5XKZk08+mRdeeKGv9L7tttuyyvcbbriBCy64gFarRblcZsuWLWzZsiVb99Zbb+Xee+/lW9/6Fn/8x3/Mhg0bCIKAkZGRfaoOHxoa4o477shE+Te/+U201txxxx3Ze+vXvvY1xsfHeeihh3jb297Wdz+33HILv/u7v0u1WuV73/seH/rQh6jVavzJn/zJotu0L3ih7vF41j1aJ65D0WmUqvsol1WMMZp641mmJp9gcuoJGo1nu5aH4ZjtTHTsDMZGTyMMh1eopZ65ELJAGAxlEt13IurJdzSXrzpPkmSfK82N6XTemWhNnI47WX4wVZanJw7SbHFltBPiOTmeLnexJIGKUFEwZ8eJ+96gnAjvFeJKdSS40d0y/IBUg+dJ5berVM+kt+4R4jbSxT54etWJcNMT25JPkOmsY7rG86Lb0LNyOsd0TXanxBwkdCXH5GYI0buGHReADAJM1LLT2fqd9dII+HxkjUir4EljZOx4R8TbinmCAjosYIKirXwPAnBC3gROyC+DeE9PtM0n3QMpbdSMtJXtoZPuvVXuner22e//AiiENjYmq2wPO52lHkiRncr2fh2kDqpqD0OvWDyetUBYKvEn3/irFbnfhXLxxRdzwQUX8Mgjj/DYY4/xne98h9tvv5077riDK664Ytb6zzzzDKeeeirlXAV8b0RMSl7KH3744QDs2rWLo48+mlqtxs0338z999/Piy++SJIkNJtNtm/f3ndfi+WUU07pqjp/6qmn+MUvfsHIyEjXeq1Wi2effbZ384ybbropG3/Na15DvV7n05/+tBfqHo/Hsz8o1c5J9Mb8G3hWDKUaTE0/ydSkzUNPksmu5UPVV2QSfWjoBIQ4sJVLnvkRIsyqz4NgmCDwAv1gpZ8wT+ctloO5ujwfsZLodLxTQd6R43p5O+FMZbdWLitcZXK8S5QrBRg7PKBCvKuxnVgUkxPjWuUEuMpJ8UFV7AudN7ezNF1rdJdE5wW4cQK8I61NNkxXMzlZnglwc3AK7gNN9sj3nFyYvUZnPFAa1UcUz0XW92o6zIS70/Suil64SnEApK1mFyLIxo0bEhQwYQEdFKxwPwDi3b5FaOIBb/epcE+r2kPX2WkgRRYvA/ZRjBKN7Rmne2cCuirZM9keSArywMr29PNtPtneO/SV7R7P6kAIsaDolZWmXC5z3nnncd5553HTTTfx/ve/n49//ON9hfpiKBQ6kZvp+1Ja5HLdddfxwAMP8JnPfIYTTjiBSqXCJZdcQhRFffeVIqWcdWVZHM9OBBgaGuqartVqnHHGGdx1112z1t24cePCDgg466yzuPXWW2m32wuKyNlfvFD3eDzrhiSpZxI930GlZ/XRav2GyaknmJp8gpnaTzEmyZYFQZXR0dOyKJdCYXzlGurpjxCuAn2YMBz2efUHIalIiOO4S5wvNqIldtEjqSSPlXa3/e/kUzthal2lzglKjXZzczW9nTGTW+ZkZpe6N53pTIZ2rdO/3WkHnEprV13fmae1dvEqZPK8H/1iKbrHuidE3uAqhTAaoaxMLmlNpEFqY+drW4Ft17FxJAI6nTl23UGu8rarHbkpt31Pl5BIt9f0luaBi1SCg+vIU4FRVohnVePKyfJUiHcqyLOOP7O29JZpL6V97v775yV4v7syueeV/b+3M03IS/c+ISd2nsg/oum+cx1xpvcpOo92tp4QPftxdybsX8dk6/uT1iuBu3CkM9E1MuhJm3RNZVI+VwEvXDa8zDpZDRAuSgYRQKEIhRK6UMIEBQitfDephF/CrPP5hHsWIyMlYS5SJnQV70LY52mc7WN+2V4MpZ23imR7EAR9K9uDILB/J4/H45mDk08+mfvuu6/vshNPPJFvfvObXUL58ccfX/R9PProo1xxxRW8613vAqzwTjsVTSkWi7MKZjZu3MiOHTswxmTvufkOSgdx+umn85d/+Zds2rSJ0dHRRbc35cknn2RiYuKAyHTwQt3j8axhjNEkSc1J9JkuKetZXWgdU6v9SybRW+3fdC0vl17O2PhrGR97LcPDJ/lOKlchMigTZgJ9yF8pcBCQj2npvS1UnGttiJ0wj7UV5YnSREoRJQqllRNJGoMV3cZY4azRbn4aYWGFayrDdVYJbTrb2YZzIGvXNWBcNb3BoDRZJnlXR55L1SQXnZKKcaGcWE6ndU6Ou8py0fv3MmCKBUzUQtEts7NqbqM7itYYOtq187h3Kr9zHWoOIo1OSUW7u09pAKPz6tfddyrnRWfc/SOz+XStlf83r85kNie/pHN/Om2ee07lPXx6eqVbiO8vuZL0Pov6aT+Rb/Kyk3bI6YS9sBEk7q9Ob2eexo131rXxJXZ9F2PiWXYyKd8l5N3rbh6kwIp2IREyREjXoWpYgEIZUyxiCiVEUIBC0Ur3MFxS4a607SQ6GtDewEXApBXtobSiPAwWJtvzMTJFV9m+ErI9jZHpV+kppRxY3R64Tm89Hs/BwUsvvcSll17KlVdeyamnnsrIyAhPPPEEt99+OxdddFHfbS6//HJuvPFGrr76am644Qa2b9/OZz7zGWBx/Y+84hWv4J577uHCCy9ECMFNN900K6Jx8+bNPPzww1x22WWUSiUOOeQQzj33XHbv3s3tt9/OJZdcwne/+12+853vzCvJ3/ve9/LpT3+aiy66iFtuuYUjjzyS559/nnvuuYfrr7+eI488ctY23/72t9m5cyevf/3rKZfLPPDAA3zyk5/kuuuuW/Bx7i9eqHs8njWF1jFJMuPz0NcAcTzJ1NSPrESfehKtm9kyIUJGhl/F2PgZjI+9lnL55SvYUk8/bA56R6D7kxzrl37iPK0877euMgpttI0bMYp2oohUQpQkmSiPlaKtlK3GTqvDTUeYrwUMVoQrZYV9XpQrbTDaduS33+iOBJdaQybKnQxPY1Wym4tXMR1RllVrA2lHmXn53RHm6TiEYgTRntm/tndJ8rSK3Lgqcsikls5Vn/cefs9w7vubfwWj86vlrjToHoE+Ol52zRdOxHfoFvN23Vlyf12kOaTPq6US+U7Ii1TCS3cPQSbhDQKddeKZCnnhhPy6eFBXNdpgjTaa3sr3PMbluYus0r2AKZYwhRIUSk7AF1zlewERLJ1usJ2cDug8NM1rl4IwzI27KJn5YmRWi2zXWg+MVBBCdMn1fKW7r273eNYfw8PDnHXWWXz+85/n2WefJY5jjjrqKK666ir+9E//tO82o6OjfPvb3+aDH/wgp512Gqeccgrbtm3j8ssv78pVn4/Pfe5zXHnllbzhDW/gkEMOYevWrUxPT3etc8stt/CHf/iHHH/88bTbbYwxnHTSSXz5y1/mk5/8JLfeeisXX3wx1113HV/5ylfmvL9qtcrDDz/M1q1befe7383MzAxHHHEEb3nLWwbK+EKhwJe+9CWuvfZajDGccMIJfO5zn+vbAetyIcxir81d50xPTzM2NsbU1NR+XWqwGtFas2vXLjZt2uQ/cD1ritWeh661Yc+eBhs2VLs6XDrYMMbQaPzSCfQnqNd/Qf5XeBiOMT72WsbGbYeiQVBducZ6ZiGEdJ2IDrsc9JXPFPSfW0tPKspbUYsojmhHbeIkRmmFRtuhE+V5eR4pJ8uVmtXx51r8Jqly1eNpHnk2T9vl+3xYxkpwkRPjaINUylWWJ6ASpFJInXSEdyrCjc7ktBXVTm6ilkBsdgjLIyStAUK9R5QLk2aPpxLfzCnJF0p6ZAZchbOd1q4S3Vb3p3ElhrRmPq32N8ZghMhkfBosY0Rnv52Yk9xycBK3e7vs8NORXKYzg9btkW35qvp0up+o711X9GyVi9C2c0x+/7Nb0nsVguhdt+dPlY/hSeN9skcsH9djOo+iFezpdGe9tA6d3H7SdZfmnTuV8bba3V7PYKNMtJBuvl2uV0FFfFApo5qtFW3DiiID+zcRNrddF0qYYhlTLENYQBSLmGIRKUOE7MTSLJe37pLtQa6j1Fxu+yBWk2yfDyHErIr2vHRf69+j/HfCxbOe3dZiabVaPPfccxx77LGLEsvrgbvuuov3ve99TE1NUan4mM75WMxzxVeoezyeVYnPQ18bKNVievqpTKLH8d6u5dXq8U6iv5ah6vE+JmSVEQRVgnCIMEhjXFbPD0PP4rCZ3AmJSUh0QpREtOM27XabVtyy4jyOSXSCMv0r/JQyJEY7YW5jWpTrFHSNFJUDLqc8X1WuDcpolHPAg/LJ5yQvyXVaPa4RKkGqGJkkSJWATmyVudGIXK53WiG+1FJ8X44DlDueGJm0smpyjcIYQZo6b5zYzsJeRCq+bVWxkZ1IEJ2LBzGZhO4W5cZVb2ttE88R/arHXTMP8MOylJg+Y/2nF7azfJCNzI1bUZ9T8iI/381dJe/pwkX7CEyXvJdZ/I+xirxnHZkfdyeXpFE26d3MJes7At6Q3gYJ+ABfAb/EaGXf64ghgaBd6yxzFe4I2ymqLhRRYQldKEJoq9pNoYQIAyu7hUQIgQzc9SH7IFLTyvbZaeapbHeSPewfI7OYDlJXKrMduq8268dcwt1Hyng864c777yT4447jiOOOIKnnnqKrVu38p73vMfL9GXAC3WPx7MqMMagVI04thLd56GvXtrt3UxNPc7k5BNMz/wEYzo9d0tZZnR0i5XoY2dQLG5YwZZ6epGymOtIdAgp/deA1Yw22krynChXWnVNJ8rK8yiOUInKbr05hylGQ6y1rTBXxo3b/G+9ZCHfy0cqyw1kbd4fWZ6Jca0RiQIdEygrx0WSILUbV2nHmKojx1foLEOnTryTW92dLg+g0RonuY0V49q4aYmWgmpQoFYsZ8J83xtkcnEtpjvHOe2sM/cvs8Y9c5Ge3kiz3he7cW8VvOxS9PmhXDYZbxCotOR+CR1jt4w3HdHeNc9GIqXzpM4tS9cjQAvhThZZ4W6ERIvASngkBi8bl4S03wcSoE0Q1bsf2SCwj3UQooMiulhChUWSQhEThuiwgAxC+1QSEimkrXIXEumGi6l2t7Ld0EZDT/2OrWjvVLYXsnH7Kpkvsz2V7TaGRlKUMhPvK3FF63zCHWyGeyrX+42nQ4/Hs3rZsWMH27ZtY8eOHRx++OFceuml3HbbbSvdrHXJmvklfdttt3H//ffz5JNPUiwWmZycnLXO9u3b+eAHP8jf/u3fMjw8zB/8wR/wqU99ijBcM4fp8RxUGKOyPPQkqWEGVE16VhZjNPX6L5icepzJycdpNn/VtbxUPDTrUHRk5NU+a3s1IQRhMEQQjrgq9IPrEsfVjDaaWNuK8VjFnXHdGU96TixqrbukuUpsx2b93KTWEGuVdQJqK87t+GpF445RO8nhIlgSYxYvy7W2EStKIVRMkMRIFVtJnlaVK5UJ8nk71FwC8hJcgxV4iK6hzlV162wZuK5ZMQgXD5OLX8k6Z80LmoBZ/q9n2h71oGrPtCNYN+4OwMyS5AeIfbyzgZstQeOX6/j3WbMN2DD9a6VRLfN+08r12dqR7fmseNFdGb+MIn4+8q+V/RH1skfGB0YjSZAmRmo3bWyFr0A6UR9gROAq3q2MXw1xM2se5arbVURAg6CZWyYDewVMUESFRUyxjApLtsPUILSdpDqEq2wXUiLdECFyAj6YV7on2pAMyGwPpciiYNIImYIUBH1l+2ykwMn1jmS3MTQrGyWjtUZrTRzHA9cRQswS7P2ku49l8XhWhuuvv57rr79+pZtxULBmTHMURVx66aWcffbZ/Lf/9t9mLVdKccEFF3DYYYfxgx/8gBdffJH/8B/+A4VCgU9+8pMr0GKPx9MPrZMsyiVRtWUXGJ59Q6kmU9NPMjX5BJNTT5AkU7mlkuHhExkfex3j46+jXD5y1VxW7rFV6GE4QhiOuBgX/4PmQLMvsrwXpRQq7ojzJEkwfSrIbXW5ziJaYpdtrtTqe2/VgFIabXqqy51AX1CL0847VYJIIoIkQajYSvIkJtAJIoltR57oJa8iV5kQ7whwLXIyvFeE90jzWRi7105WeSrIbcejqE7NOSxBcW+umlxjUMqq+ixqpeePMOtvMt/yvvc5x7ar72m64hzYh2Tue5v/VTl7DSE6El6IVELbwJp8ZE3a4avMPqMWe+T9Xw1ijldJlhnfs4pyN9dgyFras6LoHrUC3tWvmxhhDIGBAqBMHWlkdkWAlGn0jK/u3We0sn8ClRBGDWjYxxqwsl2GmLCACsuYUskOCwXiMJz9R8c9N4W0N+mqxruq3gdL90Qbkmi2LZcCJ9globTjqXjPV6VrA+1E005mf0al1e2htNI9X90eBhCssKi2VxW7E/pzYB9f+9yf75aX9B6Px7NWWDNC/c/+7M8A+PrXv953+fe+9z1++tOf8v3vf59DDz2U0047jVtvvZWtW7dy8803UywWD2BrPR5PHq3bxMkMSTyNUvWVbo5nAO32LleF/gQzMz/pit0Jgiqjo69hfPy1jI2eQaFwcHdss5qwnYlWnUAfIQhKK92kdU8qzCMVEakoG0+F+aCM8kHkpXkq0Xv7jE9SWa5c5Xmy+rLNu7LLFSijrTTXkCzk5KmrKpdxhFQRMomybHKbUx4j0mze/bCOaaW4FgLVUx2uhXTV47KvJF/0HeHy1A1Io3LGWuUqy+faftZo96E7326MyQlqk2WSpwXlWUF7jkQa4ujA69v5FW33cNDyLgadq5hnX/MtW75s7UFh8YOq/zviWvRZd3Yr5z5iMc8qos/4gh+JAfu1Vzy415LJDyUmNzRIjJFoYwW0Ni7ayMhM1neOos/jlWto7/x+J7XcPSJF75BsOuhZZqexy7KhwUV+MyQN9cD1mZDdj3DiHaSxsj4QAmmswJdCECCRRrpUd1+osCi0sp8PSRtJDXKx7SYIMUEBUyyhwyI6LKOLJUyhgJYBoAZeupFKdzIxPLd01wYipYn6XA0WSCvDQ5mLgglmy/Z8dXsz7i/cC6EkEGmsTE+Hq3JlImV6McZgjBkYQTeIQRIebGeBjUaDIAgyYT/XzePxeJaTNSPU5+Pv//7vOeWUUzj00EOzeW9/+9v54Ac/yD//8z/zmte8pu927bbtsCtlenoa6FzutJ7QWu/Th5rHsy8o1SJJpomTabRqrXRzlpX0C6NxsQRrBWMU9fq/MjX1BJNTj9Nqbe9aXiodxtjY6xgbfS3Dwyd1Rbmshazl9YyUJcKwk4Wer0JfT+/xK/m5FevYVpermEh3pHmko3mry+diPnluOwRVxApipbLK89VwMY8BlItkSbRB6UUIc2MQSmeiPEisIJcuiiWT5fsQ/ZUJcKwgtyJc5sbTKnK5b2K87/FYxSmMk/tpRbk2dM5yaNJycINd1Gc38xhdk/5PXpCneSz7+rTQaZv6taenSf1kZe96Jr9wTWO6Xmum7yPSmdO/grv/X2UFgnIGkAppe2JJGUliApSRnRuya36SW2bniWy93m0T415nxqaTZ/L8IIlCkWgrOoUiFJqC0ITu1jUuB8x3Aj8UhqJQFAUUhaEgoIyhKCB0ETWhwcaZkHZMK10b8t3WrofX5f4hVIJQCUTN7usDhMQEoZXshRKmWEYX3LiLj7Hf713HzYOkO/NId+xQKXv1WdTH3geumj2UkiDoxMiEgbCds+YwQDvLkunfKCkEhUDYTleDTiRNtt8VjJWZj0Hf+4wx1Ot1wjBccNt7BXtaDd87b2RkZKkPY1Wwnn4TeDyrkXUj1Hfs2NEl04FseseOHQO3+9SnPpVVv+fZvXs3rdb6koBaa6ampjDG+Ewzz7KgVAulGijVOKg6FdUaarUIYwSr/aWldYNm8yc0Gj+m0XwKradzSwWl0u9QrZ5OtXI6hcLhCCFIEpicjIHBeYqe5cV2tlVCygpBUMmd3Gi62/pkOT+3tNEoo0hUklWVZx2A6mQBUQdzYzAYbWwHocqepM/nnRtj5XSsDdp1Dqq06SvOD+TbSppbro3NLNfGoAwY3b9DxDQxuKg1wsWuSK0RygpyW13eySrvi5BQ6FxZkUal2DzxTqRK2vmmFpI0O1kJq5IG0ZVoPMsSO8U5q+TbDbNyap2bzkrC3XqBC5oOOne4GEy3aE1PrqS77/cs7Pso5kT37G36Pz7lUoVklQqVuZn9dxtczT6/8F4NirsfvX8Zk55E0ZBoiLUgMZJECTcu0FqQGNBaoo1NDDLpeZ70yZE+942rzhbGVWnjXnGGoqvlFiRunU4ldxpe1Bl3y6XJ1rH30BH3XceRr7F35fW52Pae4+6u2k0r3PPD9MRAZ7rzfmF65vdOp6I/NgEJksidMIiRRCYgIshOCCgj7PuiO0mg+v6VQGMf+9gszzt3QWhKUlMK7LAsTTZeEYaKVJSlpiIUFamoSkVFaipSUxSGQOTy723JfybkbRRPelyyz9GtVxJIEkhyV9EGNkJGhwVMULTV7EGhK6e9i/S1lXuDzr9XC3DSPZfvbieQAoyQxEKQ9HnQpbBXMwTS3mQ2zpxiuT1wifsLu32FbiglBEIgpCAQ9n7t/NXxTEiFOsx93ItFSkmzuT6/S8/MzKx0Ezyedc2KCvUbbriBP//zP59znX/5l3/hla985bK14aMf/Sgf/vCHs+np6WmOOuooNm7cyOjo+oo00FojhGDjxo1eqHuWBJuhVyOObceiHYledLeDA2MMQhg2bKisymqPKNrN5NTjTE0+zkztn/pEuZzO2NhrGRs9nTBcnxUaaxFbhT6Sq0Jffc+t5WYpPrdiFdNW7Syepa3atHW7b5W5QFBw/y0WlSiSOOkMU3kuITGaSGsSINY24zzuzU2Vwt4OAEobV2Ge3vT8VebG2IzypE2QRIi47arMIyfR+59ENdj6uawaVghUFqcis2nlKsjTCJaOhcvJ6/ygRzx3l3q7oc4J1TkTMBQi64Ez3+Hn4lVruoXOVTobOnEsVmwa8ofYuacD/xrf2zgQP7YHnSToHpstv/tVha9O/W0jVJyodH9Q4ZqaTZObb0AZG2NiY07AGIEwnWdB2lFmgCFAz3p7KMDi3qnmPve0MqyW9iwg18Z+BLu/ce7z2LiTeh1pD2GpTLOdECNJREBs7C3CivsYW8mfmNw4ktjYW2IksRGddYzMKvxjI4mVpLb4i3kAQ1FoylJREpqySCgLxZBMGBIJVeluufGK0ISyk3pvq3rzOfly3VfEpy8dCbaqvVBEFcuYsIgultBFGyMzby+nXR8rvZ8x6SmatILaVrqLfLW7EQhlq91T8pntWaSMq0APFliFPuvTu8/Xk0Cm+xcutsZK9yCQVvYHgnCZ5Xt6wnlsbGxJvxOHYcjGjRuXbH+riXK5vNJN8HjWNSsq1D/ykY9wxRVXzLnOcccdt6B9HXbYYfzDP/xD17ydO3dmywZRKpUolWbnzeazutYT+Uwyj2dfMEaTJDOuY9EZjLs8P+146mBE63zHOyv/GBijaTR+yeTkP7B38h9oNn/VtbxUejnj469lfOx1Lspl3VystLYRgjAYyjoUldJnocPCPre00Zks7x3q/vW8+/V+pZXOIluSOCFJEitLtY1piZQhVi7nfFBcyzK/XypjSJRx8txGsyTazu9/UNqK8TiywjyJCZO2i2WJrDDvs60V5oJYBJkoTwW56ophkd0bpYO8GNfp3E5OipmrVHvBaERWoju/MO9dml8rC3MxHbVr69fNXLvsZs18VuZz2bsr6dOx+ST4ahXgGU5gi7wM1+k8MgGel+O9ojybz2L9cHq6aQBz7EwbULjXl6uytlXTrpraLUtvNp6ls0y5eTpbz1V/m1wFuOmuBk+rudNKcbtObtzJ5HwFem/ee696Fu7B61S8gxCdZdl6wkaphMIQoAjRBEJnwwBDIFznoK6V6XzhTkpIbPGDNN1V+emJi/T+sr9pzx/A5F4MvX1c5I9XALoRUQIGfYqnnz+pGE0lNS6+Ja1axmWyS2xFfEJIywREJqBNQFsHtE06lLTTZbn56bRy2jsyAZFaTMePhqpQfWW7HbfLrJBvUxbKxtCIjhyWItPvtt8XwB7VGvw9ajQiahFGPVeyCzBhEVUouaz2MrpYRhfKizpZbjDuahR7onsQ0kXMZB2qugD/LMpECqRwnaMG0kW/CELREe4L/c1icJ2w9n5G90EAQdCpqJfuuSzz4+73Ulp5LyQE7iTNfG1ajnz09HvmemS9HpfHs1pYUYuycePGJTsbePbZZ3Pbbbexa9cuNm3aBMADDzzA6OgoJ5988pLch8dzsGKMsnno8TRK1bIsQc/qQeuI6emnXaeijxPHe3JLJcPDJzI+fibj42dSKR+xYu30dCNkgTAYySrR81nontkkOulUmefluY6W7T6NMbbiPLa550mcYLRx2eZWmqcdkCl1YOVhJs1dZ6DzVZoLpQjiFkEcWXGeVZnHCB3PimRJ41UiIdAiRElJ4uR4ksrzNODB/dNVMZ4X11p1pPNy0FVlrlw7dF85nqq9tJoU8s1KJXJPerZZxrYvG6anKrxzABrbaWySZdavMRGe4popjZPiOQHeK8R7pXg2vdRNMpCQVhzbimTlqo8TV6GcViQnLoO8M95vncBmmKciPNO/64RV9FQLUBSkInSV2yURUxIJJZFQFAklFEWhKKAouGHoxH7oZH6AoShDlEr6n5WjI+QHifnBRBSFoCRgJBWLgAiswJZOTmZRLjnpmBjREe456d7SAQ0T0jAFmjqkqUNaOqSpAyJtu0dtmJCGCuc8/5MiMFRFwpBMGJExwzJmWCZuGDMSJAyJmCGZuCih/vJdYoVx4P4yq77y3YCII8I4gvyVPwKb014ouZz2EjosoQtlTBDu8wlWbXT2eTff30VK+yj2yvdUtttb4DLbA9vB6T52bGpwfcHs4wvbnldKZTxdMl4ArWaMCqOeuKLOdvY43QkxkY7nn2ei85Cny+QqehPyePYBIQT33nsv73znO1e6KQcda6Yscfv27ezZs4ft27ejlOLJJ58E4IQTTmB4eJi3ve1tnHzyyfz7f//vuf3229mxYwcf+9jH+KM/+qO+Fegej2dutI5dFfo0iar3rUz0rCxxPMnk1I+YnHyc6ekfo3UnLVHKMmNjr2F87EzGxs6gUFhfEVZrmSCoZlXoQVBZ6easSmId007aNOMme5p7aEw1iE28X52BLpQ0siWNb1GJ7Rg0ShSx6yD0QMrzVJYnLts8yXUK2g8rzdsEcRsZR4Rxy1Wet5GmI3g0oJwYV0KggoKVdULa+a7iFHJePJPjqQiyVXTLSUeAa0yuytxksliDq7CFXm/VKwNy1fA52c5iqssPKIOF+OzqcNMzNv/B2Cia5fr7ddvq3krlnplOfBuEtmJcmHRoIJ3WZPMhJ8yXSLRFRhLj4jmyYWde1LXMzc8tS0xA5OT5vmh6gSEUigBlq6+lJsBK3arQLvbFVl9LYZCk4z1D3DJhOvON7ehS5OejbTW4EdmppaxqPKvYpv980RnvXteOd6rYO0tNrpq9a7nJT3e3pLMNWTW9ckeedoqqs5MNaZV+0KnKT9fJVeSnHaqm+4iNdLXqoAhQOgCK1Bb9F+z+WxZFQkkmVsrLhLKIqYqIIRFTFQkVJ+dLQlEwmoJ7LWav+QHS3XaSCQt9w+pU9EIoBQUBw2kFeZCLcOkjdhMETVOkbopOuhdpKFsl39IBLS3tUAW0lc2dNwjqpkBdFdilBn/HERiGMtGeE+658WEZURUqE6Bp5Ix0le5Z5XsWO7MKq94NiCQhSBKCZr17USgxYcnJdhsfY8IyJixgxGKuIpgbrXMdmObke79SBIFAuKpmIYSrbpcUAkkYyk6kTBBScMvEEnZwat8TbN8ys5YZQ9xOaMtoSSvUq6Uihw8ONPB4VpTdu3ezbds27r//fnbu3MnExARbtmxh27ZtvPGNbwTgxRdfZGJi4oC3bfPmzVxzzTVcc801B/y+83z961/nc5/7HD//+c8ZHR3l0ksv5Utf+tIBue81I9S3bdvGN77xjWz6Na95DQB/+7d/y7nnnksQBPz1X/81H/zgBzn77LMZGhriD/7gD7jllltWqskez5pD6zZxMkMST6FUY6Wb4+nBGEOr9f+YnHycycl/oFZ/hvwPqkLhZYyPv46J8TMZGXk1Uh48OfarGSECwnDYCfQRH7GTQxttq82TNi3VopW0aKtOvrkxhkbcQCu9LJFS/aJbkkQTJdrFtthxPUBeLyVptXnipHmirUjvd89CKYIkIojayLhNGLdtLEscOWluuoR5JCSJCElkkSSNZDGCrnJyQ9bp4XLb5d6q8UzpGo0x2km0fDTLXPRYWTrRDF3CfEUvrOovxjtSPFc6nS7pKqfubCOyfzrxGb331XmpuG1y23d2AmGhQqHUyt1vR4r2ImZtn2tP992DFlaCKztECyvBdX6c7nn7KcW1gZg0CiN0HUqGtE1I5OZH2fyAyM3PBPkCJbjAEAhFKFyFsogpyhZVmbjpxEpxod3QVTDnxtPte9eRYvlec0uG6Tk1Yrofs273K2avY9KTdCK3k+5nk+m7Xvf6S3ZdgduNclcKxCYkIR26KwzccyRxOeizh7JrOj0Z0DYF2qoALOzEeV7Cl0VCSSgqbrxMwnAatUJMRSQU6HxOpic4Tfo+nqOznHkrmdPqZVvAbCVpVSqGRLMTTxOmnb7acB3bSbS9gkkhaOuAhpY0dUBDhTS1pKGsdG+qgIYKaOgQg6CmC9T03D0BSAxDTrqPyJgRGTMqY0aCiFE3PizbXakqAht3kgn4nHhfTRXvItGIpIlsdXeIaQJppXqhiApLmGLZVreHBYzY96r2hWA7VO88UdR81e+5zkwLgSQIbL56GARZ3nogpYs0SivHZXcFuchqyLOS8qWOdfF41ioXX3wxURTxjW98g+OOO46dO3fy4IMP8tJLL2XrzBVxvRaIoohicd+8xec+9zk++9nP8ulPf5qzzjqLer3Or371q6Vt4BwIs/hrzdY109PTjI2NMTU1tS47JU0jcXyelidFqZaNc0mm0Ko1/waeWWht2LOnwYYN1SXPUDdGMTPz0yzKpd1+sWt5tXpcFuVSrRzrv3yuEjodio4ctB2K9hKpiJZqZfK8ndiolrmiJYwxNPY0qG6o7vdjaIzprj6PFO0kIUo0caJpK23zzpdRvBrIYllipbPOQftVmwulbGV51M4qzoMkQiYRQicYozsV5q6TOyUEibBRETqVnro7B3u56K0Q133mp5XmrmdO0uTmxV0B1R3JsnTCPF9R3ZHZwg3tot6Kbp0JOSN0R88Ine3LkA+WyYlpkVeIK8N4aQOT7T2DV0gfYC0QOpXf0o6bzrx0OpPl+4iBTHi3jJXhLQpWiveI8l4xnswrxF2WthPaqfwuyoSiiCnJmLKMKAcRJRFRkIqCk+ShSMcTgrUgvQ8WTLew75y0EjkBnxPz6fnCnOjvEvbGLlsQnTL9zjbC3rdCUi1PsKvRIDIhbVMg0u7kjg6JTMFlmxeIdEDbFEjM4quRBYaKiG1+uYyzmJWqTBgiYkjGVEREOSfe89I9P72o+3WxMjKX1Z0KeKTEiAAjgo5od1nfeTTQ0pKGCmloaSvdk4CmkjR1SF0F1FVIw4Qs5G8iMAynol3GjAYxI7Ij3EeCmCGRzPLQ/cR7J2pGuGr31fP9zQQSwgAddGS7LpYgKIIMMDJY0sr2pUQKQSDtY57GuQQijXOxQl6kw9xvKXcax30HNJg4QhTLnXiX3jsa+Oca/HccqpR50xmv2udjW82sZ7e1WFqtFs899xzHHnts1lmrMQYTH/iKC1GQC/pdMzk5ycTEBA899BDnnHPO4P31RL784Ac/4EMf+hA/+9nPePWrX83HPvYx3vWud/HjH/+Y0047jYceeog3v/nNfP/732fr1q389Kc/5bTTTuNrX/saJ554IgDPPvssH/7wh3nssceo1+ucdNJJfOpTn+Ktb30rAOeeey5/93d/19UOYww333wz9913X5YoAvCFL3yBL3zhC5novuKKK5icnOR1r3sdX/rSlyiVSjz33HP8+te/5iMf+Qjf+973kFLypje9iS9+8Yts3ry573Hv3buXI444gm9/+9u85S1vmffxXCj9niuD2KcyucnJSf7qr/6KZ599lv/0n/4TGzZs4B//8R859NBDOeIIn83r8ax2lGoQJ9Mk8RR6GbOHPfuGUk2mpv6RvZP/wNTUj1Cqc+GxECGjI6cyPv46xsZfS6m4PnulX3P4DkUzlFa0Vbtbnqs2yiwgfHUJMdpk8jyJE1qtmChRRImmnejBnYUuARpQShNr2ymoUoOzzW1ES0TQbhMkLYKoRRC3ESpGG0MkXNWfy1hWIiSRBdsBYG+ut8m3YGkYVE2u+8zLjqlLmtuwBky/aur+9zi3MM+Jb5f5IYSBoLN/0ckCsfNyYdlpuIQdt7EvVpR32tb9kHZPrR61sg8YOuJbC5JEI9tFV1FOf0G+D0dsgNhIIgIrxXNivG1C2uSHqSi3Ynzh8srGo4RSUREtK8WDmIqMqMg21aDFUNhkOGgyJNsEPiN36eipQl9Juk54dV2ZMfuKjAWTE+1p5IwV7h05b5x8N26+AXdCCUIEw6JNZGqd+w/zDexU4aaTGuGEe4G2dq+HnIRPhy1doKmLtI2t8LYRLEV+O+fHq6GSynaRUJWxG3cyXkSMyJgSMVawpzdy47n3R2MwKg3N6k9adSykoJAFYQcYEWKCECFCqgKqhTl+gwhQBiIlaCtJUwlX4R5Sc7cZXWRGh2ikGx9c4RigM+luhXsq4CNGg5gxGVESuk/xt3BZ79LK93zkDAc2ZkYoDUoTEAONjsiRYAL72OowwITFLLMdGbrH3sn2FSrw0MZgC9/N/FdKCFf5LoSV7q4KXmIITWxfazL9O6QnRugS8YshiVfnSQjP8mNizW+2/eCA3+/Lb3kDojj/8254eJjh4WHuu+8+Xv/61y8oynp6epoLL7yQ888/n7vvvpvnn39+YCTLjTfeyGc/+1k2btzIBz7wAa688koeffRRAGq1Gueffz633XYbpVKJO++8kwsvvJBnnnmGo48+mnvuuYctW7Zw9dVXc9VVVy3q+AEefPBBRkdHeeCBBwCI45i3v/3tnH322TzyyCOEYcgnPvEJ3vGOd/D000/3rWB/4IEH0FrzwgsvcNJJJzEzM8Mb3vAGPvvZz3LUUUctuk37wqKF+tNPP81b3/pWxsbG+NWvfsVVV13Fhg0buOeee9i+fTt33nnncrTT4/HsB8YYlKq7TPQZL9FXIVG0x1ah7/0h0zNPY3JZ0WE4wtjYa61EH32Nz91eJQgROoE+etB2KBrrmGbSpJXYuJaWahHreEXaopQiiaw8j9oJzXZElHYYukyxLRpIEk1iDElWcW5/OHZhDFIpwigiiJu2U9CoRRC3bD46msTYzj8TYavNEzGgIiJzRft/PP2keG9F+RzXDyC03YN1lWoB7bJyXaSaWtgMZ5O7NyGchM/Jb5GPP5kXk6tEzf+bHp/prLeS7PPd9z636MSmaNlVTS7SivIB0SptFAHz/zhLEK4jw5CmKdCgOKuC3EpzV41LsI+nHjQFkVAStlK8KtsMBS2qQYOhoG0ryN2tIBWDTKmYNZWrWM6WDzpVIGaN964n+qzTNSX6L9sXuvZg3LF0PQdE71p9yV8j0fde9vH5OPsKo9knpvrvOn1tdg+XhVm7nn1fxr3nZDXsadF5l6Sf60Rl9z4LpQpF1Zwt3rNKeeHEvJ0vDVRIqIgWWXZJILor4XN/am0EbV2gqQu0dIGWKdJUBVrGTesiTV2grQsYBE1ToKnmjlZJhfOwk8zpcCSw84ZEhET3le2zpburiNcm504ToJ09rlLYinYhJUYGIEN0EEIQgpBgz5NSCQyVQDHes4+0zVJpIiVoKElTS+oqpKYKzOgC07rAtC5S0yEKyZQuMaVLMKA7lqJQjKWV7blImTE3PixjBjnbuavdbWuXLWZGg9AJIk6c2q+njbLxMUGICQJ0GEJYQhWKmKAIUoIIMDLECGkf91WAMa7/GAzd3ygNRTQRCQPf/93JHAlZp70yfb6l53by6wkIwgNb8OHxLJQwDPn617/OVVddxV/8xV9w+umnc84553DZZZdx6qmn9t3m7rvvRgjBV7/6VcrlMieffDIvvPBCX+l92223ZZXvN9xwAxdccAGtVotyucyWLVvYsmVLtu6tt97Kvffey7e+9S3++I//mA0bNhAEASMjI/sUOTM0NMQdd9yRifJvfvObaK254447sur9r33ta4yPj/PQQw/xtre9bdY+fvnLX6K15pOf/CRf/OIXGRsb42Mf+xjnnXfeQAm/1CxaqH/4wx/miiuu4Pbbb2dkZCSbf/7553P55ZcvaeM8Hs++Y4wmSWqZRDcHoDM/z+JoNv8fk5M/ZO/kD6nXf961rFR6ORMuymV4+ETEKr2E82BDyhJhYZQwGCEMh1a6OQeUWMU0VUeeN5PmAekktB/5+Ja4ndBsRbRi5SrQrdxeamLlcs213X+i7Q++LrRGJglhbPPNg6iFiFqYOEIbbVWAELZDQylRptBVpdh9kPvX3rwQX0hV+SBmV5srJ7yVK7S0e+2W4DqrHietEBdmP+J0nCTPCfv+VeT78KAtaJN+Am6huzC5FRbYPifJRRqvoiTCyM50VkUu9yliJTLSVodToKFDmqZIi9BJ8kI23jJ2HbWf1ZcSRVmmgjyiErRdJXlEJYipynQ6zgnMVD31E9zFniWrIQ05R/Y8z724+/7pB8nwQY/3Phzlqnpg9ofu1719Z+k+5Zd/H5h9MrAj7vv9KcR+nFToT4ikkJ0ENMLk3hPzbepppZuVCne3MUY7Ae+GEkEFRUW0Ieyuds+f1TEGeyJMF51oTyV8ftrK9y7h3BdDVaQ55lG3eA9ihoOIotPnqWDXur907wh3hS1X7jkRL7BFClKCtDI4rbS2uSFpJ7ISFUhEAEPAEIZDiBEmIjSawGhCo0FrWiqwUTImdKLdSXdlpXvTRUvtVhV2q8qsJtlmGUakrWZPq9pHg5jRnIQvCjPnc8nmucuubPdUxKf/LtkL1+By2m0hlf0lMUPBNgQTBmhX2W7CABMEmKBop0VgH38CV+EuV7TCfaGkzy3Xxe+CtokHnWHxrHtEQfLyW96wIve7UC6++GIuuOACHnnkER577DG+853vcPvtt3PHHXdwxRVXzFr/mWee4dRTT+2KKjnzzDP77jsv5Q8//HAAdu3axdFHH02tVuPmm2/m/vvv58UXXyRJEprNJtu3b19w2+filFNO6RLeTz31FL/4xS+6HDPY+JVnn3227z601sRxzH/+z/85E+7//b//dw477DD+9m//lre//e1L0ta5WLRQf/zxx/mv//W/zpp/xBFHsGPHjiVplMfj2TeMUSTJTE6ir2gvbJ4ejNHU6j9ncvKHTO79Ia32b7qWDw39DuPjZzIxfhbl8pE+d3s1cJBGueTleVqBvlLyHLDxLYmtPm+2IprNmLaLb1nq6Jasc1DlOgdVZnZUizHIJCGIImS7RdBqQLuN0gnKGCKMzTfHZpwjCv284H79Zp5LmM9dWd69B4F2lVoKjAajkEJbke4qyAnTdftr7GxvZkAe71wNMp0aVXKrzSnJBx5cP4U2QIcf6C6E0nMLWRW5dONWknfJcrM4ga0hyxhvmAINU6RprCBqmQJNCrRcdXkbG4/Qr4Gd2ueFPTEDFENBRDWV5TKi6qYrMp0fURBqYQ7GBPsoNZfwb5ntapah7EO/ZctZ4Wk6d7vITfaNBd7RAfmq0n16pf+1A/tD/jqZzhuWmTUnnTtIzfeSux5iAat3XeGQr44PwIj8KVHs+3Va6Q4YF92UVr4bJ2bLJJRlTOZpuy+jAGzFe1MXqKsSTV2kros0VYmGLtqbKqGQ9v1FFdipqn3bX0QxHEQuTiXKbmNhxIiMCFLNmRPsvdI9PWTjRHjfcnIhnFy3sje7BQEIiRGCWNjOZPOUgIrRHKabhKZOoDUhCmk0RhlmTJFpEzKli5l0n1JFJ9+LaATTusi0Lg6scq+IpKfCPZXudnxYJu7ztv/27gCzmBkr3mWfmJmFXZ0yEG0QUULQ50BMICCwlevaiXYCiZadKwiMkBjpribAPvZGSPu8879fPGsEIcSColdWmnK5zHnnncd5553HTTfdxPvf/34+/vGP9xXqi6FQ6Fy5lHoHre379HXXXccDDzzAZz7zGU444QQqlQqXXHIJUTR30oGUclbn2HE8+wzl0FB3YVqtVuOMM87grrvumrXuxo39I27TkwAnn3xy17qHHHLIkon/+Vi0UC+VSkxPT8+a//Of/3zggXo8nuVD69gJ9GkSVT/wksAzJ1pHTE8/zd7JHzI5+ThJMpkt6+Sh20r0YnHDyjXUkyFEkAn0MBxZ91cHpPK8GTdpqdaKy3MArbTNPW9GTO2tEU/XiJUmWsJOQzNxrnPivF8sTJwgohjZaiGiNiZqQhyToO0+pCQRgU1jkPvUNU1fekV5OpxbmKeC3EWnCFspnlaNC2GQqTh30St2R4Me1G5lpGF2bvvAA+gvyrN9DjTvc4hwM/jI95mBon8R2xv6VpILLW0VeRq9sgj5oYG2CWhhBXldF2lSoGlsrEPTxa00XcRKP7Ei0Uh3IPYUyVyyV3T9jSoyZki2rRQPIoZSYS7bbjqi2KeTvxVnwUK8d/5+yqkDyQH7mjfgjvb7app5HucV+TPk9eS+NKDz3mWAkJAChUzF69x6etF9XLhWzboaxX43yV6DXV9VDIYkq5BPG2Yr3610R6Ti3UaUDMmEoaBNv+NPK90bqkhTW9HeVEUaukRDFanrks15J2CPqrBH9YsmNAyJND4lctXdEWOyzaiMKMvZsr2fdM8apBJ760evbM+NayGIgsC9b/Y8okYzrjWHOOEeak1gFAEGbaCGrW6fMgUn1jvCfVoXaZuApglpqpCdfR8DmwM+0iXaoyzXPR0vSY39OjK/eBcCnG7vqnrfH/kulH18BcnsTw2JjYhxol0HTqa7W7aStNFfRoQuxshdWZDK+DVQ7e7xrFZOPvlk7rvvvr7LTjzxRL75zW/SbrezzPXHH3980ffx6KOPcsUVV/Cud70LsMI77VQ0pVgsolR3ZNLGjRvZsWMHxphM0uc7KB3E6aefzl/+5V+yadOmBXeg+8Y3vhGwVflHHnkkAHv27OG3v/0txxxzzIL2sb8s+pff7/3e73HLLbfwP/7H/wDsmYzt27ezdetWLr744iVvoMfjmY3WbeJkhiSeQqnGSjfH00OS1JiceoLJyR8yNfVjtG5ly4KgytjYGUyMn8XY2OkEQf8qH8+BRcqiy0IfIQiG1u3VAWnm+WqS59AR6I1mm3ojotmObXRLoghijSrsX8VTojVxvupcG7rcuTZopZBRAu02QdvGtKgkQiuNFoZE4KrNsZecL0Elaq807y/MO5IcJ8lFjyTP5HnvL29jwOTEudH9LPWsSnMGVZrntzE925p8xeYcYnwxUrx3tXk368ijQQp1UfszgBG5SnKZyyQP9kmUJ9jOB5sUqOsiNVOyueSukrxpCjRNkfYASR6iCIVCCvtoCzSBEag+ckgjZ6m7AMVwYOX4WNFQNDNUZeQqze38iowG5gQfELqk+DoU4mud/Rb6fXYg5l7cnwF/7xUS8um/Vh0Kgj6vydnMroxfKgk/qyo+TYbpenxy955G0miRfupgT7TZT5sKCZUgwph6704ASIykpToV7Q1Vpq5KzOgSM6pETEDdFKknRX4za2soicTll0dOurez8WrYOXk3V3V7Jty1cnEy/R4aOVC2K2kjZNo9fzoBBFpT0Ioxo3mZbhLqOqHRSGOsZAZaSKZ0gemccJ/WBaazKnfbofiULjI1R5V7Sai+on3EVboPy5jQ/b2MAZUm1e+HfHfKG+YT8Glee2Ib3/VQCTKxnt2kzFW39/velJfsHemezZf2+5+xPY97PAcVL730EpdeeilXXnklp556KiMjIzzxxBPcfvvtXHTRRX23ufzyy7nxxhu5+uqrueGGG9i+fTuf+cxnABb1+/YVr3gF99xzDxdeeCFCCG666aasej1l8+bNPPzww1x22WWUSiUOOeQQzj33XHbv3s3tt9/OJZdcwne/+12+853vzCvJ3/ve9/LpT3+aiy66iFtuuYUjjzyS559/nnvuuYfrr78+E+Z5fud3foeLLrqI//gf/yNf+cpXGB0d5aMf/SivfOUrefOb37zgY90fFi3UP/vZz3LJJZewadMmms0m55xzDjt27ODss8/mtttuW442ejweQKkmSTJNnEyjVWv+DTwHlDjZza5dP2Fy6h+Ymfln8hWfhcLLXB76WYyMvAop5+4YynMAEIJAVrNORYNg/UW5aKNpJS0aSYNm0qQRN1aFPAcr0KN2TL3ZptGIaEUJrUTtd/V51kmoNsS9VefaoI3GKBBxgmjHELcx7Qij2hitiNEoQKU2UWDzaffjV1yvJO+e1rmKcg3SINEdad5PkvfDGNDzVZzP1t0DH2+TCzQw2drk5U92v/n2zTLzAxvcV3rP8jzLRFbpqcNOJXkauWI60SudTiDnJ0bSMjZypW5K1EzJSvL05mR50keyCTQlkVAQikBqqrQpI0iMpK1DktzX9YSAZEA0SiiUqyRvMxS0GZYRQ4GdrrrpfFX5SHWCmcbexT58C2efxPjq6BTvoMEYhLEdDEudGzcGoXvGjUZo46a1Wzc3nRvPdt/vx7sQ3U8NN9J3Xm5zIwRaSnRgJZvObgId9MwP7HDwidjVIuP3pTLeuM+R9D1Zd32m7FsHr6LzvijSkwJke7XYz6jsc0RId47WHkGApBhEjCBt/Ez+eAxEJnSivUJdlairMjOqyLS2JxXbJmSXCtmlqrPyy0M0IzJiLGgzng3bjAcRFdFftg+ubteQaPqHpIvZoj0IMTIgEYIknP39XRpDYDQFrQm1ZkxqXqYbhKKGTN+q3cOhDMy4KvdB0t32ZTF3ljvYaBmbY29vwzJhJEjH7bDSFbe1GPnuHg4n4UVOwtvpASLeCESiEMmgkxlkgt3IjnDPhmlG/hwtCoKAUBsr291zrCPi85819ioMe3PrCkijkHx1vGctMDw8zFlnncXnP/95nn32WeI45qijjuKqq67iT//0T/tuMzo6yre//W0++MEPctppp3HKKaewbds2Lr/88q5c9fn43Oc+x5VXXskb3vAGDjnkELZu3TorqeSWW27hD//wDzn++ONpt9sYYzjppJP48pe/zCc/+UluvfVWLr74Yq677jq+8pWvzHl/1WqVhx9+mK1bt/Lud7+bmZkZjjjiCN7ylrfMKePvvPNOrr32Wi644AKklJxzzjl897vf7YqzWU6E6Q24WSD/9//+X55++mlqtRqnn346b33rW5e6bSvC9PQ0Y2NjTE1NLfhSg7WC1ppdu3axadMmpPQ/WNYCSVLP4ly0njuvynNgMcbQbG1ncu9j7Nn7Q5rNX3Ytr1SOZnz8LCbGz6JaPX7dVjyvJYSQBMEwhcIoQTCCXMJ4jtVAW7Vpxk1bgZ7YCvR9+2G99CilaDWdQG9GtNrJwrLPjRlYoZ7POo+1QilIjMFog9FWnBttEFEE7RidRBBHGBWj0SiRaoj9p780dzXnMh+9sg+yPI9xVen5y957LHav0+6KaMmqyjsV5p1tXNV+3yr23B5zIvxACfB+iNyPZplriUjFkKseJ5dNjrad+tEre+YgzSdPK8pnTDmT5XVTpIGtKO/XcWeApiIjijKxXXu6qnJlJIkJaGmba74QiVwQCUM5QZ5K8/y84kKzyh2LEurzynEvxvcLYwiUIogTwiQd2vEwTgiSBKm0XUcpZKKQ2k0nGpnOd+t0hopA6e5hum2ibHXtOkY7CW9ykl1L0SXdVRiiCgFJGJKk4wU3HoYkhYCkUECFAUlYmL28aMdNTgSOVEeZacyOSD2wGPd51K/yfTE58Auk54IRk4uUMQjQBoO053+NJD1bIrHvic2kQl2VaShb0T6jS0zrEjVdyMRpP4ooK9j7yPaCyJ3cyTpE7ZbsOpXt874WRE6yz85t7/fmGxhNoA0FrWwHqdp2khro7gAu4x4Ig+00esoUmDEh07poK95dpMy0KlDThX5BLH0J0Fa05yR72omsFfFJrtp96cjke3b9lnD/d4R8tl5Obks3T7tOaEUwW7qHhcKgcwz7gH0ch4eGeM/v/dsl2+tqYj27rcXSarV47rnnOPbYYxclltcDd911F+973/uYmpqiUukfR+XpsJjnyqJtwvbt2zn00EP5N//m3/Bv/s2/yeYbY/j1r3/N0UcfvfgWezweAIzRJEkt61jUrJJqUo/FGE29/gv2Tv49e/f+kHZXp6KC4eGTmBg/i/HxMymXD1+xdno6CFkgDEacRB9CiPUheRKdZOI8vSkzoCJoBVCxot6MOgI9SlBq33+wJVoTa2zeubLxLVpp+4PYiXOjFKKdYBKFUhEijtA6QQmNNgaRVmXtx7mtVIHbn+gKIwxGKCvNc7I8FEvwt+iNa+mqOu8V567aPCcMOuLcbe/K0e1jYekV4ivx6kjFePdP7+7xrjnZWYuOHO8d0pM1POiZlyC6qsqnTdlKclPMOvdsEdLvSVMWVmSPiQYvkzWbVW4gQRLrgKYu0NAlaro8OKI+ewwMQ7LtoljaDActhoM2w1mleZuiXMLXd/4Ei0l7Kuxu0bqT48ZkmfIiG+7je5IxhHFib1FCGMdumGRDmSiCWCETK66DRFlBHic94wlhrAhcfIKWkigskIQhcRCShIEbhlb+ilxlthAkUhJJiRZFO68g0SWJkjKr6FZSooXESDFre4RwVeou3MO9h2Qn7VxGSK54OXdGrTPT0POMMYpCoghVYjt+VDGh6j8vTOflpGb3e5Nx++xU0kulkVq7aW1PIOjZLzRpDFIpUGpgpe9SoaUkCa1s18US7WJAVCwSl4pEpYIdFovE5SJRqUhcLNihW67CcImrZu17ZrCAD728bs+r9kVVvPeczRX511h2Hs64Y0z3a9eQWlAoRIyYaZfxLhHGhY9oSdOJ9poqM63LTKkSk7rEjLZ9SOxWVXb36SjVZrZ3BPuYtOJ9JIjsxWf5JvdUtWvcdwv3WQymk9ve77nUU9VuI2RsjEwUzL4yKRPsOckeak3JaA6lzaGiDUE9y1RJpbs20DIB04TUtBXvM7pAzRSYUTZWpqYLNEyIQnbiZeagLBKGZEJVJFSlG8+mlZ3nlpUXcOI2++7RPXPh9OuHNpXy1WGSRr0TBSMlSBcZE6TzbAepSAkyXaffdSB2KojX94lFz8HHnXfeyXHHHccRRxzBU089xdatW3nPe97jZfoysGihvnnzZk466SS+9a1vcfzxx2fzd+3axbHHHjsrlN7j8cxNp1PRGZSq217tPasGrRNqtX9m794fsnfyMeJ4T7ZMiJDR0dMYHzsLY17Nxo2HIVc0eNYDIGWJsDBKIRxdFxn1xhhaqpXFtjSTJtEqu2IliRQzjRaNZkSjFdOK4n2Ob4mVJk7FeawpJJqadhXVysW2JAaZJCiVYJIEk1h5roV20Se57yJ9okXmI72c3giFERpyNyE0Uizl+7QT5/nL0dP5pC68u4LOYFy1n5W4xuSq3ef5XbicanQxcnxQO8xAWQ5aSyen5/+LaqCNleUzusSUqTBjSjbD10nz/vErxmaJBxGHyUlKMrGyXBi0sbK8pa2An0yG+lam91IScU6WtxmWLYaCyIpz2d7/zPJFVY/nxwvutniE0RRIKJiYAgmhSbLpAEVA2pmfIkRl43Z+QoDumW/HrQLShD3zpUuEl7hYJGM64zlJLt1JKJmT5kFak2vAJAIVCVQs0ZFEJQIdS1QsbGeLpkyDEk3KtCjTFCUaokRLlGjJEk1RohWUaBSKtIslonCYdrFINFykXSja8S4hnhPjYUgShMRhITcekgSdZeZgvoLURWdIl0udjgfaDY3NsA514obd4wWVuFtMMUkoJDGlJKKYJBRjNx5HlNytkFixH7irALpOcuSuEsiW55e5dcM4yar8pdYUI00xiqHeZHiRh6+lJCoWugV8qUhcdMNSgXalRLtSplUp066UaVdKS/Kc6bxLD8593y/pnp3E63x2pidnbGRIKjxTAa/TC6IwQMVElA1M6PTEqiDQAeiAhip3i3Yn21smpG4K1JMCv+n5a9iOQSNX1d7ODSMqMqHXf2eiHYHSwk1rjNZglG3TXLnt/fLaAyvc28FsHZNGyAR9hHsADKEYQoFsuw16HmoJsRHUdEgNW+Fey8R72CXeExdX1lIhL839V8weu2pOvqfjQ7PGFWWRUBR6SfrkyL7vYL8Horq/h8133ZkRYKToEe/2ipXIrK7v1B7P/rJjxw62bdvGjh07OPzww7n00kt9PPcysU/Xu5900kmceeaZ/I//8T94y1veks3fx/QYj+egw+ah2yp0pZor3RxPD1q3mZp+ir17/57JySdQaiZbJmWZ8bHXMjHxesbGziAIKmht2LPHdw67kgTBkJPoI0i5tvPQE53QSBqZPG8lrX3okGx5SWLNTKNJrdGm0YiJ4mT+q6X70CvPo0TZ36OpONcwDMRRjFYKkyToJEabGIOrTsyVMi3mqmWDAZGrMs8NhaswX3gwyELvtFPpJlIJblJh3rkwn67M104kS67xB4zZkrwTsZLlqrLwxylNqTFaYFSvNF+YMDfYzPKmi12Z1mWmTIW6KVJzwrzdp7I8rQQfCttslDNUZZuCUAgMGmk71dMF6q6y/LfRMHoeYZ6vLk8FeUea2+ryglzk63efBXl+H4YiEUUTUySiZGKKJsrmlUzEsAnR0QwhCQWTUCCmYJKu6Y4oTwjdcpsEf+DfkwxQN2VqusqMHmbGVKiZKnVRZYYKDSrUZJWGLFMPKjRkhXpYphlWaAYlGsUKrWKJZqlMq2SH7YIV4VFx7grOlaKk2xS0ffwDYyNaAlRHOqM6EhornQNj+2ZIxyUdIZ2uI43unGiA7JSEFtKe0hDSns4QnVMZ+WWdeZ3tdG4fiQhQwm0vJCrNPxcymzcrX10Iu82COvPcf4QT9EUVU1QxpfSW9Eznlhd71gkwiLTKPifcR2WRZGovhSii2I4ptCOKUUShHVNsR93z25GtpNeacqtNudVe1HG0S0Xa1Y5kbznp3plXypbpcN8f24VK93zETDo+8DtM9l6nyZ8HT9/SBAIhpatsz9+1AaOsbKdJSUsOMQZhBFJLQiNJVIm6KjGlykzpMpOqyJS2wj1BMqVLTOkSz/c0qSgUE6lkD9rZ+KiMCIUhlGkDA2yoSgllBNoYtBFgNCaV672yvd+Fx306SVWuup1Ct6oRgMxVtgfuxFPo5HuAuwJNQxHDBhGzgbjvn8xgJXPTBNRMSMOE1LNhQEPb8YYOqbvxtgnQCGq6QI1C999sDopCURKKktBuaMeLQlGS+Xm5dXrmB/v5ZUwYEMoACnoy3gteYXnWGddffz3XX3/9SjfjoGDRQl0IwZe//GXuuusuLrjgAm6//Xb+5E/+JFvm8XhmY4xGqbqT6DM+D30VkiR1pqaeYO/kD5ma+ke07nT8GoajjI+fycT46xkdPRUpV+cP74OJNA897VR0LeehRyqiETcyid7Wi/sxfSCII8VMo00jl4G+6H2k8jzRtCNFHGuXd+5uuCqwWKG1QiUxJkkoFANarQZCq0yeL7wez8pxIwxIhUZhpBXp/az0knyLMWBzaFx0gVaZSLfH6LLjs3iWTpJ7V5XfMv7AE64mUGTj3Wp8sZI8Txbr3ltlrhaeX66BiCCT5ZM6rS4vUcfGsfQT3aFQDMsWG4MZG5ci25RljBU6gkiH1HSZGVVmVzxCTR+CWaAwH8liWFrZ+EjQYkhGyIWcyZlXkksbJUJC2cSUTZsybUqmTdm0KZmIIk6KZ5K8M17MCfOSiSkuJN9iid5qIkJiUcCq+NDKVKxQjQmYCarMhEPMBMPUgiozQZWaqFA3FRqU7U2WacoyzaBkb2GZZqFEo1CmWSxn8vtAVHBLrSmomIJKbCSJq4S2AsuK6FRQhyZdrty4JkjHjSI0SdfyVIwXTEKoEgrpuIkpaJXJczsvyarw7f12qv1Dkqyi385LsvHQJHbddD03HrhlIZ3x5T450qZoq/vzN8q0RImGKDMjh2jKCrWgQlNUqMkKTVmhKUtEopjF1dh4m4BEhiQyIJaBG4bZeJKNd9aJe9ZPghDtot+MkESBJAr2veOygkpmy3YVMywEYXOaShJRSdruFlGJ25RVNCvSJkiSLvGel+15+V5qtSk3W5SaLUqtCGEMpXZEqR0xunf+zPa4WMiEeybbqxWaQxWaw1WaQ1WaQxWS4j5euYKYJ2Im7VBVzy3cTW4kf/V7tmtb0Z6+k8ogn2OlSEiAiKqZoWrg5UYitSQwECQhLZ0X7WlVe5FpXSQyATtVlZ09ETICw6irau8V7mWput7SDQFaFFDGKm5tXNyaTuz3AyfYhbtCbaGdpBrZke3tsDArIkgYQ2hysj2tbu+T254m8AyhGBIKxNwfCAYbk9YkoK6tfK/nJHwjlfBuWUOHWdZ7ZAIiEzAz5z3MTYgT7JPGXbVkCIW9UikQhsANQ6G7l+XG88vy25Qp8OgvfssbTzhkP1ro8XgORhZtINIq9GuvvZZXvvKV/P7v/z4/+clP2LZt25I3zuNZy2id5KJcaj7KZRUSx5NMTv4De/c+xvTM012Z9cXiIYyPv56JidczMnwSQhyYiinPYIQIM4EehsNrMg/dGGOjW5IGzdgOk1XYV0Ica2qNFrVmRL3RJlqkQI9dznkcK6JYEycao7TrCMyuYwCdKJRSaKXRKoYkQqAQOkGaxP5QDqsE85xkECiQnVgWLez00nU76hqcXYOei2XR5AR6Wn6drzB3Pj1XDbqc1eZpoIro+a8jzfefrMpcSSvMVbc4X0iFeeQqzGeMFeZ7dYWaKdkOPyn03UdFRk6YT2eV4BXZRmJsp3a60BHmyQgzaiOxmfurrkQ7Yd7JLh+RLYaDFiNBm6psz325elrm5x7j0CSZAC8TWTFuokyMl0kFuZtOl7v54UJL/haIRhBRIBJF2qKYjUeigAmHaChDQkgsQmIKxCLMptsUaARVZkJ3C4ZohBXqQZl6WKEVlGjKIokIiIWVl+2gQBQUaIdF2oUCreLydPxVbrcoRxGluE3JxXkUkpiiSijoJBPYgdGEaKQTKlJaiZJGh1j51JHigVYEB+wSEAGExITElGmmsw5wfZI0KjtZUzBJ7sqGzgmcAnHXsJid4LHrFUxE0SQUek7olNyJnzGzeJWmkDRFmTYuakeUaYgKdVGlLivZeENUaIgqdVEhEfOLYIWwcTtOuEdBaJ+zuVuUH4az58dOwseBjfSp0yeXdqL//QujKSdRt2yPc9J9PgGforWV6c0W5WbbSvbcuBXv7Wye1JpCFFOIYkamanM+RlGxYCX7UJXmcDq0sr2Rl+6LLqZL474GfaeeR7jPWdHu+gTIsv1tB5guIwYdKDQQFxXQYtxMMYFAJgEhIHWAVpJpNZRJ9r2uon1SlYgJBla1l0XSiY7pqWqXuXOoJghQFDFIGzkmJFprcKJd5CvbjbYftnPmtsuOcJe2085YBsQDOkpNO0lNI2Sy6nZjBfxcf00BFDAUSBiVC/tOmBhBy0jaBLSRtE3gbpIWnfHuYfe82D1XEncVWX05vjLPwGP3/ISHr3/zMuzc4/GsZ/arpO/f/tt/yw9+8AN+7/d+j3/4h39YqjZ5PGsWpVq5KBcfAbIaabd3sXfyMfbufYxa7Wfke4srl49gYvz1TEycTbV6vL/qZhUgZdEJ9FHCcGilm7NolFZd8S3NpLnq4lsAolhRb0QuBz0miuIFi16lDe1YE8WKKLaV51rrrgx149az8lyhk8TKc5PYynOTEM77uNj8cqRCZPEsGoTKflfvswYbJMvt3Xb/iCfNMrd57Tq3bV7gL3W1eVpV3h230tHkS316KT1EG8OSk+ZqYVXmMZImIXVdYtKU2aOrzJhyFsnSrzK8JGJGwxaHBlOMBq4SXLYIhUIZSUOXmFZlZrQV5s+2N9LQ80c8VV2FebrPEVdlPhK0+ueXuysIiiRUdJuqaVExLTdMp5u5ec1sWFgCIa4RtCjRdhW97UyGWxHepphJ8Wxebnkkim6dAi1RtHI7LNIKirTDgh0GBUxlhJpWXbIwElYwtoOCrQhfohOXUimGWk2qrSZDzSaVdpNqq0U5bttMaxehUdCJq9JWBEJnFYTC+SFCCYHwn89LiBYBLQJaYulOfkij3EmlFmXTpmLalE0rO4lUok3FtCi5ZekwXd9WlmqGTYNhGgt+D40oONHeke112S3dG6JKQ9t1lNi3n8Ia0Xmd5E8iuWlTHmHKGJqFEs2wRCMs0XKvQyMkzUKZZmFhj3dHwLcZilsMxS2Go2Y2PhQ3GY6aVJL24M8BYyjEsZXsjZatdG84Ad9oUak3qdQbVOpNilGc3cbmqHqPC2G3cM8J+MZQlcbI0D5Uui9GuOvOeHaWN/dEEbkRIXMpWfbzywh3Yr+g3LVvCmGgTJMjEBxhBIGWBEaAljSSIpOqwmRSYVKX2OtEe80UaZmQHSpkh+r+nioxjLps9rxwH5f2ZHD2tSOw158YUUSJAE1gjylX0S6caO+OkrHfQwb2uCuDLume5rZHUtqOU/sId2kMoe70Y5BWuqfLFvOJEArDsFAM78fnojZYIW8kLRNgykO0mi2UESgkCuHGxazxxNgoqmTgOtLG9ciAU448fJ/b6PF4Dl4W/S3inHPOoZjLGTz55JP54Q9/yLvf/W6foe456PBRLmuDVus37N379+zZ+wMajWe7llWrxzMx8Xomxl9PpXLUCrXQkycIKplED4LlqW5cLmIVZwK9kTRoqdb8G60A7VhRb8bU6i3qzTZxlCxIWChjiGJNFCmiOCGODUrprt+wBnv1stIarWwFukkiAhUjjUK4OINBpNXmQiqEUMhQIEtTWSprl99eKGnESr6KHJh7Z7pjlTEY5TpeWyZx3l1VLnt0+fIwqwPQRUhzg/2RWzdFpkyZl9QQk6ZTZd6vs84AxXDQ5shgMhPaNjalRYCmaawwn06stNje3sC0Ks+bqVwQSWd/MifOA1tpHgqbWV/VLYZMg2HTpGraVJNmJstny/HWPleLa0RX1EU7i7roTDdFue/8ligR0V35qYEoKFghFxQyMd7uEuRFWm5eK7csWYI4rDBJGG7WGW40GGo2GG42GG7UGWo1snnlJLKdPqqYglG2AjIV4tKgQ2k7WSyXiFxniyoM7HHaKOI+rL2rkDwWLQKaokKzX+X2fBhDERd7lJPwFVpUdYMh06RqmgyZRtcwRGVV8+Nm/vgTgBZFanKIGTFMTQwxLYez8ZlsvIruuUpRYiirmLLqLzJHqmPMNKZmzVdC0HRyvSPaSzTDIo1COj5YwO+pjA08FmE01bjNcOxke9Rk2An3TMKXWxTHej5/e97mwyjuEuyVeoNKrUk1m27aKJo4oTA5zejk4Me6XSrSGBmiPjJkh6ND1EeG3bwqOlzs+1NeuPe+adhPY512mmrSaSeie4+3t4JbpJJduK48DLF0/akYEMWYQ6hzKDYwTSqBMAGxCZiMS0zGFSvcXWX7lMtqn9RlJvXs77Klrqr2jnAfky0CYTBCokVgI4+CUtZ3gT1U2+9Kl2DXyhYE9Mtun1O4d6S7khLlqtyRQXfFf7rJLNFusgisQLvOhOf5Ky4GKaCCoiLscRRLIVFcX8J7gHK1yr+//JIl3afH4zk4WPS37L/927+dNe9lL3sZf/d3f7ckDfJ4VjtKtUhUDZXMoFTDR7msUprNX7N37w/Ys/fvaTZ/lVsiGRk+ifGJ1zMxfhal0qaVaqInRQjCYCiXh752MupbSYtG0qAe12nEqzO+BSBONLWcQI/a81ega2x2ejtSxImi3dYo3UeeI1Bao5JOdEuQtK081wlFk9ic0B56xblI41qwP4vTlPNEaOL5GpvLJJ8dxzL/42NMem821x2js8oxsovOyf7dF3FuJbn9mSkzTb68wjzFaJwol/smzSkypcu8pKrsNUNMuzzz2ReIG4ZkxMZwpktwj7jOOhMjmNEVK81Vhd9EY0yrw5hR5Tk7/xSYLLs8rTQfDlqMyQaHykk2MMOIsaJtyDQZ0g2GVZOhpMGQaTjh1kLuwx8uIXDVrWWauWGzz7yGKNMSZdoUB0YhKATtsEgzLNIKi7TCEq0gP+1uQTETb+1gX6IVOkitGW7UGWnUGGnUGanb8eFGo0eU1xluNinHLZsNbRQhGhMKonKJdrlkhXi5RLtctNNDJaKJAsghEob69rnn8SwKIdzVFkWmGVnYNq4TXivbGwzp/tK9mk03CdA2lklHHMLewbsG2/GtsIJ9xgl4K9w74y1K875OA2MYjlsMxws72Z4X8I2wTL3gbsUK9UKZWqFMvVChUShjhLTzi3OfxCiouKvKfThuMtJuMBo1GIkajNAgKRaYmRgdfBxx0i3daw2qPdNptnupHTHx2/6Pb7NazoR7fWSYxugQ9eEhGqNDNIaqmGAxatZ+lgazRHtaJW9QaSQb9uqyNFrGbU7/anacaLcn9GO3L0IQRiERjBQixplBYjW/cCeqZ1SJyaTMZFxmUqU3W9XeNiE7VcjOnqp2gWFEpoI9yirax4MmVZFY8e16V1AyxAQhuvfTbaBwT6d1j3Cfg0y4SxCB7Vw4le4DomWkMZl4T8ezGybrVLkzz+PxeNYmCxLq09PTjI6OZuNzka7n8awXtE5QqkaS1EhUDaMX0NGX54BjjKHZfN5J9B/Qav2/3FLJ6OipTEyczcT4WRQK4yvVTI8j7VS0ULCV6Gslo76ZNG31uatAX60CPUkM9XbMTK0j0I0eLBMNhihyleeJJoo1Saxm6ccEQWK6q8+DqI3UMdIkBLmOQ1P6iXMhNLna70yez6k7zaD88oU/Lgbl1neXiOs0wqVTdb6v4ryfMBfZnOWnq9pcWWFutLSZ5mZ+ad6gyKQus0cN8ZKx8Sw2mmX2tkOyzWHhFGNBk9GwaYdBi6ps0dQlplVHmu+KR5hWFWZUue++UiSa0aDFaNDkEDnNMcEujpK7OVzs4RCmGHYSbNgJ8qHYCrPFSHIDnQzmLHu5QtNlMzczMd6ZFzP7svj8/lpB0cU6dAR4KyzSDEpdgrzpJHkU7vsJw0qr6YS4E+Ndgrwzf7RRY7hRZ9RNh0YRl4pZZ4Ttcol2pYQYHWdaajs9UqJZ3shUuYgO1sb78Xqm66Jf0zN0490Cbe5x0zWe+y/vEvtsn53uMz3Ts9YVfebt13mgARibRZ1/pxb2WCIkM2IIQ9V2RC3s8RlhMEJjhHuXd8MyLYZoMmLqjNBgzNQZNw3GTZMx3bRD0yDA2OgZ0+BwdjHowpWYgJqT6814gt/qCpNilCk5yqQcZUqMLDpiplvAD/4NrhE0CiUn3CtWtBcr1JxsT6cjl/8+GRSYLA8+WVGNW12SfTSqW9keWflOAWrjI9TGB+8jjGKqtTpD03WGZupUZ+wwHS/ECZVGi0qjxct2vjT7mISgOVShPjqck+5D1MeGqY2NEJUGn7jsT77D1NnV7ZlgN7nsduG+I+Slce4+jQCFQaG6asCtfxYUQ81hpSYvN7ayPv0+kKiAyaTE3qTKZOKku5PtMQHTusS0LrG95ytmEcVY0GZMRowGEWOyzVgQMSablKVBC9eNsQit+KaYHWpf4d5b3W46Ve5ZIcRCpLuQuWgZK9y1CEike9wGiPds80y0G1fxnr/pLhkfCnsFwQp0N+HxrFqEENx77728853vXOmmHHQs6FN9YmKCF198kU2bNjE+Pt43t9AYgxACpeZ5w/V4VjnGGBvjomqopIZSzZVukmcAxhgajWfZs/fv2bv372m3f5MtEyJkdHQLExNvYGL8dYShP9m30qy1TkXzHYimAl2Z1fkZp5ShESXM1FvUGxGtVoRRg6+eiRMrz9uRzTyP+shzDcRCkhiXfZ5oSCLC2GafhzqhaOLsR9cgcQ5p7Tcu9XQOed4lzd0asYJosScu7I/FtMKcnDy3l4GnMmbhcS35DPPeaJYD+aPOGKwwz8S5XFBnoDGSBgUmdZnf6mF+q4eY1mUa9JfmVdnm0HCa0SAV5k3GwiYjskXbhEypKlNJhSlV4TfROJNJlZouzdmGgIQjgz0cF+7gGLmTI+VLHMYeNjHJBNOMmjojukaVtpVWC3i59UrymhjKxuuySi0dF0PURWXOTHCDjVZJ5XgavZAX5s1s2s7bl4xxYTRDzSZj9RnGajOMzUwzVpthtF7LDae7pkcaNQruO7YKJK1MjJdpV0qd8dESjUM3sLdyOO1ymXa5iBkgyAfFUnhmk75raJN2lWj/S6c7c9x7jMBVwqZyPH+qzrjzgZ03nXxsZp93p4z03UYY0RkfNM/QNS1M//WlsScDpVn6d7OlTwMVPcK/e7hYIuAld+t/b4YqTUaoMUqNEXcbpZ4br1GlRQHFhJliQk2BeoET++xvUpR5SVZ5SQyxJxhmjxhirxxmUo4wLUeBCiEBoSkQEiz47yHJi/fJwccrA+qFSlblXiuUqRWrTBerzBQrzBSrxEGBRqFMo1BmJxv67qcStzoV7VGD0XZnfCRuUNSKpFhgesM40xvGZ+/AGIrtqCPZe6R7tVYnUJqhWoOhWv8+qaJigZqT6/XRYTs+OkJtbJioPP/VAt0MyG5PT0KZ7g5S0/x1k//Yzcd0ifT1rdLdAyCN/RYhQ8NomDBhGrlr1ey7SEMVmIwr7E0qVrQ72T6ji0QE7FZVdqvqrBSXAoqxIGJURpl0H5NtRkNFWWgXIRPa6Bhhq82RQf4wuw/dmC7BjtG2o9Qe+W77fNWgtO08dZ7HGZleBSCzcSNs1IwSgjgv5/tEzoyWykzr9L3MyniBsbE8Tsp35ndkfbpcdC238wPfJ4dnFbN79262bdvG/fffz86dO5mYmGDLli1s27aNN77xjQC8+OKLTExMHPC2bd68mWuuuYZrrrnmgN83wNe//nXe97739V22c+dONm1a/iSCBQn1v/mbv2HDBvuB2i/yxeNZ6yjVRqkZkqSGUnUf47KKMUZTr/9rlokeRbuyZUIUGBt7DRMTb2B87LWE4fAKttQDaaeiIy4PfWhVdySXF+j1uE4zaa5qgd6MFfVGm5lGm1Yrth199vlVpJQmijTttiJKFFGkZnX/aYAY+0NGaSvPjUoI4oggiSiQIHSCNAlgEEKBVEihEFLb6dy+5pTnqWFaaKX5vN9UdJaVajsKtfuenXc+f9V5rzS39eUHJpall0ycpzEtqpN1PkgfpdXmNYrs1VV2qWH26CGmTJmkT0h1WURsyqR5q0ueGwRTymbCTiVVftneyFSjwnRS6bsvgWYTkxwld3FssIuj5S6OEL/lMLGHjUyxgWnGTI1CegVDzjX0IyLMohRqYsiJ8aFFS3INNi6hUKYRlmkUSjQKZephmWYhJ8ndTcvFC/JKu8loo854bZqxmWkmpqeYmJpirD7DaK3mhjNOoNcYbtQIekyjCgJalTKtatnK8mqZ1miZPYcdxouVcld1eVIYXDW/VrDvDwolNFooFJ1hZ55CC+3mKSuwhUajZw/7LXPyqzOd3y4VYz1CXHSGneV2+mBAGJAmICRAGklgJIEJCHBDY8V7gBtHdg/d+qEJKJiQ0IQUTEhB58Z7psN0Pd2ZLhBmJwXSd3fhTt9mKq2rEr/P66HP+VJ7bsN0fS4poUnss43EPdcS7PMuEQpFkZcYYad7PvQjJHGC3Yr2MWYYZ5oxphlnmgmmKRIzblqMqxbHs4d++UgzVJlklL2MsFeMsEcM8ZKosltW2B2UqQeGRCY2mUTYT6cAQSCC7HErUaSoi32iT6CoFcV2jYl2re9xpFfdzBQrzJSGnGi3t+lilZlS1Z50dJnuO4f6C/dy3GYsqjPWrjPWrrlhnfGoRjmJEEJk8VGTG/vswxjKjVZOsteozjQYnq4xNF2j6jpP3bB7Lxt27521eVwsUBsdzqrZ6258emyEdmXuE7/9ELnq9oCg9wllv8KkV94J9/wSZtb7tBXtOr9jAKSx+5cICmHMYUHC4dRy3zxsBf2UKjGVlJhKykw52T6tSszoIjEBv1UVfqsqs2R7iGYsaFvZ7oT7aBAzEiRUhAEZoBEYYYe2bQLSKyr6VblDp9I9i5fRiFTC99xEugedfktc6IPfLeCbrYItkBACg8Ck0j2T7z3T+XkD+P+z9+fBlq0FfTf+eZ5njXs+U0935l7Ei3AvggxCfMGZgsIB9BeLJL8fwWCMZap81QoUKloStIpgglZpWfHyogRRkxRSpigTFYtALpJggugr8x36Tt2nz7iHNT/D74+19j57n3O6+/S9fbuby/l2rX6eNey9115n77XX+jzf5/t0gq+dqMljff3pDW94A2VZ8nu/93s861nPYn19nY997GNsbe01BZ86deo67uFTV1mWC+N0HlX/8B/+Q1796lcvLHvTm95EnufXBKYDCHc8kuiCRqMR/X6f4XD4jIuvsdZy4cIFTpw4gXwSN4zPJNUxLkkD0CfHg4ne4HLOMpl8cZaJXlV7PyBSBvT738LS0rcy6H8LSj2JAbCeoqx1bG+nLC+3kPJrG3JcDUkV4c8GFb32f4+jyjo7i3CZAnR7JRf511DWQlZpkrwiSQrSrMRo3dyY7Mm5ueiWUlNUFn1I1ItGUAlB5QTGGpwxiEqjqgJlp4OHVihXLrrO5Vw3YPbgeV3OQYorheaXUC8cMCp2qbHKNNu8eSVX35y5pn4UeD5F5YsO82sXzbJfe+C8hudMo1rsxc8lBsjxGRGybVqcN112XYvJIbnmAkdPZQxUysDL6KuUgZcyUBmesIxMxNDUTvPacd5iaGIyu3hhK7GcYIebxQa3iAvcqc5zu1znJrHJabZYZRfviN+fVESMRYfRLIe4nqYDAl4uj9gBlfRI/AaQz4HyRWheu8mv1EUeViWdPKWX1g7xpfGQ5d0dVnZ3WN3eZjAZsTSu4flgMpo5x/fLCkHRQPIiDheAeR7HNTRvll0PSD51qNsGIhpMXQpTA0YxN2FquDg3b8Tcsvn5BorXk2me39aIUhgs5hkGqOuGuL1Qh6lTXFC/zdncwv9Th/ich7wG2rP6nguz/r8507q9M+70XDgF/3a+UWB/I8EUTX+NNBJIJ/GcQlED+il4D5zfgPl9pd2/fFr3Uc1RPQgEG1jqPLxZY8Bc2TQseHONCdI1f7v9Tza1LeMQyLr3QvN7ZTAIMSZkk5gtWmKbttihyy5ddhmIIeHFBo6c04g22yyxxYDtZtpiiW0GaLzm72oxUlPJilJWlLKkkroGvrJx5wqBFHUjiCcUgQuIXEjgwmZA7IurUP4MtM+Ae7hXLy4Ta+WbisE+0N4vJvTLhHaVHwl1K61pjxI6owmd4Zj2cLIH2yfpJZ+j8r0ZYJ/0u7NyMoXtzXl49mv2VL4mYjowavPxECx8Ny/3ZmvQ3jTtO5o+C3tnjamME4yNz2gOuO/qiKEOGdvDxjvZk8LSkyVdWdGRJV1V0ZGatjS0lSGWtbvdzQ+KeqWaDgjv7N614RS0z+r7lj+lA38RXQS6e0rx0he9kO/+7u+++q95nfVMZltXqjzPeeihh7jjjjuIooMDBd+I2t3dZWlpiY9//OO88pWvvOh2+yNfPvWpT/ETP/ETfPGLX+R5z3seP//zP88P/uAP8tnPfpYXvOAFfPzjH+fbv/3b+Yu/+Ave+ta38vnPf54XvOAFvP/97+c5z6n7Vz3wwAP89E//NJ/+9KdJkoS7776bX/3VX+W7vuu7AHjVq151YBxN5xy/9Eu/xEc+8hH+5m/+Zrb8ve99L+9973t5+OGHgRp67+7u8uIXv5jf/M3fJAxDHnroIR599FF+5md+hj/7sz9DSsm3fdu38eu//uvcfvvtRzpeGxsb3HTTTbzvfe/jn/yTf3K0g3yIruSzcuQgt83NTZIk4bbbbpst+/u//3ve8573kCQJP/ADP8Ab3/jGJ73TxzrW0ynnDMakGJOi9fg4xuVrQM4ZxuPPs7PzKXZ2P01V7TlQpIwYDF7M0tK30u+9EKW+Nn4Un8lSqo3n9/C9LlKG13t3DtUUoCdVMgPoh3eqvwHkqB3ouWaSFmRZga70gRgXXVnKUlNWthk89GCTQB3dIpr4FjDaIKsKqSukLgicRroSRYkQFUJYpDILrvP55zLNDhqmXYLd3s3Sk4Tmhx2AaWSLw2BdtQjP59ZfDJ7Pg3PZwK7r4TSfapZxPnWbzw0QerG7ao2oBwR1EZumzbrpsutiCrwDj1EYlr2kAec1MB94KT2VYZ1g17TqvFbT4uFilV0TMzbx7EZ7D5if42Vik5vVBrfLdW5roPkJdvEuk8FiEUxEewGUj+aA+XSZvkiOsKOGNRM/JgmivWiCJn4g9Rpo7odoeQVZxM7VmcBZQj+dMBiPWB7tsjzcrSH51hYntzZZGg8ZjMcE+tJgy0pJ1orIWzHry6fJWxFZKyZvxTUwb0D5lccOXGT3628BRmi0MGih0UI34Ht+mWm2aZZRb1MJQyXrcrqtEbqG23EN2q6nHAKEjxMBTviAhxN+XZ+VHk54zTpVz+OBUDjROKiFwJMSBXhCoITAF6AEeKK+6VHC1ctweMIhRQ2UFA4pHAqHarCREnZu3V5dYZptTbNsWurmsXXDo6w9nwv1vWX1MIJiYRtz6GOm29cSs2O2d8oTODfnZXV7QH/BuT0F9A3knwJg5yTOSbAS58RcKfbGZbD1a1jX7I0D6+q9t67+XbDNT4BxoHFUOCrnKHFUWEoshTBUWIqmXmAo0BTCkDtDKSwa0A6ssJRibxjIpyLhxOEQ3vmELiC0AUFThvOlC/Ccd+gvhztQ33PNd1p9Julw1sgsZ6/fJ7Ar+E4RNNA/cB6ekUSuoM02LbdDy20Rs00ktmmxTcwWvsjpkdAj4XYe2787DOmwzRLbrs+WWWLbDNhiwA4r6Mvc8jscRhgmKqNQBaUsMbJp+JJNc5GQeCgC59PKA5az8FAXfCE9xmGLYdBmGHYYhu1m6jAOYirls9EasNEaHHisZzW9ImmA+x5o7xcJnTKd4VzjeYyW+4yW+weeQ2pDezyhMwfZp/XWJMWvNIOtXQZbuwceW8fI1Nnwe2WHpN9FB/6B7etjN2ckOLByOlDq/HrRfI3rsobtsyubpqwbzOqeNIuxMbAH2sW0LqDvWQZeCeF4YRdq2B4w0gFDEy5A95EJMUh2bMSOPfxeSmLpyIqOrOjKko7UdFRFW1ra0hAri5SXge0ziH1wm4tdMs6uL1l0uke+pCjq3pKzeMD569B9pVh8Ug7LodIVfOELX3hGAvVjXVrOOarq2o+P5/v+kXptdzodOp0OH/nIR3jZy15GGF7+Hns0GvG6172O17zmNXzoQx/i7NmzF41k+bmf+zl+7dd+jbW1NX78x3+cN7/5zdx///0ATCYTXvOa1/Cud72LMAz5wAc+wOte9zq+9KUvceutt/LhD3+Ye++9lx/7sR/jLW95yxW9f4CPfexj9Ho9/vzP/xyAqqr43u/9Xr71W7+VT37yk3iex7/+1/+aV7/61fzt3/7tkRzsH/jAB2i1WvzQD/3QFe/Pk9WR70b+5b/8l5w5c4Zf+7VfA+DChQt827d9G2fOnOHOO+/kTW96E8aYp9QScKxjXS1ZW84AujEpxuaH/oAe68ZSDdH/nu2d+9nZ+TRaD2frlGoxGLyEpaWX0++9ACmPu+ddVwmBpzpNHnoPeSVw6xppGuEyBeipTm9cgA4UlSUtNZO0JElzdKmxxszuNqy2VA04L6s6vkUfwsFm7nMh0dZhtUbpCllVeKYgpEBSIimQQiOUnYM1e9pznzuMbTo1X3Vw3ryWm2a4790I1S9lcdZgdTW7zZxt1mg6GOheqrm6bm5zmLuXm7rN55znFwPnFsjw2SViw3Q4p3vsuBblIZdpoag44Y1mwHypAegdWVA6j10Ts6NbrFddvpSfbLLN6xvlPhPuEOf5ZnGWW8QGN3sb3CI2uFVe4BTb+Ic0oizup2AouvUgewuD7dXlWHQu6gbXQjaD49WwfDIHyxM/ZtIAdCOPPiBmYCraZUYnT2tQPhmxNNpldXeHE1ubnNzY5NSF85zY3kbZy0NjKwR5K2Ky1K0BeXselMc1RG/HRxoMr3Z0l1QN4K7Laq4+X1YzSF4JTSUN5QyMVxg0B+2wV0n73kYNtYMGaIcN0A6b+QCm62UwN+8jhYcvJIEU+ELgCfAbkB1iCbAEzhII3ZSGAE3gTL2MEt+VBKLEd1VdUuGT4lPhCY2HRol68tBIYWbzX/cSF6l/DcsaD2e9WWmMjzUBWvsY46ONR2U8tFWUVlFZSWEFpRUUDnIHuXOUVlI5QWElha3x/F7kjyGVmpEs0XKCVhVGVlSqxMgKLetxQg7C9vBwAN+AeUQHOf+dFQ5DiaFkaunZD+GnyxwdoAPcNrfCEbmCE2bEmh2zZoYsuV0Gbpuu2yIgo8+kPsfz6MJxdE6QMWDsVthlhR2W2KTPJn0uiDapqBugPefhaY+Wbl/2b+Nw5LKkUCmVrNBS42QTiWNB5YJOrljCJyIkciESiRaS0RSwB3ugfRi2GYUttPTYjvtsx4eAcmvplQmDvI6sGRTjWT3Wxexjbz3FeKnPeOmQ5zCG1njqbJ+C9jGd4YTWOGliZLZZ3tg+8NisFR0C27skvXY9TsURvne2Pnh7BN7tDVRaP77u4YKo88OnPRxmgL05+nXE1UHQLtze8Oiq6fGihKDvFQy8AliE7dbBxAR1bIwJGJuASVOOTcjEBFjkbJDUw+VoC12722ew3dCRmkg5YmkIpDsUpl9SMzf54uPCdkhOcbTnmMUB7gPtM1BfLwuU4uUvf/mV7d+xnhGqqopf+ZVfueav+/a3v/1IgNjzPH73d3+Xt7zlLfz2b/82L3zhC3nlK1/Jj/zIj3DPPfcc+pgPfehDCCH4nd/5HaIo4rnPfS6PP/74odD7Xe9618z5/ra3vY3Xvva15HlOFEXce++93HvvvbNt3/nOd/LHf/zH/Mmf/Ak/+ZM/yfLyMkoput3uk4qcabfb3HfffbPj8MEPfhBrLffdd9+sseH9738/g8GAj3/843zP93zPZZ/zfe97H2984xuJ42vXQ/7IBOTTn/40v/u7vzub/8AHPsDy8jJ/8zd/g+d5vOc97+E3f/M3j4H6sa65nHNYm2NM0gD07DjC5WtIUyd6DdH/ah9E77K09BKWBt9Kr3cvUh7uDjnWtZEQcm5Q0S5CHB18XQvtz0BPq/SGjXCBemDQtDQkecUkLaiKahbj4qxr3Oc1PC9KS2XtAYbtaNznSCoh6niXBqCrqiQ0OVIUeORIigaeHw7mLA5rwbm9POGrDc7rfTbNfeQcPIfZTY5z09tGBwicNfXA5wvxLNc3pmWqQ3POjVx0hc5vT51xPiZk07R5wvTYsh1SfPbfjYei4rS3y5KX7rnOvZSIigK/dpvrFo+Wy/xdejM7pkVmg9q9KM7zLHGWO8R5blfnud1b5w5xjoFILvl+DJKR6FwRMHfUA3mOg5iJHx9wl0/nc+/oPVeiqqBd5XTKlEEyZjAZsTLcZWW4w9p2A8o31hnsjgjKozmLKt8n7cRk7RZZO55NNSivyyIKcFKgMVSyohLzk6YSO1TyApWoKOfXST2rT0H40+X6dvg4GTaQOzxQR+xfF4EI8KUkwtHC0XKWGEPsDBGGEE3oNBElESUhBQEFgSgJKPApCUSGL0o8UeKLCk9WeE2ppF6Eh9dZzkpwCmcVzimclVgncU5hm/p0qt3ZtfvaMS2ny+Tc/L5lrv6eOycP2V406+pGNMc0C3zqGmdvmznHuZh/rFUIq8D6YD2wEuEkWAXTOJjmPbkGn+FkPVG7zWexMs0kLQgnkXYe4lmEcNCMh8F0QOmFuqm3m5YL9cXH0YypIVSFlBVCacS0nC2rELKeX9hOVfW+NJJKg9Koq3zp55zA6hCrQ5wOMWULU7WwZa8p25h0uqxFVYWUOqA0PoX2KIxCS4OWe9Bdy4pCVqSyRKuKs8kFrKxA1sdHCoeU4ElXNzwhiQiIbYh3kR47s/2l/tiUhDymTvCYOzFbPj1asctYtruzaWlW3yESJS12aIkdTvLVfc8tKNwKmTtN5s6QujOM3Um2WGUifHJKMlGRi5KMkrw5xwkEoQ0JLwpZFzUP3021Tpg4TkjHKerIGR+fgJA8GDCKOnvu9qgpgxZWKnajLrtRl4f3PX+gSwbFhKV8wqCop6ViTD9P8OfGwrFKMRn0mAwORl9Mne3d4YTO7pjOsJ66wwlRlhOn9bR2bmPxGApB0m03kL2zANuzTmuh8VU2f8uLq/GnN7x3Gs8DcsHVPtuU+fCnvVgnjaXaR+v3ctpr8K6or+t7XknPO/y+2TpIrF/DdR0sQncbMNa1wz1xPonxWTcc2qFE4IiFJpaaltRN3RJLQyQd0ay0+MJdvfSz2ROJSx53Lwj4lm/5lqv0osc61tXVG97wBl772tfyyU9+kk9/+tP86Z/+Ke9+97u57777eNOb3nRg+y996Uvcc889C1ElL3nJSw597nkof/r0aaA2Tt96661MJhN+6Zd+iY9+9KOcO3cOrTVZlvHII49clff1/Oc/f6FR4XOf+xxf/epX6Xa7C9vlec4DDzxw2ef7q7/6K77whS/wH/7Df7gq+3dUHRmonz9/fiG75i//8i95/etfj+fVT/F93/d9/Oqv/upV38FjHWu/5uNbptPxIKJfW7o8RH8Zy0svp9t9/g3pfP56khDeHETvIK7UYfI0a+pAT6uUVKc37CCiMDeQaFGRpCV5XmKaGJeZ+7ywlFpf1H1ugErU8LwUEmsMsjJIneNVOaHNkLJANS50oQ7tg4yzdQROHSXhZr1mr7YOwHOYc583rqv5F3c0HnM1i2nxCYm5/rFOM3iu5WVd53VDhyRxAdsu5rzusW67jF20vwMyCsuKl7DsJSx5CcsqYclLiUVJ7ny2TZtd3eLBfG0W2+K7itvFee4Q53mROM/t8jx3eOe5TayzIsYH9mdeI9FmRw7YEf0jAXMjBIkf18A8aDH2Y8ZBi0kQN4PV1V34jyJlDZ0yo13ltKuMXp6wNB6yurvD2s4mpy9scPrCefrDMa1JSpgfzYVWBv4CKE86MeN2wLjjsdPz2ekIkshSiopSlHWmsMgpxXgfOK/B+NXMlq7d3hFORlgR42Q0m3eHzCNDAiGJgC6WtjN0bEUbQ8tWxBTELidyKREFocgIyAnFLr4sCESBJwt8WeLLCiUrPHUNHdxOIEyAtAHC+gjjI6yPtD7CBHP1enk9H+CMRwVUDkrnKB11VIiDwjp0s87YOsLAWIExoJG4JqLEGlVDbCdmvRLFzJXIXk/F/eVTfs8ACmE9hPPB1aVwXl1nrt5M2GldzerOKoSrp6Pq4v1eFndv2uPo8PUOhK3znkVzPhb1MteUtk6CwQmHkQLblEZSl0qgZTOp2omslcIIiZaKSspZ75NZ1PjMnC2aNkiHwKBUhRR1g42UFUrUn2NfFMQuJSYjIiUSGSE5gcwJRI4v68++Jws8VSBVifQKlFcgvQLZQEMhHMrPUX5+5OO8X6aMsVWrhvFlC1u1MWWMqdrYsoUp25j8BDrtYoouuuhhy5h5t60RmlJllCrHqBKtSqzUICtcA+KVdCgBSta9PVAapyqcqkDu/UUrEXFenuI8p2YNOPXBdkQuY9ntB+31FFISiU0isckSf7fwHlPajMQJEk6TuzNU3IKxtyLNKsIqnINCVORUZKJsoHsD35sppcAKR2DrgVIvJykmKLlFR1WckhonXfO5VFRBlyxcJg2XGTVgfSfqMA5alF7ABW+ZC4cMktop00Nd7fMRMnBpZ7tXlnSGE7rDcQPbm/pwjF/p2vE+mrCvcwBGKSbzWe0NaB8PupeMBFsE73PnsOks9QZO1JDcib2RGOpN9q6p6u/+9H9X825RGycQuh4XgGk0Tf14NR3fQUBXVXRVBYf8+ZyDzHpzrvba2T6F7qn1yayHQ5A6n9T4bF3mMl1iacmqBu9SE0vTTJZIGlKlKI3EF44AhycuehiPdazLyvd93v72t1+X170SRVHEd3/3d/Pd3/3d/MIv/AL/7J/9M37xF3/xUKD+ZPdj6gq3TY/On/3Zn+XP//zPec973sNdd91FHMf80A/9EGV5aeOqlJL9w3QeFqvTbi/2hppMJrzoRS/i93//9w9su7a2dtn3ct999/GCF7yAF73oRZfd9mrqyKSq1+uxu7s7y1D/X//rf/GjP/qjs/VCCIriiN1vjnWsK5C1BcZkdf65SbDmyV8AH+v6yTnDePIFdrbvZ3vnr9B6d7ZOqU4D0V9xDNFvAAnpzw0q2j5Sxtu1Uq7zGUBPdHJDA3TXDCSaVoY0K0nSGqCbUmMrM4tuKUqHtgazj+3ULqManNcudAHWICuN0jmhTvFcjhJFHd+C2d8zdub6tlPXuXlaTOeNbOMun7vrm7nPa+c7c+7zekA+SZ3KOs04P6jr8elzdi6yRV8663wa17JDzLru8ITps+tizCHZsl2ZNeA8nQH0vsowTrJj2mzrFo+Uy3wuvYWxDriJTe4ST/Ai8QB3yPPcLs5ze3CeVTG65P6PRYsducS2HLAt+mw39R05oBJ7F88OyFWwAMcnTTn2a2ie+NGR7lajqqBbZbSrjHaZ0ykz+mntLD+xtcWpzQusbm/TniS0ximtSYJfXR70loHHpBMx7gSMOj7DjmKnp9juCDZ7sNlzTEJNIUtKkVKJXSr51AGyQ+BkCydaWNnCybiZr8v9y5T0iaUgkhBj6dqKrivp2IK2S2jbjJbLaLmUiIxIbBGSE8oMX+b4qgGCF3EKXg05RxObUU9YH9eU0vhIE+KbCN/EhLpFYFooG9aA3IR7oNyESLNX1svqbXCKypVkZOQuI3c5hcsobU5hc0qbU9mC0uRUppk3u2hT7nXFX5jsJdNu5r+VT63PVAAiRDQufyGutLz6Pbac0+BKnCvBVUBVN1LWKeM4Z0A0dQxOGMCAaOoLpW0AuQFpcbKeR1qcp0AKkHI2ObV/WTMPeBh8DMppPAzKmSZH3qCcxcPMMuKltQjrkI13tpBBPRaCF5F5IZmqp8SL6wGFvZCJikm8mMSLSLwBiYrJvCtvVA1MSU8n9KqEXp7Qqyas6F0GekjfjuiZMW2b07I5odM4JUA5nLIIZRCeRvol0iuRfo7ysxmUV0GGCjL89tbR/55WoosOpuhiih467zb1LrroYvJpfQVTdLFVzKV+AY2o0F6BUyVOaaQ0CGWa+Wo2adViXfU475+edZ5yABbaLmXZ7rBit1mx26zabdbsNj03oUVCyz0EPLT3ohJyGbApl9mSyxRijYk4Rc4ZjD1B20Ws2jaxDWiZiJYN8KwiFxVpA9gzUZKKkkwUpJSkol5WCo1yipZpTQdrOURjYIzFUqgCLTWlcoxbHSbxEpOozyQaMI767EZdCi9gErSYBC0e48TCMylr6BcJg3zMUuNon8L20CzCHx0E7K4ts7u2D9g7R5jltau9ge01aK8BuzKG/vaQ/vaQ/aoCn/EMts9FyfQ76PAosZauaTDclwgmmjEU5n63lWh6rrh913+N4WHqcjdNWYm9K7lp6IqYutuRSLdnmG8pTUtpTpAeupe2ge6prYF6Zn1S683V6+Wp9Sidh0UysSGTi/V+2Hf5I3B1hJhs4sOkIRC2LqXFl3Y274vaAR9Iiy8sgXT4wiCuZaPzsW4oCSGOFL1yo+m5z30uH/nIRw5d95znPIcPfvCDFEUxy1z/zGc+c8Wvcf/99/OmN72JH/zBHwRq4D0dVHSqIAgwZvGEvba2xvnz5+vexc15aH6A0ovphS98IX/0R3/EiRMnrngA3clkwn/8j//xuhi8j0ytXvayl/Ebv/Eb/M7v/A4f/vCHGY/HfMd3fMds/Ze//GVuueWWp2Unj/X1I2urOr7FFliTok2Ks9d+oIhjXR05Z5hMvsj29v3s7P7VwsCiSnVYGryU5eVX0O3ecwzRr7OkDPC8Hr7fR6nW9d6dmQpT7GWgVyna3dgXvXllyMp6MNEkKzCFpspLqtJQFIay0pTaou3BNPf5wUNLIdGA0AZPZyid0TIpniuRskBajZw2JkyJtaUmwVisBesc04CXpwOgO0xj8Nwf3ULjTKjd57XxcOo3Vwj86zo46Lxm5lUt96Jb9MUjWwyCBJ9t1+IJ3ecJ22PiQg6LaznhjWvH+RSeqwQlLCMTs63b7Og2D+RrpNrjhNvlLvEYL5Nf4tnice4Sj3N7cB51CZI4ES125IBtMajBeTPtyAGl2Ls5yJXPKKjzaUdhm1HQYhi2a5e5H6PV5c+9U2d5t0zpVHXZLTMGkyEnt7c4vbHO0u6QdjPo23RS5vINXknssdP12O4ptvqC9T6s9w3nBobzA0MaAeTNdGVyIsLKNlZ2cLJTg3DVwck2VrZxoobiyJhAKmIJsagzX1uiomMT+nZM107o2oSOS2i5bVo8RiQyIpESqBRfZSh5dRv3rBUYU2dFmyYzuobhTZa0VmijMEZgtQLjIbSHMgGBjoh1h1j3iE2PlhnQ1su03QD1JMBvYTIKk1LYpjQphd2dLc9ts8xkFDbFPomGzqdyPpi6nUGBjBEiRMgYRIQQMUJGTT0E0awXERAhRACEV6XhuO5t0wBwSpyrgBqG11B8D447V8wtL3C2Qri9x9YA/er1vhT7yicrTxg8afGFwZcWr4FU+5cF0hBKQ6B0XUpNqJpybt4T9kju0koodrw+W8GATX/Apr/ERrDEZrA0m98M9spUtShVwKYK2AyXLvv8oS04WWxxutzkdLHBqWKD05O6frLc4FQx4VS5icJQKkWq2qSqRapiChWSq5DC96g8ifEExre4oIIgR4YpKsgQ0uLHI/x4BDx+2X2yVlKWMWXZpipamKKHzZZwyRo2XUFnA3TeR2cDnL2829HhcLLCKY3zSpyssF7Fhqq40IB565XYoMBTE1bcNiumhuwrdptVs82SGxJRcrM9z832/OLfCMWWXGJLLbPpL/OgXGVDrbBDn4iIlglp24iWDWmbiDXbqed1SNuGOJi52mfAfR+ET0VBRokUktjETbc9WMkBhs20F0cw8SVb7Zjddpth3GMcdxlFfcZRFyMV23GP7fgguGlVeQ3a8xq0LzXQfb+rHSEoWjFFK2bz9KKDUlhLa5LOomP2XO11XrtfVixv7LC8scN+5XFYO9n73T3gvtQh6XWw3mV+s+d75eztzTQ/Zu/qqyHi0+HbDz7P4lNMr1oNDi0sNWavo/lkY5KAOrMdt9cXTwpoK01bafAzLiXtBFkD1/dAez1lpl5WuIDcCkrrzYZtLpxHYTzg6NFy85I4/vLffYL/9n//X0/q8cc61tOlra0tfviHf5g3v/nN3HPPPXS7Xf76r/+ad7/73Xz/93//oY954xvfyM/93M/xYz/2Y7ztbW/jkUce4T3veQ/AFV3rPPvZz+bDH/4wr3vd6xBC8Au/8Asz9/pUt99+O5/4xCf4kR/5EcIwZHV1lVe96lVsbGzw7ne/mx/6oR/iv/7X/8qf/umfXhaS/6N/9I/4N//m3/D93//9/PIv/zI333wzZ8+e5cMf/jD/6l/9K26++eaLPvaP/uiP0Frzj//xPz7y+7taOjLBeuc738l3fud38sEPfhCtNW9/+9tZWtq7QPnDP/zDWaD9sY51OVmrsTbH2qJxoNd1d4PDsmNdXs5ZJpMvzOJcFiF6m6XBS1lafgW97j3HmejXWVJF+F6/caJf/0gNgMpWJGVCohMm5eSGB+jTHPSsNIyznCrTlFlJmZcUpaEoLNodLb5FI1A6xzMJvsmIbYbnCkAjrdkD6HrPucnMdV7f6piFhPSriawdzk0z3OvXnrF06u+9a26gZJPVKfGa2JYbQ7MxqKbQ/DJ55xWCCQGbts0TZsB50yPj4Dmrr1JWvIQVb8KKN2HZS4hEVce16Dbbps0XstNkWrFqdrhTnOMl8ivcJR7j2eJxbvE3Lpo/nROyKZdmDvN5aF6I+sbRCMkoaNXAPGjPoPm0LLzLO29aVV7D8jKbgfNuldHNJ6ztbLO2vUV3NKE9TmjPlZfLL7fAbley2YMLfcdGHzb6go0ebAxqh3npw9Rxe1DNJ0q0cKKNU2207GK8bg3Ep2C8mTwZ0JbQko621LRJ6TChzYSeG9E3I3puna6rl0UiI5QpgcwXsptnakx9R5VzAmO82aCJRgf1/H4wrj1M5WG0wlYSUylMCaZwmMKiC0tYKlomoONiOqJNJNtEajq1iFSbULUJZXz0G6Rms8Jk5CZpwHgNw/MZNG/mbUbhcgpX1LELUtaxAlPHclN3nqgHm5MCZAQiBtlEEMymZv3csoX1+9bVnkMf6UKECxA2REwjZKaTma979bx7ag3zDgNSg6jqSVYIUTvDERWCclbOT7KB4MJVDViqn2122N20tHhU+E7jOY3nDB4a31V4TqNsPa+a9cpZFBrlDNJZxPQML2ztTBWu/swJ0XjCa1/4Xl1gkEwfuTDv6lI7iUFSOYlGol09VU6hbb3czEXQaFc35OSHnAufjAQOTzk8afGUw5cOpRyedHgKlHIo1USeKIevHL5nOak2ucW7gC8dQrgaqzXHXQCZ9Bn6HXb9HrvzZdBjx++y4++Vu36XQoY8Ep/hkfjMxffVWVarXU4XFzhdbHKq2ORM2cD3YpPT6Qanyw06ZhEaOgcFESM1YOJ3SLw2mRdS+D6lL9GBxQYGFxSIMEOFY5RfIKUlihKi6NJjXwDklU9aReR5mzLvofM+Nl3BJauIyUlEcgpT9BA2ABtAdXnjxESVjFXJQ16J8wqsVyJURktuM5AXWBFPcEo8xprbYMXu4GM4ZTc5ZTcXnqdCsSlXuCBX2FCrXPBXeDxcZSzaey5qB6HzaduQlonq0kYMTMwZO6jBu4nwUVgsGSWJKEhFMStTUZJQkIicRORoYelUls5uwm27CXBhtk8WmEQtdlsdduMu2+26Poy7ZEGL1I9I/YgnuouQXFnTuNjHTV77XhnYxYZEJyVJr4bg67ecXlh3IK+9GRi1szsmznKirCDKClbPLx5LB2TtmEnzvEm/s1fvdTBhcJFLv32xVzNNz7tNfVaIA7HjUxAvZ571g0+Fq69thRANap+usHuPn+3CgQwbPOHoeiVdLt5TqxP3mGQjnGt6cVpF6eqBiQvnLcyXTlHsm6+325t30/Pl1YoAO9axrqI6nQ4vfelL+Xf/7t/xwAMPUFUVt9xyC295y1suGlXT6/X4L//lv/Av/sW/4AUveAHPf/7zecc73sEb3/jGhVz1y+nf/tt/y5vf/GZe/vKXs7q6ylvf+lZGo8UuIr/8y7/MP//n/5w777yToihwznH33XfzW7/1W/zKr/wK73znO3nDG97Az/7sz/Lv//2/v+TrtVotPvGJT/DWt76V17/+9YzHY2666Sa+8zu/87Iw/n3vex+vf/3rGQwGR35/V0vC7Q+4uYQ2Nze5//77OXXqFC996UsX1n30ox/luc99LnfcccdV38lrqdFoRL/fZzgcXnFXgxtd1louXLjAiRMnkPLa5CA7Z+aAeQ3NjS2OXefPMNUQ/YtzEH17tk6pFoPBS1leesUzdmBRax3b2ynLyy2kvFHw4eFSqo3n9/C9LlI+OSfH1ZSxhkTX7vNJOaGwN3Z0mLWQlpqsMkyyimxSUGYFWVpS5prSWCpz+FCoGjGD55WQWGFRJkOZHG9a2oo9gF4PUDojwQamHqEmNAXDtYhv2ec+bw6EmDmbQDg5y9682urGS4yzgw6uy2kW26Iv7Tx3QCkkYxeyYTs8pgdcsB2qfZ4DgWNpBs4TVht4roRlR7fZ0m22dZtSC5bNkNvEeZ4tHq8d5/JxbhabB157qpSITbXChlxmUy6zKev6RLRxQpB6YQ3IwzbDGSyvXecTP75sJEuryukVCb0yoVekTb12mfeTEf3RiPYooTOa0BpPiEcj2uOEziRH2Ut/wrY7cGEA6wPBhQFc6As2+7DRE2z1wKjFfZPOR4kWiDZOdjGqh1Z9Cn+A8QZY2UWomI4UdJSjI0o6TGZgfK8c07Njum5MW0xoiQRPPLUGOGslWgfNVANxbeq61kE9r4MakE/rlcIUClsKbOEQWtdTVSKNRkwnrVHGEMsWkdchVp0GjneIVbtZVs9Hqo28gvEqnHNkLiV1CRkpGSmpy8lFTkFJIUoqoeu8Y1XV41pKSdzqkZZpA7SnUFzOge0jvTjSWJQxSGNQ2iKtRRrTlBZhBNLUEBwbzKCeIwQX4gixRDgirKiz5nmy43U4i2cyPJ3i6RS/SvGrCX6VNFOKrxO8aamzZkpR9sZuwL1esoD26kx07SkqJTFK1fNKYpSsSzmdRL2NlGgp0bKB/k1yluVqeu8BzwNPNaV3yPwh6+bug4wQTJoBlMd+XEdgTedngy1Hswz4yyk0JUtVynK+w1qxy8l8m5PFFqfy2vG+pMcErsKnwncVftOoMm1YsSaipEWuInIvIvMict+n9BVVCCYsIcrw4hFevFMP3noEWQcTrUiqgLSKyYsWZdZDZwNscgLGZ1DDm4jLZdQVNE5ZVeJUifISIjmk3QD3VfE4N8kHWVLrhGJ84JSSEdaAfQrb5SoX1AqFuAjwcRA4j46NaJuIto3pmLApo5n7faoKU4N25qF7XR/JlInIKdEHrqEK5c3g+k6rw26r28y3sZf4DOxltS/C9k6VXdHVkVdWdSb77nRQ1Aa2D8eXbcQuwoCk12HSrwH7FLZP+h2KOGoc6kc5vc9BdrEPtF8ViQbJi9l1mWAPwk+tIaKJoHFuuszRjrsk2Xi2S1Pn/JO5FnYOtJMIAv6//7+f5JblG6eH7tXSM5ltXanyPOehhx7ijjvuuCKw/EzQ7//+7/NP/+k/ZTgcEsfx9d6dG15X8lm5IqD+9aBn8knn6QTqztnGbT6Na5m6z5++LNBjXV85Z5kkX2Zn+3+wvfOprzuIPq8bGqgLgafazaCivev+t3DOkeqUpEqYVBNynXMw/OQGkqtjXNLSkOQVk3FBnpZkSU6RVxTGYg6JbzmQfy4AoVG2wDN5DdJ1ibIVOIO0FdLqmet8Cs9hDz7ULpqnKb7FmblbEldHtszc57XDcuo+F048bfD8MB0FqC8MGKplDdLt4fC8EIqhi1g3XR7VA7ZdG7PPbaUwLHsJK34Nzle8CUtegnWSLd1hS7fZ1TE9PeIme4FvlI9yt3iEb5CPcUpcfF9HtOvu8HJv2pArJCIm9SOGYYfdqMPurGwzDDuXBTm+0ftgeVMva3Ae5zmt4YhwvE1ruEt7OKY3ShmMCtrZpeM5SlUD8wsDwfqgBufrS3sA3XgegWuhaCNkZwbJK29A6Q3I/GUIOrSloKM0PTK6jOgxosuwKcfNsiE9N6IlDs9iPYqslegqQuuAaga9AyodNvWwWRc2kNyfQXTnVJ3ZrTXCVA0crxBGI5tS7C+dQwpFrDrEqks8B8tj1SHyaid57HWI5NFv1i2ORCSMVUoiU1JZkKmSQmoqYdDCUsqKQlYUosThUNqgjKnLWV0jtcHTpi6Nmc1H0sfkSQ3EdQPAtUGZGojXkNzulbqG5jiJES2MaqG9DmXQpfK7lEGX0u9SBR0qv03ldyj9DlY9ucZbpTP8akLQwHCvSvB1DcU93QByndbrZmW20E/nqJq2tYlpKLtwTbtC44Det5xm3Yw3zc3vd3buzUzPsrVD3yGxQjTn9roHQJ08LrBir5yuc67eto6Xr0HUfOqWaFo8BRIpPITwEFIhhEIKD4SHFAohvXoS9TrR9CoSTRiXEA1wFrKpq7qBQ9SlkHt1muev18u9beePwEXonQOckDhBfRxmE/WxmM4znQcj6pxng8OKuuHXOoPDzgbarss6csw2Zb3eNaWpX0OClQIjHVYJjOcwSmA80J7A+ALjS4xyGOlIPH8G2OsymgPw9fxRegQFpqJfJPTLtJ6aeq9MGBQpwXzDjnOzXgw+FaErCV1BYAs8o5DaR+BRj3nrsIHD+QYXlRCleNEQL97Fi4YIefnvhXUwNoJdrRiXEVneIsv7VMkyNllDjU/TSk8Ql30C3T1yrxAhKgI1oq02GajzrMgn6KkNOnKDrtqkozZRTYPoSHQayF5HxlyQq2zKZYy4/GtJJ2g3wH0PvEcz4N4xEWputAWHo0AvOt0p2JUTdmVCInIKTNMLUDKO4gawd9mNO+y2Ouy0uuTBxc9xntH08zqrfVBMatheThgUE6IrMZg5R5AXdEZ1D7HOaFL3GGvqUXZpQ4r2PJJeew+y99ozZ3vaaeOkPMDLp6e9Aye0i7nar6L2wmkEU3+8QNCJOyRZsv+0urcbcwsPvwqcBtVMZx2BlPzkv3zbVd3/G0XPZLZ1pfp6Auof+MAHeNaznsVNN93E5z73OX7yJ3+SV73qVXzwgx+83rv2NaEr+awchxYf67JyzuFchXMaa/VcvcK5qs49d+Uh3ciO9UyTc44k+UrjRL+fstxzXNYQ/SUNRH/BdQe3X9eaQfR+A9Gv76k+09lCDvrh/u0bR9MYlyTXjCY52bggTUuytEDbw+NbHMy5zwVaGAQa5WqA7uscpXUN0E1VA/QFB/qe7Gx6uvLPL+4+r2GMQDaZ54L57rk3hmbw3Ehc4z7HzG77FlQJwchFrNsOj1TLbLjOAXjuC82aN56B8xV/Ql+m5C5gS7fZ0h0eTJdZ03A753mV+Fvulo/wbPEYoXe4M3CHLluqHrRtCs031TK7XncOmrfnwHmHSl38nCmco1Om9Br4MnWYT+F5oHMql+JNtohHu7RHY/q7CUu7OWs7Ff3k0t+5UQznl/ag+YWBYLsfMOxHpO0OUnZxsodVA0pvidJfgbBDEPq0/YoBu/TZZcBuA8bP0+XLdBnRZUTEFfQ8mSYAOIEuW/VUhVRVSKX9ejJeA8HDGppXYV2vAqz1OPBZcLYG4LqqwbiewvIEYSo8rQkagI41C4/2vJgg6OCHHcKwTdSpXeQd2aUjevTo0aZ95LenMSRiQkpC4VKqZrwYqzNclWLLCbYcYosJXlWiqtrZ3tKGrq4BuTK2LucBunny51WHQHstyqBD6Xcpgx5V0CXzO5TtKSTvNuu6GO/K3U3CajyTokyKsinKZEjXTDZDkiMoEE2JLGvg6UlcKLGxpJICLR2lMPhC4wuNJzSBcPhCYURMIBShqAhF2UwFIQWRrEC6mvsK1zDfeTh+lOMEBSGFmE4BhQjJCCmb+VyElASUIqQUPqUL0CLE0MYQYl2MxMdDopzCc2qulCjq+mx+WkeinEQ220gn9kpXD+s8ffyxnqIc0CT9LCx2Fo3BoDFYDAYjLFbkaJlipKOSjkIJiiBgR1pGvmI38NkKfbaikK0wIPEkqddlHPY41xZkXt2gMFWkC/pFA9ubxtFB0zg6KBI8d4nvugOaGH6GAnSAqEJ8LervhZfj+UUdKRNmqDDBb+3gtbbxW1tIr6LvOfqehmgCvQnzUSkAmYUdLdg2klHpkxZtsryLTQbE4zU641U65RJhuYTQK1jTxTmfQq9Q6BW2eQ4PHrLrkdylpzboyg06apOu2uCk2qSrHqAlt8g80TjaV1lvyqHoLXx5rXCMVcZYXSSr20HkggXg3pkB95gTpkfo/AODolpsPYBqUZCMCkYiYcN7lKFMase7J9iJegzjXh0j0wD3UdxGK4+tdp+tdv/A7sRlTj+bMMgnDLK9gVF7ZYI330DX2MrLOGI7jtg+uXLgubyymsWxdYYNaB9PaA8ntJIMT+uLDpBqhSBrx6SdFmmnTdptkU3rnRZpp4Xxp/cS04tCsVDUDYkNBBf74PyTGKNib4j7xYtQjaGafTnFHtuf7cwUvjOrz7bdj9ybWXuMxI71DNP58+d5xzvewfnz5zl9+jQ//MM/zLve9a7rvVvPSB071PfpmdyKt9+hXoNy3UBxfQCaW1fhrD7ONf86l3OONH2Q7Z3/wfb2/ZTl3oW1lFHtRF9+Bf3eN3/dQvQbwaEuhESpDr5fO9HFkxh47mqpNOXMgf61MJDoNMZlkmvG44LRKCNNS4qspNIac8ivZD2AqKQUAi0cRmikqBCuwNM50mhUpZG6QDiNNFMH+sEnu9YAfeo+r/NmG3A+BelwQzWOOgftoM8kGe85z/Xh8NwAExGwYTs8Wg04Z/uU+26Sang+YdXfA+hdmTO2MZu6zXbVIjI5p8wmd4nHuVuc5W75CDeJrUP3LyVkXa6xqVZYl2tsqBXOeWusRysMw/ae27yZcv8STl3nGmDe3FwX9dTNR3h6m0KmpCLFy0a0hyN6w4Sl3Yy1nYqT24YTw0s3fuy24dySYGPJY2spZNiPGfXaDPtLZK1ljFrCBl28MEKGCj8oCb2UnhgxYGcOmu/QY4i3nzhcRtZ4mKKDLtvoskVVRlRVRFn5lFpRGo9S+1S6Xq51wGUdb1Pn+MKkkbpsHOQ1QHfGgKcwvqTyBZXvqALw/RjfaxF6MbFs0RYdevQY2D5Lpp6CI2ZFG1uhyyGmHGKLES4fQjZEZENEsg35EJcPcWXC0xXUNNsXKdGeogw75PGAIuhThH3KsFfDcb+L9roYr4MWMUbGteP4ClTnjZfNQIYVziuxqsJ5FU7tTVbVgx8izeKf0zmCOtiC2GW0bFO6nMjltJp67OrlscsJXY5/hZ+7/SoIyEVELiIyQnJCMhFSuJDMRWhalK6NcW2sa2FdPXipI0S6EM95M+Dt49XzzT9/rq7wajiOd1UGPH2yMm6Kfu0UAc9qdvpP1L8PFocTdZO3my4TrqmDldNl9fp6XVNnbvt9v2RH+bRfvKeaQ9hpjJBDaYtnHMo6lHEoQ123DmVB2npeWoF09TlR2r2xPYQTOKnqSSmc9HDKB+UjVADSRyofKT2k8PGu0XVtqhyJJ0g8SaJg4olmHhJPkHqCRMHQF1SixLkM4RI8PSE0I3rlmF6Roq703GIlQoeIKkJUEZ6wBH5G4KcE4QQ/3sVvbeG3tvHaW3jh5fPctYNdI9jSgi0t2S49yqxNe9SnN1phkKzSLZbwq2VMtUpiVjFHGExSUdJRm/TUBbpqnZ66QKy2qIKS1HdseW02vBq0V+LJ/918qxo3ezwH3etYmY6JiN3F97VCk4qSoUi44O2wrkY82oJzrYDNuMVu1GUU9xjGXdLw4g2Twll6WVrD9rSG7P1swlI2pmWK+eEmFnrJLMzPP58xtMfpgrO9LhPa48mRGmSLMCDt7gH2/fC9iMJLg/P5KLG58vAruourzlAfX+Q1jvIMYs5WUff0CYXk//6Xb72Cvfja0TOZbV2pvp4c6sd6ajp2qB/rUGk9pijWSZIxCHOcY36si8o5R5adZXv7f7C9cz9FcW62TsqQQf/FLC//A/r9b74hcri/XiWExPO6jRO9i3iymbNPUdrqmQM9qRLKGz3qqYlxGacVw3HJcJwzmeSURUlZmkNv7C007nPQUmMxSFEhKfF0RVCVyLJCmiY32VZItzhE6PxzTQH60+PVPwSg2yYGoMYKTff+Zm9mAP36g/QD0S1aMnIFsNiN3gKZ8Nh2LR7XAx7RS6T4LPqULKvemDV/zJo3Zs2f0JUZQ9NiU3fYLSNElhPZjHvFl3muPMtzxKO0ZXHoeFubDLigVtlUK5yXazwY3sLD8Rm24x47UZftuMdu2CEJLu3ebZcZg2IyA+f9YkxYbiLNBXIxJlEJpZkQDce0thOWd0rObMPpbcfpbQgv0T6V+bCx7LE1CNntx4wHHUaDJbZXT2EHXWTk40UFfpARqYSb1ZjnsUufRxiwS8xFXH0XUVV20Fkfk/XQRYeqbFFVMWXpUWpBaSSFlpQmQDuPI+diG43UOaIq51zl5R40n+YQeQrnKSofSt9RtAyVqjCUhHh0iejZHn3TZdktsWSX6YolOnKJSDVuwakb9RKyxQiX7eLyXWy2i8t35uq72GwHqsNjavY3klkh0L6P8T20pzBeU/reQl37HsZTaK8uje81udUBRrUxsoURLaxo4YhxLgIbgQ2RJkCYAOGuEJLLBoCrGpA71UByVTbzVbOsXATkzuFTNRC8BuGtBoLHNiM2c/OzMkfNnQGdg8pJKtsMhmkVlVNUVjKyim0Xo20b4+qBMnMXUjif3AVoF2No42gBMRAjiZCESBHiEeKJEE/4+CKYm0I86dOVAUsieOrw9HLtP06jbYVxGuOqWV27CrOvrt3BdfVksEcpMVj31Bofjv6+G1A2zeIXoh5FdDqArWqiYBaWqX3rD1vWPOZKMv0vpybz36sqvErjlRVeWREUJX5W4hfzU4UsSoSpe8w4qbAqQPsR2g+xQYTxAowfYL0QqXyU8FANiPdEgC8DfBniy6CZD+eWhcimIatlBC0Da8VRrwqiZqqdyqmCkS+YeI5UakpZUVHiyBA2RbiUUlR1TFRTVqLCSYsLMlxQn/sN7PUnshGMbkZs3YXQNXBXVuJ7RQ3cozF+vIPf3sJvbaHam/jREE86Vr16ahL4gRxu2gIeJLWwpQXntGRTC8rCEacB/WGP5fEKS9kSrXIZp5dJzBoTs0pilzAEDM0ZhubwgWM9kdFTF3ieWidQQ5yfUviGcSDZDgN2VetIn6NKGnZlwq53eOOBcnKfwz1eiJTp2pi+a3Fr2QxomgH72uQ1BWf9C/xtL+XLHcNjbY+NOGY77jCKemjlM2x1GLY6PLJyavF9Gk0/S+hlCb082atnCZ0iReIOwnWhGEZdRnEXTs8vB3DEWUZrktIap7QmSV2fTuMUv6oIi5KwKFnaPDzWzii1B9q7dZm1YopWTN6KyOOQIo7qaJk5zX4jD8TINB7zA38zd/EGuCNdxroDzbLVIRGBxzrWsY51FB0D9a8jGZNjTIYx4sbLeT7WDaEse4Tt7fvZ3vkf5Pnjs+VSBvT738Ly0ivo978F9STzUI/11CWEmuWhe17nukD0aQ76pJyQVAmZuTIIdz1UactoUjKcFGyNCrJJSV6UVJXGHdJ92lA70CthMNJghUGICukqvKoGfLIskVWJdE3G8sxjvqhrDtCNYzpcaD1UqJg5lx0Wcanu4tdYzrIAzw+Lbpnmnu+6iHOmx8N6maGLD2zXUylr3oQ1f8wJf8xATUhszGbVYVL5xJljxe3wHfL/8E3iYW4X60jl2J+QUOJxTqyxpVZYV6t8ObqDL7duZz1eZjvushP12I66l8zKjapi5jDvFxPaxTZetYE05ynYJWlysbfMBLuTctOW4+ZNxy2bcNOm48TuoUwfACNhux+wO4gZ9zuky23yU12Skz3yJYUKS4IgJfbGnJAjniM+T5f/eeS/ibYBedmnKvrYtIdIeuisR1W2KMqQonLk2lFqWX83pMOpIwAvAThX545XZe0irxpQbnT9uRQOiUWJOqdfOItwBcKWSJ2jdI5XlcTGo0uXDn3asktLLRP5S/jBMjJeRsRLiPnc+YtwZWeqGRB3+S4u28Xmu7hmXudDKpugFWjfRwc16Na+hw58dNtD+x20P9hb783B8P2Q3PNw6iJ/2cYpKk1QlzpE6KAuTVDXTYCo/IUGgMv9Aswg+RSQN6XzSsKWT6p3ZrC86bayAMjbM0ie0bIpsckIy4zAlHimQJkKaSqsFZRWUVqPagrErSR1ipFVVNanshGVW27WKbSTGBcCLaRoEcgQX0b4MmzqIUEzvzcFhDKkPQcq5VXukWWdRduSypVoVzVTXa+m80xLXS+ra01Z/zPOoEUDwjE40ST3zr4qc3Uh9v6Y89+lw75Xzu0rp5nl3iwT+PDykGWuiR1zdi+CzNq95XZu/XT+sP1pGm4PZGVcLTWQXShVg/fpQKPTuqrnnadAeYvrpgPtAgiB9RSlpyifxLhswlr8otoH3sd4+SYiLXFliak0xjoSXaKdoxKC3FfkvkfpL956S1QN22egPcATISE+MT6hCAhUhKdCfC+CoIcIu3iqRYhPy9TN5C0DrVl3Oq+ZYuBgzMhUDkchNKUsyWU9eHEuC/Jmflb3S/Jwq8mvr9NkkvoJIDmJ2L195nCXOsBX9W9QEA0JOht4nQ1U9xx+e5MoTGlJaAWOW4L5z0oGZBi3zo4RPKgFO1qgCwhzQz91rA3brCXLdIsVquoEI3OCsTnJyKyR2GW0i9nWt7Gtbzv4dwNOiTGxt4XyJmi/IA0cI19SBhrr5UfOtzPCMvJSRhzeiCqcoG3DWX77DL7PZboHzuPOapk7t5YPwHZHzkZY8GAbvtAt+FKn4mxLcaEVMwpbdYRMp89W5+DfVlpLN6/hej9P6WWTOfieog69/hNMaDFptZiml+13vPtlSTtJaaUpraQG7u2kAe5JSpRmKGPoNoOoXkpFFJLHUQPZI4rWdD6mmC0PKRvH++yv0gB3Zx3OWvafS69jR6BjHetYX8e64sgXpRTnzp3jxIkTC8u3trY4ceIExlwjN8TTpGdyt5gsW+fcuYduzIETj3XdlOWP1wOLbt9Plj8yWy6ET7//QpaXXsFg8GKUOh4R+mJ6uiNfhPDwvB6+30OpznXpPl6YYgbQkyq54XPQrXaMs5KdYcn2uGA8KciLAq1NHf+wTwYoBRhp0FLjMAih67iWStfgvCwRVT2QqHAWyQ3gQHcWbH1TPu9Bn4IWN4X81998vug+Nw1AP8QVZICxCFk3HR7SK1ywXew+bBiJcgbOp/nnhfPY1F12y5Bls8ut9jzPkw/zfPEgd4knkOLgQdihy/kmsuULrTv5QutOzrZO77nOo+7Fs82do18kLOVjBsUuUbGBX51H6HOUbJGohESmJColKA03b8LNDTi/eRNu3nScOBhlOlMWeeycbJHe3KI8GZGu+WSrHroHQZDS8iZ05S4tcbQGrdKFjPUyebGMTge4pI+c9JDjHrpok1eKvNJU5BiV42SJbQbrQx0BWDqLqKoFUC6tQVqNZzRepQmrksBYQm2IqoqwyAmznLgoCIuKqDB4BkTUR7ZWEe1VZGsFEe+BctlaRniX76rrrMGUQ3QxpNIjSj2msAmZS8hFSiJzcs/sAfIGklezeR+r5OFA80pkJcIEhwDyOWhuQoQ9usfFCbMIx6f1OVhuVVFDclmfhaSpaOuESKdEOiXQOTEWVyQNFDdgDc5YnHVoIymt10DyxWm+MUsKRSBjAhnNgPisVPsBeTQD5X4zr64SDHfOUTX/NBWV0PWcaDC31HW9GdS1kgYtm1IYtLTNsjoG5SqPr3dFEs4hcMj5sqmLufXCUbtRm3q9bN82+7Zf2KZZf6WqIyNdMwSHOzhv63lrbQO/5uoXW37IuquZSiqVRCiJVAoxV0dJpOeBpxC+B74Hno/zvToWBnBCNjE49dG2Qi5knh+mVqtPmg6nBwyvrAizAj/N8NIMmWWIvMRVGms0xjkqAYWSVN5RzreOqNK0SkMLn0i1qfonSVbOkPdOULWWcEEXpSJC69PX0K8cvcrRLx2dJ3G7XorqIGyfg/CFLMlkQSFLrHD1ua+K66mMEVULZRWhnxDEQ/z2JrJ7Dtl7gqC9SSseoeSlr5pSC5tasltKqkIS5IKlRHPr2HDrOMSr1hrIfoKROclY12XuLndPb4nUEM8bof2CxLfkgcX4OdbPmwbHKz9mF9NerMwiaJ8ua9kQeUhzaSXgiVjwaEvyWEvySEvwcNvyWCxYjwOMvEQTq3NEZR0j18sTBmnKUpozyDN6WUJgnnw8ozSGOMtoJ0kN3dOEdpoSZTlRns9KeQXfaStEDdgXphDb6ZEoqAKfyvcpA58qCJp5rxkYmX3XvZf447m6LfM7/q/v5uUvf/mTPAI3rp7JbOtKdRz5cqyj6mmNfLnYxU1RFATB5Uc2P9axjnX9lefnZpnoWfbwbLkQHr3eC1he/gcsDV6CUq3rt5Nf5xLSx2+c6Eq1rzlEN9YwqSazLPTqRo+IsjBJSzaHBdujguGkpChKjDE4czC7XANaWIzUaGmwQteDhDqLrOpu3rKqs5iV1Q1A19cFoDtMYyas3YHCieZGS6Gm9qHGddQk3c7e7/VsOnVuz32OrgcQPcx9XgrJrot5zPR5WK8wduHCdp6wnPCGs+iWVW+MwLGpu+xUMXnqEHbMN4uz3Csf5BvEY/jKHHAlb9HjMXma/7fzDfxd5zk80LqF9XiF7ajLbtRBX2TwXuks/XzCUj6iXWwSVuvI6nGseYRE7jJREx6XdSf5lnHctAW3bc6B8y3H6ujwY2RDR3rGY3JLTH7apzyhKFeAbkUcTojlJi2gBQwucawTWgztCpNqmaJYQmdLuPEAbzgg3OljJ20KN8J4Oxg1xsgCJy1WOZyagMrq47VwzbjvAFqDrJpGJV2iqgq/zInzglaa0pskdLKCVpbTSXN8Yy/y+ROIqIdorSBbtyJ7q019pYborWXEEQZSLmxK5ibkZGQyJ1EFY79kHJSMvYpMlY0jePG1odNMT1EOhPHnwPhcaWpQLnSItEePEXHCYL0C5xUNJC8aOJ7jZI4TGZYMYUswBqVLQpPh6wIvL+ueM0aDMVjjMAaMqaN3tFMU1HEOi+04EZI2gYoaKB41MDwi9CK6cm753DZB4x5XVyFj2uKoRAO/haacwm9RzdXngbhGC0MpNFrszV+vE55wDjkD33YRhM/At61LV38vFsr59TdC6+dlJIS4JtckB+C8qUtr5qbLzE9ljQVjMRwdGkolUZ5CKonnKaQnUUrVy7zaLS99hWjc8A6BFQIrFMoPCYoE08B3qyRVN6LotS4L5EVV4Y8TvEmKyjJEUeLKqgbv1lLK+nXywCcPfLYByKE8C+fOwrnaqdwqNXFZEZaGcafPg6unuLB2kvNrp7mwcpK0s4oLOgwqWC4cy6VjpXSsFI7l0rKaW1YLy1IFnhMEzicwPj1z+UGYS1GRyaKZctKwIIsTMpmTyYKxqCjzAWJ8GnH2FYgyRlYRvqoI4l389gau/yhiBtuHtIKSloRbA8utgV04jVvgC7ZgqzrHpNxEF19G5T5LqeCuseV0YvF0hNZdMrO6B9ybsnIxuVkCswRF/es3/y6VKAi9HaQ3Bj9F+wW5r5kEUPn6ikdvv1ysjHAQ2/Bw6F6GvDAPecVmsDDIpqFiI9qD7Y/NgfdHW5LME+RhlzzssnFIxwVpMny9Q1ANCcshcTkmKie0i4RukdHLNZHxCKyP53w866FsPXiyVYqk0yHpXOK31TnCoqgB+/yU7dXjPCPMC6KiQDpHnGbE6ZX1gi39GrTXsD2Y1avAp/SDPRC/r/65T37yGQnUj3WsYz29OjJQ/43f+A2gvoi677776MydMI0xfOITn+Abv/Ebr/4eHutYx7oqKor1Js7lftL0gdlyIRS97r0sL7+CweCleN5VAA3HelLag+h9PO/yNyxXU845Mp0xqSZMqgm5zi8xSNj1l7OQZRVbw5ytUcEwKUmL2umFOehC1ziMrNDSoIXFUbvPsRaRG7yqRGpdg0JrAIN0+lC4cU0HEbUCNT946NSx1AB0i6338ToDdFfb9vbiW4w4NL7FAqnw2bBtzuplHjcDqn3gtiNzTvqj2bTSjnlkbNkqW1S5RZoJ3yge4V75IM8VZwlVdYD9jmjzheBZ/J/u8/i77jfw1dYtrLdW2Ip6aHX4pY+yhkE+plfsEJUb+OU5hH4EbR5hooaMZca4eTtSOk7vwjdccNx2wXHbOtx+AZYni58GGzjMMuS3OLLTHvlpj2pNYJccolviBxV1fkdGwP6k+FoTOmyxyrZbJtHLFPkSOl1CjAd4uwPi7R6tsQC1iZabWDXGyBwrxzg5YajOw/L+93wQggpd1bC8KvCLgjDPalA+njDYGdJNM+JKE2pz2c+ZCHuI3gq2s4rureC6tdPcD1eI/JXLQliLZaxqF3mictKmTGQ9pSrHiKexl4xjwUVeg/IIWc2BcxMi3NEit5wwOK/EyBynEqyYgJhgSYEM5zKwOZg6PspLazjuaY3TFmMczh1+1KefIAAlPALZq4G3immrmDCIZxA8VDGhioia9b6MG5f4U4PiUyBew++KUjQZzlNALjRVM1/OQfGygejXFYY3jm05ndiD4nuQ3CGdbdY5lLN7j3mSLu9jXV5CCISqj666WG7TJTR1zl8WwGuL0QZr9krgAJS/3L5OQbvyFCreRrkK31d4nofyFcpXyMZBXDd9ixlcn4H3admNML2YUkiskBghcKLpU+AcVBqKAjVJUEmKzHJcWWGMRjuHlZJJFDCJpr8qDjU5x+nJOU4/9DcE2hAXFYGxjDvL7AzWuLB6ks+dvIlHT93EEysn0J43PZD0KlguLSulYy033JTm3JSWnMg1K4WjXwk6xiOyARI5g+99c/F7CoMln0L3uCDrZKSyIAPyco38/EnyRz3QEaKKkUYRtnYRvccxg4dQ/ccI25u04zG9oCSWcHNoIDTQzWevo4GvWNipUiZlSlFMUPkFuslXOZVYnpPv0K0qhI4p9YCJWWNkTjHSJxmZk0zsCsaFpNUpqE4xP9RI/e4ssdohUjv4/hDhJRg/p/RL0sCRKI9UxlfU28kJSFVBqgo2/MO7sgkniG3QgPeQ2Ia0bMggCTkzDnmVDYltQOQCHLATiAXI/tgceN8JJVbFFCqmCM9wWGiLcJaoSgj0Lkpv48wFjDsPZgOvakC8Lgmsj288YtvCtz6B8+vBm209oLNy9WDOyrVRrodyEuUU0imkk0gnURbirKSVFnvQPZtC9xKvKvHLevwiv6zwqwqvue4PqoqgunITkFlagrc+MwcmPdaxjvX06ciRL3fccQcAZ8+e5eabb0bNdf8NgoDbb7+dX/7lX+alL33p07On10jP5G4xx5EvX38qinW2dz7F9vb9pOlX59ZIer3ns7z0D1haeime98z6rF9rPZXIFymDuYFFry1EL01Zu9DLhEQnmGs1gNmTkDOOPK/YGpZsjXJ204q00LgGnu93oRsMWlZ1hIswOKfBGTCuHvCw0khdT8o10S7OIA/xmE8Bumsc6E8nQJdWINw0/3wK6/aAucXNAND11AygV3P554cAPy0EQyLOmS4PVatsu9YCfpJYVrzJHjz3JmQu4ELZBa252azzHB7lXvkA3yQepiPyA6+xK9p8uv0C/qb7XP6+cxcPtm5mvbXMJDi8h00NznfpFJuE5TqqehxnzlKYR0jU5ICruZM6btuYQnPBHRcEZzYNvnE44TADMCcces1hVh3FCUW1JnBLBtG6/HdqQocN1tjkBBucYFitUaYrMFrG31mmtxsySDLaxSZObmDlCCNTrDA46bBK4bygzgm+hISukGVBkGd1Bmqa0Bkn9CYT+qMx7aK8hKu8aQyJJeNYMOxIisEKdNbwWmuE4Qna/ip9scaSWyE4tGlg/rksE5mTqKyB5hkTlTORGROVkcniEHf5VZITTfRKdLi7vIlhEYd0t194GmdxLsWKEU6McGKCY4IjrQG5K8AWOFMhTIXQGvTRzrEC0UDxFqGMCVVMIGNCFdJSIZGKCJvJlzGebOGJFlI8+Z6iDlfD7mbAwikUL6fge2HZQWh+vanyDHTjUFMAvr/EHbLsWMda1BTCG21q2G7MJetXclEgpZzB9XnQfhh0P0wGgZESI5ppvt7Adw1QVlCU9ZRlqDSDvMBqfdkoHU8bosqQt3rs9tfYGqyxvnqKx0+c5tFTZyiCw8dREs6ylE+4NRlz+zjj1qTgpqxiNXcz4BvbiNiGRHbRXX0pFaKcud1TWZI5S2YcmVFklSKvQjAK2T2PXvoqbnAWr3ueuL1NL0roeYZLXZoXVjCqApKiRVX0cNmAfuJzMp1wsthg2YxQVUBuVhjpkwxNDdpH5hRDcxLtLh2JOR0staW2CLxdlDeqXe5eQREYEhUyFh3Gsk1JcPUG4G2knGxge0DLhLRsRGsG4iNiG4AI2Q4DzkeC87HkfCRYj+Rsfj0SVEe4vwmMoV9mtMuEuBrh6xHKjhBmhLO7OLuDtluU7JLLjFwe1pNsUdKJ2hHvPHznEcgQZ2xtM3FiZjbxK2iV0CoccW5pFRAXllbhiApLXDjiwjZ1Q1RYwrIpC4O86QT3/ulfXq3DfsPomcy2rlTHkS/HOqqu5LNyxRnq3/7t386HP/xhlpaWntJO3qh6Jp90joH614emEH1n+1Mk6Vfm1ki63W9ieekVLC19K75/8YGKjnVlulKgXkP0Hr7fv6axOsYaEp2QlHWMS2nLa/baVypnHGmm2R0XbA1zhqkmKXXT7Xu/C91im4xcIw0ajXUGjK2d3MYgjUEajdQGaSqkMzVEbwD1wmuzB9ANTwdAd7imu7+wAlyNzhcA3syBfgMBdCPnBhAVBwC6A3Kh2HYtHtUDzuoVsn1O6EhUnGjg+Ql/RCgrtnWH7TJmRe9yp3uMb5Zf4YXyq5wW2wf24zH/BJ/svJDPde/mC507ebh9ho1ogJWHuxc7xYRusUFUnkOVZzH6ATL7IEYedC9J6zi9DXesC+5a97j9Aty0oeklVQ3N1xz6RD2ZNUd1ol52ub5+CS02ODkHzesyy1ZhtEx3GLEyqlhOUgbpBoF+AiNGWFlghcUpiVM+zr8MLHVuBszDLKWdJHTHE/qjEcu7Q7ppfgAe5qFPFvtMWqoG5W3YaRm2OoZhWxDEq8T+CXpqjWW3xulqjTPVGqvVEuoSKNLiZu7ypIHkE5XN6unTCcyNQuqoBuZV2NTDZsC8GqIfBnKcq8BlOFs7xp1NcGKCZQIkOJeCzXE2B1MPpHpU1e7wGo4HKiZWEW0vpOVFNRyXMYFs4ck2nmwjiJ/0gNMW28DuklJoiikAlxXFDJbXpYxDRuVOA9IvBcXrFZf7i13eqy32lfsfvxefMnWJqxn8np/mljGNWDn6fl4LXXxPDi4TF6lf/LGHP+9hkWQHj/iNcHSeOZrG0hhjZk53oy1WhehkhKkMutIYbXCHDeh6iIQUeH4D2D21WA88PN+7bOTOpcC7tg5baswMuheQ5Ygsx+lLn9f8ylBGHUa9ldrVvnKSc6uneOzkGdL4Io3YxrCaDVkpxqzmI9ayESfSMWuFodUA9tjUsL01D95NiHfEngm5KElFSYYmdZbMCHKtyCqf1FWMlr5CtfQAsv8ofmeDdmvIIMhZ8twlYXtpJOMqIi86iKxDL1X0spKVdMLJYosVs01puw1gP8nQnKrr+hRDc4rELnG5oaNjuUNfrdNV63TUJr63i/QnOC+l9CwT1WIsOkxEm7HsMBEt9FPsVXSYlJOE1idyPqENiKxPZANC5xPYgMKLGAcxu2HIduCzGfmsx5L1qAbuW+HRf7OUdSyVdcxQvzT0Kk23qmhVBbHOCHRKYCZ4ZoIyYyqRNg0qOYUsMViMMFgsRlissBj2lcJgcRhhDllnMRiscE1pOdU5xR//f/7kqh/X661nMtu6Uj2TgboQgj/+4z/mB37gB673rjwj9LQC9We6nsknnWOg/sxVUVxoIPr9F4HoL28g+uB67eIzWkcB6tcLouc6r2NcygmpTm/YGJcaoFeMJiVb44LdSUVaarR1M3g+daELDFaUNUBHUzmDdRZsMzmHsLaB5wZppjnotQP92gN0ZoBcWIl0++D53Prp/1cycNPToQWAXl08/zwRPhdMhwf1CudsH7PvfS2pZAbQl72Ewnps6B6mstxszvN88RAvlF/h+eIhQrEHuTWKL7Vu4xPdb+Hv+t/EF1q38kjrFIl/+HfHMxX9fJOoPI9XPorVD1Dqr2DFYR2XoZPCN54PueuCx23rcHqrZEXnsGLQDTivXeegV93hWSzTfXWKC+Ik5znNBU4uwPMtt0Y4iVkdGVZHFUtJxlKyxSB9HGW3MSLHYXBSYj0f54eXdKcJo/GKnDBLaSUpncmY3mjC0u6QpdEI37o6W7cVkbdi8lbEuOUx7Ei2O46NjmG9V3Gul3O+kxLR4ky1xulyldPl2kJ92Vy60bUSuo7BUelsmoLzVOb1oHRXW/Pu8hksjxpYXs9PB/esB0kscC7B2RSasp5Paje5S8E2cStH7KEjkTUcVy1CFdP1IjpeRMuLiL0ajAeyhZJtlGgjaD9pOF4D8HIBhB8E5HphfTUXn3IQcC9+j1utHkk6mjvnXV3sWmeE1wD8MNe4OtRFfqynQ256Xpn/CBx6qtn/l69BvZtuLvbKeYnZdmJ+4cKzHLb8qsnt7cdhH97DGhsWHuvmZ/bqYv96x2zZxb8tAtFbxY02F9ZZY2dwfR60m6p2uutKHxm6K78G7V7gzSD7tJRKHjnjfgretVAYKamcoKo0ptCYssQVJeQ1cOcSsN0BVdBi0llmt7/KxnKd1f7oqZvIosMd3K0i49Rom9V8xJJOWCknrGYjQqtnT+o7r4Hs0QJ0bzV54rGJ8I+QYGuxZGgyDKl15EaSasmWv8NO78uMlr6C7T9K3N6iGyWs+pYldTnYrkjLFiKLaGWKblaxnCacSnYYVAkCMM5jbE4wbPLad/VpduxpRuYkiV6jcpe+H5BUdNUGPXWBnlqnp9bpqgtEagfhJVhVkaqYRLQOTBNZl0+H6x0AB4GrY34i5yNdSO63SYIW46DFMIgY+z6jwGPkewwDxW4gGftXfpZva8dyUUP4QWVp63pZWztapq63tKM9X9fQNnW9ZcC7zFdr1Mp47ju+50kejBtXz2S2daX6WgXqGxsbvOMd7+CjH/0o6+vrLC0tce+99/KOd7yDV7ziFQCcP3+epaUlwvDwHkRPl26//XZ+6qd+ip/6qZ+6pq87r8985jO87W1v43//7/+NEIKXvOQlvPvd7+bee+990s/5tA5K+oY3vIGXvOQlvHVfxtS73/1uPvOZz/Cf/tN/utKnPNaxjvUkNIPoO/eTJPsh+nPnnOiD67WLX/eSMsDz+/heH6Uu3SX0aml+MNFxOUa7o7sor6XsHEAfTkq2JyV5ZaiMO+BCF1Q4UaKFQYuSCou1QDkX8+KYOdCVngfo5tAb6RqcP50A3SEQCDsdq2rfz+0CQHezHPTrBZOcEzgtcFqBFocCdAtMRMC66fCAXmXddpnfYw/DaX+3dp97I0Kp2TUttqoWOjX02OBF8iu8UHyFW+TGzLRVCo8vte/gM51v4tPde/l89y7Otk5TqUMcWM7RKYe0ivP45WO46iEq82WcXUfgKIFZvwtRZ4yeHrd57hMBd50X3DoqWBUT/H6BPpFjnu3QLwe95ti6BDQ3TrHpTvCEPMN5TrPOKc5zmvOcZkusIqxkdWRYG1Uspzk3J0OeP36Cbvq/kSYBNFZKjB9gg4iqrajwOGxwTGEMfp4SJwmd8Zj+aMzScMhgOAYlKBpQnrcislbM+NYTPHb3KTa7lgvdio12wdhLGKsJE7WJ7xRnyhPcXJ7k5uIk31ie5Oadk5xZX6NjL30zn4uSscoYNbB8rBLGKmOiUnJRXn0w5kQDyusB6mQ1D8wjqIL6fGBTsLVr3NkLdfSKTTAurWG5S8CmTL9hl5JoAHmk6miVrl8D8rYKibyYSLXxZRtPdJCiixBPrkG0FHsO8UKUFLLam6bzjaO8kCWlsDMX/+JYDZdyYQuu5NJ+muN8VAlHA8EXAfl+MD6bv0EbcG9ULUBvuR/XSty+jkFO0ICyg42diPnnu0YmGjf/KXVzn1Q3B6HtbPn8etxTzKKfb0Q69ImunZFIIFCBwoQ+ws014juFCn3UvmOCq79bwk2he3UodNeVxlQG51wN4StDkRYHX1+KA5B9HrzPw3aFQ1lDgKkvjOo3UA9QHflYfLTsYYSkclCVhqrUmKLEFhWuKCAvEMYQlCnL2ynL24/xrIeat4xg3O4zbhztGyunObd2mnOrJ0nDmAfXbuJBblrY/7XhNqd3Nzk52WG5nNAXGV2VIA/7jW6gbstGtEx0aBnbEFkPvVwPNCqbyQc4CelJSL+N6jFL5iypdQwp2Ag22ek/wLj3VbLeI8j2BiuBZs1zDJQjUIYgHkNcN9znwBPAE8RUpoPNI8JM0coN/fRxTmZf4NlZSVDunXVz22ZkTrJtbuK8uZ0de5qJWSPXy1S6j8VnaM4wNGcO/axJKjpqi67aoCs3WFYb3KY26KpH6aoNOmoTJ+wcaG+TNKB9MgffUxGTiYhchBhxxN8QQdMbSrMw7noFUQVRAicPeZgRgkyFFF5M6cUUXkzuRWReROYFJH5I4gdMfJ+J76GlJPEEiSd4tA0HBs05osIZXHcNjGcByJ9SLX7xST3zsY719OoNb3gDZVnye7/3ezzrWc9ifX2dj33sY2xtbc22OXXq1HXcw6eusiwJgiuPLZxMJrz61a/m+77v+/it3/ottNb84i/+It/7vd/Lo48+iu9f/d48+3XFDvW1tTX+8i//kuc///kLy//u7/6O7/qu72J9ff2q7uC11jO5Fe/Yof61r6K4wM7Op9g+ANHFPif6MzOS6UbVvEPd88JrDtEznTEp68FEM53dkC50ox1JXjGZlIySit0GoBfGYhZc6CWSAkeFpkQ7TenAOgd20UE6H+PimRLc5QcSPRyvP0XNOdWk5fCBCi8C0K+X5gG6qy4+gOiIkHO2xwPVKluuveAyDETFKX/EqWDIskowTrCpexSV4BZ7nnvEA7xIfoV7xIO0RH3Tn8mAL7Sfxd92nsP/7N7D33W/gYdbZ9Dy4A2cZ0o6xTpxdQ5bPIDWX0GYRxDuEIDgBF3T5cy4xTc8obhrXHHaJXTDCXK5QJ9y6FMO2734MbFWsmvWWHenedS7iSfkHDRnDSvqm7hualgblaxOUlbHG6xtn2V5+DjSlRil0EGICaJLR7Q4h1fkRElCezKhNxrRyTOiqsIGHnmnRdqOyTrtumxHDGPD2EuZyEkDyyeMVUKiJlgcK3rAzeUJbilO1fC8PMlNxQlO6pWL7weQyHwPmsuUiUpnAL2SV7lBztHklEfIKq5BeRUhdYwoJFQV2ATsBGcnONeUNoEGltdDzF1aEkWkWkSqTSto0/FjOl5MW0W0VItQtfFEtwHkVz52hcNSiZxcluRCk0lNriryBoznDRzP5Z5z3IobL2yj2+qSTYZHBOTH7vGLyQmxAMH3hogWODlnbhZiAW5fN/B9o2o2uPY+2E4DnBsYv/crbp86iH9aJFCdZcxkm6fyrZ+9L1dHIQnqeBlbGXRZYcoKU2h0oTGlnsH3y+kwd7sf+niBd8n89sPkgIoatpelRleGqqiwRYmdutsPudbRymOrv8pw6QS7/TU2lk9ybu00O/3D71/8quLmjfPcvL3OqdEWa9mQZZ0iYo+8fekBP4WDyIaLsH0feI/c5UGOc44Ew1BkbAabbHcfZLf/AHnnMbx4l3aQsuwbli5jhbZWIHOfKHN08pKlNKWda+LMEOV751nrJBvuDI/ZZ3PB3Ma2PcNYr6FND6Ej0BGXi5OBOlKmqzbpyg266gIdtVkD+GYKxWTh8JV45CKaAfZMROSEB5fNyrqeE+KeZG+si8kBpfJJvZDMC8n8ENfqM9IVlfIopV+XyqOSHqXyKaXXrKuXXywScL/uiAL+6lufe1X3/0bQM5ltXam+Fh3qu7u7LC0t8fGPf5xXvvKVF91uf+TLpz71KX7iJ36CL37xizzvec/j53/+5/nBH/xBPvvZz/KCF7yAj3/843z7t387f/EXf8Fb3/pWPv/5z/OCF7yA97///TznOc8B4IEHHuCnf/qn+fSnP02SJNx999386q/+Kt/1Xd8FwKte9Sr++3//7wv74Zzjl37pl/jIRz7C3/zN38yWv/e97+W9730vDz/8MABvetOb2N3d5cUvfjG/+Zu/SRiGPPTQQzz66KP8zM/8DH/2Z3+GlJJv+7Zv49d//de5/fbbD33ff/3Xf82LX/xiHnnkEW655Rag5tL33HMPX/nKV7jrrruexFF/mh3qk8nk0NYD3/cZjUaHPOJYxzrWU1FRbLCzcz/bO58iSb48t+YYot8okjLE9wPa7VvxLxJJcTWlrSapklmUy43oQjfaMUlLxmlFkmp204KychTaoBdc6CXSZjhXYFyJFhWlFRgL+29E92JcKpSpkPbyA4laxBE8qlcot9drXlp5+P3yPoA+zUG/vg70ufiWQwC6QTAk5HHT5wG9wq5rLWwTiZLTwZBT/pCOzMmtzwXdJc8cfTZ5sfwSLxRf5lnqPChIZMzfd+7kQ53X8tnu3Xy2ezcPt87MwPS8fJPTzs/hlWdx1Zex+isoXbvOp59uyRSc9+ibLqdHMd80qrhFT1jyJgSdLVhZR7/SMR0j7OAQppCnPTb0zTwhb+Gsf4aHwps4z2k25Rp2bsB1ZRyr45KT44R7dr7Cqc2zrO48SlilVGFEGcWYMAbPI1tZPvS4y6okTFPiNCFugLmPAd8j67RIOy2StRNsxbeAlGg0IzVm7E0YqREjtcVYjZmoBCMMkQ25uWjc5sk3zFznN5UniNzFu3kWomKoEoYqZeQljFQyi2mx4ip+QxwIEyCrCDGF5mWALByi1PVAeTZpQPn6DJxrOwEO5tovHEskkWoTqTax36Ltd2h7MW2vRUvFRComEB3Uk4DkDosVKZWo81kzWZFIy0Q68gaQ17BckzfZ5DcgxQNoAPg0ZmUOiNt9887hS4FJh9x4qP/aagbEG8f3DOsKMXOEH4Dh4uCyYz1FiT3v+oFP5KUOs6vBu2weDe4QAH+VnPDXULNjMGt0EfUPoafw4uDQm3hnbRPXUmHyClNUNWxvysu525Wv8AMfL/TwA38G2pWnDo2REUCAJRDQDiWEEjo+UF8LG+cotKMoDVVZ1ftRlHh5wcnt85zcPr/wfFkYs7l8kq3lk+wsnWBj6STrq6fIw4iHztzCQ2duWdh+ZXeHZz3+CLdunqtd7dkuHVtQdNsk/Q55O8YJQaYKMlWw5Q8PPdbKyRlgb5t4Abi3TURsI5SQdPDo0OWmsgtbd8DWdy7uPyWbwTab3a+y23uQorUO0TZ+NKYdZPQ8g5IOWiV5C3IEm8z9XjnwckErN3Szgjjb4tb8As/JPkGcG1Tzcz0SHTbFKufdrWzYW9g1pxmZVbTp7g24XUUIp8jsEpld4gLPPvS9eyKnIzfpqC1acoe22qYtd2jJbdpqh77coa0exReXH3cpJ1iA7IUI0HhUwqfCoxIeFX5TTpfX84vb7W0vtSU0FUvFBIBumTBOD/87HiYjxCHgfQ7GSw8jPV79yu868nMe65kj5xzWZtf8daWMjxTN1el06HQ6fOQjH+FlL3vZkSJdRqMRr3vd63jNa17Dhz70Ic6ePXvRSJaf+7mf49d+7ddYW1vjx3/8x3nzm9/M/fffD9Tc9zWveQ3vete7CMOQD3zgA7zuda/jS1/6Erfeeisf/vCHuffee/mxH/sx3vKWt1zR+wf42Mc+Rq/X48///M8BqKqK7/3e7+Vbv/Vb+eQnP4nnefzrf/2vefWrX83f/u3fHsqgn/Oc57CyssL73vc+3v72t2OM4X3vex933333RSH81dYVA/XnP//5/NEf/RHveMc7Fpb/4R/+Ic997jOvVe9Yx7oeqiH61Im+D6J3nsvy8iuOIfp11l6cywAhAtL0Ako9fa3daZXWMS7VmExf+x/+y0lryyStZlOSagptKLSl1Bbjahc6JkfaFGEyDCXaGQonMAt3z3OOtIUYl+r65KA3AF0BXBSg1zfre2hyGnlwPSRwjr0BRC/iQK+EYNdFPGYGPKBXmbhwYZu2zDntDznhj4ikZmJCLlQd0lTwbPE4L5Ff5KXyi6z5Q8aqxd92voE/6/5f/G3nG2p4Hp851K3k65RW8The+RBGfxlZPog0GwuxvhLomDYD3eeUWOXmLOdZRcqqGNGKR8jBBextlvkxT+dxrDNgRh1G+SkeFc/mK+Gz+GL7Vh4MbqZoH/yedrOKZw1HnNo6z5mNR1jbfpxuNqSMYoq4jYliUB7F6ioHEIRz+HlGmKeEZYFnDcqTmNCn6MSkp9qMvP6sS7TDUYiCkZow8oaM1eMNPB+Tqvq73dcdbivO8M3JXdxanObm8gQ3l6dY1YOL/tUtlrHKGKqUoWqguZcyVBMKUV097udEfbNexsgyRGQgC4MoSqgKsCnObjbO8gnOJVzKMylRxF6bWJ0g9ru0gy5tv03ba9OSMZHsEIgO8oqd5BonxmiRUMqMXJYk0jCWll0lSaSpneRNFvmNTNn2AHlT2sXYlXlQfgUBLk/jHl8fHeYUd0LuQXG5dx500/ljIH4ZfQ00tjSh7nZvpin2N95OPwhuzgXfQHe3D75f0XfpxpGQsobtcQD7hsFwzmG1qYF7UTvca8BdofMKZ+wMtpPsf15xKGi/nKtdCUHLF7R8Ce29H2znHFob8spSlpqqqGNk4qLklnMPc8u5h/e2RTDsDthcPsnGyim2Vk5xYfkU24NltgZLbA2W+Ax7WblBWXL7uce487GzPOvBR7lp9wInJjsQ+aS9Dkm/Q9rrLDjbjbCMvZQx6eFvpHG5t/eB9j23e0zofGICbilPccvWKdj6BweexoiK7fZZtrsPM24/Rtlax8XbBOGYVpDhSYeOHaNYMlo62MvVLyyt3BAVhji/wG35OZ5T/BVxbghzi3YB23KJbbnMplhik9Ns2zOM9CqYVg3ZTYiswrrR2wRoF7FrbmbX3HzRvyOAFDmhGhGpEbHcoSO36cpNenKDvtqkLbdpyR2W5Ajc1TVZGuQMtNvUr3u2Mt/4OR8itdjHZe9bvdi/ZX47geDm6C/glv/nqu73sW58WZvx8f/+/MtveJX1qlf+3ZHGVPM8j9/93d/lLW95C7/927/NC1/4Ql75ylfyIz/yI9xzzz2HPuZDH/oQQgh+53d+hyiKeO5zn8vjjz9+KPR+17veNXO+v+1tb+O1r30teZ4TRRH33nvvQg75O9/5Tv74j/+YP/mTP+Enf/InWV5eRilFt9t9UpEz7Xab++67bwbKP/jBD2Kt5b777ps1Nrz//e9nMBjw8Y9/nO/5noNjHHS7XT7+8Y/zAz/wA7zzne8E4NnPfjb/7b/9NzzvilH3k9IVv8ov/MIv8PrXv54HHniA7/iO7wDq1oU/+IM/OM5PP9axnoKy7FF2dj/Nzs6nSdMH5tbUEH1p+RUsH0P066qLZaJbe9U90DMX+rgck1TJDedCr7RlkpRMMs0k0WRFRWksRWWptKGy4KxBmBSpE1SVUFFS4SidQM9Q8+It616Mi8bT5XXJQa+dbQKJoM5pOJSgg3NzHdLrGJfrM5io2BtEtHGgH5aBroVg28U8opd4UK+S7htps69STvlDVr0JUlhGOmZTd8gTy/PkV3mx/BIvkV8kDks+376Tz/bu5p3db+ez3bv5auvWQ+F5UI2JiseQ1QPY6st41cNIs7MXkUPtDOvrJQamx80i4jYst9oRPX+HYOksYvDVA1xk9o2rwG3FFKMVNqvb+Ur8TXy+cxd/37uJ4fJBF4ewjlO7Y2658AQ3rT/M2vY5eukYAo+81caELfA8zMoyu+xznTuHV+b4RYFvKoQS6E5E0YlxvZiceMERb3GkMmWkNhg1jvOxmjBSY0pZO716us1txRlelH0jt5Wnua04zW3FGfrmYLb6VJkoGamEoZfWjvMGnk9UhhOHQ6ArBkNW1rEsmYfMQOQGUVQ1MK8SnD2Hs2Nwk+a9HpREEqs2sXeGSHWIgwGx36lhuWoRyxah6OBdUSa5RrKLE2OMTChFTi4LEqkZKxhK2FIeE+VuaBc57OWRqxkQn4Jyt2/5146j9qppCkckc45xiW1OMfPO8GcuGH8yvyUHH/Okf5GeaYcTqH+3aT5fUzUfqkN+v2Z4zrkZkpMz9/uc6/1rREIIlO+hfA86BxuWrTbovETnFTovZ6DdFBXOOsq8pMwPupSVr/BCvwbtgY8fepd0tU/3xfc9fB9oLV6LWGMpi4qiNHWMTFmxVCQMzn6Ru85+cbZd6QVsrNSQfWPlNJsrp7iwcpIyCPnybc/iy7c9a+F5T25tcOfjj3Dnow9z5xcf4XlPPEa/Ssh6HZJeh7Rfl0m/S9GKFs8pAnJVkF/C5e5ZNXO2t+diZeIGuLdsiHI+a5O7WJscjCFwWHQ4pGidY6dzlkn7MYr2Oi7axg9H+J6mCiXDUDLk8FzgoLBERU6UP8ZN+VnuLP4PUW4ICkdRdtmNltiWS2zJZbbFMtuskJs+Qof1gN8mRJgAoYN6mQmQOkA4hXURmY7I9Al2Dn316bGqkF6Kpyb4MkXJDF+mBHJCKBJCNSESYyI5JhZDWnJMSIFPhe8qfDS+0/hUs9OQwqIoiVzJoS30V+Nr+MRnr8KTHOtYV19veMMbeO1rX8snP/lJPv3pT/Onf/qnvPvd7+a+++7jTW9604Htv/SlL3HPPfcsRJW85CUvOfS556H86dOnAbhw4QK33nork8mEX/qlX+KjH/0o586dQ2tNlmU88sgjV+V9Pf/5z19wnX/uc5/jq1/9Kt3uYj5nnuc88MAD+x8OQJZl/OiP/iiveMUr+IM/+AOMMbznPe/hta99LZ/5zGeI46c/fveKgfrrXvc6PvKRj/Arv/Ir/Of//J+J45h77rmHv/iLv7hkrs+xjnWsRTnnSNMH2Nn5K3Z2/yd5/tjc2j2IvjR4GUFweJzAsZ5+SRngeT18v3+kluSnomkW+o3oQq/mHOjjpL7R0cbOHOiltlhnkDpF6jFST9C2onSOAokWisOyHoVzCK2RuqohpdXXNgfdTR3RElH3q0ZYN5dDP/dKF4lxufbcYQ6gNw70wwC6QbBDxKN6wANmrXGg72nZm3DKG9H3UnCwY9rsVDGDYpeXyC/wEvlFvll+lfXBKp/t3s3Hu/+Af9f7Z/y/nWdTHjI6WFjtEhaPQPUAVF/FL88i7eKNZ2RDBvoEJ2yXWz3FTZ7hhBzS7e7g988hgsMbp0QKcsPH7PRJJmd4gm/kc4MX8PdLt3FuOWB8+pDPlnWc2tnh9ifOcvP6WZYmO7R0jo5bmKiF83xYGpAsDRYf6ByqKlC6ROIwkY9theBJEBEV0YIbvnaGjxiqESNvVDvP1ZiJGmOaOJWOibmtOMM3Znc30Pw0txc3MTCHh7o7HGOZseslDFXCbhPTMlQJWmr2vFj73vOhz3YRGYlMFTJ1yNzWwLwsQWegJzUwb4Z43Y+NlPBpeV1a6nZaXo84WKYV9GpXuWoRiRbBFYHyEiW2UWzh5IhKJA0oLxkpy64S7EjFlgopRHgZeHrp6JinU4ImcsXOQfI59/j88q+nPPKDzvG9OJVnBhy/3C/StGF2zh05G1106ppmbv2+dQDusN+9yxyn/Q+YDXLrFl5C7H+AgL1N3Nw2c+tnj59/kbn0eDF9gmaZuDL4LA5UDr6niz7bRVY0LP3Se2EPvuiek7VxwTcN5675mwk3fW92FjsjpMSo6aDkbt9+He3zPXf4romkpwg6MUFnEUA462q4XjSgPa/QRXnA1V7sC1kTSuJHPl4Y4Ee1q90PfHylLvnGpJJErZBo30+Is46qrKiKirw0BEVFtLvOTeuP7m2DYLe/zIWVU2ysnOLC6mk2Vk4x6gxYX1ljfWWNT93zotn2cZ7xrMcf5c7Hz3LnY49w5+fPcu8Tj+AbPedm75LMwfYyPvw3SEvDSCaMvOTAumbnCJ2/kOMe65i2bs8GT42LAZ1iic7OwV7/xptQti5QxZuU8QaT1jmK+AIm2kZEQ6SqKENJGUpGF4nK9stdomKLW3LLs3NDVFgofIqyQ1L1Gdk+Q7nEUPQYij5j0UT/WYUwNXQXppn+/+z9ebQk2V3fi3723hGRw8k8mWeuuWvqUVJL6r5YCBZGGAS2WCwEGsyVB4QeyPIFX7i2jGRkCSwsLEsy4PWeve61sUGyEAs/npDNwmDLA5YuMr4aW0PPQ3VV13TmnDOGvff7I4aMHM6pc6pO+vYk3wABAABJREFUdVdX57fWqYiMiIzckWPEZ3/395dB+BjAy6iAsAqsiwlrBGGNa4fEJE+NiDAqwqoQK9NpCCpASh8p+yjVx5FdKkVJP2wihUaIEIRGCjP07Zn3pOdDpIbWZR1j4FjLj/yld+yxtVPdTpKyxOu++xsvyOPuR8Vikde//vW8/vWv5/3vfz8/+ZM/yS/+4i9OBOr7Ub5oZ9oBmhoF3/3ud/PZz36Wj33sY5w9e5ZSqcSb3/xmgmD3T7aUktEynWE4fm4+MzM88rTdbvPggw/y27/922PbLi0tTXysT33qU5w7d47/8T/+RzZa6lOf+hRzc3P8u3/37/ixH/uxXdt6ELouH/wP/uAP8oM/+IMH3ZapprrtZa2m1X6Era0/Y3v7zwiC9WydEA6z1fuZm3st9fq34br1F66hL3EJ6eI6szhODcfZf8G6vcpYk+Wgt8M2oXnhQNCogsjQ6YW0OyGtbkQQRGhtCbWmH8bTyGhk1EaELVTYwpiIvoVAKEKhAGfidaOMNDKKkhiXYE856AfmAxsC6HF8i7BgrSHFhtnjDAH0eO6FiXERMXwxYtiBboefXA00KfKcrvFEtETTFsm/AHOqw2GvwYzsY5BshBWu+jMsBmv8Ofkof04+yqHyFg/P3slXq/fy/579Cb5WvZumMw59Hd2l2H8WwseRwZO4wdNIMxjiKyxUdZW56Ch3qAJHHcGKFzLnNZgpXsYpn5t8qCG4lwXiike4tUSzc4Zn3FfwtSOv4NyhWS7fpWjOjGewC2s5srbGyUvPsLS1Rr3boBL5mGIRUyiCK2Fubvhy31pkFCBNhFUCPAcKDiiBEAUMhey1jyGMpSN7NFSThtNIpnFUS5pDXtZF7vCP8LLuyzO3+R3+Eeb1zoWgYnDeZjsB59uqzbbTxor0PTn8MdoXagw1skMMzXsR+D4i6GGjNpg2+U9VOqeEQ0lVKXuHY2juzlF265ScKmWnQlmW8cS1MxyTBqDYjGG52ESKTULRwZd9OjKkqTRbUrCpijTVLE1RRQuH+PTUAW7e9+9+JGAoZiVzjxsz5CZXL2Ch4edTeUCevkNNCstzsSomyya/dQC5zaqEisSwnH6XJu3PzefXx1x0EBGQzdvkGEfWTYTiu7cs2Tz5DUpBdeamTn57Uve+SBEvyfM7uH8qkT73Io01GGbh12qKzd0+uHd27tdc5NLSs3bbBL4n24pceEMC5TM4n94/NwWbUuwx7ekVUWkbd2r7LsvSguQWcBTac9H5jgmbdMJbkxQmHywf3mWu+2JSY3dcEeugQbyQYhAjk/tOHkTIhANXe38QI2O1Iej4BJ3hoDSZZsAXY9DuFV0cz0OquHNCmPTtYMfa4RU9vKI39MuQB+1BEFH0+yxcfIK7n/5Wtk3fK8aAPXGzry4eYn1+hV6xxLfO3MW3ztw1eBxjOLp2lTPPPRs72p97lrPfeJqlrU0EELrOOGxP5oOit/P3nYjrmfgyZIvW5E1sroBqWKYcVSlHZTzjUNSKmdYRKs1TSASL+ecAi3E7hMV1wlLyV9wgLK3hl9aIShvg9Ak9SehJWmOndSGwjjBrzAWGlcBQ8A1uACZ0CcMSflihE83SjBbY1vNsyzq+GDZXWKMSuO4hdAGMg9AuQjsI4+bmk+XGQSAQ1kFFTlJodWdFwPaE5RaDlQaEHkzF8DIrNCTLrNAgTbyN0ChhONd/FSd3ffSpbkcJIW66Ye5m6L777uMzn/nMxHV33303n/zkJ/F9P8tc/+IXv7jvx/jTP/1T3v72t/MjP/IjQAy806KiqTzPQ+vhYSNLS0tcuXIFa20G6fMFSnfSAw88wO/+7u+yvLy85wK63W4XKeXQaKj09s1IEJik6wLq29vb/N7v/R5PP/007373u5mfn+crX/kKKysrHD169KDbONVUL2oZE9JsPsTW9p+xvf3/EEUD6CRlkVrtAebq306t9uBNhbdT7S4hHFy3dtMheqhDWmGLVtCiG3YxB18y87rkh4auH9Jqh7R7IYGvMcYSaRtHuUSGKAogaqPCNiJqQhTSQxAIJwbowpt4jSe0RmqN0mEc42Ki5y8H3YJAoBKMnl5vxwA99Zqn28YrTe7Oz3+MSw7qGDHsQB8B6AZo4XFR13gyWmJzpIhoGuEyIwMiK1iPqlzpVXhQXuI18hFe5p4jnCvy0Ow9fLX6IP+6+le5VFwea5E0YRzbEjyBCJ+I4Xm0OohtsZJ6VOOoPcEdjuKwp1n0+lSKDUrFp5Bq8ntcbYBzSaAuOYRby3RaZzjv3c83T9/FY8cXee4+h83qBHhuDIfXVzl+9TkWG+vUem2qYQ/pFbCulwSwzxDlL7lNXMxWCBvD9aKbgHMP8Mbetr4IxsB5QzUJZdzpJazgSLDEy7unOd0/xpn+MU77x3fNOG/LfgLLO2w7bbZUh4bTIRLRwNWYP84d95STteAHyK5G9iyiF8VZ5kHsMscOgwyBoORUmfHqlJ0TlNUsZXeekjsbw3NZpiD3BssFHZRYR4k1HLGBEmsINvFll44KaUrDtnRpqtnY7SZnaYkqRkx25b8QmoLygawQQxErafZ4zIZz5R6fLwd5DljbDFTKZFk6nzQKOXB8WzE8n3ZITkLJB3UY1iYgPO2xTTtn82A4BdwjHWQ5cB5/QuMNx1s72tidbt86nReTNdphQTY/YfY6NQ7c8yA+ds8nietJx2W6LL097Lzfo/IvgWAkRSbvjVVjZ34CE3fyYuN5E58jCWuz/oHsPjkGP9QBBIPOn4nO/l0g/PUcbi5CZpKrPY6PCYh6g6kOIkykCVo9gtbwSEzpObhFL4PtTikG7vH4QZs8AQZhQOYK1+8JtPshtc4qJzcvor8Z/44bIdmsL7C6cHgA2xcP0ylXeW7lMM+tHOa/P/jt2f4q3Q5nL5zLIPuZ557l5DefwIsGkYyh5w7iY2rVeH52hm61sqOzfeh5E4wUUL08/rwbQUGXKAezOJGHRKAAD0nJd6j0jzK7cSeLuorKWUC000kg+zpRaWMIvkfFDbTXxkpBv6joF0fPvfzkb4MqzzBrLHcGBicAEShMWCAIS/TDKu2wFkP3aAHflJj0vhv63JsEtieQnQy+J7eNg8xBeWlcMCJ2w6fPCRJhJOBMjoTZgz7/u49z8hWL195wqqmeR21sbPCWt7yFd7zjHdx///1Uq1W+9KUv8ZGPfIQf/uEfnnift73tbbzvfe/jne98J+9973s5f/48H/vYxwDYSyHUVHfeeSef/vSn+aEf+iGEELz//e8fg9QnT57kc5/7HD/2Yz9GoVBgcXGR173udaytrfGRj3yEN7/5zfzxH/8xf/RHf3RNSP5X/spf4aMf/Sg//MM/zAc/+EGOHTvGs88+y6c//Wl+/ud/nmPHxus8vP71r+fv/t2/y0//9E/zt/7W38IYw4c//GEcx+F7vud79nysN6J9A/Wvf/3rfN/3fR+1Wo1z587xkz/5k8zPz/PpT3+a8+fP84lPfOJmtHOqqV5U0rpHo/Hl2Ine+PJQ9WilqszVv425uW9ndvaVyD3Ci6kOXkI4uTiXmX39yOxV1lp6UY9W0KIdtunr/rXvdLNloR9pur6m3Q1odyKCQGO0wVoIIo0fWcKwD1ELEbQgbIMJ8a3El7ED3crJTpK0mKgKAxwdxpnoRGMAHW5CjEvCM+KLCBmfxpv04tOMI/yRHHTxAgF0EFgTg/PUhY4Zfj9aoI3HJTPLk+Ei67YyhGCrsseK26QkA7SVbEQVLvVneVA+wWvkwxypNmjU6ny59jI+Uf3LPFG+Yzz33BqKwVVU8CQifALHfxonfC7p4ohBcl3PcsIe4bTrcMTTLBQ7VEqbeN7FyUfYj8G5e1HgXJREm/N0W3dydeZOHj1xlm+cOcFzr/a4OO8QuuOfwUPrVzm6eomF1hb1bpNa5KMcB2RyMeU54FWz11ZEcfFaoSzWcxCeAikRE1zVEZpmDpinAL2nBp/Tki5w0j/Ka9r3cbp/jLP9E9zhH6Zgx2NvADqyn7jN20PTUMbdRKPwfLzLYERaI/o+9ENk1yB7EcL3IexB1CGPnwSCkqow49aYKRyi7NSYcRaouHOU3RiYywlZwaMSdBNYnvyxjpPMR6JBU0U0VIFtWWdb1OOprNEUkwvRvhCKY1YsyuhhOG5eOqB8Z0ie0F3PwS95B+siz4B2ArkT4BfPp0A8B7mtzKIzBtun7yGb+3+C9trkvfVOxVA8iyrJPXoKSIWNRzaJFMCmAHzwFOZRuMg98EGeXdgd5q+5duITaSeXCXlRK31vDUzguckelQD2FMwLs6fb1yuLBJFjgWM/DLGzXWGJC6bGfypnDhhsmnyGbHrWI+LzoHT1WNyQGO6vPwD4LqTALRdwy8O/u0abMcge9QNMqDFBhB9E+M3hwqCq4A4c7YlTXhVcRNrxZJKOE5N0mOi4T0tIrgna677PsatPEl54BO3HoL1TnGFt8RCrC4ez6JjNuSXa5Rm+dvfL+NrdLxu0TWuOrF/l7HPPctezTyeg/TxHnrrAqCLXoVudid3ts3Fh1O7sDJ3ZCv2ZchaJdS1ZaenLLn13pwKqAsICXR0RxifkSGHxBBSEpBoWmO+tMB/dxXxU41A0i0JiRURUaBAVtnLT7aE/XdgeAu9klwExcFdsU+MCNeA4gAUVKkSkEJGD0Q46cgm0h6+L9PUMXV0h0EUiXSCKPLQuoCOP/HjQ/FuuMlOj3WmkT0b8ZxTCSqyVCKOGlgkjwcbL0nUiP28k0igOnx2P2ZlqqhdalUqF17zmNfzar/0aTz31FGEYcvz4cX7qp36KX/iFX5h4n9nZWf7gD/6Av/k3/yavetWreMUrXsEHPvAB3va2tw3lql9Lv/qrv8o73vEOvuM7voPFxUXe85730GwOFxz+4Ac/yN/4G3+DM2fO4Ps+1lruvfde/vk//+f8yq/8Cr/8y7/Mm970Jt797nfzL/7Fv9j18crlMp/73Od4z3vew4/+6I/SarU4evQo3/u937sjjL/nnnv4gz/4A/7BP/gHvPa1r0VKyatf/Wr++I//OMuEv9kSdjTg5hr6vu/7Ph544AE+8pGPUK1Weeihhzh9+jRf+MIXeNvb3jY2DODFpmazSa1Wo9Fo7HmowYtFvd5VLl9+hvn5MnKPP9pT7V1h2GS78f+wtfVnNJsPYe0gvsN1F5ibew1z9W+nWn0ZQlwToUx1kySEwnFquO4sSlUOBKIbY1hdXWV5eRkp5VBB0XbYRtvrtEsclCz0Q003iGh1Qrq9BKBHsYMudqFr/H4XGzQh6qCiNmEU4hMD9EA4I/7ZYUmdi3HRO8e4WAbFRAeBFjd2bMMAXcT0PHOhj24/Ocbl+VMOoNsUoMdO9PhKevAcW6CDyxVT5clwkVVbJZ+8PCN9VtwGRRkSGcmmrtKOXF4tn+TV3pPU6j6btQW+WruPr1TvpT1h5IUXbuL4T8fwPHgKNziHSFzNwkJNVzklKpxyFEcKEQuFDpXyFq4zIT/PgFoD96LAvShxLgm4WqEVnaZZPcW5I2f45ukzPH2kysWFye7zUr/H8SvPsbK9xny3wXy/S0HKybDPGIQJ43eSIxEFBa6auKnF0pN9ttU2W8422wk4b6v2ACRYWI7mOdU/yun+Me7s38Fp/ygr4cLEVzJCs+W02XLabDotNpOolkBG6SucDfW/5reMMeAHiL6P6AbIbhTP+10wA5e5QFBUFWacWgzNnRozTp0Zd4EZZ5ay2gswD3HEKkqsxX9sJPMxNBdig7aQNFSNrQyY19iWdbZkHV/s/WT8ZknlcspjSK4Th7lOltuJdRhuC6VAPItbyRXrTPIjR7PJd5I7UyfsbA8vnADEY4d4DoqPwXGZgfPJ2gWM7+EnePwwRP6rdJc72gGbF2RO5RiOx50NMiHhg92lSDwF5eNw/HaVzb9CORJt8wszZ3Q8FUMbiOz/bF+DHusU7e6g8TWTuyMmtGlsLfkW7LjtYJuD/K6IQXyhMkPYbQy53kUyn8H367GF7/CYk2B7fG6zR8hvUwBP8plOFufhu53w6u0C3/dzeFlB1ASwh7143uod6qpIkbnYnXIhAe0FpBr+/cuAu40NFAILeiTbPj2UHGiP/yICP0QHIZFUbMwtJ6D9UOZq748GvSea7ba5Y/USpy5d4M5nn+Gup5/i5JWLeNHkaEctJb1qOYHsw8C9V53BqAO6brQQGmgR0BQ9GrJDS7UwToiQESWhmI0qzOoZZnU8relKtqymK8zqIp7nJ5A9he/bOQAfw3jj7ZAlv0eJyIsjYMIiJiqidZEoKiKYIQwtxiisVRjjYI3K3Vbo5LYhmRoZL7cKk4xussQdqAaLsvAzP/teZPG6whtuad3ObGu/6vf7PPPMM5w6dWpfYPl20G//9m/zEz/xEzQajeelUOeLXft5r+z7W+OLX/wi/9f/9X+NLT969ChXrlzZ7+6mmupFrb5/hcb2l9ja/p+0Wt8if+JaKBxhbu7bmat/OzMzZxG3iGvvpSghZOJErx8YRB9VoAM2ehu0oza9qDd8Yfo8y5rYgd4LNJ1+nIMehgYdmPgE0oIfRoR+i6jfQuguImpjtCZA0MchkA5GuTs+RlpM1IkCnMhHGD0xxgUGAP1AYlxGALpExIVPEoA+tv8xgP58x7gMA3Q0uxYS9VFctRWeiha4qOtEOZtaSQYsO02KMiQ0io2owgV/nleIp7i7eolSHdbrC3x19l7+28z3j7VE6T5ecA4RPBbDc/+pQe65hbqucFrWOeVIjhY0C4UOM+VNHHV1/LB07Dr3Lgjc8wL3gkBecukUTtCYPcna/CkeOXmWR75rhYuLDpfnFYE7fkF4aP0qhzavstjeZqHfphb4yPznM72I1BHSRCBt7DgvOCDTyJZhWSxt2WbLaSTwfJstp4EvB2DaNQ53+Id5bfsVnO2diF3nwWHKZvJJU0f2Y3CuWhlAb6puxheSYIm4yRP3QEygwgjR7w/AeS+Efh8R9kg/Ha7wqLhzVNwVKtU6FXeOGWeOGadO2ZnZAzCPUGIVR1xNwHk6vYIjVpFsEQnFlqyzLutsiwScy5Nsy1fRELOYF7DTN3WVO6Nu8tz87Yg2R3PJMze5zEVF7DVuJY1LMXIcgucAuXAqBN3cevLfSTt9R05AkNndbK55ggyhJsemcmsYmk//j7fPdysKSIY9kQFxm+Zq51hfFqeSPo3JCoHMssTTf3tRytuGsWzSRSYmbDvh/oN7Pr/v2HwnwKB7YOc5JtxKOxPyfnsQQ6/vfs+lbPxDPXTb2sQhb0feV0ldkwHYPVjsPbFtA8yWtcVma002Z3P3sbktsv+tBeNidfEa54I2A+550J6f7s35LrBCEcWzY4+xJ9guDIhJpeNHdxeDdZM+brKLSeB9L673FLpPKoiaZrQPudl7MWy3xhJ2fcKuDxuDPHLlOTilQhwXU44hu/IchMwdWY5+CECaxL5vLY4rcUuFpNBs0o4EtK/4AeHGU4SXHiXwI6IgpDVTS4qfJkVQFw6zVZunWa7wjZN38Y2Td8F3pE+xYam9zdHNVU5euciZ585x19NPcer8szjaUGm0qTTa40850K+U6STu9l41huy9SpludQa/XNzb70JywK6CeTzm8YBafJKe+H4CEdKmT5uAZ+QmbfciLdWm5TZpuw20jDd0rKKqZ5iNYvBe61WYbVeYC4+yECwwH9apmwIzMsJzfBzXRzo+uD7G7aHdDtrtYNwO2snNu22MG4/qtk4ATgDFJoJBZRWAGx3bHcfHeHGEjI6nX/wPX+M1P/p7N7jnqaa6NfSJT3yC06dPc/ToUR566CHe85738Na3vnUK02+C9g3UC4XCmNUf4PHHH9+x+upUU90uMiak1X6YRuPLNBpfpt8fjjgol08zV38Nc3OvpVg8flPA7VR7lBA4qorr1nGc6oF3aFhr6YQd2mGbht+g0WlQLpRfkNc8D9C7/ZB2LyLyNVFkMCa+KAjDkLDfJOq3sWELoi4aS2AVfQSBdNBycoRFqtSF7oR9lA6ROwS1HGiMSw6gizRJM7vCBjPm/o8v2PMA/fmNcckDKYHVDMe4jJCYCMEGZZ6J5nk2WqDHoBPDEyFHndSBngD0YJ573POcqm/h1CWr9SUeqn4bX3DHc6kLwVVk8CQqeBzXfxIVXshekZouc6cqc9JZ4agXJbEtG0i5On5IIbjPxdA8hefuZUEoqjRmT7NWP80zx+7k6687zYUll4vzio3aOJgu9XscWb/CYmuTpW6TpV6Hgo6GNxICoUOEiRAKbMGhWpuj47eYhKo1hqZqsuUMnOfbqkEkB/v1jMsp/yh39k5wX+8sd/aPczhYGsoWTWUwbKsOm06bLafFZgLPfZl3lcUDkQU7FKhNIlpEv4/o+YhegOgF4PcQyfvVk0Uq7hxV5xCVmTkqbp2KM0/FnaOodj/ZtWiE2MARV/DE5SFo7oirSLYQwmAQbIs6q3KOTTnHpjzGlryfTTlHS1T2fgF+gJJJTrljBs7yUXB+2/1qjjjKx2JXIC7oucPrYZMh7XGH3AQwnjnFB+smOkZtWsRygHeFkSiToucYsA3wfd6hbWO4moOs6bENIsBtuijFzukDD9PlnEs8Wy9yf9lOLEqIDIbLZM8yxbs5QH7N90wO2N5cLLuHZkyYH/QOpMeTvCYinU+PMX6thci/ksPzAoERBxShdsBK8+EHt+HaL95AeSA/CuMzBG7j6Lr9AvjRroMblcSjkPxm2WQ8nsmw++A21mKsza1Jtxt6hwAJYJd6BMLrazje9wfbZTLd8dlLPqfZb9+Op9YCjBhyvKfRTnuG7kIgPYeC61CYHTjBrbVoP4xd7F0/gew+JtToIEIHEX5j4I6Oi6omLvZyIYuPkSp2Kms5+SDir6HY3a48B1UpUMrlt6eg/ZS/Tnj+MuETcVZ7zwjW51dYWzjE2vwK68m0XyyzOjvP6uw8Xz15T/Y4rg5Z6mxzZGudE2uXOXXpAnede5pDV69SbrZxIk2p3aXU7sLltbF2GinoVcr0KjFkT2F7Ou3PlLLRS9eSZ13mcZlPXw9DXK+0H3/murJPW3ZoyR5tfNqyy6pq8ZR3ma473hkwSaVghvn+InPNRerBIRaCCgtRgUWtmNeCOQw11cMtdBFuH+EFWDdAO4bI1UROhJUGIyOs0vFUaoxKpjLCygijwngqQ6wKhz4fVkVYFZ8nZlcR3Wi8sVNN9SLVlStX+MAHPsCVK1c4fPgwb3nLW/jQhz70QjfrttS+I19+8id/ko2NDf7tv/23zM/P8/Wvfx2lFG984xv583/+z/Prv/7rN6mpz49u52Ex08iX65MfrNFofIVG48s0m1/HmHwGtqRauZd6/TXMzb2GQmHlBWvnVCQQfSaB6LMHHq2jjaYdtseiXKy1dDe7lOefH6BuDfTCiF5o6PkRnV5EGGqiwGCS4bEmCgl7TSK/hQ5aoHtoawmQ+Ch8IYmu4UUS1iLCEFf7qDBA2mhijEJ6zn2Ny7A9Htw4QM9caokLfeITwgsV4zLs6rQmAegJRB/NQTdAgwIX9BxPRYs0bDG7r8Kw4LQpy4AoyUDvWYeTM+scnmti6x6Xaod4YmY8+1wZH89/BoLHcYMncf0nkSZ2bXlGcZescqfrcNzTLBU7zBSbSDkhkicQuBckhWdtBtCdqwJhBJ3SMo3aGTbrp3nijrv41ollLi1Yzq3M0CuOd8Ysba2z0lhnsb3NcrfNXK89dj2fwXNpoeCCpxBqeKtquUar2yAUIduqMQTPm6qJyV0kucbhlH+Uu3p38LLuWc72T3A4XJwIz/siGALnW06LbdUZ2l8Kzyd6TMMI0esjer1k6sd/URyHU1QzVJzYYV5xYmhedeeoOPN4and/lRZthLiKJy5SFudzLvOrKDaTCIFYTVFNgPkcWxk8n3/enebCksBxPeQqzy+73cZpDWeUC4wUQ0U8R0F5Go0yBMmT3Nf8PFZiTToGh+R7MQfCczw6A+EivT1waQNDy0mXJwud2Qq6eWPD8gcNssO3E/ftaKOHITnkjjKD5HL80/aikBQiPhqRBpAJZBInI5MlKR6XaalsIeNRObkXLftFkfnOi/wLOUliaDshBr/NaVeHIf1JErl1Yui3Ox1JZhhA6Wv5o23238jCfF/KJMJtRzaeuHM7sm2ub+Sa7bp5AP5akjMepjMhGm2fGiD25BgwGXBP0bsmddBrhNQ5Z/tgPgXxe1UeroscbD/QZykF7cQ1ZIDrjpgRNo6NiaNifKJuDNmjfrBjk1XBzaJinLKHWyogXbXn83gBw3Ey1sZPsTZD0TFREOH7IQ2nxNrcMmsLK6zPH2JtYYWN+hLamTwadMbvsthvcqi9xbGNq9xx5SKnnztPbbsRA/ZWh2Knd83zXSugP1OOHe2VGXrV8jBwr5QPJFImQtNRXVqyQ0t1acsuHdGnJ326skdXdTOH+7UkrKAUzjITzDIT1CgHNWbDMnNhDN1ntaVmLLM6pG4jyqKHK7oUZBdPdPHSqejgyR6e6CKkxkiBkaClGMwLgVGS0Flh5W9984afh1tNtzPb2q9eypEvU+1P+3mv7BuoNxoN3vzmN/OlL32JVqvFkSNHuHLlCq997Wv5D//hPzAzM57R+mLS7fylMwXqe5MxEe3Oo5kLvdc7P7Tedeeo1R6gNvsgs7OvxJmQSzzV8yulZnDdGo5TQ8qDzb8LdUgrbNEKWnTCDpOG795soG4SgN4PTeZCjwJDFBp0mFxaRSGRnwB0v4WNEoAuJL5VBEiCPbj0ZaRRkY8bBUgdTMxBhwOMcUnAkEwAuhwD6DBecGtyjMvNr6yWu9BLAboFIoFJstDReYd6/Nx0cLmcFBJdtZWcr9kyp7rMKB9tBdvRDF3hsVjrsjLXIpor8WztKA13/LeoGK6C/wRO8CSO/wROeCFGItZyQsxwr1PgDg8OFXrUSg2UGr+IMX2FuuRQelonAF2i1uILGSMUreoJtmunWZ87w6MnT3Fu2eX8ssszh+YI3eELQC/wObS1xkprk+VOk+VWg4IeyQrVEVKHCGXBU1Bwx+B5qkCEbDlbbDpbtAod1sQabTUM/lzjcNI/wj2909zXPcNZ/ziHg8nwvCcCNtwmG06TdafFhtOkK/2x6/J8dEu2KkrBefLXTaZRiCsLVN15Zt0Fqu48VXc+g+juNUZ8hKKNlas44jJlnqUsnsURl3HEZaToDW3bo5hB8005n8HzLVknnBB7czOUB+bOiLvcsfq2K/BphQCVeq3jnPLUVW4BK3Pw247OC5I7IGzcsZaPz8i7uoUdvO/y3x5i/OtmaJr+1txItreandkdqA+B8klO8uSzImOYPHCwy8HxvlCQPHne8m76bLEQcZ+HGF4hkmOQIsbdQiikTCG5QAkRA3AZ/14pIVBKxuulzPVajLiwZe5x2H9UygstawegfdCBPoD1JttmAOqNHQD6yTsd3r+dcGMMs5vBcpOeACRxHfmRa4OvogSbT8yNyT9Iup2OO8VNArF1csZnTQbj9/otd1BAfT+yybNvxrB7Oq8xQoOIMnc7CWwf3N79CGPAbpFoSKZxHvlNqhVkJSZ9qYag+96Au7UW3Q+IusEAsvcCTDS5vcKJI1/cHGRXRfe6PrPCEndCGAAD2mL8iCjNaA9C/CBitVhjdW45drXPr7A2f4hGbX6HfRpqvTYL/RbzQZuFXovD2+scW73M/PY2pVaHcrtLqd2h1OpSbHdR5todKf1SEb9cxC+X6JcH8365SD+Z+uXinp3uk2SxBCKkK/sxYJd9ern59K8n+3Fx6H3I1QUKUTn7K0ZlvGRaiEoUohLlqMCMEVS1oGoss0ZTNZpSAt/dSoXXfPAfXvfx3aq6ndnWfjUF6lPtVTc1Q71Wq/HZz36WP/3TP+Whhx6i3W7zwAMP8H3f933X3eC96EMf+hB/+Id/yNe+9jU8z2N7e3to/UMPPcSHP/xh/u//+/9mfX2dkydP8q53vYuf/dmfvantmur2UBBs0mh+NXGhfw2t85XTJZWZu6jVHqRWf5By6eQ0D/0WkFIlHLeO68wirwGu9qte1KMdxE70nu5d+w4HrBSg90JNPzD0gogoMOhgEONiwwAbtAgTB7qJehgLAQIfSYCHL+ROZp5MwlpUGKAiHxWFKBsxabD44AJa7IDY96gRgB6jlvRiluSidfQR4ivk5z/GZRLRIo5xSSJcbDi8DuIc9FU7w1PhIhdNnTAXVVKRfSqqj7WCpi6xKat0azMszXWozTm0Z5e5KF3yYVKZ+zyMneeu/0SWfT6Hw31OiTOlKkcKIQulJq6zPnYkJlTYq0UKT0PlMR/vvEBtpD5FSejMsF07RePkGa4snOSpo3XOLzk8c6jKuUOLY+6lUr/H4e1VDjW3OdzaZKHdHB69kMJzacBzoOiCVBNHjURotp1tNhOAvuls0XKGhw67xuFs7zgv657l3t5pzvjHORwsoCbEwPRFwLrTZMNtJQB9Mjwfc59HOuc2z/2FIWVVZdZbpOqeYNZboDoTQ/SSUxl7/MHeLb7oouUGSlyiIC5Q5WlmxHmUuIIU/th9mqLChlxmXS6wIReS6Tw9Obnw2UHqpQTMU1huYTiCxSoMEiMUFpW5ya2WSB07yDEyYcppCEniTMx1lQ3z79StncBvQVIRT4x8xew93/uGlTrHhQGVOFdHHeYJF5bE8DnF4nIojuQAQHkKvhMYnXIrmXa2pcVDUxCdbS8Gz1sKspPtBj0XMnGAx39KDEB4djRCIMTgF2nXGgUTDnXQsZHbJA/yh2+Mw/aJ82Liij1DvbGOwsk3htPqJ3y+dzKN7/S4k3ZhQVubAfmIGLZrQNsBrNd2cJ4x1p68SX3EDm+RCQ8f5K1n26cAPCGyhtx6O2Dped6+4wlO4s42BrA6jtMzNobwNoHw1mCTngQp4/fj0L5vsuLXM/5V3LmWB8mxp9idGLRn4D3CyAhEkDnbs1gZqePnW4BBjbyx0viYuGNfEI9SumHQLgyZB2zSR3PE5W6TZSlwFwKcsodT9gbHj0CHUZzJnkTGRN04p91GhqDVI2jlzv2FyOJiMkd7yRsrgDqhaWghk3bLmLoUXBQlHKBs4t+NZW2w0Tbh2hr6wlcJg4CuFlwqz7FaWxo42udX6JVm2C7Psl2e5amRxyv7XRa6DRb8FvNBlwW/zXyvyWJzi3JrANlL7U7mcC+1uziRptjrU+z1YWN712Pyi14G2jP4Xiriz6Tz8TrjjL8DBYKC9Shojzm9M9g1WPrCj2G7ysP2eN53Qvq2jy8CwiTeL1Q+ofJpF7Z2bf9Ym6zAMwUKusAdlbN8al/3nmqqqabaI1Cfn5/n8ccfZ3FxkXe84x3803/6T/nO7/xOvvM7v/Nmty9TEAS85S1v4bWvfS3/6l/9q7H1X/7yl1leXuaTn/wkx48f5wtf+ALvfOc7UUrxMz/zM89bO6d6cchaTbvzROZC73afHlrvOLOxC732ILXZV+E44/nEUz3/krKQONHrqGtEJuxH+Tz0ZtAkNOG173SAGopwCTT9QBNFmig0MUiPDIR9CNuYoEUYtDG6j9aWCEFfSHzrEcSeoWtKRmFWTFTqcGKMCxyQC92mbCMd4j4M0OP8ULi2C90kLvTrbchetANAt2RFRCfFuGgEGzbJQddzdHPlkgoiZFF1EEBDF2kWZmjP1Zib66PqJfzKAj7QyO3Pi7aR/uNJ9vnjOMF5BJoicLdT5E7P5bhXZrnUoeQ1geG6JsYIwu0K6oLHzGMRs492ca6CsOn7WtItLtJYOUOjdor12hxPHp7h/HKRJ48tcmFlPLpqttviUGODQ80tjjQ2qOXjW4xGRvHFN56EogdqMjw3GBqqGYNzN4bnDdUcciMJKzjhH+L+zt28vHsnZ4MTHPLndoTnG06L9cR9vuE06UyE5wMXMFojM7f5AKA7kaXizMXA3D3ObGGB2UrsOnd26bTrEdCXDVAXKYpnKYtz1O0TlMVzCDGeyWmBbVFjQx6NgbmaZ10usinn8cXBfa9NkjIGx2jcUWBudJyjezsoheMyRtxGSIxVWJykbLLCWokwKRyPQblMs8StxUlGvYx2l6WAPAZXZvBVkQKTPDQX8bY7NvJmaKKjPNfOpM0iySSXnkYWTPb9DHsA5QnEzh+rUAM3OlIMYHy6XRZpksa9pMAx/XUY6Vwg1+ScVV8mLnEhJE7mGlcoEYN+JRMHOSJeJnOvyfDuk+PMHiS3Ugw3Jf9yTnXTlbraU8CuGQbw2TyTUe0YwM4B+Pyg7Mz9bnPoPnWhW2LjAmBNnHGOlRgTwz6Mg03mJ0F4C1jXglPCWAPGxDnpxmCtHlj7k6F4aTuSwPH4/CcH/G+GRDYqEMZwQDYSwGT/snkRgQixMiSOlBnEzFgh4kLqyYclPeMQVmegPXa0p6/yQRyITb6O7C7APek8zQF3VZAor0ShliuCagxRLyTsJqC9G8fH5Aug5i02quDiltMCqPFUuXvzKlrICk4jJbhJMVXigptV4LAxmGid6OolomcDwn5IQ3hcKc+xWplns77IxtwSG/Ul2pUa3UKZbqHMBQ4PPZYbBix0tpnvN2PIHvZYCNrU+22UNbh+QKndpdDtU+j2KCbTQrc/NC+tpdAPKPQD2GyMH1ROQcHFL5UIih5hwSMqeISeS1jwcn8uoZebL3hYGX9/l22Rsi6yoOtj+y6Xa3S78eMbDIEICUSILwN8ERKIAF+m0yBeJwICmUyTbbUwWGHxVR9f9WmXNvf02k011VRT5bWnyJdKpcLXv/51Tp8+jVKKK1euvGAFSH/rt36Ln/u5nxtzqE/ST//0T/PII4/wX//rf93z/m/nYTEv9ciXMNxOXOhfodH4Glq3htbPlO/MIPrMzJkDz9+e6vokpYfjzOK6ddQ1ivXtRzvloV+P9hv5MlRENNT4oUZHMTyPIkMUaGzQg6ANYZsoaKGNT6QtkRX0k/gWH0VkBdeizMIYVBTghD6O9pMczHEdSDHRIYA+GPafrU7dUaNteEFiXHYG6OjYfW4iAdHIeqCFxwVd5+lokQ1bztYrNLOqj8DQtsU4m7LuMTOnCeeKdAvjEVGl4CLWfxw3AegyWkVhucNR3KeKcXRLsU+10B6rW2gt+L0q5moZ72mH2rd6zD7ZQkTDG7bLh9iu30mnvMJqvcLTh0s8c6jKwydPsDa/MNam+fY2hxqbHG5ucrixQcXvZQ8oogBpQnAElDzwnIn1FC2WlmoPOc+3nW30SI5rLarwiu6d3N+5m7v7JznhH6JoxwF2Cs83cu7ztuzvQLqSEQxBgOz2EN1eNvVCQd1bpOouZFEts+4CM05tx8+vsZa2COiJBta5RFE+yax4ggX7CDNi8kWYQbAl51jPOc03kmkkJmem3qiEBWU1TgbOB/O3S8FPK0Qct2IkRjhYmzrKHayRIFQMy61AmsRFnjgmJ5XrHHwLiCG4KtLzpFGivisov0kayyg3jEevWBACmYHsXCHPpLillDGMzvK6y2VEv49MFsXAWyDVwA0uZezuRiX8W8qEmQ9D8EHR0sGy7Llk2F2d3U4AuUKhpMzyxBWJm3z09s16fqd6USrFslEK3208n8L3FLrf0Ki6vbTDxODdAtrE4DwgKV6p47aQgHlj4vMfoy3GaqwxmBS467Rs6aQHsQPLfXK+ZEcgvL3Zp0yjTUpjZLJgGY0VEVaGWBGCDBOXe8R4fnvqaM9Hx+w2ROBmHUQaKSPSfowhh3tcADUi6voD0N4LMOHkawbpqCwqJnW0q8L1Rcbs3m4LfkjUD4n8kI4WXC3McnVmjrXqPBv1JTbrS2zV5rFy8vWsNJp6p8F8p8F8v0U97FLXfWphj9mwP2y2sRavH+RAey8B8H0KvR7FTgLee32Uvv7XMHLUMHTPQ3jPJSp4iGqNvvYxUqIdhZESk06VQqt4anLTSSepETqD64aAN/2v/y8eXHnwutt+q+p2Zlv71TTyZaq96sAjX1772tfyxje+kQcffBBrLf/7//6/UypNBlv/+l//6/23+Cap0WgwPz85gyyV7/v4/mDYdbMZO/1McoJzO8mYtCCP5TY7tIkKgjVarW/Rbj9Mq/0wvn9xaL1SM8zOvpra7APMzr4a161n69LoialeGAnhJE702aGM+hv9TIYmzKJcOtHkPPTrUfq52vE9Y6EXDgN0DLELPTBEfoT2exB0EWELo1uE2kcbiLTFF4o+DgGKEBG32+Z2PkGxC93HiXyUnhzjkl663KgLPU4H2BmgDy7yxiF65hKDGHi9AAA9aUrsQk+iXEazOX0UV0yFp6JFLpla7MKK70lV9lHC0KFAvzbD2lwdpy6J6gWipNhU6uWRNqTgPwPBE7j+40l8S4uKtNzjeNxTcDg+67BQ6uBIDQxHn/hBmV6jjrpQovw4zH+jwcxWExj8jlkkrcpRGtVTBF6VtdkiTx+d4bFji3z9zrvZmq0NPyvGsNTa4nBzk0ONDQ43NihGibcsCpE6QAgLBQUzBYT0gGHgbbF0ZW8Inm85W9lw3FSucbine5pXde7lvt4pTvlHmdPjI4BCNBtukzWnQWcm4jlzZRd4DhiN6vUR3W4Gzp1eRF3WqXlL1LyT1AqL1CpLu8a0BNbQIqAjmxh1haLzODXxKPP2cY6zOf7wYgDOV+Ui63Ixi2vZlHM3pSiotBbH6PgvcZi7RiexLLvd80WAI20cJWCFylzlGgmo2BWauipt4oi2hnirSaA8xm2Zizp1To44oYen+SfweTwHyBcIzsNyQRwPk8B9R8gEaKv4TyXeciWQUqFUEl+i4sKYQqUQPckGl2TzCEEgXIoUBuz7AKCPIgbkMdh3kAKcZHSSFLGLXCHi9u9nx/agfrGnuiW00+dw4jo7vk0iJXaIN8lta2wC2EUcORMltyMGQD7aYQDcNaOcR9ZLwFqB0hYv+eyl5xNpv5dJ3AtZzJ0RyXKLMYYoshidgHatE8e8jp3ukHwWLKnnILk1/PSkdNgkLvjU7m6BJKYm2dV1Kz7fc4Y/xznzeR64x7A9xGSwPUAIjZV66PtvkNF+E4uhDh2ETb5ed3K4S5Qr8WbKWFvOiqbqUBN1whi0J9Exuh9iIk3Q7BE0c152KbKoGDeJi3FKhWtGxuzebgHFAk4xdrUXgQXgPhrYYBt78Qn0kwF+GLHmzHC1WGN1Zp61auJsry8RegU2q/NsVsdZiTCG2W6TWrdJvdei7neoFbvUqz417VO00Q5eBosThBQ7MVz3+gGuH+AGAY4fZvNuOu8HuEGIG8TnnE6kcaIepc7Bxm1qKYcAe36qlcQqxaEr/1/Mr7z6QB/3VtDtxrOmmupW056A+ic/+Ul+7dd+jaeeitO6Go0G/X7/pjbsRvWFL3yB3/3d3+UP//APd93uH/2jf8Q/+Af/YGz52traLX+M+5Xvb9NqBVgruIGaIrekrLVE0VX6/UeTv0eI9GiOsMDzTlAqvYpy6ZUUCmczF3qrBdAd3e1Uz6OEkEhZwnEqSFlM3Byd5O/6FZqQXtijG3UJ9M0pEGWx+G1/aGh5EBmCSONrQxCZ7GJJR3EhUR34EPYRuo8wPZSN0MYQGktoXUJRIBKC0InzQZ0EGu0kYQzShKgkuzoG0w44ztA3/aCI2PW70NOT6NgvOOIatIOpHQPodmgT0giOm05JJgB0a4l8TZj8mWi4EQbBFmWeieY4p+do20HvdElGVKRPV7n0amU25+ow52CqXlawKcXIju7g+o8jUoAePI1jA466lpe5Jc7UBIcLlhm3BwxfQGjt0e2tEG3O4T7lUfmmz+FnrlDsD3+3GSTt6nHaM4fRqsjWjOKpI1W+dfoYX737ZWzO1oe2VzpipbnF4QSerzQ3cZOLdRkFOMKgPBenOoMqVic6qyIi1uU6V+Uaq3KVVbVGb6SQJhaO+Mv8L92X8/LenZzpH2XFn59YNLTp9tj02mwWOmwW2jTdXtanUSqUEX6BahKlY4MA22lBu41ttxHtLpWwQM1dpObdEU9rS1QW6ju6wjrG0JYhHdVFO2sU3Ceoy28wb57huF7FtbnYp9xboytm2HBX2HBWWHfi6aazhJ7gOL+R1HMBOMYgrUaZOItWWZu4zAUoCdwcl/vNUer2izPJQSYhTgpLXMwTRFafRFqSNeNfDpMc5QMgvOPGL5xEAsSzXPI4oiCmOBZUErEiRewGT53aUqBkUhRTxOvT4xxkCu/vwPLfyBaIUPgjnaCTlJWMTopyCgEq7UJNXOSCGJRP0pCXM/uNmOLxW1ajn6Whvmi7+3a7gvHhm8+bxPhNh/GL4BSuZw73FLpb9mU6sNaiBWiVfNaveU+bm4ikU0rGRvQUvCc58FpbTKSx2mJ04mo3OWtCxp5tDPJtjNrTs690FTkQT3oeNrof4mKsN+80zSTfDTqJkomwIna5IwxIkyD5eFuZnr1a+7y62Xe8ZF4g/l0DMAKtNWG7T9juZn9Rp4c1hrDjE3ZGImOKBdxKGXemnE1VwTswN7tLDNprwFkA2tiwhbn4JNGTfTaMwxWnxNVClfXSLFvlWbardRrVObTj0qjUaVTqnJ+wby/oU283qPdazPU71IMec1GfeRtS9wy6vkhPCPaMxY3B8QNc38fpBzi+j+P7uLl5px+vd0MNYYjUOv6L9NC80Bqlh0cQKBObDwjHY/hStb/0ZVZXV/fa4heNWq3WtTeaaqqprlt7inzJ69SpU3zpS19iYWF8iPh+9d73vpd//I//8a7bPPLII9xzzz3Z7b1Evnzzm9/ke77ne/jZn/1Z/v7f//u77n+SQ/348eNsbW3ddsNier1VrlyJI18OfOjZ8yxrDf3+BVrtb9FuxQ70KNoa2UpSLp+hWrmPSuVlVCr3TLPQbzUJgaMquG4dx6keWLHXftSnHbRphk36+uZ3jFlj2V5vY8se/cjSC6LMORSFGu1HBJ0ett+GqIUwXaz1CY0h0pZAQ1849IUkQMVDf/fw1SwjHzeKC4o6evJJYnrJkRYTva6LosQoGYNQOXZxMYhxyfvNSReOFRMVNw2k7OJAT54IG8osDz2/jQU6uDynazwdLbJmZ0hLDCo0JRniex79+gxmzsPMFbDVcaBZDFcheALHfwLXfwwVXqQmNaddwb2eyx2eYanYRcnhC0Frodev02ovEl2dp/yox9yjbRbWL1AIhk+GjVC0KsfoFxewQtEsWh4/PseXX3Yf3zhzNxuzc0PbS6NZaW5xZHudo9trrDS3YjAb+kgdxPSy4EK5MIi5yLcNS0d22XA3WXc22HA22XYaQ7nnADNRiQe69/GKzl3c2T/BiWCFshkfJtcXAWtugzWnyZrbYMNpEsgJ719rEX2fsoZgax3R7VH1XeoidZ0vUUuiW9QOTvC+MTStpiF6dNUG0n2amvMVDolzLJkNqrY98X4RinW5yKpcZE0tsSqXWJOLdOV4ZM/1Slgbx7HY2G3upq5zY3YuKHcryoK1CkwSw2IVZLnlbvI5ktl7SwiZOct35N9J0PZQHvmusPwAv1NSai0mLMqOIVcgUwpIwJlwZBxxoGLqLRySLPHYRa6EQEoHJePvU6UkjoyB9H7h+I0eokAQ4FERNs4bz0WrpNErEonzIj9ffElJTPqz48vYYXkKvKcv+URFFkI7cLmHub+IXEFVawlDcF1u+vVWEtGO1oYoNOhIE2mNieJ5HWV2cYBsRGF6Xgcic86n8D5LZ0mAvEiAfjYS05gEIqcW+YOPm4k97QZLiJURVgS5KJkIITQIm/2WYM3B57PfqKyM89f7mrAdEHaDJDZm58gYoWQukz2OjXGKHkKKa4+WOIgmG0MYRGyLAhvODBveDBvFKlulWTZn6mxX6nRmrsFHrKHablLvbFPptan4PWaCLpWwz0zkU4l8KibAE4CbGH/28TnJZ6jv3AaLMBaVgnZtsqkauS21xosMP/Cjb6P6fd+353a8WNRsNpmbm5tGvnB7R74IIfj93/993vjGN77QTbktdOCRL/mipN/zPd+D5+1cnGs/+jt/5+/w9re/fddtTp8+va99Pvzww3zv934v73znO68J0wEKhQKFwngRsNQldDtpMOxXvOgy1K3VdLvP0Gp9i1b7W7Raj4xloAvhMDNzF9XqyxKIfs+BZm5PdXBSaiaJdKkh5d4K+FxL3bBLK2jRClr4ZtBJdrMuZoLI0A2SGJcgxLYDsAJtLGE/Imr30L1WDNB1ByGCuIio1gQG+lbSx8GXikiK2GF0DceNsBoVDiD6TvEoN5yFbuOie3KoaNXYJglI20Mx0ZsK0He2oGbFRJMol9EYlxDJVVPhqWiBS6aGnzh+BZaCCIlKDv16hXDeoztXwJbH36sl/wI2eBzXfxTXfxxPb3DMM9zpKu6ckRwthlTcdGTEwKsTRR6tziKt9jL60jLVhxWLF9Y5tn6OYjDsB9LCoVM5QuBWEVbT8SK+8rIzfOXel/PwHWfZqNaHtpdJhMvR7XWObK9xqLmJE0XIoI+0EbgCO1NAVMejWyB2n286W2y4m2w4m6y7m/jSH97IwsneUb6t83Lu653lTP8oi1FtzOuqMWw6LdbcBusJQG/J3vjLZS3C95GdLqLTpdANmY8qzDlL1L0lau4DzNYXcOXkop2hMTSNpUlIQ3bwnat47iOsuF/nsLnCy8waBZLXYeQtuy1qrKnFDJqvyiW25Bz2gDr40gzzFJorm07HgfKtJxHnkhuJtSqbN6g4zsY6WKGyQpNpLrbE4Awz6ezbSFgDSab38Ec4cWzDyMd6n98fI0B8tJstLpwJiNzjJ67rQfHMZD0WnCQiRVpQJl4tLSLuN8gKYTpK4BDHsCghsz/xPJ5LquQbOwX3UsSBDJIkEiYp3umIOBt421jqaSzFVLeGBGRh/zsB8R1g+P5exulrvl+5YvdxQToH2LcNuAoiRAbcb8aZkFAgFTiuolBUjLbQGkuUwPUo1LmpQWuz93hLm77tJMLEb7g0iUUYm0F6qy3SmnidJobthixmZq8PJ5BJmIwz+M3O+gYS2C4CjAiJZIhJYmSk0CA10mok+vmJjdnxIDRCgTcj8GYKkCtYr0NN2NaEnbgIatgJiPohVpvE5Z4zAwlwil4cFVNOpiUP6Thj3903Ct2FFHhFl2UMy7RAt6BzJR4svB53FvUNbMgy684MG4UKm4Uqm6VZthLgHroerWqd1si56ajc0Gem26LSaTPTb1Ppd5jxu8wEPSphPwbw2qdoDSIF766zt/esEFgliPY4ms+1UPv+79/Tc/Ri0+3Gs16KWltb4wMf+AB/+Id/yNWrV5mbm+OVr3wlH/jAB/jO7/xOAC5fvszc3Nw19nTwOnnyJD/3cz/Hz/3czz3vj53qv/yX/8L73/9+vvGNbzAzM8OP//iP86EPfQjHORjGdC3t6VGCIKDZbLK4uMjHP/5x/vE//sdUqzfu9F1aWjrQ4qbf+ta3+At/4S9kT+JUL14ZE9LpPJnA82/Rbj+CMcNOYykLVGbuoVq9j2r15czM3ImUB9PZM9XBS6oirlPHdWsH9jp1wy7NoEkzaBKa8Np3uAGFkaEXGnpBRDfQ6GT4rbWWqBegmz2C9Q1s2EKYGKALY4isje+rBX3p4OMSCIlNHD1xtarJJ4cCG0dwRD4qCpIs9HHdsAs9Aeg75aAnm2Su+yEiuUMx0ZsD0XeyqubaqBOIHsmJLvQtW+RZPc+zep5tW8zWuyLCqZA50HtzBSgO+4SF1ZT8cwlAfwzXf4waLU4VNPe6ipNlWC70UXL42K0VdPs1Wu0lOq1DRBcPM/eYZunKJU5vnqPUf3hoeyMU3fIKoVNG6j4b8w5fvP9+HrrzXh4/cpKNSn2kXZalVupAX+dQYwMv6CPDuDgqBYWdKSJqgw7G9FmxWNqyk4PnGzRUc8x97hmHV3bu5dWde7mnd5ITwSFmJrjPW7KXwPMGa26DTac9VoQ0dp4HyE4H0e0y0xPMh1Xm3UXq3p3MectUFiafFGpraesYnjdEn6bTInQuUC0+wjH1OGfsFZbMOm565Z0zvkco1uQiV9QKV+UyayoG6IGYDOn3o3yu+cBpHmec7/yOvQVkJdaoHDSXybyKs8ylIrFmk/JvHEF8iTroEBiaChjOK0/h9khUBIxc/Y98Z6SgQIixx5H5bWSyRiZFMTNQPgrHGX8hEigupEmKblpwbBzLksBzJ4leiZ3kbhzHIFTm4r7Zdt7Y369iSJ6BeoUkBvdSymnRzltNuznFd4HlB9SHN9ULJCXiv4KFSEI9Z7y1FgILITFwD0bc7TfNdiAFrqdwvfFxT1YbtDHoKCL0DVEUEYVxbrtJnO+DHSWG9SxrfNBiy/BtnbdhWIkwYG0MxqWJXdBom4Tbx8YMqQXWmD0B9wy2W2dwAkwaYaPR6Ay0IwKsDEBGSBGOQXbxArnZlatQc4rinAfEI9+ssYS9MIbsuT+rDVEvIOoFkKuBnrrZh/9cpJO81hZ2Ovu4XvAuhKCk4Bg9jukedNfjxNStwUO2ZIE1JwbuDadE0yvT8sq0CmVahRnapQqBWyB0C2zXCmzXFnd/rqKQmV6bmU6LSrdFudemKDy8KKAQBhSiwZ9nQgpRRMGEeDqKDYRKxr1OUibzElRyO1lmhSQMfFzvxs8Hp5rqoPWmN72JIAj4+Mc/zunTp7l69Sr/5b/8FzY2NrJtDh069AK28MYVBMF1mbYfeugh3vCGN/C+972PT3ziE1y8eJF3vetdaK352Mc+dhNaOq49Rb68/vWv5+rVqzz44IN8/OMf5y//5b/8vBclPX/+PJubm/z7f//v+ehHP8rnP/95AM6ePUulUuGb3/wmf+Ev/AV+4Ad+gI9+9KPZ/ZRS+4L2t3Ml5F7vKpcvx5Evt5JDPYpadLvn6PbO0eudo9s9R693HmuHAalSZSqV+xIH+ssol08fmLt5qpsjKT0ct4br1FHqxodWWWvphB2aQZNW0CKyO2fh3ai0tvRCTTeI6AWGMFe1XoeasNMjbLcw/SZCd3CERNNBawi1xjeCnpX0hcIXCmNFMkx2969cYTVO2MeNfGQU3iQXehyIGfvP1USADru70AfdADczxmV3gJ40JYtwmeRC76O4qGs8rRe4aqpZMVEhDHLWwa+XMHMFzFwBvGGaIU1IyX8KEzyO5z+K6z/BYdXltGe4xxPcUTDUvPGOnDAq0Oos0u4s0tk6gb14hMVnGyxevcTc1tPM9IYzGo2Q9IsLRKqIlQFryyW+eP8DPHT2Hp5cOcFGuTZy0JbFdoOj22sc2V7ncGODQrcVFw+VFlF0MOUSYkLBq4iIDXeLjSS6ZcPdGnefA4vBHN/WuZ9XdO7krH+Mw8ECzkgQicaw4TRZdRusutusuQ16cqROgbWIIEB0uqhOj1rPYV5XmXOWmCusUPeWKarJMSpdHdHQgqY1bMsuLWcL4Z5jyX2S4/JxVuwqC2YTNWFUh4/LagLOr6hlrsoVNuT8DRcJldbiGo1rogFA1zoecp7o1vl1ZQiYW5PGsiQA3cYXkVYlnzEpc07zYfYH6SdRJIBb5D6aI8B8krt8gmt84qc7AeQyg+JyAMzzESuj9vNRJQ2PYTkgLVLZ+PPh2MxhLhExKCcu9JlBa26+u3xQvDPJSh+JXImn6qbF/0wd6vtQ+pbLYLgdB+O521Mw/tKWtZZtH+oF9vTZeqFg+04yOobqWmt0FBEFhiiMMJY4t92C0TehXRawFptWjdUWaw0isskoThDaghntYt3Lrk3yL8TKADPkavdxRDQSG3NrFHK01qIDPQTYo15I1Nv5+ke6ahy0F92J54Txg+z8PN6smBlfOjTdMg23SEMVaaoiTadE0y3T9EoxeC/M0Cvc2EhzN/AphD4Fv48X9CkE/fh24OP5+dt9FlyHj73/Fw/oCG8d3c5sa796MUa+bG9vMzc3x5/8yZ/w3d/93TtuNxr58oUvfIH/7X/733j00Ud5+ctfzt//+3+fH/mRH+GrX/0qr3rVq/iTP/kTvud7vof//J//M+95z3t4+OGHedWrXsVv/uZvcvfddwPw1FNP8bf/9t/mz/7sz+h0Otx77738o3/0j/i+JBrpda97Hf/9v//3oXZYa/mlX/olPvOZz/C1r30tW/7rv/7r/Pqv/zrnzp0D4O1vfzvb29t827d9G//sn/0zCoUCzzzzDBcuXODv/J2/w3/6T/8JKSXf9V3fxT/9p/+UkydPTjzuX/iFX+Czn/0sX/ziF7Nlf/AHf8Bb3/pWVldXr9sEfuCRL/mipEKIF6Qo6Qc+8AE+/vGPZ7df/epXA/Df/tt/43Wvex2/93u/x9raGp/85Cf55Cc/mW13xx13ZC/cVC+srNX0+5dicJ4A9G73HGG4MXF7x6nF7vPKy6hWX0apdCIrIjrVrSshFI5TSyJdKje8P2MN7bBN02/SDttoe3PcJMZAL4zoJTEufpTzXFtL1O4TdNpEnSZELSR+PJzTWLS1aFNiW1t6OPSFRyREfGFgrhHjgkXqACf0UZGP0npXF7pN/DT7O8e1iQtd7jHGBXZ3occxLgePYPYA0C0QgY0EJpSgh7c3wIYt83S0wHOmTispJmqFRdYdorkSZr6AqXvgDD8LyvQp9p/ABrH7vBw+yR2uz2nPcG8Zjs5rCmo8+7zbr9NqL9FqrdDbPIW4usih59Y5un6Zue1vUOn8x+H7AH6hTqQ8giKsHa7x1ftewTfO3M0z80e4OjOPGQF58+1G5kA/srVKqdNAmjC2w5U9WCiCKGb7T5+Rvuiz7m6w5m6w7myw5WyPuc+lkdzTO82ru/dxX/cUJ/3DzOvxk+40+3zV3eaq02DDbQ67z61F+CGi08Ht+Mz1iyyYWeacw9S9FereEk5x3H1graWlIxpa0jCGLdWh6W5QKjzLIfcxTrrneHV4kTm7PWC0ua+BrihxVS5zVS1zRa5wVS2zJeZuyDksrcXVEa6NgXnqPJe3GjhPHOVDsNwObqcQ20oRR9gIiXDI+LRi4Pa+NjCHidBc2l0AuUy4eN4tLkb+IKuUvtuTmnfyJrvJO8yliqGmUDEsR9gEmCegHCeLYZHEEPug3eUxc41BuZK5PPIElKupm/zWUB6Gy5xLPA/Mc7en/Q1T3UwJAQWRDwQZyCZgPWAYtvv25iWFSyWRSuLkojKsBZtA9hS2R2GEjizGpJA9mZq9R7sMKfliF54YWpSfpo2x2mCj2OlutQFjETpxvxuRZcULK0hDDBUShQOmNOZqNxi0CHKudh8pgvgPjcTEcWXPc/eGEAKn4OAUHErzA7icutmjbgLauxFRN0QHGhNqgrBH0BwuCaoKTg6yF3BKLqrg7toBOMbad3G9w94BfMFELPlNlvzmrtuFQtFySzS9BLa7JdrFGj2t6SmPvnTpOy495eE7BfqOh+94RCpGXKFXIPQKtK+V+w7Md5o8P37WqW4lWWvpmue/A60s5Z46XCuVCpVKhc985jN8+7d/+8So6lE1m01+6Id+iDe84Q186lOf4tlnn90xkuV973sf/+Sf/BOWlpZ417vexTve8Q7+9E//FIB2u80b3vAGPvShD1EoFPjEJz7BD/3QD/HYY49x4sQJPv3pT/PKV76Sd77znfzUT/3Uvo4f4qiW2dlZPvvZzwIQhiE/8AM/wGtf+1o+//nP4zgO//Af/kP+4l/8i3z961+f6GD3fX8MeJdKJfr9Pl/+8pd53etet+927Vd7AuorKyt8+MMfBuKipP/m3/ybAylKuh/91m/9Fr/1W7+14/pf+qVf4pd+6Zeet/ZMtbsmu84vYG0wcfuCt0KpfAfl0qlsWigcmrqmXiQSQuI4VRwnLS56Y6+bsYZW0KIZNGkHbczNcIpY6IVpBrrGj/TQBYDu+4TtDlGnie61EKKHEBESMMbSN5q+kfSsoi8URVlgG5u40Hdvr7QaGfl4UR+pQ6Q+eBe6tTpxnyfuyx23Y4ILPabqNzfGZdj3upustpkD3UbjLvQuLhd0jXN6nlVTRSOxAkTNIZovDgD6iDvH1R08/zFI4lvmomc4XQg442nunoXlgh6rE6iNot1ZpNVZotU4TH/9DN5GjeVL65zavEh9+wtU28+NvWKBWyF0C7RnXa4eX+Thu+7mkRNnOT+7wsXqIqEaznic7bU5trXG0a01jm5cZqa9jbAa4UnsTBGWymOUJ45vacfwPIHobTVedLMazfDqzn3c37mbO/snOBYsUbbjJ2gN1WHViQH6qrtNQ3WHX6ooQna6eO0+i/0ZFkyNOecwc94K1cICsjjBIW81zShiWysaxrItuzTcLcqFiyy7j3OHepT/xV5mwWwO4HnuZ6MpKlxNoHk6bYrqdRMvZUwW0ZKfypHX74X7JRIxJNcS7MBpnsay5Ftmk8zQJKckyf2OmWAKzlNQPpxfPgzMBWSUXSRD+4deySSCReSiVoAYiqcr9uokHxzmIFImBZgpb88iWAagHAlC5oG5TGJRBtnlscv9YF65SaB8UuyKM7UmvzDK9+ZIxh3kcgrIp3pxSgjwxKRqJ4PCqP7I9GYEIMbfxWoQJ5LIGptzs6fO9ihebmJYZcwAtuuD6AUQAuEohLODycok5+LaYKzFRBphDDYCjEFYkeTXiOSrQiKtwrHeUC9FHB9j0YSE0gcZAD5CBigRIESEysLin18JKfBmPLwZD3ID8U1kYtCeQPawG0N3Exm0H6H9CH+7m9sROCUXt+TiFF1U0cUpeMiih1Qqd12U70zf+VpgvwB+7LhGdu1azXzQZj5Iz2UFqjKPbm/u2o5ISPrKpa+8GLarGLr3HS9bnl/fdwq8/Ow9e27nVLePusZw5nPfeN4f96k//wpm1LWNoo7j8Fu/9Vv81E/9FP/n//l/8sADD/Dd3/3d/NiP/Rj333//xPt86lOfQgjBv/yX/5Jisch9993HxYsXJ0LvD33oQ5nz/b3vfS8/+IM/SL/fp1gs8spXvpJXvvKV2ba//Mu/zO///u/z7//9v+dnfuZnmJ+fRylFtVq9rsiZmZkZfuM3fiMD5Z/85CcxxvAbv/EbGUv6zd/8Ter1On/yJ3/C90+oc/ADP/AD/Pqv/zq/8zu/w1vf+lauXLnCBz/4QSDOlX8+tO+8jGeeeeZmtGOqF6kGrvNn6XWfodt7lm73mR1d51IWKZXuoFy6g3L5JKXSKUqlEzjO5CH/U93CEgJHzeC6dRxn9oZHD2QQPXGi3wyI7ocmjnBJstDzfNhEEbrVJeg20b0m6C5CxCRPSkukIdCajlX0rENfFOJT6MSFXsBgzeSTamE1wka4kY8Kg7iy/A5wOnaf79+FbjEIG7seY8zjTHa678mFHse4vGAAPcnVNEEC0M3wfTSCVTPD03qBS7pGhwJWgq25MTyfKyYAffhx3KiF5z+C8B/F8x/hCBc440Wc8Qxny4aaN368QVii1V6i2V6i0ziGv3GK8laZ+dUWp7cuMLf935ltPpMUvBoodEr0iyUai0UunTzGU6dO8fTyMc5Xl3muukTXGx7GWgx9jm6tcWxrjWOrzzHXWEeIOP/cVMqIQ7G7Jt9CjWHb2U7c5+uTi4cCS8EC/0v75dzfvYuz/WMcCud3iW/ZziJc+jJ3WW4sotvDbfdZ6BVYjGosyEPMFw5TdeeHHGWpfBOyHWkaRtHUgi3Ro+VtUyxcjWNbnIf5NvscS2Z9ENuS+wg1RJXL6hBbxROc13WuymW68vp+K/JRLa4eRLaM4s8XhrOl0FyNxLIosHJ009htnmWBDhh2Cs3lDi7zvEE8D62zXQsGnaFDTvKEyqe3U1C+1ydrN1ieQn9pQVkQA2gupI2LaibAXBEX2TxIYD4F5bewhhzjxFB8UuTKwfWbTDXVi0qOiP9GQzFM4mT3gdDE82mkzEH7q4UUKOmg3GGkkMXGRDFg11rHTnIy3h0725Op0dfpap8kKUDGwD39GhnIZrntaJOAfw1GY6M4zjAeeCfizHcrUNYD6yF0DOFtFiATEYkQI30EfYTsI0WEkgHS7n8s6YEcuiMpVAsUqsMmCR3oDK7nQbs1liiZH9uXJ3GKCWwvuTgFF6fkoDwPQVyzKSboIh7BkN0zd9zXAPCjmpg+k91dZDd3SakBQGGY0T4zevyceOL20uN/feMb9trMqaZ6XvWmN72JH/zBH+Tzn/88f/Znf8Yf/dEf8ZGPfITf+I3f4O1vf/vY9o899hj333//kHP7z/25Pzdx33kof/jwYQBWV1c5ceIE7XabX/qlX+IP//APuXz5MlEU0ev1OH/+/IEc1yte8Yoh1/lDDz3Ek08+ORbT0u/3eeqppybu4/u///v56Ec/yrve9S7+2l/7axQKBd7//vfz+c9//nkryLtnoP6GN7yB3/md36FWi7NcP/zhD/Oud72Ler0OwMbGBt/1Xd/Fww8/vMtepnoxyZiQMNwkCNYJgg2CcIMg2CAM1gfz4TY7xVl43jLl8skR1/lKXDBsqhetlColEL2GlNeunL6bbjZEjyJLN9R0/YheOCgkCoDW6F6fsN1CdxvosIMQPqlD01pLaCzdCDpW0RcOvpDENHpneA4QZ4pHSB0OstC1mcifTPYn9nX0FpPkoKdlRL39udCThUMxLljkgZ3/7x2gp50SNhDYKHXjDt+nZT2e1XNc0HOs2hmMlJi6h50roOcL2NokgN6k0H8Egkco+o9wWlzgTMFwZ1FzctZQGOkDGopv6SzR2boDu3mE0naZ6nbA8vZ55rb+O/XtJ3DM8GibSBXoVkpsrNS5cOYEF48d4bnZZS4kAH2rPDzcVGnN4cY6x7bWOH71Assbl5EyKSBarcCRenYNkR5VIMKkcOg6684GG+4WWgy/D6WVHPcP82D7Zby8dyen+kdYjmpjYxT6IsjA+aq7zYbTGsS3WIsIQpx2l/lugcWwwgILLHiHmPUWkTPj77SO9hN47tLUgm18ul4Dt7DOvPcMx9XDPMg5VswqXuqfG4ptKXJZHuKKOsQldZjL8lAGzyvlKu1ua+wxd1LqMnd1hJdAdDXhSv35ZXD7gObk3OaIzPmdGr8dYggsUmieOMWlSGB6fHPg5E5uDrJddnCVS9ixeOfOh7U7LM9PpY3jYZIpIu4TGESjqAxoK248kiUdnxNHraQu9uHolSkof5416iQfco5PIflUUx2EpICigCIM0WSbuthJILuJb0ccfGJ4Fhvj5WJjjB0C7DqKsDo5QU3aZyyZu/3m5LWLOCoMBQlwH1KSWWNTl7sxcRtt3EGQbmMRSCORFJGmiKUeG0GwRNZgiaNjEH2E6CNEiJQh6qZ0a1xbylMoT0F9ANistWh/ANqjfkTUi/9MZDCBIQh8guYIlBbgFB2ckhOD9mzeQznO4PDScxs7uA7IX4aRg/DDz8jI8yNGlqfnNwf4PJqDu/iZ6kWmspQ89edf8YI87n5ULBZ5/etfz+tf/3re//7385M/+ZP84i/+4kSgvh+57uA7OjXVmCQC593vfjef/exn+djHPsbZs2cplUq8+c1vJggmJ06kklIyWqYzDMc77WZmhk1S7XabBx98kN/+7d8e23a3mph/+2//bf6P/+P/4PLly8zNzXHu3Dn+3t/7e5w+fXrXdh6U9gzU/+N//I/4/uAL9Vd+5Vd461vfmgH1KIp47LHHDryBU90cGeMTBAksDzcIg40Emq9nAD2KGnva17jr/CSl0h1T1/ltJCm9BKLXUerGKqDfTIhuDXSTHPRuoAmiYYBs+n10p0PYbWD8FtbEOegQX7xrbfG1pmsdutahLxQ6yUJHGyw7FwES1uBoH6V9lA6RUYQ0k0/QrseFbjFYa5MUSJDXAujxnUYg+s10oe8ToNv4qs5EChulec8DRQgum1me1fNc1LN0VQFT8zDzHiYF6CN5LG7YoOA/DMGjVPyHuVNd5ExBc7akOVGzo4kvaK1od5P4lvYy3Y2TuNsLFJszFDqC5cY55re+wNzW43jhMNDV0qFTnWHt6CLn7jrFxvICV8rzXKgs8Vx1iauV+dhFnDvmpdY2x7ZWOXH1PEdWn8MlwhadGKAfnRt7L3Rlj3VnPYtw2VaNsafWMx6n+sd5sPMy7uue5mRwiPmoymiZ2Y7sc8Xd4qq7zVV3azi+RWtUs8dix4nhuakz7y5T95ZRRSe5Kh+orwO2ooBt7bBtHLZMRN9roQob1L1zHHUe4dXiKQ6bK5RJ6q3k3oYBDlfVIS7JQ1xW8V9D1PZN0LKcc6PxTJRFtkzay/PD5kQGzPcCzdOGWSXizHyZ5o0nHWXxdX8MzoVI6nXGR5LeHlxYQtzDZgfAXMhkmjrL9wnL021T5p5zDKftHHrJJAgxAs0lKBkX/lRCoISbuM2TbPHrcI8IyO6vhIr3n8S9pMU8Y5f5VAerQUdM+p6M5+P/hCIueicsQsVvEqkSeBX39mQxQUJMmCZRQojBY+Sn8fsu12GUtWp42fg2uXYOzez8UbjuX8Xc7+lQVIJN5/YwP7SPbGF2O561Y/Px773N7mOtSfrN88ty8+ZggdRUt75EHrQD6UC1tChqQAzYU9B+0NExQgocz8HJ4YfhyJgYshudZpUPPqExaE/c7DfD1Z41UoBSpINuJwJ3HcfJxGYQHRtCjAaT/j4JIHa1QwVhBcYatNGE1mDoI22AED5CBCgilIiy65HnS0KIGIYXHZgfHudgQkPUDwl7A8ge9ZNiqJZsGQzX1BOOxCk6uKUYsquig1NQqIKDdCVy6KQhOakY+ipKTmzSqBgrRtbFL5Hd7XzRDk122yTTaLzjVC8dCSH2FL1yq+m+++7jM5/5zMR1d999N5/85CfxfT/LXM8X7dyr/vRP/5S3v/3t/MiP/AgQA+/R2pSe56FHsryWlpa4cuUK1trsHC5foHQnPfDAA/zu7/4uy8vL+y6gK4TgyJEjAPzO7/wOx48f54EHHtjXPq5Xewbqo70Mo7enurV1+fL/j8uXP0On8xznL2yh9d7cfkK4eN4CnruA6y3G88ltL7ntOLWp6/w2lBAOrlvDdesoVb6hfd3MTPR+qOn5mk6o8cPhHHQbBphej6jTIOo1sVEfmw9kJo5y6WobR7ng5lzoNi5utMMp2ZALXft4coZSbxsx4bvRMnCh7/V0eQDQY/+5g4Ng50J2k13ok4uJHsyndX8AHSw2sthI7uhCb9oC5/Qcz+k6q7KKrhdigD63C0DvPwzBI9TDh7lbXeRswXBmRnO4bsdOkIOwSKu9TLMTFxANNk9Q2qridSoUwhLL288wv/Vl5rYepdxfH7qvEZL27AyrR1c4f+cdbC7Ns12ocr66zPnqEhdnl4ic4REbtW6bo1urnLhynuNXn6Wk+9iSi61W4Uh96FNgsXRklzV3nTV3nVV3nY7qjD2VM3qGu3oneXXnXu7pneJ4sERdjxf/bahOAs9jgN6WfZKhF4hun7mOZNGfYVHXmFdLzHnLOK4HI4NOfBOwHfbZ0pKGKbCtoav62OI2M+WLHHIf5171TY6Zi9RtMz2Y7GOjkazJRS6pw7H7XB5iQy7EBTL3KAFZTEs+tkXt+Nm8ybJyCJxb7ewOzbO7xeDcSpklqQih4mH7Nr6tEkou87BSZv69IQfvDbvL020nAPMs1WV0XxOc5jJxmTtSIoWDI0QMuq8jliWGEQpHCKR0YgifZqNPXeVZ50jWyZIsE/nlkLudrCfdZgDDjYV+EFApFuL3ncgD7mRbKRBKxGA8BeIyhueD2znoPdWLTtaYDLRnf8ZOWLbbdmb8fi9Akbeprk/5oqhVyEC7TkC7n/yl8wf5yk6KjIld6Slg1xgdxeHrwqKykYhisG0aH2NjV7u+GaA9a7CIne1JfvvwN5+Ni6Tm4mTiIqkGYQTKpmF7g4gDaw0RGt8arO0jbIAV8VSJEAeDECY5bxeDx7nJkq7Ecwt4I9Exqas9D9jTPx3EsTlhOyBsT3CwiqQwakGhEsiewnaVLLv2b4lAqAjpJt09ky3uDF+jpOvT+fHHkDcYWzrVVDdLGxsbvOUtb+Ed73gH999/P9VqlS996Ut85CMf4Yd/+Icn3udtb3sb73vf+3jnO9/Je9/7Xs6fP8/HPhaX3N3P+dqdd97Jpz/9aX7oh34IIQTvf//7M/d6qpMnT/K5z32OH/uxH6NQKLC4uMjrXvc61tbW+MhHPsKb3/xm/viP/5g/+qM/uiYk/yt/5a/w0Y9+lB/+4R/mgx/8IMeOHePZZ5/l05/+ND//8z/PsWPHJt7vox/9KH/xL/5FpJR8+tOf5sMf/jD/9t/+W9Tz1FGy7wz1qV6c6nbPsbX9haFlUhZiKO4u4HoL2XwKzV138UAKTE714lFcXHQ2geiVG3rtbxZEDyNDLzR0/YhuGDH0va41xu+ju0mMS9DFmD75My1rLL4xtI1KXOhOArmT4Z12Nxe6RtkIaQKcKEBEOotyUYXSEEzfb0FRi8Fik1HviiT04Lpc6LkBtAdYTPQ6ALq2YAQmVBOz0CMEl/Usz5p5nrM1OvVKnIE+700E6E7QoOh/C4JvsRI9wt3OZc56mtNVw5I7fox9v0KzvRxD9OYh9NZRKptlnF6Nop3lUPMZ5ra+xfzWY1RGColaoD1b4eqxQ1w8dYyNlQV6bpHnKkucryxxobZCqzQ8CqcY+Bzbusrxqxc4cfkctaCFLXkxQD80i2E2t39LS7VZc2J4vuau01O94WfcQj2qc2/vDK/q3MNd/RMcCRapmtHEVNhUrQyeX3W36ankYkZrSq2QO7plFqNZllhk3juEp4pjzvPQhGyFXbY1bJsiDSPpWIMp9FHldRa8p7nX+RYneIoVcxU37R7K9RKty3muJM7zS+owq3IJLfZ+qiGsjWNadBS7znVEUYq4rsGET9LN/HXK3OV6BJxf41HjjHOBUSrh3TJ2gglwkmkKzVP4aRNYHk9F9mczcJ7Q7es54JRpJxB/V2BOutwOZZpLYXFUArWFgxISR6h9ucxTWK5EAlDGYHkM0l/0Sl7vDG4nowXysFskIwdS0C1k6vhObzOI9BGDbQ5KIvk69nqWwqwXQyopBoB8CspfMhJy5476G5VJIjNi2JnmVZsMuBszvCzdPp2/eVR0qr1ICSiJ8Yz2tABqYMHPudkPbLyjAOUo1EjR0TxkT6NjBBalmAzaLUPxMQnbvokSoAQCCc4O7vbROBljkcbgGAP54vA2LokaEGFsgLU+li4IP3G0h8lgtPh3Wtrk98KKuOgqg2lyZpHu+MaOMO9qHzmJNNqg+9HA1d6P0P0I7Wt0EOf26GTZTlLeALargsIp5uY9Jx79FD9afCwj3Py6j8t5CXfUT3VLq1Kp8JrXvIZf+7Vf46mnniIMQ44fP85P/dRP8Qu/8AsT7zM7O8sf/MEf8Df/5t/kVa96Fa94xSv4wAc+wNve9rahXPVr6Vd/9Vd5xzvewXd8x3ewuLjIe97zHprN5tA2H/zgB/kbf+NvcObMGXzfx1rLvffeyz//5/+cX/mVX+GXf/mXedOb3sS73/1u/sW/+Be7Pl65XOZzn/sc73nPe/jRH/1RWq0WR48e5Xu/93t3hfF/9Ed/xIc+9CF83+eVr3wl/+7f/Tv+0l/6S3s+zhuVsHu0miuluHLlSpZfU61W+frXv86pU6cAuHr1KkeOHBmz/L/Y1Gw2qdVqNBqNfQ81uJXVbH6dzc3/SbttWFg4QqGwiFIz04ulqRgUF51Liote/0nFzYDoxpAUEtV0fU2oR2JcAh/b62J6DUK/jY16GDN8sqa1pastbRy6VhGkx5ie2F7LhW5ClA5ROkLqCKnHt68U6jT87X1EucRFjeLzwSTrNyknuuM9Mhd6rs0TYlwmueT3r/0DdJICU1YnLvRoZxf6eTvHam0ePV/YMcJFBQ1K/W8hwm9yTD/MPc4VzhQMpz1NbYTRDvLPl2OI3jyC2FpmZrOI8ueIxDyz7QvMbz7K3NZj1JrPIEc6TzqVMlePHeLyiSOsH17Cdz1WS3OcryxxvrbM6uzC0DBTaTSHtzc4cfU8d1x6huXOGrZcjAH6SIEui6Whmhk8X3PXxwqICiuYD+d4ee9OXtW5hzv7xzkcLlA2ww4hg2HDGQbogYzAWqQfstByWfYrLJo5Fp1lqu782EsWmYjtqM12ZNg2BRrGo23AuF1sYZuZwkUOu49yUn2LY+YSs3Z8VFOPApfUES6pw1xUR7isDuGLvZ+opZEtac65pyMcO/qdIVCz8+jm5h67pvYrMeI2T+Na9gDOk5xzKxRGgpIKqeLh3o4QcdZ53jEMA3CegvLE8Rv/XYfDPN1+J5e53GF3GWA3GTRXApQjYnBOArwTp7m4BjSPYXmaTx4XD3VeTM7yPATPAHYykkDk1sn8NulIAzHY5oUeNy6T9qRAXDEMytP4FcBYy2qjx3KtNDIMf6qpbg1l4N1arDYYazDaZDDe6GRqdDZ/KzjjrbVs+1AvvHQ6pdJ89oBBZEyaz34zZSJNFOkEtkfo6Npn4Nrk4mOSnPZbAl+kcTLWJOfTg/x2a0x2WMZqDAaNj7Uh2D6aJK+dCCVDhDCDvyQIS1iRjHRNgHsK3TMYny0lSZMiN0nmR5/bvZ2XWWPRgUb7EZGvY8jux7A9Sub3sivpSlSxiHQMypFxjIyrUMlUuhKVTHf+PR5f7jklfvSnf3VPx/Ji0+3Ktq5H/X6fZ555hlOnTu0LLN8O+u3f/m1+4id+gkajQak0bsyaalj7ea/sK/Ll7W9/e5bD0+/3ede73pWFyefz1ae69TQ7ez+uu4Ixz1AqlZEv9EXfVC+4lCrjurUbLi56MyB6FuMSaPxoNMYlxPZ9TL+J7jcwYQ+jfczQRpbAQMcIOkbRFQ4akZxBW6zd+YRbWo20EdKGKB0gIoOM9ESXd76gaIAg3JWE2STGJb6lULi4SaTLLvfaIcplgNQPKsZFsCd4nm9UMsQWI7CRxEQK9IgL3QoumVnO2XnOV5fpz8/sWERUBS2K/YdR4UOcNN/iPucqZwqaUzOG0sgBWiNodRezCJd24wjO9jyVzSIymGdGLVDsbzK/9Qjzm59jbvsx3GjYAd4vFbhy7DCrx1ZYPbJMv1SiqUpcqCxzvrbMc/VlAtcbuk+90+TE1ec4eflpjm1exCk6mNkqzLmYucPZdgbDlrPNmrvBmrPOurtOIIcTSZWVLATz3Nc/yyszgD4/BtA1hjW3kQH0VadBJDUYw0zHcnSrxHK4xKJYZM5dxpFuPHY7p2bYYjPss2UctswMbSMwooAptnDKl1nwnuYu55uJ+3wNZ8R9bhCsywUuqiNcUke4qI6wKeb2HOchrcXTUQbOXaMnwPOBxMj8jf9ipeDciad7jGlJlcFzpbAygcRS4hCn5CgxDE6sBETsMLeSuMDoQUHzNMc8dZjvBM1Jt4vd5kJahARHSVyVusQT2H2NAqASMje5I9VQ4VAnhe77PKQDlYyd8hkAl3FWa+oOlxkMlxkUl4nz/0VxPpSA+ziPfBq9MtVLQ0IIhEpG6u1jTLXROgHtOfCeA+5DED7L657qRjSUz577WY1ykTGpm333cnb7k3QU3qiTPYHsaVzMKGRXMm3j8NmFtmD1IKfdpjntB9jeXZXGyTApToYJwL08cLtbAyaG7dqGGBNibYC1IYYA6CFkiBQahEEIjZAm7lQfe5wBWAcGjvfcUpE9dyIB9WTbZEVI80+cAqfkQGlyHS5rU+CuifwoAe9RBtujfhS/HqHBhN09PZ1SSaQXA3aVg+3KVROWT387p7q99IlPfILTp09z9OhRHnroId7znvfw1re+dQrTb4L2fHry4z/+40O3/+pf/atj2/z1v/7Xb7xFU0011U1TWlzUdetIef3FRa21tMK4sGgraN0wRI+0pRdoOn7sRNf5Yp5GY3wf0+uC30AHHYzuo6No2DVhLH0LbS3pJFEuNslCR+sJropYsaM7RJoIZUNUpOMijdpMdHrvJ8rFMugMkIgsymVvLvT00RhzocvEhX5jp3/XB9DTm1kWeqTGXOgNW+Ccmefpygobc3NxjEu9MA7QwzbF3mM44Vc5Zb/Jy5wrnC1oTs4YvFGAriWt9hLbnUM028t0mocobc1S3irhRYtUnQWcsMvc9mPMb36F+a1HKY3koIeuw+rRFVaPrnD16ArtaoUAh4szi1yoLnN+foVGuTp0n0IYcHztIicuPcMda+epyhA7W8WWCnB0OXvnazSbznbiPl9j3dkkksPeLMcqFoMF7u2d5ZXduznbP7YDQNesug2uuFtccbdYd5toYVCBYantcV+/GrvP1TJlpxrnneauJ33tsxW22IwM27bEtikS2iLGsdjiNpXCw5xyH+Wk/BbH7EWqNslqz32MuxQz5/kldZTL6hCBGO5c2EnKmCyuJS0YqnYZNXHQlzEDp7mTTWPH+R4k0siWGJyjYlDrSIGTOc9zg6cTyGmlSKA5g2zz/WonaL6XGHLBULa5SqC5o1QWz7Kb0zy+hFe5joIEmj+f7vLEFS4z8J3MyziLfeAOj+elEAlIf3FfCI/B8dEinmoKyqeaaj+SSiH3kZ1qjInhawbZNTqbxu7nKXi/PsVRZzAD2XmKyUH2fgLaAw7u2R2F7MOZ7FEC2seNNUqQkJHhHBFjwYyC9hcikehawB0bmyBSR3satZS43LWO42OMCbA2iOcJsdZHygAhLEKYBLin8xYhr8O+bxlC79kh2OHnNr9WOAJZhkJyUiuySBkRj1aJQPc1xlTR3S10GGECgw4NJtTJ1GCC5JpJG0zPJMVTryEBH3/mZ/jxj/5/9n+sU011C+rKlSt84AMf4MqVKxw+fJi3vOUtfOhDH3qhm3Vbas9A/Td/8zdvZjummmqqmyQhXdwsF/36i4taa+mEHRpBg1bQQtsbGB9poRdqOkFEz9f40TCQt4GP6fWx/SY2aGJ0H6MDopGoFa0tbQNd69BBEZIrKKoj9uJCFzZCRRoZaUSShz6q+LT72lEuaSHRVAN8fiMu9EGMy40hrRsD6LELPY5xsTqtjBgrsoLnbI3HK0e4XFvEny9j5rzEBjSQDLsUe09QCL+cAPSL3Fkw3FExSa50TqGi015gtX2cVmeZbnOZyuYMpUaZUrSI4y4gTESl+Qzzm19gbusRZlvnh7o5jBBsrCwkEP0Qm4tzGCtZK9Y4X13iQv0QV2oLmBxkFMZwaHuNE5ee4eTqsyz5DcRsFVsswEotB9ANm85mEuGyxrq7iRbDnwnXuCwFC9zTP8sru3dxpn+UQ+EcM2Z46NhEgG41sz3FcqPMmeAQi2KBurMUF3nMDSgx1tAIG7H7XCu2bJWudbDMYgttRPEKc97TnHC+wSnxOIfM1YH73KQTwZpc5GLiPL+ojrAt6ntyn+fhuWciPK2Ru3xKDhQLWhk7zYfg+bWjWgaNSSG4wiqVwHOFFzNyHEgKn8ZwM3WZG8UgruVGwLkYgPNd41nykgk4FwZHSRwl4piWxDXu7FAIVAIOTg6YOzhCojK3+QEr7xiXKnGIDyB5vE7G9VQTeP6Cx6UctNLXV4kdXeVC3WbHPNVUuyodVpPrKRztPRwafpPvURTjUxhZxg7r2XV9Zli+how2MWCPohhOao3JuaCNjuLsd2Og04OZ0WHi+bi+kenQvB2ch+Xvm3dcZPMmd9/ktiVZnt/+1ukQkGI8mz2NjPEZRMb07cEUQB3OZPeyx0tftxS079RpIgXInUB7WhA1l9P+wkX/JycvTIbuCkjD5W3mdo97CyKjMdrHGh+rQ4wNgRBLhLFRPAZXpI52E494S8A7SbTMaFNsdhUzvPy6pYCCwCkUwReoHTBWDN8tJrDY0GCCxNkeWGxoMYHBhBabTiObfFRujc/HVFMdhH7+53+en//5n3+hm/GS0LQo6VRT3YYSQuE4tSTSpXJD++qEHZp+k2bQJNqlYOe1FEaGTqDpBZpuEA2ftxiN6fcx/S7429ioi9Z+fNEydI5m8bWgY6BjHbo48cl2FuUyGaIPZaGjEVojtd4xD90SQ3SD2PVkPg/QLRphSRC6s+vF2cSCokMudJO40K/33DN/0r9/gJ4uil3ocgcXuscj5WM8W1+hMTeLmSuAMwrQ+xR7T1AMv8ppvs4rnAucLRiOV8yoWR0ZSPxWnSudE2x0jtFvLjG7UaDYqDBjlvHcObAWr3uZuc2HmN96hLntJ1BmOEalWZ/NHOhrh5aIHJcuHuery5yvr3BhfoW+N+wIr3Zb3HH5HCevnONYew23XMCWS1D3gKXk/WDYcjZZdddYdddZdzfGAHrBFFgKFrm7d5pXdu/itH9kB4AeR7ikAH3NbWCtYbHlsdKu8PLoFEtqmaJKip7mjOG9qMNG2GQrMmyZEg1TwYgKVhQxxSZe8QkOu49zynmIE/YcC3YreUHJPhpdUeKiPJzB8yvqEOEe3OeDzPM4tuX5c56LHDhX2fzeEEjcjjiyJXacoxxQCuWI+LLTWpSNVwkGTnOrJCYlLfs9mBtxm5PcV5ososVxBK7KOcYnRLQ4iZPckU4G15VUB1TsUyBUEp2i1ACKSzVwkacQPSuweRtLxC7yvKs8heVTV/lULx6lX0qT/kbX7bTtDstHIfkeixffytoreA+DgOjKFWbrdaxJXdFhfE4bRS9szrtJoPEQkE/IcDpvzQDapxGJ2TIzMp/uwwzWXYd2ioxJC6BmTnYbF0C9UcWQ3UE5AxRiLUlniSaKoqSzZOeOCBn3x+dGXw5Ae5bRnjjatb5FeK0QSeFUErd7rPgMMHe9mAJ3LGiLtlEcr2lC0D7GhhidOt2jxHJkJjvcRfxeE0kB1TH4fuCHKBCuIE4zvbZdwBqLZ8v8pTe/76a2a6qppro9NQXqU011m0gIieNUcZw6jlO9oYv5btilGTRp+I3rhujWQDeM6AYTiokCNggw/R6234SgibV9dBSgE4dHtp219I2gZSRtqwgSz2h8thqxU11lYTXKRkgbJTDdIKIIGZld89B3j3IZFBIlca6mLnQXD4+doeROLvT4seMYF67bhX7jAD1ujshB9HEX+hOlQzxZP8La3DzBXAnc4daK0KfUe5py+BVOi69xv3OeswXN0YodrTeK0wfdqrDeOc6Fzhn6nSVm1wqUmhWqZpmiO5c8cIP5rceY33qEhc2H8cL20H76pQKrR1ZYPbbC1SMr9EpltBZcLdY5Xz/E+fkV1qr1IfjoRiHHr57njivnON64Qk0Z7MxMYpmawxJnoKcO9FV3bUeAvhwmAL1zFyf9wxwO5/cE0J1IcKhd5HirygPmXhacJZRw4gvJ5G2kbcRWsJm5z7ftLH2KwCJG9bHlbWaKj3HEfYRT8hsct88xY5Oc+NzbbEPMcVEd4TnnKBfUMbb2kH0uLFneubdjwdCR++y6do+yEqOdAUDXDjhVos6175oOIEaQwXOrHKyjkCrOO3esjYtvIhBKJJEtuazz/R7IjbjN0+ZKi5TE0NyRcVxL4hyXOQg1iGVRWSyLIxWukCihruP5TyC5FBkYl1JlUFxKlUwlUr34YdieNYXlU92KSt+AQsYUbxRgDy1L50Vu+aT7T9/HN0PKcXA8j2KlMvQdniqOHwljV3QUEYUD2K6j8OYC9+ejYyOD82YwH1esH4HyehjkG51bF693BbgiQb0JGx3NZe8fJGR3HZTr4CWFaGIYHo9KiJLCp1bv/vpIEbdVjYD2xByeRcbcUgVRR5XFywAOOLgMjylIFQ8j0CaKAbvxB6BdJxnuJsIYDUS5KM0ErpM63CEG8il0f/4gvJAC5TjMHTpy0x5jqqmmun01BepTTfVilhA4agbXreM4swhx/QP3e1GPpt+kETQIzfWdmgaRoePHEL0fDhcTxRpM38f0OuBvI3QXY/pordGRHWK72ljaVtA2Dl2rEsidnImaaGIe+qgLHWuQWiOinfPQrx3lMlxIFGxSRFSiruFChwkQfdSFnux4/5c3BwTQLVidA+hm0BILXCnWeKR2nEv1JdpzFSgMv79EFFLsPks1/AqnxJd5lfMsZwsRR6rjz2ahZ5DNIlvtIzzdvZtm7wizax6lRoWqXabozgMQElJrPcnC5n9lceMblHtrQ/vRSrF+aJHVoytcOXqIRr0WFyiVRS7UVjg/t8Jzc0tjxUQXt9Y4efkZ7th8jkNRB1EpxxeW9XIOoG+x5q5lAD0aA+geS+ESZ/oneFXnHk77RzgczFM1wxcZYwDdaVAJXFY6Jc42a3wHp5l1kg6DXP55X3fZCDbZDCM2TZGGrWHFXPwu9NpQvMq89wwn3G9wSjzKIXMVdyS+JUJyRa4k7vOjPKeO0pVlrvU+cbUecp47Ru96j4PAMAO3ubPvIqEiAecSMEqCimNbrFLgxAOBHWwMoVUcK2IV2ASOWuzooItrPeCBgHMlBY4j4sKgTlrgc5BtrhAooXClg5NzmTvC2V8sSxLtIhJX+8BVHncuvOQgeU4icRSKKSyf6mYrfZNJNQDaMge30+VyEuzO3e82cHdPNVCa8e7uUMrIJK52E0XoMExAezp/k4H7QUjmvPw3midm8jDegNE4GBxjmMmBd601vjH4WtPXmr4xhCa1yly/hBQ40gHXySwz1tg4JkbHr0sURWPn1xP3JRIzuxwG7bBDQdQXND5mr4pPxJR0UY5LkpY/UcZajI2wJgITJIVTI6wJ4+U2wugIS7yNtJA6rGwuskjIIqE/Qzr0Mv7JHplPpgJih0h6X5E8oclUJGD/gCwhU0011UtQU6A+1VQvQilVTuJc6kh5/R9jX/s0/AZNv4lv/H3f3xjoBlFWTHQ049yGIbbfx/QaEDYQ1sfqAG3sGEQPNLSMoItDx+Zd6GmsygSInmShKxshiMCCimKILvU4EIzBaRzlspMhZDgHfeBCl8m/3U65di8oeiMu9IMB6Glzsiz0ERd60yvxaP0Yz9ZW2JqvYYru8J21pti5SDV8iJPif/Jq5ynuKoYcngDQS52IYtOh1V7mfPdOLvTOMLtRpNioUDTLSG8BAF9ZZjqXOXT5P7O0/jVmW+eRI/n8Wwv1JMblEOtLi2ihiLTkcmWe8/OHuDC3zGalNnSfgt/njsvPcMf6BY53NygXHXAcKAugghmNcHE2xoqIesZjOVzkZP84r+rezen+UY6E89T08AWDwbDmNLnibXHF3WTDaTHfK7DSneEV0RKL8j4KMoHuuY9rI9hgIykeumlm6DKHECtYYdDFJm7hKVa8Jzjlfo07eIZFs5m8iAziW3LFQ59TR7msVoiEx27vkzT33NPxn2uiXd+TBwPPh13nVjt72nMGzkUyRFkpbOI8N47CKIkkSXIRceFQlYBRmxR2BIsZeqhdrlBHo1rkdYBzAUoxcJsnxUHTmJbUae6oOMfcFWof0Syxq1ypOG4lnUopYkiTi115KWooszwPy7Pc8pfm8zLVfiVGYHcCtcdA9yQwnkzlgVcmmOolIikV0lPgTSbuRmt0GBKFQTINXzywfb/K4Pzu1zoKKCd/qbS1BMbQjzR9HeFrTWh0DGeHYmtSWJ9cJaRRNyYNgBw+ZxBS4HgOTq5NNsnXT0H7XiF71n7BxIKo1uZy2u0gp/3F+DJLIZDCJc5imeR2H8hYi0FjTZTkuSfA3URIt4QUDtZqsPHradNxxmZQdyqtRZW9fLneCTty2xU3Fo861VRTvXQ1BepTTfUikVRFXKeO684i5Q62lj0o0EEW59LX/X3f3w8NXT+iE2r8MRe6xfT72F4X628jdAdsH2sMUWTROu8tt/S0pG0EbRS+HY1yibcZlbQh0kQoIkjiV1QUJRB9vKhoejq8U5TLOECPIZ7MlRTdTYMYShNfyCQAPd7TwBm/P4h+gADdAkZgQjXmQu+6Bc7VV3iydoS1uTnC8sj7yhi8ziq14BvcIb/Aq9Vj3F0MdgTo9W1Nrz3Ppc4pvhncjVqfp9SsYMwyNW8RAN8BN2izcvX/YXn1y9SbT+GGvaF99colrh6LAfrVw8v4bhGroeGUM4B+cW6JSOV+wqzl0Ppl7lg9xx3NNZboIwpe/MRXihgs22qLVS92oK/tAtCP+Ud4VeduzvjHOBLMM6+rw88plg2nxWV3kyveFg3ZZqFbYqVT4UFznHm5gExHiyRNjEzIZrDGRthlK5Js2hqRqCLELFZE6HKDYuGbHPIe4azzNU7Y81RtknOSu3DaFPXEfX6Y59RRNuQ8VuxciFNYi2c0ng4zgK6uUZjsxpCjGAPney0UmnedAzGVVgoKHqZSwTqxk1slQ8CVSHLPpQRhE3N73nl+jYtZdQPgnHhbR4HjyJzjPHadSyGSIqAKR0pcVJJtHuec77xPiUrci0rJBJIrpBq4y1+yykexZCZekYtlmbrLp0o0CXyPQW9n4BafBM+nmuoWVeZwL44WPSWLjRkA9wgdBkRh+GKwOx+olBCUlKKkBsVIjbX4xtA3g2loJo17zWkIwOvclAzGC2twkr80vsboCBMmr8d1QHYYdNCPxsfEx5L6jgaw3abJOft6lFtPUggkTlzzhuH3uXQcXFkfu4+xNh59SJz9bq3F2DjMcwi62zgu1Ca5/xYNpZ2d9VNNNdVUu2kK1Kea6haWlB6OW8N16ig1fuK8V4U6pBE0aAZNelHv2nfISWtLL9Q7u9CjCNtLXehNhO2BDTA6vm9+e2stXaNoGUEHh9DuJcrFIGyIMhqZpiQai4p2Liq6ex56Pgc9vg0gMxe6ur6CoslQxjTGZX9Y5+AAerp6UkFR33G5NLfIU/VDXKwv0auUx+7odDap+Q9zSn6B+9U3ua/Y43BlQoRLJ2JpO0Q2i6x2jvN0dBfN9TsoNGsYs4zjLQHQd0CYiPrWY6xc/SJzjcco9TaHjlIrxdrhpUGMS3UWqwWBUVyqL3FhbpkL8ys0ysMOknKvHce4bF/hqL9N0UsKNRbA4rKtGokDPXahh3I4ysgzHkvhIkf9Q7yyezdn+sc4Es6zEFWRI++CLdXmsrfJZWeLtuyy0Cuy0qnymvYpZlU93ijJzQToRW3WgzU2woAt7dFkHmT8nBgnwBS3mPGe4Ij3Le5UD3HMXKREMkokeVtpJFflcgbQL8qjdNQMZpcqmY4xeDqkkES3uGb3cM6DgecOJnKwxgGzN1fmGDyXcV6nlSp2njsxTJeAU/QoaIsjReziEgk0T6r22msN6U5AeQrMU8Pbno9dxPdxlUwKhMbw3FUqiWVRsQMdB1eqLKpl4q5SF7lSCTiXSKlQjswyy1+yEjEgz6JXVHJ76i5/CSpxiEtnFyC+EyQfL9g71VQvFWWFNovjDuA4NiaG6zoK0UE8fSnBdplB9sEyay2+sfSNyaZBHrJnhXYBRkZu7vZY5Lz1yYhboyNMFKCDAB0lHR06gnzh18x+nof24yN1d8pqh11g+4siRub6JEV6DZW8Vvv4GagUp0B9qqmmuj5NgfpUU91iEtLFdWZxnBqOc/0/8JGJMid6N+ru676ZCz3Q+JEeO/kyvo/tdbD9BiJqI+gnGYagtRkqsKONpY2irSUd6xB7N2IYbM3k9HKZRLlIGyASWCa0ReqdIfpueeiW/DGkMyLnQd9rlEs+0yX3lwwtnFTsdLIOFqADcUHRMIHoOgaukZRcqS1wvr7Ms3MrNKrVMdCg2k1q/mOcFP+D+52v8LJCmyMz44/jdjTL2wG1bU2jvcI5c5Ynt+5Ebx/B6hX8wjIQA3SspdS9yuErf8bc9sNU2pdRI2B3e77G6rFDXDlyiLXFOMbFRNAoVjk/v8L5+WUu1xfRuWHz0miOrF7kjs3nONHdYJ4gy562BUVLtrnqDQC6L4djjFzjshQucjhY4f7uXdzZP87hcJ6lsDbWjdJUXS67MUDviz5zfY+VTo3XcoayTMC+TF8eSyNcZz3YZDO0bJoSfbmEEMcAMF4PU9yiVvgax51vcEZ+k6P2Ci6JQz65dgpwuaQOxfEt8giX1GEi4WGETJIgh187YW2WeV5I3OfyJrrP83nnRjtg9nYKMQrP4yJXcbFQoyTWUVjHAUHs4JYijm8RJr5gdMB6cc7lNT9h+ZzzBKLvZggfa6tIHOeOxFECz4kLhHrKxZFJEdAkrsUV43UUROoslypxEcqB23wKzKfA/CUlkQPcOQA+BMmdQWRKttyZOsSnmuomKIXt3oS0jSgMiQI/drYHQfwXBrcvfc1JCEFRCYq5EWApZPetwdeD6XUnrYi4ULpUDtIr4uT8LNaYpEhtiA4iIh3uXKnUptcgqTHI5C9SsnmZXJ8om1uevJbW6qT+q04y2y1W2wy+v7iVnCuL3HWWSG+L3EmwHNwWArzyhH1NNdWLR0IIfv/3f583vvGNL3RTXnKaAvWpproFNIDoszjO9ee4aaNpBk2aQZNO2Jno+J54v5wLvRto9Ci4NRrj+5heG/wthO4i8LEWQg0mMuSL3gcGWkbSxqFnZC7KRU/MQx8rKJpB9LiwqIw0cgJM3gmiT4pxAZIMdHVDBUUtkwuc7q6bANAtYwVFDbBWrXNxbpln68uszs5jRyIiZLdLtfskp8T/5H7vf/IKb3siQJddzcp2wOJ2iGwUOGdP81j7LJsb96KjI/jeSnyBEFd/xAm7HLryZ8xvf4Nq+wIFf3gkRL9YYPVY7EC/emiFnlfCaghxuDS7mED0FVojwy6r7QYn185zorXKkbBJIX36JHRkj6uZA32NnhqOMFJWsRQusBKs8PLeWe7u3cGRYIHlsI47UimrI/txhIu7jY/PXM9jpVvjO7gLL41YSp5KbTVb/hXWwgabkWDLVIjkEkLUscJiSh0oXGLee5o7vK9xRjzGillDZbn68aRLMck+jwuIrspFtHAxQmAnuNAdo/F09Ly4z+OCoW4c3RK5e4ptEcn/Qgy/41EyLhaqFMZxMK6TWLfizHAlQGFRwiKkBWGyO1sG10FjD5aD5/npniTAkQLHUTgKXEdRcBQF5SWwPHGaS4Ur1NDDi8RdrhyFVA5KyXh+CsynwPx2lJgEwlPwPWHZFIpPNdWLTo7r4rjj7msdDQC7DkPCBLrfdlntI8ogO3KIlvjaDEH2/v+fvf+Okuys7/XR5313qNw5d0+e0WhGmiAJIQTGEof4A7QwCLw4cK6vkJGMw8Gkn4TByBgssywwwXfZ5hidQ7jAWj73WGjZh598EDKDhISEctZIM9PTPdPTOVZ1hR3e9/6xd6VO0z1Bk/aj1aqprp2quqq76qlPfb4nI9nL+5IS045h2rFKCXydZA9rY7Tv18jhE//9WvNhyiVRSoc1lrrm34Tng++HR1lzsvg11yI7v4oZMSt+v/aJpVkrzsUanvwtgxkJ9Yizl/HxcW677TZ++tOfMjo6SnNzM3v27OG2227jDW94AwDDw8M0Nze/6se2ceNGPvGJT/CJT3ziVd93mY9//OM8+OCDPPfcc+zYsYOnnnpq0TLPPPMMf/zHf8yjjz5Ke3s7//W//lduueWWU7L/SKhHRJwhTpVEV1qRdbLMlmbJublVS/Si61Mo+cw7PkV3sZjTnofOF1DF2XCgaAGJh9LgeqD8eole8AVZLclpE0eL4/ahLxooGi4iVThU1Fuc+A4zGfiV3Hr1kqVqXICwCz0Q6WurclmQRF9TlcupF+gQfho0rHHRXpBankmmGWoLalGGGtvwFr4gKrmkcoNs5hF2Ww+xJzZCb+sSRTgFRce0Q+eMQ+Osx6jfw6CzhxemdjJbuJiS1YOWRvAs3AgOpn3sMVqnnqQhN0gqt6DGRUomu9oY7e1kpLuL6cYmtC/QCmYTK6TQfZ/eiaNsnB5mfXGaJlWsbLdgFDhcI9DnjfpPXkgtaXNb6HDaubi4hR2FTfQ6rXS5zcR0/e1SEA4j9hSj5iyudmgsWnQWmthYvAhThH8awzuMq0pMlEaYcOeYcg1mdAPaaEeIjkCgJ7MYscO0xV5mk/Ukm/Qh2vVkeMNSuTvOiTRHjd5QoPcwKcL+cwE+9cI6SJ+7xGqGh5629LkyUDXp8zUPDK3ZvzAEWhpow0CbBp5pBYXnwgApMAmaTA2hkUKF6XG98u7C1cuvIdda2SIEQSWLKbBNA9s0SFo2Vo04L1e1VNYxjCDNFybKAoEepM0v5J7uytDPGmFekeeRMD+7qa1EKSfDizakWsC0FlSomFF9SkREBIZpYZgWsWR92MH3vFCyB0n2snQ/30V7zJDEFkh2RylKlbqYoJt9iQ/Srok6yR6itaoMn/U9H+W5KM9bYSsnhpTiuEOVfUVQdemHveVhpUxVwp+uqHvwacWw9+807SMi4uzi+uuvx3Ecvv/977N582ZGR0e57777mJycrCzT1dV1Bo/w5HEcB9u2T3j9G2+8kUceeYRnnnlm0WVzc3O87W1v4y1veQvf/va3efbZZ7nxxhtpamri5ptvPpnDBiKhHhHxqiKEiWU1nhKJnnNzgUR3coFMPg7HTaETVrnk59GlaYQ3j6CIJHhiWB4qqiohW828Msgqybw28Or60P0lxX5Q5eJg6HCgaLChQKK7Poa/OP29XB/6cin0oMrFPMEql/LtuNaSwZrY9KkU6BpQAu1JlGeAL8jZCYZa2xkKu8ULsQXd+q5PLDvOBvUYu81fcVn8IOubw+qMGryConXGZd10ieZZF8dLMOBv5tnZ7QxnryBrbkXLUEKHz+cb5vppn3iETO4QmewYllvfST7X1MBobyej3V2MtbfjShN8cKXJsUyQQj/S0sncwhT6/Cwbx4+yfn6cXmcWO/w5lESJo/YEo9YYY9YEWTNbt57QghavmU63nS3F9VyS30qv00a320xK1d8ujvAYsaYZN2fxlEOmZNFZaGaD2IYsd4KEJ0V/nvHiMJPuPJOeSVa0gOxGiB60ofBjc5jxA3TaL7HFfJJNHKJJzwUr1zwUJ0VznUCfkw2En8dYlEI3lMJWLrGw//y0pc+1rMpzL0igrybptKQ8D/tUgsoWA98yg+5zGcjzsK0Fs5xAl37wQmilK1BOmtcOCrVXf50NITFMiW0KLNMgblkkLBtbmpjCwK6Ic4E0a4d/RtIcYNHgzxp5jsGFe7ucVYga4R0mwevOl2tUzJXFuFLgjEFDR5Qmj4iIWBOVrnbqk73K9/GcUqVC5kIQ7baU2FJSO77erUh2wkS7wj1ZyS6WkOxolOfVCHYXz/ODyaSnkeDDr6Kmv70eTVgFr4PhoFpRL951cJlSOnzteFoPNyLinGVmZoYHHniAffv2cc011wCwYcMGXvva19Ytt7Dy5aGHHuKP/uiPeOmll7j00kv58z//c9773vfy5JNPsnfvXvbt28eb3vQmfv7zn3PrrbfywgsvsHfvXr773e+yfft2AA4ePMinPvUpHn74Yebn59mxYwdf+cpXeMtb3gLAtddey8DAAJ/85Cf55Cc/CQRO5Ytf/CJ33313XVL8m9/8Jt/85jc5fPgwADfccAMzMzNceeWV/P3f/z2xWIz+/n6OHDnCpz/9aX72s58hpeSNb3wj3/rWt9i4ceOyt9Hf/d3fAUGSfymh/qMf/QjHcfgf/+N/YNs2l1xyCU899RRf//rXI6EeEXEuUCvRDSN1wkJCa03OzTHnzJF1svj6+E+Wiq5PvuSTXyaFjvJRxSKqMAfObFjl4iAAX4PvaXxPV7yv0pqcNsn6khxG8KRohT70oMrFRSoPA696uQ6SyMJbvUQvT22v/2hheT8iTKIbx1HoC6pcyv2D5ez7qp/sLpVAX0Gmr1KglxetHShaMmyGmtoYampnqLmdmWSmfgVfY8zN0us9wx7rAS6PPcPmJi/4NGQNpZKmccZl01SR1hmXmKsZ0V0cnd/LI9nLGVJXoYywWDMUmLHCBB0Tj5CZf4V0bph0Lle3Tce2gkGiPV2MdHWSj6eC2UkIZuOpSo3LcGMbvrEghT45xIbZUdYXp2l25xGAi8e4NcGoPcaYNc6MObvgxoFmv4kOp50NpV4uzW9lndNOt9tCo78gPYXPmDXLhBEk0NOOSWexlfVya3Wh0CHl3BnGSyNMugUmfZu8aEfI9Qgh0JaPH5vDjr9Il/UiW6wn2agHaNC5yjEBKARjsp2jRg9HjV6GjG4KIhkuItFC1A0TtXyfmCpV0uemXvnVxIlqzOrQUCtInuvjDw1dsrpFikCqSxkMDbUslBV2n0tRWS8Q6BpDKAypaje45I4WyvOFfefLPWIEYEgZDAo1JXHbImFZxCwLO+w4t4WJECIY/hm++DfLEt28gKW5rBflUcr8TLJQjhvHOR9VqURERJy9SMPATiQX9bSXq2PcUlmyB9Ux5yuWlFhSUhud8rXGUSpMsQdJdledXGWMQFQ+RQDVIInyfZTvhWl2DxV+vVoEz9HK/zr+84rlBDyqJsilQGk/yGUI6j4BGhFxomgdBA5fbRLW6l6HpNNp0uk0d999N6973euIxWLHXWdubo7rrruOd77znfz4xz9mYGBg2UqWz3/+8/zt3/4t7e3tfOxjH+PGG2/kwQcfBCCXy/HOd76T22+/nVgsxg9+8AOuu+469u/fz/r167nrrrvYs2cPN998MzfddNOarj/AfffdR0NDA/feey8Aruvy9re/nauvvpoHHngA0zT5q7/6K97xjnfwzDPPnHCC/de//jW//du/Xbf+29/+dv7mb/6G6enpk67KiYR6RMRp4FRJdIB5d57Z0ixZJ4unV34y5PmaghOk0Avu0in0oMolH1a5zCB0EUnwh2Qpie4qyGGQVQaFsKd7xT507WNoD1lb5UKwmOEHSXTp+4ueXi0t0ZcaJhogK/+t3Ie+qMrlhFLop6fCpbK4olLj4vkmI42tHO3q4GhTOxOZJnTt/Udr5FyRjtJ+LjUf4Mr4b9jWkCe24EYouILYrMuWqQI90y7xkqKEzVBxM7/J7eaQcw052VO9WgaYTo6W6adomH+RdH6IhukpzJrBSBqYbm9hpK+Lka4uJptbUCqQxK40ONYYptCbO5hL1n8CIzM/x8apIdbnJ+ktTGErHx+fSXOK55LjjFpjTJnTaFF/mzV6DXS47fSWutmV38p6p4Mut4VWLxMI3hCFZtKcY8KYw9FFUq5JZ6mVbrmpurHwNppxxhgvjTHpOkz5MRzZhTC2gABteaj4LPH4c3RbL7DVfIoNapAU+fKOAPCRDMvOMIEeCHRXlP9Q16fQhQbb84gpJxTo7nEz4Sf0G0NLlGeG3ecnWd0ig05KbUi0ZeFbQf85hllXZ2kKMNGYUiOEWr4dorauJfDyqx4WKgBTmlhhZUvSskjaMWzTDKtaTMyaXnPDMMP0XHD+gqTcZ25G0vzVQywQ4EvJ8CWEeURERMR5zlLVMVqpurqYQLaXzts0uyEECcMgUfNrX2uNUzf89NRUxgRD0Y1l0uxlwe7ieR6cBbf3agW81gba9xHhJwk14Wuo4NKaTx1TaeusfGK6LOoX3LZagYiM2AVLwfXZedv/edX3+8KX3k7SPv4dzzRNvve973HTTTfx7W9/m8svv5xrrrmGD37wg+zevXvJdX784x8jhOA73/kO8XicnTt3MjQ0tKT0vv322yvJ989+9rO8613volgsEo/H2bNnD3v27Kks++Uvf5mf/OQn/Ou//it/8id/QktLC4ZhkMlkTqhyJpVKceedd1ZE9w9/+EOUUtx5550Vd/bd736XpqYm9u3bx9ve9rY17wNgZGSETZs21X2vs7Ozclkk1CMizhKEMDHNBiyrAcNIn5REz7t55pw5ZkuzK0t0HaTQ5x2fguNRdJd+UhRUueQWVLkEzyh8FdTB1Er0khLMKck8JkVV24e+tESXlYGiNVUu4fEZnofw1JISfeFQ0aDGRVVXrkPUZNBPsMplFan+8r6qp6sU6FqBv7rt11a5+K7BVKKJo23tHG3uYLixFc+o/9Uscg5N+UF2yl9zVfx+dqanSDTUb7PgCbwcbJqcZ+tkkWRRIYAZv5kD8zs5XHwDR9RrUIQ1LhIMr0BD9mUacs+RLB6lcWac5Hz9MNFCMs5obxfDPV2MdnRSMmNhdyHM2qlKF/qxpvbFKfTpYdZnx9iQn6S5FPT7z5gzHIyNMWqNM2FN4ov62yzlJ+l0O+gqdbArv40NThfdbgvtbuOiFvxpmWPCmsPRJZKOpMNpZYdcV11ABvVIM84Y484oE67LlJ/EN7oRcjtI0KaLH58hGXuKHvs5thpPs14dIUEp2EZ413ExOCa7GTJ6OGL0Mmx04YlqL3ttCj2obykPEHWx1OL7ft3Pd4XLVlqrmj4PJDp6NdUtgBCL5Xk41EmbJtoy8E0TZQWDRGsxRdh/LjUGi6uEKhst17WssfNcIjCkgW1JYpZJwrLRVoxmwyBmGJiGhWmW+81NpGlgGgbyQhTnZWleFuVmJM1PORXxbVVluGEtkOPheSN6Sh0RERGxWoSUWLE41oLqwnI/e21ljOeUztBRnl6EEMQMsaiX3auT7EF9jHOS3rs+zV6lnGZXvofveyjPx38VamNOBcFz2NpztaerJ5E48e7miIjTzfXXX8+73vUuHnjgAR5++GHuuece7rjjDu68805uuOGGRcvv37+f3bt3E49Xf7curIgpUyvlu7u7ARgbG2P9+vXkcjm++MUv8tOf/pTh4WE8z6NQKDA4OHhKrteuXbvqUuNPP/00Bw4cIJOp/zR+sVjk4MGDp2Sfp4Po2X9ExEkgpIVpZF5Vie55mrzrky955F1v6WCBVkGVS36mpsrFrTzFWCjRNVDwJXNaMK9N3Nqhov7iPvRlq1ygRqL7SF8dR6LrFVPoJybRw6x7uc5lVSn0U5BAP85utAbtS7QryckkQ42dHGnpYKipnfzCHvSST2p2jO3iN7wuto/dySNkUvU7KCpBNmfQOV1g73iOprwfVvVIRksbeLZwJQe832bW762sI32HhvmXSedfJOEMkM5N0Dw+VTf81ZeSia62sMali5lMY0XU+kJyrKmVweYOjjR3MJNurDumTH4uGCaan6R3fgJLeWSNLKPWOC9kgkGirqz/iG9Mxeh02ulw2tlZ2MKWUh/dbjNdbjOWrv8TlRMFJq0sRV0g7kravRa2qZ7qAqFAny6NMOaMMeF6TKskyuhByJ3B5ZaDik+Tjr1Er/UsW+UzrNPHiOEE2wgfTyUsjhk9HAkrXEZlB35dhKWaQjeUIu77xHz39NW31A4O9Sy0qh9iuvy+FqTPRdiDLYKYuDaD6hZlmUECfcEmjVCgG1JhoJcW6MbJyXMrrGxJWTYJ2yZumtiGhW1ZSMNkRinakwks00QaF17dRW3SvDIQ1Iyk+QkhjBohXvNlWJEgj4iIiDgLKPezx5LVfnatdTXNHibZ3dL5m2Y3pcDEIFWTFVBher2kNK4K0uyuOvlu9nKavTIwKURrFch1v5xoD/6t/VevOiYi4nSTsAxe+NLbz8h+10I8Huetb30rb33rW/nCF77ARz/6Uf7iL/5iSaG+Fiyr+gZb2WOp8PfqZz7zGe69916+9rWvsXXrVhKJBO9///txHGfFbUopa+bcBbhLVHylUvV1rblcjiuuuIIf/ehHi5Ztb29f3RVagq6uLkZHR+u+Vz5/Koa5Rq8WIiLWiDTiWGYDppnBMJLHX2EFViXRNeQdj7zrUyj5lLylnzyWq1x0cRrcWYQuVapcIAhPe6FEDxvDySuDrBLMY+LV9NUtNVR02SqX8BgNz0N6PmIZia4qEn2lFHptH/rKVS6wsA+9vE1/FZ16p7fCpbJaWOXiKItj6Q6OdgQ1LlMLRDS+wpqZZ6P/DK+1f8FVyWdoba9PhjgKJgoWyRnFFRPTrJ91KrdPwU9yoHgph5zfYtC5HEenKgeQnh8gUTpI3D1EsjBG6+gE8WJ90ifbmGGkp5Ph7m7G2trxZbUqJGsnONLcwWBzG0MtXbg1yRapfHqmR9mQG2PD/ATNxSx5mWfUGuOJ5Dij1jhFo1i3L0uZtLvt4SDRDWwvrKfHbaXbaSah65/MF3FCgZ4n5knaVAsbnI7qAhJ87TFVGmasNM6E5zOj0mijGyEvAQOUXULFp8nEnmOd/QxbxbP06WGs8n1Yl/dlc1T2ctTs5YjRw5jsQC/oJCmn0E1fEQu7z2O+V/m0x3KciPbUvoX2zFCiryF9jqhI7/r0OWAYaNsM0uemiV6Y6g7FuyE1htCYSyXQZSjlwxmHIjx/PCry3DBIxiySlk3SDjrPY1YMy7Qwa3vOw2NTWjNfKGLZFvJ87jwXQcK8IssrEv08vs6nioWSvPJvK5DitZI86h+PiIiIOOcQQmDZMSw7BulqejFIswdyvSza/VexK/zVRC5RGQPVbvZTLdqFkBiWxLDqE+0ajS6Ldj8ciOp7KN8/K+pjIiLWghBiVdUrZxs7d+7k7rvvXvKy7du388Mf/pBSqVTpXH/00UfXvI8HH3yQG264gfe+971AILzLQ0XL2LaNv+AT+u3t7YyMjKC1rkj62gGly3H55Zfzz//8z3R0dNDQ0HDc5VfL1Vdfzec//3lc1628gXDvvfeyffv2k657gUioR0QcHyEwjRRmKNGlPLmPha1GorueIu/44Ze3bMhaOyVUfg6KM+DlEJQq8k7r4HlNrUT3NcFQUSXIayPs6AsFulpDlUu4WiDRPeSCsr+ysPcRKDSqkhhf+oqsqQ9dl0Pnfs03jvcE7gQFutarkPMLVlMC35OMxVs52tzJ0eYORhpbULKuNBEjW6K9cJjLzft5Q/JB1jfn6uSlp2GkaOHPmeyYzHLN5AxmzbFMOj0cLl1Fv/NaxtxtaILtJ/MjpJzniPn9xJ1hmqYmaR6frrvWrmUy1h0MEx3u7GI+karcLr4QjDa0MNjYxpGWTiYbW+quY6o4z4aZYTbMT7AuO47W84xZ4xyyxhltHiNnzNctL7Wk3W2lw21nQ6mPHYVN9DqtdDstNKj6N6RcfKbMOfI6T8yXtOoWet1WoDVYQICnXCZLxxh3xpl0FdMqDWYvQnaFAr2Iik/TEHuW9dbTbJXP0qtHMMtvLoW3YZ4ER4xejshehoweJozWRQK9vFPL97GUj+0HNS6nvP9cC1S597w8PPQku88FAm2ZKDMYHOpbZrmgsu5AhSgPEV1CoJeFeXlo6BrluV2R5zESlkU8ZpG04hiWhWEamFZQ23IhJa3r+szNKG2+LEKGQtyKJHlERERExJJU0+zVpKNSfiXJXu5l946TqDyXWaqbHepFu6M0TnjeO1nRjkCYJtJcrJGq9TFhmt3zUcoPZPuq51ZFRESUmZyc5AMf+AA33ngju3fvJpPJ8Nhjj3HHHXfwnve8Z8l1PvShD/H5z3+em2++mc9+9rMMDg7yta99DWBNbQrbtm3jrrvu4rrrrkMIwRe+8IVKer3Mxo0buf/++/ngBz9ILBajra2Na6+9lvHxce644w7e//738+///u/cc889x5XkH/7wh/nqV7/Ke97zHr70pS/R19fHwMAAd911F7fccgt9fX1LrnfgwAFyuRwjIyMUCoWKvN+5cye2bfOhD32Iv/zLv+T3f//3ufXWW3nuuef41re+xTe+8Y1V3xYrEQn1iIglCPrQM+FXGiFOrp/3eBLd94MJ03nHI+/4eMtNo9EKVSiiijNQmkX483Vp8YpE93RlG8FQUZOskuSVXLEPfcUql3AHhucvK9F9qFS5qNppoEsgwyoXibH6KpdVDxR9dQR6eVXtS0aKBgfTF3G0qZOh5nZKVv0bL0bBJZ2d4BIe4beS/8HO1BBWfUUYI47BdC5O+7TizSOjtPnVFwCeMjns7OJw6bUMlK4gp4KPPtmlaZoKzyLFEWx/iHR2ms5jY9il+hcP0y1NQY1LdxfjzW3oGsGft2IcaWpjsKmNI209ODVDjIRWdM2OsyE3zobsGE2FSSatSUatcfY1jDFtzNTdxEJDs9dMp9tBb6mLSwpb6HXa6F5ykKhi2sgxTx7Lgxaa6PSagfDdYgGucpgoDjHuTDDpaWZVJhToPWCCNovo+BQNsSfZYD3NFvE8vXoEo/wGUPjzzJFk0OjjiOzliNHLtGxeUmIKrYn5HqbSWL6PfTr6z8v1LZ6F8k1Qq/tTLBBBKrx8XgTnEQIhJNo0AoFuhQJ9oWgMHw6m1MEg0YUCvSZ1vtrqlvLAUNswSNo2STtG0jZJxuMk7Hjlxa5pXVh1LXUDQc3g38Hte4GL8yVFee15u1q/EhERERERsUakNLDjCex4ovI9rXVFrNdK9vO1MgbWJtpPRaIdautjFqOVqsh15XsopdCeQqng31G6PSJiMel0mquuuopvfOMbHDx4ENd1WbduHTfddBOf+9znllynoaGBf/u3f+MP//AP2bt3L7t27eK2227jQx/6UF2v+vH4+te/zo033sjrX/962trauPXWW5mbm6tb5ktf+hJ/8Ad/wJYtWyiVSmit2bFjB//wD//AX//1X/PlL3+Z66+/ns985jP80z/904r7SyaT3H///dx66628733vI5vN0tvby5vf/OYVZfxHP/pRfvnLX1bOX3bZZQD09/ezceNGGhsb+dnPfsYf//Efc8UVV9DW1sZtt93GzTffvOrbYiWEXlhwc4EzNzdHY2Mjs7Ozp/SjBmcDhcIow8P9tLQkkVEabhFSxkKB3oBhJE9afKwo0TWhQF95mCiA9j10fh5dqFa51KbFtQ470WskekkJZjGYVwaluqGialGn1YpVLuEODNdH+itJdI1Ch457uV8pJ9iHrhWrT6GffoFeXt1RFkPJLgYauzna3MFsMl23jPR8EjNzbPBe4A3x+7gy/Swpo/46zHiCo/k4cjbGZeNZXp8brUs/57xmDjtXcrj0GoZKu/GIYXp50rlDIEcw5DESxWk6hsdompyp27ZjW4z2BMNEhzu6KMaraXAFjKcbOZJpZrCtm7GWzrp1E06B9bNBlUvf3CgFMcaoVR0kqkT99Wj0Guhw2+lyOtlZ2ML6UjvdbgsdbtOiQaKzMk+OHIavaKaJmKj/wx4I9KOMORNMuppZ3YAwexEyeGHkmwV0fJLmWD/rrafYJl+gS41VBXrInEhzRPYyaPQxKPuYlY2Uq8NrMbTCDhPoQRL9dNS3BLUtax4eukJ9ixQSZYbd57a1ZP95+eEgJRWBbgpduaycPq98HefKCcAUJqZhkLAsUnaMVMwmlYiTjCeCxHk4MPRUiWOlNeOFIu2J+FlZ+VIR52Zt4vzsO87Tj6iR4QtEeZ00j0T52YJSirGxMTo6OpBRyj8i4pQRPbbOHTzXrXayO0FtjPLP/mGcpwOlA8Hu6UCuO0rjhrLdO7GXS2tCaxXKdh+tfJQfdLgrFXyVX8Nq30cYxikNKCQTSd70+tefsu2dTZzPbmutFItF+vv72bRp05rE8vnAj370Iz7ykY8wOztLIpE4/goXOGu5r0QJ9YgLl7DKxTAzWGYGKWPHX+c4rCTRHU+RL/lBF/oKNS4QVrkU5qA4DW4OgVPnysKaczxf4YeV4fNKklXGqvrQpfaQ2sXQS1S5wIoSPRj5qQORfpwU+molemUzKiiIWd1A0VdPoIeHxqTVzECmhyNNnQw3ttbVuAilSWRztBeOcIV1P7+dfpD21nzdNgoK+osW2Wya7knB26ZG6FXjdcuMuVvoL17J4dKVTHibkMojne0nwyOo2BiWmqR1ZpKOoTGsBQM+ptqaGe7pZrizi6nmlroUetEwGUo3MtjcwUDnujrBDtCRnWRDdowNcyPES0cZt0YZtcZ4rnFi0SDRhJ+gy+2gw2lne2ETm5weepwWutxm7AWDRPOixKzIIn2fJhppVEkaSVZ+bMsL9HVggbby6PgEzfYhNlpPsVW+SKcaq/aWh3ffWZHhiOwLBXovM6IxaDgRmnBeJgCm8iv955ZS4UDW5V/wrv3puqgkz9dW3xL8f5FAD+tbhCFQhhkI9GUGiJYfDiIU6AYKszxIdMHg0CXbbRZgCANLGMQsk7Rtk4rHSSfipBIJTMsKBfqF8TSiXNVSEecXUuK8kiq3g7oVww6+ZM2/owGeERERERHnGMFzGQuohmLqetkdB69UPG972WuRQhA3ap8xV9E6lOuhdHfLsl0rXHVqZLsQEsOUGKa15OVaK3zPw83PI+0YaIVWupJuV1pVk+5RXjTiAucHP/gBmzdvpre3l6effppbb72V3/3d341k+mkgegUUcUEhhIFppsMUehopT/4hsJxE93xNIexAL7gr1LhAWOWSR1eqXPLhCM8qSgeDRX1P4atAaueUSU5J5jHwFCde5RLuwPBWkOha4wW6e+n1a/Zm1Gj0Za9y+RB17ZDSlZ4ErUGgl3egT/xZntZQFDEGU10MNPRwtLmDfKz+j1CsUKQ1O8pFPMGbUj9na8MI1Lz572kYKEmO5dNYM0munMhzU/EocYZrlrE4UtrD4VKQRM+rFtK5I8S8QRriL4A9ScabpevoCI3Ts3X7L8XsoAe9u5uRjk5KtR9vBaatGEcaWxho72W4rQddk5Sy3RLrs2NsmBujMzvAnDzCqDXGb2LjFJKFuv1YyqIjHCS6ubCObaX19DgtdLstpFT9u7YOLjMiC8qjgQaSxEnqWOXH5imH8eIQ4844E64KBXrfIoHeYh9gk/0kW3iJTj1e/amHd5Vp0VhJoB+RvUECHZBCgwgqTYJjrw4PtZUPuvZ+tPj+tPb+c4nyavrPV13fAgixdP+5kAgpggS6eXyBTiWBHta4LEyeryJ9LoXEEJK4aZG0Y2TsGOlUglQijm3bF4w8FzJMmNdUtQjzPBbndbK8nCi3a1LlkSyPiIiIiLhwWLaXvVQj2c/zXvaFCCGwhcAGUkt80CyojCkn3Mt97Rpfa1Z6+bu2YwhkuzJtrHhixedlWiu0CoS71j5KaXQ4L6wi4EMJH1XNRJyPjIyMcNtttzEyMkJ3dzcf+MAHuP3228/0YZ2XRK+SIs5vyin0ytfJV7korci5ObJOlpyTq0h0rSDveqFE93G8lf9Aa9dFF+bQxWlw5xDaWeTLFkp0V8O8DvvQtUSFQhrlLapbOW6VS7iDZSW6Dmpcqhn25Z8RCUTYib66oaJViV43ZXTRVquna0ihH6eyYyV8LRiNt3I408uRxk4mMs3omvuL4fs0zU3R6xzk6th/cFXmSWLt9T/nY47gUCFGLtvM+imTt+dG2er1VxPVwLzfzOHSFRwuXcnR0h6MYp5U4RAx6zfozCymnaV9fJSOoTHMmlSMBqbaWxnu7mK4q4vpppY6Se4pxXAyzWBLF4e7N5BNN9YdW2t+hg1zY/TNHUU4+xm3RjlsjfNMY30fmtSSNreVTreDvlJ3MEjUDQaJNvv11TY+PjMii/IdMjQQl3E6dEudQJ8oDTFWWijQ+0KBPo9OjAcC3XqSrbxEh54IVq/5UU6JJgZlH0eMXgZlH1kZFNCLMIFtCIUgEOgxzyXmudi+jxACRVgIzuJXAWv9baCVgfYttGeiPAv06iosFgl0IYLfRYKqQDcMlB3I85UEupZgoDEhqHGROkhQr7L7vNJ7Lk2Slk06HiedTJBJJojHY+GLyfO8mkPUCvPzeDhobS+5Eav5d5Qsj4iIiIiIWA1SGtiJJHai+ulOrVTQye6U6hLtF2I62pISC0gu8dRR6UCy++Gpp8FTQUjL0xpPBdL9VGptISTCkOHT/qUT77XEbfu4y0REnEvccsst3HLLLWf6MC4IoldSEecXQmDIBKaZrhHoJ99f6CqXnBNI9Hl3HoVCKyh6PkXHZ971Kbn+ys+htEYV81CcQRdnEX4OUIvEl6/B90D5gUQvKUFWG+S0SVGJmioXb4kqFxepXAx8ln1qsoJE97UO+9CDBPxKyMp/q5DoKuhCD7a4XAr91RfoADkzzkCyh/6GXoabFg8Tzcxn6Zof4mLxBG/K/JzOpvqU+KwPLxdMxvItmNMZXj9X4E+Kg7Tqo3XLTbgb6Q9T6JOFPhqy/RhiGLvhp6hMkURhkq5DwzRO1W+/GI8x0tPFsa5uRju7cGI11URKMe/7HGls5XBnH0e6NuDXfFTS9D16s+NsmBuhYX4/OXGQEWuMh2PT6HjN7aah2Wui0+2g2+lkR2Ez65x2up0W2r0GZM1PWKOZJYurimTIEJcJWnVT5ROinnKZKB1lrDTOpKuZ0Zl6gW7Po+NjtNgH2Gw9yVb206EnKsdRub1EM0fC+pYjso+crIp8gQ4EuiBIn3suMd8l5nsIQAkDhUALq+5efEL958oIKlw8a9X958G+wq7z8nkpqt8TEsoC3TKDIaLHEegCsMLrbRkao1zjsor0uSEMLGmQMAN53pBMVtLnF4I8F8YCeW4G9S3nBbXpcnOhMI8tHkwbERERERERcdIIKbHicayafl2tNZ7rhL3s1QGo5/Pw0+Mhw3T78fB1UCXjV0Q7gYgnkO5lGX86OG8/hRgREXHaiYR6xDmPYSQwjFRFop8KgQ5Q8ktknSxzzhwFr4BSUHCDAaKF1Qh0AN9DFWaDKhdnDqFKwGJvFkh0HXxpKPiSOQzy2qKkIBDHwUfX6qtcFEK7GMpH4rIcwtdIfwmJXn6iAmHBzPEkelDkIjFW7kNfVQr9BAX6SfSgA/hCMpRs53C6l8GGLmbS9QNaLM+la26EDd7LvC72C3ZnXsJIVnfoaThYkhzMx5id62DzbIy35Se41D1EnGJ1P9rkqLOLw6XXMFC8HGYKxN0jOKkXEc1P48l52o6OcPELI9hO9Wengcn2Voa7u4MUenNL1ZhqjS4VGI8lGGjtpr9nE1MtHXXHnynNs2FuhI7sYUTpWSbMY7xijeOl6j+lkPZTdDoddDodbC9uZGOpi2436EG3FvSgZ5mnqOZJkSIpUzTRADK43TzlMllOoHs+M6rcgV4v0Ftjr7DZDAR6u56sXtmQcdESCvQghT4vUnXHECTRNTEVyPO472L7LgKJFhIfiS8sau9LJzxA1LNQYQp9pX71+uOrF+gyHCBaSaKHAl1bJq5l4hvm4k2XBXp4aqExhcY0FKYR3A2OV98iERjSIGZYpGybhmSSTCpFJpnAjlnnfW2LMAXCCvvOrfOgrkWWRXmNJK9NmEfCPCIiIiIi4qxACIFlx7Ds+rlcvufWdLIHkv1C6GVfC4YQGMcJOyilmPJd0nEbLaqVpH45a0Y57a5rzof/PsUp+IiIiAiIhHrEOYg04mGNSxrTTCHEqUtXlvvQs06Wglui4PoUw6+Sp1b1KT5dygc1LsVZcJdOoevAj+P5GuVrXAU5bTC/ij50qf1wqKiDWOGpQUWiex6yJsWtQ4nuA/4qzLSs9KEfZ6ioCuR59XiXk+ivrkAHmLOSHE73cKihj+HGtkBm1uynLTfNumI/O+Xj/FbmlzQ0F+vWH3UFLxUNhnKNiNkuXjfv8oeFITb5T2GIatd9QTUEVS7FKxmf7SOeG0LZE5Raf4XXrUkNj7HpwDAtE9N12y/FbEa6gxT6SHd3XQpduA6OU+RIUzuHO9cx0LeFUk2Xu9CK7twkvXNDpPLPMa9fYswaY9Qs1P2Gt5VNp9tOp9PBluJ6tpT6Kj3oSVX/xL+oi+RUlriIk5YZMqTIyEBwK+0zWTrGaGmUScdnWqfB7EPIXjBB27lAoNuvsCVMoLfpqfC2ru5jXLSGA0QDgZ4X9UNSIahxifku8VCi276LBDQSJSS+sKm10ic0QNQPqlvWMkA0WLMq0BcNEC0LdClRloWyTXyjPBW0biN1Al0CllTYMhDoqxkeagoTU0gSlk0mmaAhkSKTipNMJjBN8/yrMCkTdp3L2tS5eS5eVxGI8XK6vO40SphHRERERESc6ximFQzbrMmKKOXXCPZqmj1ieYQQGEIQM+QJhSW0rhfuPhqlNaYdKbGIiIgTI/rtEXHWI2WspsIldUoGiZap7UOfLswx7zjknSCFfrwO9Aq+hyrNhQNF5xB+ccnFtAZfBUl0z9c4SpDFIKckBSWXrXIJBop6x69yAYSvkL6ql+hhF7qCikhfGVEzUnQVEr1S5bKURF+rQOekBomW8YXkWLKN/kwvhxt6mEtl6i5POgXW5Y6yxX+BqxK/ZGt6AGqqwQsKXi4avFKwmJrrome+if80P8cflo7Qzf66qzft9dJffC2D+d2UxjWSUfJNQ8z2jNIwk6VrcJjtL4wQL9Y/SZ5qaQ5S6N3dTLXUdKErH5mbYdq0GGjtoX/dVoY7euvMatwtsX5uhOb5lxHFJ5k0BzlszkKNFy/3oHe5Hawr9nBxcRM9bgs9TitNfn3621EOWT2LTYyM0UBcxIkbwUdYlVZMl0YYK40w4bpMqSTa7EPILrBA2TkIE+hbzcfZysu06vANg5qf45hoqwwQHTR6KSwh0AWauHKJ+05FoovKJQIlLNzyFE5OUKB7Fqo8QPSUCHQZ/GiEQBsSZQYCXRkGeimZHVa4lHdrmRpL+NgSjOMI9Nr0eToWoyGZIpNKhulzG2mcn/JVSJAxgWGJagL9XHqjQBiLRblZkzY/lxP0EREREREREWtGSgM7nsCOV0MyUWXM6UUIQZC9qH/eZZ7n1YcRERGnj0ioR5xdCIEh40iZwDTLAv34w0TWQrkPfSI/w2Q+S95xKbg+3hrGkKtiFkozUMqCs3QKHWqGivoK14e8kuSUQR4zqHLRCpRGa4+FA0Wl9jBWGihaXtZXQRLd9ZGhlC6n0DXghTJ9ZVYh0cuuXK/Uhy5Yu0Q/+R50CLrQD2d6OJTp41hjB15NtYXQmu7sGJtLr7Db/A1XZh7Gbq6+taA0DDqSl4qSwfkMKtvLnqLF/ys3xSXuQRplNVGutWDE3U5/8UrGJ3txs3nc1BTFDaPMN+TpPDrC5pdHaP3VJKLmtnEti+HuTobDFHoxkajcBtIpwHyWY5kW+ns2cmjDdnKp+iqatvw0XdkB4vlnKfhPM2mNMy0UVKsbafQa6XKCHvSdhc30Oe30OK2LetA95TGnZzExyMhGbGnTSnvl8unSKGOlYSZch0k/gTJ7EXIXmODb8xAfpy32EFvMx9nKK4sEuqZWoPcxaPRSFNUXDJWfC5qY75FQJWIqqHEp32s0AoSBjxE+usRq71X1e6j0n5trFOhQO0RU1gp0AUiBlrKmA92oGxBbu6FagW6YGlsoLKmxVhDoAjCEiSUkccsmk0zSmEqRSSVIJePnbXVLXVWLKdCmxpyTmI0SeTaLZ2mCGV86ZR4N/oyIiIiIiIg4DitVxlQFuxNUxrjLV31GRERERLw6RK/yIs4YQhhIGccw4hhGAikTSBk75X23Wmvybp6pQpbx+VmmCzmK3toEunYLwTDR0iw4WVDL57zLfejK1zgKcsokpwzmtYGvj5dC9zDwOF7Lm/QVwvORXijRwxR6ucZFHXcLwV6NGo2+9BUnTEWU624WptDPnEBXCEZTLfSHEn0m3Vh3ecIpsjl3mO3qOa5K/JK+zDGoCarPeIKXipL9RZOpbAftxU6unvf5f+fH2KoeIS4LwYISPG1zpLSHI/OXMjOaxlVZcm0FJjdO0Dg1S/fgMS6+Z5T4fL7uGGaaGhnu7mK4u4eJtraKcBW+izk7QcHzGWjv4dD2Kxjs3YxXM1DU8j26s8M0zr8ExUeZNg4xKkvBxPowSJHw43S6QQ/6xYVNbHS66XFa6XKbsWt60H3tM6OmEAgyshFTmrTQWrl81plgrHSMcafEpB/DM3qQxiVggJ+YR8THaY39ms3WE2zV+2nVM8GKdQK9nYFQoB8xeimKGtMfItDYvkeinEBXTl2NuBYyqHMJv2pb9ldHjUD3LLQyVr32agQ6UqJMA98yUaaBMpZItNQMEoVADNtCEQtrXJarhxSAKU1saZKOx2lMpmlIJ8ikktgx+9zuAV+GhfJcWIv7zk/Br4pTiAikuWmHp/FImkdEREREREScVsqVMbFk9ROmlTR7KNiDUwcVdbNHREREvGpErwAjXhWEMDGMONJIYMhEKNJjx1/xBFBKM1vKMzk/x1RhjtlSjoLrrar/vIJfQhdn0aU5dGkO4TsrL67A94OhonlPkEUyr02KSgSDOZdJoRvaQ64ihY4GqfxQoiukDrrKNRovFOmaUyDRK758pSqXcuXGq9uDDlAwYwxmujiY6eNIQyeuZdftq3N+ku3F/ewyHuOKzEPEmqu3a3mY6IsFg0OFBMZ8D5uLLbw3W2RvaYD18ucYIlxehn3oxcsZm1zH7JRFIZFjotfFuThP59Fx1h8Y5ooHxjD86q3uGQajXZ2VKpd8KnziqxVGcR5jdorxRIb+3s0c3P1bjLd1112/dGmezuwh7MJTFLxHmTemKQCEnt3UBu1uO11OBxuL67iouJ5et5Vup4W0qgpspRVz/jQ+PhmjCVOYNBktlctz7jSjxWOMuwUmfRtHdiPkxQhDVAR6S+wRNltPsE3vp6Us0FX5RDAm2ms60HsorSDQY75D3HdJKBchdN09RwsJoUDXa+5DXyjQV/8nbXUCXQQC3QwF+lKp8CUEuik0lhHWuIilr4sUBpaQxEyThlQq+EomaUglkefhR0+FAcISK8rzs4by8E8zVpXm5a+IiIiIiIiIiDNMfZq9mhhSysd3XNwayR7VxkREnN8IIfjJT37C7/zO75zpQ7ngiIR6xClHSjsU5olKAl1K+/grngBKaYqez1yxxGR+jplClplSFk+t8d157aOKs9UaF7dQuWi5KhcV9qG7viangi70eUzcyihxf5kU+vG70INjqkp0w1MIpVA1NS7lLRzPUweK0MDAZMl2ibDGRYfd5Yslejl9vop+5lPYg14+irFEM4cbejiY6WMq3VTXNxxzHTbnBtipnuE18V+xPjVYN/Bn2hO8WDR4oSAZnW+mvdjDJYUM75ubZYf/Cl3mr4IFQ38543VzZH4XU6NNTBUl2TaX8fVxki15ugcnuOJXwzROz9YdYy6d4lhPD8d6ehhvbw9Sy1ojvBLW1Ah+Ic/R1m4ObbyEQxsuIp+olrULrWnLj9E4/yIUH2FOv8CcUJVjEhqavWa63A56Sz1hjUsrPU4rLX71ybPWmpw3iyMc0rIBW8ZoMJsrlxe8HGPFIcaceSZ8k6LsRMhtCCnw4+UE+m/YbD0eCvTwOtYI9FHZzqDsY9Do46g8vkAvJ9ENAULo8gJB13iQxw4l+loQVXl+IgIdUZkLWhHoInxrSRIk0A2Jb1koIxToC38BhOfLNS7CBCl1MEhUauwlBLqgPDzUIBGzaEynySSTNKVSJBLxc6sPfBWcE/K83GteK82N8N/RINCIiIiIiIiIcxApDWTcwIrXP09Xvl+XZHfD2phItEdEnN2Mj49z22238dOf/pTR0VGam5vZs2cPt912G294wxsAGB4eprm5+ThbOvVs3LiRT3ziE3ziE5941fdd5uMf/zgPPvggzz33HDt27OCpp56qu7xYLPKxj32Mxx9/nBdffJF3v/vd3H333ads/5FQjzhhhDCR0kLKWI04T5zSoaG1KKUpuD4F1ydXcpgp5JgtZcm78zhq5QT5IrRCO3NQnEM7s+Dmj9stUFvlMu8Kckjy2iSvBDqsclmYQpdhF/qqUugEqxq+D54fJJ+VHybPA5Huh1/HQ1b+W0KiV5x3kEKvfmupgaKrleinpsYFwJEmgw1BCn2goRtnQY9g+/wUFxf3s1s+ymXph0k0VYd9+hr6S5IXigYvFkxUvoOeUjevn0vxuvlRtomnaTLHQsMZrDPqbGVkeiOTExmmTM14T4rszgwdx8boHjzG7kceJ1aq3r+UEEy0t1UkejaTCcSs9pHzWeIzk+SkwaF1Wzl48Ws40r0RVVMHYfkObbnDxPNPUXIfwmWSiqIXkPQTdLmddJU6uaSwhQ1OJ91OK51uI0Zo/rXWFPwsBV0gIVMkjBRpq1p546oSY8WjjDlZJjxJTrQh5KZAoMfmEYlxWmOPs8V6jG16P81LCPQR2RH2n5cF+lLp3KADvSzQY76LgUYKHaa8g/c/dJg+L9e5rBotUP6JCfTg5jyOQBcSLSW+baJME98w4DiDRIUJQuqwA11hsTiFXh4eahtBfUtDMkVDOkljOoVtn543F88UQoby3DpL5bkwwEqE4jw8tRLBMNCIiIiIiIiIiAsAaRjYiSR2Iln3/XI/u++6YYWMi++5UXVMRMRZwvXXX4/jOHz/+99n8+bNjI6Oct999zE5OVlZpqur6wwe4cnjOM5JvUa+8cYbeeSRR3jmmWcWXeb7PolEgo9//OP8y7/8y8kc5pJEQj1iaYRACgspbYSwkNKqObXD09OX4vOVphjK84Ljk3c85orzFPw8BS9PyS/Upb+Pi/bBm0c7WXRxLhgk6q+spsOQOb6vKfqaeWWQ8w3mtcRHB/JRKepT6KqmC30VKXQIJLrnBXUufpAUD+R5sN3VS/SgyEViLE7VV4aJBlUx5W8FQ0WrR38mBDrArJ3icGMvr2T6GM201Q13tDyXTbmjXOo/zWtiD7IhdQhqngvO+vBiweDFosGhfJzmUjd9xW4+PBPjsuJhtpi/ImXMVGpTPG0xnL+IiYl2RufSjLcYjPV2YLT5dA8Os/OJftpGJioDXgFKts1wdxfHenoZ6e7Cte1gmKhbxJ44hszOMNzSyaEN2zl09TuZbOmou37p0kyYQv8NJe9JPHxy4WWGNuhw2+hyOtla3MhFhXWVGpe4tsObXFP08xRUDlsmSJsNJMwMifAjnr72mCgeY9yZZdzTzOoWMPoQQuIn8oFAt3/OFvtxtumXlhXotQl0ZxmBXhbnMd/F9t0g2F2W6KFAF1CpcPEXVLmszIlXuARri8r+Fwl0QSjQBf4qBomWJbowg+tlSjCFCupcRP0jxRAGljCwLJPGZJKGdDIYIppMnV/1LSKQ59KsSaAvVwr/ahOJ84iIiIiIiIiINVHuZ1+IVgrPc/GdQLSXhXuUao+IePWYmZnhgQceYN++fVxzzTUAbNiwgde+9rV1yy2sfHnooYf4oz/6I1566SUuvfRS/vzP/5z3vve9PPnkk+zdu5d9+/bxpje9iZ///OfceuutvPDCC+zdu5fvfve7bN++HYCDBw/yqU99iocffpj5+Xl27NjBV77yFd7ylrcAcO211zIwMMAnP/lJPvnJTwKBs/jiF7/I3XffXZcU/+Y3v8k3v/lNDh8+DMANN9zAzMwMV155JX//939PLBajv7+fI0eO8OlPf5qf/exnSCl54xvfyLe+9S02bty47G30d3/3d0CQ5F9KqKdSKf7xH/8RgAcffJCZmZk1/QyORyTUL1CEMBDSqkpzaYf/rorz042vNI6nKHl+eKpwfIXjKTxf4/ilUKDPU/TzKL3KP95agy6BGwp0JwdO4bgCPTimQKC7nibnS3JKMK9NHC0qPS96QdK8mkJ3EatS34DSGJ6P9D3w/EpCvLYLfTVbMjDDNvQFjeiaqkQPB4pW9HBZiK9VoJ+iHnQIBW6qjf6GHg409JFNZuoubyrMcXHhZS4Xj3BZ+tckG6sVPErDYSfoQn+haDBbTNFd6mHjfB/vm1Zc4r/CRvv/ISbzEDrhkkowMreFifFmjqoUI93NTF7UQuv4VDBQ9OkXSc/l6o5htrGhkkKfbG1FS4lQHkY+S3x0AN91ONy3hQO730D/+osoxquWX2hFU/4oicLTuKVfgX+McsZdAE1eI11OJ+tKPVya30Kf206P00KTX62DKfp5pv0ZDGmSMZpImCkSYZ+N1pppZ5Sx0hTjrmJaN6CMDoToxo8XEPFx2mK/YLP1GBfx4pICfVh2hv3nvSsLdOUR8+oFOoAUGimD8hYZGmuFQGGEMn01olWgPbOaQvdN1jaCNLDnQdhcIGo70KFukKhaxSBRJBAKdCHBEBpTBCl0U1QXK9e3xGNW0H0eps9T8cTZlc4+SSqJc1Mgw9MzTiTOIyIiIiIiIiJOK0LKmo72epTv10v2MNXuuS5rG1oWEXGG0TpoKni1sZJ1NbbLkU6nSafT3H333bzuda8jFjv+PKe5uTmuu+463vnOd/LjH/+YgYGBZStZPv/5z/O3f/u3tLe387GPfYwbb7yRBx98EIBcLsc73/lObr/9dmKxGD/4wQ+47rrr2L9/P+vXr+euu+5iz5493Hzzzdx0001ruvoA9913Hw0NDdx7770AuK7L29/+dq6++moeeOABTNPkr/7qr3jHO97BM888c9Z+yjsS6hcQltVIPN5DJtON8SrJB88PJHnJrcrykhec+jUJZ195lFSJkl+g5Bcp+QV8vUo5rV1QRbSTDZLnzjzacwM7fhyqKXRFzhVkQ4Fe1BKtdNgtXn8ca65xCRG+QvoK6XqVfvXyEa59qOgCiV6+Kcs96HVVLiwYKFr+WgGtT1kPepmSYTGQ6eZQQy8DDd11A0WFVvRlR7jUfY6r7AfYln4Baqr/cj5hF7rB/pJBvNRCb6mHq2Y2cHV2ju28xLrYg5iWU0mi570GxqbXMTbVwGG7kWPre3HaLLqOjLD5xYNcfe+DWG715+dLyVhHB8d6ehju6WY+nQ5T6AWsyWGs2Umy8SQvb7iYA7vfyJGeTXVy1vaLZHIvIUuPokqPIXUeN7wspmJ0OR10O51ckt/GJqebHqeFDrcJI1TUjl9k2hsDCRmjmbiRJG5UJf2cM8lYaYIxz2PST+EbnQjRih8rhhUuv2SL9TgX8XxVoIc/v8UCvRdHLP1HyVJhAt1ziPleXcu5KXUwC0CEMjuU6D4mCrEKiS7QvllNoK9ZoFMZJLqiQDdkVaAvNUi0vDGDOoEuRdDsbgqNKYKLBWBKE1MaJOM2jakUjakUDekUidjiHvlzFWHUCPRy+vxMvjkgZFWYO0Vo6QI7GYnziIiIiIiIiIgziDQMbCMB8cSiy4IKmUCw+66L73mVChm1inBbRMSripuHv+559ff7uWNgp467mGmafO973+Omm27i29/+NpdffjnXXHMNH/zgB9m9e/eS6/z4xz9GCMF3vvMd4vE4O3fuZGhoaEnpffvtt1eS75/97Gd517veRbFYJB6Ps2fPHvbs2VNZ9stf/jI/+clP+Nd//Vf+5E/+hJaWFgzDIJPJnFDlTCqV4s4776yI8h/+8Icopbjzzjsrr0G/+93v0tTUxL59+3jb29625n28GkRC/QIiGBZqI8SprSBwQ1FeK8sd36fkKZb6RJjSCscvUvKLFFUBxy/hrrYDXSvQRYRfQJWy4ObALaFdd9Xyt5xCL7iaOV8yrwzyygwaTLQKK1GqorUs0IX2kGsQ6JWhoq6P9LxKlcuJS3SjPoe+RAq9/O3q/0RlGysf66mvcQGYjmWCgaINYZVL3UDREltz/Vymn+Cq5C9pyUzUrTvoSF4oBH3ox0omHW4nvfn1/O70Ol4zP8wW81l67P+DjFdvwazTzPh4F8O5DAebehju7SLe4tA9cIwr7n+U1tGJuluiEI8z3NPNsZ4eRjs78SwrTKHPET/yMsZ8jtG2bg5u2smBjTsYb63/Y5EsTRLPP4Uq/RrTeRkR3glNLWhz2+lyO9ha2MiOwsZFNS6ucsi6E3j4pM1G4kYS26gK2oKXY7Q0yrhTYkIlKMlOhNiMsoqQmaAl9gCb7SfYzrPVIaI1Ar1c4TJgrGNI9iwr0E3lEa+pcDFqkiVSBEn0agodCGtcqqcro33rNAp0Kj3oqtKDbi79wYuyQDdAGrX1NBoTjVWW6EJiiqD/PJmI0ZhO05BK0JjKYFvnicxdWN1icWYHoxoxsOKBQLcS1QQ6BNOfS2MQy0TDQiMiIiIiIiIizmKWq5CB4BO2vuehvLJo91ChcC+fjxLuERH1XH/99bzrXe/igQce4OGHH+aee+7hjjvu4M477+SGG25YtPz+/fvZvXs38ZrBxAsrYsrUSvnu7m4AxsbGWL9+Pblcji9+8Yv89Kc/ZXh4GM/zKBQKDA4OnpLrtWvXrrrU+dNPP82BAwfIZOqbC4rFIgcPHjwl+zwdREI9Agj/wCmNpzRKh6fheb/ma+F5/zgCVmuNU0meB6euclbXf6414FTqW3CyaKcAroPyVv8OdzBMNBD/WU+S8yXzSuAiggoXXa+16wV6WXuvkrAPHc9HeMGA0oUSfTVHHmjDBRK9LNAJu9CpVrBUJXr9VpY/zlNf4wLgIxhOt9Pf0MOhhj6yiXTd5S35GXYU9vMa42H2pn+N3eRWLispeLlo8HyYRC95MXpK3WzMbuU9U+3sdg+xKfYUndb/gpo3dGfzbYyPtzLgNnGgczOTW1tpGZ+me2CIix9/gcyCKpep5uagyqW3h+nm5qAyxClgzo6Rmp7A15rB3i0cuPxNHNx4MfO1dTRakSkMIIuPIouPYnojQOBpG1UjHaU21hV72J2/iHVuOz1OK01+cLC+9sm5U2RVibiRImM10xSrdq17ymG8NMqYM8+4Z5MT7Qi5HmWWIDFBS+whNlmPs51naGWxQB9eMER06QoXMJVPzHcqPejGgieuFYle0xOuEZUu9OMNFdW+GfSghzUuaxHoUB0kKqQIO9FrBLoAhAgEerkH3TDQxjI96DIcIloj0AEMNJZQmAIsYWALA8sySCcTNKaDCpd0PIW9zAuCcw1hVJPnZ7S6pVLXEq8R54lIlEdEREREREREnOcIITAtC1YIqCjfrwh2FUr2csrdd91l14uIOCGsZJAWPxP7XQPxeJy3vvWtvPWtb+ULX/gCH/3oR/mLv/iLJYX6mg6j5rFYToWrMBH7mc98hnvvvZevfe1rbN26lUQiwfvf/34cZ+UgrJSyMrOvjLvEYzeVqk/o53I5rrjiCn70ox8tWra9vX11V+gMEAn1C4hcyWMyV8Kx8vha4CuFr8BTSyfJTwTHL1FSRRy/SNEv4qrS6rrPtQfaQWgXdAntFqA0j/bC9Pkq6lsg8MNKBxUuBZdQnkuKChxMUHqRQBeVChc/TKCv0TArjSwLdL+aYC/vpfx1PGTlPzNQlgtqXGpT6OXrumpOk0AHKBo2Aw3VKhevRkJKpViXG2aX+wxX2fezOf0y1Hw6cNoTPF80eL5gcKAksb0UfcV1vG7mYi6fSnAxL7M5/jOaY0OVPnStBdNz7YxPNfKy2c3Bnq0UL0rQeXSEDfsPc9XPf02sVP1F70vJaGcnx3qDPvRCMolQLkY+S+LIKxjzc+QTKfZvuJgDl/8nBtZtrbsOhl8iWXgBUXwYq/gMUgWC3tQGHU43PU4nu/Lb2am20DqfrNS4KK3IutOM+ZOYRoxGq41Gu/rHIOhBH2fMmWXMk8zoVrTsQhkONEzQEvsNm+wn2c5TtDJTd5tXEuhGH4NyZYFuaD+scAkEurng8VhOnwtJXfO5CiV6ebjocmhl1gwSNVlVL3/d/sNBogKkkPUCHep70E0TZS3fgy4kYIQC3aivpjNR2EITkyYxw8S2JOlkisZ0knQqQUMshblcPcy5xFmRPhdhx/kCcW6end13ERERERERERERZx5pGEjDwFriZY1SCj82SltbG2iN8j2Ur1DKR/nBl678u/r9KPUesSxCrKp65Wxj586d3H333Utetn37dn74wx9SKpUqneuPPvromvfx4IMPcsMNN/De974XCIR3eahoGdu28RdUObW3tzMyMoLWuiLpaweULsfll1/OP//zP9PR0UFDQ8Oaj/dMcR7Yg4jVUih5ZIseft5FiJNLBPrKw9UunnJDiR4k0NVKvedaA26NOHfBL6DdQtB5Hr4TzRrS5zqYE4rjKfKeIOcK8lpQ0FZY4aJr0vDBdusFus/qdHftTgHfDyS67y6qSTnhPvSKQNc1f/jrJTpr8eGnqcYFYCaWpr+xl4OZxVUucafIRblD7OVxrkreT1NmqnKZ0kGVy/OFIIl+zBU0ek2sy2/g/5q6lL0zcJH5LJvjPyaTnqyupyRT020MzzXyQnorh3s2Yjb5dA8eY8+vn6L92BhGzbtCJduupNBHurrwLBPpFjHnpkkefRnpe0w0d3Dwor0c2LiD4Y6+Ovtqu9NYhScwi49hFV+sDJtt9BrocraxtbiBXfltrHOCYaJxbaO1JufOMOEfQQojFOitQGtluzl3lrHSNGOez6RqxBVNYGTQqUma4k+zwXqSneIJ2qjeZlBNoA8afRw5jkCXWlXS5zHfxVL1j6cw5B1UuIjFEv24Q0WVgSoLdN8CvVaBTqXGRUoZ1LjUmu/ggrAH3UIZYQ/6wsMJJXyQQtdh53ftxZqYgLiQxC1J3I6RSSWDIaKpFKlYEuM8SEYLoyzOz1D6XMggZVGW5uUE+nlw20ZERERERERERJw9CCEC6S4lsLqghla10j38t+ehlI/2FSJ6zhpxljI5OckHPvABbrzxRnbv3k0mk+Gxxx7jjjvu4D3vec+S63zoQx/i85//PDfffDOf/exnGRwc5Gtf+xqwtvlY27Zt46677uK6665DCMEXvvCFSnq9zMaNG7n//vv54Ac/SCwWo62tjWuvvZbx8XHuuOMO3v/+9/Pv//7v3HPPPceV5B/+8If56le/ynve8x6+9KUv0dfXx8DAAHfddRe33HILfX19S6534MABcrkcIyMjFAqFirzfuXNnpVLmhRdewHEcpqamyGazlWX27t276ttjOSKhHrEsnvJwlYOrHDzl4urwVLnHEecKtAO4FXEuwtS59jy066F9D+15a5a9SoNSQf953hNkPUFBCRwstCqr86rOFuhQnqtApJ+oQFcKfA/D95cU/uWtHv/aVCW6LIvISg86LCXQa06Oc5ynT6ArBCOpVvobejnY2Mdcor7bqnV+mp3FF7nSeJg9mUcwm6tJ/ZISvFQMJPoLRYOcL2h321iX28IbJnaxd36eLfaTbIr9I8nG2cp6nm8xNdHEoNPGM42XMLyum4bpOXoGjvHGp++neWK67hiymTRDvb0M9fQy2dYKQmMUc5hjA8TnZlBScrRrIwevehsHNu1gNtNct368GFS5xApPYriDwTBKZdLldtJb6uay/A42F3vodVpp8YPrX/CyzLrDzKBJm01k7GYyVLfrqCJjpQnGHZdxlSRPM8gYKjFNY3w/260n2WE8Rqeu74/XwLDsYMDoY1Cu45jsobSMQBfomgS6g60W3z+r8hwQQd68XqKvMFRUy0oHuvIs0GufwVBb4xKk0OvMd1DjYkiUaaHsoMaFhalqES5aHiRqhIn0GkwBSSlImgbxuEljKkkmlSSTTJKOpZFncsjmKaIizs9E+lyaVXleEejnz2DWiIiIiIiIiIiI8wshJYaUy3a7R0ScraTTaa666iq+8Y1vcPDgQVzXZd26ddx000187nOfW3KdhoYG/u3f/o0//MM/ZO/evezatYvbbruND33oQ3W96sfj61//OjfeeCOvf/3raWtr49Zbb2Vubq5umS996Uv8wR/8AVu2bKFUKqG1ZseOHfzDP/wDf/3Xf82Xv/xlrr/+ej7zmc/wT//0TyvuL5lMcv/993Prrbfyvve9j2w2S29vL29+85tXlPEf/ehH+eUvf1k5f9lllwHQ39/Pxo0bAXjnO9/JwMDAomUWVtOcCEKfiq2cR8zNzdHY2Mjs7Ow59VGD1TA6k6f/6DDJxhaECLqNPB0Ick854akbCHTtLl/VojWVNnDtA14ozoPkufZLgTgPU+fa9eEEp3orDZ6nmHcFOR/yLhS0ERSzLCgOF2iEVgjtIbSPcSLyPNykRiPCGhfpLe5RX2uVS9CIbiLretDLx69PLIV+GgU6gCNNjmS6ONTQS39jL45VTQEIpVifHWa39zRXx/axIVU/KGLKlTwXSvQDJYnWBl2lLtbPbWfr+CXsKk2wOf4bNsYeJS7nK+u5rsXkZCMH9Dqear+UuUwj7cMTdA8O0T1wjOR8oXr1gYm2NoZ6eznW20O2IYP0HYzcLNbEKIZTwrFs+tdt48DGHRzcsJ1SrNo3I5RLrPg8ZuEJ7OKTGP4MAE1eI92lTnYUtnJpYQt9ThtdTjMWJq4qMV0aw9Ul4kaSZrsTWTPkV2mfSWeSMafAuG8zq1vQElRshky8n/X2M+w0HqFbjy66vUdkGwPGOg4bfRyVvbgs9wdPE/O9Sg+67XuLNHhZoENVolePUhxnqKioF+hq7e+71vWgi0CiLzrAco2LZQanC2tcwgS6kIAZDBKl5noF102QMARJS5KOmWF9S5JMIkXKPvcT6MIIEucVeW6uLVlwUhh2KM6TYXVL8oxUtiilGBsbo6OjI0wjRUREnAqix1ZExOkhemxFRJweosfW2jmf3dZaKRaL9Pf3s2nTpjWJ5fOBH/3oR3zkIx9hdnaWRCJx/BUucNZyX4kS6hcQBb/AnDvNbD6Prz085VbrUBZJch+h68/Xf0+j/eBjUvh+WNUSJM9PVPAqDZ6vcLwgfZ7zBXlf4GgTv06eB6dC+wg8pAqS5+JE5Hm4OY1Gq7DGxfPr6kPKrD6FTjhQVCK1EVa5qJNPoZ/GHvQyOStBf0Mvhxr7GMp0oGqerFiuy0W5Q1ymH+d1yX00N9RUsmgYKBkViT7iCSxl0VNcx29N72Tr2MXsYJDNsYfZGP9nrGSxsq5TshmbbmS/3MzTnbtw19t0HRlm++P76Tw6guVW0+6eYTDS3cVQTy/DPd2U4jZGKY85O0n62CsIrckl0uzfsotXNu9ksGczvlH9NWf4WazCE9iFJ7CLzyN0CUtZdLkdbChu5/L5nWwqddPrtJBRSZT2mSqNMuIfxBAWLbFOOhLr6m6zrDvLaGmOMd9gSjXhiSZUTJBOD7DNvoedxiP0MlT1wOHPbky2cthYx4DRxxHZS4nEMiUrGlt5lQ5023cXaXC5SDSDELXN5ysNFRVoz6wMEdW+Wb+xVVAW6EiBXFKgA2KBQF/YV14r0I0agS5rFxHETIOkKWhImDSlE2SSKdLx5Pkh0M1AnMuyQDdeJXle6TqvkedG9PQgIiIiIiIiIiIiIiLiXOIHP/gBmzdvpre3l6effppbb72V3/3d341k+mkgesV8AZFzpiiUxsFQoXz2EbWSvIaKLFc+2veDoaAqSJprrVc9JHQptAbP1xQ9n6InKPhQ9AUlLXAx8LWg3hjrUJ77Qe+5Vgi85Ta/igMIBLrSCukphO9jLpFCX30XOlSqXLRAaCO4fcsiPfx3+T2BWkW2ohd/FQS6BsYTzRxu6OFg4zomU011l6cL81yaf5Er5cNcln6QWFN12KejJC8WBc+FVS7zShD346yb38TuqUvZOrGNbcYLbIn/mnWNd2KK6nTnUsFmZLaF52MX8WznTsy4ontgiMvvf5z2Y2PImnccCvF4JYU+2tmBlhozP4c51k9mPki3Tza1cWDPG3lly06G2+v7tUx3FKvwGLHCE5ilVxBomt0mepyN7M7vYGd+E31uGx1uI0IL5twJZpxBpoGM1UxbvKdue65yKj3o436GAkl826cxc4wNxn3sNB9mHYPIBT+0CdlcEegDso+CSCJr7g+19wtT+cTDBHrMcxdta6FAh8USXa8wVFT7JsqzT0KgE/Sgy2CQ6CKBHh6kNkKBbpnBGxuyfiNlgS5EkL6u3CCVdL3AtCRJS5KJm7SkEjQkk6TjaVJ24twW6OXhobX1Lac9fS7q5Xn59Fy+HSMiIiIiIiIiIiIiIiIAGBkZ4bbbbmNkZITu7m4+8IEPcPvtt5/pwzoviYT6BYT25xE6C64LWqGVD14wmCOQ5eH3TkKWL8T1FY6vKJSg6EPBFxSVwBUSn6V7zIT2ECikVkjthQMhT9Ao60qpChoFnkb6HtJXmAtS6OX0+WrLaSpVLkoGnrByiLVp9OoxlBdZ9pqUJbJWp02gA/hCcjTdQX9DH4cae8nX1KCgNR25SfY4z/A66wEuSj+LjFcPJuuaPFOE54oGrxQlHoK0l2ZDdhubJy5jy1QvW2OPszl+H70t38QQ1VuzMG8zNN/Bs4kdvNh+EWkzT8/hIX7r8QdoWdCHPtPYWJHoUy3NSL+EOTdN4uCzSN9HCcFwRx+v7H4jBzbtZLqhpW59s3SQWOFx7PzjGN4xbGXS6XayrfB6rsjtZKPTRY/TSkLb5L0sk8VjHNZHiBsp2uN9NNrtddubdmYYdYuMeXFmdArfTBBLHKU79iA7zIfYLA4skt6TookBsy8Q6MY6ciKF1IEzBjBqFi8PEo17DnHfwdDHF+iwWKKrZSS6VkalwkV7FixZ9bIyQXULCCERQi6qOC8PE/VNE21b+IaBNuri5YE4FwsEek2huxQC0zSIWYJ0wqI5FaclkQoqXKxzW6ALWSPOLfHq1LeU0+aRPI+IiIiIiIiIiIiIiDjvueWWW7jlllvO9GFcEERC/QLCm5vFn5kBWVhrIPX421aKkqsoujpInasgde4i8cQCcS4IhXmQjA8GhirkqlvJl6BSm6JDaa3CcLhC+j6G0kh/cWHLWmpcghS6xFCiOlC09gAqQrzu5IwLdICCGeNwppv+xj4GG7rwauocpO+zYe4oV6jHuTq+j670UN26oyWbJ4uK5womR93A7DY5zVw6dzGbx17DpmwjW+KPsDn+P+lpfxEhqlcmn40xUOrmqfSlHGzbRCtT9Bwe4q0P3Et6LldZrtKH3tfLUG8P85kURjGHNTVB+qV+BOAaJv29W3llyyUc3HAx+XiyepDaxSq+EEj0QtCH3uBl6C11c8X8e7kk7EJv8xpwVYnx4lGGvBFMYdMS62JdenvddS75RUadLGOewbifpigtrMQEHZlHudZ6mIvEc5gL3nqZNZrol70cNgKJnpUZCAW61GDW/IxrB4nGfQdrwSDR5QQ6LCfRjVCihytpUUmgn/AgUREkxIMedLl4oGc4TFSZJspeosZlKYEuqEuhSxkk0C1TkoxbNCZjtCXSNCeTJK0Eplz7cZ8tCEMg7FexvqUueZ6M5HlERERERERERERERERExGkiEuoXEHqJXvBllw1lr681Wmk8X6GUxvHBVRpPCRwt8BSUlMRF4AmzKvQIpJ/QCqmdoMJDn2TXeeXgyicaVc58q+A7wldIXyGUQi7Tg776GheQWmBqA6kXGs7FAr38z7NBoGtgOtZAf2PQhz6aagmsZohdKrE9d4CrxCO8NvVLUk1Vue0rwUAxxhMln+cLBtN+IOXaih28ZnYnW0dfy/qiwZbYr9kc/w5dHS/X7Ts7l6DfXccTTbs41tFNx9AYPS8O8a6B54kXS9X9SMlIV1eYRO/GtQ2M+TmsiUHSR4OO9UIswUsX7eXAlkvp792CVzOdXag8duEp7MLj2IVnMJVDh9vO9sIOrsxdyuZSDz1OC5YymC6NMFU6wDSajN1KZ2IDhqj++lNaMenMMeb5jPkpZjXIeIHWhpe5wvoNO8VjxEW17gYgK1IcNtZx2AwGiar0erL5WURZoNc58moPetx3Fg0SFaJco7L0z3NpiW6iglG8VHrQyzUuJzBIFIKEuFiuBz08EC0NlGWhbBPfNOs6a+oEukFVoIcpdMMQmKaJaQrsuEVDIkZzIkV7IkkmlsCS5+6fpEX1LYsi/KcQIxbIcztVkzw/d998iIiIiIiIiIiIiIiIiIg4lzhn7MXtt9/OT3/6U5566ils22ZmZmbZZScnJ9mzZw9DQ0NMT0/T1NT0qh3n2YxWgRxXWuHr4FQpje9rfKVxfY2rBK4GVws8Lcst6/jCCIca1ksiEeppgUIqD6HLS51E2rzuoMvuOZTndX3iVYEulY9YYhjq2gS6QmqJoUUwTLS2FqMyFFUvEui1p/XH/uoJdAga8YdT7fQ39nGwsZdcPFV3eSY3x67iC7zBfIBLM49itlSNb8kz2V8weaKkeKloUAy74DsLPVw9vZstI1fS5xfYEv81W+Jfpz1zqO5qzs6lOKA38ljLHmZbG+k+Mkzvo4NccfQ3YT99gGNZHOvpYaivl5HuTjQ+5twU5sBL2GFKezbdxCu7L+eVLZcy1N6HrknZSm8Su/A4sfwTWKWXSPo2faUerpx/O7vmt7HeaafFzzDvzjJaOMxB/xAxM0lnfAPbGi+vuz3mvTyjbpFxL864b+DHijQlD7DVfpxL5UNkxHzd8nkRDwS60cdhcx1TojkwxxqEhgZVL9FX6kE/nkCHlSR6sCWtTLRrBRL9BHrQg+MIetBF2IO+aAvhoFHfstCmiW+Z1RqX8DpUOtDLAr1GohtmKNAtiWUbJOJxmuNx2pJpWmMJbGPp2qezHlGTPD/d/eeGXV/bYqcieR4RERERERERERERERERcQY5Z4S64zh84AMf4Oqrr+a///f/vuKyv//7v8/u3bsZGhpacbkLjeGpHKM5j1nPC0V5KMyFQIXaTqBBq1CsBWUoUivQGkOX87C6ItJPGTXiPNizWhz31hqpVCjRfcSCnunyEa3uyIKNCy0wtERqA1k7DfGEBfrpHSK6kKK0GGjo4XBjL4cbunFrEtwoRefcOFd4T/JbsX1sSL8CNY49W4rzTFHwZElxqCRRCAxt0TO/gU2Te9g0dgW9TLE1/hCbM39Jq3WkelUVTGUbeFlu5rHWvThNFj2Hj7HjmRdoGx6vGyo6n0wy1NvLUF8PEx2tSKeAOT1B7JVnkIR1L80dvLJ1F69s3slYc2fddTScwUofuuUM0Oa1siO/hStzN7Ct2EeP24rwfcaKRzhWepphBC2xbjakL8GoSTz72mfcyYU1LjGyZoGG2CE2pJ/kTeavaBFTdfstYTEYyvPDRh+jsr2a8g8lulRVjS1RJLwScS+Q6GZNj37YjnJc510v0cuP0eDNLLREeTbKtdC+BYtqh45PpQddhj3oyxyEMkyUbaGsmhqXUKDLWoFevnJSgwGmKTAtA9MSmJaJGYvRlEjQGk/TFk+QNs9RgS7LAl0gbRDmaZLn0qzKczsJVgqMc+bPdERERERERERERERERETEBcE580r9L//yLwH43ve+t+Jy//iP/8jMzAy33XYb99xzz6twZOcOWccjpwV5DWgf8JDosDgCTqkgX0hdO0pNz/lKHSlKV5Lnhrd4MKm/4HTlnQfrChUMEzXCBHolhV4R6IvT5MtK9DMg0AFm7DT9jcFA0ZF0K7qmmsNwXDZmB7laP8zrUr+kuXGybt2xfJoniz5POpqRsA/dUnE2ZrewaeIyNk7spUcOsSX+EFua/idN5nBlXaVgMtvES8ZWHmvdg+Ereg4f5YqHH6V5comhon29DPX2MtucxshnsSbGSL10FACN4FjnOl7etptXNu1kNtVYXVkrrNLLYRL9cRLuLH2lbl6b282e/PvZUOqk0Usy7YwyVjjEC/7zJM0GupOb6U1urTuOea/IqOsy6seZ0AViiUHWJZ7hbeYDdMujdcu6GBw1eio1LsOyAyVqksA6uP+Uh4kKNLbvEvdc4r5L3BD4xRzlO8NKPei1LJboRkWkl4eIKs8GdWI96EKIUKQv0YMe7BJtGJUudN+0KhUtywp0ARga0xaYtoFpCCzbxLBtEnaC1mSKtniKZsNEns7qk9OEMMrJ87DG5XQIdCEXJ8/N2KnfT0RERERERERERERERERExCnlnBHqq+GFF17gS1/6Eo888giHDh06/gpAqVSiVKr2Os/NzQGglEKtoXP8XEC6JUztYOji6dnBAmle6TdfsVg8XEOF6fPK6Yn0n9fsKJTdUkuElhjUCHRdu/wJCPQlqmVOJ0oLRlJt9Df1cqihl9lEpu7yeC7PjsJ+fsv4FZdnHsJuqXZ9e77B0fkMv3GLPFsUZJUCBDE/wUWz29k8/hrWTV9Mj3mIrfFfs7nlf9Bgjlf37QvGci28YF/EEy27SBbz9PQP8Vu/fIB0ttq7roSoDhXt66EQNzGzM1jjg6RGPQB8aXBo/TZe3raHg+svIh+rHSrqYBefx84/RqzwJM2OYGd+G6/LXsf24np63BYcN89ooZ9DpYNIYdIRX8e2hiswpV1zWykm3AJjnsmorynZQ3Qlnucy60G2yOdra+TxkRwzuio1LkeNbnyx4FdizVBRqNa4xD0X23drEt5B8luvUh4vJdE9JL5vVXvQT6TGRYBAIGVVoi+5BSlQlln9MozFAl3W7F4AVijQLQPTFBimiWFZ2HaCxkSStniSZtMmsWD4ptKv7uPlRBBmUNuy1ABRTXWmxEnsIRgaaifBTIGdCM4vfIPjPPubcypQSqG1Pu/+HkdEnGmix1ZExOkhemxFRJweosfW2oluq4iI08t5I9RLpRL/+T//Z7761a+yfv36VQv1r3zlK5X0ey3j4+MUi6dJPJ8hpDZIGonVLbxEzcniRWoF9ioPQoFAIfywOkbVbEOGX1TV+NIufqEBr4p7gUSG4lwAaLF4nWWOte7b+gSu2ymkJAwOpdp5JdXOgXQ7pboqF03T3DSXuU9zrf0fbMm8iEhVD7LoxujPpXnQzbHfkbjaASRpL8OlM5eyafRyeuY20WvtDzrRW79JyqwmzH1PMFboZH96Fy+27SHjTNFx4DBvPvRz4oXqY6IyVLSvl9H1vSipMafGkUdeIRXWnTiWzaFte3jloj0c6t6IY1blt1Dz2IWnieUfI1Z4nvVeC6+fv5zLc3/E+kI7yZLJePEII4VnGVYFGq12epKb2ZzZU3dbFXyHUddn1DeZMWZoTrzE1tQjvFk+iCXcynIaGDO7OGJv4oi9mWPWetwaGV+j9yuDRQUKy/exlYelvGA4rRX82qz0oIfIZMOyP89yX3p5hGj4KEBpifJtlG+CMhCmxFhrSFmU0/AykOnLOHglJdo0UaaBNoMHmiQU6CwQ6ABG0DYiTQPDBEMa4b9tYnacjB0jLS2SMty/0uScErnFuz7rEKYIashNEaTRJcE7daXw62SRVjA41Ay/jFhQ0VMCSh7MZ4HsKdjR+Y9SitnZWbTWSLn2mqOIiIiliR5bERGnh+ixFRFxeogeW2snm41eb1wICCH4yU9+wu/8zu+c6UO54DijQv2zn/0sf/M3f7PiMi+++CIXX3zxcbf1Z3/2Z+zYsYP/8l/+y5qO4c/+7M/41Kc+VTk/NzfHunXraG9vp6FheUF2LuLhMu8VmPOCFH6gjJcQx6dEIAcDQ4VSgZxcovO8vKty7/ny8rw+dR6cFQhd1ecCA1nplF5Zhi95Nc9Q+rx299PxJg43dHO4oZvhdFvdME7h+nTPDXOV/xuuSd5He+NI3fqz+Qz78zYPujkGPYmmABg0llrYNLWbLeOvoWO+i177ebbE72NL+69JGNU/sJ4nGcp38mxyBy8lttA6NUXPi0d5w5H/H5ZbldKOZTHc083Rvl5Gu9vBKWBNjmG88izlRpD5eIpXtl7Kga2XMtCxHlUzQFF609iFJ4gVHiOdP8jF+Y28IXs5lxb+L3pLreRL04wU+nmu9AS2jNOV3Myu5t/CklXLrLVm0isx6pmM6TzCfpmNycd5m3k/GTlbd7tMiUb6zfVhCn0dBRm+oeQDfgEohBstJ9E1tu8Fw0Q9j5jy6n9OC2v2qz+hYLNzk5VLyr3pZYmuy3Uuno3vxYIUupKAF36tjvLwSykX17hoqhVIWgqUbaIsC9+yQAiE0gjPAz8Q6bo2gW4qTEtixiSmJTEME2maWHaMeDxBJpam2bRpNAziZYl+jiDssLrldAwQLfeem8kgeR71np9SlFIIIWhvb49ePEVEnEKix1ZExOkhemxFRJweosfW2onH42f6ECJOkvHxcW677TZ++tOfMjo6SnNzM3v27OG2227jDW94AwDDw8M0Nze/6se2ceNGPvGJT/CJT3ziVd93mY9//OM8+OCDPPfcc+zYsYOnnnqq7vJ9+/bxjW98g9/85jfMzc2xbds2/u//+//mwx/+8CnZ/xl91f/pT3+aG264YcVlNm/evKpt/cd//AfPPvss/+t//S+g+hH9trY2Pv/5zy+ZQgeIxWLEYosjoVLK8+4XtadctD7VVTb1dS1CKaRaWo2XRZ+qXLqE2tY13wvFeflsIM5NDCRCi7D/vFaeL329Fu3lDHWf16HBlSZH010MNAYSPVdbgQIY8yW2zB/it+WveF3mlyRaCpXLlBKM51p4tggPufNMKR9Cid6e72bT5F42T1xOa7GR9bGn2By7i03tjxAzqttwXYMjxS6eTl9Cv72e9pExep8Z4h3H7sGouY8U4nGG+no52tfLRFsTRn4Oc3yU+CtjlWWmM828sn0Pr2zaybGW7roqC8MdDvvQH6N1fpI3ZPdw5fw1bCv+FzIli9FCP8OFxxn05mmL99CT3MKOpqvqboui8hhzNaO+ImcM0BV7kt3J++k2BuqWy4lkRZ73m+uYlY0sSyjRLeUT9xzivkvMc5E1d4rV9qCXEeiwyqUq0ZWyKHnxikRfa42LCOPt5RqXZYeJQqUHXdkmyjQr1S1SBAK9WuGiESYYlggEui0xpYE0LQzLJh5PEo8laTLjNJkmSQnxc+XXoaipbrEFwjyVAl1U+86tZNR7/iohhDgv/yZHRJxposdWRMTpIXpsRUScHqLH1tqIbqdzn+uvvx7Hcfj+97/P5s2bGR0d5b777mNysjorr6ur6wwe4cnjOA62bR9/wWW48cYbeeSRR3jmmWcWXfbQQw+xe/dubr31Vjo7O/nf//t/83u/93s0Njby7ne/+2QOGzjDQr29vZ329vZTsq1/+Zd/oVCoysJHH32UG2+8kQceeIAtW7ackn1cWJS7zzVSawiT5kBFni9to3UozvXivvMla1RqRFfd5kQgzpFIbVBtgq5dfxUC/WyQ52U0zMQaGGjo4XBDN0OZtrr0Nr4mPTvLLvc5rrX2sbPxaWSyeh1dz+LYXAuPlzwe9fMUdHB/F9qkJ7eBzROXs3FqN82uzYbY42yxv8uGzONYRk3C3DEZcHp4smEXx4wOuiZG6Hl0iO1jz9Vp3mwmzdHeXobW9zGTiWPOTWNNjpCcHipfFUZbu3l5x15e2bCdyUxb3VU1S4ewC4+TyD/O1qzFb89dwd7877Ku2E6+OMFIoZ+ni09jyxg9iS3sav5tkmZ9N/y05zLiwpSYJGE/xc7kg7zOfBopqrdJCYtBo49+cx39xnrGZeviXuoahAZDqeogUc/BrHkjplLjsgb/KsPlDaGRQqMReG4cP5To6BMZJioQIngStKJAlwJtWyjLxLdsMKri3BRUKpTCKx4MELWDBLppGkjDRFpWRaAnzARNpkVaQlKG2zjbKQt0m3CI6Ck8aCMW9J5bqbD/PBHewBERERERERERERERERERp4eZmRkeeOAB9u3bxzXXXAPAhg0beO1rX1u33MLKl4ceeog/+qM/4qWXXuLSSy/lz//8z3nve9/Lk08+yd69e9m3bx9vetOb+PnPf86tt97KCy+8wN69e/nud7/L9u3bATh48CCf+tSnePjhh5mfn2fHjh185Stf4S1veQsA1157LQMDA3zyk5/kk5/8JBCEmr/4xS9y99131yXFv/nNb/LNb36Tw4cPA3DDDTcwMzPDlVdeyd///d8Ti8Xo7+/nyJEjfPrTn+ZnP/sZUkre+MY38q1vfYuNGzcuexv93d/9HRAk+ZcS6p/73Ofqzv/pn/4pP/vZz7jrrrvOfaG+FgYHB5mammJwcBDf9ys/oK1bt5JOpxdJ84mJCQB27NhBU1PTq3y0Zzs66DLXKvhSwfdEOWVeFtCEXlHX58mhmjaHoDaiWh/DcWT5YtkVNj8jdVDdEoSCg3xv/QDRJa8J1UNU1TNnWp4DaPCExbF0OwON3fQ3dDMXT9ctIgoePdmjXK0f4bdT+2htHqu7PF9MMTDXxCNegWf8AirsXTaUxYa5bWwZv4IN05fQqDw2xX/D1vg36G16HkNWf0KFkk2/t44nGi9lptRI99Ax1j14iF3TT9bta6qlmaO9vRxb38O8JbCmJjDGBkiOBjemEoKjvZt5efseXlm3jWyiphJJ+1ill4jlHyede5bXz67j9dk97Cj8EemiEaTQ849zyJ2kI76O7uQWdjRejSGrv4I8rRhzNWOqgGu8xEb7Aa5JPoQtq2+U+UgGjV76jUCgHzM6UWJlYS00xDyPhOcQ9x1s36sGtUXo39foYMsSvZxE930Tz43jzLeifHvNGxShyZdhAl0IsaRE14CyTLRt4lsm2qqm0OsEugwFuhlWuJgmphF0oEvbxo7FScRSxMw4KcMmbQjSAhJyxfcjzgqELFe3CKQd9KGfmg0bNcnzZFTdEhERERERERERERERcZ6itabgFY6/4CkmYSZW9QnqdDpNOp3m7rvv5nWve92SzRoLmZub47rrruOd73wnP/7xjxkYGFi2kuXzn/88f/u3f0t7ezsf+9jHuPHGG3nwwQcByOVyvPOd7+T2228nFovxgx/8gOuuu479+/ezfv167rrrLvbs2cPNN9/MTTfdtKbrD3DffffR0NDAvffeC4Drurz97W/n6quv5oEHHsA0Tf7qr/6Kd7zjHTzzzDMnlWBfyOzsLDt27Dgl2zpnbMFtt93G97///cr5yy67DIBf/OIXXHvttWfoqM4tZG4Gs1AgVqgfTlHrnhVlLS0qlwXCfIkH/KIulZV/KciwpiUQ6IH9q0jDRQJ8aSNerThXZ484L6MBJHN2isGwC/1Iph2/VsopTWx2nh3Fl7jW+iV7Gh/Fbq8ZnKkF09lWDs0n+ZU3y2EcIBgYavtx1k9fwpaJy+ibvZgm5tgc/w3bUl+kK3EAIao3Rq6Y4IDewBMNu3BmTXoGjnHxwPOk5vPVQxGC8fZ2jq7rZbinEwcHa2IM4+hByqNrPWkwsHk7L2/bzYGezRTtmloa5WAXnyVWeIy+mSO8eeZSrpjfw8b825gvjjGS7+eJwk+wpE1PcguXNL+eJruj7iab931GPcWsGCZjPciu5D5eaw7VLTMi2wOBbq7niNGLKyyOh6EUCdetSHSjpr9/rTUulfWgKtGVwPdsHC9IomttYsVSKH+VdUoieNNISkKBvlIKXYY1LhbKtgKhLAk6643wukgFUmOYEtMUWJaFaRgIy0DaJpYdD1LoVoK4jJM0BCkBKQmxszxwLYwagW6dKoEeVreUa1usJFhRx2BERERERERERERERMSFQMErcNWPrzr+gqeYRz70CEkredzlTNPke9/7HjfddBPf/va3ufzyy7nmmmv44Ac/yO7du5dc58c//jFCCL7zne8Qj8fZuXMnQ0NDS0rv22+/vZJ8/+xnP8u73vUuisUi8XicPXv2sGfPnsqyX/7yl/nJT37Cv/7rv/Inf/IntLS0YBgGmUzmhCpnUqkUd955Z0WU//CHP0QpxZ133ll5s+G73/0uTU1N7Nu3j7e97W1r3sdS/M//+T959NFH+W//7b+dku2dM0L9e9/7Ht/73vdWvfy1115b6VGPCPBcjQK8mpbo5Ypb6ljLzahrEuehNgcDodfuMFVt/HyZfvQzStjx7mMwHKbQDzd0MZ1YMMy26NE2O8aV+jHelPgFPY2DiKbqxY4bY3S2nReLkvv1FDnyQCC+k24DGyd3sXlqL91zW2mRY2yOPchF6e/Qljxat5vZQpr9YhNPp3diZH26Dw9x+ZFHiTlOZRnPMBjp6mJoXS+jnS2o0jzG5DjG4CuUdWLJsjl40W5e3nIJ/Z3r8YzqO6FCzWMXniQ2/wSvmXB409xuds2/lUxBMJo/zEjhcQ6WRmiPr6MnuYWLm15H3Kj+sQgGimomdBZtPMsW4//whuSzGKI6lHNWZDhkrqffCIaJ5uXx/9gA2J5H0nVInKIUOtRLdDwT37dxvBi+H0cvq8CXpjaFLkUQBV8yhS6CFLqyAomOZQQ96IAsC3RDgVQYhsQyJYZpYxoSYUkMy8SIBQI9YSWJGTFsYZCUgUBPSTDO4hS6MMpDRMMe9FNxsNKqqW4JBXpU3RIRERERERERERERERFxlnL99dfzrne9iwceeICHH36Ye+65hzvuuIM777xzyXmU+/fvZ/fu3XUDaRdWxJSplfLd3d0AjI2NsX79enK5HF/84hf56U9/yvDwMJ7nUSgUGBwcPCXXa9euXXWp86effpoDBw6QydTXABeLRQ4ePHhK9vmLX/yCj3zkI3znO9/hkksuOSXbPGeEesTJ4wEKUVfXsjaCRHjgJsut5sE5AwG6mj1fxZZqN1n9n16V4j8zhAJdI5mKN3E008GRTAdDmTZcoyY1rTXmbJEt+QP8tnk/VzX+mkRH/UeJ5nLNHJ1r4nHX4QkxhRZTlcuaC51snNzNxulL6cito9U8yjZ7H9savkZjYqJ2N0wVGnnR2soL1kUkJ3J0Dxzj6mMP1g0VLcZiHOvp5ti6HiaaGxDZKcyZaczD1UEWuWSGAzv2sn/jxRxt7UXVVLFIbxq78DhNued422gDr8/tYsv8+8jPjzFc6Oepwr8gkPQkt7C98Ura4+uQNTUsrtKM+S7z4gjNxi/YnvwFe43Z6vFh84q5hX5jPYfM9UyLplX1jkitiLtuRaKfihQ61Eh0Bdqz8H0b14ujtLUmiV5+Z3VVw0TLKXTLQsdMhBnIdsOg0n+OoTEMgWkYGMLCtAykIZExE2lbxOMpEnYg0C1pYYUJ9LO9ykUYQf/5KRPoQoaJ85rqFvPUfUQsIiIiIiIiIiIiIiIi4twmYSZ45EOPnJH9roV4PM5b3/pW3vrWt/KFL3yBj370o/zFX/zFkkJ9LVhW1WGV3YUKPdJnPvMZ7r33Xr72ta+xdetWEokE73//+3FqwppLIaVcFGx2XXfRcqlUqu58Lpfjiiuu4Ec/+tGiZU/F3M1f/vKXXHfddXzjG9/g937v9056e2UioX4BoVS5JmV5YS0RoMtaXNSkzGV4fnVUJXnN9yqR87Mwbb4UYYULCObsNEcznRzJtHM0005hYT1EySczM81l/lO8JfFzNjUcQDZWbwDPM5mc7QyqXNQMQ8Y8MAoSpDLomdvCxqndbJi+hIZSM53WK1xk/D9saXyEVGKuekgKxgqtPB+/iAP+BhqPzdAzMMRvjf+yfqhoOs1QXw/Dvd1MpyzMqXGM2VHs2dHKMjPNbbx88V72b7iIkcauQESGGO4wdv4xNs0c4bqxXi7PXUxTbgNj+QFGCk9yX/F/0xLvpiexld/u/AANdmvdzZH1FVNqFkM+xSbrbl6bOFSppPGRDBi99Bvr6TfXc0x2osXq7lm275FwHRKeQ+wUpdChKtGFL8G18P0Yrh9DYaxeoovaFLoMpf7SEl0LUIaBilto2wTLRIowgS41GD5IjTQElmFgYAdDRE2BsE0M28KOx4nHUsSNOLa0kUIQl5ASkJZgn6UBbGEG4lzaoUCXJynQFw4OtZJn77sHEREREREREREREREREWccIcSqqlfONnbu3Mndd9+95GXbt2/nhz/8IaVSqdK5/uijj655Hw8++CA33HAD733ve4FAeJeHipaxbRvfr4/rtre3MzIygta6IulrB5Qux+WXX84///M/09HRQUNDw3GXXwv79u3j3e9+N3/zN3/DzTfffEq3HQn1CwlXITEwtRVKvqDH/HgestaLr9iiE8r66iJnadJ8OTSEzdQUzHiNQO9gLlb/Dhq+wpwpsq54mDfIR3hD4wM0dMzWLZLPZxid7eD5ouRXYpSiMQ1iGgyIeQnWT1/CxqlLWTe7g6QvWGc9zkXGP7C+5Xlsu1TdlS8YLnXwbGI7RwtdtPVP0DM4xBvnBur2N9nSwlBfDyM97czjYU5PYkwcJT5RvXqj3et4+aI97F+3hel0/Tt9ZukQifyTvG48zzsmNnJx9hKc+S6G84d4vvATPOXQldzMpsxuXt/xO8SM6jurSmumfJeiOEy78TO2JPaxQxYrl4/J1opAHzB6ccXqEsNSK+KeS9x1SHoO5ilKoQOVx4DwTLQbJNGVttYk0etqXKQMpPcyB6UMA2UZKNuEmBUksw0QNQJdGGBKE0vYSCkxTIm0DWQ87EGPJYmbCWJGDCkkBpz1VS6nVKALo5o8t1PR4NCIiIiIiIiIiIiIiIiI847JyUk+8IEPcOONN7J7924ymQyPPfYYd9xxB+95z3uWXOdDH/oQn//857n55pv57Gc/y+DgIF/72tcAVjUItcy2bdu46667uO666xBC8IUvfKGSXi+zceNG7r//fj74wQ8Si8Voa2vj2muvZXx8nDvuuIP3v//9/Pu//zv33HPPcSX5hz/8Yb761a/ynve8hy996Uv09fUxMDDAXXfdxS233EJfX9+S6x04cIBcLsfIyAiFQqEi73fu3Ilt2/ziF7/g3e9+N3/6p3/K9ddfz8jICBC8GdDS0rLq22M5IhNxASF8MKSBoY36C2oleBgtX70KP8ekeS01At2RNscy7RzJdHA0085ksrF+WaWRsyU65kd4jXicNyZ/RU/zEWTNIFClJDOzHRzJBlUuz1qjaDFceZQ1FTrYMHUpG6cvpTO7kbScY4v5C7ZZ/186WgYwjOovKM8zOOp08UziYiZmGukYGKNn8Cgbiwcqy/hSMtbRwbF1PYx0NOEV5zGnpxHDg8Qqyxgc2bydl7fs5JWeTeRjNddLK6zSS7RmX+QdIyb/aXITrXM7mcgPMFx4jn2ln5EyG+hJbuW17e+iY0GVi6M0M3oaSzzOOutfWZ/or1yWFUleMnbQb66j31hPTqZX/WOxfI+E55BwHeI1KXQZvP9zUkgAZYBnBkl0ZaEwVy/Rw2GiSIEU4ec4whS6sSAiryQowwTbRMVMhGUEVS5h/zmGDoaLShNTWJhCYhjhMnETMx4LBomaSWJmDFMEd6RKlYuEhDj7wtjCFEi7PEj0JAW6Ga+KczsZDBKNiIiIiIiIiIiIiIiIiDiPSafTXHXVVXzjG9/g4MGDuK7LunXruOmmm/jc5z635DoNDQ3827/9G3/4h3/I3r172bVrF7fddhsf+tCH6nrVj8fXv/51brzxRl7/+tfT1tbGrbfeytzcXN0yX/rSl/iDP/gDtmzZQqlUQmvNjh07+Id/+Af++q//mi9/+ctcf/31fOYzn+Gf/umfVtxfMpnk/vvv59Zbb+V973sf2WyW3t5e3vzmN68o4z/60Y/yy1/+snL+sssuA6C/v5+NGzfy/e9/n3w+z1e+8hW+8pWvVJa75ppr2Ldv36pvj+UQOprcWcfc3ByNjY3Mzs6e8o8anGm+8//5CnlLks3PHGfJ8/AuEfaflytcfGEwnGrjaFjhMppqXlQ7IrIODXNT7FHPcE3iAbY2vYxpeHXLFAoZJmfbOZRP8qCeYtSeqa6vBd1zW9gwfSkbpi+hqdhOi3GI7fJeNluP0tQwVbetfClGv1rHc/ZFlEZMugZG6Do2guVV9+lYFsM9XRzr62a8MQnZGYxslhqvTyke59BFu9m/6SIOt2/Are3o0g524Xm2TQ/xnuEUV0524+dmGM4fYrTQj6OKtMR66EluoTe5lUa7PsWeUy4Oh2mR99Fl/wxTBh1aDlZQ4xIOEx2Xras2vUJrYr5TqXKxlK6X6Cdbqa0B3woluo3CqHytRqLXptCDQaJhJ/qC5YzmFE62iDYlOmahbYm0ZPCGitRVgS4MTGlgIpGGRIQ96EbcJJZIhj3ocSxhVfYTD7vQU2dhlYuwBNIKBbq9tne+6zdkBPK8PDTUToUdOBEXMkopxsbG6OjoQEaDZCMiThnRYysi4vQQPbYiIk4P0WNr7ZzPbmutFItF+vv72bRp05rE8vnAj370Iz7ykY8wOztLIhEF1I7HWu4rUUL9AkJVRPl5KMxrqZPnABJfmIwnGhnKBBL9WKoN36iXdSLvEZ+ZY7v3EtfEfsWuxmdJ9OTrlnGcGNOzXQznGnjO9XjaPoZrjEA4z8H24qyb2cHG6UtZN7ODpBej1/gNF4v/xvqGF4gni3Xbmyo08IrcyCveRuwjRbqPDrNr4qk6WZtPJDjW18NwTweTCYk5PYPMTWLmqkNFs02tvARAnMUAAQAASURBVLJ9N/s3bOZYUx9K1gyY8LNk8s/zmoksvzPUzIYpm6l5wXDheR5y7sMUFp2JTexpeRPdyS3EjWqPmNKanJ7D4ik67X+jz3wp+D6CYdlBv7mBQ8Z6jhrdKLF6+Wkon7gfCPS462KUh92Kuir3E0YoAb4NrgmehRYSf5USPfDBYQodEfazL92FrqRAGwbaNlDpBDomwBYII6hvQShMITClgYGJIWQ4hNPAiFlYyVilBz1uxCsy+myucqkI9HKFywkJdFFNn5cF+sK5BBEREREREREREREREREREavmBz/4AZs3b6a3t5enn36aW2+9ld/93d+NZPppIBLqFxDnpUZfQp5rJDkrwUiqhZFUC6OpZsaSTaiFadeSjzWdZ0PpEG80H+I1jY/T1D1dt4jvG8zOdjKWbeHlosHj5giz9jiY45VHT0OhjQ0zQR96V3YLCebZKn/OReJHdLYOYlqqZnuCkVIbL5pbGZltp2lwiu6hYa7IP1a33+mmJoZ7uxnubCaHizk7i5gZoxyA1wImujew/6JL2N+3kanUwqGiY3TPHeTNo/COoynkrMtIYZiR4sMcUSUSRobe5FZ2Nb+RjsQGjBoZ7mofRx8hY/yKLvunmDIbHJNo5HFzF/3Geg6b6yiKtQhQTcxzKxLd8hUylOinosoFQPgG2gslujLRQqAw8MVqJPrCFDrLDhT1TQNtSrANiJtgAxbIBCg3kN+mNDEwMIURbNc0kAkTGbdJJFJBD7ppY4nqGx9na5XLKRHo0gxT5+nqANEoWRIRERERERERERERERERccoYGRnhtttuY2RkhO7ubj7wgQ9w++23n+nDOi+JhHrEuYOGcmVL9UviSoOxZBOjoUAfSTaTt5d4983xMWZKdBaGeK18lDdkfk1Xx3BdD7rWgmy2lcnZdg4XkjzJDEfiI2g5A2Fw2/YS9M1eRN/MxfTNbqeh1EqDPMQO/g9brL+hqWmqLmXtuCaH3V5eYiv5EZuOI6N0jR6hV1WHinqGwWhXJ8O9HYw3pnCL8xjZHGJytBx+RxkmR7ds56XN2znQtYH5eGvd1YsXB7h4eozrjpjsOeYxlR9hpNDPE25QLdNid7O94Up6UhfRvKDKpaTzGDxHi/V/yBiPIYRPgRivmOv4/7N37/FR1fe+/1/fdZuZZBJCSCDcA14QKnevuCtYi3gponLZVs/eRQq2Vmu15QdaK1Is9khR0V2sVbpFN3jq7j7I1narRSrKwWq1GqhVUWi4iAmXALmR66z1+2MmQ4YESAgQhPezj+lkZr5rre9MZgUf7/nM51ton8s/nN7stQ7oK38Y8QVFa+OXWB12EGD58aDYavhVtkVAvPq83sXUuxBY0MIQPbUKPR4Sm0Q7lwP5FgSOQ+BaBCEb41kQMvFvJSSei205eLZLOEj0VrcMJuTihB3cSBpp4TRCVgjP8lIC6YgF6SYeop8orVyMe0AP9FYH6Cbe67yhbYuXDk7o8JuJiIiIiIiIyBGbMWMGM2bMaO9pnBIUqMuJ6SDheQCUhtKT1efF6dmURDKb9D/HDzDldXhl++hWv5Uh1lqGRwvomb21SR/0ffsy2bM3j22VmXxYX8Mn4a3UOpshkcmbwCKvLJ8epWfRc+9Z5Fb0xGUfva3VnB4soHvaBtIyU1u5lFen8Znfi39U98L+vJau24o5o/TjlDEV6ekUdc9je5ds9rgGU16OVVMOO8qTJ2ZNejqbTv8KH+efluiH3mhxz6Ce7MrNnL+zgm9sjJFZspviqkJ2VX/OO8QSrVzyOavD+XRNO4OIvf9DhiAIqGM7adbbZDuv4Fqf4xuLz+2u/NU+n0KnF0VW56av62G4sXgVeri+lpAfwwTx9TethorrNobGgW9BvQv1HqbexiT6mcew8Y2Nf8gQPbUKvfGCogfyHZvAMQQhK97A3G1o5RKP3OMLiVrxPuhW/H1qXAcrzcOLeIQj6UScCCE7hNX4mwOceK1c2hygW+7+qvOG9i2qPhcRERERERGRk5QCdWkfyaLwhtAcUsPz+H01lsP29I77q8/Ts6lxvKb7q45h7a0hq6qE04PPOC/0Lv06bCS7R0mTobW1YfbsyWNHeSc+rbX4m7eNvaHPoVEHk8yqHHqWnkWPvWfRrex0PN+hs1XAGf7/Jd/5kA5Ze7EanT2BDzurO/Jx0JcduzuR+XkpXYq285XaD5NjfGPYlZtDcdfO7OgYZV9dFXZlJaZsNw0NVwJjKO/chY2n9eejnr0p7tAL39r/fK3YPnqVbWP01iou+kc5FRVb2F61iU2xSgDSnEz6ZgymW3o/Ooe7p7RyiQV1GPMZHeyVRJ0/Y5sydlid+MDuxT+c4Wyxu1NnmnltD8EEPuFYHaFEJbpDAAE4iUr0oxKix2yCOg/qXSzfjr8zTHxhWR8Ln4P0bjdgaNmCooEFvmsTuAZCFngmXoXu2GBMkz7oGDCWhRVysSPxxURt45ERTsezU1/DZCsXE69Ib+9WLm0L0BPV540XDlX1uYiIiIiIiIicQhSoy7HTpL85NO51fuDQci/CnnAGu8OZ7A5nUpzekT3hjKYJZCzAlNXile2je/1WBlvrGBJdR8/szwm5NU2msW9fBuXlueyuyGJrdYi/2bv4PO0LgtAOSGSBXn2E7qVn0DPRxiWjJps0axNnBKs4LXiC3MztuGmxlP1W17psqctjY11v9hWH6Pz5DnJKiukcFCXH1HgeRd3iVeglYZugshJTVw17qpMnXywU4ov8M1jf5zQ2du5BWVrXlOOE6koZuGsHV366l55F29m5r5A9tdv5O/HAODvUjTMyz6V7ej86uFkHvFSlhK2/0MFZRcj6OxWWxya7F/9wLqDQ7kWFFaW1bD8WX0w0VosXq4v/JoP4H5PkRyFtCdED8OtdqPMg5mIFDT3NDx+iN1ShN7RwMYn7mm3l4lgErokvJBo24BhwLXBsLAy25eAaG9vYiQ8HElXoYRcvHCaSlkbYCROy4m+ifTXVuInFYMOJNi7pVjyfb09tCtAtJxGeq/pcRERERERERAQUqMuRSlnhtGWhOYCPoTSUzu5wBnsSl4af6+3m345mXz1mby0dEtXn54be48ysf5DTc2fTrD1mU16eQ1lZDjurMiishX94OymKFBN4xfEFJIm3celSlk/P0n70SLRxcey95AdrOCP2Et3DhUSyalP2H4sZdtRk81l9Prt2dyCtaB+dt+8gv/ofKXPY0zErXoWelU6piWFXVGKqy6E6/koFlmFfdg7/OO0sPunZk21ZvVJbuQCd9u3knzbv4KsbdmDv2cyOqs1UBXV8CrjGo0daP7pHz6ZruBehRhXRQeBjzCYy7DdJs98mZnaw2e1Bgd2TQvub7LKyj6BEOsCL1Sf7obtBLB5PHxiit4Vv8Os9/DoXK+amvKPi/dBtYocJ0Q/bysUC37MIQobAIz55zwbbxth2M21cwLJtTMjBDofiAboXJuyEcUzqe9UEAWEL8hyI2u3byuXIFxFV73MRERERERERkcNRoH6qSwbjqa1WUh14/+Ej1HpjsTccZXc4MyU03xuK4h+swtUPMJX1mMp63H3VdKvfykB7HUMzP6RXzlbCbnWTTaqqopSV5VBa0Ymi6jAb/Bo2p31OmVcYX0Q0reF5GrL3dSWvrC89S/vRrfQMXOOTSwH96p8n33xEh6wKLDflkwJKq9LZWN+TotJcKPbJ3b6T3PIictlfhV5v2+zI68z2ztnsSHOpr6nC1NVDZdn+KvRwiJ09+rC+T18+y+vBnrTu0KgdixOrYWDxNi75rJieRdsordxEZX0p2xOPR50suqX3p1taf3JDOfHwuOGpBdWErPeJOmtwrAK+cDL4wO5JoXMRX1hdWt0HHeILioZidUTqawjV1yW61ycW4AyOTogexCz8eo+gzsPEHCwT7F+A1VjU4zQbojcsKGosk2zpcrAQPXDBDxkCL94DHceAbYNr4VhOs21cjBOvQg9FwkTCaYTcMKEDFhOF+B/PqB1fVDRsYJcPGXa8X/zxdMQBekr1eaIHuqrPRUREREREREQOSYH6KcQPgMCOp4xHIRINgGrHo9RLVJxHMhIBepQyL/3gldD1fjI4dyqryYntpDtb6eduID9jK3kZ28nqvKfZ6vOKik6UleVQUtmBLbU2he5utkY+p97bkaw+B3BiHl0qepNX3pcu5X3oUt4bx4I0s5kz6t7kdP9X5GbuwktPbeNSU+uwpbYrm8u6UbXTI7t4Nx337KEvZftfR2PY3SmbHZ2zKckIU2YFsK8K41dDRXWiCt2ipmNHCvucyce9erK1Y09q3Y4px8or3ckln23iK1u2EezZRFndLgC+IN7KJTfci+7pg+mWlk+Gk5ayraGYdPstwta77HZ2scHtxia7F1vs/0W9cTkSjr+/Ct3z65PvDptEp/vgKITo9Q5+nYtf72H5NpYJEu1cgmSI7mOnfgGCg1ShN9cP3QI8iIWILyhqm/jFcTCOjWO7KW1cwGA5NsZ1sMMekbR0IqF4FXrj/vMNQo1auYQbZc/+gRM+hpIBumswXksDdANOeH/luarPRURERERERESOiAL1U0nQ0Ejj4FWoAVBju+xzw+xzQuxzQ+xzwvHbboh9TogqN0ylE6LKDR26+rnOx1TUYSWC806xnfRkM2eGNtI7Yxt5HbbTIW8vlmk+jayuTqO8LJe9FZ3YsS9KoV/H5vAX7AxvgnTil4RoTUfyyvvEL2V9yarOJQhV0NH/lD51r9G7/mNywyXxNi6Ng1DfUFzdicLyHpTuSidtewU5u0ro7m9NmUtph0x2dO5ESWYae1yDX12NCXyo3pcMdP1ImN1du7O+z+l8mteNkvReBNb+cNurrebCjZ9yTuHnZO7cRGVVEQEBpYnHI3aUrumD6Jp2Jp1DOXjW/kA3IEbI/J2I/Q7V9ids8TwK7V5sdkZQZSIH/x0cUkCovo5wLLGgaOAnH7GIB+ltDtET/dCDehe/zsMKLCwTxP/wpIToFkHjIzWzoGiz/dAN8RVQQ4ZYyBC4iVU/7XgvdMd1cGwXBzvZxsVYVrwXesghFE4jEo4Q9sJ4zVShGyDNgjQTr0Z326GVi3Ea9UBvaYBu7NTwXNXnIiIiIiIiIicVYwwvvPAC11xzTXtP5ZSjQP0UURmLUeKlURqJsstLbxSY7w/KG+7zreZ7VR9UdQyrsg5TUY+zr4ac2A56mU2cFi6kd3QbXTtup0O3gwfndXUe+/Zlsa+yAxVVmZRWp7GjzmaLU8rmtC1UuTuhw/7xlm/RqbJHIjzvQ+eKfCLGAWc33es+oG/tn+jBZrKc8iYV6ACl1ekUVnRnx+5s7O115OzYRXbdDrIbjdmXFmFHlxx2ZaazO2RTV1uDCQKor4b6RC9016UmK4vPe/bho57d2ZLdk6pQ5+Q+jB/jzK0buGhDId2KNlFf/jl+EJ9PBWBhkRs5i27pZ9Ml3I0sN5wyT0MFEesvYK/lC6+EQjeXQrsnZdYVrfv9NGIFfrIKPRSrTX600vB9haMTopt4FXqdR1DvYmGaCdEtfJyUEL3FrVzsGHgBfsjC9yywEx9a2BaW42C7Hq7t4Bh7/wKljoNxHZxQiLRIGiEvTNgLNVuFbhMP0Rsq0Y97Cxcn3rrFamjh0pIJNFSfJxcPDR9+GxERERERERE5Ie3cuZNZs2bxhz/8ge3bt9OxY0cGDx7MrFmzuOiiiwAoKiqiY8eOh9nT0Zefn88dd9zBHXfccdyP3eD2229nzZo1fPjhh/Tv35+CgoKUx9evX893v/tdPvroI0pLS+nWrRs33HAD9913H657ZJ0dGlOgfor40bpNLD9rZMs3qPMxNTGojV+b5HWMSKySzKCUbLObTtYueqQV0zu6jbyc7XSItDY4d9hu7WNXqITiUDExb1tK6xaAUH0aXcrzySvrS15FH3KquoBXTdh8Tp/a9+hT+yx5zg6i0SrsjNRjBwHsrsnk84oulJRmEdsJ2dt3k1ZVQU8qkuNqXZedXTqxKyuDkpBNVayO+NOog5q6RIDuUJeZSXH3fNb36Mbm7M7sTetBYHnJg+WWFHHehs/ot6UQd88WfL8mvv/EcdKcLnSLDiUv0pvOoUzclAp/H9d8hm2tZbf3OYWuT6HTk13W2UewkOh+bmx/Fbrn7/+AoSFEtwCrjSF64FsEdfFFRYOYG69wN0EijA4IjKEeO9HOZf9zPrCVC4n50DhEt2Lxxu0hQyxsETju/tfDtnBcF8f1cCzngCp0F8t18CJppIXC8Sp0p2kVOsQrzxsC9Ihp08vdasaO9z9vcYBurP3BuZcGXhRa+yGYiIiIiIiIiJywxo8fT21tLc888wx9+/Zl+/btrFy5kpKSkuSYvLy8dpxh29XW1uJ53uEHHsSUKVN45513WLduXZPHXNflX//1Xxk2bBhZWVmsXbuWadOm4fs+DzzwQFumDShQP2X85ZNdkONianyojWFqfEzimtoYVm09Ub+crGAP2dZusr095IT2kBPeQ8dQKZlZ5US9ctK8fViWf8hjNQ7OK5PBuct2s4+doRK2h7dT30xwDuDVR+i4L4/sqjw6V/SmS3lvMoIIsVAZOf56Tqv6L3rFCslx9hLJrMVEDzh2zKaoMpcvSnOo2BvBKamjY8kevLpKulKZHBezLEpystmZnUlJxKE88OMV6PjxHu9A4DjUZ2aws2tPPu3RjcKcLuxO64FvJ1qsBAHZe3dx+uf/YEhhIVk7Cwnq9h/DByyTRuf0IXRNO4O8UA6ZTuopZ7EXx17HXmczm70y/uF2YqfVCUw2R8oEPuFYHaH6WsKxWuxg/4cMjUN0Exyq+c/hBTEbPxGi4zuNQvT48QJjiGETO0yI3qQfuuWDVYdJLCjqew6BvT8wthwHx0uE6MZpUoVuux7hSBppXpiQF8Kxm/8zF7HiC4pGLfCOYzcUYyf6oDcE6PZhAnQ7tD84d9PAjRzfxF9EREREREREjpu9e/eyevVqVq1axciR8eLY3r17c95556WMO7Dly1tvvcX3vvc9PvnkE84++2x+8pOfcO211/LBBx8wZMgQVq1axSWXXMJrr73GzJkz+eijjxgyZAhPP/00/fr1A2Djxo388Ic/5O2336ayspL+/fvz85//nK9//esAjBo1is2bN3PnnXdy5513AhAEAbNnz2b58uUpleILFixgwYIFbNq0CYDJkyezd+9ezj33XBYuXEgoFKKwsJCtW7fyox/9iD/+8Y9YlsVXv/pVHn30UfLz8w/6Gj322GNAvJK/uUC9b9++9O3bN3m7d+/erFq1itWrV7f8F3EICtRPEZewk3+sW0tOuJTcUAnZoVKy0krJyCon3ask7FVhDlJZ3pza2hC1tWnU1kaoqUmncl8iOK932E41u0K72R4upu4gwblbHyK7qisd9+XRsSqP7H1dyartSMg4+F4Vxt5L75oCTqt9kW6mmI6hctz0WErfdICymjS27e3CrtIO1O+2SC+pIKO8gg7sbtwlhnrbZk92B/Z0iLIr4lJqsX/hSz8WD9Btm1hmBnu6dOXTnj35R04uu9J7UO9kAGDX19F1xzb6bNvEWZ9vIWvXVkx9VfIY8f05ZITOpGv0K+SFu5LrhnFSws8YtvUZlU4hW93dfOK5lNgdwXQFurb49T+Q7ccIx2qJ1NfixeqS1eaNr49KiF7v7A/RAxsLcBqF6CRCdB8bP3Ekk+iH3rSVS0M/9ACcGMaKEXjghxx816Oh2b0x7K9Cd7xmq9DdUJhIKEIkEaI3V4VukdrK5XA59lFjgeWaRBX64QJ0Ew/NG/c/t9v+VSQRERERERERiQuCgKCq6vADjzITibRoXbRoNEo0GmX58uVccMEFhEKhw25TVlbG2LFjufLKK3nuuefYvHnzQVuy3HPPPTz00EPk5uby3e9+lylTprBmzRoAKioquPLKK5k7dy6hUIhnn32WsWPHsn79enr16sWyZcsYPHgwN998M9OmTWvV8wdYuXIlmZmZrFixAoC6ujrGjBnDhRdeyOrVq3Ech5/97GdcfvnlrFu3rk0V7I1t2LCBV155heuuu+6o7E+B+iniis4vYbq8dsgxQWCorQ1TWxtJudTUhamq99hX71AesygNAiqtGirtfZQ7FZR4Ow8enMdCjULzPLKqupBVl0UYF9+rwvcq6BQrpEf9y3StLyIn2EMHyomk12BFgUYV6L5vKK7IpmhPLpV7wlgl9XTYXYoTqyGHHSnHLc+Isjsrg73pIUo9mwoTcGBTk8C28TOilOV24bOePdmYm8OOaA9q3Xj/qUhVJflbt9CraDOnb9tM5u4vMMGBPdltHLc7XdLOJi/ci7xQBlE7NbI27KHa2UCRu4OPw3Vst9PBuECXQ/4+Di3Ai9UTrq8lUl+TsqDoUQ3RGxYVrfPw610IrKYhOhAzNkGiGh0SFeMHtHJJ6YduxbDsOrAD/LBNzHUIbG9/2xfLYDsebiJExzqwCt0lHIoQduNBuuM2/6fMAdJtiJp4Rfpx6YduGvqfJwJ05xAHtZxEgB5N9D5P0+KhIiIiIiIiIsdQUFXF+mHDj/tx+73/V0xa2mHHOY7D4sWLmTZtGk888QTDhg1j5MiRXH/99QwaNKjZbZ577jmMMTz11FOEw2EGDBjAtm3bmg29586dm6x8v+uuu7jqqquorq4mHA4zePBgBg8enBx7//3388ILL/Diiy9y2223kZ2djW3bZGRkHFHLmfT0dBYtWpQMypcsWYLv+yxatCj5YcPTTz9NVlYWq1at4rLLLmv1MRobMWIE77//PjU1Ndx8883MmTOnTftroED9FGFZ3Sgt7ZQIydOorQtTXReiqt6lot6hNGYoCwIq7SoqnEpK3TLK3e3ErBiEiF8OwYl5dKzqQsd9XcmuyqNjVWcy6zsQaQjO3UoyzVZ6Bn+iW6yIXL+ErKCcNLsa2wkgo+k+99V6fL67C7v3dKB+tyGyax9pVVWkUUYaZclxta7Lno6Z7IlGKA05lNqGevvAUNIQOA5+NJ192Tls6NmTzzrnsD3ajepQ52T7ln4bNtKjaAt9ijaTXl5CEyYN2+lOTuRMOod7kOtlkO1Y2AdUoddZm9jpFbM+VMVmJ0gkuS14IQ8huaBorJZQfR0Wqa1cGq7bHqKnLioKptkQ3TfxhUVbFKKbGMb2sexafNfgezZ1TiillYtjWfEqdNfDctx4JXujKnTHCxFxI0RC8Sp0q8nvOM5r3A/9eGTTJl6BbmNwsy1s9xAHtUOJyvOoFg8VERERERERkWaNHz+eq666itWrV/P222/z8ssvM2/ePBYtWsTkyZObjF+/fj2DBg0iHN6fMxzYIqZB41C+a9d4t4QdO3bQq1cvKioqmD17Nn/4wx8oKiqivr6eqqoqtmzZclSe18CBA1OqzteuXcuGDRvIyEgNBqurq9m4cWObj/f8889TXl7O2rVr+f/+v/+P+fPnM2PGjDbvV4H6KeJj8nixKJtSt5RKd3c8bW1hvhuqSyOtLpO02szU6/p0wrE00mIR0ggReFXE3ErSnWJ6Wqvp7hfTObaLLL+UqKmKB+cR4pdG6mIWu8o6UlLegcqKCPVlFk5pHdG95VhBjA7sTo4NDJRmZrAnM529YZdSx2KfazfpKR3YFn56OrH0NPbmdGFz585s6ZjJ9mgelaE87FiMvJ3bGPTRJ3QvfpVeRVvxavc1ee7G6oTtdCc7fBqdw93I8SLkOAbbpIamMVPKbncr//Aq2BCqos5qXMnelgVF6xstKFrf7B6PRogeX1Q0EaLHHBpCdNsEKcF9Q4juYxM0auViNfRxaZiPCTBOgGXqMXZALGQTc2zqGrVysQDbtnGchhDdAWOwHBvjuViOQ8iNt3EJhyK4ntPsV6MMELbiVejpx6kferL63I33QQ8Aq9QcUI1+YPuWKBykn7uIiIiIiIiIHB8mEqHf+39tl+O2RjgcZvTo0YwePZp7772XqVOnct999zUbqLeG6+5vLduQs/h+vPPB9OnTWbFiBfPnz+f0008nEokwYcIEamtrD7lPy7IIgtRW0nV1dU3Gpaen9nKuqKhg+PDhLF26tMnY3Nzclj2hQ+jZsycAAwYMIBaLcfPNN/OjH/0Iu1GB55FQunOK2Fq0gy/StiVvW75FpC4jEZB3IK0ug7TaTCL16URiaYT9MBE/TAgXywrw7VoCuw7fqQWrmrTwXjL87WRX76FLbAdd6nbRMbaXDH8fju+DS/zSSG2Nzc6yLPZWZLKvLESszOCU1RGpqMIKAmyqyaQ6ZZvqUIjdWVH2poUodS3KPJfYAZXJgWXw09II0tOpzOrI5126Upjdge3RjpSFu1Fvh8kq20PnkmLO+Wwd3Yt/T97Obdh+0/YtxsnDcrqRHe5L51Aeua6TCNBTT7SY2cduZzubvQq2ehWU2pVtyc33/14Cn9AhFhRNnW0bQ/SYjV/nEtQ3hOgcIkSP90WPf3DRNES3TIBlBRg7hmXFwLWIOQ51bpjAtpIfeNiWhW3seE90xwPHxtgWxnGwPAfbDRF24iF6JBTGOOaE6IdubIPxEq1cPJrMKQiC+Gqj4Q5q3yIiIiIiIiJyAjPGtKj1yolmwIABLF++vNnH+vXrx5IlS6ipqUn2XH/33XdbfYw1a9YwefJkrr32WiAeeDcsKtrA8zxisdRMLTc3l+LiYoIgSGYmjRcoPZhhw4bx/PPP07lzZzIzM1s939bwfZ+6ujp831egLi0zuscYWBkibNJx6yxcY4NdHw/KnVp8uw4ntI9oaC9R/3M61JWRVVNKh7oyMmsrSGcfaVY1YbsG163fXxBuSKk6DwKoqbTZVdaRveVRqss8/DJwy2oJVcc/zbKoIUpNyvzqbZvyaBoVkRCVnkOla1HqOVS7Tkr1eWAMQSSCH02jNiOTos7dKMzJoiiaRVkkj1qTRs7uHXQuKWLYZx+TW/InOpcU49U180maScNyumE53cgK9SY3lEsX16eTY+OY1FOj3lSz0ylhi1dOsbeXPXbFUQnQIWhUhV6XUoUOTQ9hAVaQaKVyJEeL2YlFRT3w7eQ+4yF6o3HJxUWdeEV5k1YuAcbysRIBumVBzLHjrVzcEFh2cv6OZeMYe38VumNjuTa4LpbrEnIjhO0Q4VCYkOcRz+2bPrvj2Q/dWCQWEU0E6M0drHH7FicCdhl07KwQXURERERERESOWElJCRMnTmTKlCkMGjSIjIwM3nvvPebNm8e4ceOa3eaGG27gnnvu4eabb+auu+5iy5YtzJ8/H2g+YzmYM844g2XLljF27FiMMdx7773J6vUG+fn5vPnmm1x//fWEQiFycnIYNWoUO3fuZN68eUyYMIFXXnmFl19++bAh+Y033sgvfvELxo0bx5w5c+jRowebN29m2bJlzJgxgx49ejS73YYNG6ioqKC4uJiqqqpkeD9gwAA8z2Pp0qW4rsvAgQMJhUK899573H333fzzP/9zSoX+kVKgfoq4dFBXKv+ygbCpJlRRtD8oD/aRZqoIO7W49gEV23bi0kjgQ6zaorbapqImwr7qCFWVYarLXPzyAK+sFqc+vh+LWtJIDbKrQh4VaWEqwy4VrkOlY1EZ8qhurm0LEETC+Onp1KenU5LblU252XwR7UBpWhdqfY/cku103lHMOR+vpfOuV+lYugvrgK+YNDwZY3fCsjtjnO50CPUk1+tAN7eGjo6LY1JXVK2nlmJ3L0XeXorcPexxygmOUoDbkl7oKeNpY4he7+wP0YP97VasZkJ0v2FhUWM3DdGNHw/P7ViiGh3qXYd6N4zv2PtbuRiDY9nY2NiuF2/h4joYz8U4DrbnEXbC8YsXwvEczEFKzI9bP/SWLCTqROIBeiiaaN/S6A+w70Ojvv4iIiIiIiIiIkciGo1y/vnn88gjj7Bx40bq6uro2bMn06ZN48c//nGz22RmZvLSSy9xyy23MGTIEAYOHMisWbO44YYbUvqqH87DDz/MlClTGDFiBDk5OcycOZOystS8Y86cOXznO9/htNNOo6amhiAI6N+/P48//jgPPPAA999/P+PHj2f69Ok8+eSThzxeWloab775JjNnzuS6666jvLyc7t27c+mllx4yjJ86dSpvvPFG8vbQoUMBKCwsJD8/H8dxePDBB/n0008JgoDevXtz2223ceedd7b4tTgUExzY4OYUV1ZWRocOHSgtLT3mXzU4nnb8/HI61/y5yf1BALFaQ6zGJlZtUVPjUlkdpro6RG2NQ32NjV9toCbAro7h1NY3s/dUvjFURsJURDwqPYeKRGheGXapb+YrFYFlEYTD+OEQQTiEHw5TntmRrTm5fJGRxd5wDrHa+KKhnXcVkVtSTOeSItKrKpufgInEg3M7B8vujO3k0sHNJtsxdHOr6OiEsE3qH5N66tnullLk7abY3UOJU05gjtapEeDF6pMhuntAq5mjHqI3LCpa7xHUOTQ0hWkuRCdZiW4TGBtSWrn4GCvAtmMYy8e2IHDirVxirpNs5WKIt3JxjI2FhdUQoofceC9018VxPcJ2mIgTIeyFMJ5pvuqbeHB+PPqhG89guQ3XB87FNOp9nqhCtw7+dSDf99mxYwedO3fGUoW6yFGjc0vk2NC5JXJs6NwSOTZ0brXeyZptHYnq6moKCwvp06dPq4Llk8HSpUu56aabKC0tJdLK/u2nota8V1ShforYvgUqt3WmttqlvsbCrzFQHWDXxDhYbmyox6VpgB4Ata5DjetQ6zpUOzYVnk1lyKUi5LHPcwkOCEvjoXmIIBQPzINwiOr0DEo6dGJvegfKwlEq7Aixep+gtob0ilI6f17MsJK/k7N7O26s+SDfWNkYOxfLyY1f27lE7XQ6u3V0cfeRZdt4pgMm2QM9XoleT4wdbinF7h6Kvd3scsrwj1qADrYf27+YaKwuJcRuLkZuvLDoEYXovsGvj1ehB/VOcg/NhuhAzNgE2PjGwVgmvrioCcAEWFY9lh3DSbxk8VYuHnWukwyV91ehx4N0HAfLtbHCIYznYbkOISdMyA4TdsOEPJd495iD90NPNxC1j10/dOMkqs+9+EKiKV95Mvb+4LwhRG/FV6JERERERERERNrTs88+S9++fenevTtr165l5syZTJo0SWH6MaBA/RQROGdQ/elmIMAi1iRgrXVsah2bGsem1raoa/i50XXy0miRyZRjWIYgFE5UmYcIwmHqQhEqs7pQmZZDqRumxvepq63Dr6sitK+MDsUldCnfyJnlew5ecQ6A2yQ4N3YOEculq1tBnltJhu0SstKx8IgH5/tXDq42tZQ4Zex0yyhyd7PTLT2qAboJArxYXTJEd4LU/lKHC9GP5DP2IGYlqtD3LyoKBw/R44uLOvjGwbLirVwsfLDqsSwf2wniYbYVb+VS6zoprVwcy8IyNg4WlrHiIXrIwQqHsTwXy/OIWBFCVohIKIztWvEQvZn3is3+fuhpx6gf+iH7oFvuAQH6l28xEhERERERERGRBsXFxcyaNYvi4mK6du3KxIkTmTt3bntP66SkQP0UUdGpA7s7Z6WE48mfbbtJRTnEK9FxbALHAdshaPjZSf3ZdiLUZeSxL5RNZQBVsTpq66sJaitx95WSWfgPcsv/Sp99FYefqPEwVgeMlZlo2RIP0I2VhWcF9HT30NndR7pjEzbg4AIdE5e4OmLsToTnDSF6hVV1lBYR3f/qeLF6QrE6QrE6vFhdyu4Pdqi2h+hNFxWF1oToAZbxMbaPZfk48VbpiVYuLjVu/HfbMNf4gqIWNnY8GHdsrLCHHYlgPBfPDRO2QoTtMCEvhHE4aIjuJvqhRy0Im2NTAN4QnlueSe2D3rCAaCgjfu2Ejv7BRURERERERETayYwZM5gxY0Z7T+OUoED9FBE+71w+LfyEwPOIGcBxcZ0IthMm4oRx7DCuFcK2HDAOVZZLrWVRA9QTUBP41FFPnV9PzK8j5tfjx2qhrhanooKMre+Sva+c7MPMIzAulpWJsbLioXnykgjRrXiPIo8aeoR2ke3Wku5UEzbVhINMIC9lfz4+e5wKdjll8Ytbxl678ij2P0/OPCVAdw9o4wLHMERvZlFROHSIHph4iG6MAcvHMjGMHcO2oSFnjrk29a5N7IBWLq4V74XuNLTJcW3sSBgrEsH2XEJ2mJAdIuJEcBwn3j6luUU8iQfnDYuKho5Bq7uDtnFxwo0q0KPgeIfekYiIiIiIiIiISAsoUD9FVOwOEek4mFrq8P066v1aautrCGr2Qf0erPoanPoanPq6Jtu6iUtLBMbFWJlYyYA8NTDHhBOhp0+atYcst5yoU0vELiNk1xAyaYSDKJEgHUO00Y7jV6V2ZUp4vtspJ2b8ZufSNvEA3WtUgd7SAL3hscYLi7bu0Aa/3sWvcwnqXBrH8AcL0QNj4RuHwHISB49hTC22HWBZ5qCtXOJV6I0WFE20dzEhBysSxo5EsL0QEStMyAoTckI4ngVu8/3QDan90A+Ssx+xg7ZxcSKJCvREgG639B0rIiIiIiIiIiLScgrUTxGvfvYW2UXvA/FQ9nD1uvFw1gMrhMHFGA8rCGGMhzEemFCj60gyNN8fmINjqgg7ewg7FUTcvYTtCkJWiJBJJz2IkBHLxWlccR6QDM4B9lk17HJK2ZkIz0ucMmqt5hcnbbsA94AWLq0J0Bset9m/sGirju5bBHVufFHR2P5FReHgITrGImYcAjvRP8XyMVY1tmWwLLAw+I6N7zgprVwsmmnlYsDyPKy0MHZaBM+NELbChKwQnuthuRx0UVGbeIjeUIl+tPuhN9vGxU1LrUC39adMRERERERERESOPaVQpwivPhMTHoJFQxDuYUwofk08GCcZlnsYYx9yf5apxrZqsKxaLLsKyy3Fc8rxbI+wFSIDl0w/QmasG6EgUS0cALHU/cTwKbf3UWbvo7TxtbOPaqv22LwYicm0NUCHRNjNEYbo9U6iEj21H3pyvweG6Cb+iG8sfNtKpPf18fDcMtjGYIxFzLWJOQ61npNcUNS2LOzGC4oCWAYr7GFFIjiRCOFGIbrjxlu5HKofenoiRI8c5X7oTdu4WPsD9IYKdOvQ708REREREREREZFjQYH6KeKcMwezqWR/CBlYtWDVE1j1BFYM367Ht6oI7HICqx5MPa4V4FngGYsQJnFtEcImFHiEfJeQn0bUzybdD8cD82YKyAMCKq3qZGBelgjMS+19VFrVx6DfeVMmCHD9+kQf9Fq8WD0WTY/bkir0xgF6q3LkRCuXoM7Fr3eb9EOPF4o3F6IbAssQsy2wwFg+tvGxLLCNRWAbYq5DbWKxWIxJWVC0cSsXbAs77GEiEcJp6YScCCETxrM9bNc65KKiIQMZVrwaPXw0+6Gbhir0RJBuJwL0hvDcS1eALiIiIiIiIiIiJwQF6qeIUVdexH998TS2F8KvriYUuIQDNxGKe4mf0+L3+x6e72BirSs7rja1+0Nzp6HavJJyu+oY9Tk/mAA3FksE6HV4fj2OH2s2/G5NFTpHsKhospVLvUdQ37SVi0lUoafMwwRgAgLLwrcMgZMIyG0fY8DGIubY+J5NveMQ2PsXFHUsGxsLBzuZ+BvHwQ57WOEI4bQMwk6YkAnj2A6WYw4aojfuh55ux6vSjxbj7q9Ct9wDA/QoWMdgBVMREREREREREZE2UqB+iqh7u4hLSwe1ersaU0eNVUe1qaXGqqPG1FFtpd5XZdVQau87hv3ND83xG4XnsXocv/6gwXdLMuGGynPrSKrQadzKxQU/9RQ7eCsXHyw/HqLbBiwnHp5b8aDcsgz1rkPMdahrtKCo3cyCotgWlmNjhUO44XTC4XTCThohy8OyLSzHxBcVtY9fP/TkYqKhRBuXUKL/uVq4iIiIiIiIiIi0mjGGF154gWuuuaa9p3LKUaB+irCiLrWmjlo7xj6qDwjHa6lOBufx6xqrlhpTf1zasbSGFfjJ4LyhhUtzrVugdUF441Yura6NDohXoDfTygUOFqL7YNUnVjI1BJaDbzwsOx5qW8ZAYkHRusYLihqDa8UXEz2wCt04DlbYIxyKEglHCTkRXMvF2OaQi4oeq37oDS1cLM9gIgrQRURERERERERaYufOncyaNYs//OEPbN++nY4dOzJ48GBmzZrFRRddBEBRUREdO3Y87nPLz8/njjvu4I477jjux25w++23s2bNGj788EP69+9PQUHBQcdu2LCBoUOHYts2e/fuPSrHV6B+isgY1ZMl65ZS54Uo31fa3tNpERP4eLF6PL8eN1aP59dhBwcP+FubA7dpQdGYneyHHsSaa+VyQD904wP1GNuPt3OxHQLLJbCseAW6AcdYxDwH37Gpd/cvKOpYFtaBC4raBstxMI6NHQqTFsogHI4SdiIYE69CP9SioseiH7qxG0J0g0mLYMIZiRA9QwG6iIiIiIiIiEgLjR8/ntraWp555hn69u3L9u3bWblyJSUlJckxeXl57TjDtqutrcXzvCPefsqUKbzzzjusW7fuoGPq6ur45je/yVe/+lXeeuutIz7WgdSo+BTRXKh6orD9GF6sjvS6KjrUVNCpqpQulbvpVrmbnOoyMmv3EYnVpoTpppnL4Rji1d9OAG4Qv7ZaGKYHvoVf61G/L526sizqKzrgV6cRxFzAYAG2CXBNgGMCbBPDMrUYuxrHrcLxajBhC98L4YfTwA1hOw6250FamPqMKDVZGdSnRQg8D8d2Cdsu6XaYsBXCsxxs18MKh3Ci6aRldaJjdne6djmD7jmn0zGzC+lpUZw0GzvDYKUZjGuSv3dDvAq9sw19POjtQbbTxjA9sZionWHhdknH7ZWH0+s0rF6DMF36Q4ceEMlSmC4iIiIiIiIi0kJ79+5l9erVPPjgg1xyySX07t2b8847j7vvvpurr746Oc4Yw/Lly5O333rrLYYMGUI4HOacc85h+fLlGGOS1durVq3CGMPKlSs555xzSEtLY8SIEaxfvz65j40bNzJu3Di6dOlCNBrl3HPP5bXXXks+PmrUKDZv3sydd96JMftzp9mzZzNkyJCU57FgwQLy8/OTtydPnsw111zD3Llz6datG/369QNg69atTJo0iaysLLKzsxk3bhybNm065Gv02GOPceutt9K3b99DjvvJT37CWWedxaRJkw45rrVUoS7HhQl8HD+GE/g4fj2uH8P2Yzh+rEWf6hzJxwGN27i0uhd6QLwCvT7RxsVPDYWTfdYbWrk0VKCbAOwYtgEsi5jlUG9ssOz4eNsicF1irkO9Y4MxyV7oTarQLRNv4+LaWLZL2E0jEooSiWRg2Q7GIt4P3QHjNH12DvHFRNNNvBL9aPRDN7bBCoGJhDHRjEQVegbY+lMiIiIiIiIiIie+IAior/WP+3Edz2pRwWs0GiUajbJ8+XIuuOACQqHQYbcpKytj7NixXHnllTz33HNs3rz5oC1Z7rnnHh566CFyc3P57ne/y5QpU1izZg0AFRUVXHnllcydO5dQKMSzzz7L2LFjWb9+Pb169WLZsmUMHjyYm2++mWnTprXq+QOsXLmSzMxMVqxYAcQryMeMGcOFF17I6tWrcRyHn/3sZ1x++eWsW7euTRXsf/rTn/jd735HQUEBy5YtO+L9NEcpmBxFAY4fD8ydRFjecLEP0ue8OUea+7YpQOfQbVxo2HciQDeJAB0Tw9gBtgkSfV4sYpZLvXHiIboxmMZtXKz9vdCdRC90m8Qf1IZe6LaN5dg4tkfYjRAJZRAKp2Ns+7D90EMm3gs9zYLI0fj+iWnoge5hRTMwaZnxFi62exR2LiIiIiIiIiJyfNXX+jz5gzeO+3FvfnQkbujw3+J3HIfFixczbdo0nnjiCYYNG8bIkSO5/vrrGTRoULPbPPfccxhjeOqppwiHwwwYMIBt27Y1G3rPnTuXkSNHAnDXXXdx1VVXUV1dTTgcZvDgwQwePDg59v777+eFF17gxRdf5LbbbiM7OxvbtsnIyDiiljPp6eksWrQoGZQvWbIE3/dZtGhR8sOGp59+mqysLFatWsVll13W6mMAlJSUMHnyZJYsWUJmZuYR7eNQFKjLYZkgwAp8rIZrAmzfT9znYyeqz+3Ab/VCoG2aF20L0PENfqICPTjIYqLxnDuGZXzAByuGMX68At0YjAWBZYjhERgHLAtcBxyHmOsQ2FayCt2xLBxjY6X0Qrf290K3XULGI+RFCHsZuOFw4vGD90O3iAfn6QaiNjRTqN5qxjFYYReTEcWkZ8ar0J3DfxoqIiIiIiIiIiJtN378eK666ipWr17N22+/zcsvv8y8efNYtGgRkydPbjJ+/fr1DBo0iHA4nLzvvPPOa3bfjUP5rl27ArBjxw569epFRUUFs2fP5g9/+ANFRUXU19dTVVXFli1bjsrzGjhwYErV+dq1a9mwYQMZGRkp46qrq9m4ceMRH2fatGnccMMNXHzxxUe8j0NRoH4KSgnHEz/bjX62Dvy5Dcc6mp3brcT+jjhADyCIOfh1DW1cmr79LcAyMSxTTzxA97GshrYu8apwg8G3HGLGJrASVeeug+/a+I0WE7UsC9dYWFg42A09YjCOHQ/RbYeQ5cVD9FA6oXAaxvUwtsE4BuPQbIjumng/9HQTD9Pb3MrFgBV24hXomYkA3Q0ffjsRERERERERkS8Zx7O4+dGR7XLc1giHw4wePZrRo0dz7733MnXqVO67775mA/XWcN39XQcaMiffj7fAmT59OitWrGD+/PmcfvrpRCIRJkyYQG1t7SH3aVkWQZDanaKurq7JuPT09JTbFRUVDB8+nKVLlzYZm5ub27In1Iw//elPvPjii8yfPx+It/nxfR/HcXjyySeZMmXKEe8bFKifUjLqazB+DZmVe6AVLVha4lgsedrmAN03+DGXoN4hiDkEMbvJXiwCjBXDJgbEwPhYNo0C9HiVum8sfGwC4xDYLoHXUIVuJ9u4xKvQbZxEiG4Za38bF8fGsh1c2yVkQoQtF9eNYoc9jOdiHAvLAdzmW7mEG7VyadNCognGtbGi6ZiMTKyMDuBG2r5TEREREREREZETnDGmRa1XTjQDBgxIWYS0sX79+rFkyRJqamqSPdfffffdVh9jzZo1TJ48mWuvvRaIB94HLhDqeR6xWCzlvtzcXIqLiwmCIBnSNyyGeijDhg3j+eefp3Pnzke1Ncuf//znlDn+93//Nw8++CBvvfUW3bt3b/P+FaifQo50Yc9jzRxwoQ090IOYg58I0A9cSBTAIoax/Pi1ibdvMRZYmJQAHQy+sYjh4DsuQcgjcOK90FMD9GYWE23UxsVxPDwSIbrtYXthjOdhwm68lctBqtBt9rdyST8arVwsCyuavr8KPZTe8ERFREREREREROQEUVJSwsSJE5kyZQqDBg0iIyOD9957j3nz5jFu3Lhmt7nhhhu45557uPnmm7nrrrvYsmVLsjq7JQuhNjjjjDNYtmwZY8eOxRjDvffem6xeb5Cfn8+bb77J9ddfTygUIicnh1GjRrFz507mzZvHhAkTeOWVV3j55ZcPG5LfeOON/OIXv2DcuHHMmTOHHj16sHnzZpYtW8aMGTPo0aNHs9tt2LCBiooKiouLqaqqSob3AwYMwPM8+vfvnzL+vffew7Iszj777Ba/FoeiQP0UYthfl95eUWpDUG7BEQfnJLZtHJ4H9U7DXhuJ9z43piFA9zFWgDGNA3STzJUDDIFxqHc8Yq5H4CYq0RNBeeMA3cLsb+NiG4ztYDk2xnYIWyE8E2/l4touJuTFQ/SQg+2aeIBuN7+gaLoVv4RNG/NuY2HS07HS07EyMjHpGQrQRUREREREREROcNFolPPPP59HHnmEjRs3UldXR8+ePZk2bRo//vGPm90mMzOTl156iVtuuYUhQ4YwcOBAZs2axQ033JDSV/1wHn74YaZMmcKIESPIyclh5syZlJWVpYyZM2cO3/nOdzjttNOoqakhCAL69+/P448/zgMPPMD999/P+PHjmT59Ok8++eQhj5eWlsabb77JzJkzue666ygvL6d79+5ceumlhwzjp06dyhtv7F9YdujQoQAUFhaSn5/f4ud7pExwYIObU1xZWRkdOnSgtLT0mKwC255++/BPiZmAurJdHO2WL81JtmyBtoXnkGjf4iTat7gHtG/xwQRYDS1bGoL0RL5uTKLPuImH541zZd9Y+E6ImOvhux6B56YE6PZhA3Qbt6EPuvFwcbFsBxNyscIeVtg5aBW6A6TZkJYI0pvJ2FvBYMJpmIwoVjQTE83A2EehN4y0iO/77Nixg86dO2NZet1FjhadWyLHhs4tkWND55bIsaFzq/VO5myrtaqrqyksLKRPnz6tCpZPBkuXLuWmm26itLSUSEStfg+nNe8VVahLm6W0bGlrcJ7Q0L4lqHfwU9q3xENzrFosfAw+tvHjIblpFJ5jSLQwP2AyhpjjEnNDxLxwkwC9oQLdxmAnA3QrGZ43LCTqGo+QcXBxMcaK9yR3PUzExQ47zVahG+JtXNLM0eiFbsCLYKVHMRkZ8VYunk5nEREREREREZFT0bPPPkvfvn3p3r07a9euZebMmUyaNElh+jGgBE4OyTS6blxtfuBjRyrwrXh47tuJEN3eH54bn3iAXo9l1QA+tgmSVebx1i3sb93SzGR8yyJwHGJOiJjrEnghME17oCcDdAuwbCzHSiwkGu9/7hkHz3g4OJhEpTuuixVysSIuVshutgrdbWjjYuJhejPrjbaQASeMSUv0Qc/IxISdVvXBEhERERERERGRk1NxcTGzZs2iuLiYrl27MnHiRObOndve0zopKVA/hR0uLD+qUW1gkoH5/vCcRP+VeMsWSAToVoBFPDi3TRCfi9U4PI//cGCW7FsGbIeY4xC4HjHHI7APUYFu4hXo8cpzG+PY2LZLyHh4xsU1Hq7Zf4oYx8a4LlZaPEQ3TjzIb6xhMdGGKnTviKvQ4wE6oTSsaDTeBz3iNdt7XURERERERERETm0zZsxgxowZ7T2NU4IC9VOIZQxBEOAGx3BR0oBEYG7FL0EiOE8uiZoIzanHSulxngjOD6g8j7dxaVp97luGwLbwbRvfdeP9z22XwLiASfY/N8bCxmBhYSV6wBjbiYfjtoXrhPBw8RIhum3s5DGMAbx4eG5HPEzIahKgG/YvJprWpsVELXAi4EXii4lGMzARF8uzD7+piIiIiIiIiIiIHBcK1E8hFoaAti5H6idCcwuwCHzT6GKB3xCcN1zqk+G4RYDVTLsWEtcN7UsOGp47FtgOvuPi2w5YDr5xMRgsy8I2BjsenTcKz+PBubFtjGXh2g2Lh3p4xsEyqYG1cWysiIMV8bDCLsZpGqCHLYiYeBV6+IjbuNjghsFNi7dxyYjGW7h4ttq4iIiIiIiIiIiInKAUqJ9C4jGtDyYGKdH6/p+DwIBvEQSAbwiC/UF5/DGXg9W3x9u0+FjEu6w0hOaN82HTKEVvtmWLZfAtC982YNsEtg3J8DweoFvGYBkLx1gN8TnYBmM1hOcWlu3gWi4uLo5xcI2T7H+e8poYMOF4Gxc7zQPHShljEW/hEkmE52FzhAG6ccCNxAP0SDommo4VsjEhu0nVu4iIiIiIiIiIiJyYvjSB+ty5c/nDH/5AQUEBnuexd+/eZsctXryYhx9+mE8//ZTMzEwmTpzIwoULj+9kT1DGCQhqY/h1AYEPBHajsNyCoGnDbwuSrVhIVJiTWBiUxGMN7Voa39lctXlgDEG8MXp8sVALAssCKxGIG0OAFQ+fLRvfuGBsLMvGMRamYeFQ2yQrzo1jYVtuPDw3Lg5O/NocvFWKceNV6Ha6hwm7KQG6zf4K9EhbWrhY3v4APZyGSYtgQjZWOB76i4iIiIiIiIiIyJfPlyZQr62tZeLEiVx44YX85je/aXbMww8/zEMPPcQvfvELzj//fCorK9m0adPxneiJzI8QVFsE1ZF48xcTD5BpCI1NQCLSbhSEN5MmJ0Pm/f1aTOPQ3IpffMvCtwDbipem2/EN463RDcbYBJYNxgYcAsvBsmysxAibeGDeuPLcsUKJ8NxJhOdOSt/zpnMNsFwbE3awwonFRO394xsWEU0G6EeaddshcNPiIbqXhpUWigfoIQfjKkAXERERERERERE5GXxpAvWf/vSnQLwCvTl79uzhJz/5CS+99BKXXnpp8v5BgwYdj+l9KaSHwa8OcBr/1huKypMBeWpleZBIyoOGMvVEyxY/UW0eWIlmMbaNb8WrzI0x8dAdsBvSdxMPzA3x9i3GcgCDg8GybTDxBT+NZWGseGNy1wnhJirOXePg4mDMIcJpE2AssDw73sYl7GJCbnx/Ca6JV51HTHwRUe9Ism7jxPufO5FEH/QwJuRihZ14CxfXUh90ERERERERERGRk9CXJlA/nBUrVuD7Ptu2baN///6Ul5czYsQIHnroIXr27HnQ7WpqaqipqUneLisrA8D3fXzfP+bzPp7sUAjcWgjbBMSryOOheSIUT6wYGg/RTXMdYBKV5fGfkmE8BovEm8mywbiJti3x4NwYB8u2MMbG2CZZrW4bB9uOV5rbxsbBTiws6mDRfCgdNPR9N2BMALaJ9yIPu9ghF9z9LVxcAyEDYRMQMvHw/IA1RvEPu0KrDU44EaA3XDvx0D55SZ1rEAQEQduWfpUvF9/3CYLgpPubIdLedG6JHBs6t0SODZ1bIseGzq3W02t1ajDG8MILL3DNNde091ROOSdNoP6Pf/wD3/d54IEHePTRR+nQoQM/+clPGD16NOvWrcPzvGa3+/nPf56sfm9s586dVFdXH+tpH1f16Zn4MRs/5CbvawjDG3VvafTI/ptWo/+PV5w3NIaxwNjxNipWvILcWPEVSY1lYVsONjZWwwKiJt4H3drfNyaFn7ikLpqaCM8tMLaJ90B3HXBssG0M8aDcNj5efQ2OBS77Fw+tT1wqD/sKGbBdsL34xXLBduPHtC2MHcPY1fEe6DGgKnGRU57v+5SWlhIEAZalFj8iR4vOLZFjQ+eWyLGhc0vk2NC51Xrl5eXtPQVpo507dzJr1iz+8Ic/sH37djp27MjgwYOZNWsWF110EQBFRUV07NjxuM8tPz+fO+64gzvuuOO4H7vB7bffzpo1a/jwww/p378/BQUFKY9v2rSJPn36NNnuz3/+MxdccEGbj9+ugfpdd93Fgw8+eMgxH3/8MWedddZh9+X7PnV1dTz22GNcdtllAPyf//N/yMvL4/XXX2fMmDHNbnf33Xfzwx/+MHm7rKyMnj17kpubS2ZmZiuezYnPMz5WbRWmqhzLGBr+hyHebqUhILdtjGUnFwfFsgmMEw/RjRNvy2KseEhuLCzLxjU2ViIqd0wiMm/cniU44PpgGhY8tYJG/c9dLM/FuC6W4+CZeK/zEPGq85DZH563iuWltm5xQvEpJCrPLdeKt3DRIqJyGL7vY4whNzdX/4EnchTp3BI5NnRuiRwbOrdEjg2dW60XDofbewrSRuPHj6e2tpZnnnmGvn37sn37dlauXElJSUlyTF5eXjvOsO1qa2sPWgDdElOmTOGdd95h3bp1Bx3z2muv8ZWvfCV5u1OnTkd8vMbaNVD/0Y9+xOTJkw85pm/fvi3aV9euXQEYMGBA8r7c3FxycnLYsmXLQbcLhUKEQqEm91uWddL9oe6U0YmaijpsN4xl4u1YLOMmWrO4gJMI2q145boh8bOVWKjUHLqHeUsdEJqTKHg3ro1xXIzjYDk2Vsgl7NiETDw8DyXC89a3Jzf7q86dUKJ1SyRxUIPxrHjbmIYWLkeUzsupzhhzUv7dEGlvOrdEjg2dWyLHhs4tkWND51br6HX6ctu7dy+rV69m1apVjBw5EoDevXtz3nnnpYw7sOXLW2+9xfe+9z0++eQTzj77bH7yk59w7bXX8sEHHzBkyBBWrVrFJZdcwmuvvcbMmTP56KOPGDJkCE8//TT9+vUDYOPGjfzwhz/k7bffprKykv79+/Pzn/+cr3/96wCMGjWKzZs3c+edd3LnnXcC8dbHs2fPZvny5SmV4gsWLGDBggVs2rQJgMmTJ7N3717OPfdcFi5cSCgUorCwkK1bt/KjH/2IP/7xj1iWxVe/+lUeffRR8vPzD/oaPfbYY0C8kv9QgXqnTp2OyQcP7Rqo5+bmkpube1T21fB1h/Xr19OjRw8Adu/eza5du+jdu/dROcaXXVZmL8pKXcIxK1GNfgwdJDTHgLFtjGNjXBvHcfBcB9d18CyDA3gm3sKl9QuGNgrOG8LzhusGltkfnmsBURERERERERGRU0oQBNQ3Wk/xeHFCoRZlUNFolGg0yvLly7nggguaLQQ+UFlZGWPHjuXKK6/kueeeY/PmzQdtyXLPPffw0EMPkZuby3e/+12mTJnCmjVrAKioqODKK69k7ty5hEIhnn32WcaOHcv69evp1asXy5YtY/Dgwdx8881MmzatVc8fYOXKlWRmZrJixQoA6urqGDNmDBdeeCGrV6/GcRx+9rOfcfnllx+yhXdLXX311VRXV3PmmWcyY8YMrr766jbtr8GXpof6li1b2L17N1u2bCEWiyU/8Tj99NOJRqOceeaZjBs3jh/84Ac8+eSTZGZmcvfdd3PWWWdxySWXtO/kTzYGINhfKd5caA7x8Npx8FwbNxGchzwH17ZwTXzR0CMrBm8Izl2wG4XmTuofGONY8Ytnxavf3fhtERERERERERE5NdXX1PDYtyYc9+Pe/sx/4bagHY/jOCxevJhp06bxxBNPMGzYMEaOHMn111/PoEGDmt3mueeewxjDU089RTgcZsCAAWzbtq3Z0Hvu3LnJyve77rqLq666iurqasLhMIMHD2bw4MHJsffffz8vvPACL774IrfddhvZ2dnYtk1GRsYRVX6np6ezaNGiZFC+ZMkSfN9n0aJFyQ8bnn76abKysli1alWyrXdrRaNRHnroIS666CIsy+L//t//yzXXXMPy5cuPSqj+pQnUZ82axTPPPJO8PXToUABef/11Ro0aBcCzzz7LnXfeyVVXXYVlWYwcOZJXXnkF13Wb2+WpLRGKJ8PvRCC+v3A98VjDfabRZo1YiUvIsXE9G89z8BwHz3PxXBu7TcXfLQvOMQbjmP2huZsI0Nt2cBERERERERERkeNu/PjxXHXVVaxevZq3336bl19+mXnz5rFo0aJm22evX7+eQYMGpfTPP7BFTIPGoXxDC+0dO3bQq1cvKioqmD17Nn/4wx8oKiqivr6eqqqqQ7bTbo2BAwemVJ2vXbuWDRs2kJGRkTKuurqajRs3HvFxcnJyUtbMPPfcc/niiy/4xS9+cWoF6osXL2bx4sWHHJOZmclvfvMbfvOb3xyfSX3JmLDB8nxsAhwMFkGiNzrYjX62CLAb7rdtLNvgJK4t28a2bWzbwkq0bsE+0rYpNtgOWI0uydtuPEA/cL/GxANzr6H63I5fq++5iIiIiIiIiIgchhMKcfsz/9Uux22NcDjM6NGjGT16NPfeey9Tp07lvvvuO+x6lIfTuPC4Ic/zfR+A6dOns2LFCubPn8/pp59OJBJhwoQJ1NbWHnKflmURBEHKfXV1dU3Gpaenp9yuqKhg+PDhLF26tMnYo9UmvMH555+fbDXTVl+aQF3arpNjqCdGJxMPynEsjOVgbCseijs2xrLBtvffd6T9xY19QEjuNgrO3fh9h1vg1DLxwNy1sBJV5zhGPc9FREREREREROSIGGNa1HrlRDNgwACWL1/e7GP9+vVjyZIl1NTUJHuuv/vuu60+xpo1a5g8eTLXXnstEA+8GxYVbeB5HrFYLOW+3NxciouLCYIgmds1XqD0YIYNG8bzzz9P586dyczMbPV8W6OgoCBZkd9WCtRPIW6HDrg5HQmlR7AOGUrH69QxiaboDddYifYv1v77scCymwbnLQy9jWOBbTC2tf9nx4q3cLHV71xERERERERERE4dJSUlTJw4kSlTpjBo0CAyMjJ47733mDdvHuPGjWt2mxtuuIF77rmHm2++mbvuuostW7Ywf/58gFYVpp5xxhksW7aMsWPHYozh3nvvTVavN8jPz+fNN9/k+uuvJxQKkZOTw6hRo9i5cyfz5s1jwoQJvPLKK7z88suHDclvvPFGfvGLXzBu3DjmzJlDjx492Lx5M8uWLWPGjBn06NGj2e02bNhARUUFxcXFVFVVJcP7AQMG4HkezzzzDJ7nJVuGL1u2jH//939n0aJFLX4tDkWB+inEpHeA9BzIzIqH4MkVRBuH50c5xLYSAXkiKN8fmCd+VrW5iIiIiIiIiIgIEF9Q8/zzz+eRRx5h48aN1NXV0bNnT6ZNm8aPf/zjZrfJzMzkpZde4pZbbmHIkCEMHDiQWbNmccMNN6T0VT+chx9+mClTpjBixAhycnKYOXMmZWVlKWPmzJnDd77zHU477TRqamoIgoD+/fvz+OOP88ADD3D//fczfvx4pk+fzpNPPnnI46WlpfHmm28yc+ZMrrvuOsrLy+nevTuXXnrpIcP4qVOn8sYbbyRvNwTnhYWF5OfnA/EFVTdv3ozjOJx11lk8//zzTJhwdBajNcGBDW5OcWVlZXTo0IHS0tJj/lWD461ubzXFnxeR2yEb62gE5ya+oqlJVJjjNFNprt7mcgrwfZ8dO3bQuXNnLEvfrBA5WnRuiRwbOrdEjg2dWyLHhs6t1juZs63Wqq6uprCwkD59+rQqWD4ZLF26lJtuuonS0lIikUh7T+eE15r3iirUT2WWiQfeJvGzMWCZRLeXxM+G+BjLxBcEtWj0s8JyERERERERERGR9vbss8/St29funfvztq1a5k5cyaTJk1SmH4MKFA/hVjpLk7HEG6XKLZjt/d0RERERERERERE5CgoLi5m1qxZFBcX07VrVyZOnMjcuXPbe1onJQXqp5CG1iyqLBcRERERERERETl5zJgxgxkzZrT3NE4Jaj4lIiIiIiIiIiIiItICCtRFRERERERERERERFpAgbqIiIiIiIiIiIiISAsoUBcRERERERERERERaQEF6iIiIiIiIiIiIiIiLaBAXURERERERERERESkBRSoi4iIiIiIiIiIiHyJGGNYvnx5e0/jlKRAXUREREREREREROQEsXPnTm655RZ69epFKBQiLy+PMWPGsGbNmuSYoqIirrjiiuM+t/z8fBYsWHDcj9vY7bffzvDhwwmFQgwZMqTZMUEQMH/+fM4880xCoRDdu3dn7ty5R+X4zlHZi4iIiIiIiIiIiIi02fjx46mtreWZZ56hb9++bN++nZUrV1JSUpIck5eX144zbLva2lo8zzvi7adMmcI777zDunXrmn38Bz/4AX/84x+ZP38+AwcOZPfu3ezevfuIj9eYKtRFRERERERERERETgB79+5l9erVPPjgg1xyySX07t2b8847j7vvvpurr746Oe7Ali9vvfUWQ4YMIRwOc84557B8+XKMMRQUFACwatUqjDGsXLmSc845h7S0NEaMGMH69euT+9i4cSPjxo2jS5cuRKNRzj33XF577bXk46NGjWLz5s3ceeedGGMwxgAwe/bsJpXiCxYsID8/P3l78uTJXHPNNcydO5du3brRr18/ALZu3cqkSZPIysoiOzubcePGsWnTpkO+Ro899hi33norffv2bfbxjz/+mF/96lf893//N1dffTV9+vRh+PDhjB49+pD7bSkF6iIiIiIiIiIiInJKCIIAvzZ23C9BELRoftFolGg0yvLly6mpqWnRNmVlZYwdO5aBAwfy/vvvc//99zNz5sxmx95zzz089NBDvPfeeziOw5QpU5KPVVRUcOWVV7Jy5Uo++OADLr/8csaOHcuWLVsAWLZsGT169GDOnDkUFRVRVFTUovk1WLlyJevXr2fFihX8/ve/p66ujjFjxpCRkcHq1atZs2YN0WiUyy+/nNra2lbtu7GXXnqJvn378vvf/54+ffqQn5/P1KlTj1qFulq+iIiIiIiIiIiIyCkhqPP5YtZbx/243eaMwHj2Ycc5jsPixYuZNm0aTzzxBMOGDWPkyJFcf/31DBo0qNltnnvuOYwxPPXUU4TDYQYMGMC2bduYNm1ak7Fz585l5MiRANx1111cddVVVFdXEw6HGTx4MIMHD06Ovf/++3nhhRd48cUXue2228jOzsa2bTIyMo6o5Ux6ejqLFi1KtnpZsmQJvu+zaNGiZLX7008/TVZWFqtWreKyyy5r9TEA/vGPf7B582Z+97vf8eyzzxKLxbjzzjuZMGECf/rTn45on42pQl1ERERERERERETkBDF+/Hi++OILXnzxRS6//HJWrVrFsGHDWLx4cbPj169fz6BBgwiHw8n7zjvvvGbHNg7lu3btCsCOHTuAeIX69OnT6d+/P1lZWUSjUT7++ONkhXpbDRw4MKVv+tq1a9mwYQMZGRnJyvzs7Gyqq6vZuHHjER/H931qamp49tln+epXv8qoUaP4zW9+w+uvv57S4uZIqUL9AA1fvygrK2vnmRx9vu9TXl5OOBzGsvRZisjRonNL5NjQuSVybOjcEjk2dG6JHBs6t1qvIdNqaYuRU41xLbrNGdEux22NcDjM6NGjGT16NPfeey9Tp07lvvvuY/LkyW2ah+u6++eUqAr3fR+A6dOns2LFCubPn8/pp59OJBJhwoQJh22/YllWk/dbXV1dk3Hp6ekptysqKhg+fDhLly5tMjY3N7dlT6gZXbt2xXEczjzzzOR9/fv3B2DLli3J/u1HSoH6AcrLywHo2bNnO89ERERERERERETkyJSXl9OhQ4f2nsYJxxjTotYrJ5oBAwakLELaWL9+/ViyZAk1NTWEQiEA3n333VYfY82aNUyePJlrr70WiAfeBy4Q6nkesVgs5b7c3FyKi4sJgiAZ0jcshnoow4YN4/nnn6dz585kZma2er4Hc9FFF1FfX8/GjRs57bTTAPj0008B6N27d5v3r0D9AN26dWPr1q1kZGQk3wAni7KyMnr27MnWrVuP6ptU5FSnc0vk2NC5JXJs6NwSOTZ0bokcGzq3Wi8IAsrLy+nWrVt7T0WOQElJCRMnTmTKlCkMGjSIjIwM3nvvPebNm8e4ceOa3eaGG27gnnvu4eabb+auu+5iy5YtzJ8/H6BV+eYZZ5zBsmXLGDt2LMYY7r333mT1eoP8/HzefPNNrr/+ekKhEDk5OYwaNYqdO3cyb948JkyYwCuvvMLLL7982HP2xhtv5Be/+AXjxo1jzpw59OjRg82bN7Ns2TJmzJhBjx49mt1uw4YNVFRUUFxcTFVVVTK8HzBgAJ7n8fWvf51hw4YxZcoUFixYgO/73HrrrYwePTqlav1IKVA/gGVZB/1lnSwyMzP1j5DIMaBzS+TY0Lklcmzo3BI5NnRuiRwbOrdaR5XpX17RaJTzzz+fRx55hI0bN1JXV0fPnj2ZNm0aP/7xj5vdJjMzk5deeolbbrmFIUOGMHDgQGbNmsUNN9yQ0lf9cB5++GGmTJnCiBEjyMnJYebMmU3aYs+ZM4fvfOc7nHbaadTU1BAEAf379+fxxx/ngQce4P7772f8+PFMnz6dJ5988pDHS0tL480332TmzJlcd911lJeX0717dy699NJDnu9Tp07ljTfeSN4eOnQoAIWFheTn52NZFi+99BLf//73ufjii0lPT+eKK67goYceavFrcSgmUEOlU0ZZWRkdOnSgtLRU/wiJHEU6t0SODZ1bIseGzi2RY0PnlsixoXNL2qK6uprCwkL69OnTqmD5ZLB06VJuuukmSktLiUQi7T2dE15r3iuqUBcRERERERERERH5Env22Wfp27cv3bt3Z+3atcycOZNJkyYpTD8GFKifQkKhEPfdd19ycQIROTp0bokcGzq3RI4NnVsix4bOLZFjQ+eWSMsUFxcza9YsiouL6dq1KxMnTmTu3LntPa2Tklq+iIiIiIiIiIiIyEnnVG75Iq3TmveKdZzmJCIiIiIiIiIiIiLypaZAXURERERERERERESkBRSoi4iIiIiIiIiIiIi0gAJ1EREREREREREREZEWUKB+ili4cCH5+fmEw2HOP/98/vKXv7T3lES+VN58803Gjh1Lt27dMMawfPnylMeDIGDWrFl07dqVSCTC17/+dT777LP2mazIl8jPf/5zzj33XDIyMujcuTPXXHMN69evTxlTXV3NrbfeSqdOnYhGo4wfP57t27e304xFvhx+9atfMWjQIDIzM8nMzOTCCy/k5ZdfTj6u80rk6Pjf//t/Y4zhjjvuSN6n80vkyMyePRtjTMrlrLPOSj6uc0tEThQK1E8Bzz//PD/84Q+57777eP/99xk8eDBjxoxhx44d7T01kS+NyspKBg8ezMKFC5t9fN68eTz22GM88cQTvPPOO6SnpzNmzBiqq6uP80xFvlzeeOMNbr31Vt5++21WrFhBXV0dl112GZWVlckxd955Jy+99BK/+93veOONN/jiiy+47rrr2nHWIie+Hj168L//9//mr3/9K++99x5f+9rXGDduHH//+98BnVciR8O7777Lr3/9awYNGpRyv84vkSP3la98haKiouTl//2//5d8TOeWiJwoTBAEQXtPQo6t888/n3PPPZdf/vKXAPi+T8+ePfn+97/PXXfd1c6zE/nyMcbwwgsvcM011wDx6vRu3brxox/9iOnTpwNQWlpKly5dWLx4Mddff307zlbky2Xnzp107tyZN954g4svvpjS0lJyc3N57rnnmDBhAgCffPIJ/fv3589//jMXXHBBO89Y5MsjOzubX/ziF0yYMEHnlUgbVVRUMGzYMB5//HF+9rOfMWTIEBYsWKB/t0TaYPbs2SxfvpyCgoImj+nckiNVXV1NYWEhffr0IRwOt/d0jqoDswlpm9a8V1ShfpKrra3lr3/9K1//+teT91mWxde//nX+/Oc/t+PMRE4ehYWFFBcXp5xnHTp04Pzzz9d5JtJKpaWlQDz4A/jrX/9KXV1dyvl11lln0atXL51fIi0Ui8X47W9/S2VlJRdeeKHOK5Gj4NZbb+Wqq65KOY9A/26JtNVnn31Gt27d6Nu3LzfeeCNbtmwBdG7JqWfnzp3ccsst9OrVi1AoRF5eHmPGjGHNmjXJMUVFRVxxxRXHfW75+fksWLDguB+3sdtvv53hw4cTCoUYMmRIk8ebayFljCE9Pf2oHN85KnuRE9auXbuIxWJ06dIl5f4uXbrwySeftNOsRE4uxcXFAM2eZw2Picjh+b7PHXfcwUUXXcTZZ58NxM8vz/PIyspKGavzS+Tw/va3v3HhhRdSXV1NNBrlhRdeYMCAARQUFOi8EmmD3/72t7z//vu8++67TR7Tv1siR+78889n8eLF9OvXj6KiIn7605/y1a9+lQ8//FDnlpxyxo8fT21tLc888wx9+/Zl+/btrFy5kpKSkuSYvLy8dpxh29XW1uJ53hFvP2XKFN555x3WrVvX5LHp06fz3e9+N+W+Sy+9lHPPPfeIj9eYKtRFRETkhHDrrbfy4Ycf8tvf/ra9pyJyUujXrx8FBQW888473HLLLXzrW9/io48+au9piXypbd26lR/84AcsXbr0pGsdINLerrjiCiZOnMigQYMYM2YM//M//8PevXv5z//8z/aemshxtXfvXlavXs2DDz7IJZdcQu/evTnvvPO4++67ufrqq5PjjDEsX748efutt95iyJAhhMNhzjnnHJYvX44xJtlGadWqVRhjWLlyJeeccw5paWmMGDGC9evXJ/exceNGxo0bR5cuXYhGo5x77rm89tprycdHjRrF5s2bufPOO5NV3xCvCD+wUnzBggXk5+cnb0+ePJlrrrmGuXPn0q1bN/r16wfE/22dNGkSWVlZZGdnM27cODZt2nTI1+ixxx7j1ltvpW/fvs0+Ho1GycvLS162b9/ORx99xLe//e1D7relFKif5HJycrBtu8nK19u3b//Sf5IlcqJoOJd0nokcudtuu43f//73vP766/To0SN5f15eHrW1tezduzdlvM4vkcPzPI/TTz+d4cOH8/Of/5zBgwfz6KOP6rwSaYO//vWv7Nixg2HDhuE4Do7j8MYbb/DYY4/hOA5dunTR+SVylGRlZXHmmWeyYcMG/dslR1UQBNTW1h73S0uXsYxGo0SjUZYvX05NTU2LtikrK2Ps2LEMHDiQ999/n/vvv5+ZM2c2O/aee+7hoYce4r333sNxHKZMmZJ8rKKigiuvvJKVK1fywQcfcPnllzN27Nhk+6Vly5bRo0cP5syZk1w8uDVWrlzJ+vXrWbFiBb///e+pq6tjzJgxZGRksHr1atasWUM0GuXyyy+ntra2Vfs+lEWLFnHmmWfy1a9+9ajsTy1fTnKe5zF8+HBWrlyZXKTA931WrlzJbbfd1r6TEzlJ9OnTh7y8PFauXJn8RLasrCxZESgiBxcEAd///vd54YUXWLVqFX369El5fPjw4biuy8qVKxk/fjwA69evZ8uWLVx44YXtMWWRLy3f96mpqdF5JdIGl156KX/7299S7rvppps466yzmDlzJj179tT5JXKUVFRUsHHjRv7lX/5F/3bJUVVXV8cDDzxw3I/74x//uEUtThzHYfHixUybNo0nnniCYcOGMXLkSK6//noGDRrU7DbPPfccxhieeuopwuEwAwYMYNu2bUybNq3J2Llz5zJy5EgA7rrrLq666iqqq6sJh8MMHjyYwYMHJ8fef//9vPDCC7z44ovcdtttZGdnY9s2GRkZR/RhVnp6OosWLUq+DkuWLMH3fRYtWpSsdn/66afJyspi1apVXHbZZa0+xoGqq6tZunQpd911V5v31UCB+inghz/8Id/61rc455xzOO+881iwYAGVlZXcdNNN7T01kS+NiooKNmzYkLxdWFhIQUEB2dnZ9OrVizvuuIOf/exnnHHGGfTp04d7772Xbt26abVtkcO49dZbee655/jv//5vMjIykj0wO3ToQCQSoUOHDnz729/mhz/8IdnZ2WRmZvL973+fCy+8kAsuuKCdZy9y4rr77ru54oor6NWrF+Xl5Tz33HOsWrWKV199VeeVSBtkZGQk1/lokJ6eTqdOnZL36/wSOTLTp09n7Nix9O7dmy+++IL77rsP27b55je/qX+75JQzfvx4rrrqKlavXs3bb7/Nyy+/zLx581i0aBGTJ09uMn79+vUMGjQopR3Zeeed1+y+G4fyXbt2BWDHjh306tWLiooKZs+ezR/+8AeKioqor6+nqqoqWaHeVgMHDkz5UGHt2rVs2LCBjIyMlHHV1dVs3LjxqBzzhRdeoLy8nG9961tHZX+gQP2U8M///M/s3LmTWbNmUVxczJAhQ3jllVeaLKAoIgf33nvvcckllyRv//CHPwTgW9/6FosXL2bGjBlUVlZy8803s3fvXv7pn/6JV155Rb01RQ7jV7/6FRDvxdfY008/nfwPxUceeQTLshg/fjw1NTWMGTOGxx9//DjPVOTLZceOHfzrv/4rRUVFdOjQgUGDBvHqq68yevRoQOeVyLGk80vkyHz++ed885vfpKSkhNzcXP7pn/6Jt99+m9zcXEDnlhw9ruvy4x//uF2O2xrhcJjRo0czevRo7r33XqZOncp9993XbKB+pPNoqAr3fR+If7C1YsUK5s+fz+mnn04kEmHChAmHbb9iWVaTljZ1dXVNxqWnp6fcrqioYPjw4SxdurTJ2IZzv60WLVrEN77xjaOagypQP0XcdtttavEi0gajRo06ZL8zYwxz5sxhzpw5x3FWIl9+LekjGA6HWbhwIQsXLjwOMxI5OfzmN7855OM6r0SOnlWrVqXc1vklcmQOtzC9zi05WowxLWq9cqIZMGBAyiKkjfXr148lS5ZQU1NDKBQC4N133231MdasWcPkyZO59tprgXjgfeACoZ7nEYvFUu7Lzc2luLiYIAiSIX3DYqiHMmzYMJ5//nk6d+5MZmZmq+d7OIWFhbz++uu8+OKLR3W/WpRURERERERERERE5ARQUlLC1772NZYsWcK6desoLCzkd7/7HfPmzWPcuHHNbnPDDTfg+z4333wzH3/8Ma+++irz588H9leht8QZZ5zBsmXLKCgoYO3atcn9Npafn8+bb77Jtm3b2LVrFxAvQty5cyfz5s1j48aNLFy4kJdffvmwx7vxxhvJyclh3LhxrF69msLCQlatWsXtt9/O559/ftDtNmzYQEFBAcXFxVRVVVFQUEBBQUGTSvp///d/p2vXrlxxxRUtfg1aQoG6iIiIiIiIiIiIyAkgGo1y/vnn88gjj3DxxRdz9tlnc++99zJt2jR++ctfNrtNZmYmL730EgUFBQwZMoR77rmHWbNmAbSqFe3DDz9Mx44dGTFiBGPHjmXMmDEMGzYsZcycOXPYtGkTp512WrItS//+/Xn88cdZuHAhgwcP5i9/+QvTp08/7PHS0tJ488036dWrF9dddx39+/fn29/+NtXV1YesWJ86dSpDhw7l17/+NZ9++ilDhw5l6NChfPHFF8kxvu+zePFiJk+ejG3bLX4NWsIELfmutYiIiIiIiIiIiMiXSHV1NYWFhfTp0+eUW+Ns6dKl3HTTTZSWlhKJRNp7Oie81rxX1ENdRERERERERERE5Evs2WefpW/fvnTv3p21a9cyc+ZMJk2apDD9GFCgLiIiIiIiIiIiIvIlVlxczKxZsyguLqZr165MnDiRuXPntve0Tkpq+SIiIiIiIiIiIiInnVO55Yu0TmveK1qUVERERERERERERESkBRSoi4iIiIiIiIiIiIi0gAJ1ERERETmqJk+ezDXXXNPe0xARERERETnqtCipiIiIiLSYMeaQj9933308+uijaJkeERERERE5GSlQFxEREZEWKyoqSv78/PPPM2vWLNavX5+8LxqNEo1G22NqIiIiIiIix5xavoiIiIhIi+Xl5SUvHTp0wBiTcl80Gm3S8mXUqFF8//vf54477qBjx4506dKFp556isrKSm666SYyMjI4/fTTefnll1OO9eGHH3LFFVcQjUbp0qUL//Iv/8KuXbuO8zMWERERERHZT4G6iIiIiBxzzzzzDDk5OfzlL3/h+9//PrfccgsTJ05kxIgRvP/++1x22WX8y7/8C/v27QNg7969fO1rX2Po0KG89957vPLKK2zfvp1Jkya18zMREREREWl/xhiWL1/e3tM4JSlQFxEREZFjbvDgwfzkJz/hjDPO4O677yYcDpOTk8O0adM444wzmDVrFiUlJaxbtw6AX/7ylwwdOpQHHniAs846i6FDh/Lv//7vvP7663z66aft/GxERERERI6dnTt3csstt9CrVy9CoRB5eXmMGTOGNWvWJMcUFRVxxRVXHPe55efns2DBguN+3MZuv/12hg8fTigUYsiQIc2OefXVV7ngggvIyMggNzeX8ePHs2nTpqNyfAXqIiIiInLMDRo0KPmzbdt06tSJgQMHJu/r0qULADt27ABg7dq1vP7668me7NFolLPOOguAjRs3HseZi4iIiIgcX+PHj+eDDz7gmWee4dNPP+XFF19k1KhRlJSUJMfk5eURCoXacZZtU1tb26btp0yZwj//8z83+1hhYSHjxo3ja1/7GgUFBbz66qvs2rWL6667rk3HbKBAXURERESOOdd1U24bY1LuM8YA4Ps+ABUVFYwdO5aCgoKUy2effcbFF198/CYuIiIiInIc7d27l9WrV/Pggw9yySWX0Lt3b8477zzuvvturr766uS4A1u+vPXWWwwZMoRwOMw555zD8uXLMcZQUFAAwKpVqzDGsHLlSs455xzS0tIYMWIE69evT+5j48aNjBs3ji5duhCNRjn33HN57bXXko+PGjWKzZs3c+edd2KMSf43/OzZs5tUii9YsID8/Pzk7YZ1lubOnUu3bt3o168fAFu3bmXSpElkZWWRnZ3NuHHjDltJ/thjj3HrrbfSt2/fZh//61//SiwW42c/+xmnnXYaw4YNY/r06RQUFFBXV3fIfbeEAnUREREROeEMGzaMv//97+Tn53P66aenXNLT09t7eiIiIiLyJRUEAbHYvuN+CYKgRfNr+Hbm8uXLqampadE2ZWVljB07loEDB/L+++9z//33M3PmzGbH3nPPPTz00EO89957OI7DlClTko9VVFRw5ZVXsnLlSj744AMuv/xyxo4dy5YtWwBYtmwZPXr0YM6cORQVFVFUVNSi+TVYuXIl69evZ8WKFfz+97+nrq6OMWPGkJGRwerVq1mzZg3RaJTLL7+8TRXsw4cPx7Isnn76aWKxGKWlpfzHf/wHX//615sU+hwJp817EBERERE5ym699VaeeuopvvnNbzJjxgyys7PZsGEDv/3tb1m0aBG2bbf3FEVERETkS8j3q1j1xsDDDzzKRo38G7addthxjuOwePFipk2bxhNPPMGwYcMYOXIk119/fUobxcaee+45jDE89dRThMNhBgwYwLZt25g2bVqTsXPnzmXkyJEA3HXXXVx11VVUV1cTDocZPHgwgwcPTo69//77eeGFF3jxxRe57bbbyM7OxrZtMjIyyMvLa/VrkJ6ezqJFi/A8D4AlS5bg+z6LFi1KVrs//fTTZGVlsWrVKi677LJWHwOgT58+/PGPf2TSpEl85zvfIRaLceGFF/I///M/R7S/A6lCXUREREROON26dWPNmjXEYjEuu+wyBg4cyB133EFWVhaWpf+EFREREZGT1/jx4/niiy948cUXufzyy1m1ahXDhg1j8eLFzY5fv349gwYNIhwOJ+8777zzmh3bOJTv2rUrsH8do4qKCqZPn07//v3JysoiGo3y8ccfJyvU22rgwIHJMB3i6yZt2LCBjIyMZGV+dnY21dXVbVo3qbi4mGnTpvGtb32Ld999lzfeeAPP85gwYUKLvylwKKpQFxEREZEjMnnyZCZPntzk/gP/Q3/VqlVNxjTXF/HA/7g944wzWLZsWRtmKCIiIiKSyrIijBr5t3Y5bmuEw2FGjx7N6NGjuffee5k6dSr33Xdfs//93RqHWsdo+vTprFixgvnz53P66acTiUSYMGHCYduvWJbV5L/lm+tVfmDrxoqKCoYPH87SpUubjM3NzW3ZE2rGwoUL6dChA/PmzUvet2TJEnr27Mk777zDBRdccMT7BgXqIiIiIiIiIiIicoowxrSo9cqJZsCAASmLkDbWr18/lixZQk1NDaFQCIB333231cdYs2YNkydP5tprrwXigfeBhTCe5xGLxVLuy83Npbi4mCAIkiF9w2KohzJs2DCef/55OnfuTGZmZqvnezD79u1r8q3WhpaRDR8etIW+LysiIiIiIiIiIiJyAigpKeFrX/saS5YsYd26dRQWFvK73/2OefPmMW7cuGa3ueGGG/B9n5tvvpmPP/6YV199lfnz5wP7q9BbouEbogUFBaxduza538by8/N588032bZtG7t27QJg1KhR7Ny5k3nz5rFx40YWLlzIyy+/fNjj3XjjjeTk5DBu3DhWr15NYWEhq1at4vbbb+fzzz8/6HYbNmygoKCA4uJiqqqqKCgooKCgIFlJf9VVV/Huu+8yZ84cPvvsM95//31uuukmevfuzdChQ1v8ehyMAnURERERERERERGRE0A0GuX888/nkUce4eKLL+bss8/m3nvvZdq0afzyl79sdpvMzExeeuklCgoKGDJkCPfccw+zZs0CSOmrfjgPP/wwHTt2ZMSIEYwdO5YxY8YwbNiwlDFz5sxh06ZNnHbaacm2LP379+fxxx9n4cKFDB48mL/85S9Mnz79sMdLS0vjzTffpFevXlx33XX079+fb3/721RXVx+yYn3q1KkMHTqUX//613z66acMHTqUoUOH8sUXXwDwta99jeeee47ly5czdOhQLr/8ckKhEK+88gqRSOta7zTHBEejE7uIiIiIiIiIiIjICaS6uprCwkL69OnTqmD5ZLB06VJuuukmSktLj0qIfLJrzXtFPdRFREREREREREREvsSeffZZ+vbtS/fu3Vm7di0zZ85k0qRJCtOPAQXqIiIiIiIiIiIiIl9ixcXFzJo1i+LiYrp27crEiROZO3due0/rpKSWLyIiIiIiIiIiInLSOZVbvkjrtOa9okVJRURERERERERERERaQIG6iIiIiIiIiIiIiEgLKFAXEREREREREREREWkBBeoiIiIiIiIiIiIiIi2gQF1EREREREREREREpAUUqIuIiIiIiIiIiIiItIACdREREREREREREZEvEWMMy5cvb+9pnJIUqIuIiIiIiIiIiIicIHbu3Mktt9xCr169CIVC5OXlMWbMGNasWZMcU1RUxBVXXHHc55afn8+CBQuO+3Ebu/322xk+fDihUIghQ4Y0O+Y///M/GTJkCGlpafTu3Ztf/OIXR+34zlHbk4iIiIiIiIiIiIi0yfjx46mtreWZZ56hb9++bN++nZUrV1JSUpIck5eX144zbLva2lo8zzvi7adMmcI777zDunXrmjz28ssvc+ONN/Jv//ZvXHbZZXz88cdMmzaNSCTCbbfd1pZpA6pQFxERERERERERETkh7N27l9WrV/Pggw9yySWX0Lt3b8477zzuvvturr766uS4A1u+vPXWWwwZMoRwOMw555zD8uXLMcZQUFAAwKpVqzDGsHLlSs455xzS0tIYMWIE69evT+5j48aNjBs3ji5duhCNRjn33HN57bXXko+PGjWKzZs3c+edd2KMwRgDwOzZs5tUii9YsID8/Pzk7cmTJ3PNNdcwd+5cunXrRr9+/QDYunUrkyZNIisri+zsbMaNG8emTZsO+Ro99thj3HrrrfTt27fZx//jP/6Da665hu9+97v07duXq666irvvvpsHH3yQIAgOue+WUKAuIiIiIiIiIiIip4QgCKiMxY77paVBbjQaJRqNsnz5cmpqalq0TVlZGWPHjmXgwIG8//773H///cycObPZsffccw8PPfQQ7733Ho7jMGXKlORjFRUVXHnllaxcuZIPPviAyy+/nLFjx7JlyxYAli1bRo8ePZgzZw5FRUUUFRW1aH4NVq5cyfr161mxYgW///3vqaurY8yYMWRkZLB69WrWrFlDNBrl8ssvp7a2tlX7bqympoZwOJxyXyQS4fPPP2fz5s1HvN8GavkiIiIiIiIiIiIip4R9vs9pb/7tuB9348UDSbftw45zHIfFixczbdo0nnjiCYYNG8bIkSO5/vrrGTRoULPbPPfccxhjeOqppwiHwwwYMIBt27Yxbdq0JmPnzp3LyJEjAbjrrru46qqrqK6uJhwOM3jwYAYPHpwce//99/PCCy/w4osvctttt5GdnY1t22RkZBxRy5n09HQWLVqUbPWyZMkSfN9n0aJFyWr3p59+mqysLFatWsVll13W6mMAjBkzhjvvvJPJkydzySWXsGHDBh566CEg3nu+ceX8kVCFuoiIiIiIiIiIiMgJYvz48XzxxRe8+OKLXH755axatYphw4axePHiZsevX7+eQYMGpVRln3feec2ObRzKd+3aFYAdO3YA8Qr16dOn079/f7KysohGo3z88cfJCvW2GjhwYErf9LVr17JhwwYyMjKSlfnZ2dlUV1ezcePGIz7OtGnTuO222/jGN76B53lccMEFXH/99QBYVtvjcFWoi4iIiIiIiIiIyCkhzbLYePHAdjlua4TDYUaPHs3o0aO59957mTp1Kvfddx+TJ09u0zxc103+3FAV7vs+ANOnT2fFihXMnz+f008/nUgkwoQJEw7bfsWyrCYtberq6pqMS09PT7ldUVHB8OHDWbp0aZOxubm5LXtCzTDG8OCDD/LAAw9QXFxMbm4uK1euBDho3/XWUKAuIiIiIiIiIiIipwRjTItar5xoBgwYkLIIaWP9+vVjyZIl1NTUEAqFAHj33XdbfYw1a9YwefJkrr32WiAeeB+4QKjnecRisZT7cnNzKS4uJgiCZEjfsBjqoQwbNoznn3+ezp07k5mZ2er5Ho5t23Tv3h2A//N//g8XXnhhm4L6Bmr5IiIiIiIiIiIiInICKCkp4Wtf+xpLlixh3bp1FBYW8rvf/Y558+Yxbty4Zre54YYb8H2fm2++mY8//phXX32V+fPnA/ur0FvijDPOYNmyZRQUFLB27drkfhvLz8/nzTffZNu2bezatQuAUaNGsXPnTubNm8fGjRtZuHAhL7/88mGPd+ONN5KTk8O4ceNYvXo1hYWFrFq1ittvv53PP//8oNtt2LCBgoICiouLqaqqoqCggIKCgmQl/a5du3jiiSf45JNPKCgo4Ac/+AG/+93vWLBgQYtfi0NRoC4iIiIiIiIiIiJyAohGo5x//vk88sgjXHzxxZx99tnce++9TJs2jV/+8pfNbpOZmclLL71EQUEBQ4YM4Z577mHWrFkAKX3VD+fhhx+mY8eOjBgxgrFjxzJmzBiGDRuWMmbOnDls2rSJ0047LVnt3b9/fx5//HEWLlzI4MGD+ctf/sL06dMPe7y0tDTefPNNevXqxXXXXUf//v359re/TXV19SEr1qdOncrQoUP59a9/zaeffsrQoUMZOnQoX3zxRXLMM888wznnnMNFF13E3//+d1atWnXQvvKtZYIDG9yIiIiIiIiIiIiIfMlVV1dTWFhInz59WhUsnwyWLl3KTTfdRGlpKZFIpL2nc8JrzXtFPdRFREREREREREREvsSeffZZ+vbtS/fu3Vm7di0zZ85k0qRJCtOPAQXqIiIiIiIiIiIiIl9ixcXFzJo1i+LiYrp27crEiROZO3due0/rpKSWLyIiIiIiIiIiInLSOZVbvkjrtOa9okVJRURERERERERERERaQIG6iIiIiIiIiIiInLTUoEMOpzXvEQXqIiIiIiIiIiIictJxXReAffv2tfNM5ETX8B5peM8cihYlFRERERERERERkZOObdtkZWWxY8cOANLS0jDGtPOs5EQSBAH79u1jx44dZGVlYdv2YbfRoqQiIiIiIiIiIiJyUgqCgOLiYvbu3dveU5ETWFZWFnl5eS36wEWBuoiIiIiIiIiIiJzUYrEYdXV17T0NOQG5rtuiyvQGCtRFRERERERERERERFpAi5KKiIiIiIiIiIiIiLSAAnURERERERERERERkRZQoC4iIiIiIiIiIiIi0gIK1EVEREREREREREREWkCBuoiIiIiIiIiIiIhICyhQFxERERERERERERFpAQXqIiIiIiIiIiIiIiItoEBdRERERERERERERKQFFKiLiIiIiIiIiIiIiLSAAnURERERERERERERkRZQoC4iIiIiIiIiIiIi0gIK1EVEREREREREREREWkCBuoiIiIiIiIiIiIhICyhQFxERERERERERERFpAQXqIiIiIiIiIiIiIiItoEBdRERERERERERERKQFFKiLiIiIiIiIiIiIiLSAAnURERERERERERERkRZQoC4iIiIiIiIiIiIi0gIK1EVEREREREREREREWkCBuoiIiIiIiIiIiIhICyhQFxERERERERERERFpAQXqIiIiIiIiIiIiIiItoEBdRERERERERERERKQFFKiLiIiIiIiIiIiIiLSAAnURERERERERERERkRZQoC4iIiIiIiIiIiIi0gIK1EVEREREREREREREWkCBuoiIiIiIiIiIiIhICyhQFxERkcMyxjB79uz2nka7yM/PZ/Lkycnbq1atwhjDqlWr2m1OJ4P/+I//4KyzzsJ1XbKysg46bvLkyUSj0eM3MTkuFi9ejDGGTZs2tfdURERERERaRYG6iIjIUfC3v/2NCRMm0Lt3b8LhMN27d2f06NH827/9W3tPTeSE88knnzB58mROO+00nnrqKZ588sn2ntJRNXv2bIwxh72MGjWqvad6wjvwtUxLS2PAgAH85Cc/oaysrFX72rdvH7Nnz272w7D/+Z//OWU/NBQRERGR1nHaewIiIiJfdm+99RaXXHIJvXr1Ytq0aeTl5bF161befvttHn30Ub7//e+39xTlKLr44oupqqrC87z2nsqX1qpVq/B9n0cffZTTTz+9vadz1F133XUpz6uiooJbbrmFa6+9luuuuy55f5cuXdpjel9Kv/rVr4hGo1RUVPDHP/6RuXPn8qc//Yk1a9ZgjGnRPvbt28dPf/pTgCYfZvzP//wPCxcuVKguIiIiIoelQF1ERKSN5s6dS4cOHXj33XebtK7YsWNH+0zqBFZZWUl6enp7T+OIWZZFOBxu72l8qTWcF4dq9fJlNmjQIAYNGpS8vWvXLm655RYGDRrE//pf/6sdZ3bsHOvzesKECeTk5ADw3e9+l/Hjx7Ns2TLefvttLrzwwmN23LYIgoDq6moikUh7T0VEREREjiK1fBEREWmjjRs38pWvfKXZcLBz585N7luyZAnDhw8nEomQnZ3N9ddfz9atW5uMe+edd7jyyivp2LEj6enpDBo0iEcffTRlzJ/+9Ce++tWvkp6eTlZWFuPGjePjjz9OGdPQMmHDhg1MnjyZrKwsOnTowE033cS+fftSxtbU1HDnnXeSm5tLRkYGV199NZ9//nmTuW3evJnvfe979OvXj0gkQqdOnZg4cWKTfsgNfZLfeOMNvve979G5c2d69OjB66+/jjGGF154ocm+n3vuOYwx/PnPf27y2IH7/X//7/9x++23k5ubS1ZWFt/5zneora1l7969/Ou//isdO3akY8eOzJgxgyAIUvYxf/58RowYQadOnYhEIgwfPpz/+q//OugxGxysh/rChQvp27cvkUiE8847j9WrVzNq1KiUStiGbf/zP/+TuXPn0qNHD8LhMJdeeikbNmxI2d/q1auZOHEivXr1IhQK0bNnT+68806qqqpSxjX0GN+2bRvXXHMN0WiU3Nxcpk+fTiwWSxnbUBU+cOBAwuEwubm5XH755bz33nsAjBw5ksGDBzf7vPv168eYMWMO+/o8/vjjfOUrXyEUCtGtWzduvfVW9u7dm3w8Pz+f++67D4Dc3NwW9+f/xz/+wZgxY0hPT6dbt27MmTOnye+0srKSH/3oR/Ts2ZNQKES/fv2YP39+k3HGGG677TaWL1/O2WefTSgU4itf+QqvvPJKk+Nu27aNKVOm0KVLl+S4f//3fz/sfFvik08+YcKECWRnZxMOhznnnHN48cUXU8a09b2+adMmjDHMnz+fRx55hN69exOJRBg5ciQffvhhkzm15m/KRx99xA033EDHjh35p3/6JwDWrVvH5MmT6du3L+FwmLy8PKZMmUJJSclRec0afO1rXwOgsLCQ2tpaZs2axfDhw+nQoQPp6el89atf5fXXX095HXJzcwH46U9/mmwhM3v2bCZPnszChQsBUtrLNPB9nwULFvCVr3yFcDhMly5d+M53vsOePXtS5pSfn883vvENXn31Vc455xwikQi//vWvW3Xef/bZZ4wfP568vDzC4TA9evTg+uuvp7S09Ki+fiIiIiJy5FShLiIi0ka9e/fmz3/+Mx9++CFnn332IcfOnTuXe++9l0mTJjF16lR27tzJv/3bv3HxxRfzwQcfJEP5FStW8I1vfIOuXbvygx/8gLy8PD7++GN+//vf84Mf/ACA1157jSuuuIK+ffsye/Zsqqqq+Ld/+zcuuugi3n//ffLz81OOPWnSJPr06cPPf/5z3n//fRYtWkTnzp158MEHk2OmTp3KkiVLuOGGGxgxYgR/+tOfuOqqq5o8j3fffZe33nqL66+/nh49erBp0yZ+9atfMWrUKD766CPS0tJSxn/ve98jNzeXWbNmUVlZyahRo+jZsydLly7l2muvTRm7dOlSTjvttBZVnX7/+98nLy+Pn/70p7z99ts8+eSTZGVl8dZbb9GrVy8eeOAB/n/23jxAiupe+3/OqapeZmWbEUQEwSVyFXDfYtzFyCUuqK/RG0UNblEvrrjiikbUqEk0JuJFveC9vl6RLMQ98SfXLeaNYjSRRAIYkWUYmL27lnPO749TVV3V3bPvw/eTtFV16tTSPV09zKe+/Zzf/va3eOCBB7DPPvvgvPPOC7d99NFH8Z3vfAfnnnsuHMfBf//3f+PMM8/Eb37zm6LPuS1+9rOf4YorrsCRRx6Jq6++GuvWrcOpp56K4cOHY5dddino/8Mf/hCcc1x33XWor6/HwoULce655+KDDz4I+7zwwgtoaWnBZZddhpEjR+IPf/gDfvKTn+Crr77CCy+8ENufEALTp0/HIYccggcffBBvvPEGHnroIUyaNAmXXXZZ2O+iiy7C008/jW9/+9v4/ve/D8/zsHLlSrz//vs48MAD8b3vfQ9z5swpeC9/+OGH+Nvf/oZbb721zdfhjjvuwJ133onjjz8el112GVavXo2f/exn+PDDD/HOO+/Asiw88sgjePbZZ/HSSy+FMR7Rau5iCCFw0kkn4dBDD8XChQvxyiuv4Pbbb4fnebjrrrsA6Grg73znO/j973+Piy66CNOmTcOrr76K66+/Hhs2bMDDDz8c2+f//u//YtmyZbj88stRXl6OH//4x5g1axa+/PJLjBw5EgCwefNmHHrooaGAr6qqwssvv4yLLroIDQ0NmDt3bpvn3RafffYZjjjiCIwdOxY33ngjSktL8X//7//FqaeeihdffLHguujOex0Ann32WTQ2NuIHP/gBstksHn30URx77LH485//HEbPdPYz5cwzz8Qee+yBe++9N5T4r7/+Ov7xj3/gggsuwOjRo/HZZ5/hF7/4BT777DO8//77HY5naY81a9YAAEaOHImGhgYsWrQI3/3udzFnzhw0NjbiqaeewvTp0/GHP/wB06ZNQ1VVFX72s58VRO9MmTIFzc3N+Prrr/H666/jP//zPwuOdckll+Dpp5/GBRdcgKuuugpr167FT3/6U3z00Ufh+zpg9erV+O53v4tLLrkEc+bMwV577RWua++6dxwH06dPh23b4c97w4YN+M1vfoO6ujpUVlb2yGtHEARBEARBdBNFEARBEES3eO2115RhGMowDHXYYYepG264Qb366qvKcZxYv3Xr1inDMNSCBQti7X/+85+VaZphu+d5arfddlPjx49X27dvj/WVUobz06ZNU9XV1aq2tjZsW7VqleKcq/POOy9su/322xUAdeGFF8b2ddppp6mRI0eGyx9//LECoC6//PJYv3POOUcBULfffnvY1tLSUvA6vPfeewqAevbZZ8O2xYsXKwDqm9/8pvI8L9b/pptuUslkUtXV1YVtW7ZsUaZpxo5VjGC/06dPj70mhx12mGKMqUsvvTRs8zxP7bLLLuqoo46K7SP/OTiOo/bZZx917LHHxtrHjx+vzj///HD597//vQKgfv/73yullLJtW40cOVIddNBBynXdsN/TTz+tAMSOG2y79957K9u2w/ZHH31UAVB//vOfWz0/pZS67777FGNMrV+/Pmw7//zzFQB11113xfrut99+6oADDgiXf/e73ykA6qqrrirYb/Aa1tXVqVQqpebNmxdbf9VVV6nS0lLV1NRUsG3Ali1bVCKRUCeeeKISQoTtP/3pTxUA9R//8R9hW/CerKmpaXV/+c/vyiuvjJ3vjBkzVCKRCPexfPlyBUDdc889se3POOMMxRhTX3zxRdgGQCUSiVjbqlWrFAD1k5/8JGy76KKL1JgxY9TWrVtj+zz77LNVZWVl0Z9RMWpqagquoeOOO07tu+++KpvNxp7X4YcfrvbYY4+wrbvv9bVr1yoAKp1Oq6+++ips/+CDDxQAdfXVV4dtnf1M+e53v1vwXIu9Jv/1X/+lAKi333674HmtXbu22EtWcKzVq1ermpoatXbtWvXzn/9cJZNJtdNOO6nm5mbleV7selJKqe3bt6uddtop9rlX7OcQ8IMf/EAV+9No5cqVCoBaunRprP2VV14paB8/frwCoF555ZVY345e9x999JECoF544YU2XxOCIAiCIAiif6HIF4IgCILoJieccALee+89fOc738GqVauwcOFCTJ8+HWPHjo3FNyxbtgxSSpx11lnYunVr+Bg9ejT22GOPMJ7go48+wtq1azF37tyCGJmgunPjxo34+OOPMXv2bIwYMSJcP2XKFJxwwgn47W9/W3Cel156aWz5yCOPRG1tLRoaGgAg3Oaqq66K9StWhRvNBHZdF7W1tdh9990xbNgw/OlPfyroP2fOHBiGEWs777zzYNt2LGbl+eefh+d5Hc6Zvuiii2IVr4cccgiUUrjooovCNsMwcOCBB+If//hHq89h+/btqK+vx5FHHln0/Nvij3/8I2prazFnzhyYZu7Lf+eeey6GDx9edJsLLrggNqjpkUceCQCxc4yeX3NzM7Zu3YrDDz8cSil89NFHBfss9vON7u/FF18EYyyMW4kSvIaVlZU45ZRT8F//9V9hxbEQAs8//zxOPfXUNjOy33jjDTiOg7lz54Lz3D8x58yZg4qKCqxYsaLVbTvCFVdcETvfK664Ao7j4I033gCg37+GYRS8f6+99loopfDyyy/H2o8//nhMmjQpXJ4yZQoqKirC10wphRdffBEzZ86EUip2zU6fPh319fWdfq8EbNu2Db/73e9w1llnobGxMdxvbW0tpk+fjr///e/YsGFDbJvuvNcB4NRTT8XYsWPD5YMPPhiHHHJIeN33xGcKEH/fZrNZbN26FYceeigAdPn1AnTkUFVVFXbbbTdccskl2H333bFixQqUlJTAMIzwepJSYtu2bfA8DwceeGC3jgnob4pUVlbihBNOiL0HDjjgAJSVlcViZQBgt912azUaqb3rPqhAf/XVVwviuAiCIAiCIIiBAwl1giAIgugBDjroICxbtgzbt2/HH/7wB9x0001obGzEGWecgb/85S8AdDauUgp77LEHqqqqYo+//vWv4UCNQZRBW/Ex69evB4BYnEDA3nvvja1bt6K5uTnWvuuuu8aWA9kb5ACvX78enPOYZGztGJlMBvPnzw+zqkeNGoWqqirU1dUVzfrdbbfdCtq+8Y1v4KCDDsLSpUvDtqVLl+LQQw/F7rvvXvR555P/nAIhNW7cuIL2/Lzj3/zmNzj00EORSqUwYsSIMBKis1nFwc8i/5xN0yyIyGjtvPN/FgDw5ZdfhnIzyEU/6qijAKDgHIM89Px9Rve3Zs0a7LzzzjFZWozzzjsPX375JVauXAlAi/LNmzfje9/7XpvbtfaeTCQSmDhxYri+K3DOMXHixFjbnnvuCQBhbv/69eux8847o7y8PNZv7733jp1fQP7PAIi/ZjU1Nairq8MvfvGLguv1ggsuAND1QYe/+OILKKVw2223Few7uOGRv+/uvNcBYI899iho23PPPWOvH9C5z5Ri1/W2bdvw7//+79hpp52QTqdDCQ4Uvm87w4svvojXX38db731Fr744gt8+umnOOCAA8L1zzzzDKZMmYJUKoWRI0eiqqoKK1as6Hb2+N///nfU19ejurq64GfV1NRU8HMq9poEtHfd77bbbrjmmmuwaNEijBo1CtOnT8djjz1G+ekEQRAEQRADDMpQJwiCIIgeJJFI4KCDDsJBBx2EPffcExdccAFeeOEF3H777ZBSgjGGl19+uaBaGwDKysp69dyKHRNAwYCNHeHKK6/E4sWLMXfuXBx22GGorKwEYwxnn302pJQF/aNVq1HOO+88/Pu//zu++uor2LaN999/Hz/96U87fB6tPadi7dHnuXLlSnznO9/Bt771LTz++OMYM2YMLMvC4sWL8dxzz3X4+F2lvZ+FEAInnHACtm3bhnnz5uEb3/gGSktLsWHDBsyePbvgNW5tf11h+vTp2GmnnbBkyRJ861vfwpIlSzB69Ggcf/zxPXaMgUB7P4PgNf63f/s3nH/++UX7tpf93hrBvq+77rpWq5nzb9B09b3emxS7rs866yy8++67uP766zFt2jSUlZVBSomTTjqp6GdDR/nWt76FUaNGFV23ZMkSzJ49G6eeeiquv/56VFdXwzAM3HfffeENyq4ipUR1dXXsxl+U/BtZrX3WAR37DH7ooYcwe/Zs/PKXv8Rrr72Gq666Cvfddx/ef//9ouMxEARBEARBEH0PCXWCIAiC6CUOPPBAADpKAQAmTZoEpRR22223sLq2GEGF+KefftqqxBw/fjwAPQBePp9//jlGjRrVZjxHa/uUUmLNmjWxKtVix/if//kfnH/++XjooYfCtmw2i7q6uk4d8+yzz8Y111yD//qv/0Imk4FlWfg//+f/dGofXeHFF19EKpXCq6++imQyGbYvXry40/sKfhZffPEFjjnmmLDd8zysW7euS9L1z3/+M/72t7/hmWeeiQ0u+frrr3d6XwGTJk3Cq6++im3btrVZpW4YBs455xw8/fTTuP/++7F8+fKikT35RN+T0Wpyx3Gwdu3abgl5KSX+8Y9/xK6bv/3tbwAQfgtg/PjxeOONN9DY2BirUv/8889j59dRqqqqUF5eDiFEj99MCF4fy7L67EbF3//+94K2v/3tb7HXD+jeZ8r27dvx5ptv4s4778T8+fPbPHZP8j//8z+YOHEili1bFovFyY83amtA1NbWTZo0CW+88QaOOOKINmV5T7Lvvvti3333xa233op3330XRxxxBJ544gncc889fXJ8giAIgiAIom0o8oUgCIIgusnvf//7ohWhQeZwIKdPP/10GIaBO++8s6C/Ugq1tbUAgP333x+77bYbHnnkkQJBHWw3ZswYTJs2Dc8880ysz6efforXXnsNJ598cqefx7e//W0AwI9//ONY+yOPPFLQ1zCMgufwk5/8BEKITh1z1KhR+Pa3v40lS5Zg6dKlOOmkk1qtQu1JDMMAYyx2vuvWrcPy5cs7va8DDzwQI0eOxJNPPgnP88L2pUuXFo3e6Oj5AfHKVaUUHn300S7tDwBmzZoFpRTuvPPOgnX5P8vvfe972L59Oy655BI0NTV1KNP++OOPRyKRwI9//OPY/p566inU19djxowZXT53ALFvLiil8NOf/hSWZeG4444DAJx88skQQhR8w+Hhhx8GYyx8f3cUwzAwa9YsvPjii/j0008L1tfU1HThWWiqq6tx9NFH4+c//3l4w62n9t0ay5cvj+Wy/+EPf8AHH3wQvi498ZlS7H0LFP8M6UmKHfeDDz7Ae++9F+tXUlICAEVv/AU3C/LXnXXWWRBC4O677y7YxvO8Tt9EbIuGhobYZwig5TrnHLZt99hxCIIgCIIgiO5BFeoEQRAE0U2uvPJKtLS04LTTTsM3vvENOI6Dd999F88//zwmTJgQ5i1PmjQJ99xzD2666SasW7cOp556KsrLy7F27Vq89NJLuPjii3HdddeBc46f/exnmDlzJqZNm4YLLrgAY8aMweeff47PPvsMr776KgDggQcewLe//W0cdthhuOiii5DJZPCTn/wElZWVuOOOOzr9PKZNm4bvfve7ePzxx1FfX4/DDz8cb775Jr744ouCvv/6r/+K//zP/0RlZSUmT56M9957D2+88QZGjhzZ6eOed955OOOMMwCgqLTqDWbMmIEf/ehHOOmkk3DOOedgy5YteOyxx7D77rvjk08+6dS+EokE7rjjDlx55ZU49thjcdZZZ2HdunV4+umnMWnSpDarYlvjG9/4BiZNmoTrrrsOGzZsQEVFBV588cUuC3oAOOaYY/C9730PP/7xj/H3v/89jOBYuXIljjnmmNign/vttx/22WcfvPDCC9h7772x//77t7v/qqoq3HTTTbjzzjtx0kkn4Tvf+Q5Wr16Nxx9/HAcddFCHB5otRiqVwiuvvILzzz8fhxxyCF5++WWsWLECN998cxi5MXPmTBxzzDG45ZZbsG7dOkydOhWvvfYafvnLX2Lu3LkFYwN0hB/+8If4/e9/j0MOOQRz5szB5MmTsW3bNvzpT3/CG2+8gW3btnX5OT322GP45je/iX333Rdz5szBxIkTsXnzZrz33nv46quvsGrVqi7vuxi77747vvnNb+Kyyy6Dbdt45JFHMHLkSNxwww1hn+5+plRUVOBb3/oWFi5cCNd1MXbsWLz22mtYu3Ztjz6XfP71X/8Vy5Ytw2mnnYYZM2Zg7dq1eOKJJzB58mQ0NTWF/dLpNCZPnoznn38ee+65J0aMGIF99tkH++yzT5jHftVVV2H69OkwDANnn302jjrqKFxyySW477778PHHH+PEE0+EZVn4+9//jhdeeAGPPvpo+PnVXX73u9/hiiuuwJlnnok999wTnufhP//zP8ObOwRBEARBEMTAgIQ6QRAEQXSTBx98EC+88AJ++9vf4he/+AUcx8Guu+6Kyy+/HLfeeiuGDRsW9r3xxhux55574uGHHw4rhceNG4cTTzwR3/nOd8J+06dPx+9//3vceeedeOihhyClxKRJkzBnzpywz/HHH49XXnkFt99+O+bPnw/LsnDUUUfh/vvvb3NgvLb4j//4D1RVVWHp0qVYvnw5jj32WKxYsaJg4MNHH30UhmFg6dKlyGazOOKII/DGG2+0mgfdFjNnzsTw4cMhpYy9Br3Jsccei6eeego//OEPMXfuXOy22264//77sW7duk4LdQC44ooroJTCQw89hOuuuw5Tp07Fr371K1x11VVIpVKd3p9lWfj1r38d5ienUimcdtppuOKKKzB16tRO7y9g8eLFmDJlCp566ilcf/31qKysxIEHHojDDz+8oO95552HG264od3BSKPccccdqKqqwk9/+lNcffXVGDFiBC6++GLce++9sCyry+dtGAZeeeUVXHbZZbj++utRXl4evu8DOOf41a9+hfnz5+P555/H4sWLMWHCBDzwwAO49tpru3TcnXbaCX/4wx9w1113YdmyZXj88ccxcuRI/Mu//Avuv//+Lj8fAJg8eTL++Mc/4s4778TTTz+N2tpaVFdXY7/99os9r57ivPPOA+ccjzzyCLZs2YKDDz4YP/3pTzFmzJiwT098pjz33HO48sor8dhjj0EphRNPPBEvv/wydt555x5/TgGzZ8/Gpk2b8POf/xyvvvoqJk+ejCVLluCFF17AW2+9Feu7aNEiXHnllbj66qvhOA5uv/127LPPPjj99NNx5ZVX4r//+7+xZMkSKKVw9tlnAwCeeOIJHHDAAfj5z3+Om2++ORxw+N/+7d9wxBFH9NjzmDp1KqZPn45f//rX2LBhA0pKSjB16lS8/PLLOPTQQ3vsOARBEARBEET3YKqvRi0iCIIgCIIogud52HnnnTFz5kw89dRT/X06PYaUElVVVTj99NPx5JNP9vfpdJpHH30UV199NdatW4ddd921v0+H6CLr1q3DbrvthgceeADXXXddf58OQRAEQRAEQQx6KEOdIAiCIIh+Zfny5aipqYkNvjnYyGazBbnRzz77LLZt24ajjz66f06qGyil8NRTT+Goo44imU4QBEEQBEEQBBGBIl8IgiAIgugXPvjgA3zyySe4++67sd9+++Goo47q71PqMu+//z6uvvpqnHnmmRg5ciT+9Kc/4amnnsI+++yDM888s79Pr8M0NzfjV7/6FX7/+9/jz3/+M375y1/29ykRBEEQBEEQBEEMKEioEwRBEATRL/zsZz/DkiVLMG3aNDz99NP9fTrdYsKECRg3bhx+/OMfY9u2bRgxYgTOO+88/PCHP0Qikejv0+swNTU1OOecczBs2DDcfPPNfZZpTxAEQRAEQRAEMVigDHWCIAiCIAiCIAiCIAiCIAiC6ACUoU4QBEEQBEEQBEEQBEEQBEEQHYCEOkEQBEEQBEEQBEEQBEEQBEF0AMpQz0NKia+//hrl5eVgjPX36RAEQRAEQRAEQRAEQRBEh1FKobGxETvvvDM4p1paguhpSKjn8fXXX2PcuHH9fRoEQRAEQRAEQRAEQRAE0WX++c9/Ypdddunv0yCIIQcJ9TzKy8sB6A+dioqKfj6bnkVKiZqaGlRVVdEdSoLoQejaIojega4tgugd6NoiiN6Bri2C6B3o2uo8DQ0NGDduXOi4CILoWUio5xHEvFRUVAxJoZ7NZlFRUUG/hAiiB6FriyB6B7q2CKJ3oGuLIHoHurYIonega6vrUJQxQfQO9ElEEARBEARBEARBEARBEARBEB2AhDpBEARBEARBEARBEARBEARBdAAS6gRBEARBEARBEARBEARBEATRAShDnSAIgiAIgiAIgiAIgiCIIY0QAq7r9vdpEAMQy7JgGEaH+5NQJwiCIAiCIAiCIAiCIAhiSKKUwqZNm1BXV9ffp0IMYIYNG4bRo0d3aDBfEuoEQRAEQRAEQRAEQRAEQQxJApleXV2NkpKSDglTYsdBKYWWlhZs2bIFADBmzJh2tyGhThAEQRAEQRAEQRAEQRDEkEMIEcr0kSNH9vfpEAOUdDoNANiyZQuqq6vbjX+hQUkJgiAIgiAIgiAIgiAIghhyBJnpJSUl/XwmxEAneI90JGefhDpBEARBEARBEARBEARBEEMWinkh2qMz7xES6gRBEARBEARBEARBEARBEATRAUioEwRBEARBEARBEARBEARBDCIYY1i+fHl/n8YOCQl1giAIgiAIgiAIgiAIgiCIAUJNTQ0uu+wy7Lrrrkgmkxg9ejSmT5+Od955J+yzceNGfPvb3+7zc5swYQIeeeSRPj9ulC+//BIzZsxASUkJqqurcf3118PzvD47vtlnRyIIgiAIgiAIgiAIgiAIgiDaZNasWXAcB8888wwmTpyIzZs3480330RtbW3YZ/To0f14ht3HcRwkEolObyeEwIwZMzB69Gi8++672LhxI8477zxYloV77723F860EKpQJwiCIAiCIAiCIIg8lFRQQkF5Uj9cAekISFtAZj3IjAfZ4kI0uxBNDkSjA5lxIRociAYbol4/vHobXp0Nry4Lb7v/2OY/ajO5x9YM3K0ZuDUtuceWLjxqOvHYqo/r1WZy57Q9q8+1Tp+7qLf182nQz1E0Ovr5Njn6uTe7kC3+I+Pp18bWr5Vy/ddOSP16KtXfP1aCIIgBT11dHVauXIn7778fxxxzDMaPH4+DDz4YN910E77zne+E/fIjX959911MmzYNqVQKBx54IJYvXw7GGD7++GMAwFtvvQXGGN58800ceOCBKCkpweGHH47Vq1eH+1izZg1OOeUU7LTTTigrK8NBBx2EN954I1x/9NFHY/369bj66qvBGAsH8rzjjjswbdq02PN45JFHMGHChHB59uzZOPXUU7FgwQLsvPPO2GuvvQAA//znP3HWWWdh2LBhGDFiBE455RSsW7eu1dfntddew1/+8hcsWbIE06ZNw7e//W3cfffdeOyxx+A4Tidf7a5BFeoEQRAEQRAEQRDEoERJBSgASgFKQUl/XiqooF1Ci1x/Xvfzt0Owrb8vILe/TiKVhGj2IEwbig2e2rU+V9yMAUxPGUM4H28LlgvbGGcAj/ZnulSQMb2OIAiiHZRSyLiiz4+btoxQQLdFWVkZysrKsHz5chx66KFIJpPtbtPQ0ICZM2fi5JNPxnPPPYf169dj7ty5RfvecssteOihh1BVVYVLL70UF154YRgl09TUhJNPPhkLFixAMpnEs88+i5kzZ2L16tXYddddsWzZMkydOhUXX3wx5syZ06nnDwBvvvkmKioq8PrrrwMAXNfF9OnTcdhhh2HlypUwTRP33HMPTjrpJHzyySdFK9jfe+897Lvvvthpp53CtunTp+Oyyy7DZ599hv3226/T59VZSKgTBEEQBEEQBEEQfY6W2r7wDud92R1IcOGLcgUg6KPyRDoxuFDBzQxVVOZ3+yfKtHBnDKF4Zywi4XlE0Ef7cZLzBLGjkHEFJs9/tc+P+5e7pqMk0b6KNU0TTz/9NObMmYMnnngC+++/P4466iicffbZmDJlStFtnnvuOTDG8OSTTyKVSmHy5MnYsGFDUem9YMECHHXUUQCAG2+8ETNmzEA2m0UqlcLUqVMxderUsO/dd9+Nl156Cb/61a9wxRVXYMSIETAMA+Xl5V2KnCktLcWiRYtCUb5kyRJIKbFo0aLwZsPixYsxbNgwvPXWWzjxxBML9rFp06aYTAcQLm/atKnT59QVSKgTBEEQBEEQBEEQXUL5ElyLcESEeKRiPFiv4v1IhhO9gn8jJvru6tI7rUhFPOMsJ+J98d6qlOesQ5WoBEEQxZg1axZmzJiBlStX4v3338fLL7+MhQsXYtGiRZg9e3ZB/9WrV2PKlClIpVJh28EHH1x031EpP2bMGADAli1bsOuuu6KpqQl33HEHVqxYgY0bN8LzPGQyGXz55Zc98rz23XffWNX5qlWr8MUXX6C8vDzWL5vNYs2aNT1yzN6AhDpBEARBEARBEAQBAFBCxaR4bNrKOoIYkuRHAaELYj4q30PZXkTI87zKeE4V8gTRm6QtA3+5a3q/HLczpFIpnHDCCTjhhBNw22234fvf/z5uv/32okK9M1iWFc4HN/6klACA6667Dq+//joefPBB7L777kin0zjjjDPazSbnnBeMk+G6bkG/0tLS2HJTUxMOOOAALF26tKBvVVVV0WONHj0af/jDH2JtmzdvDtf1BSTUCYIgCIIgCIIghiiBCNdTWSDIw2VBESoE0eME1fJ+VHOnry7OilfIG3nxNAbzZTzikp4giKIwxjoUvTLQmDx5cmwQ0ih77bUXlixZAtu2w8z1Dz/8sNPHeOeddzB79mycdtppALTwzh8gNJFIQIh4Bn1VVRU2bdoEpVQo6YPBUNti//33x/PPP4/q6mpUVFR06BwPO+wwLFiwAFu2bEF1dTUA4PXXX0dFRQUmT57coX10l8EzUkoHWbFiBQ455BCk02kMHz4cp556an+fEkEQBEEQBEEQRI+hhIJyBaTtQba4EE0ORL0Nb1sW3tYM3C0tcDc1w9nQBPfrJribm+HVtMDbloWosyEaHMgmFzLjQdkCypUUwUIQAxGpoDwJ5QgoW0Bm9DUvGx2IBltfz9v1de/VtMDdrK999+smOBua4HzdpJe3tMCtaYFXm4G3PQuvXn8OiCZH7y/rQdoC0hH6eEIVVJoSBNF31NbW4thjj8WSJUvwySefYO3atXjhhRewcOFCnHLKKUW3OeeccyClxMUXX4y//vWvePXVV/Hggw8CQKfip/bYYw8sW7YMH3/8MVatWhXuN8qECRPw9ttvY8OGDdi6dSsA4Oijj0ZNTQ0WLlyINWvW4LHHHsPLL7/c7vHOPfdcjBo1CqeccgpWrlyJtWvX4q233sJVV12Fr776qug2J554IiZPnozvfe97WLVqFV599VXceuut+MEPftChAVx7gsF3O6YNXnzxRcyZMwf33nsvjj32WHieh08//bS/T4sgCIIgCIIgCKJNYpXiQSW50Mu56nKQ+CYIomP0dGRNRwZxDeZZbgDYcFBYgiA6TFlZGQ455BA8/PDDWLNmDVzXxbhx4zBnzhzcfPPNRbepqKjAr3/9a1x22WWYNm0a9t13X8yfPx/nnHNOLFe9PX70ox/hwgsvxOGHH45Ro0Zh3rx5aGhoiPW56667cMkll2DSpEmwbRtKKey99954/PHHce+99+Luu+/GrFmzcN111+EXv/hFm8crKSnB22+/jXnz5uH0009HY2Mjxo4di+OOO67VinXDMPCb3/wGl112GQ477DCUlpbi/PPPx1133dXh59ldmBoitx09z8OECRNw55134qKLLuryfhoaGlBZWYn6+voOf9VgsCClDL8OwfmQ+3ICQfQbdG0RRO9A1xZB9A50bfUtOpPcr/gUrUtzkuSDH6kkauq3oapyBDija4sgQqIDvLL85SIiPm+dVAo1W2v07y2D+x1AsTZtMJTdVmfJZrNYu3Ytdtttt06J5aHA0qVLccEFF6C+vh7pdLq/T2fA05n3ypCpUP/Tn/6EDRs2gHOO/fbbD5s2bcK0adPwwAMPYJ999unv0yMIgiAIgiAIYggRVo0HQlwoKClzglySKCcIggBQtFoe6HjFvFQSXr0NVzUX3qxiOUnPfBmPoCI+qI5n8X7wXT0MDqPUAkEMFZ599llMnDgRY8eOxapVqzBv3jycddZZJNN7gSEj1P/xj38AAO644w786Ec/woQJE/DQQw/h6KOPxt/+9jeMGDGi6Ha2bcO27XA5+BqDlLIgI2iwI6WEUmrIPS+C6G/o2iKI3oGuLYLoHejaahulIlXjgTAP41gkVZQTrSKVf20purYIoidp89rqxkcxszhY2uj6DgYw9Dt+x2TTpk2YP38+Nm3ahDFjxuDMM8/EggUL+vu0hiQDXqjfeOONuP/++9vs89e//jX8sLjlllswa9YsAMDixYuxyy674IUXXsAll1xSdNv77rsPd955Z0F7TU0NstlsN89+YCGlRH19PZRS9PVeguhB6NoiiN6Bri2C6B125GtLRavGA0kemer5/j5LYrCilER9SxMABUaRLwTRY/TWtcVMBhPNPba/gURjY2N/nwLRD9xwww244YYb+vs0dggGvFC/9tprMXv27Db7TJw4ERs3bgQATJ48OWxPJpOYOHEivvzyy1a3vemmm3DNNdeEyw0NDRg3bhyqqqqGXM6UlBKMMVRVVe1wfzwRRG9C1xZB9A50bRFE7zBUry3lV5PrCnK/kry1qnIGwPAfxJAi/IaBJ6E8BXjSn48su3o5vKES+xZCfFp0XV577r2mMEx4MFgGAAtjLnInB0Ap3RT8R0XW6ScQLisVXREZGDKIt2h1OTcgJAsiLsKM6rxlg4EZHDD0PAzuT+PLubbW+4brTA5mcsBkNBgl0SPoynSGUZXDe3R8AmZxWNWlPba/gcSOlhVOEH3NgBfqVVVVqKqqarffAQccgGQyidWrV+Ob3/wmAMB1Xaxbtw7jx49vdbtkMolkMlnQzjkfUn9gBDDGhuxzI4j+hK4tgugd6NoiiN5hMF1brUaweLJDWeUsnAahucRAQCmlxbYjoVyhp46AcgVkMB+2RaV4MVGuJTmE3md/wgBIiF7YsypIthgMoUPM4oAv2JnlP6LLRdph5a0LpgkDPMHBLINk/Q4IYwyc8Z4V6mxw/B7sCkP1eRHEQGHAC/WOUlFRgUsvvRS33347xo0bh/Hjx+OBBx4AAJx55pn9fHYEQRAEQRAEQeRTVJYXmScGFkoqKFtA2sKfelDBfFSE+7JcRsW4I8J1vQ5HpFo6InJNXUUdVlxzBsb9SmvO9LKRN213PYfiCnUtjRhWVqGlXzBAYnBbh0VmWbQtMo/4cjCrFMIKd0h/gEflRxSp6HJkXqGVZaX3J+PXW/DtjoJverQxX+y6hcipfuVKwJU9L/8ZwBIGmC/YWYKD+9N4e07Ch+uicj5h6PcCQRAEQXSCISPUAeCBBx6AaZr43ve+h0wmg0MOOQS/+93vMHz48P4+NYIgCIIgCILY4QjlnFdYWR5GatDgnv2CkgrK8aV4Ni7Gg7bYsi0gswLK9npWhndUjEZEeKzqOV+SB9XMQRxJHyKVBOodWJWlPVpFO9hQUkfuhPE6bvybBKq1dlfGInli/dzcNxn0QRDexAHc7p2wwbRgT2oBz5IcPGGA+cu5diPSznPtCUPfaCEIgiB2GIaUULcsCw8++CAefPDB/j4VgiAIgiAIghjS5FeyhuI8yJRuI4aF6FmUUlCOhMx6UBkPMuP58wIyW3xZi8juwSyuJWPSl4wpM1INnJPiPK8yOFchTNEdQxHGtaBGoucHKSgaFeTqbz3IvG9GBN+UkK4sjBDypwD051XGg8h4XT6v4FoIBXwyLuDDtlbWk5AnCIIYXAwpoU4QBEEQBEEQRPfRUtyvJPdaiXogWd5rKKm0BM94UC1enhT3ILMitz6r29HVonGTg6fi0o8nTT1NRZZT0fUGWNLs8wpwgmAsKuutbu1LSaXFuy1z39aITJUTfHND5ub9adAviLcJK+zhdilBv1NCPr9KPmno6CKCIAiizyChThAEQRAEQRA7EEEcg8x6UIrl5Sb7Az6SLO9xlJBagrf4j4wbmfcgW9xwXnWxUpZZXIvvlAmeNsHSpj+v23LLZijLScQROyqMM7CkCSS7vg8ldLV8EIsUE/LRuKRAxNvx9UGVfHeFfIdja8J5nhP2wbdJ6LOAIAYdjDG89NJLOPXUU/v7VHY4SKgTBEEQBEEQxBBCebLVwQKVJyGFgFdvw1OZHTrnuSdQUvlS3IVsdgtFeYsbSvSuRKywtC+/0xEJHpPiJlg6ItBpcEWC6FOYwcHSHDzdNbWihD+WQSvCXRZri1TPh5nyPRBbA87CMQt4weCukTEOovFNeQO+cr8dBkU5EUR3qampwfz587FixQps3rwZw4cPx9SpUzF//nwcccQRAICNGzf2y7iREyZMwNy5czF37tw+P3bAVVddhXfeeQeffvop9t57b3z88cd9enwS6gRBEARBEAQxSKAolr5BCamFeLMW5SKYb3EhmyPzLZ2UVwxahJdY4CVmbj5tgpWYus1f5mmTcpUJYojDDBbeOOsKrcXWFFbKtxJb4wjA839nSKUHKM6KLidI5Z4YCgcQtvIGEfaXkb/OKuyvTAAZF4I5UKafOW8wHTvFSd4TQ5NZs2bBcRw888wzmDhxIjZv3ow333wTtbW1YZ/Ro0f34xl2H8dxkEgkurz9hRdeiA8++ACffPJJD55VxyChThAEQRAEQRADAKVyg3mGslz6ESxBJIskWd4dlJBakDdHxLgvx0VElKtsJ6rJGXKCPJxGxHhEnLOUQeKHIIgeo0diawIpHxnUVUaX3fhU5g36GlsfDPSqEF/uARiA7dhcfCWPyHXDl+2c56S7wXwJz/VNjEDIWxxWdQkqT9qtx86TIHqCuro6rFy5Em+99RaOOuooAMD48eNx8MEHx/rlR768++67uPzyy/H5559jn332wa233orTTjsNH330EaZNm4a33noLxxxzDN544w3MmzcPf/nLXzBt2jQsXrwYe+21FwBgzZo1uOaaa/D++++jubkZe++9N+677z4cf/zxAICjjz4a69evx9VXX42rr74agP437B133IHly5fHKsUfeeQRPPLII1i3bh0AYPbs2airq8NBBx2Exx57DMlkEmvXrsU///lPXHvttXjttdfAOceRRx6JRx99FBMmTGj1Nfrxj38MQFfyk1AnCIIgCIIgiCFKu9XlXs+Jhx0NpZSuvGx2IZp8Sd7ki3N/WTS7ncsm5wy81BfjpRaMEhO8VM/rtkh1OVWSEwQxSOkJKR+g5bzU0WOuBLzcvGplHp5qt4/ytORnEuFAsDGk0r9jAXT2trO3uYWE+o6IUoDb0vfHtUqADtxYLysrQ1lZGZYvX45DDz0UyWT7F2hDQwNmzpyJk08+Gc899xzWr1/faiTLLbfcgoceeghVVVW49NJLceGFF+Kdd94BADQ1NeHkk0/GggULkEwm8eyzz2LmzJlYvXo1dt11VyxbtgxTp07FxRdfjDlz5nTq6QPAm2++iYqKCrz++usAANd1MX36dBx22GFYuXIlTNPEPffcg5NOOgmffPJJtyrYexMS6gRBEARBEATRAxRml/uigKrLu4XOKfcFeSDLY+LcgWh2c7EF7cEZeJkFo9SvJg8FuZbkhj9P1eQEQRCdQ8t5A0gaPbpfqSRq6rdhVOUIcMb9G9T6W1zhzemgTUgt2EXuW1+QkTFFZG5sEQAwR5X06LkSgwS3Bbh3574/7s1fA4nSdruZpomnn34ac+bMwRNPPIH9998fRx11FM4++2xMmTKl6DbPPfccGGN48sknkUqlMHnyZGzYsKGo9F6wYEFY+X7jjTdixowZyGazSKVSmDp1KqZOnRr2vfvuu/HSSy/hV7/6Fa644gqMGDEChmGgvLy8S5EzpaWlWLRoUSjKlyxZAiklFi1aFP67a/HixRg2bBjeeustnHjiiZ0+Rl9AQp0gCIIgCIIg2iEXxxKJYPEou7y7FMjyRkdPm4KpjmDpaMkhSxo5WV7mV5aXJbQs99tJlBMEQQxuGPfjXdC9gZiZxWHt1L7cJIj+YNasWZgxYwZWrlyJ999/Hy+//DIWLlyIRYsWYfbs2QX9V69ejSlTpiCVSoVt+RExAVEpP2bMGADAli1bsOuuu6KpqQl33HEHVqxYgY0bN8LzPGQyGXz55Zc98rz23XffWNX5qlWr8MUXX6C8vDzWL5vNYs2aNT1yzN6AhDpBEARBEASxwxOtbMuPYwkEOtE5lFJ6YM+YIPenjS5EkwPZ3EFZzv2c8pgsT+SJc0sPcEcQPUX0xkv+PRh/XayLgh5s0eRgrPh7seC+W1s34jrTlyAIgug4VomuFu+P43aCVCqFE044ASeccAJuu+02fP/738ftt99eVKh36jQsK5wPigyk1P/Wve666/D666/jwQcfxO677450Oo0zzjgDjuO0uU/OuS5AieC6bkG/0tL4TaympiYccMABWLp0aUHfqqqqjj2hfoCEOkEQBEEQBDHkyc8vV0LpbNcgu5ziWDqNdISuKG90IRqdotXlHXpdGXxRngAv12KclyXCKS/T0SxUVT5EYUzLasa0nGa5NhZZpwtRg/bcfCi6g+1j+2xrG1ZEkqNb7zMpJUzWDKu6FJz3zs0dpVROtCv/P+Gyyjn3gnUIhbyK9NftkW3DNj0N5Ui0TaqCfRIEQQwqGOtQ9MpAY/LkyVi+fHnRdXvttReWLFkC27bDzPUPP/yw08d45513MHv2bJx22mkAtPAOBhUNSCQSECI+gHtVVRU2bdoEpVT4uzQ6QGlr7L///nj++edRXV2NioqKTp9vf0FCnSAIgiAIghj0KKVyeeVebpBPEuZdQyml88n9SnItzOPiXNmi/R0BubiVqCgvD4S5zi+nQT0HCYHo9uMWwnlfeGsB7svvUJBHpHhUknPWbYG9IxK+frkWtL7U+6g8KR9K+KBdRkS9hC/uo/PBuoisJ1FPEMQOTm1tLc4880xceOGFmDJlCsrLy/HHP/4RCxcuxCmnnFJ0m3POOQe33HILLr74Ytx444348ssv8eCDDwLo3O/aPfbYA8uWLcPMmTPBGMNtt90WVq8HTJgwAW+//TbOPvtsJJNJjBo1CkcffTRqamqwcOFCnHHGGXjllVfw8ssvtyvJzz33XDzwwAM45ZRTcNddd2GXXXbB+vXrsWzZMtxwww3YZZddim73xRdfoKmpCZs2bUImkwnl/eTJk/tkIFMS6gRBEARBEMSAp60Mc4pk6QKehLc9C9XkxUV5Y+eqy1nSgFEeVJZHpmW57HJmkDAdEDCmfxa+zM6JcF9883xZ3oowJ4gIccHPIv/tPlquR0V7RMTLqLD324P5oJ3kPEEQg5SysjIccsghePjhh7FmzRq4rotx48Zhzpw5uPnmm4tuU1FRgV//+te47LLLMG3aNOy7776YP38+zjnnnFiuenv86Ec/woUXXojDDz8co0aNwrx589DQ0BDrc9ddd+GSSy7BpEmTYNs2lFLYe++98fjjj+Pee+/F3XffjVmzZuG6667DL37xizaPV1JSgrfffhvz5s3D6aefjsbGRowdOxbHHXdcmzL++9//Pv6//+//C5f3228/AMDatWsxYcKEDj/frsJUfsDNDk5DQwMqKytRX18/qL5q0BGklNiyZQuqq6t77SuIBLEjQtcWQfQOdG3teASZ5fB8We5JGvSzixTEsTT4srzBgWi0oTIdqC4PoljKE7qyvNyfL0/4bRZ4wuj9J0PkCCS3oSV3KL85A+MIRXh8PXxpTjK8t6HfWwOT1sR8bD6okpd5sp6k/IBAKoma+m2oqhwB3sr4BF1hKA9KOpTdVmfJZrNYu3Ytdtttt06J5aHA0qVLccEFF6C+vh7pdLq/T2fA05n3ClWoEwRBEARBEH1CWGXuScox7yY5Ya4luQxluZ6qbPvCnFncl+NRae5XmZf71eUUxdK7cF9+85wcz1+OraOfB0F0Gn3ddK96vkPyPVop7/dX/jIJeYIg+oJnn30WEydOxNixY7Fq1SrMmzcPZ511Fsn0XoCEOkEQBEEQBNFjKOnL8UCUB5EsgUAnqdAhlCshGuyYJI8K9A4J82gcS4WW5UZFAqzMwnbVjJFVI2FwqjDvMVikUtzgcQnOfalnMDDOfVFOESoEMVgIpbzRNSmvCuJq/BvMvozPl+9K5uXK0w1ngiA6wKZNmzB//nxs2rQJY8aMwZlnnokFCxb092kNSUioEwRBEARBEJ0iJs29SMU5VZl3GCUVZJObk+bhw4ZscCBbvHb3EQrziCzPLVvgyeL/1JdKAvUZkrkdxeBxSW5oSc6M3Dw4p6x4giBahTEt4wHWvSr5qHz3K+XblPJ+XA1VyhPEjsENN9yAG264ob9PY4eAhDpBEARBEARRgJL+wJ+uX2nuShoAtBMopaCyIpTk+cJcNDq6WrENWILDqEjCqPBzyysi0rw8AZ6k6vIuE41WMXhEjEfbGWWPEwQxYAhjoNCN6JpiA7tGxXx0UNeoqG9jHUEQxI4ICXWCIAiCIIgdFKUU4PmxLIEwd2WYc060jRJSD/pZb/sPLcplvRboym3nNeRMV5ZXalHOfXkePHiK/qneaVikcjwiynUbj+eTEwRB7GD0RKV8PtFBX2PV80Bc1AM5gR+4+Mh2uq2VflLpuwh0g5MgiAEC/SudIAiCIAhiiKMH/RRamnvxjHOqLmsb6fhV5oEwj8hz2eToP/rbgJdaOUFekQgrzo1Kf9BPkgMdg+WqxmPCPGyLVJkTBEEQfUZ00Feg69XzbSGlhGW0IFFdBs65Fu/R37/K/4+KLusZpfL6RNfTrwyCILoICXWCIAiCIIghQphl7srYPOWat04YzRKtMg+mDXb7WeYm1xXmlZHq8mC+PAFm8r55IoMZlhezYvK4JA/mCYIgCAJ+pX2BDC9ux8mZEwTRG5BQJwiCIAiCGESEMS3FxDlVmxdFKQXZ4kHU+dK8Li7P24tmYSlDS/LKpB/PkgwlOi8xqcq8PTgD8yV5ELsSi2AxKKecIAiCIAiCGDyQUCcIgiAIghiAKBmJZonJc4ppaQ2Z8SDqbXh1dlye17UvzXmZVVSYG5VJGvyzLRgDM305bkZiWMxIhTnJcoIgCIIgCGIIQUKdIAiCIAiinwmFuSuhXEHivA2kI0JJHgjzQKArW7S+IQN4eQLmsEileVB1XkHRLK3CInLcn+ZiWfx5giAIgiAIos9hjOGll17Cqaee2t+nssNBQp0gCIIgCKKPUFLFpblLGefFUELqOJbt2YJq8/YyzcNK82FJLc8jAp1yuIsQDOpp8lwci8nDQT9JmBMEQRAEQfQ9NTU1mD9/PlasWIHNmzdj+PDhmDp1KubPn48jjjgCALBx40YMHz68z89twoQJmDt3LubOndvnxwaAVatW4Yc//CH+93//F1u3bsWECRNw6aWX4t///d/77BxIqBMEQRAEQfQCxcS58tqOHdnRkFkPYrsNb3tWV5pvz0Js1/IcbdxjYGkzLssDeV6ZALMoniVGkQpzzgGTJWGNLoNh0utFEARBEAQx0Jg1axYcx8EzzzyDiRMnYvPmzXjzzTdRW1sb9hk9enQ/nmH3cRwHiUSi09v9v//3/1BdXY0lS5Zg3LhxePfdd3HxxRfDMAxcccUVvXCmhZBQJwiCIAiC6Aa66lxoYe7QAKH5KKkgGx14222IuqyebtdTlWm92pxZHMbwJIxhqQJ5TpnmeQSDfpq8IM+8WJSNlBKskYNxqj4ndlyU8mO1og+9Qt/Py2sLHrqpsB1KQSoF0dQEL5EA76WxA8IxCRjTj/x5sMhsK30YA4u2MQZwTuMdEARBDBDq6uqwcuVKvPXWWzjqqKMAAOPHj8fBBx8c65cf+fLuu+/i8ssvx+eff4599tkHt956K0477TR89NFHmDZtGt566y0cc8wxeOONNzBv3jz85S9/wbRp07B48WLstddeAIA1a9bgmmuuwfvvv4/m5mbsvffeuO+++3D88ccDAI4++misX78eV199Na6++moA+nfqHXfcgeXLl+Pjjz8Oz++RRx7BI488gnXr1gEAZs+ejbq6Ohx00EF47LHHkEwmsXbtWvzzn//Etddei9deew2ccxx55JF49NFHMWHChKKvz4UXXhhbnjhxIt577z0sW7aMhDpBEARBEMRAIxbZ4shQpBORbPPtNry6bKzyHKL1mwu8zIIxPAlzWEpPh+spL7VI7gTEqsxzsSyhPCcxTgxylJSAlOFUzytACj0fSOugjwKgZK4tf1kqAHoeSrWy3PNIpeC1tMDNZHtNqPc6zJf2nPsCnunPmFC+88I+zB98OCLnwRgY57n5oD0Q9/nzJPUJguhDlFLIeJk+P27aTHfoc66srAxlZWVYvnw5Dj30UCSTyXa3aWhowMyZM3HyySfjueeew/r161uNZLnlllvw0EMPoaqqCpdeeikuvPBCvPPOOwCApqYmnHzyyViwYAGSySSeffZZzJw5E6tXr8auu+6KZcuWYerUqbj44osxZ86cTj1/AHjzzTdRUVGB119/HQDgui6mT5+Oww47DCtXroRpmrjnnntw0kkn4ZNPPulwBXt9fT1GjBjR6fPpKiTUCYIgCIIgiqCk0tXmTkSe00ChUK6Etz0Lb1sWYlsWXm0W3rYMZKPb+kac6ViW4UkYw1Ph1BiWBE9QtTmAnDT3K81htl1lThD9hVIKEEKLbSGghASkgBJCfz4KoYW18tf7kjsqzJUvtsO+OzD6ZkGwEF0Rn8Yq4/P7FOy0g+0KQKtexx/kubN+O78/y81EiuiL99f+PifiuZbyjHOA6YGQUTDvi3vDiIv6cB++pDcM3UYQBAEg42VwyHOH9PlxPzjnA5RYJe32M00TTz/9NObMmYMnnngC+++/P4466iicffbZmDJlStFtnnvuOTDG8OSTTyKVSmHy5MnYsGFDUem9YMGCsPL9xhtvxIwZM5DNZpFKpTB16lRMnTo17Hv33XfjpZdewq9+9StcccUVGDFiBAzDQHl5eZciZ0pLS7Fo0aJQlC9ZsgRSSixatCi82bB48WIMGzYMb731Fk488cR29/nuu+/i+eefx4oVKzp9Pl2FhDpBEARBEDs8SvmV547ITXdwea48qQcErc3A25YT6KLeaXUblja1LB+WislzXp6gKmqgdWluchowlegTQhkuRFyKF8hxmasOz+8zhAV4gdz2H6HMDtoQaY9sI6WCtCWEJ6DAkHPgqlCWD92XsQcQxZt94R7OgwX/L7IuOmW57lx/syeU7kZkahh6IGbD0OtNAzA4uL8cFfmBsGcG3RQmCKJ3mDVrFmbMmIGVK1fi/fffx8svv4yFCxdi0aJFmD17dkH/1atXY8qUKUilUmFbfkRMQFTKjxkzBgCwZcsW7LrrrmhqasIdd9yBFStWYOPGjfA8D5lMBl9++WWPPK999903VnW+atUqfPHFFygvL4/1y2azWLNmTbv7+/TTT3HKKafg9ttv75B87ylIqBMEQRAEsUMRyvNYdMuOm3muhNQDgvrV5iKQ520MDMpSBswRKZgj0zBGpPT8iBR4mv5pSdKc6AuUlIDnQUkJ5YlchbjfllvnaSke9hksEVVBVbuCCsx1+NDrA8mt/H6QCNfLoJ9UuXVQOhUm6Ad/ffg51/2bfkopCHgQzIFkQbk1Yvnlsa/6h+1B9TaLSeBQBIMBPNd3h6XgRoSK/LftDeN9WhH2bZEv7PMlvWn4n/8R8W5wMG7otoi4DyW9EfQzAMMAN0jSE0RfkTbT+OCcD/rluJ0hlUrhhBNOwAknnIDbbrsN3//+93H77bcXFeqdwbKscD74vSSl/jfCddddh9dffx0PPvggdt99d6TTaZxxxhlwnNaLagCAc65vTEdw3cJvsJaWlsaWm5qacMABB2Dp0qUFfauqqto85l/+8hccd9xxuPjii3Hrrbe22benob96CIIgCIIY0iipdMW5LSD9+JYdUZ4rpSDqHXhbM6E092ozWpy34thYUovzUJqP9MV5iVV8gx2InCz3hbnFSZoTXUKJiAwXQkvwgjYBiIgk79ePsCIRLkoBQkKFOeYqNq9NNsKc8zDyJRjMUwTiW0IJBahIdbcCoFh46LDYO9o2QFBQkIaCEAyst8R3kF9eJN+cBRnnPOjI4yKeR/oBAA9iUhhY2Jc+w4pSROar6JzdQzerwtiboFKexSrpmcH0z80X81res4jA57kKe4OFgj4Q94zG3SAIAPpztCPRKwONyZMnY/ny5UXX7bXXXliyZAls2w4z1z/88MNOH+Odd97B7NmzcdpppwHQwjsYVDQgkUhAiPjNyaqqKmzatAlKqfD3THSA0tbYf//98fzzz6O6uhoVFRUdPs/PPvsMxx57LM4//3wsWLCgw9v1FCTUCYIgCIIYUihPQtpCV5/bO+agocoVOtt8a8Z/aHne2mvBLA5jZK7S3ByhK895qbljDxDHc5XmUXFOA4ESraGUKpTgeZJcuW5uvk/leDT73JffwTQ6IGg081wEAlyEYry1yBcViUjRDSwSl4KcGM+X4rHdkcxtF+W/z4Lq7C4UW7dJIHPh3yCMDigaySiPDSLKeSjkScx3k+D6kPqzJGjqSRj3b65w/3cZz914YcG8v07nzwc/c+Sy64P1sf7+vP++4eEgtdFp7vcn/R4liNapra3FmWeeiQsvvBBTpkxBeXk5/vjHP2LhwoU45ZRTim5zzjnn4JZbbsHFF1+MG2+8EV9++SUefPBBAOjUv+f32GMPLFu2DDNnzgRjDLfddltYvR4wYcIEvP322zj77LORTCYxatQoHH300aipqcHChQtxxhln4JVXXsHLL7/criQ/99xz8cADD+CUU07BXXfdhV122QXr16/HsmXLcMMNN2CXXXYp2ObTTz/Fsccei+nTp+Oaa67Bpk2bAACGYbRb1d5TDCmh/re//Q3XX3893nnnHTiOgylTpuDuu+/GMccc09+nRhAEQRBELxDLPrcFpKMF0Y6CUgqy2Y2L860ZiDq7+AYGC6NazJG5ynNeZu244pwxXd1ncsCKiHOqNid8lFKA60JFK8g9Ty/7j5hE721kfva59IW31FXtBW0656SzcS8xQe7LcAUA0i+hjeaLF4hxoqeIfn0+f+zStl7yYuOPtrcNALAgKgcSzGulT3v7gF80bxihpOVBlAnj8QzzQMYbgZynuJPeRgVRSJD9d9lGv2kRvKF4LiaJRUU8Y5AAstkmNH9dr0U98uOT8naODgh7zsCSFlK7j+uhJ0UQPUdZWRkOOeQQPPzww1izZg1c18W4ceMwZ84c3HzzzUW3qaiowK9//WtcdtllmDZtGvbdd1/Mnz8f55xzTixXvT1+9KMf4cILL8Thhx+OUaNGYd68eWhoaIj1ueuuu3DJJZdg0qRJsG0bSinsvffeePzxx3Hvvffi7rvvxqxZs3DdddfhF7/4RZvHKykpwdtvv4158+bh9NNPR2NjI8aOHYvjjjuuVRn/P//zP6ipqcGSJUuwZMmSsH38+PEF1fS9BVP5ATeDmD333BN77LEH7rvvPqTTaTzyyCN4+umnsWbNmg6PPNvQ0IDKykrU19d36qsGgwEpJbZs2YLq6mpwGuGcIHoMurYIoncodm2F8S2O0FXoO1B8ixJSx7RsjVaeZ6Ds4gKPl5gwR6X1Y2Qa5qgUjOGpHbcijEViWSweyThnO9zNBPq9hVx0SiDFg8rxcN7T1eWe17u548qX4J6ACnLQhYQSnr456LdpUe5XinfxI6+oII9GqqhoPxLkQE5mS8RfutaXFeoNoEwALBiUNNo3b2xSmb8euYahOm5pGEXOcsuxdkALU1+4M7/qPZDvnHOdNc70AKIG1/EmnAU59Ll9abHPYscM5rnfk7HcPDFwkUphm5fBCDMdCvWegJckUHrQ3j22v4HEUHZbnSWbzWLt2rXYbbfdOiWWhwJLly7FBRdcgPr6eqTTnctv3xHpzHtlyFSob926FX//+9/x1FNPhaPV/vCHP8Tjjz+OTz/9tMNCnSAIgiCIgYMSErLFhfSgRfoOMniodAS8LS3warQ0d7dmILZni2edM8AYnsrJ81EpWKPSO27Oeb44j8pzYsgTVJAr1wM8N1ZFHgrz3pTkQfV4IOaDSnIhAP+hRFBJLlqNT+kMKmZ0i0hyBagdRJArpcKXQgLtzofF2CiU5Pnyu2PHBzJMAQIRnR6o2uCORdg7sr6wfpypqOKNnkk3ZWLRzRlUbAWLWe/4M8kz4Z0kvFHQZnm9AqRAZwYPZUGciBGPpmFhPI0RiTfxq+Lz9wHkBHtEvvsBOBFhz8ARFFcz8MhLEvaPDFrKQQKfIIi+4dlnn8XEiRMxduxYrFq1CvPmzcNZZ51FMr0XGDJCfeTIkdhrr73w7LPPYv/990cymcTPf/5zVFdX44ADDmh1O9u2Ydu5r0UHX2OQUhZkBA12pD9g0FB7XgTR39C1RRA9hxIKyvYgHQGRdeFuy8IRLeBDOItVuVJXm2/JaIm+pfXIFpY0dNb5KD+2pcqvOi8ii6Ua4p9JQb65pQVKW+JcQVckE5rB+HtLFYtYCUW5B+X5srwHBHWRo/vHE1BBJnogyIM2Py+9x45YrJJcohuSfODbdKVUTHgL6LMOpjEproq3+TsCAj2sFBhkzuAqmZPXwYvqL7JITThTCjweCB/Zh4rsA3r/AIL4DDeZQMJ2dhBdGq0rD171XISHCgZGDbpG6tEVy+lnFXQIy8h53j7ht+X66H1HbkUIDjDZcQfPoCvfTV93BwN8BtKdGZF8cKNXvsmUk/KRKTom74NXKF/eB9X3zF8YKvJeKqV/b/V0UcUg+13YGYbq8yLaZtOmTZg/fz42bdqEMWPG4Mwzz+yXATt3BIaMUGeM4Y033sCpp56K8vJycM5RXV2NV155BcOHD291u/vuuw933nlnQXtNTQ2y2WxvnnKfI6VEfX09lFI77Nd7CaI3oGuLILqOUgrKk4AjIV2p58N1EvUtTQBU0UqyQYlQwHYXqHWAbQ5Q6wL1rs6szUOVGsAICxieAIZbwHALqtSAZAxu2CsLNA+tf68UwPUgaMzQWecw/IxzzrXgcvx+mf48ycHFQPq9FR3EMxyoMxzEU8eydCfmpE2CjPFwAE4RGYwzt65Hb8bEsj0Kq8lVtE9bMKDoB8dAQOVVgLc1DQWZ0jI0Iq01MiKwlf+U89b7TSzcaxuwVuY7RVwiRwdSVQBsy+re7tE/X8TqveQr1cp8b+wuEPSRXO7g5xM+QQbF4N+oYoDj93Ujn4WB7I/Ie8YZFPwc+CDrm2sJHw7oGR2YdQASjSuPVtMDQDwNjuWEvf+6RdezvCnPWxF/9ix2bBbbsuNIpdAkHCigRyNfmO2iecuWHtvfQKKxsbG/T4HoB2644QbccMMN/X0aOwQDXqjfeOONuP/++9vs89e//hV77bUXfvCDH6C6uhorV65EOp3GokWLMHPmTHz44YcYM2ZM0W1vuukmXHPNNeFyQ0MDxo0bh6qqqiGXMyWlBGMMVVVV/f7HE0EMJejaIojOIcMBRIWf/62ABPQj2k9JAAyjKocPygp1JRTEtiy8mhZ4mzNwazIQtdlIGWUOVmLCqk7DrC6BWZ2GWVUCXjLg/5nWs0SjWqJxLTQwaI/TV7+3cvErbjxyJbLc+iCeDDAM/ej8kSMV7P45CC9XZe55PVpNHh41ErsSOl/FQoM8WGNXlFIIwjei1eNCSZ3MISUkFKSS+nNbqfDFYFBgflW4oXIV4kxFlXvfPpdouIry5wKBnR+8ovy7HPntEn60jNLPUvp+T4DBSUmIrA0W9FfFn6nMc4L564u9MtEAlngkTKzOO1wfbQ/W5cvQYrDI2vx+0ULzaK9i9ypyVdOssL2ddYzF9xsK4AEx5kVU3AdTHnnCuqo9iJcBN/VnGfM/17gJZnAoxgFu+UKe50Q+gvkBgP/26ZUv/yDynowJ99xy0EcpBSE5BNOFBcX3VdherGd0c4MlUV1d3cWzH9jsaFnhBNHXDPi/1K699lrMnj27zT4TJ07E7373O/zmN7/B9u3bQxH++OOP4/XXX8czzzyDG2+8sei2yWQSyWSyoJ37A54MNRhjQ/a5EUR/QtcWQbSO8qQeQDTrQdoi/KtM/+HE2vyjkTEGzviAF+pKKojtWbh+bIu7pQXe1oyuSM+DpQxY1SUwq0vCqVG2Y+WdF+SbW8YOOThof9Ld31vBIJ65hy/IXScnzdsxMF2SYzJXwR7GvwgRk+VKtJ350NkKyYL4lXxxHkSxtMNAeXfHBbmCUBJS+kIcOvZS+YJcKR0PxIJKcSVyMSp5otbwHz11jrGXXQXqO3hoCa6fA4NkClLpsxJMi23F9K8b4QvvQPFLlqtlV5HIEOkbvEhgjP9jZjEh3p5XNE0LXmKg/LTbJlphzFQQ2KLCL0Dk5sMwF3D/mwJh32g/ADyyH678ZT9Cp6d+k0clvP4cybVGhXx+v0DgtybpOy7to7FCkaYuPyH/W1csyH1nUMyvhmcGYASC3tSCHggFvD4s9yN0gvZoVX5U+Pv9WVTYB1E6/feeLfoS5r2eSgEeGBwV/Ql284DQQmyo/v02VJ8XQQwUBrxQr6qqQlVVVbv9WlpaABR+aHDOKTuKIAiCIPoQJZWW546AyopYjMtQQdoC7uZmuBub4W5qhrepRQ+YmgdL8Jg4t6pLwMutHUccc7/q3DLiAp3vIM9/kKKkjEhyR1eWR+V5bw3qqWTeIKJBVbmr42B6ISM9JstlkQgWOTiqyrUkVxCQkEL6olz4ucMCUkq9TulIGy1Ig3Ty4sSqRTuBjMrwWEW48qWYltwCOfktmL7/KBjzl7Ucl4xBBnI80Ph5gpvoOsFrKICIUC0oP+9RAumuNa6W7syX7YGM576AZ8oX+JE27rdxpXI3cMKspCJPrsvnySKCPU/O54t5Fu+v2yLbox1Jr5R/I1DETr3VpxAMsMq0KGc8FzcTy4GHH5XWYXjumCz4CSH33ojk3utjR7//EBX8+f0j+wj3H50JbmCxeIfoNkoB8PQNHMY6l4vUal8F5tInCUEQXWPAC/WOcthhh2H48OE4//zzMX/+fKTTaTz55JNYu3YtZsyY0d+nRxAEQRBDFqUUlC/PpS2gnI6OCDY4UEpBNjhwNjbD26QluldbmFvOLA6zKh2vPK9M7BjynDGda54vzosMEEr0L/p6dSCzWYj6esj8CJY2Y1i6Sd7AogWDi7ZTWd5Z2pTlchBEsCjhV49LLcehIKWW5EG8SlBRrsvk27/J0dErspgUj1aFe9DVoh4Llhk8FkhyHpPhkuVE+EC8vdq6amtrI1V0vYKuxvaU7FQVbUHPtr651d62AxyF4MYJEMv16CKBiM+X7fH2/OUiUr7gPCM/43xh38XPjWKSvjUp36bEFx54JDOo3dMpIuARFfAMfryW1BXyDP5nCuJV+P2IAmAyBkupHn3PG6y0B/dGEMSOxJAR6qNGjcIrr7yCW265Bcceeyxc18W//Mu/4Je//CWmTp3a36dHEARBEEOKsAo9KyCzXu+Fa/YDSkh4WzJwN+Uq0GVLYd4yr0jAGlOKxJhSWKNLYYxI7RiV10HWeSKv8nxHuHEwCFBKaSnuOP7UDaNYlONCeS6kVHBbWuA0NvXc4G5tVJeH8ryHPyZUmNuBSBRLUFmODsWw9CnBCSsJJQVEIMz9h54XfvyKFujdP6TKxZsoFU6DNk8peMwX40pLcQ9aeEpfekoeVIzraW982scqzqMC318brXIPN/BnZP66SIdYdXzRfu2cVBf6pCRDVti5htbehm29PbssbPP/G5eyxQ6ek7i5ynSWt6fo+mg8SuF++57g5k1X5TxDRMr7wt2ICHijSFt0uTP0tKRvTbiHNd9BmxBtSnpEtmF+5bkW6/kS3q9899vDqvhOV8ITBEEMfoaMUAeAAw88EK+++mp/nwZBEARBDEmUJyF9ia5s0bmv2w5gZIsLd1NLKM/dLS2F2eecwaxKwxpTqh+jS2GU7gC555yBJbQ055HoFqL/KMwuj8hzP6all47c9gCjPVzVXry6PKgsRyjO+51QkgtASiilRbkKBbmuLlfSX0buHkDnD5WrGpcR6SxVrpLcBeAxwAULK8glY/AY17EqjOvq4G5Ui8fyxJUqEN/BQJ6B7M5X2cEWwc+4WFpHflPh6kIRWfQ1zW/sg/eMsBQ8rxcO1E5pOgv/o/I6qGLdi7tnlreOFenYxlOLyvmodudBS4HAZbm+LJ5t3lco+IPsBvK4E+TLeAPRKUIZX0zM98RzzF15KH4hdbOSHgike6F4D2V9dJkbeswbxvwCAwYeCne/3X+dOWM6I94/yA5RkEAQxJBiSAl1giAIgiB6FuUKyIyuQh8KUS5KKYhtWV+gN8Hd2AJRbxf0YykjJs+t6pIhH18SGyg0qDwf4s95IKKk1II8rDB34vK8t+JYoADPg3T9qvKgwtyNVJj35NFCM4wi1eUDQJYrX7P5ohxKy3KpBIT0K8mVhCdFKOQ6FroSJxDj4dQXzcFUAFqSg8H15bjOGNdi3PMryT3kBtts82mhmAwvFOEiaAnOxX9NgvuoCvFp1GorFKzs/5/nUKCdmwNt3nQour4LsMJ5lt8OIC9JO7ZNrH+0gyroGhfurcj5WL8+lvLdkfFhBbwv3IP4mUC+h+2BhFeAgZ6NO2mNwkr62EzRRQB6gOhOEvvp+lXx+ufI9E195OR8NpWAdD39zQD/Wwl6VVApHzTnxH2RtyyCjgyA2cNRYwTR1zDG8NJLL+HUU0/t71PZ4SChThAEQRBESJCHLjMCKusN+gFFlVIQdTbcDU1wvmqC81UjVLbwjydjREqL8zElsMaUDfns84KBQi2Dvq7dR8QiWfKlueP0ojAHIHQUi3QdyJYWeM1NYNE88x6Unrk4Fhab7/fs8iBrXPqyXEkwJfxscj+r3M8t95ATZp2R5TISrRKbhtXkCp4CPKYleSDIPb9yPJgKxtHauyEs4A+luIRSgRSPC3EhQ10eE+qB/S7wZSS/idYocpOkmLbv9Fsoz4LHJb0qLsmjcj5ejB/pwnwBn9vaCDZgEREPLeoDydoXvw2DqBovfCIdgwFFY2gKq+HzKuR752l0m1iVvWz9958C4DAJZLKd+/n4g6syFnmdefgfJFy3s6dMEH1GTU0N5s+fjxUrVmDz5s0YPnw4pk6divnz5+OII44AAGzcuBHDhw/v83ObMGEC5s6di7lz5/b5sQGgtrYW5557Lj755BPU1taiuroap5xyCu69915UVFT0yTmQUCcIgiCIHZyhlocuGhw4XzXC2dAE96smyOa8P5ZMBmunSPX56BLw1ND9J1FYeZ4wcrnn9NXqXiUQ5DKaYx6pNO9VPDdSZe4CfgyM8lwooZWwggolcWcGTowSE+ZBhkk0mqWvP0Zi0SvCF+cCTIowrzyXVa4H1ZR5j7Z3r6V4tKK8mCx3oUIZ7gXV5Dwqy3lB3Eq+HNfV6X5FPJQ+hsxFpcjolvmRKYP743sHIn5ro2s9eo6OVXX3omrOe//mf/Ohw69D5Ilo2a7Cxg5JeRVdFRHt/hJvpzK+r6rivS5kxufH0wRCPoinKTaAqxFZHrT/avAHV42lFEa8vXKH7r//iMHPrFmz4DgOnnnmGUycOBGbN2/Gm2++idra2rDP6NGj+/EMu4/jOEgkEp3ejnOOU045Bffccw+qqqrwxRdf4Ac/+AG2bduG5557rhfOtBD69CAIgiCIHZChlIcuml24XzXB2dAI56smyAYn3oEzPXjoLmWwdinT8S3GEI0y4Qw8EOcJgyrPe4lYLEvkEQj03rVgKi9D3QN8eS578NitCXNdAN3HwlwJfQJSAMrzq8pzueVSeb4w9+MXlD51gVx1eWu0Vk1eIM6h4CFXQe5F5Hgw70VEud5PkBWu/Ep3CQjh7zMqx3NRKn1qUXdIci9wwUudl0Edi70Itmk1/iK3nBAGHGFDRX+vxmY7+gPO78dik+KworNhUxcywgvbWtlH0eZivVkrrZGdFDv3WHMr+jpyHXVLyjO9Re7lKhIlk19Nz6Kbx8NqjLD6vX9FfFfjaQBfyLci26MyPlo1ryX+EJDyxJBEKQWVyfT5cVk63aHP4rq6OqxcuRJvvfUWjjrqKADA+PHjcfDBB8f3lxf58u677+Lyyy/H559/jn322Qe33norTjvtNHz00UeYNm0a3nrrLRxzzDF44403MG/ePPzlL3/BtGnTsHjxYuy1114AgDVr1uCaa67B+++/j+bmZuy999647777cPzxxwMAjj76aKxfvx5XX301rr76agD69bzjjjuwfPlyfPzxx+H5PfLII3jkkUewbt06AMDs2bNRV1eHgw46CI899hiSySTWrl2Lf/7zn7j22mvx2muvgXOOI488Eo8++igmTJhQ9PUZPnw4LrvssnB5/PjxuPzyy/HAAw+0+9r2FCTUCYIgCGIHQXkSMuNBZgZ3HrrMeHC+1tXnzleNENvzMtAZYO5UgsQu5UiMLYM1pnRoZoEzFopzHlSgD8Xn2U8oIXKi3LYjVeZOLw78GRxc5irbvbg877Esc4UwtzwU5v0RyRKLYPEAJcCkL8uVBxWpKhfQX6DxEI9hKXaqUTFeKMh1NbmMiLZAkgv4opwzuH6luRtklSsFGYlWEUoBUkL4ajwQ8lQx3hMEAjtPP6tcvE2oplV8fdAUHQK12I0KFf9P3pERSlnJ4L8nDHicw/Onghv6Rgo34HEGlxsQnMNMppFJOZCMQ7Ig215/U0GB5dpYMM9zfYq1+8vFTpIVnnU0KaWA/JR9Fq1KVgpcSRhK6fZAjioJhmA+1y+2DaLbSJhKwpT+VCmYUsAIlqWAqQRMKSNyOu9GgGpdvubEdrGbB/mqnhfsJ+yRt3nudeNFK+U7dCmHJ6d7s0h2TatCPnLwIB++oyI+72n0KgpaxovwpDtPUCWfe9/p92Qo5qHAFAoq5Zm/jYTOWA+3A0l6ouuoTAar9z+gz4+715/+H1hJSbv9ysrKUFZWhuXLl+PQQw9FMplsd5uGhgbMnDkTJ598Mp577jmsX7++1UiWW265BQ899BCqqqpw6aWX4sILL8Q777wDAGhqasLJJ5+MBQsWIJlM4tlnn8XMmTOxevVq7Lrrrli2bBmmTp2Kiy++GHPmzOnU8weAN998ExUVFXj99dcBAK7rYvr06TjssMOwcuVKmKaJe+65ByeddBI++eSTDlWwf/3111i2bFl486EvIKFOEARBEEMYJRRkxoVsGbwSXToC7kZdfe5uaIJXU1hNYlalYY0tQ2KXclg7l4InBmpaaBdhzI9t0ZEt3J8S3SPILZeOo+W161eb23YYj9KLR8+J8kCcO06PSfNWB/2UWkpLriBF8UrRHqNNWa4fSsmwqrwj1eXFKsmLLheR5Vp+8rCa3GGAG8a/+NtJHbcilARURLxT5XgHyOXPxO4nhDcZZFi1HfXY4XCsCvGq7kifABluGH/fSgAuN+FwE65hwjEMuIYJ2zDgcH+Z59odw4RrGKEc9ziHYPnCXM+rITyeRn/DZSDYtYA3IvOm8iW8P29KCUsKWNJDQgh/Xi9bUiAh9PpE0C4ETOXG3yksItOLSPuYrI8J92jPuKSP9fX3ycL3NkenKuSDDaNRNBEhX/BO9PsxHhmsFQMnniafoEo+vIvQyZMwLQueKv7thkDU6z3nxHzwXIN1gbQP+pVw+rcUMTAxTRNPP/005syZgyeeeAL7778/jjrqKJx99tmYMmVK0W2ee+45MMbw5JNPIpVKYfLkydiwYUNR6b1gwYJQPt94442YMWMGstksUqkUpk6diqlTp4Z97777brz00kv41a9+hSuuuAIjRoyAYRgoLy/vUuRMaWkpFi1aFIryJUuWQEqJRYsWhdX7ixcvxrBhw/DWW2/hxBNPbHVf3/3ud/HLX/4SmUwGM2fOxKJFizp9Pl2FhDpBEARBDDGUVLlK9EEY56Kkgre5Bdl19cD6Omyr/argL1FjRAqJsWU6xmVs2ZDLQGdmJPM84Q8eSlKnS8SluS/Lg/m+GC/A01EsgTiH52er98AgoAXZ5UEkSyDPW9+yewcG/M+VIK9c+LI8Nx/EtEilwspyAcCLCPP87PJiVeVBNXmQUS7zzl0AoSD3/GpyRwEOAxzG4CLIH/cryZWElEKL28H10dhHqJwAR06IA/rnAaUi0ttvl9KX4v57Lnxtmd8rUhcde811u1KAY1iwDQtZy0LWtGCbJrKGCdu0YBsmbF+AO5GpluPBo29+BxhSi13TnxoF8xIpg0E4bliBy5UEk3rekAKW6yEhPBjCg+V5sDwXlvBgep6eCuHPCxieB9NvY37lePAAVGGbCmRikXVBRbBiuupXaa8pAUiuv40hGSA4/Op4v8Kes9wy96vnOQ+ngvF4m2HA5QYc04Jr6qljmrCtBFzDhGta8AwDnmFAcAPCn/cME8LgsA0DLUZC39AwTHiG0eWKaCiVE+/Cl/EyKuMFEkL/PBK+qA/mk+FUIiG0tDeDz70oUUmPQkcc3rZkueW8Nbn24DLyr5Pcd854Bz6u8r62EK2ALzhyZB3LZcUHFfU8FO+5AV1DKd8P1fHtERf1QGdkvW1YvXNSxICHpdPY60//r1+O21FmzZqFGTNmYOXKlXj//ffx8ssvY+HChVi0aBFmz55d0H/16tWYMmUKUqlU2JYfERMQlfJjxowBAGzZsgW77rormpqacMcdd2DFihXYuHEjPM9DJpPBl19+2eFzb4t99903VnW+atUqfPHFFygvL4/1y2azWLNmTZv7evjhh3H77bfjb3/7G2666SZcc801ePzxx3vkPNtjaP31SRAEQRA7KEopqKyAbHEhs4NPosuMB+fLRtjrG+Csb9A3ApD7e8ioTMAaWx4KdKN0CP0BFFaf+5XnSWPoZrz3EkqIUJRL249lCcR5r1eaAxBemGGuXBeIRrV0Q9rHcsyD+b4a+FP5A3tGhbmKCHRfKgXCvFiFeVSYtyfLhSoMVZDQ1eUu43AYgyMBlwEuY7DB4AHwkMspF8prPQNmh0P5/8+vCJc6/kZG+vg/s/D3RnTii/Fo9EVQhhvocgUFxXQcRMbUEjxragmeNbQct03Lny+c2obVY1XgXElYgRyVnj/v5oRp2OYh5dooyWaRcmykXBtJ20bSdZF0bCRcF0nXQcJxkfAcWK4Ly/VgCQZTMFiSwZQGTBVMDRjgMJQBk5mAYuCMg8MAYwY4OBgzwBgHuAlwA+AmGDcBFpnnCX9et4FF54OqXgZwHs4zxuPr4C9H2hjr/O8U5Q/mqG+Q+BeWf1MlnPeCGywy94ZRMvzsUMFnhtTfUFEyC6jm8HNEychnij+AMCKfM8Gy9AfpFZDwICEg4TLlPwCXAzYHbIPBNhgyhgHbAGyTI2swZE0DrmnBsSy4ppb6jj+1rQQcy4KTSKDRSsCx0rCTuk2vy81zKC3dZSDh84V8ri3ptyf99mA5IbyIhCnyvm9V0BdWlgc32llEvbPgZlakY7BWxZYQay1KvpyPnVDufBgCDa/PKRD1vNjtg4jAxwCU88SOA2OsQ9Er/U0qlcIJJ5yAE044Abfddhu+//3v4/bbby8q1DuDZeX+lgo+S6TUn/vXXXcdXn/9dTz44IPYfffdkU6nccYZZ8BxnKL7CuCcF3zTzHXdgn6lpaWx5aamJhxwwAFYunRpQd+qqqo2jzl69GiMHj0a3/jGNzBixAgceeSRuO2228KbBL0JCXWCIAiCGMRI24Ns0dXo6Itq2x5CKQVvawbO+gY46xrhbm6O/U3HkgasXctgj+IYsftOsCpTre9ssBEOHGqAJXV0C+P0p2R7xAYCtW0tzh0HyrGhvL6JMwpjWcJ4GF+ai64fv0CUh1XmvSjMA0Em2q4uBxCrMPdQGMmiK4yLy3LlV5QXk+Xwt3cYgyt1RXmWcThKS/Owuhy+2AvNfC+9JgOeXGV46L2lCiu8AQXIXPxNKD39bINgWxZkHYTrcn0ABcZygtxlBjKWhRYziYxpIWMkkTETuamZRIs/zRgJuN2s9DSkQEo4SAoXKeEgJVwkhYuk35YUDtJ2FuWZFpRmMkjbwdRGOptB0rGRtB2YroeEx5AQHAlhwpIGEsqAqSxYzIIBCwZLgBtJMDMBGAkwIwEYpf40EZ+mE2BlCd13ByKU8AwAWo/FGCy/vZRwAelBZV1AeIB0oYQHSAdKOIBogRJ1gHB0XxG055Y9CLi+zHeYgsOVFvkcyBpA1uDIGAwZk8NOaAmvHxayiQTq/WVh6sp8ZRiQhgFwDmVyMM4BzsC4ltLcYL6gFxFB7yIhdDROQLtaOjDhEc9eGPjFcgXewVoV2TeL9owW0gdLXfw9GN0vi0p6Fp53IOCTBoMTk3P+65S3o9j24U0HFlmXQw7ONERiB2by5MlYvnx50XV77bUXlixZAtu2w8z1Dz/8sNPHeOeddzB79mycdtppALTwDgYVDUgkEhB5//6tqqrCpk2boJQKJX10gNLW2H///fH888+juroaFRUVnT7fgOCGgG3b7fTsGUioEwRBEMQgQzpCx7lkPCivD6pvewjpCLhfNcJe1wBnfSNkc7xiwRyZQmJ8BRITKmCNLoViCjX122BUDG6JEca3JCn7vCMo1/Vlua2rzAN5XqTCpXdOQEZiYlzAdXJZ5124adVWlnmvDf4Zi2MJsssjlZ8QYIkEmOOEMjyoMC8WyVKsqrzY4J6xUwDgSAkHDDZjcJTSMSxgupoU/uB2kaSQWIX0IPuWTWfRgptFZLiOpVGhOPfFdlhyr99EYb058yM/mAK4P2/qcJW4JMvdyvAYR4uZRLOZQouZ8kV5IpTk4bKRRMZMQnQhW5griZTnIBkKcT3VotxBqZ1BZXMDKpubUd7chLJMM0oyGZS2tCBp27BsgbRnICkMJKWFhDKRQBIGLJjMAjPTYFYKzEwBZpVeNlOAlQJLpcDKUmBWx79O31Wk8iCUp6fwIIL/MgEYDI5yIZmC8B+SyXBecAXBEVsnIXV/f6qX9TbSf19I/2YHgPCmR27g1eAdA4DlLUf6xraPPJ+oXA2ztlVuOdZH5eI/WmtnYOCKFzxYMA8GpgxwxcARWQcGLjkMBRiKgSsGw3+LmwjaOUwwGH5/Axz6OwAcBozwmwGcGbGoNGZYgGGBofffHwDiUt52oFqcuKT38pbzp/56FwKOX42f5QpOWI0P2JzBMw14pgFhmJCGFvXS4FCGAWVwKK4fMHKyngfCnjEog+v+nENyQ0f3GP68wSE519+oiMapFMByX5BAMVkf6RNr4+H7LNiulc20VJcGssLJregBXNZH/7YgiE5SW1uLM888ExdeeCGmTJmC8vJy/PGPf8TChQtxyimnFN3mnHPOwS233IKLL74YN954I7788ks8+OCDAIDOREfuscceWLZsGWbOnAnGGG677bZQVgdMmDABb7/9Ns4++2wkk0mMGjUKRx99NGpqarBw4UKcccYZeOWVV/Dyyy+3K8nPPfdcPPDAAzjllFNw1113YZdddsH69euxbNky3HDDDdhll10Ktvntb3+LzZs346CDDkJZWRk+++wzXH/99TjiiCMwYcKEDj/X7kBCnSAIgiAGAcqTfiW6C+UOHonubc/CWd8Ae30D3A3N8Sp6kyOxSxmSEyqQGF8BozwuzgsGpxsMMBbmnodV6MZgqd/rO5RSuTzzsNrc7qPBQH2iMS2OAwQivwsDgsaiWYrlmvc0rQnzvDgW3TUnzIMKcwGgUSoIofJkeaEoDyJZwv0FfaSEAz2oZ5YBDvyqcgbY4BCMQUaFbPQPuUF4abcN8514LgpDQYL5ihzQMVwyiMOADCvDFdNvGGYE0jy+2/BVC+Vmrleg2DNGAi1mCs2WFuXN4XxOnjebKdhdqLA2pYe0ZyPtOUgLGyWejbSbRWWmCSMa61HZ1IBhjQ2oaGpCWYuW4wnbQ8ozkPKluKUsWEjAYgkYRhosUQJmlQKJsWBWiX6UlIANK9FyvIeQSkAoF55y4MGDyzy43IPDPDiGhMMlHEPC4xIeE/CYhGBCz0NPBQvW5ZYFvDaHKCgvGYbG5u06u1wWyTOPtol21kfn4f/8GQvFiPLfJNHIHMX8Nn8LFVTpFumnGIPifv558DA4FNftXc4u7ylUpJ5YMf8mpD8Fy2uD38YRRGIxcC3iwWEoDgMMhjJgMOYv64epdD9TxZcNxWEqBksCpuKwFNMxP8G6YN8wYDADBouEuYQCv7TIE+s47el/Jb28qvqIyHfcnKCXuh0iaIuu83Qsj3DD+aCiP6jk94KbPH7kjmQK0jBCYa/fMxE570cRKa5v8ynOwvccWG4+9uC61lz35X47wvlEIgHHdf37icHNQ+X/rOPTYFUYWBWMGxD5nGVQMBlDje2g6soruvVzIoiepqysDIcccggefvhhrFmzBq7rYty4cZgzZw5uvvnmottUVFTg17/+NS677DJMmzYN++67L+bPn49zzjknlqveHj/60Y9w4YUX4vDDD8eoUaMwb948NDQ0xPrcdddduOSSSzBp0iTYtg2lFPbee288/vjjuPfee3H33Xdj1qxZuO666/CLX/yizeOVlJTg7bffxrx583D66aejsbERY8eOxXHHHdeqjE+n03jyySdx9dVXw7ZtjBs3DqeffjpuvPHGDj/P7sLUoPxrtfdoaGhAZWUl6uvru/VVg4GIlBJbtmxBdXU1OKdsVoLoKejaInoLJaQeXLTFg3IGx3dSlZBwNjT5US4NEPXxrD1ekQgFemJsGZjZ+jUjlURN/TZUVY4A70L+a5/AmK48Txq5QUT7W0AMIJSURaW5tO2+k6rCgwwjWhwov9q9szEthdLcrzLvjWiWTghzABDRgT8DcR48iohyoRRaUilYmUyhLJfS35+CJyRsP37FYbqq3IUevNDjDHLQhD10BgUopuU3C++OAABkrmZfS3MWEeSBJC8abtP+IaOzCgoCDM1WEk1WGs1muqggb7GSaDFTWlx1EC4lSr0sSrxsTo63NGJkYx2GNzZgWFMDKpuaUNaiBXm6xUbaNZASJlIqgaRKwGIpGFYpWKIcLFkGlsh7WN2X4p604cLR/+MuHObBNgQcLmCbEi4ToRx38x9cwGUehBIwhIDp6gE/TdeD4Ypw3nQFuBAwhASXEtwTMKQEFxKGEOBC5ta31yYlDE/o/Yihc2UIX5TmqpZ9aeo/4jLer3bmHMLgumLa5H68iamn0YeRN21lXhq862Jf+ddGh2R8IOKLV0mH12kQnxL7KQfSHzDAYCpTV9HnyfqCqTKKinxTMV/eB/0YLBgxed/f6CiufPkenfcz9MNMfOlvk9cWxo3JvG1kYZuKZPXHTyavLR6PlfuWT7Rbrr8xvAwT/+9PevgV6n+GstvqLNlsFmvXrsVuu+3WKbE8FFi6dCkuuOAC1NfXI92JAVF3VDrzXqEKdYIgCIIYYMisB9k8eAYXFc0unLX1ugr9q6Z4BT1nsHYuRdKPcjGGJQe3cPYr0HnS1IOHkkAHAD0oaDYLGVSdZ7N9G9MC6D+6HUefg+Nqee90Tpz3rTT3ZbmUgPL8SBYPuQzzHFKpWHV5MJUA3GIV5qFgDyqk9ekLqQek9JSCazBIJwMHTGcBg8MDg8c5PMbgcQNyUH67Ivf5ExYpqpzs1pIcYWW48oU5C6JWmJbjKoydUbF9hbQTWZy/kQofCrZhoclMaVlu6WmTmdZTK4VmM40WM9kpiZj2bJS4WpRXZppQXb8Noxq2YWR9HYY31qOysREVTY0oybgo9SykZQJJlUSCJcHNUi3Ck2VgiXHgiTKwZDlYWRlYouvVtaEUZw5s5sHmLrKmQNYQcLgHh7uwmQubu3CYCwcupNcCuC0wHRdW+PBgui5MX4YbrgfL9ZD2tCw3vFakeSfHVpCMwTEtuJYFxx/A0rEsZE1/0Mq032Za4UCVBcumBc80IbgBwbl+GHpecq7bDX/KfWls+P385fx+wbImqML15wGwIB8//BZDvD34d0T4llW59VwpfdNBeP5U31QwhQdDShjCgyGk3y7CqSFEpH/edkLC8hwkXFc/PH+adZB0syjJb3edcJm38m8eYXB4pgnPyj2EZfhtlt9mxNZ7pglhxbcJ2j1Ly/5Wr7FQusMX7lq2a5fLW6+Kh/8ZzTyECb4d+axoTdAX9AnOD1rAgxWvqo9MTcWKrw8Cc1gQmBNE57CwMt9QDJaCrspXDGY0p5xxIBhrYJCPE581+iZvmSD6gmeffRYTJ07E2LFjsWrVKsybNw9nnXUWyfRegIQ6QRAEQQwAlJCQzR5kizsoctFFkwt7TR3sNXVwv26OreMlJhJBFfq4cvBE/1dSdRkS6DGCinOZzUbEuQ3ldj4mpctIAeW4kK6uNofrS/QOyrM+k+ZB5bLwK8wDWS79abQy3Bfg0VgWiWBey/R8YS4RVJ/7SlgqCCUhoCCF/kq+pxRcKJ1bzhg8xvWDc1imhabEQP3jqkj8iZ8mjjBTHDlJDl0tzmKSPCfKw5sKyo8CUEEsSyuH7ugpxs5WQTCGJjOFZl+MB5K8OW/e4x37E0xXk2dQ5mRQ1bgN1XXbMKp+G0Y26GryysYGlDc3ozzjoUT4khxpWEYaLFnhP8aAJ/cCS5eDDavocvW4K7OwmQ2bOchyFxnTQ8bwkOWOFuXcgasykE4zlNsC5WZgOU4oxQNBnrD1fHlElofivAOfI5Ix2IkEMokUMskkWpIpZJLlyFSkkEmlkEnq9mwqhWwqgazf1pJOI5NKoSXok9APx7TgGhYcw4Jn0J/G/Y0ZSnYXSddBwnNhRZZTto2UYyNtZ5Fy7Miy7S9nkcraSNXbSDst/vosUraNtN/f9EehlIyFkt1NWPASJlzLgpew4Ca0qHcTpl5uY96zTCAYWLxAxGvZrhAs8zwR78v4op95RYjI+eBbSHar/yTJl/QostzaAVrBr8DXETosJuDBDChuhlPFdBsYj8wzAH62PeNg4NADi/IgeR+5OT+TX3EYgH8c5GWuR55p3g2lwvbIdiq+bbakAru388oQxGBh06ZNmD9/PjZt2oQxY8bgzDPPxIIFC/r7tIYk9K8GgiAIguhHBlM1umhyYK+ph/1FHdyNcYlu7lQSRrmYVenBK51Dga4HEWWWAcYH6XPpBkqpXFRL1oays1qiO31Yca5kpOLcAfxBQjuacR74bOULc8iIQO+xcwwEefuxLDIizYPBP+NV5rnBPkUkmkVC6amU8KCgfFku/JxuW8KX5UF1ua6IdbkFwXiriob32TVa+FV8FU4jFbRMV4ezoJUF5iSyPQNCoa4Cwe7rbAX94nYlcqXYKcfOXh+rxUyi0SpBo5VGU0JPg+VGK40WM9XhqvKUZ6My04idt2/B6O012Gn7Noys344R9XWobGzAsBYH5Z6JtEwhhRR4olwL8lQFeHK8nq+sAKsu11nNnUAoDw6yyDI7IsddZLkLmzuwYUN4LZBuM5TTCJZtgpW1kbAdJGwHyawDy3ZQknUw3NbzyawDo7XxD5gCNxSUCWRKU2gpS6O5vAQNpcPRVFKCppIStJSUoCldiqZUCRrTpWhKlaIxVYrGZCmaEiVoskrQYqaQMfvmJhBXAknpICUdJCOPYssJ6eaWlQNLujCVgKEETP/BlSxsgwznjci63FTm5iHBlAoz0HMR0Sw+7eD6AMEMeMyAYAZcZsBjJjy/LZh3manXcxMuM+EwCy4zYTMLHrPgMN3uMgsOt8I+WSMJmyf8h14XPFxuwuUWnEC8+nimBc+00NKLP2bT8/IkexYl2SxKshmkbT0tyWZRYmeRDuZbMkhvy6I8W+/3yaLEziCd1WI/Jub9afDwIvO5tngf10pAmqb/g2P6Bi/yYmoUj4v4cNoa7Uj6rvwKYCwU+a1X9yP/118XDxbfTgEoqShFfXMWgnEIziCZjhoSnEMy5rcbkEyvE1y3yWDKmP+tj9wyMzimH3FwF8+PIAYeN9xwA2644Yb+Po0dAhLqBEEQBNHHDKZqdNHo6Er0L+rhbsqT6KNLkJo0DMndhxUMKDpoYAzMigj0xI4n0OMxLblpn2WcA4DnhuJc2bYW6a7b7jmE1eYRWa785R4hmmUuvQ5XmcfEOSLSPBTkuTgWTwGeFFqkKwlPSkgl/X7Sr1DnoSzXFeaWP+2PHPP8zywV/q/ARDMZRqwAKJTkYYmgDLdR0K9TGLXiV5O3WlHeWVqJYckaVk6Q+7K8KSLMm610h7LKufBQ3bgdY7dtxk7bt2KnulqMqt+GEfX1GNZQj2FZqUW5SiHBS8FTlWCpSrDUMLDkePDSSrCRlWBmslNPy1NahGe4jRbDRYupq8Yz3IYnmiGcJii7AcjWw8g0IZmxkcxqQZ7IOii3HYz05xPCBTcluKX0I5g3Fbgl0VxagsbhZWgoK8WWkirUl5ajPp17NCZK0ZgoRYNVhkarFA1mKRrMMjQZJTF52l1KvRaUikzuITMoEfoRbU+LLNLCRko4SAnbf+jnaUkPlvRgSg8Jf2pKAQ79/QYJDq2+OTwYEDDhgftTAwIcIjY1/GuShRIbQN48kAttMeDChNtav0jFM2MKHMo/m+ARX2aQMKD8s8m1G5AwIMCgwrPkkDDhwYKHJGwkmIskHFjwYEaeTW/jwYDNE8iG8j2BrJEMlzM8iWZegiZegkajBI28FE1GCZqNEjQZabTwNFqMFFqMFLJGEhme1DLfSOgH199CCK5fzzTRZJahqaSsR86fS4l0VL77or00m/HlvH6UZjJI2xmU1mdQkm3B8KB/tgWl2QwSjgMDEiJftheV8tFq+YSuprf0zQjlV313aODWTqNamY/Qo7+SWGzOUgIJ0bM39hMcuOqcmT26T4IgdgxIqBMEQRBEHzFYqtFFg5bo2S/q4G1uia2zxpQiOakSyUmDV6KzhLFDCvQw5zybjclzJfvwvRitOg8GKXUcqNYqW1EkosWPZumxiJZAmgvXrzIPcswDaR7tqiuVvUg0S1Ct50VzyyNV5o4S8IQfxSJlKMmlP9UiPppdzuFxMybQe5digjwXsBKtdfVfhJwYD79LnyfJw+XYbnX4isrtS0kJyB4S5ZHjRGcVFDzG0WSl0ODL8garpECcdySGJWVnMG7rJoyt3Yydt21B9fZaVNVtw/CGeozMSFR4FtIqBdMq9yV5JViqGjy1B9iwSrDRFWAdjHsBtCTPsixauI0W00WL4SLLbDiqBcJtgnSaoLL1YJkGWJlmJDNZpO0sSr0WjPIySMssUsqBaQnwhIJhaTFuJCR4UsKrMLUM94X4lnQ1GpLlqEtUYJtVge1WJbabFaizyrHdrMQ2S88L1r0/IZPCRrloQZnXjDIvg1LRghLPRomXQdpzkPZspDwXKS/I2fZgCZ2VbviDgiolIZmW2oH+9XwFLCKK2UMJGlGKxo6eXLE3Y3/+iuhQ/nYPowCAg/lV0QwsjMhgALjStwt48FAqlPYcEgaTMJUHEy4seLCYgwQcWHCQZDaSsJFEFklmI4UMUiyLlMwgxWyk0QQLLizWszFiCoDDrFC8t/A0Go0SNBhlqDMqUGeUocEoR6OhbwA1Gb60N9NoNrSwzxhJZM0UskYCWSMBx9D/BpKcozldguZ0SbfPk0upBXtGV8uXZuJSviSsoM+gpFFL/FK7IWxLZzOwpIeE8GBAwotE2YRiPmnBDWNugtgaLeM9f1wAz7B0dAsQ3tQpkPJhZE3em7O3PtAB/+ZqF2/ytHoNDezCFoIgBi4k1AmCIAiiFxks1eiiwYb9RT2ya4pI9J1LkZw0DMlJlTDKBqFE5ww8ZYKnDLCkCTYoB1rsHMp1IbNZyExGx7ZkMn0b1wJ0uuq8oNq8JyNalIzFszAZrTLvWDSLbovHsQil4CoBRyh4kBBChJXlgTAPnq8XZJhzDo/rSJZgueerzIvFrMSryBUMSNh6WTE95ZH1TIExvQ1rS5QDetDP4Kn6Nwkg/WlPo3KT4Pk43AwleUMgzCPT5naiWLgQGLW9FrvUbsbOtZsxZtsWVG/388qbWjDM5iiXSSSMMvD0MF1Nnh4OnhoPNmwY2OhKMN7xsSIclUWGZdFiOGg2dRW5rVrguU2Qdh3MbC1S2c0ocetR5rWgRLZgmLSRhIMkc2FYUsvxQJKXSxgjFbyEgW2pYdiaGIZaaxT+bg1HbWIYtlrDsDUyX2vpPi1G1wVgUtgo91pQ5rWg1M1qEe46SDkCSU8g4QqYroLhSZieAncFDE/BEi4M5UFBQDHhv+eKweAiARcJNBdf3Tt0Z7/+tpxzSCmK7EsV9O3w4Vl889irFgrOIrT28ha0s7xZ6X/0ik74Ue4/AKAL/1ZQOi8bMMAkB1ccXAFc6exsQ+nqegtCS3e4sJij5TyyWsyzDNJoQZq1oIQ1I4UsLGZrqa8cVMhmDPc6fHulTSQYWowUmo00mowSbDfKtZw3K1BvlKPeKEOjUYYGsxSNphb0TWYaLUYaLWYaLYaupM8YSThGAooxSM7RVNIz1fNMynhsTaRyPh2T81mkWrJIOzbSdj2G+Xn0CdfJfYND6cFnGQdEOAisrpL3LBOuFQwOqwfl9RJaynuGAWHq8Qk8wwC4rp4vyJEHIqIesW9m9NjF3uq1MHALXAiCGNiQUCcIgiCIXmAwVKOLehvZNXWwv6iDtyUTW2ftXIrk7sOQnDgMRlnn8nn7nehAoiljcA+K2gGkbUNlMrlpNtvhATp7Bp23Hq86d6FE8XMIs82l/4d0Tw0IGlaaB9LczzaXxaW5HugzMhAoCqW5FwhzT8KFhCckJIQv06WOJvHPWwI5Yc4MLRNYLqqlZz4FojflopXk+V/DD6yzb+EYoJjW9ooBDBKKWYDh5MWw5AgVhpKQYQG6nyaukBvgs6cIRXkkW10fEhkjEaksT6MhUYqGRCDNS2Gbrcu7pGNjbM0mjKndgnFb9XSn7VsxansdRmUFKj0TJUj70SvDfWE+ASw1DXzccDCrY2HOSinYyCDDbTSbDloMGy6awEQdDHcbLG8rEu4WpL0tSItmVCCLKjhIcheW4cJMSF05XqrAfJcmwLHNqkBNYgS+sqqwNTEctValluO+FI/ON5qdl3BcCpSILEo8GynXRcr1kHQlEq5C2pFI2UK32S5SroukZyPp2jDgQkFAcgHFPD/epyMH7KF6UIXwJkl42HAMxuA9rT9stB/W1wlTMqxyZVLqaSRWiAUVsEoBMtIHEkyKcHsG4d88krn+wTrG9LcvwhPN+2dAdEHlzbSTqKH8UnEFxGK0Y8vIFQ6H85E2nYjFIJnSw/ZyQDEGxQ2AMx3LY3CA8XBAScZzA0zqMVK4P8/DwSVZdJBJGOCMgyndxpWueGf+STIV/cxn4UQx/TMLfnqtwwEk/Ud5692UP7yl4mDKAJQ+F0MymAowlR8jAg+WcpDkNpLIIIUM0qwFadaMNGtCimWRYBkkWNZ/2EjARtqzUSYy2Anb2jzb9pBgyPAUGs0SNBqlaDRLsN2oxHajAvVmua6gN8v9daVoMvzKeTOonvcr6I0EbCPp/zx7rnI+IIi3CQZ7Tds6gz4dW7aRdrJI2g6SjoOEl0XCcZD2XFiejlkypIQpg7EDpH5ATxkkOFOQpglhGhCmAc80IUwTVkkZKj0HknNIw/CnXOeh+8uKGxDBOm5AGFyL/EDcx54RG7D/RicIYuBDQp0gCIIgeojBUI3u1duwv/Alek1EojPA2rnMl+iVMEoHl0RnJgdL+lEuKXNIxrjvydNBAAEAAElEQVQoKXNRLYE47+vIFiiorA3p2P6gpQ6kU5i3XjSmJRggtDunWyzTPDIoaJSoNA+qzIM880CaCwW4yoPjKR3NIgU8v7I8X5jD39bjHC7jMWHuMgOiW4N85ovy/Ezy/KlvxiIV5IoBjEkt3KClebTiPD85gnEBMFcfWeaOG1aYd/XnVLBdTpDnu8NgIctNNCRL0ZAoRb0vyxsSpWiwdJtrFP+TJZ3NYKeaGlTV1WJM7RaMrd2M0du2omr7NlRnBIZ5FtK8VFeTp4f7VeX7gg0b3qmqck+5yLIWZI0WuEYTJKuHIbbBFDVIys1IiU1IYQsqWAYJaGFkGv7P1PAfkafeaJRiS2IE/pnYGTWJEahJjMCWxAhssfQ0WN5qDYfoROU7AHAlkXZtpF0XJY6LEtdDiS30IyuRtj39cG0knSwsaQPMg+QeFPOguNA3TYJc+yJva2Xpa6lThG/dqARXeiBaJQEI/Z6VQktsqQf5ZUIAngcu9QNSf8OES6EvbinBpP+NiOAOWf49pgFHsc+KgfA7K/gc6rkbsgoK0lAQhoJnKHiGhMuDeQXBFYTBoAwDytAyFAaHYiZgGODM0CKfG+DMBGcmGPTUUAY4THAY4JKDKwNcMV/iB5Je5b4N4SfV5+aKEUj6YXlPhOl9Kg4GA0wa4NIAUwYMacBSCqZUSPhyPgkbCWSRYrpaPsWakeAZWCzji/lMTsz7cj4hHIyWtRiN2m6+5kALT6HJLNFV8f6j0SxBnaGr5xuCynmjFI1GCTJGGs1RMc915bzNtaR3/YGPezLepj0SjoOE5yDpuEh4DhL+1BQifBjCgyEkTOHpZRms85edSD+pBwc2pD/2gJTgSkIpicX3PoQLbr62158TQRBDCxLqBEEQBNFNBno1unQE7C/qkP3rNrgbI1+eZ4A1tgwpX6LzkkEk0YMq9CDKxRpaVehKSi3NI+K8zwcKVTIU5iprQzm6Cj0WOxAWgUZiWhS6PyhoLJ4lGAjU9cvbcydQrNI8kOaBOHeVhCsEbCngSAlXevAiGeb5r6kE4HIDHjPhGbq63PWrzDsvzeOV31otR59D/hS5MtNARDMVF+NM+dXAuq1AlAN+JblCbmxPGSptJfVzFqaA57WjRQtzJQrleMFCtF2fgMMNv6o8EOZaltcntTwPsoijpLMZVG+vxcRta1G1fZsfxVKD0du3o7rFwzDPQMooAysZAZ7yZXl6H7Dhw8HGVOrK2XZQSsJFM1zeCGk0QLF6mGorEmoLkmoLUtiEFN+ElNFYmBhjIvaXlMNMLcUTI/2pfmw2RmKLNRKbEyNQkxyBranhsI1ODDiqFNKegxLH8eW4hxJH6qktkc4KlNge0raLtOPAEhkow4HkDiR3tSBn/gC6+c8h0ZZYzD+P+CJDUN0tEIw9wJQA8/Q1yzwBJl1wzwUTLrjwACH9h+pJZ9v+x6IhAUNBmXoqDQVlSEiuIDmguILkCorpZckVJAMEU7F5wf0pU/DCecBjCl4w5fpqi6ZVRe8jhikXQDgGQf59RhVpj24D/6OAKRYmMOmq78h8pJ0rpQUz9HYczN8+N28oBkMCpmIwpR+tIlnuoQAuGQzBwBUDlwxc6jYmGZjQbQiW9YvlV6L7teqCwRCdCYFR0O/Mjr07BVPwTAnXUHBNCc9UcA0FYXF4BoMwfVlvGAA3AW6CcwvMF/ScmTBggcOEobSoN5SpJX0QYcOCz2MJ5d9OEpF/dmSKnBdgAaj0H8GrwfxYG10xz5UBJgwwZYJJE1yaMKVCUkoklIsEHKRgI8lbkOAtMHkGFmuBxbKRhw3Ll/MWHFhMy/lSkcVw1oBE529/FeDBQMZIhnnyzUYJWngqjLxpCSrmeQpNfgROhqeQ4Slkw0Fmg4Fmk7C5Fc473NKD0RqJ2MDPTiIBJ5FAU++7e+xSvwUX9P5hCIIYYpBQJwiCIIguoJSCbPEgmxwod+BVoyul4H7VhMxft8H+R50u0QW0RN+lDKlJw5CcNAw8PXj+KcBMriNcUuaQGkxUKaWFeSaTk+j9Is9tXf3ux7ZE5XlMnPvCPKw87/Ix/Wpz4ebEufQHA41UbMcyzVuR5o4ScD0BR2lp7igBV4qcMM97LQWYluRGbuBPr9PSPF5BXryqPHrgSFZs8N8glsK3YK3J8tgxlS+1g3sBKndc7a/bqC6PWTs/riKvuePvOxXeQPQYR6NVgvpkKeqtiDhPanGeteIC2fQ8jKrbhp1rNmLatq2o3l6LnbduwZhtW7Bzk4MRDkeJUaYleckIsPQI8NS/gA0f1glZLiDQAMW3g/FaWGwrEmoz0mwjErwGBqsFx3Yw1vbntwcDmxKjsCk5ChvZKGw0RmGTNQobE6OwKVWFzemRqCkZgbpUZZv7ySfhuSh1HJQ4HkptD2VZgdKsQEnWQ2nWQ0nWRYnjIO1lAGZD+JJccU8Lcpb3g+KATAF2+y9MbqqCCBS/Glz6MlzoB/ccMM8B9xxw1wM8X4b3JEwBpgQsCWVJSFNBmhKeKXUVsynh+LLU4woOV7D9qcMBmyvYXMI1AI/rSmgRVj9LCD+yebDCQpuuUcVujAxAmARM4Ut6wWEKLdZN/2FIBlNwmAJISI6kYEhIwBIclmSwgr7+9oZgMDw9zz0G5nIwqT8HDMVguAaS7fr3INir7atEMi3mXVPBMRVci0FYBjyLQ5ocwjB8OW+AcQucWVrMw4LBTBjKioh5w4/BAcLfE5Fvfwgg9g2W1jEAVACo0FKecb9q3gjjbJg0taSXJri0AKklPZMMCSl0jrwv4U2egclaYPEMLJ6BwWyYcGAyGybzp3BhMgcWc/UAs8KFJTyUwEEFWvSAs3BhwusRaQ8ALjNC8Z7lSdj+VAv5BGyegMcMuMyEx0y4zITLzbBNBOu4CZcZYR+9nOsXtHnMgMcMjBRZACf2yHMgiL6GMYaXXnoJp556an+fyg7H4PkrmiAIgiAGAEooyGYXotnVlXYDDK/ORvbzbch+vg2yKffXpTE8idTeI5Dac8TgyURnDDzBYVQmYZYkwMz2JdpgQDoOVEuLFueZTN/HtkgBaQcDhdp+/rl+r4QVzZLpXPMeEee+JPeFuY5piVebK7/S3ItIcxF7SNhCwBMCti/LXSnhyuJV5kCk0pznKsxd3plBQHPXd/HK8rZkOXJZzlA67pdJLW+ZP8hn4Qvly3HkyfLcfgqEucptW7RyvGiD36xU21+oyZW36wgBM4l6qxT1ybKwyrw+oZebrHQuykNKDGtqQPW2Wuy1fSOqfWE+prYGO9c3YHRGoVwlYaSHa1FeMgIsPQ68ZCrYyGFgvP0/T5TyAGwHZ7VI8C2wWA1MpiW5wbbCYFvBUadvULSC53J8rUZgI6/CRlNL8k2JUdicGolNpVXYXDoSW0uHo66kQmdKdwAuJUodB6W2i1Jb6EdGoNT2UJp1UWp7SNs20m4LDNi6ijwU5UVKthOA3VZZb0yO67xvJnwxLlwtxl0HXDhgbhaGbYN5omdu1pkSsARUQkJaEl5CS3DHknBNCcdQsA0J21BoMSSyBtBiSGR82R0IS8F7XhDrQSwNWMpCWhq+2OQwoedNX3QafrY3j01ZZDk+b4R54AyGn8vNwWH4Od3BfGm6EpmMHvgyzAzXS8hfCoR5dH1+v3yiV3vkdlpYRa0iaxQr7Bdtl1CQTEJC+lMFESyHbdJvy+/bervHJAQTEFxAGAIuE8gyCQ8CgomwCr87MAkt3j2em4bzDJbQoj4lGJIeR1IyWB5DwtOC3/Q4DI/D8Bi4x7Wkh67ETxYV9P5N4E58vcIxJBwL8BIcnsXhmRzCMiBNLeWlXzXPmK6aN2DBgBmpljf9Kvn4TRUVRpx5ubED2v2YilxrDGBIAkiBYWQuzkZxcBiA1KKeSxOQJrgyAWGCKw4duq93kht4WoLDhQkbJrdh8iw4c8DhwmAeGHPBmQvOPBjMheHPc3gwIMCZC4NJnakuBAwhYUDoXHUIGBAog41KtPinr8JHfBlF2nLrkLcc9G1SFQCu7/DPlSD6ipqaGsyfPx8rVqzA5s2bMXz4cEydOhXz58/HEUccAQDYuHEjhg8f3ufnNmHCBMydOxdz587t82PnU1tbi6lTp2LDhg3Yvn07hg0b1ifHJaFOEARBEB1AeRKiyYFs9tC2hep7pO1Hunwej3RhSQOpPYYhtfcImNUl/kBiAxzOdIxL2oSyGIytLTDKEnpAtEGI8jwtzlsyUJmW/hsw1PZjW+xsTp5HBweVvPsZ58EAoNIDky6KDQiqs8mRk+eIynMJV3hw/GgWPRXwpNRFsa1I81CYc6MT8Sz5meW5SJRCWx2V5fr10QN7BrnlCuB+/jNTrVQ8F5HlgC8jclI0vLGi4Av8rlaPt4cKJWyAyzgarFLUJUvRkNDSPBDmDYlSeH6OueW6qNpei9E1WzF+2zpUb6vFTtu2YudttRjb5GKky2ElK8HTIyLCfBL42OFgEzowwKeS4KiFwWpg8hoYbKsvy7dGZHl9gSyXAhA2h8gaaHST2MjH42urGl8nqrApVYVN6VHYVD4KmyqqUFMxAtvLKyE7mE/OlESp7aLM9lCW9VCWEf7UF+VOFiVOCxKiBcqwIbnbuiQ3Ac9sJYM8+N0i/Vxxv1KceUG1uKsFuWuDO1ktzzv0DIpgSCAhoRIC0pIQCS3CXUvANhWylkTGlGgxJZoMhSZDImMpXS1uScjufiQrwABHQpkwpQlL6UdCWkgoK1y2lAlTmaEED6R4KMbBc4JcGdAt/fu7rkyV6W/c9BIsIt5jtHKfbiCiZbzwBbuEx7RoFxC5+YiAF0y3e0zAgweXef6yB8/04CU8ZJmHRubBRReFvdJV9QmPw/KYlvP+fNCW9jhSgiHlcSTCvhymx2F6DNzl4JHq+YTgSAgAWf2s/d9anTklgDG4FofrS3lhcT1YZ5A7b5i6Yp4ZYNyX8SwSYRMqn3j2UO6mTJHPqTav77iY17/3IsuI3BJSFoCkrtIP8+0Nf1BaHXkDxQHpV9krBuXHGCk/rij6T27ODEgpoHwhHr2xFASlBTezVfTJssgtpWAQ7kiMT9Iswd7t/jQIou+ZNWsWHMfBM888g4kTJ2Lz5s148803UVubG2th9OjR/XiG3cdxHCQSHQ8FK8ZFF12EKVOmYMOGDT10Vh2DhDpBEARBtIG0BWSTA5npvT+Ou4KSfqTL54WRLoldy5H6xggkd6scHFXdBgdP+1EuSSMU/1IOvG8AtIWSUovzbCYn0d0OJxT3DJ4LmbUh7Wwu9zwYpC+sNudaondbnLt+TIsHKBfBDqVScJEbDDQQ5i4AoQQ8SLie50tzCUe5cKSCknqbfCR0pIhnRCvNjXakuUJOmgfCvJXq8jCznEEp7rtzqduCqnJDgkGA+VnmcXcQkeWI//EfRKoE8RphcbmK/LHf48Lr/2fv34Nty+r6bvgzxpjrvta+73Pp06cvp7uhu6UvYBQx5QNGUUuKMgbwJZpEpARF8+QVpWgSpCUQtAKK+lRhLCUFWmoqVQlSMQRLNPLKg8EoEUQREOz7OfvsffZlXed1jPH+Mcaca661195n79Pn0g3re2qeeb+uy17zM77z+yt2MjHVWBgGNe8wbxO2VtmSil7VAfNh1cHu1mjIqZ1LnNi4xG07j3By+xIndy9x016fm0aaJVtFNlbHUSzNOxELL0ScWDhSFIuwPQfJ5WYJlpc6dopGiSyW6FCSRZIkkuhYsadbXKjey4XaOhuNdTaaq2y217i4usbmyirbi8v0Wp0jXipLK0kdHI+060IXudKOExpxSDMZUdNDkAlGxhiV7I9bAahCcsA+Cgd57h7Psn1wXCaxg+dHO/LyBYWqxtYMpqrJqpqkYoirhqhiGFU0/YqhH1h6gZsWVw1aXeEbzzpYFhiJQjnobSrUbIWaqVIzVeq2Rs1UqdoKgVUTYDzvO+z9LGjkPa5KT/kU1uE8T9zDQuu/a4yVGCTGCKwrk4gxcmK+W1667ya/g/IzLnkbaP7wClPTcw+uczWL0jw7nieMayCU/imcAjga/x1YfEOOnb1i7PiVvi/EeBmJRQqLwiKFKwKphEVikMIiEQRWUhGVq/4d6L7xTQHc0xy8Twzn88ZdJlIymZJVUtIc0JOSCH3sQ5TaxddU00k4XwbzDe+cr+fAXkuCVKJS55x3YF6AtVQTTTW5ssZ4CyAVVjpXfBZMgnmjpHfK+6KwUiGEAhEghS8G65qu/Bb3FwWYvj52YugQV3/+McmX3VcUxL/P/HKVoEqqx5E9Ez8BiqfC2LcdMT2/tHNlLP/3//2vZh/fXF/VstaSJdf/XiOoyiOZnPb29vjEJz7Bxz/+cV784hcDcOutt/KN3/iNE8tNR7786Z/+KT/2Yz/GF77wBZ73vOfx0z/903zv934vf/mXf8mDDz7Ixz/+cb71W7+VP/zDP+Shhx7i85//PA8++CAf+MAHeO5znwvAV77yFX7yJ3+ST33qUwyHQ+655x5+7ud+jm//9m8H4CUveQmPPfYYb3zjG3njG98IuOv59re/nQ9/+MN85jOfKY7vl37pl/ilX/olHn30UQBe85rXsLe3xzd8wzfwvve9j1qtxiOPPMITTzzBT/3UT/EHf/AHSCn5lm/5Fn75l3+Z22677dDr9B/+w39gb2+Phx9+mI9+9KOXva5XU3OgPtdcc80111xTstZiwww9SLFXeANzrZTtRkRf2CX64qxIl1Xqz1l+VkS6iIorKCoaAbL67CwoapMEMxqNu+iy6cVXV0b7zHPnPjdxhEl0yXUuxu7zK1FeGDR3nE+Bc21tAcxzt3kKpNa7DLUhLdzmGamxaGsxZjY/yYSYHdFyIKTNI1im88vLd/rT7nLp3Wl5hq1FKO1v2h0w34cGbGnrdnJa4Y8zY9t57jq/dg+yWGZt3FqXDZ9nme9V2w6e13KXeZtUKpZ7XU5tb3HqkYs8f/eSA+Y7l7hpEHE6gqZqO3d5cwXZXEU0bkGeWkWcPYq7PEbhYbm8hGJrCphfQuuMNA7QA4EZQhopwkiSRYo92+Z8/QEuNE6w0Vpjc2mVrbVVB8uXV9lZXCas1Y90lZQ2dKKUTqTpjDSdKKM9ymjFEa0kpJkMaWQDEOPYlZmgvALZrK9Ua5yTXGvvIk+RaYxIYmSaOEiepS7m6EhH7FXV2LpG1zRpTRNXNWFVM6oYhhXLINB0A8OoYokrLmLl2FzaM1OBLJzeDnpXqJkKNVulYWo0TI2mbtAyDWq25tzkNnhmg3ALWIkwCqxC2HF8BUYhTD5Nok0FaxXWKAesbd6X4JfBx7wU7tpSXyJ88U/hI2GED+cQLNzo63AVlXuYc3+1Eb5+Be4pHT013eCLtAKpgMyPa3zhVnDFXAEjDBqLET42RvjisH4Y4WJkLAak9U99aJQ0BMK4SBBRHrZu3E+fHm6UhhVuvcAD/4P4ljt/QypSB9/lJIgvgLxM0DIhkympTMiClLSSkQhNSEqCOXYt3n1gXksqqYu1qWQu0iZ3zVe1pOrhfZB5OJ+5zHmZWWSmIQMVwzHKIpeuAx7Mj8G7VW4c6cC8VgoTSIySfjnXIRywR0gP651TXYry779pUO+mlb+VkzSjHDp/Nf7MauBXf+1XnhGxFXNdX2WJ4df+v/+/677f1//yi6nULn/v0263abfbfPjDH+abvumbqNUu/8nt9Xq8/OUv57u/+7v5nd/5HR577LED39tvfetb+YVf+AXW19f50R/9UV772tfyyU9+EoDBYMB3f/d38653vYtarcZv/uZv8vKXv5wvfvGL3HLLLXzoQx/igQce4PWvfz2ve93rjnX+AH/0R3/EwsICH/vYxwBI05Tv/M7v5EUvehGf+MQnCIKAf/fv/h3f9V3fxV/91V8d6GD//Oc/zzve8Q7+7M/+jL//+78/9nE8Xc2B+lxzzTXXXHN5WePy0c0wxWbPHHd0EenytzukG1ORLs9Zpn73CsGJxjM+0kVUFbIROJBeeRY456dkomgMz4ej6+w+n4xuMVGEidKJjHPnOr+CxomZ4NyV/bS+IGg52zwDEgypNWQ6I8X4gqAZqXaRLsZaSoy5UBHRIhRpCZxnUrH/E2eK/sEZ5tPAXHnDXAmYSw3SOcyZBuYlp7gBMJOZ5W4RWzK7l9KLrwkwn+0uzydZ64q2dWst9vIs81q7yDXvV5ss9vsOmF/c4u6dJzm1vcXp7W1uHiScTKBaXUI2Vz0sP41sPg9xbvlI2eXOXb5JIDc9KN9EiS2w26R6jywboUOJGQr0wGBHgixSZJFkoOtcaHwdm0sOjm8ur7J1cpWLKw6YX1paPTIsr6WaTpjRCTWd0NAZZbTimHYc0kpGNNIhVT3EKucqnxm9oiCb9XExBmE06AyZZYgsQaQxMolRSeSc5VmKOOobwAPyrKZJq5q4pgkrmkHVMKgauoGhVzFENU1UMdgr/Wq0IH38ScVWqBrnGG+YGg1bp62btHWTjm7TtLUbBMW9w1lqpDAIoX1OuUBZixTuqJR3N0vwyznHM2L8VIjw49LXJJA+bkkKg5AGhEYI4z7/fl/FsHTj4wLAkyq+Iw6MDbncfFzjnc+bth7M2xkdhRPddyYfFhjUeNhIrAmwJsCYClYrrKm4adpP88NWB1hTwegATAVjXP618XnY1owbRQQgLf51YGZcjkBMQoMS7Lz6T9gcTSmWVIz7WWk4h/hu2DKCYjgrDae49RJhSbEYoTHSvW8CD+wDdAHdAzEedjB+cl6d/cvl61f8NEOGlpqkcMVnJDIjFQlaxWgVk8nYQXmRkqmUVGUkNU2CoW8zYmaGtFxWwuBd8nnu/Ng9H2hBVQtqWlDTkqrxrnrtomwCLV1x2MwVl5VaOFAfuwalK5X7e+2hu5SuXkUJws+eLty4EFPDEuunuW2KqemT8/P1AXYvXbjic5hrrmulIAj44Ac/yOte9zp+9Vd/lRe84AW8+MUv5tWvfjX333//zHV+53d+ByEEv/7rv069Xufee+/lqaeemgm93/WudxXO97e85S287GUvI4oi6vU6DzzwAA888ECx7Dvf+U5+93d/l//23/4b//Jf/ktWVlZQStHpdK4ocqbVavH+97+/AOW/9Vu/hTGG97///cX97Ac+8AGWlpb4+Mc/znd8x/6iwXEc80//6T/lPe95D7fccsscqM8111xzzTXXjZDNDNqD9JmZEzdAE5EuX9lzNBN8pMsC9XtWqN228MyOdBECUZVjiP5MPtYpWWtd4dBSZ69nEVqdeWgeYUYeojs739iBzjHhuTWuGOgMcG48ONcWUu82T4DEajKryYwrBJpZTaINmXea5+B8+sqkeUSLkIXjPBVqRkRLkY8wBc0PAebWJ6d696IQxgHzIp6gFLNScpZbShnlBbj2wNyOjycvsnbtgPlsd7mfCxZCGdCttdmrdQqXea/WpltpUY0SB8y3t7hl5zEHzHe2OdtPOBELavUlRHMV2VhFNG9GNh9E3LV0+TgWq5FsE3hgrsQWVuyQ2q6D5XEXHWaYAYiuRnY1OlRkoSS2FS4tneLiyhpbHpZv3rbK1vIKF1fX2VxeYdBsH+kK1RPNQpjRGRkWRppOlNCKI9pRSDMd0UwGKEKMig92lfuc8snzy93kHogn3kWexsg0HYPyyxFCYZ2DvJ45B3lNM6o5QN6raPaqhsEVAXL/fp+apFAOjtsqdVOjrms0TZ22btG0dZqmTt3UqNnK04LkAoNUGVJopMpQMkNKjZSTw25cI4VzCUthUFKjpEYI7Zf1sFxqhMwcQFeZG74KxSjnevoSxuK+Oi1Sg9IWZSxKW6T7Si3AqdACYQRCS6SW2Ew5oK8DjA6wuoLNKmhTwegKOquR6TqprpNQJ7VVMlsjtVUSWyO1NTJqZLaCtlW0rWAIMLaCJcBa/3QBeX9cNDZXBUHFx41cbahvsCQ48J4IB+YTD+jH4w7KJwJGwk6M56A/KS2f+kMVWAfcZ8D3SjF9CtQXYN6tq4RFihQrEmc3l5HrByOkCrHKfT9qmXow7+NupCYJHJhPyBhZS2wtVxA0NaGiOGwB3z2ANw6+K+O6ihFUNFSsJDB+eTOer/w60nhgX/RB5MP+T7/ru6x1UUw7/nnkQH90tD9Pc32VKahKXv/LL74h+z2qXvGKV/Cyl72MT3ziE3zqU5/iox/9KO9+97t5//vfz2te85p9y3/xi1/k/vvvp14fGxSmI2JylaH86dOnAdjc3OSWW25hMBjw9re/nY985CNcuHCBLMsIw5DHH3/8yMd+mO67774J1/lnP/tZvvzlL9PpTEb2RVHEV77ylZnb+Nf/+l9zzz338M/+2T+7Ksd0JZoD9bnmmmuuub5mZRKNGaQuH/0ZUmjUhBnh3+4Qfu4Spj9O5FUrdep3r1B/7jKq9QyOdBECWVeIuofo6pntms9ltZ5wn5twdF2ddzZLfe56hBmGmFg717nGA+VjNkbYDHQKNs85T8FqzFRMSwbEGBJryEyGtoZUGzKbFcVAc3CumWxvGhcELbvN3fB+f3UOt80UNM97YhzJUgCS/K7Zu0llKcfcGsqwHL/VcV41lF/Acu3Pa+syvwww930DxKriXOY+03yv7oC51pLl7h6nL21x+rFN7rv0V9y6vcnNg4yltEK1tuyAeXMV2bwF0Xw+YmXxCMA8QeFguZXbaNkjMbskuk8Sd9GjHnagEXsGtZui9jTWOLzcb7a4uHKWiyurbK6ssXnLKheX17i44rLLdxcWnUvwMqpmhs5IszgyPoYloR1FtOKQdjKkmfQ9LI88LJ9xGtWpkn5FPnmKzEG5d5SL1BXylFmCOLQmg4fkbT0FyTW9qmY3MAxrDpLHVcPRuE3+Pph1ElCxATVTo2EcFG+bJg1T912NpqlRN7UJiDi9ESEMSqWoSoxSQzcsM9dXKUqmKJUhfX88PSv6Y1B+/Z/KslphjAOyxjuvta6gTUCWd7pCZgMyo8isQltJZiTGCrQV/vtJYPKivnkUj9EoY1BGI41Bae07Nyx1htS++KulyCqHy3wvzJhnZ7whhLSu8UDkw/gnZsb9ffP9OuNhNw/hM8uV66QsDSuLUAYh8+FZyxmm6+9aKVwtyGPBVMuhedjTykBkUMsE9QxkBlJbVOYBfmYJjCXIDFVjqGhDxRiq2lC1mkpmqJQgP1Y4GO87N1wns1VS8mE3PTV1Itsksg1i2yCxdRLbmFjHwfwaxlaxtgK431YSQR2oWzjih/0IV24S0idTkD4H8dPTwhKYTzyYTz2kz+DAuKcc3JdjbaZjbhrC0BEGJVKkjJEq9F2EVBFCxUgZg4oQKsGKGFSClSlG5J1Gqwxd0aRoMiyJhYFvnLdPE9YfW1OwXRb90jSTg/jxvJX6nKh/LUoIcaTolRuter3OS1/6Ul760pfytre9jR/+4R/mZ37mZ2YC9eOoUhnfT07Xr3rTm97Exz72MX7+53+eO++8k0ajwStf+UqSZGa1mEJSysKYkiud8URvq9WaGB8MBnz91389v/3bv71v2fX19Zn7+p//83/yuc99jv/yX/4LQLHftbU13vrWt/Jv/+2/PfRYr4bmQH2uueaaa66vOZkwQw8SbPzMyUdPN0eEn7tE9KXdwo3+rIl0kQJZD5ANX1RUPkOPs6Qbm39usVGMDkPsMEaHMTYxJXgORwbo1oD1rnM9zjk31hRRLal1N+Ex3mVuNInVaKNJjXNka+Oc5q5+6WRci4ExNJ+KapmU8WenZ0Bz7zK3EouaMKB7+xlCZD6mwXWTsLxEpDVMU60JYI4t1rvuwDxfxA9HquKd5m263m0+lFUag4jV3V1ufuoCD25+mVu3Njg90CxlNaqVZURzbQzM2y9Ari0e4dBiJJugdkjlHrHok5guUdonGXXJ+kPEbkawm9LsjajG7gYnVcq7ys9ycWWNzeescXHZgfM8uzw6QhSL0oaFke9CTSdMaEcx7XhEKxnSSgYEZuSc5Sqe6SyfBctdEU9fwNPnk4s0cZA8PdxVbqXBNDRJJyOqa8Kapl9zLvK9qoPmx3GSi6Ip5sCwZaq2QsM0PBRveAd5vcgkzzsJKJUSeMgdqARVSQmCIUrtjqeVlinDcKlS5DVwe1sjMLqGzWqYrIrRNUxWwxbDVazvm6xKomskukqsa0S6SmQqRLpCbANiExCZCqFVhKZCZBVDHZAYi9YGazOUGVG1MTUdUzcRNR1TMzE1k/i+66omoWpiKjal/C151KZGn7yNe7LneI3S40gZFzGD8PvNEyOEhxEC92SWlJjie8K/O4Uo3jvFe0jkBUNLT+FMTBP+q1OMl5lunRt/UY5jiCa+iPJpxsF1YRx4l65xUkqDVBoVGGRgkIF1/YpB5MNT0+Ws6flwxVD8aQhclzdhTjbZ+AsHHOVpK/eAlcQkEpsKSCWkBpmFiHSEyiyVzMH5ILNUtGFRG9a1oWo0da2pWU1VGirSOcCnf1IZKx2ctw1SWy91ftzMmGbrxKZBbJse3DfI/HQH62u40BxBDahdRUhvcBE2hWt+KvYmYRx7U3bVl6NyhhNROK6f598/PRaeF6B1DXpSJkiZoGSCkClSpggZu75w893TLAlCpAiZgkz974LUtcb43wgWF9VUfqrNitIwFiuMq5ciDAaL9rVTrF/W/9Lx24LQXucC8nPN9TR077338uEPf3jmvOc+97n81m/9FnEcF5nrf/7nf37sfXzyk5/kNa95Dd/7vd8LOOCdFxXNVa1W0XryXnp9fZ2NjQ2stcV9a7lA6UF6wQtewH/+z/+ZEydOsLBwtCok//W//lfCMCzG//zP/5zXvva1fOITn+COO+440jaeruZAfa655pprrq8JWWsxowwzSLDpMyMf3WpD/OU9Rp+7RLYxKqYHaw0a969Rv2v5mZs17p3oshEg6sEzHqLbNMUMh+jBEDMcXt/8c2vQYYgZxJhRiA1TTGZdfEuhI1w/m4HOwCaF69yazBV4sw6eJzhwnhjnOE/QaG1IjSkcnBPgnLHrXAtBKiYd5/tjWspu8yz3hZfM5rnLPIfmEp8rAGiQCfiMWlfSDoob4DKJPghaT0Dz6+cyPwiYg3ea1108y16tTa/SREUZS90ut196grs3/5abti5ysp+xmDaoyjzDfA3ROols3ou4a+UIDvMIyzZa7RKrPiM5JNR9wnhAPNhDd4fU9hJa/SHNwYh6GDtMVW+wu7LGxZXTbJxe4+LXrbOxus7myioXV9bY7Sy6XNrLqBVpFoeWhZFmIUzphC6zvB07WF7VA6x0sHxmZnllFizXPqM8Qcaxh+SJg+ZZ4mH5jEuhDLqhSVoOlA+rml5Ns1fV9GuG0DvMj1KwU3pfskMxhyxsoWGaNE2jcJK3dZ1FEbAgJB0paEtLRWUElTII35uC4wkqcPOulnRax6R1TFbHpA0/3MCkNXTmx9OGn++GdeaWz7IKoa4R6iojUyW0ikhALCAStuhPDkNGijQR9bzTEQ0TUdejCRDeMAlL+bhOqNrkiJzOUpGaijBUpSYIxi7bQOaFJXOnt0BI57oWYrIYopEKIxRaBmipMDIglQFaVchEQCYraKF8PyAriieO85UPrFZ5gNrNJQajvWO+ijdYxeMz+VM+xg2nFhILxjpgb21pmXzcuM+zH3ZZ9qXGH5kRqNRFCSmNDDL3xESgkYFGVcZ9FRhk1aAqDt6rqvsbIySomkHVDv79lvpurLzJxSEPa0AnCp1IdCIxiSogvUmVz2qRkAlEJlAZBKkl0EOqukddZzRlRkfFNGVMXWVUpaYiNVXpolhmXVbnms8d8jmMd8OJaewD9KmflpShvW2SmgaZraF9SVGJoApU7dWPvQHQGFdMVlhfTHZcbDbzwN5l14vCfT+enxefrfqitRYtfMOWGBe1zaeluP1Mzr9qbQ+XkaGzEF2PHc0117G0vb3Nq171Kl772tdy//330+l0+Iu/+Ave/e538z3f8z0z1/n+7/9+3vrWt/L617+et7zlLTz++OP8/M//PMCxjFl33XUXH/rQh3j5y1+OEIK3ve1thXs912233caf/Mmf8OpXv5parcba2hoveclL2Nra4t3vfjevfOUr+f3f/30++tGPXhaS/8AP/ADvec97+J7v+R7e8Y53cPPNN/PYY4/xoQ99iDe/+c3cfPPN+9aZhuaXLl0C4J577mFpaenI5/p09KwB6u9617v4yEc+wmc+8xmq1Sp7e3v7lnn88cd5wxvewB//8R/Tbrf5wR/8QX7u536OIHjWnOZcc80111xXWQVI7yfPmEKjepAQ/vU24d9sY0OPmKSgdscizfvXCU41n7FudFFTyGblGR/nUkS4DAauiw9/RPGq7jtNMcMIPYyxoxgdJ+4OcUKHgTvr4Lnx4FynWO86Tz0MT4EITezBeYom065QqDXW85BxTEvuOjdAJoSD5sJDcw/QJx/9LxcENYUv11stvdNcgpG4EoIuKxmhQabOSUYO0nN/4tj2njvIZ516MfmaRbPMAOb55NJhlb8tMiHZyzPN620iKpzc2+Tm7QucvfQkL9y6yHo3ph23qIglVGPNu8xPI1v3IW5bQajDXbHWphh2SFSXUTCkL0OGesgoGhD1dqn192j2hrT6I5qDIY1hRA2QrQ79VR+/ctsaG6vrPoplnY2VNQatyz/KHmjLwtCwmOeWhzELubs8HtJMe0gRoWWEUTNyy2dlluvMRbCkMTJxgHyfu3z6SQNh0Q1N3MwIGxmDmmavpulWDaN6VoDyNLCHfoRyH3JVuCK5Du/PXsEgUFayamssixpLBCyJgI4UDpILS0NZaiqjohKCYEQQ7HlAnhyXte6TzqqYtI5Om5ikhU58P21ikmbRN2l9Co7Xin7u046whNISevAdCjccSuvHIfRwfCQ9GJdQEQkNMaJudqhrD8gzB8ibOmKlAOYxdR1SNzEVO24eCYSmJjVVDxhzyFgJXC50JR/37uCK0EgJVikPvhVaecjtu0TWSESNSNSIRJVEVBlRIRFVElEhoXKkmKFro8s1hk56521pyOLAc+FJt7Z48kFg/Udr7DjP/er5+OQebalvSx/L2ctNOtiZ/PyJfJZkaiH/JNHkmdqJN74s7S0/MzeshUB76JrvURjhvoKzkhMfB3usb1B1qV7u75kUKUokzumsUgKRjJ/YKHdB5rqK7wKNqjpQL6SD8kFdE9Sv7OnE0MIwkWwkATquOjgfS7JEoWMH6k2qMJnCpsplzWcSm0lEJpEaAmkJpKEqNFU1oip61GVGXSa0ZUpDRLRlTEdGNOXs75exk37smM8mHPUu+iaxDTJTO2C5yenaVslsFVN6ekMhURMN2ddfhQ/dO86t8E9pCDv1ucLH6dupaXmzfen/Ytp4C2tLxy+qONdc11rtdpsXvvCF/OIv/iJf+cpXSNOUs2fP8rrXvY5/82/+zcx1FhYW+L3f+z3e8IY38OCDD3Lffffx8MMP8/3f//0TueqX03vf+15e+9rX8s3f/M2sra3x0EMP0ev1JpZ5xzvewY/8yI9wxx13EMcx1lruuecefuVXfoWf/dmf5Z3vfCeveMUreNOb3sSv/dqvHbq/ZrPJn/zJn/DQQw/xT/7JP6Hf73PmzBm+7du+7ciO9RshYacDbp6h+pmf+RmWlpZ48skn+Y//8T/uA+paax588EFOnTrFe97zHi5cuMC/+Bf/gte97nX87M/+7JH30+v1WFxcpNvtPqNfuCuRMYbNzU1OnDiBPIITaa655jqa5p+tZ6astZhhihmkzwiQbq0lfWpA+LlLxH/fLW5QZKtC43mr1O9dfcZmo4uKdBC9cX0Lix7ns5UXEc0d6NczA91GCdnAx7eMYmxyjJt1awENOi7guTEJmbWkONd5hCa2xhcFzXzGee44x/PhSXiuLWQIUilJCsf5YeDcYvKYlgKa+0xhiy+Caj0wd1nmCF2MWzHeTtlFfuApX3On+SQ0nwXMYRKaGwS9apO9eocwqLAc7XFyb4vTO1uc2L7E2naPxbBKVS8jgnVkaw3RWkc215CtdUSlcfgRWY2mS6T6DIIRPRWzR0QY9bHDLardS7R6Q1r9Ia2ec5ljYbez6CC5h+Y5MN9YcdOOEsfSiB0sXxwaFkcZnTCmE+Xu8iG1bOCK2KkIexTntLVjZ3kew+KBuUxjB8vt5PeurhiShneU1zPnKPeAfFTPGNU1UfVgR7kA6kDgCVOKccbZGSsEWFrK0pawIGFFVFgSigUpWZCClrQ0laauNFXvGpfyyt+AOquSpQ100hwD8aSJSTqYuF0C5A102kInDUzaQqcNMLONPzGGkbSMBIw8FA+9OzzMYbkcA/JQjN2cFZPS0CENHdLUIQ1TGtYhDT2iqUNadsSiHdJSMVU5huI1qalKB8drJUhekxlV5ftSIxVoFZDIOqGoMxJ1IlEjFHViHAiPRblfI6JGLKoYcT1za/fD3jweooDUHl67cTMJvQsHtimWKfcdJDd+PagvnCDuXkQU+3DbkbMOafZooVkO3eJJivIGRf5fDsL3rziGjqX5YsYyh+mwBqR986a3NmN85iMopU0Ww8KfnSiK7+Zna/NIHN/Aki9jhXtiCvIceV8gV2YugkRo/9nPY5SyEpgvA3qNDK7O70gdS++QV+N+XBqPJ6cbHaDTAKMr2Mw11AjpnsiQ0kUQSWkJhEUp657g8E91VGRGVbjPa00mNHDgviES6iKhRkod18/jo3JYn9kaGa6fw3aXXV+dmj+erm2VtFi+hibA2ABNxfcDtHXFZ8fzJvvmBvk9W2qT17zv1Tdk39dSX81s67iKoohHHnmE22+//Vhg+atBv/3bv80P/dAP0e12aTQO/6061/HeK88a63YeKP/BD35w5vw/+IM/4POf/zx/+Id/yMmTJ3nwwQd55zvfyUMPPcTb3/72iQqyc80111xzffXqmQbSTaKJvrhL+LlL6J3xI6WVm1o07l+ndvviM9LpLQKJbATIZoCoPDML9pgocu7zoY9xMVeVyM6UNRabZJh+iB5GmFGMTY8I0At4niBMCjpF25TMGDILMRCSEec558blnGvrs8DzdJUSPNe4IqM5NE+kIhOuPxnVMnacG0zJKe6guTUCrHud3azMZZdK7SJaAo2VxQEwhar3cZJrn2k+w2V+iMO8tBbDoIapCGrErAx3Wd/dZnV3l+XdLgs9SzVdBHsCUV93wLx1t4Pna5ePZclsn1D26VUi9oKUXRGTpnvY4Raqv0WzN6DVG9HqD1npDTkVJx6Yr7GxdoLPnT3Hxuo6F9bWC4d5Wrn8b9h2mANzzeJI0xnFdOIRnWhEK+mjGKGVK/a5L46lAsl0W57RYzd5Go9jWPLxUhSLxZLWDVEjY7SQ0atrujXNqOYged5pNfvFl0BLCFoIFoREWweTQ2vRHpnVBLSlpa0sLQltZd24hEXhILmbZ2mojIqafvWP9ji/MYosraOzOlnSQCct37XRUQcTLbguXkTHbT+vCfbyt1Qx2jnDhWUoBUMJo4olFAkjCSMPyYfeYV5OhBLWjGG4CWlmIW0dsq5DWmbEAiMWbZ81uqyLPRZlSE1l1FVGXWbUqm645sfz4XJERUSVyEPxUNQJRY1ItAhFnR3RIPSgPBJjeJ6J69cIbEpfMsLmMNsVFRXWIK1xma05DLcWmResxSCs9vzWIPP5l8PHs5nz/mmFu9vB3EAYtNLOAZuDblEC4fk6QhTAvPCUF8D7iBfm8CO7wTrCk1mXeQnc9Sn5i8X4yaWDNjDRfJKPuFq1AGgkrnkOYLIw3vRmnX9eIIT1BX5NEVkjgwypNFL54r4qc4V+g8wN5/2KRvrvpHFsTTZ7v5eRyQTax9TkjnidyNI0RZZIknQM6U1UQSc1tI+4yRIfyyYVVhVk3oF6gYvw8zFKeV+Aj1fyEN93SkRIGaKkj2Qiz6jXKGGoCEtduM9nXhRV+k4xHlcYlNUugsu6qy6RYAUCifDF2UVeuBzXL37DkBcVFqXpoljW+G2VlzP58lYwDBrAVx9Qn+trU7/5m7/JuXPnOHPmDJ/97Gd56KGH+L7v+745TL8GetYA9cvpf/2v/8V9993HyZMni2nf+Z3fyRve8Ab+5m/+huc///k38Ojmmmuuuea61rLGYkYpup+CvvEgPduNXJHRL+xgE388gaT+3GWa960RrD0Df9RIgWwGyEYF+Qysem+TBO3huRkMsNm1LyprtQPoehBhhjE2jDHJ0Ry8ZXhuS/A88cAwsg6apzYj1Q6cl13nAMaOc84zLDGSRAaF4zw5sDioxaALwmyMu2l0N5TKLSKMd5gnoLRzUyqfb24ngcW0s3viNO14xF5DaD7tMj/wU24tFRJqQUZdRKz0d1nd3WFlt0tnZ0QtbGPMKYw6iWyuI5p3IVvryJvWEbce/rk0NiWiRzcI2a2m9FTIiAF6dAnR36TZ6xUu85XekDP9EYNmmwtrLrf8S+vP4cLdJ7i46pzmG6vrxNXaofsUxrIQ5u5yB807YcSCd5g3kwFCDtFBiJFT+eUSdD2PPCkpy5BpXuBzv8McnaNsS1I3hHXNoJnSq2cM6ppRw7nMh77Q56yCngroCEFbSFYJELgGoNBaejYjkJaOgo60dJQt+u18PJ8nLVfyYIyxgiyrkaV1srRJljTRSYss6mDiDjpaREeLmNB38SJWH/5alKUxxGhCkTGUGX0l6EvJSNgCkDuH+X5AnqumI5p6REuPaJiQFTOiY0cs02eNPU6JXc6KTU6pPZoqde9pmRWwvCozDipfEVFjKBqMZIOR6LArGox8N/T9UDQKV/m1doyXApyQVnsQ7sG41WP4bY2bj3V53NYiCyg+5fI+SAeA8EnQOiam+deYLQqL+mMuYHdpgx6CF/71fPliZ5KgqsjqARNU9rADfcZoumX0gJHr/nx76TodK1R7CryLg+YdvEv33nDLah34wO8rMOoJ4/Lj8xz5A/oq8A56pR20V5nLlw/ct7grAquh8fR+/1gNOs1jaiQmk5hU+L4fz+F9Md9NKy+TzVjHXbz9mMnmdQkclR83KAnh6xbgp00uk3dWCCpBjVTnEX5i6u1Q+kxOTYOpz3FpQAj45m946dO6nnPN9UzSxsYGDz/8MBsbG5w+fZpXvepVvOtd77rRh/VVqa8aoL6xsTEB04FifGNj48D14jgmjuNiPM8FMsbsC91/tssY59z4ajuvuea60Zp/tm6srHGOdD288SDdGkvyWI/oc9ukTwyK6XKxSuO+NWp3Lxeg2thnyPtFCOdEbwSImiqy258J72edpujBgDjLsMMh9igg+2nIWusyXVONHkbYYYyNIwfQLwcQ7BieG52SeXie+siWyGhSq0mNJjGZi2Yxdkxy/P4NPiNdQCQUsXKFQfO4lilPNu5WX/vacA7IO9ojsSZfXiO80xzlcs6FNA6oz4pnmQXOzXjm1Y1o2Q/Ny5D+oHdhxSasmh4NEVEnZGnYZWm3x+Jej+ZeDMk6mTmNVqeQzXuQrRPI9gnEXWsIeTg4TMyAvhqxV0noVUL6asTI9LGDLSqDbVrdAe3egHZvyFpviDGCC2snOL92gsdWb2Xj1nU2Vte4sHaSjdV1otplIK21LIwMSx6YLw00Cz6SpRMNaaQ9CIZoFe0H5gGks37N62wcv+IjWcZO8xhhXC5+XHfZ5P16xmDRQfLLwXKBpSOhIyTLKOq2jrIKYwVGJaQyBqXdMmoKknuXeVvCcR/M0VqRZTXSrEaW1ceAPG6j4w466nhAvowOV7DhAtIcHZADaDQJKSGaUBgGUtBVip5SDD0oH3qXeTwBUcG9aQ3KZt5JHtFKQ07ZIYsMWBU9Too9zohL3CIvcrvaYKkS0ainVKW+bBZ7imIkmgxFk0s5GJfTkLzJSNQZicY1A+Q5GHdQXHsgblDWgM3GANyDcqwp3OBu3hF3NAOK53+fxsEt+xZwUyVFxrcVAitLGxMCJBjkGKBPb2fWwUxHtEwcy+SyIlCIapXL/+F4NujoH9SDz3b678v0k02z/ugcsmELE38dJlpbyyscN89mesEyhH+ar6VV6EyhsypX9kvGFm54JbUfHndKZvumSZlD+fG4VO67RigI1JXnyR8m7SG7zQRGS6wWWCMwWrhh3xkjsH6+Gy7Ny4eL9cbbyX8jWF+M1eaPdOTD+XTccPGbwk6ty3j4kU//D77lFf+fq34tbrSeCb/l57r+evOb38yb3/zmG30YXxO6oUD9LW95C//+3//7Q5f527/9W+6+++5rdgw/93M/V8TJlLW1tUUUfXVVezbG0O12sdbOc57nmusqav7ZujGyxmLjDB1mh1hVr5NiDV8ewZcGiKG7ObEAZ+rw3Db6dI2BEAyi7lGTB66thM9FrylERSFSwRXe4V11mTTFhiEmDNFRRC+KSWu1a1Ok1VjnQNdAnKDjFJIEk2WT987TH+u8aKjNwGRonZHhYlsSDIk0GKPJlEFrF1RgpAAbgAyAmt+MA+gpgkRIUiHIhCSTciquxZX9lH7f1nikZcHavBicv0sUHpRLn+fr+/lWXDdbk6b0MdW+KuB8GprnAzATUwhrWNB7LOpd2rpLzfRpD/Zo73Zp7/aRPUmaniazN2HUKUTzPgfNOyfgpItmqQCzAimMzQjFkH4loV/PGFZihiokNn3ob1LrdWnu9Wju9Vjb63FTf8Reo8WFtRNcWD3BX505x/kHTnB+/RQX1k7Qbx0QGVBSZ2RYHGmWhoalgWFhlLIYhrSjEU29h/DAXMsYI0ofxioks8yQRiOTMSAvnOZ5nrnRpIFh2ND0GymDjmbYyBwob7jh0QxY3hCWRWVZkoKbCWiYOi1boSEUCotVGUkwQqqYhcCyIC0LHpq3XGrAsZRldTJdR+sGWdYgS1rotE0WLfhuETNaIhsuYZMWpBXIKohZlviSyqzbWkNKTEzKSBiGwtJTkq5S7KpKAcmH0tUtcCtOFpUEjbSauolpmZAzjFgSA9ZFl9Nyh1vkFnfK8zxXPs4J2T1yoVKDIJQturLFSLZdp1qMZIuhbDMqprdIRXVmLvYsNY+2+5Jj3FBEo5THS85wShEqcuI6HeNFL7i2mFqrHI2Sg/I8D5t9gHw6/9sW6x79UCY2cMVriZlTq9VF5Izv2lkv3+wj8O/gWTMPfA+ImYOzNvv0nPH7m3UPG5+cdsAfEzt2gR9qkj+GJsvEHQTsJyG8KE+fHi6vNzHd7l9m336PeBbHOFkLaO2648kiZOZz5FM/nCKlKywuhHPICz8uhS6WF1IjRFYsK/24y6UfH4iqWFTl2j9BeFWV7bC5uXmjj+Kqq9/v3+hDmGuur2rdUKD+Uz/1U7zmNa85dJlz584daVunTp3if//v/z0x7eLFi8W8g/Sv//W/5id/8ieL8V6vx9mzZ1lfX/+qK9xgjEEIwfr6+hz6zTXXVdT8s3V9VTjSBwkEFjo37lh0LyH8yy2iv91xtmJA1BT1e1eoP28VtfDMqt8xLi5aecbktrvM+xFmOED3emMXulSYRhMsrDabyKsA1K222NR1JoyxowTSGBPHU/nr06425z5HJ2QmIdUpiXV556HRpCYjNRmZ8ZEtzqg6sTXpi4wmQhFKQSwUsXTOc7dovkLmXeZ5/Is7LuPjWvwBeWjubmQRBiEzNy2ff9h1KN//X82YFjt+ON6WOMJB7V3KapZMj2Wzx4rpsmj7dJI+C3t9mrtD0n6TND1Dam/CqDsRjRPI1gmypXXkTSsIZgNzgMymDOnTC0L2qhG9IKQvh4R6D9W7RGdvQKs3oN0dstwbsJgJLi0uc37tBF9aO8n5O57jgflJtpaWMerw7/Zm5BzmS0PN0sDB88VRTDse0Mp2QQ0Kh7kR2Rga1lx2/v5raRBJDsvjyeE0wZqUsK7pe0g+aE8B83pGWhm/qBIHvpeU5bSydFAsU6FjKrREQBWBFBajUmwQUa0ktFVER1lqx/izZqwgyaoOlKcN0qxOmjo3eRa3fMzKAtloCRMtI9ImMqshdA2RVRGHBHpMfwNoG5PZmJiMkdQOlEvBngrYCSr0VMDQx624lWc2ryCsoWYTOiaiI0as0Oek3OOMvMTt8iLn5Aa38xSn2D0yKI+oMpTOTT4Qpb6flo+Hoo49KJe/3BZG6LvDlRfHdA5xXfTdsPbzstK8vKFuGm+7i5Y/8JLPNcUFGAPxYqgMt0stGqI0YoXESP/1IwRWSheFI3y2cR6nIt33XfEO1pe3kdupo5roi/E8UQLVk+cwG5MfqjLcL00zQUakU0otD/4gp6B3AbdtsZ1yQMXMXRbFIqac+sXwAeuBbzSZWtfD4X0NHM8ad/04Ub0M7s3UlPKoxRR/o67G3z5r9x/BeNSW+uPr6p8FnAD6UPrxsO8P5yEt0LPA/+yFDllMAqXfrMe+LhYhjXPB+76QBiHs/r5wjf1yxrTLLSeDAKuT/A3tPzb+mhaNcXYi1kmUnjQolimtKwQsLJ7kxIkTxz3pZ7y+1opvzjXX9dYNBerr6+usr69flW296EUv4l3vehebm5vFl+HHPvYxFhYWuPfeew9cr1arUZvxKK6U8qsSjAkhvmrPba65bqTmn61rL2ssZuBBurFIZtzIXiell0JGn75I/OW94qYjWG/QuG+N+nOWEVcS+HutlEe6tJ45uehWa0y/jx4MMP0+1kf1OK4y+ZoKIZC+O/5+PEDPLDbKMFGMjULXn4oHKkCMtWASMCmZjsl0SmJ0EdsS24zUaDKtXWyLnUGMrSVFEElJJKSLbtkX2WJ8TIvBmBycW1xPFkdV5Jwr7d1hPrrF7ejw8y8xEZvD7qcNDyxFUdISJzg4miVlzXRZNl1WfH9Bd1kYDKjvRST9Ckl0mlSfQYvnQf00Wfskg8WTyNMrbhsHbDs1cQHNd2sx/SCkp4YMbZ+gt027N6DTHdDuDjjVH7Ioa2wurnJ+/SR/u3Y3T91zhvPrJ7m4skpYPzwaRGnL0tCwPNAsD10sy9JQ04l7tNJdlOyhgwgjnMPcYtz3UxXiA9rVRJZOusoTB8xlEpPZiEEzY9DIGDYyBkuTwDys6YLNVYQD5YvKcloZ1gLLipAsUKFpK9RtQIBAqAyhEiqVhEYQIsXlAW2uREuirEqcuTxyk7bIkiZp0nSQPFwgC5cw4RJS1xFZ7VBQftANiLUWa0NSIhJSRmQMpaUnJXtKsRNU2A5qDKQkKyD5Qe8Qi7IZbWI6hKzJHifFLmflJW6VF7mdC9zBU9zENlIc7YMRU2EgW/RFi4FoMhAtBrLl+qJFX7YYiiaZuFq3WLkzPCtBco3w0Spu3M2TOSSfWFt40pw7yYX/rEryp1UMchL8FkBclrbjZ4jyuNu+9YUL82gV65czRe6x29bRoq+nkbgg97OXjdVj/C1Lax5TU+fopvnfFR7yT0wv+qJ8ALNVURylUO3kwTjZGdPKsgfPujaacHCXjs4WKfKlBSePXvisMOH//kye5dV7tHB/c0v+jTPd2JEPyCNeQ1s6q3x4PzR3jciuSWfib+wVPw0w0erte9PXeUajx7Trfh9ot1OrzIDsR/oqtDMGXbFPbQN0duQNHbK9WRLUW6eIhhvH3P7h2w5UhR/5yQ8cf3vPAs3vS+ea69rqWZOh/vjjj7Ozs8Pjjz+O1prPfOYzANx55520222+4zu+g3vvvZd//s//Oe9+97vZ2Njgp3/6p/nxH//xmcB8rrnmmmuuZ4emQfoNOw5rSc8PGf2fiySPjR+hrJ7t0Pz6E1TOtK9NLMkVSlSkg+jNCuK4OQzXQCaOHUTv9zGj0TUxv00A9NRiowQTRw6ixwdk2tgMdILWCZlOSU1KZHVRMDQx2WTm+QwGkAKhVIRCEUpJLMqFQk3xtrXaYK2ruWANTJbXE9jCdZ4V4FyIy0OHa+I4n3abXwaar5s9Vs2eB+euvxD1qPUS4l5APFojTW8m425McBOj1inC9knk2XWEVAeG0SQmYiAG9NSQvXpMLwjpqREDMSDo7zlovumg+eogohbUUe1lzq+f5HMnz/HEfTdzYW2draUl9GVc5p2Rd5gPDcsDN7w4Cmmne9TtLiYYOZe5SDDWN2oEgjSYlZgkmHaZu4gW108IGdZihg3NoJExWPTgvJkxaGiSwICAuoflS4HlZmU4UbGsBoYFIWnYgJoNUAiEsCiVEQQZsgipTvYdVVnGwlBLRlmFOKuRZDV00sKkLYgXMdESOlwkGy0j0rYD5FkVWYbl1r1qU97GfbLWgh2hbUhCTOTjV/pS0FWSHRWwFdTZDupoKYGG7w7cIBUyWiJmWQw4Ife4Sexws9jkNrHBOc5zjvMsitGh1yBXiiqA+BiOO2A+LIHyRFydp46Kwps2K7LIpcmK6Xh4roriBSVkOAV3DQJsgKHqo6J8UT+E+5s08+vfHsqF3QMxfjvSw3JwwNxvs5g/+wz3gfHcBZ6z+/H8mejz6JoG4wLIGwmEGDvSywUR4cAG+X1Tj3Vgbl9CSqSa+kY78Dv5alikj7qbg/dlOWC+GA9MIPGr9bOicMj7ZpsJUD8N6X0RW9/QND4Ew1W5jvtUfnbhgBPeT/MPkJ04G/+XenoR7573n+N9cP7gbeef6X0gvuTOngnhD93sUUH31KFcLTf9vkUFKAWVYHrG01NlzormmmuuK9OzBqg//PDD/MZv/EYx/vznPx+AP/7jP+YlL3kJSin++3//77zhDW/gRS96Ea1Wix/8wR/kHe94x4065LnmmmuuuZ6GHEhP0IP0hoP05JEuw09vkl30cEZA7c4lmi84QWX9qGm110FCIJvejV69sW70Ispl0J+Mcrma+9AleJ5a0AYTRdgocv3pIrXWgk2xOibNEjKTEhvNiIxYZ2Q2IzYZxuDjVth3z2aAUEgH0D1ET4VgDM49LLcOnmPBFI5z72DDuoxzkSCUBjKEMsgjOPYKvnY1wPkxoDnW0rFD1swuK2aXNb3LqtljRe/SGo2IuxXifoc4uZnM3IGWZ9itn0K2TyLXTiIq7rHjmfUzbUbf9unLAXu1iL1qSC8Y0ZMDZNij3R3Q3nZu84UwRVSamMYCT62f5v+cuoen7j/NxuoqOwvtQwCfc5kvD5zLfGXgXOaLUUQn7tPKdpFyMHaZk7hrIiW2NiNsI9+P1sg0ci7zCWA+YlgZOVjezBh2MgZND88bGVlgqRWw3HAysHxdYFkLDEuBpSWgahXSKvCwXMryq2OA7MBzHWjoacUoqxCmVZK0QZa2sHEHOVpDhSep6zPEQzuG5LqGTF1fmErRyHE5hGzNCGuGZDYkFsmEq3xXKXaCKpeCBv2giRUt4HKZ85aaSFkQIWuix0m5y81ii1vEJrexwW3iArfZC1TF0TJ6h6JBXzhXeV+2J/veYZ5w9Hzy2RLjaBWTx6pY7yTXjF3mLnZl7HQWJcexcGBYCBABEPhXWE7h6YOOcwzJp73lxVgBwqWLVfEO8sJNLn1D38xdTMJFkaeEF2B+/P/xrlx5YOwQF8W12A/Ei73I0vSDt3zdJZDu+CcnXqd9P11NQ167f86sPzwzzc/T6x4E7Mew/mmB+plwfhLM5855x57LT3RcXdf8fh0hWEgAqCPA8/IZzYi3sR7YH1hAfIYDfhaAF1Bck+M2LF0TCQgUVK8uUBeVZw0Sm2uuuZ5hetZ8e3zwgx/kgx/84KHL3HrrrfyP//E/rs8BzTXXXHPNdU1UZKT3b7AjXRuiL+0y+j+b6F2fcqwEjXtWaDz/BMHiM8fRIqrKgfQb7EY/KMrlqm3fjOG5zSxosGkyhuhJMnmP5QF65gF6msWMyAhNRuqjW7Q2B0a3WCCWisgD9JFw7nNrTXEDa0yGNf422fqs82Jt4W51ZeyzzrUv3nUwCC0feg4HDr4pPspFy2+5x/C9FMG7T4FNWTFd1swuq2aX1QKc7yFDTdStEA/XiONbyOy97AZn2GudRrZPI5eXgP3lHN0+DUM7pCeG9CpDdmsRvcqQrhoRMqLdH9LZ7dF5akB9lJCqBmFjkSdPnuWJmx7g/AMn2FhZod86PA+0mlpWBtqB875maZSwFI1YSHrUzQ4mCDEy9MBcOyegUiT72p9KUFFnHphH40gWPWIYDBnUQwaNjP5SVkS0DBoaFRgHy5WD5bdXHCxf9AU86xKklVgLUtpSrmtZGdPQPDLQ1YKuFgyygDBzsDxNG9hokWB0gsrwNPV4mSBreDd5nVpapZG7ykuvzmHNgdamWDPAmgHajryrXNOXrqjntgrYChp0Kx1GqokV7UNfG79V6qR0pItgOSV2uFlc4haxye1c4Jw4zy12g+ByT2YIV9Cz793kvQKUt+iLMTQfiBZaqHyVAzdmS0tMmEIt3imuPRg3KKOhyCXPAJ9ZXgDhqX5BnN0nYwIYTgeOl08QMT6yCaP5/vdKDsrxcNz6eKncUe7mT4PyaRe5HKP7ApIf7B7fB8Knl/PTRdkZnoNvKUDK0o6m5s91AzX1GpReE3HAIpeZXNJsWG9Lw+VFbWl4Eskf8BfsasD5KSgviz/GZSjvnfITUTbXGsjnGn/W8qF9z16Jqf6Bms6fPzh7vphTNMSXflBMuODh+lyHueaaa64br2cNUJ9rrrnmmuurW87RnKL7KVxlEHscmUQTfX6b0We2MAPnqhZVSeO+NRr3r6NaB+X1XmdJUUD0G+lGt2mK7vfR3e5Vj3JxAN2gBxqjAQ3YQ1zoUwA9ziJGZES+aGjhPj8guiURkli62JZQKiIhyGyea24wRmONBlQJnivGN5fGxbTIzMe1aKS8vIt2fL9+ha7zCQehLbZ34MPd1tK2Q9bMnnObm11W9R6rZpdF0ycLJVG3RjQ6TZLcQmK/ifOVM8jWaWTnNGLZYdhZMS2RGdFlSDcY0auO6NZG9NSIvhohspTOXp+FS33q/RAlqsjqAv2l03z+1F08ee4UF1aX6bUPifrAFQBdHhhWBpqlYcZSGLIYDVlIelTpumgWGWFt4p5isAKkIsoL8RaW4KCAABN55kkMWUQkhgwqA3p1n2e+nNFvpgyaGY2aZSXIOFmxnK1Y1pVhObC0laUhoFzz9+BUjMk3YZgFdFPFnoZta+hlkiirk8RNiFeoDk7RiE7QTpZoJB2CrEknraJSB8qlOVojn3tyYog1Qw/Lh8QkDIVhIC07KmAzqLMTtBhWWoRqGS3WjrJl6t5Zvip7nBK73Cy3OCu2uJUN7uApbrEbl3eWC9BIeqJNX7bpFY5yNzyQLXqizUg0SgU9c6TlgPCs971hHFEiCzBukMYBc8oOczIEmYNq5dzsMvwurOCzmpCmTgjBRHVPACumQPn+6+kXwwrhQbkogXMHyItppf2VYRsIlD/+aUg+BqQH+GbFAY5zWXKPI7xTPJ/G1ywgzxtVXFLOoV7kmdf+MBB6ta7kZf+82BnDZfB9hMXzsf1/y2bDejFj1gGT9u/pICg/AeQn/0Yeqikor4974W2+mXF+/H6X/KzomusF5MvaH80085tMQPHX/giQPv+/HHIzWXy9PDxu9J9oLill2V2VoulzzfVVLCEEv/u7v8s//sf/+EYfytec5kB9rrnmmmuuGy4zStG9BJvdQJAeZoz+aovwry5hYwd8ZDOg8eAJGs9bveERKrlEVblIl0Zww9zoNsscRN/bu/oQPbPYxGJSi0kNNrMYG0Mc73ehW4s1CalJyLKEKIsIfXxLYjMSfXD2eSZE4T6PpGIkBKkFg8VYg80ysK7IFlZg7bigqHNqeXguMlAa6d3nh57bxFPWx4TnUwtOrDu7fQCApglZN9uc0Nusm23WzQ7reoeaTTw4bxCFZ0nSu+lylr3KGUTrNHLhJGLZhX1Mg3NrDQMzYE8O2amGdGtDepUBXTUkFSm1MKaz16e5NSDTAVnQpt85zfm123jyzlNsrC6zs9A8NJ6lFRlW+pqVvmZ5FLMUjViMB3TSLoHoo1WIkRE2y1xBVysx/vXE4hpfcmCe76bsNE8iEjsiVEP6lQG9ZkR/0TnM46am1jCsVTJuqmXcWbGsKcNiAC1pqR6TE1oLSVpnlNToZwF7mWDbGi6ZjJ5WmHiJ2uAmOtEJOvEyrWSJZtJhIan7CJY64sDCm9P7yrCmD95ZbuyAxMYMRUZXSS4GDbYqDXpBm1HQIpInyOTRtl0hoyNDVuSA03KHM2Kbs2xyq3Cw/HZ7nrq4TLSTGDvL+6JNT7YLcN4VbXqyQ9/nlhdxKEx/xZQB96Rc3EqeQ65RxrvIfcFOic8nF6XYlekNqX0Dh57PuIFmfGyTQLs0a2rdPG7FlmC5FWClh+VTxTzFxFalL849uVcpykvmKx4himUCkrt18McxAcifJZBclGBt8XoUwN+3AUyvs2+gdM3F2L0/8erOuBxKKgJ1fW6zj/pqHGW56T9HV5Vj2okeOfEuwGv+RNah64zHJxqM80bkqXiaAtXuO5FJIH8gjJ9wxh/xahTttg5NH9slfyQgTym25ka45A9T+XM3Pnl3NY7xO3qijXB87SuyipUNSj+mZvjs9//lmJFYX8xXcyQ21zNYW1tbPPzww3zkIx/h4sWLLC8v88ADD/Dwww/zD//hPwTgwoULLC8vX/dju+222/iJn/gJfuInfuK67zvXrPpl/+k//Sde/epXX5f9z7895pprrrnmumEyUeZAenK0LNxrId1LGH1mk/Dz25D5H9eLNZovOEH9ucuI4PBChtdF3o2uWhVE5caAfas1utfDdLvo4fCq3WlPxLikORm2rohpOCKLR2Sp9516gJ5o32URI5uRmtQDdF3kn5fvKS3OfR6pgEhIRlISA9pYNAartb+B9pEMJvDr5Tdg2rmJhXOeS+kgujjkIpThubVmPO2yF2S/k+4o4LxqE9b1NifMjgPn2vXbNkSngqhbJxzcRpw+n01uw1Sd41wsrSOWZ9/qauOyzXfUyIHz+pB+0KevRmhhqIURnZ0ecjtjJNrstU5yceks50+c4MLdy1xaah1aCLSWGFYGhpV+xsooYikcsZT0WEy6KNF3TnNiyDRkYK0gEwGZUA6Ya18Ks8xErSmgOUnkssxVn161T7cZ0l/NyFqWSktzoq45U0u5u5qy7KNYGhKCYwKQJKkRx23iqMUwrdLNFDvasmVTellAFi/SildYSNboxEu04gVW4jYnsgZSN44Oy02EtQOs6WPNAMwAbYYMpOFSUOViUOdS0GZQaTNSDSJ1E6moHAmASgxtGbEsBpyUXU7LbRfFwkVu5zx38iQr9A/fiHBv+YFoekjeoeeheVd0Cng+EE3vLB+/cJbZMLM4PmNQ1ker2AxpNBKDMBmCvHincZ/TaUi+j5sLLgt2yqsX760yKhclvjX7+pYLe+6LXpGzYfkYRUmk8NN8ZrgcL8g+YH6Ypt3kipKbvESXr5oH+sqUA+vipXIXYAJ8l1/C/FoJIcbO8ImFruAYSv3xq5GPTYLC/c8B+ClCIEQNpMlPARg/F5C3g7tXOV8Hf66lbfhtlpcXpeGjnuqsj7+YMe+w+pMz0ljKXuJSO/F+gGn9+sW4Lf9t883T5Wiy8vZt8exXsW2Di0GzuFRAW/pX3sas8yhAeWnEFGB/kt7bydX8TxNbjOi8KaCUpVakFB7HET+tpwvk8wOmBOWxnklPg/lJp3xp91y7Qq9XovI7XpI/GTg996Dx2SpBenX4U3FzzXUj9YpXvIIkSfiN3/gNzp07x8WLF/mjP/ojtre3i2VOnTp1A4/w6StJEqrVKy/6/oEPfIDv+q7vKsaXlpauwlEdTXOgPtdcc80113WXSTS6GxdO8Buh7FLI8C83ib+0W/yuDtYbNL/+JLVzizc0izyXqCkX6XKD3OhFJnq3ix4Mrh5EL7nQ80aMWVEu1hq0TAmThEw7B3qUw3OTkhmDNvuLhxpc9nksFaGSDJFoa8msIXOZL1jrYxpM4G9cjb8Rz93nGQiNUBlCaudoPeh8xnf/7kb/ctep5Hrza01OPgScBzZj1ex6x/mOd5/vsGj7zgk9DAh7NxHFd7Bnvp1tdRaaZ5Htk4i2g4jTARWpjunaPttByHY9Yrc+JJRdhirECqjECe3dAVkP9oJVLrVOsrF8gvO3rnHhBQuM6gcDYaUtK33Naj9jeRR5p3mfpXSPGj10MMKKBBKNzQxWQyYUmayCEUDFddP1/dLEQfM0JGHESA3oVvvs1gekqxbRsnTamrP1lFtrMWvVlIXAUhNwnI+SMZI4bhJHbaK4RRy3iOMm3SRgRwt6SQ2jm1R1k0bSphMv0og7rGUtTuom4rIlPZ2sCQtQbm0fa/oYM6QvLVuqyka1yU61zSBoE6omsVomFRXnS7wsMHdRLItyxAnZ5bTY5Yy8xK1qh1v0E9zJk9xkty6fWw7EVOjKTgmQd+jKDj2x4PstjDgYVk9Dc2FtAcoDn00urUYajYtccc5yB5VK2H2aKBYbPkIDaHkTYhZ8ERTZ5gdAc+cid9e+DMtNAcsnY1gmcKxwxTyFGGPYHJ4fS7NAOX5aOYLlOkkIMYbfB8Hw/HoL4d31x4fg5bYR6fcwxtvloRxIl+e46VK6Y5X+OCR5TMsYXOf9vK1h4lxKy5bn5fNDG9AQ1WeLmf9p6MpQ5tVWwbSnOge+c3CfQ/gc0tsxH7fWdf5vuCnN1/4PvC5BfJPD9AmUX/qrXgb3ftvj7PF8WqkBIm8YKPVL3HtiH0dC9NNQvjTt2CrgfAnET8TUlA4UCue8+8p286a+PX3/meGkd0PPAOPMXDdE1lqyOL7u+w1qtZnO6mnt7e3xiU98go9//OO8+MUvBlzdyG/8xm+cWG468uVP//RP+bEf+zG+8IUv8LznPY+f/umf5nu/93v5y7/8Sx588EE+/vGP863f+q384R/+IQ899BCf//znefDBB/nABz7Ac5/7XAC+8pWv8JM/+ZN86lOfYjgccs899/BzP/dzfPu3fzsAL3nJS3jsscd44xvfyBvf+EbAXc+3v/3tfPjDH+Yzn/lMcXy/9Eu/xC/90i/x6KOPAvCa17yGvb09vuEbvoH3ve991Go1HnnkEZ544gl+6qd+ij/4gz9ASsm3fMu38Mu//Mvcdttth16npaWlG9aoMAfqc80111xzXTfZ1KB7MSa8fFHGa6Xk/IDRpzdJHusV0ypn27RecJLKze0j/cC5phIC2QiQ7RuTjW6NKSC6GQxcnMbT3uYsFzpjiB6Grm8sxmbEWUySxURZyG5Vshv2SU2G1v6mdgqgawSRUsRSMpKKCMisQVuLzhyYtyiwCmvdNbVof1uqQYzhuZSHR7ccy3l+ADifmHUQPLeWZdPllLnEuo9rOWF2WDZdJBaTCka9VaLROQbZC+mKW7G1s8jOTYiVceHO8jso1TF7psdmZcRmI2a3MSIWu8Qydjwuy2h0R4Rhg25lja32GTaW1rhwdonNpRbZQU9rWMvS0LDWS1kZhizGIUtxn8W0S9PsYishRiSQGmySYTLXoBHJKiKrUkBzweQvU60LaB4zJFRDetUe/XqI6VhqHcvJdsrpesKdtYiVakJd2mMB8zSrEEctoqjjYHnkoHkUtUjCRUZJgwyBMFVqaYNa2qCatmnqNh17NFebNZGD5R6UWzMgJWQkMnal4kKlwXZ1kX7QZqRaRGqVTARHhOW5uzxmRfY9MN/hjLhU5JbfyRMsMdy/YvltLlwUS8/HrjhQ7pzl3WK8QyyOltMuAGUMEkNgtXOSW4NiHMcifUa5mV6x3Kfs0LzMtSjNnnbyzlzY5t3+DeTA3CKwyvdlyW0+QeJLCNfDcoTwgFkeH9UIQKqybXkMx/PM9mvoKJ8FxvPvkTEU96C6cIcfYbtFl/+TpXHpvaeiaGiQ+XxRWsPvT/lt+TaNiWHJVL+8TH4MV/vS5fsQgAVpQKnxfqZj+MtvaTFjO8WomOxPLG8n1zvs2PYNHrb8tEP7sJ8AM+ZNTyoXw56eVl44/5tY/rM5MVxaZ8IIXtrGvtNS+Od/xKy5T0s5jB+71z1s98DdxcfZwkWvrfvNUAb8xbLFMmOg7363eBjvHeT5esVlMWUAPwn3p1/I6dezOO6p6eUFcxA/9q77Jwiu5qUs7U+UJgj/QouJhSxKVFyD+yEq1rHTML88b7xde5womrm+qpTFMf/PD77yuu/3X/3Gf6FSr192uXa7Tbvd5sMf/jDf9E3fRK12+d9gvV6Pl7/85Xz3d383v/M7v8Njjz12YCTLW9/6Vn7hF36B9fV1fvRHf5TXvva1fPKTnwRgMBjw3d/93bzrXe+iVqvxm7/5m7z85S/ni1/8Irfccgsf+tCHeOCBB3j961/P6173umOdP8Af/dEfsbCwwMc+9jEA0jTlO7/zO3nRi17EJz7xCYIg4N/9u3/Hd33Xd/FXf/VXhzrYf/zHf5wf/uEf5ty5c/zoj/4oP/RDP3Td7ufnQH2uueaaa65rLpsZdC9xIP0GVRdKnhow/LMLpOfHYKl25xLNF5ygcqJ5Q45pQlKgWhVku4I4JCbjWsgagxkMHETv968ORJ/lQgcwGh1FEIZoD9ETnRDriCSNGJmI1KTEJiXRhlS0kFFSjtAkFcLFtyhBiCIGDIbMWHSmsVZ4gE4B0P1tLBCB1CAzhMzd5wef75EKhh4CzottML4Bn5a0mjWzyym9xSmzxSl9iZN6ixop1kI8bBEObieOv47z3Iqu3IponkG2FqDlt1HanjEZ/azLlhqyUY+52E4YVXbRduCAjDGofkbYX2K3ss6lziobS8tsrHTY7dQOzDZX2rLa16z3QlaGI5aSAUtJl47eRgUDjMwg1egkQacpGEFEBSnroEo/hINJtCGyFJGEpGZEJAcMgyGjWoReSFha0ZxqJ9xWi1mtRbQrCUoe3dmWakmY1InCBZLhMlHUIYraxGGHdLQCaQela1ijELpCoGsEWZO6adJAsXiZ7VubYE3POctND2MGJCImlBk9YdkIGmxVF+gHCwxVi0iuksqjxbDkqoqMRTliVfY5KfY4LXY4Ky5yKxvcJZ7kVnPh8tnl5O7yBfZyOF5bZzOresd5m4FolYp8HqzcVa6MJvC55MK62BXhh6X3g+bwZxbVmGJhl9lpqTcNIQ9byYKzjI+n5VEsyIPc5XIKGHkHs4e9gYfaoph+DJVd5RO0d6q7SpqA40pMOqmvAIyP/eD5FRm7xBV5PI0srlV5frmhq4DiwhXwzYF4fjnyeRPjHOfSeFTvr3dxPFI6d7oY9yleEoH0FF4ikNLtWABCeuAvBUIKhMTDfVHMy6m5xbIzgNWOP2chij8CnrcX5H0acFvysrpl2WLevqlieim3bWsZv8j5DspUPj+G/G+TP8ZZMWN2goiL0nHY4k+fLdFwW9qAtcatb/MGaO/UtrP7uYu7WH7WH9wJGj8Go/nvlvxYcshc7GM8Ol6uBJeLXdvZ8/bB+9L3kCpf6uIaP73P8eHAvgzlx7E5xuZQ3pBZsD7Wrgz3jTGFG3/8u2YM6SffZ0cLrJmA+KXjPmipo8yaubQFqaqo4BAQeQWXXdRax19prrmug4Ig4IMf/CCve93r+NVf/VVe8IIX8OIXv5hXv/rV3H///TPX+Z3f+R2EEPz6r/869Xqde++9l6eeemom9H7Xu95VON/f8pa38LKXvYwoiqjX6zzwwAM88MADxbLvfOc7+d3f/V3+23/7b/zLf/kvWVlZQSlFp9O5Ind4q9Xi/e9/fwHKf+u3fgtjDO9///sLGP6BD3yApaUlPv7xj/Md3/EdM7fzjne8g3/0j/4RzWaTP/iDP+DHfuzHGAwG/Kt/9a+OfUxXojlQn2uuueaa65rJaoseJJhBesNAenphyODPLpA+OXATpKB+zwrN558gWDqa2/JaSlSkKzLarFzXWBdr7SRE10/v8dsDXegAWqOjEDsaYZKEVGfEOiZJI8JsRGwTEuOLiBpfRDS/KTMQI4kDyUhIYild8VBj0Aa01ZgCoAvwxUONLz4IKagMVIb0AP3ga8L45vyg6JZDslHdqu41PKhNIrAZJ8y2g+e+O2G2CdBYC9FgjdHgLrbTbydT56B+K7K1DkvjbeReKmsNYdpjmwEbtZjzrYSdVoi1l5D+BTCJJI477Jl1Nlt3s7G8zIXVNoPGwT8B64lhrZuw3h+xMhywmPZZMF3aZhuCCLAkaUgaR5BaEhOgqCOCBsgKUEdNVzIFRBpjspCEIZEcEVUiskbK4umIkwsJt9RDVmoh9UrsXqsjfBy0hTALGCZVhmGHaLCKGa6RjpZIhquQLKB0HanrKF1D6hpK12nZy0exOKCTZ5b30WZAKiJCmfooFsVFtcBeY9FFscgVtAiODUTrImFJjliTfU7IXW4W29wiNjjHeZ5jn+A0l1AHPR5fgDMYiAZdH73inOXj4T25sM9d3mku0h91J6ZJa1A+r1xhXOOLTRHeWS5wAN19xuxMeGHFpPn9UE27Z48My6c2krvNYZxbLgQ2uJy7vOSYzl3lAvDe8mM1bUrp84RyWC7H1E1cHVf51QDk+fKyCDspQe98fbxDvATF3TXavy0pfKqxzPcvUf5aOjAuPWx3EFoVjTYCYaWH3v5YpERKBfkwAiHcNKkEUkp3mZVESokqpkmEdMMqUA6WKx+lUwLm10RC+k6BkBghCe2Q9vKCA/YTnRgPI6amzZo3vd7lz8HBUTOG0zkmLRp+8/Hxo17W1yCYXNeHpNjxeHm92f18nav3e6+ISjHj8yhAvRkDYWvMeHkPla0n0W7YTzfa/603pe0Yv74pfgNMEvQS6DfGH4NfxuTZ8H44/+1g8saCfPl8k/5c/DbKufMUjQj2MsA+n3Dl7+kJYG/9K+dr0BjcbzqDdb/JcMXajaVw0Wv/mhTROfl6fvt5iN749OzEPvcdT9E4Aoeh/UBKxNMo+Dtr39XrVEB4rmeeglqNf/Ub/+WG7PeoesUrXsHLXvYyPvGJT/CpT32Kj370o7z73e/m/e9/P695zWv2Lf/FL36R+++/n3rJAT8dEZOrDOVPnz4NwObmJrfccguDwYC3v/3tfOQjH+HChQtkWUYYhjz++ONHPvbDdN999024zj/72c/y5S9/mU6nM7FcFEV85StfOXA7b3vb24rh5z//+QyHQ97znvfMgfpcc80111zPXlljMYMUPUgOJovXWOnFEcM/u0DyuC+kJwWNe1do/oOTqPaVFz65WhL1ANWuIOvX90+xHgzRe3uYfu/pQ3TtXOg2sdjMTs3LMKMQG4WkUUSsU5IsIspGxDoitimxTjHGFQct88JESEaBZCgkNqgSVjLvqgKdGbQVWAIwEl9OC2s1oLEicc5zNXagzzz2sgPN3/DOXsgPzvJbWecynHyLj0eqNhmDc+P6a2bXRbYYiIc3MRrdy2Z6p4PnzVuRtUVYdutP5JwnA3ZNl4uViPPNlAsLGaNgj4YeIABtFFG6RD9e5FLzFi4uLrGx3Ga3c3C++cIwY70bsd7vszrq0zE92nSpsYeQhoSEUdLDxgkmEYxMlYAGUjWRwSI1Fvf/krQW0ghtRiQiJFExup7QWgxZX4pYb41YqI6oVUMClR76dEC+ucQKBpmkl1bohi0G/RVs7yYqvbOIcBWlGwUod/C8RsNWuFwgSxHFYvoY2ycVEbFM6EvDnpRsBlUuqSV6lQWG8iYyeXxYDpamSFhSI1ZFn5Ny18WxiIvcwVPcZZ/gJDv7gfnUZcnjWBwgd6B8T3ToSQ/ORYdMHP5dMgHLraap68i4j7QpeVa5EM5XbmA/q/GG1iuC5WLfpGMqB+YC44GxA+Ry7C4XFOB8ctWxn1qKPK9cHc9dfhAsvwpZ5QUk99srx5JcDpBPw/Gxb54xjC7AuI+gKZzLEqxvYCgBdSWkh+Fu2EFw7+rGDSspfaeQUiGEQopg7ODGXa/C+S088FauU0qgpEAGsnCGC+kvs19vPO1qg3DhI3XUuC/yaWMwPh6XU+PT86eOzxjQm7B8wp3EdZZrOFA3NL99DOZNCdbv7x80XEzDFOAbmc+7hscNbn8FGD8A3Fv/m8CYAopPQHsPmwtgXnLqH3S9Co5fhu0FlLeTx2EYNzDsg/M+Fs9teHxmEz9y7EQOuipOfnrZy1nHxw0yeUOCzRtkbN7QkJ+fO06D+y2X7yYH8mZqX9O3Dvm2MtlEVd131/6nAiabQMrTJxogxOQytdokwJvra0dCiCNFr9xo1et1XvrSl/LSl76Ut73tbfzwD/8wP/MzPzMTqB9Hlcr4HiFvdDa+cfJNb3oTH/vYx/j5n/957rzzThqNBq985StJkuTQbUopJxsKcXEu02q1Jp8MGQwGfP3Xfz2//du/vW/Z9fX1o50Q8MIXvpB3vvOdxHF8pIicp6s5UJ9rrrnmmuuqyVqLGabofgpPE9ZeqdKtEcM/2yB51GekC6jfs0LrH5xCLdxgkC4EsulAuqhcv8xGmyRke3vo3T3sjB81x9qWh+gmsZNRLoDNUkwYkoUhUTgi1QlRFhJnI1KTEJmUTJt9OeiZEIyUZCQUI+n8r8a4m6yqMYwyOwnQLVhygJ6WAPrB+edjs96M6JapG83Z7imKG0A7ORWAhgk5bTY5pS8VAH3FOPevMZJodAuj0T9gI7uDTJ1DNG9FVJrkmSI5drHWEEY7bIk+TzQSnuhkXFyIqOs96jrFGsWQVQZmgR1xN1vLi1xcanNpoYI5ADy1w4xTOyNOdrusj/bo6D2aqktFhqQiYyAGxGmXLNKMEkWW1anSRKkm7apzrDDN5a2FLCYzI1IZYasRzYWQpaWItfaQdr1PrToiUAnyMhEt1kJqBQMt2M5gO6qz21tHXzpHo3sb7XiNqm4hdZ1A11nRNaS9/E9Ya0Y+jqVPJoYkImIoM7oKtlSFTdVhRy0wCFZJxakrhqJNEbOkRqzJHqeEA+a3iQ3u4Dx32idYZ/eywFwj6Yk2e3KBrlhgz4PyvaLYZ/vQOBZpDRWdFbBcWpdfLs3YXY4YF9MDUKaKYkCep2SOc/plLvG0Yfnkhg0OYE4Dc+vjWCZ25A/AI1znhi7FjhwJZ14DWJ7DcGdOzyH++HpJD62nN51HqjhP99gZrkQOvCVCKIRVbhnhSwzbHMPn4x6pW+8Yty7iROFAeCAc0K54sB0oQeDd4e543XVwPYkQ0l8K6R3hwsNzf/kUk+OSfaD8qjrEhQIZlMC4dONlSC6nhot15gUIr7XGUP/q/86xVpcA/Oxh659QG8N5PQXotR+e/CJ2n0/JNTjs0vHngDx3rpsxpC9B/Ms67XHr5o73ojHAlgF7/tvHT8sH7SR0L0fa5MsUpvwSGD+oQeDpeeVL1yVvtCA/lskGBWMh0oKqWnRWinzZ0m+68dOFZZf74Q33tVr7aR79XHNdX9177718+MMfnjnvuc99Lr/1W781AZT//M///Nj7+OQnP8lrXvMavvd7vxdwwDsvKpqrWq2i9eR91/r6OhsbG1hri7/75QKlB+kFL3gB//k//2dOnDjBwsLCsY8312c+8xmWl5evC0yHOVCfa6655prrKsmMUnQvwWY3BqRn2yHD/71B/BUHMRFQf84yzW88RbB4g6NdpEC1q8hWBaGuj23MWovpdtF7e+jBjIKEx9lWVoLoeoYTfTgkGg4JoyFpFhNlQxITk5iUeCrGBZwZPQfooZAkQhQ3l1o7B7ohwBqFNBW01pMAXaUI5YqICjH7/XYgQL+M69xNFxM3ktOSVnPCbHNGb3Cz3uBMdpEVm8PzClF4jtHoWziv7yAL7kA0bkYEVfC/Dwt4rlNG8SUuiiGPNVMeW9BsLkQsZl1qqSY2y+yqNbrmJJfa97G50GZzqUoazH4P1RLD6Z0hp3a7nOhvs5LuUFddVC1hKEf0ZJ/E9ujGGUlcoZ41qdkWC6qFra068uXrg0LJ6aUTjA7RIqbaGtDqxCwvjVhs79Go9ahWQpS6vG85MzAykl0NG7Fku7dGvHWO+s45FuITNNIlKrrNgq6zZA921hevkxlhTRdj+2RiRCxjhlKzpwQXVZWLapFLaolQnXlaDuKaSFlUYZFhfrPY8sD8KZ7D45y0OwTTvu0ZwLwr2g6Sl6C5A+YL9A/JL5fWEBiDshkK5zIXaJTJcJnlzlnu2qjyB+1LgEPMguWHXI8pWH61v7GMh8NWSSwSUwLnE8C87HD3/5TMS1XKAj4fenzXAJZL7yifiFzJ3eTSH5Hf7GxALpGi4uJOCJyz2ypEDiBtGYzPAubulALh8scVIJWD44GSVAJJRUoCJagohVA+yiaPRREuTqUMuB34FmMY7p3hMmfVM2D5VZHwILzo1P5xoabmzwsIfi1LiKsH6vfDeD0Dwo/hvHsSbhrQ5+sc9fj9EyfHL1d8LE277WHsJM/t3xMufFv6TWTy6B4KOF0Ab+0d5Tncx2J03jDgtp1HxpRd+RNROOw3wbvNiwnzwr5zshaTQqNy/O+gsWu+hNj9OVfrRyswPtdc11vb29u86lWv4rWvfS33338/nU6Hv/iLv+Dd73433/M93zNzne///u/nrW99K69//et5y1vewuOPP87P//zPA8f73Nx111186EMf4uUvfzlCCN72trcV7vVct912G3/yJ3/Cq1/9amq1Gmtra7zkJS9ha2uLd7/73bzyla/k93//9/noRz96WUj+Az/wA7znPe/he77ne3jHO97BzTffzGOPPcaHPvQh3vzmN3PzzTfvW+f3fu/3uHjxIt/0Td9EvV7nYx/7GD/7sz/Lm970piOf59PVHKjPNddcc831tGSiDN2NsekNAum7kQPpf7dXTKvdtUTrG08RLN/Yx/hERSLbVWQzuG7Vxk0YOoje7WKzI4cz7JPNHEC3idmf8WA0ejRiOOgTjvrEWUiSDoos9EzbiRgXC0RSMJQOoMdSYuw47zTTFk3gstCtLBzolgxDjA364wiXywB0W2yX8R0Th8FzHMDy+Z+lqYXaZsAZfbEA6Kf1JhU01kri5HaGg/+L8/q5ZMGdiPpphFLgnyAu4HkWMQi32FBDHm1lPLJk2FrMWE66NCPDkHW2q2vsyEX+crXDxnKdfnM2NAi05eTOiNM7u5zqbrMWXqLDDrqV0KtG9GWfsNbnKR3SGEnaey1aepFTchFTOw0qgCquK52tNRqrQ0QQ0mwPaHci2gt9Oq1d6rU+1Up0pIiW2Aj2MsFWXGd3b5X+1s0E27fRiU7RyFaomAUWTIPFy6BaQ4SxPaztkzEgljEDadhVgo2gzkW1yJZcJpNLh27ncqoITUdGrMgBJ+QeN4ltbuUidwgHzM/YLRrEUyc6fayiyCo/DjAX1iKtoWo0yiQojHOXW400GkHmaweOUXn+Xs7fr0WcSgmEH3hly8vIa2PWNQKQCiuc29wK6aJYpMAyG5iDd1LjDqzkxz74XPYV+JQlup2D9KOriF6ZcpS7yJI8Y91jbRsUYByrUCgHxwkQIkBZNy5EGYa7bHBg8v1jx5dDQeEcD6SH40oSBML1laSixNhJ7iH59FVyl0MUySRyBiDPneVXL19cgKocDscnxq8kQmmuua6ehJD+KY+nh0TGETdjMD+Ospketn65yWEHsI8H5w/T9XDbXy0VX4f7KDuTOe3GsLMTsbJUc9/xXgIxbgAQpQ3mvwOFmy/8E45uV+MvYaWe+ZEfc31tqt1u88IXvpBf/MVf5Ctf+QppmnL27Fle97rX8W/+zb+Zuc7CwgK/93u/xxve8AYefPBB7rvvPh5++GG+//u/fyJX/XJ673vfy2tf+1q++Zu/mbW1NR566CF6vd7EMu94xzv4kR/5Ee644w7iOMZayz333MOv/Mqv8LM/+7O8853v5BWveAVvetOb+LVf+7VD99dsNvmTP/kTHnroIf7JP/kn9Pt9zpw5w7d927cdCOMrlQrve9/7eOMb34i1ljvvvJP3vve9MwuwXisJOx1w8zWuXq/H4uIi3W73aT1q8EyUMYbNzU1OnDiBnD/uONdcV01fq58tmxp0N8ZE2Q3Zf9aNGf3vDaIv7RY/nmt3LDqQvnpj3SayHiA7FWTt+rRbW60dRN/bw4TRlW8ntZjEYJMxDB/PNKRRxLDXJRr2iJIBiR4Rm4RYZ2gzGeOSCBhIRSQkIykxpZ8brpioRFuJtYqxed1BdOdATxEqo93oMIy6+4+1BND3u88Pwudj97k54OePshmn9NYEQF+0A5dwYtcIh/cQxveQiOdC/XaE2h8jZOIBg2iT80HII62Mv18WXFrUrCY9WkNJT51gu7bKdmOBjYUWF5erRNXZsHW1G3HzpV1O72xxqr/JYnYJ2xixuZTRCwYM6GPCIZWhZjFsspgu0bALiEoLU2vMJqbWYHVEtd6j3R7SbI9odnq0mns0an2C4PKxQNbCyAh2hm12d04y2DqL3j5LdXSCul6lYheR+3Jipl8LjZYhRgwwDEgYMhQxO0qwEdQ4r5bZFEuYy2SDM+nH3n8dsbRkzJIccUJ2uUluc6u4yDnOc5d4glvNBRa5/FMcA9FgTywW0Hy3NNwVnZnAPM8tD6z2cSwelluNtJnDAIW7PMfmB52H7x90qsdylgtq7RPEg00u9zj8tIwAlBi7y4WD5kjp41rYt3PhC10WYSy+2OWB0HyiqKdwcLyA5z5o/Ije+YkscumgdX6NXJSKQgmFsAESlwUubNk5HiCFQvpphXv8iBKAUoKKdDA8CBQVD8YrgSqc5dUgL645e9s5JM+ju6V02y1nj5eB+VWRUFOQPDhk/FlA7q6DvlZ/E851dTQJ5y3OPT9r+IjZ88W8Z7+MsezsjFhZaV7V2gpS1Wm37rpq23sm6auZbR1XURTxyCOPcPvttx8LLH816Ld/+7f5oR/6IbrdLo3G/ImMy+k475W5Q32uueaaa65jyWqL7seYYTb7mcxrLN1LGP7FBtHf7hQcqHr7Aq1vPEVlvXndj6eQEMhWgGpVEZXrcxOtBwMH0Xs9/+jt8WStxaaucWQmRAfiMGTQ7xIP94ijAYkZEZuUOMsmXOgZMJSSUEpGUpGVIJ3VFm0FGoX2OejucDXWOniOSpHehT7zWHO3ew7QjxDd4pZ3N12mlKlZmsmi7XNGbxQA/ZTeIsBgbJ04vYvR8GXOfV59DrK6VESi5LdyNg0ZDs/zhBrylY7my8uC7SXBWjykPVR0KyfZqi1zqdLh02tNNhcDshmRLUpbTm/3ufXiJmcvnefk8ClUcIkL64adRszeYo9LjRFqFLM4qLL6+DJnskWq8iym3sRU61AXUJ86S5NRq+3Rbu/R6gxodrq0WrvUq8PLZpv7S8QoarLXXaN76WbCzduQ/VME8RqBXUaIgCqwcsD6WsZoFWHUCC2GJGLEUKRsScGjcoELcpWhXaQIk599FBwOTwUBmgXlXOan5C43iy1uFxe4SzzJc+3jrNsdqpTeW1NGOICYigfki+yKhWJ4zw+nYn8DgTKawBoaOkFZQ4BBWI3y7nIr3Luz7C53WAT0ZVJXJsD5NY5hKcv4ZJE8w9z4PHNEDszlAcCcovinEOPSmDkwL0fQjO3xPrNElOB53h1BjpGLcUFPmxfgVChRQYmgAOF5X1AZTyNwoD0/rvIxHjStdM4VpZx73MesVAPvIg/cvErgXOaHBdPk8Soqh+Fq7B6/JpBcBiArHoQrN1yA8anxuYN8rrmuq65V/vykW95ODE8AeXAwvsiYt1PL5NPMZN/ZyZmVTT/XXHNdX/3mb/4m586d48yZM3z2s5/loYce4vu+7/vmMP0aaA7U55prrrnmOpKstZhBiu4nRf7i9ZQeJIz+4iLh53eK/Vdv7dD6xtNUTt5AkJ7no7criKvomDlIT7fAqIPoLhPdJpb9LNoSJgnD7h7RYI8k2iPREZFJSLWZgOiRFAyUZCAlyQQwshgD2iq0lRgrffS6vyETGSJIECpFymxmjEgB0I1BZ+MbtMPguTu/gwG6tJrTepNb9PkCoHfsCGslqTlLFD/IdnQPiXwO1G52j4L7354SF4mi++fZynb4cjPjC6uCx9cUCyZjqRewWz3JVmOZrVqLPz9ZY7ujsDPeE7VEc3Zzj9svnOfs9hOsDB8nbu3x5AnLZivi8zf1+dswpNOD9YsLnEmWudOchloLU2tiK9UiUmaMiC3VoEertUOr0xs7zhs91AGFWsfXDExWJxws09s5RX/zHNnOWQjXkXoF4R3iEmiVVxRgMWgVoYMQrVyXipCRTLikBOdZ5EmzTNcuAkszdl4eONx63ZQJCzJkXfY4Lbe5RWxxTpznuTzG7eY8S/SREw0mTLy/y7Esu3JxwmG+KxYJRX0fQFRGExhNJdPUbUpgDcJmrvAnGjMBzMclP49a4DOPECmd5uS0a6AcmBslyKrKOeQ90DYyd19P2sxzYD72mY+h+b4CoAfmlh8flrttB1ghkUgUFRQKJStuWCgkFQQBioormIkaQ/L8oMv96eHJvSKVRIqxazyPXql6OO6GFRXFgaC8MNKXgLg6AJRftTiwApLncPyA8Tkkn2uurzmN422uj8bAfTp/pVwUvjxtejn2TTPGUK3u0GislBoYp7/PZn2/7Z82+b07f5Jkrq8ubWxs8PDDD7OxscHp06d51atexbve9a4bfVhflZoD9bnmmmuuuS6rG1lwVA9TRp++SPg320VBzMrNbdovPE3ldOsya19DKYlqV1yh0WsM0q9GgVGbWkxsZkJ0gyVMUka9XcL+DmnUI9YhsUlItcVot44BRlIyVJLhtAvdgjECgyIzCu2LPTnHUoZQMQQZSqaIGYB3X4SLv5EyJndAzTgnACsY172aDdBv1U9xa/YUZ/UFqmRou0ScPZcw/L84r+9GV+9AqIa7p2qOb73MaIfR8CkeC0Z8YUnwhRMB0R0VTvYgNetcbK6y0Vzg/EqNnc5sN1l7lHDrxiXueOpxbtl6lIZ5gr2FAU+sWzaXYh5b6lEZpqz0qqxfaHNPtEyDk5h6C91oQSuA1mSMfSUIaTV3aLZ2HTxvdWk2upeNajFakUWLRN2T9LZuY7R1DtM/BekqTMWzFGczC5oHIVpFpCqkLzXbtNnQHS6ZFnt2iSxfe9/LfHlo3pIxy2rESbnHGXHJucx5krt5lNNcomVLkUZTwBwgJXCw3ENyN7zIrlxiT3QwJdefsNbFsBiNMoYFM0J5h3lgMwSmBMzHxT6PDMxLxmdRGkdc29t3K8DmDnPhssuNh9kmd4WjUJUqadYA7AQwd/1DoLlSYzB+7CgWn6NuXdSKQCGkIrAejosKgagSUCGQeQSLRCGRTwMGCSGKQpxKuciVWuDjVwJBNXeTK0kgQcmDYXnhIi+D8n1u8qsFykUJhped5dPj8zzyueaa65mjHN5fza8lYwxBkFCpLM3jlOaa6xC9+c1v5s1vfvONPoyvCc2B+lxzzTXXXAfKJBq9F2OTKy9uecX7DjNG/+cio89dgsyD9JtatF54muqZ9nU/nlwikMh2Bdm89iD96RYYtdpiY5eLPg03tTWM0oxRf5eot0Ma7RLrmDBLMMaBbKxLNe9L5UC6cG5Wv3UP0RWZVWgj3C6sxqJBZgiZIIIUpWaDXmv8g8LGHsmBnuefHw7QtyYAesWmaHuCKLuPvfAVJOI+qJ50K/j4cwHYLCLbe5wtvcMX24bPr0rOn23RMgHt4Ro7tTU22otcWK6zcUeAVvtf+9XuiNsvXOTOJx7hpu2/wwYX2FwJeXLV8nc3RXzm9IDOQLLaq7L2ZIOvj5apczPWw3PbrkEb8qulVEqzuUmruU2r3aXZ7tFs7lGtxPv2XVwjC1ZXScNFkv4phlu3Mdi4Gz04jdWdQ66twciQLIjQQVQC5yFGRWQIdmyTS6bl+nqFvazOJBq2l83tBgfNF1XISbnHzR6aP4cnuJdHOT1dAHTG22EoGuyKBXbl0hiYe3g+EM2JO/giv1xrWjYm8PnlymYI64G52A/Mk2MC83xATE2/Ft8QVpShuYtjMa6aJ1aBFUVKuAfXeBReRsQuFiXwzvQcl0spXNRAAcvlFDSfdUYSawUWhTUelguFskHhJJcEVGQFJQMqIiAQDpBL5KSb/NhyjnIhBMoX6qwEkqqSVCqSSqCo5lnlwoHy4IDv7YnolSlArtQ1cJTn+eSqOnaRF8NVP354HYK55pprrrnmmmuuuW6M5kB9rrnmmmuufbKZLzgaXv+CoybRhJ/ZYvSXm9jUOZODk03a33Says3tqwczjikRSGSnimwG1/QYrLWYXo9sewczGh1/fePjXGKLzSZpZGYNwyxj1Nsl7u+QhTtEWUSUFxX10D0WMBCKoZJEE+dqsVY4iG4UmfUg0mdvFjEuKkOI2S50613oORW/HEC3gC7swJPLCmv2O9BtSmZvItL3sRd+H4l4HlTW3Aq1/DgMpn+BsP8kj1Yj/npZ8aUTNeI7FlkerpHaRS62ltlYbHF+JWBU3++EaoYJdz51kbsf/Ttu2vxrktpTnD+R8NSy4VN3hsR3RKz2qqx2q6w+VuM54SpNzqHrbUyjhenUYUEU8LxSCWm1nqLT3qbV2aHd3qNe7x/o7spjWrJwkbh3mnDndgYX7ibtnwFTO/CaaoboYIgOYrJKjAlCMhViVAy+sSS2im3TYts02dIrXMpajKjimx4QWI/O9z9qnb9CTZm4IqCqyxlxidvERQ/NH+EmtmjZsPxC71NPtNiRS64TJXAuF0jE+PyEtQRGO2ieGRbtEGU1yqQIjMswF7aUYV7KLz/cSL1/cEY8S66r6ZWzwjcVqTEwLxznklKMUO42B4FyKwLCTmLzsdPcFbyUUiGEpFptYEXHb0ZOwXLnJLe+cDA2H5aAj1shIFBVNyQdnK9IB8uVUE/TmSgc3JfjQp1SeDDu41eKvHIpCCS+m/VofwmOq/3QPB++et/rogTFfT93khfu8ursgsFzzTXXXHPNNddccz0rNAfqc80111xzFbLGYvoJepBe96JC1liiz28z/N8bmJED+cF6wznSb+3cOJBekcj2dQDpWYbe3SXb2T12NnqRix77XPSStDWMjGU47BF3t0gHW4RZVBQVdS5xGAlRRLlM790an4NuAlJrPUTXgEYECTKIkWp/40se42LynVh7KEB360xGuNgiC90DdLPFrdlT3Jo96QF6RmZvIdL30Y1+gER8HQRLbmPV/Pg1Zu9ReoMn+Hxb8+mTVS7evUJVnKQW1ehWl7mw2OH8SmVmdIvShlsvbvOcRx/h9qc+i7J/z8ZKl0dPwJ/eEaHPZax2q6x1q9zylRrPH52mYRcxDec8N50mLErvu7bU6gParSdoty/R7uzSau9Sq4b79ptfQ5M2SEfLJL2bCHduZ7hxD0nvJkrBLFPraLTootUQXYlJq4lznQcjmCpEOrIVtnSTjWydLdOmZ+skqAKN232oWBQ+9IrIWFIhJ2SXm+UlzokLPEc8wT08yhm7SceWGoRmvOx90ZyA5vnwrlycKACa55gHxlDPMlo2RtoMZTQI4zPAvcseF01kLscqp93lHPJo+hRcvxrfAvsLf3pQLgRG2qmDKZf1lCVgPu67wpwOPAvpYlKkVGN3uc80tzg4bqzEyCaZAGuUnx6grEJQJRDKdUpRkcrliAuFkupAh/fRNekqRwqUlKjcWR4ol1euBMEELN8fwzLtKp/IKffDasbTJE/n2CfyyMtOclUdO8zn8StzzTXXXHPNNddcX9WaA/W55pprrrmcK3roctKvd8FRay3Joz0Gf3oeveuQo1yo0n7RaWp3Lt1QkK46VWTz2j5yb6IIvb3tYl2Oee1tVspFL3FSbS0jYxglI5LuDnH/IlHUJ8oyMl9UVGMYiICREgyF2pcJnUP0zARk1mKsxpKRFxRVQYKQMyC6ATMm6UcsIirG65SWF9ZwMj3P18Vf4Db9FGez81StJrW3E+kXsBffRyruBeWjTPxLZXWK3v17Bv0n+Ot2xqdPNdj8uhNUeA7oNhfbS5xfqbGxpGZGt5zY7XPX449zxxN/Q6v/13QXNnnklOFvTqZ8+kxGZxSwvlfj1JM17u8u0NEr2EYH3WihO01YCjw8NzSbXdrtR2m1t2m3d2i3d2dmnVsL1gRk0QJJ7yZGl+5gcP4Bku7ZQ65dTCZ20cGArJIQVzKSaopQIUrsz53vmyqPp0tsmAV2bYOICgaBmYGJx+EtlraMWVFDTstdbpUXuYsneR6PcJd9nBW640KgMzLNh6IxAct35GIxnIhqsZwymorRKKNpZjHSDF2OudU+4mScZ25xDnM9uz3B6aA4lsN0FV3nl49l2e/uz8t6CgraXjr4PJLFAWgplIfSLoPcCjXhJjdItPURLFSQWYCggsKtW5GSOhWaUhBIRVUqD7gFT4+X+6KeZWe57ypKUPWwPFCCQECgBBUPy6ejXyYd5M5hrkr55eqqusrznZYh+RQsnxf1nGuuueaaa6655prLaw7U55prrrm+xmWiDN2Ni3iV66n04pDBJ8+TnneFNkVd0fqGUzSet4pQN+ZxeFFVDqQ3ru2fSN3rkW1vY4bHi3U5KBfdYhlpwyhNiEdd0t5FRsNdwjRGa+dEz3we+iCQREJOsE/HsyXWSBIboEsQXcgMKjFKJQhpKFPTiRgX41zChx6/z0Eftx1MUti2GXJH9hh3ZI9xLnuCmjUk9k5i/Q3sJR6gy4Zb2L9ENovQO3/PsPcof93WfPpUm63nncKo+x1A7yzw+Hp1pvu8Fcbc+eQFzj3xt6zs/RWJfIzHT8Y8tqb50v2aIBOsdquc2KvxzY+1WRt0qASL6GYb3WhjTjeIhUDKjFZrl1Z7g3Zrm3Znh2arizqgAKvJ6qTDNaLdWxht3k3//H3YdHZtAG0HZHKXLOiRVlLCqmBYMViZ0CSlWoLnAZBZwYZu86RZZMu0GdgaMcG4WOgMBWgWVcgJ1eOMd5s/VzzOffw9Z+zFcTHQGe0jMRW25bLvyvB8ibgUzxJ4p7kymkaW0DLDIsscUc4zdyw5PUIky7GA+Yz188ErQaRll7mR0gN04bsZu8wD1q30+/ORLdZllVvERCSLlApEBSEqIAL3+cRBc2Ml2laQJkDqAIlE+Uxy5bPRXQyLQilBIMQEMLdYrLSIQBxYfHPWRSuc5UqN41iEJCjHsPjolbK7vFKi9IdGsCg/fDWzynNNZJNXx8NliD6H5XPNNddcc80111xzHUFzoD7XXHPN9TUqm2qyboKNrn9OetaNGf6vC8Rf3nMTlKD5wDrNrz+JrB1mO712ElWFWqgi69fuT6PV2sW6bO8cK9bl4Fx0D9G1Jor66P4lwv4Wo3hEqg1WOyd6XyoGShHKWRDduVhTo8jQaGuBFCEzRCVBBqnPQx+v6WqIege6vXxDjLXeBW33W5iFNZzRF7kze5Q7ssc5pbdI7W1E+gV00x8i5R6QHsr6t4ZNR+jtLzPqPsLftA1/cVOHi193hrT2QjBtLnbaPLFeodtSU/uynL24w3Me+yInLn0Gkf4dF5d3eOQU/L93uliadhhwYrfG877c4sRuncVkAdPooBtt9EIbvVpDY2k0eiwvXGChc4nOwhat1h5C7KfN1giyuEPSP0W4fY7B+fuIds+B2f8+MzYmlZdIKnsk1Yh+NWC3KtEYakazIGKaIiUAFgFtBT1b53Hd5ILpsGubDG2VmICDEHFDJiW3+SZ3iSe5l0d4rn2MVbtHkDeIzHCb74lOAc4vlfoD0SpAZBma17OUphmhzCQ0NwKfbS7ILhOzcsXAfMa24Hiu81lZ5kYBpUzzfbsqjrvsMJfg88iREqGEA+U4mCv8sEBhbR6/UkHYAGklUihfQlThy3gWwFxIUDkoR7jIkyu6UPszy1XuMFeSipJUApdXXjnEXV6G5WVn+TUr7FkcvjwYkhdRLPPM8rnmmmuuueaa66tLQgh+93d/l3/8j//xjT6UrznNgfpcc80119eYrDboXoIZHi+n+2rIhBnDv9gg/Nx2YVGu371C64WnUJ3qZda+NhI1D9Jr1+5PooljF+uyt3fkWJeDc9EtkbEMsow4HqHDPeL+FsNRjyTNMMZirKEvAvpKHgDRA+dENxJdhugqRfrCokJMOtGNdWAfe3mIPulC3x/l0jIj70J/nHPZ41Rtjdg8nzD7Z5zXL8DKZbegzK9fH739d4R7j/A3rYxP37zMxefdTNj4VqxtsrnQ5PH1CsOp4qFSG26/sMkdT/w1i3t/Sai+xFduivnsaQunQWnhcs/P1zixW2O926CiPDxvdtCnWoQqIAhiOp1LdBaeZKGzRXthm0qQ7Dtvk1XIwmWivZsZbT2H4cbzSAfrTGNciyEVW8TBDmltQFi1bFbq7BIgrKBuLavCsCS6tABjBT1qbJo2O6bBJduma+sMbV4odL9qImMlGHJa7nBOXuAeHucB8XfcZZ9g0Q7yA9kHzVMCtuVSCZqvFON5rrm0pgDnQapZNl2UScFmMAHMHXTOZrWR5QB2/6Qr1xVEtoyjWYTPMxeYA7PMJ0cLl7kVIL17XCisrWBEACJAyApQRRIgCJBUkVSQBBSY3EoEsoTLpQPRwmeAl4C5VIIriQQXQjjnuxRI5eJdjDRUZMXlpAcOmgcSqt7RHig8OPfFTUU5l3wyeuXa5JWXNAuQTwzPb2nmmmuuueaaa66vLm1tbfHwww/zkY98hIsXL7K8vMwDDzzAww8/zD/8h/8QgAsXLrC8vHzdj+22227jJ37iJ/iJn/iJ677vsj74wQ/y3ve+ly996UssLCzwqle9ive9733XZd/zX59zzTXXXF8jsqaUk369C45mhtFntxh9+iI2cTC2ekuH1jffRGWtcV2PJZeoBy7a5Ro64nW/70D6YHjkdayx2Mhlo5fTU2JjGGpDmISYuEc62GI47BJFkYt0sZa+kPSlYiSqY3MsZSe6chDdajQGyBxEr6QImXiHdV6MEozBhaJbt/0Djxl8ocN8bL8L/Sa9yZ3ZY9yRPcppvUNi7ybS30Q3/XEycc45TMHxySxGX/oS8aUv8NfNmE/fvMbGfbfSa38n1rbYXKjzxHpAVJ1EppVMc8eT5zl74bM0B5+lX/0KX74p5S/PAGegHktO7TS444kap3abLIxqmHqniG/JVppoaWm1dukU7vNLNBr9Ga+TJB2tEO7cxvDCfYw27yYLl5mmukb2COU2UXWPuB7Tq9a4KBvs6jpW12nYgHU55AQ9bhYZEQE7tslTZpHPmdNs2yY9W5tRHNSfs8hYViNOq11ulxvcIx7nAftlnmMfY5meO5r85Si9LH3R5JJc2ec474pOQY3zXPNAaxppSMf0ECZFYjACH9Hineb7QOrYUn5VXObTOkZky75olrwYqBITn5Nie8Vxi/EEIR1ktxXXiQBLBStrDpTbCpIaAVUqKiAQwT5XuSyKi/ryoko4WC5EyWkuizqix9HYVe4s4Eq5KBYXoaIcJC8c5Q7Kh1nMSr1GRckbC8sRDooHtYOB+TyKZa655pprrrnm+hrTK17xCpIk4Td+4zc4d+4cFy9e5I/+6I/Y3t4uljl16tQNPMKnryRJqFavzFj33ve+l1/4hV/gPe95Dy984QsZDoc8+uijV/cAD5Gwh90hfw2q1+uxuLhIt9tlYWHhRh/OVZUxhs3NTU6cOIGcP/Y611xXTc+Gz5YZOZBus+ubk26NJfriDsM/28AMnCM+WGvQ/uabqN7Sua7Hkks2AmSniqxeG5ButUbv7ZFtb2OToz8FYBKLzQuMeiXWFLnoJu6ThTuM+juMwgFZZrHGMhSSgZAM5OzColhFqiUZhsxaQCOCFBFkSJnAQRD9MgVFrc9+NjNiXACaJuRc9jh3Zo9xTj9OVS8SmRcQ6RcQmQdANCeW190n0JufZzN8kv/3zAJfuvVONteegxUdNheqPLkWkAaTJ1iPU+548jFOb36WSvTXbDcf4fETuihWWYslp3bq3LTd4KbtJq2oim4tOPd5s42p1anVhnQWLtHpXGKhc4l2Zxsp939O0rBDvHeW4cV7GW3eTdw9A7bkSxAJaWWTYbDDqDZgVIdd0eaSbbGTNYiyKv9/9v48TrKqvv/Hn+fcpZauXqe7Z99nmAVmYVgHVEAWDXwQZTEGk88XiRA1JnH7CHFBA0ETxETze+jHKH40BDEuQaIhqKyCrMO+DdvsS+9Lde333nPO749bXd0907M0dDeK5+mj7emqW3VPVXVR1c/7qte7UZRpk3naZZ5mShTw6Tdp+nW69r3I+G8oXaFodorMcgZZKLtYKXaxjldZpbeNHQy6D3mRokfOqH610C1n0Ou0UBbJeNnGxElzo3B0hKtDZPXLUO00F7oqlcdR12KKhPk++xj9z/H2MSzNtRRxPcthSvPaD0JgcNA4aONihI/BI8JF4OPg45DEFbEs94SLJzxGWsv3/2+/lOOnzCdeyzJ60GecMh8R5rE892UszIf7y71qf7nnxD/vW8OCNAwUy7Q3pXAdMYWyHBBOVZj7B0iXT+3gZ4tlOvl9eE9osfw+Yp9bE+fN7LYmSrlcZtu2bSxevJhkMvlGL+ewGBwcpLm5mXvvvZdTTjnlgNvtW/ny4IMP8pGPfIQXX3yRo446is997nO85z3v4cknn2T9+vXce++9nHbaadx5551cccUVvPDCC6xfv57vfe97rFixAoAtW7bwiU98gocffphCocCqVav48pe/zBlnnAHAqaeeym9+85sx6zDG8MUvfpFbb72Vp556qnb61772Nb72ta/VRPcll1zC4OAgxx13HN/4xjdIJBJs27aNXbt28clPfpJf//rXSCl561vfyte//nUWLVo07u0eGBhg7ty5/OIXv+D0009/bXfyOEzkd8Um1C0Wi+VNjAkV0WAFU9l/MOJUU9kxROHBvUR98TBDWe+ROXE2iSOaJ78/9zAQCQenMTFlIl0HwUitizq8AxdGVweMVkYGjGoMBaUphBFRkEeVBynn+ygUcoRBiNFQEJAX8XBRtc99abQA4xJpSWQMkdEYQoQbIp0Q6YxIdMPIUFG0rqbQDy7RjRHVDziMrYTBGObobpZGO1gW7mCWyhLotZT128lGG1Bizsi2olrj0v0CQe+LPFNX4bEli9n+tqPIp99BNp1gZ5tH4I29bXWlCkt2b6Gt9ymInqerYRfdzYbuufH5iUAytyfF/N4Ms/tS1JVcVDpDVNeAam+gmPJjcd7YWUuf+355v9upQp9Kdi7FnhWUuldQGliMDupGrT9AJfeQ93sY9AtkEx79uok+laE/mktOJWgul2iXedpkniNED4Hn1sT59rCFfpM+4JDQeqfMLCfLYtnJarmDtWzhSLOFVjOIE09+3e9hKpKkx2kZI8575AxK1QGuwhg8HeFqhReEpHQRoQOkUWhMraIlrjqp1p7UEtrO8MMWf5/Kp+9B+s61iPvMlYiluZbxYg6ZNBdipI5llDTXeBjhgfHB+Dgk8IRLUrq4wsPHw5Uu7gHeLk9eynyUMHecWMI7TlWgSxxX4lU7y4cHfXqymjZ3wHNFrZ/cqabJa/92xk+Wa2PIRwLPE7X+89fM6DoWNzFOd/kbMxfDYrFYLBaL5UDE9ZrTGzYDEJ48rL+FM5kMmUyGW2+9lRNPPJFEInHIywwNDXHuuedy9tlnc/PNN7Njx44DVrJ89rOf5atf/SptbW186EMf4tJLL+WBBx4AIJ/Pc/bZZ3PttdeSSCS48cYbOffcc3nppZdYsGABt9xyC+vWrePyyy/nsssum9DtB7jrrrtoaGjgjjvuACAMQ97xjnewceNG7r//flzX5e///u955zvfyTPPPDNugv2OO+5Aa82ePXtYtWoVuVyOk046ia9+9avMnz9/wmt6LbwmoT44OMhPf/pTtmzZwv/5P/+HlpYWnnjiCWbOnMncuXMne40Wi8VimSBGGVSugi5E017vEvYUyT/YQbgrrskQviR97CzSa1sR7vQnSoTv4DROXUe6LhaJentRQ/vXghwIE8YS3VRGHpuK1uSUohyUoTJEpdBDPj9EpVxCR4aSgFxVokf7SnQDaBelnapEN+hqnUutF73aiT6SQgfMYUj0/QaKjmwrjWJxtJtV0assC3fg61nVFPq76dCroNq5jQCjFap/C6r7BXqLO3lg/gxeWrma3bP+mLJXz54ZHoOZseItUyyzZPdmmgeeJuQF9jR10JmCzupbDT+QLOhMsqC3gdn9SdIFEfef19UTtTZQrEtQ39BHW1MnjY1PU1/fi+OMPbhktCDItVPqXU6x9whKfUsI8+3UzK4MIbWXYv1z9Ps5+l2XAdNMX9hMT7SEoTCFH0bMlDnaZZ7FcgCkIWtS9Os0T0dzyJpUnOjfB4mmxS0yx+lnudzDWrGVY9nMUr2bJNWO9n3e55fx6ZEt9DhjU+cFkQYhxibOw4BG3Y/UAdJEaHRNmg+nt/Vw5nufepZpOeY1jjyP+8zjpLkaJc21FOOWogsx/H+xMNfGqX3XwgV8wEcaH2FcHFx8kcAVHp5wY2EunDF1LPsu0an2mTuiKq4nnDKPa1eG+8uHRbl0JLKaMvck8bDPUQlzT4Lviaowr8p7J/bTtX9PxYDPfe8BZ3R/eWJ/eW7rWCwWi8VisfyeYULN3qsenPb9zrn6JMRhBLxc1+X73/8+l112Gd/61rfYsGEDp5xyCu973/tYu3btuJe5+eabEULwne98h2QyyerVq9mzZ8+40vvaa6+tJd+vvPJKzjnnHMrlMslkknXr1rFu3brattdccw0/+9nP+PnPf85HP/pRWlpacByH+vr611Q5U1dXxw033FAT5TfddBNaa2644Yba+9rvfe97NDU1ce+993LWWWftdx1bt25Fa82XvvQlvv71r9PY2MjnPvc5zjzzzANK+MlmwnbhmWee4YwzzqCxsZHt27dz2WWX0dLSwi233MLOnTu58cYbp2KdFovFYjkMjBnVk36Ywy8nCzUUUHikg/JLA/EJUpBa20rdMTORqen/QJTwJE5DYsr2rfIFop5udKF4WNsbHQ8X1WUDKn5slDEUtSYfKVQlhyoPUCr0kc/niSohFQM5Kcm5LuF4Et04GOWgjCAwGo0CGSHcAMcLEGgQcXWL0tTi6IccKnoQie4YxeJoJ6ujV1ke7AZ9JCV9FkPRcWjRNHIlAnShh6j7ecLuF3i+LmLT8iN4Zd2JDGYuYDDjsafFxYyyko7SLOzYzszuTQQ8zZ6mXXQkoWN2fL4fShZ2pljU20h7v08qbzDJNFG6AdVcT3F+koamfhqbOmlsfJb6+t796luiSppSTyzPy31LKA8uwKjqGy4ZIjN7CGc+zGCyn07p0R/NYCBspSdcxmApBQgShMyUOZaJXnxXUTYufaaOzdHMA1a2JERIq5tngdPDSrGLo8UrbDAvMtv0jps6V0i65Qy6ZGtVnsfiPCcyNYEZDwaNcKKQBj2IVAHShBh0fFW1BLdEIWs99dMqzUfvcNR+a4NApYyT51JUv8a7fNxhrnEww8IcF4ODEaMHfsbfnao4d0niyvjfUkgcIcetZhHDdSyvuZrlUMI8TpZ7jsAVw+Jc4DuQ8AW+O5Ik31ecT/2necT4krwmzz0rzC0Wi8VisVjeAC644ALOOecc7r//fh5++GFuv/12rrvuOm644QYuueSS/bZ/6aWXWLt27ZiqkuOPP37c6x4t5WfPjv/Y6u7uZsGCBeTzeb74xS9y22230dHRQRRFlEoldu7cOSm3a82aNWOE99NPP82rr75Kff3YSthyucyWLVvGvQ6tNWEY8i//8i814f7DH/6QWbNmcc899/COd7xjUtZ6MCZsGT7xiU9wySWXcN111425sWeffTYXX3zxpC7OYrFYLIePLkeobGXaP7qmKxHFx7opPtNTE8WJ5U1kNs7GaTj0R9MmG+HKuCM97U6JjFK5HFFPD7pYOqztTTQqjV4VpsNp9FJQRgQ5gnI/+XyWcqFIFIYMSYchx6M8rkSXGO2itCAymgiNEVFc6eIGCKlBaAwGbeJPK4wMFR3/IMvYoaKwb52LayKWRDvjJHrQhdFHU1LvoV8dgxHVobICTFRG9b5E1PUCA/ntPLRoDs+sWc/O2ZdRSGXY0+JSTowVmq2DA8zb+zhO5Um6My+SSwTkWuPzvFCwqLOBBb31tPV7JPMavERc4dJYT3leioaWftobu2hsfI5MfS9Sjr2NUTlDoXsVpe4VFHuOIMjNihcrI7z6PZiZm8ile+l2FHsq7QyU59IXLaM/m64NAk0S0iZyzHGyOBgKJkGvqWOnbhn3/qyXZWa6WZbITlaL7RwrXuRIvZVmciN3+KhllkjQ6bTRJVvpctrolG30ymZ0tWrF0RpXh7hRRL0eROoQRwcj4nw4pS0FWgjAHQmdT1Wv+YEQY/9tHKqd5qLabx6L87h2aPS2Mq5jEQ7GuPF3PBAeAr821NMRMhbnxkUKNx77KTxktdvcoSqx9xHn+0pzV4p4O8lhSPO4kkUIgeO41T7yuM88Fudxet2rDv2Mvwt8NxbmCU+MkuSjUuYTK1J/jRxg4KdwQQzBrDlxzN1isVgsFovlDwjhSeZcfdIbst+JkEwmOfPMMznzzDP5/Oc/zwc/+EG+8IUvjCvUJ4LnjcywGf6bWevYI3zqU5/ijjvu4Prrr2fZsmWkUikuvPBCgiA46HVKKdl3TGcY7j9TrK6ubszP+XyeY445hh/84Af7bdvW1jbuvoYPAqxevXrMtq2trZMm/g/FhIX6pk2b+Nd//df9Tp87dy6dnZ2TsiiLxWKxHD4m1KhsBV2Opne/2lB6vo/CIx2Yclyj4c3NkDlpDt7M9CEuPQVIgdPgI+u8qRHp2Wws0suVQ25rTJxGN2WDiUbS6AWlyUcROsyjS4MUS4MUijnCUoWShqxwyLnJ/fqgh4eLRlqidSzRFRrhBkg3RMgIMBihY4leHSxq9MEk+vBQUarbjD0Q45mQpdEOVoVbWBJmUeoYSvpP6VNrxlS56GI/UedTRHuf4oVMxCOr1rL5uNPpa5hHX4NLf8PYjzQmKwELOjaTGdrEYOJZcql+9mSATLyM9oEkR3TPYHZPgvSQwrgeKl1PVN9AZW6C+tZsVaA/T6a+H7GPmA2LjRS7V1HsOYJizxG1+hY3NYDbvBU1+xF6Enl2llvoyi+nL1hOf3F9nOAeXiMhs8UQaRmgjSRrUuw2TRi1/xvgellmrtvPSmcX68QWTuAFloyubNnnIegXDXQ5bXTJNrqcVjplG0NjUucRrgpJRXkcHSBVBRG3nFOz41Kg3Vic137Vp1ucDyOIa1mG0+bVf2shxk4QFVT7y12oinNwMcZHyOGUucQlHrbpxBnx6kENJ06eCxdHeDjCwcVBirE1LUJQleaiJs1rIv0Qd46UEiEljnQQtQGgccpcSDm2u9wReA4kPEGyKszdUSnzA/WWTw0HEOajTxsPrUEe3qdrLBaLxWKxWN5sCCEOq3rld43Vq1dz6623jnveihUruOmmm6hUKrXO9U2bNk14Hw888ACXXHIJ73nPe4BYeA8PFR3G932UGlul2dbWRmdnJ8aY2t/joweUHogNGzbwox/9iPb29sMeoHvyyScDcSp/3rx5APT399Pb28vChQsP6zpeLxMW6olEgqGhof1Of/nllw945MBisVgsk4/RBpUL0Plw2nvSg105cvfvQfXHAx2d5gSZk+fgL2yY/oGjUuBkfGTGQ0xy4tMYgxocRPX2oisHPyIPcRpclw0m0DU/XdKaglKUwgqikiMs95Mv5ikX8wTliKwUDDkewT6udrgXPdLxkf7IGBQROAHCDXFlFNe5CI02pjZYdCSNPs76DiHRfROwLNrOqnALi4KASB9HSV1On15RqwtBgBraS9TxFEHnUzzRluY3x76VV87+G7J1GbqaHdQomSi0YVb/Hlp7NlERT9Of3saA1Aw0xecnK5KVnTOY11dPcz/IQMU96JlGKstT1M/M0djYRWPjZjKZgf0EepCfEQ8PHRbohVbAkGjag9+2mcriO+h2K2zJLWbH0Aq6e44gNGPf/iQJaJMlfBRlPPp1mr2mqTYotradCJnpZFnu7mWDfJmTeZZVejs+4X7iPELSI2dUk+dtdMpWup1WKmLkUxuuCnFVQFoP4KoQR1eq4rx6R0vAjZPbomrM36j2jeFuc+PIWJY746XNBVpUq1iIO8wFHuAjhY+Iy1cQDAtzqsJdVsV5nDh3hYccFuf79Ju/9k7zsYM/HSkR0kE6opo0j2W564x0lyc8QbL63R+VMnfc6ahiGVn3axLmFovFYrFYLJbfW/r6+rjooou49NJLWbt2LfX19Tz22GNcd911nHfeeeNe5uKLL+azn/0sl19+OVdeeSU7d+7k+uuvByb23nX58uXccsstnHvuuQgh+PznP19Lrw+zaNEi7rvvPt73vveRSCRobW3l1FNPpaenh+uuu44LL7yQX/7yl9x+++2HlOTvf//7+cpXvsJ5553H1Vdfzbx589ixYwe33HILn/70p2vCfDRHHHEE5513Hn/zN3/Dt7/9bRoaGvjbv/1bVq5cyWmnnXbYt/X1MGGh/q53vYurr76aH//4x0D8oOzcuZMrrriCCy64YNIXaLFYLJb9UYUQla1Me096NFgh/+Begq1ZAETCoe6EWaSOap10mX1IhEBmPJyMj5jkNKjRGjUwQNTbhxnnY2r7ogMdp9HD4TS6Jq8MhUihwzymnKVUzpIv5QiKZQqRISslBc/bLz9utEQrB20kkVEoNEaGCC9AOiFCGEw8XnKUROeAvehj61z2l+gJU2F5tJ2VwRYWhA6hOoGSPo8+M+rIvgDVv42o40kqnU/x2JxW7jrhNLYsOIeexhTZfYaJ1hdyzOp5Gqf8OP2p54lEic7qJ/ukhiW99Szsm0Fbn0cyF4BwiOoaCFobSc2JaJvRRXPLU9TX9+0v0HNtFHtW1BLoUXEGwi2TatlKev7D5DJ76RCKVwaO5NXBVfQOHFerbhkmTYVGp4wygiGdooxPpx7bfe6iaHXyLHB6We+8wlvFM6zXL1FPtepn1N0Y4LHXaadTttUE+ujKFmEMjg5xo4A6VUDqMo6OYB95btxR4ni6n09VTDVxrh1ZTZ3HVTJGjIhzQ1zJoo2HkLEwF/gIMaqaZViYj0FAVbYL3Ko4j5Pno8W5IK5DceTEpLkQoirL45S5U02Xy6o4j1PrkHBErYol4cX/TvpiGgd97nOfjO4rr3WYW2FusVgsFovF8odKJpPhhBNO4J//+Z/ZsmULYRgyf/58LrvsMj7zmc+Me5mGhgZ+8Ytf8OEPf5j169ezZs0arrrqKi6++OIxveqH4p/+6Z+49NJLOemkk2htbeWKK67YL1h99dVX8xd/8RcsXbqUSqWCMYZVq1bxzW9+ky996Utcc801XHDBBXzqU5/i29/+9kH3l06nue+++7jiiis4//zzyeVyzJ07l9NPP/2gMv7GG2/k4x//OOeccw5SSk455RR++ctfjqmzmUqEOVCM7QBks1kuvPBCHnvsMXK5HHPmzKGzs5ONGzfyP//zP/t14fy+MTQ0RGNjI9ls9rA/avD7gtaa7u5u2tvbkbYv02KZNKbzuaUrKu5JD9ShN57M/QaK4mNdFJ/qiSW+gNSaVuqOn4VMTvPAUSGQaRenwUc4k3t/G6VQ/f1E/f2Y8OAVOsYYTMWgy7qaZDYUlSavNOUoQFbT6IVynlKpSKUSkDUwJF32VfRxvblLpCRaGxQGJRS4lRGJLnTcmW04rOGixgh0rTtm7HZJU+aIcBsrw23MC+sI1ImU1IkoZo5cXqu4D73jSSpdz/LIkgXcefzpbJ23mu7mJMXkyH3vKMXMvlfJZB9lyHuaSHaNkaltQz7LelqZNZihfkAhgwjtJ4gyTYiWBA1zczS37KW5uQPPG1upUxmaGQv07iMo9R5BVGrGTfWTan0Vb8YWcnUd7DEuL/cczQv9q8iq/d+HpESFehlQ1i5DJsm+5SgCTYsoMdsZYIWzm7fIp3iLeZo2svtdl0LSJVvZ68yMv+RMemUzZnjgp9G4KsDR1S9VQZpozN6o1qIIZDV1Pr3yvFrFH/eaCxn3nFfluaiKcyMctHExuAjpAgmESCDwa3UszgFLZobFuUDgjUqc7yPOBTgy7jF3pMAVAkdKDva0rlWz1LrMnVqfuZDginjIp+9B0pckPUHSh6Qv8DxZFebT/SmaA4jyN3Dop31PaLFMDfa5ZbFMDfa5NXHezG5ropTLZbZt28bixYsnJJbfDPzgBz/gAx/4ANlsllQq9UYv53eeifyuTNiCNDY2cscdd/Db3/6WZ555hnw+z4YNGzjjjDNe84IPh2uvvZbbbruNp556Ct/3GRwcHHP+008/zT/8wz/w29/+lt7eXhYtWsSHPvQh/uZv/mZK12WxWCzTgYmqPeml6e9JL7/YT+HhDnQx3rc/v57MW+fitkz/mxGZ9mKR7k6ySI8ior5+VH8fRh18qKvRcTe6rsS1LsoYckpRiDQmLGDKWYJylny5QLlcIhcqskiK0t2v5NpoidYOWsdpdI1GOxWkF+AIhRGxNNeY6qcRzMF70Y1Ax2XVjDdY9IhoK2uDLcwOWqnoEymrS+mncdT9EBB1P0fU8RTlnud5YMVK7jzrDLbPvYTupgSBN3IDvDBgVt+ziNKDFNxnCE2ZgWqbSaYkOKKnmdlDM2gadPByJTAClfYJm+tJzVO0tPfS0vwMmfr+MbdBhUkKnaspdB5FofNIonITicZdpFq3MGPtTxiq62J3pZEXuzfw5M53UtL7/h4a0rJCSkSUtUfBJCiZBCU1UrVSL8q0yxwLnR42yJc5i4dYxm7k8P016u7tlc3sle3sdWaxx5lJl2xFCXf4AcTRIX6Yw1WVuPPcjD7YFcvz+MBP3Ncy7fJ8OHEunWplSzwcVFTXY4SDIa5jMcLHEUkQPg4uXlV9H5y4rkXiVYeD+vuJc2dU2jweCioPkjYfv5rFcUVc0SKoCnNBwpMk/ZEu87QvcFzxBghzd5+E+T5p8zeqp8disVgsFovF8gfFjTfeyJIlS5g7dy5PP/00V1xxBe9973utTJ8CJizUd+7cycyZM3nLW97CW97yltrpxhh27drFggULJnWBwwRBwEUXXcTGjRv57ne/u9/5jz/+OO3t7dx0003Mnz+fBx98kMsvvxzHcfjoRz86JWuyWCyWqcZog84HqNwb0JO+N0/+/j1EPXHFhdOYIPOWOfiLpr8nXSZdZIOPnOTBMSYMifr6UP39VVF9kG1VnEY3FQMGKkaTixTFKERWckSlAYqVPMVyiWIlIKsMOSmJ5NiX2jhh7hApidEChSYSAXgVpBsgoVrpoqtRYg3ajOrW3mddVJPo40h0jGGu6mJt8CLLK0ki9RZK+oMMMDI01gQFos6niTqeotj3EveuP4a7znsHO2Z/iJ4mHz1KTqYqBVr7HieMHiJiM2UUOOBFsKwnxYL+NpqLGZKDATII0Y5GZerRS5pomJ+neUYHTU1P4rpjM/qlgfkUOtZQ6DyKUt9iEg0dpGduZuYx/06+vovtuVk8372BJ1+5iPI+Al2iqJMBrtAUtU/FeBR1kpFxi4ZmUWK2zHKEs4fTnCd4u3lkpLplFEOirpY6H06gD3eeG+LaFhmVSOqgKtDDEd1cHcIp4r6QaZfnRoAWcVWLqVa06GpdC0JicJF4CJFEyFici8NU5jFx6hwcHOni4OMIHxcXKeRIJcuogaCOlPHux9nBsDCXjlMdADoizR05UseSTFQT5p4k6QtSiek/KIGQ+6TLR/87EXfEWCwWi8VisVgsbzCdnZ1cddVVdHZ2Mnv2bC666CKuvfbaN3pZb0omXPkipWTVqlX8/Oc/Z+nSpbXTu7q6mDNnzn5TXieb73//+3zsYx/bL6E+Hn/5l3/J5s2bufvuuw/7+t/MH4uxH5OyWKaGqXpu6WKIGgow0cET05ONGgrIP7iXyquDAAhfUnfcLFJrWye9YuVQiISD05BAJiZZpAcBUW8v0cDAgcLeI9uGVZEexMnwotLklKISVpBBjqDYR65coFQpMxRoBo2mLPa/n4wWaO2itUAZjQaUEyDcACmjuBN9WIgfotJl/+GiY29Evc6zJniRNUERLzyWojoFzYza+brYT9T5FNHeJyllt3P7iW/lN8ecys5ZC+hrcMcY0ExxgKbBhymbR0BtRVT3lS7Dqs4M87MzqcsncIeKYAw6kUI1ZEjPVzTN6qe5ZS91dWOrU6JKmnznURQ71lDoWo1wQupmvkDdzM04M15hR7mRpzuP4+Huo8mH9WMu6xOSdkIMUFQJQsb+bkg0raLALDnEcmcvp8gnOYmnaGVwzHZl/DG1LXudmeRkhuF7VJgIRwW4OsBRZVwVjCTYIRbmkqo8l9MmeY2oynNHYIREyxFxbnAANx4AKnwQCYTwcUXyMKX5MBJwqjUtHrJa2zKcOq+J82pNi+vIcdPmY+pZqqlzxx2R574nSFW7zFOJOGWe9AVJ7w14j+L4f1A95vY9ocUyNdjnlsUyNdjn1sR5M7utifKHXPlimRhTWvkCsGrVKo4//nh+/OMfc/rpp9dOn6Cbn3Ky2SwtLS0H3aZSqVCpjPS1Dhfta633m2L7+47WGmPMm+52WSxvNJP93NKBQg1VMJXp7Uk3oab4RDelJ3tAxT3pyVUtpE+YhUy7sbY9SGf3ZCI8iVOfQKbil6nJu28Dop5eVHbwkCJdV6qDRiODHhbpkUIFJUSYpVIcJFcukK8EDEaaIRMnhBkl08dLo2sRob0A6QRIESfPVU2k6wNWuowdLgr79qK7JmRFtJV15S5awyMoqj+jYhYy/ApnggLhnseIdj1CPreL/zrlTB446wPsnDWXobqxbwea8ntJDT1ImUdxow4qxPnktiys6mxgVn4miaKHzBWACJVOIRa3UL+gQHNrF41NT+M4I7+/xgiK/Qsp7F1HsfMogsIM6tpfIj1zM61H/pxBp8KLvat5uPMEXnnpYrQZkeQZGeCLkMhI8jpBgEegRgSni6Jd5pkpcyyTnZwknuYYsZm5dOKMuo/6RSO7nNnsdOawy5lDn2yuHTgwaIQO8MIhHFXBVQGuGfv8E8Npb+S0pc+HxbkWEiNBOcPy3sHggfGqafMEQiZwhX/oKx1DnDoXwsURHg5xZYsrXFzioZ5SgiupDgfdX5zXBoGOSppLR+J6sTQfHvqZqMrzOGUu8Q8ySFhPxftJ4YyIcjlKlB9OLcub8H2TfU9osUwN9rllsUwN9rk1cex9ZbFMLRMW6kIIvvnNb/KDH/yAc845h+uuu46//uu/rp33u8KDDz7Ij370I2677baDbvflL3+Zv/u7v9vv9J6eHsrl8lQt7w1Ba002m8UYY4/qWiyTyGQ9t4zW6EKEnmaRjjGwrQhPZhGl+I2XmZmAYxspNfuUwiHGmc04NUhwUi7CdRG5AuQm52pNFKGyWVShcHCRbgwmjL/ifnRNSRnKSoMuY4I8lUqRUhhQUhF5Iyl7SfDAH3s1oB0UAqPj3LCWETgaIcHgx0J0TBr9QJUusZAe+WnsjmaHuzmy8BJzizMIorcTmDUMz2A3KiTqfIZo18NUel7gv95yGne88y/YOWs2xeSItBZa05zfhlt8gEg9hqMGiIjfJCztgFW9M2gN5kAJGBrCEKDSPu6KRpoWDTGj/UXS6bGT34NSA4XOIyl2rKPYs5RE017q2jcz65h/RzbuYcfQAu7v3MDjT76d/vLIwe+kjKh3S0RGMhj55LXP6Hs3SchMmaNd5lkoezlBPM9q8SqL2Um6evjAAD3uTPZ689nrL2CPN5+C01A9zyDQNOoQRwVIE+FqFVe1uEkgGXvm4S+qw0an+D2OkaClwCBGDQiVVXHuIoQD+AjhIV9TIj6W8RIXiYsj4gS6ROBUu8mlBAeBdARyn8sKKRCy2m0uJULGgt3xJK6Mh4D6nsR3wXPBd8CVBiHG/s5WwvhrShBuLMnlqO/Sq/7biY9BDf9tWVHE04TfXO/1Dhf7ntBimRrsc8timRrsc2vi5HKT9IeUxWIZlwkL9eE/+D/+8Y+zcuVK/uRP/oRnn32Wq666asI7v/LKK/nHf/zHg26zefNmVq5cOaHrfe655zjvvPP4whe+wFlnnXXQbf/2b/+WT3ziE7Wfh4aGmD9/Pm1tbW+6j8VorRFC0NbWZl+ELJZJ5PU+t4wx6HyIygeQNDCNn0ILO4sUfruXqCtunJYNPnUnzcZfMs096UIg6zycej9OAk8S8bDRPlQ2Gye/U+nxtxseNBrEg0YDNDmjKEcRTpAnVR4gX86TD0oMBZp+paiMI8CNlkTKietdCOImdC9AOBXQBh0ZGJVGP1A3+v7DRcfSoHOsDV5ldTmJEx1PSb+bPCOp7ajnJaLdDxPufYJHly3jx+99Dy8u+iSF1Mg2jgppym3GVB5ABE8hTREDJEPDUTsFS/taqI9mokKDLJQwDKFSdaRW1dO0KMuM9hdIJgu169NaUuhbTLGaQhdOSF37izQtvZfZJ9zAUJjk2Z6jeHz7H/Fi/3JCHUtyl4gWJ76enE5Q1i5lPfL2JCMqzBQ5Zsocc+Qg68QrHCG2sZQdzGAQAUQ47HFmsquaPt/lzK51n2utMeUynhrCi8p4KsCpps+HG+eVFFVvPvX1LYaqPHeqdS1OPHQT42Ci4YMHCaRIxMNBHTHi9jFAcBh7EQjh4Qi/mjpP4AkX33GQUhwwcb5f2txx8HyJ47m4rqh1mKdqKXNIuAI5bf+tEKPqWKr95a5X/bdvu8wngH1PaLFMDfa5ZbFMDfa5NXFstYnFMrW8psqXYf7oj/6IBx98kHe96108+uijE778Jz/5SS655JKDbrNkyZIJXecLL7zA6aefzuWXX87nPve5Q26fSCRIJBL7nT6cwHqzIYR40942i+WN5LU+t3QpQmcrmEjHowGnSUypfED+oQ4qLw0AccVK+piZpNe3Idzp/e+DTLk4jYlJ3a9Riqi3D9Xfh1E6FpLj3LdGGXSpOmgUQ6najx5EIU4lhyn3M1jKkauEDCjNoFKofUR6nEZ3ibRA6zgBrZ0A7VYQMgKGKyx0LNEP1o1eq3QZFu8jeCZkRbCV9ZWQhvBISuqvCMjUzldDe4h2PUy4exM7Mx7/9r/ey5MrL6W/YeQggqNCGnJPYSr34VaeRxBHhRsKhqO3CRYOzsCnnSDSyGIZTRGTTpM4Kk3Twiwz2p7HT4wM81SRR65rJYWdx1MemkNd6xbqZm6mdeUvEX6JbdkF3NO9jmdefQ8dhVnEWljT6JTx3QoF7VPUCfrVyNsRn4jZcog5cog5MssRchfL2M5SdjCPDlw0ZXx2uXN42lnFLjmHvc5MlHCrLfQGTIgbZfGiMr4Ka/UtNSkt5SEE+uRUjuw7KBTHiZPS+GB8DAmESGCMG6fFHcnwmILD/y+BE/ecy7iyxcHHlz6uI6v95vFw0NHjD0YPBHVcB9dzcH2J60l8X5L0BKkEpHxJwhH4jiDhTpM0F7IqyhMjQz9df+S7ZdKw7wktlqnBPrcslqnBPrcmhr2fLJapZcJC/ZRTTsH3R/6gWb16NY888gjnn3/+hDvU29raaGtrm+gSDsjzzz/P29/+dv6//+//s1NsLRbL7zQm1ETZCqYcTe9+I03xyW4Kj3dDddhpcmULdRtn49RN7+A94Ts4jT4y8bqO7Y7BaI3q7yfq7cVEB67OGT1oVBlDXmnySqHDMrIyRFQcoD8okg1D+pWmEGn0PhLcGNAqHjKqDWgUxg0wbgUjTLXJRYOo9kyoA6TREWhzgDS6McxXHWwo9zGnsphA/QmKdorVs3V5kGjXI4S7HiEb9PGDP3oP9//ZNXS0NmOqklgYTX3+JUT5Xrzy4wgT16LM7TUcvUUwP99G5LVSUQpZqhBShLoUqbUJmhYN0tK6Bc8bSUVHYYJcx5Hkdx6HCtPUz36B1iNvw6/vpBCmeKb3SJ5+8b0837eSUhTL/HpZpt3NERiXrEqRVSOSX2BoE3nmOlnmyCFmiizLxE5WsIUj2Eo9RXKijh3OHH7tvo3dcjbdckY8kLOq0IWOcFQeP6rsL9DFaIE+df3no+V5TZw7LuBjtI8RcfJcGwcpHERVdEtx+PJciOFBoT4OPq7wSUgP6QhcKXBFdWBo9QqHxbnjOri+g+e5uIlYnA8PAB2W5gkXEk48aHTKEdV6ndrQz9EC/c03ANRisVgsFovFYrG8uZiwxbjnnnv2O23GjBn85je/mZQFHYidO3fS39/Pzp07UUrx1FNPAbBs2TIymQzPPfccb3/723nHO97BJz7xCTo7OwFwHGdSpb3FYrG8How2qKEAXQir0eZp2q8xVLZkyT+wB52LU8nerDoyb52LN3P8GpQpw5E4Df6kCnxjDGpggKinBxMe+CCFDjSmFA8aDYwmF2mKkUJERShnqZSzDJUL9CvDgNKUomi/x8loQaQctI7Fo5Yhxq9gZFjtO6/WudSGjB4qjQ77ivS0LnFMZTurSm0Y9TZCs4zhXLiOSqg9TxDuephK/xZuO/lUbnvXX7N17lzUqBhyXXEXbvFe3PLDSB33m8/vNmzcDHMLMynWzaAURZQqAaZSRGSS1B3t0rRwkOYZr+C6I/djWEkz1HEUhV3HgFQ0zHmO2cfejJvM0V9u5N7ODTy++U/Yml2IQZIUFRqcCnVujqxKkdNJcnrkY6cNoswcGQv0WXKIJpFnBVtZwRaWsJNIuGxz5nOPexK9dSvZU4k/vaGr/xM6wI3KJNWhBPrUVLiM1LY41eLxuLPbmAQYHy18jPEw2kGIWJpLJ16Hd5gCfWRQaAIpPBJOAl+6OOOkzmvi3IvFue+7OAkHz4uleToRS/OkGyfNE840zL0ZPQTUTewj0K00t1gsFovFYrFYLL+/HJZQHxoaqvWJDw0NHXTbqeodv+qqq/i3f/u32s9HH300EAv+U089lZ/+9Kf09PRw0003cdNNN9W2W7hwIdu3b5+SNVksFsvhYoxBF0LUUMAoizotRH0lcvfvIdydB0BmPDInzSGxvGnae9Kdeh+Z8Sa1J10NDhJ2d2OCA0861IFGlwxEhpLWDEURFaWRYQFRHiRfHCIbFBnQgkGlCMYV6bIm0g0a4wQYr4wWKt7UGOIhh1WRPl7H+sHS6MDsqIuNpSLtlTWU9bkE1ZdpoxWq6znCXQ8Tdj7DphUr+Y/3v5cXlhxBxR95KU9W+vELv8Et/xYn6gagbdBw8guGFd1N5OpnUTCaAUJMoYhs8KlfI2laMEDzjJeQcmRNlVKGob1rKexdg5fM0Tj3WZo33oB0Q/pKTdzVeRybutazLbsQiabZLdLu5sjrJAWdoByN1KkN17jMlVlmyyHqZUArfTWJPotudjtz2OrO5z73BLrFcAJdk3EbiMo9eFHlIAK9Wpckpkigi1Hy3HWqQjgBJoHCwxgfo914vwIcGSfhpRw12/QgCBHXtjgigYNHwkniOe5+qXMpJbJW0eLgJ1wc38GtivOUJ0m4sThPToc437eepSbNk9V0vsVisVgsFovFYpkqhBD87Gc/493vfvcbvZQ/OIQ5jJ4Wx3Ho6Oigvb0dKcf/Q9UYgxACpQ78EfvfB4aGhmhsbCSbzb4ph5J2d3fXHkeLxTI5HOq5pSsRarCCCcdPKk/ZuiqKwqOdlJ7piQWuI0hvaKduw0yEN8096WkPp9FHOJO3XzU0RNTdjS5XDriNrlRFujIUlSKrFKGKkJUcujRIrpxnMCgzYCAbaVQ0VsrH1ecOkZbVfnSNcSvoWq3L8Euoqkr0iafRHaNYU9nF+lIzbnQykZlXOy8a2Ea080GiPY+zraWRf/+j97DpyA3k6lK1bbywQLL4EE7pPtxgGwJoLBg2bjYcs8WnUj+P3lQCSmUMIJtc6o8IaV4wQFNLN0KMvA0oF5oY2ruOfPcy0vU9NM57hmTzDoQw9JaaeazraB7rPJptQwtIENHollBIBqI0mpHHVqBpl/lqD/oQM0QBR2gWsJcVbGEFW4mkwxZ3IVud+ex056Fwagl0YyI8VcGPKjTVNRNkOxBxLnzYoo+S6JMr0I0grstxqpUtjotwfLROoISP1i7G+AgR23IhqkM5D1Ogx9sncIWPxCc5jjx3pMDxHDzfjataEg5uwsX1BAlPjhLmgqQ7DYNBa5K8+n1YnttO899b7HtCi2VqsM8ti2VqsM+tifNmdlsTpVwus23bNhYvXvx7Nay1p6eHq666ittuu42uri6am5tZt24dV111FSeffDIAnZ2dNDc3jzsbcipZtGgRH/vYx/jYxz42rfsd5vvf/z4f+MAHxj2vq6uL9vb213S9E/ldOaz40N13301LSwswfuWLxWKxWPbHRBqVraBL09yTbgzlzf3kH+rAVPftL2mk/uQ5OI3T+0IrEg5OYwLpO5N2nSqfj0V6sXTAbUZEuqagNFmliKIQp5JFlwcZKubpjiIGgUKoMNHYxyhubZEo7VRFusJ4FbRTQYvhDUYGjY4n0g+VRm9QOTaWhlhYWU6gLiXOcYOJynESfft99JocP3n72dz1wT+mp6W5dllHhaSKT+CUfoNXfh6BJlUxnPCS4cTNBt+Zy96WBnY3BAhjQAdk1hlmLBugacZYiV7MtZLds5bC4FwaW3bTNPcZ2pfHNW49pRbu3f52Hutaz/ahBdTLMnVOQLNTYkCl6I5G3pzXizLz5CCzZY5ZcghfaDwClrGDlWxhNp3s9WayzVnAQ+4G8rIOYWKBrtA4qoSnKiSjCp4Oa40tDo3xrN5hgY5ETOIfUibuY6nJ8zh97lfluYcxLkZV0+cGhBQ4hynQY3nuV+V5gqSTwHO8mjx3HYHjSrzEiDj3Em783ZWkPEGyVtUCyakU58IZkeSjpbmTiJP5FovFYrFYLBaLZdq44IILCIKAf/u3f2PJkiV0dXVx11130dfXV9tm1qxZb+AKXz9BEIyZ03m4/PEf/zHvfOc7x5x2ySWXUC6XX7NMnyiHJdRPOeWUcf9tsVgslv0x2qBzASo/vT3pAGFXgdx9e4i64rGVTlOCzNvmklgwvakE4cpYpKcmr/ZBF4uEXV3oQvHA21Q0uhQPAM0pTS5SRKoq0kuD9BVz9CjFgIEgjDBqf5GulYtS1Ty0iPvRtQyrSny0SFfj17ocJI2OMSwNeziumCITHk9kFjI87jPK7iTa+hvKHY/xwOqjuOkjf8mr8xeOGS6aLm5Glu4lUXoSYSp4kWHDq3Gly+xcE9vnzKSj2SCiCFMuk14qaF6Ro2V255hO9Hx2Ftk9R1EoNNPavo32JQ/h+PEBiu7iDB7bdgaPda5nR24eLU6RhFTUywo5nSKnR9Lx7XKI+XKQ+TJLoygjBNSTYwVbWcp2hDRs9+bzoLuBbtkK1SGiGoXRBTwVkIoqJFSAY3ScQh821ELCsOx2XSbFIwuq4tiNvxwPhIfCQ2sfpV1QXrW6JR5eKgQ41UT8wQR6LM893OrA0ISTwHMSNXnuuRIvIfF8Dy8hcZNuLNI9ie8IUqOqWlKuwHOmSJw7o+pZauLc9ppbLBaLxWKxWCy/KwwODnL//fdz77331jzswoULOf7448dst2/ly4MPPshHPvIRXnzxRY466ig+97nP8Z73vIcnn3yS9evXc++993Laaadx5513csUVV/DCCy+wfv16vve977FixQoAtmzZwic+8QkefvhhCoUCq1at4stf/jJnnHEGAKeeeio7duzg4x//OB//+MeBONT3xS9+kVtvvbU28xLga1/7Gl/72tdqVdyXXHIJg4ODHHfccXzjG98gkUiwbds2du3axSc/+Ul+/etfI6XkrW99K1//+tdZtGjRuPdPKpUilRr5u7Snp4e7776b7373u6/3rj9sDtt09Pb2UigUWLhwYe20559/nuuvv55CocC73/1uLr744ilZpMVisfy+oIZ70tU017sUQ/IPdVDe3A+A8CR1x80ita51UmtWDokc1ZM+SUlaXS4TdXWhcvlxzzfGYAKDLmmMMuSVZihSKBXgVobQpUF6izm6lWbAQDSuSBco5aBUvGbjBBi3gpLRKGkeDxo1utqTPvryY9LoZr/zPR1wfDnLitICjHovhmScRlcB4e5HCbfdRxdD/OiMc/jVxkvIp0cGxaZKO3BK95IoPorUQwhtWLs9luird/rsmD+P3gaf/mQAYYjfZmg+ssyMhd0kkiMHH8qlevp3ryOXn8Gs2S8xZ+U9CBnXtHUVW3ls98k81nU0e3KzmeEWcYQhKSL6VSauhgckmnnOIPPEIPOcIdIirshpYYDVvEyb6CfrZtjiLeQpZzVKuGAiFApNGUfF8jwRVfB0VE2hV+8rIeIk9Jgal2GpLfa7Tw8HIQRGOAjXxXgeOC6KBMrE6XOtXIRwEMTd57IqsSUCJEgpDijQpYyHhrokSMgkvpvAlRJXSnzfwU8Op80lftLF9T2kiCtahqV5yhNTlDoXcT2LlxwlzqtfNm1usVgsFovFYvkDxxhDGB54BtdU4XmH93dyJpMhk8lw6623cuKJJx5WpcvQ0BDnnnsuZ599NjfffDM7duw4YCXLZz/7Wb761a/S1tbGhz70IS699FIeeOABAPL5PGeffTbXXnstiUSCG2+8kXPPPZeXXnqJBQsWcMstt7Bu3Touv/xyLrvssgndfoC77rqLhoYG7rjjDgDCMOQd73gHGzdu5P7778d1Xf7+7/+ed77znTzzzDOHlWC/8cYbSafTXHjhhRNez2vlsIX6X/3VXzFnzhy++tWvAtDd3c1b3/pW5syZw9KlS7nkkktQSvFnf/ZnU7ZYi8Vi+V1Fh5qwp4gIpzeRbpSh9FwvhUc6MEEs8ZMrmqk7aQ5O3TQmToVA1nk49T5ikpK1OgiIurtRg9lxzx8t0rUy5CPNkFLoqFIT6Z2lPJ1aM6hBheH+Il1LIiXRcY8Lxi1j3AqR0NVaF4hFuq6K9H3XUBXpDG83lrYox8lFlxmVdSizpLZFlN8bp9F3P8Km5Udw0wc/wAtLltfS6G5UxC/8hkThbtyoE4AVuw0nv6A57kVD98w57J7RwKZFIQJw3DIN60JmLB0g0zhQ238U+fR3rKS/fz4zWncwe+lDzBmW6IU2Hutaz2Nd6+nJt9HkltEmFtmjq1w8IhY7vcyTWWbJPL6Ib0UjQ6zmZTJOni63lSe8NRRlKr6vTIQmAl3GVxVSUSzRHcwogc6IREfWEuGvB8nI0FDjehjHQQkfpRNxfUvkjSTPpcCpXY5qAn18gS6EwJEuDgk8EiTcFL704mGgSZdE0sVPOHjV1LnjOrhyJG0+dUNCxf5pcy8V/3s6Bw5bLBaLxWKxWCy/R4RhyJe+9KVp3+9nPvOZwxLEruvy/e9/n8suu4xvfetbbNiwgVNOOYX3ve99rF27dtzL3HzzzQgh+M53vkMymWT16tXs2bNnXOl97bXX1pLvV155Jeeccw7lcplkMsm6detYt25dbdtrrrmGn/3sZ/z85z/nox/9KC0tLTiOQ319/WuqnKmrq+OGG26o3Q833XQTWmtuuOGG2t9K3/ve92hqauLee+/lrLPOOuR1fve73+Xiiy8ek1qfag5bqD/88MN8//vfr/1844030tLSwlNPPYXrulx//fV84xvfsELdYrH8QWEiTZQto7IVTKOKBxVOE8HuHLn79qD6ywC4bSnq3zYPb3bdtK0BQCZdnMbEpA06NUoR9fQQ9fWNG0o2xmAqBl3WqChOpOcihVaxSI9Kg+wtFejSiqwW44p0rSRKj4h03BLKLVeD2KNEulHj96MfpNZFGM3acp61pVm40dswpFGA0SHB3sdRW++jO+rl1lPO4ucf/jpDmUztssnSK3iFO0gUH0MQMq/H8LbnNBs3G5TXxKvz23hkBfEnIFSFhpWK5hU5mtq7kTJekNaCwb5F9HYtxa/rZ8H852if/wwA2Uo9D3Ucx8MdxzJUbKZeBlSMS9n4dIQjQ1fqRIXlTidzRI4ZsoxTleAZ8qxgKymnRJfXyiZvHZFwY3luFMoUcVVQS6H7Ohpb4wLVKhd4vV3oEhDCiSthPBft+mjHQeGjtI9WHiZya2l3UZXlw5c9mEB3pBPXt4xKn/uOg59ySSVd/JSLn3Dxkx7SGVvZMvx9citbxD7CPAFu9bsV5xaLxWKxWCwWy5uOCy64gHPOOYf777+fhx9+mNtvv53rrruOG264gUsuuWS/7V966SXWrl07ZpjmvhUxw4yW8rNnzwbi4PSCBQvI5/N88Ytf5LbbbqOjo4MoiiiVSuzcuXNSbteaNWvGHFR4+umnefXVV6mvrx+zXblcZsuWLYe8voceeojNmzfz7//+75OyvsPlsIV6Z2fnmO6au+++m/PPPx/Xja/iXe96F1/+8pcnfYEWi8Xyu4jRBp0PULkQPU5yeSpRuYD8b/dQ2RInt0XSIXPibJKrZyDk9Mk14UqcpgQyOTk96cYYVH8/UU8PJhovDT5WpOciRa4qlp1ylqicZU+5QKdWDGmBDkOMUmN67LWSKOXEMlwotF/GyAA1xtyPL9LjNpdhkb5/rUtGBZxcFMwtr0Sb5bXLqFIX4Zb7CHY9zKYli/nRn72XJ484ElOVyU5UIlG8j0T+btxoL34IJ23WnPGUZnafz0tL5vPEskQ8OFUrUnNDmo8s0zKvG9cb+ZhifqiN7s4jKGnD8sVP0tK2DYBQOzzRuZ4H9p7A7sEFpGREUflkVR1ZNXLwpUXmWensZbbIkxGq5mlTlFjKDhJuhU6vlcfco0CIUSn0Cn51mOi4KfRq//jYKpeJ45hqmt2Nq1u066JcF218lPbQykNrFzG8D0mtSiUOw8dSXYqxAn0kfe6PpM9dn2RSkkx7pFIeXtLBS/g4jsQRgrQXfyXd+Ls7mc87x69K81S1ssWKc4vFYrFYLBaLZTLxPI/PfOYzb8h+J0IymeTMM8/kzDPP5POf/zwf/OAH+cIXvjCuUH+t6xj++0zr+O/fT33qU9xxxx1cf/31LFu2jFQqxYUXXkgQBONe1zBSyv1mjI1Xq1NXNzYAmM/nOeaYY/jBD36w37ZtbW2HvC033HAD69ev55hjjjnktpPJYVuQhoYGBgcHax3qjz76KH/+539eO18IQaVSmfwVWiwWy+8Yb1RPuok0xSe7KTzeBVGc+k0d1UrdCbMmTWofFkLgNExuT7oaGiLq6kJX9n+Rron0kkYpzVCkySsNURmnkiUoD9FRLtKpFTkNOopi+XwgkS5DjFcmcqKxL/hGgdEY9hXpo/vR93/M5wcVTiq0kA7fgiETb2EiKl3PoF69h55KJ/9z0mnc8sHrGGhsql0uWdoSp9FLjyJMyMIuwxlPaU5+3tDX1MKrc1p5pVUhAC9doumoCjOW9pNMF2rXUSmn6e5cQV+xnsULnmHJEQ/UztuaXcCDe0/g+a4j8YygqH0G1Og3L4Z5Tj+r5R5miQJSjvwOJSizQOzFc0M6vVaecVaAMBijMJQxWpGMYomeVBXEGIHOmBT6a6lyEYA0EiEcHNfHSdWjPImRIwJdKQ8TjBXozqj9xLuX+w0SlVLiCB8XH18mSSYS+J5LXZ1PKuXhp108z8Nx4271tBenztNe3HnuT1byXMiqNE+N1LR4qThxb7FYLBaLxWKxWKYMIcRhVa/8rrF69WpuvfXWcc9bsWIFN910E5VKpda5vmnTpgnv44EHHuCSSy7hPe95DxAL7+GhosP4vo9SY0NwbW1tdHZ2Yoyp/f03ekDpgdiwYQM/+tGPaG9vp6Gh4ZDbjyafz/PjH//4DQl4H7aBOfHEE/mXf/kXvvOd73DLLbeQy+V4+9vfXjv/5ZdfZv78+VOySIvFYvldQJejuNolnGaRbgzBtiFyv92DHoqFszenjvq3zcNtnb6OMACZ9nAafIQ7OfUuulQi7OxEF4r7nTdapEdKk400BaURwyK9NMTucpFurcgb0FEYJ9tHJcu1kkSRgwGEE6LdEkooTK3WhVFp9H1E+iH60VeVFccU5uCqtRDnstGVXoIt9xPsfJAnFs7jPy86l0eOXI92YknqqDJ+4T6ShXtww90kQjj5+TiNPr9bsnnxXO4/MoVRGukGtKys0LJiiPqW0b3oLn09S+gabKe5bQvzFz3J8KvvYKWBh/Yex2MdRxNVMgTGoyfKYBhOahuWuN2sk9tpEyUqYliwu3gEzBFdOK6iw2/lJWcJoNBGAUUYJdETKthfotfMtfOaDrQ4RlY70OP0ufbj79LPUFISFXkY49WGlIpRCfThZYyXQneGBbpIkHRjgZ6uS1CXTpBMO3i+h+O6CKrDQj1B2pW1gaGTgpOI0+ZeekScu4ceLGSxWCwWi8VisVj+8Ojr6+Oiiy7i0ksvZe3atdTX1/PYY49x3XXXcd555417mYsvvpjPfvazXH755Vx55ZXs3LmT66+/HpjYHKfly5dzyy23cO655yKE4POf/3wtvT7MokWLuO+++3jf+95HIpGgtbWVU089lZ6eHq677jouvPBCfvnLX3L77bcfUpK///3v5ytf+QrnnXceV199NfPmzWPHjh3ccsstfPrTn2bevHkHvOyPfvQjoijiT//0Tw/79k0Why3Ur7nmGk4//XRuuukmoijiM5/5DM3NzbXz/+M//qNWaG+xWCxvJkyoUdkKuhwdeuNJJhook79/D8HOHACyziNz8hwSy5smebjhwRGexGlKIhOTk541YUjY1Y0aHNz/vFEiPVSabKQoKoMIS7hBlqCYY1elSJfWFI0ZlUjfR6QriTGiJtIjoRhl0eM0uhl92vD+DyzShTYcW5asLi5F6GW104P+54levIu+4k5+ufFt3HLJtfQ0z6idnyhvxS/cSaL4CMIELO6EM59UnPSCoZhI8+KiWbzcHu8z2VyiZX2RGYt6cBxVW9Ng/xw6+uaj0r2snvsKM2e/DMSVLk92r+XhPcfSNzQHhUt3mEEx8ljNcfo53nmFBWKQIdECSCrU4RAxU/SCZ+jyZ7BNzkejwEQYU0CYYYleJqHCA0j011bl4hiBRCKlg/ZieR54Lkb4KOXFg0TLLo6sQ2u5n0AHkNU6GUeOI9BlgpSXIJVIka5PUl/nk0j5uK6LkIKEE8vzWvrcff1DURHOqLR5eqSy5XV0xVssFovFYrFYLJY/LDKZDCeccAL//M//zJYtWwjDkPnz53PZZZcdsKqmoaGBX/ziF3z4wx9m/fr1rFmzhquuuoqLL754TK/6ofinf/onLr30Uk466SRaW1u54oorGBoaGrPN1VdfzV/8xV+wdOlSKpUKxhhWrVrFN7/5Tb70pS9xzTXXcMEFF/CpT32Kb3/72wfdXzqd5r777uOKK67g/PPPJ5fLMXfuXE4//fRDyvjvfve7nH/++TQ1NR327ZsshNm34OYg9Pb28sADDzBr1ixOOOGEMefddtttrF69msWLF0/6IqeToaEhGhsbyWazE/6owe86Wmu6u7tpb29H2j/uLZZDYpRB5Srowtj6kH3RRtOT7aetsQU5SUNJdaAobuqk+HRP7HSlIH10O+lj2pH+NFZCyGq9S93k1LsYrYl6e1G9vRi9/32qA40uasJotEgvVhPpefYGJTqUpmwUOlIHEekgnAjlFVFjGtINaI1h7MGRsf3osK9IdzW8pZBkUXklmOokcxNR6dhE+OKveXJmA7eecha/XX8cqppGl6pCong/yfw9uOFOEqHgbc8qTn9Ks7BbsG32DLbObCbSGuFoGo8o0npUjkzLYG2/hUIje7uWMqgjVi54nnp/5GN1W7MLeXDPcWzrXUGkfXrCDBUz0oXXIvNsdF9kNXsYkG1ExOcJNK1iAO1Bn9+MlgKNxpgQjcLVimRUjpPoOhzpQx/mNUr0mkAXEuO5KMdF+Q7G8VDaR6lYpAvhgqCWRE8n0xTLxeraiYeLipEUuiMdHOHhOT5JP0k6lSaTSZKpS5JIutX0eSzP66rd53WewHm9vefCiaW5n67WtqRt6tzye4N9T2ixTA32uWWxTA32uTVx3sxua6KUy2W2bdvG4sWLJySW3wz84Ac/4AMf+ADZbJZUano/3f77yER+VyZUutva2nrAjxacc845E7kqi8Vi+Z3FGIPOh6hcAONI36ned/mlAQoP7kUXY+nrL2og85a5uE3TK+tkxsOpTyAmqTM6Ghgg6u7GhPsn/U1o0EVNFCoGRol0t5KlUsqzIyjTqRUVHaGVrg7oHCvSQyXBxNUuxisRjivSxybSx/aj7z9otE5J3pavZ2blKKA6dVzlKW3/LZUt93D3kav54V//NdvmLqhdxi9vxy/cSbL4MMJUWNIlOOsxxUmbDUq4bF40lxdnJ8AYvEyZWWuLzFjeh+fHdT5aS3p7FrBrsJ2Zc15k+ZInatc9WG7goY7jeK5zHcVKPX1RhoIe+b2oE2VOdF/iOPkqZRoYFE30MAeADHlcL2LAb6TLaUGjUCYAo/B0RCKqkIrK+Doc1YU+/F1WB4sevkR3jEAgcZDgOESeg/JcAs/BmGoKXSXQ4UgPunT2/ziiENXeczki0F3p4rk+SS9JXV2aTH0ddekEvu/hOBIpxsrztPc60+fD8txLVQW6lecWi8VisVgsFovld4sbb7yRJUuWMHfuXJ5++mmuuOIK3vve91qZPgVM4xQ7i8Vi+d1HF+OBoyaa3p50gLC7SO6+3USdcRrXafTJvHUeiUXTmygQCQenMTFpSXiVLxB1daJL5f3OM1FVpAdxIj1f7Uh3K4NUijm2BWW6tCKoiXQNekTIq2oiHQO4IcY9TJF+iH701tDnLfkWmsLVQDysxgTdlF6+m2znk/xi41v4yfu/VBsyKnRIonA/yfzdeOEOkqHgbc8aznwiYkEPdDTX89DKdkoSEIb6hTlmrC3SNLuvts9yuY49ncsYMCFHzX+ZY2ZuByBULk92r+HJjg10D81hUNUxqNK1y/ki4hj3VU4Rz5IWsFUspJNY8LuEpJ0SQ4k6hpw6lFBoU8EYha9D0tVOdN+Mmr7+GiX6iEAXIB2076Bdh4rrYRxnJIVe9hDCqQ0rdfbpKR/dhe4I8FwHiY/n+qQTSerq6mOBnkzg+3F9iydHCXRfvr7ucyGr8nxU8tz7w0qyWCwWi8VisVgslt8/Ojs7ueqqq+js7GT27NlcdNFFXHvttW/0st6UWKFusVgsxBUrarCCCdShN57sfZci8g91UH4hlqvCk6SPnUl6fRvCmcaPNDoSt9FHpr1Db3sY6CAg6uxEDeX2O8+oqkivaHJKkYs0RlVwy4OE5TzbyyU6dUSgongAitIYNSLSIyVQyqmK9ADjlojQr0+kG1hUSXN8cRbp6IiR21F4ldLzd7Gnsov/fPs7+e+T/zeV6tR0Jxoikf8lqfw9SJ1ncbfLHz2i2PiiQRjJq3Pa+dW6BjQGNxXRfmSOGauyJNKl6npgYGAOO3rnkG7ezYpFT9f2uyc/i9/uPImtvSvIRhl6ovraeRLNUd5OzhKPM18M8qJYTieLauenZYGynyDwXEqiDkUIRuGriLqoTDos4zLOTIAJS3SJiwQEuA6R51LxXIznYrRbrXHxD51CJ65ykVLgCIHnOXiuT10qQzqdpr6ujkw6he/Hb1sSTizPM74k7Qn81/opipo8T42S6FaeWywWi8VisVgslt8/Pv3pT/PpT3/6jV7GHwRWqFsslj9oTFQdOFqa/oGjRhtKz/ZSeLQTU4lFfuKIZjInzcHJTI7UPiyEwMl4yHof8Xp7pQETRUQ9PUT9/fs2qMQivaRRFU0u0uQihdYBbjlLVM6zvVJkjwpjka4MKHVgke5U0F4ZNa5I14wW5gcdNGoER5YaWVecj6fnVi+giQafovLsr3muUfLjs8/hvqOPx1Q7G71gD8ncbSQKD+EpxckvSt71YMS83ohsOsFjy2eS9T3AkJ5doHVtgaYF/UgZ7zsME3R0LmFvxeeIOVs4+oi9ACgtear7KB7e9RY68rPoDBswDB9UMSx1u/gj+SjrxXa2iCV0sIDeahrdI0R7ECY8hmQyPsBgSrhak4lKpMPS2CR67Q6QxE7cOaRElwjEsEQXAvxYoivPw8hRKfSSV7u+8VLo8XUBUuI64HoSz/FI+Snq6xuoTzeQqU/iuw6lUoWW+iQZ3yHtx0l097X+nrrVyhY/MzI8dBqH+1osFovFYrFYLBaL5fcfK9QtFssfJEYbdC5A5cODDhydKoLdOXL37UH1xzUobmuKzNvm4s/JTOs6RNLFbUwgvNefhDfGoPr74550NVZaG23QJYOuKPLVgaNaRzjlQWQ5x+5KiV0qpBypaiI9invSqygFkXLHiHSNHq3MJyzSPe2yodjMitISpGmuXqBC0PkQpefv4rfLFvDjS/83zy9dUbuMX3qOVO42vPJzZCou73hcc/ajIXVlwY7WRu5Y20okQHqKGSsGmHFUnnRjvnb5oaFWdnQtIEwOsXbOSyxw4jVlK/Xcv/Nknutcz97KjDG96LOdAd7hPMbp4gm6xBw2s4zfMhuIB4w6jiLwPUquQyQUhhLCaNJRmWRUJhWV93fGE5DojhE4SERVohvfJap+gUukfFSUQGvvoCl0iIU8EjxPkPAdPC9BQ7qJ+kw9mbo0dan4dqfcOH2ecqHgK2Y1eciJim8hwasDf9SXnMaBvhaLxWKxWCwWi8VieVMyYaHuOA4dHR20t7ePOb2vr4/29naUmv66BIvFYjlcjDHoQtyTPt0DRwFULiD/wF4qrw4CcV95ZuNskqtnTEo6/HARrsRpSiCTk3NcVQ0NEXZ2YoKxCWhjDKZk0OW41mUoUigd4ZSHcMtD7K2U2aUCilG12kWrWKRXD3K8dpEuRz28Y0V6OkpwQrGVBeVlCOLhLEINUtx5H7lXH+CXxx7HTz79t3S0zYzP0wq/+ADp3O244W5m5nze/YDgbc+U0cLhxTkz2dMcHwhJtpSZuSZHy7JBHDeq3gaHru7F7BxqYnb7btYsHxky+urAIu7bfirbsovpCJow1QLzhAg5zXuG93MHkUzzFEdyF2+vXc4REaHvoj1BWYKmjDAKP4pIR0XSYRkpqre71okuqnUuB5foApDGwUUgEBgpUJ6L9uMkOjhEKoEKfLT2R/rOD9BbLoXA8Qy+L/E9n3Sqnvp0Aw11jdSlE7hOtQPdF9T7kow/kkDXxjBO9f74OH5c2eJnYnnupWz63GKxWCwWi8VisVgsk86ETYo5QJKzUqng+/7rXpDFYrFMFboUoYYqmHD6B46aSFN8spvC410QGRCQOqqVuhNmTZrUPiyEwGnwkRnvsDqyD4WuVIg6OlD5wpjTjTGYSlzvUggV2UgRaYWsDOFVcnSXS2yPAvLVpDpaV0V6/NiMEeluGeNWUK9TpDeEKU4uzKI9WIYgTiqLYDf5V++hu2czP3vb6fz8z64jXxfLcakKJPN3kszdgaOzHNGd5sJ7YN3WIkXf5YnFc+mrS4I0NC3JMmNNgfr2bG1/xWIDuzqX0K/hqPkvc+LsVwGoKI+Hdp/AY3tOYGdx1pg0+mKniz9x7mKjeImnxFHcxem18wQa7Qm0DxVp0KIMaBytaAhLpKMy3nClixi5VK0TXR74UwjSCCSymkQHIyXK92KR7jkYHJRKoILhJPqBJboAhAueDwnPIZnMxCn0ugYy6TRJ30EgyPjDX69liKiIhblfNyLRXfsexGKxWCwWi8VisVgsU89hW5x/+Zd/AeKPcN9www1kMiO1BEop7rvvPlauXDn5K7RYLJbXia5EqGzwhgwcNcYQbBsi99s96KEAAG9OHZm3zcNrTU3rWmTKxWlMINxJqHdRKu5J7+vbryddVzS6qCmGiqxShEojgxxuZYi+cpkdYYUhHaGjCGM0JtKgo+r1QqQctBEYt4xxywxr8+qeJyzSG6M6TsrPpj1YEteWAKL4HEMv3MurJstPzjibu4+9nMiNXxLdoJtk/n9IFn6Lq0KO2ZHivXdpFvQMMZBOcP/KOeQTHtJTtK7qp21dlkQ6jlFrLejrm8+2vlmk6rMctfipWki6qzCDu7aewUt9q9gTNNfS6EkRcJr3DH/OfxPKOh5lPf/J8pEb4Bi0D8rV1UoXjdSKuqhCXVgioSv7P0CHMVzUMcMCXcQS3XGIfBfluxjXxWiJ0glUJYE2h5Do0uD64PmSZCJJfaqJunQDjXWNpBIuroSkO5JAT3tiYgd0hAOJzEh1i1cHBzlAYLFYLBaLxWKxWCwWy1Rx2EL9n//5n4FYDn3rW9/CcUZ6SH3fZ9GiRXzrW9+a/BVaLBbLa0QHCjUUYMrTP3AUIBook79vD8GuHACyziNz8hwSy5smJR1+uAhP4jROXr1LNDAQ96SHY+9XHWh00VAOFYNRRKAMMszjlgfJBhW2BQGDKkCrKG50iaLawFGjTSzStaxVuxg0I4dAJi7Sm6IMG/NzaA8W1UQ6uccZeupXbJrZyI/P/188vmpNbXuv/DKp3P/gl54gHXmcstnn/LuLNBYDOhrruPPINgLXwU1FzFrTQ+uRWVw/ToQHQZI9HcvZXaxj6ZxtHL/y0XhFRvB4xzoe3PlWtuTmk9fJ2v6WOJ38iXM37xCbeEYcya84k5DhlLXB+BD5GiUVERrHaBJViZ5WJcbNhjsCOHAa3RlV5QLDEt2rSnQHox2U8onKCcxoiT7O76twFF4CEgmP+nQjmXRznEJPpvBdge+MJNAznsCZSKWRdKuDQzNgijBrvhXoFovFYrFYLBaLxWL5neCw7cq2bdsAOO2007jllltobm6eskVZLBbL68GEGjVUQZfeGJGuA0Xh0U5Kz/TEjlcK0ke3kz6mHelP41DEya53KZUIOzrQxdKY001o0EVNOYhFekWDDPN45SFylRJbwwoDUYAaFuk6wkQKjMFoiLREKwkywCTKaKFel0hvjjKckJ/HrGDRyIm5TQw+fSd3LJvPjz7yEbbPmV+9Ik2i+Cip3O14wVZmlNOc9VSG/3XfAI4qsrWtiUeWtqCkINFYYd76XlqWDyKrw0SLxQZ27D2CrBGsW/gMi/04LZ4L0ty59Uye6VrLrkrrmDT6292n+QtxKwkpeISj+X9cPHK7ZCzSQy8iEgqBwVMhDVGJurCIwzh1RTIeFnqgNPp+Et1zCKt1LsYZluiJqkR3axJ9vyGgwoCj8ROQTHrUp9poyDTTkG6iLuniOYJ6X1DnxRI9MZEaFyFjgZ6or3agp+PTtYaCnc1isVgsFovFYrFYLPsihOBnP/sZ7373u9/opfzBMeG44j333DMV67BYLJbXjYk0aiiIRfoB5j1M6f6NofRiP4WH9qKLscz3FzWQectc3KbEIS49uUxqvUsUEXV1EQ0Mjj1dxSK9UlFkQ0VJG0RYxK0MUqxU2BZW6I0q6CiM5bdWVZGuY5FuBDpyqyK9gBbR/iLd6FjkVntlDibSW8J6ji/MZ1awoHaayD1C7zN3ccfyRdz813/D3uqgUanKJAr3kMr9Gkf1snCoiXc9lOEtTwwSCcHmua3saWnACEF6ZpH2owdpXJCt1bcMZdvY1rGUyA84esnjSBkv6sW+5dyz7e28OLh0TBp9qdPJnzh3cYH4DS+IFdzDaQzSWLutxgXla0InQgmDaxSZoEx9WMA3Ywe9xjdMguSAA0bHS6KHvodKjEj0SCVQ4SEkutQIV+EnJOlUikyymcZMCw3pepK+S8oTNPiShsREa1xEtb5lWKLX2QGiFovFYrFYLBaLxVKlp6eHq666ittuu42uri6am5tZt24dV111FSeffDIAHR0db0jgedGiRXzsYx/jYx/72LTve5hNmzZx5ZVX8vjjjyOE4Pjjj+e6665j3bp107L/CQv1Cy64gOOPP54rrrhizOnXXXcdmzZt4ic/+cmkLc5isVgOB6MMKhegC+EbItIB6AvI3rGFqKsIgNOYIPO2uSQWNkzrMoQrcZomp97FGIMaGCDq6sKoUelwHQ8bjcqagTCiqAwiKuOWByiHFV6tBHRFFZSqoDWxQA/jgaPGQKQFOnIwIgI/h5EhilFV7FpjjIpFujAYYpFuDiDSZ4QNHJefz6xwfu18mXuE7mfu5lcrlnHz33yCrhltAMgoRyp3G8n83Xi6wureFs7/TZojX+ml4Ls8umQ2fZkUCGhYmKf96CyZmbnavnp757GtczGphixrVzyMEHHC/o6tp/PonuPZUZo5Jo1+uvsUHxa30iZzPMLRfINLiPDi+7Fa6xL6EZGMDyV4KqQxLJKJCsh9y+kPUeniGIlb7UQHMFIQ+T5RotqJbiQqShCFyYNIdAOOQroGzxfUpTPUp2fQmGkmk6oj5TrU+YKGhKQhMcFhosPDQxMZ8OtthYvFYrFYLBaLxWKxHIALLriAIAj4t3/7N5YsWUJXVxd33XUXfX19tW1mzZr1Bq7w9RMEAb7vH3rDfcjn87zzne/kXe96F9/85jeJoogvfOELvOMd72DXrl14njcFqx2LMGZi9qmtrY27776bNWvWjDn92Wef5YwzzqCrq2tSFzjdDA0N0djYSDabpaFhekXYVKO1pru7m/b2dqQVGZY3AUYbdD5A5d44ka6LIbmHOyi/0I8g7itPHzeT9Lo2hDONzzMhcOp9ZP0k1bsUCnG9S3lk4KUxBlM2RCXFUKjIRRqjKrjlLJWgyM4wpDMsE0UhWmswGpSu9aQrBZFyMSYCr4xxwrFFLkZj9HAiXR+mSF/IrHBu7XyZf4juZ+/lf1YewQ/POo+elhkAyChLKvffpPL3kFSG43a3cMHdg8ztyNNbl+SFua3kkwmEq2lenqV9fZZkY1xto7Wkq2sJ23rm0d7WwdJZLyEEFMMkv3jlf7GpcwMD0cig7qVOB+937uSPxV3sEAt4hPXsYH7tfCMNyjeEXogSBokhFZWoD4okxxswepBKl/0kuhBoz0UlfJTnACKuc1FJtPZrEn3M9QiNcRSOZ0j4DnWpRhrSLTRkmsikUqRch0xC0lAV6Z5zmL9fTiJOnw8LdGfiB3ns65bFMjXY55bFMjXY55bFMjXY59bEeTO7rYlSLpfZtm0bixcvJplMHvoCvwMMDg7S3NzMvffeyymnnHLA7fatfHnwwQf5yEc+wosvvshRRx3F5z73Od7znvfw5JNPsn79eu69915OO+007rzzTq644gpeeOEF1q9fz/e+9z1WrFgBwJYtW/jEJz7Bww8/TKFQYNWqVXz5y1/mjDPOAODUU0/lN7/5zZh1GGP44he/yK233spTTz1VO/1rX/saX/va19i+fTsAl1xyCYODgxx33HF84xvfIJFIsG3bNnbt2sUnP/lJfv3rXyOl5K1vfStf//rXWbRo0bi3+7HHHuO4445j586dzJ8f/6397LPPsnbtWl555RWWLVv2Gu71if2uTPiv23w+P+7RA8/zGBoamujVWSwWy4Qx2qALISoXMKr/Y3rXoDTFp3soburChBoBJI5oInPSXJzM1B8NHc2k1ruEIWFXF2owO+Z0XdHokiYXKLKRQusIpzyIrhTYESp2hyWCsBKLdBgzcFQpUMpBG43xC3HFC4zUuxhNfGxXg4gvrw8i0tvCRo7JL2JWOLt6isLJP0DHc/dx2+oj+Y+PXUFfU/yxNycaIDn036QK95COJCdvb+GiX/fSNLibnS313Ll6IYHn4viK9tW9tK3N4qWC6k3w2Lv3CHYMzGbJ3Jc5ae29AHQXZ/Dzl97Fk31HUtbx62FChJzhPslHxK0skp08wRr+lf/NEPXxTcSAC6GvCJ0II8A1isZKgYaogGP27UavptHHqXTZV6IDGD8eLhp5HkiJ1i5RmESpBEJIhJBIh5HrchTGUbgeJH2fulQz9XUtNNY1U5fwSXsODYlYoGf8wxwoKr1Ynica4iS6O/GkgcVisVgsFovFYrFMNcYYtC4desNJRsrUYQXgMpkMmUyGW2+9lRNPPJFE4tAVskNDQ5x77rmcffbZ3HzzzezYseOAlSyf/exn+epXv0pbWxsf+tCHuPTSS3nggQeA2PueffbZXHvttSQSCW688UbOPfdcXnrpJRYsWMAtt9zCunXruPzyy7nssssmdPsB7rrrLhoaGrjjjjsACMOQd7zjHWzcuJH7778f13X5+7//e975znfyzDPPjOugV6xYwYwZM/jud7/LZz7zGZRSfPe732XVqlUHlPCTzYSF+po1a/jRj37EVVddNeb0//iP/2D16tWTtjCLxWLZF2OGRXoIapzhjNO0hsqWLPkH96KHYvHqtqUIj85Qv3w2UkxfYmLS6116e4l6ejCjDlIMDxwtVCIGI0WkNbKSxank6AgVu8IyxbCCrsrzuCc97rDXGiIl0RqMVwKncmCRXpXmB+tIbw+a2FBYxKxw+GNtCid/P3uf/y2/OHINP/r4ZxhoiHvJnbCfVO7nJPP3UadcTtoxk4t+1U19djevzGrm0XmzUI7EqwuZs6aLGauzOF68skolze7dK9mTb+XIxU/x1gXPA/By/1Jue+VsXsguRRM/zs0yz5+6d3K5+AV5keFR1nML56KqL69GGLRnCP2QqNqznlQV6oMCaVViv7dSQoLcP43uGIGDgxwt0Z1YoquEh3FktdIlSRQkMcaJ61wcMUai4yhc35BMpKhLtdKQnkFjXSPphEfGd6pVLvFg0cP6pIOXhmRjVaKnD729xWKxWCwWi8VisbzBaF3i3t+sOfSGk8yppzyL4xz67ybXdfn+97/PZZddxre+9S02bNjAKaecwvve9z7Wrl077mVuvvlmhBB85zvfIZlMsnr1avbs2TOu9L722mtryfcrr7ySc845h3K5TDKZZN26dWN6yK+55hp+9rOf8fOf/5yPfvSjtLS04DgO9fX1r6lypq6ujhtuuKEmym+66Sa01txwww21v0G/973v0dTUxL333stZZ52133XU19dz77338u53v5trrrkGgOXLl/OrX/0K1339fuRwmPBePv/5z3P++eezZcsW3v72twPx0YUf/vCHtj/dYrFMGboYooYCTPTGiHSAsLtI/rd7CPcWAJBpl7qNc/BXNNI7NDB9C5nkeheVzxN1dKArQe204YGj5bJiMIqoKIMM87iVLL1BxI6wQj4soVQUJ8m1rop0jdGGSDkoLcEtgV/BYEaJdFOV6SMDRw8u0ps5prCYmWH78Ipx879hzwsPcutR6/nxxz9Ltj7+GKMT9pAa+jnJwv1kVIKTds7hgl93kRncwYtzWtmzYBZGCJItZeau66dp2VBtoGih0MTO3avoqdRz9LKHWZp+AmPg4b3HcsfWM9henFNb02Knkw87/8W7xf1sEwv5Meeyi7m18400RL4i8OI0uoOhPixQHxbx9ThDRqWMJfqoj7DGEl0iRml0I2VVose96BjiSpfK2EoXOSaJHuH5kPCTZNJtNGZaaUw3kPY9GpNxF3q9L0h5h3EwSMhqjUsjJBvAmd5PY1gsFovFYrFYLBbLHwIXXHAB55xzDvfffz8PP/wwt99+O9dddx033HADl1xyyX7bv/TSS6xdu3ZMVcnxxx8/7nWPlvKzZ8ef/O7u7mbBggXk83m++MUvctttt9HR0UEURZRKJXbu3Dkpt2vNmjVjUudPP/00r776KvX19WO2K5fLbNmyZdzrKJVK/Pmf/zknn3wyP/zhD1FKcf3113POOeewadMmUqnUpKz1YExYqJ977rnceuutfOlLX+KnP/0pqVSKtWvXcueddx6018disVheC7ocobIVTPjGiXRVCCk83EF5c398giNIb2gnfXQ70o+rTKaLyax30UFA1NmJGhoZujk8cDQsKwZDFQ8cDYu45UGyYcjOKKQ/KKKiIBbppirS9bBIlyjtgFsBv1wT6bGyNtWBo3pk4KgRaDN8W8bej7OCFo4uLGZm2FY9JcIt3MvOFx7i1rXH8tOPf46hTPyi6wZdpHL/RaLwIA1Rko17FvLuX3fSMLCNF+bMYO+8dhCCutlFZq7vp2HByG0eHJzJjt0ryQuXY5Y9wKpEmVC5/M+Ws7h311vpC+LUu8BwvPsSH5c/5jj5Ms9xBN/mT+llxvCtw7ia0I8IHQ0CfBNRV8lTHxYPPGR0VK2LAKRxqpUu1cdECJTvonwf5ccv21q7REEKpfz9K12qEj3uRE+STjbRUNdKc6aJTDJJS2qkzsU/nD50x48T6MkGO0zUYrFYLBaLxWKx/N4jZYpTT3n2DdnvREgmk5x55pmceeaZfP7zn+eDH/wgX/jCF8YV6hNh9NDO4b9Fh+tbP/WpT3HHHXdw/fXXs2zZMlKpFBdeeCFBEIx7XcNIKdl3TGcY7h8mq6urG/NzPp/nmGOO4Qc/+MF+27a1te13GsRp/O3bt/PQQw/V5ircfPPNNDc381//9V+8733vO+haJ4PXlIM/55xzOOeccyZ7LRaLxVJDV6I4kV5Rh954ijCRpvhUD8XHu2pCP3FEM5mNs3Hqp7cfelLrXbQm6ulF9fXW6l2GB46GxerAUaVBVXDLgxTDMjtDRW9YJAyD/XrSjYbIgIrcqkivYNDjiHRTFen6oCJ9RtjAsfllzK4l0kPcwj3sfPFh/nPtCfz0E1+gkI5fhN2gg9TQf5EoPkRjVMeJe5fwrrs6aezdwgtzZtAxpzUW6bOKzDq2j/q5+ertFfT2LGD73hWQKrNh1QM4TkQuyHDL8+/loY5jKer4yL5PyB95j/EJ8SPmyD6e5Ci+xqXkRvWjK18T+CFaxlI8rUrUBwVSapwho+PUuozbi+45RAmPyPdBCIyWqDBJpMapdJEK40ZIT+P7PulEM3WpGTTVNdNQl6Il6dKUkjQerkT36mKBbqtcLBaLxWKxWCwWy5sMIcRhVa/8rrF69WpuvfXWcc9bsWIFN910E5VKpda5vmnTpgnv44EHHuCSSy7hPe95DxAL7+GhosP4vo9SY11NW1sbnZ2dGGNqf+eOHlB6IDZs2MCPfvQj2tvbD3uAbrFYRMqxNanDP9d8xRTzmszM4OAgP/3pT9m6dSuf+tSnaGlp4YknnmDmzJnMnTv30FdgsVgsB0CXqyI9eANFujFUXh2Me9Jz8RFVd2aa+rfMxZtdd4hLTzKTXe+SzRJ2dmFGHSnWFY0qaXIVxVCk0CbCLQ8SlAtsVYauoEQ5LKN19TEZ1ZMeKYOKXIwTYJIFQI9qRK9ua4iHjR5CpDdEaTYUlrOoMjxsNMQr3s32Fx/lJ+s3csvH/45iKn7T41b2kMrdSqL4CM1RPcd1HsG5d3fS2P0KL8yZwWOrF8YifWZVpM+LRbrWkq7OpWzrOIL65h6OWXsnUmr25Gbx81fO5cm+1SjjANAoCrzfu5O/EL/AF4pNrOVmLqBCLNqNMES+puKHcdjcaBqDOI3umnF+f/epdZGAYxzkvmn0hE+U8DCuM1LposapdJEK44YIT+F7CZJ+A3WpFhrSTTTV1dOU8piRkjQmJUn3EL87tsrFYrFYLBaLxWKxWH4n6Ovr46KLLuLSSy9l7dq11NfX89hjj3Hddddx3nnnjXuZiy++mM9+9rNcfvnlXHnllezcuZPrr78eYEIuYfny5dxyyy2ce+65CCH4/Oc/v5+kXrRoEffddx/ve9/7SCQStLa2cuqpp9LT08N1113HhRdeyC9/+Utuv/32Q0ry97///XzlK1/hvPPO4+qrr2bevHns2LGDW265hU9/+tPMmzdvv8uceeaZ/J//83/4y7/8S/7qr/4KrTX/8A//gOu6nHbaaYd9W18PExbqzzzzDGeccQaNjY1s376dD37wg7S0tHDLLbewc+dObrzxxqlYp8VieRNjjMGUIlQueEOrXQDCrmpPeke1Jz3jkdk4m8QRzZMitCfCpNe77N2Lyhdqpw0PHM1XIrKRItIKpzKEqAyxWxn2hhVKQQkVRXHSfFRPulIGpRy0UJhEDoQaO3BUjxo4KjQGgdbDt8PAqPqTtEqwrrCUI8rzEEhA41XuY9tLD/Afa0/i1o9fTbnaA+dVdpEa+hl+6TFaogaO61rNH93bSWPnS2yeM4MnVi0EAemZRWYd20vDvEJ1ObFI37p3Je0zd7Bxw/8Ahud6V3Hblj/ilaFFtfUsdLr4sPw5F8j7KIskD3Ism1hHNGrQaJiI+9ERkNARmWCIurDE/o/U/rUuzj6VLlAdMJr0iBLDaXSHKEgRqWQs0YcrXRwdS3RX4/keSS9DOtFEXbqJ5roGmtMJZqQdmpKC9KE60WtVLo2xTJ/m32+LxWKxWCwWi8VisexPJpPhhBNO4J//+Z/ZsmULYRgyf/58LrvsMj7zmc+Me5mGhgZ+8Ytf8OEPf5j169ezZs0arrrqKi6++OIxveqH4p/+6Z+49NJLOemkk2htbeWKK65gaGhozDZXX301f/EXf8HSpUupVCoYY1i1ahXf/OY3+dKXvsQ111zDBRdcwKc+9Sm+/e1vH3R/6XSa++67jyuuuILzzz+fXC7H3LlzOf300w8o41euXMkvfvEL/u7v/o6NGzcipeToo4/ml7/8Za0TfqoRZt+Cm0NwxhlnsGHDBq677jrq6+t5+umnWbJkCQ8++CAXX3zxfh8D+H1jaGiIxsZGstnsYX/U4PcFrTXd3d20t7fXOoYsljcSYwy6GKFzb+ywUQCVDyg81EH5pepwUVdSV+1JF4cQk9poerL9tDW2IMXrf25NRb1L1NtTc9jDA0dLZcVAFBFWB45SHqQnhD1RhVxQRKmRnnSUrta7GEIlURrwSggnQo8ZOFoV6dWe9Hhe6WhRO/I4+9pjTXExq4sLcKqy2osepeOVO7lx5Qnccto7KSeqtSvl7SRzt+KXnqA1bOKY3vmcdV8nTXt72Ty7hb76uhGRfkwvDfOHRbqgq2sp2/aspq19O8vmP4sykgf2nMCvtp1BV7l1eOEc577Mx+RPOUk8T79o5DecyLOsxFQ1uZGGMBESuHE/elIF1Ic56qLyOA/i2FqXeMCoM0ajD3ejR0k/HjBKNY0eVdPoMq5ziSW6QjgKL+GSclMkE/UkE000pRtpqU/SVufSlJBkfHHwAz9uElLNsUT3pn5Qy+vFvm5ZLFODfW5ZLFODfW5ZLFODfW5NnDez25oo5XKZbdu2sXjx4gmJ5TcDP/jBD/jABz5ANpudlkGdv+9M5HdlwrZm06ZN/Ou//ut+p8+dO5fOzs6JXt1hc+2113Lbbbfx1FNP4fs+g4ODB9y2r6+PdevWsWfPHgYGBmhqapqydVksloljtEEXQlQ+JDazb+BaQk3xyW4KT3RDVeonVzRTt3E2TmZ6e9Invd4llyPs6MAEcb3L8MDRSikeOFrWBhkWcMtZ+rVidxAxFBQIwzJ6+FCrijBRLNIjLVBKYtwKwg8wGCKqnr4m0qvDRoVBGzEqiD7yOLvGYVVxIWuKi/BNfB975gWyW3/BTbNX88PLPkuuLgOAX9pKMvcz/PJTtIcz2NC3nrc/0EnT7ud5cdYMnluxADCk20vMOrZnf5G+ezUz2nZz4oZfUNE+v9jyDu7aeSr5KK6O8Yh4p/cYHxc/ZonspIM2fsC7eZVFUJXf2tEEfkTkaoSAdFSmPsyRUvsOZREjEl3KkQGjZpw0esIjSnhxDYwRRGGcRjc4SCFxPDBuCG6E67skvCQpvx7fq6cx3URLfZqZGZ/mpKQ+Ua2AORBOIpboqabfC4lusVgsFovFYrFYLJaJc+ONN7JkyRLmzp3L008/zRVXXMF73/teK9OngAkL9UQisV/UH+Dll18+4PTVySAIAi666CI2btzId7/73YNu++d//uesXbuWPXv2TNl6LBbLxDHaoPMhKh8wYmzfoLUYQ+XlQfIP7UXnY+Hszaoj89Y59cozFwABAABJREFUeDOnuSedya13MUFA2NmJGsrFPxuDqcQDRweCiKIyiKiMWx4gG4XsiQzZoEg5LI10o1XrXYzWKG2IIhlXjSTLUE2k6/jKMUbH4lxojNBxR7oZFrwjIl0YwRHleawvLCVVHfjpso1g13/yvboF/PvFn6SvqRmARHk3idxP8EtPMCtoZf3AMZzycDdNu57jpZnNbF4+HzCk24rMPLaXxgUjw0a7upawbdeRNM3Yy4nH/DdlleC/tpzNXTtPoaTi/TaIIhe7d/Fh+XMaRIHtzONfuZgOZtbWq9y4H127BoEhE5WoD/Ik9L6TysfWujhG4Bpn7IBRITCeS5jw0b5bvYtdoiCFUgmEkHE3uqcwbhnpCZJ+ilRiBp6ToS7ZwIz6BmbVJ2hJCxoTEkceTKL7kGyKRbodKmqxWCwWi8VisVgsb3o6Ozu56qqr6OzsZPbs2Vx00UVce+21b/Sy3pRMWKi/613v4uqrr+bHP/4xEBfb79y5kyuuuIILLrhg0hc4zN/93d8B8P3vf/+g2/3f//t/GRwc5KqrruL222+fsvVYLJbDxyiNyoexuJ5Yy9SUEHYWyN2/h6irCICs98icNIfEsqZp70kXnsRpnKR6F2NQvb1EPT2Y6gELHWhUUTNUHThqdIhbHqQYltgbQV9YinvSVVS9kmpPuq72pEcS5ShEssjwwNG43sVUe9KpDRzVRmLGGzhqYHFlFkfnl9Og44MVDp3Q/RN+ohv43rs+zN72WQAkyj34hf8kUXiQmeEMjh48nrc82k3jjud4tb2Jl5fMBQyptiKzjumhcWGhetuHRfpRNDR3cvyG2yjpBD979Rzu2vk2Kjqecj5TDvBR51b+WN6NKxSbWc6d4i0MmKbqUg3a1VQSEdoxSAz1YZ7GoLD/oFExnEh3cISIB4zul0aXRL6PSnoYKeMho1GCMEphjFeV6Aa8keGiqWQjCbeBhFdPS10Ts5uStGdcGhMSzznI76f04hR6sgkSmcP9tbFYLBaLxWKxWCwWy5uAT3/603z6059+o5fxB8GEDc5Xv/pVLrzwQtrb2ymVSpxyyil0dnaycePGN/yoxwsvvMDVV1/NI488wtatW9/QtVgsFjCRRuUDdCH6nRDpKheQf6iDystxT7rwJOlj2kmvb5+UZPiEEAKnwUdmJqneJV8g6tiLrsQ1JEYZdEGTL48aOFrOEgR5dmlBbxBQDAooFY48NFGEURFKVweOojCJAkLosT3pYwaOGowRcSo9PnNkUQbmBq1sKBzBjCju7ZMM4GRv4X9yITecdTFb5i8CwA+y+Pn/Ipm/h5aojqOzx/LWTX007niOLa2NbFk0B9CkWuNho40LRxLp3V2L2b5rDanGXo47+jaKKslPXzmXe3e/hUDHlTJzZB8fd37K+fI+EILHWMNvxIkUTRpMLNKVF4t0Iw2O0TQFOerDIo7Zp5ZIiLiqRUhcJC4OwoxKoyMwvkOU8FG+V12njGtdomQtjS48BV6I4zmk/BTJRAZXZGhINdHeVMfC5iRNSUnSPZhEd6tJ9KZ4sKjFYrFYLBaLxWKxWCyWKWXCQr2xsZE77riDBx54gKeffpp8Ps+GDRs444wzpmJ9h02lUuFP/uRP+MpXvsKCBQsOW6hXKhUqlUrt5+E6G631SPXBmwRdlWBvtttl+d3DhCpOpJd+N0S6LkeUHu+m9GwfqHg9iZXN1J04C1nnYSCuLXmt11/tD9eHeR0y5eI0xPUuxhgmOBt6DCYMCbu6UNn4v121nvRiPHA0qA4cNZUsezV0h4p8kCcKKyOtO1rF9S5KEylBpAX4RYSMG9IP2JNuzKiBo2Nve1vYyDH5FcwKWwAQFEiU/ovfdHfzr6ddyDPLVwHghUX8/G2k8r+iIfJYm1/LyU+XaX95M1tn1LNj/kxikV5g1jG9NC4aJdK7F7N9x1EkGwbYsP52CjrJT159F7/ZdTKhiUX2fNnDJ90f8S7xEFpI7ud4HuBYQvyaSI98ReBHGAmujmio5KmLSji1x6V6G6uDRoV0cIyDyz5pdCmJEh7K9zDVAzRaeURRCqV9hJBIX8dpdFeTSCRI+S34bizSmzINLJyRYla9T0NiZLio3vf3QzjxUNFkUyzRhw/IvAn/225ftyyWqcE+tyyWqcE+tyyWqcE+tyaOva8slqnlsIR6S0sLL7/8Mq2trVx66aV8/etf5+STT+bkk09+XTu/8sor+cd//MeDbrN582ZWrlx5yOv627/9W1atWsWf/umfTmgNX/7yl2t1MqPp6emhXC5P6Lp+19Fak81mMcbYydiWKUGHGlMK0cHvyIt3pGFzHl7IIcJYSpp2H45pojzDpxzlIPv6d2OMJlvMAwYhDvzcEq5Apj1k5EB/7nXu06BzOVQ2G9e7GIMJDVFFUYg0FQ2oCgQF8kbRr6AclQmjACnA9xPxZZTCCImSLloJHCci4YRACs2wSB8t/TWGOJVeXcmYddUHKY4cnM/cYkv1lIBU+D880fES3zjxfB5+9wYAnCggmb+DZP6/qY80G8KjOfFVn/bHnmVHXYLn5rQDitSMarXL4tEifRE7dq7Fy2Q5ev2vyOsU//HKu/ntnhOJTPyyttTp4pPOf/BH4hG0kPxWnMBvOY6gej5S4KQdZNolIQVNOiIVlUhog3AbgIbRjxxIiRQCaSRyX5HuSJTvolwHVwhcI1DaQysf6Th4PuAocDWu6+C5Pr6XRJAg4aVoTqWY2ZCgPiHxHEOlUqGnwj7IuAvdz4CXhkBAUAbeXK9T+2JftyyWqcE+tyyWqcE+tyyWqcE+tyZOLvf6/t60WCwHR5jDiEZmMhmeeeYZlixZguM4dHZ2TsoA0p6eHvr6+g66zZIlS/B9v/bz97//fT72sY8xODg4Zrv169fz7LPP1hJ9w0cvHcfhs5/97LjSHMZPqM+fP5+BgQEaGhrGvczvK1prenp6aGtrsy9ClklFVyJULsBU1KE3ngaMMpRf6KO4qRtTirvBnRlJ6jbOwltQP+k96dpoerMDtDY2I8cT6kLg1E9evYsuFAg7O9Hl+L9dIz3pEUORBlXBqQwyFIV0KkE2KFEKCmN60lEaoyIipasDRyOEG8vZkXqXUT3paIwYnUiPTxumTiVZX1jG0vLcqm5WJPVdvLr3Uf5/a87l7mNPwkiJ0IrM0G/wCreSCgusLi1nw55mlj32It2eZLAu7lhPNJWYfXwPTYuHB6tCT/ditu9cg5MusGbZgwzpFLdtPYsH9p6AMg4ARzh7+LT8IafLJ9BC8IA4lvs5ntDEryNGGIJEROgpEJCKAjLhEGkdIvZ9ORyudRFOXOvC2MdO+y5hwkMP17pohyhKEqkkQjjgKYQfIT1Dwk+R9tO4Th2uSFOfbmDhjDRzmxI0+OIAvxdiVBK9IV7PHxj2dctimRrsc8timRrsc8timRrsc2viDA0N0dzcTDabfdO5rYlSLpfZtm0bixcvJplMvtHLsfwOM5HflcNKqG/cuJF3v/vdHHPMMRhj+Ou//mtSqdS42/6///f/DnuhbW1tkyLmAf7zP/+TUqlU+3nTpk1ceuml3H///SxduvSAl0skEiQSif1Ol1K+Kf9DLYR40942y/RitEEXQ3QhxIQaAQdNZ0/Lmoyh8soghUc6UNm4S1w2+GROmE3iiKkdOCqEQAq5n1CXKRenKYFwXv99Y6KIsLMLVT2gKBTooiJfVgxGCq2j2sDRTiUZDEIKQZ5IBSPNOyrCRNWe9EighEEkC4g4d040vDOtqpcxsUg3wDj1Lr52WVtYyqrSAhxiqZ3kQTq77uRfFp3FbZdci3Lil5qGwYdxiv/J/5+9+46zs6z3vf+5rrutPn3Sk0kjJKQROojAluIGOYiUzYNbRY4g2+3xgLoBRaKiWLChz6PHoyhlA251CxFFlBqIQRCUKhAgJJM2va96l+t6/rjXtCSUQCpc79eLV2bWrHKvyVpryHf95vtLBF3MK81mSfcS9nv8JQaDTl6szQAWTrrExIO6qJ83gJDVIL2rhdbWxZAosXjRvQyoFP/54gd4pO1gVPU2F1gbuFzewtHyGbQQrBKHbBukuyGBGyGEJh2WyQRDJFT4GkG6s1Wti0YjUJ5NkHDRtl39VjkEYQqlXISlEMkI4fq4jkvSy+I5KQQpEnaG5possxpSNGdt3FdbMGonIdUAyTqw3vqy2n2d+bllGLuGeW4Zxq5hnluGsWuY59aOMd8nw9i13tC/1G+++Wa+973vsXbtWgAGBgZ2ex3Khg0b6O3tZcOGDURRxJNPPgnAnDlzyGQy24Tm3d3dAMyfP5/a2trdeqyG8Xamg4ioEOw1i0YhDtL9DUMU/tJG2B2/sSaSNulDJpA8oGGnhNk7SjgSq9ZDejsnEA17ewk7OtCRqr6ZoSiV4p70IFJIf4ioMsQWBX1BxJA/SBCUxvSkq2pPekQQCSI0uCWEiCtcIsb0pFcvpEU8nT5aDT8apEstmFeazpLCbBLV0NoVTzHYfQffaT6K2875KhU3frOypv9pROlXeP5G5pRbWDR4DPv/fT2VgX+wPpeCRBLLLdO8tIOmRX1IO76d7u5prF+/FOUELFr4AH1RiptePJO/ti9DE/+dLrFe4XLrFo6Qz6OAVfJg/qwPw3+VID0TlMgGQ7g62ipIF2AJhLCxsbC26UcXhK5D5Hkj/ehR5BIGKZS2Ea5CuGVs18JzkyTdJLZMIUmSSWSZ3pBiZkOSnCe3/8aOsOLFoqkGcNNv5iFiGIZhGIZhGIZhGMZu8IaSngkTJvCNb3wDgJkzZ/Kf//mfNDQ07NID29ry5cu58cYbRz4/8MADAXjggQc49thjd+uxGMY7jdYaXQqJCsFeU+syLGgvkP9LG8HmuGNbOJLUsmaSS5qQrrX7D0ju5HqXYpGgrQ1VKsd/D2VNpRjS70eUVLxwlPIAHUrTHWrylSLloDC6hEYrdBgvHQ01hJEGp4KQIRqNgrjeZWThKMSlL2N3XI7pxNcw3W/moPw8aqI4+LVFK9Hgf/H/phbwi/cvJ5/KAFAz8BKUfoVXeYGWynQWFo5j3rNtyLZn2JxNQk0dQpZoPKCdCQf2YCfix9bAQDPrXllGGZvFCx6kN0pzw4tn8reOpehqzH2w9SKXW7dwsHwJDTwkD+HP+lB8VQ3SqVa7DE+kB2Wy4SCe2n6QLrFxhb1NrUu8aNQlTDgjlStR6BGEKTQWwguRXgXX9Uh6tSTsFJDEkWmachlmNyWZlPNefRrdzcQheqL2HVnpYhiGYRiGYRiGYbw5Qghuv/123v/+9+/pQ3nH2eGlpMcdd9y4TvPd5YYbbuCGG254w+c/9thjeQP18IZhvAYdKlQhICoEjI467x3C3jKFR9qovFLdKioFycWNpA+agEzumZoMmXJwahM7rd4l7Owk7O0D4p70sKAYqIQMRQoRVRClXnpVRFcoyAdlin6eKAxH14RW611CpQhCAZaP8IL4+oZ70qsj6HpskD7ur3o0TG8IchyS35+JQbxwVNKH4/8XN6k6fn78Z+iprQOgZnAjlH6NU3mCaZVJLCoey5yXh0ite4aOdAJq6oESdXM7mHRwN242PqZCoYb16w6kr9DAonmr6JcuP1tzNk92LR45hsPt5/mcvJklct1okM74ID1wI3wvRAhIB6XXDNJtHGxhs3XcrS2LMFEN0hGgIQyThGESpIBEiJWI8NwEaS+DLZNIUiTdNNPqU8xuSlGbsLb/pop0IFUPyXpwTIefYRiGYRiGYRiGMV5XVxfLly/nzjvvpKOjg7q6OpYsWcLy5cs56qijAGhra6Ourm63H1tLSwsXX3wxF1988W6/7WH33XcfV155Jc888wzpdJqPfOQjXH311dj27smD3tCt+L7P4OAgjY2N3HjjjXzzm98km83u6mMzDGMPUeUQlQ9Q5fD1z7ybRUM+hb+2U36hN56mFpDYv570oROxsrv/zT6o1rvUuNh1CcROmDIO+/riepcwQocaVYwYLEcMBBFKh1jlfgbDEh2RpFAJyAd5grAy2sCj4on0KIoIQomWCuHFNV2j9S5jF46CRr1qkJ6KEiwrzGVOeUr1lAopvYJ78l1898gP0Tp5KgDZfBd24b+xKn9hot/AouLRzNysqHthDZ2ew1C2DnSJ7NRuJh/WSbIhXqpaqaRoXb+Etp7pzJv9V2pnPM/Na9/H3zuXMnx0R9vP8jl5MwvkRjTwoDyE1a8VpIfVahcVIscG6UIgpMTCwRbWNkG6cmxCzyXynOpNC8IwSRAmwNaIdIDt2STdNAkvhUUSmwx1mTSzm9NMq/Xw7O09BgR42eo0eg3swj5/wzAMwzAMwzAMY992xhln4Ps+N954I7NmzaKjo4P77ruPnp6ekfNMnDhxDx7hW+f7/psa2n7qqac4+eSTueKKK7jpppvYvHkzF110EVEU8e1vf3sXHOm29uhSUsMw9h46GrNkNFSvf4HdTJVCin/voPh0N0RxQOrOqiFz2ETshu2/Hu1yUmDlXEhayK7CW746VS4TbGlDFYsjPemFYkh/FBFGEbIyiB8UaNeCfEVRCPKUgyJqOAnXCh3EPelhBCEavNGFo4pqTK7UyG/waFR82kjmPPp3byuLRcVZHFBswa4u/0yK+3lu8DG+vuhf+Pu8RfFp5Tzp/tvBv5+GIMPi4uHM6EnS+MyL9FqCzmQO8Ek19TH5sE4yk4sABIHLpo0L2dQ2l6lTn2P+kvv43bqT+MuWQ6od6Zrj7Ke4Qt7MHLkFgIesbatdAjfCd0OEhFRYJhcM4qoIqcc+jgXCkji4WFstjtUIlGsTJEcXjaIlQZgkDF3wNCLl43oeKa+WhJ0EUtgyzYRcmv2b00yscbc/jW55cYieqgfL2cFHhGEYhmEYhmEYhvFO09/fz6pVq1i5ciXHHHMMADNmzODQQw8dd76tK18efvhhPvGJT/DCCy+wcOFCvvCFL3D66afzxBNPsHTpUlauXMlxxx3Hvffey2WXXcZzzz3H0qVLuf7665k3bx4Aa9eu5dOf/jSPPPIIhUKB+fPn8/Wvf53jjz8eiBtBWltbueSSS7jkkkuAuCb4S1/6EitWrBjZeQlw7bXXcu2117J+/XoAzjvvPPr7+znkkEP44Q9/iOd5rFu3jo0bN/KZz3yGu+++GyklRx99NN///vdpaWnZ7vfnl7/8JYsXL2b58uVAvF/zmmuu4eyzz+aLX/zibhkC3+GlpEKIPbKU1DCMXUNVIlQhQJX2niWjY+kgovhUN8W/d6D9OCB1JqfJHDEZZ9IeWt4oBDLtYOVchBSjfeVvko6iar1LL1ppdElTLob0BSEVRXXh6CBtGgYCKPoFin6RSI35DYIwREUhYaTH9KRHr9qTrqv1Lno7QbrQMKc8lWWFuSRVvFjUFc/QW/odX5h8En86/iq0lNhhQFPn3fjRHeQCyeLSgUwfrGPC0y8xFIb0OClA4dUMMOmQLmpnD8W3pCSbN+/Pxo0HUNe4iQVL7+FPG49j5cMfJdLxj6WjrH/wResG9pOb44l061BW64Pxo/h4hoP0wA2hGqRnK3GQbm0VpEvLwsbZNkgXgsi1CRMe2o7fMNBKEoQpIu2Aq5CZEM9LkPJqcWUSSOJZGabWpZg3IUV9ejvvpgsZT6GnGuKpdMMwDMMwDMMwDGOvobWm+Bb/Hf9mpKR8Q7vWMpkMmUyGFStWcPjhh+N53uteZnBwkFNPPZWTTz6ZW2+9ldbW1letZLniiiv4zne+Q1NTExdddBHnn38+q1evBiCfz3PyySdz9dVX43keN910E6eeeipr1qxh+vTp3HbbbSxZsoQLL7yQCy64YIfuP8RVLblcjnvuuQeAIAg46aSTOOKII1i1ahW2bfPVr36V9773vTz99NPbnWCvVCokEuPrU5PJJOVymb/97W+7ZdfmPrOU1DCMnSeefq5Oowd73zQ6xBPzped6KD7WjirGwbHdmCB9xGTc6dmdsvDzzRAJG7vGQzg7Z4Fk1N9P0NGBDkJURREUFP1+SCFSiLCMLvfSqTR9kaDkV8j7Q4SRv516F4UfKrDCkZ50jSYE0BqtVTVI14AeU++iGTOezuRKI4fk51EXxUGwJbagg1/wvfQB3Hrsl6i48Q/yKVv+Qkn/CisY5JDiPGbnp9D8j1coF9votxJgu9jJISYu66Zhfj9CxuF9R8dsNrQuwUkNMn/R/TzQfjg/+MvnRybOl1pr+aJ1AwfKtSgEK61DWc0hBNGYiXQnIvDiID0ZlslU4moXe5sg3cbBRm4dpEtJ6DlEnouu9t1rZROEKcLqolHbUyS8FEkviS0SCNKknDQzG5LMaU6TSWznx6eTikP0ZB3IPbAQ1zAMwzAMwzAMw3hdRaWY/dAzu/121757EWnr9f+taNs2N9xwAxdccAE//vGPWbZsGccccwznnHMOixcv3u5lbr31VoQQ/PSnPyWRSLBgwQI2b9683dD76quvHpl8v/zyyznllFMol8skEgmWLFnCkiVLRs77la98hdtvv5077riDT37yk9TX12NZFtls9k1VzqTTaa677rqRoPzmm29GKcV11103kvNcf/311NbWsnLlSk488cRtruOkk07i2muv5Re/+AVnn3027e3tXHXVVUDcK7877HBT+7p163bFcRiGsRsoP6oG6XvnNDqAjhTlNX0U/9ZBNOADIHMumcMm4e1Xu+eCdFti1XrI7QWpb4KqVAi2bEEVinFPeiFioBwxGEYo5SNK/Qxon65QUvYDhoICQVAaDcKr9S5RFBKEoK0I4cWd5G+mJ702zHBwfh5T/ab4/jJEkl9yq/b44bsupq+mFoCJXWuIyrcSqvUsLM1mfvFgmtdsJup5lrztgZ1D2oM0L+mlaXEvlhPfRk/PFNavO5BASObO+zOP9i3m54/9B8UwBcBcuZnl1o0cbT0LwF+spTzAkeMm0kMn7kh/vSDdkja2cJBbPVa0lIRJl9BzRzrMVeQQhEkiSyKTIa5nkUzWkLKTCBJIUmQTKeY0pZjZmCLhbP0/PyIO0NNN4KZ26DFgGIZhGIZhGIZhGNtzxhlncMopp7Bq1SoeeeQR7rrrLq655hquu+46zjvvvG3Ov2bNGhYvXjxucnvriphhY0P5SZMmAdDZ2cn06dPJ5/N86Utf4s4776StrY0wDCmVSmzYsGGn3K9FixaNmzp/6qmnePnll7epaSmXy6xdu3a713HiiSfyrW99i4suuogPfehDeJ7HlVdeyapVq5A7Ya/dG/GGk6GTTz6ZX/ziF9TU1ADwjW98g4suuoja2loAenp6OProo3nuued2yYEahvHm6EChSnGly946jQ6gQxVPpD/RiRqKJ6xF0iZ9yASSBzQgrN3zorgNKbCyLjLj7JQwXytF2NVF2N0dB+mlak96GBGqEFkepBAW6dKCUqApVIYoBYXxtTJhiAoCQqUJtQKvMtKTrqnWu2zdk/4qQXpCuRyYn8vc8lQkAghJy9/zUNjKN5Z8mHWTpwNQ399BYuC/8MXjtFSmsKhwHE0b87gb/kHZcsCpQ4gBGhZ0MmFZN04yAmBwsJH165YxWKph3pxHeKYwg68++SkG/RwAU2UXV1g38175GELAU3Ief5LHVIN2UQ3SFb4XoqUmGVbIVoZwVYCl1ZilogJLWtjC3X6QnnAJE6NBehS5hJFHZAmsjCaZcEh6NSQsD0hikaI+nWJuc4rp9QnsracIpBNPo6cbTTe6YRiGYRiGYRjGPiQlJWvfvWiP3O6OSCQSnHDCCZxwwglceeWVfOxjH+OLX/zidgP1HeE4o/+GHc45hjOHz372s9xzzz18+9vfZs6cOSSTSc4880x833/N65RSjmQQw4Ig2OZ86fT46t58Ps9BBx3ELbfcss15m5qaXvX2Pv3pT3PJJZfQ1tZGXV0d69ev53Of+xyzZs16zePcWd5woP6nP/2JSqUy8vnXvvY1zj777JFAPQxD1qxZs9MP0DCMHadDhSqGqNLeW+kyTPkRpWd7KD3ZOVLtIlM2qaXNJBY2IN09V50x0pO+k8L8aHCQoK0d5fvokqZUDOkPQiqRRvpDVPxBOrWkGAiKQYlikCcMx/SkqygO0qOIUGmwA4SMg2tVnUof35NebUrfTk+6pSULii0sLs7CqfaWJ+Rq1oYP8dWWf+GxeR8CIFXKM6Htdobs+6gNa1hSOJoJPRbZNS9TBipOPah+amdtZNKhXXi5+AdmsZhj/boD6e6fxKyWJxgix7ef/yjdpUYAmsQAn7V/yZnyQSyhWSun8zv5HvrDGlDxD/TQjqh4IdraOkjXiDE1NbZ0sMW2b3hoSxJ61Yl0ORyke3G9jA1WSpBJpEm5SWzpAsl40Wg2wf7NaSbUJJByqzdRnFQ8jZ6sGwnnDcMwDMMwDMMwjH2HEOINVa/sbRYsWMCKFSu2+7V58+Zx8803U6lURjrXH3vssR2+jdWrV3Peeedx+umnA3HgPbxUdJjrukRRNO60pqYm2tvb0VqP/Nt87ILSV7Ns2TJ++ctf0tzcTC6X26FjFUIwefJkAH7xi18wbdo0li1btkPX8Wa94UB963cZtv7cMIw9S4cKVQrjSXQ/ev0L7GGqHFJ6upviU13oSny8MuuQWjaB5Px6hL2HJtIB4VlYNd5OC/OV7xO2tREN5as96RF9fkgx0sigQFQepB3NUCQpV3wKwRB+WBnTk66qPekhQaTQMkK4oz3pW9e76DFLR6meayRV1zCrMoll+f3IqCQAjniRIW7jqobj+P3Sr6KkxA5DZrXeTa/7WxCCdw0uY+pgLTXPr8MPAsoyB6pEunkLU47sINUUL6r2K0laNyymvWM2kyY/T7q+n//7yulsKcQ/5HKiwKfs2/mw/BOuiNgsmvmtfSKdYSOE1dDbUlS8AGXHQXqmPIQ3HKSP+dljCxdb2tsG6cMT6eOCdAdfJ8AGO2ORSmVI2AksHAQZPCvJ1FqPuU1p6rPeVtcp4iWj6SbwMjvhEWEYhmEYhmEYhmEY29fT08NZZ53F+eefz+LFi8lmszz++ONcc801nHbaadu9zLnnnssVV1zBhRdeyOWXX86GDRv49re/DbBDv20/d+5cbrvtNk499VSEEFx55ZXjf2MeaGlp4aGHHuKcc87B8zwaGxs59thj6erq4pprruHMM8/kj3/8I3fdddfrhuQf/OAH+da3vsVpp53GVVddxdSpU2ltbeW2227j0ksvZerUqdu93Le+9S3e+973IqXktttu4xvf+Aa/+tWvsHbTGyU7pwzYMIw9Yl8L0QFUMaD4ZBelZ7pHpuetWo/UsmYS8+oR1p6b+hW2xMq5yNTOqfDQWhN2dRF1d6Mqiqg42pOuowq63EeXjuhVAt8PKQYFykGBkZ9VWkMUT6VXomgkSBewVb1LNBKkg2L8j7rRz5r9Wg7J709TWBvfX9GNI2/hR+lZ3LDsSspe3LU2d/0j5PkVBaufZfl5zB6aSs3LG4kGOvBlGoSDm+5m8mGd1M4eAiAMHTZtWsCmTfOpa9hM3Zyn+K/1J7FusAWAlChzoXUnF1q/JyUqdIsa7rBPZEM4BYLqr5hJRcULiWxFQvlky0O4ysceE6QLBJawseV2JtKlJEw4RJ6HlsMd6Ta+9tCOxE7aZJIZknYC8BCkyLgpptV5zGlKkU26469TWHGlS6oR7G03ixuGYRiGYRiGYRjGzpbJZDjssMP43ve+x9q1awmCgGnTpnHBBRfw+c9/fruXyeVy/O53v+Pf/u3fWLp0KYsWLWL58uWce+6543rVX893v/tdzj//fI488kgaGxu57LLLGBwcHHeeq666io9//OPMnj2bSqWC1pr58+fzox/9iK997Wt85Stf4YwzzuCzn/0sP/nJT17z9lKpFA899BCXXXYZH/jABxgaGmLKlCm85z3vec0w/q677uLqq6+mUqmwZMkSfvvb3/LP//zPb/h+vlVCv8FRc8uyaG9vH+mvyWazPP3008ycOROAjo4OJk+evM3I/75mcHCQmpoaBgYGdvhXDfZ2Sik6Oztpbm7ebSX9xs6nozEhemXfeb5FQz7Fv3dSeq4Hovhlx25IkDp4At7sWsTW1Rq7kxBYWQeZcd/UcWzvuRXl8/HS0ZKPKirypbgnPVIhotxPf1SmR1v4fkTJL1HwC0RqbL1LiApCwjAiRIHjj9ScjKt3qZaja711lD76cTpKcFB+HrMq8bIRTYmM9Wv+2424dsm/0lNTD8D0LS9hF26l4L7C3PJMFhRmk93Qg93WhRIeQqYQVg8TlvXQtKgXaWm0FrS3z6F1/RLc5BDpSa38buN7eL53HgAuAR+y7+VT1m+oEUUGRYbf28fxUjQLreLvlRIa3wsJnQhXh2SDPImojKUVckeCdNdDW9sG6W7KIZ3MjPSjS9LUJD1m1SdoaUyR9LYKy+1EtdalHsxr5R5lfm4Zxq5hnluGsWuY55Zh7BrmubXj3s7Z1o4ql8usW7eOmTNn7lCw/HZwyy238NGPfpSBgQGSyeSePpy93o48Vnao8uW8884b6eEpl8tcdNFFI2XyY/vVDcPYuXSkRxeL7kMhOkDYX6H4tw7Ka3pHMl57Qor0wRNwW3I7ZdHnWyGTNlaNt9MqZrTvE7S3E/YPokqacjGkLwzxI4WoDFAIinQh8ANBOSiT94cII3+bepcg8gkjwAkQIv47H6l30RqtVdyT/hpBuq0tFhZmsrA4ExsLjSJt3c2jzvN8db8Ps3ZSCwBNvZ00t/8XHZnHmM5k3t13LLUdFRLrXyTSAm01ge6ifl4HEw/uwknFx9PXN5FX1h6MH7k0zniOP3UewRNPnQKARcQZ9ir+w/ovmsQgBZHgdvsEnlHzUYE1cn98LyRwIywUdcEQybCEpTWWju9HHKQ7r1Ht4hC5Lrrac6+Uha9dtGPjplwyyQxetR9dkqYxnWBOU5IptUk8d6vfRPBycZCeeGf/D6dhGIZhGIZhGIax77npppuYNWsWU6ZM4amnnuKyyy7j7LPPNmH6LvCGA/WPfOQj4z7/13/9123O8+EPf/itH5FhGABopcdPou9jewvC7hKFv3VQebl/pL7bmZIhffAEnKmZPR6kC7fak+7tnH4trTVhdzdRVxeqpAiKY3rSqwtHu7SkFAn8SkAhLFAJiqjhv1atIFJEgY8fRWgrQrjxxHq8XDSeTB/bk67GdqNvpyf9oPw80ip+V9UWz9Lu3cn/nnI6D885C4B0scB+r6xgc+YeIi/H8f1H0dzjkFzbigpDlGwEPUB6UitTjugg2RC/cVos5lj3ykH09k9g0rTneXBwIX959kI0EoHivfbjXGHdzFTRTRmXP7pH85haQhTYgECjCZyIwAsRUlMT5EkFRSytsMcF6a8xke45RN5okK6VpIKLtly8tEt6XJCeGgnSp9alcJ0xP/qEhFRDHKTb3k55LBiGYRiGYRiGYRjG7tbe3s7y5ctpb29n0qRJnHXWWVx99dV7+rDelt5woH799dfvyuMwDANQfoSuRKhyiPbVPheiAwQdBQqPd+CvG+3Ycmfk4iB9UnoPHlmVFfekW+md05MOEOULhG1tVLSDLikGKiGDoUKEZcJyP90ohiJB6IcUgyLFoDB+qUcUxj3pYYiWaqQnHcbUuyhVnUwfjs63P5XeGNRw6NB8mqs96YgucG/hG3VL+dXCL6MsCysKWfL8PXR5v6UvrTmicCDT+mpIvrIZiiWUrAPh42Y3M/nwTmpa8gAEgcuG1sVsaZtLQ3Mr3U15bnnpQwQqrkw52nqGL1o3MkduIcDiQecQVnMIvu9C9R4FdoSfCEEqMmGRdLmAraN44Sg6DtKxsC0HIcb/1sB2g3QtqhPpHm7SI5vK4AiH4Yn0pozHnMYkk7eeSLe8OERP1YPc97a7G4ZhGIZhGIZhGMZYl156KZdeeumePox3BLOU1DD2IB2qODyvRKhKxOi48r5Fa02wJQ7Sg41DI6d7c2pJHdSM05Tag0dXJQRWxkFm31xP+vZo3yfo6MDv6Scc8BlSmsFIEUU+utRPtw4Y0JLAV5TDMoVKnjAa25OuUKFPGISExBPpwz3pGk0IcU96NUV/rXqXVOSxrLAfc8pTqpevkLJ/xa05ix8ccAlDqQwAC198nCj4Be2ZPhaU5rJfz1QSG9qxel8GkUHIBqTdyYSDumla2IuQoJSgrW0eG1oX46UGCSa185ONpzAUZOPrlOv5qv0zlsq1REgetRfxgDyScpAEHX+vI0tR8QKUrUlHZTKlIWwdYWuF0GOD9Dh8HzuVHgfpLpHnjAbpEAfpdgIvlSSbTGMLG0ghSdOcdZldn2BSXYrE2CDdSUOmGZK1O+ERYBiGYRiGYRiGYRjGO40J1A1jN9KRRldCVCWeRNehev0L7cW00vitgxT/3knQVohPFJCYV0fqoAnYdXvBwg8hkCkbK+cirJ3Uk641YVcXYWcXUT6iVAzprQR4KERliIGoRI+WhAFUggqFII8flkd/4UArdDDck66rPenxY2Gk3mWbnvSx9S6jjxtLSw4otrCoMAun+pLuyfv5a/ZZrpr9EVqbpgIwvW0DE7fczPqG55mjZ/Ku7iWkN/fhtK0BPIQ1Ea3baJi/gYkHd2Mn4p70np4prHvlIPzIxZmwmd9sOYb2zokATJI9fNG6kZPk4yDgaXse91hHM+RnIKwG6VLheyGRrUgon2x5EEeF2FojtYqDdB1PpCPkqwTpNtoa07uuXXCSeKkkmcRwkJ5GkmJC1mVWfYKJtSmS3pgg3cvFQbqX3SmPAcMwDMMwDMMwDMMw3plMoG4Yu5BWGj1c41KJ0P6+tVD01ahSSOm5HkrPdqOGgvhES5CcX09qWTNWbu/oopZJGyvnIZydtwk+GhzE39KGGvQpF0MGgohiGBH5RQpBiR4h8UOB7wcUwwLloMDYdhfCkCgI8JVfrXcZXTiqgWibnnRge1PpGloqEzk4P4+MiheMCPkiPanf8uXJp7F65mkA1AwNsPS5X/Ni44OUa5p5b/+x1G2p4G56GZRGWJPRUSfZKS8x+fBOEnU+AIVCLa+sPYj+wQnUTFjP/X0HsWbtuwHIiBKXWL/mw9Y9OCJirTWNPzjH0ePXjwTpSsQLR0MnwtUhdZUhXFVBaj3Sk25riS0dsKxtg3TXIUo4I0E6QuELDy2TJFIpUokkjnCBFJZIMSHjMqvBY0JNiqTnjn67EjWQmQDuXlA3ZBiGYRiGYRiGYRjGPs8E6oaxk6mxAfo+uEz01WitCduLFJ/tpvJS/0g9jfAskgsaSC5pwsrsvF7yt0J41YWj7s7rxlaVCsGWLYQ9eYJiRL8fUYgUMihQrgzQI8BXgsAPKYcVCn6eSI2td4ninvQgQMsI4YQjPekj9S5jetJfNUgH6oMch+b3Z2JQH39F9CG9m/lu0wH8Yt4XUZaFHYYc+eQf6Uj8lo1NNkcWDmNKh4e7YRPCDxDWJBBDeLlXmHxEJ7lp8W8Y+L5Ha+tS2tpmk2to48WMxcPrzgHAIeRD9j1cbP03OVGiQzbwB/dYNoRT0eXhKpY4SA/cCJuIej9PIiojtcLSCkEcpFvSRlj2+CBdiNEg3barpykC4aJlimQ6TcpLYot42agl0kzMOsys82iuiSfS4+sTcaVLZgI4Zpu5YRiGYRiGYRiGYRg7jwnUDeMt0qGKw/NyuE/3oL8aHUSUX+yn9Gw3YVdp5HS7OUVyUQOJuXUIe+dNgL8VwpFxkJ7YeS9tWinCri78LZ1EBcVgJWIwjCAs45f76RWKvIYoVFQqAQU/TxBVtq13CStjetKrX6ouHNXVnvTq4Par1rskI5cDC/sxtzwFgUARkHB+w68bFNfO/V8MpeI6k4Oeewx36Be8PKGfhaV5zN3cTKK1DZkvgmxASIl0NjLp4C4a5vdXe9Ilmzfvz8YNi3ASBXrqS9yy5VRCbSPQnGQ9xnL7JiaLXgZFmtvdE3hG7Y8qW4BAowncCN8NkVJT6+dJhkUkCltrhNbYWiKFjbStcQtHtRCEjk2UcNFO9fqkIsRBWTUkU8NBusPwRPrErMOsOo/GmiQpzx0N0lMNcbWLvXf8loRhGIZhGIZhGIZhGG8vJlA3jB2gQxVXuAQKFcQfv90C9GFhX5nSsz2Un+9B+9VQ1xIk5taRXNSIM2EvWDRaJWyJzLpY6Z07IR/19+NvaiMa8EeC9CisEJUH6NEhQ1oQ+ZogDAmoMFQaHH04aI2OIqKggq8CsCOEGF04+vr1LqOhutSCBcUWFhdn4+r4ZVtaq3mm7u98ueXDrG+Ie9Jnbm5l3ks389T0F2ixW3hfxyLSG3qwe9YCaaQ1Fa030Liwj4nLurG8+La6u6azbt0ygsihVDfEf3W8i0IQLzFdar3MV62fsVC2UsHhfvdw/iIOIqg4UH1rILQjKl4IliIbFkmXC1jEE+lSaywtsYSzbZCOIHJtIs9BOTYIgZYRkbAJZS2pZJZMIokUNoIUUqSYnHVpqXNoyKVIJ6pBupCQaoyDdGvv+C0JwzAMwzAMwzAMwzDenkygbhiv4p0Ung/TSuOvH6D4TA/BxqGR02XOJbWwkcT8emRyL3rZkAIr6yLTDkKK1z//G6RKJfyNbYQ9eQqlkP4oIoxCVLmfvqjCABZRCIEfUgqLFIMirmOPPjxUSFQJ8HUl7kl3RqfMVXUqHRW9oZ706X4zBw/tT07Fb2BEcj2D2d/w5Snv48/TPg9A7dAA73r817ww4UE2TW3i+IF307CxhN32CkJLhD0DHbaRmfo8U47owKuJe++HhupZ98rBDAw2YdV18YfeQ2jbNAGAabKLL1vXc5x8Ei0Ej9sLud8+kqKfAjVm4WgiRNmKdFgiXcpj6WikJ11qiYWDZclxC0c1AuVYhK6Ddhy0JUCEhJZFJGpIJrLUJdNYwqkG6Umm5Fxm1Do0ZJOkkh5SCBAWpJvi/6y96HFpGIZhGIZhGIZhGLuYEILbb7+d97///Xv6UN5xTAJhGLwzw/OxVDGg9I8eSv/oQeWDkdPdlhzJRY2407Pjuq73OCGwMg4y6+7UIF2HIUF7B/7mHsqliP4gpBJF6MogA2GJfiEIIkHoh1SiMgU/TxgN96TboBQqDKj4FbQMEbbafr2LGtuTDqMfjZ5SF2Y4dGg+k4IGAEIxhEjcyv83aQ63zrqSqNqTfvyjd9Fv38E/WiyWFg5h2loHd9NmRBAirKmg87iZF5lyZMdIT3qlkmT9+gPp7JiFV9PDX50GnttyGAA1Is9/WL/iHOt+bKF40W7hT87R9Pr1Iz3pYxeOJpRPtjyIoyKkVtsJ0scvHFWWRZiIJ9K1ZYEIiSxBJHK4iRy1iTS2jIN0S6SZnHOYXg3S0wkPKQVIJ55GTzWC3DvqhgzDMAzDMAzDMAxjZ+nq6mL58uXceeeddHR0UFdXx5IlS1i+fDlHHXUUAG1tbdTV1e32Y2tpaeHiiy/m4osv3u23PexTn/oUq1ev5tlnn2X+/Pk8+eST25zn6aef5t///d957LHHaGpq4n/9r//FpZdeulNu3wTqxjvOuPC8+uc7KTwfprUmaCtQeqabytqB0SWjieqS0YUNWLm9rIdaCGTSxsq5O723PejpIWhtxx/y6QsiiqECf4hBP0+fFAQKwiDCD0MK/tC2PelRhF8qEooA4UbjgnQFKK2rYfrYMpdtg3RPOSzLz2VueRoSgSJEOr/nrokFvjvzIoaScRXL4U8/RlPHL/j77F7mV+ZxUGsTiQ3tyGIZZCPS8hBWKxMP7qLxgD6EhEhJNm9awMYNC7HcMmtTNqs6/hkAVwT8T+suPmndTlpU2CKbuNs7mtZwKrokGdeT7oU4RDT4Q3hRBVHtSbeUiIN0KUButXDUiifSI9dG2xaICGVHRCKD49aSSyRxLBeGg/Ssw4xal/psgkwyEQfplhsvGk3WmyDdMAzDMAzDMAzDeNs644wz8H2fG2+8kVmzZtHR0cF9991HT0/PyHkmTpy4B4/wrfN9H9d13/Tlzz//fB599FGefvrpbb42ODjIiSeeyPHHH8+Pf/xjnnnmGc4//3xqa2u58MIL38phAyZQN96mdKTRkYJQoUMdh+iReseG52MpP6LyYh/FZ7qJesojp9sTU6QWNeLNrt1rloyOJRM2Vo2LcKyder1RPo/fugW/txj3pEcKEeQpVIboERAgCMoRURRRDAqUg+L4h1AYEgY+QkSEdpmxg/xxvcsb70nfvzSDpYXZuDruAQ+tv/FC48N8ecaHWFc3DYBZm1o59Mn/5NE5L6BntHBy5wFk1/dg9a8HUkh7FipaT928HiYd0oWdjADo7p7GulcOwg88etKKO7uPJtQOAsWp1iN8wb6ZZtHPgMhym3cMz+p5qFK8IBSqPemJECEVNUGeVFBEorG0wtYCS9tYQoC1VU+6lITe2CBdoW2fSGSwnFpqEmlcO142KkWaCWmHmXUO9dkk2VQCS0qwE9UgvQ72pt+UMAzDMAzDMAzDMIydrL+/n1WrVrFy5UqOOeYYAGbMmMGhhx467nxbV748/PDDfOITn+CFF15g4cKFfOELX+D000/niSeeYOnSpaxcuZLjjjuOe++9l8suu4znnnuOpUuXcv311zNv3jwA1q5dy6c//WkeeeQRCoUC8+fP5+tf/zrHH388AMceeyytra1ccsklXHLJJUA8sPmlL32JFStWjJsUv/baa7n22mtZv349AOeddx79/f0ccsgh/PCHP8TzPNatW8fGjRv5zGc+w913342UkqOPPprvf//7tLS0vOr36Ac/+AEQT/JvL1C/5ZZb8H2fn//857iuywEHHMCTTz7Jd7/7XROoG+9sOhoNyxnzsQ5NaL41rTVhR5Hymj7KL/TGbywA2ILEfnUkFzbiNO89S0bHEq6FVeMhvZ0bpOsgoLKhjaCtjyE/YiCM0H6Jkj9AL5qKhjDQhEFU7UkvoNSYnnMVEfk+vorrXRwrO5L1jtS7bNOTPhqgj+1Jn+o3cUh+f2qiNAC+3MJQ7td8dfpJrJo02pN+8qpf8WLjQzwzv4EjB4+mubWE1bEOoS2kPQcdtZNsfJYpR7WTaqwAUCjU8MraQ+jvn0iQyfO7/GIGC1kADrFe4KvWz5knN1HG5V73SB6xlhJW3FftSc+Uh5BopFY4WmNpC1tI2HrhqJSETrxwdCRId3yUSCPsWrLJNK7lIkQKQYamlENLnUNjNkE2lcCxLXBS1SC9dqf+3RuGYRiGYRiGYRjvXFprSkG022836VhvqE43k8mQyWRYsWIFhx9+OJ73+u0Bg4ODnHrqqZx88snceuuttLa2vmolyxVXXMF3vvMdmpqauOiiizj//PNZvXo1APl8npNPPpmrr74az/O46aabOPXUU1mzZg3Tp0/ntttuY8mSJVx44YVccMEFO3T/Ae677z5yuRz33HMPAEEQcNJJJ3HEEUewatUqbNvmq1/9Ku9973t5+umn3/QE+1/+8hfe/e53j7v8SSedxDe/+U36+vreclWOCdSNvdrIZHmoq9Pmw/9VU0rjVWmtCbtLVF7qp/xSP2rIH/maVeuRXNRIYv86pLd3vgwIR2LlvJ2+BDWuuukk2NDJUDFgIIwIwwp+eYAeQkpaEoWaMFCUozLFcT3pVHvSfSrBcE+63k69i0JrjVav3ZNeE6Y5ND+fKX4jAIEoEiV/xU+mTeOW6Z8jknFP+vtW3UUU/JaH95csLRzE9Bcd3E1bEFGEsKcjtI/lPc/kwzupmzMYX1fgsqF1MW1t8yBRYhVTWNs9BYAWq52r5M95t/UsEZK/uotZaR1GyU+h/TgU10JT2V5POgpbga0FNjZsvXBUCELXJnIdsG201GAHKMsDq4m0l8VznGqQnqYu4TGz1qYx55FLJ/EcG+wkZCeaIN0wDMMwDMMwDMPY6UpBxILlf9rtt/vcVSeRcl8/47BtmxtuuIELLriAH//4xyxbtoxjjjmGc845h8WLF2/3MrfeeitCCH7605+SSCRYsGABmzdv3m7offXVV49Mvl9++eWccsoplMtlEokES5YsYcmSJSPn/cpXvsLtt9/OHXfcwSc/+Unq6+uxLItsNvumKmfS6TTXXXfdSNB98803o5TiuuuuG8kVrr/+empra1m5ciUnnnjiDt8GQHt7OzNnzhx32oQJE0a+ZgJ1Y5+jlQal4z+jrf9Uo183ofmbEvaWKb/UR+WlfqL+ysjpwpHxktEFDThTM3vXktExhCOxsi4y5ez06w57+/HXt1EcKNMXhvhRSFTupzvyKQpJGEIUhPhRQMHPb9uTHoQEQZlQBghnfJCugXBMT/prBemucjiwMId5pWlIJIqIyL2XP03u5jszPspQIu5JP/Kpx5j38q08uLCXmWo/TmltItHajiz7IBux7BqUfpmmJd1MWNqDdOJlp+1tc2ltXUqoJWvsDA/3HQoIamSey+UvONtaiSU0z9uzudc9kt6g7g30pGtsrXEUWNjxMlhpjQ/SneEg3UJbgB2gbQctm0m6ORKuixBJBBmynsvMOofmjEsunSDpuWB5cZCeqt/pf/eGYRiGYRiGYRiGsa8444wzOOWUU1i1ahWPPPIId911F9dccw3XXXcd55133jbnX7NmDYsXLyaRSIyctnVFzLCxofykSZMA6OzsZPr06eTzeb70pS9x55130tbWRhiGlEolNmzYsFPu16JFi8ZNjT/11FO8/PLLZLPZcecrl8usXbt2p9zmrmACdWOn0FG1J3q7IbkeDckjE5LvCuFAhcpL/VRe6iMc04uOJfBm5PD2q8ObkUM4e183+jDhWnGQvpMn0gGioQKVdVso9eYZDCOKYUBUGaIvLDEkJJGCMAiJwoh8WKASFMc/TMMQ3y8TUhkXpEMcpodolFKoaGxDut7qPxBaMK80jQMLc/B0/AOkZP+Dl5oe5CszzmVdzWhP+nv//J+s3u8F/rFoOv/U/S5y63uwBjcASWx7f8JoHZlprzDliE7cbABAf38zr6w9hEKxll4P7upfRoCDI0LOs/7ExdZ/kxYVNlkTuMd9FxvVFFQxDtJh+z3pAo3UGq8apEvBuJ50jUA5FqFro20bbQuwQ7AtlGwk4dSQcD2kTCDIkHZdWmpcJmQdsukE6YSLsD3IVIP0vfSNHsMwDMMwDMMwDOPtIelYPHfVSXvkdndEIpHghBNO4IQTTuDKK6/kYx/7GF/84he3G6jvCMcZHWAcHpIbrrj97Gc/yz333MO3v/1t5syZQzKZ5Mwzz8T3/e1e1zApJXqrvC8Igm3Ol06nx32ez+c56KCDuOWWW7Y5b1NT0xu7Q9sxceJEOjo6xp02/PnOWOZqAvV3kLiCotozLuLP44Jn4rBbM/q5HvO52urzMX9qNeZzY7eKhnwqL8d1LmFncfQLUuBOy5LYrxZ3Zg3S3bnd4zub8KpBemLnvxypYpnK+jbKXf30BxHFMEL7Q/QFBQaERGlBWAmJIk0xLFIK8qix/fsqIqz4+LoEdoQYE6WP9qTH9S5Kv/ZU+uRKI4fm96c2iqfPS7KL/tx/c83M41jVfBkQ96Sfffev2FjzIA8cXM+Bg0cx4ZkSVlcrAgvLmYeKurFzTzLjyA6yU+K/91I5zfp1y+jumkHg+fzRn09PKQfA8fbf+LJ1A1NEDwMiy2+8Y/kHc1FlG/RwT3ocpGtbb9uTrsDGxtoqSAfQlkXgOSjHinvS7RDhCJSsw7Pq4iDdSiBIk7ASTK91mJx1yKY9MskE0narE+kNJkg3DMMwDMMwDMMwdgshxBuqXtnbLFiwgBUrVmz3a/PmzePmm2+mUqmMdK4/9thjO3wbq1ev5rzzzuP0008H4sB7eKnoMNd1iaLxHfRNTU20t7ejtR4J6ccuKH01y5Yt45e//CXNzc3kcrkdPt5Xc8QRR3DFFVcQBMHIGwj33HMP8+bNe8t1L2AC9XcUNRQQ9pYJogJS7L2TysariwoBlbX9VF7qJ2grjH5BgDM1Q2JuHd6sml0STu9swrOwcu4u6XBXfoC/oYPy5h76g5BCGKKDAgNBngEg0oIwUEThq/ekR4GPH5XRVlD9YVCtNnmVnvQ4ht82SM+FaQ7Jz2Oa3wyAL8oUk7/lP2c0cvPUzxBJCycIeP/Ku8j038H9SwQLKss48QUHZ0sbQimEPQOJBPkPJh/WTeP8PoSEKLLYtOkANm08ACUVjzCJFwbiKff97I18Q/6UZfJlfBwe8A7nL9aBBBUXHQ33pKtqT7oa15Mu0Dha4ygLC7FtT7qUhK5D5NpoW4ITIZwQLbNYop6Ml8CyPQQZHCvJtJzN1JxDJuWRTSWwHTdeNppqBGleiwzDMAzDMAzDMAxjWE9PD2eddRbnn38+ixcvJpvN8vjjj3PNNddw2mmnbfcy5557LldccQUXXnghl19+ORs2bODb3/42wA5V/s6dO5fbbruNU089FSEEV1555cj0+rCWlhYeeughzjnnHDzPo7GxkWOPPZauri6uueYazjzzTP74xz9y1113vW5I/sEPfpBvfetbnHbaaVx11VVMnTqV1tZWbrvtNi699FKmTp263cu9/PLL5PN52tvbKZVKI+H9ggULcF2Xc889ly9/+cv8z//5P7nssst49tln+f73v8/3vve9N/y9eC17f+pmGO9wqhRSeWWA8kt9BJvzw8ktAM7kNN7cOhKza3ZJ5/iuIBM2Mufuksl5FSqCTZ2UNnYxWPEZCiN0kGfQz9MvIEIQBYowUAQqoOAPEYT+6LdUK1QQUglKaMtH2IxMpQ/3pEfb7UnXxJ+N7Um3WVKYw/zS9GpPuiLv/pmHpm7iu9PPZdCL+8GOfuJRDnvyF/zxoD6aps7lpA0NJDZ0Iv0AZAO2M4EwXEPdgi4mHtyFnYhvo7NzBuvXLaPip1gnM/w5P58ISb01wBfkzZwuV4OAJ5353O8ewZCfQVdeuyedak+6qyQ2FkhA2tsuHHVccATa0Qg3QosUUjaQdFNYtosUWWyZZHLWYlqtQzbhkk0ncB0vDtLTTSZINwzDMAzDMAzDMIztyGQyHHbYYXzve99j7dq1BEHAtGnTuOCCC/j85z+/3cvkcjl+97vf8W//9m8sXbqURYsWsXz5cs4999xxveqv57vf/S7nn38+Rx55JI2NjVx22WUMDg6OO89VV13Fxz/+cWbPnk2lUkFrzfz58/nRj37E1772Nb7yla9wxhln8NnPfpaf/OQnr3l7qVSKhx56iMsuu4wPfOADDA0NMWXKFN7znve8Zhj/sY99jAcffHDk8wMPPBCAdevW0dLSQk1NDXfffTf//u//zkEHHURjYyPLly/nwgsvfMPfi9ci9NYFN+9wg4OD1NTUMDAwsFN/1WBvEPSXad/URlNNvZlQ38upSkhl3SCVl/rxNw6OzWmxJ6RIzK3Fm1OLlXFf/Ur2MjJpI7O7JkjXkSZo76XU2s5gqcxQEKGCPIN+gX6h4yA9VESBIoq205OuNTqKCColQllGWMCYeheFJiLeE6DGBenxVwGyqRxDxX6EFuxXnsqB+bkkqj3pg/bLvNz0AF+feRbrsvEE+eyN6/mXu2/ikTlrGJg8jaWdLdS+0ossFIEEtjOXKGolPbGNKUd2kGyIF8wO5etYt/ZgBgYmMuDAn4YWU8TDEz4XWHfySWsFCRHQak3mT97RtKsJqPLYnvSw2pOuyY70pIPUioQScZC+nZ70yLUJHTteOOpqhKPA9pCigYSTxXZcpMggRIpJGYsZtQ6ZhEMunSThJeIQPdMMcu+uIDL2LkopOjs7aW5uRpo3YQxjpzHPLcPYNcxzyzB2DfPc2nFv52xrR5XLZdatW8fMmTN3KFh+O7jlllv46Ec/ysDAAMlkck8fzl5vRx4rZkLdMPYCOlIEHUX8jUP4G4biTvQxb3XZjYl4En1OLVaNt+cOdEcJgUzaWFkHsYPLN94IrTRh1wDl1nYGhooMBSHRmCBdCUEYaqIwIooUpZGe9DFXEoX4foWQEsJRCMZ0hKNHJtKVGrteFLZX7zLRr+fQofnUR/H0eUH20VV7Bz+YeRgPNX4agLrBAT70h1/Sbz/Ebe+u5cDBw1nyRBm7dxMgsZz5aDWETPyNqYd3UjtrCAA/8NiwfgltbXMJbc0DwWw2l+sRaE52HuGL8iYmiH56RQ2/SxzJ88yOe9JVdcGIjCiP9KQXyZTzSDSCeOGoo+04crctQIxMpUe2Reg6aNtCuyDcCOE4SNGIK2txXAcpM0iRpjll01LrkEnY5NJJUslqkJ5uBsv8uDEMwzAMwzAMwzCMXeWmm25i1qxZTJkyhaeeeorLLruMs88+24Tpu8A+k3BcffXV3HnnnTz55JO4rkt/f/92z3fDDTfw3e9+lxdffJFcLsdZZ53FD3/4w917sIbxOrTWRH2VkQA92JJHB+Pnnq06L+5En1uLXbePvYs6HKTnXIS98ycItNJEfQXKre0M9g8yEEREwRCDlSL9QqGEIAo1YRihIk0pLFIMiig1ZmmGUoSVCr4uVBeOWsDwRHa1J12pkSWlr7VwNBsmObxzP6YU6wHwhU9P6h7+uyXJf07+N1S1J/3M+//A9A13cOcRmhl6KSc9Z+O0dyK0RtgzsEih9PM0H9hJ85JepK1RStDeth+trUsIIoen9QSezM9AI1jovMI3xHUslOsp43KvdyR/tZcSVBx0ONqTHnghvqPwVECuPFDtSQdHC1wl43ttCRDWaL2LZRG4Nsq2wRVoVyFciSXqsUQdruNh2WkEGRqTNjPqHGoScU96OplAZpriehdr36giMgzDMAzDMAzDMIx9WXt7O8uXL6e9vZ1JkyZx1llncfXVV+/pw3pb2mcCdd/3OeusszjiiCP42c9+tt3zfPe73+U73/kO3/rWtzjssMMoFArbbKI1jD0lKgQEm+IA3d+URxWCcV8XCQt3WnbkPyu779S5jBACmbaxMrswSB8sU9nQwUB3L4NhROhvFaRHmjCI0JGmHFUoBHmisQtHtSLyA/yohLYq1VqTeHp+tCd9/MLR6gUZ7UqPucpmcWE280szsKo96d3e33l46jq+P/1shtwMAO/++6P886pbufOQXjYfPYd3b2ggtaEbEYYg6nGc6QThC2RmdzD5sE7cTHy8vX0TWbf2YArFWtpEiodK8yjj0Gz38kVxEyfLv6KF4HFnIQ+6h5EP0ujCaE965IaUvQgLRb0/RCIqA+Boiauq93rrnnQp455024570l2N8MCWaSQNuE4Sy04hRZas6zCz1qUhY5NKuGRTSazhIN3eBx+/hmEYhmEYhmEYhrGPuvTSS7n00kv39GG8I+wzgfqXv/xlIJ5A356+vj6+8IUv8Lvf/Y73vOc9I6cvXrx4dxyeYWxDBxH+lkI8hb5xiKinPP4MlsCZnB4J0O3G5A5tXt6rCIFMO3G1i7WLgvSCj7+pi4GOHgZ9n8DPM1ApMFAN0pWCwA/RCipRmUJQIAyDsVcSLxwNi3GQbsvqVHpMjal30dvtSR8tfJFaMK80nSWF2SM96f3uFp5vuo/vzjyVdenjAJizcT0fveMmnpm2hl+/dzJLOw+n7tE+ZKkdRALHXUQYbcau+QszjuogM7EEQKGUpfWVZfT0TKMoJfdX9qdbZ0jIMp+2b+fj4vd4IuQVaxp3e++iUzWiihboak2LFVFJhGhLkQ2LZPx8tSddklDVF/6te9KFIHRsIseKe9I9jXDBcjxs3YhtpbHdJFLk8CyXllqbiVmXpBfXuzjZJshOBHsfqiQyDMMwDMMwDMMwDMPYQftMoP567rnnHpRSbN68mfnz5zM0NMSRRx7Jd77zHaZNm/aql6tUKlQqlZHPhzfXxlUP6tUutk9S1albpd9e92tvEfd5lwg25gk2DRG0FUGN3/lrNSZwp2VxpmVwJqXHTXFrNPvcjmBLYqUcZNpBWCKOnHfi80ZrjSoEBB39DLR1MlAqE/gFBoM8/QwH6ZrIj6tZAuVT8PMEoT/ada41KgzxgxLKKiMcjdCjQbquLhzVr7FwdORPDdMrEzi4sB+5KA3AoDXAxto/cd3MJaxq+AQAdQP9nP+7XyIqD/HL43LsXzqUY58oY/W3ARLLPQCUj7YeY+oRndTPG0AICCObTRsWsmnTAkIkjwYzeDFqRqB5v/cQV3ILDWKIblnL7d67eEm0EFUsiEbrXfxEQGBrEsqnpjSIpRUCC1eBN/xNsSQIiRBizMJRCyyB9kB4Gtt1sVQtlshhuwksK4ctEkzOSqbVuiQdm2wmSSLbANlJKKfayfY2e9009iylqj+3zOPKMHYq89wyjF3DPLcMY9cwz60dZ75XhrFrvW0C9VdeeQWlFF/72tf4/ve/T01NDV/4whc44YQTePrpp3Hd7dcPfP3rXx+Zfh+rq6uLcrm8nUvsu8K8z0BxCNAjU6nGW6A09AfQ7UN7BdrLCH98IK7TFkz0YFICJnqECYu4zCOAQv8eOOidQzgSmbAQtoUoC9jJTxWtNLoSEg2WKPb2ky9XCMIKpaBEAYVGoDSoSKEiTURERZcJlI+0BJ4VT0mrSBGFFYQbkUw4wPjpaUX8BoDS43bAMhqkj55aV0mzuHcGjZV4Q3pZ+rRlV3HbdIdfTjxvpCf9rPv+wLJnf8ttx0Bz7jBOfNFCbGkDDcKagS3rCMNnaFzYycSDurHc+LbaO2bSum4ZFT/Jy6qBx/wZ+NgsS7zIN9RP2U9spiwSrMycxFPegRQKEVGxWmUjwE5biHSCFJpUWMJRAtxmbA22rrbDCwFSIqguKrUkkW0hpMRyNMIVSEsiRBKLDNJxsKwUQiSo8yRNaQvPsdDCRjkZBu0GBsMk9A0BQzvxEWAYMaUUAwMDaK2R0vzcMoydxTy3DGPXMM8tw9g1zHNrxw0NmX+fGcautEcD9csvv5xvfvObr3me559/nv333/91r0spRRAE/OAHP+DEE08E4Be/+AUTJ07kgQce4KSTTtru5T73uc/x6U9/euTzwcFBpk2bRlNTE7lcbgfuzd4v8MqoUkhjTR3SBOo7REeaqLdM2FUk7CwRdpUIe8oQjY9hhStxpmRwpmVwp2WRNe6+W+OyteF+9JSDcKzXP/+boJVG5QPC/iL5zkHyAwNUKkXKwVA8kU5c7aJCTRQqIhVSCApUwhJjh/t1GBIEZUJRREjF2Je6sT3pSumtf4mAOEwffTc/EyVZlp/LrMpkAEIiNif/xoPTO7lu6vsp2vFk9rv//ij/8qdbuGdpL7efMoulrY2knuxGRApELa67H0G4huSkZ5l8RCeJWh+A/sFG1r9yEEODzfTgsaoyl36dZLLbyVX6Bo7nSSIpedRdwkPuIZT8FGqoDNVQPLID/ESIlpAdLGAHRQIgqta7AIRb17tISeg5RMg4aU+AtCW2TCGiBoSTBDsFIkMuYdFS51DjxT3pmVwNVs0USNbuhL9xw3htSimEEDQ1NZl/PBnGTmSeW4axa5jnlmHsGua5teMSicSePgTDeFvbo4H6Zz7zGc4777zXPM+sWbPe0HVNmjQJgAULFoyc1tTURGNjIxs2bHjVy3meh+dt2/krpXzbvVDLasWDFNIE6q9BR5qwt1QNzosEnSXCntI24TnEAbrdnMKdHAfo9oQUQr5NAvQq4Uhk2kGmnF1233SoiPIBYV+ega4eBgcGKFeKDPmjQbrWkihQhKFC6YhiUKQcFMYF4joKCfwKocgjLF3tSB99mYt70lU8Aa+3V+8yfuHoouIsFhRnYGGh0Wx2X+Lvk5/h/854Hx2JRgDmr3uJC2+/mXWNL3H9aRNY2H0osx/pR1Y6QXg43iKiqAuRXMXMIzvITS8AUKok2bh+KR0ds6kIycP+LFpVHRmryOet/+Sj4m4cGfGi3cK93lF0q/q4J11Vp8tlhJ/wCW1BOqqQKQ1V610kngJ3+B0G2wJEXO8iGF04amtIaYRr4VgJLF2HEGnsRAYpM2Qchxm1Dk1pB8+1yWUzuPXTINUQT7obxm4ihHhb/kw2jD3NPLcMY9cwzy3D2DXMc2vHmO+TYexaezRQb2pqoqmpaadc11FHHQXAmjVrmDp1KgC9vb10d3czY8aMnXIbxtvPmwnPnaYUdnMSuymF9XaaQB9LCGTCQmYcpLfrXiaUH1Un0gv0d/Uw0D9AxR9iICgyNBKkC6JQEQYKpRWlsEgpKKDGJOlaRQSVMqEoIKwIgc3wBDfEU+nhG1w4KrRgXmkaSwtzRhaOdjodPNu0mp/PPJoXMucBMKm7gwtv/wVe4a/817FZ5tpH8+4n+rGGOgGB9BYilSTSjzHx4E6aFvYiLIiUZMvm/dm4YRFB5PB0OJlnwkkgNOck7+Nz6r+oEUU6ZT33JN7FK2I6qmKhw9Ge9NALqDgaV0c0lgdwVYhA4mgLR+l41aoUIK2RnvRwTE86SQ0JC9dykdQgyGG7KSyrhoTtMq3GYnLWw7EluUyKZP1UyDSD3DW/mWAYhmEYhmEYhmEYhrGv2Gc61Dds2EBvby8bNmwgiiKefPJJAObMmUMmk2G//fbjtNNO43//7//NT37yE3K5HJ/73OfYf//9Oe644/bswRt7BR0pwt5yXNfS+QbC86YUTvM7IDwfSwqsTHUa3d5172irckiUDwiGSvR3djPY30+pMshAWCJfPY9GxBPpQbyAphyWKAQFlIrGXFFEUKkQiiLYAULbgDPyZY0mqgbp2y4cHQ7RRxeOTvObOTg/j5rqwtEBa4jn6/7ML2fOYlX9RwDIFvJ86A+3sfT5e/jVsTZ23WIOX2Pjdm+Or8eehmNNIQieonZuG5MO7cRJxcfc1TON1leWUSrl2KSyPBLMJK89jkg+zdei65mpOyjIJH/wjuXv9gIi30b7EhDxfXHiehcB1AV5kmEJkNjawlUaGx2/j2DZI49VZVkEnoOWAhIaUhLHtrHIgs5hO2ksK4djp5iSlkytdfBsi0wqSaZhMiI3CazR76lhGIZhGIZhGIZhGHueEILbb7+d97///Xv6UN5x9plAffny5dx4440jnx944IEAPPDAAxx77LEA3HTTTVxyySWccsopSCk55phj+OMf/4jjmDDonUIHimigQjRYIer3Ccd8rPL+1psngbHheRK7OfXOCc/HEK6FlXEQSXuX3W+tNboUB+l+vkxfVxdDfb0UykMMRBVKYvh8xP3oYVzNUlYVin6eMApHr0wpwsAn0HmwfMAB/UaDdNi63qUhyHFIfn8mBvUAlESFF3KPcVeLze0TzkQLiRMEnL7yT5z64AruPLTCLWfMYuG6WpIv9CKURshabPcAwuBl3Nr7mXlUB6mmeFvrULGW1rXL6OubwhAOf/FnskXV0OJt5sf8nHfp5wml5GF3GX92D6IcJlAFC/RwKB7iJ3wiS5IJy6T9PBKQWLgKHK3jeXx7Oz3pUoKrIC2xXBdXJNGqFmmlcZwcUqaZkJK01DokXZtkwiVXPwGrdio4pnfPMAzDMAzDMAzDMHa3rq4uli9fzp133klHRwd1dXUsWbKE5cuXj7R0tLW1UVdXt9uPraWlhYsvvpiLL754t9/2sE996lOsXr2aZ599lvnz548MXg8rl8tcdNFF/O1vf+P555/nfe97HytWrNhpt7/PBOo33HADN9xww2ueJ5fL8bOf/Yyf/exnu+egjD1CVaI4NB+oEA344z5WheA1LzsuPG9KYTe/88LzEUIgU3bcj+7uuioPrTSqGKDyAZVimd7ObvJ9XQxV8gwoHx8BYjRIDwMFWlNRFQpBgSgMRt8HUYoo8Al0ASUrCGlDtZYF4iBdaY16g0F6OkqwLD+X2ZUpQLxw9KX086yc3sktU06ibMWB8j899jAf+f1/8cSsbn78L1OZ3zGZQ/7Shwh7ABcruRQdDoK1kulHdlI3dxAAP3TZ2LqIti37E2jJE8E0no+ayTl5vuJexwf1A0ihed6ezf2JI+lVtURjetK1jAg8n8ABLwqpLw1i6wiBxNUSW6m43sUSIKr1LkKM6UlXkAIr4eIID0EtkMbxarBklrqEZFadSy5h4zgWNXVNuA3TwU3vxEeAYRiGYRiGYRiGYRg74owzzsD3fW688UZmzZpFR0cH9913Hz09PSPnmThx4h48wrfO931c1339M76K888/n0cffZSnn356m69FUUQymeRTn/oUv/nNb97KYW7XPhOoG+8cI5PMAz7RYIWwf3xwrsvRa15eeBZWjYtV41X/G/1YpnbdBPa+QtjVJaPpXbdkFOJ+elXwifIB5VKFnq5uCj0dDPp5BnRIhAAESmlUqAnDOEgvqwrFrYN0rYiCgCAqoOwyAguh3ZHfONBotI4Xjr6RIN1RVnXhaAt2HEmzLrGe1ZPXcPOMf6LbPQKARS+/wEW/uZkh7xV+9j/qmFY6mMMfzyMr3YBEJBZjaY/I/xvNS9ppXtqD5cQLT7e07cfG1sUEQZKXowb+FkwjlJoPp+/i0vC/SVGhzWrinsS7aJVTUOUxPeloIq9C4CoEmrrKEImogkBiawdHKWwU8Zi6vW1PugSSGpl0cGwXmyyRymI5OWy7lrRjMbPWpiHt4tiSbK6GVFMLJGt3/gPBMAzDMAzDMAzDMIw3rL+/n1WrVrFy5UqOOeYYAGbMmMGhhx467nxbV748/PDDfOITn+CFF15g4cKFfOELX+D000/niSeeYOnSpaxcuZLjjjuOe++9l8suu4znnnuOpUuXcv311zNv3jwA1q5dy6c//WkeeeQRCoUC8+fP5+tf/zrHH388AMceeyytra1ccsklXHLJJUCc433pS19ixYoV4ybFr732Wq699lrWr18PwHnnnUd/fz+HHHIIP/zhD/E8j3Xr1rFx40Y+85nPcPfddyOl5Oijj+b73/8+LS0tr/o9+sEPfgDEk/zbC9TT6TT/5//8HwBWr15Nf3//Dv0dvB4TqBu7hQ4VqhiiSmE8rVwa/rj6ZylAj3wcbreaZSyZsrFy1bC81os/ro2Dc5kwD+ttSIFM2PFE+i7+/uhAEeV9VDGkWK7Q19XFYPeWeNGoVugxQXoU6rjapTqRvv0gPSRQ+Xgi3RZxkD78ZTQaiJSKg/ltjmZ8kC60YL/SVJYW5pDUHgDtTjePTHyC/5pxEC+nzwRgakcbH7/9Vqa0Pc6vj0uTyCzl4OcDrHxvfEXuLBw5mcB/kszMLUw+rBM3G/92RE//RFpfWUYh30CPSvJI0EKXznBs+nGuDm9gStTLkExxh/cenrL3R/nWuJ505QQEXkAkJdmgSDooIJEIHDyl4wl1AVij9S6jPemApxEZG9d2sUiiVQ3YWTy3Ds92mZ6TTKrxcKQgnc6QmTATmW6Ad/gbTYZhGIZhGIZhGMY7hNYQFHf/7TqpN/Rv70wmQyaTYcWKFRx++OF4nve6lxkcHOTUU0/l5JNP5tZbb6W1tfVVK1muuOIKvvOd79DU1MRFF13E+eefz+rVqwHI5/OcfPLJXH311Xiex0033cSpp57KmjVrmD59OrfddhtLlizhwgsv5IILLtihuw9w3333kcvluOeeewAIgoCTTjqJI444glWrVmHbNl/96ld573vfy9NPP/2WJth3JZM8GjtERwodKnSg0KFGBxG6Eo0Px4txQK5KIbr6uQ62jTpfj8w420yYD3+8KytK3jaEQCaseMFowtrlk/nKj1BDPqoUMlSu0NfdxWBXHKQXRg8qDtIDRRTFU+WVqEwxKIzvSNcKFUQEUYHIKiEsgdDOuDdaFPp1gvThpaPxHy2ViRxYmDtm4WieRxueZMXMKfy19gMA1AwN8pE7f8O7/3Yftx8l+fPhC9j/RRf3hbjCBbsZy52PqryIU3sPLUd0kJ5YAqBQzrBx3VK6ulqoaJvHw2m8HDUyN7WeH6tvclC0lkBYrHIPZrW7DD/ytulJD70KoS1IRCHZ0iCWBomNowW2iqr1LhKEjKfSpSR0HSJbgKMQaRvbdXBkAh1lQdbgejU4dprmtKSlxsFzLJKJBNkJM7BzE0HuuuWzhmEYhmEYhmEYhrHXCYrwtcm7/3Y/v+UNVazats0NN9zABRdcwI9//GOWLVvGMcccwznnnMPixYu3e5lbb70VIQQ//elPSSQSLFiwgM2bN2839L766qtHJt8vv/xyTjnlFMrlMolEgiVLlrBkyZKR837lK1/h9ttv54477uCTn/wk9fX1WJZFNpt9U5Uz6XSa6667biQov/nmm1FKcd11143kVtdffz21tbWsXLmSE088cYdvY3cwgfo7RNBRoLxuADoLlByNCHU1FFejf479uPonW319O8nlGyernd1JG5lyqn/aI3+KZPXjZPw1YZmJ2R02HKInbUTC3qWVLjCmnqcQoCoRg+UKvR3tDHS3MRCVqYw5r1KawI/QKr5cOSxRCovbBOnxRHoRJYsIWyK0PRI6QzVI19UgfZvfZNg2SJ/qN7GsMJf6MAdAWfg8Xvscf5ohuGvCPwPgBD5n3XcXZ9/zWx5cVOFHH5zB/q11THpkAEEFLTLIzIGIcgeWvIepx3ZRNycO2YPIYdPGBWzZNJ9IOTwfNvNkOIWcO8g3Ez/irHA1QsCz9lzuTxzJgM4SlSyIqvUuQsX1Lo5Cak19eQBXBUgsLC1xtMLWW9W7CEHg2kS2BbZCpAQymcQTDkJniKIcrluLZeeoTwhm1rpkEzaObZNrnopXPw0s8/JvGIZhGIZhGIZhGHujM844g1NOOYVVq1bxyCOPcNddd3HNNddw3XXXcd55521z/jVr1rB48WISicTIaVtXxAwbG8pPmjQJgM7OTqZPn04+n+dLX/oSd955J21tbYRhSKlUYsOGDTvlfi1atGjc1PlTTz3Fyy+/TDabHXe+crnM2rVrd8pt7gomUXmHKPytk/xDmxBAgb63foUChCPjwNO14mB8OCQfE5SLVDUgT9nx+U2txM4nBMKzRr73uzpEh2qtSzFAFQKU0vSXy/S2bWagt4OByGdMRB4vGg0VWoHSinJYohgUUWpMF75SRGFAoKvVLpasTqSP3heNJnzVIH04RB99x2eiX8+BhblMCOKN174IeSrzEiun97Ni0jFUrPhXpk545CH+5x2/orWplx/+ywSm909h2V8HEWoAcCC3DLsSosurmHBgJ02LepF23JO+uX0um1sX4/sp2lWWR4LplKXko9k7uMT/LYkoYJM9gXu8o9kkJ6IqFjqIK280GuX6BG6AlpKsXyQZFpFILBzsar2LFIAd17toBJFjEbg2SI1IamTSxbE9bBJEUQ3CqcWza8i6NjNrberTLrYlyNY1k54wC5zE1t88wzAMwzAMwzAMw3jncFLxtPieuN0dkEgkOOGEEzjhhBO48sor+djHPsYXv/jF7QbqO3QYjjPy8XBOp1Scp3z2s5/lnnvu4dvf/jZz5swhmUxy5pln4vv+a16nlBKtx4c1QRBsc750evyEfj6f56CDDuKWW27Z5rxNTU1v7A7tASZQf4ewGxM4UzP4UYCX9BCOFYfhthwNxrf+s/oxtqieX4x+zTI1EXvaaIju7JZpfq30SAe+rkRUlKa/UKCvfTMD/V0M6QDF6HGEoYr70atBeiksUdoqSNdKEQU+oc6jrApCWHGQzvggPdKKaLtBOmzdk94Q5FiW348pQWN8HEQ8k17PQ1PbuWPKkQw48aT6gWv+wUW/uRm3sp5bT8iRtpaw5JkSIuiPbz+9GFvVEOYfp3beFiYe0oWTjI+9s28Km15ZSqFQz5B2eTyYxgZVw0k1f+Gqys00B4MMyAx3JY7lWWs/dGChinLkfik7iOtdLEkqDMiUh7AQSBxszfbrXSyLwHVQFkhPIdIOtuPhCpcwyqJkHW5yfE+6LQWpTA3ZSbOxkjVv+TFgGIZhGIZhGIZhGPs8Id5Q9creZsGCBaxYsWK7X5s3bx4333wzlUplpHP9scce2+HbWL16Needdx6nn346EAfew0tFh7muSxRF405ramqivb0drfVISD92QemrWbZsGb/85S9pbm4ml8vt8PHuKSZQf4fIHDoJb7862je1kaupRwoTiO+LhDtmEt3ePX+Hyo/iRbLFEKU0+TCit7ebvq428vl+SiPZt4gXhI4L0iOKYYlyUBx5txNAq4jQrxCJItqqgLaqy0bffJBeG2Y4MD+XGf6E6lcV/0huYOW0Lfx+yqH0uEsBmLFlEx+//Vbmv/IEt7/LY2DSQuasUVilofiKkrOw5ExU+SmSkx9m8uEdJOvjd2IHCrVsWreU3t6pBNriqXAyz0cTWJhdw/8XfZNFlY342Kz0DuMvzlKCyEUVLVDVIF1GqESZ0AZLaRrKfThKIbGwtcTWEbbWIAVIa6QnPaj2pAsnQqYsHC+NLR20ShHqWhy3AddJMSElmV5rk3BsXC9JbtJM3JoJb/kxYBiGYRiGYRiGYRjG7tHT08NZZ53F+eefz+LFi8lmszz++ONcc801nHbaadu9zLnnnssVV1zBhRdeyOWXX86GDRv49re/DbBDbRFz587ltttu49RTT0UIwZVXXjkuzwFoaWnhoYce4pxzzsHzPBobGzn22GPp6urimmuu4cwzz+SPf/wjd9111+uG5B/84Af51re+xWmnncZVV13F1KlTaW1t5bbbbuPSSy9l6tSp273cyy+/TD6fp729nVKpNBLeL1iwYKRS5rnnnsP3fXp7exkaGho5z9KlS9/w9+PVmEDdMPZywpGjtTm7KUTXSo+E6NqP8LWmv1Khu2Mzg70d5INKPI1efU3WekyQrkGpiGJYpByWxr3wqigkDCooWUTbFdA2qPHbqjUapRXhGwzSs2GSpYU5zKpMRiBQaF5MbOb+KZv4w7SltHuLAJjc1cFHfv/fHPO31dxzkMVP/2UOc9YmmPBkvFRUO02I5GJkaR1O5k4mH9NJblq8TrUcJNi4fhEd7fuhlOTFqIknwilMSHXwf6xrODF4GoCnnP15wDucIZ1BlSz0Vj3pkR2ihSTr50mGlWq9i42lFbYKx9e7CEHg2ESOhbAVVgpkIoVruQjtEUW1WE49jlPtSa9zyXo20rLJNU8n1TjNLBw1DMMwDMMwDMMwjH1MJpPhsMMO43vf+x5r164lCAKmTZvGBRdcwOc///ntXiaXy/G73/2Of/u3f2Pp0qUsWrSI5cuXc+65547rVX893/3udzn//PM58sgjaWxs5LLLLmNwcHDcea666io+/vGPM3v2bCqVClpr5s+fz49+9CO+9rWv8ZWvfIUzzjiDz372s/zkJz95zdtLpVI89NBDXHbZZXzgAx9gaGiIKVOm8J73vOc1w/iPfexjPPjggyOfH3jggQCsW7eOlpYWAE4++WRaW1u3Oc/W1TRvhtA741reRgYHB6mpqWFgYGCf+lWDNyLoL9O+qY0mM6G+14tD9OokumPttttVfhT3ohdDtI6n0XuG+ujp2sLQQB/+Vi8XSmlUqAnDOOCOVEgpLFEOC4x9A1OFIWFURokCWgZxkK7Hv5+n0YRKofQbC9JTkceSwmzmlqciiR/Pa9127p66kbunzmdjMl6s0dTXw4f+cBv//PCDPLK/4pGDpzC9vZ5MRxyWa5lG1xyCU+hHWH9n4sEdNOzfj5AQKcmGzQto37iAMPRoi7L8NZyO5Zb5ZPK/+XDpQaTQrLem8Jfa9/Kyn0RVJNqP612Ge9Ij1ycSklRUJuPnR4J0qTXOcL2LbREvJ5AoxyJ0bbStsTwFSQ/PTiCFQxRlEVYjjlNL1rVoqbVpSLtIKcjUTyQzcRbSdjGMtwOlFJ2dnTQ3NyPNG0SGsdOY55Zh7BrmuWUYu4Z5bu24t3O2taPK5TLr1q1j5syZOxQsvx3ccsstfPSjH2VgYIBkMrmnD2evtyOPFTOhbhh7A0siPQuZsBCetVs76kem0QsBOlAEWjPo+7T3tNPf206hWNrmMmMXjQKEKqQYFvGD4rgwPA7SSyhZQFthdSJ9/IvScJAeKc32390bH6R7ymFRYRbzS9Ox4iiajW4Xd03ewL1TZ/NK+p8AqB3s54N//C3/Y9V9PDct5P89ZwLNQxOZ/3QeoQtobKK6g/FKNmpoNQ0L25hwYA+WG9/W5q6ZbFm3hHI5y6DyeCycRo90+VDdH7i4cAfJckiXVcd93pG8ZLXgBRmifGVkkaqyg3gqXYKjNLWVPhytsXCQWmy/3mW4J93WWG4ESQfHy+AIm0iliHQjjldH0vWYlpVMysU96V6mlprJc7CT47diG4ZhGIZhGIZhGIbxznDTTTcxa9YspkyZwlNPPcVll13G2WefbcL0XcAE6oaxJwiB9CxEwkJ6drz8dTdTlRBVCFGlELSmECk68wN097Yz1NdDGIbjzq+VJor0SK0LWlPRFcpBmSAsjwbpWqGCiFAVUHYJbUWvGaSH2x9HZ+sg3VE2BxRbOKDUglOdbm93evn9pI3cP20qL2aOBSBTzHPO3b/nAyv/yOa6Cj89rZFMNIX9ni8iVNyTHuUW4UQTkAOPkZ25gcmHdeJm4/vbPdjM5leWMjg4Ab/ak/6SruOUulV8ofRLGooF8jLFnd67eNJZQBRZqKJFUfmAQMuIyKug7AjQ1PhFElGAwMJCYGk9pt7FHtOTbhPZEsuLsFwLO5nBlS5Ku4RRPbbTiOemmJASTK9xSLg2lpukZtJsErV77+ZrwzAMwzAMwzAMwzB2vfb2dpYvX057ezuTJk3irLPO4uqrr97Th/W2ZAJ1w9hNhDtmAt21dmgpxM6iIxUvFy0E6FARaugvl2gb7Ka/r4tSIQ/R+GUTUaRQYRymAyitKEclykGJSIXoMUF6FASEuoi2imihQTvxf2MorQi1JnqDQbqlJfOLM1hYnElCx1Um3fYAd07cyANTG3m25l0AJCslzrz3D5x93x8YTBS55YQahLcfLevKiCgf35fsLCy5H07hHyQaHmXKCR2kJ5QByJezbFi3hJ6uFpQWvBg18WQ4iUPqn+au4OvMLnThY/OQewh/8Q7EV27ckx5W3wwRELlllBOghCAVlkkFJSwsLGyE1jgqHKl32bonXToRlqewEylsx0NgEUY1SGsCiWSWhoRgRp1LLmEjLJtM0wwyzdP2yOPIMAzDMAzDMAzDMIy9y6WXXsqll166pw/jHcEE6oaxiwhbxhPoroVI2Ai5Z4JPHSpUOZ5E174CrSmGEZ3FAdr7u8kP9qJKZcb2rYwsGY1Ga10CFVIJi5TD8rhFo1opVOgT6AJYJbQW1SB9/NT9jgbpUgv2K01jcXEWqep0e7+V5w/NG7l/Wo4n644AwA183r/ybv6fu+9A6yFWvCtNsfYApqwNEFERgCg9DZ1YgDe0Ccu7g0nHdlI3O55W90OH1o2L6Nw8D6VstkQ5/hpOY2puIzfIr3J4cS0Kwd+dBTzkHcYQaVRZooMxPelOQLY2RV8lwA0DMkEBRwskDkKDM1zvYgkQ8ZspkWMTujaiWu9ieS6Ol0IKSaQyKNGM49WSS9i01Iz2pCfrJpGbOAvLGf9GhWEYhmEYhmEYhmEYhrHrmUDdMHYWWa1x8SxkwkbYe25Zig4VqjQcokcABFrTXy7Slu+jd6AXv5iHsj/uckppojCudYF483FFVSgHJYKogt6qHz2KKihRRFsVtBKg3XFBukajlY6D9Ffdf7ztRPqc8hQWFmaSVSkAhmSRPzZt4t7pCf5WfygAdhRyyp/v51/vWkGq3MddhybonLQ/09Yq6jvjqXOVmkiQXkRqsAcKf2TCsk4aF/YhLY3Sgg1t82hvXUgQJBlQCR4LpyESeZbX/JjT848jgBftFu73jqBLNqB9iarEQTqM9qRrqREyRU15CE9F1XKXuN7FUhGWBCx7pCfddx20A9KJEAkL18thSRulPYKoEcdpJJXwmJqVTMq5OFJip+upmTIHL5l+cw8KwzAMwzAMwzAMwzAM4y0zgbphvEnClghHxvUtnhV/vAfrN3QQoUoRqhQvFwUINfSWh+goDNJXHKJczEOxDGP60TXVafQxS0aViihGZSpBCaXC0eF1pYjCAKVLRLJcXTQqIfIYDpnj64wn0SOteNWB9G060i3mlaZzQKmFpPIAKMoy9zZs4k/Tbf7acCBaSKSKOPGRVXzkzt/QMNDNvQe6rJs1l2mvCGasCeJrTjRSyS0lMziE3X8fjYs6aF7SO7JwtK13GlvWLaFYqKNS7UnvsF3Ob7ydjw/ei53XbJFN3Jc4ivXWVHQgUEVrdOGojFBeBW1HaA2poETO9ygrgcRGaLBViC0YrXcZ7kl3JJarkI7A9tI4jofGIozqsewJpBNJJmYk02tcEo6F9DJkJ8wkVdtg6l0MwzAMwzAMwzAMwzD2MBOoG8YbMBKeOxbCrf5p7flwU/kRengSvTpVHipNb2mIjuIAPaU8fqUEpQpUKuNqXZTSqFATVi+H1vg6oBQWCcIKakwSrqKQKPRHp9G1ri4a3TZID5UmUopXzdG3CtITymV+cQbzS9Nxq33reVniodrN3DXD4tGmxShhAXDs4w/z0d//N1M72vjzQpvn3jOTSa0uLWviNwiUV0O57kCyAwqrdxX187cw4cAe7GQ8pd811ET7+kX0901GacGaqJkXqOO0xvv5j/wKsoM+/SLLA4nD+Ye9HyqSqIIFKr6PWqh4It0O0QK8sEw6qGAjsbCQiLgnXWuEJUFIkDLuSXetuNrFibBdD8dNxdUvKocQE0kkctQnJTPqXGoSNlguqabpZBsnY1nWm3uAGIZhGIZhGIZhGIZhGDuVCdQNYyt7a3g+TFWiOEAvj4bokdJ0FgbpLA3QVy7gBxUol+MgfUwwrgEVKsKx0+ha4UdlimGRKNp6yWiEoogSpThEVgKUDXp8wBsH6Yrw1cfR2TpIz0RJDii2MLc0FTte1Um/lefehjYemOLwt8ZFhDJ+iTr86cf52B2/ZvbmDfx9tuSPR02jqS3F9BdDIEQ5aUoNB5EbtJGdf6Vmv41MPKgbNxMH7X2FOja3Lqavexog2BTV8EQ0icOaHucP5V8xZWCAEh73ekfymLuYUNnjFo5qNMr1Ua6PFuBEAZmgiKPBwgIEQmvcKMSSeqTeZbgnXbo6DtIdF9tLIqWF0kkiNQHHqSeXtJlRY9GY9pCWhVs7idyEGbiu+yYeIYZhGIZhGIZhGIZhGMauYgJ14x1tbw/PIe4x19UQXZUjiKohehTSURikszxITzkOwylX4hB9TKULbNuNDhCqkHJUohyUUSoavT0VEYUVIopgVVBaxwH6VrUuAErHtS47EqTXhhkWFWYyszIJSRxYd9n93NncyaopGZ6uW4oW8elL1zzNBSt+xYL1a3lxiuBn/2MStb01TF0bACHKTlJqXEo2nyPT+VeyLa1MPKSLRG3cDT9UzrKhdRG9HTMBSY9K8bdwKtPrX+Z6/i+LB9qIkDziLmG1ezBFkttdOKpcH6RGqIisXyShFBILAdV6lwgHhbatMT3pNrgg3QjLtnDcLNJx0NomjBqx7GZyCY+pOavak24hMw3kJs4klc7syEPEMAzDMAzDMAzDMAzD2E1MoG68MwiBsMRW4bmMazn2QlqNDdHDkSnzIApoLwzQVRyizy/Giz4rFSiVoRKMu47hSpcoUiNT51prKrpC2S8RRpXR4fWtp9Gt6qS6suNql60ESsXX/6rFLrr632iQ3hTUsqgwi+l+88hpm5xuVkzq4+HJ9bxYc9DI6Yc/81c+dNfvWLDuZTY1wH++t4lEsZ5JrSEQoC2HYvOBZPJNZLoeIz35FSad2EmqqQJA0U/SumExPW2z0dpiUHk8EU4hV7uFr3jX8k99axDAP+y5PJA4nD5R86oLR5EaoRWpoEQyDKoLR+OJekdF1XoXC6QFlkXg2OiERDgKaQkcN4XlJQBBqOqQciKpdJqJ6dGedBI5Mk0tZGrrkHLvfEwahmEYhmEYhmEYhrH3EEJw++238/73v39PH8o7jgnUjbcPIRC2QNgSbBkH6LaMP7fEXr3QUSuN9qM4RK9E8VLRagpeCX06Cv10FYfoDUpxhF0J4mn0coXRjpbth+hoTaBDKlGZSliJl4wOB+wqIgoDIgrVaXQVL95UbrxsdAyl40WjoVa8uuEQXY98OsVvZFFxFhOD+upJmlcSHfx6cp5HJ09kY3oZAJYKOe6xP/Ovf/wdM9q30FkDv/qnOpRuoqEtAkK0tCk0LyRdnk626wmSjSuZdFwnmUml+HsVuKzbtIjeLXOJIoeidngqnIyb6+Y/kj/mvX3/QBZhgzWZexNHsVlOQIcCVR5dOKplVO1JjxBaj/Skxx3p8UumpTWWirCkAMsGYRE5Nn7KQ3oKaUc4toftJUFKlEqjmYiXqKUhYTGj1iGXcBBuEq9+KjWNE7Ft83JsGIZhGIZhGIZhGAZ0dXWxfPly7rzzTjo6Oqirq2PJkiUsX76co446CoC2tjbq6up2+7G1tLRw8cUXc/HFF+/22x72qU99itWrV/Pss88yf/58nnzyyXFfX7lyJd/73vf461//yuDgIHPnzuU//uM/+OAHP7hTbt8kOMa+RVZDcmtMcG4Pn7bvTPa+VoAOUKwU6SwO0lnK0x+W4xMjFU+il8ojtS9QDdGjaog+JusOVByi+1EZFYXjptFVGBHqElqU0HYQX07ZoB22rnUZXjL6WmtGR0P0+DxCw4zKRBYVZ9EQ5uLDR/F8agu/murz2KRpdCXmApAISvzzn+/nnHv+QHNfL1vqBb96Tz2RbqKmJwQitJQUmxfg+bPJ9fwDL/crJp3QSW56IT7GyGLt5oX0btqPMEzga4tnwolE2SEuytzA/+h9EqsE7bKRBxOH8ZLdgo4kUUGCqvakj1k4igAnrJAJK9haYFVfKoXW8VS6BOyxPekOyYRAOhGOZWO7GYRjo7WLiiZiOQ3Uphym11o0pjyk7WDnJpJrnkoikXiDjxrDMAzDMAzDMAzDMN4JzjjjDHzf58Ybb2TWrFl0dHRw33330dPTM3KeiRMn7sEjfOt8339Lu+POP/98Hn30UZ5++ultvvbwww+zePFiLrvsMiZMmMDvf/97PvzhD1NTU8P73ve+t3LYAAit9WulZO84g4OD1NTUMDAwQC6X29OHs1MF/WXaN7XRVFOPFHtp+CwFQop4otyS1QlzUZ04l3tdv/kb9VoButaaol+gt1Sgt1JkwC9T1tVO82hMpUsw2ov+aiF6qEL8qEI5qqCUjxrzNRVFqChAUQSrjELFS0axtql1eWPT6LB1P7rUgtnlKSwqziQXpQEIRMjf05v59Qz4e/MMBt0sANnSIO+//4+cef/d5IoFNjQJ/rK4ERnUkR6I778WgmLzPGw1j9TAy9jJJ5h4cBd1cwar3wfB2rYF9G7cH99PEWnB89EECqky59X8jg/0/Q0n1HTLOh70DuN5ezZaCVRl+wtHEWCrkFRQwFMCq9rxLjTYOsJGg2UhhERbFkHCQTgaXE3Ka0JRQHoeIAmjJqQ1gUzSY2rWYlKNi2PZiEwT2aZppDOZvfq3Jgxjb6CUorOzk+bmZlOHZBg7kXluGcauYZ5bhrFrmOfWjns7Z1s7qlwus27dOmbOnLnPDLT19/dTV1fHypUrOeaYY171fFtXvjz88MN84hOf4IUXXmDhwoV84Qtf4PTTT+eJJ55g6dKlrFy5kuOOO457772Xyy67jOeee46lS5dy/fXXM2/ePADWrl3Lpz/9aR555BEKhQLz58/n61//OscffzwAxx57LA8++OC449Ba86UvfYkVK1aMmxS/9tprufbaa1m/fj0A5513Hv39/RxyyCH88Ic/xPM81q1bx8aNG/nMZz7D3XffjZSSo48+mu9///u0tLS87vdqe7f7ak455RQmTJjAz3/+8+1+fUceK2ZC3di1hIhDckuMD8vldk4f/vNt4LUCdKUUxaBIf7lAb7lIv1+hosPR+e9IQ+BD2Y/D9OoXXitED7RPOSgTqRA1JkXXUUQUBWhdRlllsEOU0tVp9PFLRnX1NkKt4kWkr2l8kG4ri3nlaRxQbCGl4hedsvD5S+0WfjPd5qnGOZTs+PSmwU7O+tMfeN+fV5L0K7wyUXLXkU1YhVqy3Yp4Il1QbJqFYAG5/k1I+zYmHt5J/bx+hIy/la90zKNnw/5UyjmUhpejRvqSiv+n4XbO7n6URJemT+R4KHEozzr7obR8zYWjUkek/BLJKMKqdqQDWFphK4W0JVDtSfcc8ATCibClxLYT2IkkoQ6JVA2ISSRTGSZnLKbWuCQdG5K1JBumkqutw7JGr98wDMMwDMMwDMMwjN1Ha00pLO32203ayTc0WJfJZMhkMqxYsYLDDz8cz/Ne9zKDg4OceuqpnHzyydx66620tra+aiXLFVdcwXe+8x2ampq46KKLOP/881m9ejUA+Xyek08+mauvvhrP87jppps49dRTWbNmDdOnT+e2225jyZIlXHjhhVxwwQU7dP8B7rvvPnK5HPfccw8AQRBw0kknccQRR7Bq1Sps2+arX/0q733ve3n66aff0gT71gYGBpg/f/5OuS4TqBuvTQgQxEG3GP0cIRDDn0sQUsZ/WnLb4Pwd4LUC9EhFFP0iA5UifZUi/ZUyvlZEYytUomg0QPdffxJdqYgKAZWgRBgFaDVayDISolNGyThE15r48pEN2mJskP5mp9EBMlGS/UrTmFeahqcdAAqyxAP1bayYnuLZhvmEMn6Zmdbdyrm//z3HP/YXbBXx4hSLJ+ZPxBvIkO2Ku9e1bTHUPAep96Omrwv4PROWtdO4oA9px/ewtWsmXRsOoFSIe8LWR3W0exZnTLqLD/Y+TKpdMSgy3Jc4mKec+UTaQlUk2h+zcNQK44WjlkJoTSIskQ58LOyRhaNSa+zhnnTbBikJXRsSFrgKS4IjXaSXANtGkySKmnC8WppSNtOHe9ITGZzaydTUN+3UHwSGYRiGYRiGYRiGYey4UljisFsP2+23++i5j5JyUq97Ptu2ueGGG7jgggv48Y9/zLJlyzjmmGM455xzWLx48XYvc+uttyKE4Kc//SmJRIIFCxawefPm7YbeV1999cjk++WXX84pp5xCuVwmkUiwZMkSliz5/9m78zip6jvf/6/vWWvvfWdpEEVQFsElmknUa1CjQzBBHcfcX4JETBxNRo0DJo5oNMSRmGhyb0wmIePyUO84cy8SjaOJIaIMLhEVjFExIJvQDc3Se9dyzvn+/jjV1StLI4jI5+mjrK6qs3yrur/dPN71qc93UmHbO+64g8cff5wnnniCa6+9ltLSUkzTJJlMHlDLmXg8zqJFiwr5yMMPP0wQBCxatKjwZsP9999PcXExy5Yt49xzzx3yOQbzH//xH7z66qv867/+60E5ngTqRxEVMTHjFmZxBNM0+oTjqPCjIn1uHyVh+FDpQKNzATrn56+DPgG6F/h0ZDtoz3SyO9NFazZNOgjwegfoGshmw0smB55feGiPIbr2yeocGS9Nzsuhtd+zuGjvEN1Mg+WjtQ4fHyREL1Sj77M3OvQP0pWGumwFx3eNoC5bjsoft8Vs56mK7fzX8CLWlExA59sKjf3gHb7yxJOc/uc3UMBbIy3+cmwN0V1Rkk0K0ASOQ2vVsbiZYynZuQX0U1RM2EbFxF2YTnjuLbvr2LZhAh1tFQA0+Ek2Oy5/W/sHvrLrBRKNPu0qxu/cqbzunICHNTBIN3yC/IKjABEvTczLYGsDVeiTnm/vonQYpKswSNcRE2VrDEtjKxvTdcG20dgEfgWWU0lp0mJkiU153MWwIxjJKpJlVcTj8X28xkIIIYQQQgghhBChmTNncuGFF7J8+XJefvllnn76aRYuXMiiRYuYNWvWgO3XrFnDxIkT+7QqOfXUUwc9du9QvqamBoDt27czYsQI2tvbue2223jqqadoaGjA8zy6urrYtGnTQXleEyZM6FNsuHr1atauXUsymeyzXTqdZt26dQflnM899xxXXHEFv/rVrzjhhBMOyjElUD+KGI6JEbUx47b0HdtP2gsGhude3yrtrJ+jM9NJR66L3ZlO2rIZMjog279tih9ApleIXmgBo8OLF173FuiArM6S8TNhiB54fUL0wM8SkEabYUhcCNGDwUN0rcEPAny9rxi97yKjAFHf5dj0MI7rGkYiiBbu/8DewVPVrTw7rIINqZ53MU9au5JZjz/JxPffA2DVaJs19ZXEdrv5IB28WIyWiuNIdoymbPs6lLmYislNlI9vLgTp21sq+WDjJDqaqwDFziDGeivOObV/5K6W5ynemqNTuSx1T2OlM4EsNjprEGQN0OF5tOGHC46afrjgaJAjnu3A0SZGr/YuVhBgEaBME5RJYJsErgWuxrB8bGVjWTa4DiiLICgDVUUi5lIZMxlR6uK6EYiVEy+rIZlMylwTQgghhBBCCCE+RqJWlFcuf+WwnHcoIpEI06ZNY9q0adxyyy1ceeWV3HrrrYMG6kNh23bh6+6q8O72wTfeeCPPPvssd999N2PGjCEajXLxxReTzWb3ekzDMOi/TGculxuwXf+Cw/b2dqZOncojjzwyYNuKior9e0J78fzzzzN9+nTuuecevvKVr3zo43WTQF0I+lWdewE627fqHMIgOu2lSeeypL0MXbkMbV6WtO+RC8IAfUBMnfPC8DydAS9s5aI1herzwA/on7sHgU+WHDk/S87P4vu9Q3Qvv7BoGm1mw57ohRDdBKxCiAw9kbgfaIIDqEZHQ02ujLFdwxmRqcTIL9KZVlneTGzlN7WwqrKGbbFRAJiBz6fe/m++9vhvGbX1AwBWHuvyfl0F8d0OyZ3h2LKpJC1lx1HWUk9FwztY7mNUnrqD0uNaCq1ddrSW88HmCbTtrAMUrYHLOjPJGcOXc2vbUsq35kjj8Lx7Kq84k8ngoHMGQaZfkO5k0ZYHKhxfIteJ4wWYqufXX6G9i2WEr6Fl4UVsiACWj42FbbngOGCaBLoEHVQTjcSoTVnUJm2yvsJJVeEUV1NUXNznD5QQQgghhBBCCCE+HpRS+9V65eNm/PjxLFmyZNDHxo4dy8MPP0wmkyn0XH/11VeHfI4VK1Ywa9YsvvjFLwJh4N29qGg3x3Hwfb/PfRUVFTQ2NqK1LoT0+7NQ6JQpU3jssceorKw86AvoLlu2jL/927/lrrvu4qqrrjqox5ZAXRx1eqrOe1We96o611qT8bKkcxnSfoZ0LkOXl6XLz5ENNJ7WZPu3cOkWaMjlwn7o2Sz4YYQd+AHaD0P5/q3KAx3gaY9ckCMXZPF8v18l+r5CdBN0TxV0oRJd72+I3h279wzMDWzGpOs4rms4RX7Pu4fb7F38oXwXz9YU8V7pWLJm+DEd10tz5ht/5IolT1O9aweBgleOj7CpspxYi0Nit0IDXSUltJaMpWpnLVUfvImTfISqv9lJ8TGt5DvEsHVXDQ1bTqBzdzWg6NQ2a1WKKcNfYm7nH6jakiGHxQpnCi87J9GpouicIsiYPUG6CsKK9HyQbuiAeK6DaM7HUBaosCpdabACH8skbO9imniuDREFto+tTCzDRTlO2N5Fxwj8Ghy3iKqExfAih2TERrspvCBCce1Iae8ihBBCCCGEEEKIA7Zz504uueQSZs+ezcSJE0kmk6xcuZKFCxcyY8aMQfe5/PLLufnmm7nqqqu46aab2LRpE3fffTfAfi2E2u3YY49l8eLFTJ8+HaUUt9xyS6F6vVt9fT0vvPACl112Ga7rUl5ezllnnUVTUxMLFy7k4osv5plnnuHpp5/eZ0j+5S9/mR/+8IfMmDGD22+/nWHDhrFx40YWL17M3LlzGTZs2KD7rV27lvb2dhobG+nq6iqE9+PHj8dxHJ577jn+9m//ln/8x39k5syZNDY2AuGbAaWlpfv9euyJBOriE0cHOgyyPY32A7SvwQuvtReEoXdexvdI59KkvSxpL03Gy5HxsuS0Ty6AnNbkgoDc3kJpPwgXE81kIZsDvec+6OEANTnt4+OR8bN4fhYdBD2/oHT4tR40RNe9KtF7WpUEADpfia73J0Tv3qtvNXqFV8zxncOpz1Rj5luhZJXHX2INPF7n83plDY3xkYVd6lo2c/ZLf+SSZ5eT6uzAM+Cl8TG2FpcS7XCJt4BWivaKMjriY6nZWUl80+tEyv5I1ek7KRrZXjjWxqZ6tm8ZR7q1DFCktcn7qojxdSv5afb31G3pwsfkT84kXnSm0q5iaC8fpAc9QXrgZAnsXLgOgNbEcx3Ecj6GMqFXVbod+JhKo7oXHHXt/IKjHlY+SDdMC1wHrSIEfiWWXUZ5yqa+2KYo6mBEkqh4OfFUCaqjg2h0aB/fEkIIIYQQQgghhOgtkUhw2mmncc8997Bu3TpyuRzDhw9nzpw5fPe73x10n1QqxZNPPsnVV1/N5MmTmTBhAvPnz+fyyy/v01d9X3784x8ze/ZszjjjDMrLy5k3bx6tra19trn99tv5+te/zjHHHEMmk0Frzbhx47jvvvv4wQ9+wB133MHMmTO58cYb+eUvf7nX88ViMV544QXmzZvHl770Jdra2qirq+Occ87Zaxh/5ZVX8vzzzxdun3TSSQCsX7+e+vp6HnzwQTo7O7nzzju58847C9udeeaZLFu2bL9fjz1Run+Dm6Nca2srRUVFtLS0HPSPGhxuQRCwfft2Kisrj+i+zjrIB+N+PjD38gH6IIE5hJXaOT9HNvDI5noqzzNeDl97eFrjdYfnOiCn9Z7jaE3YxiWXy1888INCH3Tta3x/4N5+4JHDw/M9sn6WIPB7FhXVQT5Q9wh0FsiiTQ+UT4AO3yDQBmElek8gHIS7EuihhOjde/YE6XZgMjpdy9iuEZT6PYtA7LBa+GPZTp6pTbCmbDiZfDW6HWSZ+v7LfOF3z/Gpt95FAVkT/jQ+QVO8GLcr/GiRNg1aq6pIu8dR21RE0PUqidq/UjV5J4naznAbDe9vO44dW8aS7SgGoFPbbDZijK19na96Sxm5vQOtDVbZ4/lv92RaVWKfQTpoYrkukrk0CjtcaDfP1BpT+5j5Pumea4VBuhtgKYVlWBhGGKRjOARBOcqooDjmMqLYoizhYjkxiFcQTZWSSqVQSn0i5pYQHzeflL9bQnzcyNwS4tCQuSXEoSFza+g+ydnWUKXTadavX8+oUaOGFCx/EjzyyCNcccUVtLS0SAHgfhjKz4pUqIuPFR1oCPIhcndVeaHCPF9t3isw11qHQbiXKYTmOS9sn5L1fXJBDj/w6V5c09e6p/J8X+F5uAN4ubDyPB+g6yD8g66DcLyB1nts4+KRI+tl8YOwjUsQEKbIOiDwcgRk0XhoMwemj0bnFxbVEOT7eecXF+1uzNIdomsd4B9giA5QmksytmsEozM12Pmg3sPnnVgjS+py/KmyhoZEzyKjte1b+JuVf+TvnlpOaXsbADuTijeOLaLdSOHkbNwuCGyL3dXV+OY4apss/MyfSI5YT+XkHcQqMuFofMV7jePZveVYvHQY4rdrh222ydS6l7iu8yWqt6QBxZ/t41nunsJuVYT2FUHayL82oNFhkO5kC+uvRrwwSDe1Bapn5ei+fdJtAtcmcE1wNaapsQ07rGK37Xx7l1K0riQRizGiyKYy6eA4UUiU4yTCIL17Zer+H38SQgghhBBCCCGE+Cg99NBDjB49mrq6OlavXs28efO49NJLJUw/BI6YQH3BggU89dRTrFq1CsdxaG5uHrDNq6++yk033cRrr72GUopTTz2VhQsXMmnSpIEHFIdUWFXdKxz3u3t+99xG654A3dc9zb978bUm5+XIBjlyXo5c4JH1c+T8HLnAJ+f7aPouhKA1eGj8gLD6PH8J4+p98Px8eB5Woeucv8/wPDynzgfo4fh8Pxvup/OLjgY+gRegyRCQAyOHtnwgX1muNTpQ+fDcyFekq8JLEr6cYYge7M/zAAYL0U1tMCpdw9iu4VR4xYX7m812nivdwVPDYrxbOoq0FVaZW4HHSZtf4dylz/E/Vr6Nkf/+vDvcYV1tETqTwPANHB/8iMPO6lqsYBxVOzyC7CukjtlE5eSdRIrD1aD9nMk7DRNo3XIMfi5cAKQlcGmNeXym9o/Ma15N+cYsAQZv2WNZ4ZzMTrME7Sn8jAH+noN018uQ8jqxAgut7ML9SoOlfSxDhX3SLQsvaoOrMSyNbViYKLDscNFRkvh+NZFIkuFFNrUpJ3xnMlaOGS8hlUrJHyMhhBBCCCGEEEJ8rDQ2NjJ//nwaGxupqanhkksuYcGCBYd7WJ9IR0ygns1mueSSSzj99NP59a9/PeDx9vZ2zj//fL7whS9w33334Xket956K+eddx6bN2/Gtu3DMOqPH50PsbXWPeF19wKXmvB/hVLo7vs1hQQ3/7Xu3jZfcd0djKPJh+N9I99Ah7G373v4gY+v/fA6CPB0QBDkb+sAX/t4QYAXeH2qy/s+D/AJW7X4+Sr1AI2n2f/WJ4HOB+ce5LLorEfg+fsMz8Nd82PFxws8cn6OQPvhAqIaCMLnpIMsAVmU4RFYPtBdhU6vVi4Dq9DJv+fAQQjRlVbUZMuoz1QzMlOFq8O54BPw1+g2Hq/N8mJVFQ3JCYV9ajob+NTqP3LxU8up3dkCQNqG149NsDOWwsxFUelw22xRjB3ltSTS46nd1krgLaPk+A+omLgLJ+GF26Rt3mk4ibat9Wg/DOt3BRG8ojbOq/wvPrtjHcXve+Sw+ZMziVecybQaSbQPQYeJ7h2k27kwSDfCV8T2cxR5Hdi+Qiu7e13SXkE6YJhhkB6xIQLKCrCVhaWM8DHXQRsJAr8S2ymmNmkzosglEXUgVoaKlZJIJkkkEkNazEMIIYQQQgghhBDiozB37lzmzp17uIdxVDhiAvXvfe97ADzwwAODPv7uu++ya9cubr/9doYPHw7ArbfeysSJE9m4cSNjxoz5qIb6seW3ZfF2psl57Riqp++Y1jrMxfNfa3TYwiL/deG+Xu1IdOGxsL2Jr4N8QN43FA90gJ+/7h/07lO+0tzTYWjua/B0gJ8P04f+Avg9lecZLwzQ/WBo4bn28AKPwPcJtAbth29QBN190LNosqByBKYPRlB4DcNwXOX7oIdV6H3auBSed5D/nny4EL06V8qodDUjMlVEdE/rkzajk+dLt/PksCh/KRtZqEY3tcdJW1/lMy88x98uf6tQjb611OQv9UVk/CQGFmYubOvSWpmgOTmcqt1jGbFlK5r/omx8AxUn7saKhp8a6OqI8k7DFDoahkM+yN+po9hljXyx5D85ubGB5DqfDhXheXcqK50JpFUkDNI7TbS35yDdCjyKMh24WhMoqxCkh48FWEqjzL5BOpaPjYVtOKCMfHuXGEFQjqHKqCpyGVnqUBRxMGIlECsjlkiSTCbDnutCCCGEEEIIIYQQ4qh2xATq+zJ27FjKysr49a9/zXe/+1183+fXv/4148aNo76+fo/7ZTIZMplM4Xb3yrVBEHzi+iLvaGlic3MD29O7ge5i80Kk+5GOJchXkne3RO+uYA/yQfIBh+ZA2OvFg5yP9nx0r97n+w7PwzcDwvDcx89Xyev8wqHdF3SQb+mSC8NzvHAhUUPTp42LVr0WFDXRKLo/HNAToOd7qqPD6vb9KoAePESvypUwKl3NyEx1nxC9S2VYE9vG76s0K6or2dKrGr0qvZ1T317K9P9azrFbwp+NQMGbo6JsKU4S+HGUb2AQVqM3VZSgOYYRTdWUNf0Fw/pPKiZvp2xcM6YTjqmtNck7W6eS2V4bPnegiQglVRv4avz3jN+6m9iugGaV5OnISay2x5HDRvsKnTH6VKRry8N3M4Ug3QwCirIdRIKAAKt7XdLwMa2xCDDyQbofsdARVQjSLcMKX17bASea75NeRkk8yogSh7K4gxkpgng5djROKpUqfLplb78Pwp8F/Yn7nSHE4SZzS4hDQ+aWEIeGzC0hDg2ZW0Mnr5UQh9YnJlBPJpMsW7aMiy66iDvuuAOAY489lt/97ndY1p6f5p133lmofu+tqamJdDp9yMZ7OOxq3k1Xpgtf+/ve+ACFcXJ3SJ4PRMkH5br78YMU3gcB+AHaC9C+D54XLlxaaGkzoPNMSIEy81XPOsAnINB+4WvIH4MApTVWfjuUD6ZPYOW/VqBRhNPIygfl3Ym4WahA7x5Hn6HoMNgH+lRW7+MJM+CNDw3l6RTDOkup6yglEvSE6Bkjx/uJ3fyhOuBPZUnWJsaSM8K5YGifk7av5NSXn+MLf3iTiBcety2qWH1MEW1GAq1cCEA5Nu01KXYkqyjbfRwjt3biZ1YRr/kvyk5rpmhkG90feNi9u5Q1W6eS21kJhHfuUA61de9wrfUco7d24G4LaLKqeL7odP4aGU+Awkz75DpyBF7PH30zonDiFoblADFAE/PSRH2PwI5Dr9YrSmtMNIahwDAJbBPtGphGgKUMDGWEQbphhGE6cbQuwo1EqYxbFEUtbCdKu1WEoVyiWmH6Prt3796/70wQ0NLSgtZaVp0X4iCSuSXEoSFzS4hDQ+aWEIeGzK2ha2trO9xDEOIT7bAG6jfddBN33XXXXrd55513OP744/d5rK6uLr72ta/x6U9/mv/zf/4Pvu9z9913c+GFF/Lqq6/ucRHB73znO9xwww2F262trQwfPpyKigpSqdTQntDHnJdOs7O5Gdd199gHurtyuicI7wmDg+7e33S3Tg+38buvD1WVux+gcx4650HGQ/s5dC4g8IM9h+Z9npMOA3N0T+V5voc7QRAG2/k2LgSaIPDQ5ACfQHlg+KC626+Er07Q3WuenjYuWhtojLC1fJ8APb/wancblyG14C404+n1hKAyV8KofE/0WBApPJRWWd6LbufZao9Xy4vZkBqJZ/ZM89quRk5a9zz/49nlTHlvZ+H+9VUO71clyOhU2FMcyKVibKtK4BmjqN82iqJt74F6kpKx2ykftxu3KFfYv3F7DesaJxM0lwGKQEOzbTJm2Ot8xX+J4Q1pbE+zwazjxdgU3jdHoAOFbmknyBiFdxV6t3bJGZp0FlRGk8h1kcql0cqho0+QDpYOsEyFZ1oErk3gKDADbN/Eyr+p4RsmuBEwkgR+Ka5bzPCkRW2RSyQah3gFyo2TSCSIx+ND7pMeBAFKKSoqKuQfeEIcRDK3hDg0ZG4JcWjI3BLi0JC5NXSRSGTfGwkhDthhDdS//e1vM2vWrL1uM3r06P061qOPPsqGDRt46aWXCr9gH330UUpKSvjNb37DZZddNuh+ruviuu6A+w3D+MT9ok4HAWkNGS8ApfIV2r3C8gM9cPcikPvXq2QA7euwwtwPwhYtvg+eT5D10Dkf7e/7o0r9Q/OAoNDbPcj3JCfIt2Lxe4Xn2su3bfEIlA/KC9cIBfYcnis0YYAORt/+592CfBsX1auNy369PLrfpefuylxxfmHRauK9QvSMyrIm2sSzVR6vVhSxIXVsnxB9WFcDE7e+yLg3VvLZFzeQ6grvz5nw5ugEO9w4vpkIT2ObtFTGaCqpoLRtHKO2KvzMKqJlz1E2ZTfFo9swzHBcXsbk3cYT2b5tDHY6VnjabW7AxBEv8bnON6ndlMYI4F1rNC/Fp7LVrArflMkaBNl+QbqTJbBzhdYuoInn0hRlu1DKxDecwv1Kg0WA1V2RHnEIIgrsAFuZWIYdvtzKDCvS7RR+UIJjllBX7DCyJEosGoF4ObgpYrHYh+6TrpT6RP7eEOJwk7klxKEhc0uIQ0PmlhCHhsytoZHXSYhD67AG6hUVFVRUVByUY3V2dmIYRp/K0u7b0jsqlA4CMvn+3wcafu+3ME8OY2HPQ3sBePme5oGPzgXghy1awsR5Pw65p9A8CMLYu7Bgar7PeRAQBGFwrgMfjY/GA+WjlQ+G1yu27qnL173Cc50Pz9EGOjD6x9y9BxcG6Plqfd07QN/nSx30u+55DSu8IurTNdT3C9GzKsea6HZ+X+XxakUxG1JjBoTokxtWcNzqlXzq5Y1UtPYcdkfK5O1hSTqNFIEZ9gfPpWI0VEfIWiMYvW0cZevWo4OlFB27lbJxzUTLetYZ2LWjlHeaTiKzoxpbG9iApxWZeJrThj/Pp3evpWpdhkAbvGmP56XoSewyS8I3HtIGOmsUXhStgp4gvfA69QTppjLIKafPa2gFAbYJmBbacfCjBtg+tlJYhpPfVIHjoOwkflCGaZRQl3QZXuKSjLoY8XKIFuNGIn36pAshhBBCCCGEEEIIsTdHTA/1TZs2sWvXLjZt2oTv+6xatQqAMWPGkEgkmDZtGv/0T//ENddcwze/+U2CIOBf/uVfsCyLs88++/AO/kiU7zTSO0DWunuhzcIdYVjdXVnu+WjfCxcF7b4M4c2MQAegdb51THdo7ocLlnaH5oDW+bA8X2WutZ/vm+6FFwJQQRiaKw3KQ+d/0vcUngeBKvRDD4N0I6xGH0x33xsd1vUH9OqDvt8Liva+7mEHFtW5Emqy5YzIVJIIeloVZVWO96JN/L7K408VRWwoGoNn9Ezh4V1bOWnbCo55cyVTX9lE3a6e43a6ineGx2mxo2TsJFoptGXSWhmloayY4vZxjN6aIMi8iVt0P2Wn7qZkTAumnX/Fcor3GsbxQdM43I6wGt0GujCIlm7ns1UvcNL2BsrXZMli87IzhT85E2k3Emgfgi4Tnet5l0EbAb6TQVtenyA9mesimU1jKgNP2eR6vUFmao2lwLAttGvjRwxwNLbSvYJ0wHJQThJfl2JSQlUqwshSl1TUxYiXQaQEy3FIpVLyMTghhBBCCCGEEEIckZRSPP7441x00UWHeyhHnSMmUJ8/fz4PPvhg4fZJJ50EwHPPPcdZZ53F8ccfz5NPPsn3vvc9Tj/9dAzD4KSTTuKZZ56hpqbmcA37YyWXC/By4QKeYXjcHQzrQkW39nuVlgcBqrufSRAUqrC725nss0dMd89wHeRbymiCfIjcHZTr/OKcule4HGbVg1SY+2GFeRi5B2DkQ3M0GH07uPcOzsOvuhcp7e4Db6C1BSiCoKdierDnMCA8hyG0cOkeR+/rHoZWVOSKqc2WUZMto9wrwqDno1k55fFetInfVef4U3kRG4qO6ROij+jawtTtKxj51komvrqZUdt6jp214J3hcXa7EbrsJLq7N3oySkONQ6dTx+jtEzhxbQOB9zKp0ZspG7ebeFXPYrytu1O8tX0KnU11uIGBm39JMq5Hfd2f+RvjNUY2dpJ8x6ddxXjOncprzolklIv2VFiR7vU8H236YZBu+j2tgrQmmesklcugBgnSDa2xFRiWCa6NFzHBCbAVPa1dAEwb5SYIKEWrEioTMUaUuhTHXIxYKURLMSyLZDJJLBYbcp90IYQQQgghhBBCiI9CU1MT8+fP56mnnmLbtm2UlJQwadIk5s+fz6c//WkAGhoaKCkp+cjHVl9fz3XXXcd11133kZ+727e+9S1WrFjBW2+9xbhx4wqF193WrFnDN77xDd5++21aWlqora3l8ssv59Zbbz0oXQqOmED9gQce4IEHHtjrNtOmTWPatGkfzYCOQH5rB0FrRxiah6uKDgjG+0SMulATHq6rmd9Q97ruCcjzrVbQhaC8e290z8qmmnxwrzW6EMzntw+8fOzuh0dU3ZXm4TVWMEho3tNvPCiE5YWW5+EbB1oRYIZl5Hpf4Xm+Cj//LIPuF2VI2Wv3CAapztdQ6iWpyYUBelW2BLvfNGwxO3g/upvnKjWvlBexsWh0nxB9ZNcWTm76b4a/8yrHr9zC2A969vUVrBkWoykeIW2l8PM9wf14lN3lJttK4hS1jWVUYxU6/Rfs2MOUn7STkuNasNxwvNqHdVuP5f2mCbhtcQwFLpBD4ZZs55TqF5m4ewtVm7JYvmarUcHzkRP5sz0WDysM0rMG+L2CdMvLB+k9r4nSAalcmlS2CwwTT9noPguOamzANBW4Dl7EAjfIV6T3CtINE+UkCIwSNKWUxuOMLHMpiUYw42GQrkyzsOCo9JITQgghhBBCCCHEx9nMmTPJZrM8+OCDjB49mm3btrF06VJ27txZ2Ka6uvowjvDDy2azOI6z7w33YPbs2bzyyiu8+eabAx6zbZuvfOUrTJkyheLiYlavXs2cOXMIgoAf/OAHH2bYwBEUqIsPL93VTibbied5+cAbusNyX/eEwIUe4kBPf5eer/ssXxr0+iII8nl02KddB/lwXAVh2K7zwbjS4X1oUDofmGswBi967463e6rL+wbnulAynl9NtBCa7ykFz7+hkG/03if+HnJ43v+FGBiiJ/woNdmyQhV6RPf9ZdGlMmx0d/FSWZY3Sh3eT5WyPT6WQPUEv/VdH3Dqjv+mds1Kjnl9C+M2gNnrxVpbE6EhFSVtpchZ4bT2E1F2lZs0lEaIpIczqul4qpuaCHJvkBzxW8rG7SZZ11k4RmdrjNWNU2lpGkncV0Tzr0fOzjGi7i+cbr3OyG0dpN7xyGHzpj2e1yMn0GhWht+PnCLImhB0v4CawPbw7Sz0CtINHZDKdVGUTRMoE89wBgTpliJccDTihBXprh4YpCsT7ARYRQSqlOJokvpSl5J4BCteAtFSMEzi8TiJROJDLTgqhBBCCCGEEEII8VFobm5m+fLlLFu2jDPPPBOAkSNHcuqpp/bZrn/LlxdffJF/+Id/4N133+XEE0/kn//5n/niF7/IG2+8weTJk1m2bBlnn302f/jDH5g3bx5vv/02kydP5v7772fs2LEArFu3jhtuuIGXX36Zjo4Oxo0bx5133snnPvc5AM466yw2btzI9ddfz/XXXw+E3SBuu+02lixZ0qdS/N577+Xee+9lw4YNAMyaNYvm5mZOOeUUfvazn+G6LuvXr2fz5s18+9vf5ve//z2GYfCZz3yGn/zkJ9TX1+/xNfrpT38KhJX8gwXqo0ePZvTo0YXbI0eOZNmyZSxfvnz/vxF7IYH6USTd0Uw200E2nV9gsndWng+Cu8P0QjsYFUDvx1TQa9t8GB5oMMLttAr31SoAs+9p+oflPZXk3b3Re2rO0d0V8L13VoSpe+/rvaTf3ak7+crz/FsBhcshCM8B3MCmOltKbbacmmwZqSDW5/Gc8thi7+LV0jSvllr8taiIhkTfKnSAUZ0fcPrOF6ha+xrDVm3lxPfB8Xoe31Th8kFJlE4rRTb/cRU/EWNXhWJrqYObHs6opnHUbm/Bz63BSTxIyYnNlI5txo754UsUwIaGUaxpmozTksRWmjjgA5HiHUyqfoVJrZuo3pzB9jUNRgUrIifwln0cWeWEHzDIGGFFuu4dpOfwnSwYPd91Qweksp0U5TIEyiS7pyDd7G7tku+RbvRr7YIJdhScEoKgmOJoESNLHMqSMaxYMcTKwDCJRqMkk0ksS37NCSGEEEIIIYQQIqS1Rnd1feTnVdHofrWfTSQSJBIJlixZwqc+9Slc193nPq2trUyfPp0LLriARx99lI0bN+6xJcvNN9/Mj370IyoqKvjGN77B7NmzWbFiBQDt7e1ccMEFLFiwANd1eeihh5g+fTpr1qxhxIgRLF68mEmTJnHVVVcxZ86cIT1/gKVLl5JKpXj22WcByOVynHfeeZx++uksX74cy7L4/ve/z/nnn8+bb775oSrYe1u7di3PPPMMX/rSlw7K8SRpOop0plvxgg4yQVt+4c6e4LzQ5EQN3v+lO8/uE4p3P96rsrxQ6E4+pNc9Fe19u6T3Uripei7daffeWrR0B+X9QvPuQ3744Lz3qPe8uKqpDaqyJdTkwir0Ui+F6nXCgIDtdguvp9p5pdzgneIkWxLDyVh9fylUZHdxxu7XGd76JqkN71K8ppUT1ipimZ5tGkpsNpQn6DLjpF0XDfjJMETfUmLhZoYzqmk8J29vw8++hx1/mJJxzRQf00qkJFs4Tqbd5Y3GqexsOoZUDuIASuNbHsNq3uEU93VGb2+l6N2wGv0texyvR06gwahEo9C+QmcNtNfrxVUa384SONk+r7epfVLZsEd6oKyBQToaSyksywTHxYsqsAfpkY4CMwZOEZoS4k4Ro8oilCej2LESiJWCYRGJREgmkwelJ5YQQgghhBBCCCE+WXRXF2umTP3Izzv29ddQsdg+t7MsiwceeIA5c+bwi1/8gilTpnDmmWdy2WWXMXHixEH3efTRR1FK8atf/YpIJML48ePZsmXLoKH3ggULCpXvN910ExdeeCHpdJpIJMKkSZOYNGlSYds77riDxx9/nCeeeIJrr72W0tJSTNMkmUweUMuZeDzOokWLCkH5ww8/TBAELFq0qPBmw/33309xcTHLli3j3HPPHfI5ejvjjDN4/fXXyWQyXHXVVdx+++0f6njdJFA/irR1dZDVOdJ6YIV6wSBl5D113QM37Bth7+lY3aFr754u+1FhDj19zSEsp+51Ht3vcuChebf9C8+LvQRlXhFluRRlXooSL4lJ377cu802/pxs5cVyeKs4xqZUBZ32iD7bJL0Ozmh+g7Gtq0g0vkN0XROlH5gc9wFYhf4zsDNpsa4qQacZo9ONoJXKh+gGm8sUbnoYo5tO5NRtnfjZNdjxRyg+vpni0W1ES3vSeO0pNm4bybs7J2I2lxAhIJV/7dzUTsZXv8bkjvepbUjjeJpGo5wXIyfwlj22pxo9axDkjF5tXQAjCIN0O9fne2AHPqlcF8lcOl+R7vYL0slXpFthj/QoKAscpbCM3mG4AiOCclP4qpS4U8TIkhiVqQhOorQQpDuOQyqVOmjvXgohhBBCCCGEEEIcDjNnzuTCCy9k+fLlvPzyyzz99NMsXLiQRYsWMWvWrAHbr1mzhokTJxKJRAr39W8R0613KF9TUwPA9u3bGTFiBO3t7dx222089dRTNDQ04HkeXV1dbNq06aA8rwkTJvTJbVavXs3atWtJJpN9tkun06xbt+5Dn++xxx6jra2N1atX80//9E/cfffdzJ0790MfVwL1o4ivfTQ+Wvv9IvLBkvV+Bi1N711Rnr+te923x2MVStjpHcn3KW/vddqDG5r3O+c+wvMSL1kIzsu8Ikq8BAYDF7XsMLp4N97Mf5cHvFnssiFVTkukts82rp/h1NY/M6XlDZK7/oKzfgvuFouxG6GoEwo9coCmlM3GijhdZpS2SLQQou+sVGwqC3DTwxnddAKfejubr0T/PxSP3R2G6GW9QnRfsbFxBG/vnkBmVxVlOktchc9bmx411e8xObqa43bspOS9HDks3raP5/X4iWzdWzU6Gm17eP36owPYgUdRtouElyFQBlnDJegXpNsKTMskiDh4ETBMjWtYmH0++qRAuSg3RWCU4DrFjCiOUVMUxYnnK9JNG9u2SSaTff5oCCGEEEIIIYQQQgxGRaOMff21w3LeoYhEIkybNo1p06Zxyy23cOWVV3LrrbcOGqgPRe9P9HdXhQdBmO3ceOONPPvss9x9992MGTOGaDTKxRdfTDabHfRY3QzDKLRy7pbL5QZsF4/H+9xub29n6tSpPPLIIwO2raio2L8ntBfDhw8HYPz48fi+z1VXXcW3v/3tD73OngTqRxFP+2itCHR3IDxID5cBVeP7kWD3Cci7v9CDBuS9t+h/ffAC8269g949jwXC8LzUS/UKz1MU7yE8T6ssTXYrbycz/CWl+WvKZX2qlB2x4/od02dy67uc3vI6Fa1/xty8gWCLwYhNipFN0Hv6ddmK96sTtLoOaStGl+sU2rnsrFRsLPNxM3WM2nEiZ/zFDyvRY/+X4uN2UXxMa58QPfAVGxtH8pfmMEQvDzIkFSQJW7E4iWaOrVrF1Mx71G3rxM1pthllPJOvRs8ot6cavU9vdMAIwv7odnbA98rNB+lxL4OvDLKG02dhVQU4CgzHRrsWngumpYkYFkafgxmgHJSdIDCLcewShhcnqC2O4CZKwh7ppl34iFFsPz4uJYQQQgghhBBCCAFhiLw/rVc+bsaPH8+SJUsGfWzs2LE8/PDDZDKZQs/1V199dcjnWLFiBbNmzeKLX/wiEAbe3YuKdnMcB9/3+9xXUVFBY2MjWutCSN97gdI9mTJlCo899hiVlZWkUqkhj3cogiAgl8sRBIEE6mL/6SzgW+D1/rb3Xpl0QD340M/R67pPaH5Qg/LeZ+s9zj1Xm/dmaZPSXJJSL0V5vnVLkR8fNDzvUhm2Oa28lczydpFiXdJmazzJjugwcubAHt3Ht7/P3zS/xui21ajta0lvDSjdbHH8Zo3j9UzWANhUGWVbKkZOObRFwyr0wHXIFkXYUeLzQUkON13FqB0T+PRfDPzcGqzIYkqO20nx6Fai5X0r0ddvG8lfdk8kvauSiiBLkdJABhTY0TbqKv/KWPOvHLu7ibJ1OTws3rbH8nrsRLaYVfuoRvfx7QzaHPgaR/0cRdk0UT+DrxSZQYJ01wDlOAQRE88Gy4KIYfYL0k0UDjgJAqsI2yqmrihBXXGEaKIE4mVgOhiGUQjS92cxDyGEEEIIIYQQQogjxc6dO7nkkkuYPXs2EydOJJlMsnLlShYuXMiMGTMG3efyyy/n5ptv5qqrruKmm25i06ZN3H333QBDyk6OPfZYFi9ezPTp01FKccsttxSq17vV19fzwgsvcNlll+G6LuXl5Zx11lk0NTWxcOFCLr74Yp555hmefvrpfYbkX/7yl/nhD3/IjBkzuP322xk2bBgbN25k8eLFzJ07l2HDhg2639q1a2lvb6exsZGurq5CeD9+/Hgcx+GRRx7Btm0mTJiA67qsXLmS73znO/zd3/3dQVlzTwL1o0gQ5PI9yf1BH9dD+fojyzH7B7j7F5qjIRo4JP0YKT+ev45R7CUo8hP9gtxQl5Fhq9PKm6kc7xQp1iVdGmJJdkZH4hsD37ly/QwntK9jQvt7jG/7M1bru7RvzWBusRm7AUrbFWEbl/BV25Ww2FiRJG04tEei5CwTbVvkUjF2lQZsLuskrVxK24YzrPlY/maLRmfXYkafoPjYHRQf00qsvG8l+vrtI/nLromkd1VRGWQo7h2iR9qprVjLWPuvjGndTtnmLGYA241Sfhc5kT/vqxrdzFejWwOr0ZXWJLwMRbku7MDfY5DumAaGY+FHTLQDtqFwDbPf4UwUbhikm0VEnGJqU3FqiiPEegXpSikSiQTxeBzDGPjmhxBCCCGEEEIIIcSRLpFIcNppp3HPPfewbt06crkcw4cPZ86cOXz3u98ddJ9UKsWTTz7J1VdfzeTJk5kwYQLz58/n8ssvH1KL3B//+MfMnj2bM844g/LycubNm0dra2ufbW6//Xa+/vWvc8wxx5DJZNBaM27cOO677z5+8IMfcMcddzBz5kxuvPFGfvnLX+71fLFYjBdeeIF58+bxpS99iba2Nurq6jjnnHP2GsZfeeWVPP/884XbJ510EgDr16+nvr4ey7K46667eO+999BaM3LkSK699lquv/76/X4t9kbp/g1ujnKtra0UFRXR0tJyyD9q8FH7xS/uIYOmrbPlMI9kTxXwQ6yM1xAPIiT9WCEw731t6z2/X9RppPnAbWNVkcfbRYoNCZeGeIpdkRRaDQxr414nE9r/yqT2NYxve49EZj2d7U3sarbxmhxGboJRjfSpcc9YYRuXlmiUjOHQ4Tpoy8RLxWkpgQ/KOtntmBR11DGs+Tiqd5dgZBsJvA3Y8XUU1e+meHQrsYpeleiBYt32et7eNYGunVVUBFls1fMmgxNpp7piHcdZazmutZGy3WGIvsso4h1rDO/Yx9BoVOy1Gh3bx7OzaHPgGy9O4JPMZUjkujDQ+MrEU2bfIF0pXEOhIg6eq1AO2IaB1f911SZKRcCJo61iYk4xw4vjVBZFceMlECspBOnxeJxEIvGxDdKDIGD79u1UVlZ+bMcoxJFI5pYQh4bMLSEODZlbQhwaMreG7pOcbQ1VOp1m/fr1jBo16qhbe+2RRx7hiiuuoKWlhegQ+7cfjYbysyIV6keVQ/HeSf9u6IM9fuDnVVqR8CMk/ThJP9qn2jzpRzHZc8+jAE2H0cUuq5N1CY+Ncc37cZP1yQiNsRTNbjkM8rGX4lwrE9veY1L7u5zQ9leK0u/TnNlFU4tLZqdDZrtBXaNmdFt8wL4flEXYWpLE0xatsQi+ZeInYrSVmDSUddEYzxHtjDOs9Tgmvl+L07WLILcR011KonYHybpOEnUdOHGv53kEinVNo3h75wQ6d1VT6acpUQElpMNKdLeD6vL1HGe/x3GtDZRvCUP0nUYxL1kTedsew3ajDJTaRzW6R2Bl+twNYdQe9XIU5bqI+OEiFJ6yyCoT3ev1M5SBbRoYEQvPVZg2uKaJ2b8nv7bCinQ3hjZLSEWLGV4co6wojhMvhWgJ5D8REIvFSCaTH7q3lRBCCCGEEEIIIcQn2UMPPcTo0aOpq6tj9erVzJs3j0svvVTC9ENAAvWjic6BMtnvtik9O+7h6wOnNLjaIRI4RAOXaOAQyV+Ht12SfpSEHx20t3m3gIA2s4sGN83auMemOHwQNdgWtdgRidDiJmm3KwcNzgGqMjuZ2PYuE9vf48T29yhNv892r5XG1gidu1x2NBkkGzTH705xfL/XIAAaSiNsL46TNhw6HYe0bREkYnQU2zSWpdlc3ImdtqhpPZZRW+qZ1J4myG1Cma8Rr/4tyXEdJOo6iRT3XS3Z9wzW7RrFOztPoH1HDVVBhlLlU0pnGKI7nVSVr+dY+6+Ma9tCWUMYou8wSnjRmsTb9jE09Q7RcwY6F1al969G9+0swSDV6KbWJHIZUrkurHybIM+w8BgYpDuWgYrYeJHwRyxi9u+PrkDb+dYuMbBLKY4WMbwsRmkyiRUvAzcF+WqDWCxGIpHAsuRXlBBCCCGEEEIIIcS+NDY2Mn/+fBobG6mpqeGSSy5hwYIFh3tYn0iSVh1FPC8HtsHQA/X9o7TKB+Q94fiAwFyHt93AGbSP+aDjxqfZ7GRjLMv7cZ9NcdgaNdkWddjlRmhxS8lYzl6PEfHTDO9q5LiujUxqW8OJ7e9Rnn6fBt3J5vYIbbtcNu4wodFgVFMxYwrvG/S8gbC9yKWhJEGn7aADRVvUxbNMgliEdMphe1mWDaWt+J5PdWs9w3aMYfw6A53bAqwnVrGMxIkdJOs6iZan+2T8OoAPmmt5u/l4djTXkWstpk61U6q8nhDd7qKibCPH2n/lhI5NYYiuw57oK6xjeNseww6zrHA8nTUIPAV+vzckzABsD28P1ehO4FOU7SLqpQl/WhRZw8bHLGTxSiksw8C0TXBMfLd7oVGr39sfBgQ2SjngxFFWKWWJIkaUxilKFWHES8IgPX/M7iBdKtKFEEIIIYQQQggh9t/cuXOZO3fu4R7GUUEC9aPKwOpypRW2NrG0lb82sbWVv+57/2DbWNrEDewwJNc2aoirlaZVlnYzw3bHY3skoMkN2OHATlfRGLXYHnXY5cZodaoIBlkYtLfSbDMjuho4pmszo9IfUN+1lZHprVSmG+iijU2mxeZOl5bdEf6yw2JEo0v9NpcRheLsntdnd9xmS3mC1kgUPOiIOGQdmyAeIRt3aE36NBWlaUi24/sBFW1VDNt9HOdsSmFkGwj8DURL/4PEcW0k6zqJVXXSf/jbWit4a/fxNDYPJ91SRnmQodToYgSA0QyAZaXDEN1ZywntGynflsHUsM0o47+dY3jbGsNOszQcvQ86YxDkDAj6fR/MAKyAwMriGwOr0Q0g5uVIZTtxgxwAvjLIKKtvf3TDxDJNTMfAdxTaAdMwcIz+b4+YqMAG5YAbw3DKKE8WM6IkTjJVjBErDSvVodAjPR6PS5AuhBBCCCGEEEIIIT7WJFA/SrS/tJUzt0/BxMLwe0J0cy/tVA5EgCZtZNlpZ2l0fba7ATtczU4XdjuK3Y5Jq23SZtt02DadVoK0VbrHliy9mYFPTaaJ+q4tHNO1ifr0Vuq7tlKf3kpt11Z2mh6bTJutns2uDof17S6bWxQlzVFqdkWobobhhdbkPVX6Ha7JpookzfE4OlB02SbpiEsQj5JOWLQkfbYXd9EQbyPwcxR3VlPRMZq6xlomvhfByO0k8DbipJ4hOXI3iboOEjVdmE7fTwLs7kzxl93j2LxrJG3NlRR7AZVGOyOUBpoLK5rG47soSTUwytzEiR3rqdiewdDQaJTzgnMS71jHsMssQevwaQRpA+31D9E1ytRoOyAwcwSGN+DtFAVYWpPKpYnnujB1OF5PWXi9+6MrA8MwMB0TwzYI3D21dYEwSHdA2eDGsdwyqlLFDC+JEy8qg2gp5D9NYBhGIUiXhWWEEEIIIYQQQgghxJFAAvWjhN+apSS355WdfQK6DI92K6DdDGi3AjosTbul6TI1Haam04IuU9NlQpepSOcvHZZBq23Rbtt02A6dVnyf1eT9KR2Q8joozbZQlttNZXYXo9Jb8qH5FkZ2baUq00STBRttmw98ix0dUf7c7vKXVkVxcxk1uzXVu+CkQjvygQuipm2DzRUJdiaTeFjklKYzHsFPxOhKmDSncmwr6mRbrAXtpSnprKWiYzQjt1QzpdXFyO0m8LdjWOuIlCwnOipNrKKLZG0nVrRv5XdHJsrbu8eyftdompuriWZMaow2hikfaKF7PVXX7aAk1cAwezPHeRupa2sl1uCjgAajgmXOMbxjjWG3WZwP0RVBWqFz/RYWzYfo5EN0b5AQHfKLjPo+yVwnUS9TiMT790dXysC0LJRjggNmvhrdGiz81hZKOyhstBPDjVZQU1RMbWmCaKosv9Bo+OvGNE3i8TixWEyCdCGEEEIIIYQQQghxRJFA/SjxTL3Lr0/NkjZNupQmaxhkTZOc0X2xCA5yuBnzuijJtVKWa6Yiu4uq7E4qc7soyzVTnm2mPLeb8lwz5dndlORaMfHpVIom02S7ZbIZi20dcV7qiPBSm0NqdzVVuzW1u2BiV/dZBvaDD4AdRRGaimK0RWNkTQflB3gqoCMRDRcNTSh2F+VoLOqkKbYbneukrGMYFe2jGbOpilPbbIxcM4HXiOm+S7T0eaJj0kTL08TK0zhJb8B5s57Nmt1jeG/XGHbursXsjFJrtlKjctTQVgjQTTNLcVEjte4WjvU3UN/eRLIpDNA7VIQN5ig2RobxvjWcZqMoDNH9vYTolgYrQFs5cspHD9baBzA1JLwM8VwXTuDlXytFzrB6+qMrhTJMTDsfpLsBlqmwTGPQanQCC0V40XYcN1bB8NJiqkpSuMkyiBQXFho1TZNEIkEsFkPtxycShBBCCCGEEEIIIYT4uJFA/SixzmvmzZKy/drW0D5RP0MkyBL100T9NLEgTdzvIuqH14mgk7jfRcxPk/A7qMjuDgPyfFBelmsmGoSl4j6w2zDYYZnsME22BRGasjHWZ2wyGQOdLsbuTBHt8ilq1xR3aErbYHw7jAdgYHgNsCvh0FQcZ3c8TtqOhAtx6hzpRBQ/FiEbMemKatpiHi2xLLviXTTbTahcjPKOYVS0H8PxGyo4o9XOV543YsfeIlK2jFhdGJ5Hy9LYsYE9xwGaOkrZ2DaCzW117GiuwW9PUavaqDTSVNIJVicASvmkkk1URbcyhg0c27GVot05DA1pHDZZw3nJHc4Gq44mowyUQmvQvkJnVNjOZbAQ3Q7QpoenfIJB3ljoDtFjfo5YLk3E76lG95WB190fXSkUCmVZGI6NcgJMR2GZClMN8itCWyhtAxbKMNFWkmisjBFlxVSWFWPHy8FNFtr4WJZFIpEgGo1KkC6EEEIIIYQQQgghjmgSqB8lzt/6NHXvv0HMTxMN0sTyIXksH4oX7vPTODq316VFNdClFJ2Gol0Z7DRctqoEm3IR3so6dGVLCDLFGF0+kU6PRKdHcQcUt2uKO2B8uvtIuX2Ouz1i0ViaYFciTkckho8FeOSiFtlYhGzUoCMa0BrPsTuWYXfMo91oxNOKRKaUonQFRelaineXMeqDGEXtJiq3Gx004iRWES3bRXREhlg+PDfdQSretaKxvZINbSPY3FrH7vYKutqLSAU+VWYrpSpLORkwmwr7xOO7qIg1MFptZGxmE+VtXZitkMNks1nLG04dG6zhNBgVaGUUqtB1VqE9hfYV0C9EtzXKCgj2EaIbKKJelriXJuJl+nTJ790fXeWr0ZVtoRwD01WYJtimNcj3v7saPVx4Vhs2lltCcaqcYcVxiotLMRNl4MQLe9i2XQjShRBCCCGEEEIIIYT4JJBA/ShRvKmTsz5YRatyaVMW7cpmq2HRRhFpv5isD1lfk/PBD3wCX4Pnozwf0/Mwcz5OLsDOeUSyAZEcRLKaaBaSXVDfDmOCHPsTkgPkTEVzwqUlHqEtGqUjEiFjOfiGjUahDU1gazIJl3RU0RHz81XmaZojHXSoTrRvUZSpoChdTio9nNrGEsZ1uCS6DCyvC+23gNqFHVuHnXgVtzRLZEyGaFmaaFkGwxrYGiXnm2xtq2F92wg+aKtjd1s5uc4UFXRQYbZTg0ctaTDS9E6qHaeD8kQD9eZGxmY3UtfeitWh8THYalbxonUi661hbDGr8ZW5HwE6oMJKdGUHBIaHr3z8PYbo4Po+CS9NJJfG7NX2xVcGvjLDti5GTzU6joXpGNiOxjQV5oDqcZWvRreAfMhuxYlGS6guLaeyOBkuNBopChusF14Lh2Qyieu6+/WzIIQQQgghhBBCCCGGRinF448/zkUXXXS4h3LUkUD9KPH/3nqdY/7sEcl5RDOQzEJlFtzBu6kcsNaoTXMiQks8Sns0SmckQsZ0CUwH3zLQBmD5+LYm6yqyjqbL8elyPDojHu1OB512hrSZoV114XhRitIVpNLlFHWVc8yOJEWdDrEuheF3oP1mTHc7dmI1brIDZ1gWN5XDSWVxkjmcxJ6fYMZz2NQ6jI1tw9ncVkdLWxmq06XWbKHESjMi0IykHcz2XnspLCtDMraTMnsHtaqREbltjGjfibMr7F7eaFTwqjWZ9e4wNps15JSzfwF6vpWLMsNKdN8ICCN0f0BX9O4Q3Q4CErk0US+NpXvC9gCFb5j4ysq3XlEo0wTLRDkWpgu2BVY+YO+rXzU6JpadpLiokrqyFCXFZZjxEnAShbYuAK7rkkwmcRwHIYQQQgghhBBCCHFgmpqamD9/Pk899RTbtm2jpKSESZMmMX/+fD796U8D0NDQQElJyUc+tvr6eq677jquu+66j/zc3b71rW+xYsUK3nrrLcaNG8eqVav2uO3atWs56aSTME2T5ubmg3J+CdSPEm57hnEf7PnxnKnockzSrkWXY9PlOqQdm4wdXrK2TdZy8E0Lz7DRpkVgWGhDERgQ2AG+lSMws2SdgC7Xo9Px6IjkaHM6yJhZ0kaGjMrgo4nmEkRzSWK5FNFckmg2QXJ3nOoul2jWJpoxiGY0ym8DdmHHt+Mk1uKkMrjD8mF5KoebzGLYAyvNe8t4Dk2dZWzrqmBbZyVbWmtpay8l2eVT5bSSNLOM8Q2gGez8TgGE4XmaVGwnFVYTdTQyMreNms7dOK3hOX0MdhglrDZPZIMzjI1WHWkV2f8KdLMnQNcGhBF62M5lTyG6FWgSXppoLo2t+/Z39/ILjGrDCPcwTQLbwrBMDBccE0yTvVSj26ju1VOVSzRSTGVZJTXlJcRS3dXods9eShGJREgkEti2jRBCCCGEEEIIIYT4cGbOnEk2m+XBBx9k9OjRbNu2jaVLl7Jz587CNtXV1YdxhB9eNpv9UEWZs2fP5pVXXuHNN9/c4za5XI6///u/5zOf+QwvvvjiAZ+rPwnUjxKlZ/89DxStwrdsPBUQmOBZAYEZ4Jse2shh6AzQhSZDzgrIWj5ZMyBn+WTMDnyjFU/5eMrHVx4efv52DiOwieWSYTieSxLLFpPojFO9y+WYjEMkY+JmDRxPY/oeOujAtNsw3DZMtwHL7cSK5LBKPayIjxX1cJI53FQOO773MvpAK5q7UmzvqmB7VzlNXeXs6Coj0xHFaVckyJGyM8TsLEmlOd4LgJ3QPWf9cBrYdhdFkV1UWtuo09uozzZQ1dmC1RpulsNim1nGm8YJbLMraDAraDJK8ZV1QAE6BgQqwNMBAd6AAJ38ERRgaYh7aWK5NE7Q9/XwlYmvTALDDLc2TALHQtkmylHETL2HEB3ARAX5BUZRaK2wrBipRCV1VRWUlJRiJfLV6L33Mk3i8TixWAzDMAY5rhBCCCGEEEIIIYQYqubmZpYvX86yZcs488wzARg5ciSnnnpqn+36t3x58cUX+Yd/+AfeffddTjzxRP75n/+ZL37xi7zxxhtMnjyZZcuWcfbZZ/OHP/yBefPm8fbbbzN58mTuv/9+xo4dC8C6deu44YYbePnll+no6GDcuHHceeedfO5znwPgrLPOYuPGjVx//fVcf/31AGitue2221iyZEmfSvF7772Xe++9lw0bNgAwa9YsmpubOeWUU/jZz36G67qsX7+ezZs38+1vf5vf//73GIbBZz7zGX7yk59QX1+/x9fopz/9KRBW8u8tUP/nf/5njj/+eM455xwJ1MXQNR7byH/lfgcaDG1i+y524GL5DnbgYns2rufi5mwcrwgnY5H0TGzfxvYMLN/E8gyswMDyFZavMAKFGWhMX2MEaSy3FdNtxXR3Y0W2YEU8rBIfM+qHX0f8/CX8Wpn7P/50rrvKvJKmrnJ2dpaQbXVxOhRuNiDhZom5HralqcOkKpdD6wB6t/H2e/X5tjspjuykygjD81HZBirSbRj5FvBduDSaFbzqjKLRrKDRqGCXUdyzgGgAOlDonAqD9L0F6JZGmWGArhUEuqcKfbAUvbsS3dCKuJch6qVx/Wyfo/vKIFAWvmGEW5sGge2g7bCdS8wIsMKW6QPHhQJto7RVqEZX2sR1UlRVVFNdWUG8qAIiKTD6/oqIRCLEYjEikch+fueEEEIIIYQQQgghPj601njZgWvUHWqWY6AGLXbsK5FIkEgkWLJkCZ/61Kf2a4261tZWpk+fzgUXXMCjjz7Kxo0b99iS5eabb+ZHP/oRFRUVfOMb32D27NmsWLECgPb2di644AIWLFiA67o89NBDTJ8+nTVr1jBixAgWL17MpEmTuOqqq5gzZ86Qnj/A0qVLSaVSPPvss0BYQX7eeedx+umns3z5cizL4vvf/z7nn38+b7755oeqYP/jH//If/7nf7Jq1SoWL158wMcZjATqR4lgSStX7ZyEaeZQRg7DyqHMHIaZQ5ntGJaPYQUoU2PYAUY0DIMNK8DIV1QblsYww2uVv9+wAkwnwHQP7BdRJufQno3RlkvQmk3RmkvSlYmQ7XLJtTmodgMnAzErRzTmY7qaKtOkzPPI5FxwVNjHhCgE4GehpwlKQMTpIGG3UWw2U0Izlf4uRme3UpbrKKyf2qriNJoVrHGOp9GsYJtZTotKolGgw+AcT4UBuq8K7WAGGCRAVwp87eMRhL3Q9xCgAxgYOIFPxM8Q8bI4fhaj34aeYYeLmvYK0QPbwnINoqaPber8PoOMT5so3VONDmCpCMl4KXWVVZRW1mDFS8CJ9dnNMAxisRixWAzLkl8ZQgghhBBCCCGEOHJ52YBf/uPzH/l5r/rJmdjuvqtLLcvigQceYM6cOfziF79gypQpnHnmmVx22WVMnDhx0H0effRRlFL86le/IhKJMH78eLZs2TJo6L1gwYJC5ftNN93EhRdeSDqdJhKJMGnSJCZNmlTY9o477uDxxx/niSee4Nprr6W0tBTTNEkmkwfUciYej7No0aJCUP7www8TBAGLFi0qvNlw//33U1xczLJlyzj33HOHfA6AnTt3MmvWLB5++GFSqdQBHWNvJB07SlQOW8Xwc/5ySM8RaEVXNkpHNkpHJkZXOkY27eJ12vidFmQUKqMwchoz0FiA6WgsJ8BwIeYYRCwDT0E2UKRxyTmxQmuWjAbSfc9pGB4xu42k1UqpaqZU76bCb6Yqt5syvxUrG0A2Pz4Uu40UjUYtq9xytuUrzzuNaE/Veb5tC34YoKP39M6hBlOjDI0y6Rugo/NV6AGBHvyNhrAKXWFoiPpZIn4W18v0WVi0e0PfsMKWLphgGvi2Q2A7mC5EzADH1Bj4g59Fmyht0TtEVxi4Kk5FeSVVNbWkSqry1eh9f6k7jkM8HicSiezXO6hCCCGEEEIIIYQQ4sObOXMmF154IcuXL+fll1/m6aefZuHChSxatIhZs2YN2H7NmjVMnDixT0eB/i1iuvUO5WtqagDYvn07I0aMoL29ndtuu42nnnqKhoYGPM+jq6uLTZs2HZTnNWHChD5V56tXr2bt2rUkk8k+26XTadatW3fA55kzZw6XX345n/3sZw/4GHsjgfpRwndKyeUsfN8ML154CXyTwDMIcgY6Z4CnIKdQ+V7gdPcD90EF4TU+oEEFGqVBaR9H+RgmGFGIRG2U42LbDlnDJWu6ZGMRclaEnBMJK8vp13fby18GYZsZ4nYbxcZuSmmhLNhNpddMlbebZNCBygCZcNsuXHYbKXYa5ax1RtNspGg2ithtFNGiEgQYYdW5r3p6ngd7qTpHh0G5EVaf032twvA8v0VPGxc9cDHR7iOHz9gg4ntE/Ayul8UJcn3Pmr/hKwttmHiFEN0mcF0M28A1AyKm3/8V7DmAtlDapE+IrhW2skm4KaoqaymvG4adKAU72ndvpYhGo8TjcVlkVAghhBBCCCGEEJ84lmNw1U/OPCznHYpIJMK0adOYNm0at9xyC1deeSW33nrroIH6UPTOe7oLKIMgLPC88cYbefbZZ7n77rsZM2YM0WiUiy++mGw2u9djGoaB7teWIZfLDdguHo/3ud3e3s7UqVN55JFHBmxbUVGxf09oEH/84x954oknuPvuu4GwzU8QBFiWxS9/+Utmz559wMcGCdSPGmfoKNtfs/BME88yCSwLzzDxDQvPzFdAKwvfMfEcCz9uEWAS+BZ+YOWvw9tBEAbz4bWF5zlo3au6OUuhKnxvbDODa3QRNdLEVAdx1UVcd5LUnSSDDipyzZTRQtTPFPq4+Bi0qCTNRoq/2vX5sDyVD85TdJF/Jy7f4xyt0B4QqMLCoYMH54QtW4y+lecYmv7F2T4arQMCHfZB31OADmEbF0sHRPwsES8M0c3ee3RvqBS+sgiUgY8JpolvW3iui2mbRCyfiOHvpRLd6lWJ3nNoG4eEk6S8pJzSmlpixRXgJqHfQqKWZRGPx4lGo7LIqBBCCCGEEEIIIT6xlFL71Xrl42b8+PEsWbJk0MfGjh3Lww8/TCaTKfRcf/XVV4d8jhUrVjBr1iy++MUvAmHg3b2oaDfHcfD9vvlURUUFjY2NaK0LIX3vBUr3ZMqUKTz22GNUVlYe1NYsL730Up8x/uY3v+Guu+7ixRdfpK6u7kMfXwL1o8QbOsl72UsO6TlMlcM100RVF3HVQYJO4rorDMj9DpK6M7yPLmJ0YfoB/fPhLDYdKkqnitJspdhoDOsVmhfRTCLsH94dkAf5wFzvq9K8t3zVudk3QO9ddd4tIOyBHuT/04PG56HuNi4KRcTPhQG6n8UJvL4bFRJvC08ZBBgEpoVv2QS2BY6DssFVPilDYw767oTRrxK95/A2DgkrTkVJBcU1NcTLqsFJDAjRAaLRKLFYbL8WuBBCCCGEEEIIIYQQh9bOnTu55JJLmD17NhMnTiSZTLJy5UoWLlzIjBkzBt3n8ssv5+abb+aqq67ipptuYtOmTYXq7KG08T322GNZvHgx06dPRynFLbfcUqhe71ZfX88LL7zAZZddhuu6lJeXc9ZZZ9HU1MTChQu5+OKLeeaZZ3j66af3GZJ/+ctf5oc//CEzZszg9ttvZ9iwYWzcuJHFixczd+5chg0bNuh+a9eupb29ncbGRrq6ugrh/fjx43Ech3HjxvXZfuXKlRiGwYknnrjfr8XeSKB+lCiOxgGNwsdSPpbysPCwVA6HHDZe/jr/tc4VLj2P9Vzbva5dssTpxNHegLYtaRw6VZROI0KHitGgKulUkfA+FaXDyF8TpZMoHlYYjmvyITlha5YcEISLhO47MId8LxqUQU+VuZEPzo2BwTmEh/Z10Cs8H7z6vPcIugN0O/Bx/SwRL4vrZzG69+zp9QLKwFcGGhPPMAlsB9+2wLbBsbBUQNTwccj17N+H0asS3ewTojs4JMwoZcXllNQMI1ZRjdpDiG6aZmGRUdM88t6RFUIIIYQQQgghhPikSiQSnHbaadxzzz2sW7eOXC7H8OHDmTNnDt/97ncH3SeVSvHkk09y9dVXM3nyZCZMmMD8+fO5/PLL+/RV35cf//jHzJ49mzPOOIPy8nLmzZtHa2trn21uv/12vv71r3PMMceQyWTQWjNu3Djuu+8+fvCDH3DHHXcwc+ZMbrzxRn75y1/u9XyxWIwXXniBefPm8aUvfYm2tjbq6uo455xz9hrGX3nllTz/fM/CsieddBIA69evp76+fr+f74FSun+Dm6Nca2srRUVFtLS0HJJVYA8X79nvoVbci8ngi2T2piGM1pVFDgsvfz3wdrhNFocOFaVdRWlXcTqI0UWELiIE2iBsSUIhJO//9X6H5L1HqCiE44VWLQYotefAvL9C6xb23Lql98iMfHm5Cdi+hxPkcPzwYmm/Z+NebVzAxMu3c/EtB9+2wbHRjo1hBESMAFsF2HqwVi4AZq+FRc1eYwEbm6QZpSxVQknNcKKVdahIctAnr5QiEokQjUaH9ItU7J8gCNi+fTuVlZXSMkeIg0jmlhCHhswtIQ4NmVtCHBoyt4buk5ptHYh0Os369esZNWrUUZeHPPLII1xxxRW0tLQQjUb3vcNRbig/K1KhfpTYWvY3LHMayBkOac8PA15t4CsTXxv53t1h+xGtB+kzrukJnPu3VTmgUHxPdCGUDtuwDKwyH6w1yz6OGAbmWg+hdQuEHdDBDnzsXuG5HXjhM+1dIq4U3XfqfB/0nOXgOy7asdC2jWEqHCNcwNXW6Z4qdN3v7DpfiY6F6rX0qAE4+RC9NFFCSfUwItV1GNHUHkN013WJRqO4riv/8BBCCCGEEEIIIYT4hHrooYcYPXo0dXV1rF69mnnz5nHppZdKmH4ISKB+lFizM+D9bPVHcKZerU5UPgTPf10Iwgfc1oVweihBeX8BoLWPpjs4D+/d20cw+ofnpg7C4DzwsP0ctp/DVL2eE4Ch+r13kK9Ctxxytou2HXAssAwsQ2MrH5uwil31eokKBy0E6Ca9q9DDI4chesqOUBwpobi6jmhVHUayZPDnIyG6EEIIIYQQQgghxFGnsbGR+fPn09jYSE1NDZdccgkLFiw43MP6RDoiAvUNGzZwxx138Mc//pHGxkZqa2v5n//zf3LzzTfjOE5huzfffJNrrrmGV199lYqKCr75zW8yd+7cwzjyj4/q6mocR4FhkPNz9Am+8waE2b3T30Ef6y7K7qkqH/Q4B1l3qxbdKzrfn75FhSw//1/YuiXXq/rcw8Lv9VxVmGj3e/JamfiGhWdaeLYDlot2TLAMlAGO8nHwsLQOW+wMIUAHsFW+nYsVhuhFlbXEKmtRqRLUHgLy7hA9EolIiC6EEEIIIYQQQghxlJk7d67koB+RIyJQf/fddwmCgH/9139lzJgxvPXWW8yZM4eOjo7CirWtra2ce+65fO5zn+MXv/gFf/7zn5k9ezbFxcVcddVVh/kZHH4TJkzg+WVL8O0IbZ3pwz2cfQogXBQ036alOzzfV3Deu8d4T3QOhtZY2i/0PreDfOuW3uG50fsI3XebeKaJb9n4poNvu2CbYIbhOQoMFeCgschiax/VP0DHgGBfAbpF3HBJ2nFisSISJWW4pVUYxaUoa/Bp6rpuoS+6hOhCCCGEEEIIIYQQQhx6R0Sgfv7553P++ecXbo8ePZo1a9bw85//vBCoP/LII2SzWf7t3/4Nx3E44YQTWLVqFT/+8Y8lUP+Y6R2Wd/9HIS7fW3fzUJ/W5fn/57NtTB1gBR5W4GPpXtc66Nmrd+uW3kdVBr5l4ps2geniOTbaclCWyvduD1vYWAThMQmwdIDRZ13ffQfoltI4WEQNl5QdIxYtJp4owikpx0qVoGIxlGkO+twdxylUopt72EYIIYQQQgghhBBCCHFoHBGB+mBaWlooLS0t3H7ppZf47Gc/26cFzHnnncddd93F7t27KSkZvOd0JpMhk8kUbre2tgLhKtJBEAy6jxhcuPinBt0TjffE5PvXlqW3nmrznui8OzgPg3I/DM+7r4MgXOhzsJYzqncFd094rk0bz7IJbIfAssEywvDcCEdrEWBqjY2PpcHU/iCjNCEwewXofQcQBugmEdMlYUWJR0uIR5M4yRLMohKMaBQViaB69crRvUJ6x3EKLV16h+jy8/nxEQT5T1PI90SIg0rmlhCHhswtIQ4NmVtCHBoyt4ZOXishDq0jMlBfu3Yt/+t//a9CdTqEjfdHjRrVZ7uqqqrCY3sK1O+8806+973vDbi/qamJdPrj3xplKCLRJIHp7HM7XbjWoHtXjHd/3fP/7uryA9W7yrzndvdjAaYOMLUfXgcBJgGGDvLh9d4OnD+SAgyFNgwCZRIYFtqyCAwLZSpQGrtXjxYLjYHGRGNqjerz3AzQYazfN97vy0RjKYWjLKJmBMeJEXUTWE4UIxpDRSL4jkO6u5VLNhteerEsC9u2cRwH3/fp7Oyks7Nzf19W8RELgoCWlha01tJ+R4iDSOaWEIeGzC0hDg2ZW0IcGjK3hq6tre1wD0GIT7TDGqjfdNNN3HXXXXvd5p133uH4448v3N6yZQvnn38+l1xyCXPmzPnQY/jOd77DDTfcULjd2trK8OHDqaioIJVKfejjf5x0djWTsyK0dO6iJwrvCcQPPBbv0TteNvrF5eECpuEWpg6DcVP3Dc2N7q+7q8378fOX7irz7sAc00Ab+cDcNPFNE22ZYFgEhkFgAMoH5RWOZQYaS2ss/J4FRAvPwsDXJkobhMG5MaDyvJulNI5SuIZDwooSjZSQjJZgu1HMaBIjFsWIx8Mq9D388bcsq1CJ7jiO/CPhCBMEAUopKioq5HsnxEEkc0uIQ0PmlhCHhswtIQ4NmVtDF4lEDvcQhPhEO6yB+re//W1mzZq1121Gjx5d+Hrr1q2cffbZnHHGGfzyl7/ss111dTXbtm3rc1/37erq6j0e33VdXNcdcL9hGJ+4X9SBERDg49O/bUmPQbuldEfJSg3YpicyD28Z9ArF89dGd3V599c62EM03W8kysgXgSswDLRhoEyTQJloOwzQtWERmAa+MggM1bfEvSCsODfQmDrARodjAQpV59rKd2I36X4roD+DMDy3lMIxTCLKJuJEce0k8VgxjpvAtKOoiIsZi6HicQxn8E8EmKZZCNBd15V+6J8ASqlP5O8NIQ43mVtCHBoyt4Q4NGRuCXFoyNwaGnmdhDi0DmugXlFRQUVFxX5tu2XLFs4++2ymTp3K/fffP+CXw+mnn87NN99MLpfDtm0Ann32WcaOHbvHdi9HG8d28QMDK99PvPfinv1vGQQowgU3VXeblUBjaB0+pnXhMVMHGEH+ekBVueppvwJhNbkyC/drI19lroz8IqHhtVJh1XlgmASmCq+Vka8233McbxGOyyQotG0JK8/z7Vm0AdpE4TBYv/Oe44BlaGxD4Sobx3SIWnFcJ0EkksCyY1i2izIslKFQsRhGNF+JPkg4rpQqhOeO4xR+RoUQQgghhBBCCCGEGCqlFI8//jgXXXTR4R7KUeeI6KG+ZcsWzjrrLEaOHMndd99NU1NT4bHu6vPLL7+c733ve3zta19j3rx5vPXWW/zkJz/hnnvuOVzD/tiJqwDl5zBynT1heSEgJx+Wh33DBwTNfZub931AKbBMUFa+4NsoVJUrlX9cqfy6oDrf0zxczDPobkuuwipzrSAgDM4Hr5fvbsASYGqwCCvNTR3eHwbmCoVFd+uWXjX2Ayi6q87BNRWOsokYUVw3juskcZw4th3DtN3CoqHKtlCRCEYkEl7voQq9dwW6bdt9Fh0VQgghhBBCCCGEEGIwTU1NzJ8/n6eeeopt27ZRUlLCpEmTmD9/Pp/+9KcBaGhoOCxFxPX19Vx33XVcd911H/m5u33rW99ixYoVvPXWW4wbN45Vq1b1eXzDhg0D1toEeOmll/jUpz71oc9/RATqzz77LGvXrmXt2rUMGzasz2NahxXRRUVF/P73v+eaa65h6tSplJeXM3/+fK666qrDMeSPpWQkgvbasCygu8JfgVK9q/3zoW8h/NU9Xxv9I+78YypMsw0UgQr3DfIXlMoH5QYag0ApNPv30aOeNi3dleYKUyuUJt+eRQE2ewvMez8rk7Dq3FLgGiaOaeNaMVwnSdRJYNkJLCeCafZUjysF5MNzIxJBue6gFegQ9kHvXYUuH7ESQgghhBBCCCGEEEM1c+ZMstksDz74IKNHj2bbtm0sXbqUnTt3FrbZW4vrI0E2m8XZQ5Hq/pg9ezavvPIKb7755h63+cMf/sAJJ5xQuF1WVnbA5+vtiEj8Zs2ahdZ60EtvEydOZPny5aTTaT744APmzZt3mEb88WQn4lhREytpYsWN/EVhxjRmPMCMa4x4AHEN8QDioBOKIK7wEwZezCQXs8jGbDIxh3QsQlcsQmc0RkckQUskSZubpN1J0GnHSVsx0maUnOHiKRtfmYUw3SBcENTRmojWxANNItCkfCj2NKUeFHsGKc8m7rtEgyhOEMHULgYuChtF2Pe8O063lMY1NDFDk7I0JQ5UuSbDIlFGxosYWVTF6JLRHFs5idG1p1E/7HTqaqdQXn4s8VQNbjSJFYliJBNYFeXYw+qwR43Cqa3FKi3FiMUKYbpSCsdxiMfjFBcXU1VVRWVlJUVFRUQiEQnThRBCCCGEEEIIIcSQNTc3s3z5cu666y7OPvtsRo4cyamnnsp3vvMdvvCFLxS2U0qxZMmSwu0XX3yRyZMnE4lEOPnkk1myZAlKqUL19rJly1BKsXTpUk4++WRisRhnnHEGa9asKRxj3bp1zJgxg6qqKhKJBKeccgp/+MMfCo+fddZZbNy4keuvvx6lVKEbw2233cbkyZP7PI97772X+vr6wu1Zs2Zx0UUXsWDBAmpraxk7diwAmzdv5tJLL6W4uJjS0lJmzJjBhg0b9voa/fSnP+Waa67ps/bmYMrKyqiuri5cDlYL5iOiQl0cHIETIWM5dBEFCOu/lUIDevDVPPdTr0VJdU/tuKl7KsNV0L3cZ/cipvuqKe/LAIx8axYDsE2wlMJSBrbhYhk2phXBtiI4VhTTjGBaEUzLwTCsQQNupQA3ghFxe6rPrYFTQimFbduF3ue2bWMNsp0QQgghhBBCCCGE+HjTWuNlMh/5eS3X3a92wIlEgkQiwZIlS/jUpz6F67r73Ke1tZXp06dzwQUX8Oijj7Jx48Y9tmS5+eab+dGPfkRFRQXf+MY3mD17NitWrACgvb2dCy64gAULFuC6Lg899BDTp09nzZo1jBgxgsWLFzNp0iSuuuoq5syZM6TnD7B06VJSqRTPPvssALlcjvPOO4/TTz+d5cuXY1kW3//+9zn//PN58803P1QFO8AXvvAF0uk0xx13HHPnzu3zhsSHIang0cSM4ikXjyiFEDxf5K/6BepK97RNDy8aQ+cXLNUU+qx3dynv7r2+v3XZPd3NQSkdrlXafSwDLJUPzA0DWzkYpo1lhoG5bUUxzSim5WKaDqZp71dFuLItlOtiuC6qO0Dv94vMMIxCaC7huRBCCCGEEEIIIcQni5fJ8NOvXvyRn/dbD/5f7Ehkn9tZlsUDDzzAnDlz+MUvfsGUKVM488wzueyyy5g4ceKg+zz66KMopfjVr35FJBJh/PjxbNmyZdDQe8GCBZx55pkA3HTTTVx44YWk02kikQiTJk1i0qRJhW3vuOMOHn/8cZ544gmuvfZaSktLMU2TZDJ5QC1n4vE4ixYtKgTlDz/8MEEQsGjRokJGd//991NcXMyyZcs499xzh3wOCN+U+NGPfsSnP/1pDMPg//2//8dFF13EkiVLDkqoLknhUSSiHCKBgenn25bQE2rn69Xz13vS02Kne59C4K50voo8fNwkDMbN/JqkZj4gN5SBqYywXYthYxgmpnIwDBvLtDBMG4UdhuSmi2VFMEwLo9fHSPZKgbLC4FzZNoZtQ77yXPUL3SU8F0IIIYQQQgghhBAfNzNnzuTCCy9k+fLlvPzyyzz99NMsXLiQRYsWMWvWrAHbr1mzhokTJxLpFdifeuqpgx67dyhfU1MDwPbt2xkxYgTt7e3cdtttPPXUUzQ0NOB5Hl1dXWzatOmgPK8JEyb0qTpfvXo1a9euJZlM9tkunU6zbt26Az5PeXk5N9xwQ+H2KaecwtatW/nhD38ogboYmjLbIG0EGLbfp/ocetYoNcivM5q/X+WX/0SpcBud30sZhYVBlTJRysQ0LExlY1h2eG3YGEZ3cG5jGA6GaaGUgVJq/0PyQSgFOA7KcVCWheG6YNso2x5wTKUUlmVhmiaWZUl4LoQQQgghhBBCCHGUslyXbz34fw/LeYciEokwbdo0pk2bxi233MKVV17JrbfeOmigPhS9+4h3Z2hBEABw44038uyzz3L33XczZswYotEoF198Mdlsdq/HNAxjwFqXuVxuwHbxeLzP7fb2dqZOncojjzwyYNuKior9e0L76bTTTiu0mvmwJFE8ilSV15Bp6yJmVIahdtjdHMPIB+TKDCeSMvOBek/4rQwjH6KHJeeFML776w8Rju+NMlQYnNs2Rj5Ap7vyvBfDMPqE5r2vzfxCokIIIYQQQgghhBDi6KaU2q/WKx8348eP77MIaW9jx47l4YcfJpPJFHquv/rqq0M+x4oVK5g1axZf/OIXgTDw7r9AqOM4+L7f576KigoaGxvRWhfywe7FUPdmypQpPPbYY1RWVpJKpYY83qFYtWpVoSL/w5JA/SgSS1SSSHSSHKSK+3BRpgGWhTLNcEHQ/LWy7LDnea/gfLCwvPt6f3qoCyGEEEIIIYQQQgjxcbZz504uueQSZs+ezcSJE0kmk6xcuZKFCxcyY8aMQfe5/PLLufnmm7nqqqu46aab2LRpE3fffTfAkDLAY489lsWLFzN9+nSUUtxyyy2F6vVu9fX1vPDCC1x22WW4rkt5eTlnnXUWTU1NLFy4kIsvvphnnnmGp59+ep8h+Ze//GV++MMfMmPGDG6//XaGDRvGxo0bWbx4MXPnzmXYsGGD7rd27Vra29tpbGykq6urEN6PHz8ex3F48MEHcRyHk046CYDFixfzb//2byxatGi/X4u9kUBdHDLKMvuE5YXQPH9Rplnoa94dive+9A/NPy5vAgghhBBCCCGEEEIIcSgkEglOO+007rnnHtatW0cul2P48OHMmTOH7373u4Puk0qlePLJJ7n66quZPHkyEyZMYP78+Vx++eV9+qrvy49//GNmz57NGWecQXl5OfPmzaO1tbXPNrfffjtf//rXOeaYY8hkMmitGTduHPfddx8/+MEPuOOOO5g5cyY33ngjv/zlL/d6vlgsxgsvvMC8efP40pe+RFtbG3V1dZxzzjl7DeOvvPJKnn/++cLt7uB8/fr11NfXA+GCqhs3bsSyLI4//ngee+wxLr744CxGq3T/BjdHudbWVoqKimhpaTnkHzX4qO18/30+WL/hwCrUVf4dLdMMG64bRhiGG0afwBzLwrAsDMfBMIxBg/LB7hfiSBYEAdu3b6eyslJ+noU4iGRuCXFoyNwS4tCQuSXEoSFza+g+ydnWUKXTadavX8+oUaOGFCx/EjzyyCNcccUVtLS0EI1GD/dwPvaG8rMiFepHkTDwNlERF8M0w/Yq+UDcMIwwFO++bZo915YVXuf7pA926R+UCyGEEEIIIYQQQgghPhoPPfQQo0ePpq6ujtWrVzNv3jwuvfRSCdMPAQnUjyLJ2lrKLYvKyspCCxVpoyKEEEIIIYQQQgghxJGtsbGR+fPn09jYSE1NDZdccgkLFiw43MP6RJJA/ShimmbhIlXkQgghhBBCCCGEEEJ8MsydO5e5c+ce7mEcFSRVFUIIIYQQQgghhBBCCCH2gwTqQgghhBBCCCGEEEIIIcR+kEBdCCGEEEIIIYQQQgghhNgPEqgLIYQQQgghhBBCCCGEEPtBAnUhhBBCCCGEEEIIIYQQYj9IoC6EEEIIIYQQQgghhBBC7AcJ1IUQQgghhBBCCCGEEOIIopRiyZIlh3sYRyUJ1IUQQgghhBBCCCGEEOJjoqmpiauvvpoRI0bgui7V1dWcd955rFixorBNQ0MDn//85z/ysdXX13Pvvfd+5Oft7Vvf+hZTp07FdV0mT5486DZaa+6++26OO+44XNelrq6OBQsWHJTzWwflKEIIIYQQQgghhBBCCCE+tJkzZ5LNZnnwwQcZPXo027ZtY+nSpezcubOwTXV19WEc4YeXzWZxHOeA9589ezavvPIKb7755qCP/+M//iO///3vufvuu5kwYQK7du1i165dB3y+3qRCXQghhBBCCCGEEEIIIT4GmpubWb58OXfddRdnn302I0eO5NRTT+U73/kOX/jCFwrb9W/58uKLLzJ58mQikQgnn3wyS5YsQSnFqlWrAFi2bBlKKZYuXcrJJ59MLBbjjDPOYM2aNYVjrFu3jhkzZlBVVUUikeCUU07hD3/4Q+Hxs846i40bN3L99dejlEIpBcBtt902oFL83nvvpb6+vnB71qxZXHTRRSxYsIDa2lrGjh0LwObNm7n00kspLi6mtLSUGTNmsGHDhr2+Rj/96U+55pprGD169KCPv/POO/z85z/nN7/5DV/4whcYNWoUU6dOZdq0aXs97v6SQF0IIYQQQgghhBBCCHFU0FoTZP2P/KK13q/xJRIJEokES5YsIZPJ7Nc+ra2tTJ8+nQkTJvD6669zxx13MG/evEG3vfnmm/nRj37EypUrsSyL2bNnFx5rb2/nggsuYOnSpbzxxhucf/75TJ8+nU2bNgGwePFihg0bxu23305DQwMNDQ37Nb5uS5cuZc2aNTz77LP89re/JZfLcd5555FMJlm+fDkrVqwgkUhw/vnnk81mh3Ts3p588klGjx7Nb3/7W0aNGkV9fT1XXnnlQatQl5YvQgghhBBCCCGEEEKIo4LOBWyd/+JHft7a289AOeY+t7MsiwceeIA5c+bwi1/8gilTpnDmmWdy2WWXMXHixEH3efTRR1FK8atf/YpIJML48ePZsmULc+bMGbDtggULOPPMMwG46aabuPDCC0mn00QiESZNmsSkSZMK295xxx08/vjjPPHEE1x77bWUlpZimibJZPKAWs7E43EWLVpUaPXy8MMPEwQBixYtKlS733///RQXF7Ns2TLOPffcIZ8D4P3332fjxo3853/+Jw899BC+73P99ddz8cUX88c//vGAjtmbVKgLIYQQQgghhBBCCCHEx8TMmTPZunUrTzzxBOeffz7Lli1jypQpPPDAA4Nuv2bNGiZOnEgkEincd+qppw66be9QvqamBoDt27cDYYX6jTfeyLhx4yguLiaRSPDOO+8UKtQ/rAkTJvTpm7569WrWrl1LMpksVOaXlpaSTqdZt27dAZ8nCAIymQwPPfQQn/nMZzjrrLP49a9/zXPPPdenxc2Bkgr1fro/ftHa2nqYR3LwBUFAW1sbkUgEw5D3UoQ4WGRuCXFoyNwS4tCQuSXEoSFzS4hDQ+bW0HVnWvvbYuRoo2yD2tvPOCznHYpIJMK0adOYNm0at9xyC1deeSW33nors2bN+lDjsG27Z0z5qvAgCAC48cYbefbZZ7n77rsZM2YM0WiUiy++eJ/tVwzDGPDzlsvlBmwXj8f73G5vb2fq1Kk88sgjA7atqKjYvyc0iJqaGizL4rjjjivcN27cOAA2bdpU6N9+oCRQ76etrQ2A4cOHH+aRCCGEEEIIIYQQQghxYNra2igqKjrcw/jYUUrtV+uVj5vx48f3WYS0t7Fjx/Lwww+TyWRwXReAV199dcjnWLFiBbNmzeKLX/wiEAbe/RcIdRwH3/f73FdRUUFjYyNa60JI370Y6t5MmTKFxx57jMrKSlKp1JDHuyef/vSn8TyPdevWccwxxwDw3nvvATBy5MgPfXwJ1Pupra1l8+bNJJPJwg/AJ0VrayvDhw9n8+bNB/WHVIijncwtIQ4NmVtCHBoyt4Q4NGRuCXFoyNwaOq01bW1t1NbWHu6hiAOwc+dOLrnkEmbPns3EiRNJJpOsXLmShQsXMmPGjEH3ufzyy7n55pu56qqruOmmm9i0aRN33303wJDyzWOPPZbFixczffp0lFLccssther1bvX19bzwwgtcdtlluK5LeXk5Z511Fk1NTSxcuJCLL76YZ555hqeffnqfc/bLX/4yP/zhD5kxYwa33347w4YNY+PGjSxevJi5c+cybNiwQfdbu3Yt7e3tNDY20tXVVQjvx48fj+M4fO5zn2PKlCnMnj2be++9lyAIuOaaa5g2bVqfqvUDJYF6P4Zh7PGb9UmRSqXkj5AQh4DMLSEODZlbQhwaMreEODRkbglxaMjcGhqpTD9yJRIJTjvtNO655x7WrVtHLpdj+PDhzJkzh+9+97uD7pNKpXjyySe5+uqrmTx5MhMmTGD+/Plcfvnlffqq78uPf/xjZs+ezRlnnEF5eTnz5s0b0Bb79ttv5+tf/zrHHHMMmUwGrTXjxo3jvvvu4wc/+AF33HEHM2fO5MYbb+SXv/zlXs8Xi8V44YUXmDdvHl/60pdoa2ujrq6Oc845Z6/z/corr+T5558v3D7ppJMAWL9+PfX19RiGwZNPPsk3v/lNPvvZzxKPx/n85z/Pj370o/1+LfZGaWmodNRobW2lqKiIlpYW+SMkxEEkc0uIQ0PmlhCHhswtIQ4NmVtCHBoyt8SHkU6nWb9+PaNGjRpSsPxJ8Mgjj3DFFVfQ0tJCNBo93MP52BvKz4pUqAshhBBCCCGEEEIIIcQR7KGHHmL06NHU1dWxevVq5s2bx6WXXiph+iEggfpRxHVdbr311sLiBEKIg0PmlhCHhswtIQ4NmVtCHBoyt4Q4NGRuCbF/GhsbmT9/Po2NjdTU1HDJJZewYMGCwz2sTyRp+SKEEEIIIYQQQgghhPjEOZpbvoihGcrPivERjUkIIYQQQgghhBBCCCGEOKJJoC6EEEIIIYQQQgghhBBC7AcJ1IUQQgghhBBCCCGEEEKI/SCBuhBCCCGEEEIIIYQQQgixHyRQP0r87Gc/o76+nkgkwmmnncaf/vSnwz0kIY4oL7zwAtOnT6e2thalFEuWLOnzuNaa+fPnU1NTQzQa5XOf+xx//etfD89ghTiC3HnnnZxyyikkk0kqKyu56KKLWLNmTZ9t0uk011xzDWVlZSQSCWbOnMm2bdsO04iFODL8/Oc/Z+LEiaRSKVKpFKeffjpPP/104XGZV0IcHP/yL/+CUorrrruucJ/MLyEOzG233YZSqs/l+OOPLzwuc0sI8XEhgfpR4LHHHuOGG27g1ltv5fXXX2fSpEmcd955bN++/XAPTYgjRkdHB5MmTeJnP/vZoI8vXLiQn/70p/ziF7/glVdeIR6Pc95555FOpz/ikQpxZHn++ee55pprePnll3n22WfJ5XKce+65dHR0FLa5/vrrefLJJ/nP//xPnn/+ebZu3cqXvvSlwzhqIT7+hg0bxr/8y7/w2muvsXLlSv7H//gfzJgxg7/85S+AzCshDoZXX32Vf/3Xf2XixIl97pf5JcSBO+GEE2hoaChc/vu//7vwmMwtIcTHhdJa68M9CHFonXbaaZxyyin87//9vwEIgoDhw4fzzW9+k5tuuukwj06II49Siscff5yLLroICKvTa2tr+fa3v82NN94IQEtLC1VVVTzwwANcdtllh3G0QhxZmpqaqKys5Pnnn+ezn/0sLS0tVFRU8Oijj3LxxRcD8O677zJu3DheeuklPvWpTx3mEQtx5CgtLeWHP/whF198scwrIT6k9vZ2pkyZwn333cf3v/99Jk+ezL333it/t4T4EG677TaWLFnCqlWrBjwmc0scqHQ6zfr16xk1ahSRSORwD+eg6p9NiA9nKD8rUqH+CZfNZnnttdf43Oc+V7jPMAw+97nP8dJLLx3GkQnxybF+/XoaGxv7zLOioiJOO+00mWdCDFFLSwsQBn8Ar732Grlcrs/8Ov744xkxYoTMLyH2k+/7/Pu//zsdHR2cfvrpMq+EOAiuueYaLrzwwj7zCOTvlhAf1l//+ldqa2sZPXo0X/7yl9m0aRMgc0scfZqamrj66qsZMWIErutSXV3Neeedx4oVKwrbNDQ08PnPf/4jH1t9fT333nvvR37e3r71rW8xdepUXNdl8uTJAx4frIWUUop4PH5Qzm8dlKOIj60dO3bg+z5VVVV97q+qquLdd989TKMS4pOlsbERYNB51v2YEGLfgiDguuuu49Of/jQnnngiEM4vx3EoLi7us63MLyH27c9//jOnn3466XSaRCLB448/zvjx41m1apXMKyE+hH//93/n9ddf59VXXx3wmPzdEuLAnXbaaTzwwAOMHTuWhoYGvve97/GZz3yGt956S+aWOOrMnDmTbDbLgw8+yOjRo9m2bRtLly5l586dhW2qq6sP4wg/vGw2i+M4B7z/7NmzeeWVV3jzzTcHPHbjjTfyjW98o89955xzDqeccsoBn683qVAXQgghxMfCNddcw1tvvcW///u/H+6hCPGJMHbsWFatWsUrr7zC1VdfzVe/+lXefvvtwz0sIY5omzdv5h//8R955JFHPnGtA4Q43D7/+c9zySWXMHHiRM477zz+67/+i+bmZv7jP/7jcA9NiI9Uc3Mzy5cv56677uLss89m5MiRnHrqqXznO9/hC1/4QmE7pRRLliwp3H7xxReZPHkykUiEk08+mSVLlqCUKrRRWrZsGUopli5dysknn0wsFuOMM85gzZo1hWOsW7eOGTNmUFVVRSKR4JRTTuEPf/hD4fGzzjqLjRs3cv311xeqviGsCO9fKX7vvfdSX19fuD1r1iwuuugiFixYQG1tLWPHjgXCv62XXnopxcXFlJaWMmPGDDZs2LDX1+inP/0p11xzDaNHjx708UQiQXV1deGybds23n77bb72ta/t9bj7SwL1T7jy8nJM0xyw8vW2bduO+HeyhPi46J5LMs+EOHDXXnstv/3tb3nuuecYNmxY4f7q6mqy2SzNzc19tpf5JcS+OY7DmDFjmDp1KnfeeSeTJk3iJz/5icwrIT6E1157je3btzNlyhQsy8KyLJ5//nl++tOfYlkWVVVVMr+EOEiKi4s57rjjWLt2rfztEgeV1ppsNvuRX/Z3GctEIkEikWDJkiVkMpn92qe1tZXp06czYcIEXn/9de644w7mzZs36LY333wzP/rRj1i5ciWWZTF79uzCY+3t7VxwwQUsXbqUN954g/PPP5/p06cX2i8tXryYYcOGcfvttxcWDx6KpUuXsmbNGp599ll++9vfksvlOO+880gmkyxfvpwVK1aQSCQ4//zzyWazQzr23ixatIjjjjuOz3zmMwfleNLy5RPOcRymTp3K0qVLC4sUBEHA0qVLufbaaw/v4IT4hBg1ahTV1dUsXbq08I5sa2troSJQCLFnWmu++c1v8vjjj7Ns2TJGjRrV5/GpU6di2zZLly5l5syZAKxZs4ZNmzZx+umnH44hC3HECoKATCYj80qID+Gcc87hz3/+c5/7rrjiCo4//njmzZvH8OHDZX4JcZC0t7ezbt06/r//7/+Tv13ioMrlcvzgBz/4yM/73e9+d79anFiWxQMPPMCcOXP4xS9+wZQpUzjzzDO57LLLmDhx4qD7PProoyil+NWvfkUkEmH8+PFs2bKFOXPmDNh2wYIFnHnmmQDcdNNNXHjhhaTTaSKRCJMmTWLSpEmFbe+44w4ef/xxnnjiCa699lpKS0sxTZNkMnlAb2bF43EWLVpUeB0efvhhgiBg0aJFhWr3+++/n+LiYpYtW8a555475HP0l06neeSRR7jppps+9LG6SaB+FLjhhhv46le/ysknn8ypp57KvffeS0dHB1dcccXhHpoQR4z29nbWrl1buL1+/XpWrVpFaWkpI0aM4LrrruP73/8+xx57LKNGjeKWW26htrZWVtsWYh+uueYaHn30UX7zm9+QTCYLPTCLioqIRqMUFRXxta99jRtuuIHS0lJSqRTf/OY3Of300/nUpz51mEcvxMfXd77zHT7/+c8zYsQI2traePTRR1m2bBm/+93vZF4J8SEkk8nCOh/d4vE4ZWVlhftlfglxYG688UamT5/OyJEj2bp1K7feeiumafL3f//38rdLHHVmzpzJhRdeyPLly3n55Zd5+umnWbhwIYsWLWLWrFkDtl+zZg0TJ07s047s1FNPHfTYvUP5mpoaALZv386IESNob2/ntttu46mnnqKhoQHP8+jq6ipUqH9YEyZM6POmwurVq1m7di3JZLLPdul0mnXr1h2Ucz7++OO0tbXx1a9+9aAcDyRQPyr83d/9HU1NTcyfP5/GxkYmT57MM888M2ABRSHEnq1cuZKzzz67cPuGG24A4Ktf/SoPPPAAc+fOpaOjg6uuuorm5mb+5m/+hmeeeUZ6awqxDz//+c+BsBdfb/fff3/hH4r33HMPhmEwc+ZMMpkM5513Hvfdd99HPFIhjizbt2/nK1/5Cg0NDRQVFTFx4kR+97vfMW3aNEDmlRCHkswvIQ7MBx98wN///d+zc+dOKioq+Ju/+RtefvllKioqAJlb4uCxbZvvfvf/b+/+Y6q+rz+Ovy4oXOBCkYmCdoqosRgR7sWqZYkiGYK1FH8yp2mGCm5G62pCZv06sMHRRIY/1onRyOqPgpszsQSbWWeJtxCaVJ1e3BqGhVxtVW4VEm2YggT4/mG4FaFyERXE5yO5Cffzeb8/73NvPje5OZx73v/XJ+v2hNFoVFxcnOLi4pSRkaHU1FRt3ry5y4T648bRXhXe2toq6f4/tk6dOqXc3FyNGzdOXl5eWrRoUbftV9zc3Dq1tGlubu40zsfHp8PzhoYGRUVFqbCwsNPY9s9+b+Xn5+uNN954onlQEuoviLVr19LiBeiFmJiYR/Y7MxgMysrKUlZW1jOMCnj+udJH0Gg0Ki8vT3l5ec8gImBg+Mtf/vLI83yugCfHarV2eM7nC3g83W1Mz2cLT4rBYHCp9Up/M3HixA6bkD5owoQJKigoUFNTkzw9PSVJZ8+e7fEa5eXlSklJ0fz58yXdT3g/vEGoh4eHWlpaOhwLDAyUw+FQW1ubM0nfvhnqo1gsFh05ckTDhg2Tn59fj+Ptjt1u1+nTp1VcXPxEr8umpAAAAAAAAADQD9TX1ys2NlYFBQW6ePGi7Ha7jh49qpycHCUlJXU5Z+nSpWptbdWqVatUWVmpkydPKjc3V9IPVeiuGD9+vI4dOyabzaaKigrndR8UEhKi0tJSXbt2TXV1dZLuFyHevHlTOTk5qqmpUV5enk6cONHtesuWLdPQoUOVlJSksrIy2e12Wa1WrVu3TlevXv3RedXV1bLZbHI4HLp7965sNptsNlunSvoPP/xQwcHBmjNnjsvvgStIqAMAAAAAAABAP2AymTRt2jTt2LFDM2bM0KRJk5SRkaG0tDTt2rWryzl+fn46fvy4bDabIiMjtWnTJmVmZkpSj1rRbt++XUOGDFF0dLQSExMVHx8vi8XSYUxWVpYuX76ssWPHOtuyhIWFaffu3crLy1NERITOnDmj9PT0btfz9vZWaWmpRo0apQULFigsLEwrV65UY2PjIyvWU1NTZTabtXfvXl26dElms1lms1nXr193jmltbdWBAweUkpIid3d3l98DVxjaXPmtNQAAAAAAAAA8RxobG2W32zVmzJgXbo+zwsJCLV++XLdv35aXl1dfh9Pv9eReoYc6AAAAAAAAADzHDh06pNDQUI0cOVIVFRXasGGDkpOTSaY/BSTUAQAAAAAAAOA55nA4lJmZKYfDoeDgYC1evFjZ2dl9HdaARMsXAAAAAAAAAAPOi9zyBT3Tk3uFTUkBAAAAAAAAAHABCXUAAAAAAAAAAFxAQh0AAABPVEpKiubNm9fXYQAAAADAE8empAAAAHCZwWB45PnNmzfrT3/6k9imBwAAAMBAREIdAAAALqutrXX+feTIEWVmZqqqqsp5zGQyyWQy9UVoAAAAAPDU0fIFAAAALgsKCnI+XnrpJRkMhg7HTCZTp5YvMTExevvtt/XOO+9oyJAhGj58uPbt26f//e9/Wr58uXx9fTVu3DidOHGiw1r/+c9/NGfOHJlMJg0fPlxvvfWW6urqnvErBgAAAIAfkFAHAADAU3fw4EENHTpUZ86c0dtvv63Vq1dr8eLFio6O1vnz5zV79my99dZbunPnjiTp1q1bio2Nldls1rlz5/Tpp5/qu+++U3Jych+/EgAAAKDvGQwGFRUV9XUYLyQS6gAAAHjqIiIi9Pvf/17jx4/Xxo0bZTQaNXToUKWlpWn8+PHKzMxUfX29Ll68KEnatWuXzGaz3n//fb3yyisym8368MMPdfr0aV26dKmPXw0AAADw9Ny8eVOrV6/WqFGj5OnpqaCgIMXHx6u8vNw5pra2VnPmzHnmsYWEhGjnzp3PfN0HrVu3TlFRUfL09FRkZGSXY06ePKnp06fL19dXgYGBWrhwoS5fvvxE1iehDgAAgKdu8uTJzr/d3d31k5/8ROHh4c5jw4cPlyTduHFDklRRUaHTp087e7KbTCa98sorkqSamppnGDkAAADwbC1cuFAXLlzQwYMHdenSJRUXFysmJkb19fXOMUFBQfL09OzDKHvn3r17vZq/YsUK/eIXv+jynN1uV1JSkmJjY2Wz2XTy5EnV1dVpwYIFvVqzHQl1AAAAPHWDBw/u8NxgMHQ4ZjAYJEmtra2SpIaGBiUmJspms3V4fP3115oxY8azCxwAAAB4hm7duqWysjJt3bpVs2bN0ujRozV16lRt3LhRb775pnPcwy1fvvjiC0VGRspoNGrKlCkqKiqSwWCQzWaTJFmtVhkMBpWUlGjKlCny9vZWdHS0qqqqnNeoqalRUlKShg8fLpPJpFdffVWfffaZ83xMTIyuXLmi9evXy2AwOL/Dv/fee50qxXfu3KmQkBDn8/Z9lrKzszVixAhNmDBBkvTtt98qOTlZ/v7+CggIUFJSUreV5B988IHWrFmj0NDQLs//61//UktLi/7whz9o7NixslgsSk9Pl81mU3Nz8yOv7QoS6gAAAOh3LBaLvvrqK4WEhGjcuHEdHj4+Pn0dHgAAAJ5TbW1tamm588wfbW1tLsXX/uvMoqIiNTU1uTTn+++/V2JiosLDw3X+/Hlt2bJFGzZs6HLspk2btG3bNp07d06DBg3SihUrnOcaGhr0+uuvq6SkRBcuXFBCQoISExP1zTffSJKOHTuml19+WVlZWaqtrVVtba1L8bUrKSlRVVWVTp06pU8++UTNzc2Kj4+Xr6+vysrKVF5eLpPJpISEhF5VsEdFRcnNzU379+9XS0uLbt++rY8++kg///nPOxX6PI5Bvb4CAAAA8IStWbNG+/bt0y9/+Uv97ne/U0BAgKqrq/W3v/1N+fn5cnd37+sQAQAA8Bxqbb0r6+fh3Q98wmJm/lvu7t7djhs0aJAOHDigtLQ07dmzRxaLRTNnztSSJUs6tFF80OHDh2UwGLRv3z4ZjUZNnDhR165dU1paWqex2dnZmjlzpiTp3Xff1dy5c9XY2Cij0aiIiAhFREQ4x27ZskUff/yxiouLtXbtWgUEBMjd3V2+vr4KCgrq8Xvg4+Oj/Px8eSH8Rs0AAAz2SURBVHh4SJIKCgrU2tqq/Px8Z7X7/v375e/vL6vVqtmzZ/d4DUkaM2aM/vnPfyo5OVm//vWv1dLSotdee03/+Mc/Hut6D6NCHQAAAP3OiBEjVF5erpaWFs2ePVvh4eF655135O/vLzc3vsICAABg4Fq4cKGuX7+u4uJiJSQkyGq1ymKx6MCBA12Or6qq0uTJk2U0Gp3Hpk6d2uXYB5PywcHBkn7Yx6ihoUHp6ekKCwuTv7+/TCaTKisrnRXqvRUeHu5Mpkv3902qrq6Wr6+vszI/ICBAjY2Nvdo3yeFwKC0tTb/61a909uxZff755/Lw8NCiRYtc/qXAo1ChDgAAgMeSkpKilJSUTscf/qJvtVo7jemqL+LDX27Hjx+vY8eO9SJCAAAAoCM3Ny/FzPx3n6zbE0ajUXFxcYqLi1NGRoZSU1O1efPmLr9/98Sj9jFKT0/XqVOnlJubq3HjxsnLy0uLFi3qtv2Km5tbp+/yXfUqf7h1Y0NDg6KiolRYWNhpbGBgoGsvqAt5eXl66aWXlJOT4zxWUFCgn/70p/ryyy81ffr0x762REIdAAAAAAAAwAvCYDC41Hqlv5k4cWKHTUgfNGHCBBUUFKipqUmenp6SpLNnz/Z4jfLycqWkpGj+/PmS7ie8Hy6E8fDwUEtLS4djgYGBcjgcamtrcybp2zdDfRSLxaIjR45o2LBh8vPz63G8P+bOnTudftXa3jKy/Z8HvcHvZQEAAAAAAACgH6ivr1dsbKwKCgp08eJF2e12HT16VDk5OUpKSupyztKlS9Xa2qpVq1apsrJSJ0+eVG5urqQfqtBd0f4LUZvNpoqKCud1HxQSEqLS0lJdu3ZNdXV1kqSYmBjdvHlTOTk5qqmpUV5enk6cONHtesuWLdPQoUOVlJSksrIy2e12Wa1WrVu3TlevXv3RedXV1bLZbHI4HLp7965sNptsNpuzkn7u3Lk6e/assrKy9PXXX+v8+fNavny5Ro8eLbPZ7PL78WNIqAMAAAAAAABAP2AymTRt2jTt2LFDM2bM0KRJk5SRkaG0tDTt2rWryzl+fn46fvy4bDabIiMjtWnTJmVmZkpSh77q3dm+fbuGDBmi6OhoJSYmKj4+XhaLpcOYrKwsXb58WWPHjnW2ZQkLC9Pu3buVl5eniIgInTlzRunp6d2u5+3trdLSUo0aNUoLFixQWFiYVq5cqcbGxkdWrKempspsNmvv3r26dOmSzGazzGazrl+/LkmKjY3V4cOHVVRUJLPZrISEBHl6eurTTz+Vl1fPWu90xdD2JDqxAwAAAAAAAEA/0tjYKLvdrjFjxvQosTwQFBYWavny5bp9+/YTSSIPdD25V+ihDgAAAAAAAADPsUOHDik0NFQjR45URUWFNmzYoOTkZJLpTwEJdQAAAAAAAAB4jjkcDmVmZsrhcCg4OFiLFy9WdnZ2X4c1INHyBQAAAAAAAMCA8yK3fEHP9OReYVNSAAAAAAAAAABcQEIdAAAAAAAAAAAXkFAHAAAAAAAAAMAFJNQBAAAAAAAAAHABCXUAAAAAAAAAAFxAQh0AAAAAAAAAABeQUAcAAAAAAACA54jBYFBRUVFfh/FCIqEOAAAAAAAAAP3EzZs3tXr1ao0aNUqenp4KCgpSfHy8ysvLnWNqa2s1Z86cZx5bSEiIdu7c+czXfdC6desUFRUlT09PRUZGdjnm73//uyIjI+Xt7a3Ro0frj3/84xNbf9ATuxIAAAAAAAAAoFcWLlyoe/fu6eDBgwoNDdV3332nkpIS1dfXO8cEBQX1YYS9d+/ePXl4eDz2/BUrVujLL7/UxYsXO507ceKEli1bpj//+c+aPXu2KisrlZaWJi8vL61du7Y3YUuiQh0AAAAAAAAA+oVbt26prKxMW7du1axZszR69GhNnTpVGzdu1Jtvvukc93DLly+++EKRkZEyGo2aMmWKioqKZDAYZLPZJElWq1UGg0ElJSWaMmWKvL29FR0draqqKuc1ampqlJSUpOHDh8tkMunVV1/VZ5995jwfExOjK1euaP369TIYDDIYDJKk9957r1Ol+M6dOxUSEuJ8npKSonnz5ik7O1sjRozQhAkTJEnffvutkpOT5e/vr4CAACUlJeny5cuPfI8++OADrVmzRqGhoV2e/+ijjzRv3jz95je/UWhoqObOnauNGzdq69atamtre+S1XUFCHQAAAAAAAMALoa2tTf9raXnmD1cTuSaTSSaTSUVFRWpqanJpzvfff6/ExESFh4fr/Pnz2rJlizZs2NDl2E2bNmnbtm06d+6cBg0apBUrVjjPNTQ06PXXX1dJSYkuXLighIQEJSYm6ptvvpEkHTt2TC+//LKysrJUW1ur2tpal+JrV1JSoqqqKp06dUqffPKJmpubFR8fL19fX5WVlam8vFwmk0kJCQm6d+9ej679oKamJhmNxg7HvLy8dPXqVV25cuWxr9uOli8AAAAAAAAAXgh3Wls1tvTfz3zdmhnh8nF373bcoEGDdODAAaWlpWnPnj2yWCyaOXOmlixZosmTJ3c55/DhwzIYDNq3b5+MRqMmTpyoa9euKS0trdPY7OxszZw5U5L07rvvau7cuWpsbJTRaFRERIQiIiKcY7ds2aKPP/5YxcXFWrt2rQICAuTu7i5fX9/Hajnj4+Oj/Px8Z6uXgoICtba2Kj8/31ntvn//fvn7+8tqtWr27Nk9XkOS4uPjtX79eqWkpGjWrFmqrq7Wtm3bJN3vPf9g5fzjoEIdAAAAAAAAAPqJhQsX6vr16youLlZCQoKsVqssFosOHDjQ5fiqqipNnjy5Q1X21KlTuxz7YFI+ODhYknTjxg1J9yvU09PTFRYWJn9/f5lMJlVWVjor1HsrPDy8Q9/0iooKVVdXy9fX11mZHxAQoMbGRtXU1Dz2OmlpaVq7dq3eeOMNeXh4aPr06VqyZIkkyc2t9+lwKtQBAAAAAAAAvBC83dxUMyO8T9btCaPRqLi4OMXFxSkjI0OpqanavHmzUlJSehXH4MGDnX+3V4W3trZKktLT03Xq1Cnl5uZq3Lhx8vLy0qJFi7ptv+Lm5tappU1zc3OncT4+Ph2eNzQ0KCoqSoWFhZ3GBgYGuvaCumAwGLR161a9//77cjgcCgwMVElJiST9aN/1niChDgAAAAAAAOCFYDAYXGq90t9MnDixwyakD5owYYIKCgrU1NQkT09PSdLZs2d7vEZ5eblSUlI0f/58SfcT3g9vEOrh4aGWlpYOxwIDA+VwONTW1uZM0rdvhvooFotFR44c0bBhw+Tn59fjeLvj7u6ukSNHSpL++te/6rXXXutVor4dLV8AAAAAAAAAoB+or69XbGysCgoKdPHiRdntdh09elQ5OTlKSkrqcs7SpUvV2tqqVatWqbKyUidPnlRubq6kH6rQXTF+/HgdO3ZMNptNFRUVzus+KCQkRKWlpbp27Zrq6uokSTExMbp586ZycnJUU1OjvLw8nThxotv1li1bpqFDhyopKUllZWWy2+2yWq1at26drl69+qPzqqurZbPZ5HA4dPfuXdlsNtlsNmclfV1dnfbs2aP//ve/stls+u1vf6ujR49q586dLr8Xj0JCHQAAAAAAAAD6AZPJpGnTpmnHjh2aMWOGJk2apIyMDKWlpWnXrl1dzvHz89Px48dls9kUGRmpTZs2KTMzU5I69FXvzvbt2zVkyBBFR0crMTFR8fHxslgsHcZkZWXp8uXLGjt2rLPaOywsTLt371ZeXp4iIiJ05swZpaend7uet7e3SktLNWrUKC1YsEBhYWFauXKlGhsbH1mxnpqaKrPZrL179+rSpUsym80ym826fv26c8zBgwc1ZcoU/exnP9NXX30lq9X6o33le8rQ9nCDGwAAAAAAAAB4zjU2Nsput2vMmDE9SiwPBIWFhVq+fLlu374tLy+vvg6n3+vJvUIPdQAAAAAAAAB4jh06dEihoaEaOXKkKioqtGHDBiUnJ5NMfwpIqAMAAAAAAADAc8zhcCgzM1MOh0PBwcFavHixsrOz+zqsAYmWLwAAAAAAAAAGnBe55Qt6pif3CpuSAgAAAAAAAADgAhLqAAAAAAAAAAYsGnSgOz25R0ioAwAAAAAAABhwBg8eLEm6c+dOH0eC/q79Hmm/Zx6FTUkBAAAAAAAADDju7u7y9/fXjRs3JEne3t4yGAx9HBX6k7a2Nt25c0c3btyQv7+/3N3du53DpqQAAAAAAAAABqS2tjY5HA7dunWrr0NBP+bv76+goCCX/uFCQh0AAAAAAADAgNbS0qLm5ua+DgP90ODBg12qTG9HQh0AAAAAAAAAABewKSkAAAAAAAAAAC4goQ4AAAAAAAAAgAtIqAMAAAAAAAAA4AIS6gAAAAAAAAAAuICEOgAAAAAAAAAALiChDgAAAAAAAACAC0ioAwAAAAAAAADggv8HNp/dRT+UxMgAAAAASUVORK5CYII=",
      "text/plain": [
       "<Figure size 1500x1500 with 3 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import torch\n",
    "import numpy as np\n",
    "import os\n",
    "import glob\n",
    "\n",
    "def analyze_pooled_cluster_patterns(base_dir):\n",
    "    \"\"\"\n",
    "    Analyze patterns pooling across all model.pt files in subdirectories\n",
    "    \"\"\"\n",
    "    # Get all output directories\n",
    "    output_dirs = sorted(glob.glob(os.path.join(base_dir, 'output_*')))\n",
    "    \n",
    "    # Initialize storage for pooled phi values\n",
    "    first_model = torch.load(os.path.join(output_dirs[0], 'model.pt'))\n",
    "    disease_names = first_model['disease_names']\n",
    "    phi_shape = first_model['model_state_dict']['phi'].shape\n",
    "    pooled_phi = np.zeros((len(output_dirs), *phi_shape))\n",
    "    \n",
    "    # Load and pool phi values\n",
    "    for i, dir_path in enumerate(output_dirs):\n",
    "        model_path = os.path.join(dir_path, 'model.pt')\n",
    "        try:\n",
    "            checkpoint = torch.load(model_path)\n",
    "            phi = checkpoint['model_state_dict']['phi']\n",
    "            if torch.is_tensor(phi):\n",
    "                phi = phi.detach().cpu().numpy()\n",
    "            pooled_phi[i] = phi\n",
    "            \n",
    "            # Use clusters from first model (assuming consistent across runs)\n",
    "            if i == 0:\n",
    "                clusters = checkpoint['clusters']\n",
    "                \n",
    "        except Exception as e:\n",
    "            print(f\"Error loading from {dir_path}: {e}\")\n",
    "    \n",
    "    # Calculate mean and std of phi across all models\n",
    "    mean_phi = np.mean(pooled_phi, axis=0)\n",
    "    std_phi = np.std(pooled_phi, axis=0)\n",
    "    \n",
    "    # Analyze patterns for each cluster\n",
    "    unique_clusters = np.unique(clusters)\n",
    "    for cluster in unique_clusters:\n",
    "        cluster_diseases = np.where(clusters == cluster)[0]\n",
    "        \n",
    "        print(f\"\\nCluster {cluster} diseases:\")\n",
    "        print(\"------------------------\")\n",
    "        \n",
    "        # Get average phi values for diseases in this cluster\n",
    "        cluster_phi = mean_phi[:, cluster_diseases, :].mean(axis=2)  # Average over time\n",
    "        cluster_phi_std = std_phi[:, cluster_diseases, :].mean(axis=2)  # Average std over time\n",
    "        \n",
    "        # Find dominant signature\n",
    "        dominant_signature = np.argmax(np.abs(cluster_phi).mean(axis=1))\n",
    "        \n",
    "        # Sort diseases by their strength in the dominant signature\n",
    "        disease_strengths = mean_phi[dominant_signature, cluster_diseases, :].mean(axis=1)\n",
    "        disease_stds = std_phi[dominant_signature, cluster_diseases, :].mean(axis=1)\n",
    "        sorted_indices = np.argsort(np.abs(disease_strengths))[::-1]\n",
    "        \n",
    "        # Print top 5 most characteristic diseases\n",
    "        print(f\"Top diseases (strongest in signature {dominant_signature}):\")\n",
    "        for idx in sorted_indices[:5]:\n",
    "            disease_idx = cluster_diseases[idx]\n",
    "            strength = disease_strengths[idx]\n",
    "            std = disease_stds[idx]\n",
    "            print(f\"- {disease_names[disease_idx]}: strength = {strength:.3f}  {std:.3f}\")\n",
    "        \n",
    "        # Find non-specific diseases\n",
    "        other_sigs = np.delete(np.arange(mean_phi.shape[0]), dominant_signature)\n",
    "        non_specific_diseases = []\n",
    "        \n",
    "        for disease_idx in cluster_diseases:\n",
    "            disease_phi = mean_phi[:, disease_idx, :].mean(axis=1)\n",
    "            if np.any(np.abs(disease_phi[other_sigs]) > 0.5 * np.abs(disease_phi[dominant_signature])):\n",
    "                non_specific_diseases.append(disease_idx)\n",
    "        \n",
    "        if non_specific_diseases:\n",
    "            print(\"\\nNon-specific diseases (strong effects in multiple signatures):\")\n",
    "            for disease_idx in non_specific_diseases[:5]:\n",
    "                disease_phi = mean_phi[:, disease_idx, :].mean(axis=1)\n",
    "                disease_phi_std = std_phi[:, disease_idx, :].mean(axis=1)\n",
    "                print(f\"\\n{disease_names[disease_idx]}:\")\n",
    "                for sig in range(len(disease_phi)):\n",
    "                    if abs(disease_phi[sig]) > 0.1:\n",
    "                        print(f\"  Signature {sig}: {disease_phi[sig]:.3f}  {disease_phi_std[sig]:.3f}\")\n",
    "    \n",
    "    return pooled_phi, disease_names, clusters\n",
    "\n",
    "def plot_pooled_disease_patterns(pooled_phi, disease_names, disease_indices, title=None):\n",
    "    \"\"\"\n",
    "    Plot temporal patterns with uncertainty bands for specific diseases\n",
    "    \"\"\"\n",
    "    mean_phi = np.mean(pooled_phi, axis=0)\n",
    "    std_phi = np.std(pooled_phi, axis=0)\n",
    "    \n",
    "    n_signatures = mean_phi.shape[0]\n",
    "    n_timepoints = mean_phi.shape[2]\n",
    "    \n",
    "    plt.figure(figsize=(15, 5 * len(disease_indices)))\n",
    "    \n",
    "    for i, disease_idx in enumerate(disease_indices):\n",
    "        plt.subplot(len(disease_indices), 1, i+1)\n",
    "        \n",
    "        for sig in range(n_signatures):\n",
    "            mean_pattern = mean_phi[sig, disease_idx, :]\n",
    "            std_pattern = std_phi[sig, disease_idx, :]\n",
    "            \n",
    "            plt.plot(range(n_timepoints), mean_pattern, label=f'Signature {sig}')\n",
    "            plt.fill_between(range(n_timepoints), \n",
    "                           mean_pattern - std_pattern,\n",
    "                           mean_pattern + std_pattern,\n",
    "                           alpha=0.2)\n",
    "        \n",
    "        plt.title(f\"{disease_names[disease_idx]} Temporal Patterns\")\n",
    "        plt.xlabel('Time')\n",
    "        plt.ylabel('Effect Size')\n",
    "        plt.legend(bbox_to_anchor=(1.05, 1), loc='upper left')\n",
    "        plt.grid(True, alpha=0.3)\n",
    "    \n",
    "    if title:\n",
    "        plt.suptitle(title, y=1.02)\n",
    "    plt.tight_layout()\n",
    "    plt.show()\n",
    "\n",
    "# Usage:\n",
    "base_dir = '/Users/sarahurbut/Dropbox (Personal)/results_10k_unsharedseed/'\n",
    "pooled_phi, disease_names, clusters = analyze_pooled_cluster_patterns(base_dir)\n",
    "\n",
    "# After identifying interesting diseases from the analysis:\n",
    "interesting_diseases = [10, 20, 30]  # Replace with actual disease indices\n",
    "plot_pooled_disease_patterns(pooled_phi, disease_names, interesting_diseases,\n",
    "                           title=\"Comparison of Cluster-Specific vs Non-Specific Diseases\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 79,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/2f/nxrbr3pn1msgrl4ffyj33zd00000gn/T/ipykernel_68206/3328720815.py:6: FutureWarning: You are using `torch.load` with `weights_only=False` (the current default value), which uses the default pickle module implicitly. It is possible to construct malicious pickle data which will execute arbitrary code during unpickling (See https://github.com/pytorch/pytorch/blob/main/SECURITY.md#untrusted-models for more details). In a future release, the default value for `weights_only` will be flipped to `True`. This limits the functions that could be executed during unpickling. Arbitrary objects will no longer be allowed to be loaded via this mode unless they are explicitly allowlisted by the user via `torch.serialization.add_safe_globals`. We recommend you start setting `weights_only=True` for any use case where you don't have full control of the loaded file. Please open an issue on GitHub for any issues related to this experimental feature.\n",
      "  first_model = torch.load(os.path.join(base_dir, 'output_0_10000_20241223_041640/model.pt'))\n",
      "/var/folders/2f/nxrbr3pn1msgrl4ffyj33zd00000gn/T/ipykernel_68206/3328720815.py:26: FutureWarning: You are using `torch.load` with `weights_only=False` (the current default value), which uses the default pickle module implicitly. It is possible to construct malicious pickle data which will execute arbitrary code during unpickling (See https://github.com/pytorch/pytorch/blob/main/SECURITY.md#untrusted-models for more details). In a future release, the default value for `weights_only` will be flipped to `True`. This limits the functions that could be executed during unpickling. Arbitrary objects will no longer be allowed to be loaded via this mode unless they are explicitly allowlisted by the user via `torch.serialization.add_safe_globals`. We recommend you start setting `weights_only=True` for any use case where you don't have full control of the loaded file. Please open an issue on GitHub for any issues related to this experimental feature.\n",
      "  checkpoint = torch.load(model_path)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Disease: Colon cancer\n",
      "Assigned signature (positive psi): 17\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1200x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Average effect sizes across signatures:\n",
      "Signature 0: -11.836  0.998\n",
      "Signature 1: -11.932  0.896\n",
      "Signature 2: -11.600  0.833\n",
      "Signature 3: -11.601  0.983\n",
      "Signature 4: -11.800  1.042\n",
      "Signature 5: -11.226  0.995\n",
      "Signature 6: -11.603  0.907\n",
      "Signature 7: -12.255  0.977\n",
      "Signature 8: -11.841  0.732\n",
      "Signature 9: -12.044  0.786\n",
      "Signature 10: -11.665  0.888\n",
      "Signature 11: -11.905  0.963\n",
      "Signature 12: -11.471  0.790\n",
      "Signature 13: -11.757  0.936\n",
      "Signature 14: -11.446  0.806\n",
      "Signature 15: -11.586  0.745\n",
      "Signature 16: -11.608  0.709\n",
      "Signature 17: -9.470  1.116 *\n",
      "Signature 18: -11.534  0.748\n",
      "Signature 19: -11.790  0.826\n"
     ]
    }
   ],
   "source": [
    "\n",
    "def verify_disease_signature_specificity(base_dir, disease_idx):\n",
    "    \"\"\"\n",
    "    Verify that the dominant signature matches the cluster assignment for a disease\n",
    "    \"\"\"\n",
    "    # Load first model to get psi and cluster assignments\n",
    "    first_model = torch.load(os.path.join(base_dir, 'output_0_10000_20241223_041640/model.pt'))\n",
    "    psi = first_model['model_state_dict']['psi']\n",
    "    disease_names = first_model['disease_names']\n",
    "    \n",
    "    if torch.is_tensor(psi):\n",
    "        psi = psi.detach().cpu().numpy()\n",
    "    \n",
    "    # Find which signature has positive psi for this disease\n",
    "    assigned_signature = np.where(psi[:, disease_idx] > 0)[0]\n",
    "    print(f\"\\nDisease: {disease_names[disease_idx]}\")\n",
    "    print(f\"Assigned signature (positive psi): {assigned_signature[0]}\")\n",
    "    \n",
    "    # Now load and pool phi values across all models\n",
    "    output_dirs = sorted(glob.glob(os.path.join(base_dir, 'output_*')))\n",
    "    phi_shape = first_model['model_state_dict']['phi'].shape\n",
    "    pooled_phi = np.zeros((len(output_dirs), *phi_shape))\n",
    "    \n",
    "    for i, dir_path in enumerate(output_dirs):\n",
    "        model_path = os.path.join(dir_path, 'model.pt')\n",
    "        try:\n",
    "            checkpoint = torch.load(model_path)\n",
    "            phi = checkpoint['model_state_dict']['phi']\n",
    "            if torch.is_tensor(phi):\n",
    "                phi = phi.detach().cpu().numpy()\n",
    "            pooled_phi[i] = phi\n",
    "        except Exception as e:\n",
    "            print(f\"Error loading from {dir_path}: {e}\")\n",
    "    \n",
    "    # Calculate mean phi\n",
    "    mean_phi = np.mean(pooled_phi, axis=0)\n",
    "    std_phi = np.std(pooled_phi, axis=0)\n",
    "    \n",
    "    # Plot temporal patterns with assigned signature highlighted\n",
    "    plt.figure(figsize=(12, 6))\n",
    "    \n",
    "    for sig in range(mean_phi.shape[0]):\n",
    "        mean_pattern = mean_phi[sig, disease_idx, :]\n",
    "        std_pattern = std_phi[sig, disease_idx, :]\n",
    "        \n",
    "        # Highlight assigned signature\n",
    "        if sig == assigned_signature:\n",
    "            color = 'red'\n",
    "            linewidth = 2\n",
    "            label = f'Signature {sig} (Assigned)'\n",
    "        else:\n",
    "            color = f'C{sig}'\n",
    "            linewidth = 1\n",
    "            label = f'Signature {sig}'\n",
    "        \n",
    "        plt.plot(range(mean_pattern.shape[0]), mean_pattern, \n",
    "                label=label, color=color, linewidth=linewidth)\n",
    "        plt.fill_between(range(mean_pattern.shape[0]), \n",
    "                        mean_pattern - std_pattern,\n",
    "                        mean_pattern + std_pattern,\n",
    "                        color=color, alpha=0.2)\n",
    "    \n",
    "    plt.title(f\"{disease_names[disease_idx]} Temporal Patterns\\nAssigned to Signature {assigned_signature[0]}\")\n",
    "    plt.xlabel('Time')\n",
    "    plt.ylabel('Effect Size')\n",
    "    plt.legend(bbox_to_anchor=(1.05, 1), loc='upper left')\n",
    "    plt.grid(True, alpha=0.3)\n",
    "    plt.tight_layout()\n",
    "    plt.show()\n",
    "    \n",
    "    # Print effect sizes\n",
    "    mean_effects = mean_phi[:, disease_idx, :].mean(axis=1)\n",
    "    std_effects = std_phi[:, disease_idx, :].mean(axis=1)\n",
    "    \n",
    "    print(\"\\nAverage effect sizes across signatures:\")\n",
    "    for sig in range(len(mean_effects)):\n",
    "        star = \" *\" if sig == assigned_signature else \"\"\n",
    "        print(f\"Signature {sig}: {mean_effects[sig]:.3f}  {std_effects[sig]:.3f}{star}\")\n",
    "\n",
    "# Usage:\n",
    "base_dir = '/Users/sarahurbut/Dropbox (Personal)/results_10k_unsharedseed/'\n",
    "disease_idx = 10  # Replace with the disease index you want to check\n",
    "verify_disease_signature_specificity(base_dir, disease_idx)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 80,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/2f/nxrbr3pn1msgrl4ffyj33zd00000gn/T/ipykernel_68206/3328720815.py:6: FutureWarning: You are using `torch.load` with `weights_only=False` (the current default value), which uses the default pickle module implicitly. It is possible to construct malicious pickle data which will execute arbitrary code during unpickling (See https://github.com/pytorch/pytorch/blob/main/SECURITY.md#untrusted-models for more details). In a future release, the default value for `weights_only` will be flipped to `True`. This limits the functions that could be executed during unpickling. Arbitrary objects will no longer be allowed to be loaded via this mode unless they are explicitly allowlisted by the user via `torch.serialization.add_safe_globals`. We recommend you start setting `weights_only=True` for any use case where you don't have full control of the loaded file. Please open an issue on GitHub for any issues related to this experimental feature.\n",
      "  first_model = torch.load(os.path.join(base_dir, 'output_0_10000_20241223_041640/model.pt'))\n",
      "/var/folders/2f/nxrbr3pn1msgrl4ffyj33zd00000gn/T/ipykernel_68206/3328720815.py:26: FutureWarning: You are using `torch.load` with `weights_only=False` (the current default value), which uses the default pickle module implicitly. It is possible to construct malicious pickle data which will execute arbitrary code during unpickling (See https://github.com/pytorch/pytorch/blob/main/SECURITY.md#untrusted-models for more details). In a future release, the default value for `weights_only` will be flipped to `True`. This limits the functions that could be executed during unpickling. Arbitrary objects will no longer be allowed to be loaded via this mode unless they are explicitly allowlisted by the user via `torch.serialization.add_safe_globals`. We recommend you start setting `weights_only=True` for any use case where you don't have full control of the loaded file. Please open an issue on GitHub for any issues related to this experimental feature.\n",
      "  checkpoint = torch.load(model_path)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Disease: Bacterial infection NOS\n",
      "Assigned signature (positive psi): 16\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1200x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Average effect sizes across signatures:\n",
      "Signature 0: -9.492  0.946\n",
      "Signature 1: -9.610  0.722\n",
      "Signature 2: -9.932  0.824\n",
      "Signature 3: -9.445  0.948\n",
      "Signature 4: -9.496  0.884\n",
      "Signature 5: -9.696  0.819\n",
      "Signature 6: -9.748  0.930\n",
      "Signature 7: -9.843  0.944\n",
      "Signature 8: -9.616  1.069\n",
      "Signature 9: -9.774  1.052\n",
      "Signature 10: -10.063  0.913\n",
      "Signature 11: -10.153  0.987\n",
      "Signature 12: -9.442  0.967\n",
      "Signature 13: -9.832  0.957\n",
      "Signature 14: -9.875  0.906\n",
      "Signature 15: -9.632  0.884\n",
      "Signature 16: -6.758  1.074 *\n",
      "Signature 17: -10.247  0.873\n",
      "Signature 18: -9.902  0.758\n",
      "Signature 19: -9.945  0.951\n"
     ]
    }
   ],
   "source": [
    "verify_disease_signature_specificity(base_dir, 3)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 71,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_0_10000_20241225_062028',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_100000_110000_20241225_225116',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_10000_20000_20241225_062028',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_110000_120000_20241225_225127',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_120000_130000_20241226_020120',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_130000_140000_20241226_020134',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_140000_150000_20241226_051212',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_150000_160000_20241226_051223',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_160000_170000_20241226_082535',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_170000_180000_20241226_082558',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_180000_190000_20241226_113728',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_190000_200000_20241226_113741',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_200000_210000_20241225_064324',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_20000_30000_20241225_093441',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_210000_220000_20241225_064324',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_220000_230000_20241225_094650',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_230000_240000_20241225_094700',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_240000_250000_20241225_125056',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_250000_260000_20241225_125114',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_260000_270000_20241225_155547',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_270000_280000_20241225_155604',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_280000_290000_20241225_190119',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_290000_300000_20241225_190127',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_300000_310000_20241225_220551',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_30000_40000_20241225_093452',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_310000_320000_20241225_220601',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_320000_330000_20241226_010910',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_330000_340000_20241226_011037',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_340000_350000_20241226_041424',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_350000_360000_20241226_041550',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_360000_370000_20241226_071910',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_370000_380000_20241226_072111',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_380000_390000_20241226_102351',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_390000_400000_20241226_102603',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_40000_50000_20241225_124544',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_50000_60000_20241225_124613',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_60000_70000_20241225_155446',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_70000_80000_20241225_155500',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_80000_90000_20241225_193439',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_90000_100000_20241225_193459']"
      ]
     },
     "execution_count": 71,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "NOw do all with same seed\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import torch\n",
    "import numpy as np\n",
    "import os\n",
    "import glob\n",
    "\n",
    "# Base directory containing all output folders\n",
    "base_dir = '/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/'\n",
    "\n",
    "# List all output directories\n",
    "output_dirs = sorted(glob.glob(os.path.join(base_dir, 'output_*')))\n",
    "\n",
    "# Initialize list to store all phis\n",
    "all_phis = []\n",
    "\n",
    "# Load phi from each model\n",
    "for dir_path in output_dirs:\n",
    "    model_path = os.path.join(dir_path, 'model.pt')\n",
    "    try:\n",
    "        # Load the saved model\n",
    "        checkpoint = torch.load(model_path)\n",
    "        \n",
    "        # Extract phi - might need to adjust based on how it's stored\n",
    "        if 'model_state_dict' in checkpoint:\n",
    "            # If phi is in state dict\n",
    "            phi = checkpoint['model_state_dict']['phi']\n",
    "        else:\n",
    "            # If phi is stored directly\n",
    "            phi = checkpoint['phi']\n",
    "            \n",
    "        # Convert to numpy if it's a tensor\n",
    "        if torch.is_tensor(phi):\n",
    "            phi = phi.detach().cpu().numpy()\n",
    "            \n",
    "        all_phis.append(phi)\n",
    "        print(f\"Loaded phi from {dir_path}\")\n",
    "        \n",
    "    except Exception as e:\n",
    "        print(f\"Error loading from {dir_path}: {e}\")\n",
    "\n",
    "# Convert list to numpy array\n",
    "all_phis = np.array(all_phis)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([-14.4437685, -14.447313 , -14.424282 , -14.378359 , -14.314302 ,\n",
       "       -14.237385 , -14.152662 , -14.064531 , -13.976446 , -13.890878 ,\n",
       "       -13.809409 , -13.732987 , -13.662123 , -13.597082 , -13.537991 ,\n",
       "       -13.484928 , -13.437833 , -13.396535 , -13.360718 , -13.329936 ,\n",
       "       -13.303594 , -13.281114 , -13.2618885, -13.245349 , -13.231022 ,\n",
       "       -13.218549 , -13.207606 , -13.197881 , -13.189055 , -13.18072  ,\n",
       "       -13.172402 , -13.16368  , -13.154117 , -13.143393 , -13.13146  ,\n",
       "       -13.1185   , -13.104954 , -13.0915   , -13.078987 , -13.0683155,\n",
       "       -13.060321 , -13.055646 , -13.05455  , -13.056743 , -13.061204 ,\n",
       "       -13.06601  , -13.068282 , -13.064287 , -13.049746 , -13.020224 ,\n",
       "       -12.971797 , -12.9016905], dtype=float32)"
      ]
     },
     "execution_count": 56,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "all_phis[3,5,7,:]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(40, 20, 348, 52)"
      ]
     },
     "execution_count": 58,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "all_phis.shape\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_0_10000_20241225_062028',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_100000_110000_20241225_225116',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_10000_20000_20241225_062028',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_110000_120000_20241225_225127',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_120000_130000_20241226_020120',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_130000_140000_20241226_020134',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_140000_150000_20241226_051212',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_150000_160000_20241226_051223',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_160000_170000_20241226_082535',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_170000_180000_20241226_082558',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_180000_190000_20241226_113728',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_190000_200000_20241226_113741',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_200000_210000_20241225_064324',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_20000_30000_20241225_093441',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_210000_220000_20241225_064324',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_220000_230000_20241225_094650',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_230000_240000_20241225_094700',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_240000_250000_20241225_125056',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_250000_260000_20241225_125114',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_260000_270000_20241225_155547',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_270000_280000_20241225_155604',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_280000_290000_20241225_190119',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_290000_300000_20241225_190127',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_300000_310000_20241225_220551',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_30000_40000_20241225_093452',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_310000_320000_20241225_220601',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_320000_330000_20241226_010910',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_330000_340000_20241226_011037',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_340000_350000_20241226_041424',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_350000_360000_20241226_041550',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_360000_370000_20241226_071910',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_370000_380000_20241226_072111',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_380000_390000_20241226_102351',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_390000_400000_20241226_102603',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_40000_50000_20241225_124544',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_50000_60000_20241225_124613',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_60000_70000_20241225_155446',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_70000_80000_20241225_155500',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_80000_90000_20241225_193439',\n",
       " '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_90000_100000_20241225_193459']"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "base_dir = '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/'\n",
    "\n",
    "# List all output directories\n",
    "output_dirs = sorted(glob.glob(os.path.join(base_dir, 'output_*')))\n",
    "output_dirs\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/2f/nxrbr3pn1msgrl4ffyj33zd00000gn/T/ipykernel_6481/1906698428.py:5: FutureWarning: You are using `torch.load` with `weights_only=False` (the current default value), which uses the default pickle module implicitly. It is possible to construct malicious pickle data which will execute arbitrary code during unpickling (See https://github.com/pytorch/pytorch/blob/main/SECURITY.md#untrusted-models for more details). In a future release, the default value for `weights_only` will be flipped to `True`. This limits the functions that could be executed during unpickling. Arbitrary objects will no longer be allowed to be loaded via this mode unless they are explicitly allowlisted by the user via `torch.serialization.add_safe_globals`. We recommend you start setting `weights_only=True` for any use case where you don't have full control of the loaded file. Please open an issue on GitHub for any issues related to this experimental feature.\n",
      "  checkpoint = torch.load(model_path)\n"
     ]
    }
   ],
   "source": [
    "\n",
    "# Initialize list to store all phis\n",
    "all_phis = []\n",
    "dir_path=output_dirs[0]\n",
    "model_path = os.path.join(dir_path, 'model.pt')\n",
    "checkpoint = torch.load(model_path)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "torch.Size([36, 20])"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "gamma = checkpoint['model_state_dict']['gamma']\n",
    "gamma.shape\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "torch.Tensor"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "type(gamma)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['AAM', 'AMD', 'AD', 'AST', 'AF', 'BD', 'BMI', 'CRC', 'BC', 'CVD',\n",
       "       'CED', 'CAD', 'CD', 'EOC', 'EBMDT', 'HBA1C_DF', 'HEIGHT', 'HDL',\n",
       "       'HT', 'IOP', 'ISS', 'LDL_SF', 'MEL', 'MS', 'OP', 'PD', 'POAG',\n",
       "       'PC', 'PSO', 'RA', 'SCZ', 'SLE', 'T1D', 'T2D', 'UC', 'VTE'],\n",
       "      dtype='<U8')"
      ]
     },
     "execution_count": 25,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import pandas as pd\n",
    "import seaborn as sns\n",
    "import matplotlib.pyplot as plt\n",
    "import rpy2.robjects as robjects\n",
    "import numpy as np\n",
    "\n",
    "# Read the RDS file using rpy2\n",
    "prs_names = np.array(robjects.r.readRDS('/Users/sarahurbut/Dropbox (Personal)/prs_names.rds'))\n",
    "prs_names\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "torch.Size([36, 20])"
      ]
     },
     "execution_count": 34,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "gamma.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(20, 36)"
      ]
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "gamma_np.shape\n",
    "gamma_df.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1200x800 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Create signature names (20 signatures)\n",
    "sig_names = [f'Signature_{i}' for i in range(20)]\n",
    "\n",
    "# Create the DataFrame with correct dimensions\n",
    "gamma_df = pd.DataFrame(gamma_np)  # Transpose to get PRS traits as rows (36) and signatures as columns (20)\n",
    "\n",
    "# Set the labels\n",
    "gamma_df.columns = sig_names  # 20 signature names for columns\n",
    "gamma_df.index = prs_names    # 36 PRS names for rows\n",
    "\n",
    "# Create heatmap with rotated labels\n",
    "plt.figure(figsize=(12, 8))\n",
    "sns.heatmap(gamma_df, \n",
    "            cmap='RdBu_r',\n",
    "            center=0,\n",
    "            xticklabels=True,\n",
    "            yticklabels=True)\n",
    "\n",
    "# Rotate x-axis labels for better readability\n",
    "plt.xticks(rotation=45, ha='right')\n",
    "plt.yticks(rotation=0)\n",
    "\n",
    "plt.title('PRS-Signature Associations')\n",
    "plt.tight_layout()\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([-15.503987 , -15.431744 , -15.304807 , -15.132924 , -14.928651 ,\n",
       "       -14.705385 , -14.475567 , -14.249226 , -14.033224 , -13.831159 ,\n",
       "       -13.643805 , -13.469866 , -13.306853 , -13.151834 , -13.002043 ,\n",
       "       -12.85515  , -12.709556 , -12.564185 , -12.418597 , -12.272718 ,\n",
       "       -12.126815 , -11.981623 , -11.838055 , -11.697049 , -11.559786 ,\n",
       "       -11.427589 , -11.301643 , -11.183104 , -11.072846 , -10.971567 ,\n",
       "       -10.879671 , -10.797351 , -10.724629 , -10.661487 , -10.608015 ,\n",
       "       -10.564512 , -10.531619 , -10.510289 , -10.501758 , -10.507432 ,\n",
       "       -10.528638 , -10.566407 , -10.621158 , -10.69248  , -10.778897 ,\n",
       "       -10.877775 , -10.985331 , -11.0967865, -11.206731 , -11.30963  ,\n",
       "       -11.400389 , -11.474953 ], dtype=float32)"
      ]
     },
     "execution_count": 46,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "all_phis[3,1,1,:]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Calculate statistics\n",
    "mean_phi = np.mean(all_phis, axis=0)\n",
    "std_phi = np.std(all_phis, axis=0)\n",
    "ci_phi = 1.96 * std_phi / np.sqrt(len(all_phis))  # 95% CI\n",
    "\n",
    "# Save results\n",
    "np.save('mean_phi_same.npy', mean_phi)\n",
    "np.save('std_phi_same.npy', std_phi)\n",
    "np.save('ci_phi_same.npy', ci_phi)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "# Select some interesting diseases and signatures to plot\n",
    "diseases_to_plot = [0, 1, 2]  # replace with actual disease indices of interest\n",
    "signatures_to_plot = [0, 1, 2]  # replace with signatures of interest\n",
    "\n",
    "# Create plots\n",
    "for k in signatures_to_plot:\n",
    "    for d in diseases_to_plot:\n",
    "        plt.figure(figsize=(12, 6))\n",
    "        \n",
    "        # Plot individual batch trajectories in light gray\n",
    "        for batch_phi in all_phis:\n",
    "            plt.plot(batch_phi[k, d, :], color='gray', alpha=0.2)\n",
    "        \n",
    "        # Plot mean trajectory in bold\n",
    "        plt.plot(mean_phi[k, d, :], color='blue', linewidth=2, label='Mean')\n",
    "        \n",
    "        # Add confidence intervals\n",
    "        std_phi = np.std(all_phis[:, k, d, :], axis=0)\n",
    "        ci = 1.96 * std_phi / np.sqrt(len(all_phis))\n",
    "        plt.fill_between(range(mean_phi.shape[2]), \n",
    "                        mean_phi[k, d, :] - ci,\n",
    "                        mean_phi[k, d, :] + ci,\n",
    "                        alpha=0.2, color='blue')\n",
    "        \n",
    "        plt.title(f'Signature {k}, Disease {d} Temporal Pattern')\n",
    "        plt.xlabel('Time')\n",
    "        plt.ylabel('Phi Value')\n",
    "        plt.grid(True, alpha=0.3)\n",
    "        plt.savefig(f'phi_trajectory_sig{k}_disease{d}_sameseed.png')\n",
    "        plt.close()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 123,
   "metadata": {},
   "outputs": [],
   "source": [
    "import torch\n",
    "import numpy as np\n",
    "import os\n",
    "import glob\n",
    "\n",
    "# Base directory containing all output folders\n",
    "base_dir = '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/'\n",
    "\n",
    "# List all output directories\n",
    "# List all output directories\n",
    "dir_path = sorted(glob.glob(os.path.join(base_dir, 'output_10000_20000_20241225_062028')))\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 125,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_10000_20000_20241225_062028']"
      ]
     },
     "execution_count": 125,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dir_path"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/2f/nxrbr3pn1msgrl4ffyj33zd00000gn/T/ipykernel_6481/1505807544.py:2: FutureWarning: You are using `torch.load` with `weights_only=False` (the current default value), which uses the default pickle module implicitly. It is possible to construct malicious pickle data which will execute arbitrary code during unpickling (See https://github.com/pytorch/pytorch/blob/main/SECURITY.md#untrusted-models for more details). In a future release, the default value for `weights_only` will be flipped to `True`. This limits the functions that could be executed during unpickling. Arbitrary objects will no longer be allowed to be loaded via this mode unless they are explicitly allowlisted by the user via `torch.serialization.add_safe_globals`. We recommend you start setting `weights_only=True` for any use case where you don't have full control of the loaded file. Please open an issue on GitHub for any issues related to this experimental feature.\n",
      "  checkpoint = torch.load(model_path)\n"
     ]
    }
   ],
   "source": [
    "\n",
    "\n",
    "model_path = os.path.join(dir_path, 'model.pt')\n",
    "checkpoint = torch.load(model_path)\n",
    "ytest=checkpoint['Y']\n",
    "indes=checkpoint['indices']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 109,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/2f/nxrbr3pn1msgrl4ffyj33zd00000gn/T/ipykernel_68206/1397768674.py:1: FutureWarning: You are using `torch.load` with `weights_only=False` (the current default value), which uses the default pickle module implicitly. It is possible to construct malicious pickle data which will execute arbitrary code during unpickling (See https://github.com/pytorch/pytorch/blob/main/SECURITY.md#untrusted-models for more details). In a future release, the default value for `weights_only` will be flipped to `True`. This limits the functions that could be executed during unpickling. Arbitrary objects will no longer be allowed to be loaded via this mode unless they are explicitly allowlisted by the user via `torch.serialization.add_safe_globals`. We recommend you start setting `weights_only=True` for any use case where you don't have full control of the loaded file. Please open an issue on GitHub for any issues related to this experimental feature.\n",
      "  Yt=torch.load(\"/Users/sarahurbut/Dropbox (Personal)/filesforupload/Y_tensor.pt\")\n",
      "/var/folders/2f/nxrbr3pn1msgrl4ffyj33zd00000gn/T/ipykernel_68206/1397768674.py:2: FutureWarning: You are using `torch.load` with `weights_only=False` (the current default value), which uses the default pickle module implicitly. It is possible to construct malicious pickle data which will execute arbitrary code during unpickling (See https://github.com/pytorch/pytorch/blob/main/SECURITY.md#untrusted-models for more details). In a future release, the default value for `weights_only` will be flipped to `True`. This limits the functions that could be executed during unpickling. Arbitrary objects will no longer be allowed to be loaded via this mode unless they are explicitly allowlisted by the user via `torch.serialization.add_safe_globals`. We recommend you start setting `weights_only=True` for any use case where you don't have full control of the loaded file. Please open an issue on GitHub for any issues related to this experimental feature.\n",
      "  E=torch.load(\"/Users/sarahurbut/Dropbox (Personal)/filesforupload/E_matrix.pt\")\n"
     ]
    }
   ],
   "source": [
    "Yt=torch.load(\"/Users/sarahurbut/Dropbox (Personal)/filesforupload/Y_tensor.pt\")\n",
    "E=torch.load(\"/Users/sarahurbut/Dropbox (Personal)/filesforupload/E_matrix.pt\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 116,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Positions: [ 90 109 180 230 299 344 347]\n",
      "Values: tensor([42, 42, 38, 42, 35, 35, 42])\n",
      "Position 90: 42\n",
      "Position 109: 42\n",
      "Position 180: 38\n",
      "Position 230: 42\n",
      "Position 299: 35\n",
      "Position 344: 35\n",
      "Position 347: 42\n"
     ]
    }
   ],
   "source": [
    "# Python\n",
    "# Assuming E is a numpy array\n",
    "indices = np.where(E[10000,:] != 51)[0]\n",
    "values = E[10000,indices]\n",
    "print(\"Positions:\", indices)\n",
    "print(\"Values:\", values)\n",
    "\n",
    "# To see position-value pairs:\n",
    "for pos, val in zip(indices, values):\n",
    "    print(f\"Position {pos}: {val}\")\n",
    "\n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 118,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "tensor(1.)"
      ]
     },
     "execution_count": 118,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "Yt[10000,90,42]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 128,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Successfully extracted 407878 patient IDs\n",
      "First few IDs: ['1000015' '1000023' '1000037' '1000042' '1000059']\n",
      "First batch IDs: ['1000015' '1000023' '1000037' '1000042' '1000059']...\n"
     ]
    }
   ],
   "source": [
    "import rpy2.robjects as robjects\n",
    "import numpy as np\n",
    "\n",
    "# Load the original sparse array from R\n",
    "r_sparse = robjects.r.readRDS('/Users/sarahurbut/Dropbox (Personal)/withsparse/sparse_array.rds')\n",
    "matrix = r_sparse[0]  # Get first timepoint\n",
    "\n",
    "# Try to get rownames using R functions directly\n",
    "try:\n",
    "    # Convert to R matrix first\n",
    "    robjects.r('''\n",
    "        get_rownames <- function(sparse_matrix) {\n",
    "            rownames(sparse_matrix)\n",
    "        }\n",
    "    ''')\n",
    "    get_rownames = robjects.globalenv['get_rownames']\n",
    "    all_patient_ids = np.array(get_rownames(matrix))\n",
    "    print(f\"Successfully extracted {len(all_patient_ids)} patient IDs\")\n",
    "except Exception as e:\n",
    "    print(f\"Error with R method: {e}\")\n",
    "    try:\n",
    "        # Alternative: try getting directly from matrix slots\n",
    "        all_patient_ids = np.array(matrix.slots['Dimnames'][0])\n",
    "        print(f\"Got IDs from slots: {len(all_patient_ids)} IDs\")\n",
    "    except Exception as e2:\n",
    "        print(f\"Error with slots method: {e2}\")\n",
    "\n",
    "# Verify we have the IDs\n",
    "if 'all_patient_ids' in locals():\n",
    "    print(\"First few IDs:\", all_patient_ids[:5])\n",
    "    \n",
    "    def get_batch_ids(start_idx, end_idx):\n",
    "        return all_patient_ids[start_idx:end_idx]\n",
    "\n",
    "    # Example: get IDs for first batch\n",
    "    batch_0_10k_ids = get_batch_ids(0, 10000)\n",
    "    print(f\"First batch IDs: {batch_0_10k_ids[:5]}...\")\n",
    "else:\n",
    "    print(\"Failed to get patient IDs\")\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 129,
   "metadata": {},
   "outputs": [],
   "source": [
    "import numpy as np\n",
    "\n",
    "# Convert to numpy array if not already\n",
    "patient_ids = np.array(all_patient_ids)\n",
    "\n",
    "# Save to file\n",
    "np.save('patient_ids.npy', patient_ids)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 145,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Verifying directory sorting:\n",
      "/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_0_10000_20241225_062028\n",
      "/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_10000_20000_20241225_062028\n",
      "/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_20000_30000_20241225_093441\n",
      "/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_30000_40000_20241225_093452\n",
      "/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_40000_50000_20241225_124544\n",
      "\n",
      "Processing batch 0-10000\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/2f/nxrbr3pn1msgrl4ffyj33zd00000gn/T/ipykernel_68206/1239961796.py:50: FutureWarning: You are using `torch.load` with `weights_only=False` (the current default value), which uses the default pickle module implicitly. It is possible to construct malicious pickle data which will execute arbitrary code during unpickling (See https://github.com/pytorch/pytorch/blob/main/SECURITY.md#untrusted-models for more details). In a future release, the default value for `weights_only` will be flipped to `True`. This limits the functions that could be executed during unpickling. Arbitrary objects will no longer be allowed to be loaded via this mode unless they are explicitly allowlisted by the user via `torch.serialization.add_safe_globals`. We recommend you start setting `weights_only=True` for any use case where you don't have full control of the loaded file. Please open an issue on GitHub for any issues related to this experimental feature.\n",
      "  checkpoint = torch.load(model_path)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_0_10000_20241225_062028\n",
      "Batch size: 10000\n",
      "Current index range: 0 to 10000\n",
      "\n",
      "Processing batch 10000-20000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_10000_20000_20241225_062028\n",
      "Batch size: 10000\n",
      "Current index range: 10000 to 20000\n",
      "\n",
      "Processing batch 20000-30000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_20000_30000_20241225_093441\n",
      "Batch size: 10000\n",
      "Current index range: 20000 to 30000\n",
      "\n",
      "Processing batch 30000-40000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_30000_40000_20241225_093452\n",
      "Batch size: 10000\n",
      "Current index range: 30000 to 40000\n",
      "\n",
      "Processing batch 40000-50000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_40000_50000_20241225_124544\n",
      "Batch size: 10000\n",
      "Current index range: 40000 to 50000\n",
      "\n",
      "Processing batch 50000-60000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_50000_60000_20241225_124613\n",
      "Batch size: 10000\n",
      "Current index range: 50000 to 60000\n",
      "\n",
      "Processing batch 60000-70000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_60000_70000_20241225_155446\n",
      "Batch size: 10000\n",
      "Current index range: 60000 to 70000\n",
      "\n",
      "Processing batch 70000-80000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_70000_80000_20241225_155500\n",
      "Batch size: 10000\n",
      "Current index range: 70000 to 80000\n",
      "\n",
      "Processing batch 80000-90000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_80000_90000_20241225_193439\n",
      "Batch size: 10000\n",
      "Current index range: 80000 to 90000\n",
      "\n",
      "Processing batch 90000-100000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_90000_100000_20241225_193459\n",
      "Batch size: 10000\n",
      "Current index range: 90000 to 100000\n",
      "\n",
      "Processing batch 100000-110000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_100000_110000_20241225_225116\n",
      "Batch size: 10000\n",
      "Current index range: 100000 to 110000\n",
      "\n",
      "Processing batch 110000-120000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_110000_120000_20241225_225127\n",
      "Batch size: 10000\n",
      "Current index range: 110000 to 120000\n",
      "\n",
      "Processing batch 120000-130000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_120000_130000_20241226_020120\n",
      "Batch size: 10000\n",
      "Current index range: 120000 to 130000\n",
      "\n",
      "Processing batch 130000-140000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_130000_140000_20241226_020134\n",
      "Batch size: 10000\n",
      "Current index range: 130000 to 140000\n",
      "\n",
      "Processing batch 140000-150000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_140000_150000_20241226_051212\n",
      "Batch size: 10000\n",
      "Current index range: 140000 to 150000\n",
      "\n",
      "Processing batch 150000-160000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_150000_160000_20241226_051223\n",
      "Batch size: 10000\n",
      "Current index range: 150000 to 160000\n",
      "\n",
      "Processing batch 160000-170000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_160000_170000_20241226_082535\n",
      "Batch size: 10000\n",
      "Current index range: 160000 to 170000\n",
      "\n",
      "Processing batch 170000-180000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_170000_180000_20241226_082558\n",
      "Batch size: 10000\n",
      "Current index range: 170000 to 180000\n",
      "\n",
      "Processing batch 180000-190000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_180000_190000_20241226_113728\n",
      "Batch size: 10000\n",
      "Current index range: 180000 to 190000\n",
      "\n",
      "Processing batch 190000-200000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_190000_200000_20241226_113741\n",
      "Batch size: 10000\n",
      "Current index range: 190000 to 200000\n",
      "\n",
      "Processing batch 200000-210000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_200000_210000_20241225_064324\n",
      "Batch size: 10000\n",
      "Current index range: 200000 to 210000\n",
      "\n",
      "Processing batch 210000-220000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_210000_220000_20241225_064324\n",
      "Batch size: 10000\n",
      "Current index range: 210000 to 220000\n",
      "\n",
      "Processing batch 220000-230000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_220000_230000_20241225_094650\n",
      "Batch size: 10000\n",
      "Current index range: 220000 to 230000\n",
      "\n",
      "Processing batch 230000-240000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_230000_240000_20241225_094700\n",
      "Batch size: 10000\n",
      "Current index range: 230000 to 240000\n",
      "\n",
      "Processing batch 240000-250000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_240000_250000_20241225_125056\n",
      "Batch size: 10000\n",
      "Current index range: 240000 to 250000\n",
      "\n",
      "Processing batch 250000-260000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_250000_260000_20241225_125114\n",
      "Batch size: 10000\n",
      "Current index range: 250000 to 260000\n",
      "\n",
      "Processing batch 260000-270000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_260000_270000_20241225_155547\n",
      "Batch size: 10000\n",
      "Current index range: 260000 to 270000\n",
      "\n",
      "Processing batch 270000-280000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_270000_280000_20241225_155604\n",
      "Batch size: 10000\n",
      "Current index range: 270000 to 280000\n",
      "\n",
      "Processing batch 280000-290000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_280000_290000_20241225_190119\n",
      "Batch size: 10000\n",
      "Current index range: 280000 to 290000\n",
      "\n",
      "Processing batch 290000-300000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_290000_300000_20241225_190127\n",
      "Batch size: 10000\n",
      "Current index range: 290000 to 300000\n",
      "\n",
      "Processing batch 300000-310000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_300000_310000_20241225_220551\n",
      "Batch size: 10000\n",
      "Current index range: 300000 to 310000\n",
      "\n",
      "Processing batch 310000-320000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_310000_320000_20241225_220601\n",
      "Batch size: 10000\n",
      "Current index range: 310000 to 320000\n",
      "\n",
      "Processing batch 320000-330000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_320000_330000_20241226_010910\n",
      "Batch size: 10000\n",
      "Current index range: 320000 to 330000\n",
      "\n",
      "Processing batch 330000-340000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_330000_340000_20241226_011037\n",
      "Batch size: 10000\n",
      "Current index range: 330000 to 340000\n",
      "\n",
      "Processing batch 340000-350000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_340000_350000_20241226_041424\n",
      "Batch size: 10000\n",
      "Current index range: 340000 to 350000\n",
      "\n",
      "Processing batch 350000-360000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_350000_360000_20241226_041550\n",
      "Batch size: 10000\n",
      "Current index range: 350000 to 360000\n",
      "\n",
      "Processing batch 360000-370000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_360000_370000_20241226_071910\n",
      "Batch size: 10000\n",
      "Current index range: 360000 to 370000\n",
      "\n",
      "Processing batch 370000-380000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_370000_380000_20241226_072111\n",
      "Batch size: 10000\n",
      "Current index range: 370000 to 380000\n",
      "\n",
      "Processing batch 380000-390000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_380000_390000_20241226_102351\n",
      "Batch size: 10000\n",
      "Current index range: 380000 to 390000\n",
      "\n",
      "Processing batch 390000-400000\n",
      "Loaded lambda from /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_390000_400000_20241226_102603\n",
      "Batch size: 10000\n",
      "Current index range: 390000 to 400000\n",
      "\n",
      "Final verification:\n",
      "Shape of all_lambdas: (400000, 20, 52)\n",
      "Total individuals processed: 400000\n",
      "Processed ranges: [(0, 10000), (10000, 20000), (20000, 30000), (30000, 40000), (40000, 50000), (50000, 60000), (60000, 70000), (70000, 80000), (80000, 90000), (90000, 100000), (100000, 110000), (110000, 120000), (120000, 130000), (130000, 140000), (140000, 150000), (150000, 160000), (160000, 170000), (170000, 180000), (180000, 190000), (190000, 200000), (200000, 210000), (210000, 220000), (220000, 230000), (230000, 240000), (240000, 250000), (250000, 260000), (260000, 270000), (270000, 280000), (280000, 290000), (290000, 300000), (300000, 310000), (310000, 320000), (320000, 330000), (330000, 340000), (340000, 350000), (350000, 360000), (360000, 370000), (370000, 380000), (380000, 390000), (390000, 400000)]\n",
      "Total available patient IDs: 407878\n",
      "Processed lambda shape: (400000, 20, 52)\n",
      "\n",
      "Verification of processed IDs:\n",
      "Number of processed IDs: 400000\n",
      "First few IDs: ['1000015' '1000023' '1000037' '1000042' '1000059']\n",
      "Last few IDs: ['5929605' '5929616' '5929627' '5929638' '5929643']\n",
      "\n",
      "Unprocessed patients:\n",
      "Number of unprocessed IDs: 7878\n",
      "First few unprocessed IDs: ['5929652' '5929660' '5929679' '5929681' '5929694']\n"
     ]
    }
   ],
   "source": [
    "import os\n",
    "import glob\n",
    "import numpy as np\n",
    "import torch\n",
    "import re\n",
    "\n",
    "# Base directory containing all output folders\n",
    "base_dir = '/Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/'\n",
    "\n",
    "# List all output directories and sort them properly by their index numbers\n",
    "def sort_by_index(dir_name):\n",
    "    # Extract just the start number from directory name\n",
    "    # e.g., from 'output_10000_20000_20241225_062028' get '10000'\n",
    "    match = re.search(r'output_(\\d+)_\\d+_\\d+', dir_name)\n",
    "    if match:\n",
    "        return int(match.group(1))\n",
    "    return 0\n",
    "\n",
    "# Test the sorting\n",
    "output_dirs = sorted(glob.glob(os.path.join(base_dir, 'output_*')), key=sort_by_index)\n",
    "\n",
    "# Print first few directories to verify sorting\n",
    "print(\"Verifying directory sorting:\")\n",
    "for dir_path in output_dirs[:5]:\n",
    "    print(dir_path)\n",
    "\n",
    "\n",
    "# Initialize the full array\n",
    "all_lambdas = np.zeros((400000, 20, 52))  # [n_individuals, n_signatures, n_timepoints]\n",
    "\n",
    "# Keep track of processed indices\n",
    "processed_ranges = []\n",
    "\n",
    "# Load and combine lambda from each model\n",
    "current_idx = 0\n",
    "for dir_path in output_dirs:\n",
    "    model_path = os.path.join(dir_path, 'model.pt')\n",
    "    try:\n",
    "        # Extract batch range from directory name\n",
    "        batch_range = re.findall(r'output_(\\d+)_(\\d+)', os.path.basename(dir_path))\n",
    "        if batch_range:\n",
    "            start_idx, end_idx = map(int, batch_range[0])\n",
    "            print(f\"\\nProcessing batch {start_idx}-{end_idx}\")\n",
    "            \n",
    "            # Verify this matches our current_idx\n",
    "            if current_idx != start_idx:\n",
    "                print(f\"WARNING: Index mismatch! current_idx={current_idx}, but batch starts at {start_idx}\")\n",
    "        \n",
    "        # Load the saved model\n",
    "        checkpoint = torch.load(model_path)\n",
    "        \n",
    "        # Extract lambda\n",
    "        if 'model_state_dict' in checkpoint:\n",
    "            lambda_values = checkpoint['model_state_dict']['lambda_']\n",
    "        else:\n",
    "            lambda_values = checkpoint['lambda_']\n",
    "            \n",
    "        # Convert to numpy if it's a tensor\n",
    "        if torch.is_tensor(lambda_values):\n",
    "            lambda_values = lambda_values.detach().cpu().numpy()\n",
    "        \n",
    "        # Get batch size\n",
    "        batch_size = lambda_values.shape[0]\n",
    "        \n",
    "        # Add to the full array\n",
    "        all_lambdas[current_idx:current_idx + batch_size] = lambda_values\n",
    "        \n",
    "        # Store processed range\n",
    "        processed_ranges.append((current_idx, current_idx + batch_size))\n",
    "        \n",
    "        print(f\"Loaded lambda from {dir_path}\")\n",
    "        print(f\"Batch size: {batch_size}\")\n",
    "        print(f\"Current index range: {current_idx} to {current_idx + batch_size}\")\n",
    "        \n",
    "        current_idx += batch_size\n",
    "        \n",
    "    except Exception as e:\n",
    "        print(f\"Error loading from {dir_path}: {e}\")\n",
    "\n",
    "# Verify no gaps or overlaps in processed ranges\n",
    "processed_ranges.sort()\n",
    "for i in range(len(processed_ranges)-1):\n",
    "    if processed_ranges[i][1] != processed_ranges[i+1][0]:\n",
    "        print(f\"WARNING: Gap or overlap between batches! {processed_ranges[i]} and {processed_ranges[i+1]}\")\n",
    "\n",
    "# Save the combined lambdas\n",
    "np.save('all_lambdas_combined.npy', all_lambdas)\n",
    "\n",
    "# Print final verification\n",
    "print(\"\\nFinal verification:\")\n",
    "print(\"Shape of all_lambdas:\", all_lambdas.shape)\n",
    "print(\"Total individuals processed:\", current_idx)\n",
    "print(\"Processed ranges:\", processed_ranges)\n",
    "\n",
    "# Load patient IDs and verify length matches\n",
    "patient_ids = np.load('/Users/sarahurbut/Dropbox (Personal)/patient_ids.npy')\n",
    "# Verify dimensions\n",
    "print(\"Total available patient IDs:\", len(patient_ids))  # Should be 407,878\n",
    "print(\"Processed lambda shape:\", all_lambdas.shape)      # Should be (400000, 20, 52)\n",
    "\n",
    "# Create mapping of processed IDs\n",
    "processed_ids = patient_ids[:400000]  # Get just the first 400K IDs we processed\n",
    "print(\"\\nVerification of processed IDs:\")\n",
    "print(\"Number of processed IDs:\", len(processed_ids))\n",
    "print(\"First few IDs:\", processed_ids[:5])\n",
    "print(\"Last few IDs:\", processed_ids[-5:])\n",
    "\n",
    "# Save the processed IDs mapping\n",
    "np.save('processed_patient_ids.npy', processed_ids)\n",
    "\n",
    "# Print some stats about unprocessed patients\n",
    "unprocessed_ids = patient_ids[400000:]\n",
    "print(\"\\nUnprocessed patients:\")\n",
    "print(\"Number of unprocessed IDs:\", len(unprocessed_ids))\n",
    "print(\"First few unprocessed IDs:\", unprocessed_ids[:5])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/2f/nxrbr3pn1msgrl4ffyj33zd00000gn/T/ipykernel_6481/4171784616.py:34: FutureWarning: You are using `torch.load` with `weights_only=False` (the current default value), which uses the default pickle module implicitly. It is possible to construct malicious pickle data which will execute arbitrary code during unpickling (See https://github.com/pytorch/pytorch/blob/main/SECURITY.md#untrusted-models for more details). In a future release, the default value for `weights_only` will be flipped to `True`. This limits the functions that could be executed during unpickling. Arbitrary objects will no longer be allowed to be loaded via this mode unless they are explicitly allowlisted by the user via `torch.serialization.add_safe_globals`. We recommend you start setting `weights_only=True` for any use case where you don't have full control of the loaded file. Please open an issue on GitHub for any issues related to this experimental feature.\n",
      "  checkpoint = torch.load(model_path)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_0_10000_20241225_062028: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_100000_110000_20241225_225116: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_10000_20000_20241225_062028: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_110000_120000_20241225_225127: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_120000_130000_20241226_020120: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_130000_140000_20241226_020134: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_140000_150000_20241226_051212: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_150000_160000_20241226_051223: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_160000_170000_20241226_082535: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_170000_180000_20241226_082558: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_180000_190000_20241226_113728: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_190000_200000_20241226_113741: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_200000_210000_20241225_064324: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_20000_30000_20241225_093441: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_210000_220000_20241225_064324: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_220000_230000_20241225_094650: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_230000_240000_20241225_094700: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_240000_250000_20241225_125056: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_250000_260000_20241225_125114: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_260000_270000_20241225_155547: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_270000_280000_20241225_155604: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_280000_290000_20241225_190119: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_290000_300000_20241225_190127: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_300000_310000_20241225_220551: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_30000_40000_20241225_093452: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_310000_320000_20241225_220601: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_320000_330000_20241226_010910: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_330000_340000_20241226_011037: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_340000_350000_20241226_041424: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_350000_360000_20241226_041550: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_360000_370000_20241226_071910: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_370000_380000_20241226_072111: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_380000_390000_20241226_102351: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_390000_400000_20241226_102603: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_40000_50000_20241225_124544: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_50000_60000_20241225_124613: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_60000_70000_20241225_155446: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_70000_80000_20241225_155500: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_80000_90000_20241225_193439: 'CAD' is not in list\n",
      "Error processing /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_90000_100000_20241225_193459: 'CAD' is not in list\n"
     ]
    },
    {
     "ename": "ValueError",
     "evalue": "need at least one array to concatenate",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mValueError\u001b[0m                                Traceback (most recent call last)",
      "Cell \u001b[0;32mIn[41], line 79\u001b[0m\n\u001b[1;32m     76\u001b[0m         \u001b[38;5;28mprint\u001b[39m(\u001b[38;5;124mf\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mError processing \u001b[39m\u001b[38;5;132;01m{\u001b[39;00mdir_path\u001b[38;5;132;01m}\u001b[39;00m\u001b[38;5;124m: \u001b[39m\u001b[38;5;132;01m{\u001b[39;00me\u001b[38;5;132;01m}\u001b[39;00m\u001b[38;5;124m\"\u001b[39m)\n\u001b[1;32m     78\u001b[0m \u001b[38;5;66;03m# Combine results\u001b[39;00m\n\u001b[0;32m---> 79\u001b[0m all_conditional_probs \u001b[38;5;241m=\u001b[39m \u001b[43mnp\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mconcatenate\u001b[49m\u001b[43m(\u001b[49m\u001b[43mall_conditional_probs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43maxis\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[38;5;241;43m0\u001b[39;49m\u001b[43m)\u001b[49m\n\u001b[1;32m     80\u001b[0m all_cad_statuses \u001b[38;5;241m=\u001b[39m np\u001b[38;5;241m.\u001b[39mconcatenate(all_cad_statuses, axis\u001b[38;5;241m=\u001b[39m\u001b[38;5;241m0\u001b[39m)\n\u001b[1;32m     82\u001b[0m \u001b[38;5;66;03m# Calculate statistics for those with CAD before time_x\u001b[39;00m\n",
      "\u001b[0;31mValueError\u001b[0m: need at least one array to concatenate"
     ]
    }
   ],
   "source": [
    "import os\n",
    "import glob\n",
    "import numpy as np\n",
    "import torch\n",
    "from scipy.special import softmax, expit\n",
    "\n",
    "def calculate_conditional_probs(lambda_values, phi_values, Y_data, cad_idx, time_x, target_disease_idx):\n",
    "    \"\"\"\n",
    "    Calculate conditional probabilities for a batch of individuals\n",
    "    \"\"\"\n",
    "    # Get CAD status before time_x\n",
    "    cad_before_x = np.any(Y_data[:, cad_idx, :time_x], axis=1)\n",
    "    \n",
    "    # Calculate thetas\n",
    "    thetas = softmax(lambda_values, axis=1)\n",
    "    \n",
    "    # Calculate pi for target disease\n",
    "    pi = np.zeros((lambda_values.shape[0], lambda_values.shape[2]))\n",
    "    for t in range(lambda_values.shape[2]):\n",
    "        for k in range(lambda_values.shape[1]):\n",
    "            pi[:, t] += thetas[:, k, t] * expit(phi_values[k, target_disease_idx, t])\n",
    "    \n",
    "    return pi, cad_before_x\n",
    "\n",
    "# Initialize storage for results\n",
    "all_conditional_probs = []\n",
    "all_cad_statuses = []\n",
    "\n",
    "# Process each batch\n",
    "for dir_path in output_dirs:\n",
    "    model_path = os.path.join(dir_path, 'model.pt')\n",
    "    try:\n",
    "        # Load the saved model\n",
    "        checkpoint = torch.load(model_path)\n",
    "        \n",
    "        # Extract necessary components\n",
    "        if 'model_state_dict' in checkpoint:\n",
    "            lambda_values = checkpoint['model_state_dict']['lambda_']\n",
    "            phi_values = checkpoint['model_state_dict']['phi']\n",
    "        else:\n",
    "            lambda_values = checkpoint['lambda_']\n",
    "            phi_values = checkpoint['phi']\n",
    "            \n",
    "        # Convert to numpy if needed\n",
    "        if torch.is_tensor(lambda_values):\n",
    "            lambda_values = lambda_values.detach().cpu().numpy()\n",
    "        if torch.is_tensor(phi_values):\n",
    "            phi_values = phi_values.detach().cpu().numpy()\n",
    "            \n",
    "        # Get Y data for this batch\n",
    "        Y_batch = checkpoint['Y']\n",
    "        if torch.is_tensor(Y_batch):\n",
    "            Y_batch = Y_batch.detach().cpu().numpy()\n",
    "            \n",
    "        # Get disease indices\n",
    "        disease_names = checkpoint['disease_names']\n",
    "        cad_idx = disease_names.index('CAD')  # adjust if CAD is named differently\n",
    "        target_disease_idx = disease_names.index('TARGET_DISEASE')  # replace with your target disease\n",
    "        \n",
    "        # Calculate conditional probabilities for this batch\n",
    "        time_x = 26  # halfway point, adjust as needed\n",
    "        pi_batch, cad_status = calculate_conditional_probs(\n",
    "            lambda_values,\n",
    "            phi_values,\n",
    "            Y_batch,\n",
    "            cad_idx,\n",
    "            time_x,\n",
    "            target_disease_idx\n",
    "        )\n",
    "        \n",
    "        # Store results\n",
    "        all_conditional_probs.append(pi_batch)\n",
    "        all_cad_statuses.append(cad_status)\n",
    "        \n",
    "    except Exception as e:\n",
    "        print(f\"Error processing {dir_path}: {e}\")\n",
    "\n",
    "# Combine results\n",
    "all_conditional_probs = np.concatenate(all_conditional_probs, axis=0)\n",
    "all_cad_statuses = np.concatenate(all_cad_statuses, axis=0)\n",
    "\n",
    "# Calculate statistics for those with CAD before time_x\n",
    "conditional_probs_given_cad = all_conditional_probs[all_cad_statuses]\n",
    "mean_trajectory = np.mean(conditional_probs_given_cad, axis=0)\n",
    "ci_lower = np.percentile(conditional_probs_given_cad, 2.5, axis=0)\n",
    "ci_upper = np.percentile(conditional_probs_given_cad, 97.5, axis=0)\n",
    "\n",
    "# Save results\n",
    "np.save('conditional_probs.npy', conditional_probs_given_cad)\n",
    "np.save('mean_trajectory.npy', mean_trajectory)\n",
    "np.save('ci_bounds.npy', np.array([ci_lower, ci_upper]))\n",
    "\n",
    "# Print summary statistics\n",
    "print(f\"Total individuals: {len(all_cad_statuses)}\")\n",
    "print(f\"Individuals with early CAD: {np.sum(all_cad_statuses)}\")\n",
    "print(f\"Proportion with early CAD: {np.mean(all_cad_statuses):.3f}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 143,
   "metadata": {},
   "outputs": [],
   "source": [
    "bpc = robjects.r.readRDS('/Users/sarahurbut/Downloads/baseline_withPCS.rds')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 149,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/2f/nxrbr3pn1msgrl4ffyj33zd00000gn/T/ipykernel_68206/2601109579.py:21: DeprecationWarning: `trapz` is deprecated. Use `trapezoid` instead, or one of the numerical integration functions in `scipy.integrate`.\n",
      "  theta_aucs = np.array([np.trapz(all_thetas[:, s, :], timepoints) for s in range(20)]).T\n"
     ]
    }
   ],
   "source": [
    "def softmax(x):\n",
    "    \"\"\"\n",
    "    Compute softmax values for each set of scores in x.\n",
    "    x shape: (n_individuals, n_signatures, n_timepoints)\n",
    "    \"\"\"\n",
    "    # Reshape to (n_individuals * n_timepoints, n_signatures)\n",
    "    x_reshaped = x.transpose(0, 2, 1).reshape(-1, x.shape[1])\n",
    "    \n",
    "    # Compute softmax\n",
    "    e_x = np.exp(x_reshaped - np.max(x_reshaped, axis=1, keepdims=True))\n",
    "    softmax_x = e_x / np.sum(e_x, axis=1, keepdims=True)\n",
    "    \n",
    "    # Reshape back to original shape\n",
    "    return softmax_x.reshape(x.shape[0], x.shape[2], x.shape[1]).transpose(0, 2, 1)\n",
    "\n",
    "# Calculate thetas using softmax\n",
    "all_thetas = softmax(all_lambdas)  # shape: (400000, 20, 52)\n",
    "\n",
    "# Calculate AUC\n",
    "timepoints = np.arange(52)\n",
    "theta_aucs = np.array([np.trapz(all_thetas[:, s, :], timepoints) for s in range(20)]).T\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 153,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Verifying lambda to theta conversion:\n",
      "\n",
      "Person 0 (ID: 1000015):\n",
      "\n",
      "Timepoint 0:\n",
      "Lambdas:\n",
      "Signature 1: -0.9725\n",
      "Signature 2: 1.0956\n",
      "Signature 3: 0.9542\n",
      "Signature 4: -1.4610\n",
      "Signature 5: 1.4508\n",
      "Signature 6: 1.2617\n",
      "Signature 7: 1.4442\n",
      "Signature 8: 0.5232\n",
      "Signature 9: -0.0611\n",
      "Signature 10: 0.0414\n",
      "Signature 11: -0.4500\n",
      "Signature 12: 1.1507\n",
      "Signature 13: 0.1874\n",
      "Signature 14: -0.0070\n",
      "Signature 15: -0.1920\n",
      "Signature 16: 1.7625\n",
      "Signature 17: -1.4313\n",
      "Signature 18: -0.5677\n",
      "Signature 19: -0.7202\n",
      "Signature 20: 0.0943\n",
      "\n",
      "Thetas (after softmax):\n",
      "Signature 1: 0.0102\n",
      "Signature 2: 0.0810\n",
      "Signature 3: 0.0703\n",
      "Signature 4: 0.0063\n",
      "Signature 5: 0.1155\n",
      "Signature 6: 0.0956\n",
      "Signature 7: 0.1147\n",
      "Signature 8: 0.0457\n",
      "Signature 9: 0.0255\n",
      "Signature 10: 0.0282\n",
      "Signature 11: 0.0173\n",
      "Signature 12: 0.0855\n",
      "Signature 13: 0.0326\n",
      "Signature 14: 0.0269\n",
      "Signature 15: 0.0223\n",
      "Signature 16: 0.1577\n",
      "Signature 17: 0.0065\n",
      "Signature 18: 0.0153\n",
      "Signature 19: 0.0132\n",
      "Signature 20: 0.0297\n",
      "\n",
      "Sum of thetas: 1.000000\n",
      "\n",
      "Top 3 signatures:\n",
      "Signature 16: 0.1577\n",
      "Signature 5: 0.1155\n",
      "Signature 7: 0.1147\n",
      "\n",
      "Timepoint 25:\n",
      "Lambdas:\n",
      "Signature 1: 1.2293\n",
      "Signature 2: 0.3679\n",
      "Signature 3: 0.6240\n",
      "Signature 4: 0.3370\n",
      "Signature 5: 1.2001\n",
      "Signature 6: 1.2606\n",
      "Signature 7: 0.2316\n",
      "Signature 8: -0.4296\n",
      "Signature 9: 1.7946\n",
      "Signature 10: -1.0903\n",
      "Signature 11: -0.3441\n",
      "Signature 12: -0.4124\n",
      "Signature 13: 1.4032\n",
      "Signature 14: -0.8037\n",
      "Signature 15: -0.2231\n",
      "Signature 16: 0.8881\n",
      "Signature 17: -0.8544\n",
      "Signature 18: 0.4114\n",
      "Signature 19: 0.0674\n",
      "Signature 20: 0.3708\n",
      "\n",
      "Thetas (after softmax):\n",
      "Signature 1: 0.0929\n",
      "Signature 2: 0.0392\n",
      "Signature 3: 0.0507\n",
      "Signature 4: 0.0381\n",
      "Signature 5: 0.0902\n",
      "Signature 6: 0.0958\n",
      "Signature 7: 0.0342\n",
      "Signature 8: 0.0177\n",
      "Signature 9: 0.1634\n",
      "Signature 10: 0.0091\n",
      "Signature 11: 0.0193\n",
      "Signature 12: 0.0180\n",
      "Signature 13: 0.1105\n",
      "Signature 14: 0.0122\n",
      "Signature 15: 0.0217\n",
      "Signature 16: 0.0660\n",
      "Signature 17: 0.0116\n",
      "Signature 18: 0.0410\n",
      "Signature 19: 0.0291\n",
      "Signature 20: 0.0394\n",
      "\n",
      "Sum of thetas: 1.000000\n",
      "\n",
      "Top 3 signatures:\n",
      "Signature 9: 0.1634\n",
      "Signature 13: 0.1105\n",
      "Signature 6: 0.0958\n",
      "\n",
      "Timepoint 51:\n",
      "Lambdas:\n",
      "Signature 1: 0.7433\n",
      "Signature 2: -0.0488\n",
      "Signature 3: 0.2872\n",
      "Signature 4: 0.7366\n",
      "Signature 5: 0.5448\n",
      "Signature 6: 0.2498\n",
      "Signature 7: 1.5411\n",
      "Signature 8: -1.5042\n",
      "Signature 9: 1.1490\n",
      "Signature 10: 0.8726\n",
      "Signature 11: -0.3113\n",
      "Signature 12: -0.4970\n",
      "Signature 13: 0.6224\n",
      "Signature 14: 0.9008\n",
      "Signature 15: 0.7221\n",
      "Signature 16: -0.4160\n",
      "Signature 17: 0.1025\n",
      "Signature 18: -1.2889\n",
      "Signature 19: 0.2779\n",
      "Signature 20: 1.7579\n",
      "\n",
      "Thetas (after softmax):\n",
      "Signature 1: 0.0571\n",
      "Signature 2: 0.0259\n",
      "Signature 3: 0.0362\n",
      "Signature 4: 0.0567\n",
      "Signature 5: 0.0468\n",
      "Signature 6: 0.0349\n",
      "Signature 7: 0.1269\n",
      "Signature 8: 0.0060\n",
      "Signature 9: 0.0857\n",
      "Signature 10: 0.0650\n",
      "Signature 11: 0.0199\n",
      "Signature 12: 0.0165\n",
      "Signature 13: 0.0506\n",
      "Signature 14: 0.0669\n",
      "Signature 15: 0.0559\n",
      "Signature 16: 0.0179\n",
      "Signature 17: 0.0301\n",
      "Signature 18: 0.0075\n",
      "Signature 19: 0.0359\n",
      "Signature 20: 0.1576\n",
      "\n",
      "Sum of thetas: 1.000000\n",
      "\n",
      "Top 3 signatures:\n",
      "Signature 20: 0.1576\n",
      "Signature 7: 0.1269\n",
      "Signature 9: 0.0857\n",
      "\n",
      "Person 100 (ID: 1001303):\n",
      "\n",
      "Timepoint 0:\n",
      "Lambdas:\n",
      "Signature 1: 1.0947\n",
      "Signature 2: 1.1814\n",
      "Signature 3: -0.4208\n",
      "Signature 4: 0.6525\n",
      "Signature 5: -0.5153\n",
      "Signature 6: 1.1256\n",
      "Signature 7: -0.6152\n",
      "Signature 8: -0.7507\n",
      "Signature 9: -1.1638\n",
      "Signature 10: 0.1431\n",
      "Signature 11: 0.5801\n",
      "Signature 12: -0.1224\n",
      "Signature 13: 0.2972\n",
      "Signature 14: -0.3677\n",
      "Signature 15: -0.7405\n",
      "Signature 16: -0.9838\n",
      "Signature 17: -0.3338\n",
      "Signature 18: 1.1218\n",
      "Signature 19: 0.4225\n",
      "Signature 20: 0.2979\n",
      "\n",
      "Thetas (after softmax):\n",
      "Signature 1: 0.1099\n",
      "Signature 2: 0.1198\n",
      "Signature 3: 0.0241\n",
      "Signature 4: 0.0706\n",
      "Signature 5: 0.0220\n",
      "Signature 6: 0.1133\n",
      "Signature 7: 0.0199\n",
      "Signature 8: 0.0174\n",
      "Signature 9: 0.0115\n",
      "Signature 10: 0.0424\n",
      "Signature 11: 0.0657\n",
      "Signature 12: 0.0325\n",
      "Signature 13: 0.0495\n",
      "Signature 14: 0.0255\n",
      "Signature 15: 0.0175\n",
      "Signature 16: 0.0137\n",
      "Signature 17: 0.0263\n",
      "Signature 18: 0.1129\n",
      "Signature 19: 0.0561\n",
      "Signature 20: 0.0495\n",
      "\n",
      "Sum of thetas: 1.000000\n",
      "\n",
      "Top 3 signatures:\n",
      "Signature 2: 0.1198\n",
      "Signature 6: 0.1133\n",
      "Signature 18: 0.1129\n",
      "\n",
      "Timepoint 25:\n",
      "Lambdas:\n",
      "Signature 1: -0.6510\n",
      "Signature 2: 1.0262\n",
      "Signature 3: -0.0149\n",
      "Signature 4: -0.1665\n",
      "Signature 5: -0.2694\n",
      "Signature 6: -1.9335\n",
      "Signature 7: -0.8584\n",
      "Signature 8: -0.1696\n",
      "Signature 9: 0.0020\n",
      "Signature 10: -0.5530\n",
      "Signature 11: 0.1040\n",
      "Signature 12: 0.5564\n",
      "Signature 13: 0.5091\n",
      "Signature 14: 1.1126\n",
      "Signature 15: 0.1666\n",
      "Signature 16: -1.1284\n",
      "Signature 17: -1.7216\n",
      "Signature 18: 1.1214\n",
      "Signature 19: -0.8409\n",
      "Signature 20: 0.7987\n",
      "\n",
      "Thetas (after softmax):\n",
      "Signature 1: 0.0219\n",
      "Signature 2: 0.1169\n",
      "Signature 3: 0.0413\n",
      "Signature 4: 0.0355\n",
      "Signature 5: 0.0320\n",
      "Signature 6: 0.0061\n",
      "Signature 7: 0.0178\n",
      "Signature 8: 0.0354\n",
      "Signature 9: 0.0420\n",
      "Signature 10: 0.0241\n",
      "Signature 11: 0.0465\n",
      "Signature 12: 0.0731\n",
      "Signature 13: 0.0697\n",
      "Signature 14: 0.1275\n",
      "Signature 15: 0.0495\n",
      "Signature 16: 0.0136\n",
      "Signature 17: 0.0075\n",
      "Signature 18: 0.1286\n",
      "Signature 19: 0.0181\n",
      "Signature 20: 0.0931\n",
      "\n",
      "Sum of thetas: 1.000000\n",
      "\n",
      "Top 3 signatures:\n",
      "Signature 18: 0.1286\n",
      "Signature 14: 0.1275\n",
      "Signature 2: 0.1169\n",
      "\n",
      "Timepoint 51:\n",
      "Lambdas:\n",
      "Signature 1: 2.0688\n",
      "Signature 2: 1.4838\n",
      "Signature 3: -0.0256\n",
      "Signature 4: -2.2101\n",
      "Signature 5: 0.6222\n",
      "Signature 6: -0.7794\n",
      "Signature 7: 1.4034\n",
      "Signature 8: -2.0101\n",
      "Signature 9: -0.0902\n",
      "Signature 10: 0.4614\n",
      "Signature 11: -0.0186\n",
      "Signature 12: 0.7160\n",
      "Signature 13: -0.7853\n",
      "Signature 14: 0.5823\n",
      "Signature 15: 0.5296\n",
      "Signature 16: 0.1122\n",
      "Signature 17: -0.0379\n",
      "Signature 18: 0.2186\n",
      "Signature 19: -1.0989\n",
      "Signature 20: -0.3381\n",
      "\n",
      "Thetas (after softmax):\n",
      "Signature 1: 0.2343\n",
      "Signature 2: 0.1306\n",
      "Signature 3: 0.0289\n",
      "Signature 4: 0.0032\n",
      "Signature 5: 0.0552\n",
      "Signature 6: 0.0136\n",
      "Signature 7: 0.1205\n",
      "Signature 8: 0.0040\n",
      "Signature 9: 0.0271\n",
      "Signature 10: 0.0470\n",
      "Signature 11: 0.0291\n",
      "Signature 12: 0.0606\n",
      "Signature 13: 0.0135\n",
      "Signature 14: 0.0530\n",
      "Signature 15: 0.0503\n",
      "Signature 16: 0.0331\n",
      "Signature 17: 0.0285\n",
      "Signature 18: 0.0368\n",
      "Signature 19: 0.0099\n",
      "Signature 20: 0.0211\n",
      "\n",
      "Sum of thetas: 1.000000\n",
      "\n",
      "Top 3 signatures:\n",
      "Signature 1: 0.2343\n",
      "Signature 2: 0.1306\n",
      "Signature 7: 0.1205\n",
      "\n",
      "Person 399999 (ID: 5929643):\n",
      "\n",
      "Timepoint 0:\n",
      "Lambdas:\n",
      "Signature 1: -0.4154\n",
      "Signature 2: -0.7084\n",
      "Signature 3: 0.6977\n",
      "Signature 4: -2.0409\n",
      "Signature 5: -0.4085\n",
      "Signature 6: -0.6489\n",
      "Signature 7: -0.6260\n",
      "Signature 8: 0.2834\n",
      "Signature 9: 1.0145\n",
      "Signature 10: 0.0539\n",
      "Signature 11: 1.3817\n",
      "Signature 12: -1.5443\n",
      "Signature 13: -0.1805\n",
      "Signature 14: 0.6860\n",
      "Signature 15: -0.9810\n",
      "Signature 16: -0.3796\n",
      "Signature 17: 1.2622\n",
      "Signature 18: -0.5229\n",
      "Signature 19: -0.4359\n",
      "Signature 20: -0.0503\n",
      "\n",
      "Thetas (after softmax):\n",
      "Signature 1: 0.0276\n",
      "Signature 2: 0.0206\n",
      "Signature 3: 0.0839\n",
      "Signature 4: 0.0054\n",
      "Signature 5: 0.0277\n",
      "Signature 6: 0.0218\n",
      "Signature 7: 0.0223\n",
      "Signature 8: 0.0554\n",
      "Signature 9: 0.1151\n",
      "Signature 10: 0.0441\n",
      "Signature 11: 0.1662\n",
      "Signature 12: 0.0089\n",
      "Signature 13: 0.0349\n",
      "Signature 14: 0.0829\n",
      "Signature 15: 0.0157\n",
      "Signature 16: 0.0286\n",
      "Signature 17: 0.1475\n",
      "Signature 18: 0.0247\n",
      "Signature 19: 0.0270\n",
      "Signature 20: 0.0397\n",
      "\n",
      "Sum of thetas: 1.000000\n",
      "\n",
      "Top 3 signatures:\n",
      "Signature 11: 0.1662\n",
      "Signature 17: 0.1475\n",
      "Signature 9: 0.1151\n",
      "\n",
      "Timepoint 25:\n",
      "Lambdas:\n",
      "Signature 1: -0.4628\n",
      "Signature 2: -0.7675\n",
      "Signature 3: 1.2028\n",
      "Signature 4: -0.1800\n",
      "Signature 5: -0.1046\n",
      "Signature 6: -0.2278\n",
      "Signature 7: -0.2150\n",
      "Signature 8: -0.3246\n",
      "Signature 9: -1.1737\n",
      "Signature 10: 0.1760\n",
      "Signature 11: 0.5038\n",
      "Signature 12: 0.0561\n",
      "Signature 13: -0.1700\n",
      "Signature 14: -0.7141\n",
      "Signature 15: 1.5473\n",
      "Signature 16: -0.7423\n",
      "Signature 17: 1.7887\n",
      "Signature 18: 0.1150\n",
      "Signature 19: 0.1253\n",
      "Signature 20: 0.4961\n",
      "\n",
      "Thetas (after softmax):\n",
      "Signature 1: 0.0216\n",
      "Signature 2: 0.0160\n",
      "Signature 3: 0.1145\n",
      "Signature 4: 0.0287\n",
      "Signature 5: 0.0310\n",
      "Signature 6: 0.0274\n",
      "Signature 7: 0.0277\n",
      "Signature 8: 0.0249\n",
      "Signature 9: 0.0106\n",
      "Signature 10: 0.0410\n",
      "Signature 11: 0.0569\n",
      "Signature 12: 0.0364\n",
      "Signature 13: 0.0290\n",
      "Signature 14: 0.0168\n",
      "Signature 15: 0.1615\n",
      "Signature 16: 0.0164\n",
      "Signature 17: 0.2057\n",
      "Signature 18: 0.0386\n",
      "Signature 19: 0.0390\n",
      "Signature 20: 0.0565\n",
      "\n",
      "Sum of thetas: 1.000000\n",
      "\n",
      "Top 3 signatures:\n",
      "Signature 17: 0.2057\n",
      "Signature 15: 0.1615\n",
      "Signature 3: 0.1145\n",
      "\n",
      "Timepoint 51:\n",
      "Lambdas:\n",
      "Signature 1: -0.5370\n",
      "Signature 2: 0.5345\n",
      "Signature 3: 0.1862\n",
      "Signature 4: 0.0805\n",
      "Signature 5: -0.1816\n",
      "Signature 6: 0.2055\n",
      "Signature 7: -0.4125\n",
      "Signature 8: -0.8577\n",
      "Signature 9: -0.4736\n",
      "Signature 10: -1.0163\n",
      "Signature 11: 0.8261\n",
      "Signature 12: 0.6161\n",
      "Signature 13: -1.0700\n",
      "Signature 14: 0.0761\n",
      "Signature 15: 1.2071\n",
      "Signature 16: -0.6500\n",
      "Signature 17: 0.1751\n",
      "Signature 18: -0.4871\n",
      "Signature 19: -0.2174\n",
      "Signature 20: 0.0787\n",
      "\n",
      "Thetas (after softmax):\n",
      "Signature 1: 0.0268\n",
      "Signature 2: 0.0782\n",
      "Signature 3: 0.0552\n",
      "Signature 4: 0.0496\n",
      "Signature 5: 0.0382\n",
      "Signature 6: 0.0563\n",
      "Signature 7: 0.0303\n",
      "Signature 8: 0.0194\n",
      "Signature 9: 0.0285\n",
      "Signature 10: 0.0166\n",
      "Signature 11: 0.1047\n",
      "Signature 12: 0.0848\n",
      "Signature 13: 0.0157\n",
      "Signature 14: 0.0494\n",
      "Signature 15: 0.1532\n",
      "Signature 16: 0.0239\n",
      "Signature 17: 0.0546\n",
      "Signature 18: 0.0281\n",
      "Signature 19: 0.0369\n",
      "Signature 20: 0.0496\n",
      "\n",
      "Sum of thetas: 1.000000\n",
      "\n",
      "Top 3 signatures:\n",
      "Signature 15: 0.1532\n",
      "Signature 11: 0.1047\n",
      "Signature 12: 0.0848\n",
      "\n",
      "Array shapes:\n",
      "Lambda array shape: (400000, 20, 52)\n",
      "Theta array shape: (400000, 20, 52)\n"
     ]
    }
   ],
   "source": [
    "def softmax_single(x):\n",
    "    \"\"\"\n",
    "    Compute softmax for a single timepoint\n",
    "    x shape: (n_signatures,)\n",
    "    \"\"\"\n",
    "    e_x = np.exp(x - np.max(x))\n",
    "    return e_x / np.sum(e_x)\n",
    "\n",
    "def softmax_full(x):\n",
    "    \"\"\"\n",
    "    Compute softmax for full array\n",
    "    x shape: (n_individuals, n_signatures, n_timepoints)\n",
    "    \"\"\"\n",
    "    # Reshape to (n_individuals * n_timepoints, n_signatures)\n",
    "    x_reshaped = x.transpose(0, 2, 1).reshape(-1, x.shape[1])\n",
    "    \n",
    "    # Compute softmax\n",
    "    e_x = np.exp(x_reshaped - np.max(x_reshaped, axis=1, keepdims=True))\n",
    "    softmax_x = e_x / np.sum(e_x, axis=1, keepdims=True)\n",
    "    \n",
    "    # Reshape back\n",
    "    return softmax_x.reshape(x.shape[0], x.shape[2], x.shape[1]).transpose(0, 2, 1)\n",
    "\n",
    "# Let's check a few random people at different timepoints\n",
    "sample_people = [0, 100, 399999]  # First, middle, and last person\n",
    "sample_timepoints = [0, 25, 51]   # First, middle, and last timepoint\n",
    "\n",
    "print(\"Verifying lambda to theta conversion:\")\n",
    "for person in sample_people:\n",
    "    print(f\"\\nPerson {person} (ID: {patient_ids[person]}):\")\n",
    "    \n",
    "    for t in sample_timepoints:\n",
    "        print(f\"\\nTimepoint {t}:\")\n",
    "        \n",
    "        # Get lambdas for this person at this timepoint\n",
    "        lambdas_t = all_lambdas[person, :, t]\n",
    "        print(\"Lambdas:\")\n",
    "        for s in range(20):\n",
    "            print(f\"Signature {s+1}: {lambdas_t[s]:.4f}\")\n",
    "        \n",
    "        # Calculate thetas using softmax\n",
    "        thetas_t = softmax_single(lambdas_t)\n",
    "        print(\"\\nThetas (after softmax):\")\n",
    "        for s in range(20):\n",
    "            print(f\"Signature {s+1}: {thetas_t[s]:.4f}\")\n",
    "            \n",
    "        # Verify sum to 1\n",
    "        print(f\"\\nSum of thetas: {np.sum(thetas_t):.6f}\")\n",
    "        \n",
    "        # Show top 3 signatures at this timepoint\n",
    "        top_sigs = np.argsort(thetas_t)[-3:][::-1]\n",
    "        print(\"\\nTop 3 signatures:\")\n",
    "        for s in top_sigs:\n",
    "            print(f\"Signature {s+1}: {thetas_t[s]:.4f}\")\n",
    "\n",
    "# Calculate full theta array\n",
    "all_thetas = softmax_full(all_lambdas)\n",
    "\n",
    "# Verify shapes\n",
    "print(\"\\nArray shapes:\")\n",
    "print(f\"Lambda array shape: {all_lambdas.shape}\")\n",
    "print(f\"Theta array shape: {all_thetas.shape}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 160,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([0.01075749, 0.04174133, 0.01236625, 0.14625188, 0.13679618,\n",
       "       0.03809534, 0.02233924, 0.09782585, 0.07387062, 0.01759529,\n",
       "       0.02754722, 0.01361824, 0.02753008, 0.07331311, 0.01398763,\n",
       "       0.08847629, 0.0433737 , 0.08821341, 0.00426847, 0.02203236])"
      ]
     },
     "execution_count": 160,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "\n",
    "softmax_single(all_lambdas[1,:,1])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 164,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([0.01023533, 0.08096029, 0.07028231, 0.00627936, 0.11547649,\n",
       "       0.09558394, 0.1147219 , 0.0456719 , 0.02546299, 0.02821098,\n",
       "       0.01725846, 0.08554672, 0.03264462, 0.02687726, 0.02233783,\n",
       "       0.15772179, 0.0064689 , 0.01534278, 0.0131727 , 0.02974346])"
      ]
     },
     "execution_count": 164,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "all_thetas[0,:,0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 168,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([0.01023533, 0.08096029, 0.07028231, 0.00627936, 0.11547649,\n",
       "       0.09558394, 0.1147219 , 0.0456719 , 0.02546299, 0.02821098,\n",
       "       0.01725846, 0.08554672, 0.03264462, 0.02687726, 0.02233783,\n",
       "       0.15772179, 0.0064689 , 0.01534278, 0.0131727 , 0.02974346])"
      ]
     },
     "execution_count": 168,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "person_idx = 0\n",
    "\n",
    "# Calculate thetas for this person\n",
    "thetas_person = torch.softmax(torch.tensor(all_lambdas[person_idx]), dim=0).numpy()\n",
    "thetas_person[:,0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 162,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Signature 20 AUC: 3.731\n",
      "Mean theta: 0.074\n",
      "\n",
      "Signature 9 AUC: 5.579\n",
      "Mean theta: 0.108\n",
      "\n",
      "Signature 6 AUC: 5.350\n",
      "Mean theta: 0.104\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/2f/nxrbr3pn1msgrl4ffyj33zd00000gn/T/ipykernel_68206/3816044577.py:28: DeprecationWarning: `trapz` is deprecated. Use `trapezoid` instead, or one of the numerical integration functions in `scipy.integrate`.\n",
      "  auc = np.trapz(thetas_person[sig], timepoints)\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1200x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "\n",
    "# Take one person as an example\n",
    "person_idx = 0\n",
    "\n",
    "# Calculate thetas for this person\n",
    "thetas_person = torch.softmax(torch.tensor(all_lambdas[person_idx]), dim=0).numpy()\n",
    "\n",
    "# Plot trajectories for a few signatures\n",
    "plt.figure(figsize=(12, 6))\n",
    "timepoints = np.arange(52)\n",
    "\n",
    "# Plot top 3 signatures by max value\n",
    "top_sigs = np.argsort(np.max(thetas_person, axis=1))[-3:]\n",
    "\n",
    "for sig in top_sigs:\n",
    "    plt.fill_between(timepoints, 0, thetas_person[sig], alpha=0.3, label=f'AUC Sig {sig+1}')\n",
    "    plt.plot(timepoints, thetas_person[sig], label=f'Signature {sig+1}')\n",
    "\n",
    "plt.title(f'Theta Trajectories for Person {patient_ids[person_idx]}')\n",
    "plt.xlabel('Timepoint')\n",
    "plt.ylabel('Theta (probability)')\n",
    "plt.legend()\n",
    "plt.grid(True)\n",
    "\n",
    "# Calculate and print AUCs for these signatures\n",
    "for sig in top_sigs:\n",
    "    auc = np.trapz(thetas_person[sig], timepoints)\n",
    "    print(f\"\\nSignature {sig+1} AUC: {auc:.3f}\")\n",
    "    print(f\"Mean theta: {np.mean(thetas_person[sig]):.3f}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 169,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Calculating thetas...\n",
      "Calculating AUCs...\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/2f/nxrbr3pn1msgrl4ffyj33zd00000gn/T/ipykernel_68206/1559298529.py:11: DeprecationWarning: `trapz` is deprecated. Use `trapezoid` instead, or one of the numerical integration functions in `scipy.integrate`.\n",
      "  theta_aucs = np.array([np.trapz(all_thetas[:, s, :], timepoints) for s in range(20)]).T\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Creating REGENIE phenotype file: signature_auc_phenotypes.txt\n",
      "\n",
      "Summary statistics for signature AUCs:\n",
      "\n",
      "Signature 1:\n",
      "Mean: 2.5491\n",
      "Std: 1.9036\n",
      "Min: 0.1160\n",
      "Max: 22.8440\n",
      "\n",
      "Signature 2:\n",
      "Mean: 2.5505\n",
      "Std: 1.9289\n",
      "Min: 0.1067\n",
      "Max: 18.8861\n",
      "\n",
      "Signature 3:\n",
      "Mean: 2.5170\n",
      "Std: 1.8609\n",
      "Min: 0.1117\n",
      "Max: 21.2460\n",
      "\n",
      "Signature 4:\n",
      "Mean: 2.5230\n",
      "Std: 1.9095\n",
      "Min: 0.1136\n",
      "Max: 19.1575\n",
      "\n",
      "Signature 5:\n",
      "Mean: 2.5408\n",
      "Std: 1.8979\n",
      "Min: 0.1226\n",
      "Max: 17.3734\n",
      "\n",
      "Signature 6:\n",
      "Mean: 2.6476\n",
      "Std: 2.2507\n",
      "Min: 0.0477\n",
      "Max: 31.1047\n",
      "\n",
      "Signature 7:\n",
      "Mean: 2.5494\n",
      "Std: 1.9189\n",
      "Min: 0.0737\n",
      "Max: 19.3823\n",
      "\n",
      "Signature 8:\n",
      "Mean: 2.5566\n",
      "Std: 1.9146\n",
      "Min: 0.1088\n",
      "Max: 20.9530\n",
      "\n",
      "Signature 9:\n",
      "Mean: 2.5182\n",
      "Std: 1.8696\n",
      "Min: 0.1226\n",
      "Max: 18.7159\n",
      "\n",
      "Signature 10:\n",
      "Mean: 2.5633\n",
      "Std: 1.9499\n",
      "Min: 0.1011\n",
      "Max: 24.3861\n",
      "\n",
      "Signature 11:\n",
      "Mean: 2.5566\n",
      "Std: 1.8972\n",
      "Min: 0.1055\n",
      "Max: 19.8881\n",
      "\n",
      "Signature 12:\n",
      "Mean: 2.5323\n",
      "Std: 1.8809\n",
      "Min: 0.1040\n",
      "Max: 18.5127\n",
      "\n",
      "Signature 13:\n",
      "Mean: 2.5252\n",
      "Std: 1.9231\n",
      "Min: 0.0955\n",
      "Max: 18.7850\n",
      "\n",
      "Signature 14:\n",
      "Mean: 2.5493\n",
      "Std: 1.9483\n",
      "Min: 0.0753\n",
      "Max: 24.4520\n",
      "\n",
      "Signature 15:\n",
      "Mean: 2.5316\n",
      "Std: 1.9195\n",
      "Min: 0.0811\n",
      "Max: 23.7423\n",
      "\n",
      "Signature 16:\n",
      "Mean: 2.5698\n",
      "Std: 1.9961\n",
      "Min: 0.0435\n",
      "Max: 27.0263\n",
      "\n",
      "Signature 17:\n",
      "Mean: 2.5555\n",
      "Std: 1.9030\n",
      "Min: 0.1294\n",
      "Max: 21.2753\n",
      "\n",
      "Signature 18:\n",
      "Mean: 2.5292\n",
      "Std: 1.9297\n",
      "Min: 0.0864\n",
      "Max: 20.1505\n",
      "\n",
      "Signature 19:\n",
      "Mean: 2.5514\n",
      "Std: 1.9164\n",
      "Min: 0.1298\n",
      "Max: 22.4548\n",
      "\n",
      "Signature 20:\n",
      "Mean: 2.5835\n",
      "Std: 1.9509\n",
      "Min: 0.1066\n",
      "Max: 18.8907\n",
      "\n",
      "Files created:\n",
      "1. signature_auc_phenotypes.txt - REGENIE format\n",
      "2. signature_aucs.npy - NumPy array\n",
      "\n",
      "Verifying random individuals:\n",
      "\n",
      "Person 4955343:\n",
      "AUCs: [0.49185821 1.48149409 0.88366922 0.51814608 5.78338168 1.40136606\n",
      " 6.57270063 1.2263644  1.71508353 7.72398883 1.43154796 1.46597249\n",
      " 0.87887829 2.20613149 3.31790173 1.90939571 0.58103277 1.75903624\n",
      " 4.92696876 4.72508183]\n",
      "Sum of AUCs: 51.0\n",
      "\n",
      "Person 3532874:\n",
      "AUCs: [2.06743809 1.21941577 2.13431897 1.69349019 5.30481649 7.47113701\n",
      " 2.2277805  1.92880634 1.02383026 2.29847146 2.67786376 0.95140533\n",
      " 7.55572133 1.30238641 2.63091914 0.83159688 1.0003566  2.59762337\n",
      " 2.36654364 1.71607844]\n",
      "Sum of AUCs: 51.0\n",
      "\n",
      "Person 1819404:\n",
      "AUCs: [0.55525031 0.96573985 1.41234603 8.06224064 1.13412722 6.26798826\n",
      " 0.48030258 2.47915213 3.16950494 2.0318974  1.28028193 1.73869703\n",
      " 1.52371801 4.65672362 2.86011323 1.08018101 2.16017259 1.52234015\n",
      " 1.68858633 5.93063674]\n",
      "Sum of AUCs: 51.0\n"
     ]
    }
   ],
   "source": [
    "import numpy as np\n",
    "import torch\n",
    "\n",
    "# Calculate thetas for all individuals\n",
    "print(\"Calculating thetas...\")\n",
    "all_thetas = torch.softmax(torch.tensor(all_lambdas), dim=1).numpy()\n",
    "\n",
    "# Calculate AUC for each person and signature\n",
    "print(\"Calculating AUCs...\")\n",
    "timepoints = np.arange(52)\n",
    "theta_aucs = np.array([np.trapz(all_thetas[:, s, :], timepoints) for s in range(20)]).T\n",
    "\n",
    "# Create REGENIE phenotype file\n",
    "output_file = 'signature_auc_phenotypes.txt'\n",
    "print(f\"\\nCreating REGENIE phenotype file: {output_file}\")\n",
    "\n",
    "with open(output_file, 'w') as f:\n",
    "    # Write header\n",
    "    header = ['FID', 'IID'] + [f'SIG{i+1}_AUC' for i in range(20)]\n",
    "    f.write('\\t'.join(header) + '\\n')\n",
    "    \n",
    "    # Write data for each person\n",
    "    for i in range(len(patient_ids)):\n",
    "        fid = patient_ids[i]\n",
    "        iid = patient_ids[i]\n",
    "        aucs = theta_aucs[i]\n",
    "        \n",
    "        line = [str(fid), str(iid)] + [f\"{x:.6f}\" for x in aucs]\n",
    "        f.write('\\t'.join(line) + '\\n')\n",
    "\n",
    "# Print summary statistics\n",
    "print(\"\\nSummary statistics for signature AUCs:\")\n",
    "for sig in range(20):\n",
    "    print(f\"\\nSignature {sig+1}:\")\n",
    "    print(f\"Mean: {np.mean(theta_aucs[:, sig]):.4f}\")\n",
    "    print(f\"Std: {np.std(theta_aucs[:, sig]):.4f}\")\n",
    "    print(f\"Min: {np.min(theta_aucs[:, sig]):.4f}\")\n",
    "    print(f\"Max: {np.max(theta_aucs[:, sig]):.4f}\")\n",
    "\n",
    "# Save numpy array version too\n",
    "np.save('signature_aucs.npy', theta_aucs)\n",
    "\n",
    "print(\"\\nFiles created:\")\n",
    "print(f\"1. {output_file} - REGENIE format\")\n",
    "print(\"2. signature_aucs.npy - NumPy array\")\n",
    "\n",
    "# Quick verification of a few random individuals\n",
    "print(\"\\nVerifying random individuals:\")\n",
    "for idx in np.random.choice(len(patient_ids), 3):\n",
    "    print(f\"\\nPerson {patient_ids[idx]}:\")\n",
    "    print(\"AUCs:\", theta_aucs[idx])\n",
    "    print(\"Sum of AUCs:\", np.sum(theta_aucs[idx]))  # Note: won't necessarily sum to 52 (total timepoints)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "print(\"\\nSummary statistics for theta AUCs:\")\n",
    "for sig in range(20):\n",
    "    print(f\"\\nSignature {sig+1}:\")\n",
    "    print(f\"Mean: {np.mean(theta_aucs[:, sig]):.4f}\")\n",
    "    print(f\"Std: {np.std(theta_aucs[:, sig]):.4f}\")\n",
    "    print(f\"Min: {np.min(theta_aucs[:, sig]):.4f}\")\n",
    "    print(f\"Max: {np.max(theta_aucs[:, sig]):.4f}\")\n",
    "\n",
    "# Calculate AUC for each person and signature\n",
    "for i in range(400000):\n",
    "    for s in range(20):\n",
    "        theta_aucs[i, s] = np.trapz(all_thetas[i, s, :], timepoints)\n",
    "\n",
    "# 2. Load and process covariates from R\n",
    "# Convert R dataframe to pandas\n",
    "bpc_pd = pd.DataFrame({\n",
    "    'identifier': robjects.r.rownames(bpc),\n",
    "    'sex': np.array(bpc.rx2('f.31.0.0')),\n",
    "    'birth_year': np.array(bpc.rx2('f.34.0.0')),\n",
    "    'enrollment': np.array(bpc.rx2('f.53.0.0'))\n",
    "})\n",
    "\n",
    "# Add PCs\n",
    "for i in range(1, 41):  # assuming 40 PCs\n",
    "    col_name = f'f.22009.0.{i}'\n",
    "    if col_name in bpc.names:\n",
    "        bpc_pd[f'PC{i}'] = np.array(bpc.rx2(col_name))\n",
    "\n",
    "# Create REGENIE phenotype file with patient IDs and theta AUCs\n",
    "output_file = 'theta_auc_phenotypes_for_regenie.txt'\n",
    "\n",
    "print(\"\\nPreparing REGENIE phenotype file...\")\n",
    "with open(output_file, 'w') as f:\n",
    "    # Write header\n",
    "    header = ['FID', 'IID'] + [f'theta_auc_{i+1}' for i in range(20)]\n",
    "    f.write('\\t'.join(header) + '\\n')\n",
    "    \n",
    "    # Write data for each person\n",
    "    for i in range(len(patient_ids)):\n",
    "        fid = patient_ids[i]\n",
    "        iid = patient_ids[i]\n",
    "        \n",
    "        # Get AUC values for this person\n",
    "        person_aucs = theta_aucs[i]\n",
    "        \n",
    "        # Create line with FID, IID, and AUC values\n",
    "        line = [str(fid), str(iid)] + [f\"{x:.6f}\" for x in person_aucs]\n",
    "        f.write('\\t'.join(line) + '\\n')\n",
    "\n",
    "# Print summary statistics\n",
    "print(\"\\nSummary statistics for theta AUCs:\")\n",
    "for sig in range(20):\n",
    "    print(f\"\\nSignature {sig+1}:\")\n",
    "    print(f\"Mean: {np.mean(theta_aucs[:, sig]):.4f}\")\n",
    "    print(f\"Std: {np.std(theta_aucs[:, sig]):.4f}\")\n",
    "    print(f\"Min: {np.min(theta_aucs[:, sig]):.4f}\")\n",
    "    print(f\"Max: {np.max(theta_aucs[:, sig]):.4f}\")\n",
    "\n",
    "# Save covariates file\n",
    "covariates_file = 'regenie_covariates.txt'\n",
    "bpc_pd.to_csv(covariates_file, sep='\\t', index=False)\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 171,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of patient IDs: 400000\n",
      "Number of BPC IDs: 502461\n",
      "Number of overlapping IDs: 0\n",
      "\n",
      "First few patient IDs not in BPC:\n",
      "['1234688', '5153541', '4607103', '2404957', '5605258']\n",
      "\n",
      "First few BPC IDs not in patient_ids:\n",
      "['295171', '268173', '135683', '373788', '181245']\n",
      "\n",
      "Preparing REGENIE covariate file...\n"
     ]
    },
    {
     "ename": "KeyboardInterrupt",
     "evalue": "",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mKeyboardInterrupt\u001b[0m                         Traceback (most recent call last)",
      "Cell \u001b[0;32mIn[171], line 37\u001b[0m\n\u001b[1;32m     34\u001b[0m iid \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mstr\u001b[39m(patient_ids[i])\n\u001b[1;32m     36\u001b[0m \u001b[38;5;66;03m# Check if this ID exists in bpc_pd\u001b[39;00m\n\u001b[0;32m---> 37\u001b[0m matching_rows \u001b[38;5;241m=\u001b[39m bpc_pd[\u001b[43mbpc_pd\u001b[49m\u001b[43m[\u001b[49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43midentifier\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[43m]\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m==\u001b[39;49m\u001b[43m \u001b[49m\u001b[43miid\u001b[49m]\n\u001b[1;32m     38\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;28mlen\u001b[39m(matching_rows) \u001b[38;5;241m==\u001b[39m \u001b[38;5;241m0\u001b[39m:\n\u001b[1;32m     39\u001b[0m     \u001b[38;5;28;01mcontinue\u001b[39;00m\n",
      "File \u001b[0;32m/opt/miniconda3/envs/new_env_pyro2/lib/python3.9/site-packages/pandas/core/ops/common.py:76\u001b[0m, in \u001b[0;36m_unpack_zerodim_and_defer.<locals>.new_method\u001b[0;34m(self, other)\u001b[0m\n\u001b[1;32m     72\u001b[0m             \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28mNotImplemented\u001b[39m\n\u001b[1;32m     74\u001b[0m other \u001b[38;5;241m=\u001b[39m item_from_zerodim(other)\n\u001b[0;32m---> 76\u001b[0m \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[43mmethod\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;28;43mself\u001b[39;49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mother\u001b[49m\u001b[43m)\u001b[49m\n",
      "File \u001b[0;32m/opt/miniconda3/envs/new_env_pyro2/lib/python3.9/site-packages/pandas/core/arraylike.py:40\u001b[0m, in \u001b[0;36mOpsMixin.__eq__\u001b[0;34m(self, other)\u001b[0m\n\u001b[1;32m     38\u001b[0m \u001b[38;5;129m@unpack_zerodim_and_defer\u001b[39m(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m__eq__\u001b[39m\u001b[38;5;124m\"\u001b[39m)\n\u001b[1;32m     39\u001b[0m \u001b[38;5;28;01mdef\u001b[39;00m \u001b[38;5;21m__eq__\u001b[39m(\u001b[38;5;28mself\u001b[39m, other):\n\u001b[0;32m---> 40\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43m_cmp_method\u001b[49m\u001b[43m(\u001b[49m\u001b[43mother\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43moperator\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43meq\u001b[49m\u001b[43m)\u001b[49m\n",
      "File \u001b[0;32m/opt/miniconda3/envs/new_env_pyro2/lib/python3.9/site-packages/pandas/core/series.py:6119\u001b[0m, in \u001b[0;36mSeries._cmp_method\u001b[0;34m(self, other, op)\u001b[0m\n\u001b[1;32m   6116\u001b[0m lvalues \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_values\n\u001b[1;32m   6117\u001b[0m rvalues \u001b[38;5;241m=\u001b[39m extract_array(other, extract_numpy\u001b[38;5;241m=\u001b[39m\u001b[38;5;28;01mTrue\u001b[39;00m, extract_range\u001b[38;5;241m=\u001b[39m\u001b[38;5;28;01mTrue\u001b[39;00m)\n\u001b[0;32m-> 6119\u001b[0m res_values \u001b[38;5;241m=\u001b[39m \u001b[43mops\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mcomparison_op\u001b[49m\u001b[43m(\u001b[49m\u001b[43mlvalues\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mrvalues\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mop\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m   6121\u001b[0m \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_construct_result(res_values, name\u001b[38;5;241m=\u001b[39mres_name)\n",
      "File \u001b[0;32m/opt/miniconda3/envs/new_env_pyro2/lib/python3.9/site-packages/pandas/core/ops/array_ops.py:344\u001b[0m, in \u001b[0;36mcomparison_op\u001b[0;34m(left, right, op)\u001b[0m\n\u001b[1;32m    341\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m invalid_comparison(lvalues, rvalues, op)\n\u001b[1;32m    343\u001b[0m \u001b[38;5;28;01melif\u001b[39;00m lvalues\u001b[38;5;241m.\u001b[39mdtype \u001b[38;5;241m==\u001b[39m \u001b[38;5;28mobject\u001b[39m \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28misinstance\u001b[39m(rvalues, \u001b[38;5;28mstr\u001b[39m):\n\u001b[0;32m--> 344\u001b[0m     res_values \u001b[38;5;241m=\u001b[39m \u001b[43mcomp_method_OBJECT_ARRAY\u001b[49m\u001b[43m(\u001b[49m\u001b[43mop\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mlvalues\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mrvalues\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m    346\u001b[0m \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[1;32m    347\u001b[0m     res_values \u001b[38;5;241m=\u001b[39m _na_arithmetic_op(lvalues, rvalues, op, is_cmp\u001b[38;5;241m=\u001b[39m\u001b[38;5;28;01mTrue\u001b[39;00m)\n",
      "File \u001b[0;32m/opt/miniconda3/envs/new_env_pyro2/lib/python3.9/site-packages/pandas/core/ops/array_ops.py:129\u001b[0m, in \u001b[0;36mcomp_method_OBJECT_ARRAY\u001b[0;34m(op, x, y)\u001b[0m\n\u001b[1;32m    127\u001b[0m     result \u001b[38;5;241m=\u001b[39m libops\u001b[38;5;241m.\u001b[39mvec_compare(x\u001b[38;5;241m.\u001b[39mravel(), y\u001b[38;5;241m.\u001b[39mravel(), op)\n\u001b[1;32m    128\u001b[0m \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[0;32m--> 129\u001b[0m     result \u001b[38;5;241m=\u001b[39m \u001b[43mlibops\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mscalar_compare\u001b[49m\u001b[43m(\u001b[49m\u001b[43mx\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mravel\u001b[49m\u001b[43m(\u001b[49m\u001b[43m)\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43my\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mop\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m    130\u001b[0m \u001b[38;5;28;01mreturn\u001b[39;00m result\u001b[38;5;241m.\u001b[39mreshape(x\u001b[38;5;241m.\u001b[39mshape)\n",
      "\u001b[0;31mKeyboardInterrupt\u001b[0m: "
     ]
    }
   ],
   "source": [
    "\n",
    "# Create REGENIE covariate file\n",
    "# First, let's check the overlap between patient_ids and bpc_pd identifiers\n",
    "bpc_ids = set(bpc_pd['identifier'].values)\n",
    "patient_ids_set = set(map(str, patient_ids))\n",
    "\n",
    "print(\"Number of patient IDs:\", len(patient_ids))\n",
    "print(\"Number of BPC IDs:\", len(bpc_ids))\n",
    "print(\"Number of overlapping IDs:\", len(patient_ids_set.intersection(bpc_ids)))\n",
    "\n",
    "# Show some examples of non-matching IDs\n",
    "print(\"\\nFirst few patient IDs not in BPC:\")\n",
    "missing_ids = patient_ids_set - bpc_ids\n",
    "print(list(missing_ids)[:5])\n",
    "\n",
    "print(\"\\nFirst few BPC IDs not in patient_ids:\")\n",
    "extra_ids = bpc_ids - patient_ids_set\n",
    "print(list(extra_ids)[:5])\n",
    "\n",
    "# Now create the covariate file only for matching IDs\n",
    "covariates_file = 'regenie_covariates.txt'\n",
    "\n",
    "print(\"\\nPreparing REGENIE covariate file...\")\n",
    "with open(covariates_file, 'w') as f:\n",
    "    # Header: FID, IID, sex, age, PCs\n",
    "    header = ['FID', 'IID', 'sex', 'age'] + [f'PC{i}' for i in range(1, 41)]\n",
    "    f.write('\\t'.join(header) + '\\n')\n",
    "    \n",
    "    # Track which IDs we write covariates for\n",
    "    included_ids = []\n",
    "    \n",
    "    # Write data for each person\n",
    "    for i in range(len(patient_ids)):\n",
    "        fid = patient_ids[i]\n",
    "        iid = str(patient_ids[i])\n",
    "        \n",
    "        # Check if this ID exists in bpc_pd\n",
    "        matching_rows = bpc_pd[bpc_pd['identifier'] == iid]\n",
    "        if len(matching_rows) == 0:\n",
    "            continue\n",
    "            \n",
    "        person_data = matching_rows.iloc[0]\n",
    "        \n",
    "        # Calculate age from birth year\n",
    "        birth_year = person_data['birth_year']\n",
    "        age = 2024 - birth_year\n",
    "        \n",
    "        # Get sex and PCs\n",
    "        sex = person_data['sex']\n",
    "        pcs = [person_data[f'PC{i}'] for i in range(1, 41)]\n",
    "        \n",
    "        # Create line\n",
    "        line = [str(fid), iid, str(sex), str(age)] + [f\"{x:.6f}\" for x in pcs]\n",
    "        f.write('\\t'.join(line) + '\\n')\n",
    "        included_ids.append(iid)\n",
    "\n",
    "print(f\"\\nCreated covariate file with {len(included_ids)} individuals\")\n",
    "\n",
    "# We should also filter the phenotype file to match\n",
    "print(\"\\nNow we need to filter the phenotype file to match these IDs\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 172,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Patient IDs format:\n",
      "First 5 patient_ids: ['1000015' '1000023' '1000037' '1000042' '1000059']\n",
      "Type of first ID: <class 'numpy.str_'>\n",
      "\n",
      "BPC IDs format:\n",
      "First 5 BPC IDs: ['1' '2' '3' '4' '5']\n",
      "Type of first BPC ID: <class 'str'>\n",
      "\n",
      "BPC DataFrame head:\n",
      "  identifier sex  birth_year  enrollment       PC1      PC2       PC3  \\\n",
      "0          1   1        1938  2008-07-23 -12.02340  3.25100  1.224590   \n",
      "1          2   1        1963  2008-09-11 -14.07040  2.83809 -1.709870   \n",
      "2          3   0        1939  2009-01-22 -15.00630  4.03881 -1.711670   \n",
      "3          4   1        1942  2009-11-13 -12.08720  6.29019 -1.486040   \n",
      "4          5   0        1954  2009-05-20  -9.58886  3.77243  0.274298   \n",
      "\n",
      "        PC4      PC5       PC6  ...     PC31     PC32      PC33      PC34  \\\n",
      "0  4.776840  2.31802  2.445040  ... -2.93831 -6.00180  1.427810  0.048215   \n",
      "1 -0.782455 -7.93571 -2.176480  ...  2.92506  2.69514 -0.676219 -0.874275   \n",
      "2  6.200160 -2.77040  0.809991  ... -1.52633  5.36257  1.691210 -0.595323   \n",
      "3 -3.426860 -5.35913 -0.146506  ...  1.14629 -1.03183 -4.740160  1.682810   \n",
      "4 -1.357730  1.91795 -1.627780  ... -1.01016  3.06305 -1.532750 -0.362556   \n",
      "\n",
      "       PC35      PC36      PC37      PC38      PC39      PC40  \n",
      "0  0.090928  0.100052 -0.003548 -0.896448  0.333270 -3.430610  \n",
      "1 -8.578010 -0.270212  2.136970 -0.133714 -1.178090  0.574305  \n",
      "2 -1.478730 -0.592636  3.204850  2.676030  3.491280 -3.693190  \n",
      "3  2.342120 -2.554380 -3.682020  1.025730  2.813870 -2.281720  \n",
      "4  2.906110  1.209830  1.826390  0.371744  0.121161 -1.950290  \n",
      "\n",
      "[5 rows x 44 columns]\n",
      "\n",
      "Sample ID comparisons:\n",
      "Patient ID example: 1000015\n",
      "BPC ID example: 1\n",
      "Patient ID length: 7\n",
      "BPC ID length: 1\n",
      "\n",
      "R object structure:\n",
      "Classes data.table and 'data.frame':\t502461 obs. of  59 variables:\n",
      " $ identifier  : num  1e+06 1e+06 1e+06 1e+06 1e+06 ...\n",
      " $ f.31.0.0    : chr  \"1\" \"1\" \"0\" \"1\" ...\n",
      " $ f.34.0.0    : int  1938 1963 1939 1942 1954 1960 1946 1961 1946 1959 ...\n",
      " $ f.53.0.0    : chr  \"2008-07-23\" \"2008-09-11\" \"2009-01-22\" \"2009-11-13\" ...\n",
      " $ f.53.1.0    : chr  NA NA NA NA ...\n",
      " $ f.53.2.0    : chr  NA NA NA NA ...\n",
      " $ f.53.3.0    : chr  NA NA NA NA ...\n",
      " $ f.54.0.0    : chr  \"11010\" \"11011\" \"11009\" \"11011\" ...\n",
      " $ f.54.1.0    : chr  NA NA NA NA ...\n",
      " $ f.54.2.0    : chr  NA NA NA NA ...\n",
      " $ f.54.3.0    : chr  NA NA NA NA ...\n",
      " $ f.21001.0.0 : num  26.3 26 31.7 21.9 35 ...\n",
      " $ f.21001.1.0 : num  NA NA NA NA NA NA NA NA NA NA ...\n",
      " $ f.21001.2.0 : num  NA NA NA NA NA ...\n",
      " $ f.21001.3.0 : num  NA NA NA NA NA NA NA NA NA NA ...\n",
      " $ f.21003.0.0 : int  69 44 69 66 54 47 63 48 59 49 ...\n",
      " $ f.21003.1.0 : int  NA NA NA NA NA NA NA NA NA NA ...\n",
      " $ f.21003.2.0 : int  NA NA NA NA NA NA NA NA NA 57 ...\n",
      " $ f.21003.3.0 : int  NA NA NA NA NA NA NA NA NA NA ...\n",
      " $ f.22009.0.1 : num  -12.02 -14.07 -15.01 -12.09 -9.59 ...\n",
      " $ f.22009.0.2 : num  3.25 2.84 4.04 6.29 3.77 ...\n",
      " $ f.22009.0.3 : num  1.225 -1.71 -1.712 -1.486 0.274 ...\n",
      " $ f.22009.0.4 : num  4.777 -0.782 6.2 -3.427 -1.358 ...\n",
      " $ f.22009.0.5 : num  2.32 -7.94 -2.77 -5.36 1.92 ...\n",
      " $ f.22009.0.6 : num  2.445 -2.176 0.81 -0.147 -1.628 ...\n",
      " $ f.22009.0.7 : num  -3.067 -0.688 1.012 2.788 -0.192 ...\n",
      " $ f.22009.0.8 : num  -1.09 -2.59 3.04 -4.26 -1.28 ...\n",
      " $ f.22009.0.9 : num  0.551 4.89 5.836 -6.282 2.726 ...\n",
      " $ f.22009.0.10: num  1.202 5.056 -1.956 -0.862 1.321 ...\n",
      " $ f.22009.0.11: num  2.024 5.74 -4.519 -2.001 0.691 ...\n",
      " $ f.22009.0.12: num  1.641 -1.726 4.028 -0.999 -0.825 ...\n",
      " $ f.22009.0.13: num  0.1614 -1.5665 1.866 -0.6241 0.0623 ...\n",
      " $ f.22009.0.14: num  -2.293 0.139 4.177 -1.643 -3.161 ...\n",
      " $ f.22009.0.15: num  1.08 1.01 2.08 -3.59 -1.96 ...\n",
      " $ f.22009.0.16: num  -0.718 2.153 -0.897 -5.716 2.282 ...\n",
      " $ f.22009.0.17: num  -0.627 -0.82 1.994 5.212 0.893 ...\n",
      " $ f.22009.0.18: num  -0.0829 3.0283 2.3328 -0.6926 -0.2344 ...\n",
      " $ f.22009.0.19: num  3.6 2.69 -5.01 3.3 -0.61 ...\n",
      " $ f.22009.0.20: num  4.935 -0.238 3.937 -2.631 -0.556 ...\n",
      " $ f.22009.0.21: num  2.161 2.039 0.725 -4.154 4.096 ...\n",
      " $ f.22009.0.22: num  0.726 -0.837 4.844 3.539 -0.467 ...\n",
      " $ f.22009.0.23: num  -1.117 -1.768 2.377 0.103 2.606 ...\n",
      " $ f.22009.0.24: num  3.233 4.402 2.114 1.04 0.188 ...\n",
      " $ f.22009.0.25: num  2.617 2.211 3.888 -4.342 -0.429 ...\n",
      " $ f.22009.0.26: num  3.196 -8.401 3.05 2.09 -0.592 ...\n",
      " $ f.22009.0.27: num  -0.214 2.997 -2.012 -3.472 -3.545 ...\n",
      " $ f.22009.0.28: num  1.92 0.0681 1.3086 -2.1043 1.5619 ...\n",
      " $ f.22009.0.29: num  -2.3032 -0.3349 -1.9395 -0.0796 0.5548 ...\n",
      " $ f.22009.0.30: num  0.704 5.234 2.166 -1.25 -1.546 ...\n",
      " $ f.22009.0.31: num  -2.94 2.93 -1.53 1.15 -1.01 ...\n",
      " $ f.22009.0.32: num  -6 2.7 5.36 -1.03 3.06 ...\n",
      " $ f.22009.0.33: num  1.428 -0.676 1.691 -4.74 -1.533 ...\n",
      " $ f.22009.0.34: num  0.0482 -0.8743 -0.5953 1.6828 -0.3626 ...\n",
      " $ f.22009.0.35: num  0.0909 -8.578 -1.4787 2.3421 2.9061 ...\n",
      " $ f.22009.0.36: num  0.1 -0.27 -0.593 -2.554 1.21 ...\n",
      " $ f.22009.0.37: num  -0.00355 2.13697 3.20485 -3.68202 1.82639 ...\n",
      " $ f.22009.0.38: num  -0.896 -0.134 2.676 1.026 0.372 ...\n",
      " $ f.22009.0.39: num  0.333 -1.178 3.491 2.814 0.121 ...\n",
      " $ f.22009.0.40: num  -3.431 0.574 -3.693 -2.282 -1.95 ...\n",
      " - attr(*, \".internal.selfref\")=<externalptr> \n",
      "<rpy2.rinterface_lib.sexp.NULLType object at 0x14637b640> [RTYPES.NILSXP]\n"
     ]
    }
   ],
   "source": [
    "# Check format of patient_ids\n",
    "print(\"Patient IDs format:\")\n",
    "print(\"First 5 patient_ids:\", patient_ids[:5])\n",
    "print(\"Type of first ID:\", type(patient_ids[0]))\n",
    "\n",
    "# Check format of BPC IDs\n",
    "print(\"\\nBPC IDs format:\")\n",
    "print(\"First 5 BPC IDs:\", bpc_pd['identifier'].head().values)\n",
    "print(\"Type of first BPC ID:\", type(bpc_pd['identifier'].iloc[0]))\n",
    "\n",
    "# Let's look at the full BPC data structure\n",
    "print(\"\\nBPC DataFrame head:\")\n",
    "print(bpc_pd.head())\n",
    "\n",
    "# Check if there are any formatting differences\n",
    "print(\"\\nSample ID comparisons:\")\n",
    "print(\"Patient ID example:\", patient_ids[0])\n",
    "print(\"BPC ID example:\", bpc_pd['identifier'].iloc[0])\n",
    "print(\"Patient ID length:\", len(str(patient_ids[0])))\n",
    "print(\"BPC ID length:\", len(str(bpc_pd['identifier'].iloc[0])))\n",
    "\n",
    "# Try printing the R object structure\n",
    "print(\"\\nR object structure:\")\n",
    "print(robjects.r.str(bpc))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 177,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "After standardization:\n",
      "Number of patient IDs: 400000\n",
      "Number of BPC IDs: 502461\n",
      "Number of overlapping IDs: 400000\n",
      "\n",
      "Sample patient IDs: ['1000015', '1000023', '1000037', '1000042', '1000059']\n",
      "Sample BPC IDs: ['1000015', '1000023', '1000037', '1000042', '1000059']\n",
      "\n",
      "ID ranges:\n",
      "Patient IDs range: 1000015 to 5929643\n",
      "BPC IDs range: 1000015 to 6026656\n"
     ]
    }
   ],
   "source": [
    "# 1. First, ensure IDs are in the same format\n",
    "def standardize_ids(ids):\n",
    "    return set(str(int(float(id))) for id in ids if not pd.isna(id))\n",
    "\n",
    "# 2. Load and process BPC data\n",
    "bpc_pd = pd.DataFrame({\n",
    "    'identifier': np.array(bpc.rx2('identifier')).astype(int),  # Convert to integer\n",
    "    'sex': np.array(bpc.rx2('f.31.0.0')),\n",
    "    'birth_year': np.array(bpc.rx2('f.34.0.0')),\n",
    "    'enrollment': np.array(bpc.rx2('f.53.0.0'))\n",
    "})\n",
    "\n",
    "# Add PCs\n",
    "for i in range(1, 41):\n",
    "    col_name = f'f.22009.0.{i}'\n",
    "    if col_name in bpc.names:\n",
    "        bpc_pd[f'PC{i}'] = np.array(bpc.rx2(col_name))\n",
    "\n",
    "# 3. Convert IDs to standardized format\n",
    "bpc_ids = standardize_ids(bpc_pd['identifier'])\n",
    "patient_ids_set = standardize_ids(patient_ids)\n",
    "\n",
    "# 4. Check overlap\n",
    "print(\"\\nAfter standardization:\")\n",
    "print(\"Number of patient IDs:\", len(patient_ids_set))\n",
    "print(\"Number of BPC IDs:\", len(bpc_ids))\n",
    "print(\"Number of overlapping IDs:\", len(patient_ids_set.intersection(bpc_ids)))\n",
    "\n",
    "# 5. Debug sample IDs\n",
    "print(\"\\nSample patient IDs:\", list(sorted(list(patient_ids_set)))[:5])\n",
    "print(\"Sample BPC IDs:\", list(sorted(list(bpc_ids)))[:5])\n",
    "\n",
    "# 6. Check ID ranges\n",
    "print(\"\\nID ranges:\")\n",
    "print(\"Patient IDs range:\", min(patient_ids_set), \"to\", max(patient_ids_set))\n",
    "print(\"BPC IDs range:\", min(bpc_ids), \"to\", max(bpc_ids))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 179,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Verification:\n",
      "Number of rows in matched data: 400000\n",
      "Number of columns: 24\n",
      "\n",
      "Columns: ['identifier', 'sex', 'birth_year', 'enrollment', 'PC1', 'PC2', 'PC3', 'PC4', 'PC5', 'PC6', 'PC7', 'PC8', 'PC9', 'PC10', 'PC11', 'PC12', 'PC13', 'PC14', 'PC15', 'PC16', 'PC17', 'PC18', 'PC19', 'PC20']\n"
     ]
    }
   ],
   "source": [
    "# Create matched BPC dataframe with only our patients and their covariates\n",
    "matched_bpc = pd.DataFrame({\n",
    "    'identifier': np.array(bpc.rx2('identifier')).astype(float).astype(int).astype(str),\n",
    "    'sex': np.array(bpc.rx2('f.31.0.0')),\n",
    "    'birth_year': np.array(bpc.rx2('f.34.0.0')),\n",
    "    'enrollment': np.array(bpc.rx2('f.53.0.0'))\n",
    "})\n",
    "\n",
    "# Add just 20 PCs\n",
    "for i in range(1, 21):  # Changed from 41 to 21 to get PCs 1-20\n",
    "    col_name = f'f.22009.0.{i}'\n",
    "    matched_bpc[f'PC{i}'] = np.array(bpc.rx2(col_name))\n",
    "\n",
    "# Convert patient_ids and sort\n",
    "patient_ids = [str(int(float(id))) for id in patient_ids]\n",
    "matched_bpc = matched_bpc[matched_bpc['identifier'].isin(patient_ids)].copy()\n",
    "id_to_position = {id: i for i, id in enumerate(patient_ids)}\n",
    "matched_bpc['sort_idx'] = matched_bpc['identifier'].map(id_to_position)\n",
    "matched_bpc = matched_bpc.sort_values('sort_idx').drop('sort_idx', axis=1)\n",
    "\n",
    "# Verify\n",
    "print(\"Verification:\")\n",
    "print(f\"Number of rows in matched data: {len(matched_bpc)}\")\n",
    "print(f\"Number of columns: {len(matched_bpc.columns)}\")  # Should be 24 (identifier + sex + birth_year + enrollment + 20 PCs)\n",
    "print(\"\\nColumns:\", matched_bpc.columns.tolist())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 180,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Files saved:\n",
      "1. ukbb_covariates_400k.txt - Full covariate file\n",
      "2. ukbb_sample_ids_400k.txt - Sample IDs only\n",
      "\n",
      "First few lines of covariate file:\n",
      "  identifier sex  birth_year  enrollment       PC1      PC2       PC3       PC4      PC5       PC6       PC7      PC8       PC9      PC10      PC11      PC12      PC13      PC14     PC15      PC16      PC17      PC18      PC19      PC20\n",
      "0    1000015   1        1938  2008-07-23 -12.02340  3.25100  1.224590  4.776840  2.31802  2.445040 -3.067290 -1.08792  0.550964  1.201910  2.023600  1.641170  0.161407 -2.293140  1.08346 -0.717937 -0.627368 -0.082943  3.601450  4.934770\n",
      "1    1000023   1        1963  2008-09-11 -14.07040  2.83809 -1.709870 -0.782455 -7.93571 -2.176480 -0.688286 -2.59305  4.890120  5.056270  5.740360 -1.726000 -1.566490  0.139009  1.01087  2.152510 -0.819635  3.028260  2.686200 -0.237987\n",
      "2    1000037   0        1939  2009-01-22 -15.00630  4.03881 -1.711670  6.200160 -2.77040  0.809991  1.012190  3.03839  5.836320 -1.955720 -4.519320  4.027890  1.865970  4.176570  2.07576 -0.896987  1.993830  2.332760 -5.014460  3.937040\n",
      "3    1000042   1        1942  2009-11-13 -12.08720  6.29019 -1.486040 -3.426860 -5.35913 -0.146506  2.788340 -4.25511 -6.282060 -0.862379 -2.000660 -0.999069 -0.624147 -1.642880 -3.59239 -5.715930  5.212110 -0.692624  3.301050 -2.631200\n",
      "4    1000059   0        1954  2009-05-20  -9.58886  3.77243  0.274298 -1.357730  1.91795 -1.627780 -0.191782 -1.28348  2.726250  1.320520  0.691295 -0.825097  0.062332 -3.160660 -1.96172  2.282220  0.892687 -0.234448 -0.609894 -0.555967\n"
     ]
    }
   ],
   "source": [
    "# 1. Save main phenotype/covariate file\n",
    "# Reorder columns to have identifier first, then covariates\n",
    "cols_order = ['identifier', 'sex', 'birth_year', 'enrollment'] + [f'PC{i}' for i in range(1,21)]\n",
    "matched_bpc = matched_bpc[cols_order]\n",
    "\n",
    "# Save as space-delimited file (common format for genetic analyses)\n",
    "matched_bpc.to_csv('ukbb_covariates_400k.txt', sep=' ', index=False)\n",
    "\n",
    "# 2. Also save a sample ID file (if needed)\n",
    "matched_bpc['identifier'].to_csv('ukbb_sample_ids_400k.txt', index=False, header=False)\n",
    "\n",
    "print(\"Files saved:\")\n",
    "print(\"1. ukbb_covariates_400k.txt - Full covariate file\")\n",
    "print(\"2. ukbb_sample_ids_400k.txt - Sample IDs only\")\n",
    "print(\"\\nFirst few lines of covariate file:\")\n",
    "print(matched_bpc.head().to_string())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 181,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Reformat covariate file for REGENIE\n",
    "covar_df = pd.DataFrame({\n",
    "    'FID': matched_bpc['identifier'],\n",
    "    'IID': matched_bpc['identifier']\n",
    "})\n",
    "# Add covariates\n",
    "covar_df = pd.concat([covar_df, matched_bpc.drop('identifier', axis=1)], axis=1)\n",
    "covar_df.to_csv('ukbb_covariates_400k.txt', sep='\\t', index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 141,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Lambda values across time (person 0, signature 0):\n",
      "[-0.97246844 -0.97156751 -0.95896935 -0.93358129 -0.89460641 -0.84161705\n",
      " -0.77464342 -0.69413167 -0.60099077 -0.4965362  -0.38246843 -0.26077977\n",
      " -0.1336567  -0.00332997  0.12789893  0.25791314  0.3848049   0.50694793\n",
      "  0.62305105  0.73224109  0.83394819  0.92792988  1.01422715  1.09303355\n",
      "  1.1646291   1.22931647  1.28728104  1.33857441  1.38303626  1.42035031\n",
      "  1.44990563  1.4710176   1.48293328  1.48489487  1.4762671   1.45668697\n",
      "  1.42607749  1.38479793  1.33370399  1.27409756  1.20778573  1.13698697\n",
      "  1.06427026  0.9924255   0.92430037  0.8627193   0.81027436  0.76914525\n",
      "  0.74107599  0.72720611  0.72802496  0.74334592]\n",
      "\n",
      "Mean lambda before taking max:\n",
      "Mean across all dimensions: -0.0002805107205678313\n",
      "Mean across people and time for each signature:\n",
      "Signature 1: 0.0071\n",
      "Signature 2: 0.0001\n",
      "Signature 3: -0.0024\n",
      "Signature 4: -0.0046\n",
      "Signature 5: 0.0008\n",
      "Signature 6: -0.0156\n",
      "Signature 7: -0.0012\n",
      "Signature 8: 0.0090\n",
      "Signature 9: -0.0046\n",
      "Signature 10: 0.0095\n",
      "Signature 11: 0.0049\n",
      "Signature 12: -0.0027\n",
      "Signature 13: -0.0102\n",
      "Signature 14: 0.0015\n",
      "Signature 15: -0.0048\n",
      "Signature 16: -0.0053\n",
      "Signature 17: 0.0067\n",
      "Signature 18: -0.0089\n",
      "Signature 19: 0.0050\n",
      "Signature 20: 0.0103\n"
     ]
    }
   ],
   "source": [
    "# Look at lambda values across time for first person, first signature\n",
    "print(\"Lambda values across time (person 0, signature 0):\")\n",
    "print(all_lambdas[0, 0, :])\n",
    "\n",
    "# Let's also look at the mean across all timepoints (before taking max)\n",
    "print(\"\\nMean lambda before taking max:\")\n",
    "print(\"Mean across all dimensions:\", np.mean(all_lambdas))\n",
    "print(\"Mean across people and time for each signature:\")\n",
    "for sig in range(20):\n",
    "    print(f\"Signature {sig+1}: {np.mean(all_lambdas[:, sig, :]):.4f}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 139,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([[[-9.72468436e-01, -9.71567512e-01, -9.58969355e-01, ...,\n",
       "          7.27206111e-01,  7.28024960e-01,  7.43345916e-01],\n",
       "        [ 1.09564531e+00,  1.07519448e+00,  1.05129600e+00, ...,\n",
       "         -6.81177676e-02, -6.38196021e-02, -4.87865806e-02],\n",
       "        [ 9.54206586e-01,  9.57348943e-01,  9.43076611e-01, ...,\n",
       "          4.39828008e-01,  3.61439556e-01,  2.87209004e-01],\n",
       "        ...,\n",
       "        [-5.67668676e-01, -6.42190874e-01, -7.11026847e-01, ...,\n",
       "         -1.37222672e+00, -1.34143424e+00, -1.28889871e+00],\n",
       "        [-7.20167160e-01, -7.14601636e-01, -7.10028291e-01, ...,\n",
       "          3.38450253e-01,  3.08193982e-01,  2.77857155e-01],\n",
       "        [ 9.42958593e-02,  1.42019673e-03, -8.94123912e-02, ...,\n",
       "          1.87509251e+00,  1.81850469e+00,  1.75791097e+00]],\n",
       "\n",
       "       [[-1.11385918e+00, -1.13852382e+00, -1.15815556e+00, ...,\n",
       "          5.30274391e-01,  4.73810285e-01,  3.99507314e-01],\n",
       "        [ 2.04134881e-01,  2.17365623e-01,  2.30911449e-01, ...,\n",
       "         -9.47873294e-02, -1.82343066e-01, -2.65162498e-01],\n",
       "        [-1.04369187e+00, -9.99154866e-01, -9.47847784e-01, ...,\n",
       "          3.70238423e-02, -6.74120709e-02, -1.85091436e-01],\n",
       "        ...,\n",
       "        [ 8.84838402e-01,  9.65632915e-01,  1.04474151e+00, ...,\n",
       "          3.98797423e-01,  4.67843026e-01,  5.35232008e-01],\n",
       "        [-2.14241099e+00, -2.06287074e+00, -1.97749090e+00, ...,\n",
       "         -1.90191972e+00, -2.04771900e+00, -2.18540955e+00],\n",
       "        [-3.40127975e-01, -4.21613902e-01, -4.98221219e-01, ...,\n",
       "          7.63031900e-01,  7.48733878e-01,  7.19731271e-01]],\n",
       "\n",
       "       [[-8.99133742e-01, -9.13506627e-01, -9.19593155e-01, ...,\n",
       "          4.41271812e-01,  4.91333783e-01,  5.27467608e-01],\n",
       "        [ 1.64883828e+00,  1.70874560e+00,  1.74877524e+00, ...,\n",
       "          7.61453390e-01,  8.52252364e-01,  9.32204664e-01],\n",
       "        [ 3.10238838e-01,  2.04066992e-01,  9.19202268e-02, ...,\n",
       "          1.95590436e+00,  1.97648847e+00,  1.98580134e+00],\n",
       "        ...,\n",
       "        [ 1.36803067e+00,  1.33434987e+00,  1.30786669e+00, ...,\n",
       "         -1.47239828e+00, -1.67914581e+00, -1.87808645e+00],\n",
       "        [-1.46963656e+00, -1.48878253e+00, -1.51476038e+00, ...,\n",
       "         -4.36941922e-01, -4.46056604e-01, -4.45227444e-01],\n",
       "        [ 1.35588145e+00,  1.23488545e+00,  1.10920131e+00, ...,\n",
       "         -1.18280530e+00, -1.25208473e+00, -1.32373786e+00]],\n",
       "\n",
       "       ...,\n",
       "\n",
       "       [[ 3.30960870e-01,  4.61263299e-01,  5.84349453e-01, ...,\n",
       "          6.85293786e-03,  3.01145180e-03, -4.45635198e-03],\n",
       "        [-3.87296766e-01, -3.52907687e-01, -3.10876489e-01, ...,\n",
       "          6.45583928e-01,  5.66569865e-01,  4.83525306e-01],\n",
       "        [-6.23355448e-01, -7.28870571e-01, -8.25337708e-01, ...,\n",
       "         -2.32128635e-01, -1.64059654e-01, -9.01054591e-02],\n",
       "        ...,\n",
       "        [ 7.38885403e-01,  9.05830264e-01,  1.07033229e+00, ...,\n",
       "          8.58418763e-01,  6.87746108e-01,  5.20928502e-01],\n",
       "        [ 5.30263245e-01,  5.67215919e-01,  6.00509644e-01, ...,\n",
       "         -2.23093837e-01, -2.58950889e-01, -2.88579881e-01],\n",
       "        [ 4.62017715e-01,  4.84212816e-01,  5.04501283e-01, ...,\n",
       "         -3.36372346e-01, -3.03123027e-01, -2.60970116e-01]],\n",
       "\n",
       "       [[ 1.09070599e+00,  1.15123725e+00,  1.19510865e+00, ...,\n",
       "          4.20506764e-03,  8.51576179e-02,  1.69880658e-01],\n",
       "        [-2.60669947e-01, -3.62163872e-01, -4.57999319e-01, ...,\n",
       "          1.26748693e+00,  1.18571091e+00,  1.10556674e+00],\n",
       "        [-7.84654796e-01, -8.22314084e-01, -8.62763286e-01, ...,\n",
       "         -1.98982644e+00, -1.88487077e+00, -1.77878249e+00],\n",
       "        ...,\n",
       "        [ 3.69982153e-01,  3.60974073e-01,  3.58309150e-01, ...,\n",
       "         -6.65349007e-01, -6.28940940e-01, -5.88762403e-01],\n",
       "        [-7.06978977e-01, -7.26713061e-01, -7.38761544e-01, ...,\n",
       "          1.13377929e+00,  1.16769946e+00,  1.19139028e+00],\n",
       "        [-1.16254103e+00, -1.22148514e+00, -1.26801872e+00, ...,\n",
       "          6.94834352e-01,  7.26527750e-01,  7.44437277e-01]],\n",
       "\n",
       "       [[-4.15445179e-01, -4.01889354e-01, -3.88760924e-01, ...,\n",
       "         -5.80055177e-01, -5.64324439e-01, -5.36991835e-01],\n",
       "        [-7.08366394e-01, -5.45800388e-01, -3.84428710e-01, ...,\n",
       "          4.69482809e-01,  5.00906289e-01,  5.34486353e-01],\n",
       "        [ 6.97683752e-01,  7.58521616e-01,  8.05742025e-01, ...,\n",
       "          2.92670161e-01,  2.34747723e-01,  1.86249256e-01],\n",
       "        ...,\n",
       "        [-5.22944629e-01, -4.77961987e-01, -4.31160152e-01, ...,\n",
       "         -3.62326920e-01, -4.24999416e-01, -4.87134367e-01],\n",
       "        [-4.35878038e-01, -3.79837036e-01, -3.25854182e-01, ...,\n",
       "          5.79114370e-02, -7.67233372e-02, -2.17437774e-01],\n",
       "        [-5.02568372e-02, -2.50570104e-02,  4.78485599e-03, ...,\n",
       "          1.95269734e-01,  1.42949209e-01,  7.87066817e-02]]])"
      ]
     },
     "execution_count": 139,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "all_lambdas"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 135,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Processed ranges in order:\n",
      "0-10000\n",
      "10000-20000\n",
      "20000-30000\n",
      "30000-40000\n",
      "40000-50000\n",
      "50000-60000\n",
      "60000-70000\n",
      "70000-80000\n",
      "80000-90000\n",
      "90000-100000\n",
      "100000-110000\n",
      "110000-120000\n",
      "120000-130000\n",
      "130000-140000\n",
      "140000-150000\n",
      "150000-160000\n",
      "160000-170000\n",
      "170000-180000\n",
      "180000-190000\n",
      "190000-200000\n",
      "200000-210000\n",
      "210000-220000\n",
      "220000-230000\n",
      "230000-240000\n",
      "240000-250000\n",
      "250000-260000\n",
      "260000-270000\n",
      "270000-280000\n",
      "280000-290000\n",
      "290000-300000\n",
      "300000-310000\n",
      "310000-320000\n",
      "320000-330000\n",
      "330000-340000\n",
      "340000-350000\n",
      "350000-360000\n",
      "360000-370000\n",
      "370000-380000\n",
      "380000-390000\n",
      "390000-400000\n",
      "\n",
      "Checking for overlaps...\n",
      "\n",
      "Verifying data at transition points...\n",
      "\n",
      "Transition from batch (0, 10000) to (10000, 20000)\n",
      "Last 3 IDs of batch 0: ['1123575' '1123587' '1123600']\n",
      "First 3 IDs of batch 1: ['1123614' '1123622' '1123633']\n",
      "\n",
      "Transition from batch (10000, 20000) to (20000, 30000)\n",
      "Last 3 IDs of batch 1: ['1247203' '1247224' '1247230']\n",
      "First 3 IDs of batch 2: ['1247245' '1247256' '1247268']\n",
      "\n",
      "Transition from batch (20000, 30000) to (30000, 40000)\n",
      "Last 3 IDs of batch 2: ['1370053' '1370064' '1370072']\n",
      "First 3 IDs of batch 3: ['1370095' '1370109' '1370121']\n",
      "\n",
      "Transition from batch (30000, 40000) to (40000, 50000)\n",
      "Last 3 IDs of batch 3: ['1491875' '1491887' '1491892']\n",
      "First 3 IDs of batch 4: ['1491901' '1491929' '1491932']\n",
      "\n",
      "Transition from batch (40000, 50000) to (50000, 60000)\n",
      "Last 3 IDs of batch 4: ['1614527' '1614538' '1614543']\n",
      "First 3 IDs of batch 5: ['1614552' '1614560' '1614581']\n",
      "\n",
      "Transition from batch (50000, 60000) to (60000, 70000)\n",
      "Last 3 IDs of batch 5: ['1737984' '1737996' '1738005']\n",
      "First 3 IDs of batch 6: ['1738016' '1738027' '1738038']\n",
      "\n",
      "Transition from batch (60000, 70000) to (70000, 80000)\n",
      "Last 3 IDs of batch 6: ['1860301' '1860310' '1860329']\n",
      "First 3 IDs of batch 7: ['1860332' '1860348' '1860357']\n",
      "\n",
      "Transition from batch (70000, 80000) to (80000, 90000)\n",
      "Last 3 IDs of batch 7: ['1984597' '1984605' '1984616']\n",
      "First 3 IDs of batch 8: ['1984627' '1984638' '1984643']\n",
      "\n",
      "Transition from batch (80000, 90000) to (90000, 100000)\n",
      "Last 3 IDs of batch 8: ['2107218' '2107236' '2107254']\n",
      "First 3 IDs of batch 9: ['2107263' '2107275' '2107287']\n",
      "\n",
      "Transition from batch (90000, 100000) to (100000, 110000)\n",
      "Last 3 IDs of batch 9: ['2230324' '2230330' '2230345']\n",
      "First 3 IDs of batch 10: ['2230356' '2230368' '2230371']\n",
      "\n",
      "Transition from batch (100000, 110000) to (110000, 120000)\n",
      "Last 3 IDs of batch 10: ['2353328' '2353339' '2353353']\n",
      "First 3 IDs of batch 11: ['2353364' '2353372' '2353380']\n",
      "\n",
      "Transition from batch (110000, 120000) to (120000, 130000)\n",
      "Last 3 IDs of batch 11: ['2476562' '2476574' '2476583']\n",
      "First 3 IDs of batch 12: ['2476599' '2476601' '2476610']\n",
      "\n",
      "Transition from batch (120000, 130000) to (130000, 140000)\n",
      "Last 3 IDs of batch 12: ['2599513' '2599534' '2599551']\n",
      "First 3 IDs of batch 13: ['2599569' '2599570' '2599582']\n",
      "\n",
      "Transition from batch (130000, 140000) to (140000, 150000)\n",
      "Last 3 IDs of batch 13: ['2722925' '2722934' '2722946']\n",
      "First 3 IDs of batch 14: ['2722951' '2722970' '2722982']\n",
      "\n",
      "Transition from batch (140000, 150000) to (150000, 160000)\n",
      "Last 3 IDs of batch 14: ['2846659' '2846686' '2846690']\n",
      "First 3 IDs of batch 15: ['2846705' '2846716' '2846727']\n",
      "\n",
      "Transition from batch (150000, 160000) to (160000, 170000)\n",
      "Last 3 IDs of batch 15: ['2969950' '2969974' '2969983']\n",
      "First 3 IDs of batch 16: ['2969999' '2970003' '2970012']\n",
      "\n",
      "Transition from batch (160000, 170000) to (170000, 180000)\n",
      "Last 3 IDs of batch 16: ['3093656' '3093671' '3093689']\n",
      "First 3 IDs of batch 17: ['3093697' '3093702' '3093719']\n",
      "\n",
      "Transition from batch (170000, 180000) to (180000, 190000)\n",
      "Last 3 IDs of batch 17: ['3217671' '3217697' '3217702']\n",
      "First 3 IDs of batch 18: ['3217719' '3217720' '3217731']\n",
      "\n",
      "Transition from batch (180000, 190000) to (190000, 200000)\n",
      "Last 3 IDs of batch 18: ['3341494' '3341501' '3341510']\n",
      "First 3 IDs of batch 19: ['3341529' '3341532' '3341548']\n",
      "\n",
      "Transition from batch (190000, 200000) to (200000, 210000)\n",
      "Last 3 IDs of batch 19: ['3465186' '3465218' '3465263']\n",
      "First 3 IDs of batch 20: ['3465287' '3465292' '3465301']\n",
      "\n",
      "Transition from batch (200000, 210000) to (210000, 220000)\n",
      "Last 3 IDs of batch 20: ['3587326' '3587335' '3587341']\n",
      "First 3 IDs of batch 21: ['3587350' '3587362' '3587374']\n",
      "\n",
      "Transition from batch (210000, 220000) to (220000, 230000)\n",
      "Last 3 IDs of batch 21: ['3711049' '3711066' '3711077']\n",
      "First 3 IDs of batch 22: ['3711085' '3711103' '3711112']\n",
      "\n",
      "Transition from batch (220000, 230000) to (230000, 240000)\n",
      "Last 3 IDs of batch 22: ['3833431' '3833455' '3833467']\n",
      "First 3 IDs of batch 23: ['3833476' '3833488' '3833508']\n",
      "\n",
      "Transition from batch (230000, 240000) to (240000, 250000)\n",
      "Last 3 IDs of batch 23: ['3956889' '3956904' '3956942']\n",
      "First 3 IDs of batch 24: ['3956959' '3956961' '3956978']\n",
      "\n",
      "Transition from batch (240000, 250000) to (250000, 260000)\n",
      "Last 3 IDs of batch 24: ['4079824' '4079830' '4079845']\n",
      "First 3 IDs of batch 25: ['4079868' '4079871' '4079889']\n",
      "\n",
      "Transition from batch (250000, 260000) to (260000, 270000)\n",
      "Last 3 IDs of batch 25: ['4202470' '4202482' '4202502']\n",
      "First 3 IDs of batch 26: ['4202520' '4202531' '4202544']\n",
      "\n",
      "Transition from batch (260000, 270000) to (270000, 280000)\n",
      "Last 3 IDs of batch 26: ['4325092' '4325106' '4325111']\n",
      "First 3 IDs of batch 27: ['4325128' '4325139' '4325147']\n",
      "\n",
      "Transition from batch (270000, 280000) to (280000, 290000)\n",
      "Last 3 IDs of batch 27: ['4447934' '4447946' '4447951']\n",
      "First 3 IDs of batch 28: ['4447969' '4447970' '4447982']\n",
      "\n",
      "Transition from batch (280000, 290000) to (290000, 300000)\n",
      "Last 3 IDs of batch 28: ['4571171' '4571189' '4571206']\n",
      "First 3 IDs of batch 29: ['4571211' '4571228' '4571239']\n",
      "\n",
      "Transition from batch (290000, 300000) to (300000, 310000)\n",
      "Last 3 IDs of batch 29: ['4694679' '4694694' '4694706']\n",
      "First 3 IDs of batch 30: ['4694711' '4694728' '4694739']\n",
      "\n",
      "Transition from batch (300000, 310000) to (310000, 320000)\n",
      "Last 3 IDs of batch 30: ['4817736' '4817740' '4817754']\n",
      "First 3 IDs of batch 31: ['4817763' '4817775' '4817807']\n",
      "\n",
      "Transition from batch (310000, 320000) to (320000, 330000)\n",
      "Last 3 IDs of batch 31: ['4942035' '4942041' '4942050']\n",
      "First 3 IDs of batch 32: ['4942062' '4942074' '4942083']\n",
      "\n",
      "Transition from batch (320000, 330000) to (330000, 340000)\n",
      "Last 3 IDs of batch 32: ['5066016' '5066027' '5066038']\n",
      "First 3 IDs of batch 33: ['5066043' '5066052' '5066060']\n",
      "\n",
      "Transition from batch (330000, 340000) to (340000, 350000)\n",
      "Last 3 IDs of batch 33: ['5189359' '5189361' '5189378']\n",
      "First 3 IDs of batch 34: ['5189386' '5189405' '5189416']\n",
      "\n",
      "Transition from batch (340000, 350000) to (350000, 360000)\n",
      "Last 3 IDs of batch 34: ['5313320' '5313331' '5313344']\n",
      "First 3 IDs of batch 35: ['5313367' '5313388' '5313393']\n",
      "\n",
      "Transition from batch (350000, 360000) to (360000, 370000)\n",
      "Last 3 IDs of batch 35: ['5436719' '5436731' '5436744']\n",
      "First 3 IDs of batch 36: ['5436755' '5436767' '5436776']\n",
      "\n",
      "Transition from batch (360000, 370000) to (370000, 380000)\n",
      "Last 3 IDs of batch 36: ['5559321' '5559336' '5559340']\n",
      "First 3 IDs of batch 37: ['5559354' '5559363' '5559387']\n",
      "\n",
      "Transition from batch (370000, 380000) to (380000, 390000)\n",
      "Last 3 IDs of batch 37: ['5683317' '5683326' '5683341']\n",
      "First 3 IDs of batch 38: ['5683374' '5683383' '5683399']\n",
      "\n",
      "Transition from batch (380000, 390000) to (390000, 400000)\n",
      "Last 3 IDs of batch 38: ['5806990' '5807005' '5807016']\n",
      "First 3 IDs of batch 39: ['5807027' '5807038' '5807043']\n"
     ]
    }
   ],
   "source": [
    "# Print out all processed ranges in order\n",
    "print(\"Processed ranges in order:\")\n",
    "for start, end in processed_ranges:\n",
    "    print(f\"{start}-{end}\")\n",
    "\n",
    "# Check for overlaps\n",
    "print(\"\\nChecking for overlaps...\")\n",
    "processed_ranges.sort()  # Make sure they're in order\n",
    "for i in range(len(processed_ranges)-1):\n",
    "    current_end = processed_ranges[i][1]\n",
    "    next_start = processed_ranges[i+1][0]\n",
    "    if current_end != next_start:\n",
    "        print(f\"WARNING: Gap or overlap between {processed_ranges[i]} and {processed_ranges[i+1]}\")\n",
    "\n",
    "# Let's also verify the actual data\n",
    "print(\"\\nVerifying data at transition points...\")\n",
    "for i in range(len(processed_ranges)-1):\n",
    "    current_end = processed_ranges[i][1]\n",
    "    next_start = processed_ranges[i+1][0]\n",
    "    \n",
    "    print(f\"\\nTransition from batch {processed_ranges[i]} to {processed_ranges[i+1]}\")\n",
    "    print(f\"Last 3 IDs of batch {i}: {patient_ids[current_end-3:current_end]}\")\n",
    "    print(f\"First 3 IDs of batch {i+1}: {patient_ids[next_start:next_start+3]}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 136,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "First batch end:\n",
      "Last ID in batch 0-10000: 1123600\n",
      "First ID in batch 10000-20000: 1123614\n",
      "\n",
      "Verifying no overlap:\n",
      "Any IDs in both sets? False\n"
     ]
    }
   ],
   "source": [
    "# Let's verify this with a small example\n",
    "print(\"First batch end:\")\n",
    "print(f\"Last ID in batch 0-10000: {patient_ids[9999]}\")  # Last ID of first batch\n",
    "print(f\"First ID in batch 10000-20000: {patient_ids[10000]}\")  # First ID of second batch\n",
    "\n",
    "# Verify no overlap\n",
    "print(\"\\nVerifying no overlap:\")\n",
    "batch1_end = set(patient_ids[9990:10000])    # Last 10 IDs of first batch\n",
    "batch2_start = set(patient_ids[10000:10010])  # First 10 IDs of second batch\n",
    "print(f\"Any IDs in both sets? {len(batch1_end.intersection(batch2_start)) > 0}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 137,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Checking batch directory: /Users/sarahurbut/Dropbox (Personal)/from_AWS/10kbatches_sameseed/output_390000_400000_20241226_102603\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/2f/nxrbr3pn1msgrl4ffyj33zd00000gn/T/ipykernel_68206/197857465.py:7: FutureWarning: You are using `torch.load` with `weights_only=False` (the current default value), which uses the default pickle module implicitly. It is possible to construct malicious pickle data which will execute arbitrary code during unpickling (See https://github.com/pytorch/pytorch/blob/main/SECURITY.md#untrusted-models for more details). In a future release, the default value for `weights_only` will be flipped to `True`. This limits the functions that could be executed during unpickling. Arbitrary objects will no longer be allowed to be loaded via this mode unless they are explicitly allowlisted by the user via `torch.serialization.add_safe_globals`. We recommend you start setting `weights_only=True` for any use case where you don't have full control of the loaded file. Please open an issue on GitHub for any issues related to this experimental feature.\n",
      "  checkpoint = torch.load(os.path.join(last_batch_dir, 'model.pt'))\n",
      "/var/folders/2f/nxrbr3pn1msgrl4ffyj33zd00000gn/T/ipykernel_68206/197857465.py:14: FutureWarning: You are using `torch.load` with `weights_only=False` (the current default value), which uses the default pickle module implicitly. It is possible to construct malicious pickle data which will execute arbitrary code during unpickling (See https://github.com/pytorch/pytorch/blob/main/SECURITY.md#untrusted-models for more details). In a future release, the default value for `weights_only` will be flipped to `True`. This limits the functions that could be executed during unpickling. Arbitrary objects will no longer be allowed to be loaded via this mode unless they are explicitly allowlisted by the user via `torch.serialization.add_safe_globals`. We recommend you start setting `weights_only=True` for any use case where you don't have full control of the loaded file. Please open an issue on GitHub for any issues related to this experimental feature.\n",
      "  Yt = torch.load(\"/Users/sarahurbut/Dropbox (Personal)/filesforupload/Y_tensor.pt\")\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Verifying final batch data:\n",
      "\n",
      "Patient 399995:\n",
      "Patient ID: 5929605\n",
      "Disease occurrences in batch:\n",
      "Disease 47 at timepoint 17\n",
      "Disease 79 at timepoint 7\n",
      "Disease 254 at timepoint 24\n",
      "Disease 284 at timepoint 17\n",
      "\n",
      "Patient 399996:\n",
      "Patient ID: 5929616\n",
      "Disease occurrences in batch:\n",
      "Disease 203 at timepoint 27\n",
      "Disease 294 at timepoint 6\n",
      "Disease 299 at timepoint 28\n",
      "Disease 344 at timepoint 28\n",
      "\n",
      "Patient 399997:\n",
      "Patient ID: 5929627\n",
      "Disease occurrences in batch:\n",
      "Disease 10 at timepoint 42\n",
      "Disease 57 at timepoint 46\n",
      "Disease 58 at timepoint 46\n",
      "Disease 60 at timepoint 42\n",
      "Disease 89 at timepoint 48\n",
      "Disease 109 at timepoint 48\n",
      "Disease 112 at timepoint 46\n",
      "Disease 128 at timepoint 42\n",
      "Disease 131 at timepoint 46\n",
      "Disease 145 at timepoint 42\n",
      "Disease 168 at timepoint 46\n",
      "Disease 170 at timepoint 46\n",
      "Disease 171 at timepoint 46\n",
      "Disease 178 at timepoint 38\n",
      "Disease 180 at timepoint 42\n",
      "Disease 197 at timepoint 46\n",
      "Disease 203 at timepoint 42\n",
      "Disease 210 at timepoint 46\n",
      "Disease 269 at timepoint 36\n",
      "Disease 281 at timepoint 36\n",
      "Disease 299 at timepoint 48\n",
      "Disease 320 at timepoint 37\n",
      "Disease 345 at timepoint 37\n",
      "Disease 346 at timepoint 46\n",
      "\n",
      "Patient 399998:\n",
      "Patient ID: 5929638\n",
      "Disease occurrences in batch:\n",
      "Disease 95 at timepoint 24\n",
      "Disease 134 at timepoint 30\n",
      "\n",
      "Patient 399999:\n",
      "Patient ID: 5929643\n",
      "Disease occurrences in batch:\n",
      "Disease 79 at timepoint 25\n",
      "Disease 87 at timepoint 37\n",
      "Disease 92 at timepoint 34\n",
      "Disease 145 at timepoint 37\n",
      "Disease 201 at timepoint 37\n",
      "Disease 225 at timepoint 37\n",
      "Disease 299 at timepoint 37\n",
      "Disease 332 at timepoint 37\n",
      "Disease 336 at timepoint 40\n"
     ]
    }
   ],
   "source": [
    "# Find the batch directory for 390000-400000\n",
    "target_batch = \"output_390000_400000\"\n",
    "last_batch_dir = [d for d in output_dirs if target_batch in d][0]\n",
    "print(f\"Checking batch directory: {last_batch_dir}\")\n",
    "\n",
    "# Load the model from this batch\n",
    "checkpoint = torch.load(os.path.join(last_batch_dir, 'model.pt'))\n",
    "\n",
    "# Get the indices and Y values that were used for this batch\n",
    "batch_indices = checkpoint['indices']  # The indices used in this batch\n",
    "batch_Y = checkpoint['Y']  # The Y values used in this batch\n",
    "\n",
    "# Load the full Y tensor for comparison\n",
    "Yt = torch.load(\"/Users/sarahurbut/Dropbox (Personal)/filesforupload/Y_tensor.pt\")\n",
    "\n",
    "# Check the last few examples\n",
    "print(\"\\nVerifying final batch data:\")\n",
    "for i in range(-5, 0):  # Look at last 5 patients in the batch\n",
    "    batch_idx = batch_indices[i]  # Index in the original data\n",
    "    print(f\"\\nPatient {batch_idx}:\")\n",
    "    print(f\"Patient ID: {patient_ids[batch_idx]}\")\n",
    "    \n",
    "    # Compare Y values\n",
    "    batch_y = batch_Y[i]  # Y values used in the batch\n",
    "    full_y = Yt[batch_idx]  # Y values from full tensor\n",
    "    \n",
    "    # Find where diseases occurred\n",
    "    disease_timepoints = torch.where(batch_y == 1)\n",
    "    if len(disease_timepoints[0]) > 0:\n",
    "        print(\"Disease occurrences in batch:\")\n",
    "        for d, t in zip(*disease_timepoints):\n",
    "            print(f\"Disease {d} at timepoint {t}\")\n",
    "            # Verify this matches the full Y tensor\n",
    "            assert full_y[d, t] == 1, f\"Mismatch at disease {d}, timepoint {t}\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 138,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Verifying patient ID 5929643 (index 399999):\n",
      "\n",
      "Checking Y tensor:\n",
      "Disease occurrences in Y tensor:\n",
      "Disease 79 at timepoint 25\n",
      "Disease 87 at timepoint 37\n",
      "Disease 92 at timepoint 34\n",
      "Disease 145 at timepoint 37\n",
      "Disease 201 at timepoint 37\n",
      "Disease 225 at timepoint 37\n",
      "Disease 299 at timepoint 37\n",
      "Disease 332 at timepoint 37\n",
      "Disease 336 at timepoint 40\n",
      "\n",
      "Do Y values match exactly? True\n",
      "\n",
      "Verifying specific disease occurrence:\n",
      "Disease 79, timepoint 25 in batch Y: 1.0\n",
      "Disease 79, timepoint 25 in Y tensor: 1.0\n"
     ]
    }
   ],
   "source": [
    "# Let's verify patient 399999 (our last patient) against the Y tensor\n",
    "last_idx = 399999\n",
    "print(f\"Verifying patient ID {patient_ids[last_idx]} (index {last_idx}):\")\n",
    "\n",
    "# Get Y values from both sources\n",
    "y_from_batch = batch_Y[-1]  # Last patient in the batch\n",
    "y_from_tensor = Yt[last_idx]  # Same patient in full tensor\n",
    "\n",
    "# Compare disease occurrences\n",
    "print(\"\\nChecking Y tensor:\")\n",
    "tensor_diseases = torch.where(y_from_tensor == 1)\n",
    "if len(tensor_diseases[0]) > 0:\n",
    "    print(\"Disease occurrences in Y tensor:\")\n",
    "    for d, t in zip(*tensor_diseases):\n",
    "        print(f\"Disease {d} at timepoint {t}\")\n",
    "\n",
    "# Verify they match exactly\n",
    "diseases_match = torch.all(y_from_batch == y_from_tensor)\n",
    "print(f\"\\nDo Y values match exactly? {diseases_match}\")\n",
    "\n",
    "# Also check a specific disease occurrence from the list\n",
    "# For example, verify Disease 79 at timepoint 25\n",
    "print(f\"\\nVerifying specific disease occurrence:\")\n",
    "print(f\"Disease 79, timepoint 25 in batch Y: {y_from_batch[79, 25]}\")\n",
    "print(f\"Disease 79, timepoint 25 in Y tensor: {y_from_tensor[79, 25]}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([ 0.20413488,  0.21736562,  0.23091145,  0.24547055,  0.26165587,\n",
       "        0.27994749,  0.30064756,  0.32378125,  0.34916401,  0.37634063,\n",
       "        0.40462556,  0.43315411,  0.46091533,  0.48688394,  0.51003999,\n",
       "        0.52950007,  0.54457837,  0.55486327,  0.56024164,  0.56095457,\n",
       "        0.55757529,  0.550955  ,  0.5421983 ,  0.53256631,  0.52338463,\n",
       "        0.5159148 ,  0.51125938,  0.51026201,  0.51343566,  0.52088815,\n",
       "        0.53227633,  0.54682457,  0.56336963,  0.58040059,  0.59613395,\n",
       "        0.60867625,  0.61608684,  0.61655253,  0.60842836,  0.59044385,\n",
       "        0.56171596,  0.5218395 ,  0.47088966,  0.40947041,  0.33864847,\n",
       "        0.25989029,  0.17502795,  0.08613784, -0.00455711, -0.09478733,\n",
       "       -0.18234307, -0.2651625 ])"
      ]
     },
     "execution_count": 69,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "all_lambdas[1,1,:]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 64,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/2f/nxrbr3pn1msgrl4ffyj33zd00000gn/T/ipykernel_68206/3104653736.py:1: FutureWarning: You are using `torch.load` with `weights_only=False` (the current default value), which uses the default pickle module implicitly. It is possible to construct malicious pickle data which will execute arbitrary code during unpickling (See https://github.com/pytorch/pytorch/blob/main/SECURITY.md#untrusted-models for more details). In a future release, the default value for `weights_only` will be flipped to `True`. This limits the functions that could be executed during unpickling. Arbitrary objects will no longer be allowed to be loaded via this mode unless they are explicitly allowlisted by the user via `torch.serialization.add_safe_globals`. We recommend you start setting `weights_only=True` for any use case where you don't have full control of the loaded file. Please open an issue on GitHub for any issues related to this experimental feature.\n",
      "  t=torch.load('/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_0_10000_20241225_062028/model.pt')\n"
     ]
    }
   ],
   "source": [
    "t=torch.load('/Users/sarahurbut/Dropbox (Personal)/10kbatches_sameseed/output_0_10000_20241225_062028/model.pt')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([[[0., 0., 0., ..., 0., 0., 0.],\n",
       "        [0., 0., 0., ..., 0., 0., 0.],\n",
       "        [0., 0., 0., ..., 0., 0., 0.],\n",
       "        ...,\n",
       "        [0., 0., 0., ..., 0., 0., 0.],\n",
       "        [0., 0., 0., ..., 0., 0., 0.],\n",
       "        [0., 0., 0., ..., 0., 0., 0.]],\n",
       "\n",
       "       [[0., 0., 0., ..., 0., 0., 0.],\n",
       "        [0., 0., 0., ..., 0., 0., 0.],\n",
       "        [0., 0., 0., ..., 0., 0., 0.],\n",
       "        ...,\n",
       "        [0., 0., 0., ..., 0., 0., 0.],\n",
       "        [0., 0., 0., ..., 0., 0., 0.],\n",
       "        [0., 0., 0., ..., 0., 0., 0.]],\n",
       "\n",
       "       [[0., 0., 0., ..., 0., 0., 0.],\n",
       "        [0., 0., 0., ..., 0., 0., 0.],\n",
       "        [0., 0., 0., ..., 0., 0., 0.],\n",
       "        ...,\n",
       "        [0., 0., 0., ..., 0., 0., 0.],\n",
       "        [0., 0., 0., ..., 0., 0., 0.],\n",
       "        [0., 0., 0., ..., 0., 0., 0.]],\n",
       "\n",
       "       ...,\n",
       "\n",
       "       [[0., 0., 0., ..., 0., 0., 0.],\n",
       "        [0., 0., 0., ..., 0., 0., 0.],\n",
       "        [0., 0., 0., ..., 0., 0., 0.],\n",
       "        ...,\n",
       "        [0., 0., 0., ..., 0., 0., 0.],\n",
       "        [0., 0., 0., ..., 0., 0., 0.],\n",
       "        [0., 0., 0., ..., 0., 0., 0.]],\n",
       "\n",
       "       [[0., 0., 0., ..., 0., 0., 0.],\n",
       "        [0., 0., 0., ..., 0., 0., 0.],\n",
       "        [0., 0., 0., ..., 0., 0., 0.],\n",
       "        ...,\n",
       "        [0., 0., 0., ..., 0., 0., 0.],\n",
       "        [0., 0., 0., ..., 0., 0., 0.],\n",
       "        [0., 0., 0., ..., 0., 0., 0.]],\n",
       "\n",
       "       [[0., 0., 0., ..., 0., 0., 0.],\n",
       "        [0., 0., 0., ..., 0., 0., 0.],\n",
       "        [0., 0., 0., ..., 0., 0., 0.],\n",
       "        ...,\n",
       "        [0., 0., 0., ..., 0., 0., 0.],\n",
       "        [0., 0., 0., ..., 0., 0., 0.],\n",
       "        [0., 0., 0., ..., 0., 0., 0.]]])"
      ]
     },
     "execution_count": 50,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "all_lambdas"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "def analyze_cluster_patterns(model_path):\n",
    "    # Load the saved model\n",
    "    checkpoint = torch.load(model_path)\n",
    "    \n",
    "    # Extract relevant components\n",
    "    disease_names = checkpoint['disease_names']\n",
    "    clusters = checkpoint['clusters']\n",
    "    phi = checkpoint['model_state_dict']['phi']\n",
    "    psi = checkpoint['model_state_dict']['psi']\n",
    "    \n",
    "    # Convert tensors to numpy if needed\n",
    "    if torch.is_tensor(phi):\n",
    "        phi = phi.detach().numpy()\n",
    "    if torch.is_tensor(psi):\n",
    "        psi = psi.detach().numpy()\n",
    "    \n",
    "    # For each cluster\n",
    "    unique_clusters = np.unique(clusters)\n",
    "    for cluster in unique_clusters:\n",
    "        # Get diseases in this cluster\n",
    "        cluster_diseases = np.where(clusters == cluster)[0]\n",
    "        \n",
    "        print(f\"\\nCluster {cluster} diseases:\")\n",
    "        print(\"------------------------\")\n",
    "        \n",
    "        # Get average phi values for diseases in this cluster\n",
    "        cluster_phi = phi[:, cluster_diseases, :].mean(axis=2)  # Average over time\n",
    "        \n",
    "        # Find which signature has strongest effect on these diseases\n",
    "        dominant_signature = np.argmax(np.abs(cluster_phi).mean(axis=1))\n",
    "        \n",
    "        # Sort diseases by their strength in the dominant signature\n",
    "        disease_strengths = phi[dominant_signature, cluster_diseases, :].mean(axis=1)\n",
    "        sorted_indices = np.argsort(np.abs(disease_strengths))[::-1]\n",
    "        \n",
    "        # Print top 5 most characteristic diseases\n",
    "        print(f\"Top diseases (strongest in signature {dominant_signature}):\")\n",
    "        for idx in sorted_indices[:5]:\n",
    "            disease_idx = cluster_diseases[idx]\n",
    "            strength = disease_strengths[idx]\n",
    "            print(f\"- {disease_names[disease_idx]}: strength = {strength:.3f}\")\n",
    "            \n",
    "        # Find diseases that appear in other signatures\n",
    "        other_sigs = np.delete(np.arange(phi.shape[0]), dominant_signature)\n",
    "        non_specific_diseases = []\n",
    "        \n",
    "        for disease_idx in cluster_diseases:\n",
    "            disease_phi = phi[:, disease_idx, :].mean(axis=1)  # Average over time\n",
    "            if np.any(np.abs(disease_phi[other_sigs]) > 0.5 * np.abs(disease_phi[dominant_signature])):\n",
    "                non_specific_diseases.append(disease_idx)\n",
    "        \n",
    "        if non_specific_diseases:\n",
    "            print(\"\\nNon-specific diseases (strong effects in multiple signatures):\")\n",
    "            for disease_idx in non_specific_diseases[:5]:  # Show up to 5 examples\n",
    "                disease_phi = phi[:, disease_idx, :].mean(axis=1)\n",
    "                print(f\"\\n{disease_names[disease_idx]}:\")\n",
    "                for sig in range(len(disease_phi)):\n",
    "                    if abs(disease_phi[sig]) > 0.1:  # Show only significant effects\n",
    "                        print(f\"  Signature {sig}: {disease_phi[sig]:.3f}\")\n",
    "\n",
    "def plot_disease_patterns(model_path, disease_indices, title=None):\n",
    "    \"\"\"\n",
    "    Plot temporal patterns for specific diseases across all signatures\n",
    "    \"\"\"\n",
    "    checkpoint = torch.load(model_path)\n",
    "    phi = checkpoint['model_state_dict']['phi']\n",
    "    disease_names = checkpoint['disease_names']\n",
    "    \n",
    "    if torch.is_tensor(phi):\n",
    "        phi = phi.detach().numpy()\n",
    "    \n",
    "    n_signatures = phi.shape[0]\n",
    "    n_timepoints = phi.shape[2]\n",
    "    \n",
    "    plt.figure(figsize=(15, 5 * len(disease_indices)))\n",
    "    \n",
    "    for i, disease_idx in enumerate(disease_indices):\n",
    "        plt.subplot(len(disease_indices), 1, i+1)\n",
    "        \n",
    "        for sig in range(n_signatures):\n",
    "            plt.plot(range(n_timepoints), phi[sig, disease_idx, :], \n",
    "                    label=f'Signature {sig}')\n",
    "        \n",
    "        plt.title(f\"{disease_names[disease_idx]} Temporal Patterns\")\n",
    "        plt.xlabel('Time')\n",
    "        plt.ylabel('Effect Size')\n",
    "        plt.legend(bbox_to_anchor=(1.05, 1), loc='upper left')\n",
    "        plt.grid(True, alpha=0.3)\n",
    "    \n",
    "    if title:\n",
    "        plt.suptitle(title, y=1.02)\n",
    "    plt.tight_layout()\n",
    "    plt.show()\n",
    "\n",
    "# Usage:\n",
    "model_path = '/path/to/your/model.pt'\n",
    "analyze_cluster_patterns(model_path)\n",
    "\n",
    "# After identifying interesting diseases, plot their patterns:\n",
    "interesting_diseases = [10, 20, 30]  # Replace with actual disease indices\n",
    "plot_disease_patterns(model_path, interesting_diseases, \n",
    "                     title=\"Comparison of Cluster-Specific vs Non-Specific Diseases\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/2f/nxrbr3pn1msgrl4ffyj33zd00000gn/T/ipykernel_68206/1662465921.py:17: FutureWarning: You are using `torch.load` with `weights_only=False` (the current default value), which uses the default pickle module implicitly. It is possible to construct malicious pickle data which will execute arbitrary code during unpickling (See https://github.com/pytorch/pytorch/blob/main/SECURITY.md#untrusted-models for more details). In a future release, the default value for `weights_only` will be flipped to `True`. This limits the functions that could be executed during unpickling. Arbitrary objects will no longer be allowed to be loaded via this mode unless they are explicitly allowlisted by the user via `torch.serialization.add_safe_globals`. We recommend you start setting `weights_only=True` for any use case where you don't have full control of the loaded file. Please open an issue on GitHub for any issues related to this experimental feature.\n",
      "  checkpoint = torch.load(path)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Comparing initial phis:\n",
      "Max difference between output_0_10000_20241224_154530 and output_20000_30000_20241224_154713: 6.381223\n",
      "Max difference between output_0_10000_20241224_154530 and output_50000_60000_20241224_154856: 5.794329\n",
      "Max difference between output_20000_30000_20241224_154713 and output_50000_60000_20241224_154856: 5.582039\n",
      "\n",
      "Comparing values for Signature 1, Disease 0:\n",
      "\n",
      "output_0_10000_20241224_154530:\n",
      "tensor([-13.6336, -13.6174, -13.5620, -13.4702, -13.3499, -13.2084, -13.0516,\n",
      "        -12.8876, -12.7173, -12.5471, -12.3843, -12.2211, -12.0653, -11.9177,\n",
      "        -11.7781, -11.6455, -11.5197, -11.4053, -11.3003, -11.2090, -11.1262,\n",
      "        -11.0592, -11.0024, -10.9609, -10.9343, -10.9234, -10.9248, -10.9423,\n",
      "        -10.9747, -11.0211, -11.0806, -11.1481, -11.2308, -11.3210, -11.4169,\n",
      "        -11.5189, -11.6237, -11.7309, -11.8402, -11.9507, -12.0614, -12.1706,\n",
      "        -12.2786, -12.3818, -12.4800, -12.5684, -12.6478, -12.7097, -12.7477,\n",
      "        -12.7623, -12.7469, -12.7022])\n",
      "\n",
      "output_20000_30000_20241224_154713:\n",
      "tensor([-13.9232, -14.0299, -14.0997, -14.1399, -14.1544, -14.1536, -14.1300,\n",
      "        -14.1007, -14.0612, -14.0175, -13.9669, -13.9138, -13.8559, -13.7874,\n",
      "        -13.7141, -13.6350, -13.5479, -13.4513, -13.3470, -13.2388, -13.1201,\n",
      "        -12.9984, -12.8743, -12.7462, -12.6173, -12.4885, -12.3655, -12.2455,\n",
      "        -12.1308, -12.0257, -11.9272, -11.8379, -11.7557, -11.6814, -11.6188,\n",
      "        -11.5595, -11.5096, -11.4679, -11.4365, -11.4116, -11.3960, -11.3895,\n",
      "        -11.3907, -11.3992, -11.4145, -11.4327, -11.4537, -11.4669, -11.4737,\n",
      "        -11.4681, -11.4509, -11.4111])\n",
      "\n",
      "output_50000_60000_20241224_154856:\n",
      "tensor([-13.7703, -13.7310, -13.6547, -13.5493, -13.4158, -13.2662, -13.1066,\n",
      "        -12.9401, -12.7736, -12.6072, -12.4494, -12.2967, -12.1499, -12.0119,\n",
      "        -11.8798, -11.7542, -11.6322, -11.5156, -11.4064, -11.2970, -11.1965,\n",
      "        -11.0989, -11.0073, -10.9178, -10.8301, -10.7454, -10.6672, -10.5924,\n",
      "        -10.5180, -10.4514, -10.3849, -10.3207, -10.2610, -10.1998, -10.1400,\n",
      "        -10.0863, -10.0279,  -9.9770,  -9.9260,  -9.8826,  -9.8430,  -9.8123,\n",
      "         -9.7903,  -9.7807,  -9.7761,  -9.7827,  -9.7909,  -9.8076,  -9.8208,\n",
      "         -9.8318,  -9.8347,  -9.8301])\n"
     ]
    }
   ],
   "source": [
    "# verify initialiation\n",
    "import torch\n",
    "import os\n",
    "\n",
    "# Load the three models\n",
    "model_paths = [\n",
    "    'results/output_0_10000_20241224_154530/model.pt',\n",
    "    'results/output_20000_30000_20241224_154713/model.pt',\n",
    "    'results/output_50000_60000_20241224_154856/model.pt'\n",
    "]\n",
    "\n",
    "initial_phis = []\n",
    "batch_info = []\n",
    "\n",
    "# Load each model and extract initial phi\n",
    "for path in model_paths:\n",
    "    checkpoint = torch.load(path)\n",
    "    initial_phi = checkpoint['initial_phi']  # Assuming we saved initial_phi\n",
    "    initial_phis.append(initial_phi)\n",
    "    \n",
    "    # Get batch info from path\n",
    "    dir_name = os.path.basename(os.path.dirname(path))\n",
    "    batch_info.append(dir_name)\n",
    "\n",
    "# Compare initial phis\n",
    "print(\"\\nComparing initial phis:\")\n",
    "for i in range(len(initial_phis)):\n",
    "    for j in range(i+1, len(initial_phis)):\n",
    "        diff = torch.abs(initial_phis[i] - initial_phis[j]).max()\n",
    "        print(f\"Max difference between {batch_info[i]} and {batch_info[j]}: {diff:.6f}\")\n",
    "\n",
    "# If they're not identical, let's look at where they differ\n",
    "if diff > 1e-6:  # if there are meaningful differences\n",
    "    # Look at specific signature/disease combinations\n",
    "    k, d = 1, 0  # Signature 1, Disease 0 (from your plot)\n",
    "    print(f\"\\nComparing values for Signature {k}, Disease {d}:\")\n",
    "    for i, phi in enumerate(initial_phis):\n",
    "        print(f\"\\n{batch_info[i]}:\")\n",
    "        print(phi[k, d, :])  # Print the full trajectory"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "RUN 0\n",
      "\n",
      "Test 1: Basic random numbers\n",
      "Batch 0: tensor([ 0.3367,  0.1288,  0.2345,  0.2303, -1.1229])\n",
      "Batch 1: tensor([-0.1863,  2.2082, -0.6380,  0.4617,  0.2674])\n",
      "Batch 2: tensor([ 0.5349,  0.8094,  1.1103, -1.6898, -0.9890])\n",
      "\n",
      "Test 2: GP-like sampling\n",
      "\n",
      "Batch 0:\n",
      "k=0: tensor([0.6734, 0.4655])\n",
      "k=1: tensor([0.4689, 0.4648])\n",
      "\n",
      "Batch 1:\n",
      "k=0: tensor([-2.2457, -1.3092])\n",
      "k=1: tensor([4.4164, 1.5702])\n",
      "\n",
      "Batch 2:\n",
      "k=0: tensor([0.9233, 0.7290])\n",
      "k=1: tensor([1.0698, 1.3443])\n",
      "\n",
      "RUN 1\n",
      "\n",
      "Test 1: Basic random numbers\n",
      "Batch 0: tensor([ 0.3367,  0.1288,  0.2345,  0.2303, -1.1229])\n",
      "Batch 1: tensor([-0.1863,  2.2082, -0.6380,  0.4617,  0.2674])\n",
      "Batch 2: tensor([ 0.5349,  0.8094,  1.1103, -1.6898, -0.9890])\n",
      "\n",
      "Test 2: GP-like sampling\n",
      "\n",
      "Batch 0:\n",
      "k=0: tensor([0.6734, 0.4655])\n",
      "k=1: tensor([0.4689, 0.4648])\n",
      "\n",
      "Batch 1:\n",
      "k=0: tensor([-2.2457, -1.3092])\n",
      "k=1: tensor([4.4164, 1.5702])\n",
      "\n",
      "Batch 2:\n",
      "k=0: tensor([0.9233, 0.7290])\n",
      "k=1: tensor([1.0698, 1.3443])\n"
     ]
    }
   ],
   "source": [
    "def test_random_seed_persistence():\n",
    "    # Test 1: Basic torch random numbers\n",
    "    torch.manual_seed(42)\n",
    "    print(\"\\nTest 1: Basic random numbers\")\n",
    "    for i in range(3):\n",
    "        print(f\"Batch {i}:\", torch.randn(5))\n",
    "    \n",
    "    # Test 2: With model-like GP sampling\n",
    "    print(\"\\nTest 2: GP-like sampling\")\n",
    "    torch.manual_seed(42)\n",
    "    for batch in range(3):\n",
    "        print(f\"\\nBatch {batch}:\")\n",
    "        # Simulate what happens in initialize_params\n",
    "        L = torch.tensor([[2.0, 0.0], [1.0, 1.0]])  # Simple triangular matrix\n",
    "        for k in range(2):\n",
    "            eps = L @ torch.randn(2)\n",
    "            print(f\"k={k}:\", eps)\n",
    "\n",
    "# Run the test multiple times\n",
    "for run in range(2):\n",
    "    print(f\"\\nRUN {run}\")\n",
    "    test_random_seed_persistence()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/2f/nxrbr3pn1msgrl4ffyj33zd00000gn/T/ipykernel_68206/931674136.py:16: FutureWarning: You are using `torch.load` with `weights_only=False` (the current default value), which uses the default pickle module implicitly. It is possible to construct malicious pickle data which will execute arbitrary code during unpickling (See https://github.com/pytorch/pytorch/blob/main/SECURITY.md#untrusted-models for more details). In a future release, the default value for `weights_only` will be flipped to `True`. This limits the functions that could be executed during unpickling. Arbitrary objects will no longer be allowed to be loaded via this mode unless they are explicitly allowlisted by the user via `torch.serialization.add_safe_globals`. We recommend you start setting `weights_only=True` for any use case where you don't have full control of the loaded file. Please open an issue on GitHub for any issues related to this experimental feature.\n",
      "  checkpoint = torch.load(path)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Comparing Signature 1, Disease 0 trajectories:\n",
      "\n",
      "output_0_10000_20241224_155933:\n",
      "tensor([-12.2591, -12.2489, -12.2013, -12.1217, -12.0126, -11.8842, -11.7397,\n",
      "        -11.5901, -11.4350, -11.2803, -11.1312, -10.9859, -10.8463, -10.7124,\n",
      "        -10.5870, -10.4690, -10.3578, -10.2559, -10.1648, -10.0832, -10.0133,\n",
      "         -9.9527,  -9.9056,  -9.8712,  -9.8527,  -9.8476,  -9.8568,  -9.8822,\n",
      "         -9.9221,  -9.9786, -10.0469, -10.1313, -10.2260, -10.3335, -10.4476,\n",
      "        -10.5676, -10.6957, -10.8272, -10.9631, -11.1032, -11.2460, -11.3907,\n",
      "        -11.5375, -11.6814, -11.8250, -11.9635, -12.0926, -12.2085, -12.3078,\n",
      "        -12.3880, -12.4409, -12.4720])\n",
      "\n",
      "output_20000_30000_20241224_160033:\n",
      "tensor([-12.2591, -12.2489, -12.2013, -12.1217, -12.0126, -11.8842, -11.7397,\n",
      "        -11.5901, -11.4350, -11.2803, -11.1312, -10.9859, -10.8463, -10.7124,\n",
      "        -10.5870, -10.4690, -10.3578, -10.2559, -10.1648, -10.0832, -10.0133,\n",
      "         -9.9527,  -9.9056,  -9.8712,  -9.8527,  -9.8476,  -9.8568,  -9.8822,\n",
      "         -9.9221,  -9.9786, -10.0469, -10.1313, -10.2260, -10.3335, -10.4476,\n",
      "        -10.5676, -10.6957, -10.8272, -10.9631, -11.1032, -11.2460, -11.3907,\n",
      "        -11.5375, -11.6814, -11.8250, -11.9635, -12.0926, -12.2085, -12.3078,\n",
      "        -12.3880, -12.4409, -12.4720])\n",
      "\n",
      "output_50000_60000_20241224_160134:\n",
      "tensor([-12.2591, -12.2489, -12.2013, -12.1217, -12.0126, -11.8842, -11.7397,\n",
      "        -11.5901, -11.4350, -11.2803, -11.1312, -10.9859, -10.8463, -10.7124,\n",
      "        -10.5870, -10.4690, -10.3578, -10.2559, -10.1648, -10.0832, -10.0133,\n",
      "         -9.9527,  -9.9056,  -9.8712,  -9.8527,  -9.8476,  -9.8568,  -9.8822,\n",
      "         -9.9221,  -9.9786, -10.0469, -10.1313, -10.2260, -10.3335, -10.4476,\n",
      "        -10.5676, -10.6957, -10.8272, -10.9631, -11.1032, -11.2460, -11.3907,\n",
      "        -11.5375, -11.6814, -11.8250, -11.9635, -12.0926, -12.2085, -12.3078,\n",
      "        -12.3880, -12.4409, -12.4720])\n",
      "\n",
      "Max differences between batches:\n",
      "Max difference between output_0_10000_20241224_155933 and output_20000_30000_20241224_160033: 0.000000\n",
      "Max difference between output_0_10000_20241224_155933 and output_50000_60000_20241224_160134: 0.000000\n",
      "Max difference between output_20000_30000_20241224_160033 and output_50000_60000_20241224_160134: 0.000000\n"
     ]
    }
   ],
   "source": [
    "import torch\n",
    "import os\n",
    "\n",
    "# Load the three new models\n",
    "model_paths = [\n",
    "    'results/output_0_10000_20241224_155933/model.pt',\n",
    "    'results/output_20000_30000_20241224_160033/model.pt',\n",
    "    'results/output_50000_60000_20241224_160134/model.pt'\n",
    "]\n",
    "\n",
    "initial_phis = []\n",
    "batch_info = []\n",
    "\n",
    "# Load each model and extract initial phi\n",
    "for path in model_paths:\n",
    "    checkpoint = torch.load(path)\n",
    "    initial_phi = checkpoint['initial_phi']\n",
    "    initial_phis.append(initial_phi)\n",
    "    \n",
    "    # Get batch info from path\n",
    "    dir_name = os.path.basename(os.path.dirname(path))\n",
    "    batch_info.append(dir_name)\n",
    "\n",
    "# Compare initial phis for signature 1, disease 0\n",
    "k, d = 1, 0\n",
    "print(\"\\nComparing Signature 1, Disease 0 trajectories:\")\n",
    "for i, batch in enumerate(batch_info):\n",
    "    print(f\"\\n{batch}:\")\n",
    "    print(initial_phis[i][k, d, :])\n",
    "\n",
    "# Calculate max differences between batches\n",
    "print(\"\\nMax differences between batches:\")\n",
    "for i in range(len(initial_phis)):\n",
    "    for j in range(i+1, len(initial_phis)):\n",
    "        diff = torch.abs(initial_phis[i] - initial_phis[j]).max()\n",
    "        print(f\"Max difference between {batch_info[i]} and {batch_info[j]}: {diff:.6f}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/2f/nxrbr3pn1msgrl4ffyj33zd00000gn/T/ipykernel_68206/3428415070.py:16: FutureWarning: You are using `torch.load` with `weights_only=False` (the current default value), which uses the default pickle module implicitly. It is possible to construct malicious pickle data which will execute arbitrary code during unpickling (See https://github.com/pytorch/pytorch/blob/main/SECURITY.md#untrusted-models for more details). In a future release, the default value for `weights_only` will be flipped to `True`. This limits the functions that could be executed during unpickling. Arbitrary objects will no longer be allowed to be loaded via this mode unless they are explicitly allowlisted by the user via `torch.serialization.add_safe_globals`. We recommend you start setting `weights_only=True` for any use case where you don't have full control of the loaded file. Please open an issue on GitHub for any issues related to this experimental feature.\n",
      "  checkpoint = torch.load(path)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Comparing Signature 1, Disease 0 trajectories:\n",
      "\n",
      "output_0_10000_20241224_164101:\n",
      "tensor([-13.3435, -13.3436, -13.3088, -13.2362, -13.1345, -13.0095, -12.8667,\n",
      "        -12.7069, -12.5430, -12.3674, -12.1872, -12.0040, -11.8178, -11.6290,\n",
      "        -11.4342, -11.2392, -11.0435, -10.8493, -10.6511, -10.4587, -10.2699,\n",
      "        -10.0860,  -9.9134,  -9.7484,  -9.5951,  -9.4565,  -9.3294,  -9.2206,\n",
      "         -9.1286,  -9.0556,  -8.9969,  -8.9540,  -8.9318,  -8.9222,  -8.9255,\n",
      "         -8.9414,  -8.9674,  -9.0056,  -9.0523,  -9.1078,  -9.1709,  -9.2385,\n",
      "         -9.3167,  -9.3965,  -9.4766,  -9.5612,  -9.6376,  -9.7082,  -9.7641,\n",
      "         -9.8025,  -9.8202,  -9.8154])\n",
      "\n",
      "output_20000_30000_20241224_164200:\n",
      "tensor([-13.3435, -13.3436, -13.3088, -13.2362, -13.1345, -13.0095, -12.8667,\n",
      "        -12.7069, -12.5430, -12.3674, -12.1872, -12.0040, -11.8178, -11.6290,\n",
      "        -11.4342, -11.2392, -11.0435, -10.8493, -10.6511, -10.4587, -10.2699,\n",
      "        -10.0860,  -9.9134,  -9.7484,  -9.5951,  -9.4565,  -9.3294,  -9.2206,\n",
      "         -9.1286,  -9.0556,  -8.9969,  -8.9540,  -8.9318,  -8.9222,  -8.9255,\n",
      "         -8.9414,  -8.9674,  -9.0056,  -9.0523,  -9.1078,  -9.1709,  -9.2385,\n",
      "         -9.3167,  -9.3965,  -9.4766,  -9.5612,  -9.6376,  -9.7082,  -9.7641,\n",
      "         -9.8025,  -9.8202,  -9.8154])\n",
      "\n",
      "output_50000_60000_20241224_164257:\n",
      "tensor([-13.3435, -13.3436, -13.3088, -13.2362, -13.1345, -13.0095, -12.8667,\n",
      "        -12.7069, -12.5430, -12.3674, -12.1872, -12.0040, -11.8178, -11.6290,\n",
      "        -11.4342, -11.2392, -11.0435, -10.8493, -10.6511, -10.4587, -10.2699,\n",
      "        -10.0860,  -9.9134,  -9.7484,  -9.5951,  -9.4565,  -9.3294,  -9.2206,\n",
      "         -9.1286,  -9.0556,  -8.9969,  -8.9540,  -8.9318,  -8.9222,  -8.9255,\n",
      "         -8.9414,  -8.9674,  -9.0056,  -9.0523,  -9.1078,  -9.1709,  -9.2385,\n",
      "         -9.3167,  -9.3965,  -9.4766,  -9.5612,  -9.6376,  -9.7082,  -9.7641,\n",
      "         -9.8025,  -9.8202,  -9.8154])\n",
      "\n",
      "Max differences between batches:\n",
      "Max difference between output_0_10000_20241224_164101 and output_20000_30000_20241224_164200: 0.000000\n",
      "Max difference between output_0_10000_20241224_164101 and output_50000_60000_20241224_164257: 0.000000\n",
      "Max difference between output_20000_30000_20241224_164200 and output_50000_60000_20241224_164257: 0.000000\n"
     ]
    }
   ],
   "source": [
    "import torch\n",
    "import os\n",
    "\n",
    "# Load the three new models\n",
    "model_paths = [\n",
    "    'results/output_0_10000_20241224_164101/model.pt',\n",
    "    'results/output_20000_30000_20241224_164200/model.pt',\n",
    "    'results/output_50000_60000_20241224_164257/model.pt'\n",
    "]\n",
    "\n",
    "initial_phis = []\n",
    "batch_info = []\n",
    "\n",
    "# Load each model and extract initial phi\n",
    "for path in model_paths:\n",
    "    checkpoint = torch.load(path)\n",
    "    initial_phi = checkpoint['initial_phi']\n",
    "    initial_phis.append(initial_phi)\n",
    "    \n",
    "    # Get batch info from path\n",
    "    dir_name = os.path.basename(os.path.dirname(path))\n",
    "    batch_info.append(dir_name)\n",
    "\n",
    "# Compare initial phis for signature 1, disease 0\n",
    "k, d = 1, 0\n",
    "print(\"\\nComparing Signature 1, Disease 0 trajectories:\")\n",
    "for i, batch in enumerate(batch_info):\n",
    "    print(f\"\\n{batch}:\")\n",
    "    print(initial_phis[i][k, d, :])\n",
    "\n",
    "# Calculate max differences between batches\n",
    "print(\"\\nMax differences between batches:\")\n",
    "for i in range(len(initial_phis)):\n",
    "    for j in range(i+1, len(initial_phis)):\n",
    "        diff = torch.abs(initial_phis[i] - initial_phis[j]).max()\n",
    "        print(f\"Max difference between {batch_info[i]} and {batch_info[j]}: {diff:.6f}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/2f/nxrbr3pn1msgrl4ffyj33zd00000gn/T/ipykernel_68206/2180824174.py:16: FutureWarning: You are using `torch.load` with `weights_only=False` (the current default value), which uses the default pickle module implicitly. It is possible to construct malicious pickle data which will execute arbitrary code during unpickling (See https://github.com/pytorch/pytorch/blob/main/SECURITY.md#untrusted-models for more details). In a future release, the default value for `weights_only` will be flipped to `True`. This limits the functions that could be executed during unpickling. Arbitrary objects will no longer be allowed to be loaded via this mode unless they are explicitly allowlisted by the user via `torch.serialization.add_safe_globals`. We recommend you start setting `weights_only=True` for any use case where you don't have full control of the loaded file. Please open an issue on GitHub for any issues related to this experimental feature.\n",
      "  checkpoint = torch.load(path)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Comparing Signature 1, Disease 0 trajectories:\n",
      "\n",
      "output_0_10000_20241224_171453:\n",
      "tensor([-12.2693, -12.1499, -12.0072, -11.8431, -11.6656, -11.4857, -11.3074,\n",
      "        -11.1378, -10.9805, -10.8397, -10.7154, -10.6142, -10.5262, -10.4544,\n",
      "        -10.3995, -10.3559, -10.3243, -10.3016, -10.2877, -10.2804, -10.2773,\n",
      "        -10.2789, -10.2834, -10.2937, -10.3035, -10.3189, -10.3354, -10.3528,\n",
      "        -10.3720, -10.3968, -10.4239, -10.4554, -10.4842, -10.5209, -10.5584,\n",
      "        -10.5980, -10.6410, -10.6872, -10.7393, -10.7962, -10.8606, -10.9313,\n",
      "        -11.0110, -11.0984, -11.1896, -11.2868, -11.3819, -11.4768, -11.5602,\n",
      "        -11.6376, -11.6913, -11.7301])\n",
      "\n",
      "output_20000_30000_20241224_171556:\n",
      "tensor([-12.2693, -12.1499, -12.0072, -11.8431, -11.6656, -11.4857, -11.3074,\n",
      "        -11.1378, -10.9805, -10.8397, -10.7154, -10.6142, -10.5262, -10.4544,\n",
      "        -10.3995, -10.3559, -10.3243, -10.3016, -10.2877, -10.2804, -10.2773,\n",
      "        -10.2789, -10.2834, -10.2937, -10.3035, -10.3189, -10.3354, -10.3528,\n",
      "        -10.3720, -10.3968, -10.4239, -10.4554, -10.4842, -10.5209, -10.5584,\n",
      "        -10.5980, -10.6410, -10.6872, -10.7393, -10.7962, -10.8606, -10.9313,\n",
      "        -11.0110, -11.0984, -11.1896, -11.2868, -11.3819, -11.4768, -11.5602,\n",
      "        -11.6376, -11.6913, -11.7301])\n",
      "\n",
      "output_50000_60000_20241224_171658:\n",
      "tensor([-12.2693, -12.1499, -12.0072, -11.8431, -11.6656, -11.4857, -11.3074,\n",
      "        -11.1378, -10.9805, -10.8397, -10.7154, -10.6142, -10.5262, -10.4544,\n",
      "        -10.3995, -10.3559, -10.3243, -10.3016, -10.2877, -10.2804, -10.2773,\n",
      "        -10.2789, -10.2834, -10.2937, -10.3035, -10.3189, -10.3354, -10.3528,\n",
      "        -10.3720, -10.3968, -10.4239, -10.4554, -10.4842, -10.5209, -10.5584,\n",
      "        -10.5980, -10.6410, -10.6872, -10.7393, -10.7962, -10.8606, -10.9313,\n",
      "        -11.0110, -11.0984, -11.1896, -11.2868, -11.3819, -11.4768, -11.5602,\n",
      "        -11.6376, -11.6913, -11.7301])\n",
      "\n",
      "Max differences between batches:\n",
      "Max difference between output_0_10000_20241224_171453 and output_20000_30000_20241224_171556: 0.000000\n",
      "Max difference between output_0_10000_20241224_171453 and output_50000_60000_20241224_171658: 0.000000\n",
      "Max difference between output_20000_30000_20241224_171556 and output_50000_60000_20241224_171658: 0.000000\n"
     ]
    }
   ],
   "source": [
    "import torch\n",
    "import os\n",
    "\n",
    "# Load the three new models\n",
    "model_paths = [\n",
    "    'results/output_0_10000_20241224_171453/model.pt',\n",
    "    'results/output_20000_30000_20241224_171556/model.pt',\n",
    "    'results/output_50000_60000_20241224_171658/model.pt'\n",
    "]\n",
    "\n",
    "initial_phis = []\n",
    "batch_info = []\n",
    "\n",
    "# Load each model and extracret initial phi\n",
    "for path in model_paths:\n",
    "    checkpoint = torch.load(path)\n",
    "    initial_phi = checkpoint['initial_phi']\n",
    "    initial_phis.append(initial_phi)\n",
    "    \n",
    "    # Get batch info from path\n",
    "    dir_name = os.path.basename(os.path.dirname(path))\n",
    "    batch_info.append(dir_name)\n",
    "\n",
    "# Compare initial phis for signature 1, disease 0\n",
    "k, d = 1, 0\n",
    "print(\"\\nComparing Signature 1, Disease 0 trajectories:\")\n",
    "for i, batch in enumerate(batch_info):\n",
    "    print(f\"\\n{batch}:\")\n",
    "    print(initial_phis[i][k, d, :])\n",
    "\n",
    "# Calculate max differences between batches\n",
    "print(\"\\nMax differences between batches:\")\n",
    "for i in range(len(initial_phis)):\n",
    "    for j in range(i+1, len(initial_phis)):\n",
    "        diff = torch.abs(initial_phis[i] - initial_phis[j]).max()\n",
    "        print(f\"Max difference between {batch_info[i]} and {batch_info[j]}: {diff:.6f}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "import torch\n",
    "import os\n",
    "\n",
    "# Load the three new models\n",
    "model_paths = [\n",
    "    '/Users/sarahurbut/Downloads/cloud2/output_0_10000_20241224_224725/model.pt',\n",
    "    '/Users/sarahurbut/Downloads/cloud2/output_20000_30000_20241224_225111/model.pt',\n",
    "    '/Users/sarahurbut/Downloads/cloud2/output_10000_20000_20241224_224913/model.pt'\n",
    "]\n",
    "\n",
    "\n",
    "initial_phis = []\n",
    "batch_info = []\n",
    "\n",
    "# Load each model and extracret initial phi\n",
    "for path in model_paths:\n",
    "    checkpoint = torch.load(path)\n",
    "    initial_phi = checkpoint['initial_phi']\n",
    "    initial_phis.append(initial_phi)\n",
    "    \n",
    "    # Get batch info from path\n",
    "    dir_name = os.path.basename(os.path.dirname(path))\n",
    "    batch_info.append(dir_name)\n",
    "\n",
    "# Compare initial phis for signature 1, disease 0\n",
    "k, d = 1, 0\n",
    "print(\"\\nComparing Signature 1, Disease 0 trajectories:\")\n",
    "for i, batch in enumerate(batch_info):\n",
    "    print(f\"\\n{batch}:\")\n",
    "    print(initial_phis[i][k, d, :])\n",
    "\n",
    "# Calculate max differences between batches\n",
    "print(\"\\nMax differences between batches:\")\n",
    "for i in range(len(initial_phis)):\n",
    "    for j in range(i+1, len(initial_phis)):\n",
    "        diff = torch.abs(initial_phis[i] - initial_phis[j]).max()\n",
    "        print(f\"Max difference between {batch_info[i]} and {batch_info[j]}: {diff:.6f}\")"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "new_env_pyro2",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.21"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
